id,adj.P.Val.xBirA.over.NoBirA,AveExpr.xBirA.over.NoBirA,Log.P.Value.xBirA.over.NoBirA,logFC.xBirA.over.NoBirA,P.Value.xBirA.over.NoBirA,t.xBirA.over.NoBirA,Liver_Searched..126.126.127.128.129.130.131..No_BirA_4.multimedian,Liver_Searched..127.126.127.128.129.130.131..No_BirA_5.multimedian,Liver_Searched..129.126.127.128.129.130.131..No_BirA_6.multimedian,Liver_Searched..128.126.127.128.129.130.131..XBirA_2.multimedian,Liver_Searched..130.126.127.128.129.130.131..XBirA_3.multimedian,Liver_Searched..131.126.127.128.129.130.131..XBirA_1.multimedian,id.query,id.mapped,id.concat,accession_number,geneSymbol,numColumnsProteinObserved,numSpectraProteinObserved,numPepsUnique,numPepsUniqueSubgroupSpecificCI,accession_numbers,species,protein_mw,percentCoverage,groupNum,subgroupNum,scoreUnique,scoreUniqueSubgroupSpecificCI,orfCategory,sequenceLength,entry_name,cellular_component,biological_process,molecular_function,Liver_Searched.unique_peptides,Liver_Searched.numSpectra,Liver_Searched.totalIntensity,Liver_Searched.pct_cov
Q8VDD5,0.584741827,-0.139,6.626357834,0.39,0.217452406,1.362917937,0.024,0.01,-1.036,-0.02,0.158,0.03,Q8VDD5,Myh9,Q8VDD5_Myh9,Q8VDD5,Myh9,1,2802,342,273,Q8VDD5|F2Z494|A2AQP0|B1AR69|E9Q264,MOUSE,227566.2,85,1,1.1,5253.84,4294.33,,1960,Myosin-9,stress fiber|ruffle|uropod|nucleus|cytoplasm|actomyosin contractile ring|cytosol|plasma membrane|brush border|cell-cell adherens junction|cell cortex|actin cytoskeleton|membrane|myosin complex|myosin II complex|cortical cytoskeleton|cell leading edge|cleavage furrow|actomyosin|protein complex|extracellular exosome|myosin II filament|immunological synapse|spindle|plasma membrane|focal adhesion|COP9 signalosome|integrin complex|neuromuscular junction|,"meiotic spindle organization|cell morphogenesis involved in differentiation|cytokinesis|angiogenesis|in utero embryonic development|establishment of T cell polarity|membrane protein ectodomain proteolysis|phagocytosis, engulfment|cell adhesion|myoblast fusion|regulation of cell shape|protein transport|single organismal cell-cell adhesion|actin filament-based movement|platelet formation|monocyte differentiation|actomyosin structure organization|actin cytoskeleton reorganization|uropod organization|blood vessel endothelial cell migration|establishment of meiotic spindle localization|platelet aggregation|negative regulation of actin filament severing|positive regulation of protein processing in phagocytic vesicle|actin filament polymerization|actin filament capping|",microfilament motor activity|actin binding|protein binding|calmodulin binding|ATP binding|ATPase activity|protein domain specific binding|actin-dependent ATPase activity|protein homodimerization activity|protein anchor|ADP binding|poly(A) RNA binding|actin filament binding|,343,2802,1.12E+13,85.0%
E9QPE7,0.430366134,-0.219833333,9.789405344,0.866333333,0.104968615,1.87742327,-0.751,0.306,-1.514,0.486,-0.294,0.448,E9QPE7,Myh11,E9QPE7_Myh11,E9QPE7,Myh11,1,50,234,13,E9QPE7,MOUSE,224209.2,76.9,1,1.2,3358.94,219.28,,1938,Myosin-11,myosin complex|extracellular exosome|,metabolic process|elastic fiber assembly|cardiac muscle fiber development|regulation of mitochondrion degradation|,motor activity|actin binding|ATP binding|structural constituent of muscle|,13,50,35400000000,5.6%
O08638,0.502661212,-0.110333333,8.165395902,0.458666667,0.152566931,1.616076711,-0.357,0.225,-0.887,0.131,-0.136,0.362,O08638,NotFound,O08638_NotFound,O08638,Myh11,1,20,222,7,O08638,MOUSE,227879.9,73.1,1,1.3,3111.83,91.01,,1972,Myosin-11,stress fiber|muscle myosin complex|brush border|myosin complex|myofibril|smooth muscle contractile fiber|myosin filament|melanosome|extracellular exosome|,smooth muscle contraction|metabolic process|skeletal muscle myosin thick filament assembly|elastic fiber assembly|cardiac muscle fiber development|activation of mitophagy in response to mitochondrial depolarization|,motor activity|actin binding|calmodulin binding|ATP binding|structural constituent of muscle|,7,20,8620000000,2.4%
Q3UH59,0.689434001,-0.148666667,4.714099369,0.35,0.337745882,1.033263941,-0.064,0.226,-1.133,-0.151,0.188,0.042,Q3UH59,Myh10,Q3UH59_Myh10,Q3UH59,Myh10,1,311,182,113,Q3UH59|Q61879|Q5SV64|Q8BXF2,MOUSE,234472.2,65.7,1,1.4,2489.89,1586.46,,2013,Myosin-10,stress fiber|nucleus|cytoplasm|mitochondrion|cell cortex|actin cytoskeleton|myosin complex|myosin II complex|axon|growth cone|midbody|cleavage furrow|actomyosin|neuron projection|neuronal cell body|dendritic spine|extracellular exosome|myosin II filament|spindle|plasma membrane|neuromuscular junction|,"mitotic cytokinesis|in utero embryonic development|neuron migration|plasma membrane repair|exocytosis|substrate-dependent cell migration, cell extension|nuclear migration|axonogenesis|axon guidance|brain development|adult heart development|metabolic process|cell proliferation|regulation of cell shape|fourth ventricle development|lateral ventricle development|third ventricle development|cerebellar Purkinje cell layer development|actin cytoskeleton organization|actin filament-based movement|myofibril assembly|actomyosin structure organization|neuron projection development|neuromuscular process controlling balance|cardiac myofibril assembly|ventricular cardiac muscle cell development|retina development in camera-type eye|",microfilament motor activity|protein binding|ATP binding|actin-dependent ATPase activity|ADP binding|actin filament binding|,113,311,1.15E+11,48.6%
Q6URW6,0.309308638,-0.031166667,12.55243799,0.372333333,0.055559228,2.318908872,-0.023,-0.071,-0.558,0.039,0.17,0.256,Q6URW6,Myh14,Q6URW6_Myh14,Q6URW6,Myh14,1,9,140,3,Q6URW6|K3W4R2,MOUSE,229494.5,56.5,1,1.5,1974.38,42.03,,2000,Myosin-14,stress fiber|cytoplasm|brush border|membrane|myosin complex|myosin II complex|axon|growth cone|actomyosin|myelin sheath|extracellular exosome|myosin II filament|,skeletal muscle contraction|skeletal muscle tissue development|sensory perception of sound|metabolic process|regulation of cell shape|neuronal action potential|actin filament-based movement|actomyosin structure organization|mitochondrion morphogenesis|vocalization behavior|,microfilament motor activity|calmodulin binding|ATP binding|actin-dependent ATPase activity|actin filament binding|actin-dependent ATPase activity|actin filament binding|,3,9,695000000,1.0%
Q6URW6-2,0.200960775,-0.113666667,15.90693128,0.557333333,0.025662967,2.865260882,-0.142,-0.191,-0.844,0.086,0.171,0.238,Q6URW6,Myh14,Q6URW6-2_Myh14,Q6URW6-2,Myh14,1,6,139,2,Q6URW6-2|Q6URW6-3,MOUSE,228667.6,56.3,1,1.6,1954.93,22.58,,2000,Isoform 2 of Myosin-14,stress fiber|cytoplasm|brush border|membrane|myosin complex|myosin II complex|axon|growth cone|actomyosin|myelin sheath|extracellular exosome|myosin II filament|,skeletal muscle contraction|skeletal muscle tissue development|sensory perception of sound|metabolic process|regulation of cell shape|neuronal action potential|actin filament-based movement|actomyosin structure organization|mitochondrion morphogenesis|vocalization behavior|,microfilament motor activity|calmodulin binding|ATP binding|actin-dependent ATPase activity|actin filament binding|actin-dependent ATPase activity|actin filament binding|,2,6,541000000,0.6%
Q8C196,0.895316777,-0.043666667,1.655896475,-0.097333333,0.682983721,-0.426911368,0.266,0.27,-0.521,-0.002,-0.011,-0.264,Q8C196,Cps1,Q8C196_Cps1,Q8C196,Cps1,1,3698,193,193,Q8C196,MOUSE,165813.2,88,2,2.1,3323.4,3323.4,,1500,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",nucleolus|cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial nucleoid|protein complex|,urea cycle|glycogen catabolic process|'de novo' pyrimidine nucleobase biosynthetic process|proteolysis|arginine biosynthetic process|glutamine metabolic process|midgut development|response to toxic substance|response to zinc ion|response to amine|triglyceride catabolic process|response to food|response to lipopolysaccharide|response to drug|response to starvation|response to amino acid|cellular response to fibroblast growth factor stimulus|positive regulation of vasodilation|nitric oxide metabolic process|homocysteine metabolic process|anion homeostasis|response to growth hormone|hepatocyte differentiation|carbamoyl phosphate biosynthetic process|cellular response to cAMP|cellular response to glucagon stimulus|cellular response to oleic acid|response to dexamethasone|,carbamoyl-phosphate synthase (ammonia) activity|carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity|endopeptidase activity|calcium ion binding|protein binding|ATP binding|phospholipid binding|glutamate binding|protein complex binding|modified amino acid binding|,193,3698,1.12E+14,88.0%
Q9JHU4,0.520760306,-0.007,7.809480389,-0.145333333,0.165596808,-1.555947626,0.153,0.057,-0.013,0.021,-0.13,-0.13,Q9JHU4,Dync1h1,Q9JHU4_Dync1h1,Q9JHU4,Dync1h1,1,666,218,218,Q9JHU4,MOUSE,534774.4,51.4,3,3.1,3031.9,3031.9,,4644,Cytoplasmic dynein 1 heavy chain 1,cytoplasm|centrosome|cytoplasmic dynein complex|microtubule|membrane|filopodium|extracellular exosome|,cilium movement|transport|metabolic process|cytoplasmic mRNA processing body assembly|stress granule assembly|establishment of spindle localization|,microtubule motor activity|protein binding|ATP binding|ATPase activity|poly(A) RNA binding|dynein light intermediate chain binding|,218,666,5.37E+11,51.4%
Q9QXS1,0.218345207,-0.013666667,15.21590667,0.421333333,0.030089109,2.751007572,-0.276,0.02,-0.417,-0.028,0.327,0.292,Q9QXS1,Plec,Q9QXS1_Plec,Q9QXS1,Plec,1,575,232,227,Q9QXS1|Q9QXS1-2|Q9QXS1-8|Q9QXS1-7|Q9QXS1-6|Q9QXS1-14|Q9QXS1-4|Q9QXS1-16|Q9QXS1-5|Q9QXS1-3|Q9QXS1-13|Q9QXS1-11|Q9QXS1-12|Q9QXS1-9|Q9QXS1-10|Q9QXS1-15|E9Q3W4,MOUSE,536118,52.8,4,4.1,2963.28,2894.71,,4691,Plectin,cytoplasm|brush border|focal adhesion|hemidesmosome|sarcolemma|contractile fiber|intermediate filament cytoskeleton|extracellular exosome|,hemidesmosome assembly|,actin binding|protein binding|structural constituent of muscle|ankyrin binding|poly(A) RNA binding|,232,575,1.92E+11,53.0%
Q8R0W0,0.247122038,0.003333333,14.2856325,0.270666667,0.037276639,2.592620327,-0.241,-0.115,-0.04,-0.001,0.185,0.232,Q8R0W0,Eppk1,Q8R0W0_Eppk1,Q8R0W0,Eppk1,1,136,68,65,Q8R0W0|E9QPN6|Q3ULM0,MOUSE,727450.5,12.4,4,4.2,817.32,764.05,,6548,Epiplakin,cytoplasm|cytoskeleton|,,poly(A) RNA binding|,65,136,22900000000,12.1%
P19096,0.234120725,-0.066,14.67208604,0.456,0.034102907,2.661811246,-0.153,-0.061,-0.668,0.271,0.144,0.071,P19096,Fasn,P19096_Fasn,P19096,Fasn,1,737,153,153,P19096|A0A0U1RNJ1,MOUSE,275162,67.8,5,5.1,2328.71,2328.71,,2504,Fatty acid synthase,cytoplasm|mitochondrion|Golgi apparatus|plasma membrane|membrane|melanosome|glycogen granule|extracellular exosome|,osteoblast differentiation|acetyl-CoA metabolic process|fatty acid biosynthetic process|mammary gland development|oxidation-reduction process|cellular response to interleukin-4|,"[acyl-carrier-protein] S-acetyltransferase activity|[acyl-carrier-protein] S-malonyltransferase activity|3-oxoacyl-[acyl-carrier-protein] synthase activity|3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity|3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity|enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity|oleoyl-[acyl-carrier-protein] hydrolase activity|drug binding|zinc ion binding|myristoyl-[acyl-carrier-protein] hydrolase activity|palmitoyl-[acyl-carrier-protein] hydrolase activity|protein homodimerization activity|poly(A) RNA binding|enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity|3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity|NADPH binding|",153,737,7.7E+11,67.8%
Q3UQ44,0.693581167,-0.006166667,4.649591744,-0.126333333,0.34280001,-1.021705911,0.221,0.101,-0.151,0.032,-0.059,-0.181,Q3UQ44,Iqgap2,Q3UQ44_Iqgap2,Q3UQ44,Iqgap2,1,648,138,131,Q3UQ44|Q3UQP1,MOUSE,181209.2,74,6,6.1,2131.02,2052.03,,1575,Ras GTPase-activating-like protein IQGAP2,cytoplasm|microtubule|microvillus|cell surface|lamellipodium|filopodium|extracellular exosome|filamentous actin|,small GTPase mediated signal transduction|Arp2/3 complex-mediated actin nucleation|positive regulation of GTPase activity|thrombin receptor signaling pathway|,"GTPase activator activity|calmodulin binding|phosphatidylinositol-3,4,5-trisphosphate binding|Rho GTPase binding|Rac GTPase binding|actin filament binding|Arp2/3 complex binding|",138,648,5.42E+11,74.0%
Q9JKF1,0.907855509,0.0165,1.486517175,-0.051,0.710147042,-0.38806068,-0.001,-0.126,0.253,0.15,-0.121,-0.056,Q9JKF1,Iqgap1,Q9JKF1_Iqgap1,Q9JKF1,Iqgap1,1,72,42,35,Q9JKF1,MOUSE,189537.7,31,6,6.2,510.27,431.28,,1657,Ras GTPase-activating-like protein IQGAP1,nucleoplasm|cytoplasm|microtubule|plasma membrane|cell-cell junction|focal adhesion|membrane|lateral plasma membrane|cell junction|axon|growth cone|midbody|ribonucleoprotein complex|extrinsic component of cytoplasmic side of plasma membrane|cell leading edge|slit diaphragm|cytoplasmic ribonucleoprotein granule|neuron projection|extracellular exosome|actin cytoskeleton|microtubule cytoskeleton|,epidermal growth factor receptor signaling pathway|small GTPase mediated signal transduction|fibroblast growth factor receptor signaling pathway|negative regulation of dephosphorylation|cellular response to platelet-derived growth factor stimulus|positive regulation of GTPase activity|cellular response to fibroblast growth factor stimulus|positive regulation of protein kinase activity|platelet-derived growth factor receptor signaling pathway|cellular response to calcium ion|cellular response to epidermal growth factor stimulus|positive regulation of protein serine/threonine kinase activity|glomerular visceral epithelial cell development|neuron projection extension|,"GTPase activator activity|protein binding|calmodulin binding|phosphatidylinositol-3,4,5-trisphosphate binding|Rho GTPase binding|protein kinase binding|protein phosphatase binding|protein complex binding|protein serine/threonine kinase activator activity|Rac GTPase binding|",35,72,7950000000,27.8%
E9QPD7,0.020834966,-0.019,28.18049677,-0.534,0.001520374,-5.15246082,0.192,0.225,0.327,-0.413,-0.31,-0.135,E9QPD7,Pcx,E9QPD7_Pcx,E9QPD7,Pcx,1,2040,130,130,E9QPD7|G5E8R3|Q05920,MOUSE,130571.1,88.8,7,7.1,2071.98,2071.98,,1179,Pyruvate carboxylase,mitochondrion|,pyruvate metabolic process|gluconeogenesis|negative regulation of gene expression|viral RNA genome packaging|positive regulation by host of viral release from host cell|,DNA binding|biotin carboxylase activity|pyruvate carboxylase activity|ATP binding|biotin binding|metal ion binding|,130,2040,4.67E+13,88.8%
Q8BI84,0.000181451,-0.346,58.31188351,2.748,1.47507E-06,16.11413111,-1.636,-1.561,-1.963,0.722,1.186,1.176,Q8BI84,Mia3,Q8BI84_Mia3,Q8BI84,Mia3,1,616,138,77,Q8BI84|Q8BI84-2|Q8BI84-3,MOUSE,214298.7,59.3,8,8.1,2019.99,1208.71,,1930,Transport and Golgi organization protein 1 homolog,endoplasmic reticulum membrane|membrane|integral component of membrane|intracellular membrane-bounded organelle|,chondrocyte development|positive regulation of leukocyte migration|exocytosis|negative regulation of cell adhesion|protein transport|collagen fibril organization|negative regulation of cell migration|positive regulation of bone mineralization|wound healing|,,138,616,7.13E+11,59.3%
E9Q4Z2,0.662092914,0.015333333,5.149950694,0.204,0.30549558,1.110477541,0.072,-0.179,-0.153,0.284,-0.281,0.349,E9Q4Z2,Acacb,E9Q4Z2_Acacb,E9Q4Z2,Acacb,1,639,134,117,E9Q4Z2,MOUSE,278141.4,60.1,9,9.1,1970.91,1731.28,,2448,Acetyl-CoA carboxylase 2,nucleus|mitochondrion|endomembrane system|membrane|,acetyl-CoA metabolic process|fatty acid biosynthetic process|positive regulation of lipid storage|negative regulation of fatty acid oxidation|protein homotetramerization|positive regulation of heart growth|malonyl-CoA biosynthetic process|,acetyl-CoA carboxylase activity|biotin carboxylase activity|ATP binding|metal ion binding|,134,639,6.45E+11,60.1%
Q5SWU9,0.892090805,-0.013,1.725176907,0.048,0.672174928,0.442393988,0.079,-0.019,-0.171,0.12,-0.115,0.028,Q5SWU9,Acaca,Q5SWU9_Acaca,Q5SWU9,Acaca,1,436,131,114,Q5SWU9|Q5SWU9-2,MOUSE,266849.4,58.5,9,9.2,1889.2,1649.57,,2345,Acetyl-CoA carboxylase 1,nucleolus|cytoplasm|mitochondrion|cytosol|actin cytoskeleton|extracellular exosome|,tissue homeostasis|acetyl-CoA metabolic process|lipid metabolic process|fatty acid biosynthetic process|multicellular organismal protein metabolic process|protein homotetramerization|lipid homeostasis|cellular response to prostaglandin E stimulus|malonyl-CoA biosynthetic process|,acetyl-CoA carboxylase activity|biotin carboxylase activity|protein binding|ATP binding|metal ion binding|,114,436,2.2E+11,51.2%
P16546,0.140457009,0.016833333,17.97694978,0.487,0.015933274,3.214774699,-0.111,-0.14,-0.429,0.047,0.224,0.51,P16546,NotFound,P16546_NotFound,P16546,Sptan1,1,412,145,1,P16546|P08032,MOUSE,285391,58.5,10,10.1,1950.27,4.57,,2472,"Spectrin alpha chain, non-erythrocytic 1",fascia adherens|microtubule cytoskeleton|membrane|lateral plasma membrane|Z disc|cortical cytoskeleton|cuticular plate|paranode region of axon|myelin sheath|intracellular membrane-bounded organelle|extracellular exosome|extracellular vesicle|,actin filament capping|,actin binding|calcium ion binding|protein binding|calmodulin binding|spectrin binding|protein heterodimerization activity|,146,412,1.52E+11,58.5%
Q91ZX7,0.000181451,-0.153833333,58.39703809,1.535,1.44643E-06,15.89265058,-0.895,-0.83,-1.039,0.524,0.648,0.669,Q91ZX7,Lrp1,Q91ZX7_Lrp1,Q91ZX7,Lrp1,1,444,131,131,A0A0R4J0I9|Q91ZX7|Q3U5J2|D3Z5M3,MOUSE,523675.1,36.3,11,11.1,1744.7,1744.7,,4545,Prolow-density lipoprotein receptor-related protein 1,nucleolus|cytoplasm|lysosomal membrane|integral component of plasma membrane|coated pit|focal adhesion|membrane|receptor complex|perinuclear region of cytoplasm|,receptor-mediated endocytosis|cholesterol metabolic process|positive regulation of cholesterol efflux|negative regulation of smooth muscle cell migration|negative regulation of Wnt signaling pathway|positive regulation of lipid transport|regulation of cholesterol transport|regulation of phospholipase A2 activity|regulation of actin cytoskeleton organization|aorta morphogenesis|apoptotic cell clearance|beta-amyloid clearance|negative regulation of platelet-derived growth factor receptor-beta signaling pathway|,calcium ion binding|protein binding|protein complex binding|apolipoprotein binding|poly(A) RNA binding|,131,444,1.52E+11,36.3%
Q62261,0.179289466,0.009333333,16.6378378,0.469333333,0.021687836,2.987346757,-0.126,-0.084,-0.466,0.024,0.236,0.472,Q62261,Sptbn1,Q62261_Sptbn1,Q62261,Sptbn1,1,388,121,9,Q62261|A2ASS6-3|Q91XZ2,MOUSE,275074,49.4,12,12.1,1599.58,119.63,,2363,"Spectrin beta chain, non-erythrocytic 1",nucleus|nucleolus|cytoplasm|plasma membrane|spectrin|membrane|axolemma|cortical cytoskeleton|M band|cuticular plate|extracellular exosome|neuronal postsynaptic density|,mitotic cytokinesis|plasma membrane organization|common-partner SMAD protein phosphorylation|SMAD protein import into nucleus|Golgi to plasma membrane protein transport|actin filament capping|membrane assembly|protein targeting to plasma membrane|positive regulation of interleukin-2 secretion|regulation of protein localization to plasma membrane|positive regulation of protein localization to plasma membrane|,actin binding|structural constituent of cytoskeleton|protein binding|calmodulin binding|phospholipid binding|ankyrin binding|poly(A) RNA binding|GTPase binding|,124,388,1.4E+11,49.4%
Q62261-2,0.522251937,-0.0125,7.781458107,0.215,0.166668754,1.553586757,-0.043,-0.033,-0.284,0.17,-0.148,0.263,Q62261,Sptbn1,Q62261-2_Sptbn1,Q62261-2,Sptbn1,1,4,115,2,Q62261-2,MOUSE,251893.6,51.2,12,12.2,1512.62,27.45,,2363,"Isoform 2 of Spectrin beta chain, non-erythrocytic 1",nucleus|nucleolus|cytoplasm|plasma membrane|spectrin|membrane|axolemma|cortical cytoskeleton|M band|cuticular plate|extracellular exosome|neuronal postsynaptic density|,mitotic cytokinesis|plasma membrane organization|common-partner SMAD protein phosphorylation|SMAD protein import into nucleus|Golgi to plasma membrane protein transport|actin filament capping|membrane assembly|protein targeting to plasma membrane|positive regulation of interleukin-2 secretion|regulation of protein localization to plasma membrane|positive regulation of protein localization to plasma membrane|,actin binding|structural constituent of cytoskeleton|protein binding|calmodulin binding|phospholipid binding|ankyrin binding|poly(A) RNA binding|GTPase binding|,2,4,84900000,1.4%
Q68FG2,0.457962014,-0.059166667,9.18783527,0.330333333,0.120563674,1.781038343,-0.203,0.099,-0.569,-0.068,0.105,0.281,Q68FG2,Sptbn2,Q68FG2_Sptbn2,Q68FG2,Sptbn2,1,272,109,98,Q68FG2,MOUSE,272173.4,54.2,12,12.3,1551.46,1404.61,,2388,Spectrin beta chain,photoreceptor inner segment|extracellular space|cytoplasm|plasma membrane|spectrin|apical plasma membrane|cell junction|neuronal cell body|,synapse assembly|vesicle-mediated transport|cerebellar Purkinje cell layer morphogenesis|adult behavior|multicellular organism growth|,actin binding|structural constituent of cytoskeleton|phospholipid binding|,98,272,2.94E+11,49.4%
A2ASS6,0.189605832,-0.035166667,16.33482694,-0.453,0.023255052,-2.936570559,0.068,0.406,0.1,-0.531,-0.149,-0.105,A2ASS6,NotFound,A2ASS6_NotFound,A2ASS6,Ttn,1,8,9,6,A2ASS6|E9Q8K5|E9Q8N1|A2ASS6-2,MOUSE,3935740.7,0.3,12,12.5,54.19,30.82,,35213,Titin,nucleus|cytoplasm|,somitogenesis|protein phosphorylation|heart development|regulation of relaxation of cardiac muscle|,protein serine/threonine kinase activity|protein binding|calmodulin binding|ATP binding|ankyrin binding|metal ion binding|,6,8,2820000000,0.2%
Q8CC88,0.51414471,0.017833333,7.942088776,-0.241,0.160616857,-1.579775176,0.358,0.216,-0.159,0.004,-0.071,-0.241,Q8CC88,Vwa8,Q8CC88_Vwa8,Q8CC88,Vwa8,1,409,104,36,Q8CC88|Q8CC88-3,MOUSE,214501.4,58.7,13,13.1,1589.05,523.53,,1905,von Willebrand factor A domain-containing protein 8,extracellular region|mitochondrion|,metabolic process|,ATP binding|ATPase activity|,104,409,2.6E+11,58.7%
Q8CC88-2,0.392624283,-0.019833333,10.55291887,-0.308333333,0.088045692,-1.999381678,0.325,0.16,-0.082,-0.09,-0.01,-0.422,Q8CC88,Vwa8,Q8CC88-2_Vwa8,Q8CC88-2,Vwa8,1,6,69,2,Q8CC88-2,MOUSE,116696.4,67.7,13,13.2,1080.89,29.67,,1905,Isoform 2 of von Willebrand factor A domain-containing protein 8,extracellular region|mitochondrion|,metabolic process|,ATP binding|ATPase activity|,2,6,3570000000,2.7%
Q80X90,0.864103982,0.000833333,2.166154912,-0.043,0.60727375,-0.539086151,0.051,0.023,-0.007,0.028,-0.037,-0.053,Q80X90,Flnb,Q80X90_Flnb,Q80X90,Flnb,1,331,112,105,Q80X90,MOUSE,280272.8,51.6,14,14.1,1559.58,1456.59,,2602,Filamin-B,stress fiber|cytoplasm|plasma membrane|brush border|focal adhesion|cell cortex|Z disc|extracellular exosome|,keratinocyte development|epithelial cell morphogenesis|skeletal muscle tissue development|actin cytoskeleton organization|,actin binding|protein binding|identical protein binding|poly(A) RNA binding|,112,331,91200000000,51.6%
Q8BTM8,0.993378838,0.028833333,0.112220469,-0.005,0.974491271,-0.03320335,-0.114,-0.084,0.292,0.175,-0.176,0.08,Q8BTM8,Flna,Q8BTM8_Flna,Q8BTM8,Flna,1,144,59,53,Q8BTM8|B7FAU9|Q8BTM8-2,MOUSE,284069.1,27.9,14,14.2,779.93,707.8,,2647,Filamin-A,nucleus|nucleolus|cytoplasm|trans-Golgi network|plasma membrane|brush border|focal adhesion|cell cortex|actin cytoskeleton|membrane|Myb complex|actin filament bundle|extracellular exosome|,epithelial to mesenchymal transition|adenylate cyclase-inhibiting dopamine receptor signaling pathway|negative regulation of transcription from RNA polymerase I promoter|actin cytoskeleton organization|actin cytoskeleton reorganization|protein localization to cell surface|negative regulation of protein catabolic process|cilium assembly|positive regulation of transcription factor import into nucleus|negative regulation of apoptotic process|receptor clustering|positive regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of sequence-specific DNA binding transcription factor activity|early endosome to late endosome transport|establishment of protein localization|protein stabilization|cytoplasmic sequestering of protein|actin crosslink formation|platelet aggregation|mitotic spindle assembly|positive regulation of substrate adhesion-dependent cell spreading|positive regulation of integrin-mediated signaling pathway|,glycoprotein binding|actin binding|signal transducer activity|protein kinase C binding|protein binding|transcription factor binding|Rho GTPase binding|Ral GTPase binding|small GTPase binding|Fc-gamma receptor I complex binding|protein homodimerization activity|poly(A) RNA binding|Rac GTPase binding|actin filament binding|,53,144,28600000000,26.4%
Q8VHX6,0.029284048,-0.1125,26.44275633,0.837,0.002268425,4.810221481,-0.652,-0.767,-0.174,0.313,0.454,0.151,Q8VHX6,Flnc,Q8VHX6_Flnc,Q8VHX6,Flnc,1,4,11,2,Q8VHX6|Q8VHX6-2,MOUSE,293738.4,4.3,14,14.3,135.64,9.4,,2726,Filamin-C,cytoplasm|plasma membrane|focal adhesion|actin cytoskeleton|Z disc|sarcolemma|,actin filament-based process|muscle fiber development|,actin binding|cytoskeletal protein binding|ankyrin binding|actin filament binding|,2,4,225000000,0.9%
P01027,0.020324029,-0.005166667,28.32186306,0.775666667,0.001471681,5.212266409,-0.445,-0.487,-0.247,0.246,0.225,0.677,P01027,C3,P01027_C3,P01027,C3,1,423,106,90,P01027|P01027-2,MOUSE,188021,65.4,15,15.1,1534.94,1345.96,,1663,Complement C3,extracellular space|extracellular exosome|blood microparticle|,"positive regulation of type IIa hypersensitivity|positive regulation of protein phosphorylation|positive regulation of activation of membrane attack complex|tolerance induction|fatty acid metabolic process|inflammatory response|complement activation|complement activation, alternative pathway|complement activation, classical pathway|blood coagulation|positive regulation of vascular endothelial growth factor production|positive regulation of glucose transport|regulation of triglyceride biosynthetic process|positive regulation of lipid storage|negative regulation of endopeptidase activity|response to magnesium ion|response to estradiol|response to progesterone|positive regulation of G-protein coupled receptor protein signaling pathway|positive regulation of angiogenesis|positive regulation of developmental growth|positive regulation of phagocytosis|response to glucocorticoid|positive regulation of ERK1 and ERK2 cascade|positive regulation of apoptotic cell clearance|",endopeptidase inhibitor activity|protein binding|lipid binding|C5L2 anaphylatoxin chemotactic receptor binding|cofactor binding|,106,423,3.52E+11,65.4%
Q8CGC7,0.461918472,0.001333333,9.057014003,-0.156,0.12425063,-1.757105239,0.13,0.114,-0.006,0.003,-0.122,-0.111,Q8CGC7,Eprs,Q8CGC7_Eprs,Q8CGC7,Eprs,1,423,101,101,Q8CGC7|A0A0A6YWA4,MOUSE,171844.7,62.8,16,16.1,1427.45,1427.45,,1512,Bifunctional glutamate/proline--tRNA ligase,cytoplasm|membrane|aminoacyl-tRNA synthetase multienzyme complex|ribonucleoprotein complex|GAIT complex|,glutamyl-tRNA aminoacylation|prolyl-tRNA aminoacylation|negative regulation of translation|cellular response to interferon-gamma|,glutamate-tRNA ligase activity|proline-tRNA ligase activity|ATP binding|RNA stem-loop binding|GTPase binding|,101,423,2.56E+11,62.8%
Q5SXR6,0.551084904,0.077333333,7.242374775,-0.356666667,0.188695925,-1.465165241,-0.208,0.21,0.765,-0.291,-0.027,0.015,Q5SXR6,NotFound,Q5SXR6_NotFound,Q5SXR6,Cltc,1,380,93,93,Q5SXR6|Q68FD5,MOUSE,193751.2,62.2,17,17.1,1416.61,1416.61,,1679,Clathrin heavy chain,cytoplasm|mitochondrion|spindle|focal adhesion|membrane|membrane coat|clathrin coat of trans-Golgi network vesicle|clathrin coat of coated pit|clathrin-coated vesicle|Myb complex|intracellular membrane-bounded organelle|protein complex|extracellular exosome|clathrin complex|extracellular vesicle|,osteoblast differentiation|intracellular protein transport|receptor-mediated endocytosis|mitotic nuclear division|receptor internalization|transferrin transport|mitotic spindle assembly|negative regulation of hyaluronan biosynthetic process|negative regulation of protein localization to plasma membrane|,double-stranded RNA binding|structural molecule activity|protein binding|clathrin light chain binding|poly(A) RNA binding|,93,380,2.75E+11,62.2%
Q9JKR6,0.000368062,-0.2285,52.60537405,1.879666667,5.48861E-06,13.14039737,-1.091,-1.011,-1.403,0.618,0.604,0.912,Q9JKR6,Hyou1,Q9JKR6_Hyou1,Q9JKR6,Hyou1,1,525,91,91,Q9JKR6|E0CYZ2,MOUSE,111407.3,67.3,18,18.1,1403.79,1403.79,,999,Hypoxia up-regulated protein 1,extracellular region|endoplasmic reticulum lumen|focal adhesion|membrane|endoplasmic reticulum chaperone complex|extracellular exosome|,response to ischemia|response to endoplasmic reticulum stress|negative regulation of apoptotic process|cellular response to hypoxia|negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway|negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway|,ATP binding|,91,525,9.72E+11,67.3%
Q8VDJ3,0.576085848,0.002166667,6.843298901,-0.121,0.206856947,-1.397350558,0.011,0.133,0.044,0.001,-0.13,-0.046,Q8VDJ3,Hdlbp,Q8VDJ3_Hdlbp,Q8VDJ3,Hdlbp,1,447,97,97,Q8VDJ3|A0A087WP83,MOUSE,142310.9,66.7,19,19.1,1378.25,1378.25,,1268,Vigilin,nucleus|cytoplasm|high-density lipoprotein particle|,lipid transport|cholesterol metabolic process|,poly(A) RNA binding|,97,447,5.2E+11,66.7%
P08113,0.000498463,-0.308666667,49.86527973,1.986,1.03151E-05,11.90335676,-1.164,-1.064,-1.677,0.646,0.681,0.726,P08113,Hsp90b1,P08113_Hsp90b1,P08113,Hsp90b1,1,635,87,85,P08113,MOUSE,92759.4,70.6,20,20.1,1370.58,1332.82,,802,Endoplasmin,extracellular region|nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|cytosol|plasma membrane|focal adhesion|membrane|midbody|extracellular matrix|endoplasmic reticulum chaperone complex|melanosome|perinuclear region of cytoplasm|extracellular exosome|,"response to hypoxia|protein folding|ER-associated ubiquitin-dependent protein catabolic process|retrograde protein transport, ER to cytosol|actin rod assembly|negative regulation of apoptotic process|regulation of phosphoprotein phosphatase activity|cellular response to ATP|",RNA binding|protein binding|ATP binding|protein phosphatase binding|virion binding|low-density lipoprotein particle receptor binding|unfolded protein binding|,87,635,1.97E+12,70.6%
P11499,0.720877135,-0.022833333,4.21648727,0.105666667,0.378748806,0.942746561,-0.039,0.074,-0.262,0.103,-0.032,0.019,P11499,Hsp90ab1,P11499_Hsp90ab1,P11499,Hsp90ab1,1,309,81,53,P11499|E9PX27,MOUSE,83622,77.6,20,20.2,1189.09,779.84,,724,Heat shock protein HSP 90-beta,intracellular|cytoplasm|mitochondrion|cytosol|cell surface|membrane|inclusion body|basolateral plasma membrane|apical plasma membrane|brush border membrane|melanosome|extracellular exosome|COP9 signalosome|,"placenta development|protein folding|response to salt stress|virion attachment to host cell|positive regulation of protein binding|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of protein import into nucleus, translocation|negative regulation of neuron apoptotic process|positive regulation of nitric oxide biosynthetic process|positive regulation of cell size|regulation of interferon-gamma-mediated signaling pathway|regulation of type I interferon-mediated signaling pathway|cellular response to interleukin-4|cellular response to organic cyclic compound|positive regulation of protein serine/threonine kinase activity|fibril organization|",UTP binding|CTP binding|double-stranded RNA binding|protein binding|ATP binding|GTP binding|sulfonylurea receptor binding|kinase binding|protein kinase binding|MHC class II protein complex binding|nitric-oxide synthase regulator activity|TPR domain binding|dATP binding|ion channel binding|poly(A) RNA binding|unfolded protein binding|,53,309,7.14E+11,60.0%
P07901,0.946747465,-0.013833333,0.793441262,-0.037,0.833020854,-0.219304321,-0.286,0.325,-0.025,-0.184,0.003,0.084,P07901,Hsp90aa1,P07901_Hsp90aa1,P07901,Hsp90aa1,1,141,58,32,P07901,MOUSE,85185.7,64.2,20,20.3,867.71,496.22,,733,Heat shock protein HSP 90-alpha,intracellular|nucleus|nucleoplasm|cytoplasm|mitochondrion|cytosol|membrane|ruffle membrane|melanosome|myelin sheath|extracellular exosome|,nitric oxide biosynthetic process|response to unfolded protein|response to cold|protein refolding|protein import into mitochondrial outer membrane|positive regulation of nitric oxide biosynthetic process|positive regulation of cytotoxic T cell differentiation|regulation of catalytic activity|chaperone-mediated protein complex assembly|,protein binding|ATP binding|ATPase activity|MHC class II protein complex binding|nitric-oxide synthase regulator activity|TPR domain binding|identical protein binding|protein homodimerization activity|poly(A) RNA binding|GTPase binding|unfolded protein binding|,32,141,87100000000,45.8%
Q9CQN1,0.951421295,-0.071166667,0.736275019,0.041666667,0.844058404,0.204565352,0.165,0.112,-0.553,0.084,-0.055,-0.18,Q9CQN1,Trap1,Q9CQN1_Trap1,Q9CQN1,Trap1,1,236,50,49,Q9CQN1,MOUSE,80549.8,66.2,20,20.4,765.6,748,,706,"Heat shock protein 75 kDa, mitochondrial",nucleoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial intermembrane space|mitochondrial matrix|lipid particle|membrane|extracellular exosome|,protein folding|response to stress|translational attenuation|negative regulation of cellular respiration|negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|,ATP binding|protein kinase binding|poly(A) RNA binding|unfolded protein binding|,49,236,2.36E+11,64.3%
P26039,0.856747233,-0.013333333,2.284830097,0.047333333,0.590904082,0.56435315,-0.03,0.037,-0.118,0.013,0.012,0.006,P26039,Tln1,P26039_Tln1,P26039,Tln1,1,277,89,81,P26039,MOUSE,271984.6,50.8,21,21.1,1356.34,1233.14,,2541,Talin-1,ruffle|cytoplasm|microtubule organizing center|plasma membrane|focal adhesion|cell surface|ruffle membrane|extracellular exosome|,cytoskeletal anchoring at plasma membrane|cell-substrate junction assembly|cortical actin cytoskeleton organization|platelet aggregation|,insulin receptor binding|integrin binding|structural constituent of cytoskeleton|protein binding|vinculin binding|LIM domain binding|actin filament binding|,89,277,79200000000,50.8%
E9PUM4,0.495960654,-0.005666667,8.290189905,0.14,0.148245326,1.633842849,-0.118,-0.093,-0.016,0.069,-0.007,0.131,E9PUM4,Tln2,E9PUM4_Tln2,E9PUM4,Tln2,1,23,25,17,A0A1L1SQ51|E9PUM4|Q71LX4|Q8CDM9,MOUSE,273944.6,13.8,21,21.2,321.83,198.63,,2542,Talin-2,ruffle|cytoskeleton|fascia adherens|focal adhesion|synapse|,cytoskeletal anchoring at plasma membrane|cell adhesion|,insulin receptor binding|structural constituent of cytoskeleton|actin filament binding|,17,23,524000000,10.0%
Q91ZA3,0.92551138,-0.025666667,1.100490729,-0.044666667,0.77615941,-0.296191131,0.116,0.198,-0.324,-0.134,0.006,-0.016,Q91ZA3,Pcca,Q91ZA3_Pcca,Q91ZA3,Pcca,1,1161,78,78,Q91ZA3,MOUSE,80547.9,81,22,22.1,1325.81,1325.81,,724,"Propionyl-CoA carboxylase alpha chain, mitochondrial",mitochondrion|mitochondrial matrix|,metabolic process|,biotin carboxylase activity|propionyl-CoA carboxylase activity|ATP binding|enzyme binding|metal ion binding|,78,1161,1.36E+13,81.0%
Q922D8,0.801983355,-0.0705,3.045429937,0.142333333,0.495971825,0.720314468,0.179,-0.033,-0.571,0.104,0.038,-0.14,Q922D8,Mthfd1,Q922D8_Mthfd1,Q922D8,Mthfd1,1,548,81,81,Q922D8|A0A1W2P733,MOUSE,101882.4,86,23,23.1,1314.62,1314.62,,935,"C-1-tetrahydrofolate synthase, cytoplasmic",mitochondrion|cytosol|membrane|extracellular exosome|,histidine biosynthetic process|neutrophil homeostasis|neural tube closure|purine nucleotide biosynthetic process|methionine metabolic process|one-carbon metabolic process|heart development|serine family amino acid metabolic process|serine family amino acid biosynthetic process|methionine biosynthetic process|10-formyltetrahydrofolate biosynthetic process|transsulfuration|tetrahydrofolate interconversion|oxidation-reduction process|somite development|,formate-tetrahydrofolate ligase activity|methenyltetrahydrofolate cyclohydrolase activity|methylenetetrahydrofolate dehydrogenase (NAD+) activity|methylenetetrahydrofolate dehydrogenase (NADP+) activity|ATP binding|,81,548,1.53E+12,86.0%
Q8R0Y6,0.5499389,0.051666667,7.304500915,0.212666667,0.186015832,1.475401015,-0.026,-0.056,-0.082,-0.059,0.463,0.07,Q8R0Y6,Aldh1l1,Q8R0Y6_Aldh1l1,Q8R0Y6,Aldh1l1,1,373,76,76,Q8R0Y6|A0A0N4SW56|Q8K009|D3Z6B9,MOUSE,99563.2,82.4,24,24.1,1217.26,1217.26,,902,Cytosolic 10-formyltetrahydrofolate dehydrogenase,mitochondrion|extracellular exosome|,one-carbon metabolic process|biosynthetic process|10-formyltetrahydrofolate catabolic process|methylation|oxidation-reduction process|,"aldehyde dehydrogenase (NAD) activity|protein binding|methyltransferase activity|formyltetrahydrofolate dehydrogenase activity|hydroxymethyl-, formyl- and related transferase activity|",77,373,3.94E+11,82.4%
Q91ZV0,0.00070612,-0.208,46.89050234,2.415333333,2.04621E-05,10.68238417,-1.235,-1.24,-1.772,0.584,1.231,1.184,Q91ZV0,Mia2,Q91ZV0_Mia2,Q91ZV0,Mia2,1,325,80,80,A0A1W2P711|Q91ZV0|H3BJS0|E9Q3S2|Q8R311|H3BKH2|H3BK48|E9PY90|H3BK44|H3BJI6|H3BL19|H3BKL6|Q91ZV0-2,MOUSE,157029.1,57.3,25,25.1,1195.21,1195.21,,1396,Melanoma inhibitory activity protein 2,extracellular region|endoplasmic reticulum exit site|,cholesterol homeostasis|triglyceride homeostasis|,,80,325,2.61E+11,57.3%
Q9DBM2,0.91325,-0.082,1.376829047,0.139333333,0.728311379,0.362447741,0.609,-0.023,-1.041,0.038,0.064,-0.139,Q9DBM2,Ehhadh,Q9DBM2_Ehhadh,Q9DBM2,Ehhadh,1,514,71,71,Q9DBM2,MOUSE,78870.6,84.4,26,26.1,1190.9,1190.9,,718,Peroxisomal bifunctional enzyme,mitochondrion|peroxisome|cytosol|,internal protein amino acid acetylation|fatty acid beta-oxidation|acyl-CoA metabolic process|,3-hydroxyacyl-CoA dehydrogenase activity|dodecenoyl-CoA delta-isomerase activity|enoyl-CoA hydratase activity|receptor binding|enzyme binding|,71,514,1.54E+12,84.4%
P63038,0.949381271,-0.082333333,0.774455144,0.049333333,0.836670556,0.214424849,0.255,0.033,-0.609,0.086,0.003,-0.262,P63038,Hspd1,P63038_Hspd1,P63038,Hspd1,1,601,68,68,P63038|P63038-2,MOUSE,61125.6,89.3,27,27.1,1178.39,1178.39,,573,"60 kDa heat shock protein, mitochondrial",extracellular space|cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial matrix|early endosome|rough endoplasmic reticulum|Golgi apparatus|cytosol|plasma membrane|coated pit|cell surface|membrane|mitochondrial crista|coated vesicle|secretory granule|zymogen granule|myelin sheath|intracellular membrane-bounded organelle|protein complex|membrane raft|lipopolysaccharide receptor complex|extracellular exosome|cyclin-dependent protein kinase activating kinase holoenzyme complex|,response to hypoxia|detection of misfolded protein|B cell cytokine production|MyD88-dependent toll-like receptor signaling pathway|positive regulation of T cell mediated immune response to tumor cell|activation of cysteine-type endopeptidase activity involved in apoptotic process|response to unfolded protein|response to heat|response to cold|response to lipopolysaccharide|positive regulation of interferon-alpha production|positive regulation of interferon-gamma production|positive regulation of interleukin-10 production|positive regulation of interleukin-12 production|positive regulation of interleukin-6 production|response to ATP|protein refolding|B cell proliferation|T cell activation|B cell activation|response to cocaine|response to drug|response to hydrogen peroxide|positive regulation of macrophage activation|positive regulation of apoptotic process|negative regulation of apoptotic process|negative regulation of neuron apoptotic process|response to estrogen|isotype switching to IgG isotypes|positive regulation of inflammatory response|protein stabilization|positive regulation of T cell activation|chaperone mediated protein folding requiring cofactor|,lipopolysaccharide binding|protease binding|p53 binding|double-stranded RNA binding|ATP binding|ubiquitin protein ligase binding|protein complex binding|insulin binding|poly(A) RNA binding|protein heterodimerization activity|chaperone binding|misfolded protein binding|,68,601,1.82E+12,89.3%
P09103,4.90594E-05,-0.683166667,78.61093289,3.219,1.37691E-08,32.12936514,-2.221,-2.207,-2.45,0.909,0.887,0.983,P09103,P4hb,P09103_P4hb,P09103,P4hb,1,503,74,72,P09103|P05307|A6H7J6|E9Q8G8,MOUSE,57456.8,85.8,28,28.1,1178.33,1157.15,,509,Protein disulfide-isomerase,endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|focal adhesion|external side of plasma membrane|procollagen-proline 4-dioxygenase complex|endoplasmic reticulum chaperone complex|melanosome|extracellular exosome|,protein folding|peptidyl-proline hydroxylation to 4-hydroxy-L-proline|response to endoplasmic reticulum stress|cell redox homeostasis|cellular response to hypoxia|regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|,protein disulfide isomerase activity|integrin binding|protein binding|enzyme binding|poly(A) RNA binding|protein heterodimerization activity|procollagen-proline 4-dioxygenase activity|peptidyl-proline 4-dioxygenase activity|,74,503,1.86E+12,85.8%
Q91W90,0.003267009,-0.201166667,37.84812411,1.857,0.00016413,7.623738239,-0.941,-0.794,-1.654,0.48,0.758,0.944,Q91W90,Txndc5,Q91W90_Txndc5,Q91W90,Txndc5,1,50,16,14,Q91W90|E9PXX7|A0A0R4J1Y7,MOUSE,47099.3,40.5,28,28.2,225.45,204.27,,417,Thioredoxin domain-containing protein 5,endoplasmic reticulum lumen|extracellular exosome|,protein folding|response to endoplasmic reticulum stress|apoptotic cell clearance|cell redox homeostasis|,protein disulfide isomerase activity|,14,50,16400000000,39.0%
Q99K67,0.34703809,0.014833333,11.51700111,-0.336333333,0.070517984,-2.153240822,0.357,0.297,-0.105,-0.286,0.041,-0.215,Q99K67,Aass,Q99K67_Aass,Q99K67,Aass,1,514,73,73,Q99K67,MOUSE,103714.6,76.3,29,29.1,1177.12,1177.12,,926,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",mitochondrion|intracellular membrane-bounded organelle|,generation of precursor metabolites and energy|L-lysine catabolic process|L-lysine catabolic process to acetyl-CoA via saccharopine|oxidation-reduction process|,"saccharopine dehydrogenase (NADP+, L-lysine-forming) activity|saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity|",73,514,1.47E+12,76.3%
O08601-2,0.000399949,-0.391166667,51.5741942,2.572333333,6.95954E-06,12.66148442,-1.509,-1.411,-2.112,1.014,0.983,0.688,O08601,Mttp,O08601-2_Mttp,O08601-2,Mttp,1,435,75,75,O08601-2|O08601,MOUSE,101433.7,73,30,30.1,1161.02,1161.02,,894,Isoform 2 of Microsomal triglyceride transfer protein large subunit,endoplasmic reticulum|rough endoplasmic reticulum|Golgi apparatus|basolateral plasma membrane|brush border membrane|microvillus membrane|membrane-bounded vesicle|receptor complex|,protein lipidation|lipid metabolic process|triglyceride metabolic process|lipid transport|circadian rhythm|cholesterol metabolic process|lipoprotein metabolic process|cholesterol homeostasis|lipoprotein transport|response to calcium ion|,lipid transporter activity|protein binding|lipid binding|apolipoprotein binding|protein heterodimerization activity|,75,435,6E+11,73.0%
P20029,0.000552294,-0.114166667,48.88160772,1.506333333,1.29372E-05,11.48618986,-0.851,-0.855,-0.896,0.532,0.474,0.911,P20029,Hspa5,P20029_Hspa5,P20029,Hspa5,1,632,73,70,P20029,MOUSE,72534.8,82.5,31,31.1,1141.03,1098.77,,655,78 kDa glucose-regulated protein,extracellular region|nucleus|mitochondrion|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|smooth endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|plasma membrane|focal adhesion|cell surface|membrane|integral component of endoplasmic reticulum membrane|midbody|endoplasmic reticulum chaperone complex|melanosome|myelin sheath|extracellular exosome|COP9 signalosome|,ER overload response|activation of signaling protein activity involved in unfolded protein response|cerebellum structural organization|cerebellar Purkinje cell layer development|substantia nigra development|positive regulation of cell migration|negative regulation of transforming growth factor beta receptor signaling pathway|positive regulation of protein ubiquitination|response to endoplasmic reticulum stress|maintenance of protein localization in endoplasmic reticulum|positive regulation of embryonic development|cellular response to glucose starvation|negative regulation of apoptotic process|proteolysis involved in cellular protein catabolic process|cellular response to antibiotic|cellular response to interleukin-4|toxin transport|,glycoprotein binding|protein binding|ATP binding|ATPase activity|enzyme binding|protein domain specific binding|ubiquitin protein ligase binding|ribosome binding|unfolded protein binding|misfolded protein binding|,73,632,2.17E+12,82.5%
P63017,0.497381785,-0.0375,8.234760416,0.181,0.150149524,1.625960199,-0.028,-0.022,-0.334,0.062,0.015,0.082,P63017,Hspa8,P63017_Hspa8,P63017,Hspa8,1,283,65,46,P63017|Q504P4,MOUSE,71098,79.7,31,31.2,1000.1,728.33,,646,Heat shock cognate 71 kDa protein,Prp19 complex|extracellular space|intracellular|nucleus|spliceosomal complex|nucleolus|cytosol|plasma membrane|focal adhesion|membrane|ribonucleoprotein complex|melanosome|myelin sheath|extracellular exosome|blood microparticle|ubiquitin ligase complex|,"transcription, DNA-templated|mRNA processing|protein folding|RNA splicing|protein refolding|negative regulation of transcription, DNA-templated|ATP metabolic process|positive regulation of mRNA splicing, via spliceosome|chaperone mediated protein folding requiring cofactor|regulation of cell cycle|clathrin coat disassembly|negative regulation of fibril organization|","G-protein coupled receptor binding|protein binding|ATP binding|ATPase activity|enzyme binding|MHC class II protein complex binding|heat shock protein binding|ubiquitin protein ligase binding|ATPase activity, coupled|poly(A) RNA binding|unfolded protein binding|C3HC4-type RING finger domain binding|",46,283,4.33E+11,62.5%
P17879,0.798009538,-0.003666667,3.092202852,-0.064,0.490658938,-0.729077314,0.089,0.076,-0.08,-0.058,-0.01,-0.039,P17879,Hspa1b,P17879_Hspa1b,P17879,Hspa1b,1,43,26,18,P17879|Q61696,MOUSE,70460.3,45.1,31,31.3,343.24,242.55,,642,Heat shock 70 kDa protein 1B,cytoplasm|,,protein binding|ATP binding|,18,43,5150000000,33.1%
P17156,0.911411213,0.007666667,1.419684939,-0.039333333,0.721159794,-0.37234312,-0.148,0.091,0.139,0.052,-0.034,-0.054,P17156,Hspa2,P17156_Hspa2,P17156,Hspa2,1,6,22,3,P17156,MOUSE,69925.7,28.1,31,31.4,283.54,27.22,,633,Heat shock-related 70 kDa protein 2,synaptonemal complex|male germ cell nucleus|nucleus|nucleoplasm|mitochondrion|cytosol|cell surface|membrane|CatSper complex|myelin sheath|extracellular exosome|blood microparticle|,positive regulation of protein phosphorylation|male meiosis|male meiosis I|spermatid development|response to cold|positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle|positive regulation of ATPase activity|protein refolding|synaptonemal complex disassembly|negative regulation of inclusion body assembly|positive regulation of calcium-transporting ATPase activity|,protein binding|ATP binding|enzyme binding|unfolded protein binding|glycolipid binding|,3,6,597000000,7.7%
E9PVA8,0.951665602,-0.005833333,0.718613783,0.023,0.847497882,0.199954243,0.07,0.037,-0.159,0.175,-0.099,-0.059,E9PVA8,Gcn1l1,E9PVA8_Gcn1l1,E9PVA8,Gcn1,1,194,90,90,E9PVA8,MOUSE,295811,40.5,32,32.1,1137.1,1137.1,,2671,eIF-2-alpha kinase activator GCN1,cytoplasm|membrane|,,protein binding|poly(A) RNA binding|,90,194,45500000000,40.5%
P58252,0.838867494,0.0005,2.542913112,-0.051,0.556812131,-0.618299343,-0.01,0.097,-0.009,-0.062,-0.016,0.003,P58252,Eef2,P58252_Eef2,P58252,Eef2,1,390,77,75,P58252,MOUSE,96282.3,79.7,33,33.1,1133.54,1113.54,,858,Elongation factor 2,cytoplasm|polysome|plasma membrane|membrane|aggresome|ribonucleoprotein complex|extracellular exosome|nucleus|,hematopoietic progenitor cell differentiation|translational elongation|positive regulation of translation|,translation elongation factor activity|GTPase activity|protein binding|GTP binding|protein kinase binding|poly(A) RNA binding|,77,390,6.23E+11,79.7%
A2AH85,0.963376742,0.028666667,0.502258317,-0.017333333,0.890787611,-0.142680656,-0.144,0.02,0.236,-0.008,-0.055,0.123,A2AH85,Eftud2,A2AH85_Eftud2,A2AH85,Eftud2,1,10,10,8,A2AH85|O08810|G3UZ34,MOUSE,110459.8,11.5,33,33.2,113.39,93.39,,972,116 kDa U5 small nuclear ribonucleoprotein component,nucleus|nucleoplasm|cytoplasm|Cajal body|membrane|nuclear speck|catalytic step 2 spliceosome|,translational elongation|,translation elongation factor activity|GTPase activity|GTP binding|poly(A) RNA binding|,8,10,138000000,10.3%
E9Q414,0.004483934,-0.072166667,36.2140297,0.829,0.00023911,7.143146532,-0.405,-0.346,-0.709,0.318,0.36,0.349,E9Q414,Apob,E9Q414_Apob,E9Q414,Apob,1,282,92,92,E9Q414,MOUSE,510791.9,20.9,34,34.1,1132.54,1132.54,,4505,Apolipoprotein B-100,extracellular region|cytoplasm|endoplasmic reticulum|Golgi apparatus|plasma membrane|vesicle membrane|actin cytoskeleton|vesicle lumen|mature chylomicron|very-low-density lipoprotein particle|low-density lipoprotein particle|intermediate-density lipoprotein particle|chylomicron|neuronal cell body|extracellular exosome|,in utero embryonic development|lipid metabolic process|triglyceride mobilization|spermatogenesis|nervous system development|cholesterol metabolic process|fertilization|response to virus|response to carbohydrate|post-embryonic development|response to selenium ion|positive regulation of gene expression|positive regulation of macrophage derived foam cell differentiation|positive regulation of lipid storage|positive regulation of cholesterol storage|lipid catabolic process|triglyceride catabolic process|cholesterol transport|sperm motility|response to lipopolysaccharide|cholesterol efflux|low-density lipoprotein particle remodeling|low-density lipoprotein particle clearance|lipoprotein metabolic process|lipoprotein biosynthetic process|lipoprotein catabolic process|cholesterol homeostasis|lipoprotein transport|regulation of cholesterol biosynthetic process|artery morphogenesis|cellular response to tumor necrosis factor|cellular response to prostaglandin stimulus|,phospholipid binding|heparin binding|cholesterol transporter activity|lipase binding|low-density lipoprotein particle receptor binding|,92,282,1.76E+11,20.9%
P16460,0.994928853,-0.0725,0.081092713,-0.005666667,0.98150096,-0.024076798,0.261,0.144,-0.614,-0.011,0.026,-0.241,P16460,Ass1,P16460_Ass1,P16460,Ass1,1,942,67,67,P16460,MOUSE,46868.9,95.8,35,35.1,1095.46,1095.46,,412,Argininosuccinate synthase,cytoplasm|mitochondrion|myelin sheath|extracellular exosome|,urea cycle|citrulline metabolic process|argininosuccinate metabolic process|arginine biosynthetic process|aspartate metabolic process|positive regulation of nitric oxide biosynthetic process|cellular response to laminar fluid shear stress|negative regulation of leukocyte cell-cell adhesion|,argininosuccinate synthase activity|ATP binding|amino acid binding|identical protein binding|poly(A) RNA binding|,67,942,2.17E+13,95.8%
Q03265,0.90651412,-0.022833333,1.522605178,-0.071,0.704270476,-0.396407872,0.177,0.253,-0.392,-0.055,0.021,-0.141,Q03265,Atp5a1,Q03265_Atp5a1,Q03265,Atp5a1,1,843,69,69,Q03265|D3Z6F5|D6RJ16,MOUSE,59865.6,86.6,36,36.1,1095.1,1095.1,,553,"ATP synthase subunit alpha, mitochondrial","mitochondrion|mitochondrial inner membrane|mitochondrial proton-transporting ATP synthase complex|plasma membrane|membrane|myelin sheath|proton-transporting ATP synthase complex, catalytic core F(1)|extracellular exosome|COP9 signalosome|",negative regulation of endothelial cell proliferation|lipid metabolic process|ATP synthesis coupled proton transport|ATP hydrolysis coupled proton transport|,"ATP binding|MHC class I protein binding|poly(A) RNA binding|proton-transporting ATP synthase activity, rotational mechanism|proton-transporting ATPase activity, rotational mechanism|ATPase activity|",69,843,1.02E+13,86.6%
Q8BWT1,0.953420192,-0.058166667,0.696906304,0.035,0.851744562,0.194331812,0.101,0.151,-0.479,0.041,-0.011,-0.152,Q8BWT1,Acaa2,Q8BWT1_Acaa2,Q8BWT1,Acaa2,1,902,59,59,Q8BWT1,MOUSE,42285.6,96.4,37,37.1,1073.17,1073.17,,397,"3-ketoacyl-CoA thiolase, mitochondrial",mitochondrion|mitochondrial inner membrane|extracellular exosome|,fatty acid metabolic process|cellular response to hypoxia|negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway|negative regulation of mitochondrial membrane permeability involved in apoptotic process|,acetyl-CoA C-acyltransferase activity|poly(A) RNA binding|,59,902,8.56E+12,96.4%
P20152,0.875118284,0.0165,2.026982497,-0.049666667,0.627049391,-0.509057718,-0.109,0.083,0.15,0.016,-0.016,-0.025,P20152,Vim,P20152_Vim,P20152,Vim,1,200,54,45,P20152|A0A0A6YWC8|G3X981|P15331-2|G5E846|P15331|P15331-3|A0A0R4J036|P08553|P46660|D3YZ35|P19246|P08551,MOUSE,53743.8,88.6,38,38.2,748.74,626.69,,466,Vimentin,cytoplasm|peroxisome|cytosol|cytoskeleton|intermediate filament|plasma membrane|focal adhesion|cell leading edge|cell projection|neuron projection|type III intermediate filament|intermediate filament cytoskeleton|extracellular exosome|plasma membrane|,positive regulation of gene expression|negative regulation of neuron projection development|astrocyte development|intermediate filament-based process|intermediate filament organization|Bergmann glial cell differentiation|SMAD protein signal transduction|lens fiber cell development|,glycoprotein binding|double-stranded RNA binding|structural molecule activity|structural constituent of cytoskeleton|structural constituent of eye lens|protein binding|protein C-terminus binding|identical protein binding|scaffold protein binding|keratin filament binding|,45,200,2.52E+11,82.8%
P31001,0.654656582,0.006666667,5.265554352,0.126666667,0.297470953,1.130160333,-0.196,0.003,0.023,0.226,-0.039,0.023,P31001,Des,P31001_Des,P31001,Des,1,90,40,32,P31001,MOUSE,53553.9,71,38,38.3,528.32,418.36,,469,Desmin,intracellular|cytoplasm|cytoskeleton|fascia adherens|Z disc|neuromuscular junction|sarcolemma|contractile fiber|extracellular exosome|intermediate filament|,muscle organ development|,structural constituent of cytoskeleton|protein binding|cytoskeletal protein binding|identical protein binding|,32,90,38300000000,65.6%
Q6PB66,0.875832617,-0.050833333,2.006237712,0.085,0.63005176,0.504819181,0.157,0.006,-0.443,0.106,0.006,-0.137,Q6PB66,Lrpprc,Q6PB66_Lrpprc,Q6PB66,Lrpprc,1,239,70,70,Q6PB66,MOUSE,157867.1,56,39,39.1,1029.86,1029.86,,1392,"Leucine-rich PPR motif-containing protein, mitochondrial",condensed nuclear chromosome|nucleus|nuclear inner membrane|nuclear outer membrane|nucleoplasm|cytoplasm|mitochondrion|cytoskeleton|microtubule|membrane|ribonucleoprotein complex|mitochondrial nucleoid|perinuclear region of cytoplasm|mitochondrion|,"negative regulation of mitochondrial RNA catabolic process|transcription, DNA-templated|regulation of transcription, DNA-templated|mRNA transport|regulation of mitochondrial translation|",single-stranded DNA binding|RNA binding|protein binding|ubiquitin protein ligase binding|poly(A) RNA binding|beta-tubulin binding|actin filament binding|,70,239,69500000000,56.0%
Q99MR8,0.05611474,0.011666667,23.04629392,-0.407333333,0.004958732,-4.111437756,0.351,0.168,0.127,-0.133,-0.278,-0.165,Q99MR8,Mccc1,Q99MR8_Mccc1,Q99MR8,Mccc1,1,705,64,64,Q99MR8|A0A0G2JFQ5,MOUSE,79741.8,83.1,40,40.1,1028.28,1028.28,,717,"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial","3-methylcrotonyl-CoA carboxylase complex, mitochondrial|mitochondrion|mitochondrial inner membrane|mitochondrial matrix|",leucine catabolic process|,biotin carboxylase activity|methylcrotonoyl-CoA carboxylase activity|ATP binding|metal ion binding|methylcrotonoyl-CoA carboxylase activity|,64,705,3.29E+12,83.1%
E9Q6R7,0.726796323,-0.008166667,4.153538288,0.083,0.384278575,0.930811492,0.02,-0.04,-0.129,0.112,-0.026,0.014,E9Q6R7,Utrn,E9Q6R7_Utrn,E9Q6R7,Utrn,1,148,79,79,E9Q6R7|Q61636|A0A1W2P7C0,MOUSE,394866.7,29.2,41,41.1,1020.18,1020.18,,3430,Utrophin,nucleoplasm|cytoplasm|plasma membrane|dystrophin-associated glycoprotein complex|filopodium|filopodium membrane|neuromuscular junction|sarcolemma|protein complex|synapse|extracellular exosome|contractile ring|,positive regulation of cell-matrix adhesion|adult somatic muscle development|,actin binding|integrin binding|protein binding|zinc ion binding|vinculin binding|protein kinase binding|,79,148,23700000000,29.2%
Q8BMS1,0.926554478,-1.15648E-18,1.05887726,-0.043333333,0.783632202,-0.285983371,-0.134,0.137,0.062,-0.262,0.249,-0.052,Q8BMS1,Hadha,Q8BMS1_Hadha,Q8BMS1,Hadha,1,311,62,62,Q8BMS1,MOUSE,83353,76.6,42,42.1,1012.86,1012.86,,763,"Trifunctional enzyme subunit alpha, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial fatty acid beta-oxidation multienzyme complex|mitochondrial nucleoid|,fatty acid beta-oxidation|response to insulin|response to drug|,fatty-acyl-CoA binding|acetyl-CoA C-acyltransferase activity|enoyl-CoA hydratase activity|long-chain-enoyl-CoA hydratase activity|long-chain-3-hydroxyacyl-CoA dehydrogenase activity|protein complex binding|NAD binding|,62,311,3.28E+11,76.6%
Q8CIE6,0.450561932,0.009166667,9.371151309,-0.152333333,0.11558058,-1.807333529,0.009,0.119,0.128,-0.108,-0.074,-0.019,Q8CIE6,Copa,Q8CIE6_Copa,Q8CIE6,Copa,1,267,71,71,Q8CIE6|F8WHL2,MOUSE,140084,65.9,43,43.1,1004.68,1004.68,,1224,Coatomer subunit alpha,extracellular space|cytoplasm|membrane|COPI vesicle coat|extracellular exosome|,intracellular protein transport|vesicle-mediated transport|pancreatic juice secretion|,hormone activity|structural molecule activity|,71,267,2.31E+11,65.9%
E9QAX2,0.322603598,-0.0505,12.17720498,0.301,0.060573058,2.258783884,-0.049,-0.079,-0.475,0.101,0.043,0.156,E9QAX2,Myo18a,E9QAX2_Myo18a,E9QAX2,Myo18a,1,175,79,79,E9QAX2|Q9JMH9-6|Q9JMH9|B2RRE2|K3W4L0|Q9JMH9-1|Q9JMH9-4|A0A1C7ZN10|Q9JMH9-2|Q9JMH9-7|Q9JMH9-5|E9Q405|E9QA74,MOUSE,237125.2,41,44,44.1,1003.41,1003.41,,2083,Unconventional myosin-XVIIIa,Golgi membrane|trans-Golgi network|cytoskeleton|membrane|myosin complex|actomyosin|,Golgi organization|metabolic process|cell migration|actomyosin structure organization|negative regulation of apoptotic process|Golgi vesicle budding|positive regulation of protein secretion|Golgi ribbon formation|asymmetric Golgi ribbon formation|,motor activity|ATP binding|ADP binding|poly(A) RNA binding|actin filament binding|,79,175,52000000000,41.0%
O35488,0.766683359,-0.002333333,3.620634665,-0.123333333,0.434446731,-0.831896829,0.233,0.194,-0.249,-0.102,0.044,-0.134,O35488,Slc27a2,O35488_Slc27a2,O35488,Slc27a2,1,332,68,68,O35488|A2ANX6,MOUSE,71220,77.7,45,45.1,982.74,982.74,,620,Very long-chain acyl-CoA synthetase,mitochondrion|peroxisome|peroxisomal membrane|integral component of peroxisomal membrane|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|integral component of endoplasmic reticulum membrane|extracellular exosome|,very long-chain fatty acid metabolic process|fatty acid alpha-oxidation|long-chain fatty acid metabolic process|fatty acid beta-oxidation|bile acid biosynthetic process|fatty acid transport|very long-chain fatty acid catabolic process|long-chain fatty acid import|methyl-branched fatty acid metabolic process|,long-chain fatty acid-CoA ligase activity|receptor binding|ATP binding|fatty acid transporter activity|enzyme binding|very long-chain fatty acid-CoA ligase activity|phytanate-CoA ligase activity|pristanate-CoA ligase activity|,68,332,5.93E+11,77.7%
P08003,0.000492789,-0.447333333,50.14056946,2.562666667,9.68151E-06,12.02257613,-1.572,-1.401,-2.213,0.73,0.81,0.962,P08003,Pdia4,P08003_Pdia4,P08003,Pdia4,1,338,67,66,A0A0R4J0Z1|P08003|F1MEN8|Q29RV1,MOUSE,72323.4,70.5,46,46.1,980.42,964.42,,638,Protein disulfide-isomerase A4,endoplasmic reticulum|endoplasmic reticulum lumen|cell surface|endoplasmic reticulum chaperone complex|melanosome|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|chaperone-mediated protein folding|,protein disulfide isomerase activity|poly(A) RNA binding|,66,338,3.87E+11,70.5%
Q8BHN3-2,0.000128795,-0.317,61.52698621,2.213333333,7.0356E-07,18.06148774,-1.353,-1.266,-1.652,0.711,0.807,0.851,Q8BHN3,Ganab,Q8BHN3-2_Ganab,Q8BHN3-2,Ganab,1,314,63,4,Q8BHN3-2|Q8BHN3-3,MOUSE,109858.4,62.4,47,47.1,966.89,67.36,,944,Isoform 2 of Neutral alpha-glucosidase AB,endoplasmic reticulum|Golgi apparatus|membrane|glucosidase II complex|melanosome|extracellular exosome|,N-glycan processing|,"protein binding|glucosidase activity|carbohydrate binding|glucan 1,3-alpha-glucosidase activity|poly(A) RNA binding|",63,314,3.91E+11,62.4%
Q8BHN3,4.99445E-05,-0.963166667,69.41385684,3.893,1.1445E-07,23.85260202,-2.682,-2.783,-3.264,0.892,1,1.058,Q8BHN3,Ganab,Q8BHN3_Ganab,Q8BHN3,Ganab,1,11,60,2,Q8BHN3,MOUSE,107365.6,62,47,47.2,921.27,33.49,,944,Neutral alpha-glucosidase AB,endoplasmic reticulum|Golgi apparatus|membrane|glucosidase II complex|melanosome|extracellular exosome|,N-glycan processing|,"protein binding|glucosidase activity|carbohydrate binding|glucan 1,3-alpha-glucosidase activity|poly(A) RNA binding|",2,11,11700000000,5.0%
J3QQ16,0.836873322,0.0315,2.572702893,0.073666667,0.553005831,0.624757409,-0.05,-0.011,0.045,0.294,-0.055,-0.034,J3QQ16,Col6a3,J3QQ16_Col6a3,J3QQ16,Col6a3,1,212,75,75,J3QQ16|A0A087WS16|E9PWQ3,MOUSE,290173.5,31.3,48,48.1,966.8,966.8,,2677,"Collagen, type VI, alpha 3",proteinaceous extracellular matrix|collagen trimer|extracellular space|extracellular matrix|sarcolemma|extracellular exosome|extracellular vesicle|extracellular matrix|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,75,212,1.18E+11,31.3%
A0A286YCV9,0.878981958,-0.002833333,1.968900026,-0.042333333,0.635491868,-0.496392873,0.03,0.09,-0.065,-0.007,-0.063,-0.002,A0A286YCV9,Kif13b,A0A286YCV9_Kif13b,A0A286YCV9,Kif13b,1,201,72,70,A0A286YCV9|E9Q4K7|Q9EQW7|F8VQ75|A0A1D5RMD4|B1AVY7,MOUSE,206307.4,42.4,49,49.1,946.99,917.13,,1847,Kinesin family member 13B,,,,72,201,42600000000,42.4%
E9Q9B0,0.778792734,-0.0125,3.412878723,0.084333333,0.455734732,0.791661941,0.036,0.015,-0.215,0.126,-0.056,0.019,E9Q9B0,NotFound,E9Q9B0_NotFound,E9Q9B0,Kif1c,1,23,18,13,E9Q9B0|O35071|Q3V3Y9,MOUSE,124612.2,20.7,49,49.2,255.3,181.18,,1112,Kinesin-like protein KIF1C,Golgi apparatus|kinesin complex|microtubule|,"retrograde vesicle-mediated transport, Golgi to ER|microtubule-based movement|metabolic process|cytoskeleton-dependent intracellular transport|","ATP binding|microtubule binding|ATP-dependent microtubule motor activity, plus-end-directed|poly(A) RNA binding|",13,23,786000000,16.3%
Q60575-2,0.823136545,0.053,2.716053839,-0.072,0.535050305,-0.653871866,0.024,-0.027,0.27,0.107,-0.047,-0.009,Q60575,Kif1b,Q60575-2_Kif1b,Q60575-2,Kif1b,1,4,15,4,Q60575-2|Q60575|A0A087WQE8|E9Q9G6|G3UW47|Q6TA13|P33173|E9QAN4,MOUSE,200228.9,12.2,49,49.3,169.64,28.79,,1816,Isoform 2 of Kinesin-like protein KIF1B,mitochondrion|kinesin complex|microtubule|microtubule associated complex|cytoplasmic vesicle membrane|cytoplasmic vesicle|neuron projection|,microtubule-based movement|neuron-neuron synaptic transmission|neuromuscular synaptic transmission|anterograde axon cargo transport|metabolic process|embryo development|vesicle-mediated transport|cytoskeleton-dependent intracellular transport|mitochondrion transport along microtubule|,"microtubule motor activity|protein binding|ATP binding|microtubule binding|ATP-dependent microtubule motor activity, plus-end-directed|ATPase activity|",4,4,103000000,3.0%
Q60575-3,0.994928853,-0.0755,0.078368431,0.007666667,0.982116838,0.023275053,0.196,0.396,-0.83,-0.254,0.249,-0.21,Q60575,Kif1b,Q60575-3_Kif1b,Q60575-3,Kif1b,1,7,13,2,Q60575-3|A2AH75,MOUSE,131262.1,16.2,49,49.4,152.44,11.59,,1816,Isoform 3 of Kinesin-like protein KIF1B,mitochondrion|kinesin complex|microtubule|microtubule associated complex|cytoplasmic vesicle membrane|cytoplasmic vesicle|neuron projection|,microtubule-based movement|neuron-neuron synaptic transmission|neuromuscular synaptic transmission|anterograde axon cargo transport|metabolic process|embryo development|vesicle-mediated transport|cytoskeleton-dependent intracellular transport|mitochondrion transport along microtubule|,"microtubule motor activity|protein binding|ATP binding|microtubule binding|ATP-dependent microtubule motor activity, plus-end-directed|ATPase activity|",2,7,5.51E+11,2.1%
Q80TF6,0.980828826,-0.032666667,0.297667577,-0.011333333,0.933755649,-0.086331742,-0.019,0.188,-0.25,-0.005,-0.146,0.036,Q80TF6,NotFound,Q80TF6_NotFound,Q80TF6,Stard9,1,6,4,3,Q80TF6,MOUSE,506167.6,1.2,49,49.5,32.8,17.26,,4561,StAR-related lipid transfer protein 9,nucleus|nucleoplasm|cytoplasm|Golgi apparatus|centriole|kinesin complex|,microtubule-based movement|metabolic process|spindle assembly|,"microtubule motor activity|ATP binding|microtubule binding|lipid binding|ATP-dependent microtubule motor activity, plus-end-directed|",3,6,1160000000,1.0%
P58281-2,0.779399555,-0.0665,3.405332197,0.149,0.456527329,0.790662964,0.113,0.01,-0.546,0.158,0.006,-0.14,P58281,Opa1,P58281-2_Opa1,P58281-2,Opa1,1,220,62,62,P58281-2|P58281|H7BX01|E0CXD1,MOUSE,116104.3,57.8,50,50.1,944.63,944.63,,960,"Isoform 2 of Dynamin-like 120 kDa protein, mitochondrial",nucleoplasm|cytoplasm|mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|mitochondrial intermembrane space|membrane|integral component of membrane|mitochondrial crista|dendrite|,mitochondrial genome maintenance|neural tube closure|apoptotic process|mitochondrion organization|inner mitochondrial membrane organization|visual perception|mitochondrial fusion|metabolic process|negative regulation of release of cytochrome c from mitochondria|cellular senescence|negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|negative regulation of intrinsic apoptotic signaling pathway|,GTPase activity|protein binding|GTP binding|,62,220,89900000000,57.8%
Q9WTI7-3,0.419278528,-0.073166667,9.985793293,0.408333333,0.100327657,1.908821586,0.008,-0.087,-0.753,0.1,0.308,-0.015,Q9WTI7,Myo1c,Q9WTI7-3_Myo1c,Q9WTI7-3,Myo1c,1,268,67,1,Q9WTI7-3|Q9WTI7-2|Q8CG29|G3V011,MOUSE,120673.1,57.2,52,52.1,930.26,13.87,,1063,Isoform 3 of Unconventional myosin-Ic,ruffle|nuclear pore|nucleoplasm|nucleolus|cytoplasm|mitochondrion|cytosol|plasma membrane|microvillus|brush border|basal plasma membrane|membrane|cytoplasmic membrane-bounded vesicle|lateral plasma membrane|filamentous actin|stereocilium|membrane raft|myosin I complex|stereocilium membrane|extracellular exosome|,protein targeting|protein targeting to membrane|transport|metabolic process|positive regulation of cell migration|positive regulation of cell migration by vascular endothelial growth factor signaling pathway|mRNA transport|positive regulation of protein targeting to membrane|positive regulation of vascular endothelial growth factor signaling pathway|regulation of bicellular tight junction assembly|,motor activity|actin binding|receptor binding|protein binding|calmodulin binding|ATP binding|phospholipid binding|protein C-terminus binding|Ral GTPase binding|actin-dependent ATPase activity|,68,268,1.62E+11,57.2%
Q7TQD7,0.732049775,-0.1425,4.066968403,0.271666667,0.392015428,0.915588697,0.177,-0.07,-0.942,0.176,0.097,-0.293,Q7TQD7,Myo1b,Q7TQD7_Myo1b,Q7TQD7,Myo1b,1,174,56,49,Q7TQD7|P46735|E9Q580|E9QNH6|P46735-2,MOUSE,133078.5,48.1,52,52.3,819.16,734.48,,1136,Myo1b protein,early endosome|actin filament|plasma membrane|brush border|endosome membrane|myosin complex|filopodium|perinuclear region of cytoplasm|extracellular exosome|trans-Golgi network membrane|,post-Golgi vesicle-mediated transport|actin filament organization|metabolic process|actin filament-based movement|actin filament bundle assembly|,"microfilament motor activity|ATP binding|phosphatidylinositol-4,5-bisphosphate binding|phosphatidylinositol-3,4,5-trisphosphate binding|actin-dependent ATPase activity|actin filament binding|",49,174,1.07E+11,44.1%
E9Q634,0.922738081,0.0155,1.142734814,-0.032333333,0.76864626,-0.306365918,-0.039,0.209,-0.075,0.046,-0.058,0.01,E9Q634,Myo1e,E9Q634_Myo1e,E9Q634,Myo1e,1,33,17,15,E9Q634|A0A1L1STM1,MOUSE,127443.2,19.7,52,52.4,201.37,180.23,,1107,Unconventional myosin-Ie,cytoplasm|cytoskeleton|brush border|cell-cell junction|adherens junction|myosin complex|extracellular exosome|clathrin-coated endocytic vesicle|,vasculogenesis|in utero embryonic development|kidney development|glomerular filtration|nitrogen compound metabolic process|endocytosis|hemopoiesis|glomerular basement membrane development|post-embryonic hemopoiesis|platelet-derived growth factor receptor signaling pathway|glomerular visceral epithelial cell development|,"motor activity|calmodulin binding|ATP binding|phosphatidylinositol binding|ATPase activity, coupled|actin filament binding|",15,33,12400000000,18.1%
O88329,0.022289725,-0.089666667,27.83755371,-0.786666667,0.001645298,-5.106664344,0.155,0.351,0.405,-0.616,-0.659,-0.174,O88329,Myo1a,O88329_Myo1a,O88329,Myo1a,1,4,8,2,O88329,MOUSE,119491.4,7.7,52,52.5,82.08,8.84,,1043,Unconventional myosin-Ia,cytoplasm|microvillus|brush border|basal plasma membrane|basolateral plasma membrane|apical plasma membrane|lateral plasma membrane|myosin complex|growth cone|cortical actin cytoskeleton|cell leading edge|filamentous actin|neuronal cell body|plasma membrane raft|,sensory perception of sound|metabolic process|cell projection organization|microvillus assembly|regulation of protein localization|vesicle localization|,motor activity|calmodulin binding|ATP binding|actin filament binding|,2,4,1620000000,2.8%
Q6P5E4,0.000151804,-0.282166667,59.90321852,2.111,1.02253E-06,17.05132264,-1.252,-1.209,-1.552,0.648,0.805,0.867,Q6P5E4,Uggt1,Q6P5E4_Uggt1,Q6P5E4,Uggt1,1,212,62,62,Q6P5E4|G3UZU8,MOUSE,177115,47.3,53,53.1,915.56,915.56,,1551,UDP-glucose:glycoprotein glucosyltransferase 1,endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|extracellular exosome|,protein glycosylation|UDP-glucosylation|,UDP-glucose:glycoprotein glucosyltransferase activity|protein binding|unfolded protein binding|,62,212,1.05E+11,47.3%
Q8CGK3,0.804910693,-0.0715,3.022657923,0.147666667,0.498579259,0.715798842,0.097,0.043,-0.576,0.22,-0.02,-0.193,Q8CGK3,Lonp1,Q8CGK3_Lonp1,Q8CGK3,Lonp1,1,237,59,59,Q8CGK3,MOUSE,106411.3,74.1,54,54.1,907.69,907.69,,949,"Lon protease homolog, mitochondrial",cytoplasm|mitochondrion|mitochondrial matrix|membrane|mitochondrial nucleoid|,response to hypoxia|proteolysis|misfolded or incompletely synthesized protein catabolic process|mitochondrion organization|aging|response to hormone|response to aluminum ion|cellular response to oxidative stress|chaperone-mediated protein complex assembly|protein homooligomerization|proteolysis involved in cellular protein catabolic process|oxidation-dependent protein catabolic process|regulation of mitochondrial DNA replication|,single-stranded DNA binding|single-stranded RNA binding|ATP-dependent peptidase activity|serine-type endopeptidase activity|ATP binding|ATPase activity|ADP binding|sequence-specific DNA binding|G-quadruplex DNA binding|DNA polymerase binding|mitochondrial light strand promoter anti-sense binding|mitochondrial heavy strand promoter anti-sense binding|mitochondrial light strand promoter sense binding|mitochondrial heavy strand promoter sense binding|,59,237,1.73E+11,74.1%
P38647,0.883773419,-0.031333333,1.892877716,0.056666667,0.646713949,0.47990819,0.075,0.032,-0.286,-0.04,0.045,-0.014,P38647,Hspa9,P38647_Hspa9,P38647,Hspa9,1,357,57,57,P38647,MOUSE,73745.2,72.6,55,55.1,889.49,889.49,,679,"Stress-70 protein, mitochondrial",nucleolus|cytoplasm|mitochondrion|focal adhesion|mitochondrial nucleoid|myelin sheath|extracellular exosome|,protein folding|protein export from nucleus|response to toxic substance|cellular response to interleukin-1|,protein binding|ATP binding|fibroblast growth factor binding|enzyme binding|heat shock protein binding|ubiquitin protein ligase binding|poly(A) RNA binding|unfolded protein binding|,57,357,4.74E+11,72.6%
Q8VCT4,0.000108653,-0.4245,63.69646311,2.892333333,4.26927E-07,19.50165975,-1.789,-1.845,-1.978,0.797,1.317,0.951,Q8VCT4,Ces1d,Q8VCT4_Ces1d,Q8VCT4,Ces1d,1,318,50,47,Q8VCT4,MOUSE,62071.9,72.5,56,56.1,883.52,834.41,,565,Carboxylesterase 1D,endoplasmic reticulum|endoplasmic reticulum lumen|lipid particle|cytosol|,acyl-CoA metabolic process|response to toxic substance|lipid catabolic process|short-chain fatty acid catabolic process|epithelial cell differentiation|very-low-density lipoprotein particle assembly|acylglycerol catabolic process|,sterol esterase activity|triglyceride lipase activity|fatty-acyl-ethyl-ester synthase activity|carboxylic ester hydrolase activity|,50,318,9.17E+11,72.5%
Q8VCC2,0.000108653,-0.379,64.15147113,2.369333333,3.84462E-07,19.81751695,-1.487,-1.436,-1.768,0.791,0.915,0.711,Q8VCC2,Ces1g,Q8VCC2_Ces1g,Q8VCC2,Ces1,1,148,31,28,Q8VCC2,MOUSE,63078.1,68.3,56,56.2,494.3,446.52,,565,Liver carboxylesterase 1,endoplasmic reticulum lumen|,metabolic process|,carboxylic ester hydrolase activity|,28,148,3.19E+11,64.6%
P23953,0.025113944,-0.158833333,27.28655027,1.616333333,0.001867863,4.988216291,-0.687,-0.497,-1.717,0.362,0.79,0.796,P23953,Ces1c,P23953_Ces1c,P23953,Ces1c,1,12,10,6,P23953,MOUSE,61339.9,24.1,56,56.3,130.68,71.66,,554,Carboxylesterase 1C,extracellular space|endoplasmic reticulum lumen|,metabolic process|,"hydrolase activity, acting on ester bonds|carboxylic ester hydrolase activity|",6,12,2180000000,18.2%
Q8VDM4,0.895491675,-0.010833333,1.646151969,0.053,0.68451789,0.424698357,0.135,0.002,-0.249,0.129,-0.006,-0.076,Q8VDM4,Psmd2,Q8VDM4_Psmd2,Q8VDM4,Psmd2,1,171,60,60,Q8VDM4|E9Q2S8,MOUSE,100999.6,68.3,57,57.1,869.48,869.48,,908,26S proteasome non-ATPase regulatory subunit 2,proteasome complex|proteasome regulatory particle|membrane|proteasome accessory complex|extracellular exosome|,regulation of protein catabolic process|regulation of catalytic activity|,protein binding|enzyme regulator activity|,60,171,79300000000,68.3%
P56480,0.95520268,-0.029333333,0.661633514,-0.038,0.858690481,-0.185103873,0.146,0.304,-0.481,-0.08,0.055,-0.12,P56480,Atp5b,P56480_Atp5b,P56480,Atp5b,1,624,44,44,P56480,MOUSE,56299.5,85.6,58,58.1,854.74,854.74,,529,"ATP synthase subunit beta, mitochondrial","nucleus|mitochondrion|mitochondrial inner membrane|mitochondrial proton-transporting ATP synthase complex|plasma membrane|cell surface|membrane|mitochondrial membrane|mitochondrial nucleoid|myelin sheath|proton-transporting ATP synthase complex, catalytic core F(1)|extracellular exosome|",angiogenesis|osteoblast differentiation|lipid metabolic process|ATP biosynthetic process|negative regulation of cell adhesion involved in substrate-bound cell migration|ATP synthesis coupled proton transport|ATP hydrolysis coupled proton transport|proton transport|regulation of intracellular pH|,"ATP binding|MHC class I protein binding|proton-transporting ATP synthase activity, rotational mechanism|proton-transporting ATPase activity, rotational mechanism|ATPase activity|",44,624,6.14E+12,85.6%
P54869,0.868023996,-0.038,2.125762295,-0.109333333,0.612948195,-0.530712175,0.283,0.192,-0.425,-0.116,0.102,-0.264,P54869,Hmgcs2,P54869_Hmgcs2,P54869,Hmgcs2,1,586,51,49,P54869,MOUSE,57335.2,78.9,59,59.1,846.62,808.17,,508,"Hydroxymethylglutaryl-CoA synthase, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial matrix|,kidney development|liver development|cholesterol biosynthetic process|brain development|midgut development|response to nutrient|isoprenoid biosynthetic process|response to temperature stimulus|response to metal ion|lung development|cellular response to insulin stimulus|multicellular organismal response to stress|response to testosterone|response to glucagon|response to triglyceride|response to monosaccharide|response to prostaglandin F|response to drug|response to starvation|response to ethanol|ketone body biosynthetic process|response to cAMP|response to growth hormone|adipose tissue development|response to linoleic acid|cellular response to lipopolysaccharide|cellular response to amino acid stimulus|cellular response to glucocorticoid stimulus|cellular response to fatty acid|,hydroxymethylglutaryl-CoA synthase activity|,51,586,5.89E+12,78.9%
Q8JZK9,0.430655636,0.035666667,9.76030187,0.246666667,0.105674405,1.872767905,-0.068,-0.008,-0.187,0.075,-0.009,0.411,Q8JZK9,Hmgcs1,Q8JZK9_Hmgcs1,Q8JZK9,Hmgcs1,1,11,8,6,Q8JZK9,MOUSE,58195.5,17.5,59,59.2,122.76,84.31,,520,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",nucleus|nucleoplasm|cytoplasm|cytosol|plasma membrane|,liver development|cholesterol biosynthetic process|brain development|isoprenoid biosynthetic process|male gonad development|response to low light intensity stimulus|response to purine-containing compound|response to vitamin E|response to drug|response to tellurium ion|response to lipoprotein particle|cellular response to follicle-stimulating hormone stimulus|cellular response to cholesterol|,hydroxymethylglutaryl-CoA synthase activity|drug binding|isomerase activity|protein homodimerization activity|organic acid binding|,6,11,7570000000,15.0%
Q8VCW8,0.891701906,-0.065833333,1.731996341,0.095,0.671120285,0.444104588,0.257,-0.027,-0.57,0.085,0.049,-0.189,Q8VCW8,Acsf2,Q8VCW8_Acsf2,Q8VCW8,Acsf2,1,370,53,53,Q8VCW8,MOUSE,68634,66.9,60,60.1,845.29,845.29,,615,"Acyl-CoA synthetase family member 2, mitochondrial",mitochondrion|,fatty acid metabolic process|,ATP binding|ligase activity|,53,370,8.52E+11,66.9%
Q8CAQ8,0.857449938,0.048166667,2.25626345,0.093,0.594803691,0.558617848,-0.06,0.214,-0.149,0.406,-0.087,-0.035,Q8CAQ8,Immt,Q8CAQ8_Immt,Q8CAQ8,Immt,1,263,58,58,Q8CAQ8|Q8CAQ8-2|Q8CAQ8-5|E9Q800|Q8CAQ8-3|E9QAY6|A0A0U1RP81|Q8CAQ8-4,MOUSE,84298,68.4,61,61.1,830.5,830.5,,757,MICOS complex subunit Mic60,mitochondrion|mitochondrial inner membrane|membrane|integral component of membrane|myelin sheath|,mitochondrial calcium ion homeostasis|,protein binding|poly(A) RNA binding|,58,263,1.76E+11,68.4%
P20918,0.007959674,0.0325,33.36310014,1.125666667,0.000460988,6.402662091,-0.447,-0.47,-0.674,0.292,0.948,0.546,P20918,Plg,P20918_Plg,P20918,Plg,1,208,58,58,P20918,MOUSE,93544.9,67.2,62,62.1,801.48,801.48,,812,Plasminogen,extracellular region|extracellular space|cell surface|extrinsic component of plasma membrane|extrinsic component of external side of plasma membrane|plasma lipoprotein particle|intracellular membrane-bounded organelle|extracellular exosome|blood microparticle|,blood coagulation|negative regulation of cell-substrate adhesion|negative regulation of angiogenesis|extracellular matrix disassembly|tissue regeneration|fibrinolysis|myoblast differentiation|muscle cell cellular homeostasis|tissue remodeling|proteolysis involved in cellular protein catabolic process|negative regulation of fibrinolysis|positive regulation of fibrinolysis|trophoblast giant cell differentiation|labyrinthine layer blood vessel development|mononuclear cell migration|,fibronectin binding|serine-type endopeptidase activity|receptor binding|protein domain specific binding|apolipoprotein binding|,58,208,99900000000,67.2%
Q9Z0,0.654656582,0.0095,5.266697789,-0.097666667,0.297392643,-1.129810619,0.147,0.06,-0.032,-0.034,-0.027,-0.057,Q9Z0,NotFound,Q9Z0_NotFound,Q9Z0,Aifm1,1,280,51,51,Q9Z0|B1AU25,MOUSE,66992.5,68.9,63,63.1,788.42,788.42,,612,"Apoptosis-inducing factor 1, mitochondrial",nucleus|cytoplasm|mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|mitochondrial intermembrane space|cytosol|perinuclear region of cytoplasm|,apoptotic process|activation of cysteine-type endopeptidase activity involved in apoptotic process|response to oxidative stress|apoptotic mitochondrial changes|positive regulation of cell death|neuron differentiation|mitochondrial respiratory chain complex I assembly|positive regulation of apoptotic process|cell redox homeostasis|neuron apoptotic process|oxidation-reduction process|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress|regulation of apoptotic DNA fragmentation|,"DNA binding|electron-transferring-flavoprotein dehydrogenase activity|protein binding|NAD(P)H oxidase activity|oxidoreductase activity, acting on NAD(P)H|protein dimerization activity|FAD binding|",51,280,4.9E+11,68.9%
O70475,0.935853609,0.0045,0.912119813,-0.039666667,0.81056532,-0.249463293,0.28,0.026,-0.233,-0.167,0.179,-0.058,O70475,Ugdh,O70475_Ugdh,O70475,Ugdh,1,249,53,53,O70475,MOUSE,55515.6,89.2,64,64.1,782.97,782.97,,493,UDP-glucose 6-dehydrogenase,nucleoplasm|extracellular exosome|,gastrulation with mouth forming second|UDP-glucuronate biosynthetic process|oxidation-reduction process|,UDP-glucose 6-dehydrogenase activity|NAD binding|,53,249,4.04E+11,89.2%
O88428,0.895491675,-0.060666667,1.645248007,0.085333333,0.684660384,0.424492931,0.185,0.077,-0.572,-0.066,0.059,-0.047,O88428,Papss2,O88428_Papss2,O88428,Papss2,1,302,49,49,O88428|Q60967|Q6NZM8,MOUSE,70977,72.6,65,65.1,782.8,782.8,,621,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2,,sulfate assimilation|blood coagulation|phosphorylation|3'-phosphoadenosine 5'-phosphosulfate biosynthetic process|bone development|,adenylylsulfate kinase activity|sulfate adenylyltransferase (ATP) activity|ATP binding|nucleotidyltransferase activity|,49,302,2.49E+11,72.6%
Q80XL6,0.961523652,-0.023,0.530125015,0.020666667,0.885090131,0.150187133,0.167,0.053,-0.32,0.017,-0.022,-0.033,Q80XL6,Acad11,Q80XL6_Acad11,Q80XL6,Acad11,1,203,53,53,Q80XL6|A0A0R4J0I6|D3YTQ5|A0A087WSI8|F6U473,MOUSE,88106.5,72.1,66,66.1,774.76,774.76,,779,Acyl-CoA dehydrogenase family member 11,nucleus|mitochondrion|peroxisome|mitochondrial membrane|,fatty acid beta-oxidation using acyl-CoA dehydrogenase|,long-chain-acyl-CoA dehydrogenase activity|very-long-chain-acyl-CoA dehydrogenase activity|flavin adenine dinucleotide binding|medium-chain-acyl-CoA dehydrogenase activity|,53,203,1.88E+11,72.1%
P27773,0.000372555,-0.373666667,52.27749073,2.31,5.91904E-06,12.98631593,-1.45,-1.24,-1.896,0.716,0.699,0.929,P27773,Pdia3,P27773_Pdia3,P27773,Pdia3,1,280,50,50,P27773|A5D7E8|P38657,MOUSE,57133.7,68.9,67,67.1,773.01,773.01,,505,Protein disulfide-isomerase A3,nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|focal adhesion|cell surface|melanosome|myelin sheath|extracellular exosome|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|positive regulation of extrinsic apoptotic signaling pathway|,protein disulfide isomerase activity|protein binding|poly(A) RNA binding|,50,280,4.45E+11,68.9%
P10126,0.93787838,-0.017166667,0.877475853,-0.028333333,0.817057112,-0.240697883,0.125,0.097,-0.231,0.006,-0.039,-0.061,P10126,Eef1a1,P10126_Eef1a1,P10126,Eef1a1,1,586,47,47,P10126|P62631,MOUSE,50455.3,76.6,68,68.1,769.6,769.6,,462,Elongation factor 1-alpha 1,extracellular space|nucleus|nucleolus|cytoplasm|cytosol|plasma membrane|membrane|cortical actin cytoskeleton|ruffle membrane|myelin sheath|extracellular exosome|,translational elongation|cellular response to epidermal growth factor stimulus|,tRNA binding|translation elongation factor activity|GTPase activity|protein binding|GTP binding|protein kinase binding|poly(A) RNA binding|,47,586,4.25E+12,76.6%
Q6ZQ38,0.960763421,-0.006,0.589828205,-0.02,0.873005902,-0.166141011,0.158,0.038,-0.184,0.104,-0.025,-0.127,Q6ZQ38,Cand1,Q6ZQ38_Cand1,Q6ZQ38,Cand1,1,193,54,54,Q6ZQ38,MOUSE,138040.8,44.8,69,69.1,760.39,760.39,,1230,Cullin-associated NEDD8-dissociated protein 1,ubiquitin ligase complex|nucleus|nucleoplasm|cytoplasm|membrane|cullin-RING ubiquitin ligase complex|extracellular exosome|,"SCF complex assembly|protein ubiquitination|cell differentiation|negative regulation of catalytic activity|positive regulation of transcription, DNA-templated|positive regulation of RNA polymerase II transcriptional preinitiation complex assembly|",protein binding|TBP-class protein binding|,54,193,1.63E+11,44.8%
Q9ET01,0.116705641,-0.053666667,19.12978453,0.556666667,0.012218603,3.414965851,-0.393,-0.059,-0.544,0.134,0.459,0.081,Q9ET01,Pygl,Q9ET01_Pygl,Q9ET01,Pygl,1,184,55,48,Q9ET01|Q3UEJ6,MOUSE,97917.7,66.4,70,70.1,759.41,680.6,,850,"Glycogen phosphorylase, liver form",cytoplasm|plasma membrane|extracellular exosome|,glycogen metabolic process|glycogen catabolic process|5-phosphoribose 1-diphosphate biosynthetic process|glucose homeostasis|necroptotic process|,purine nucleobase binding|protein binding|ATP binding|drug binding|glycogen phosphorylase activity|AMP binding|vitamin binding|pyridoxal phosphate binding|carbohydrate binding|bile acid binding|protein homodimerization activity|,55,184,91700000000,66.4%
Q8CI94,0.615860336,-0.0145,6.050735048,0.175,0.248271287,1.265919462,-0.36,-0.01,0.064,0.047,-0.035,0.207,Q8CI94,Pygb,Q8CI94_Pygb,Q8CI94,Pygb,1,4,10,4,Q8CI94,MOUSE,97412.8,14.2,70,70.2,94.66,35.18,,843,"Glycogen phosphorylase, brain form",cytoplasm|membrane|axon|extracellular exosome|,glycogen catabolic process|,drug binding|glycogen phosphorylase activity|pyridoxal phosphate binding|carbohydrate binding|protein homodimerization activity|,4,4,80900000,8.6%
P23116,0.699942953,0.012833333,4.55601834,-0.131666667,0.350266148,-1.004876194,-0.16,0.215,0.181,-0.161,-0.07,0.072,P23116,Eif3a,P23116_Eif3a,P23116,Eif3a,1,178,67,67,P23116,MOUSE,162332.9,41.5,71,71.1,754.18,754.18,,1344,Eukaryotic translation initiation factor 3 subunit A,"nucleus|nucleolus|cytoplasm|microtubule organizing center|eukaryotic translation initiation factor 3 complex|membrane|eukaryotic 43S preinitiation complex|eukaryotic 48S preinitiation complex|eukaryotic translation initiation factor 3 complex, eIF3m|",formation of translation preinitiation complex|formation of cytoplasmic translation initiation complex|regulation of translational initiation|,protein binding|poly(A) RNA binding|translation initiation factor activity|,67,178,42700000000,41.5%
Q8BMJ2,0.797504707,-0.0055,3.118539608,-0.060333333,0.487692458,-0.734265203,0.046,0.059,-0.031,0.018,-0.052,-0.073,Q8BMJ2,Lars,Q8BMJ2_Lars,Q8BMJ2,Lars,1,142,59,59,Q8BMJ2,MOUSE,135445.1,51.3,72,72.1,753.92,753.92,,1178,"Leucine--tRNA ligase, cytoplasmic",nucleus|cytoplasm|cytosol|,leucyl-tRNA aminoacylation|regulation of translational fidelity|methionyl-tRNA aminoacylation|,aminoacyl-tRNA editing activity|leucine-tRNA ligase activity|ATP binding|methionine-tRNA ligase activity|,59,142,33000000000,51.3%
Q64458,0.951421295,-0.075166667,0.757872925,0.050333333,0.839871236,0.2101505,0.134,0.176,-0.611,-0.258,0.221,-0.113,Q64458,Cyp2c29,Q64458_Cyp2c29,Q64458,Cyp2c29,1,261,49,27,Q64458|Q3UT49|H3BLM0,MOUSE,56399.5,81.8,73,73.1,748.78,455.44,,490,Cytochrome P450 2C29,cytoplasm|endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,xenobiotic metabolic process|epoxygenase P450 pathway|exogenous drug catabolic process|oxidation-reduction process|,"monooxygenase activity|iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|caffeine oxidase activity|aromatase activity|",49,261,3.84E+11,81.8%
Q91X77,0.907352513,-0.035833333,1.496826502,-0.108333333,0.708463287,-0.390449183,0.116,0.518,-0.579,-0.296,0.131,-0.105,Q91X77,Cyp2c50,Q91X77_Cyp2c50,Q91X77,Cyp2c50,1,34,42,10,Q91X77|Q91X77-2|Q5GLZ0,MOUSE,56562.5,69.3,73,73.2,562.81,124.1,,490,Cytochrome P450 2C50,cytoplasm|endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,xenobiotic metabolic process|arachidonic acid metabolic process|epoxygenase P450 pathway|exogenous drug catabolic process|linoleic acid metabolic process|oxidation-reduction process|,"iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|aromatase activity|linoleic acid epoxygenase activity|",10,34,55300000000,22.2%
Q6XVG2,0.951421295,0.0035,0.731424996,-0.035,0.84500154,-0.203308342,0.102,0.311,-0.35,-0.072,-0.03,0.06,Q6XVG2,Cyp2c54,Q6XVG2_Cyp2c54,Q6XVG2,Cyp2c54,1,53,36,7,Q6XVG2,MOUSE,56598.5,61.8,73,73.3,490.18,108.76,,490,Cytochrome P450 2C54,cytoplasm|endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,xenobiotic metabolic process|arachidonic acid metabolic process|epoxygenase P450 pathway|exogenous drug catabolic process|linoleic acid metabolic process|oxidation-reduction process|,"iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|aromatase activity|linoleic acid epoxygenase activity|",7,53,23800000000,22.6%
P56654,0.706061876,-0.1655,4.456194186,0.338333333,0.358410382,0.986836309,0.072,0.102,-1.178,-0.065,0.172,-0.096,P56654,Cyp2c37,P56654_Cyp2c37,P56654,Cyp2c37,1,27,33,9,P56654,MOUSE,56290,58.3,73,73.4,469.56,116.98,,490,Cytochrome P450 2C37,cytoplasm|endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,xenobiotic metabolic process|epoxygenase P450 pathway|exogenous drug catabolic process|oxidation-reduction process|,"iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|aromatase activity|",9,27,1.38E+11,10.6%
P33267,0.956385108,-0.056,0.632917124,0.042666667,0.864387121,0.177549142,0.104,0.309,-0.645,-0.057,-0.099,0.052,P33267,Cyp2f2,P33267_Cyp2f2,P33267,Cyp2f2,1,82,26,24,P33267,MOUSE,56175.9,48,73,73.5,315.91,287.77,,491,Cytochrome P450 2F2,cytoplasm|endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,xenobiotic metabolic process|response to toxic substance|naphthalene metabolic process|trichloroethylene metabolic process|epoxygenase P450 pathway|exogenous drug catabolic process|oxidation-reduction process|,"iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|",24,82,56500000000,45.8%
Q91W64,0.685093743,0.063166667,4.777687532,-0.169,0.33283673,-1.044622954,0.016,0.509,-0.082,0,-0.003,-0.061,Q91W64,Cyp2c70,Q91W64_Cyp2c70,Q91W64,Cyp2c70,1,39,16,13,Q91W64|E9Q2L0|E9Q8U5,MOUSE,56475.5,34.5,73,73.6,225.84,192.53,,489,Cytochrome P450 2C70,cytoplasm|endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,xenobiotic metabolic process|epoxygenase P450 pathway|exogenous drug catabolic process|oxidation-reduction process|,"iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|aromatase activity|",13,39,12900000000,32.3%
P56655,0.32559784,0.028333333,12.1047441,-0.334,0.061592182,-2.247186481,0.151,0.482,-0.047,-0.127,-0.046,-0.243,P56655,Cyp2c38,P56655_Cyp2c38,P56655,Cyp2c38,1,5,16,5,P56655,MOUSE,56912.9,34.6,73,73.7,181.74,63.45,,490,Cytochrome P450 2C38,cytoplasm|endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,xenobiotic metabolic process|epoxygenase P450 pathway|exogenous drug catabolic process|oxidation-reduction process|,"monooxygenase activity|iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|caffeine oxidase activity|aromatase activity|",5,5,591000000,13.2%
Q91WU0,4.99445E-05,-0.463,74.99221657,2.600666667,3.16795E-08,28.34241871,-1.695,-1.708,-1.887,0.807,0.881,0.824,Q91WU0,Ces1f,Q91WU0_Ces1f,Q91WU0,Ces1f,1,305,43,40,Q91WU0,MOUSE,62010.5,69.6,74,74.1,741.6,691.03,,561,Carboxylesterase 1F,lipid particle|cytosol|,short-chain fatty acid catabolic process|,hydrolase activity|,43,305,5.34E+11,69.6%
Q64176,0.002068715,-0.231166667,40.40215446,2.259666667,9.11559E-05,8.399396832,-1.228,-1.09,-1.765,0.613,1.419,0.664,Q64176,Ces1e,Q64176_Ces1e,Q64176,Ces1e,1,73,21,18,Q64176|H3BL34|D3Z298,MOUSE,61865.8,47.6,74,74.2,338.85,288.28,,562,Carboxylesterase 1E,endoplasmic reticulum lumen|,metabolic process|,carboxylic ester hydrolase activity|,18,73,35300000000,41.6%
P50544,0.584741827,0.005333333,6.639211749,-0.286666667,0.216809758,-1.36506669,-0.075,0.522,-0.001,-0.464,0.095,-0.045,P50544,Acadvl,P50544_Acadvl,P50544,Acadvl,1,224,46,46,P50544|B1AR28,MOUSE,71273.6,72.2,75,75.1,740.94,740.94,,656,"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial",nucleus|nucleolus|cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial nucleoid|,temperature homeostasis|epithelial cell differentiation|fatty acid beta-oxidation using acyl-CoA dehydrogenase|negative regulation of fatty acid biosynthetic process|negative regulation of fatty acid oxidation|regulation of cholesterol metabolic process|,acyl-CoA dehydrogenase activity|flavin adenine dinucleotide binding|,46,224,2.59E+11,72.2%
Q05421,0.221080485,0.002666667,15.13538464,-0.242666667,0.030652192,-2.729600132,0.186,0.05,0.136,-0.2,-0.051,-0.105,Q05421,Cyp2e1,Q05421_Cyp2e1,Q05421,Cyp2e1,1,264,54,54,Q05421|A0A1B0GSV7|Q0PGA1,MOUSE,57203.4,71.1,76,76.1,738.77,738.77,,493,Cytochrome P450 2E1,Golgi membrane|cytoplasm|mitochondrion|endoplasmic reticulum|intrinsic component of endoplasmic reticulum membrane|,triglyceride metabolic process|xenobiotic metabolic process|steroid metabolic process|response to ozone|response to organonitrogen compound|monoterpenoid metabolic process|drug metabolic process|epoxygenase P450 pathway|exogenous drug catabolic process|response to ethanol|heterocycle metabolic process|oxidation-reduction process|,"monooxygenase activity|iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|enzyme binding|heme binding|",54,264,6.78E+11,71.1%
Q62167,0.290441955,-0.001166667,13.09882,-0.195,0.048991191,-2.400661003,0.084,0.163,0.042,-0.089,-0.108,-0.099,Q62167,Ddx3x,Q62167_Ddx3x,Q62167,Ddx3x,1,232,52,16,Q62167|P16381,MOUSE,73499.5,75.2,77,77.1,736.18,221.38,,662,ATP-dependent RNA helicase DDX3X,nucleus|cytoplasm|mitochondrial outer membrane|cytoplasmic stress granule|nuclear speck|cytoplasmic ribonucleoprotein granule|extracellular exosome|eukaryotic translation initiation factor 3 complex|cytosolic small ribosomal subunit|,"transcription, DNA-templated|translational initiation|chromosome segregation|extrinsic apoptotic signaling pathway via death domain receptors|response to virus|regulation of gene expression|RNA secondary structure unwinding|positive regulation of gene expression|negative regulation of translation|positive regulation of cell growth|negative regulation of cell growth|negative regulation of protein complex assembly|DNA duplex unwinding|stress granule assembly|intracellular signal transduction|mature ribosome assembly|positive regulation of apoptotic process|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of viral genome replication|innate immune response|positive regulation of translation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of translational initiation|cellular response to arsenic-containing substance|cellular response to osmotic stress|intrinsic apoptotic signaling pathway|positive regulation of G1/S transition of mitotic cell cycle|negative regulation of intrinsic apoptotic signaling pathway|",DNA binding|RNA binding|GTPase activity|ATP-dependent DNA helicase activity|ATP-dependent RNA helicase activity|protein binding|ATP binding|transcription factor binding|poly(A) binding|eukaryotic initiation factor 4E binding|ATPase activity|nucleoside-triphosphatase activity|translation initiation factor binding|RNA stem-loop binding|ribosomal small subunit binding|CTPase activity|poly(A) RNA binding|mRNA 5'-UTR binding|,52,232,1.91E+11,75.2%
Q61656,0.407684573,0.009333333,10.23461208,-0.162,0.09474118,-1.944876423,0.166,0.074,0.031,-0.047,-0.065,-0.103,Q61656,NotFound,Q61656_NotFound,Q61656,Ddx5,1,144,50,39,Q61656|Q8BTS0|S4R1I6|S4R1E3,MOUSE,69802.5,60.7,77,77.2,683.66,522.02,,614,Probable ATP-dependent RNA helicase DDX5,nucleus|nucleoplasm|nucleolus|membrane|ribonucleoprotein complex|extracellular exosome|catalytic step 2 spliceosome|,"negative regulation of transcription from RNA polymerase II promoter|regulation of alternative mRNA splicing, via spliceosome|in utero embryonic development|mRNA processing|circadian rhythm|RNA splicing|mRNA transcription|RNA secondary structure unwinding|positive regulation of intracellular estrogen receptor signaling pathway|positive regulation of DNA damage response, signal transduction by p53 class mediator|regulation of osteoblast differentiation|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|regulation of androgen receptor signaling pathway|intrinsic apoptotic signaling pathway by p53 class mediator|regulation of skeletal muscle cell differentiation|",transcription cofactor activity|transcription coactivator activity|RNA helicase activity|ATP-dependent RNA helicase activity|protein binding|ATP binding|estrogen receptor binding|pre-mRNA binding|poly(A) RNA binding|androgen receptor binding|,39,144,1.07E+11,53.5%
Q3U741,0.797504707,-0.0035,3.140217866,-0.059666667,0.485264156,-0.738527602,0.043,0.024,0.012,-0.088,-0.038,0.026,Q3U741,Ddx17,Q3U741_Ddx17,Q3U741,Ddx17,1,68,38,27,Q3U741|Q501J6|Q501J6-2,MOUSE,73211,50.9,77,77.3,476.95,315.31,,652,"DEAD (Asp-Glu-Ala-Asp) box polypeptide 17, isoform CRA_a",nucleus|nucleoplasm|membrane|,"post-embryonic development|RNA secondary structure unwinding|positive regulation of intracellular estrogen receptor signaling pathway|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|cardiovascular system development|regulation of skeletal muscle cell differentiation|",transcription coactivator activity|ATP-dependent RNA helicase activity|ATP binding|estrogen receptor binding|poly(A) RNA binding|,27,68,16900000000,39.2%
Q3V086,0.805699632,-0.117666667,2.99879416,0.196666667,0.50132641,0.711058057,0.134,0.048,-0.83,0.253,-0.05,-0.261,Q3V086,Ddx4,Q3V086_Ddx4,Q3V086,Ddx4,1,8,5,3,Q3V086|Q61496,MOUSE,80137.7,7.9,77,77.5,62.07,26.03,,728,ATP-dependent RNA helicase DDX4,nucleus|cytoplasm|ribonucleoprotein complex|chromatoid body|perinuclear region of cytoplasm|pi-body|,male meiosis I|spermatogenesis|RNA secondary structure unwinding|sperm motility|regulation of protein localization|,nucleic acid binding|ATP-dependent RNA helicase activity|protein binding|ATP binding|,3,8,1980000000,5.0%
P56593,0.971375526,-0.0865,0.410724584,-0.029,0.909761474,-0.117746065,0.266,0.141,-0.623,-0.325,0.07,-0.048,P56593,Cyp2a12,P56593_Cyp2a12,P56593,Cyp2a12,1,303,50,23,P56593,MOUSE,56349.3,83.3,78,78.1,735.53,359.82,,492,Cytochrome P450 2A12,cytoplasm|endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,xenobiotic metabolic process|coumarin metabolic process|epoxygenase P450 pathway|exogenous drug catabolic process|oxidation-reduction process|,"iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|aromatase activity|",50,303,5.21E+11,83.3%
Q91X75,0.867701819,-0.226833333,2.130800411,0.207666667,0.612237545,0.531796448,0.025,0.228,-1.245,-0.007,0.104,-0.466,Q91X75,Cyp2a5,Q91X75_Cyp2a5,Q91X75,Cyp2a5,1,39,42,11,Q91X75|P20852|E9Q5D4,MOUSE,56825.8,68.4,78,78.2,605.84,164.15,,494,Cyp2a4 protein,,oxidation-reduction process|,"iron ion binding|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|heme binding|",11,39,50600000000,23.4%
P15392,0.35633016,-0.183666667,11.33002259,0.951333333,0.073620327,2.123388382,0.112,-0.414,-1.676,0.59,-0.096,0.382,P15392,Cyp2a4,P15392_Cyp2a4,P15392,Cyp2a4,1,41,42,13,P15392,MOUSE,56894.9,66.1,78,78.3,584.57,163.4,,494,Cytochrome P450 2A4,endoplasmic reticulum membrane|,response to stilbenoid|oxidation-reduction process|,iron ion binding|heme binding|aromatase activity|,13,41,29100000000,24.2%
B2RXZ2,0.567098888,-0.127,7.005526977,0.48,0.199272469,1.426021321,0.197,-0.142,-1.156,0.13,0.3,-0.091,B2RXZ2,Cyp2a22,B2RXZ2_Cyp2a22,B2RXZ2,Cyp2a22,1,29,34,10,B2RXZ2,MOUSE,56488.6,60.9,78,78.4,454.68,110.39,,492,Cyp2a22 protein,cytoplasm|intracellular membrane-bounded organelle|,xenobiotic metabolic process|coumarin metabolic process|epoxygenase P450 pathway|exogenous drug catabolic process|oxidation-reduction process|,"iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|",10,29,11300000000,24.7%
E9Q5K4,0.615860336,-0.013,6.047788558,0.136666667,0.248439785,1.264345059,-0.012,0.021,-0.253,0.067,-0.034,0.133,E9Q5K4,Cyp2c23,E9Q5K4_Cyp2c23,E9Q5K4,Cyp2c23,1,93,32,30,E9Q5K4|A0A1D5RLI1,MOUSE,56877.4,53.8,78,78.5,420.9,389.82,,494,"Cytochrome P450, family 2, subfamily c, polypeptide 23",cytoplasm|intracellular membrane-bounded organelle|,xenobiotic metabolic process|epoxygenase P450 pathway|response to testosterone|exogenous drug catabolic process|oxidation-reduction process|,"iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|",30,93,52300000000,51.6%
O35490,0.295433851,-0.023833333,12.91300806,0.307,0.051132755,2.376811203,-0.047,-0.072,-0.413,0.028,0.25,0.111,O35490,Bhmt,O35490_Bhmt,O35490,Bhmt,1,494,42,42,O35490|Q91WS4,MOUSE,45476.1,84.7,79,79.1,724.63,724.63,,407,Betaine--homocysteine S-methyltransferase 1,cytoplasm|,amino-acid betaine catabolic process|methionine biosynthetic process|methylation|,zinc ion binding|S-adenosylmethionine-homocysteine S-methyltransferase activity|betaine-homocysteine S-methyltransferase activity|,43,494,2.38E+12,84.7%
P01029,0.006552138,-0.089,34.34402786,0.838666667,0.000367788,6.655579061,-0.613,-0.633,-0.279,0.26,0.281,0.45,P01029,C4b,P01029_C4b,P01029,C4b,1,149,56,53,P01029|P01030,MOUSE,194566.4,37,80,80.1,716.48,685.93,,1738,Complement C4-B,extracellular space|,"inflammatory response|complement activation, classical pathway|negative regulation of endopeptidase activity|innate immune response|",endopeptidase inhibitor activity|,56,149,44100000000,37.0%
Q8BFR5,0.911411213,-0.0185,1.420173269,-0.065666667,0.72107871,-0.372613147,0.186,0.238,-0.381,0.043,-0.064,-0.133,Q8BFR5,Tufm,Q8BFR5_Tufm,Q8BFR5,Tufm,1,294,42,42,Q8BFR5|Q8BFR5-2,MOUSE,49906.8,75.2,81,81.1,711.62,711.62,,452,"Elongation factor Tu, mitochondrial",mitochondrion|mitochondrial inner membrane|membrane|mitochondrial nucleoid|myelin sheath|extracellular exosome|,translational elongation|,translation elongation factor activity|GTPase activity|GTP binding|poly(A) RNA binding|,42,294,7.22E+11,75.2%
Q99MN9,0.424416597,-0.012833333,9.885161981,0.406333333,0.102679513,1.892736017,-0.219,0.123,-0.552,-0.149,0.37,0.35,Q99MN9,Pccb,Q99MN9_Pccb,Q99MN9,Pccb,1,482,42,42,Q99MN9|E9Q1J7,MOUSE,59035.6,77,82,82.1,709.64,709.64,,541,"Propionyl-CoA carboxylase beta chain, mitochondrial",mitochondrion|mitochondrial matrix|,metabolic process|,propionyl-CoA carboxylase activity|ATP binding|,42,482,2.53E+12,77.0%
Q3UPL0,0.663574238,-0.005666667,5.106206546,-0.088666667,0.308588221,-1.101741798,0.032,0.06,0.024,0,-0.107,-0.043,Q3UPL0,Sec31a,Q3UPL0_Sec31a,Q3UPL0,Sec31a,1,169,53,53,Q3UPL0|Q3UPL0-2|Q3UPL0-3,MOUSE,134593.8,42.1,83,83.1,706.07,706.07,,1230,Protein transport protein Sec31A,cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|ER to Golgi transport vesicle membrane|vesicle coat|ER to Golgi transport vesicle|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|endoplasmic reticulum exit site|,protein transport|vesicle-mediated transport|response to calcium ion|,calcium-dependent protein binding|,53,169,1.12E+11,42.1%
O55143,0.944597899,0.013,0.807470938,0.034666667,0.830334162,0.222900105,-0.072,0.056,0.003,0.341,-0.248,-0.002,O55143,Atp2a2,O55143_Atp2a2,O55143,Atp2a2,1,234,45,45,O55143|O55143-2|Q8R429|Q64518|E9Q559|Q64518-3|B1ATS5|Q64518-2|B1ATS4,MOUSE,116510.6,43.9,84,84.1,702.05,702.05,,1044,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2,endoplasmic reticulum|endoplasmic reticulum membrane|vesicle membrane|longitudinal sarcoplasmic reticulum|membrane|sarcoplasmic reticulum|extrinsic component of cytoplasmic side of plasma membrane|sarcoplasmic reticulum membrane|perinuclear region of cytoplasm|calcium ion-transporting ATPase complex|ribbon synapse|intercalated disc|,regulation of the force of heart contraction|cellular calcium ion homeostasis|regulation of muscle contraction|ER-nucleus signaling pathway|organelle organization|metabolic process|regulation of cardiac muscle contraction by calcium ion signaling|transition between fast and slow fiber|endoplasmic reticulum calcium ion homeostasis|positive regulation of endoplasmic reticulum calcium ion concentration|T-tubule organization|response to endoplasmic reticulum stress|response to peptide hormone|negative regulation of heart contraction|relaxation of cardiac muscle|sarcoplasmic reticulum calcium ion transport|calcium ion transmembrane transport|regulation of cardiac muscle cell membrane potential|regulation of cardiac muscle cell action potential involved in regulation of contraction|regulation of calcium ion-dependent exocytosis of neurotransmitter|calcium ion transport from cytosol to endoplasmic reticulum|calcium ion import into sarcoplasmic reticulum|,calcium-transporting ATPase activity|calcium ion binding|protein binding|ATP binding|protein C-terminus binding|enzyme binding|lutropin-choriogonadotropic hormone receptor binding|S100 protein binding|calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential|,45,234,1.68E+11,43.9%
P24549,0.64206681,0.062666667,5.508195093,0.192,0.281306969,1.172904191,-0.028,-0.025,-0.047,-0.09,0.524,0.042,P24549,Aldh1a1,P24549_Aldh1a1,P24549,Aldh1a1,1,262,45,26,P24549|Q62148|Q9JHW9,MOUSE,55094.4,67.4,85,85.1,686.09,410.9,,501,Retinal dehydrogenase 1,nucleus|cytoplasm|extracellular exosome|,kidney development|liver development|optic cup morphogenesis involved in camera-type eye development|response to oxidative stress|midgut development|response to estradiol|response to retinoic acid|response to drug|retinol metabolic process|retinoic acid metabolic process|9-cis-retinoic acid biosynthetic process|positive regulation of apoptotic process|estrous cycle|response to ethanol|embryonic eye morphogenesis|protein homotetramerization|oxidation-reduction process|,retinal dehydrogenase activity|3-chloroallyl aldehyde dehydrogenase activity|aldehyde dehydrogenase (NAD) activity|benzaldehyde dehydrogenase (NAD+) activity|identical protein binding|,48,262,4.64E+11,67.4%
Q9CZS1,0.894042447,0.019,1.678786798,0.047333333,0.679393395,0.431928798,0.097,-0.057,-0.054,-0.047,0.219,-0.044,Q9CZS1,Aldh1b1,Q9CZS1_Aldh1b1,Q9CZS1,Aldh1b1,1,230,43,39,Q9CZS1,MOUSE,58122.4,80.9,85,85.2,668.43,613.27,,519,"Aldehyde dehydrogenase X, mitochondrial",nucleoplasm|mitochondrion|mitochondrial matrix|intracellular membrane-bounded organelle|,ethanol catabolic process|oxidation-reduction process|,aldehyde dehydrogenase (NAD) activity|,39,230,3.92E+11,77.8%
P47738,0.921098534,0.0035,1.154850333,-0.051,0.766504955,-0.309431315,0.012,0.053,0.022,-0.298,0.337,-0.105,P47738,Aldh2,P47738_Aldh2,P47738,Aldh2,1,256,42,39,P47738|A0A0G2JEU1,MOUSE,57050,82,85,85.3,697.85,654.91,,519,"Aldehyde dehydrogenase, mitochondrial",mitochondrion|mitochondrial matrix|extracellular exosome|,liver development|ethanol catabolic process|response to estradiol|response to lipopolysaccharide|response to progesterone|cellular response to hormone stimulus|response to testosterone|response to nicotine|negative regulation of apoptotic process|response to hyperoxia|oxidation-reduction process|cellular response to fatty acid|,aldehyde dehydrogenase (NAD) activity|protein binding|identical protein binding|NADH binding|,39,256,7.01E+11,80.5%
O35945,0.34143853,0.002,11.64197253,0.174666667,0.068517695,2.168438474,-0.05,-0.119,-0.087,0.092,0.134,0.042,O35945,Aldh1a7,O35945_Aldh1a7,O35945,Aldh1a7,1,37,30,11,O35945,MOUSE,55043.2,52.8,85,85.4,428.76,153.57,,501,"Aldehyde dehydrogenase, cytosolic 1",cytoplasm|,ethanol catabolic process|oxidation-reduction process|retinoic acid metabolic process|,retinal dehydrogenase activity|3-chloroallyl aldehyde dehydrogenase activity|benzaldehyde dehydrogenase (NAD+) activity|,11,37,9170000000,27.5%
Q9QY30,0.826081644,-0.017833333,2.681831401,-0.101,0.539283161,-0.647207608,0.108,0.258,-0.268,-0.069,0.07,-0.206,Q9QY30,Abcb11,Q9QY30_Abcb11,Q9QY30,Abcb11,1,157,47,47,Q9QY30|J3QNY6,MOUSE,147830.3,37.2,86,86.1,697.35,697.35,,1321,Bile salt export pump,membrane|integral component of membrane|apical part of cell|intercellular canaliculus|extracellular exosome|,metabolic process|canalicular bile acid transport|transmembrane transport|,"ATP binding|canalicular bile acid transmembrane transporter activity|ATPase activity, coupled to transmembrane movement of substances|",47,157,1.01E+11,37.2%
Q9JIF7,0.289366522,0.004166667,13.13666354,-0.200333333,0.048566147,-2.406718861,0.137,0.101,0.075,-0.019,-0.124,-0.145,Q9JIF7,Copb1,Q9JIF7_Copb1,Q9JIF7,Copb1,1,153,51,51,Q9JIF7,MOUSE,108205.3,57.8,87,87.1,697.19,697.19,,953,Coatomer subunit beta,cytoplasm|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|plasma membrane|membrane|COPI vesicle coat|COPI-coated vesicle|intracellular membrane-bounded organelle|,intracellular protein transport|intra-Golgi vesicle-mediated transport|,structural molecule activity|,51,153,1.01E+11,57.8%
Q9R0H0,0.647450828,-0.015333333,5.431489317,0.133333333,0.286319593,1.159237088,-0.033,-0.253,0.04,-0.07,0.058,0.166,Q9R0H0,Acox1,Q9R0H0_Acox1,Q9R0H0,Acox1,1,196,44,3,Q9R0H0,MOUSE,75046.8,77.3,88,88.1,694.93,54.23,,661,Peroxisomal acyl-coenzyme A oxidase 1,nucleus|nucleoplasm|nucleolus|cytoplasm|mitochondrion|peroxisome|peroxisomal membrane|plasma membrane|membrane|intracellular membrane-bounded organelle|,very long-chain fatty acid metabolic process|generation of precursor metabolites and energy|lipid metabolic process|fatty acid beta-oxidation|prostaglandin metabolic process|spermatogenesis|peroxisome fission|fatty acid oxidation|fatty acid beta-oxidation using acyl-CoA oxidase|lipid homeostasis|positive regulation of cholesterol homeostasis|,acyl-CoA dehydrogenase activity|acyl-CoA oxidase activity|receptor binding|palmitoyl-CoA oxidase activity|PDZ domain binding|protein N-terminus binding|FAD binding|,44,196,1.26E+11,77.3%
Q9R0H0-2,0.915900752,-0.011,1.298966904,0.034666667,0.741486604,0.343871647,0.017,-0.121,0.019,-0.09,-0.037,0.146,Q9R0H0,Acox1,Q9R0H0-2_Acox1,Q9R0H0-2,Acox1,1,11,42,2,Q9R0H0-2,MOUSE,75115.7,76.5,88,88.2,667.7,44,,661,Isoform 2 of Peroxisomal acyl-coenzyme A oxidase 1,nucleus|nucleoplasm|nucleolus|cytoplasm|mitochondrion|peroxisome|peroxisomal membrane|plasma membrane|membrane|intracellular membrane-bounded organelle|,very long-chain fatty acid metabolic process|generation of precursor metabolites and energy|lipid metabolic process|fatty acid beta-oxidation|prostaglandin metabolic process|spermatogenesis|peroxisome fission|fatty acid oxidation|fatty acid beta-oxidation using acyl-CoA oxidase|lipid homeostasis|positive regulation of cholesterol homeostasis|,acyl-CoA dehydrogenase activity|acyl-CoA oxidase activity|receptor binding|palmitoyl-CoA oxidase activity|PDZ domain binding|protein N-terminus binding|FAD binding|,2,11,15500000000,7.5%
Q8VDN2,0.815095629,-0.039166667,2.884019511,0.089666667,0.514752007,0.688130319,0.013,0.078,-0.343,-0.03,0.083,-0.036,Q8VDN2,Atp1a1,Q8VDN2_Atp1a1,Q8VDN2,Atp1a1,1,271,47,47,Q8VDN2|Q8VCE0|A0A0G2JGX4|Q6PIC6|Q6PIE5|D3YYN7|Q9WV27|E9QNX7|Q64436|Q91WH7|Q9Z1W8,MOUSE,114292.4,45.9,89,89.1,692.61,692.61,,1023,Sodium/potassium-transporting ATPase subunit alpha-1,endosome|endoplasmic reticulum|Golgi apparatus|plasma membrane|sodium:potassium-exchanging ATPase complex|caveola|intercalated disc|membrane|integral component of membrane|basolateral plasma membrane|apical plasma membrane|T-tubule|sarcolemma|melanosome|myelin sheath|protein complex|extracellular exosome|neuronal postsynaptic density|extracellular vesicle|,regulation of the force of heart contraction|regulation of sodium ion transport|cellular sodium ion homeostasis|regulation of blood pressure|potassium ion import|dephosphorylation|cellular potassium ion homeostasis|negative regulation of glucocorticoid biosynthetic process|sodium ion export from cell|response to drug|negative regulation of heart contraction|positive regulation of heart contraction|positive regulation of striated muscle contraction|membrane hyperpolarization|cellular response to mechanical stimulus|cellular response to steroid hormone stimulus|regulation of cardiac muscle cell contraction|membrane repolarization|potassium ion import across plasma membrane|response to glycoside|,sodium:potassium-exchanging ATPase activity|protein binding|ATP binding|phosphatase activity|protein kinase binding|protein domain specific binding|ankyrin binding|potassium ion binding|sodium ion binding|ADP binding|phosphatidylinositol 3-kinase binding|chaperone binding|steroid hormone binding|,47,271,2.5E+11,45.9%
Q8JZR0,0.64206681,-0.075666667,5.51179156,0.263333333,0.28107411,1.173526579,0.172,-0.088,-0.706,0.198,0.04,-0.07,Q8JZR0,Acsl5,Q8JZR0_Acsl5,Q8JZR0,Acsl5,1,238,48,45,Q8JZR0,MOUSE,77060.8,66.3,90,90.1,692.45,648.38,,683,Long-chain-fatty-acid--CoA ligase 5,nucleus|nucleolus|mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,long-chain fatty acid metabolic process|regulation of extrinsic apoptotic signaling pathway|,long-chain fatty acid-CoA ligase activity|ATP binding|,48,238,4.49E+11,66.3%
D3Z041,0.856589514,-0.098333333,2.293455204,0.114666667,0.589731709,0.566503729,0.018,0.118,-0.603,-0.012,0.092,-0.203,D3Z041,NotFound,D3Z041_NotFound,D3Z041,Acsl1,1,103,29,26,D3Z041|P41216,MOUSE,79060,42.3,90,90.2,410.25,366.18,,699,Long-chain-fatty-acid--CoA ligase 1,mitochondrion|membrane|,long-chain fatty acid metabolic process|lipid biosynthetic process|adiponectin-activated signaling pathway|long-chain fatty acid import|positive regulation of protein serine/threonine kinase activity|,long-chain fatty acid-CoA ligase activity|,26,103,71300000000,39.9%
Q925I1,0.905685074,-0.058,1.533005731,0.076666667,0.702585895,0.398806395,0.205,0.011,-0.505,0.111,0.002,-0.172,Q925I1,Atad3a,Q925I1_Atad3a,Q925I1,Atad3,1,202,51,51,Q925I1|Q925I1-2|H3BKI6,MOUSE,66912,66.1,91,91.1,691.69,691.69,,591,ATPase family AAA domain-containing protein 3,mitochondrion|mitochondrial inner membrane|integral component of membrane|mitochondrial nucleoid|,cell growth|negative regulation of apoptotic process|,ATP binding|,51,202,1.17E+11,66.1%
P37040,0.000756975,-0.123333333,46.31341578,1.697333333,2.337E-05,10.45914327,-0.929,-0.835,-1.152,0.492,1.029,0.655,P37040,Por,P37040_Por,P37040,Por,1,145,48,48,P37040|Q05DV1,MOUSE,77441.9,62.5,92,92.1,681.85,681.85,,678,NADPH--cytochrome P450 reductase,mitochondrion|endoplasmic reticulum membrane|cytosol|membrane|intracellular membrane-bounded organelle|,regulation of growth plate cartilage chondrocyte proliferation|response to nutrient|carnitine metabolic process|flavonoid metabolic process|internal peptidyl-lysine acetylation|fatty acid oxidation|positive regulation of chondrocyte differentiation|positive regulation of monooxygenase activity|response to drug|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|nitrate catabolic process|positive regulation of cholesterol biosynthetic process|positive regulation of smoothened signaling pathway|nitric oxide catabolic process|oxidation-reduction process|negative regulation of lipase activity|demethylation|cellular response to follicle-stimulating hormone stimulus|cellular response to peptide hormone stimulus|positive regulation of steroid hormone biosynthetic process|cellular organofluorine metabolic process|,"NADPH-hemoprotein reductase activity|cytochrome-b5 reductase activity, acting on NAD(P)H|iron ion binding|nitric oxide dioxygenase activity|electron carrier activity|FMN binding|oxidoreductase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen|hydrolase activity|enzyme binding|iron-cytochrome-c reductase activity|flavin adenine dinucleotide binding|NADP binding|",48,145,1.05E+11,62.5%
Q99PL5,0.666695042,0.012833333,5.063803603,0.130333333,0.311615922,1.095331782,-0.17,-0.099,0.112,0.085,-0.068,0.217,Q99PL5,Rrbp1,Q99PL5_Rrbp1,Q99PL5,Rrbp1,1,159,48,48,Q99PL5|A2AVJ7|Q99PL5-2|Q99PL5-3|Q99PL5-4|Q99PL5-5|Q99PL5-7|Q99PL5-6|Q99PL5-8|Q99PL5-9|Q99PL5-10|Q99PL5-11|Q99PL5-12,MOUSE,173332.6,33.8,93,93.1,679.08,679.08,,1605,Ribosome-binding protein 1,integral component of endoplasmic reticulum membrane|,signal transduction|protein transport|,protein binding|,48,159,98500000000,33.8%
Q9WU78,0.760472992,-0.005,3.690510782,-0.072666667,0.427512603,-0.844522904,-0.025,0.077,0.042,-0.124,-0.01,0.01,Q9WU78,Pdcd6ip,Q9WU78_Pdcd6ip,Q9WU78,Pdcd6ip,1,170,51,51,Q9WU78|Q9WU78-3|Q9WU78-2,MOUSE,96593,60.5,94,94.1,677.26,677.26,,869,Programmed cell death 6-interacting protein,immunological synapse|cytoplasm|microtubule organizing center|cytosol|focal adhesion|membrane|melanosome|myelin sheath|extracellular exosome|endoplasmic reticulum exit site|extracellular vesicle|,cell separation after cytokinesis|apoptotic process|cell cycle|regulation of centrosome duplication|protein transport|viral budding via host ESCRT complex|ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway|positive regulation of exosomal secretion|regulation of extracellular exosome assembly|positive regulation of extracellular exosome assembly|,protein binding|SH3 domain binding|proteinase activated receptor binding|protein homodimerization activity|protein dimerization activity|calcium-dependent protein binding|,51,170,79800000000,60.5%
E9Q7G0,0.797128744,-0.000166667,3.163687772,-0.062333333,0.482648791,-0.743134361,0.076,0.055,-0.038,0.014,-0.083,-0.025,E9Q7G0,Numa1,E9Q7G0_Numa1,E9Q7G0,Numa1,1,96,54,54,E9Q7G0,MOUSE,236710.3,32.9,95,95.1,676.31,676.31,,2094,Nuclear mitotic apparatus protein 1,Golgi membrane|spindle pole|nucleus|nucleoplasm|cytoplasm|spindle microtubule|nuclear matrix|dendrite|neuronal cell body|apical part of cell|extracellular exosome|,establishment of mitotic spindle orientation|meiotic cell cycle|lung epithelial cell differentiation|,microtubule binding|tubulin binding|,54,96,56300000000,32.9%
Q8VC30,0.718098103,-0.089833333,4.242551711,0.252333333,0.376482531,0.947914785,0.131,0.017,-0.796,0.311,-0.207,0.005,Q8VC30,Tkfc,Q8VC30_Tkfc,Q8VC30,Tkfc,1,347,39,39,Q8VC30,MOUSE,59975.3,68.8,96,96.1,674.07,674.07,,578,Triokinase/FMN cyclase,nucleus|extracellular exosome|,glycerol metabolic process|negative regulation of MDA-5 signaling pathway|cellular carbohydrate metabolic process|regulation of innate immune response|carbohydrate phosphorylation|,glycerone kinase activity|protein binding|ATP binding|FAD-AMP lyase (cyclizing) activity|metal ion binding|triokinase activity|,39,347,1.14E+12,68.8%
Q3ULD5,0.480593503,0.048333333,8.556222524,-0.310666667,0.139436909,-1.679349761,0.598,0.07,-0.057,0.045,-0.242,-0.124,Q3ULD5,Mccc2,Q3ULD5_Mccc2,Q3ULD5,Mccc2,1,205,39,39,Q3ULD5,MOUSE,61948.5,78.8,97,97.1,673.21,673.21,,563,"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial",mitochondrion|mitochondrial matrix|,leucine catabolic process|coenzyme A metabolic process|,methylcrotonoyl-CoA carboxylase activity|ATP binding|,39,205,1.93E+11,78.8%
Q8BU30,0.72790298,-0.0065,4.142006368,-0.090333333,0.385300314,-0.928690872,0.106,0.091,-0.081,0.048,-0.102,-0.101,Q8BU30,Iars,Q8BU30_Iars,Q8BU30,Iars,1,110,48,48,Q8BU30,MOUSE,145637.5,39.4,98,98.1,669.84,669.84,,1262,"Isoleucine--tRNA ligase, cytoplasmic",nucleoplasm|cytoplasm|cytosol|membrane|extracellular exosome|,osteoblast differentiation|isoleucyl-tRNA aminoacylation|regulation of translational fidelity|,aminoacyl-tRNA editing activity|isoleucine-tRNA ligase activity|ATP binding|GTPase binding|,48,110,48700000000,39.4%
P16858,0.788628825,-0.010833333,3.28402507,-0.188333333,0.469458809,-0.76715876,0.483,-0.37,0.137,-0.422,0.16,-0.053,P16858,Gapdh,P16858_Gapdh,P16858,Gapdh,1,444,42,8,A0A0A0MQF6|P16858|A0A1D5RLD8|P10096|V9GXA7|Q64467|S4R2G5|A0A0R4J0X7,MOUSE,36094.6,81.6,99,99.1,663.21,105.24,,333,Glyceraldehyde-3-phosphate dehydrogenase,nucleus|cytoplasm|cytosol|microtubule cytoskeleton|myelin sheath|GAIT complex|,microtubule cytoskeleton organization|glucose metabolic process|glycolytic process|negative regulation of translation|peptidyl-cysteine S-trans-nitrosylation|protein stabilization|neuron apoptotic process|oxidation-reduction process|,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity|protein binding|microtubule binding|enzyme binding|peptidyl-cysteine S-nitrosylase activity|NADP binding|NAD binding|,43,444,3.7E+12,81.6%
V9GX06,0.857449938,0.054666667,2.252266259,0.290666667,0.595351393,0.557768574,1.072,-0.354,-0.99,-0.219,0.68,0.139,V9GX06,NotFound,V9GX06_NotFound,V9GX06,Gm11214,1,14,5,2,V9GX06,MOUSE,20092.7,28.4,99,99.3,83.67,37.75,,183,Predicted gene 11214 (Fragment),,oxidation-reduction process|,,2,14,1.45E+11,19.6%
P51660,0.942471768,-0.021666667,0.832057495,-0.028666667,0.825646702,-0.229181581,0.064,0.152,-0.238,-0.038,0.051,-0.121,P51660,Hsd17b4,P51660_Hsd17b4,P51660,Hsd17b4,1,196,45,45,P51660,MOUSE,79993.9,61.6,100,100.1,662.84,662.84,,735,Peroxisomal multifunctional enzyme type 2,mitochondrion|peroxisome|peroxisomal membrane|membrane|intracellular membrane-bounded organelle|,very long-chain fatty acid metabolic process|osteoblast differentiation|fatty acid beta-oxidation|androgen metabolic process|estrogen metabolic process|very long-chain fatty-acyl-CoA metabolic process|medium-chain fatty-acyl-CoA metabolic process|oxidation-reduction process|Sertoli cell development|,"3-hydroxyacyl-CoA dehydrogenase activity|receptor binding|long-chain-enoyl-CoA hydratase activity|isomerase activity|3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity|protein homodimerization activity|17-beta-hydroxysteroid dehydrogenase (NAD+) activity|",45,196,2.16E+11,61.6%
A2AN08-5,0.985063154,-0.021666667,0.236911717,-0.007333333,0.946910273,-0.069128436,0.064,0.059,-0.177,0.077,-0.055,-0.098,A2AN08,Ubr4,A2AN08-5_Ubr4,A2AN08-5,Ubr4,1,98,57,57,A2AN08-5|A2AN08|A2AN08-3|A2AN08-2|A2AN08-4,MOUSE,582297.7,14.6,101,101.1,662.56,662.56,,5180,Isoform 5 of E3 ubiquitin-protein ligase UBR4,nucleoplasm|cytoplasm|centrosome|membrane|integral component of membrane|,protein ubiquitination involved in ubiquitin-dependent protein catabolic process|,ubiquitin-protein transferase activity|protein binding|calmodulin binding|zinc ion binding|ligase activity|,57,98,10500000000,14.6%
P06151,0.582708025,-0.102166667,6.674480203,-0.605666667,0.215056206,-1.370958836,-0.303,0.058,0.847,-1.294,0.083,-0.004,P06151,Ldha,P06151_Ldha,P06151,Ldha,1,287,40,37,P06151|A0A1B0GSX0|A0A1B0GSR9|A0A1B0GQX5|A0A1B0GS79|P00342|A0A1B0GRE9|A0A1B0GSR2,MOUSE,36840.2,84.9,102,102.1,659.66,619.12,,332,L-lactate dehydrogenase A chain,nucleus|mitochondrion|cytosol|membrane|sperm fibrous sheath|extracellular exosome|,carbohydrate metabolic process|lactate biosynthetic process from pyruvate|cellular response to extracellular stimulus|oxidation-reduction process|,L-lactate dehydrogenase activity|protein binding|,40,287,1.21E+12,84.9%
P16125,0.884566234,-0.066333333,1.857980889,-0.081333333,0.651931418,-0.472231128,-0.267,0.06,0.13,-0.412,0.11,-0.019,P16125,Ldhb,P16125_Ldhb,P16125,Ldhb,1,18,14,11,P16125,MOUSE,36856.9,40.1,102,102.2,147.34,106.8,,334,L-lactate dehydrogenase B chain,cytoplasm|mitochondrion|membrane|myelin sheath|membrane raft|extracellular exosome|,carbohydrate metabolic process|lactate biosynthetic process from pyruvate|NAD metabolic process|oxidation-reduction process|,L-lactate dehydrogenase activity|kinase binding|identical protein binding|NAD binding|,11,18,2130000000,32.6%
Q78PY7,0.546002425,0.1025,7.350782436,-0.341,0.184044039,-1.483018055,-0.009,0.821,0.007,-0.125,0.04,-0.119,Q78PY7,Snd1,Q78PY7_Snd1,Q78PY7,Snd1,1,141,48,48,Q78PY7|Q3TJ56|E9Q3E9,MOUSE,102770.9,57.5,103,103.1,653.37,653.37,,910,Staphylococcal nuclease domain-containing protein 1,nucleus|cytoplasm|mitochondrion|membrane|RISC complex|melanosome|extracellular exosome|dense body|,"osteoblast differentiation|transcription, DNA-templated|regulation of transcription, DNA-templated|posttranscriptional gene silencing by RNA|nucleic acid phosphodiester bond hydrolysis|",transcription cofactor activity|nuclease activity|protein binding|poly(A) RNA binding|,48,141,61700000000,57.5%
A11111,0.000365132,-0.232666667,53.22535028,2.758666667,4.75844E-06,13.43642546,-1.476,-1.502,-1.858,0.731,1.43,1.279,A11111,NotFound,A11111_NotFound,A11111,,1,268,36,36,A11111|P06709,MOUSE,39099.5,82,104,104.1,651.83,651.83,,,BirAG3ER,,,,36,268,8.77E+11,82.0%
Q921X9,0.919416995,0.007,1.248029924,-0.029333333,0.750234459,-0.331726606,0.023,-0.062,0.104,0.034,-0.071,0.014,Q921X9,Pdia5,Q921X9_Pdia5,Q921X9,Pdia5,1,169,44,36,Q921X9,MOUSE,60007.8,65.5,105,105.1,651.28,539.2,,517,Protein disulfide-isomerase A5,endoplasmic reticulum lumen|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|,protein disulfide isomerase activity|,44,169,1.66E+11,65.5%
A0A087WSN6,0.277283754,-0.0615,13.43968413,0.332333333,0.045293052,2.46165941,-0.362,-0.371,0.05,0.03,0.147,0.137,A0A087WSN6,Fn1,A0A087WSN6_Fn1,A0A087WSN6,Fn1,1,143,51,51,A0A087WSN6|B9EHT6|B7ZNJ1|P11276|A0A087WR50|Q3UHL6|A0A087WS56|Q4KL80,MOUSE,256658.4,31.6,106,106.1,647.88,647.88,,2296,Fibronectin,fibrinogen complex|proteinaceous extracellular matrix|basement membrane|basal lamina|extracellular space|endoplasmic reticulum-Golgi intermediate compartment|apical plasma membrane|extracellular matrix|extracellular exosome|blood microparticle|extracellular matrix|,"regulation of protein phosphorylation|cell-substrate junction assembly|cell adhesion|cell-matrix adhesion|calcium-independent cell-matrix adhesion|positive regulation of cell proliferation|positive regulation of gene expression|positive regulation of peptidase activity|peptide cross-linking|integrin activation|substrate adhesion-dependent cell spreading|endodermal cell differentiation|wound healing|positive regulation of axon extension|positive regulation of fibroblast proliferation|regulation of ERK1 and ERK2 cascade|positive regulation of substrate-dependent cell migration, cell attachment to substrate|negative regulation of transforming growth factor-beta secretion|",protease binding|integrin binding|protein binding|peptidase activator activity|,51,143,32800000000,31.6%
Q9WU79,0.951421295,-0.0375,0.724016603,-0.030333333,0.846444212,-0.201386261,0.11,0.164,-0.341,-0.011,0.004,-0.151,Q9WU79,Prodh,Q9WU79_Prodh,Q9WU79,Prodh,1,216,45,45,Q9WU79|A0A0R4J1T9|E9PUR5,MOUSE,68662.4,67.1,107,107.1,644.53,644.53,,599,"Proline dehydrogenase 1, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial matrix|,proline catabolic process to glutamate|oxidation-reduction process|,proline dehydrogenase activity|amino acid binding|FAD binding|,45,216,1.79E+11,67.1%
P32020,0.438500879,0.027166667,9.600870442,-0.187666667,0.109625845,-1.844013089,0.119,0.267,-0.023,-0.033,-0.054,-0.113,P32020,Scp2,P32020_Scp2,P32020,Scp2,1,220,42,42,P32020|P32020-2,MOUSE,59752.2,70,108,108.1,641.9,641.9,,547,Non-specific lipid-transfer protein,nucleoplasm|cytoplasm|mitochondrion|peroxisome|membrane|intracellular membrane-bounded organelle|protein complex|extracellular exosome|,acyl-CoA metabolic process|steroid biosynthetic process|progesterone biosynthetic process|peroxisome organization|phospholipid transport|positive regulation of intracellular cholesterol transport|inositol trisphosphate biosynthetic process|positive regulation of steroid metabolic process|protein localization to plasma membrane|lipid hydroperoxide transport|,fatty-acyl-CoA binding|receptor binding|protein binding|phosphatidylinositol transporter activity|cholesterol binding|propanoyl-CoA C-acyltransferase activity|long-chain fatty acyl-CoA binding|propionyl-CoA C2-trimethyltridecanoyltransferase activity|oleic acid binding|,42,220,2.97E+11,70.0%
Q9D0I9,0.491381718,-0.0255,8.383810877,-0.187,0.145083797,-1.650229188,0.165,0.075,-0.036,0.059,-0.171,-0.245,Q9D0I9,Rars,Q9D0I9_Rars,Q9D0I9,Rars,1,163,45,45,Q9D0I9,MOUSE,76470.9,68.9,109,109.1,639.45,639.45,,660,"Arginine--tRNA ligase, cytoplasmic",nucleoplasm|cytoplasm|mitochondrion|membrane|aminoacyl-tRNA synthetase multienzyme complex|extracellular exosome|,arginyl-tRNA aminoacylation|,tRNA binding|arginine-tRNA ligase activity|ATP binding|arginine binding|,45,163,87000000000,68.9%
Q8QZT1,0.718098103,-0.019166667,4.24284679,-0.165,0.376456951,-0.947968848,-0.085,0.306,-0.031,-0.395,0.157,-0.067,Q8QZT1,Acat1,Q8QZT1_Acat1,Q8QZT1,Acat1,1,332,39,39,Q8QZT1,MOUSE,45157.7,68.1,110,110.1,634.5,634.5,,424,"Acetyl-CoA acetyltransferase, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial matrix|extracellular exosome|,liver development|brain development|metabolic process|response to hormone|response to organic cyclic compound|response to starvation|protein homooligomerization|adipose tissue development|metanephric proximal convoluted tubule development|,acetyl-CoA C-acetyltransferase activity|enzyme binding|protein homodimerization activity|metal ion binding|coenzyme binding|,39,332,7.53E+11,68.1%
Q9Z2I9,0.844723818,0.000666667,2.42910612,-0.137333333,0.571596272,-0.595024791,0.344,0.342,-0.478,-0.071,0.04,-0.173,Q9Z2I9,Sucla2,Q9Z2I9_Sucla2,Q9Z2I9,Sucla2,1,211,39,39,Q9Z2I9|Q8R366|A0A0R4J117|G3UYZ1,MOUSE,50455.4,76.2,111,111.1,633.57,633.57,,463,"Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial",mitochondrion|myelin sheath|extracellular exosome|,tricarboxylic acid cycle|succinyl-CoA metabolic process|succinate metabolic process|,succinate-CoA ligase activity|succinate-CoA ligase (ADP-forming) activity|ATP binding|metal ion binding|,39,211,3.47E+11,76.2%
Q91YW3,0.001644128,-0.141,41.9286538,1.520666667,6.41408E-05,8.894081496,-0.884,-0.656,-1.164,0.464,0.513,0.881,Q91YW3,Dnajc3,Q91YW3_Dnajc3,Q91YW3,Dnajc3,1,174,44,44,Q91YW3,MOUSE,57919.4,69.2,112,112.1,632.18,632.18,,504,DnaJ homolog subfamily C member 3,cytoplasm|endoplasmic reticulum lumen|smooth endoplasmic reticulum|cytosol|membrane|extracellular exosome|extracellular vesicle|endoplasmic reticulum Sec complex|,negative regulation of protein kinase activity|endoplasmic reticulum unfolded protein response|negative regulation of apoptotic process|proteolysis involved in cellular protein catabolic process|negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation|negative regulation of cyclin-dependent protein kinase activity|,protein binding|chaperone binding|misfolded protein binding|,44,174,1.5E+11,69.2%
Q91X83,0.265196004,0.000666667,13.7851253,-0.232666667,0.041829962,-2.510799557,0.032,0.143,0.176,-0.198,-0.019,-0.13,Q91X83,Mat1a,Q91X83_Mat1a,Q91X83,Mat1a,1,323,38,28,Q91X83|Q6PH08-3|Q3UHT7|Q6PH08|Q924H9|Q6PH08-2|Q6PH08-4|A0A1W2P7Y8|Q61657,MOUSE,44078.4,79.7,113,113.1,628.1,475.17,,396,S-adenosylmethionine synthase isoform type-1,cytosol|,S-adenosylmethionine biosynthetic process|one-carbon metabolic process|,methionine adenosyltransferase activity|ATP binding|metal ion binding|,38,323,1.64E+12,79.7%
Q3THS6,0.886698259,0.013666667,1.802134766,-0.045333333,0.660368765,-0.459573519,0.168,-0.084,0.025,0.054,-0.015,-0.066,Q3THS6,Mat2a,Q3THS6_Mat2a,Q3THS6,Mat2a,1,27,20,11,Q3THS6|A0A0U1RNK6|A0A0U1RNT6,MOUSE,44030.3,43.7,113,113.2,278.39,131.76,,395,S-adenosylmethionine synthase isoform type-2,cytosol|methionine adenosyltransferase complex|,S-adenosylmethionine biosynthetic process|one-carbon metabolic process|,methionine adenosyltransferase activity|ATP binding|metal ion binding|,11,27,7730000000,30.6%
Q64514-2,0.953420192,-0.040833333,0.69954851,-0.028333333,0.851226527,-0.195020792,-0.116,0.085,-0.049,-0.351,0.106,0.08,Q64514,Tpp2,Q64514-2_Tpp2,Q64514-2,Tpp2,1,126,48,48,Q64514-2|Q64514|A0A087WRC0|Q05DJ9,MOUSE,140001.1,39.3,114,114.1,626.72,626.72,,1262,Isoform Short of Tripeptidyl-peptidase 2,nucleus|nucleoplasm|cytoplasm|,proteolysis|,aminopeptidase activity|serine-type endopeptidase activity|,48,126,32000000000,39.3%
Q6GQT9,0.000372555,-0.304,52.10997648,2.074666667,6.1518E-06,12.90824899,-1.191,-1.144,-1.689,0.633,0.816,0.751,Q6GQT9,Nomo1,Q6GQT9_Nomo1,Q6GQT9,Nomo1,1,161,41,41,Q6GQT9,MOUSE,134444.5,50.4,115,115.1,618.14,618.14,,1214,Nodal modulator 1,endoplasmic reticulum membrane|membrane|integral component of membrane|,,carbohydrate binding|,41,161,70400000000,50.4%
Q9QXY6,0.647450828,-0.026333333,5.407511614,0.156,0.287904756,1.155446559,0.085,-0.044,-0.354,0.17,0.018,-0.033,Q9QXY6,Ehd3,Q9QXY6_Ehd3,Q9QXY6,Ehd3,1,135,40,28,Q9QXY6,MOUSE,60877,81.4,116,116.1,617.83,446.29,,535,EH domain-containing protein 3,cytoplasm|plasma membrane|focal adhesion|endocytic vesicle|myelin sheath|perinuclear region of cytoplasm|recycling endosome membrane|,endocytic recycling|protein homooligomerization|protein targeting to plasma membrane|regulation of cardiac muscle cell membrane potential|,calcium ion binding|protein binding|ATP binding|GTP binding|,40,135,65900000000,81.4%
Q9WVK4,0.527697801,-0.009333333,7.683552144,0.202666667,0.170468754,1.53759122,0.055,-0.111,-0.276,0.29,0.025,-0.039,Q9WVK4,Ehd1,Q9WVK4_Ehd1,Q9WVK4,Ehd1,1,85,34,22,Q9WVK4,MOUSE,60658.7,72.4,116,116.2,498.56,330.7,,534,EH domain-containing protein 1,endosome|early endosome|lipid particle|plasma membrane|endosome membrane|membrane|endocytic vesicle|platelet dense tubular network membrane|early endosome membrane|myelin sheath|perinuclear region of cytoplasm|recycling endosome membrane|extracellular exosome|,intracellular protein transport|endocytosis|positive regulation of cholesterol storage|endosomal transport|neuron projection development|endocytic recycling|low-density lipoprotein particle clearance|cholesterol homeostasis|protein homooligomerization|positive regulation of myoblast fusion|cellular response to nerve growth factor stimulus|positive regulation of endocytic recycling|,protein binding|ATP binding|GTP binding|Rab GTPase binding|,22,85,29900000000,50.3%
Q9EQP2,0.497381785,-0.0135,8.229102428,-0.183666667,0.150345266,-1.625208737,0.077,-0.032,0.19,0.062,-0.229,-0.149,Q9EQP2,Ehd4,Q9EQP2_Ehd4,Q9EQP2,Ehd4,1,30,16,12,Q9EQP2,MOUSE,61707.7,35.4,116,116.3,213.73,165.65,,541,EH domain-containing protein 4,endoplasmic reticulum|plasma membrane|membrane|early endosome membrane|perinuclear region of cytoplasm|recycling endosome membrane|extracellular exosome|,pinocytosis|regulation of endocytosis|endocytic recycling|positive regulation of peptidyl-tyrosine phosphorylation|protein homooligomerization|cellular response to growth factor stimulus|,calcium ion binding|protein binding|ATP binding|GTP binding|,12,30,2400000000,28.2%
Q8BH64,0.530752353,-0.035833333,7.585417126,0.233,0.174364588,1.521531483,-0.063,0.047,-0.441,0.25,-0.035,0.027,Q8BH64,Ehd2,Q8BH64_Ehd2,Q8BH64,Ehd2,1,10,7,6,Q8BH64,MOUSE,61344.5,13.8,116,116.4,70.46,56.79,,543,EH domain-containing protein 2,plasma membrane|caveola|membrane|perinuclear region of cytoplasm|recycling endosome membrane|extracellular exosome|,endocytosis|metabolic process|cortical actin cytoskeleton organization|endocytic recycling|protein localization to plasma membrane|positive regulation of myoblast fusion|positive regulation of endocytic recycling|,calcium ion binding|protein binding|ATP binding|GTP binding|hydrolase activity|protein domain specific binding|,6,10,5470000000,13.8%
P28666,0.001353499,-0.0215,42.90024274,1.127,5.12833E-05,9.221855499,-0.643,-0.533,-0.579,0.537,0.338,0.751,P28666,Mug2,P28666_Mug2,P28666,Mug2,1,137,47,23,P28666|A0A0N4SVU1,MOUSE,163805.4,40.7,117,117.1,616.99,305.99,,1451,Murinoglobulin-2,extracellular space|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,49,137,51000000000,40.7%
P28665,0.014157971,-0.154166667,30.31598946,1.433666667,0.000929825,5.662504392,-0.64,-0.516,-1.457,0.409,0.743,0.536,P28665,Mug1,P28665_Mug1,P28665,Mug1,1,47,46,20,P28665,MOUSE,166721,41.5,117,117.2,614.63,289.56,,1476,Murinoglobulin-1,extracellular space|,embryo implantation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,20,47,16600000000,22.1%
Q571F8,0.991556352,-0.076166667,0.176073117,-0.014333333,0.960268512,-0.051731964,0.209,0.309,-0.725,-0.091,0.086,-0.245,Q571F8,Gls2,Q571F8_Gls2,Q571F8,Gls2,1,190,38,38,Q571F8|D6RI88|E0CYF7,MOUSE,67220.6,59.4,118,118.1,616.21,616.21,,602,"Glutaminase liver isoform, mitochondrial",mitochondrion|,glutamine metabolic process|regulation of apoptotic process|reactive oxygen species metabolic process|positive regulation of protein targeting to mitochondrion|,glutaminase activity|,38,190,1.34E+11,59.4%
Q9DBN5,0.855039332,0.050166667,2.315491734,-0.092333333,0.586746931,-0.57116255,0.394,-0.067,-0.038,0.194,-0.178,-0.004,Q9DBN5,Lonp2,Q9DBN5_Lonp2,Q9DBN5,Lonp2,1,128,43,43,Q9DBN5|Q9DBN5-3|Q9DBN5-2|Q8BK80,MOUSE,95038.2,51.8,119,119.1,614.76,614.76,,852,"Lon protease homolog 2, peroxisomal",nucleus|cytoplasm|peroxisome|peroxisomal matrix|membrane|,misfolded or incompletely synthesized protein catabolic process|protein targeting to peroxisome|response to organic cyclic compound|protein processing|protein import into peroxisome matrix|regulation of fatty acid beta-oxidation|,protease binding|ATP-dependent peptidase activity|serine-type endopeptidase activity|receptor binding|protein binding|ATP binding|peptidase activity|enzyme binding|,43,128,1.13E+11,51.8%
Q9QZE5,0.526056,-0.011333333,7.705068097,-0.137333333,0.1696263,-1.538950174,0.12,0.055,-0.003,0.016,-0.133,-0.123,Q9QZE5,Copg1,Q9QZE5_Copg1,Q9QZE5,Copg1,1,179,44,39,Q9QZE5|Q7TNQ1,MOUSE,98766.3,55.4,120,120.1,614.37,541.96,,874,Coatomer subunit gamma-1,cytosol|COPI vesicle coat|,intracellular protein transport|vesicle-mediated transport|,structural molecule activity|,44,179,1E+11,55.4%
Q9QXK3,0.797504707,0.002666667,3.112399044,-0.068,0.488382502,-0.733056556,0.109,0.03,-0.029,0.079,-0.091,-0.082,Q9QXK3,Copg2,Q9QXK3_Copg2,Q9QXK3,Copg2,1,47,25,20,Q9QXK3|Q9QXK3-4|Q9QXK3-3|Q9QXK3-2,MOUSE,98876.9,35.8,120,120.2,359.56,287.15,,871,Coatomer subunit gamma-2,cytosol|COPI vesicle coat|,intracellular protein transport|intra-Golgi vesicle-mediated transport|,structural molecule activity|,20,47,17700000000,29.8%
Q8BH00,0.935853609,-0.037166667,0.917629021,0.039666667,0.809537736,0.250849368,-0.224,0.019,0.034,-0.319,0.214,0.053,Q8BH00,Aldh8a1,Q8BH00_Aldh8a1,Q8BH00,Aldh8a1,1,195,38,38,Q8BH00,MOUSE,54404.6,77.2,121,121.1,611.61,611.61,,487,Aldehyde dehydrogenase family 8 member A1,intracellular|cytoplasm|extracellular exosome|,retinoic acid metabolic process|retinal metabolic process|9-cis-retinoic acid biosynthetic process|oxidation-reduction process|,retinal dehydrogenase activity|aldehyde dehydrogenase (NAD) activity|,38,195,2.54E+11,77.2%
P55096,0.714714682,-0.086333333,4.288712152,0.212,0.372502151,0.956361582,0.143,-0.024,-0.696,0.15,0.029,-0.12,P55096,Abcd3,P55096_Abcd3,P55096,Abcd3,1,200,42,42,P55096|A0A0G2JDI9|A0A0G2JGA4,MOUSE,75986.8,57.3,122,122.1,610.98,610.98,,659,ATP-binding cassette sub-family D member 3,mitochondrion|mitochondrial inner membrane|peroxisome|peroxisomal membrane|peroxisomal matrix|membrane|integral component of membrane|intracellular membrane-bounded organelle|,fatty acid biosynthetic process|fatty acid beta-oxidation|peroxisome organization|response to organic cyclic compound|peroxisomal long-chain fatty acid import|response to drug|very long-chain fatty acid catabolic process|transmembrane transport|,"long-chain fatty acid transporter activity|protein binding|ATP binding|ATPase activity|ATPase activity, coupled to transmembrane movement of substances|protein homodimerization activity|protein self-association|",42,200,3.34E+11,57.3%
P60710,0.522394747,-0.042666667,7.761509175,0.241333333,0.167436093,1.550329679,-0.014,0.009,-0.485,-0.059,0.139,0.154,P60710,Actb,P60710_Actb,P60710,Actb,1,560,38,1,P60710|E9Q1F2|V9GXQ2,MOUSE,42078.3,83.7,123,123.1,606.39,19.78,,375,"Actin, cytoplasmic 1",nuclear chromatin|extracellular space|cytosol|plasma membrane|focal adhesion|membrane|ribonucleoprotein complex|cortical cytoskeleton|NuA4 histone acetyltransferase complex|cytoplasmic ribonucleoprotein granule|myelin sheath|protein complex|extracellular exosome|MLL5-L complex|blood microparticle|dense body|,retina homeostasis|substantia nigra development|ATP-dependent chromatin remodeling|platelet aggregation|,protein binding|ATP binding|kinesin binding|Tat protein binding|identical protein binding|nitric-oxide synthase binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|,38,560,5.01E+12,83.7%
P68033,0.430655636,-0.078666667,9.764894796,0.372666667,0.105562707,1.873502628,-0.111,0.029,-0.713,0.094,0.003,0.226,P68033,Actc1,P68033_Actc1,P68033,Actc1,1,77,34,12,P68033|P62737|P63268|P68134,MOUSE,42360.6,66.8,123,123.3,509.98,183.91,,377,"Actin, alpha cardiac muscle 1","extracellular space|cytoplasm|actin filament|focal adhesion|membrane|sarcomere|lamellipodium|filopodium|I band|actomyosin, actin portion|cell body|extracellular exosome|blood microparticle|",metabolic process|positive regulation of gene expression|actin filament-based movement|skeletal muscle thin filament assembly|actomyosin structure organization|actin-myosin filament sliding|response to drug|negative regulation of apoptotic process|response to ethanol|cardiac myofibril assembly|cardiac muscle tissue morphogenesis|heart contraction|cardiac muscle contraction|actin-mediated cell contraction|mesenchyme migration|,protein binding|ATP binding|ATPase activity|myosin binding|,12,77,3.73E+11,37.9%
E9PXC3,0.585175913,-0.166666667,6.610044,0.530666667,0.21827078,1.360189787,-0.009,0.038,-1.325,0.153,-0.284,0.427,E9PXC3,Cyp2c69,E9PXC3_Cyp2c69,E9PXC3,Cyp2c69,1,215,39,10,E9PXC3,MOUSE,56876.7,67.8,124,124.1,605.13,171.27,,491,"Cytochrome P450, family 2, subfamily c, polypeptide 69",cytoplasm|intracellular membrane-bounded organelle|,xenobiotic metabolic process|epoxygenase P450 pathway|exogenous drug catabolic process|oxidation-reduction process|,"iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|",39,215,3.38E+11,67.8%
Q569X9,0.81292793,0.010833333,2.903540256,-0.089,0.512443483,-0.692044862,-0.125,0.27,0.021,-0.135,-0.061,0.095,Q569X9,Cyp2c67,Q569X9_Cyp2c67,Q569X9,Cyp2c67,1,4,31,3,Q569X9,MOUSE,56942.8,49.6,124,124.3,436.89,29.56,,491,"Cytochrome P450, family 2, subfamily c, polypeptide 67",cytoplasm|intracellular membrane-bounded organelle|,xenobiotic metabolic process|epoxygenase P450 pathway|exogenous drug catabolic process|oxidation-reduction process|,"iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|",3,4,1810000000,5.9%
K7N6C2,0.972248418,-0.0245,0.400533083,-0.016333333,0.9118989,-0.114942747,0.059,0.198,-0.306,-0.103,0.021,-0.016,K7N6C2,Cyp2c68,K7N6C2_Cyp2c68,K7N6C2,Cyp2c68,1,9,29,3,K7N6C2,MOUSE,56798.6,52.1,124,124.4,404.5,34.71,,491,"Cytochrome P450, family 2, subfamily c, polypeptide 68",cytoplasm|intracellular membrane-bounded organelle|,xenobiotic metabolic process|epoxygenase P450 pathway|exogenous drug catabolic process|oxidation-reduction process|,"iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|",3,9,1470000000,6.9%
Q9QXX4,0.584741827,-0.020166667,6.627881468,-0.498333333,0.21737613,-1.363172675,-0.309,0.883,0.113,-0.863,0.101,-0.046,Q9QXX4,Slc25a13,Q9QXX4_Slc25a13,Q9QXX4,Slc25a13,1,223,40,33,Q9QXX4,MOUSE,74864.9,72,125,125.1,604.9,526.68,,676,Calcium-binding mitochondrial carrier protein Aralar2,mitochondrion|mitochondrial inner membrane|integral component of membrane|,ATP biosynthetic process|aspartate transport|L-glutamate transport|malate-aspartate shuttle|cellular respiration|response to calcium ion|L-glutamate transmembrane transport|L-aspartate transmembrane transport|,L-glutamate transmembrane transporter activity|calcium ion binding|L-aspartate transmembrane transporter activity|,40,223,3.49E+11,72.0%
Q8BH59,0.612622361,-0.0475,6.122002179,-0.431,0.244230435,-1.278016116,-0.474,0.566,0.412,-0.798,-0.076,0.085,Q8BH59,Slc25a12,Q8BH59_Slc25a12,Q8BH59,Slc25a12,1,37,23,16,Q8BH59|V9GXX9,MOUSE,74967.6,41.5,125,125.2,291.71,213.49,,677,Calcium-binding mitochondrial carrier protein Aralar1,mitochondrion|mitochondrial inner membrane|integral component of membrane|myelin sheath|,aspartate transport|L-glutamate transport|malate-aspartate shuttle|response to calcium ion|L-glutamate transmembrane transport|L-aspartate transmembrane transport|,L-glutamate transmembrane transporter activity|calcium ion binding|L-aspartate transmembrane transporter activity|,16,37,15500000000,33.2%
P68372,0.940972966,-0.013333333,0.847806251,-0.028,0.822658094,-0.233191874,0.163,0.051,-0.212,0.058,-0.045,-0.095,P68372,Tubb4b,P68372_Tubb4b,P68372,Tubb4b,1,363,34,2,P68372,MOUSE,50286.6,76.1,126,126.1,601.85,40.09,,445,Tubulin beta-4B chain,nucleus|cytoplasm|microtubule|myelin sheath|tubulin complex|extracellular exosome|extracellular vesicle|,microtubule-based process|metabolic process|protein polymerization|,double-stranded RNA binding|GTPase activity|structural constituent of cytoskeleton|GTP binding|,34,363,1.76E+12,76.1%
P99024,0.922247203,0.012166667,1.146957136,-0.026333333,0.767899326,-0.307369462,0.089,-0.021,0.008,0.075,-0.036,-0.042,P99024,Tubb5,P99024_Tubb5,P99024,Tubb5,1,31,34,6,P99024|A0A1D5RM76,MOUSE,50126.4,76.3,126,126.2,591.66,109.83,,444,Tubulin beta-5 chain,nucleus|nuclear envelope lumen|cytosol|microtubule|cytoplasmic ribonucleoprotein granule|cell body|tubulin complex|extracellular exosome|,protein folding|microtubule-based process|cellular process|spindle assembly|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|protein domain specific binding|ubiquitin protein ligase binding|protein complex binding|GTPase activating protein binding|MHC class I protein binding|,6,31,66500000000,17.1%
Q7TMM9,0.815095629,-0.040333333,2.879739846,0.09,0.515259509,0.687271272,0.069,0.017,-0.342,-0.004,0.09,-0.072,Q7TMM9,Tubb2a,Q7TMM9_Tubb2a,Q7TMM9,Tubb2a,1,46,32,6,Q7TMM9|Q9CWF2,MOUSE,50305.5,76.1,126,126.3,550.69,100.8,,445,Tubulin beta-2A chain,nucleus|cytoplasm|microtubule|extracellular exosome|extracellular vesicle|,microtubule-based process|metabolic process|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,6,46,87000000000,22.2%
Q922F4,0.965288537,0.049666667,0.469866134,0.016,0.897456457,0.133906064,0.112,-0.064,0.077,0.267,-0.077,-0.017,Q922F4,Tubb6,Q922F4_Tubb6,Q922F4,Tubb6,1,9,18,3,Q922F4,MOUSE,50545.9,38.7,126,126.5,254.92,38.56,,447,Tubulin beta-6 chain,nucleus|cytoplasm|microtubule|extracellular exosome|,microtubule-based process|metabolic process|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,3,9,1010000000,9.6%
A2AQ07,0.894455479,-0.045166667,1.668464978,-0.069666667,0.68101002,-0.429761847,0.259,0.015,-0.305,0.045,-0.041,-0.244,A2AQ07,Tubb1,A2AQ07_Tubb1,A2AQ07,Tubb1,1,4,9,3,A2AQ07,MOUSE,51124.7,20.1,126,126.7,110.08,30.83,,451,Tubulin beta-1 chain,cytoplasm|microtubule|extracellular exosome|,microtubule-based process|metabolic process|spindle assembly|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,3,4,642000000,15.9%
Q4LDG0,0.811763387,-0.031166667,2.93611747,-0.099,0.508613933,-0.698563831,0.12,0.162,-0.227,-0.118,0.095,-0.219,Q4LDG0,Slc27a5,Q4LDG0_Slc27a5,Q4LDG0,Slc27a5,1,206,39,39,Q4LDG0|E9PXV4,MOUSE,77171.4,60,127,127.1,601.71,601.71,,689,Bile acyl-CoA synthetase,endoplasmic reticulum|basal plasma membrane|integral component of endoplasmic reticulum membrane|protein complex|,very long-chain fatty acid metabolic process|long-chain fatty acid metabolic process|triglyceride mobilization|bile acid biosynthetic process|bile acid metabolic process|fatty acid transport|plasma membrane long-chain fatty acid transport|ketone body biosynthetic process|,long-chain fatty acid-CoA ligase activity|ATP binding|fatty acid transporter activity|very long-chain fatty acid-CoA ligase activity|protein complex binding|cholate-CoA ligase activity|,39,206,4.54E+11,60.0%
P00329,0.553672549,-0.027166667,7.204267415,0.195666667,0.190358932,1.458880378,0.004,0.005,-0.384,-0.014,0.185,0.041,P00329,Adh1,P00329_Adh1,P00329,Adh1,1,333,35,35,P00329,MOUSE,40626.5,77.8,128,128.1,601.16,601.16,,375,Alcohol dehydrogenase 1,intracellular|mitochondrion|,retinoid metabolic process|ethanol catabolic process|ethanol oxidation|response to retinoic acid|response to testosterone|retinol metabolic process|retinoic acid metabolic process|behavioral response to ethanol|response to steroid hormone|,alcohol dehydrogenase (NAD) activity|zinc ion binding|protein homodimerization activity|,35,333,4.93E+12,77.8%
Q9ERU9,0.981340898,-0.023666667,0.294120641,0.009333333,0.93451857,0.085306258,0.047,0.094,-0.226,0.018,-0.037,-0.038,Q9ERU9,Ranbp2,Q9ERU9_Ranbp2,Q9ERU9,Ranbp2,1,105,50,50,Q9ERU9,MOUSE,344937.3,20.9,129,129.1,595.88,595.88,,3053,E3 SUMO-protein ligase RanBP2,mitochondrion|nuclear membrane|nuclear inclusion body|nuclear pore cytoplasmic filaments|nuclear pore nuclear basket|,protein peptidyl-prolyl isomerization|response to amphetamine|protein folding|protein transport|protein sumoylation|negative regulation of glucokinase activity|intracellular transport|mRNA transport|regulation of gluconeogenesis involved in cellular glucose homeostasis|,RNA binding|peptidyl-prolyl cis-trans isomerase activity|protein binding|zinc ion binding|ligase activity|protein complex binding|,50,105,16200000000,20.9%
P26443,0.996774804,-0.059166667,0.037250576,0.003,0.991459418,0.011114732,0.181,0.345,-0.708,0.065,-0.088,-0.15,P26443,Glud1,P26443_Glud1,P26443,Glud1,1,204,40,40,P26443|P00366,MOUSE,61678,65.7,130,130.1,593.47,593.47,,558,"Glutamate dehydrogenase 1, mitochondrial",cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial matrix|,glutamate biosynthetic process|glutamate catabolic process|glutamine metabolic process|long-term memory|response to aluminum ion|positive regulation of insulin secretion|oxidation-reduction process|tricarboxylic acid metabolic process|,glutamate dehydrogenase (NAD+) activity|glutamate dehydrogenase [NAD(P)+] activity|protein binding|ATP binding|GTP binding|enzyme binding|ADP binding|NAD+ binding|leucine binding|,40,204,4.11E+11,65.7%
P39054,0.639638704,0.000833333,5.552692899,-0.101,0.278439413,-1.179388701,0.111,0.009,0.034,0.028,-0.103,-0.074,P39054,Dnm2,P39054_Dnm2,P39054,Dnm2,1,122,47,2,P39054|Q3T9X3|F8WIV5|P39054-2|P39053|P39053-4|P39053-6|A0A0J9YUN4|P39053-5|P39053-3|A0A0J9YUE9|E0CXZ8|F2Z460|G3UY64|D6RH60,MOUSE,98485.9,50.3,131,131.1,592.47,25.17,,870,Dynamin-2,Golgi membrane|phagocytic cup|photoreceptor inner segment|nucleus|cytoplasm|endosome|Golgi apparatus|trans-Golgi network|centrosome|cytosol|microtubule|coated pit|focal adhesion|postsynaptic density|lamellipodium|cell junction|midbody|ruffle membrane|postsynaptic membrane|clathrin-coated endocytic vesicle|perinuclear region of cytoplasm|extracellular exosome|growth cone|,G-protein coupled receptor internalization|Golgi to plasma membrane transport|receptor-mediated endocytosis|spermatogenesis|response to light stimulus|positive regulation of lamellipodium assembly|negative regulation of transforming growth factor beta receptor signaling pathway|regulation of axon extension|receptor internalization|transferrin transport|regulation of Rac protein signal transduction|response to cocaine|macropinocytosis|positive regulation of nitric oxide biosynthetic process|neuron projection morphogenesis|positive regulation of phagocytosis|cilium morphogenesis|cellular response to carbon monoxide|cellular response to X-ray|cellular response to nitric oxide|positive regulation of substrate adhesion-dependent cell spreading|cellular response to dopamine|regulation of Golgi organization|positive regulation of sodium:potassium-exchanging ATPase activity|negative regulation of membrane tubulation|,GTPase activity|protein binding|GTP binding|SH3 domain binding|protein kinase binding|D2 dopamine receptor binding|protein complex binding|phosphatidylinositol 3-kinase regulatory subunit binding|WW domain binding|nitric-oxide synthase binding|,47,122,35100000000,50.3%
P00186,0.480058024,-0.005666667,8.568423917,-0.216666667,0.139045715,-1.6813203,0.033,0.287,-0.012,-0.265,0.066,-0.143,P00186,Cyp1a2,P00186_Cyp1a2,P00186,Cyp1a2,1,213,36,36,P00186|P00184,MOUSE,58525.1,73.6,132,132.1,587.04,587.04,,513,Cytochrome P450 1A2,endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,steroid catabolic process|cellular aromatic compound metabolic process|porphyrin-containing compound metabolic process|toxin biosynthetic process|toxin metabolic process|post-embryonic development|alkaloid metabolic process|regulation of gene expression|monoterpenoid metabolic process|drug metabolic process|dibenzo-p-dioxin metabolic process|lung development|response to estradiol|response to lipopolysaccharide|monocarboxylic acid metabolic process|response to immobilization stress|drug catabolic process|exogenous drug catabolic process|cellular respiration|heterocycle metabolic process|hydrogen peroxide biosynthetic process|oxidation-reduction process|oxidative demethylation|cellular response to cadmium ion|oxidative deethylation|,"monooxygenase activity|iron ion binding|oxidoreductase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|enzyme binding|heme binding|demethylase activity|caffeine oxidase activity|aromatase activity|",36,213,3.56E+11,73.6%
Q922B2,0.933608247,0.009333333,0.947131609,-0.033333333,0.804057004,-0.258251519,0.194,0.027,-0.143,0.178,-0.111,-0.089,Q922B2,Dars,Q922B2_Dars,Q922B2,Dars,1,184,41,41,Q922B2|Q8BJY7,MOUSE,57602.6,72.8,133,133.1,585.92,585.92,,501,"Aspartate--tRNA ligase, cytoplasmic",cytoplasm|membrane|extracellular exosome|,aspartyl-tRNA aminoacylation|,aspartate-tRNA ligase activity|ATP binding|poly(A) RNA binding|,41,184,1.84E+11,72.8%
P97742,0.656833435,-0.001,5.227061702,-0.138,0.300119234,-1.123989125,0.137,0.226,-0.159,-0.07,0.006,-0.146,P97742,Cpt1a,P97742_Cpt1a,P97742,Cpt1a,1,146,41,41,P97742|Q924X2,MOUSE,88991.6,52.9,134,134.1,585.03,585.03,,773,"Carnitine O-palmitoyltransferase 1, liver isoform",mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|membrane|integral component of mitochondrial outer membrane|,long-chain fatty acid metabolic process|glucose metabolic process|fatty acid beta-oxidation|triglyceride metabolic process|transport|circadian rhythm|carnitine metabolic process|response to organic cyclic compound|epithelial cell differentiation|positive regulation of fatty acid beta-oxidation|response to drug|eating behavior|regulation of insulin secretion|protein homooligomerization|cellular response to fatty acid|,carnitine O-palmitoyltransferase activity|identical protein binding|,41,146,1.43E+11,52.9%
E9Q035,0.000552294,-0.215666667,48.68524298,1.73,1.35355E-05,11.40453657,-0.998,-0.893,-1.351,0.563,0.542,0.843,E9Q035,NotFound,E9Q035_NotFound,E9Q035,Gm20425,1,166,41,5,E9Q035|P47758|Q2HJF0|Q29443|E9Q939,MOUSE,109962.4,39.4,135,135.1,581.34,71.68,,978,Predicted gene 20425,extracellular region|intracellular|,small GTPase mediated signal transduction|,GTP binding|,41,166,66400000000,39.4%
Q921I1,0.001709747,-0.217166667,41.5751594,1.821,6.95799E-05,8.777356785,-0.88,-0.924,-1.579,0.615,0.567,0.898,Q921I1,Trf,Q921I1_Trf,Q921I1,Tf,1,13,38,3,Q921I1,MOUSE,78890.5,52.6,135,135.2,544.25,51.74,,697,Serotransferrin,extracellular space|endosome|early endosome|late endosome|coated pit|basal plasma membrane|cell surface|membrane|cytoplasmic membrane-bounded vesicle|apical plasma membrane|vesicle coat|endocytic vesicle|vesicle|basal part of cell|perinuclear region of cytoplasm|recycling endosome|extracellular exosome|blood microparticle|dense body|,"iron ion transport|cellular iron ion homeostasis|actin filament organization|activation of JUN kinase activity|ferric iron transport|osteoclast differentiation|positive regulation of phosphorylation|positive regulation of bone resorption|positive regulation of transcription, DNA-templated|SMAD protein signal transduction|ERK1 and ERK2 cascade|positive regulation of cell motility|",protein binding|ferric iron binding|ferric iron transmembrane transporter activity|,3,13,2200000000,7.8%
Q01405,0.894042447,-0.0115,1.690774578,-0.042333333,0.677520659,-0.434586198,0.038,0.126,-0.135,-0.021,-0.013,-0.064,Q01405,Sec23a,Q01405_Sec23a,Q01405,Sec23a,1,142,36,31,Q01405|E9Q1S3,MOUSE,87073.1,58.4,136,136.1,579.13,511.21,,765,Protein transport protein Sec23A,Golgi membrane|endoplasmic reticulum membrane|COPII vesicle coat|ER to Golgi transport vesicle|smooth endoplasmic reticulum membrane|perinuclear region of cytoplasm|,intracellular protein transport|ER to Golgi vesicle-mediated transport|,protein binding|zinc ion binding|,36,142,75200000000,58.4%
Q9D662,0.550838715,0.019666667,7.260798389,-0.149333333,0.187897136,-1.46627889,-0.032,0.087,0.228,-0.043,-0.137,0.015,Q9D662,Sec23b,Q9D662_Sec23b,Q9D662,Sec23b,1,52,25,20,Q9D662,MOUSE,87348.4,40.8,136,136.2,337.22,269.3,,767,Protein transport protein Sec23B,Golgi membrane|endoplasmic reticulum membrane|endomembrane system|COPII vesicle coat|endoplasmic reticulum-Golgi intermediate compartment membrane|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|,intracellular protein transport|ER to Golgi vesicle-mediated transport|,protein binding|zinc ion binding|,20,52,8680000000,36.2%
P97872,0.852968656,-0.032333333,2.346185188,-0.122666667,0.582614758,-0.577634844,0.249,0.281,-0.443,-0.139,0.092,-0.234,P97872,Fmo5,P97872_Fmo5,P97872,Fmo5,1,266,42,42,P97872,MOUSE,60570,75,137,137.1,578.39,578.39,,533,Dimethylaniline monooxygenase [N-oxide-forming] 5,endoplasmic reticulum membrane|integral component of membrane|,drug metabolic process|oxidation-reduction process|,"N,N-dimethylaniline monooxygenase activity|flavin adenine dinucleotide binding|NADP binding|",42,266,7.69E+11,75.0%
P14685,0.771416168,0.002833333,3.579392679,-0.073,0.438592027,-0.823442385,0.133,0.014,-0.029,0.025,-0.087,-0.039,P14685,Psmd3,P14685_Psmd3,P14685,Psmd3,1,142,40,40,P14685,MOUSE,60831.3,62.8,138,138.1,577.65,577.65,,530,26S proteasome non-ATPase regulatory subunit 3,"proteasome complex|nucleus|nucleoplasm|cytoplasm|proteasome regulatory particle|proteasome regulatory particle, lid subcomplex|membrane|proteasome accessory complex|extracellular exosome|",ubiquitin-dependent protein catabolic process|regulation of protein catabolic process|regulation of catalytic activity|,protein binding|enzyme regulator activity|,40,142,93800000000,62.8%
P24270,0.070340991,0.019,21.90059584,0.438,0.006455657,3.906541142,-0.236,-0.283,-0.081,0.077,0.261,0.376,P24270,Cat,P24270_Cat,P24270,Cat,1,176,40,40,P24270|A2AL20,MOUSE,60079.5,77.4,139,139.1,575.39,575.39,,527,Catalase,extracellular space|mitochondrion|mitochondrial intermembrane space|lysosome|peroxisome|peroxisomal membrane|endoplasmic reticulum|Golgi apparatus|cytosol|plasma membrane|focal adhesion|membrane|intracellular membrane-bounded organelle|extracellular exosome|,response to reactive oxygen species|osteoblast differentiation|ureteric bud development|response to hypoxia|triglyceride metabolic process|response to oxidative stress|aging|cholesterol metabolic process|aerobic respiration|response to toxic substance|response to light intensity|UV protection|response to ozone|response to lead ion|positive regulation of phosphatidylinositol 3-kinase signaling|response to activity|response to inactivity|hemoglobin metabolic process|negative regulation of NF-kappaB transcription factor activity|response to estradiol|response to insulin|response to vitamin A|response to vitamin E|response to L-ascorbic acid|response to drug|hydrogen peroxide catabolic process|negative regulation of apoptotic process|response to ethanol|response to cadmium ion|positive regulation of NF-kappaB transcription factor activity|protein tetramerization|protein homotetramerization|positive regulation of cell division|response to hyperoxia|response to fatty acid|cellular response to growth factor stimulus|response to phenylpropanoid|,"aminoacylase activity|catalase activity|receptor binding|antioxidant activity|oxidoreductase activity, acting on peroxide as acceptor|enzyme binding|heme binding|protein homodimerization activity|metal ion binding|NADP binding|",40,176,1.31E+11,77.4%
P48678,0.636939506,0.021333333,5.619541119,-0.249333333,0.274186387,-1.192135508,-0.288,0.371,0.355,-0.27,-0.183,0.143,P48678,Lmna,P48678_Lmna,P48678,Lmna,1,124,46,45,P48678|P48678-2|P48678-3,MOUSE,74521.5,63.6,140,140.1,575.18,570.98,,665,Prelamin-A/C,nucleus|nuclear envelope|lamin filament|nucleoplasm|cytoplasm|nuclear matrix|nuclear membrane|perinuclear region of cytoplasm|,nucleus organization|nuclear envelope organization|spermatogenesis|muscle organ development|establishment of cell polarity|regulation of cell migration|establishment or maintenance of microtubule cytoskeleton polarity|protein localization to nucleus|sterol regulatory element binding protein import into nucleus|ventricular cardiac muscle cell development|cellular response to hypoxia|negative regulation of release of cytochrome c from mitochondria|positive regulation of cell aging|regulation of protein localization to nucleus|negative regulation of extrinsic apoptotic signaling pathway|,structural molecule activity|protein binding|,45,124,45600000000,63.3%
E9Q509,0.078872109,-0.033166667,21.2597567,0.511666667,0.007482114,3.797228103,-0.147,-0.182,-0.538,0.347,0.218,0.103,E9Q509,Pklr,E9Q509_Pklr,E9Q509,Pklr,1,120,39,37,E9Q509|G3X925|P53657,MOUSE,59161.9,76.2,141,141.1,573.93,552.95,,543,Pyruvate kinase,extracellular exosome|,glycolytic process|phosphorylation|response to other organism|,magnesium ion binding|pyruvate kinase activity|potassium ion binding|,39,120,98800000000,76.2%
P52480,0.463113208,0.163166667,9.034052676,-0.546333333,0.124909288,-1.756333949,0.026,0.074,1.209,-0.172,-0.052,-0.106,P52480,Pkm,P52480_Pkm,P52480,Pkm,1,51,27,25,P52480|P52480-2,MOUSE,58414.4,56.3,141,141.2,343.03,322.05,,531,Pyruvate kinase PKM,nucleus|cytoplasm|mitochondrion|plasma membrane|cilium|extracellular matrix|vesicle|myelin sheath|extracellular exosome|extracellular vesicle|,glycolytic process|programmed cell death|phosphorylation|,magnesium ion binding|pyruvate kinase activity|protein binding|ATP binding|MHC class II protein complex binding|potassium ion binding|poly(A) RNA binding|,25,51,11900000000,53.1%
Q64459,0.952015192,-0.016666667,0.7129145,-0.02,0.848610791,-0.198412758,0.031,0.085,-0.136,0.024,0.029,-0.133,Q64459,Cyp3a11,Q64459_Cyp3a11,Q64459,Cyp3a11,1,214,40,17,Q64459,MOUSE,58195.8,54.1,142,142.1,572.63,238.99,,504,Cytochrome P450 3A11,endoplasmic reticulum membrane|,oxidation-reduction process|,monooxygenase activity|iron ion binding|oxidoreductase activity|heme binding|aromatase activity|,40,214,8.43E+11,54.1%
Q9JMA7,0.773512169,-0.123666667,3.520946333,0.472666667,0.444534392,0.812879442,0.584,0.028,-1.692,0.662,-0.288,-0.036,Q9JMA7,Cyp3a41a,Q9JMA7_Cyp3a41a,Q9JMA7,Cyp3a41a,1,64,36,15,Q9JMA7,MOUSE,58385.1,65.8,142,142.2,549.27,249.14,,504,Cytochrome P450 3A41,endoplasmic reticulum membrane|,oxidation-reduction process|,iron ion binding|heme binding|aromatase activity|,15,64,94900000000,40.8%
Q9EQW4,0.80197926,-0.057833333,3.050326428,0.233666667,0.495412953,0.721284381,0.368,-0.092,-0.8,0.477,-0.274,-0.026,Q9EQW4,Cyp3a44,Q9EQW4_Cyp3a44,Q9EQW4,Cyp3a44,1,16,24,6,Q9EQW4,MOUSE,58072.6,38,142,142.3,339.63,97.58,,504,"Cytochrome P450, CYP3A",,oxidation-reduction process|,"iron ion binding|oxidoreductase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|heme binding|",6,16,31100000000,15.4%
Q64481,0.773512169,0.0805,3.492706803,0.451,0.447434347,0.807469125,1,-0.28,-1.155,0.972,-0.141,0.087,Q64481,Cyp3a16,Q64481_Cyp3a16,Q64481,Cyp3a16,1,38,22,9,Q64481,MOUSE,58267.9,44.4,142,142.4,307.4,135.37,,504,Cytochrome P450 3A16,endoplasmic reticulum membrane|,oxidation-reduction process|,iron ion binding|oxidoreductase activity|heme binding|aromatase activity|,9,38,26200000000,23.4%
Q9R112,0.115484489,0.045833333,19.19918257,-0.482333333,0.012024907,-3.427158332,0.066,0.251,0.544,-0.177,-0.312,-0.097,Q9R112,Sqor,Q9R112_Sqor,Q9R112,Sqor,1,182,39,39,Q9R112|F6ZKZ3,MOUSE,50737.9,75.7,143,143.1,571.69,571.69,,450,"Sulfide:quinone oxidoreductase, mitochondrial",mitochondrion|mitochondrial inner membrane|,"sulfide oxidation, using sulfide:quinone oxidoreductase|hydrogen sulfide metabolic process|",quinone binding|sulfide:quinone oxidoreductase activity|,39,182,2.85E+11,75.7%
Q91YQ5,0.033710539,-0.048,25.72263687,0.538666667,0.002677542,4.653527017,-0.448,-0.135,-0.369,0.143,0.177,0.344,Q91YQ5,Rpn1,Q91YQ5_Rpn1,Q91YQ5,Rpn1,1,177,39,39,Q91YQ5,MOUSE,68698.2,57.5,144,144.1,571.63,571.63,,608,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1,endoplasmic reticulum membrane|rough endoplasmic reticulum|membrane|integral component of membrane|melanosome|,protein N-linked glycosylation via asparagine|,dolichyl-diphosphooligosaccharide-protein glycotransferase activity|poly(A) RNA binding|,39,177,1.57E+11,57.5%
Q9EQ20,0.553776122,-0.0295,7.199911268,-0.245666667,0.190549965,-1.458161627,0.119,0.333,-0.172,-0.269,0.101,-0.289,Q9EQ20,Aldh6a1,Q9EQ20_Aldh6a1,Q9EQ20,Aldh6a1,1,149,35,35,Q9EQ20,MOUSE,58371.1,71.9,145,145.1,567.95,567.95,,535,"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial",nucleoplasm|mitochondrion|extracellular exosome|,thymine catabolic process|valine catabolic process|beta-alanine catabolic process|brown fat cell differentiation|oxidation-reduction process|,aldehyde dehydrogenase (NAD) activity|methylmalonate-semialdehyde dehydrogenase (acylating) activity|thiolester hydrolase activity|malonate-semialdehyde dehydrogenase (acetylating) activity|poly(A) RNA binding|,35,149,1.12E+11,71.9%
Q8K1M6-3,0.888176718,-0.033333333,1.782715632,0.055333333,0.663328163,0.455477447,0.066,0.045,-0.294,0.066,-0.029,-0.054,Q8K1M6,Dnm1l,Q8K1M6-3_Dnm1l,Q8K1M6-3,Dnm1l,1,101,38,3,Q8K1M6-3|E9PUD2|Q8K1M6-5,MOUSE,78523,63.9,146,146.1,565.32,52.86,,742,Isoform 3 of Dynamin-1-like protein,cytoplasm|mitochondrion|mitochondrial outer membrane|peroxisome|Golgi apparatus|cytosol|microtubule|brush border|coated pit|membrane|cell junction|synaptic vesicle membrane|intracellular membrane-bounded organelle|protein complex|perinuclear region of cytoplasm|,mitochondrial fission|release of cytochrome c from mitochondria|dynamin polymerization involved in mitochondrial fission|endocytosis|metabolic process|regulation of mitochondrion organization|peroxisome fission|regulation of protein oligomerization|positive regulation of apoptotic process|mitochondrial fragmentation involved in apoptotic process|positive regulation of protein secretion|protein homotetramerization|heart contraction|membrane fusion|necroptotic process|mitochondrion morphogenesis|protein localization to mitochondrion|positive regulation of mitochondrial fission|mitochondrial membrane fission|positive regulation of release of cytochrome c from mitochondria|regulation of peroxisome organization|regulation of mitochondrion degradation|regulation of ATP metabolic process|positive regulation of intrinsic apoptotic signaling pathway|,GTPase activity|protein binding|GTP binding|lipid binding|ubiquitin protein ligase binding|identical protein binding|protein homodimerization activity|,38,101,27600000000,63.9%
E9PVU0,0.054299327,-0.033833333,23.24260983,0.689666667,0.004739571,4.169659124,-0.152,-0.298,-0.686,0.107,0.411,0.415,E9PVU0,NotFound,E9PVU0_NotFound,E9PVU0,Myo6,1,136,43,1,E9PVU0|E9Q175|E9Q174|E9Q3L1,MOUSE,147731.2,37.2,147,147.1,563.81,20.35,,1266,Unconventional myosin-VI,"ruffle|nucleus|nucleoplasm|cytoplasm|Golgi apparatus|plasma membrane|vesicle membrane|membrane|cytoplasmic membrane-bounded vesicle|myosin complex|DNA-directed RNA polymerase II, holoenzyme|axon|filamentous actin|nuclear membrane|neuronal cell body|synapse|perinuclear region of cytoplasm|extracellular exosome|clathrin-coated endocytic vesicle|","protein targeting|endocytosis|synaptic transmission|synapse assembly|sensory perception of sound|locomotory behavior|metabolic process|glutamate secretion|dendrite development|DNA damage response, signal transduction by p53 class mediator|inner ear morphogenesis|auditory receptor cell differentiation|positive regulation of transcription from RNA polymerase II promoter|regulation of synaptic plasticity|inner ear development|regulation of secretion|cellular response to electrical stimulus|",motor activity|protein binding|ATP binding|actin filament binding|,43,136,1.32E+11,37.2%
Q64331,0.196511417,-0.101333333,16.05215522,0.789333333,0.024819011,2.889412488,-0.095,-0.258,-1.135,0.097,0.408,0.375,Q64331,NotFound,Q64331_NotFound,Q64331,Myo6,1,10,32,3,Q64331,MOUSE,147776.1,25.2,147,147.3,396.7,16.77,,1265,Unconventional myosin-VI,"ruffle|nucleus|nucleoplasm|cytoplasm|Golgi apparatus|plasma membrane|brush border|coated pit|vesicle membrane|membrane|cytoplasmic membrane-bounded vesicle|myosin complex|DNA-directed RNA polymerase II, holoenzyme|axon|filamentous actin|nuclear membrane|neuronal cell body|synapse|perinuclear region of cytoplasm|extracellular exosome|clathrin-coated endocytic vesicle|","protein targeting|endocytosis|synaptic transmission|synapse assembly|sensory perception of sound|locomotory behavior|metabolic process|glutamate secretion|dendrite development|DNA damage response, signal transduction by p53 class mediator|inner ear morphogenesis|auditory receptor cell differentiation|positive regulation of transcription from RNA polymerase II promoter|regulation of synaptic plasticity|inner ear development|regulation of secretion|cellular response to electrical stimulus|",motor activity|protein binding|calmodulin binding|ATP binding|actin filament binding|,3,10,584000000,2.6%
P97501,0.459323034,-0.224,9.156466947,0.626,0.121437636,1.776001674,0.146,-0.41,-1.347,0.247,-0.007,0.027,P97501,Fmo3,P97501_Fmo3,P97501,Fmo3,1,212,35,34,P97501|J3QMN6|A0A0J9YUC0,MOUSE,61199.5,64.4,148,148.1,563.25,548.65,,534,Dimethylaniline monooxygenase [N-oxide-forming] 3,endoplasmic reticulum membrane|integral component of membrane|,drug metabolic process|oxidation-reduction process|,"N,N-dimethylaniline monooxygenase activity|trimethylamine monooxygenase activity|flavin adenine dinucleotide binding|NADP binding|",35,212,6.08E+11,64.4%
Q8VHG0,0.797504707,-0.108,3.117154874,0.155333333,0.487847982,0.734485324,0.069,-0.062,-0.564,0.156,0.113,-0.36,Q8VHG0,Fmo4,Q8VHG0_Fmo4,Q8VHG0,Fmo4,1,42,17,16,Q8VHG0,MOUSE,64475.5,37.5,148,148.2,227.35,212.75,,560,Dimethylaniline monooxygenase [N-oxide-forming] 4,endoplasmic reticulum membrane|integral component of membrane|,drug catabolic process|oxidation-reduction process|,"N,N-dimethylaniline monooxygenase activity|flavin adenine dinucleotide binding|NADP binding|",16,42,6870000000,35.8%
Q91YI0,0.821409751,-0.019833333,2.770571668,-0.075666667,0.528375696,-0.665068643,0.031,-0.08,0.103,-0.242,0.077,-0.008,Q91YI0,Asl,Q91YI0_Asl,Q91YI0,Asl,1,190,37,37,Q91YI0,MOUSE,51909.4,77.1,149,149.1,562.27,562.27,,464,Argininosuccinate lyase,extracellular exosome|,urea cycle|internal protein amino acid acetylation|cellular amino acid metabolic process|locomotory behavior|post-embryonic development|ammonia assimilation cycle|arginine biosynthetic process via ornithine|,argininosuccinate lyase activity|,37,190,2.83E+11,77.1%
Q6PDI5,0.836873322,-0.016166667,2.569808128,0.075,0.553374557,0.624224412,0.087,-0.001,-0.247,0.154,-0.037,-0.053,Q6PDI5,Ecpas,Q6PDI5_Ecpas,Q6PDI5,Ecm29,1,91,42,42,Q6PDI5|Q6PDI5-2|A2ALV6|A2ALW1,MOUSE,205525.4,29.4,150,150.1,560.98,560.98,,1840,Proteasome-associated protein ECM29 homolog,nucleus|early endosome|late endosome|multivesicular body|endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|centrosome|membrane|cytoplasmic membrane-bounded vesicle|ER to Golgi transport vesicle|endocytic vesicle|proteasome complex|,ER-associated ubiquitin-dependent protein catabolic process|,,42,91,10300000000,29.4%
P28271,0.847271066,-0.097,2.383659321,0.125333333,0.577609155,0.585510916,-0.5,0.078,-0.057,-0.413,0.146,0.164,P28271,Aco1,P28271_Aco1,P28271,Aco1,1,128,44,44,P28271,MOUSE,98751.4,51.8,151,151.1,558.76,558.76,,889,Cytoplasmic aconitate hydratase,cytoplasm|mitochondrion|endoplasmic reticulum|Golgi apparatus|cytosol|extracellular exosome|,tricarboxylic acid cycle|citrate metabolic process|regulation of translation|cellular iron ion homeostasis|post-embryonic development|response to iron(II) ion|regulation of gene expression|intestinal absorption|,"RNA binding|aconitate hydratase activity|iron-responsive element binding|metal ion binding|4 iron, 4 sulfur cluster binding|",44,128,73400000000,51.8%
Q8BGT5,0.982455642,-0.0925,0.282794967,0.015,0.936958819,0.082146175,0.086,0.061,-0.447,-0.012,0.085,-0.328,Q8BGT5,Gpt2,Q8BGT5_Gpt2,Q8BGT5,Gpt2,1,207,35,35,Q8BGT5|D6RFQ8,MOUSE,58741.5,68.1,152,152.1,558.47,558.47,,522,Alanine aminotransferase 2,mitochondrion|,2-oxoglutarate metabolic process|biosynthetic process|L-alanine metabolic process|L-alanine catabolic process|,L-alanine:2-oxoglutarate aminotransferase activity|pyridoxal phosphate binding|,35,207,1.58E+11,68.1%
Q01853,0.35633016,-0.004333333,11.32245493,0.198,0.073748723,2.117674898,-0.055,-0.048,-0.207,0.026,0.184,0.074,Q01853,Vcp,Q01853_Vcp,Q01853,Vcp,1,94,40,40,Q01853,MOUSE,90004.9,62.1,153,153.1,558.18,558.18,,806,Transitional endoplasmic reticulum ATPase,proteasome complex|Hrd1p ubiquitin ligase complex|nucleus|nucleoplasm|cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|lipid particle|cytosol|VCP-NPL4-UFD1 AAA ATPase complex|site of double-strand break|myelin sheath|protein complex|perinuclear region of cytoplasm|extracellular exosome|VCP-NSFL1C complex|,"double-strand break repair|ubiquitin-dependent protein catabolic process|ER to Golgi vesicle-mediated transport|activation of cysteine-type endopeptidase activity involved in apoptotic process|cellular response to DNA damage stimulus|protein ubiquitination|protein N-linked glycosylation via asparagine|viral genome replication|translesion synthesis|ER-associated ubiquitin-dependent protein catabolic process|retrograde protein transport, ER to cytosol|positive regulation of protein complex assembly|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|protein hexamerization|positive regulation of protein catabolic process|ATP metabolic process|protein homooligomerization|aggresome assembly|ER-associated misfolded protein catabolic process|positive regulation of protein K63-linked deubiquitination|positive regulation of Lys63-specific deubiquitinase activity|",protein binding|ATP binding|lipid binding|ATPase activity|protein phosphatase binding|protein domain specific binding|polyubiquitin binding|protein complex binding|deubiquitinase activator activity|K48-linked polyubiquitin binding|MHC class I protein binding|identical protein binding|ADP binding|ubiquitin-like protein ligase binding|poly(A) RNA binding|ubiquitin-specific protease binding|,40,94,34100000000,62.1%
P51881,0.635598413,0.013666667,5.65648051,-0.213333333,0.271864154,-1.198498634,0.324,0.312,-0.275,-0.065,-0.002,-0.212,P51881,Slc25a5,P51881_Slc25a5,P51881,Slc25a5,1,279,37,22,P51881|Q3V132,MOUSE,33158.9,77.5,154,154.1,554.96,319.98,,298,ADP/ATP translocase 2,nucleus|mitochondrion|mitochondrial inner membrane|membrane|integral component of membrane|mitochondrial nucleoid|myelin sheath|extracellular exosome|MMXD complex|,chromosome segregation|positive regulation of cell proliferation|transmembrane transport|negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway|,transporter activity|ubiquitin protein ligase binding|poly(A) RNA binding|,37,279,1.44E+12,77.5%
P48962,0.461918472,0.007,9.055009776,-0.144666667,0.124307984,-1.756784352,0.054,0.129,0.055,-0.003,-0.101,-0.092,P48962,Slc25a4,P48962_Slc25a4,P48962,Slc25a4,1,15,22,6,P48962,MOUSE,33131.9,58.7,154,154.2,335.44,89.59,,298,ADP/ATP translocase 1,nucleus|mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|integral component of membrane|myelin sheath|,apoptotic mitochondrial changes|transmembrane transport|negative regulation of necroptotic process|,transporter activity|protein binding|,6,15,2650000000,19.7%
P60843,0.143726505,0.008833333,17.82556931,-0.273666667,0.016498447,-3.177203522,0.113,0.243,0.081,-0.154,-0.126,-0.104,P60843,Eif4a1,P60843_Eif4a1,P60843,Eif4a1,1,199,36,18,P60843,MOUSE,46381.4,80.7,155,155.1,554,305.27,,406,Eukaryotic initiation factor 4A-I,cytoplasm|membrane|extracellular exosome|,translational initiation|regulation of gene expression|RNA secondary structure unwinding|organ regeneration|,double-stranded RNA binding|translation initiation factor activity|ATP-dependent RNA helicase activity|protein binding|ATP binding|poly(A) RNA binding|,36,199,3.74E+11,80.7%
P10630-2,0.34703809,0.049666667,11.5212548,-0.286666667,0.070448949,-2.153920102,-0.019,0.433,0.165,-0.176,-0.105,0,P10630,Eif4a2,P10630-2_Eif4a2,P10630-2,Eif4a2,1,31,25,7,P10630-2|P10630|Q8BTU6|E9Q561|D6RJ11|D6RJ60,MOUSE,46716.7,64.9,155,155.2,373.45,124.72,,407,Isoform 2 of Eukaryotic initiation factor 4A-II,perinuclear region of cytoplasm|,translational initiation|regulation of gene expression|RNA secondary structure unwinding|negative regulation of RNA-directed RNA polymerase activity|,translation initiation factor activity|ATP-dependent RNA helicase activity|ATP binding|ATPase activity|poly(A) RNA binding|,7,31,12200000000,28.6%
Q91VC3,0.294965152,0.031666667,12.95293691,-0.217333333,0.050664797,-2.377323552,0.027,0.227,0.167,-0.122,-0.029,-0.08,Q91VC3,Eif4a3,Q91VC3_Eif4a3,Q91VC3,Eif4a3,1,14,24,4,Q91VC3|A0A0N4SVP8,MOUSE,47124.4,53.5,155,155.3,297.23,66.45,,411,Eukaryotic initiation factor 4A-III,cytoplasm|membrane|nuclear speck|exon-exon junction complex|catalytic step 2 spliceosome|,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|regulation of alternative mRNA splicing, via spliceosome|rRNA processing|mRNA processing|RNA splicing|negative regulation of translation|positive regulation of translation|embryonic cranial skeleton morphogenesis|mRNA transport|",mRNA binding|ATP-dependent RNA helicase activity|ATP binding|poly(A) binding|,4,14,4250000000,17.5%
Q9QZ85,0.734072404,0.009833333,4.031249832,-0.105,0.395252856,-0.908761557,0.219,-0.067,0.035,0.064,-0.187,-0.005,Q9QZ85,Iigp1,Q9QZ85_Iigp1,Q9QZ85,Iigp1,1,165,33,24,Q9QZ85,MOUSE,47799.1,74.5,156,156.1,553.74,436.41,,413,Interferon-inducible GTPase 1,endoplasmic reticulum membrane|symbiont-containing vacuole membrane|nuclear membrane|Golgi cisterna membrane|,metabolic process|regulation of autophagy|cytokine-mediated signaling pathway|cellular response to interferon-beta|defense response to protozoan|innate immune response|defense response to Gram-negative bacterium|,GTPase activity|GTP binding|GDP binding|identical protein binding|,33,165,1.48E+11,74.5%
Q3UED7,0.991556352,-0.002166667,0.169834922,0.004333333,0.961648831,0.049911386,0.083,-0.024,-0.072,0.04,-0.053,0.013,Q3UED7,Gm4951,Q3UED7_Gm4951,Q3UED7,Gm4951,1,20,19,10,Q3UED7,MOUSE,47586.5,49.5,156,156.2,245.03,127.7,,406,Interferon-gamma-inducible GTPase Ifgga2 protein,membrane|,cellular response to interferon-beta|,GTP binding|,10,20,1520000000,33.0%
Q3THK7,0.785249508,-0.011666667,3.327999928,-0.082666667,0.464729249,-0.775267892,0.162,0.066,-0.139,0.011,-0.051,-0.119,Q3THK7,Gmps,Q3THK7_Gmps,Q3THK7,Gmps,1,110,36,36,Q3THK7,MOUSE,77463.8,63.7,157,157.1,552.76,552.76,,693,GMP synthase [glutamine-hydrolyzing],cytosol|,GMP biosynthetic process|glutamine metabolic process|,GMP synthase activity|GMP synthase (glutamine-hydrolyzing) activity|ATP binding|pyrophosphatase activity|,36,110,29400000000,63.7%
E9PVC5,0.651971232,-0.042333333,5.299375863,0.152,0.295163338,1.136622184,-0.024,0.057,-0.388,-0.029,0.1,0.03,E9PVC5,Eif4g1,E9PVC5_Eif4g1,E9PVC5,Eif4g1,1,126,45,41,E9PVC5|E9PVC6|Q6NZJ6|E9Q9E1|Q6NZJ6-2|A0A0J9YUS5|Q8BQR8,MOUSE,176311.8,30.1,158,158.1,551.05,496.68,,1594,Eukaryotic translation initiation factor 4 gamma 1,cytoplasm|membrane|,behavioral fear response|regulation of translational initiation|positive regulation of neuron differentiation|,eukaryotic initiation factor 4E binding|poly(A) RNA binding|,46,126,40800000000,30.1%
Q80XI3-3,0.762829105,0.017666667,3.670576387,0.109333333,0.429479423,0.841377369,0.029,-0.105,-0.035,0.307,-0.143,0.053,Q80XI3,Eif4g3,Q80XI3-3_Eif4g3,Q80XI3-3,Eif4g3,1,6,10,5,A0A0N4SVL0|Q80XI3-3|Q80XI3|A2AMI2|Q80XI3-4|A0A0R4J112|Z4YKC4|Q80XI3-2|A2AMI6,MOUSE,177369.5,7.3,158,158.2,111.52,51.45,,1579,Isoform 3 of Eukaryotic translation initiation factor 4 gamma 3,,positive regulation of protein phosphorylation|translational initiation|spermatogenesis|positive regulation of translation|positive regulation of meiosis I|,translation initiation factor activity|protein binding|poly(A) RNA binding|,5,6,361000000,4.2%
Q5XJY5,0.991556352,-0.0285,0.168410318,-0.006333333,0.961964329,-0.049521819,0.096,0.118,-0.29,-0.035,-0.02,-0.04,Q5XJY5,Arcn1,Q5XJY5_Arcn1,Q5XJY5,Arcn1,1,166,39,39,Q5XJY5,MOUSE,57684.8,64.7,159,159.1,549.97,549.97,,511,Coatomer subunit delta,cytoplasm|endoplasmic reticulum|Golgi apparatus|membrane|COPI vesicle coat|clathrin adaptor complex|COPI-coated vesicle|intracellular membrane-bounded organelle|,"intracellular protein transport|retrograde vesicle-mediated transport, Golgi to ER|adult locomotory behavior|cerebellar Purkinje cell layer maturation|pigmentation|Golgi vesicle transport|",poly(A) RNA binding|,39,166,84000000000,64.7%
Q07417,0.52769863,-0.034333333,7.662618116,-0.202,0.171292437,-1.534167667,0.067,0.198,-0.065,-0.306,0.086,-0.186,Q07417,Acads,Q07417_Acads,Q07417,Acads,1,191,31,31,Q07417,MOUSE,45174.1,79.8,160,160.1,549.71,549.71,,412,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial",nucleus|mitochondrion|mitochondrial matrix|,fatty acid beta-oxidation using acyl-CoA dehydrogenase|response to starvation|butyrate catabolic process|protein homotetramerization|response to glucocorticoid|,fatty-acyl-CoA binding|acyl-CoA dehydrogenase activity|butyryl-CoA dehydrogenase activity|flavin adenine dinucleotide binding|,31,191,2.22E+11,79.8%
P42932,0.003469517,-0.078,37.49095756,1.087333333,0.000178199,7.520165766,-0.639,-0.392,-0.834,0.325,0.429,0.643,P42932,Cct8,P42932_Cct8,P42932,Cct8,1,139,41,41,P42932|H3BL49|H3BKR8,MOUSE,60125,68.2,161,161.1,547.59,547.59,,548,T-complex protein 1 subunit theta,zona pellucida receptor complex|cytoplasm|centrosome|cytosol|chaperonin-containing T-complex|microtubule|aggresome|cell body|intermediate filament cytoskeleton|extracellular exosome|,protein folding|binding of sperm to zona pellucida|pore complex assembly|toxin transport|,protein binding|ATP binding|unfolded protein binding|,41,139,98800000000,68.2%
P11983,0.99575708,0.001666667,0.06133843,0.002,0.985975576,0.018246115,-0.062,0.196,-0.132,-0.034,0.005,0.037,P11983,Tcp1,P11983_Tcp1,P11983,Tcp1,1,156,36,36,P11983|P11983-2|F2Z483,MOUSE,60904,71.9,162,162.1,543.65,543.65,,556,T-complex protein 1 subunit alpha,pericentriolar material|acrosomal vesicle|zona pellucida receptor complex|nuclear heterochromatin|Golgi apparatus|centrosome|microtubule organizing center|chaperonin-containing T-complex|microtubule|myelin sheath|cell body|extracellular exosome|,protein folding|binding of sperm to zona pellucida|translocation of peptides or proteins into host cell cytoplasm|toxin transport|regulation of macrophage apoptotic process|,protein binding|ATP binding|ubiquitin protein ligase binding|poly(A) RNA binding|unfolded protein binding|,36,156,77800000000,71.9%
P45952,0.951421295,-0.009,0.733410661,-0.033333333,0.84461528,-0.203823104,0.023,-0.028,0.028,-0.35,0.293,-0.02,P45952,Acadm,P45952_Acadm,P45952,Acadm,1,226,35,35,P45952|D6RFD7,MOUSE,46936.8,64.1,163,163.1,542.81,542.81,,421,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",nucleus|mitochondrion|mitochondrial matrix|axon|extracellular exosome|,"liver development|glycogen biosynthetic process|organic acid metabolic process|regulation of gluconeogenesis|fatty acid beta-oxidation|heart development|response to nutrient|response to cold|carnitine metabolic process|post-embryonic development|carnitine metabolic process, CoA-linked|fatty acid beta-oxidation using acyl-CoA dehydrogenase|response to drug|response to starvation|carnitine biosynthetic process|response to copper ion|protein homotetramerization|response to glucocorticoid|medium-chain fatty acid metabolic process|medium-chain fatty acid catabolic process|cardiac muscle cell differentiation|oxidation-reduction process|",fatty-acyl-CoA binding|acyl-CoA dehydrogenase activity|isomerase activity|identical protein binding|flavin adenine dinucleotide binding|medium-chain-acyl-CoA dehydrogenase activity|,35,226,3.62E+11,64.1%
Q64516-1,0.919416995,-0.062666667,1.243988012,0.062666667,0.750933015,0.330918458,0.216,-0.004,-0.494,0.05,0.04,-0.184,Q64516,Gk,Q64516-1_Gk,Q64516-1,Gk,1,131,37,37,Q64516-1|Q64516|Q64516-2|B1ASZ3|Q9WU65|Q8C635,MOUSE,58255.6,72.3,164,164.1,538.79,538.79,,559,Isoform 1 of Glycerol kinase,nucleus|cytoplasm|mitochondrion|mitochondrial outer membrane|cytosol|extracellular exosome|,glycerol metabolic process|triglyceride metabolic process|phosphorylation|glycerol catabolic process|glucose homeostasis|glycerol-3-phosphate biosynthetic process|,glycerol kinase activity|ATP binding|,37,131,1.67E+11,72.3%
Q9Z2I8,0.960763421,-0.056,0.594435836,-0.029333333,0.87208018,-0.167365112,0.151,0.127,-0.402,-0.058,0.085,-0.239,Q9Z2I8,Suclg2,Q9Z2I8_Suclg2,Q9Z2I8,Suclg2,1,193,32,32,Q9Z2I8|Q9Z2I8-2,MOUSE,47124.4,65.8,165,165.1,538.36,538.36,,433,"Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial",mitochondrion|plasma membrane|,tricarboxylic acid cycle|,succinate-CoA ligase (GDP-forming) activity|succinate-semialdehyde dehydrogenase (NAD+) activity|ATP binding|GTP binding|metal ion binding|,32,193,4.65E+11,65.8%
Q9DBT9,0.873023806,-0.023,2.078409066,0.055333333,0.619668034,0.520258896,0.037,0.023,-0.212,-0.014,0.102,-0.074,Q9DBT9,Dmgdh,Q9DBT9_Dmgdh,Q9DBT9,Dmgdh,1,116,39,39,Q9DBT9,MOUSE,97481.2,56.7,166,166.1,538.31,538.31,,869,"Dimethylglycine dehydrogenase, mitochondrial",mitochondrion|,glycine metabolic process|amino-acid betaine catabolic process|oxidation-reduction process|,poly(A) RNA binding|dimethylglycine dehydrogenase activity|,39,116,44500000000,56.7%
Q8BVQ9,0.926913345,0.011,1.050574522,0.031333333,0.785131764,0.283840732,0.138,-0.018,-0.134,0.16,-0.042,-0.038,Q8BVQ9,Psmc2,Q8BVQ9_Psmc2,Q8BVQ9,Psmc2,1,137,40,40,Q8BVQ9|P46471,MOUSE,53322.1,73.4,167,167.1,534.84,534.84,,475,26S proteasome regulatory subunit 7,"proteasome complex|nucleus|cytoplasm|proteasome regulatory particle, base subcomplex|membrane|nuclear proteasome complex|cytosolic proteasome complex|",osteoblast differentiation|ubiquitin-dependent protein catabolic process|ER-associated ubiquitin-dependent protein catabolic process|positive regulation of RNA polymerase II transcriptional preinitiation complex assembly|positive regulation of proteasomal protein catabolic process|,protein binding|ATP binding|ATPase activity|TBP-class protein binding|proteasome-activating ATPase activity|,40,137,96400000000,73.4%
Q02819,0.000230546,-0.304333333,56.56546636,2.306,2.20523E-06,15.14232296,-1.38,-1.28,-1.712,0.657,1.034,0.855,Q02819,Nucb1,Q02819_Nucb1,Q02819,Nucb1,1,146,35,35,Q02819|A0A1C7CYU3,MOUSE,53407.7,66.2,168,168.1,533.38,533.38,,459,Nucleobindin-1,extracellular space|nucleus|early endosome|rough endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|Golgi-associated vesicle|cis-Golgi network|trans-Golgi network|microtubule cytoskeleton|membrane|Golgi cisterna membrane|extracellular exosome|extrinsic component of Golgi membrane|lumenal side of Golgi membrane|,response to cisplatin|regulation of protein targeting|,G-protein alpha-subunit binding|DNA binding|calcium ion binding|,35,146,88400000000,66.2%
E9Q8Z8,0.612170052,-0.011166667,6.142711511,0.107,0.243068594,1.280086907,-0.004,-0.118,-0.072,0.063,-0.015,0.079,E9Q8Z8,Ctnnd1,E9Q8Z8_Ctnnd1,E9Q8Z8,Ctnnd1,1,112,40,2,E9Q8Z8|E9Q8Z6|P30999|G3X9V2|E9Q904|E9Q901|D3Z2H2|E9Q8Z9|E9Q8Z4|E9Q905|E9Q907|D3Z7H6|E9Q986|D3Z2H7,MOUSE,108743.8,49.8,169,169.1,531.72,23.39,,967,Catenin delta-1,nucleus|cytoplasm|cytosol|plasma membrane|cell-cell junction|cell-cell adherens junction|bicellular tight junction|membrane|lamellipodium|midbody|extracellular exosome|,morphogenesis of a polarized epithelium|cell adhesion|salivary gland morphogenesis|single organismal cell-cell adhesion|keratinocyte differentiation|epithelial cell differentiation involved in salivary gland development|negative regulation of canonical Wnt signaling pathway|,receptor binding|protein binding|protein domain specific binding|cadherin binding|,40,112,28300000000,49.8%
O88685,0.703626223,-0.006833333,4.482372728,0.114333333,0.356256443,0.991325778,0.112,-0.092,-0.212,0.17,-0.006,-0.013,O88685,Psmc3,O88685_Psmc3,O88685,Psmc3,1,124,36,36,O88685|A2AGN7|B7ZCF1,MOUSE,49833.3,83,170,170.1,529.51,529.51,,442,26S proteasome regulatory subunit 6A,"proteasome complex|cytoplasmic mRNA processing body|nucleus|proteasome regulatory particle, base subcomplex|membrane|proteasome accessory complex|nuclear proteasome complex|cytosolic proteasome complex|",blastocyst development|ER-associated ubiquitin-dependent protein catabolic process|positive regulation of RNA polymerase II transcriptional preinitiation complex assembly|positive regulation of proteasomal protein catabolic process|,ATP binding|TBP-class protein binding|proteasome-activating ATPase activity|,36,124,65500000000,83.0%
A2AS03,0.615902301,-0.010166667,6.021357029,-0.122333333,0.249956421,-1.259534745,0.001,0.037,0.115,0.015,-0.21,-0.019,A2AS03,Helz2,A2AS03_Helz2,A2AS03,Helz2,1,75,45,45,A2AS03|E9QAM5|A2AS05,MOUSE,338736.3,20.5,171,171.1,527.5,527.5,,2970,Helicase with zinc finger domain 2,membrane|,positive regulation of transcription from RNA polymerase II promoter|,ATP binding|ligand-dependent nuclear receptor transcription coactivator activity|poly(A) RNA binding|,45,75,21000000000,20.5%
Q8BML9,0.536434852,-0.008333333,7.495840156,-0.128,0.177998353,-1.504795413,0.023,0.088,0.056,0.004,-0.151,-0.07,Q8BML9,Qars,Q8BML9_Qars,Q8BML9,Qars,1,121,40,40,Q8BML9|D3Z158|A0A140LIS6|A0A140LJH1|A0A140LHC3,MOUSE,88587.8,57.1,172,172.1,526.81,526.81,,775,Glutamine--tRNA ligase,cytoplasm|aminoacyl-tRNA synthetase multienzyme complex|,glutaminyl-tRNA aminoacylation|brain development|negative regulation of apoptotic process|,RNA binding|glutamine-tRNA ligase activity|ATP binding|protein kinase binding|,40,121,54500000000,57.1%
P80316,0.979995204,-0.003,0.303921737,0.010666667,0.93241194,0.088088073,-0.07,0.226,-0.181,-0.009,0.009,0.007,P80316,Cct5,P80316_Cct5,P80316,Cct5,1,121,35,34,P80316,MOUSE,60079.5,79.6,173,173.1,526.23,518.25,,541,T-complex protein 1 subunit epsilon,zona pellucida receptor complex|nucleolus|cytoplasm|centrosome|chaperonin-containing T-complex|microtubule|myelin sheath|cell body|extracellular exosome|,protein folding|binding of sperm to zona pellucida|response to virus|toxin transport|,protein binding|ATP binding|G-protein beta-subunit binding|beta-tubulin binding|unfolded protein binding|,35,121,53600000000,79.6%
P80315,0.961523652,0.002166667,0.576661966,0.020333333,0.875656556,0.162637565,-0.084,0.241,-0.181,-0.008,0.024,0.021,P80315,Cct4,P80315_Cct4,P80315,Cct4,1,94,29,28,P80315|G5E839|G3UYW5|G3UXG2|G3UXF3,MOUSE,58578.8,65.4,173,173.2,416.38,408.4,,539,T-complex protein 1 subunit delta,zona pellucida receptor complex|nucleoplasm|cytoplasm|centrosome|chaperonin-containing T-complex|microtubule|melanosome|cell body|extracellular exosome|,protein folding|binding of sperm to zona pellucida|toxin transport|,protein binding|ATP binding|poly(A) RNA binding|unfolded protein binding|,28,94,33000000000,63.6%
Q64464,0.293309675,0.068166667,13.00157197,-0.411666667,0.050100586,-2.391055018,0.17,0.01,0.642,-0.018,-0.193,-0.202,Q64464,Cyp3a13,Q64464_Cyp3a13,Q64464,Cyp3a13,1,152,36,36,Q64464,MOUSE,57833.5,62.6,174,174.1,525.67,525.67,,503,Cytochrome P450 3A13,endoplasmic reticulum membrane|,positive regulation of gene expression|oxidation-reduction process|,monooxygenase activity|iron ion binding|heme binding|aromatase activity|,36,152,1.6E+11,62.6%
P16331,0.900174519,-0.075833333,1.60971521,0.098333333,0.690285068,0.416399999,0.073,0.222,-0.67,-0.113,0.137,-0.104,P16331,Pah,P16331_Pah,P16331,Pah,1,123,36,36,P16331|A0A1W2P781,MOUSE,52412.4,82.7,175,175.1,525.6,525.6,,453,Phenylalanine-4-hydroxylase,extracellular exosome|,L-phenylalanine catabolic process|tyrosine biosynthetic process|protein hydroxylation|tetrahydrobiopterin metabolic process|oxidation-reduction process|,phenylalanine 4-monooxygenase activity|iron ion binding|amino acid binding|protein homodimerization activity|cofactor binding|,36,123,1.51E+11,82.7%
P68368,0.904214516,-0.020666667,1.573702465,-0.050666667,0.696032876,-0.408161391,0.165,0.071,-0.222,0.014,-0.008,-0.144,P68368,Tuba4a,P68368_Tuba4a,P68368,Tuba4a,1,314,31,9,P68368,MOUSE,50665.2,71.4,176,176.1,525.31,160.01,,448,Tubulin alpha-4A chain,cytoplasm|microtubule|extracellular exosome|,microtubule-based process|metabolic process|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,31,314,1.41E+12,71.4%
P68373,0.708523608,-0.085,4.41636828,0.269333333,0.361712212,0.979613662,0.112,0.07,-0.841,0.318,-0.031,-0.138,P68373,Tuba1c,P68373_Tuba1c,P68373,Tuba1c,1,23,30,2,P68373|Q9JJZ2,MOUSE,50593.1,66.8,176,176.2,494.13,38.78,,449,Tubulin alpha-1C chain,nucleus|cytoplasmic microtubule|vesicle|,microtubule-based process|metabolic process|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,2,23,24700000000,9.5%
P68369,0.899563151,-0.045666667,1.614624652,-0.074,0.689505183,-0.417520279,0.028,0.321,-0.375,-0.112,0.001,-0.137,P68369,Tuba1a,P68369_Tuba1a,P68369,Tuba1a,1,3,30,2,P68369|P05214,MOUSE,50819.4,66.9,176,176.3,489.43,26.27,,451,Tubulin alpha-1A chain,nucleus|microtubule|cytoplasmic microtubule|cytoplasmic ribonucleoprotein granule|myelin sheath|recycling endosome|extracellular exosome|,microtubule-based process|metabolic process|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|protein binding|GTP binding|protein domain specific binding|,2,3,1560000000,7.7%
P13707,0.70184245,-0.075833333,4.515472854,0.213,0.353551525,0.997559818,0.127,-0.004,-0.67,0.155,0.029,-0.092,P13707,Gpd1,P13707_Gpd1,P13707,Gpd1,1,215,33,30,P13707|E0CXN5,MOUSE,38199.6,85.3,177,177.1,523.68,478.59,,349,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",mitochondrion|cytosol|glycerol-3-phosphate dehydrogenase complex|extracellular exosome|,glycerol-3-phosphate metabolic process|gluconeogenesis|NADH oxidation|glycerophosphate shuttle|positive regulation of glycolytic process|glycerol-3-phosphate catabolic process|glycerolipid metabolic process|cellular response to cAMP|cellular response to tumor necrosis factor|,glycerol-3-phosphate dehydrogenase [NAD+] activity|glycerol-3-phosphate dehydrogenase activity|protein homodimerization activity|NAD binding|,33,215,4.27E+11,85.3%
Q3ULJ0,0.809729234,-0.064,2.963112085,0.122666667,0.505462326,0.703952715,0.114,-0.004,-0.486,0.086,0.077,-0.171,Q3ULJ0,Gpd1l,Q3ULJ0_Gpd1l,Q3ULJ0,Gpd1l,1,56,21,18,Q3ULJ0|Q3ULJ0-2|D3Z0L6,MOUSE,38852.4,63.5,177,177.2,323.95,278.86,,351,Glycerol-3-phosphate dehydrogenase 1-like protein,plasma membrane|glycerol-3-phosphate dehydrogenase complex|membrane|extracellular exosome|,regulation of heart rate|carbohydrate metabolic process|NADH metabolic process|positive regulation of sodium ion transport|NAD metabolic process|negative regulation of peptidyl-serine phosphorylation|glycerol-3-phosphate catabolic process|oxidation-reduction process|regulation of ventricular cardiac muscle cell membrane depolarization|ventricular cardiac muscle cell action potential|negative regulation of protein kinase C signaling|positive regulation of protein localization to cell surface|regulation of sodium ion transmembrane transporter activity|,glycerol-3-phosphate dehydrogenase [NAD+] activity|sodium channel regulator activity|protein homodimerization activity|ion channel binding|NAD binding|,18,56,26000000000,56.6%
Q61838,0.000693181,-0.082333333,47.06647919,1.456,1.96495E-05,10.75130981,-0.741,-0.71,-0.98,0.456,0.623,0.858,Q61838,NotFound,Q61838_NotFound,Q61838,Pzp,1,110,43,43,Q61838|F1MI18|F1MJK3,MOUSE,167218.8,36.8,178,178.1,520.97,520.97,,1495,Pregnancy zone protein,extracellular region|extracellular space|,embryo implantation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|protein complex binding|,43,110,90600000000,36.8%
P62196,0.919416995,-0.005,1.220136423,0.041333333,0.755068509,0.3251956,0.175,-0.021,-0.231,0.134,-0.037,-0.05,P62196,Psmc5,P62196_Psmc5,P62196,Psmc5,1,158,37,35,P62196|Q8K1K2,MOUSE,45796.4,79,179,179.1,520.38,493.76,,406,26S proteasome regulatory subunit 8,"proteasome complex|nucleus|holo TFIIH complex|cytoplasm|proteasome regulatory particle|proteasome regulatory particle, base subcomplex|membrane|inclusion body|proteasome accessory complex|cytoplasmic vesicle|nuclear proteasome complex|cytosolic proteasome complex|extracellular exosome|blood microparticle|","ER-associated ubiquitin-dependent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|negative regulation of transcription, DNA-templated|positive regulation of RNA polymerase II transcriptional preinitiation complex assembly|positive regulation of inclusion body assembly|positive regulation of proteasomal protein catabolic process|",receptor binding|protein binding|ATP binding|transcription factor binding|TBP-class protein binding|thyrotropin-releasing hormone receptor binding|proteasome-activating ATPase activity|,37,158,91000000000,79.0%
P62192,0.994928853,0.009166667,0.072534145,0.002333333,0.983437094,0.021549283,0.162,-0.012,-0.126,0.117,-0.034,-0.052,P62192,Psmc1,P62192_Psmc1,P62192,Psmc1,1,120,32,30,P62192,MOUSE,49354.8,66.3,179,179.2,473.68,447.06,,440,26S proteasome regulatory subunit 4,"proteasome complex|nucleus|nucleoplasm|cytoplasm|proteasome regulatory particle|proteasome regulatory particle, base subcomplex|membrane|proteasome accessory complex|cell junction|nuclear proteasome complex|cytosolic proteasome complex|",ER-associated ubiquitin-dependent protein catabolic process|positive regulation of RNA polymerase II transcriptional preinitiation complex assembly|positive regulation of proteasomal protein catabolic process|,ATP binding|TBP-class protein binding|proteasome-activating ATPase activity|poly(A) RNA binding|,30,120,82300000000,62.0%
Q8CC86,0.654663152,0.010833333,5.262164503,-0.099666667,0.297703232,-1.129020299,0.164,0.008,0.01,-0.022,-0.007,-0.088,Q8CC86,Naprt,Q8CC86_Naprt,Q8CC86,Naprt,1,138,33,33,Q8CC86,MOUSE,58834.8,69.1,180,180.1,519.58,519.58,,538,Nicotinate phosphoribosyltransferase,nucleus|nucleoplasm|cytoplasm|Golgi apparatus|cytosol|extracellular exosome|,response to oxidative stress|NAD biosynthetic process|nicotinate nucleotide salvage|,nicotinate-nucleotide diphosphorylase (carboxylating) activity|nicotinate phosphoribosyltransferase activity|ligase activity|,33,138,1.14E+11,69.1%
Q91WG8,0.929192436,0.014,1.008706156,-0.027333333,0.792737467,-0.27346476,0.04,-0.08,0.123,0.097,-0.107,0.011,Q91WG8,Gne,Q91WG8_Gne,Q91WG8,Gne,1,114,34,34,Q3UW64|Q91WG8|G3UX23|G3UYD5|G3UX49,MOUSE,80224.2,55.5,181,181.1,515.99,515.99,,722,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,cytoplasm|,N-acetylglucosamine biosynthetic process|UDP-N-acetylglucosamine metabolic process|N-acetylneuraminate metabolic process|carbohydrate phosphorylation|,"catalytic activity|hydrolase activity, hydrolyzing O-glycosyl compounds|ATP binding|N-acylmannosamine kinase activity|metal ion binding|",34,114,57800000000,55.5%
E9QB02,0.600763538,-0.0165,6.326042128,-0.125666667,0.233021389,-1.310992385,0.108,0.078,-0.047,0.034,-0.114,-0.158,E9QB02,Mars,E9QB02_Mars,E9QB02,Mars,1,129,35,35,E9QB02|Q68FL6,MOUSE,103740.1,44.2,182,182.1,515.26,515.26,,910,"Methionine--tRNA ligase, cytoplasmic",nucleolus|cytoplasm|mitochondrion|cytosol|membrane|extracellular exosome|,methionyl-tRNA aminoacylation|rRNA transcription|,methionine-tRNA ligase activity|ATP binding|,35,129,51800000000,44.2%
Q8BSY0,0.000662686,-0.210833333,47.43736297,1.633666667,1.80411E-05,10.89789533,-0.825,-0.926,-1.332,0.49,0.632,0.696,Q8BSY0,Asph,Q8BSY0_Asph,Q8BSY0,Asph,1,131,37,37,Q8BSY0|A2AL85|Q8CBM2,MOUSE,83440,41.9,183,183.1,513.1,513.1,,741,Aspartyl/asparaginyl beta-hydroxylase,cytoplasm|endoplasmic reticulum|plasma membrane|integral component of membrane|integral component of endoplasmic reticulum membrane|cortical endoplasmic reticulum|sarcoplasmic reticulum membrane|,"pattern specification process|negative regulation of cell proliferation|positive regulation of calcium ion transport into cytosol|regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity|regulation of protein stability|activation of store-operated calcium channel activity|response to ATP|limb morphogenesis|peptidyl-aspartic acid hydroxylation|positive regulation of proteolysis|positive regulation of transcription, DNA-templated|oxidation-reduction process|palate development|face morphogenesis|calcium ion transmembrane transport|cellular response to calcium ion|positive regulation of intracellular protein transport|activation of cysteine-type endopeptidase activity|regulation of protein depolymerization|",peptide-aspartate beta-dioxygenase activity|calcium ion binding|protein binding|,37,131,3.36E+11,41.9%
P80318,0.951421295,-0.006666667,0.743018146,0.02,0.842748883,0.206218293,-0.075,0.134,-0.109,-0.021,0.001,0.03,P80318,Cct3,P80318_Cct3,P80318,Cct3,1,146,36,36,P80318|Q3U0I3|E9Q133,MOUSE,61199.5,65.6,184,184.1,512.42,512.42,,545,T-complex protein 1 subunit gamma,zona pellucida receptor complex|cytoplasm|chaperonin-containing T-complex|microtubule|plasma membrane|myelin sheath|cell body|extracellular exosome|,protein folding|binding of sperm to zona pellucida|pore complex assembly|toxin transport|,protein binding|ATP binding|poly(A) RNA binding|unfolded protein binding|,36,146,75500000000,65.6%
Q9Z2V4,0.90651412,-0.029333333,1.509789474,-0.05,0.706351794,-0.393448005,-0.103,0.092,-0.002,-0.286,0.106,0.017,Q9Z2V4,Pck1,Q9Z2V4_Pck1,Q9Z2V4,Pck1,1,139,34,34,Q9Z2V4,MOUSE,70095.3,63.5,185,185.1,511.44,511.44,,622,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",cytosol|extracellular exosome|,glucose metabolic process|gluconeogenesis|oxaloacetate metabolic process|internal protein amino acid acetylation|lipid metabolic process|response to activity|response to insulin|glucose homeostasis|glycerol biosynthetic process from pyruvate|cellular response to potassium ion starvation|positive regulation of transcription from RNA polymerase II promoter in response to acidic pH|,magnesium ion binding|phosphoenolpyruvate carboxykinase activity|phosphoenolpyruvate carboxykinase (GTP) activity|GTP binding|GDP binding|manganese ion binding|carboxylic acid binding|,34,139,1.59E+11,63.5%
Q5SYD0,0.556074497,-0.106333333,7.153984344,0.391333333,0.192575736,1.450579867,0.124,-0.129,-0.901,0.097,0.304,-0.133,Q5SYD0,Myo1d,Q5SYD0_Myo1d,Q5SYD0,Myo1d,1,104,38,38,Q5SYD0|Q5SYD0-2|Q5SUA5,MOUSE,116877.7,43.8,186,186.1,510.46,510.46,,1006,Unconventional myosin-Id,endosome|smooth endoplasmic reticulum|brush border|basolateral plasma membrane|myosin complex|axon|axolemma|cytoplasmic vesicle|neuron projection|neuronal cell body|myelin sheath|plasma membrane raft|extracellular exosome|apical dendrite|,metabolic process|negative regulation of phosphatase activity|cellular localization|early endosome to recycling endosome transport|,microfilament motor activity|protein binding|calmodulin binding|ATP binding|protein domain specific binding|actin-dependent ATPase activity|calcium-dependent protein binding|actin filament binding|,38,104,31200000000,43.8%
A0A0R4IZY2,0.982507762,-0.073333333,0.279620129,0.016666667,0.937644018,0.081251046,-0.374,0.026,0.103,-0.451,0.184,0.072,A0A0R4IZY2,Cyp2d26,A0A0R4IZY2_Cyp2d26,A0A0R4IZY2,Cyp2d26,1,156,32,26,A0A0R4IZY2|Q8CIM7|Q6P8N9,MOUSE,57234,70.8,187,187.1,510.27,429.94,,500,Cytochrome P450 2D26,,,,32,156,1.5E+11,70.8%
P24456,0.982112023,-0.084333333,0.287066857,0.016666667,0.936037643,0.083349698,-0.415,0.1,0.037,-0.422,0.134,0.06,P24456,Cyp2d10,P24456_Cyp2d10,P24456,Cyp2d10,1,88,27,20,P24456,MOUSE,57574.7,69.2,187,187.2,425.15,316.46,,504,Cytochrome P450 2D10,cytoplasm|endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,xenobiotic metabolic process|arachidonic acid metabolic process|exogenous drug catabolic process|oxidation-reduction process|,"iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|aromatase activity|",20,88,87600000000,54.3%
Q9JKY7,0.961523652,0.016,0.562930181,0.034666667,0.878429641,0.158974745,0.02,0.388,-0.412,-0.144,0.276,-0.032,Q9JKY7,Cyp2d22,Q9JKY7_Cyp2d22,Q9JKY7,Cyp2d22,1,45,16,13,Q9JKY7,MOUSE,57037,36.2,187,187.3,250.43,196.71,,500,Cytochrome P450 CYP2D22,cytoplasm|intracellular membrane-bounded organelle|,xenobiotic metabolic process|female pregnancy|response to organic substance|arachidonic acid metabolic process|dopamine biosynthetic process|exogenous drug catabolic process|oxidation-reduction process|,"steroid 21-monooxygenase activity|iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|",13,45,22400000000,31.8%
P11714,0.438500879,0.035833333,9.599676499,-0.371666667,0.109655987,-1.847062084,-0.162,0.334,0.493,-0.339,0.115,-0.226,P11714,Cyp2d9,P11714_Cyp2d9,P11714,Cyp2d9,1,13,10,6,P11714,MOUSE,57291.3,24.8,187,187.4,141.34,78.49,,504,Cytochrome P450 2D9,cytoplasm|endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,xenobiotic metabolic process|arachidonic acid metabolic process|exogenous drug catabolic process|oxidation-reduction process|,"iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|aromatase activity|",6,13,1760000000,14.2%
Q99LC5,0.895491675,-0.088166667,1.647039108,0.118333333,0.684378077,0.424899938,0.334,-0.052,-0.724,0.178,0.062,-0.327,Q99LC5,Etfa,Q99LC5_Etfa,Q99LC5,Etfa,1,216,30,30,Q99LC5|Q2KJE4|F1MWR3,MOUSE,35351.1,78.9,188,188.1,507.03,507.03,,333,"Electron transfer flavoprotein subunit alpha, mitochondrial",mitochondrion|mitochondrial electron transfer flavoprotein complex|extracellular exosome|,oxidation-reduction process|,protein binding|electron carrier activity|oxidoreductase activity|flavin adenine dinucleotide binding|,30,216,4.72E+11,78.9%
E9Q0S6,0.797128744,0.003333333,3.168571392,-0.069333333,0.48210636,-0.744091908,0.013,0.167,-0.066,-0.051,-0.023,-0.02,E9Q0S6,Tns1,E9Q0S6_Tns1,E9Q0S6,Tns1,1,94,36,33,E9Q0S6|A0A1D5RM59|A0A087WQS0|A0A087WQM0|Q9DBT6,MOUSE,203033.4,23.9,189,189.1,506.92,466.89,,1888,Tensin 1,intracellular|focal adhesion|cell-substrate junction|,cell-substrate junction assembly|fibroblast migration|intracellular signal transduction|,actin binding|poly(A) RNA binding|metal ion binding|,36,94,14000000000,23.9%
Q8CGB6-3,0.53169579,-0.001833333,7.561147339,-0.121,0.175341722,-1.515470246,0.082,0.095,-0.001,-0.056,-0.064,-0.067,Q8CGB6,Tns2,Q8CGB6-3_Tns2,Q8CGB6-3,Tns2,1,38,25,23,Q8CGB6-3|Q8CGB6|Q8CGB6-4|Q8CGB6-2,MOUSE,154719.4,24.4,189,189.2,311.26,277.94,,1400,Isoform 3 of Tensin-2,intracellular|plasma membrane|focal adhesion|,kidney development|negative regulation of cell proliferation|response to muscle activity|dephosphorylation|cellular homeostasis|collagen metabolic process|multicellular organism growth|intracellular signal transduction|multicellular organismal homeostasis|,phosphoprotein phosphatase activity|receptor binding|kinase binding|protein kinase binding|metal ion binding|,23,38,15100000000,23.4%
Q5SSZ5,0.668368738,-0.006,5.030442403,-0.084666667,0.31401888,-1.088425599,0.003,0.065,0.041,-0.041,-0.042,-0.062,Q5SSZ5,Tns3,Q5SSZ5_Tns3,Q5SSZ5,Tns3,1,13,12,9,Q5SSZ5|Q5SSZ5-2,MOUSE,157126.7,11.9,189,189.3,125.9,85.87,,1440,Tensin-3,cytoplasm|focal adhesion|,positive regulation of cell proliferation|cell migration|lung alveolus development|,,9,13,2970000000,10.4%
Q8VEK3,0.463547563,0.006,9.011942065,-0.144666667,0.125546842,-1.749887585,0.029,0.121,0.085,-0.127,-0.048,-0.024,Q8VEK3,Hnrnpu,Q8VEK3_Hnrnpu,Q8VEK3,Hnrnpu,1,154,38,38,Q8VEK3|Q8VEK3-2,MOUSE,88714.9,41.7,190,190.1,506.91,506.91,,800,Heterogeneous nuclear ribonucleoprotein U,nucleus|nucleoplasm|cell surface|membrane|ribonucleoprotein complex|cytoplasmic ribonucleoprotein granule|CRD-mediated mRNA stability complex|catalytic step 2 spliceosome|,osteoblast differentiation|mRNA processing|RNA splicing|circadian regulation of gene expression|CRD-mediated mRNA stabilization|,core promoter binding|protein binding|ATP binding|poly(A) RNA binding|,38,154,1.04E+11,41.7%
Q8K010,0.926554478,0.005,1.059352077,0.024,0.783546531,0.285966145,-0.001,-0.022,0.002,0.093,-0.061,0.019,Q8K010,Oplah,Q8K010_Oplah,Q8K010,Oplah,1,117,39,39,Q8K010,MOUSE,139035.1,37.6,191,191.1,506.15,506.15,,1288,5-oxoprolinase,,glutathione metabolic process|,ATP binding|5-oxoprolinase (ATP-hydrolyzing) activity|,39,117,22600000000,37.6%
E9QNL5,0.64206681,-0.107,5.516029734,0.284,0.28079995,1.174259912,0.172,-0.111,-0.808,0.076,0.094,-0.065,E9QNL5,NotFound,E9QNL5_NotFound,E9QNL5,Sult1a1,1,214,32,6,E9QNL5|D3Z3G5|P52840,MOUSE,34113,89.6,192,192.1,506.06,79,,291,Sulfotransferase,,metabolic process|,nucleotide binding|sulfotransferase activity|,32,214,5.63E+11,89.6%
Q91W19,0.618717314,-0.134166667,5.977591468,0.341666667,0.252488065,1.253476555,0.08,-0.027,-0.968,-0.009,0.139,-0.02,Q91W19,Sult1a1,Q91W19_Sult1a1,Q91W19,Sult1a1,1,24,29,3,Q91W19,MOUSE,30633.1,88.5,192,192.2,461.6,34.54,,263,Sulfotransferase,,catecholamine metabolic process|xenobiotic metabolic process|estrogen metabolic process|regulation of blood pressure|response to activity|response to insecticide|4-nitrophenol metabolic process|response to glucocorticoid|sulfation|,nucleotide binding|aryl sulfotransferase activity|sulfotransferase activity|protein homodimerization activity|3'-phosphoadenosine 5'-phosphosulfate binding|,3,24,1.27E+11,9.1%
Q9EPU0-2,0.706444596,0.036,4.446320169,-0.112,0.359226183,-0.984672879,-0.036,0.019,0.293,-0.083,-0.03,0.053,Q9EPU0,Upf1,Q9EPU0-2_Upf1,Q9EPU0-2,Upf1,1,71,42,42,Q9EPU0-2|Q9EPU0,MOUSE,123967.3,40.5,193,193.1,505.61,505.61,,1124,Isoform 2 of Regulator of nonsense transcripts 1,chromatin|cytoplasmic mRNA processing body|nucleus|nucleoplasm|exon-exon junction complex|supraspliceosomal complex|,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|nuclear-transcribed mRNA catabolic process|DNA replication|DNA repair|regulation of translational termination|dosage compensation by inactivation of X chromosome|histone mRNA catabolic process|",DNA binding|chromatin binding|ATP-dependent RNA helicase activity|ATP binding|zinc ion binding|poly(A) RNA binding|,42,71,32800000000,40.5%
Q3V117,0.21736368,-0.076166667,15.26209021,0.531666667,0.029770832,2.758610533,-0.571,-0.499,0.044,-0.007,0.17,0.406,Q3V117,Acly,Q3V117_Acly,Q3V117,Acly,1,97,39,39,Q3V117|Q91V92|Q3TS02,MOUSE,121705.9,41.7,194,194.1,505.33,505.33,,1101,ATP-citrate synthase,intracellular|nucleoplasm|cytoplasm|mitochondrion|plasma membrane|membrane|extracellular exosome|,acetyl-CoA biosynthetic process|citrate metabolic process|fatty acid biosynthetic process|lipid biosynthetic process|cellular carbohydrate metabolic process|,ATP citrate synthase activity|ATP binding|cofactor binding|,39,97,22400000000,41.7%
Q921H8,0.639352439,-0.079333333,5.566551358,0.302666667,0.277552322,1.182992947,0.242,-0.199,-0.735,0.244,0.173,-0.201,Q921H8,Acaa1a,Q921H8_Acaa1a,Q921H8,Acaa1a,1,231,27,11,Q921H8|H3BKL5|H3BJZ9,MOUSE,44409,84.4,195,195.1,503.23,209.27,,424,"3-ketoacyl-CoA thiolase A, peroxisomal",mitochondrion|peroxisome|membrane|intracellular membrane-bounded organelle|,very long-chain fatty acid metabolic process|fatty acid metabolic process|fatty acid beta-oxidation|bile acid metabolic process|,acetyl-CoA C-acetyltransferase activity|palmitoyl-CoA oxidase activity|,27,231,4.65E+11,84.4%
Q8VCH0,0.469727509,-0.191,8.899207043,0.636,0.128848479,1.734644935,0.175,-0.383,-1.319,0.292,0.265,-0.176,Q8VCH0,Acaa1b,Q8VCH0_Acaa1b,Q8VCH0,Acaa1b,1,99,26,10,Q8VCH0,MOUSE,44508.1,80.1,195,195.2,501.37,207.41,,424,"3-ketoacyl-CoA thiolase B, peroxisomal",mitochondrion|peroxisome|,fatty acid metabolic process|,acetyl-CoA C-acyltransferase activity|,10,99,1.99E+11,28.7%
Q8K169,0.029899385,-0.290333333,26.30549368,1.618666667,0.002341265,4.781644966,-0.772,-0.586,-1.941,0.484,0.542,0.531,Q8K169,Ugt2b5,Q8K169_Ugt2b5,Q8K169,Ugt2b5,1,157,29,6,Q8K169|P17717,MOUSE,61443.5,60.5,196,196.1,501.02,122.74,,530,UDP-glucuronosyltransferase,mitochondrial inner membrane|endoplasmic reticulum|intracellular membrane-bounded organelle|,flavonoid biosynthetic process|cellular response to hormone stimulus|flavonoid glucuronidation|,glucuronosyltransferase activity|,29,157,8.39E+11,60.5%
Q8BWQ1,0.027763855,-0.292,26.73767147,1.749333333,0.002119497,4.871974327,-0.839,-0.609,-2.052,0.618,0.663,0.467,Q8BWQ1,Ugt2a3,Q8BWQ1_Ugt2a3,Q8BWQ1,Ugt2a3,1,101,26,23,Q8BWQ1|A0A0J9YU36|Q80X89|Q6PDD0|D3YUX6,MOUSE,61860,56.5,196,196.2,373.76,329.28,,534,UDP-glucuronosyltransferase 2A3,integral component of membrane|intracellular membrane-bounded organelle|,flavonoid biosynthetic process|cellular response to hormone stimulus|cellular glucuronidation|flavonoid glucuronidation|,glucuronosyltransferase activity|,23,101,1.94E+11,52.4%
Q8R084,0.254777572,-0.301,14.02981111,1.210666667,0.039538382,2.557188211,-0.493,-0.145,-2.081,0.408,0.147,0.358,Q8R084,Ugt2b1,Q8R084_Ugt2b1,Q8R084,Ugt2b1,1,143,25,22,Q8R084,MOUSE,60840.8,49.5,196,196.3,386.27,338.4,,529,UDP-glucuronosyltransferase,intracellular membrane-bounded organelle|,flavonoid biosynthetic process|response to lipopolysaccharide|cellular response to hormone stimulus|cellular glucuronidation|flavonoid glucuronidation|biphenyl catabolic process|cellular response to ethanol|cellular response to growth hormone stimulus|cellular response to glucocorticoid stimulus|cellular response to testosterone stimulus|,glucuronosyltransferase activity|,22,143,1.89E+11,44.9%
Q63886,0.105076802,-0.078666667,19.80080623,0.616666667,0.010469342,3.533568003,-0.224,-0.164,-0.773,0.141,0.339,0.209,Q63886,Ugt1a1,Q63886_Ugt1a1,Q63886,Ugt1a1,1,51,24,12,Q63886|E9PXN7|Q6ZQM8|P70691|D3YZE6|D6RH94,MOUSE,60788,46.3,196,196.5,370.75,185.03,,535,UDP-glucuronosyltransferase 1-1,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of plasma membrane|endoplasmic reticulum chaperone complex|intracellular membrane-bounded organelle|cytochrome complex|,liver development|acute-phase response|response to nutrient|flavonoid biosynthetic process|organ regeneration|response to lipopolysaccharide|cellular response to hormone stimulus|response to drug|response to starvation|negative regulation of catalytic activity|flavone metabolic process|cellular glucuronidation|flavonoid glucuronidation|xenobiotic glucuronidation|biphenyl catabolic process|cellular response to ethanol|cellular response to glucocorticoid stimulus|negative regulation of cellular glucuronidation|,retinoic acid binding|enzyme inhibitor activity|steroid binding|glucuronosyltransferase activity|enzyme binding|protein homodimerization activity|protein heterodimerization activity|,12,51,36400000000,27.2%
Q62452,0.811763387,-0.062833333,2.920505381,0.147,0.510445597,0.695441869,-0.069,0.26,-0.6,-0.03,0.093,-0.031,Q62452,Ugt1a9,Q62452_Ugt1a9,Q62452,Ugt1a9,1,30,23,9,Q62452,MOUSE,60748.6,45.2,196,196.6,342.95,131.04,,528,UDP-glucuronosyltransferase 1-9,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|intracellular membrane-bounded organelle|extracellular exosome|,flavonoid biosynthetic process|cellular response to hormone stimulus|negative regulation of catalytic activity|flavonoid glucuronidation|xenobiotic glucuronidation|,enzyme inhibitor activity|protein kinase C binding|steroid binding|fatty acid binding|drug binding|glucuronosyltransferase activity|enzyme binding|protein homodimerization activity|protein heterodimerization activity|,9,30,10000000000,23.2%
Q3UEP4,0.107840772,-0.2665,19.66364616,1.231,0.010805264,3.50919448,-0.765,-0.213,-1.668,0.252,0.587,0.208,Q3UEP4,Ugt2b36,Q3UEP4_Ugt2b36,Q3UEP4,Ugt2b36,1,49,22,15,Q3UEP4,MOUSE,61610.8,49.8,196,196.7,294.28,198.55,,530,UDP-glucuronosyltransferase,intracellular membrane-bounded organelle|extracellular exosome|,flavonoid biosynthetic process|aromatic compound catabolic process|cellular response to hormone stimulus|response to drug|flavonoid glucuronidation|,glucuronosyltransferase activity|,15,49,24100000000,38.3%
Q8K154,0.182949568,-0.083666667,16.54000687,0.434,0.022181929,2.970926995,-0.083,-0.208,-0.611,0.121,0.175,0.104,Q8K154,Ugt2b34,Q8K154_Ugt2b34,Q8K154,Ugt2b34,1,80,20,17,Q8K154|E9PZ30,MOUSE,61389.4,43.4,196,196.8,274.01,229.53,,532,UDP-glucuronosyltransferase,intracellular membrane-bounded organelle|,flavonoid biosynthetic process|cellular response to hormone stimulus|flavonoid glucuronidation|,glucuronosyltransferase activity|,17,80,1.35E+11,37.9%
K9J7B2,0.822248694,-0.019166667,2.73774737,-0.096333333,0.532384329,-0.658595335,0.215,0.091,-0.219,-0.099,0.113,-0.216,K9J7B2,Ugt1a6b,K9J7B2_Ugt1a6b,K9J7B2,Ugt1a6b,1,25,19,5,K9J7B2,MOUSE,61117.2,36.1,196,196.9,291.05,81.25,,531,UDP-glucuronosyltransferase,endoplasmic reticulum|endoplasmic reticulum membrane|intracellular membrane-bounded organelle|extracellular exosome|,flavonoid biosynthetic process|cellular response to hormone stimulus|flavonoid glucuronidation|xenobiotic glucuronidation|,glucuronosyltransferase activity|enzyme binding|protein homodimerization activity|protein heterodimerization activity|,5,25,24300000000,13.5%
Q64435,0.856747233,-0.102,2.283083843,0.106,0.591141727,0.56430758,0.053,0.058,-0.576,0.03,0.007,-0.184,Q64435,Ugt1a6a,Q64435_Ugt1a6a,Q64435,Ugt1a6,1,16,18,4,Q64435,MOUSE,61065.1,33.5,196,196.1,282.47,72.67,,531,UDP-glucuronosyltransferase 1-6,mitochondrial inner membrane|endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|intracellular membrane-bounded organelle|extracellular exosome|,flavonoid biosynthetic process|glucuronate metabolic process|cellular response to hormone stimulus|flavonoid glucuronidation|xenobiotic glucuronidation|,glucuronosyltransferase activity|enzyme binding|protein homodimerization activity|protein heterodimerization activity|,4,16,6750000000,10.9%
B2RT14,0.178343247,-0.0495,16.67090698,0.719,0.021523322,2.992902724,-0.084,-0.258,-0.885,0.631,0.092,0.207,B2RT14,Ugt1a5,B2RT14_Ugt1a5,B2RT14,Ugt1a5,1,15,18,6,B2RT14,MOUSE,60756.8,33.6,196,196.11,248.47,62.75,,529,UDP-glucuronosyltransferase,endoplasmic reticulum|endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,flavonoid biosynthetic process|cellular response to hormone stimulus|cellular glucuronidation|flavonoid glucuronidation|xenobiotic glucuronidation|,glucuronosyltransferase activity|enzyme binding|protein homodimerization activity|protein heterodimerization activity|,6,15,3680000000,14.3%
Q8BJL9,0.070780923,0.0085,21.847037,0.545666667,0.006535763,3.905761401,-0.231,-0.104,-0.458,0.063,0.414,0.367,Q8BJL9,Ugt2b35,Q8BJL9_Ugt2b35,Q8BJL9,Ugt2b35,1,21,11,8,Q8BJL9,MOUSE,61080,21.5,196,196.13,150.95,103.08,,529,UDP-glucuronosyltransferase,intracellular membrane-bounded organelle|extracellular exosome|,flavonoid biosynthetic process|cellular response to hormone stimulus|flavonoid glucuronidation|,glucuronosyltransferase activity|,8,21,5780000000,17.0%
Q9DBG1,0.329673848,0.031,11.99310622,-0.297333333,0.063195969,-2.229326177,0.248,0.361,-0.07,-0.028,-0.1,-0.225,Q9DBG1,Cyp27a1,Q9DBG1_Cyp27a1,Q9DBG1,Cyp27a1,1,183,34,34,Q9DBG1,MOUSE,60947.3,62.4,197,197.1,500.7,500.7,,533,"Sterol 26-hydroxylase, mitochondrial",mitochondrion|mitochondrial inner membrane|,cholesterol metabolic process|calcitriol biosynthetic process from calciol|oxidation-reduction process|,iron ion binding|heme binding|vitamin D3 25-hydroxylase activity|cholesterol 26-hydroxylase activity|cholestanetriol 26-monooxygenase activity|,34,183,1.57E+11,62.4%
A2A7A7,0.000444524,-0.248,50.65071959,1.950666667,8.60851E-06,12.2464253,-1.066,-1.03,-1.574,0.648,0.783,0.751,A2A7A7,H6pd,A2A7A7_H6pd,A2A7A7,H6pd,1,140,36,36,A2A7A7|Q8CF,MOUSE,90478.8,47,198,198.1,499.56,499.56,,797,GDH/6PGL endoplasmic bifunctional protein,mitochondrion|,glucose metabolic process|pentose-phosphate shunt|oxidation-reduction process|response to alcohol|,glucose-6-phosphate dehydrogenase activity|6-phosphogluconolactonase activity|carbohydrate binding|NADP binding|,36,140,1.49E+11,47.0%
P62334,0.734218406,0.003,4.024278414,0.090666667,0.395887837,0.906967054,0.068,-0.087,-0.108,0.172,-0.028,0.001,P62334,Psmc6,P62334_Psmc6,P62334,Psmc6,1,145,35,35,P62334,MOUSE,44457.5,79.6,199,199.1,499.06,499.06,,389,26S proteasome regulatory subunit 10B,"proteasome complex|nucleus|proteasome regulatory particle, base subcomplex|membrane|inclusion body|proteasome accessory complex|nuclear proteasome complex|cytosolic proteasome complex|extracellular exosome|",ER-associated ubiquitin-dependent protein catabolic process|positive regulation of RNA polymerase II transcriptional preinitiation complex assembly|positive regulation of inclusion body assembly|positive regulation of proteasomal protein catabolic process|,ATP binding|TBP-class protein binding|proteasome-activating ATPase activity|,35,145,70600000000,79.6%
Q8CAS9-2,0.807018562,-0.0065,2.987749963,-0.103,0.502602916,-0.708860987,0.12,-0.059,0.074,0.224,-0.289,-0.109,Q8CAS9,Parp9,Q8CAS9-2_Parp9,Q8CAS9-2,Parp9,1,107,36,1,Q8CAS9-2|H7BWY5,MOUSE,93637.4,46.5,200,200.1,498.64,13.16,,866,Isoform 2 of Poly [ADP-ribose] polymerase 9,nucleus|cytoplasm|cytosol|membrane|,double-strand break repair|regulation of response to interferon-gamma|,NAD+ ADP-ribosyltransferase activity|,36,107,69700000000,46.5%
Q61176,0.584741827,-0.023666667,6.644802644,0.371333333,0.216530828,1.366001085,-0.404,-0.571,0.347,-0.159,0.174,0.471,Q61176,Arg1,Q61176_Arg1,Q61176,Arg1,1,180,33,33,Q61176,MOUSE,34978.4,67.4,201,201.1,497.23,497.23,,323,Arginase-1,extracellular space|nucleus|mitochondrial outer membrane|neuron projection|neuronal cell body|extracellular exosome|,urea cycle|liver development|positive regulation of endothelial cell proliferation|aging|response to herbicide|response to manganese ion|response to zinc ion|response to selenium ion|regulation of L-arginine import|response to amine|arginine catabolic process to ornithine|lung development|collagen biosynthetic process|response to vitamin A|response to vitamin E|response to drug|response to amino acid|response to cadmium ion|response to axon injury|response to methylmercury|mammary gland involution|maternal process involved in female pregnancy|protein homotrimerization|cellular response to hydrogen peroxide|cellular response to lipopolysaccharide|cellular response to interleukin-4|cellular response to glucagon stimulus|cellular response to dexamethasone stimulus|cellular response to transforming growth factor beta stimulus|,arginase activity|manganese ion binding|,33,180,3.59E+11,67.4%
Q91VR5,0.714714682,-0.007,4.29336921,0.082666667,0.372102921,0.956417635,0.03,-0.093,-0.082,0.102,-0.013,0.014,Q91VR5,Ddx1,Q91VR5_Ddx1,Q91VR5,Ddx1,1,98,33,33,Q91VR5,MOUSE,83525.7,45.8,202,202.1,496.94,496.94,,740,ATP-dependent RNA helicase DD,nucleus|nucleoplasm|cytoplasm|cytoplasmic stress granule|membrane|ribonucleoprotein complex|cleavage body|tRNA-splicing ligase complex|,"double-strand break repair|transcription, DNA-templated|regulation of transcription, DNA-templated|tRNA splicing, via endonucleolytic cleavage and ligation|mRNA processing|multicellular organismal development|response to virus|RNA secondary structure unwinding|DNA duplex unwinding|response to exogenous dsRNA|nucleic acid phosphodiester bond hydrolysis|",DNA binding|chromatin binding|transcription cofactor activity|double-stranded RNA binding|ATP-dependent RNA helicase activity|nuclease activity|exonuclease activity|protein binding|ATP binding|ATP-dependent helicase activity|poly(A) binding|DNA/RNA helicase activity|poly(A) RNA binding|,33,98,23700000000,45.8%
Q5YD48,0.797504707,-0.0095,3.125271393,-0.103666667,0.486937095,-0.736084016,0.215,0.154,-0.242,0.029,-0.058,-0.155,Q5YD48,A1cf,Q5YD48_A1cf,Q5YD48,A1cf,1,127,34,33,Q5YD48|Q5YD48-2|Q5YD48-3|A0A286YDF7,MOUSE,65966,69.5,203,203.1,496.28,479.7,,595,APOBEC1 complementation factor,nucleus|nucleoplasm|nuclear heterochromatin|cytoplasm|endoplasmic reticulum|apolipoprotein B mRNA editing enzyme complex|mRNA editing complex|,mRNA processing|mRNA localization resulting in posttranscriptional regulation of gene expression|cytidine to uridine editing|mRNA modification|protein stabilization|,nucleotide binding|RNA binding|single-stranded RNA binding|mRNA binding|protein binding|double-stranded RNA binding|,34,127,75500000000,69.5%
Q91WT8,0.919618833,-0.029333333,1.190814904,-0.040666667,0.760183624,-0.318133734,0.123,0.069,-0.219,0.096,-0.068,-0.177,Q91WT8,Rbm47,Q91WT8_Rbm47,Q91WT8,Rbm47,1,49,18,17,Q91WT8|D3YXZ5|Q91WT8-2|P86049|S4R1Y9|S4R2P5,MOUSE,64517.4,42.5,203,203.2,255.09,238.51,,590,RNA-binding protein 47,nucleus|,hematopoietic progenitor cell differentiation|cytidine to uridine editing|,nucleotide binding|RNA binding|protein binding|poly(A) RNA binding|,17,49,20300000000,40.6%
P21440,0.872151671,0.0085,2.086185631,-0.083,0.618559437,-0.522174837,0.337,0.081,-0.268,0.042,-0.047,-0.094,P21440,Abcb4,P21440_Abcb4,P21440,Abcb4,1,86,34,29,P21440|B5X0E4|Q9JJ59,MOUSE,140887.9,32.5,204,204.1,493.52,405.22,,1276,Phosphatidylcholine translocator ABCB4,plasma membrane|membrane|integral component of membrane|intercellular canaliculus|extracellular exosome|,drug transmembrane transport|metabolic process|xenobiotic transport|transmembrane transport|,"ATP binding|xenobiotic-transporting ATPase activity|ATPase activity, coupled to transmembrane movement of substances|",36,86,39000000000,32.5%
P34914,0.985063154,0.039666667,0.239644038,0.012666667,0.946314721,0.06993002,-0.007,0.303,-0.196,-0.163,0.346,-0.045,P34914,Ephx2,P34914_Ephx2,P34914,Ephx2,1,110,33,33,P34914|P34914-2|A8JYK8,MOUSE,63084.7,62.4,205,205.1,490.04,490.04,,554,Bifunctional epoxide hydrolase 2,cytoplasm|peroxisome|cytosol|extracellular exosome|,response to toxic substance|positive regulation of gene expression|dephosphorylation|cholesterol homeostasis|stilbene catabolic process|phospholipid dephosphorylation|regulation of cholesterol metabolic process|,magnesium ion binding|epoxide hydrolase activity|receptor binding|toxic substance binding|phosphatase activity|10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity|lipid phosphatase activity|protein homodimerization activity|,33,110,85800000000,62.4%
Q61768,0.993378838,0.01,0.10756976,-0.002666667,0.975535378,-0.031829998,-0.008,-0.001,0.043,0.086,-0.057,-0.003,Q61768,Kif5b,Q61768_Kif5b,Q61768,Kif5b,1,87,38,38,Q61768|P33175|P28738,MOUSE,110291.3,44.2,206,206.1,489.59,489.59,,963,Kinesin-1 heavy chain,cytoplasm|microtubule organizing center|cytosol|kinesin complex|microtubule|membrane|endocytic vesicle|vesicle|ciliary rootlet|neuron projection|membrane-bounded organelle|perinuclear region of cytoplasm|,"mitochondrial transport|microtubule-based process|cytoplasm organization|axon guidance|protein localization|metabolic process|positive regulation of synaptic transmission, GABAergic|stress granule disassembly|regulation of membrane potential|positive regulation of potassium ion transport|vesicle transport along microtubule|plus-end-directed vesicle transport along microtubule|positive regulation of establishment of protein localization to plasma membrane|","microtubule motor activity|protein binding|ATP binding|microtubule binding|ATP-dependent microtubule motor activity, plus-end-directed|",38,87,18200000000,44.2%
O08749,0.90651412,-0.062833333,1.518802506,0.076333333,0.704887403,0.395530127,0.078,0.165,-0.546,-0.038,0.059,-0.095,O08749,Dld,O08749_Dld,O08749,Dld,1,159,31,31,O08749,MOUSE,54784.9,68.3,207,207.1,489.54,489.54,,509,"Dihydrolipoyl dehydrogenase, mitochondrial",nucleoplasm|mitochondrion|mitochondrial matrix|cilium|acrosomal matrix|myelin sheath|oxoglutarate dehydrogenase complex|pyruvate dehydrogenase complex|,"acetyl-CoA biosynthetic process from pyruvate|2-oxoglutarate metabolic process|mitochondrial electron transport, NADH to ubiquinone|proteolysis|gastrulation|aging|lipoate metabolic process|regulation of membrane potential|cell redox homeostasis|sperm capacitation|dihydrolipoamide metabolic process|",dihydrolipoyl dehydrogenase activity|lipoamide binding|flavin adenine dinucleotide binding|NAD binding|,31,159,3.41E+11,68.3%
E9Q3M3,0.951955994,-0.015833333,0.714552199,-0.017,0.848290845,-0.198837821,0.018,0.04,-0.08,0.014,-0.091,0.004,E9Q3M3,Dctn1,E9Q3M3_Dctn1,E9Q3M3,Dctn1,1,81,38,38,E9Q3M3|E9Q586|O08788|O08788-2|D3YX34,MOUSE,140443.8,38.2,208,208.1,488.62,488.62,,1264,Dynactin subunit 1,kinetochore|spindle pole|centrosome|dynactin complex|microtubule|membrane|cell leading edge|protein complex|retromer complex|,"microtubule-based transport|melanosome transport|retrograde transport, endosome to Golgi|",protein binding|dynein binding|,38,81,16700000000,38.2%
Q9D0E1,0.797128744,-0.0455,3.181489934,0.098333333,0.480674415,0.747130338,0.028,0.059,-0.371,0.012,-0.002,0.001,Q9D0E1,Hnrnpm,Q9D0E1_Hnrnpm,Q9D0E1,Hnrnpm,1,141,37,37,Q9D0E1|Q9D0E1-2|B8JK32|B8JK33,MOUSE,77989.9,51.7,209,209.1,488.28,488.28,,729,Heterogeneous nuclear ribonucleoprotein M,nucleoplasm|spliceosomal complex|membrane|nuclear matrix|extracellular matrix|paraspeckles|extracellular exosome|catalytic step 2 spliceosome|,"alternative mRNA splicing, via spliceosome|",nucleotide binding|antigen binding|protein domain specific binding|poly(A) RNA binding|,37,141,51200000000,51.7%
P54775,0.969274541,0.010333333,0.425337032,0.013333333,0.906705597,0.121714945,0.164,-0.016,-0.137,0.119,-0.017,-0.051,P54775,Psmc4,P54775_Psmc4,P54775,Psmc4,1,140,35,35,P54775|A0A140LIZ5,MOUSE,47521.6,79.1,210,210.1,487.59,487.59,,418,26S proteasome regulatory subunit 6B,"proteasome complex|nucleus|nucleoplasm|cytoplasm|proteasome regulatory particle, base subcomplex|membrane|inclusion body|proteasome accessory complex|nuclear proteasome complex|cytosolic proteasome complex|",blastocyst development|ER-associated ubiquitin-dependent protein catabolic process|positive regulation of RNA polymerase II transcriptional preinitiation complex assembly|positive regulation of proteasomal protein catabolic process|,ATP binding|TBP-class protein binding|proteasome-activating ATPase activity|,35,140,1.18E+11,79.1%
Q8K441,0.942218886,-0.0555,0.837654351,0.043666667,0.824583357,0.230607955,0.173,0.046,-0.451,0.166,-0.029,-0.238,Q8K441,Abca6,Q8K441_Abca6,Q8K441,Abca6,1,86,35,35,Q8K441|Q8K449,MOUSE,184990.7,25.1,211,211.1,485.24,485.24,,1624,ATP-binding cassette sub-family A member 6,integral component of membrane|intracellular membrane-bounded organelle|,lipid transport|metabolic process|transmembrane transport|,"ATP binding|ATPase activity, coupled to transmembrane movement of substances|",35,86,29200000000,25.1%
Q8C7X2,0.000781654,-0.079166667,46.13478146,1.856333333,2.43513E-05,10.3908967,-1.005,-0.858,-1.159,0.474,1.08,0.993,Q8C7X2,Emc1,Q8C7X2_Emc1,Q8C7X2,Emc1,1,114,34,34,Q8C7X2|Z4YJW0|Q8C7X2-2|Q8C7X2-3,MOUSE,112002.5,40.1,212,212.1,483.94,483.94,,997,ER membrane protein complex subunit 1,endoplasmic reticulum|integral component of membrane|ER membrane protein complex|,,,34,114,86700000000,40.1%
Q91WT9,0.919618833,-0.000166667,1.173934223,-0.033,0.763144147,-0.313927512,0.004,0.147,-0.102,-0.123,0.083,-0.01,Q91WT9,Cbs,Q91WT9_Cbs,Q91WT9,Cbs,1,119,32,32,Q91WT9|Q91WT9-2,MOUSE,62284.3,69.1,213,213.1,482.74,482.74,,561,Cystathionine beta-synthase,nucleus|nucleolus|cytoplasm|cytosol|intracellular membrane-bounded organelle|,endochondral ossification|blood vessel remodeling|cysteine biosynthetic process from serine|superoxide metabolic process|cysteine biosynthetic process via cystathionine|cysteine biosynthetic process|transsulfuration|cerebellum morphogenesis|regulation of cGMP metabolic process|negative regulation of apoptotic process|regulation of JUN kinase activity|homocysteine metabolic process|regulation of blood vessel size|response to folic acid|oxidation-reduction process|maternal process involved in female pregnancy|cartilage development involved in endochondral bone morphogenesis|hydrogen sulfide biosynthetic process|cellular response to hypoxia|,cystathionine beta-synthase activity|oxygen binding|enzyme binding|heme binding|pyridoxal phosphate binding|ubiquitin protein ligase binding|identical protein binding|protein homodimerization activity|metal ion binding|nitrite reductase (NO-forming) activity|carbon monoxide binding|nitric oxide binding|modified amino acid binding|S-adenosyl-L-methionine binding|,32,119,79500000000,69.1%
Q64737,0.471687594,-0.007666667,8.824706286,-0.183333333,0.131077869,-1.720389251,0.14,0.151,-0.039,-0.245,-0.049,-0.004,Q64737,Gart,Q64737_Gart,Q64737,Gart,1,98,32,32,Q64737|Q64737-2|D6RCG1,MOUSE,108699.7,46.6,214,214.1,482.28,482.28,,1010,Trifunctional purine biosynthetic protein adenosine-3,cytoplasm|extracellular exosome|,brainstem development|'de novo' IMP biosynthetic process|glycine metabolic process|purine nucleobase biosynthetic process|response to organic substance|response to inorganic substance|cerebellum development|cerebral cortex development|methylation|tetrahydrofolate biosynthetic process|,phosphoribosylamine-glycine ligase activity|phosphoribosylformylglycinamidine cyclo-ligase activity|phosphoribosylglycinamide formyltransferase activity|ATP binding|methyltransferase activity|metal ion binding|,32,98,94200000000,46.6%
Q99N15,0.88044681,-0.026166667,1.939056819,-0.103666667,0.639873785,-0.490118627,0.263,0.275,-0.461,-0.009,-0.001,-0.224,Q99N15,Hsd17b10,Q99N15_Hsd17b10,Q99N15,Hsd17b10,1,212,26,26,Q99N15|A2AFQ2|O08756,MOUSE,27387.2,93.4,215,215.1,478.85,478.85,,261,17beta-hydroxysteroid dehydrogenase type 10/short chain L-3-hydroxyacyl-CoA dehydrogenase,mitochondrion|mitochondrial inner membrane|endoplasmic reticulum|mitochondrial nucleoid|,cell aging|Leydig cell differentiation|protein homotetramerization|oxidation-reduction process|,beta-amyloid binding|3-hydroxyacyl-CoA dehydrogenase activity|estradiol 17-beta-dehydrogenase activity|steroid binding|acetoacetyl-CoA reductase activity|estrogen receptor binding|identical protein binding|poly(A) RNA binding|NAD binding|,26,212,5.35E+11,93.4%
Q9D0F3,0.000128795,-0.244333333,61.4967494,2.108,7.08476E-07,17.97921116,-1.336,-1.167,-1.392,0.628,0.864,0.937,Q9D0F3,Lman1,Q9D0F3_Lman1,Q9D0F3,Lman1,1,151,36,36,Q9D0F3,MOUSE,58073,52.2,216,216.1,478.35,478.35,,517,Protein ERGIC-53,Golgi membrane|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|membrane|integral component of membrane|sarcomere|ER to Golgi transport vesicle|endoplasmic reticulum-Golgi intermediate compartment membrane|host cell perinuclear region of cytoplasm|extracellular exosome|,ER to Golgi vesicle-mediated transport|endoplasmic reticulum organization|Golgi organization|positive regulation of organelle organization|protein transport|,carbohydrate binding|metal ion binding|,36,151,1.61E+11,52.2%
Q8JZQ2,0.91325,-0.066,1.354679383,0.067333333,0.732035364,0.357230248,0.169,0.021,-0.489,0.122,-0.005,-0.214,Q8JZQ2,Afg3l2,Q8JZQ2_Afg3l2,Q8JZQ2,Afg3l2,1,118,33,29,Q8JZQ2,MOUSE,90030.6,39.5,217,217.1,476.22,418.52,,802,AFG3-like protein 2,mitochondrion|mitochondrial inner membrane|integral component of membrane|,mitochondrion organization|axonogenesis|neuromuscular junction development|mitochondrial fusion|nerve development|mitochondrial protein processing|regulation of multicellular organism growth|cristae formation|myelination|muscle fiber development|righting reflex|,metalloendopeptidase activity|ATP binding|zinc ion binding|,33,118,38400000000,39.5%
Q920A7,0.994928853,-0.020166667,0.073029149,0.003,0.98332501,0.021702315,0.186,-0.009,-0.242,0.11,0.007,-0.173,Q920A7,Afg3l1,Q920A7_Afg3l1,Q920A7,Afg3l1,1,34,18,14,Q920A7|Q920A7-2,MOUSE,87615.6,27.8,217,217.2,247.36,189.66,,789,AFG3-like protein 1,mitochondrion|integral component of membrane|mitochondrial membrane|,mitochondrion organization|mitochondrial fusion|mitochondrial protein processing|cristae formation|,metalloendopeptidase activity|ATP binding|zinc ion binding|,14,34,3330000000,24.3%
Q99KQ4,0.961523652,-0.000166667,0.552694503,-0.021666667,0.880502411,-0.156238534,0.272,-0.001,-0.239,0.014,0.011,-0.058,Q99KQ4,Nampt,Q99KQ4_Nampt,Q99KQ4,Nampt,1,136,32,32,Q99KQ4,MOUSE,55731.1,61.3,218,218.1,474.91,474.91,,491,Nicotinamide phosphoribosyltransferase,extracellular space|nucleus|cytoplasm|cytosol|extracellular exosome|,female pregnancy|circadian rhythm|NAD biosynthetic process|response to organic cyclic compound|circadian regulation of gene expression|positive regulation of transcription from RNA polymerase II promoter|positive regulation of smooth muscle cell proliferation|positive regulation of nitric-oxide synthase biosynthetic process|,nicotinate-nucleotide diphosphorylase (carboxylating) activity|cytokine activity|drug binding|protein homodimerization activity|nicotinamide phosphoribosyltransferase activity|,32,136,1.64E+11,61.3%
Q99JY0,0.647450828,0.000166667,5.426245677,-0.158333333,0.286665502,-1.158699877,-0.007,0.277,-0.032,-0.253,0.118,-0.102,Q99JY0,Hadhb,Q99JY0_Hadhb,Q99JY0,Hadhb,1,157,30,30,Q99JY0,MOUSE,51670.7,64,219,219.1,473.87,473.87,,475,"Trifunctional enzyme subunit beta, mitochondrial",mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|endoplasmic reticulum|mitochondrial fatty acid beta-oxidation multienzyme complex|mitochondrial nucleoid|extracellular exosome|,fatty acid beta-oxidation|,acetyl-CoA C-acyltransferase activity|long-chain-3-hydroxyacyl-CoA dehydrogenase activity|poly(A) RNA binding|,30,157,1.75E+11,64.0%
Q9CU62,0.297132915,-0.015666667,12.82157066,-0.202666667,0.052220729,-2.356327879,0.072,0.104,0.081,-0.037,-0.21,-0.104,Q9CU62,Smc1a,Q9CU62_Smc1a,Q9CU62,Smc1a,1,81,41,41,Q9CU62,MOUSE,143859.9,36,220,220.1,473.71,473.71,,1233,Structural maintenance of chromosomes protein 1A,kinetochore|nucleus|nucleoplasm|nucleolus|cytoplasm|cohesin core heterodimer|meiotic cohesin complex|,DNA repair|sister chromatid cohesion|mitotic sister chromatid cohesion|mitotic cell cycle checkpoint|meiotic nuclear division|response to radiation|stem cell maintenance|negative regulation of DNA endoreduplication|signal transduction in response to DNA damage|cell division|,chromatin binding|protein binding|ATP binding|mediator complex binding|poly(A) RNA binding|protein heterodimerization activity|,41,81,11400000000,36.0%
Q9DBG6,0.919618833,-0.013666667,1.177471102,0.042,0.762522898,0.314910168,-0.122,0.24,-0.222,-0.002,0.039,-0.015,Q9DBG6,Rpn2,Q9DBG6_Rpn2,Q9DBG6,Rpn2,1,104,25,25,Q9DBG6|A2ACG7,MOUSE,69175.7,50.7,221,221.1,463.1,463.1,,631,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2,autophagosome membrane|nucleus|endoplasmic reticulum|rough endoplasmic reticulum|oligosaccharyltransferase complex|membrane|integral component of membrane|,protein N-linked glycosylation|aging|response to drug|,"transferase activity, transferring glycosyl groups|ribosome binding|",25,104,1.08E+11,50.7%
Q9JHS4,0.47899797,0.023166667,8.588900715,-0.272333333,0.138391663,-1.68462672,0.453,0.152,-0.127,0.005,-0.09,-0.254,Q9JHS4,Clpx,Q9JHS4_Clpx,Q9JHS4,Clpx,1,113,32,32,Q9JHS4|Q6P8N8,MOUSE,70026.2,52.2,222,222.1,463.06,463.06,,634,"ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial",nucleoplasm|cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial matrix|endopeptidase Clp complex|mitochondrial endopeptidase Clp complex|mitochondrial nucleoid|,protein folding|positive regulation of peptidase activity|proteolysis involved in cellular protein catabolic process|,protein binding|ATP binding|peptidase activator activity|ATPase activity|metal ion binding|unfolded protein binding|ATP-dependent peptidase activity|,32,113,59000000000,52.2%
Q8BK48,0.000201502,-0.358333333,57.70415638,2.24,1.69662E-06,15.76939815,-1.393,-1.276,-1.766,0.852,0.705,0.728,Q8BK48,Ces2e,Q8BK48_Ces2e,Q8BK48,Ces2e,1,141,30,23,Q8BK48|F6Z9B9|Q08ED5|Q149K3,MOUSE,62716,62.4,223,223.1,461.09,379.17,,559,Pyrethroid hydrolase Ces2e,endoplasmic reticulum|,metabolic process|,carboxylic ester hydrolase activity|,30,141,1.72E+11,62.4%
Q8QZR3,0.000552294,-0.333,48.6615622,2.074666667,1.36096E-05,11.39472549,-1.219,-1.112,-1.78,0.616,0.788,0.709,Q8QZR3,Ces2a,Q8QZR3_Ces2a,Q8QZR3,Ces2a,1,47,17,12,Q8QZR3|Q8QZR3-2,MOUSE,62395.6,43.1,223,223.2,249.87,196.72,,558,Pyrethroid hydrolase Ces2a,,,carboxylic ester hydrolase activity|,12,47,22300000000,37.4%
E9PV38,0.002159674,-0.160666667,40.12519736,1.432,9.71584E-05,8.312210528,-0.715,-0.646,-1.269,0.502,0.594,0.57,E9PV38,Ces2g,E9PV38_Ces2g,E9PV38,Ces2g,1,26,12,8,E9PV38|Q6PDB7,MOUSE,63005,27.3,223,223.3,161.98,101,,560,Carboxylic ester hydrolase,,metabolic process|,hydrolase activity|,8,26,6600000000,16.2%
Q8CHR6,0.667069025,0.010666667,5.056748264,0.102,0.31212257,1.093053962,-0.109,-0.048,0.036,-0.02,0.167,0.038,Q8CHR6,Dpyd,Q8CHR6_Dpyd,Q8CHR6,Dpyd,1,84,34,34,Q8CHR6|A0A0G2JF48,MOUSE,113248.3,42.4,224,224.1,460.6,460.6,,1025,Dihydropyrimidine dehydrogenase [NADP(+)],cytoplasm|cytosol|,purine nucleobase catabolic process|pyrimidine nucleobase catabolic process|thymine catabolic process|uracil catabolic process|thymidine catabolic process|beta-alanine biosynthetic process|oxidation-reduction process|,"nucleotide binding|dihydropyrimidine dehydrogenase (NADP+) activity|protein homodimerization activity|metal ion binding|4 iron, 4 sulfur cluster binding|",34,84,15200000000,42.4%
P17182,0.304100014,0.022,12.67142975,0.332666667,0.054057633,2.338002293,-0.079,-0.002,-0.352,-0.036,0.323,0.278,P17182,Eno1,P17182_Eno1,P17182,Eno1,1,128,33,33,P17182|Q6PHC1|P21550|P17183|A0A0N4SUX5|D3Z6E4|A0A0N4SUW8,MOUSE,47482.3,78.3,225,225.1,460.03,460.03,,434,Alpha-enolase,phosphopyruvate hydratase complex|plasma membrane|myelin sheath|,glycolytic process|,magnesium ion binding|phosphopyruvate hydratase activity|,33,128,45600000000,78.3%
E9QA63,0.883573216,-0.000166667,1.898721996,0.038333333,0.645844255,0.480982215,0.003,-0.016,-0.045,0.069,-0.019,0.007,E9QA63,NotFound,E9QA63_NotFound,E9QA63,Macf1,1,58,46,16,E9QA63|Q9QXZ0|E9PVY8|B1ARU4|Q9QXZ0-4|Q9QXZ0-2|A0A0A0MQA6|Q9QXZ0-3|E9QNP1,MOUSE,837457.6,8.2,226,226.1,459.93,156.11,,7351,Microtubule-actin cross-linking factor 1,cell cortex|actin cytoskeleton|microtubule cytoskeleton|neuronal postsynaptic density|,mesoderm formation|posttranslational protein targeting to membrane|cell cycle arrest|establishment or maintenance of cell polarity|protein localization|metabolic process|Wnt signaling pathway|,actin binding|calcium ion binding|protein binding|microtubule binding|ATPase activity|,46,58,32000000000,8.2%
B1ARU1,0.617054235,-0.015,6.007239229,-0.135333333,0.250770287,-1.257442775,-0.02,0.015,0.163,0.07,-0.204,-0.114,B1ARU1,NotFound,B1ARU1_NotFound,B1ARU1,Macf1,1,3,32,3,B1ARU1,MOUSE,667436.8,7.5,226,226.2,330.11,31.07,,5895,Microtubule-actin cross-linking factor 1,cell cortex|actin cytoskeleton|microtubule cytoskeleton|neuronal postsynaptic density|,mesoderm formation|posttranslational protein targeting to membrane|cell cycle arrest|establishment or maintenance of cell polarity|protein localization|metabolic process|Wnt signaling pathway|,actin binding|calcium ion binding|protein binding|microtubule binding|ATPase activity|,3,3,770000000,0.7%
S4R1P5,0.47899797,0.1065,8.598201817,-0.277666667,0.138095593,-1.686128334,0.005,0.168,0.563,0.111,-0.196,-0.012,S4R1P5,Dst,S4R1P5_Dst,S4R1P5,Dst,1,5,6,5,S4R1P5|Q91ZU6-4|Q91ZU6|Q91ZU6-2|A0A087WSP0|E9Q9|Q91ZU6-3|Q91ZU6-5,MOUSE,876109,0.8,226,226.3,34.34,29.29,,7717,Dystonin,actin cytoskeleton|cytoplasmic membrane-bounded vesicle|hemidesmosome|neuronal postsynaptic density|,cytoskeleton organization|cell cycle arrest|axonogenesis|retrograde axon cargo transport|,actin binding|calcium ion binding|protein binding|,5,5,167000000,0.6%
Q8BMK4,0.000108653,-0.346833333,65.11029861,2.205666667,3.08298E-07,20.1967831,-1.442,-1.279,-1.628,0.763,0.764,0.741,Q8BMK4,Ckap4,Q8BMK4_Ckap4,Q8BMK4,Ckap4,1,120,34,34,Q8BMK4,MOUSE,63748,58.2,227,227.1,459.85,459.85,,575,Cytoskeleton-associated protein 4,endoplasmic reticulum|endoplasmic reticulum membrane|lipid particle|cytoskeleton|plasma membrane|cell surface|integral component of membrane|perinuclear region of cytoplasm|extracellular exosome|,,poly(A) RNA binding|,34,120,42300000000,58.2%
P07724,0.001346067,-0.252666667,43.00056804,1.943333333,5.01122E-05,9.256292428,-0.942,-1.047,-1.684,0.647,0.596,0.914,P07724,Alb,P07724_Alb,P07724,Alb,1,153,35,33,P07724,MOUSE,70745.2,54.7,228,228.1,459.72,420.96,,608,Serum albumin,extracellular region|extracellular space|nucleus|cytoplasm|myelin sheath|protein complex|extracellular exosome|blood microparticle|,retina homeostasis|transport|cellular response to starvation|hemolysis by symbiont of host erythrocytes|negative regulation of apoptotic process|maintenance of mitochondrion location|,DNA binding|fatty acid binding|drug binding|toxic substance binding|pyridoxal phosphate binding|metal ion binding|chaperone binding|oxygen binding|,35,153,92300000000,54.7%
Q5BL07,0.862027405,-0.006833333,2.199305552,0.062333333,0.602655945,0.546368929,0.097,-0.024,-0.187,0.167,-0.071,-0.023,Q5BL07,Pex1,Q5BL07_Pex1,Q5BL07,Pex1,1,86,36,36,Q5BL07|Q5BL07-2|A0A0G2JE39,MOUSE,142452.1,33.2,229,229.1,457.11,457.11,,1284,Peroxisome biogenesis factor 1,cytoplasm|peroxisome|peroxisomal membrane|cytosol|intracellular membrane-bounded organelle|extracellular exosome|,protein targeting to peroxisome|peroxisome organization|metabolic process|protein import into peroxisome matrix|microtubule-based peroxisome localization|,"ATP binding|protein C-terminus binding|lipid binding|protein complex binding|ATPase activity, coupled|",36,86,26800000000,33.2%
P97434-2,0.340542058,0.004333333,11.65946854,0.234666667,0.06824222,2.172334403,-0.06,-0.029,-0.25,-0.02,0.195,0.19,P97434,Mprip,P97434-2_Mprip,P97434-2,Mprip,1,68,34,3,P97434-2|P97434-5|P97434|P97434-4|P97434-3,MOUSE,118819,40.5,230,230.1,456.69,39.95,,1024,Isoform 2 of Myosin phosphatase Rho-interacting protein,cytoplasm|focal adhesion|actin cytoskeleton|,,actin binding|,34,68,7450000000,40.5%
Q5SWZ5,0.762989784,-0.029666667,3.665924782,0.091333333,0.429939673,0.840017599,-0.062,0.076,-0.24,-0.055,0.016,0.087,Q5SWZ5,Mprip,Q5SWZ5_Mprip,Q5SWZ5,Mprip,1,6,32,2,Q5SWZ5,MOUSE,259278.6,17.8,230,230.2,422.72,22.74,,2269,Myosin phosphatase Rho-interacting protein,cytoplasm|focal adhesion|actin cytoskeleton|,,,2,6,393000000,1.1%
Q99KW3,0.503888483,-0.011333333,8.144521079,0.159333333,0.153302025,1.610313998,-0.121,-0.015,-0.137,-0.046,0.05,0.201,Q99KW3,Triobp,Q99KW3_Triobp,Q99KW3,Triobp,1,12,10,9,Q99KW3|Q99KW3-4|E9QMQ3|Q99KW3-1|Q99KW3-2|G5E8W1,MOUSE,225303.5,5.5,230,230.3,101.13,90.09,,2014,TRIO and F-actin-binding protein,nucleus|cytoplasm|microtubule organizing center|focal adhesion|actin cytoskeleton|midbody|,mitotic nuclear division|regulation of actin cytoskeleton organization|cell division|positive regulation of substrate adhesion-dependent cell spreading|,ubiquitin protein ligase binding|actin filament binding|,9,12,340000000,5.0%
Q8VCB3,0.612622361,-0.058666667,6.131990557,0.305333333,0.243669372,1.279709418,-0.151,0.157,-0.64,0.219,0.316,-0.253,Q8VCB3,Gys2,Q8VCB3_Gys2,Q8VCB3,Gys2,1,125,31,31,Q8VCB3,MOUSE,81668.1,39.9,231,231.1,455.96,455.96,,704,"Glycogen [starch] synthase, liver",cytoplasm|cytosol|cytoskeleton|cell cortex|cortical actin cytoskeleton|ectoplasm|,glycogen biosynthetic process|response to glucose|,glycogen (starch) synthase activity|,31,125,69300000000,39.9%
P50247,0.982930903,0.142166667,0.268554455,0.031,0.940036149,0.078126601,-0.548,-0.043,0.971,-0.13,-0.003,0.606,P50247,Gm4737,P50247_Gm4737,P50247,Ahcy,1,158,33,31,P50247,MOUSE,48200.8,68.7,232,232.1,455.91,434.8,,432,Adenosylhomocysteinase,melanosome|,one-carbon metabolic process|,adenosylhomocysteinase activity|protein binding|,33,158,1.56E+11,68.7%
Q9D0R2,0.883773419,-0.098333333,1.893807054,0.137333333,0.646575575,0.480155407,-0.689,0.015,0.173,-0.465,0.03,0.346,Q9D0R2,Tars,Q9D0R2_Tars,Q9D0R2,Tars,1,116,36,33,Q9D0R2,MOUSE,84267.3,47.2,233,233.1,455.67,410.48,,722,"Threonine--tRNA ligase, cytoplasmic",cytoplasm|actin cytoskeleton|extracellular exosome|,threonyl-tRNA aminoacylation|,threonine-tRNA ligase activity|ATP binding|,36,116,52100000000,47.2%
Q8BLY2,0.575072566,-0.008166667,6.893165577,0.143666667,0.204495352,1.40562888,-0.018,0.002,-0.224,0.158,0.046,-0.013,Q8BLY2,Tarsl2,Q8BLY2_Tarsl2,Q8BLY2,Tarsl2,1,12,10,7,Q8BLY2,MOUSE,92229.5,14,233,233.2,114.97,69.78,,790,"Probable threonine--tRNA ligase 2, cytoplasmic",cytoplasm|,threonyl-tRNA aminoacylation|,threonine-tRNA ligase activity|ATP binding|,7,12,613000000,10.7%
Q8BWP5,0.991556352,-0.017333333,0.174297274,-0.006,0.960661249,-0.051215799,0.005,0.173,-0.221,-0.012,-0.001,-0.048,Q8BWP5,Ttpa,Q8BWP5_Ttpa,Q8BWP5,Ttpa,1,148,27,27,Q8BWP5|A2AIT6|A8Y5N9,MOUSE,32127.5,88.4,234,234.1,454.62,454.62,,278,Alpha-tocopherol transfer protein,cytoplasm|late endosome|cytosol|,placenta development|embryonic placenta development|response to nutrient|response to pH|response to toxic substance|vitamin E metabolic process|intermembrane transport|vitamin transport|intracellular pH reduction|negative regulation of cell death|negative regulation of establishment of blood-brain barrier|,"transporter activity|phosphatidylinositol-4,5-bisphosphate binding|vitamin E binding|phosphatidylinositol-3,4-bisphosphate binding|",27,148,1.26E+11,88.4%
Q80XN0,0.956068722,-0.077666667,0.650426817,0.038,0.860909139,0.182160136,0.117,0.163,-0.57,-0.078,0.088,-0.186,Q80XN0,Bdh1,Q80XN0_Bdh1,Q80XN0,Bdh1,1,255,28,28,Q80XN0,MOUSE,38640.6,68.2,235,235.1,452.5,452.5,,343,"D-beta-hydroxybutyrate dehydrogenase, mitochondrial",nucleoplasm|cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial matrix|,oxidation-reduction process|,3-hydroxybutyrate dehydrogenase activity|,28,255,8.96E+11,68.2%
P17563,0.584741827,0.012333333,6.634144865,0.135333333,0.217062856,1.362583821,-0.061,-0.09,-0.015,-0.052,0.222,0.07,P17563,Selenbp1,P17563_Selenbp1,P17563,Selenbp1,1,107,31,31,P17563|Q63836|A0A0R4J135|G3UYY2|D6RHN2,MOUSE,53083.6,72,236,236.1,449.87,449.87,,472,Selenium-binding protein 1,extracellular space|nucleolus|cytosol|membrane|extracellular exosome|,protein transport|brown fat cell differentiation|,selenium binding|,31,107,47400000000,72.0%
E9QNN1,0.248090831,0.04,14.24007843,-0.402,0.0376697,-2.591359562,0.044,0.554,0.125,-0.296,-0.141,-0.046,E9QNN1,Dhx9,E9QNN1_Dhx9,E9QNN1,Dhx9,1,98,36,36,E9QNN1|A0A087WPL5|O70133-2|O70133|O70133-3|A0A0R4J2C3,MOUSE,150999.6,30.9,237,237.1,449.05,449.05,,1384,ATP-dependent RNA helicase A,nucleus|nucleoplasm|nucleolus|cytoplasm|centrosome|membrane|ribonucleoprotein complex|cytoplasmic ribonucleoprotein granule|CRD-mediated mRNA stability complex|,osteoblast differentiation|RNA processing|circadian rhythm|cellular response to heat|CRD-mediated mRNA stabilization|,RNA polymerase II transcription factor binding|ATP-dependent RNA helicase activity|protein binding|ATP binding|poly(A) RNA binding|,36,98,93200000000,30.9%
Q6A0A9,0.797434179,-0.003,3.156672252,-0.061333333,0.483429084,-0.741758188,0.064,0.04,-0.021,0.031,-0.069,-0.063,Q6A0A9,Fam120a,Q6A0A9_Fam120a,Q6A0A9,FAM120A,1,103,32,30,Q6A0A9,MOUSE,122841.7,32.8,238,238.1,448.07,420.2,,1112,Constitutive coactivator of PPAR-gamma-like protein 1,plasma membrane|membrane|,,poly(A) RNA binding|,32,103,46300000000,32.8%
Q8C3F2,0.951667691,-0.055333333,0.717235747,-0.026666667,0.84776684,-0.199624864,0.015,0.039,-0.18,0.13,-0.295,-0.041,Q8C3F2,Fam120c,Q8C3F2_Fam120c,Q8C3F2,Fam120c,1,7,7,5,Q8C3F2|Q8C3F2-3|Q8C3F2-2,MOUSE,120971,8.4,238,238.2,77.11,49.24,,1091,Constitutive coactivator of PPAR-gamma-like protein 2,,,poly(A) RNA binding|,5,7,3130000000,6.4%
P70398,0.926534253,-0.004,1.068209148,-0.026,0.781950182,-0.288142757,0.052,0.035,-0.06,0.086,-0.064,-0.073,P70398,Usp9x,P70398_Usp9x,P70398,Usp9x,1,79,39,31,P70398|Q4FE56,MOUSE,294243.2,18.6,239,239.1,447.71,365.79,,2559,Probable ubiquitin carboxyl-terminal hydrolase FAF-X,cytoplasm|membrane|growth cone|apical part of cell|,in utero embryonic development|neuron migration|chromosome segregation|mitotic nuclear division|transforming growth factor beta receptor signaling pathway|post-embryonic development|protein deubiquitination|cerebellar cortex structural organization|hippocampus development|BMP signaling pathway|proteasome-mediated ubiquitin-dependent protein catabolic process|axon extension|cell division|regulation of proteasomal protein catabolic process|cellular response to transforming growth factor beta stimulus|neuron projection extension|,cysteine-type endopeptidase activity|ubiquitin-specific protease activity|protein binding|co-SMAD binding|,39,79,55700000000,18.6%
P14148,0.821409751,0.009,2.753873517,-0.08,0.530411154,-0.661869383,-0.095,0.221,0.021,-0.163,0.109,-0.039,P14148,Rpl7,P14148_Rpl7,P14148,Rpl7,1,160,34,34,P14148,MOUSE,31476.1,66.2,240,240.1,446.58,446.58,,270,60S ribosomal protein L7,nucleus|nucleolus|cytoplasm|polysome|focal adhesion|membrane|cytosolic large ribosomal subunit|ribonucleoprotein complex|extracellular exosome|,rRNA processing|translation|ribosomal large subunit biogenesis|,DNA binding|mRNA binding|structural constituent of ribosome|protein homodimerization activity|poly(A) RNA binding|,34,160,2.13E+11,66.2%
Q9WUM5,0.910011409,-0.032666667,1.456109537,-0.078666667,0.715136667,-0.380997152,0.2,0.277,-0.457,-0.116,0.088,-0.188,Q9WUM5,Suclg1,Q9WUM5_Suclg1,Q9WUM5,Suclg1,1,176,28,28,Q9WUM5,MOUSE,36496.4,61.2,241,241.1,445.95,445.95,,346,"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial",cytoplasm|mitochondrion|mitochondrial inner membrane|plasma membrane|succinate-CoA ligase complex (GDP-forming)|extracellular exosome|,tricarboxylic acid cycle|succinyl-CoA metabolic process|succinate metabolic process|,succinate-CoA ligase (ADP-forming) activity|succinate-CoA ligase (GDP-forming) activity|GTP binding|GDP binding|poly(A) RNA binding|protein heterodimerization activity|cofactor binding|,28,176,7.53E+11,61.2%
P12970,0.656833435,0.012833333,5.230643668,-0.119666667,0.299871805,-1.12372516,-0.06,0.244,0.034,-0.043,0.01,-0.108,P12970,Rpl7a,P12970_Rpl7a,P12970,Rpl7a,1,139,33,33,P12970|A0A140T8L1|A0A140T8L3|V9GX35,MOUSE,30147.2,71.4,242,242.1,445.65,445.65,,266,60S ribosomal protein L7a,nucleus|nucleolus|cytoplasm|focal adhesion|membrane|cytosolic large ribosomal subunit|polysomal ribosome|extracellular exosome|,ribosome biogenesis|,protein binding|poly(A) RNA binding|,33,139,1.61E+11,71.4%
Q99L88,0.935853609,-0.013,0.914490466,-0.026,0.810122983,-0.249962081,0.098,0.058,-0.156,0.06,-0.039,-0.099,Q99L88,Sntb1,Q99L88_Sntb1,Q99L88,Sntb1,1,140,30,27,Q99L88|Q99L88-2,MOUSE,58479.5,55.1,243,243.1,445.59,400.34,,537,Beta-1-syntrophin,cytoplasm|cytoskeleton|focal adhesion|sarcolemma|protein complex|synapse|,,actin binding|structural molecule activity|protein binding|calmodulin binding|PDZ domain binding|,30,140,49800000000,55.1%
Q61235,0.580760484,0.028666667,6.732077796,-0.144,0.212222888,-1.379131629,0.028,0.023,0.251,0.015,-0.15,0.005,Q61235,Sntb2,Q61235_Sntb2,Q61235,Sntb2,1,19,15,12,Q61235|B7ZNU9,MOUSE,56837.1,32.1,243,243.2,188.38,143.13,,520,Beta-2-syntrophin,cytoplasm|microtubule|focal adhesion|transport vesicle membrane|protein complex|synapse|extracellular exosome|,,actin binding|structural molecule activity|protein binding|calmodulin binding|poly(A) RNA binding|,12,19,7380000000,28.8%
A0A1Y7VJZ2,0.634404848,-0.018,5.722697247,-0.213333333,0.267750491,-1.209884457,0.352,0.065,-0.151,-0.386,0.111,-0.099,A0A1Y7VJZ2,Gstz1,A0A1Y7VJZ2_Gstz1,A0A1Y7VJZ2,Gstz1,1,223,27,1,A0A1Y7VJZ2|A0A1Y7VNC1,MOUSE,24375.9,96.7,244,244.1,445.29,13.8,,215,"Glutathione transferase zeta 1 (Maleylacetoacetate isomerase), isoform CRA_c",,,,27,223,1.18E+12,96.7%
Q2TPA8,0.517887704,0.011333333,7.841176179,-0.189333333,0.164392645,-1.563330667,0.271,0.155,-0.108,-0.168,-0.005,-0.077,Q2TPA8,Hsdl2,Q2TPA8_Hsdl2,Q2TPA8,Hsdl2,1,101,29,29,Q2TPA8|B1AX78,MOUSE,54549.7,69.5,245,245.1,444.3,444.3,,490,Hydroxysteroid dehydrogenase-like protein 2,mitochondrion|peroxisome|membrane|,oxidation-reduction process|,oxidoreductase activity|,29,101,47800000000,69.5%
Q99L20,0.826064255,-0.108833333,2.683790349,0.177,0.539039965,0.647607498,0.191,0.085,-0.868,-0.016,0.025,-0.07,Q99L20,Gstt3,Q99L20_Gstt3,Q99L20,Gstt3,1,185,27,9,Q99L20|G3UX05|G3UX71,MOUSE,27745,75.1,246,246.1,444.18,146.21,,241,Glutathione S-transferase theta-3,,glutathione metabolic process|,glutathione transferase activity|,27,185,4.81E+11,75.1%
Q9D826,0.90770516,-0.029666667,1.493024246,0.062666667,0.70908382,0.389568632,-0.007,0.219,-0.395,-0.018,0.069,-0.046,Q9D826,Pipox,Q9D826_Pipox,Q9D826,Pipox,1,142,29,29,Q9D826,MOUSE,44473.4,67.9,247,247.1,443.53,443.53,,390,Peroxisomal sarcosine oxidase,peroxisome|,L-lysine catabolic process to acetyl-CoA via L-pipecolate|tetrahydrofolate metabolic process|oxidation-reduction process|,receptor binding|sarcosine oxidase activity|L-pipecolate oxidase activity|,29,142,1.11E+11,67.9%
P17427,0.731162978,-0.031666667,4.076787333,-0.174,0.391130125,-0.917404852,-0.284,0.258,0.192,-0.402,-0.027,0.073,P17427,Ap2a2,P17427_Ap2a2,P17427,Ap2a2,1,111,33,26,P17427|A0A140LHG0,MOUSE,104927.5,38.5,248,248.1,440.08,364.92,,938,AP-2 complex subunit alpha-2,plasma membrane|coated pit|cytoplasmic membrane-bounded vesicle|membrane coat|clathrin adaptor complex|secretory granule|,intracellular protein transport|endocytosis|vesicle-mediated transport|regulation of hematopoietic stem cell differentiation|,protein binding|lipid binding|protein transporter activity|protein kinase binding|protein complex binding|,33,111,53000000000,38.5%
P17426,0.713417662,0.000666667,4.328362344,-0.107333333,0.36911676,-0.963171067,-0.123,0.193,0.093,-0.15,-0.008,-0.001,P17426,Ap2a1,P17426_Ap2a1,P17426,Ap2a1,1,51,28,21,P17426|P17426-2,MOUSE,108746.1,32.8,248,248.2,336.6,261.44,,977,AP-2 complex subunit alpha-1,coated pit|membrane|basolateral plasma membrane|apical plasma membrane|membrane coat|clathrin adaptor complex|secretory granule|filopodium tip|,intracellular protein transport|endocytosis|vesicle-mediated transport|negative regulation of hyaluronan biosynthetic process|,protein binding|protein C-terminus binding|protein transporter activity|protein kinase binding|protein complex binding|,21,51,9420000000,26.1%
E9PV24,0.811763387,0.001166667,2.922750664,0.148333333,0.510181767,0.695891103,-0.208,-0.419,0.408,0.151,-0.053,0.128,E9PV24,Fga,E9PV24_Fga,E9PV24,Fga,1,131,37,38,E9PV24|E9PV24-2|P02672|A5PJE3|E9QMF5|Q80TN7|A0A2C9F2D9|O35732|Q6PDH4|E9QP10|O08918|Q80W69-2|Q8VE42|Q3U523,MOUSE,88169.4,36.6,249,249.1,439.87,449.13,,789,Fibrinogen alpha chain,fibrinogen complex|extracellular space|rough endoplasmic reticulum|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|extracellular vesicle|,"protein complex assembly|acute-phase response|cell-matrix adhesion|signal transduction|blood coagulation|plasminogen activation|response to estradiol|response to genistein|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|induction of bacterial agglutination|response to morphine|cellular protein complex assembly|innate immune response|positive regulation of vasoconstriction|positive regulation of exocytosis|response to cycloheximide|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|cellular response to interleukin-6|cellular response to organic cyclic compound|blood coagulation, common pathway|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|liver regeneration|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|cellular response to granulocyte colony-stimulating factor|negative regulation of endothelial cell apoptotic process|","structural molecule activity|protein binding, bridging|receptor binding|cell adhesion molecule binding|",39,131,85200000000,36.6%
D3YYT1,0.884484678,-0.0255,1.871558661,0.057666667,0.649896404,0.475238132,0.064,0.047,-0.274,0.105,-0.073,-0.022,D3YYT1,Glyr1,D3YYT1_Glyr1,D3YYT1,Glyr1,1,21,13,12,D3YYT1|Q922P9,MOUSE,61061.9,26.9,249,249.2,156.5,151.4,,552,Putative oxidoreductase GLYR1,nucleoplasm|cytoplasm|Golgi apparatus|,oxidation-reduction process|,DNA binding|phosphogluconate dehydrogenase (decarboxylating) activity|methylated histone binding|NAD binding|,12,21,4630000000,26.4%
Q8BG05,0.508093395,0.015,8.05734,-0.246,0.156410534,-1.598525447,-0.115,0.354,0.175,-0.278,-0.13,0.084,Q8BG05,Hnrnpa3,Q8BG05_Hnrnpa3,Q8BG05,Hnrnpa3,1,131,33,7,Q8BG05|A2AL12,MOUSE,39879.5,61.4,250,250.1,435.73,86.78,,379,Heterogeneous nuclear ribonucleoprotein A3,spliceosomal complex|,mRNA processing|RNA splicing|,nucleotide binding|RNA binding|,33,131,62700000000,61.4%
J3QNY1,0.472088965,0.04,8.786614321,-0.32,0.132232609,-1.716514322,-0.149,0.283,0.466,-0.286,-0.191,0.117,J3QNY1,NotFound,J3QNY1_NotFound,J3QNY1,Gm9242,1,16,29,3,J3QNY1|Q8BG05-2|B2RXM2,MOUSE,37367.7,59.6,250,250.2,385.86,36.91,,357,Predicted pseudogene 9242,nucleus|cytoplasm|ribonucleoprotein granule|neuron projection|,mRNA transport|,mRNA binding|RNA transmembrane transporter activity|,3,16,15400000000,3.6%
P97807,0.71338646,-0.005,4.332013342,-0.194,0.368806584,-0.964266228,-0.251,0.094,0.433,-0.374,0.026,0.042,P97807,Fh1,P97807_Fh1,P97807,Fh,1,132,29,29,P97807|P97807-2,MOUSE,54584,64.2,251,251.1,435.62,435.62,,507,"Fumarate hydratase, mitochondrial",mitochondrion|tricarboxylic acid cycle enzyme complex|extracellular exosome|,tricarboxylic acid cycle|fumarate metabolic process|malate metabolic process|homeostasis of number of cells within a tissue|,fumarate hydratase activity|,29,132,82100000000,64.2%
Q9EP71,0.303758531,-0.0045,12.68585351,0.223,0.053878395,2.334654996,-0.031,-0.144,-0.173,-0.013,0.178,0.156,Q9EP71,Rai14,Q9EP71_Rai14,Q9EP71,Rai14,1,80,35,35,Q9EP71,MOUSE,109535,39.9,252,252.1,434.01,434.01,,979,Ankycorbin,nucleus|nucleoplasm|cytoplasm|mitochondrion|cell cortex|actin cytoskeleton|,,,35,80,9780000000,39.9%
P70694,0.997585215,0.013,0.023058031,0.002,0.994704762,0.006891134,-0.085,0.663,-0.542,0.036,0.142,-0.136,P70694,Akr1c6,P70694_Akr1c6,P70694,Akr1c6,1,146,32,26,P70694|A0A1Y7VNR7|Q3UXL1|G3XA14|Q8K023|Q8K023-2|E0CYR9|A0A1Y7VLH1,MOUSE,37446.4,88.5,253,253.1,432.93,360.69,,323,Estradiol 17 beta-dehydrogenase 5,extracellular exosome|,"steroid biosynthetic process|steroid metabolic process|daunorubicin metabolic process|doxorubicin metabolic process|negative regulation of mRNA splicing, via spliceosome|oxidation-reduction process|cellular response to jasmonic acid stimulus|","retinal dehydrogenase activity|aldo-keto reductase (NADP) activity|estradiol 17-beta-dehydrogenase activity|oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor|androsterone dehydrogenase activity|",32,146,1.85E+11,88.5%
Q91WT7,0.926033297,-0.037,1.072002436,0.086,0.781267496,0.289209816,-0.051,0.523,-0.712,0.137,0.066,-0.185,Q91WT7,Akr1c14,Q91WT7_Akr1c14,Q91WT7,Akr1c14,1,125,26,23,Q91WT7,MOUSE,37644.6,85.4,253,253.2,380.86,343.63,,323,3-alpha-hydroxysteroid dehydrogenase type 1,,hippocampus development|oxidation-reduction process|,androsterone dehydrogenase activity|,23,125,1.4E+11,83.9%
Q8VC,0.833338863,-0.024,2.611465815,0.094666667,0.548091944,0.632797833,0.127,-0.132,-0.209,0.038,0.243,-0.211,Q8VC,NotFound,Q8VC_NotFound,Q8VC,Akr1d1,1,22,12,10,Q8VC,MOUSE,37631.5,52.6,253,253.3,149.8,127.5,,325,3-oxo-5-beta-steroid 4-dehydrogenase,cytosol|extracellular exosome|,bile acid biosynthetic process|cholesterol catabolic process|digestion|C21-steroid hormone metabolic process|androgen metabolic process|bile acid catabolic process|oxidation-reduction process|,3-oxo-5-beta-steroid 4-dehydrogenase activity|delta4-3-oxosteroid 5beta-reductase activity|,10,22,5270000000,49.5%
Q8R1B4,0.833338863,0.0005,2.615877704,-0.083,0.547535434,-0.633703958,-0.207,0.154,0.179,-0.146,-0.031,0.054,Q8R1B4,Eif3c,Q8R1B4_Eif3c,Q8R1B4,Eif3c,1,97,33,33,Q8R1B4,MOUSE,106213.8,34.5,254,254.1,431.8,431.8,,911,Eukaryotic translation initiation factor 3 subunit C,"eukaryotic translation initiation factor 3 complex|eukaryotic 43S preinitiation complex|eukaryotic 48S preinitiation complex|eukaryotic translation initiation factor 3 complex, eIF3m|",formation of translation preinitiation complex|translational initiation|regulation of translational initiation|,translation initiation factor activity|translation initiation factor binding|ribosome binding|poly(A) RNA binding|translation initiation factor activity|,33,97,34600000000,34.5%
P53395,0.29603048,-0.0065,12.87387793,-0.254333333,0.051595545,-2.365952787,0.094,0.212,0.056,-0.305,-0.061,-0.035,P53395,Dbt,P53395_Dbt,P53395,Dbt,1,136,32,32,P53395,MOUSE,53587.9,61.6,255,255.1,431.07,431.07,,482,"Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial",mitochondrion|mitochondrial nucleoid|,metabolic process|,ubiquitin protein ligase binding|dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity|,32,136,1.63E+11,61.6%
Q3UIR3,0.896328129,-0.0045,1.636636587,-0.062333333,0.686019312,-0.422534838,0.118,-0.096,0.058,0.237,-0.28,-0.064,Q3UIR3,Dtx3l,Q3UIR3_Dtx3l,Q3UIR3,Dtx3l,1,100,30,30,Q3UIR3|Q3UIR3-2,MOUSE,84069.1,45.8,256,256.1,430.86,430.86,,748,E3 ubiquitin-protein ligase DTX3L,nucleus|nucleoplasm|cytoplasm|,double-strand break repair|cellular response to DNA damage stimulus|histone monoubiquitination|,ubiquitin-protein transferase activity|zinc ion binding|ligase activity|histone binding|,30,100,35000000000,45.8%
Q61699,0.471902671,-0.060666667,8.800651165,0.256666667,0.13180591,1.718775735,-0.057,0.002,-0.512,0.116,0.006,0.081,Q61699,Hsph1,Q61699_Hsph1,Q61699,Hsph1,1,73,30,28,Q61699|Q61699-2|E9Q0U7,MOUSE,97375.6,40.7,257,257.1,429.56,403.88,,858,Heat shock protein 105 kDa,extracellular region|nucleus|nucleoplasm|cytoplasm|cytosol|extracellular exosome|microtubule|,response to unfolded protein|negative regulation of neuron apoptotic process|positive regulation of MHC class I biosynthetic process|positive regulation of transcription from RNA polymerase II promoter|chaperone mediated protein folding requiring cofactor|positive regulation of NK T cell activation|positive regulation of protein tyrosine kinase activity|regulation of microtubule cytoskeleton organization|negative regulation of establishment of protein localization to mitochondrion|negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide|negative regulation of p38MAPK cascade|negative regulation of apoptotic signaling pathway|,protein binding|ATP binding|alpha-tubulin binding|,30,73,15400000000,40.7%
Q3U2G2,0.368638671,-0.015666667,11.07795247,0.221333333,0.078019786,2.079648193,-0.225,-0.19,0.036,0.01,0.091,0.184,Q3U2G2,Hspa4,Q3U2G2_Hspa4,Q3U2G2,Hspa4,1,23,18,16,Q3U2G2|Q61316,MOUSE,95005.8,29,257,257.2,208.15,182.47,,842,Heat shock 70 kDa protein 4,mitochondrion|cytosol|extracellular exosome|,protein import into mitochondrial outer membrane|chaperone-mediated protein complex assembly|,protein binding|ATP binding|,16,23,3400000000,26.3%
P48722,0.014436715,-0.040333333,30.21279589,0.586666667,0.000952183,5.604519002,-0.412,-0.183,-0.406,0.196,0.202,0.361,P48722,Hspa4l,P48722_Hspa4l,P48722,Hspa4l,1,8,9,7,P48722|P48722-2,MOUSE,95236.2,13.9,257,257.3,105.95,80.27,,838,Heat shock 70 kDa protein 4L,nucleus|cytoplasm|cytosol|,protein folding|response to unfolded protein|,protein binding|ATP binding|,7,8,3190000000,11.2%
Q9D8E6,0.733956781,-0.0225,4.035232223,0.111,0.394890583,0.909711629,-0.262,0.118,-0.09,-0.036,0.143,-0.008,Q9D8E6,Rpl4,Q9D8E6_Rpl4,Q9D8E6,Rpl4,1,116,32,32,Q9D8E6,MOUSE,47438.1,54.6,258,258.1,429.53,429.53,,419,60S ribosomal protein L4,nucleus|nucleolus|cytoplasm|focal adhesion|membrane|cytosolic large ribosomal subunit|ribonucleoprotein complex|extracellular exosome|,translation|,structural constituent of ribosome|protein binding|poly(A) RNA binding|,32,116,69100000000,54.6%
P49429,0.977234082,-0.000333333,0.337321656,0.012,0.925268622,0.09743034,-0.002,0.18,-0.197,-0.072,0.127,-0.038,P49429,Hpd,P49429_Hpd,P49429,Hpd,1,111,29,29,P49429,MOUSE,45281.6,72.2,259,259.1,428.86,428.86,,393,4-hydroxyphenylpyruvate dioxygenase,Golgi membrane|endoplasmic reticulum|endoplasmic reticulum membrane|Golgi apparatus|extracellular exosome|,L-phenylalanine catabolic process|tyrosine catabolic process|oxidation-reduction process|,4-hydroxyphenylpyruvate dioxygenase activity|metal ion binding|,29,111,71100000000,72.2%
P11881,0.797504707,-0.002333333,3.10180248,0.058,0.489575586,0.730969493,-0.06,0.004,-0.038,0.068,0.003,0.009,P11881,Itpr1,P11881_Itpr1,P11881,Itpr1,1,59,38,29,P11881|P11881-3|P11881-2|P11881-4|P11881-5|P11881-6|P11881-7|P11881-8,MOUSE,316584.8,17,260,260.1,427.24,338.93,,2749,"Inositol 1,4,5-trisphosphate receptor type 1",nuclear envelope|nuclear inner membrane|nucleolus|cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|calcineurin complex|postsynaptic density|membrane|integral component of membrane|sarcoplasmic reticulum|platelet dense granule membrane|platelet dense tubular network|protein complex|,response to hypoxia|calcium ion transport|post-embryonic development|endoplasmic reticulum calcium ion homeostasis|epithelial fluid transport|inositol phosphate-mediated signaling|negative regulation of calcium-mediated signaling|voluntary musculoskeletal movement|release of sequestered calcium ion into cytosol|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress|calcium ion transmembrane transport|,"intracellular ligand-gated calcium channel activity|inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity|protein binding|calcium channel inhibitor activity|phosphatidylinositol binding|",38,59,3790000000,17.0%
Q9Z329,0.634404848,-0.013166667,5.719117362,0.097666667,0.267971288,1.207996919,-0.091,0.001,-0.096,0.05,0.008,0.049,Q9Z329,Itpr2,Q9Z329_Itpr2,Q9Z329,Itpr2,1,45,36,28,Q9Z329|Q9Z329-3|Q9Z329-2,MOUSE,310664.4,16.1,260,260.2,380.53,299.61,,2701,"Inositol 1,4,5-trisphosphate receptor type 2",cytoplasm|plasma membrane|cell cortex|membrane|integral component of membrane|sarcoplasmic reticulum|sarcoplasmic reticulum membrane|receptor complex|,response to hypoxia|calcium ion transport|inositol phosphate-mediated signaling|calcium ion transmembrane transport|cellular response to cAMP|cellular response to ethanol|,"inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity|calcium-release channel activity|phosphatidylinositol binding|",28,45,4260000000,13.5%
Q91VI7,0.339345828,-0.228,11.68693314,0.634666667,0.067812021,2.180383701,0.149,-1.015,-0.77,0.232,0.037,-0.001,Q91VI7,Rnh1,Q91VI7_Rnh1,Q91VI7,Rnh1,1,89,27,27,A0A1B0GSG5|Q91VI7,MOUSE,51527.2,79.3,261,261.1,426.92,426.92,,456,Ribonuclease inhibitor,cytoplasm|angiogenin-PRI complex|extracellular exosome|,negative regulation of catalytic activity|regulation of angiogenesis|,ribonuclease inhibitor activity|,27,89,29600000000,79.3%
Q3UMF0-2,0.73101227,-0.016333333,4.084523676,0.090666667,0.390434002,0.918104918,-0.012,0.042,-0.215,-0.013,0.055,0.045,Q3UMF0,Cobll1,Q3UMF0-2_Cobll1,Q3UMF0-2,Cobll1,1,91,35,35,Q3UMF0-2|B1AZ14|B1AZ15|Q3UMF0-4|Q3UMF0|Q3UMF0-3,MOUSE,133972,38.6,262,262.1,425.14,425.14,,1273,Isoform 2 of Cordon-bleu protein-like 1,extracellular exosome|,,,35,91,20700000000,38.6%
O88844,0.021097933,-0.0435,28.109354,0.732333333,0.001545484,5.165755447,-0.217,-0.427,-0.585,0.168,0.539,0.261,O88844,Idh1,O88844_Idh1,O88844,Idh1,1,120,31,30,O88844,MOUSE,47073,70.7,263,263.1,425.07,411.64,,414,Isocitrate dehydrogenase [NADP] cytoplasmic,cytoplasm|mitochondrion|peroxisome|cytosol|extracellular exosome|,glyoxylate cycle|tricarboxylic acid cycle|isocitrate metabolic process|2-oxoglutarate metabolic process|glutathione metabolic process|response to oxidative stress|female gonad development|response to steroid hormone|regulation of phospholipid catabolic process|regulation of phospholipid biosynthetic process|,magnesium ion binding|isocitrate dehydrogenase (NADP+) activity|receptor binding|protein homodimerization activity|NADP binding|NAD binding|,31,120,50200000000,70.7%
P54071,0.483677438,0.004333333,8.477283085,-0.274,0.141994555,-1.666594289,0.002,0.432,-0.01,-0.287,0.101,-0.212,P54071,Idh2,P54071_Idh2,P54071,Idh2,1,88,25,24,P54071|D6RIL6|A0A0U1RPR1,MOUSE,51361.7,52.4,263,263.2,359.65,346.22,,452,"Isocitrate dehydrogenase [NADP], mitochondrial",mitochondrion|mitochondrial inner membrane|extracellular exosome|,glyoxylate cycle|tricarboxylic acid cycle|isocitrate metabolic process|2-oxoglutarate metabolic process|,magnesium ion binding|isocitrate dehydrogenase (NADP+) activity|NAD binding|,24,88,49200000000,52.4%
Q9WUA2,0.539869532,0.038333333,7.443451492,-0.163333333,0.180158539,-1.496696053,-0.006,0.318,0.048,-0.049,-0.02,-0.061,Q9WUA2,Farsb,Q9WUA2_Farsb,Q9WUA2,Farsb,1,115,30,30,Q9WUA2|A0A087WQ15,MOUSE,66380.7,54.6,264,264.1,422.22,422.22,,589,Phenylalanine--tRNA ligase beta subunit,phenylalanine-tRNA ligase complex|membrane|,phenylalanyl-tRNA aminoacylation|,magnesium ion binding|RNA binding|ATP binding|phenylalanine-tRNA ligase activity|,30,115,50700000000,54.6%
Q8JZQ9,0.854957327,-0.011,2.325696269,-0.087333333,0.585369881,-0.573316518,-0.275,0.252,0.121,-0.165,-0.048,0.049,Q8JZQ9,Eif3b,Q8JZQ9_Eif3b,Q8JZQ9,Eif3b,1,84,36,36,Q8JZQ9,MOUSE,91767.9,55.4,265,265.1,421.69,421.69,,803,Eukaryotic translation initiation factor 3 subunit B,"nucleoplasm|cytoplasm|eukaryotic translation initiation factor 3 complex|eukaryotic 43S preinitiation complex|eukaryotic 48S preinitiation complex|extracellular exosome|eukaryotic translation initiation factor 3 complex, eIF3m|",formation of translation preinitiation complex|translational initiation|regulation of translational initiation|,nucleotide binding|translation initiation factor activity|protein binding|translation initiation factor binding|translation initiation factor activity|,36,84,26600000000,55.4%
Q9WUD0,0.822567717,0.001166667,2.72679424,-0.102333333,0.533728724,-0.65636897,0.073,0.307,-0.223,-0.111,0.118,-0.157,Q9WUD0,Cyp2b10,Q9WUD0_Cyp2b10,Q9WUD0,Cyp2b10,1,104,33,13,Q9WUD0|G3X8Q9|P12791-2|P12791|Q9WV19,MOUSE,56211.9,47.6,266,266.1,408.11,164.95,,491,Cytochrome P450 2B10,cytoplasm|intracellular membrane-bounded organelle|,xenobiotic metabolic process|steroid metabolic process|drug metabolic process|epoxygenase P450 pathway|cellular ketone metabolic process|exogenous drug catabolic process|oxidation-reduction process|,"monooxygenase activity|iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|",33,104,4.97E+11,47.6%
P12790,0.602016923,-0.109833333,6.313849429,0.335666667,0.23367651,1.310452274,0.124,-0.09,-0.867,0.107,0.187,-0.12,P12790,Cyp2b9,P12790_Cyp2b9,P12790,Cyp2b9,1,75,31,15,P12790,MOUSE,56139.2,37.8,266,266.2,420.64,213.01,,491,Cytochrome P450 2B9,cytoplasm|endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,xenobiotic metabolic process|epoxygenase P450 pathway|response to stilbenoid|exogenous drug catabolic process|oxidation-reduction process|,"iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|aromatase activity|",15,75,91500000000,20.5%
A6H6J2,0.875832617,-0.0235,2.009351412,-0.051,0.629600202,-0.505223703,-0.121,0.018,0.109,-0.155,0.012,-0.004,A6H6J2,Cyp2b13,A6H6J2_Cyp2b13,A6H6J2,Cyp2b13,1,10,26,4,A6H6J2,MOUSE,56415.3,34.8,266,266.3,333.47,52.68,,491,"Cytochrome P450, family 2, subfamily b, polypeptide 13",cytoplasm|intracellular membrane-bounded organelle|,xenobiotic metabolic process|epoxygenase P450 pathway|exogenous drug catabolic process|oxidation-reduction process|,"iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|",4,10,1210000000,9.3%
P48758,0.875832617,-0.030833333,2.003073381,0.065666667,0.630510992,0.504129176,0.029,0.078,-0.298,0.138,-0.054,-0.078,P48758,Cbr1,P48758_Cbr1,P48758,Cbr1,1,149,28,28,P48758|A0A1B0GRG8,MOUSE,30925.9,84.4,267,267.1,420.27,420.27,,277,Carbonyl reductase [NADPH] 1,cytoplasm|extracellular exosome|extracellular vesicle|,drug metabolic process|epithelial cell differentiation|vitamin K metabolic process|oxidation-reduction process|,"carbonyl reductase (NADPH) activity|oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor|15-hydroxyprostaglandin dehydrogenase (NADP+) activity|prostaglandin-E2 9-reductase activity|",28,149,2.94E+11,84.4%
Q3U3J1,0.714210254,-0.019166667,4.3105283,-0.095666667,0.370635633,-0.959552164,0.012,0.033,0.041,-0.231,-0.001,0.031,Q3U3J1,Bckdha,Q3U3J1_Bckdha,Q3U3J1,Bckdha,1,123,25,25,Q3U3J1|P50136,MOUSE,51057.6,58,268,268.1,419.54,419.54,,446,"2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial",mitochondrion|mitochondrial alpha-ketoglutarate dehydrogenase complex|,response to nutrient|branched-chain amino acid catabolic process|response to glucocorticoid|response to cAMP|oxidation-reduction process|,"alpha-ketoacid dehydrogenase activity|oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor|protein complex binding|",25,123,70400000000,58.0%
Q3TML0,0.454052388,0.012,9.266941441,0.210666667,0.118387502,1.793143664,-0.233,-0.115,0.068,0.097,-0.002,0.257,Q3TML0,Pdia6,Q3TML0_Pdia6,Q3TML0,Pdia6,1,145,29,2,Q3TML0|Q0V8C4,MOUSE,49087.6,52.1,269,269.1,419.23,37.62,,445,Protein disulfide-isomerase A6,endoplasmic reticulum-Golgi intermediate compartment|extracellular exosome|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|,protein disulfide isomerase activity|,29,145,1.54E+11,52.1%
P15105,0.00070612,-0.074666667,46.70942595,1.220666667,2.13333E-05,10.57261264,-0.563,-0.777,-0.715,0.376,0.535,0.696,P15105,Glul,P15105_Glul,P15105,Glul,1,192,30,30,P15105,MOUSE,42860.6,72.9,270,270.1,418.64,418.64,,373,Glutamine synthetase,nucleus|cytoplasm|mitochondrion|rough endoplasmic reticulum|perikaryon|myelin sheath|protein complex|axon terminus|cell body|extracellular exosome|glial cell projection|,"glutamate metabolic process|glutamine biosynthetic process|cell proliferation|cellular response to starvation|response to glucose|positive regulation of insulin secretion|positive regulation of epithelial cell proliferation|protein homooligomerization|positive regulation of synaptic transmission, glutamatergic|",magnesium ion binding|glutamate decarboxylase activity|glutamate-ammonia ligase activity|protein binding|ATP binding|glutamate binding|manganese ion binding|identical protein binding|dynein light chain binding|,30,192,2.67E+11,72.9%
P46460,0.847099459,0.003,2.395280041,-0.06,0.576065672,-0.587605326,0.151,0.017,-0.069,0.092,-0.1,-0.073,P46460,Nsf,P46460_Nsf,P46460,Nsf,1,99,35,35,P46460,MOUSE,83182.5,44.3,271,271.1,417.5,417.5,,744,Vesicle-fusing ATPase,cytoplasm|lysosomal membrane|Golgi stack|plasma membrane|myelin sheath|extracellular exosome|,positive regulation of receptor recycling|potassium ion transport|intracellular protein transport|intra-Golgi vesicle-mediated transport|metabolic process|Golgi to plasma membrane protein transport|positive regulation of protein catabolic process|Golgi vesicle docking|,"protein binding|ATP binding|syntaxin-1 binding|protein kinase binding|syntaxin binding|PDZ domain binding|protein complex binding|ATPase activity, coupled|metal ion binding|",35,99,35200000000,44.3%
Q99JI4,0.925061327,0.0015,1.109920438,-0.031,0.774475986,-0.298375683,0.156,0.038,-0.143,0.037,-0.021,-0.058,Q99JI4,Psmd6,Q99JI4_Psmd6,Q99JI4,Psmd6,1,95,31,31,Q99JI4,MOUSE,45820.8,52.9,272,272.1,416.27,416.27,,389,26S proteasome non-ATPase regulatory subunit 6,proteasome complex|proteasome regulatory particle|proteasome accessory complex|extracellular exosome|,proteasome-mediated ubiquitin-dependent protein catabolic process|,,31,95,46100000000,52.9%
Q9Z1Z0,0.885307507,-0.001,1.824421578,0.05,0.656988613,0.464587132,-0.186,-0.015,0.123,0.021,-0.045,0.096,Q9Z1Z0,Uso1,Q9Z1Z0_Uso1,Q9Z1Z0,Uso1,1,82,30,30,Q9Z1Z0|Q9Z1Z0-2|Q9Z1Z0-4|Q9Z1Z0-3|A0A0J9YUG0,MOUSE,108065.4,38.8,273,273.1,415.73,415.73,,959,General vesicular transport factor p115,Golgi membrane|nucleolus|endoplasmic reticulum|Golgi apparatus|Golgi stack|cytosol|ER to Golgi transport vesicle membrane|membrane|perinuclear region of cytoplasm|,intracellular protein transport|ER to Golgi vesicle-mediated transport|transcytosis|Golgi vesicle docking|vesicle fusion with Golgi apparatus|membrane fusion|,protein binding|protein transporter activity|poly(A) RNA binding|,30,82,15100000000,38.8%
P21981,0.575882301,-0.071333333,6.852911938,0.335333333,0.206399579,1.400690427,-0.538,-0.502,0.323,-0.041,0.096,0.234,P21981,Tgm2,P21981_Tgm2,P21981,Tgm2,1,101,29,29,P21981|G3UXE8,MOUSE,78200.7,48.9,274,274.1,414.81,414.81,,686,Protein-glutamine gamma-glutamyltransferase 2,proteinaceous extracellular matrix|cytoplasm|mitochondrion|endoplasmic reticulum|cytosol|focal adhesion|membrane|intrinsic component of plasma membrane|extracellular exosome|,G-protein coupled receptor signaling pathway|phospholipase C-activating G-protein coupled receptor signaling pathway|peptide cross-linking|negative regulation of endoplasmic reticulum calcium ion concentration|positive regulation of apoptotic process|apoptotic cell clearance|positive regulation of cell adhesion|positive regulation of mitochondrial calcium ion concentration|branching involved in salivary gland morphogenesis|salivary gland cavitation|,protein-glutamine gamma-glutamyltransferase activity|calcium ion binding|GTP binding|transaminase activity|,29,101,35500000000,48.9%
P80317,0.994928853,0.003333333,0.066552615,-0.002,0.984792514,-0.019783593,-0.093,0.171,-0.065,-0.031,0.005,0.033,P80317,Cct6a,P80317_Cct6a,P80317,Cct6a,1,109,27,27,P80317|Q61390|B1AT05,MOUSE,58459.7,52.1,275,275.1,413.09,413.09,,531,T-complex protein 1 subunit zeta,acrosomal vesicle|zona pellucida receptor complex|chaperonin-containing T-complex|microtubule|cell body|extracellular exosome|,protein folding|binding of sperm to zona pellucida|toxin transport|,protein binding|ATP binding|poly(A) RNA binding|unfolded protein binding|,27,109,48900000000,52.1%
G5E866,0.647450828,-0.001,5.401501099,-0.113333333,0.288303484,-1.153254683,-0.071,0.113,0.125,-0.052,-0.145,0.024,G5E866,Sf3b1,G5E866_Sf3b1,G5E866,Sf3b1,1,67,32,32,G5E866|Q99NB9|A0A087WNS2,MOUSE,146569.5,29.2,276,276.1,412.95,412.95,,1304,Splicing factor 3B subunit 1,chromatin|nucleus|nucleoplasm|spliceosomal complex|U12-type spliceosomal complex|nuclear matrix|small nuclear ribonucleoprotein complex|catalytic step 2 spliceosome|,"RNA splicing, via transesterification reactions|mRNA splicing, via spliceosome|blastocyst formation|RNA splicing|anterior/posterior pattern specification|",chromatin binding|protein binding|poly(A) RNA binding|,32,67,11400000000,29.2%
O70194,0.586445778,0.013833333,6.571155169,-0.122333333,0.220234059,-1.352061682,0.002,0.199,0.024,-0.063,-0.037,-0.042,O70194,Eif3d,O70194_Eif3d,O70194,Eif3d,1,108,28,28,O70194,MOUSE,64615.2,58.9,277,277.1,411.94,411.94,,548,Eukaryotic translation initiation factor 3 subunit D,"eukaryotic translation initiation factor 3 complex|membrane|eukaryotic 43S preinitiation complex|eukaryotic 48S preinitiation complex|eukaryotic translation initiation factor 3 complex, eIF3m|",formation of translation preinitiation complex|formation of cytoplasmic translation initiation complex|translational initiation|regulation of translational initiation|,poly(A) RNA binding|translation initiation factor activity|,28,108,39800000000,58.9%
Q9CW03,0.215287387,-0.004333333,15.37555998,-0.248,0.029003072,-2.768871525,0.113,0.168,0.078,-0.037,-0.226,-0.122,Q9CW03,Smc3,Q9CW03_Smc3,Q9CW03,Smc3,1,61,35,35,Q9CW03,MOUSE,141952.6,36.6,278,278.1,410.81,410.81,,1217,Structural maintenance of chromosomes protein 3,"chromosome, centromeric region|chromatin|lateral element|spindle pole|basement membrane|nucleus|nucleoplasm|cytoplasm|cohesin core heterodimer|nuclear matrix|meiotic cohesin complex|nuclear meiotic cohesin complex|",regulation of DNA replication|DNA repair|mitotic spindle organization|sister chromatid cohesion|mitotic sister chromatid cohesion|meiotic nuclear division|signal transduction|stem cell maintenance|negative regulation of DNA endoreduplication|cell division|,chromatin binding|protein binding|ATP binding|mediator complex binding|dynein binding|protein heterodimerization activity|,35,61,6010000000,36.6%
P57780,0.381666571,0.021166667,10.81952206,0.358333333,0.082803328,2.04192334,-0.323,0.016,-0.167,-0.075,0.141,0.535,P57780,Actn4,P57780_Actn4,P57780,Actn4,1,73,36,26,A0A1L1SV25|P57780|Q9JI91|O88990,MOUSE,105431.6,41.8,279,279.1,410.5,286.6,,912,Alpha-actinin-4,stress fiber|extracellular space|intracellular|nucleus|cytoplasm|cell-cell junction|focal adhesion|Z disc|ribonucleoprotein complex|cortical cytoskeleton|pseudopodium|neuron projection|protein complex|perinuclear region of cytoplasm|extracellular exosome|stress fiber|actin cytoskeleton|,response to hypoxia|protein transport|vesicle transport along actin filament|positive regulation of cell migration|peroxisome proliferator activated receptor signaling pathway|regulation of apoptotic process|retinoic acid receptor signaling pathway|positive regulation of pinocytosis|actin filament bundle assembly|negative regulation of cellular component movement|positive regulation of cellular component movement|bicellular tight junction assembly|negative regulation of substrate adhesion-dependent cell spreading|positive regulation of NIK/NF-kappaB signaling|protein localization to bicellular tight junction|regulation of nucleic acid-templated transcription|,RNA polymerase II regulatory region sequence-specific DNA binding|nucleoside binding|calcium ion binding|protein binding|ligand-dependent nuclear receptor transcription coactivator activity|chromatin DNA binding|nuclear hormone receptor binding|protein homodimerization activity|retinoic acid receptor binding|ion channel binding|poly(A) RNA binding|protein N-terminus binding|actin filament binding|,37,73,15700000000,41.8%
Q7TPR4,0.51414471,0.024333333,7.932507669,0.271333333,0.16097159,1.578214962,-0.345,-0.054,0.065,-0.015,0.022,0.473,Q7TPR4,Actn1,Q7TPR4_Actn1,Q7TPR4,Actn1,1,25,22,11,Q7TPR4|A1BN54,MOUSE,103694.3,28.2,279,279.2,268.64,139.84,,892,Alpha-actinin-1,stress fiber|ruffle|extracellular space|intracellular|cytoplasm|plasma membrane|brush border|cell-cell junction|fascia adherens|focal adhesion|Z disc|secretory granule|cortical cytoskeleton|dense core granule membrane|cell projection|extracellular exosome|stress fiber|actin filament|,actin filament organization|platelet formation|cortical cytoskeleton organization|platelet morphogenesis|focal adhesion assembly|actin filament bundle assembly|negative regulation of cellular component movement|actin filament network formation|actin crosslink formation|regulation of nucleic acid-templated transcription|,double-stranded RNA binding|integrin binding|calcium ion binding|protein binding|vinculin binding|ligand-dependent nuclear receptor transcription coactivator activity|protein homodimerization activity|ion channel binding|actin filament binding|,11,25,1970000000,15.4%
Q9QXE0,0.296014913,-0.065166667,12.88110542,0.309,0.051509752,2.371682475,-0.024,-0.472,-0.163,0.052,0.061,0.155,Q9QXE0,Hacl1,Q9QXE0_Hacl1,Q9QXE0,Hacl1,1,88,29,29,Q9QXE0|D3YZ54|E9PWM4|E9Q9L4|E9Q7H7|E9Q0K0|D6RDE9,MOUSE,64629.1,60.4,280,280.1,408.97,408.97,,581,2-hydroxyacyl-CoA lyase 1,peroxisome|,fatty acid alpha-oxidation|lipid metabolic process|protein oligomerization|,magnesium ion binding|receptor binding|lyase activity|carbon-carbon lyase activity|thiamine pyrophosphate binding|identical protein binding|cofactor binding|,29,88,78600000000,60.4%
Q9JLJ2,0.797504707,-0.048,3.102308359,0.111333333,0.489518562,0.731558477,0.081,-0.003,-0.389,0.011,0.16,-0.148,Q9JLJ2,Aldh9a1,Q9JLJ2_Aldh9a1,Q9JLJ2,Aldh9a1,1,98,26,26,Q9JLJ2|Q3U367,MOUSE,54483.7,65.9,281,281.1,408.64,408.64,,494,4-trimethylaminobutyraldehyde dehydrogenase,mitochondrion|cytosol|extracellular exosome|,cellular aldehyde metabolic process|carnitine metabolic process|neurotransmitter biosynthetic process|carnitine biosynthetic process|oxidation-reduction process|,"aldehyde dehydrogenase (NAD) activity|oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor|aminobutyraldehyde dehydrogenase activity|4-trimethylammoniobutyraldehyde dehydrogenase activity|",26,98,26100000000,65.9%
B2RQC6,0.751736923,0.001833333,3.814784252,-0.071666667,0.41545269,-0.867921244,0.051,0.074,-0.012,0.029,-0.062,-0.069,B2RQC6,Cad,B2RQC6_Cad,B2RQC6,Cad,1,105,34,34,B2RQC6|E9QAI5|G3UWN2|B2RQC6-2|E9QAT6,MOUSE,245801.4,17.1,282,282.1,408.36,408.36,,2225,CAD protein,nucleus|nucleoplasm|cytoplasm|cytosol|plasma membrane|membrane|nuclear matrix|neuronal cell body|terminal bouton|protein complex|extracellular exosome|,urea cycle|liver development|'de novo' pyrimidine nucleobase biosynthetic process|UTP biosynthetic process|arginine biosynthetic process|glutamine metabolic process|heart development|female pregnancy|lactation|response to amine|drug metabolic process|peptidyl-threonine phosphorylation|response to caffeine|organ regeneration|response to testosterone|cellular response to drug|'de novo' UMP biosynthetic process|protein autophosphorylation|response to cortisol|cellular response to epidermal growth factor stimulus|,UTP binding|aspartate carbamoyltransferase activity|carbamoyl-phosphate synthase (ammonia) activity|carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity|dihydroorotase activity|protein kinase activity|ATP binding|zinc ion binding|amino acid binding|enzyme binding|identical protein binding|,34,105,3.19E+12,17.1%
Q99PG0,0.293309675,-0.0655,12.99872141,0.488333333,0.050133481,2.390596418,-0.748,-0.189,0.008,-0.002,0.29,0.248,Q99PG0,Aadac,Q99PG0_Aadac,Q99PG0,Aadac,1,121,25,25,Q99PG0,MOUSE,45420.5,47.4,283,283.1,407.35,407.35,,398,Arylacetamide deacetylase,endoplasmic reticulum membrane|integral component of membrane|,metabolic process|positive regulation of triglyceride catabolic process|,triglyceride lipase activity|lipase activity|serine hydrolase activity|deacetylase activity|,25,121,1.06E+11,47.4%
E9Q555,0.674404166,0.034333333,4.957804957,-0.2,0.319315135,-1.076619872,0.008,-0.113,0.508,0.049,-0.28,0.034,E9Q555,NotFound,E9Q555_NotFound,E9Q555,Rnf213,1,74,41,41,E9Q555|A0A171EBL2,MOUSE,592076.1,9.2,284,284.1,406.78,406.78,,5152,E3 ubiquitin-protein ligase RNF213,nucleolus|cytoplasm|membrane|,protein ubiquitination|protein autoubiquitination|,ubiquitin-protein transferase activity|zinc ion binding|ligase activity|ATPase activity|,41,74,8530000000,9.2%
Q99LB7,0.997585215,-0.0125,0.03100303,-0.001,0.992886709,-0.009254126,0.036,0.09,-0.162,-0.096,0.11,-0.053,Q99LB7,Sardh,Q99LB7_Sardh,Q99LB7,Sardh,1,97,32,32,Q99LB7,MOUSE,102707.4,38.9,285,285.1,405.21,405.21,,919,"Sarcosine dehydrogenase, mitochondrial",mitochondrion|mitochondrial matrix|,tetrahydrofolate interconversion|oxidation-reduction process|,folic acid binding|sarcosine dehydrogenase activity|flavin adenine dinucleotide binding|,32,97,51900000000,38.9%
Q9ERG0,0.648073376,-0.0665,5.38481695,0.181666667,0.28941318,1.151502348,0.03,0.01,-0.512,0.048,0.029,-0.004,Q9ERG0,Lima1,Q9ERG0_Lima1,Q9ERG0,Lima1,1,106,33,33,Q9ERG0|Q9ERG0-2|Q4U4S6,MOUSE,84685.9,46.2,286,286.1,405.12,405.12,,753,LIM domain and actin-binding protein 1,stress fiber|cytoplasm|plasma membrane|brush border|focal adhesion|actin cytoskeleton|cleavage furrow|,negative regulation of actin filament depolymerization|ruffle organization|actin filament bundle assembly|,actin monomer binding|protein binding|zinc ion binding|actin filament binding|,34,106,28900000000,46.2%
O35423-2,0.820260214,-0.083833333,2.788439325,0.149666667,0.526206329,0.668872062,0.066,0.152,-0.694,0.056,-0.028,-0.055,O35423,Agxt,O35423-2_Agxt,O35423-2,Agxt,1,140,28,28,O35423-2|O35423,MOUSE,43918.9,59.9,287,287.1,403.23,403.23,,414,"Isoform Peroxisomal of Serine--pyruvate aminotransferase, mitochondrial",mitochondrion|mitochondrial matrix|peroxisome|peroxisomal matrix|,"Notch signaling pathway|glyoxylate catabolic process|glycine biosynthetic process, by transamination of glyoxylate|L-cysteine catabolic process|L-alanine catabolic process|pyruvate biosynthetic process|glyoxylate metabolic process|oxalic acid secretion|response to glucocorticoid|response to cAMP|",serine-pyruvate transaminase activity|receptor binding|alanine-glyoxylate transaminase activity|transaminase activity|amino acid binding|pyridoxal phosphate binding|protein homodimerization activity|,28,140,2.54E+11,59.9%
O54749,0.374561053,-0.0045,10.92931985,-0.165,0.080736146,-2.055241536,0.103,0.047,0.084,-0.033,-0.104,-0.124,O54749,Cyp2j5,O54749_Cyp2j5,O54749,Cyp2j5,1,106,30,30,O54749|O54750|Q924D1|A0A140T8U1|Q3UNV2|Q3UNV4|G3UXT0|G3UZ38,MOUSE,58068.2,57.6,288,288.1,401.44,401.44,,501,Cytochrome P450 2J5,cytoplasm|endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,regulation of systemic arterial blood pressure by hormone|angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure|xenobiotic metabolic process|arachidonic acid metabolic process|exogenous drug catabolic process|oxidation-reduction process|renal tubular secretion|positive regulation of estrogen secretion|,"iron ion binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen|oxygen binding|heme binding|aromatase activity|",30,106,1.14E+11,57.6%
P29341,0.532602769,-0.011,7.550050806,0.327333333,0.175790305,1.515737012,-0.378,-0.41,0.264,0.011,0.015,0.432,P29341,Pabpc1,P29341_Pabpc1,P29341,Pabpc1,1,78,31,21,P29341|Q9D4E6|Q62029|A2A5N3|Q8C7D3,MOUSE,70897.8,45.5,289,289.1,400.81,244.42,,636,Polyadenylate-binding protein 1,nucleus|cytoplasm|focal adhesion|cytoplasmic stress granule|membrane|ribonucleoprotein complex|cytoplasmic ribonucleoprotein granule|extracellular exosome|catalytic step 2 spliceosome|,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|mRNA processing|RNA splicing|gene silencing by RNA|positive regulation of nuclear-transcribed mRNA poly(A) tail shortening|positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|",nucleotide binding|mRNA binding|protein binding|protein C-terminus binding|poly(A) binding|poly(U) RNA binding|poly(A) RNA binding|,32,78,25600000000,45.5%
Q6PHQ9,0.919416995,-0.002,1.237264564,0.03,0.752096458,0.329148953,-0.108,0.084,-0.027,0.031,-0.05,0.058,Q6PHQ9,Pabpc4,Q6PHQ9_Pabpc4,Q6PHQ9,Pabpc4,1,8,16,5,Q6PHQ9|A3KFU8|A3KFU5|Q91YZ8|D3Z5M2|V9GXG3,MOUSE,72583.5,26.6,289,289.2,227.33,66.11,,660,Polyadenylate-binding protein,nucleus|cytoplasm|cytoplasmic stress granule|ribonucleoprotein complex|,,nucleotide binding|poly(A) binding|poly(U) RNA binding|poly(A) RNA binding|poly(C) RNA binding|,5,8,1910000000,9.6%
Q8VBT2,0.50362478,-0.029666667,8.150802754,-0.181333333,0.153080448,-1.612525781,0.113,0.097,-0.027,-0.054,0.005,-0.312,Q8VBT2,Sds,Q8VBT2_Sds,Q8VBT2,Sds,1,161,24,24,Q8VBT2,MOUSE,34992,90.5,290,290.1,400.35,400.35,,327,L-serine dehydratase/L-threonine deaminase,cytoplasm|mitochondrion|,gluconeogenesis|L-serine catabolic process|threonine catabolic process|pyruvate biosynthetic process|,L-serine ammonia-lyase activity|L-threonine ammonia-lyase activity|pyridoxal phosphate binding|protein homodimerization activity|,24,161,2.66E+11,90.5%
A0A087WSP5,0.586445778,0.040166667,6.556909942,-0.277666667,0.220957631,-1.351296288,0.128,-0.177,0.586,0.021,-0.31,-0.007,A0A087WSP5,Stat1,A0A087WSP5_Stat1,A0A087WSP5,Stat1,1,90,27,27,A0A087WSP5|Q8C3V4|P42225|Q99K94,MOUSE,88658.5,43.3,291,291.1,399.77,399.77,,755,Signal transducer and activator of transcription,nuclear chromatin|nucleus|nucleoplasm|nucleolus|cytoplasm|perinuclear region of cytoplasm|,"negative regulation of endothelial cell proliferation|transcription, DNA-templated|JAK-STAT cascade|response to bacterium|negative regulation of angiogenesis|cytokine-mediated signaling pathway|lipopolysaccharide-mediated signaling pathway|response to lipopolysaccharide|tumor necrosis factor-mediated signaling pathway|negative regulation of macrophage fusion|cellular response to interferon-beta|negative regulation of I-kappaB kinase/NF-kappaB signaling|response to exogenous dsRNA|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|negative regulation by virus of viral protein levels in host cell|interferon-gamma-mediated signaling pathway|renal tubule development|cellular response to lipopolysaccharide|",RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II core promoter sequence-specific DNA binding|RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity|double-stranded DNA binding|sequence-specific DNA binding transcription factor activity|signal transducer activity|tumor necrosis factor receptor binding|enzyme binding|identical protein binding|protein homodimerization activity|,27,90,32000000000,43.3%
Q9EQH2,0.042592507,-0.020166667,24.47519094,0.349,0.003568461,4.386368445,-0.178,-0.177,-0.229,0.133,0.201,0.129,Q9EQH2,Erap1,Q9EQH2_Erap1,Q9EQH2,Erap1,1,84,32,32,Q9EQH2,MOUSE,107167.8,35.6,292,292.1,399.21,399.21,,930,Endoplasmic reticulum aminopeptidase 1,extracellular region|extracellular space|cytoplasm|endoplasmic reticulum lumen|endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular exosome|,immune system process|proteolysis|membrane protein ectodomain proteolysis|positive regulation of angiogenesis|,aminopeptidase activity|interleukin-6 receptor binding|tumor necrosis factor receptor binding|peptidase activity|metalloexopeptidase activity|zinc ion binding|,32,84,64100000000,35.6%
Q8BIJ6,0.919577834,-0.049333333,1.20335046,0.055333333,0.757992579,0.321156439,0.15,0.064,-0.445,0.1,-0.016,-0.149,Q8BIJ6,Iars2,Q8BIJ6_Iars2,Q8BIJ6,Iars2,1,89,29,29,Q8BIJ6|E9PWN2|E9PWN3,MOUSE,113943.3,35.3,293,293.1,396.41,396.41,,1012,"Isoleucine--tRNA ligase, mitochondrial",cytoplasm|mitochondrion|mitochondrial matrix|cytosol|,isoleucyl-tRNA aminoacylation|regulation of translational fidelity|mitochondrial translation|,aminoacyl-tRNA editing activity|isoleucine-tRNA ligase activity|ATP binding|,29,89,31100000000,35.3%
Q9EQF5,0.275720668,-0.039833333,13.48667936,0.259666667,0.044805576,2.463787231,-0.004,-0.217,-0.288,0.055,0.046,0.169,Q9EQF5,Dpys,Q9EQF5_Dpys,Q9EQF5,Dpys,1,76,26,26,Q9EQF5,MOUSE,57237.3,57.4,294,294.1,395.97,395.97,,519,Dihydropyrimidinase,cytosol|extracellular exosome|,pyrimidine nucleobase catabolic process|thymine catabolic process|uracil catabolic process|beta-alanine metabolic process|protein homooligomerization|protein homotetramerization|,uracil binding|thymine binding|dihydropyrimidinase activity|zinc ion binding|amino acid binding|phosphoprotein binding|,26,76,45600000000,57.4%
Q7TPV4,0.994928853,-0.014333333,0.094109467,0.002666667,0.978563591,0.027888847,0.055,0.047,-0.149,0.051,-0.06,-0.03,Q7TPV4,Mybbp1a,Q7TPV4_Mybbp1a,Q7TPV4,Mybbp1a,1,57,32,32,Q7TPV4,MOUSE,152947.1,29.6,295,295.1,394.54,394.54,,1344,Myb-binding protein 1A,nucleus|nucleolus|cytoplasm|membrane|NLS-dependent protein nuclear import complex|intracellular membrane-bounded organelle|,"osteoblast differentiation|transcription, DNA-templated|nucleocytoplasmic transport|respiratory electron transport chain|circadian regulation of gene expression|cellular response to glucose starvation|negative regulation of transcription, DNA-templated|positive regulation of cell cycle arrest|DNA biosynthetic process|intrinsic apoptotic signaling pathway by p53 class mediator|positive regulation of anoikis|",core promoter binding|transcription corepressor activity|DNA-directed DNA polymerase activity|protein binding|transcription factor binding|zinc ion binding|sequence-specific DNA binding|poly(A) RNA binding|,32,57,4970000000,29.6%
A0A0J9YUI8,0.924368294,-0.078833333,1.119002785,0.058333333,0.772858026,0.300711908,0.125,0.08,-0.529,0.038,0.045,-0.232,A0A0J9YUI8,Gckr,A0A0J9YUI8_Gckr,A0A0J9YUI8,Gckr,1,83,25,25,A0A0J9YUI8|Q91X44,MOUSE,69176.4,48.3,296,296.1,392.31,392.31,,623,Glucokinase regulatory protein,,,,25,83,49000000000,48.3%
Q91VR2,0.581377911,0.012666667,6.694234601,-0.202666667,0.214080219,-1.374256842,0.22,0.308,-0.186,-0.087,0.011,-0.19,Q91VR2,Atp5c1,Q91VR2_Atp5c1,Q91VR2,Atp5c1,1,181,25,2,Q91VR2|Q8C2Q8,MOUSE,32999.4,62.4,297,297.1,391.65,31.67,,298,"ATP synthase subunit gamma, mitochondrial","mitochondrion|mitochondrial inner membrane|mitochondrial proton-transporting ATP synthase complex|membrane|myelin sheath|proton-transporting ATP synthase complex, catalytic core F(1)|extracellular exosome|",ATP synthesis coupled proton transport|,"poly(A) RNA binding|proton-transporting ATP synthase activity, rotational mechanism|proton-transporting ATPase activity, rotational mechanism|ATPase activity|",25,181,5.78E+11,62.4%
A2AKU9,0.935669179,-0.073833333,0.928381051,0.068333333,0.807536005,0.25355102,0.266,0.141,-0.731,0.107,0.032,-0.258,A2AKU9,Atp5c1,A2AKU9_Atp5c1,A2AKU9,Atp5c1,1,3,24,2,A2AKU9,MOUSE,32884.3,62.2,297,297.2,367.91,20.7,,297,ATP synthase subunit gamma,"mitochondrion|mitochondrial inner membrane|mitochondrial proton-transporting ATP synthase complex|membrane|proton-transporting ATP synthase complex, catalytic core F(1)|extracellular exosome|",ATP synthesis coupled proton transport|,"poly(A) RNA binding|proton-transporting ATP synthase activity, rotational mechanism|proton-transporting ATPase activity, rotational mechanism|ATPase activity|",2,3,8880000000,11.1%
O08795-2,4.99445E-05,-0.670333333,69.17615451,3.134,1.20888E-07,23.65416487,-2.043,-2.172,-2.497,0.848,0.874,0.968,O08795,Prkcsh,O08795-2_Prkcsh,O08795-2,Prkcsh,1,143,25,25,O08795-2|O08795,MOUSE,60528.5,41.6,298,298.1,391.14,391.14,,521,Isoform 2 of Glucosidase 2 subunit beta,endoplasmic reticulum|,in utero embryonic development|liver development|N-glycan processing|nitrogen compound metabolic process|negative regulation of neuron projection development|protein heterooligomerization|renal system development|,RNA binding|protein kinase C binding|calcium ion binding|protein binding|ion channel binding|phosphoprotein binding|,25,143,3.41E+11,41.6%
Q7TNG8,0.372990895,-0.033833333,10.96456156,-0.203,0.080083647,-2.060865672,0.071,0.062,0.07,0.025,-0.203,-0.228,Q7TNG8,Ldhd,Q7TNG8_Ldhd,Q7TNG8,Ldhd,1,125,23,23,Q7TNG8,MOUSE,52531.6,62.3,299,299.1,390.85,390.85,,484,"Probable D-lactate dehydrogenase, mitochondrial",mitochondrion|mitochondrial inner membrane|,ATP biosynthetic process|oxidation-reduction process|,D-lactate dehydrogenase (cytochrome) activity|protein binding|D-lactate dehydrogenase activity|UDP-N-acetylmuramate dehydrogenase activity|flavin adenine dinucleotide binding|,23,125,1.07E+11,62.3%
P12382,0.972248418,-0.013666667,0.399574014,-0.012666667,0.9121003,-0.114642419,0.141,0.022,-0.185,0.033,0.006,-0.099,P12382,Pfkl,P12382_Pfkl,P12382,Pfkl,1,85,27,22,P12382,MOUSE,86157.1,42.6,300,300.1,390.76,316.45,,780,"ATP-dependent 6-phosphofructokinase, liver type",cytosol|6-phosphofructokinase complex|membrane|extracellular exosome|,"fructose 6-phosphate metabolic process|glycolytic process|response to glucose|fructose 1,6-bisphosphate metabolic process|negative regulation of insulin secretion|carbohydrate phosphorylation|protein oligomerization|protein homotetramerization|",6-phosphofructokinase activity|ATP binding|kinase binding|identical protein binding|metal ion binding|fructose binding|fructose-6-phosphate binding|6-phosphofructokinase activity|,27,85,31500000000,42.6%
P47857-3,0.797504707,-0.042833333,3.121173297,0.104333333,0.487396796,0.735276947,0.087,-0.007,-0.365,0.131,0.008,-0.111,P47857,Pfkm,P47857-3_Pfkm,P47857-3,Pfkm,1,43,24,19,P47857-3|P47857-2|P47857,MOUSE,103523.5,35.7,300,300.2,327.47,264.67,,780,"Isoform 3 of ATP-dependent 6-phosphofructokinase, muscle type",cytosol|6-phosphofructokinase complex|apical plasma membrane|extracellular exosome|sperm principal piece|,fructose 6-phosphate metabolic process|glycolytic process|positive regulation of insulin secretion|glucose homeostasis|muscle cell cellular homeostasis|carbohydrate phosphorylation|protein oligomerization|glycolytic process through fructose-6-phosphate|,6-phosphofructokinase activity|protein binding|ATP binding|protein C-terminus binding|phosphofructokinase activity|kinase binding|identical protein binding|protein homodimerization activity|metal ion binding|fructose binding|,19,43,3950000000,31.0%
Q8C605,0.463450011,0.028833333,9.017358916,-0.198333333,0.125390348,-1.752221003,0.084,0.008,0.292,-0.027,-0.202,0.018,Q8C605,Pfkp,Q8C605_Pfkp,Q8C605,Pfkp,1,4,8,4,Q8C605|Q9WUA3|Q9WUA3-2,MOUSE,86686.7,12.3,300,300.3,100.8,45.48,,784,ATP-dependent 6-phosphofructokinase,nucleus|cytosol|6-phosphofructokinase complex|membrane|extracellular exosome|,fructose 6-phosphate metabolic process|glycolytic process|carbohydrate phosphorylation|activation of mitophagy in response to mitochondrial depolarization|,6-phosphofructokinase activity|ATP binding|protein complex binding|metal ion binding|,4,4,62500000,6.8%
Q9D8W5,0.919416995,-0.009333333,1.23173272,-0.038666667,0.753055055,-0.327953838,0.183,0.016,-0.169,0.061,-0.014,-0.133,Q9D8W5,Psmd12,Q9D8W5_Psmd12,Q9D8W5,Psmd12,1,81,31,31,Q9D8W5|B1AT36|Q3TRH2,MOUSE,53293.7,62.9,301,301.1,390.53,390.53,,456,26S proteasome non-ATPase regulatory subunit 12,proteasome complex|proteasome regulatory particle|membrane|proteasome accessory complex|extracellular exosome|,,,31,81,30300000000,62.9%
Q3TQC7,0.011175942,-0.202166667,31.63087571,1.664333333,0.00068693,5.973777966,-0.702,-0.738,-1.663,0.533,0.909,0.448,Q3TQC7,Entpd5,Q3TQC7_Entpd5,Q3TQC7,Entpd5,1,120,25,25,Q3TQC7|Q9WUZ9,MOUSE,50293.2,63.7,302,302.1,389.11,389.11,,452,Ectonucleoside triphosphate diphosphohydrolase 5,extracellular exosome|,metabolic process|,hydrolase activity|,25,120,1.34E+11,63.7%
Q99LC3,0.593471457,0.013,6.437769763,-0.209333333,0.22710308,-1.331309615,0.08,0.403,-0.13,-0.215,0.074,-0.134,Q99LC3,Ndufa10,Q99LC3_Ndufa10,Q99LC3,Ndufa10,1,104,24,24,Q99LC3,MOUSE,40887.9,67.8,303,303.1,388.15,388.15,,355,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial",mitochondrion|mitochondrial respiratory chain complex I|mitochondrial matrix|myelin sheath|,"mitochondrial electron transport, NADH to ubiquinone|nucleotide biosynthetic process|response to drug|",ATP binding|NADH dehydrogenase (ubiquinone) activity|nucleoside kinase activity|,24,104,73200000000,67.8%
Q6GT24,0.126018988,-0.127666667,18.58093769,0.502666667,0.013864564,3.319115848,-0.046,-0.556,-0.535,0.074,0.166,0.131,Q6GT24,Prdx6,Q6GT24_Prdx6,Q6GT24,Prdx6,1,91,24,24,Q6GT24|D3Z0Y2|O08709|Q8BG37,MOUSE,24940.3,75,304,304.1,386.79,386.79,,224,Peroxiredoxin-6,extracellular space|cytoplasm|mitochondrion|cytosol|membrane|extracellular exosome|,response to reactive oxygen species|response to oxidative stress|phospholipid catabolic process|bleb assembly|oxidation-reduction process|,peroxidase activity|phospholipase A2 activity|ubiquitin protein ligase binding|peroxiredoxin activity|,24,91,67000000000,75.0%
P27612,0.875832617,-0.029333333,2.003969248,0.060666667,0.630380942,0.50432455,0.082,0.031,-0.292,0.056,-0.025,-0.028,P27612,Plaa,P27612_Plaa,P27612,Plaa,1,84,29,29,P27612,MOUSE,88645.9,43.9,305,305.1,385.99,385.99,,794,Phospholipase A-2-activating protein,extracellular exosome|,inflammatory response|positive regulation of catalytic activity|,protein binding|phospholipase A2 activator activity|,29,84,17200000000,43.9%
Q91WN4,0.777827379,-0.037666667,3.422432741,-0.146,0.454733266,-0.793960176,0.17,0.258,-0.322,0.079,-0.084,-0.327,Q91WN4,Kmo,Q91WN4_Kmo,Q91WN4,Kmo,1,117,26,26,Q91WN4|Q91WN4-2|Q3V0K6,MOUSE,55101.1,62,306,306.1,383.79,383.79,,479,Kynurenine 3-monooxygenase,mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|integral component of membrane|extracellular exosome|,response to salt stress|tryptophan catabolic process to kynurenine|NAD metabolic process|quinolinate biosynthetic process|'de novo' NAD biosynthetic process from tryptophan|anthranilate metabolic process|secondary metabolite biosynthetic process|oxidation-reduction process|kynurenine metabolic process|,kynurenine 3-monooxygenase activity|NAD(P)H oxidase activity|flavin adenine dinucleotide binding|,26,117,62000000000,62.0%
F8VPN4,0.397447791,0.043666667,10.47820189,0.31,0.089573555,1.987457115,-0.219,0.055,-0.17,0.266,0.425,-0.095,F8VPN4,Agl,F8VPN4_Agl,F8VPN4,Agl,1,62,34,34,F8VPN4|A0A0G2JGI9|E0CYU6,MOUSE,176737.4,27.8,307,307.1,383.65,383.65,,1532,"Amylo-1,6-glucosidase, 4-alpha-glucanotransferase",nucleus|nucleoplasm|cytoplasm|inclusion body|sarcoplasmic reticulum|,glycogen metabolic process|glycogen biosynthetic process|glycogen catabolic process|response to nutrient|response to glucocorticoid|,"glycogen debranching enzyme activity|4-alpha-glucanotransferase activity|amylo-alpha-1,6-glucosidase activity|protein binding|polysaccharide binding|polyubiquitin binding|",34,62,16400000000,27.8%
Q9CW42,0.961523652,-0.032,0.570168633,-0.029333333,0.876966769,-0.160906667,0.078,0.283,-0.413,0.019,-0.006,-0.153,Q9CW42,Marc1,Q9CW42_Marc1,Q9CW42,Marc1,1,146,22,22,Q9CW42|D3YZZ3|A0A087WPC2,MOUSE,38548.7,68.2,308,308.1,383.03,383.03,,340,Mitochondrial amidoxime-reducing component 1,mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|integral component of membrane|,nitrate metabolic process|oxidation-reduction process|,nitrate reductase activity|molybdenum ion binding|pyridoxal phosphate binding|molybdopterin cofactor binding|,22,146,2.91E+11,68.2%
Q91YH5,0.942257231,-0.035666667,0.834917495,-0.033333333,0.82510316,-0.229910622,0.188,0.062,-0.307,0.012,-0.003,-0.166,Q91YH5,Atl3,Q91YH5_Atl3,Q91YH5,Atl3,1,108,25,22,Q91YH5|E9PYT3|Q91YH5-2,MOUSE,61030.4,49.3,309,309.1,382.76,345.69,,541,Atlastin-3,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,endoplasmic reticulum organization|Golgi organization|metabolic process|protein homooligomerization|,GTPase activity|GTP binding|identical protein binding|,25,108,69100000000,49.3%
Q6PA06,0.911411213,-0.061833333,1.425880974,0.081,0.720131656,0.373947412,0.208,0.067,-0.582,0.165,-0.084,-0.145,Q6PA06,Atl2,Q6PA06_Atl2,Q6PA06,Atl2,1,71,20,18,Q6PA06|E9QND8|Q6PA06-2|Q8BH66,MOUSE,66850.5,33.6,309,309.2,275.69,252.32,,583,Atlastin-2,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,endoplasmic reticulum organization|Golgi organization|metabolic process|protein homooligomerization|,GTPase activity|protein binding|GTP binding|identical protein binding|,18,71,40100000000,31.7%
Q91Y97,0.599637454,0.039333333,6.359403384,0.192666667,0.231238243,1.318127923,-0.011,-0.056,-0.104,-0.094,0.44,0.061,Q91Y97,Aldob,Q91Y97_Aldob,Q91Y97,Aldob,1,100,26,26,Q91Y97,MOUSE,39962.7,75.2,310,310.1,381.86,381.86,,364,Fructose-bisphosphate aldolase B,nucleus|lysosome|microtubule organizing center|cytosol|plasma membrane|rough endoplasmic reticulum membrane|smooth endoplasmic reticulum membrane|centriolar satellite|perinuclear region of cytoplasm|extracellular exosome|,"liver development|fructose metabolic process|glycolytic process|NADH oxidation|response to fructose|response to zinc ion|fructose 1,6-bisphosphate metabolic process|cellular response to extracellular stimulus|positive regulation of ATPase activity|cellular response to insulin stimulus|response to drug|response to starvation|response to amino acid|response to copper ion|response to glucocorticoid|response to cAMP|vacuolar proton-transporting V-type ATPase complex assembly|response to interleukin-6|",fructose-bisphosphate aldolase activity|cytoskeletal protein binding|phosphatidylcholine binding|identical protein binding|ATPase binding|fructose-1-phosphate aldolase activity|fructose binding|,26,100,56200000000,75.2%
Q9DBG7,0.924329621,-0.011,1.120760646,0.027333333,0.772545266,0.300998244,0.006,0.028,-0.108,0.095,-0.064,-0.023,Q9DBG7,Srpr,Q9DBG7_Srpr,Q9DBG7,Srpra,1,87,27,27,Q9DBG7|F6VF36,MOUSE,70078,44.3,311,311.1,381.47,381.47,,636,Signal recognition particle receptor subunit alpha,signal recognition particle receptor complex|membrane|extracellular exosome|,SRP-dependent cotranslational protein targeting to membrane|metabolic process|,GTPase activity|signal recognition particle binding|GTP binding|poly(A) RNA binding|,27,87,39400000000,44.3%
Q3TNA1,0.759841,0.0025,3.713679447,-0.070333333,0.425237989,-0.84889914,0.047,0.101,-0.035,-0.041,-0.007,-0.05,Q3TNA1,Xylb,Q3TNA1_Xylb,Q3TNA1,Xylb,1,111,24,24,Q3TNA1|A0A1L1SUA8,MOUSE,60341.5,54.9,312,312.1,381.36,381.36,,551,Xylulose kinase,cytoplasm|extracellular exosome|,xylulose metabolic process|D-xylose metabolic process|carbohydrate phosphorylation|,xylulokinase activity|ATP binding|,24,111,70300000000,54.9%
Q99LC9,0.915850537,-0.0105,1.310002627,0.038333333,0.739604828,0.346538365,0.117,-0.019,-0.187,0.115,-0.068,-0.021,Q99LC9,Pex6,Q99LC9_Pex6,Q99LC9,Pex6,1,55,27,27,Q99LC9,MOUSE,105744.8,40.2,313,313.1,381.23,381.23,,981,Peroxisome assembly factor 2,cytoplasm|peroxisome|peroxisomal membrane|cytosol|,"protein targeting to peroxisome|peroxisome organization|metabolic process|protein import into peroxisome matrix, translocation|protein stabilization|","protein binding|ATP binding|protein C-terminus binding|ATPase activity|protein complex binding|ATPase activity, coupled|",27,55,16600000000,40.2%
P09411,0.967029453,-0.023333333,0.442437658,0.018666667,0.903142405,0.126434094,-0.217,0.068,0.051,-0.254,0.211,0.001,P09411,Pgk1,P09411_Pgk1,P09411,Pgk1,1,84,28,28,P09411|S4R2M7|P09041,MOUSE,44949.1,73.3,314,314.1,380.57,380.57,,417,Phosphoglycerate kinase 1,cytoplasm|,glycolytic process|phosphorylation|,phosphoglycerate kinase activity|ATP binding|,28,84,60000000000,73.3%
Q8BK64,0.842315612,-0.012833333,2.47943071,-0.093,0.565011034,-0.605512272,0.244,0.145,-0.288,0.038,-0.147,-0.069,Q8BK64,Ahsa1,Q8BK64_Ahsa1,Q8BK64,Ahsa1,1,90,26,26,Q8BK64,MOUSE,38344.6,78.9,315,315.1,379.9,379.9,,338,Activator of 90 kDa heat shock protein ATPase homolog 1,cytoplasm|endoplasmic reticulum|cytosol|extracellular exosome|,protein folding|response to stress|positive regulation of ATPase activity|,ATPase activator activity|chaperone binding|,26,90,75200000000,78.9%
P52792-2,0.951421295,-0.139666667,0.745423461,0.052,0.84228226,0.206933598,0.037,0.156,-0.69,-0.004,0.089,-0.426,P52792,Gck,P52792-2_Gck,P52792-2,Gck,1,86,24,24,P52792-2|P52792,MOUSE,52570,50.7,316,316.1,378.23,378.23,,465,Isoform 2 of Glucokinase,nucleus|mitochondrion|cytosol|,cellular glucose homeostasis|glucose metabolic process|glycolytic process|NADP metabolic process|endocrine pancreas development|positive regulation of insulin secretion|glucose homeostasis|regulation of potassium ion transport|negative regulation of gluconeogenesis|positive regulation of glycogen biosynthetic process|carbohydrate phosphorylation|regulation of insulin secretion|glucose 6-phosphate metabolic process|detection of glucose|calcium ion import|,glucokinase activity|hexokinase activity|protein binding|ATP binding|glucose binding|fructokinase activity|mannokinase activity|,24,86,45900000000,50.7%
Q99L04,0.742168174,-0.003166667,3.935117656,-0.111,0.404099427,-0.891100685,0.02,0.253,-0.116,-0.193,0.024,-0.007,Q99L04,Dhrs1,Q99L04_Dhrs1,Q99L04,Dhrs1,1,142,23,23,Q99L04,MOUSE,34518.1,71.8,317,317.1,376.61,376.61,,313,Dehydrogenase/reductase SDR family member 1,mitochondrion|mitochondrial inner membrane|endoplasmic reticulum|,oxidation-reduction process|,oxidoreductase activity|,23,142,2.25E+11,71.8%
Q9R0P5,0.634404848,0.002166667,5.730524639,-0.095,0.267268352,-1.209951646,0.082,0.055,0.012,-0.025,-0.044,-0.067,Q9R0P5,Dstn,Q9R0P5_Dstn,Q9R0P5,Dstn,1,136,26,24,Q9R0P5,MOUSE,18863.6,95.1,318,318.1,376.24,350.47,,165,Destrin,cytoplasm|cortical actin cytoskeleton|extracellular exosome|,actin filament depolymerization|positive regulation of actin filament depolymerization|actin filament severing|,actin binding|,26,136,2.25E+11,95.1%
P18760,0.546002425,-0.006333333,7.360324103,-0.143333333,0.183640129,-1.482602141,0.148,0.06,-0.012,0.03,-0.082,-0.182,P18760,Cfl1,P18760_Cfl1,P18760,Cfl1,1,95,20,16,P18760|F8WGL3,MOUSE,18787.4,86.1,318,318.2,325.32,268.61,,166,Cofilin-1,extracellular region|extracellular space|cytoplasm|cytosol|cell-cell junction|focal adhesion|membrane|nuclear matrix|cortical actin cytoskeleton|lamellipodium membrane|vesicle|ruffle membrane|extracellular exosome|,mitotic cytokinesis|neural crest cell migration|neural fold formation|protein phosphorylation|cytoskeleton organization|actin filament organization|regulation of cell morphogenesis|establishment of cell polarity|cell projection organization|actin filament depolymerization|positive regulation of actin filament depolymerization|response to amino acid|negative regulation of cell size|regulation of dendritic spine morphogenesis|,actin binding|,16,95,2E+11,72.8%
P45591,0.636050842,0.009833333,5.634965894,-0.181666667,0.27321429,-1.194793568,0.083,0.392,-0.173,-0.136,0.01,-0.117,P45591,Cfl2,P45591_Cfl2,P45591,Cfl2,1,28,13,9,P45591|A0A1Y7VJ71,MOUSE,18823.4,79.5,318,318.3,195.68,138.97,,166,Cofilin-2,extracellular space|actin cytoskeleton|nuclear matrix|I band|extracellular exosome|,actin filament organization|actin filament depolymerization|positive regulation of actin filament depolymerization|sarcomere organization|muscle cell cellular homeostasis|,actin binding|,9,28,10100000000,66.2%
O35129,0.873222165,-0.024666667,2.048915639,-0.101333333,0.623890591,-0.514102447,-0.358,0.097,0.339,-0.286,-0.047,0.107,O35129,Phb2,O35129_Phb2,O35129,Phb2,1,103,26,26,O35129,MOUSE,33295.8,83.2,319,319.1,374.75,374.75,,299,Prohibitin-2,nucleus|cytoplasm|mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|cell surface|nuclear matrix|protein complex|extracellular exosome|cell periphery|,"protein import into nucleus, translocation|transcription, DNA-templated|mitochondrion organization|sister chromatid cohesion|positive regulation of exit from mitosis|negative regulation of intracellular estrogen receptor signaling pathway|negative regulation of mammary gland epithelial cell proliferation|negative regulation of apoptotic process|negative regulation of sequence-specific DNA binding transcription factor activity|negative regulation of transcription, DNA-templated|protein stabilization|positive regulation of sequence-specific DNA binding transcription factor activity|mammary gland branching involved in thelarche|mammary gland alveolus development|regulation of branching involved in mammary gland duct morphogenesis|positive regulation of ERK1 and ERK2 cascade|positive regulation of cell cycle G1/S phase transition|",protein binding|protein C-terminus binding|amide binding|protein N-terminus binding|,26,103,97700000000,83.2%
Q3U2P1,0.550359036,-0.0045,7.285126302,-0.139666667,0.186847534,-1.47026148,0.131,0.118,-0.053,-0.009,-0.059,-0.155,Q3U2P1,Sec24a,Q3U2P1_Sec24a,Q3U2P1,Sec24a,1,94,24,2,Q3U2P1|Q3U2P1-2,MOUSE,119522,25.6,320,320.1,374.23,40.01,,1090,Protein transport protein Sec24A,Golgi membrane|endoplasmic reticulum membrane|COPII vesicle coat|perinuclear region of cytoplasm|,intracellular protein transport|ER to Golgi vesicle-mediated transport|regulation of low-density lipoprotein particle receptor biosynthetic process|positive regulation of protein secretion|positive regulation of cholesterol homeostasis|,zinc ion binding|,24,94,53000000000,25.6%
Q60936,0.688055485,-0.141333333,4.732710769,0.284,0.336301592,1.03659206,0.067,-0.023,-0.894,0.215,0.061,-0.274,Q60936,Coq8a,Q60936_Coq8a,Q60936,Coq8a,1,121,26,26,Q60936|Q60936-2|A0A0A6YXD9|E0CXR1|E0CYG7|E0CYD3,MOUSE,72198.1,43.7,321,321.1,373.32,373.32,,645,"Atypical kinase COQ8A, mitochondrial",mitochondrion|integral component of membrane|,ubiquinone biosynthetic process|phosphorylation|,ATP binding|kinase activity|ADP binding|,26,121,1.15E+11,43.7%
A2AQN4,0.368638671,-0.105833333,11.07267979,0.574333333,0.078114565,2.082317565,0.044,-0.254,-0.969,0.502,0.054,-0.012,A2AQN4,NotFound,A2AQN4_NotFound,A2AQN4,Acss2,1,102,27,27,A2AQN4|A2AQN5|Q9QXG4|D6RHA7,MOUSE,81640.6,31.9,322,322.1,372.39,372.39,,714,"Acetyl-coenzyme A synthetase, cytoplasmic",nucleoplasm|cytoplasm|intracellular membrane-bounded organelle|,acetyl-CoA biosynthetic process|lipid biosynthetic process|,acetate-CoA ligase activity|,27,102,81200000000,31.9%
Q60710,0.967029453,0.015666667,0.441776766,0.016666667,0.903279852,0.126253576,0.213,-0.1,-0.091,0.211,-0.059,-0.08,Q60710,Samhd1,Q60710_Samhd1,Q60710,Samhd1,1,64,31,31,Q60710|F8WJE0|E9Q0K6|E9PYG9|E0CXZ5,MOUSE,73561.9,53.7,323,323.1,372.27,372.27,,627,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1,nucleus|nucleoplasm|plasma membrane|,dGTP catabolic process|innate immune response|regulation of innate immune response|dATP catabolic process|protein homotetramerization|defense response to virus|,nucleic acid binding|RNA binding|zinc ion binding|dGTPase activity|dGTP binding|,31,64,10200000000,53.7%
P16332,0.631972503,-0.013,5.770578322,-0.121333333,0.264814748,-1.216818313,0.135,-0.008,0.016,-0.059,0.04,-0.202,P16332,Mut,P16332_Mut,P16332,Mut,1,74,28,28,P16332,MOUSE,83299.1,49.4,324,324.1,371.41,371.41,,748,"Methylmalonyl-CoA mutase, mitochondrial",mitochondrion|mitochondrial matrix|,post-embryonic development|homocysteine metabolic process|,methylmalonyl-CoA mutase activity|cobalamin binding|metal ion binding|modified amino acid binding|,28,74,26500000000,49.4%
Q9WTP7,0.649578346,-0.015833333,5.324536641,-0.129,0.293458258,-1.140452675,0.074,0.17,-0.098,-0.189,0.062,-0.114,Q9WTP7,Ak3,Q9WTP7_Ak3,Q9WTP7,Ak3,1,140,23,23,Q9WTP7,MOUSE,25482.9,83.7,325,325.1,370.64,370.64,,227,"GTP:AMP phosphotransferase AK3, mitochondrial",mitochondrion|mitochondrial matrix|,ADP biosynthetic process|AMP metabolic process|GTP metabolic process|ITP metabolic process|UTP metabolic process|nucleotide phosphorylation|,adenylate kinase activity|ATP binding|GTP binding|nucleoside triphosphate adenylate kinase activity|,23,140,1.45E+11,83.7%
P61922,0.620577434,0.013166667,5.955602915,-0.158333333,0.253769666,-1.24973034,0.059,0.322,-0.104,-0.11,0.016,-0.104,P61922,Abat,P61922_Abat,P61922,Abat,1,79,26,26,P61922|P61922-2|Q3TUE8,MOUSE,57135.5,61.6,326,326.1,370.12,370.12,,500,"4-aminobutyrate aminotransferase, mitochondrial",mitochondrion|mitochondrial matrix|4-aminobutyrate transaminase complex|neuron projection|extracellular exosome|,response to hypoxia|copulation|locomotory behavior|gamma-aminobutyric acid biosynthetic process|response to iron ion|positive regulation of heat generation|positive regulation of insulin secretion|response to nicotine|neurotransmitter catabolic process|response to drug|response to ethanol|negative regulation of blood pressure|behavioral response to cocaine|,pyridoxal phosphate binding|succinate-semialdehyde dehydrogenase binding|protein homodimerization activity|metal ion binding|(S)-3-amino-2-methylpropionate transaminase activity|iron-sulfur cluster binding|4-aminobutyrate transaminase activity|,26,79,28000000000,61.6%
Q64471,0.919618833,-0.055666667,1.193021351,0.062666667,0.759797508,0.318666169,0.227,0.05,-0.538,-0.048,0.04,-0.065,Q64471,Gstt1,Q64471_Gstt1,Q64471,Gstt1,1,189,23,23,Q64471|D3Z3X5,MOUSE,27659,64.1,327,327.1,369.18,369.18,,240,Glutathione S-transferase theta-1,nucleus|cytosol|,DNA modification|glutathione metabolic process|response to salicylic acid|response to selenium ion|dichloromethane metabolic process|response to vitamin E|response to drug|oxidation-reduction process|,glutathione transferase activity|glutathione peroxidase activity|alkylhalidase activity|,23,189,4.97E+11,64.1%
O35728,0.933278467,-0.0045,0.967933618,-0.081,0.800214908,-0.263450169,0.618,0.168,-0.678,-0.086,0.057,-0.106,O35728,Cyp4a14,O35728_Cyp4a14,O35728,Cyp4a14,1,112,24,22,O35728|A0A087WS15|A0A087WPC3,MOUSE,59289.6,46.7,328,328.1,368.27,338.83,,507,Cytochrome P450 4A14,endoplasmic reticulum membrane|,oxidation-reduction process|,iron ion binding|alkane 1-monooxygenase activity|heme binding|arachidonic acid omega-hydroxylase activity|,24,112,1.22E+11,46.7%
O88833,0.961523652,0.055,0.552802662,-0.061333333,0.880480483,-0.156267473,1.013,-0.099,-0.657,0,-0.078,0.151,O88833,Cyp4a10,O88833_Cyp4a10,O88833,Cyp4a10,1,16,12,10,O88833|A2A977|A2A8T1|F8WGU9|Q91WU1,MOUSE,58671.5,24.9,328,328.2,152.99,123.55,,509,Cytochrome P450 4A10,cytoplasm|endoplasmic reticulum membrane|apical plasma membrane|intracellular membrane-bounded organelle|extracellular exosome|,fatty acid metabolic process|leukotriene B4 catabolic process|oxidation-reduction process|,monooxygenase activity|iron ion binding|arachidonic acid epoxygenase activity|alkane 1-monooxygenase activity|heme binding|leukotriene-B4 20-monooxygenase activity|arachidonic acid omega-hydroxylase activity|,10,16,2700000000,20.0%
Q9JLN9,0.961523652,-0.004833333,0.555583768,0.014333333,0.879916828,0.156941913,0.05,-0.013,-0.073,0.108,-0.072,-0.029,Q9JLN9,Mtor,Q9JLN9_Mtor,Q9JLN9,Mtor,1,51,29,29,Q9JLN9|Q9JLN9-2,MOUSE,290838.3,15.1,329,329.1,367.77,367.77,,2549,Serine/threonine-protein kinase mTOR,Golgi membrane|nucleus|cytoplasm|mitochondrial outer membrane|lysosome|lysosomal membrane|endoplasmic reticulum membrane|cytosol|endomembrane system|membrane|dendrite|TORC1 complex|TORC2 complex|neuronal cell body|PML body|,double-strand break repair via homologous recombination|positive regulation of protein phosphorylation|positive regulation of endothelial cell proliferation|regulation of glycogen biosynthetic process|'de novo' pyrimidine nucleobase biosynthetic process|protein phosphorylation|germ cell development|negative regulation of autophagy|positive regulation of lamellipodium assembly|positive regulation of gene expression|positive regulation of myotube differentiation|cell growth|negative regulation of macroautophagy|phosphorylation|peptidyl-serine phosphorylation|peptidyl-threonine phosphorylation|cell projection organization|positive regulation of actin filament polymerization|ruffle organization|regulation of myelination|cellular response to nutrient levels|TOR signaling|regulation of fatty acid beta-oxidation|regulation of response to food|response to insulin|regulation of actin cytoskeleton organization|regulation of GTPase activity|response to amino acid|regulation of carbohydrate utilization|regulation of osteoclast differentiation|positive regulation of translation|negative regulation of cell size|regulation of protein kinase activity|positive regulation of transcription from RNA polymerase III promoter|protein autophosphorylation|positive regulation of lipid biosynthetic process|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of stress fiber assembly|negative regulation of NFAT protein import into nucleus|positive regulation of protein kinase B signaling|cardiac cell development|cellular response to hypoxia|,RNA polymerase III type 1 promoter DNA binding|RNA polymerase III type 2 promoter DNA binding|RNA polymerase III type 3 promoter DNA binding|TFIIIC-class transcription factor binding|protein serine/threonine kinase activity|protein binding|ATP binding|drug binding|kinase activity|protein domain specific binding|ribosome binding|protein dimerization activity|phosphoprotein binding|,29,51,3710000000,15.1%
Q3UEL5,0.630119805,-0.006333333,5.809587918,0.17,0.262446756,1.224785931,0.008,0.023,-0.305,-0.019,0.288,-0.033,Q3UEL5,Uroc1,Q3UEL5_Uroc1,Q3UEL5,Uroc1,1,86,24,24,Q3UEL5|Q8VC12,MOUSE,79222,43.6,330,330.1,367.57,367.57,,710,Urocanate hydratase,cytosol|,histidine catabolic process|,urocanate hydratase activity|,24,86,36300000000,43.6%
Q8VCZ9,0.972248418,-0.037333333,0.39642455,-0.014666667,0.912761987,-0.113811071,0.042,0.133,-0.265,-0.032,0.051,-0.153,Q8VCZ9,Prodh2,Q8VCZ9_Prodh2,Q8VCZ9,Prodh2,1,87,27,27,Q8VCZ9|D6RET3,MOUSE,51464,59.2,331,331.1,366.91,366.91,,456,Hydroxyproline dehydrogenase,mitochondrion|mitochondrial inner membrane|,proline catabolic process to glutamate|oxidation-reduction process|,proline dehydrogenase activity|,27,87,37400000000,59.2%
P25688,0.546002425,0.019666667,7.351494348,0.948666667,0.184013873,1.483135168,-0.547,0.48,-1.297,-0.514,1.665,0.331,P25688,Uox,P25688_Uox,P25688,Uox,1,104,26,26,P25688|D3Z4U1,MOUSE,35266.7,69.9,332,332.1,366.38,366.38,,303,Uricase,mitochondrion|peroxisome|,purine nucleobase metabolic process|urate catabolic process|oxidation-reduction process|,urate oxidase activity|,26,104,49600000000,69.9%
Q6Q899,0.991556352,0.000666667,0.180383084,-0.005333333,0.959316008,-0.052950726,0.036,-0.014,-0.012,0.142,-0.147,-0.001,Q6Q899,Ddx58,Q6Q899_Ddx58,Q6Q899,Ddx58,1,68,30,30,Q6Q899|Q6Q899-2|Q6Q899-3|Q6Q899-4,MOUSE,107399.9,35.4,333,333.1,364.11,364.11,,926,Probable ATP-dependent RNA helicase DDX58,cytoplasm|cytosol|bicellular tight junction|actin cytoskeleton|ruffle membrane|,positive regulation of defense response to virus by host|metabolic process|detection of virus|response to virus|positive regulation of gene expression|regulation of cell migration|positive regulation of granulocyte macrophage colony-stimulating factor production|positive regulation of interferon-alpha production|positive regulation of interferon-beta production|positive regulation of interleukin-6 production|positive regulation of interleukin-8 production|RIG-I signaling pathway|positive regulation of transcription factor import into nucleus|response to exogenous dsRNA|innate immune response|positive regulation of transcription from RNA polymerase II promoter|,double-stranded DNA binding|double-stranded RNA binding|single-stranded RNA binding|helicase activity|protein binding|ATP binding|zinc ion binding|identical protein binding|,30,68,10100000000,35.4%
Q9D024,0.000307098,-0.158166667,54.48594376,1.548333333,3.55964E-06,13.93063315,-0.893,-0.79,-1.114,0.531,0.659,0.658,Q9D024,Ccdc47,Q9D024_Ccdc47,Q9D024,Ccdc47,1,116,26,26,Q9D024|Q9D024-2|Q9D024-3,MOUSE,56128.1,47.8,334,334.1,363.99,363.99,,483,Coiled-coil domain-containing protein 47,endoplasmic reticulum|rough endoplasmic reticulum|membrane|integral component of membrane|,osteoblast differentiation|ER overload response|endoplasmic reticulum organization|post-embryonic development|ER-associated ubiquitin-dependent protein catabolic process|calcium ion homeostasis|,calcium ion binding|poly(A) RNA binding|,26,116,71900000000,47.8%
Q9Z1T1,0.692956416,-0.000166667,4.667266236,-0.080333333,0.341407751,-1.023968163,0.044,0.027,0.049,0.001,-0.076,-0.046,Q9Z1T1,Ap3b1,Q9Z1T1_Ap3b1,Q9Z1T1,Ap3b1,1,66,29,29,Q9Z1T1,MOUSE,123365.7,28.8,335,335.1,363.86,363.86,,1105,AP-3 complex subunit beta-1,lysosomal membrane|trans-Golgi network|membrane|AP-3 adaptor complex|clathrin-coated vesicle membrane|,"protein targeting to lysosome|zinc II ion transport|intracellular protein transport|blood coagulation|anterograde axon cargo transport|vesicle-mediated transport|antigen processing and presentation|melanosome organization|antigen processing and presentation, exogenous lipid antigen via MHC class Ib|anterograde synaptic vesicle transport|positive regulation of NK T cell differentiation|",protein phosphatase binding|GTP-dependent protein binding|,29,66,12100000000,28.8%
Q8BGQ7,0.657241764,0.0135,5.217760186,-0.103,0.300762704,-1.121271335,0.001,0.028,0.166,-0.113,0.032,-0.033,Q8BGQ7,Aars,Q8BGQ7_Aars,Q8BGQ7,Aars,1,64,27,27,Q8BGQ7,MOUSE,107762.5,39.5,336,336.1,362.55,362.55,,968,"Alanine--tRNA ligase, cytoplasmic",cytoplasm|membrane|extracellular exosome|,hair follicle development|tRNA modification|alanyl-tRNA aminoacylation|regulation of translational fidelity|protein folding|cerebellar Purkinje cell layer development|endoplasmic reticulum unfolded protein response|cellular response to unfolded protein|response to amino acid|negative regulation of neuron apoptotic process|skin development|neuromuscular process controlling balance|neuromuscular process|,tRNA binding|aminoacyl-tRNA editing activity|alanine-tRNA ligase activity|protein binding|ATP binding|zinc ion binding|,27,64,15900000000,39.5%
Q9DCW4,0.805699632,-0.068166667,3.000736823,0.183666667,0.501102209,0.711444321,0.297,-0.093,-0.684,0.231,0.082,-0.242,Q9DCW4,Etfb,Q9DCW4_Etfb,Q9DCW4,Etfb,1,148,22,22,Q9DCW4|A0A0N4SVE0|A0A0N4SWE9|Q2TBV3,MOUSE,27851,83.1,337,337.1,362.33,362.33,,255,Electron transfer flavoprotein subunit beta,mitochondrion|mitochondrial electron transfer flavoprotein complex|intracellular membrane-bounded organelle|extracellular exosome|,oxidation-reduction process|,electron carrier activity|,22,148,2.75E+11,83.1%
P51658,0.546002425,-0.074333333,7.364778251,0.358,0.183451883,1.485320137,0.091,-0.09,-0.761,0.305,-0.164,0.173,P51658,Hsd17b2,P51658_Hsd17b2,P51658,Hsd17b2,1,74,24,24,P51658,MOUSE,42462.7,57.4,338,338.1,359.72,359.72,,381,Estradiol 17-beta-dehydrogenase 2,integral component of membrane|,in utero embryonic development|placenta development|steroid biosynthetic process|response to retinoic acid|oxidation-reduction process|,estradiol 17-beta-dehydrogenase activity|testosterone dehydrogenase (NAD+) activity|,24,74,57700000000,57.4%
Q91ZJ5,0.073914047,-0.012166667,21.63260847,0.831666667,0.006866559,3.865966775,-0.43,-0.096,-0.758,0.092,0.697,0.422,Q91ZJ5,Ugp2,Q91ZJ5_Ugp2,Q91ZJ5,Ugp2,1,86,27,27,Q91ZJ5|Q91ZJ5-2,MOUSE,57149.4,59.4,339,339.1,359.7,359.7,,508,UTP--glucose-1-phosphate uridylyltransferase,nucleus|cytoplasm|extracellular exosome|,UDP-glucose metabolic process|glucose 1-phosphate metabolic process|,UTP:glucose-1-phosphate uridylyltransferase activity|glucose binding|pyrimidine ribonucleotide binding|identical protein binding|metal ion binding|,27,86,26400000000,59.4%
Q91W50,0.666695042,-0.003,5.066327699,-0.096666667,0.311434865,-1.094738112,0.024,0.13,-0.018,-0.125,-0.014,-0.015,Q91W50,Csde1,Q91W50_Csde1,Q91W50,Csde1,1,65,28,28,Q91W50|Q8JZN2|A0A0G2JF72,MOUSE,89644.8,34.9,340,340.1,358.93,358.93,,798,Cold shock domain-containing protein E1,cytoplasm|mitochondrial inner membrane|Golgi apparatus|plasma membrane|CRD-mediated mRNA stability complex|,"regulation of transcription, DNA-templated|nuclear-transcribed mRNA catabolic process, no-go decay|",DNA binding|poly(A) RNA binding|,28,65,24300000000,34.9%
E9Q557,0.273334376,0.020833333,13.56212503,0.278333333,0.044033935,2.478230791,-0.13,0.02,-0.245,0.012,0.227,0.241,E9Q557,Dsp,E9Q557_Dsp,E9Q557,Dsp,1,46,36,36,E9Q557|E9PZW0,MOUSE,335359.7,15.5,341,341.1,358.65,358.65,,2883,Desmoplakin,cornified envelope|nucleus|cytoplasm|plasma membrane|cell-cell junction|fascia adherens|intercalated disc|membrane|basolateral plasma membrane|desmosome|extracellular exosome|intermediate filament|,desmosome organization|ventricular compact myocardium morphogenesis|single organismal cell-cell adhesion|peptide cross-linking|keratinocyte differentiation|adherens junction organization|wound healing|skin development|intermediate filament cytoskeleton organization|intermediate filament organization|protein localization to adherens junction|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|regulation of ventricular cardiac muscle cell action potential|,"protein kinase C binding|structural molecule activity|protein binding|protein binding, bridging|poly(A) RNA binding|cell adhesion molecule binding|scaffold protein binding|",36,46,1910000000,15.5%
Q71RI9,0.554238961,-0.068333333,7.178607177,0.277333333,0.191486994,1.454645582,-0.029,0.04,-0.632,0.206,-0.037,0.042,Q71RI9,Kyat3,Q71RI9_Kyat3,Q71RI9,Kyat3,1,102,23,23,Q71RI9|Q71RI9-2|D6RJ70|Q8BTY1|A2AQY9|A2AQY8,MOUSE,51695.8,44.8,342,342.1,358.51,358.51,,455,Kynurenine--oxoglutarate transaminase 3,mitochondrion|,2-oxoglutarate metabolic process|cellular amino acid metabolic process|biosynthetic process|kynurenine metabolic process|L-kynurenine metabolic process|,kynurenine-oxoglutarate transaminase activity|pyridoxal phosphate binding|protein homodimerization activity|poly(A) RNA binding|kynurenine-glyoxylate transaminase activity|cysteine-S-conjugate beta-lyase activity|,23,102,73300000000,44.8%
A2AFQ0,0.995757571,-0.012833333,0.053180978,0.001666667,0.987829297,0.015833553,0.115,0.031,-0.187,0.041,-0.037,-0.04,A2AFQ0,Huwe1,A2AFQ0_Huwe1,A2AFQ0,Huwe1,1,61,31,31,A2AFQ0|Q7TMY8|Q7TMY8-3|Q7TMY8-4|Q7TMY8-2,MOUSE,486619.9,10.5,343,343.1,358.02,358.02,,4378,E3 ubiquitin-protein ligase HUWE1,nucleoplasm|cytoplasm|membrane|extracellular exosome|,protein polyubiquitination|base-excision repair|protein monoubiquitination|histone ubiquitination|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of protein targeting to mitochondrion|,ubiquitin-protein transferase activity|ligase activity|poly(A) RNA binding|,31,61,3550000000,10.5%
Q02257,0.289366522,0.003666667,13.14115074,0.205333333,0.048515993,2.407437265,-0.163,-0.068,-0.066,0.045,0.1,0.174,Q02257,Jup,Q02257_Jup,Q02257,Jup,1,56,24,20,Q02257,MOUSE,82541,43,344,344.1,357.52,317.98,,745,Junction plakoglobin,nucleus|cytoplasm|cytosol|intermediate filament|plasma membrane|cell-cell junction|cell-cell adherens junction|focal adhesion|intercalated disc|membrane|catenin complex|Z disc|desmosome|protein-DNA complex|extracellular exosome|gamma-catenin-TCF7L2 complex|,desmosome assembly|cell adhesion|signal transduction|single organismal cell-cell adhesion|cell migration|adherens junction assembly|regulation of cell proliferation|positive regulation of protein import into nucleus|regulation of cell fate specification|skin development|detection of mechanical stimulus|positive regulation of sequence-specific DNA binding transcription factor activity|cellular response to indole-3-methanol|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|establishment of protein localization to plasma membrane|regulation of ventricular cardiac muscle cell action potential|positive regulation of transcription from RNA polymerase II promoter|,transcription coactivator activity|signal transducer activity|structural molecule activity|protein binding|protein phosphatase binding|alpha-catenin binding|cadherin binding|cell adhesion molecule binding|nuclear hormone receptor binding|,24,56,12700000000,43.0%
Q02248,0.001901972,-0.029833333,40.93634788,0.896333333,8.06056E-05,8.492841862,-0.344,-0.552,-0.538,0.291,0.514,0.45,Q02248,Ctnnb1,Q02248_Ctnnb1,Q02248,Ctnnb1,1,37,21,17,Q02248|E9Q6A9|E9PW26|D3Z5Q1,MOUSE,86096.7,32.7,344,344.2,253.24,213.7,,781,Catenin beta-1,spindle pole|nucleus|transcription factor complex|nuclear euchromatin|cytoplasm|centrosome|cytosol|plasma membrane|cell-cell junction|adherens junction|cell-cell adherens junction|fascia adherens|bicellular tight junction|focal adhesion|cell cortex|intercalated disc|membrane|basolateral plasma membrane|lateral plasma membrane|catenin complex|flotillin complex|Z disc|lamellipodium|cell junction|beta-catenin destruction complex|cell projection membrane|microvillus membrane|protein-DNA complex|Scrib-APC-beta-catenin complex|protein complex|apical junction complex|nuclear transcription factor complex|apical part of cell|perinuclear region of cytoplasm|extracellular exosome|beta-catenin-TCF7L2 complex|catenin-TCF7L2 complex|cell periphery|,"negative regulation of transcription from RNA polymerase II promoter|embryonic axis specification|cell morphogenesis involved in differentiation|skeletal system development|patterning of blood vessels|vasculogenesis|branching involved in ureteric bud morphogenesis|in utero embryonic development|gastrulation with mouth forming second|endoderm formation|cell fate specification|cell fate determination|endodermal cell fate commitment|neuron migration|kidney development|neural plate development|vasculature development|positive regulation of neuroblast proliferation|positive regulation of mesenchymal cell proliferation|lens morphogenesis in camera-type eye|ventricular compact myocardium morphogenesis|regulation of secondary heart field cardioblast proliferation|mesenchymal to epithelial transition involved in metanephros morphogenesis|metanephros morphogenesis|transcription, DNA-templated|regulation of transcription, DNA-templated|regulation of transcription from RNA polymerase II promoter|cell adhesion|cell-matrix adhesion|synaptic transmission|ectoderm development|glial cell fate determination|heart development|cell proliferation|positive regulation of cell proliferation|negative regulation of cell proliferation|anterior/posterior axis specification|dorsal/ventral axis specification|dorsal/ventral pattern formation|proximal/distal pattern formation|cellular process|regulation of gene expression|positive regulation of gene expression|positive regulation of epithelial to mesenchymal transition|positive regulation of heparan sulfate proteoglycan biosynthetic process|Wnt signaling pathway|morphogenesis of embryonic epithelium|single organismal cell-cell adhesion|stem cell maintenance|layer formation in cerebral cortex|central nervous system vasculogenesis|hair cycle process|hemopoiesis|cell differentiation|T cell differentiation|osteoclast differentiation|lung development|male genitalia development|regulation of epithelial cell differentiation|positive regulation of epithelial cell differentiation|forebrain development|regulation of centriole-centriole cohesion|pancreas development|hair follicle morphogenesis|regulation of myelination|positive regulation of telomere maintenance via telomerase|negative regulation of chondrocyte differentiation|response to estradiol|T cell differentiation in thymus|negative regulation of protein sumoylation|adherens junction organization|adherens junction assembly|protein localization to cell surface|cellular protein localization|embryonic heart tube development|genitalia morphogenesis|embryonic forelimb morphogenesis|embryonic hindlimb morphogenesis|embryonic skeletal limb joint morphogenesis|regulation of cell proliferation|regulation of T cell proliferation|odontogenesis of dentin-containing tooth|response to drug|regulation of cell fate specification|embryonic digit morphogenesis|regulation of apoptotic process|positive regulation of apoptotic process|positive regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of MAPK cascade|skin development|canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition|canonical Wnt signaling pathway involved in negative regulation of apoptotic process|bone resorption|regulation of cell differentiation|negative regulation of cell differentiation|positive regulation of endothelial cell differentiation|regulation of osteoblast differentiation|positive regulation of osteoblast differentiation|regulation of osteoclast differentiation|negative regulation of osteoclast differentiation|positive regulation of fibroblast growth factor receptor signaling pathway|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|negative regulation of mitotic cell cycle, embryonic|chromatin-mediated maintenance of transcription|cell maturation|synaptic vesicle transport|organ development|thymus development|oocyte development|embryonic foregut morphogenesis|positive regulation of skeletal muscle tissue development|regulation of smooth muscle cell proliferation|negative regulation of oligodendrocyte differentiation|synapse organization|smooth muscle cell differentiation|positive regulation of telomerase activity|cardiac muscle cell proliferation|oviduct development|canonical Wnt signaling pathway|limb development|trachea morphogenesis|trachea formation|epithelial tube branching involved in lung morphogenesis|lung cell differentiation|lung-associated mesenchyme development|mesenchyme development|lung induction|epithelial cell differentiation involved in prostate gland development|positive regulation of epithelial cell proliferation involved in prostate gland development|hair follicle placode formation|mesenchymal cell proliferation involved in lung development|cardiac vascular smooth muscle cell differentiation|coronary artery morphogenesis|epicardium-derived cardiac vascular smooth muscle cell differentiation|positive regulation of branching involved in lung morphogenesis|endothelial tube morphogenesis|fungiform papilla formation|canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation|sympathetic ganglion development|regulation of centromeric sister chromatid cohesion|cellular response to growth factor stimulus|cellular response to organic cyclic compound|cellular response to indole-3-methanol|renal system development|renal vesicle formation|renal inner medulla development|renal outer medulla development|nephron tubule formation|mesenchyme morphogenesis|regulation of nephron tubule epithelial cell differentiation|regulation of calcium ion import|negative regulation of neuron death|regulation of protein localization to cell surface|positive regulation of determination of dorsal identity|negative regulation of apoptotic signaling pathway|",RNA polymerase II activating transcription factor binding|DNA binding|chromatin binding|double-stranded DNA binding|sequence-specific DNA binding transcription factor activity|transcription coactivator activity|signal transducer activity|protein binding|protein C-terminus binding|transcription factor binding|enzyme binding|kinase binding|protein phosphatase binding|estrogen receptor binding|nuclear hormone receptor binding|transcription regulatory region DNA binding|ion channel binding|alpha-catenin binding|cadherin binding|SMAD binding|I-SMAD binding|R-SMAD binding|repressing transcription factor binding|euchromatin binding|,17,37,4320000000,28.6%
Q3UTJ2-2,0.667069025,-0.054666667,5.051994966,0.18,0.312464371,1.093251404,-0.009,0.071,-0.496,-0.055,0.157,0.004,Q3UTJ2,Sorbs2,Q3UTJ2-2_Sorbs2,Q3UTJ2-2,Sorbs2,1,76,28,27,Q3UTJ2-2|B9EKP8|B7ZWM6|Q3UTJ2|D3Z080|Q3UTJ2-5|B2RXQ9|A0A0R4J1W0|Q3UTJ2-4|Z4YJR7|Q3UTJ2-3|Q3UTJ2-7|Q3UTJ2-6|A0A1B0GRC3,MOUSE,146264.3,22.2,345,345.1,356.49,346.11,,1180,Isoform 2 of Sorbin and SH3 domain-containing protein 2,cytoskeleton|plasma membrane|focal adhesion|Z disc|perinuclear region of cytoplasm|,actin filament organization|cell adhesion|Notch signaling pathway|cell migration|,protein domain specific binding|poly(A) RNA binding|metal ion binding|,28,76,24200000000,22.2%
Q62417,0.687405839,0.011166667,4.741703884,0.180333333,0.335605919,1.038199183,-0.311,-0.15,0.224,-0.026,-0.019,0.349,Q62417,Sorbs1,Q62417_Sorbs1,Q62417,Sorbs1,1,12,9,8,A0A286YCI8|Q62417|E9QNA7|Q62417-2|Q62417-7|D3Z5J3|E9PYX6|Q62417-3|E9Q6A3|Q62417-4|A0A286YDN0|Q62417-6|A0A286YCQ0|Q62417-5,MOUSE,144037.7,9.6,345,345.2,104.14,93.76,,1290,Sorbin and SH3 domain-containing protein 1,stress fiber|nucleus|nucleoplasm|cytoplasm|centrosome|cytosol|cytoskeleton|plasma membrane|cell-cell adherens junction|cell-substrate adherens junction|focal adhesion|membrane|nuclear matrix|membrane raft|insulin receptor complex|flotillin complex|,insulin receptor signaling pathway|positive regulation of signal transduction|glucose transport|cellular response to insulin stimulus|stress fiber assembly|positive regulation of glycogen biosynthetic process|positive regulation of glucose import|positive regulation of lipid biosynthetic process|focal adhesion assembly|positive regulation of establishment of protein localization to plasma membrane|,SH3/SH2 adaptor activity|insulin receptor binding|protein binding|transcription factor binding|protein kinase binding|,8,12,595000000,8.8%
P52843,0.887422221,0.026833333,1.789671859,0.307666667,0.662266541,0.457031987,1.341,-0.287,-1.435,0.153,0.719,-0.33,P52843,Sult2a1,P52843_Sult2a1,P52843,Sult2a1,1,129,23,11,P52843|V9GWV0,MOUSE,33326.8,61.4,346,346.1,356.37,166.55,,285,Bile salt sulfotransferase 1,cytoplasm|,steroid metabolic process|,sulfotransferase activity|bile-salt sulfotransferase activity|,23,129,1.49E+11,61.4%
P50236,0.709478908,-0.158666667,4.384252435,-0.751333333,0.364396969,-0.973778491,1.04,0.496,-0.885,0.993,-1.737,-0.859,P50236,NotFound,P50236_NotFound,P50236,Sult2a2,1,5,17,2,P50236,MOUSE,33442.9,47.3,346,346.2,268.7,24.65,,285,Bile salt sulfotransferase 2,cytoplasm|,steroid metabolic process|,bile-salt sulfotransferase activity|,2,5,265000000,4.9%
Q3UEP5,0.785249508,-0.088,3.337111025,-0.464,0.463755312,-0.777469557,0.954,0.422,-0.944,0.67,-0.6,-1.03,Q3UEP5,Sult2a2,Q3UEP5_Sult2a2,Q3UEP5,Sult2a2,1,9,13,2,Q3UEP5,MOUSE,22595.5,56.1,346,346.3,221.66,39.15,,194,Sulfotransferase,,metabolic process|,sulfotransferase activity|,2,9,2830000000,13.4%
D3Z1W5,0.91325,0.434833333,1.388544666,0.345666667,0.726349319,0.365201163,2.082,-0.264,-1.032,0.134,2.117,-0.428,D3Z1W5,Sult2a3,D3Z1W5_Sult2a3,D3Z1W5,Sult2a3,1,5,11,2,D3Z1W5,MOUSE,33666.3,25.9,346,346.4,159.98,24.85,,285,Sulfotransferase,,metabolic process|,sulfotransferase activity|,2,5,634000000,8.4%
K7N6K9,0.911411213,-0.0955,1.440249307,0.220333333,0.717753088,0.377301799,0.823,-0.106,-1.334,0.081,0.682,-0.719,K7N6K9,Sult2a5,K7N6K9_Sult2a5,K7N6K9,Sult2a5,1,10,11,3,K7N6K9,MOUSE,33416.7,30.1,346,346.5,157.52,37.22,,285,Sulfotransferase,,metabolic process|,sulfotransferase activity|,3,10,1230000000,14.0%
Q8BGL3,0.864130616,-0.086333333,2.164286998,0.146666667,0.607534997,0.538988861,0.308,0.024,-0.811,0.02,-0.034,-0.025,Q8BGL3,Sult2a8,Q8BGL3_Sult2a8,Q8BGL3,Sult2a8,1,11,6,5,Q8BGL3|B1PQU4,MOUSE,33522.9,26.5,346,346.6,73.42,59.19,,282,Sulfotransferase,,metabolic process|,sulfotransferase activity|,5,11,939000000,21.9%
Q8CIB5,0.53169579,0.0375,7.561407935,-0.218333333,0.175331201,-1.51759818,-0.114,0.181,0.373,-0.202,-0.044,0.031,Q8CIB5,Fermt2,Q8CIB5_Fermt2,Q8CIB5,Fermt2,1,65,26,26,Q8CIB5,MOUSE,78483.7,48.2,347,347.1,356.14,356.14,,680,Fermitin family homolog 2,nucleus|nucleoplasm|cytoplasm|focal adhesion|cell cortex|cell surface|extrinsic component of cytoplasmic side of plasma membrane|lamellipodium membrane|I band|stress fiber|filamentous actin|,cell-matrix adhesion|transforming growth factor beta receptor signaling pathway|integrin-mediated signaling pathway|regulation of cell shape|Wnt signaling pathway|integrin activation|substrate adhesion-dependent cell spreading|focal adhesion assembly|protein localization to membrane|,"phosphatidylinositol-3,4,5-trisphosphate binding|",26,65,32200000000,48.2%
Q8BMA6,0.936177499,0.0005,0.900777036,0.029,0.812685098,0.2465838,0.108,-0.001,-0.149,0.192,-0.064,-0.083,Q8BMA6,Srp68,Q8BMA6_Srp68,Q8BMA6,Srp68,1,84,27,27,Q8BMA6|A2AAN2,MOUSE,71086.4,45.9,348,348.1,354.61,354.61,,625,Signal recognition particle subunit SRP68,"nucleolus|cytoplasm|endoplasmic reticulum|signal recognition particle, endoplasmic reticulum targeting|focal adhesion|",SRP-dependent cotranslational protein targeting to membrane|response to drug|protein targeting to ER|,signal recognition particle binding|signal sequence binding|7S RNA binding|endoplasmic reticulum signal peptide binding|poly(A) RNA binding|,27,84,26000000000,45.9%
Q63880,0.000128795,-0.290666667,61.40887857,2.269333333,7.22956E-07,17.98610834,-1.479,-1.337,-1.46,0.724,0.72,1.088,Q63880,Ces3a,Q63880_Ces3a,Q63880,Ces3a,1,162,22,10,Q63880|Q63880-2,MOUSE,63715.9,46.2,349,349.1,354.29,189.74,,571,Carboxylesterase 3A,endoplasmic reticulum lumen|extracellular exosome|,metabolic process|,carboxylic ester hydrolase activity|,22,162,7.82E+11,46.2%
Q8VCU1,0.00160978,-0.2275,42.05170178,2.237666667,6.2349E-05,8.935025524,-1.189,-1.029,-1.821,0.845,0.589,1.24,Q8VCU1,Ces3b,Q8VCU1_Ces3b,Q8VCU1,Ces3b,1,53,22,10,Q8VCU1|Q8VCU1-2,MOUSE,63751.2,53.5,349,349.2,350.41,185.86,,571,Carboxylesterase 3B,endoplasmic reticulum lumen|extracellular exosome|,metabolic process|,carboxylic ester hydrolase activity|,10,53,85900000000,37.3%
E9PZ16,0.019386137,-0.020833333,28.5778437,0.558333333,0.001387445,5.240334146,-0.251,-0.287,-0.362,0.219,0.431,0.125,E9PZ16,Hspg2,E9PZ16_Hspg2,E9PZ16,Hspg2,1,54,36,36,E9PZ16|B1B0C7|Q05793,MOUSE,480502.6,9.7,350,350.1,353.21,353.21,,4383,Basement membrane-specific heparan sulfate proteoglycan core protein,proteinaceous extracellular matrix|basement membrane|basal lamina|extracellular space|focal adhesion|extracellular matrix|extracellular exosome|extracellular matrix|,endochondral ossification|chondrocyte differentiation|brain development|protein localization|extracellular matrix organization|embryonic skeletal system morphogenesis|cardiac muscle tissue development|cartilage development involved in endochondral bone morphogenesis|,protein binding|protein C-terminus binding|,37,54,4120000000,9.7%
Q9DBL1,0.915900752,-0.006333333,1.29852471,-0.063333333,0.741562106,-0.343932205,0.086,0.352,-0.362,0.073,-0.072,-0.115,Q9DBL1,Acadsb,Q9DBL1_Acadsb,Q9DBL1,Acadsb,1,91,26,26,Q9DBL1|E9Q5L3,MOUSE,48329.7,67.8,351,351.1,351.73,351.73,,432,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",mitochondrion|mitochondrial matrix|extracellular exosome|,fatty acid metabolic process|acyl-CoA metabolic process|oxidation-reduction process|,acyl-CoA dehydrogenase activity|short-branched-chain-acyl-CoA dehydrogenase activity|flavin adenine dinucleotide binding|,26,91,45100000000,67.8%
A0A0R4J1H2,0.92551138,-0.047,1.102909344,0.050666667,0.775727282,0.296782476,0.172,0.048,-0.437,0.088,-0.016,-0.137,A0A0R4J1H2,Glyctk,A0A0R4J1H2_Glyctk,A0A0R4J1H2,Glyctk,1,109,21,21,A0A0R4J1H2|Q8QZY2|Q8QZY2-2,MOUSE,55619.3,56,352,352.1,351.55,351.55,,523,Glycerate kinase,,,,21,109,2.83E+11,56.0%
Q8VHE0,0.617256008,-0.002833333,5.999824947,-0.103666667,0.251198768,-1.255879978,0.031,0.071,0.045,0.018,-0.115,-0.067,Q8VHE0,Sec63,Q8VHE0_Sec63,Q8VHE0,Sec63,1,77,25,25,Q8VHE0,MOUSE,88267.8,34.3,353,353.1,351.2,351.2,,760,Translocation protein SEC63 homolog,endoplasmic reticulum membrane|membrane|integral component of membrane|,"liver development|SRP-dependent cotranslational protein targeting to membrane|posttranslational protein targeting to membrane|nitrogen compound metabolic process|multicellular organismal aging|posttranslational protein targeting to membrane, translocation|renal system development|",protein transporter activity|poly(A) RNA binding|,25,77,30700000000,34.3%
Q9R0N0,0.988667863,-0.022833333,0.207122495,0.007,0.953427667,0.060642949,0.133,0.017,-0.229,-0.07,0.046,-0.034,Q9R0N0,Galk1,Q9R0N0_Galk1,Q9R0N0,Galk1,1,104,24,24,Q9R0N0,MOUSE,42693.8,63.2,354,354.1,350.62,350.62,,392,Galactokinase,cytoplasm|membrane|extracellular exosome|,galactose metabolic process|galactitol metabolic process|carbohydrate phosphorylation|,galactokinase activity|protein binding|ATP binding|galactose binding|,24,104,85300000000,63.2%
P67778,0.953420192,-0.040666667,0.695268445,-0.04,0.852065842,-0.193904568,-0.386,0.061,0.263,-0.348,-0.02,0.186,P67778,Phb,P67778_Phb,P67778,Phb,1,89,21,21,P67778,MOUSE,29876.6,81.9,355,355.1,349.05,349.05,,272,Prohibitin,nucleus|nucleoplasm|cytoplasm|mitochondrion|mitochondrial inner membrane|early endosome|plasma membrane|integral component of plasma membrane|cell surface|membrane|mitochondrial crista|extrinsic component of mitochondrial outer membrane|myelin sheath|extracellular exosome|,"negative regulation of transcription from RNA polymerase II promoter|ovarian follicle development|ovarian follicle atresia|osteoblast differentiation|regulation of transcription, DNA-templated|mitochondrion organization|negative regulation of cell proliferation|negative regulation of transcription by competitive promoter binding|histone deacetylation|negative regulation of cell growth|organ regeneration|response to immobilization stress|negative regulation of protein catabolic process|response to drug|negative regulation of apoptotic process|response to peptide hormone|response to ethanol|positive regulation of G-protein coupled receptor protein signaling pathway|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|positive regulation of complement activation|protein stabilization|progesterone receptor signaling pathway|negative regulation of androgen receptor signaling pathway|negative regulation of ERK1 and ERK2 cascade|positive regulation of ERK1 and ERK2 cascade|cellular response to interleukin-6|DNA biosynthetic process|negative regulation of glucocorticoid receptor signaling pathway|",sequence-specific DNA binding RNA polymerase II transcription factor activity|complement component C3a binding|complement component C3b binding|protein C-terminus binding|enzyme binding|proteinase activated receptor binding|histone deacetylase binding|transcription regulatory region DNA binding|,21,89,1.02E+11,81.9%
F8VQC1,0.91325,0.002,1.376258496,0.032,0.728407066,0.362135698,0.054,-0.025,-0.071,0.104,-0.005,-0.045,F8VQC1,Srp72,F8VQC1_Srp72,F8VQC1,Srp72,1,69,26,26,F8VQC1|E9Q740,MOUSE,75226.4,50.9,356,356.1,348.78,348.78,,671,Signal recognition particle subunit SRP72,"nucleolus|cytoplasm|endoplasmic reticulum|signal recognition particle, endoplasmic reticulum targeting|plasma membrane|",SRP-dependent cotranslational protein targeting to membrane|response to drug|,signal recognition particle binding|7S RNA binding|poly(A) RNA binding|,26,69,12300000000,50.9%
Q8VCR2-2,0.926033297,0.02,1.072245189,0.032,0.781223828,0.289172494,-0.056,0.124,-0.056,-0.071,0.203,-0.024,Q8VCR2,Hsd17b13,Q8VCR2-2_Hsd17b13,Q8VCR2-2,Hsd17b13,1,93,21,21,Q8VCR2-2|Q8VCR2|A8Y5N4,MOUSE,33757,69,357,357.1,348.25,348.25,,304,Isoform 2 of 17-beta-hydroxysteroid dehydrogenase 13,extracellular region|lipid particle|,positive regulation of lipid biosynthetic process|oxidation-reduction process|,oxidoreductase activity|,21,93,1.58E+11,69.0%
Q9DBL7,0.842023552,-0.036,2.488211438,0.076,0.563869827,0.607337103,0.099,-0.004,-0.317,0.058,-0.022,-0.03,Q9DBL7,Coasy,Q9DBL7_Coasy,Q9DBL7,Coasy,1,74,24,24,Q9DBL7,MOUSE,62250.2,50.2,358,358.1,348.07,348.07,,563,Bifunctional coenzyme A synthase,nucleoplasm|cytoplasm|mitochondrial matrix|extracellular exosome|,coenzyme A biosynthetic process|phosphorylation|,dephospho-CoA kinase activity|pantetheine-phosphate adenylyltransferase activity|ATP binding|,24,74,31400000000,50.2%
P35492,0.884566234,0.005166667,1.856730253,-0.063,0.652119181,-0.471953922,-0.151,0.021,0.24,-0.171,0.123,-0.031,P35492,Hal,P35492_Hal,P35492,Hal,1,73,27,27,P35492|F8WH73,MOUSE,72941.2,41.4,359,359.1,347.04,347.04,,657,Histidine ammonia-lyase,cytoplasm|,histidine catabolic process|biosynthetic process|histidine catabolic process to glutamate and formamide|histidine catabolic process to glutamate and formate|,histidine ammonia-lyase activity|,27,73,13900000000,41.4%
Q7TT50,0.607857354,0.008166667,6.216664777,-0.114333333,0.238964574,-1.29257398,0.011,0.162,0.023,-0.112,-0.016,-0.019,Q7TT50,Cdc42bpb,Q7TT50_Cdc42bpb,Q7TT50,Cdc42bpb,1,47,29,27,Q7TT50|P54265-8|P54265-9|P54265|P54265-3|E9Q6J9|P54265-2|D6RI32|P54265-10|P54265-7|P54265-5|P54265-6|P54265-4,MOUSE,196632,16.5,360,360.1,346.38,325.07,,1713,Serine/threonine-protein kinase MRCK beta,cytoplasm|plasma membrane|cell-cell junction|cell leading edge|actomyosin|extracellular exosome|,protein phosphorylation|cell migration|actomyosin structure organization|actin cytoskeleton reorganization|intracellular signal transduction|,magnesium ion binding|protein kinase activity|protein serine/threonine kinase activity|ATP binding|Rho GTPase binding|,29,47,7950000000,16.5%
E9PVY0,0.214980661,0.086166667,15.39080914,-0.475666667,0.028901414,-2.779825076,-0.008,0.561,0.419,-0.332,-0.131,0.008,E9PVY0,Cdc42bpa,E9PVY0_Cdc42bpa,E9PVY0,Cdc42bpa,1,3,4,2,A0A1D5RLQ9|E9PVY0|Q3UU96|D3YYN8|H7BX44|Q3UU96-2,MOUSE,199256.5,2.3,360,360.2,30.33,9.02,,1732,Serine/threonine-protein kinase MRCK alpha,actomyosin|extracellular exosome|,microtubule cytoskeleton organization|protein phosphorylation|nuclear migration|cell migration|actomyosin structure organization|actin cytoskeleton reorganization|intracellular signal transduction|,magnesium ion binding|protein serine/threonine kinase activity|ATP binding|identical protein binding|,2,3,221000000,1.3%
O70318,0.859706245,-0.000166667,2.221393476,0.047,0.599598658,0.550884674,-0.07,0.025,-0.026,0.072,-0.058,0.056,O70318,Epb41l2,O70318_Epb41l2,O70318,Epb41l2,1,49,29,20,O70318|Q80UE5|Q80UE4|A0A286YCY8,MOUSE,110451,35.9,361,361.1,346.28,263.46,,988,Band 4.1-like protein 2,nucleus|nucleoplasm|cytoplasm|plasma membrane|focal adhesion|actin cytoskeleton|extrinsic component of membrane|cell junction|extracellular exosome|COP9 signalosome|,regulation of cell shape|actin cytoskeleton organization|cortical actin cytoskeleton organization|,actin binding|structural molecule activity|protein binding|spectrin binding|PH domain binding|,29,49,17300000000,35.9%
Q9WV92-8,0.678836003,-0.024666667,4.883265714,0.163333333,0.324842937,1.063409685,-0.025,-0.016,-0.278,0.345,-0.153,-0.021,Q9WV92,Epb41l3,Q9WV92-8_Epb41l3,Q9WV92-8,Epb41l3,1,2,5,2,Q9WV92-8|Q9WV92-2|Q9WV92|Q9WV92-3|Q9WV92-5|Q9WV92-4|Q9WV92-6|A7YY80|Q9WV92-7,MOUSE,117524.4,4.6,361,361.3,35.97,14.68,,929,Isoform 8 of Band 4.1-like protein 3,cytoplasm|cytoskeleton|plasma membrane|cell-cell junction|extrinsic component of membrane|paranode region of axon|juxtaparanode region of axon|neuronal postsynaptic density|axolemma|,regulation of cell growth|protein localization to paranode region of axon|apoptotic process|cytoskeletal anchoring at plasma membrane|regulation of cell shape|cortical cytoskeleton organization|cortical actin cytoskeleton organization|paranodal junction assembly|myelin maintenance|neuron projection morphogenesis|protein localization to juxtaparanode region of axon|protein localization to plasma membrane|,actin binding|structural constituent of cytoskeleton|,2,2,1010000000,2.3%
P62908,0.56608042,-0.003333333,7.023546903,-0.118,0.198447353,-1.427182157,0.034,0.124,0.009,-0.072,-0.021,-0.094,P62908,Rps3,P62908_Rps3,P62908,Rps3,1,128,26,26,P62908|D3YV43|A0A140LI77,MOUSE,26845,81.8,362,362.1,345.55,345.55,,243,40S ribosomal protein S3,nucleus|nucleolus|cytoplasm|mitochondrial inner membrane|spindle|cytosol|focal adhesion|membrane|cytosolic small ribosomal subunit|ribonucleoprotein complex|ruffle membrane|extracellular exosome|NF-kappaB complex|,"DNA repair|transcription, DNA-templated|translation|regulation of translation|apoptotic process|mitotic nuclear division|negative regulation of DNA repair|positive regulation of NF-kappaB transcription factor activity|cell division|positive regulation of DNA N-glycosylase activity|positive regulation of apoptotic signaling pathway|",damaged DNA binding|mRNA binding|structural constituent of ribosome|DNA-(apurinic or apyrimidinic site) lyase activity|protein binding|oxidized purine nucleobase lesion DNA N-glycosylase activity|enzyme binding|protein kinase binding|poly(A) RNA binding|protein kinase A binding|NF-kappaB binding|,26,128,1.8E+11,81.8%
Q61655,0.942218886,-0.010333333,0.836486427,-0.024666667,0.824805137,-0.230228113,0.097,0.063,-0.154,0.092,-0.084,-0.076,Q61655,Ddx19a,Q61655_Ddx19a,Q61655,Ddx19a,1,57,26,6,Q61655,MOUSE,54388.5,59.6,363,363.1,345.09,72.87,,478,ATP-dependent RNA helicase DD9A,nuclear pore|cytoplasm|membrane|nuclear membrane|,mRNA export from nucleus|RNA secondary structure unwinding|protein transport|,RNA binding|ATP-dependent RNA helicase activity|ATP binding|,26,57,11700000000,59.6%
Q8BZY3,0.797128744,-0.046833333,3.168593007,0.135666667,0.482103961,0.744600365,0.198,-0.059,-0.483,-0.027,-0.083,0.173,Q8BZY3,Ddx19b,Q8BZY3_Ddx19b,Q8BZY3,Ddx19b,1,2,21,2,Q8BZY3|Q8R3C7,MOUSE,56187.6,41.2,363,363.2,270.59,11.91,,494,DEAD (Asp-Glu-Ala-Asp) box polypeptide 19b,nuclear envelope|membrane|extracellular exosome|,mRNA export from nucleus|RNA secondary structure unwinding|,nucleic acid binding|ATP-dependent RNA helicase activity|ATP binding|,2,2,22600000,4.4%
O88569,0.846769943,0.017,2.406583784,-0.098,0.574568247,-0.590315086,-0.2,0.344,0.054,-0.172,-0.102,0.178,O88569,Hnrnpa2b1,O88569_Hnrnpa2b1,O88569,Hnrnpa2b1,1,112,22,17,O88569|O88569-2|O88569-3,MOUSE,37459.1,67.9,364,364.1,342.55,276.86,,353,Heterogeneous nuclear ribonucleoproteins A2/B1,nucleus|nucleoplasm|spliceosomal complex|cytoplasm|membrane|ribonucleoprotein complex|catalytic step 2 spliceosome|,"negative regulation of transcription from RNA polymerase II promoter|mRNA processing|RNA splicing|negative regulation of mRNA splicing, via spliceosome|RNA transport|",nucleotide binding|RNA binding|single-stranded telomeric DNA binding|poly(A) RNA binding|pre-mRNA intronic binding|,22,112,39500000000,67.9%
Q5EBP8,0.71486516,-0.0055,4.283614627,0.106333333,0.372939631,0.954986015,-0.129,0.118,-0.165,0.02,-0.032,0.155,Q5EBP8,Hnrnpa1,Q5EBP8_Hnrnpa1,Q5EBP8,Hnrnpa1,1,11,11,6,Q5EBP8|P49312|P49312-2,MOUSE,38947.1,24.1,364,364.2,152.89,87.2,,373,Heterogeneous nuclear ribonucleoprotein A1,nucleus|nucleoplasm|cytoplasm|membrane|viral nucleocapsid|ribonucleoprotein complex|intermediate filament cytoskeleton|extracellular exosome|catalytic step 2 spliceosome|,"alternative mRNA splicing, via spliceosome|RNA splicing|nuclear export|nuclear import|",nucleotide binding|single-stranded DNA binding|poly(A) RNA binding|,6,11,1660000000,19.5%
Q9CZD3,0.387241291,0.04,10.66207072,-0.287333333,0.085860404,-2.016799973,-0.055,0.435,0.171,-0.205,0.014,-0.12,Q9CZD3,Gars,Q9CZD3_Gars,Q9CZD3,Gars,1,59,27,27,Q9CZD3,MOUSE,82675,40.4,365,365.1,340.31,340.31,,729,Glycine--tRNA ligase,nucleoplasm|cytoplasm|mitochondrion|secretory granule|axon|extracellular exosome|,glycyl-tRNA aminoacylation|diadenosine tetraphosphate biosynthetic process|,glycine-tRNA ligase activity|protein binding|ATP binding|protein dimerization activity|,27,59,48800000000,40.4%
Q9JHW4,0.843401516,-0.01,2.453223209,-0.061333333,0.568430901,-0.599703866,0.122,0.068,-0.128,0.046,-0.066,-0.102,Q9JHW4,Eefsec,Q9JHW4_Eefsec,Q9JHW4,Eefsec,1,72,24,24,Q9JHW4|A0A0N4SUV6|A0A0N4SWB3,MOUSE,64222.2,51.6,366,366.1,340.25,340.25,,583,Selenocysteine-specific elongation factor,nucleus|mitochondrion|ribonucleoprotein complex|,selenocysteine incorporation|,tRNA binding|translation elongation factor activity|GTPase activity|protein binding|GTP binding|selenocysteine insertion sequence binding|ribonucleoprotein complex binding|,24,72,24400000000,51.6%
Q8CHT0,0.843401516,-0.044333333,2.45208442,-0.144666667,0.568579972,-0.599819531,0.315,0.228,-0.459,-0.198,0.199,-0.351,Q8CHT0,Aldh4a1,Q8CHT0_Aldh4a1,Q8CHT0,Aldh4a1,1,131,23,23,Q8CHT0,MOUSE,62295.9,43.2,367,367.1,338,338,,562,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial",mitochondrion|mitochondrial matrix|,glutamate biosynthetic process|proline biosynthetic process|proline catabolic process to glutamate|oxidation-reduction process|,1-pyrroline-5-carboxylate dehydrogenase activity|aldehyde dehydrogenase (NAD) activity|identical protein binding|,23,131,1.59E+11,43.2%
P62702,0.676059904,-0.001166667,4.929172373,-0.097666667,0.321427302,-1.070558239,-0.054,0.102,0.095,-0.12,0.018,-0.048,P62702,Rps4x,P62702_Rps4x,P62702,Rps4x,1,101,25,25,P62702|V9GWY0,MOUSE,29825.4,66.5,368,368.1,337.75,337.75,,263,"40S ribosomal protein S4, X isoform",nucleus|ribosome|polysome|focal adhesion|small ribosomal subunit|membrane|ribonucleoprotein complex|cytoplasmic ribonucleoprotein granule|extracellular exosome|,translation|multicellular organismal development|positive regulation of cell proliferation|positive regulation of translation|,structural constituent of ribosome|rRNA binding|poly(A) RNA binding|,25,101,81600000000,66.5%
P60335,0.750398776,-0.002166667,3.827193456,-0.103666667,0.414267301,-0.870913284,0.166,0.155,-0.172,0.001,-0.029,-0.134,P60335,Pcbp1,P60335_Pcbp1,P60335,Pcbp1,1,158,20,13,P60335,MOUSE,38010.7,69.3,369,369.1,337.36,229.5,,356,Poly(rC)-binding protein 1,nucleoplasm|cytoplasm|membrane|ribonucleoprotein complex|intracellular membrane-bounded organelle|extracellular exosome|,mRNA processing|positive regulation of translation|,single-stranded DNA binding|RNA binding|protein binding|translation activator activity|poly(A) RNA binding|,20,158,3.04E+11,69.3%
Q61990,0.236746489,0.004833333,14.59030586,-0.235,0.034751169,-2.640891343,0.156,0.193,0.018,-0.109,-0.07,-0.159,Q61990,Pcbp2,Q61990_Pcbp2,Q61990,Pcbp2,1,44,15,8,Q61990|Q61990-2|Q61990-3|P57722|P57722-2|E9Q7D8,MOUSE,38620.4,49.7,369,369.2,240.69,132.83,,362,Poly(rC)-binding protein 2,nucleus|nucleoplasm|cytoplasm|focal adhesion|membrane|ribonucleoprotein complex|extracellular exosome|,proteasome-mediated ubiquitin-dependent protein catabolic process|innate immune response|negative regulation of defense response to virus|defense response to virus|,DNA binding|RNA binding|enzyme binding|ubiquitin protein ligase binding|poly(A) RNA binding|,8,44,58200000000,35.0%
Q9QZD8,0.732049775,-0.009666667,4.068034364,-0.128666667,0.391919221,-0.915785911,0.227,0.144,-0.207,-0.086,0.06,-0.196,Q9QZD8,Slc25a10,Q9QZD8_Slc25a10,Q9QZD8,Slc25a10,1,130,25,25,Q9QZD8,MOUSE,32170.8,76.6,370,370.1,337.26,337.26,,287,Mitochondrial dicarboxylate carrier,nucleus|mitochondrion|mitochondrial inner membrane|integral component of membrane|,mitochondrial transport|thiosulfate transport|phosphate ion transmembrane transport|succinate transmembrane transport|malate transmembrane transport|sulfate transmembrane transport|,phosphate ion transmembrane transporter activity|sulfate transmembrane transporter activity|thiosulfate transmembrane transporter activity|malate transmembrane transporter activity|succinate transmembrane transporter activity|secondary active transmembrane transporter activity|antiporter activity|,25,130,1.45E+11,76.6%
Q9EPE9,0.892090805,-0.003666667,1.72139093,-0.052,0.672761154,-0.441673475,-0.181,0.172,0.076,-0.123,-0.006,0.04,Q9EPE9,Atp13a1,Q9EPE9_Atp13a1,Q9EPE9,Atp13a1,1,54,25,25,Q9EPE9,MOUSE,134040.2,28.6,371,371.1,336.32,336.32,,1200,Manganese-transporting ATPase 13A1,endoplasmic reticulum membrane|membrane|integral component of membrane|,cation transport|metabolic process|,ATP binding|ATPase activity|metal ion binding|,25,54,9410000000,28.6%
P25444,0.522021196,0.004,7.795146302,-0.128666667,0.166144271,-1.553615932,0.028,0.135,0.042,-0.097,-0.014,-0.07,P25444,Rps2,P25444_Rps2,P25444,Rps2,1,117,23,7,P25444|D3YWJ3|A0A140T8L5|D3Z536,MOUSE,31516,64.1,372,372.1,335.8,95.83,,293,40S ribosomal protein S2,nucleus|nucleoplasm|cytoplasm|focal adhesion|membrane|cytosolic small ribosomal subunit|extracellular exosome|,translation|cellular response to interleukin-4|,mRNA binding|structural constituent of ribosome|fibroblast growth factor binding|enzyme binding|poly(A) RNA binding|,23,117,1.39E+11,64.1%
Q99JR1,0.611768199,-0.0415,6.153942276,-0.205666667,0.242440836,-1.283429046,-0.046,0.224,0.006,-0.464,0.059,-0.028,Q99JR1,Sfxn1,Q99JR1_Sfxn1,Q99JR1,Sfxn1,1,115,21,19,Q99JR1,MOUSE,35934,68.9,373,373.1,335.64,298.04,,322,Sideroflexin-1,mitochondrion|mitochondrial inner membrane|integral component of membrane|,iron ion transport|erythrocyte differentiation|ion transmembrane transport|iron ion homeostasis|,ion transmembrane transporter activity|,21,115,1.66E+11,68.9%
Q91V61,0.449043208,-0.002833333,9.42879111,-0.215,0.114056723,-1.819171919,-0.044,0.134,0.224,-0.268,-0.092,0.029,Q91V61,Sfxn3,Q91V61_Sfxn3,Q91V61,Sfxn3,1,6,6,4,Q91V61|Q91V61-2|Q3U4F0,MOUSE,35690.8,24.2,373,373.2,83.35,45.75,,321,Sideroflexin-3,mitochondrion|integral component of membrane|mitochondrial membrane|,ion transmembrane transport|iron ion homeostasis|,ion transmembrane transporter activity|,4,6,932000000,15.5%
P80313,0.884566234,0.014166667,1.860137394,-0.069,0.651607779,-0.472709028,-0.158,0.342,-0.038,-0.131,0.03,0.04,P80313,Cct7,P80313_Cct7,P80313,Cct7,1,77,24,24,P80313|A0A0N4SV00|A0A0N4SV22,MOUSE,60164.6,51.4,374,374.1,334.65,334.65,,544,T-complex protein 1 subunit eta,zona pellucida receptor complex|mitochondrion|chaperonin-containing T-complex|microtubule|cell body|extracellular exosome|,protein folding|binding of sperm to zona pellucida|toxin transport|,protein binding|ATP binding|identical protein binding|unfolded protein binding|,24,77,23300000000,51.4%
P27659,0.477058075,0.0305,8.633689375,-0.169,0.136971768,-1.689208563,-0.033,0.246,0.132,-0.076,-0.012,-0.074,P27659,Rpl3,P27659_Rpl3,P27659,Rpl3,1,112,25,25,P27659|E9PWZ3|Q9CQ09|A0A087WNS0,MOUSE,46394.4,48.3,375,375.1,334.44,334.44,,403,60S ribosomal protein L3,nucleus|nucleoplasm|nucleolus|cytoplasm|focal adhesion|cytosolic large ribosomal subunit|extracellular exosome|,translation|cellular response to interleukin-4|,structural constituent of ribosome|poly(A) RNA binding|,25,112,62200000000,48.3%
P14211,0.000368062,-0.439666667,52.53501277,2.629333333,5.57826E-06,13.10718943,-1.547,-1.513,-2.203,0.712,0.944,0.969,P14211,Calr,P14211_Calr,P14211,Calr,1,95,23,23,P14211,MOUSE,48164.8,52.4,376,376.1,333.53,333.53,,416,Calreticulin,acrosomal vesicle|extracellular region|extracellular space|nucleus|cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|Golgi apparatus|cytosol|polysome|focal adhesion|external side of plasma membrane|membrane|extracellular matrix|sarcoplasmic reticulum lumen|MHC class I peptide loading complex|phagocytic vesicle|perinuclear region of cytoplasm|extracellular exosome|,"negative regulation of transcription from RNA polymerase II promoter|peptide antigen assembly with MHC class I protein complex|protein export from nucleus|cell cycle arrest|spermatogenesis|positive regulation of cell proliferation|positive regulation of gene expression|negative regulation of translation|cortical actin cytoskeleton organization|response to estradiol|negative regulation of intracellular steroid hormone receptor signaling pathway|response to testosterone|protein localization to nucleus|regulation of meiotic nuclear division|response to drug|negative regulation of neuron differentiation|positive regulation of DNA replication|positive regulation of cell cycle|negative regulation of transcription, DNA-templated|negative regulation of retinoic acid receptor signaling pathway|positive regulation of phagocytosis|protein stabilization|cardiac muscle cell differentiation|chaperone-mediated protein folding|cellular response to lithium ion|cellular response to organic substance|cellular senescence|positive regulation of substrate adhesion-dependent cell spreading|positive regulation of dendritic cell chemotaxis|",glycoprotein binding|mRNA binding|integrin binding|iron ion binding|calcium ion binding|protein binding|carbohydrate binding|ubiquitin protein ligase binding|peptide binding|hormone binding|poly(A) RNA binding|androgen receptor binding|unfolded protein binding|,23,95,89600000000,52.4%
Q9DBG3-2,0.819870651,-0.024,2.801356352,-0.092,0.524643582,-0.671483671,-0.175,0.067,0.174,-0.279,0.029,0.04,Q9DBG3,Ap2b1,Q9DBG3-2_Ap2b1,Q9DBG3-2,Ap2b1,1,69,27,13,Q9DBG3-2|Q9DBG3|H3BIY9|H3BKM0,MOUSE,106632.8,28.4,377,377.1,333.34,165.73,,937,Isoform 2 of AP-2 complex subunit beta,trans-Golgi network|plasma membrane|coated pit|clathrin adaptor complex|,intracellular protein transport|endocytosis|clathrin coat assembly|,protein binding|protein transporter activity|clathrin binding|protein complex binding|,27,69,19200000000,28.4%
O35643,0.73101227,-0.036833333,4.087740894,0.133666667,0.390144879,0.919429675,-0.135,0.145,-0.321,-0.118,0.175,0.033,O35643,Ap1b1,O35643_Ap1b1,O35643,Ap1b1,1,17,24,10,O35643|Q5SVG4|Q5SVG5,MOUSE,104788.8,26,377,377.2,287.77,120.16,,943,AP-1 complex subunit beta-1,trans-Golgi network|clathrin adaptor complex|clathrin-coated vesicle membrane|,intracellular protein transport|vesicle-mediated transport|,protein binding|protein transporter activity|protein kinase binding|,10,17,9330000000,14.2%
O88587-2,0.010102874,-0.019333333,32.10911143,0.588666667,0.000615303,6.043228049,-0.243,-0.31,-0.388,0.202,0.216,0.407,O88587,Comt,O88587-2_Comt,O88587-2,Comt,1,77,20,20,O88587-2|O88587,MOUSE,24935.2,78.8,378,378.1,333.15,333.15,,265,Isoform Soluble of Catechol O-methyltransferase,mitochondrion|cytosol|membrane|integral component of membrane|axon|dendritic spine|cell body|postsynaptic membrane|extracellular exosome|,female pregnancy|learning|short-term memory|estrogen metabolic process|catechol-containing compound metabolic process|response to organic cyclic compound|cellular response to phosphate starvation|methylation|response to lipopolysaccharide|developmental process|negative regulation of renal sodium excretion|neurotransmitter catabolic process|dopamine metabolic process|dopamine catabolic process|response to drug|negative regulation of dopamine metabolic process|response to pain|multicellular organismal reproductive process|negative regulation of smooth muscle cell proliferation|positive regulation of homocysteine metabolic process|regulation of sensory perception of pain|,magnesium ion binding|catechol O-methyltransferase activity|,20,77,1.94E+11,78.8%
P35700,0.216645849,-0.026333333,15.31625415,0.268666667,0.029401845,2.759163384,-0.031,-0.222,-0.229,0.048,0.193,0.083,P35700,Prdx1,P35700_Prdx1,P35700,Prdx1,1,178,21,19,P35700,MOUSE,22404.3,66.3,379,379.1,330.92,297.49,,199,Peroxiredoxin-1,extracellular space|nucleus|cytoplasm|mitochondrion|melanosome|myelin sheath|extracellular exosome|,response to reactive oxygen species|retina homeostasis|response to oxidative stress|cell proliferation|removal of superoxide radicals|regulation of stress-activated MAPK cascade|erythrocyte homeostasis|natural killer cell mediated cytotoxicity|regulation of NF-kappaB import into nucleus|hydrogen peroxide catabolic process|oxidation-reduction process|,peroxidase activity|protein binding|thioredoxin peroxidase activity|identical protein binding|poly(A) RNA binding|,21,178,9.67E+11,66.3%
O08807,0.000498463,-0.013833333,49.62088351,1.293,1.09122E-05,11.68402666,-0.528,-0.685,-0.768,0.553,0.56,0.785,O08807,Prdx4,O08807_Prdx4,O08807,Prdx4,1,53,12,10,O08807,MOUSE,31280.1,41.6,379,379.2,173.67,140.24,,274,Peroxiredoxin-4,extracellular space|nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|smooth endoplasmic reticulum|cytosol|extracellular exosome|,spermatogenesis|male gonad development|4-hydroxyproline metabolic process|protein maturation by protein folding|extracellular matrix organization|cell redox homeostasis|oxidation-reduction process|reactive oxygen species metabolic process|negative regulation of male germ cell proliferation|,peroxidase activity|protein homodimerization activity|peroxiredoxin activity|,10,53,81400000000,37.5%
P50516,0.856747233,0.0145,2.274987,-0.046333333,0.59224486,-0.562268919,0,-0.002,0.115,-0.03,0,0.004,P50516,Atp6v1a,P50516_Atp6v1a,P50516,Atp6v1a,1,53,26,26,P50516|P50516-2,MOUSE,68667.2,48.2,380,380.1,330.89,330.89,,617,V-type proton ATPase catalytic subunit A,"mitochondrion|lysosomal membrane|cytosol|plasma membrane|microvillus|apical plasma membrane|proton-transporting V-type ATPase, V1 domain|myelin sheath|extracellular exosome|",ATP hydrolysis coupled proton transport|ATP metabolic process|,"ATP binding|proton-transporting ATPase activity, rotational mechanism|",26,53,11200000000,48.2%
P11352,0.386122129,-0.071333333,10.73856381,0.406666667,0.084361369,2.029005661,0.14,-0.444,-0.52,0.001,0.364,0.031,P11352,Gpx1,P11352_Gpx1,P11352,Gpx1,1,154,21,21,P11352|A0A0A6YVV2|A0A0A6YY34,MOUSE,22543.4,83.5,381,381.1,330.64,330.64,,201,Glutathione peroxidase 1,nucleus|cytoplasm|mitochondrion|extracellular exosome|Lewy body|,"response to reactive oxygen species|temperature homeostasis|endothelial cell development|negative regulation of inflammatory response to antigenic stimulus|lipid metabolic process|triglyceride metabolic process|glutathione metabolic process|apoptotic process|response to oxidative stress|response to lipid hydroperoxide|aging|sensory perception of sound|cell proliferation|intrinsic apoptotic signaling pathway in response to oxidative stress|response to xenobiotic stimulus|response to symbiotic bacterium|response to wounding|response to toxic substance|UV protection|response to glucose|response to selenium ion|response to gamma radiation|myotube differentiation|protein oxidation|response to estradiol|response to hydroperoxide|regulation of mammary gland epithelial cell proliferation|response to nicotine|regulation of gene expression, epigenetic|vasodilation|response to hydrogen peroxide|hydrogen peroxide catabolic process|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|skeletal muscle tissue regeneration|regulation of neuron apoptotic process|blood vessel endothelial cell migration|fat cell differentiation|cell redox homeostasis|skeletal muscle fiber development|myoblast proliferation|response to folic acid|interaction with symbiont|positive regulation of protein kinase B signaling|heart contraction|angiogenesis involved in wound healing|regulation of proteasomal protein catabolic process|negative regulation of release of cytochrome c from mitochondria|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|",glutathione peroxidase activity|protein binding|selenium binding|SH3 domain binding|glutathione binding|phospholipid-hydroperoxide glutathione peroxidase activity|,21,154,9.43E+11,83.5%
Q8BP47,0.581351655,-0.011333333,6.723396604,-0.128,0.212647529,-1.377435182,0.001,0.028,0.129,-0.188,-0.014,-0.024,Q8BP47,Nars,Q8BP47_Nars,Q8BP47,Nars,1,80,27,27,Q8BP47,MOUSE,65191,46.6,382,382.1,329.47,329.47,,559,"Asparagine--tRNA ligase, cytoplasmic",cytoplasm|mitochondrion|extracellular exosome|,asparaginyl-tRNA aminoacylation|,nucleic acid binding|asparagine-tRNA ligase activity|ATP binding|,27,80,29900000000,46.6%
Q9JLV1,0.234019027,-0.0015,14.68976263,0.221,0.033964384,2.657036127,-0.144,-0.074,-0.118,0.049,0.1,0.178,Q9JLV1,Bag3,Q9JLV1_Bag3,Q9JLV1,Bag3,1,76,24,24,Q9JLV1,MOUSE,62087.3,47.6,383,383.1,329.18,329.18,,577,BAG family molecular chaperone regulator 3,cytoplasm|cytosol|plasma membrane|Z disc|neuron projection|,brain development|extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of striated muscle cell apoptotic process|spinal cord development|protein stabilization|cellular response to mechanical stimulus|extrinsic apoptotic signaling pathway in absence of ligand|,protein binding|protein complex binding|chaperone binding|,24,76,9060000000,47.6%
Q9CR62,0.480593503,0.017833333,8.546370879,-0.237666667,0.13975357,-1.67775851,0.188,0.348,-0.126,-0.211,0.017,-0.109,Q9CR62,Slc25a11,Q9CR62_Slc25a11,Q9CR62,Slc25a11,1,122,25,25,Q9CR62,MOUSE,34325.5,72.6,384,384.1,327.31,327.31,,314,Mitochondrial 2-oxoglutarate/malate carrier protein,nucleus|mitochondrion|mitochondrial inner membrane|integral component of membrane|,transport|,poly(A) RNA binding|,25,122,88600000000,72.6%
Q6P542,0.994928853,-0.008166667,0.08009401,-0.002333333,0.981726692,-0.023772742,-0.015,0.115,-0.121,0.059,-0.084,-0.003,Q6P542,Abcf1,Q6P542_Abcf1,Q6P542,Abcf1,1,59,25,25,Q6P542,MOUSE,95400.1,35.2,385,385.1,326.64,326.64,,837,ATP-binding cassette sub-family F member 1,nuclear envelope|nucleoplasm|cytoplasm|membrane|polysomal ribosome|,translational initiation|positive regulation of translation|ribosome biogenesis|,ATP binding|translation activator activity|ATPase activity|ribosome binding|poly(A) RNA binding|,25,59,11400000000,35.2%
Q9R1S7,0.734493028,0.007,4.017745078,-0.104,0.396483841,-0.906231533,0.208,0.114,-0.145,-0.017,-0.005,-0.113,Q9R1S7,Abcc6,Q9R1S7_Abcc6,Q9R1S7,Abcc6,1,69,27,27,Q9R1S7,MOUSE,166566,24.2,386,386.1,324.88,324.88,,1498,Multidrug resistance-associated protein 6,nucleus|plasma membrane|integral component of membrane|basolateral plasma membrane|apical plasma membrane|lateral plasma membrane|,metabolic process|transmembrane transport|,"ATP binding|ATPase activity, coupled to transmembrane movement of substances|",27,69,28200000000,24.2%
O88451,0.914318415,-0.030666667,1.336742904,0.062666667,0.735064941,0.352993749,-0.211,0.13,-0.105,-0.348,0.255,0.095,O88451,Rdh7,O88451_Rdh7,O88451,Rdh7,1,103,20,9,O88451|G5E8H9,MOUSE,36116,58.2,387,387.1,324.64,152.82,,316,Retinol dehydrogenase 7,endoplasmic reticulum|,retinol metabolic process|oxidation-reduction process|,catalytic activity|retinol dehydrogenase activity|,20,103,91300000000,58.2%
Q9R092,0.491580536,-0.039333333,8.373805324,0.155333333,0.145418435,1.647337461,-0.146,0.013,-0.218,-0.005,0.058,0.062,Q9R092,Hsd17b6,Q9R092_Hsd17b6,Q9R092,Hsd17b6,1,14,14,6,Q9R092,MOUSE,36444.3,42.2,387,387.2,197.95,68.11,,317,17-beta-hydroxysteroid dehydrogenase type 6,endoplasmic reticulum|early endosome membrane|,steroid metabolic process|oxidation-reduction process|,estradiol 17-beta-dehydrogenase activity|retinol dehydrogenase activity|testosterone dehydrogenase (NAD+) activity|,6,14,32600000000,19.8%
Q8K3M1,0.836873322,-0.0175,2.574326449,0.089666667,0.552799135,0.625155865,-0.181,0.049,-0.055,-0.255,0.194,0.143,Q8K3M1,Rdh16f2,Q8K3M1_Rdh16f2,Q8K3M1,Rdh16f2,1,37,13,10,Q8K3M1,MOUSE,36323.5,46.2,387,387.3,202.33,157.8,,318,Cis-retinol/3alpha hydroxysterol short-chain dehydrogenase-like protein,,oxidation-reduction process|,oxidoreductase activity|,10,37,5320000000,41.5%
O54909,0.513922711,-0.037666667,7.95986466,0.348666667,0.159960788,1.582669248,-0.039,0.059,-0.656,-0.067,0.415,0.062,O54909,Rdh16,O54909_Rdh16,O54909,Rdh16,1,17,13,4,O54909|Q8K5C8|Q6PHA1|D6RFQ4,MOUSE,36142.3,40.6,387,387.4,201.69,68.47,,317,Cis-retinol androgen dehydrogenase 1,endoplasmic reticulum lumen|integral component of organelle membrane|,9-cis-retinoic acid biosynthetic process|oxidation-reduction process|,retinol dehydrogenase activity|protein homodimerization activity|,4,17,3640000000,21.7%
A2AI,0.949474693,-0.013333333,0.770115239,0.02,0.837507059,0.213210875,-0.011,0.09,-0.149,-0.019,-0.014,0.023,A2AI,NotFound,A2AI_NotFound,A2AI,Sec16a,1,53,27,27,A2AI|E9QAT4,MOUSE,257837.3,17.4,388,388.1,323.99,323.99,,2377,Protein transport protein sec16,Golgi membrane|cytoplasm|Golgi apparatus|cytosol|,endoplasmic reticulum organization|COPII vesicle coating|,,27,53,22400000000,17.4%
Q8BG32,0.787001391,0.009333333,3.305299505,0.097333333,0.467164733,0.771295584,0.163,-0.11,-0.171,0.215,0.002,-0.043,Q8BG32,Psmd11,Q8BG32_Psmd11,Q8BG32,Psmd11,1,81,25,25,Q8BG32|G3UYL3|G3UYI4,MOUSE,47721.2,52.3,389,389.1,323.49,323.49,,422,26S proteasome non-ATPase regulatory subunit 11,proteasome complex|nucleus|proteasome regulatory particle|membrane|proteasome accessory complex|extracellular exosome|,ubiquitin-dependent protein catabolic process|proteasome assembly|stem cell differentiation|,protein binding|,25,81,21400000000,52.3%
P80314,0.811929773,-0.023,2.91563517,0.070666667,0.511018335,0.694021789,-0.072,0.099,-0.202,0.011,0.016,0.01,P80314,Cct2,P80314_Cct2,P80314,Cct2,1,63,23,23,P80314|A0A1W2P6Q3,MOUSE,57818.6,53.8,390,390.1,322.42,322.42,,535,T-complex protein 1 subunit beta,zona pellucida receptor complex|cytoplasm|chaperonin-containing T-complex|microtubule|myelin sheath|cell body|extracellular exosome|,protein folding|binding of sperm to zona pellucida|chaperone-mediated protein complex assembly|toxin transport|,ATP binding|ubiquitin protein ligase binding|unfolded protein binding|,23,63,17600000000,53.8%
A0A0R4J0P1,0.550154827,0.043833333,7.296236247,-0.277,0.186370159,-1.474040079,0.144,0.573,-0.17,-0.132,0.006,-0.158,A0A0R4J0P1,Acad8,A0A0R4J0P1_Acad8,A0A0R4J0P1,Acad8,1,101,24,24,A0A0R4J0P1|Q9D7B6|D3YTT4,MOUSE,45889.8,58.1,391,391.1,321.42,321.42,,413,"Acyl-Coenzyme A dehydrogenase family, member 8",,,,24,101,57000000000,58.1%
E9QAS5,0.977113723,-0.0065,0.349814986,-0.011,0.92261073,-0.100875151,0.055,0.128,-0.186,0.056,-0.05,-0.042,E9QAS5,Chd4,E9QAS5_Chd4,E9QAS5,Chd4,1,45,29,21,E9QAS5|Q6PDQ2|E9QAS4|B1AR17|E9Q614,MOUSE,220170.7,19.3,392,392.1,319.47,217.29,,1922,Chromodomain-helicase-DNA-binding protein 4,nuclear chromatin|nucleus|nucleoplasm|cytoplasm|centrosome|membrane|NuRD complex|protein complex|,"regulation of transcription, DNA-templated|metabolic process|ATP-dependent chromatin remodeling|spindle assembly|",RNA polymerase II repressing transcription factor binding|protein binding|ATP binding|microtubule binding|ATP-dependent helicase activity|transcription factor binding|zinc ion binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|,29,45,6570000000,19.3%
E9Q3Y4,0.963376742,-0.005166667,0.499337168,-0.012333333,0.891386974,-0.141829021,-0.032,0.014,0.021,0.07,-0.106,0.002,E9Q3Y4,Lrba,E9Q3Y4_Lrba,E9Q3Y4,Lrba,1,44,25,25,E9Q3Y4|Q9ESE1|A0A0A6YXL6|Q9ESE1-2|A0A0A6YXX3|Q9ESE1-3|Q8BSM6|Q9EPN1|Q9EPN1-4|Q9EPN1-3|Q9EPN1-2,MOUSE,319662.1,11.8,393,393.1,319.18,319.18,,2854,Lipopolysaccharide-responsive and beige-like anchor protein,endomembrane system|membrane|cytoplasmic membrane-bounded vesicle|extrinsic component of membrane|,signal transduction|protein localization|endosomal transport|,phospholipid binding|protein kinase A binding|,25,44,3460000000,11.8%
O88986,0.980422173,-0.0125,0.300749082,0.009,0.933093345,0.087163078,-0.001,0.129,-0.179,-0.014,0.014,-0.024,O88986,Gcat,O88986_Gcat,O88986,Gcat,1,99,22,22,O88986|E9PWY6,MOUSE,45500.3,56.7,394,394.1,318.82,318.82,,416,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial",nucleoplasm|mitochondrion|,biosynthetic process|L-threonine catabolic process to glycine|,glycine C-acetyltransferase activity|pyridoxal phosphate binding|,22,99,70700000000,56.7%
Q8VI47,0.658684581,-0.001166667,5.201521405,-0.201,0.301889397,-1.119518576,0.365,0.192,-0.259,-0.014,0.003,-0.294,Q8VI47,Abcc2,Q8VI47_Abcc2,Q8VI47,Abcc2,1,64,26,26,Q8VI47,MOUSE,174980.3,22.8,395,395.1,318.74,318.74,,1543,Canalicular multispecific organic anion transporter 1,integral component of plasma membrane|cell surface|apical plasma membrane|,drug transmembrane transport|response to oxidative stress|metabolic process|response to heat|prostaglandin transport|cellular chloride ion homeostasis|response to methotrexate|response to estrogen|response to arsenic-containing substance|thyroid hormone transport|,"ATP binding|organic anion transmembrane transporter activity|protein domain specific binding|ATPase activity, coupled to transmembrane movement of substances|",26,64,23800000000,22.8%
Q9DD20,0.891701906,-0.009,1.731905727,-0.066666667,0.671134288,-0.444084209,0.265,0.071,-0.263,0.065,-0.037,-0.155,Q9DD20,Mettl7b,Q9DD20_Mettl7b,Q9DD20,Mettl7b,1,157,21,21,Q9DD20,MOUSE,28504.9,80.3,396,396.1,318.56,318.56,,244,Methyltransferase-like protein 7B,,methylation|,S-adenosylmethionine-dependent methyltransferase activity|,21,157,6.65E+11,80.3%
Q91VA0,0.847271066,-0.004666667,2.390697538,-0.068666667,0.576673834,-0.586920428,0.036,0.222,-0.169,-0.075,-0.038,-0.004,Q91VA0,Acsm1,Q91VA0_Acsm1,Q91VA0,Acsm1,1,70,21,21,Q91VA0|Q91VA0-2,MOUSE,65558,52.3,397,397.1,318.27,318.27,,573,"Acyl-coenzyme A synthetase ACSM1, mitochondrial",mitochondrion|mitochondrial matrix|extracellular exosome|blood microparticle|,fatty acid biosynthetic process|,acyl-CoA ligase activity|ATP binding|GTP binding|fatty acid ligase activity|metal ion binding|butyrate-CoA ligase activity|,21,70,30500000000,52.3%
A0A0R4J0I1,0.050597974,0.063666667,23.5822938,1.047333333,0.004382991,4.235232406,-0.526,-0.16,-0.694,0.62,0.124,1.018,A0A0R4J0I1,Serpina3k,A0A0R4J0I1_Serpina3k,A0A0R4J0I1,Serpina3k,1,80,21,13,A0A0R4J0I1|P07759,MOUSE,46900.1,50.9,398,398.1,317.71,206.81,,418,MCG1051009,,,,21,80,58200000000,50.9%
Q03734,0.773512169,0.121333333,3.50432338,-0.183333333,0.446239142,-0.809695959,-0.054,-0.023,0.716,0.236,-0.009,-0.138,Q03734,Serpina3m,Q03734_Serpina3m,Q03734,Serpina3m,1,3,11,3,Q03734,MOUSE,47234.5,28.4,398,398.2,149.14,38.24,,418,Serine protease inhibitor A3M,extracellular space|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,3,3,298000000,7.1%
Q91WP6,0.935669179,0.091,0.923086747,-0.085333333,0.808521039,-0.252221299,-0.288,-0.242,0.931,0.205,-0.24,0.18,Q91WP6,NotFound,Q91WP6_NotFound,Q91WP6,Serpina3n,1,4,6,4,Q91WP6|G3X8T9|Q5I2A0|F2Z405|Q80X76,MOUSE,46888.3,14.5,398,398.3,56.5,28.87,,418,Serine protease inhibitor A3N,extracellular region|extracellular space|extracellular exosome|blood microparticle|,acute-phase response|negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,4,4,115000000,11.0%
E9PV41,0.868452057,-0.015833333,2.117185641,-0.050333333,0.61415987,-0.52857042,0.049,0.091,-0.112,0.037,-0.065,-0.095,E9PV41,Diaph1,E9PV41_Diaph1,E9PV41,Diaph1,1,54,28,28,E9PV41|O08808|E9PXV7|F6XC54|D3Z074,MOUSE,141197.9,26.9,399,399.1,317.48,317.48,,1264,Protein diaphanous homolog 1,ruffle membrane|mitotic spindle|,cytoskeleton organization|regulation of cell shape|actin cytoskeleton organization|actin filament polymerization|regulation of microtubule-based process|protein localization to microtubule|regulation of release of sequestered calcium ion into cytosol|cellular response to histamine|,actin binding|protein binding|profilin binding|Rho GTPase binding|ion channel binding|poly(A) RNA binding|,28,54,11700000000,26.9%
P35564,0.000307098,-0.469666667,54.41290236,2.483333333,3.62001E-06,14.02101688,-1.524,-1.49,-2.12,0.779,0.81,0.727,P35564,Canx,P35564_Canx,P35564,Canx,1,67,22,22,P35564,MOUSE,67676.1,42.1,400,400.1,315.74,315.74,,591,Calnexin,endoplasmic reticulum|endoplasmic reticulum membrane|smooth endoplasmic reticulum|rough endoplasmic reticulum|ribosome|membrane|integral component of membrane|axon|dendrite cytoplasm|melanosome|neuronal cell body|dendritic spine|myelin sheath|protein complex|ER-mitochondrion membrane contact site|extracellular exosome|integral component of lumenal side of endoplasmic reticulum membrane|,aging|synaptic vesicle endocytosis|chaperone-mediated protein folding|clathrin-mediated endocytosis|,glycoprotein binding|calcium ion binding|protein binding|carbohydrate binding|apolipoprotein binding|ionotropic glutamate receptor binding|poly(A) RNA binding|unfolded protein binding|,22,67,42200000000,42.1%
P31230,0.82738711,-0.005,2.663785256,-0.056666667,0.541528695,-0.643123974,0.074,0.04,-0.044,0.047,-0.108,-0.039,P31230,NotFound,P31230_NotFound,P31230,Aimp1,1,66,21,21,P31230|Q3UZG4,MOUSE,34339,75.1,401,401.1,314.55,314.55,,310,Aminoacyl tRNA synthase complex-interacting multifunctional protein 1,extracellular space|nucleus|cytoplasm|endoplasmic reticulum|Golgi apparatus|cytosol|cell surface|membrane|aminoacyl-tRNA synthetase multienzyme complex|transport vesicle|,angiogenesis|negative regulation of endothelial cell proliferation|glucose metabolic process|translation|apoptotic process|inflammatory response|cell adhesion|cell-cell signaling|leukocyte migration|,tRNA binding|cytokine activity|protein homodimerization activity|GTPase binding|,21,66,27600000000,75.1%
Q9Z2Z6,0.415494862,-0.006666667,10.0742259,-0.293333333,0.098305408,-1.92295216,-0.018,0.383,0.055,-0.388,-0.023,-0.049,Q9Z2Z6,Slc25a20,Q9Z2Z6_Slc25a20,Q9Z2Z6,Slc25a20,1,87,23,23,Q9Z2Z6,MOUSE,33368.5,79,402,402.1,312.42,312.42,,301,Mitochondrial carnitine/acylcarnitine carrier protein,cytoplasm|mitochondrion|mitochondrial inner membrane|integral component of membrane|,transport|,,23,87,1.23E+11,79.0%
Q9WUR2,0.884566234,-0.0075,1.848188457,-0.070333333,0.653403045,-0.470059563,0.128,0.235,-0.28,-0.078,0.064,-0.114,Q9WUR2,Eci2,Q9WUR2_Eci2,Q9WUR2,Eci2,1,103,20,15,Q9WUR2|Q3TCD4|Q9WUR2-2,MOUSE,43666.3,47.3,403,403.1,312.39,221.59,,391,"Enoyl-CoA delta isomerase 2, mitochondrial",nucleoplasm|mitochondrion|peroxisome|peroxisomal matrix|membrane|intracellular membrane-bounded organelle|,fatty acid beta-oxidation|fatty acid catabolic process|,fatty-acyl-CoA binding|dodecenoyl-CoA delta-isomerase activity|receptor binding|,20,103,82800000000,47.3%
Q78JN3,0.667069025,-0.001,5.047017578,0.300666667,0.312822687,1.092374204,0.249,-0.188,-0.515,0.651,-0.211,0.008,Q78JN3,Eci3,Q78JN3_Eci3,Q78JN3,Eci3,1,2,7,2,Q78JN3,MOUSE,35401,27.1,403,403.2,111.59,20.79,,317,"Enoyl-CoA delta isomerase 3, peroxisomal",peroxisome|,fatty acid beta-oxidation|,fatty-acyl-CoA binding|dodecenoyl-CoA delta-isomerase activity|,2,2,364000000,11.6%
Q8BRF7,0.919618833,0.002833333,1.172629675,-0.026333333,0.763373417,-0.3135897,0.068,-0.009,-0.011,0.063,-0.056,-0.038,Q8BRF7,Scfd1,Q8BRF7_Scfd1,Q8BRF7,Scfd1,1,85,21,21,Q8BRF7|Q8BRF7-3|Q8BRF7-2,MOUSE,72663.9,45.6,404,404.1,311.87,311.87,,639,Sec1 family domain-containing protein 1,endoplasmic reticulum membrane|Golgi-associated vesicle|cis-Golgi network|plasma membrane|Golgi transport complex|Golgi cisterna membrane|SNARE complex|,"cell morphogenesis|response to hypoxia|retrograde vesicle-mediated transport, Golgi to ER|post-Golgi vesicle-mediated transport|vesicle docking involved in exocytosis|phagocytosis|response to toxic substance|protein transport|regulation of protein transport|regulation of ER to Golgi vesicle-mediated transport|toxin transport|negative regulation of autophagosome assembly|",syntaxin binding|protein N-terminus binding|,21,85,16700000000,45.6%
Q8K0E8,0.906772524,0.128666667,1.505677752,-0.149333333,0.707020856,-0.39249735,-0.182,-0.339,1.131,0.124,-0.168,0.206,Q8K0E8,Fgb,Q8K0E8_Fgb,Q8K0E8,Fgb,1,77,24,24,Q8K0E8|F1MAV0|P02676,MOUSE,55436.4,48.4,405,405.1,311.61,311.61,,481,Fibrinogen beta chain,fibrinogen complex|extracellular space|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|extracellular vesicle|,"cell-matrix adhesion|signal transduction|plasminogen activation|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|induction of bacterial agglutination|cellular protein complex assembly|cellular response to leptin stimulus|innate immune response|positive regulation of vasoconstriction|positive regulation of exocytosis|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|cellular response to interleukin-1|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of endothelial cell apoptotic process|","structural molecule activity|protein binding, bridging|chaperone binding|receptor binding|cell adhesion molecule binding|",25,77,26600000000,48.4%
Q9DBW0,0.919416995,-0.061666667,1.225060893,0.050666667,0.754212821,0.326378738,0.067,0.09,-0.418,0.025,0.011,-0.145,Q9DBW0,Cyp4v3,Q9DBW0_Cyp4v3,Q9DBW0,Cyp4v2,1,84,24,24,Q9DBW0|A0A1C7CYU8,MOUSE,61393.8,43,406,406.1,310.97,310.97,,525,Cytochrome P450 4V2,endoplasmic reticulum membrane|integral component of membrane|,fatty acid omega-oxidation|,"monooxygenase activity|iron ion binding|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen|heme binding|",24,84,42300000000,43.0%
P68040,0.305921134,0.015833333,12.63432616,-0.199666667,0.054521448,-2.326431103,0.029,0.138,0.18,-0.048,-0.076,-0.128,P68040,Rack1,P68040_Rack1,P68040,Rack1,1,90,22,22,P68040,MOUSE,35532.5,74.7,407,407.1,310.23,310.23,,317,Receptor of activated protein C kinase 1,phagocytic cup|nucleus|cytoplasm|mitochondrion|cytosol|cytoskeleton|dendrite|midbody|neuron projection|neuronal cell body|perikaryon|cell body|perinuclear region of cytoplasm|extracellular exosome|IRE1-RACK1-PP2A complex|,positive regulation of protein phosphorylation|regulation of translation|activation of cysteine-type endopeptidase activity involved in apoptotic process|cell cycle|gastrulation|protein localization|negative regulation of gene expression|negative regulation of Wnt signaling pathway|negative regulation of cell growth|positive regulation of cell migration|positive regulation of cAMP catabolic process|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of protein homooligomerization|regulation of protein localization|negative regulation of peptidyl-serine phosphorylation|intracellular signal transduction|positive regulation of apoptotic process|positive regulation of GTPase activity|rhythmic process|negative regulation of phagocytosis|regulation of cell division|positive regulation of cyclic-nucleotide phosphodiesterase activity|regulation of cell cycle|negative regulation of protein kinase B signaling|positive regulation of mitochondrial depolarization|negative regulation of protein tyrosine kinase activity|cellular response to glucose stimulus|negative regulation of hydrogen peroxide-induced neuron death|regulation of establishment of cell polarity|positive regulation of gastrulation|positive regulation of intrinsic apoptotic signaling pathway|,receptor activity|protein kinase C binding|protein binding|ion channel inhibitor activity|cysteine-type endopeptidase activator activity involved in apoptotic process|enzyme binding|protein phosphatase binding|protein tyrosine kinase inhibitor activity|receptor tyrosine kinase binding|signaling adaptor activity|SH2 domain binding|protein homodimerization activity|poly(A) RNA binding|,22,90,54600000000,74.7%
P11725,0.97512547,-0.004166667,0.365453185,0.011,0.919294542,0.105211841,-0.046,0.123,-0.106,-0.117,0.093,0.028,P11725,Otc,P11725_Otc,P11725,Otc,1,97,21,21,P11725|Q8R1A8,MOUSE,39878.3,55.9,408,408.1,310.22,310.22,,354,"Ornithine carbamoyltransferase, mitochondrial",cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial matrix|,urea cycle|liver development|ornithine catabolic process|midgut development|response to zinc ion|citrulline biosynthetic process|response to insulin|arginine biosynthetic process via ornithine|response to drug|protein homotrimerization|response to biotin|ammonia homeostasis|,ornithine carbamoyltransferase activity|phospholipid binding|amino acid binding|phosphate ion binding|,21,97,79300000000,55.9%
Q8CCJ3,0.92990033,-0.002833333,0.99827113,-0.025,0.794644509,-0.270875869,0.074,-0.028,-0.017,0.102,-0.081,-0.067,Q8CCJ3,Ufl1,Q8CCJ3_Ufl1,Q8CCJ3,Ufl1,1,55,22,22,Q8CCJ3|Q8CCJ3-1|Q8CCJ3-2,MOUSE,90089.1,29.8,409,409.1,310.08,310.08,,793,E3 UFM1-protein ligase 1,nucleus|nucleoplasm|cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|cytosol|membrane|neuron projection|protein complex|,osteoblast differentiation|positive regulation of cell proliferation|regulation of gene expression|negative regulation of protein ubiquitination|negative regulation of NF-kappaB transcription factor activity|regulation of proteasomal ubiquitin-dependent protein catabolic process|regulation of protein localization|regulation of intracellular estrogen receptor signaling pathway|response to endoplasmic reticulum stress|positive regulation of glial cell proliferation|protein ufmylation|response to L-glutamate|protein K69-linked ufmylation|,protein binding|ligase activity|UFM1 transferase activity|,22,55,13200000000,29.8%
P62754,0.773512169,-0.023166667,3.513803766,-0.089,0.445266091,-0.811063126,0.018,0.07,-0.024,-0.055,0.096,-0.244,P62754,Rps6,P62754_Rps6,P62754,Rps6,1,124,22,22,P62754,MOUSE,28851.3,51,410,410.1,310.07,310.07,,249,40S ribosomal protein S6,nucleus|nucleolus|cytoplasm|ribosome|polysome|small ribosomal subunit|membrane|cytosolic small ribosomal subunit|dendrite|ribonucleoprotein complex|cytoplasmic ribonucleoprotein granule|cell body|perinuclear region of cytoplasm|,G1/S transition of mitotic cell cycle|placenta development|T cell proliferation involved in immune response|rRNA processing|translation|activation-induced cell death of T cells|mitotic nuclear division|mitotic cell cycle checkpoint|gastrulation|oogenesis stage|TOR signaling|T cell differentiation in thymus|ribosomal small subunit biogenesis|glucose homeostasis|positive regulation of apoptotic process|negative regulation of apoptotic process|erythrocyte development|,structural constituent of ribosome|protein binding|protein kinase binding|poly(A) RNA binding|,22,124,2.19E+11,51.0%
A0A0R4J293,0.779644178,0.042166667,3.401888881,-0.103,0.456889431,-0.789998571,-0.001,-0.074,0.356,0.002,-0.069,0.039,A0A0R4J293,Tgm1,A0A0R4J293_Tgm1,A0A0R4J293,Tgm1,1,66,25,25,A0A0R4J293|Q9JLF6,MOUSE,90706.8,37,411,411.1,309.43,309.43,,815,Protein-glutamine gamma-glutamyltransferase K,,,,25,66,18100000000,37.0%
P61979-2,0.942218886,-0.012,0.836552306,0.025333333,0.824792626,0.230246808,-0.111,-0.007,0.044,-0.18,0.062,0.12,P61979,Hnrnpk,P61979-2_Hnrnpk,P61979-2,Hnrnpk,1,74,22,22,P61979-2|P61979|B2M1R6|P61979-3|H3BLL4|Q8BT23|H3BJ43,MOUSE,51312.6,54.9,412,412.1,308.99,308.99,,463,Isoform 2 of Heterogeneous nuclear ribonucleoprotein K,nuclear chromatin|podosome|nucleoplasm|cytoplasm|focal adhesion|membrane|cell projection|extracellular exosome|catalytic step 2 spliceosome|,"transcription from RNA polymerase II promoter|mRNA processing|RNA splicing|regulation of low-density lipoprotein particle clearance|positive regulation of low-density lipoprotein particle receptor biosynthetic process|positive regulation of transcription from RNA polymerase II promoter|negative regulation of mRNA splicing, via spliceosome|positive regulation of receptor-mediated endocytosis|regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter|regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator|",RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|RNA binding|protein binding|poly(A) RNA binding|,22,74,41700000000,54.9%
P55302,4.99445E-05,-0.3035,71.10607207,2.130333333,7.75163E-08,24.76946037,-1.361,-1.289,-1.456,0.728,0.775,0.782,P55302,Lrpap1,P55302_Lrpap1,P55302,Lrpap1,1,81,25,25,P55302,MOUSE,42214.3,50,413,413.1,308.67,308.67,,360,Alpha-2-macroglobulin receptor-associated protein,extracellular region|endoplasmic reticulum|plasma membrane|cell surface|vesicle|rough endoplasmic reticulum lumen|,negative regulation of very-low-density lipoprotein particle clearance|negative regulation of protein binding|extracellular negative regulation of signal transduction|negative regulation of beta-amyloid clearance|,heparin binding|lipase binding|receptor antagonist activity|low-density lipoprotein particle receptor binding|very-low-density lipoprotein particle receptor binding|,25,81,30500000000,50.0%
P38060,0.884484678,-0.033833333,1.872618181,-0.070333333,0.649737872,-0.475472584,0.042,0.137,-0.175,-0.273,0.186,-0.12,P38060,Hmgcl,P38060_Hmgcl,P38060,Hmgcl,1,96,18,18,P38060,MOUSE,34694.7,59.6,414,414.1,308.41,308.41,,325,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial matrix|peroxisome|,liver development|acyl-CoA metabolic process|mitochondrion organization|response to nutrient|response to starvation|ketone body biosynthetic process|protein tetramerization|response to fatty acid|,fatty-acyl-CoA binding|magnesium ion binding|hydroxymethylglutaryl-CoA lyase activity|receptor binding|manganese ion binding|carboxylic acid binding|protein homodimerization activity|metal ion binding|,18,96,52100000000,59.6%
Q8JZU2,0.513922711,-0.001666667,7.964366845,-0.23,0.159795048,-1.583402119,0.161,0.336,-0.157,-0.238,-0.003,-0.109,Q8JZU2,Slc25a1,Q8JZU2_Slc25a1,Q8JZU2,Slc25a1,1,75,23,23,Q8JZU2,MOUSE,34273.2,71.3,415,415.1,308.05,308.05,,311,"Tricarboxylate transport protein, mitochondrial",nucleus|mitochondrion|mitochondrial inner membrane|integral component of membrane|extracellular exosome|,transmembrane transport|,,23,75,52200000000,71.3%
Q9WVD5,0.306010717,0.030166667,12.61781239,-0.370333333,0.054729157,-2.329397115,0.348,0.391,-0.093,-0.153,0.003,-0.315,Q9WVD5,Slc25a15,Q9WVD5_Slc25a15,Q9WVD5,Slc25a15,1,121,19,19,Q9WVD5,MOUSE,33336.2,73,416,416.1,307.59,307.59,,301,Mitochondrial ornithine transporter 1,mitochondrion|mitochondrial inner membrane|integral component of membrane|,transport|,,19,121,1.63E+11,73.0%
P48776,0.744748173,-0.061833333,3.899113174,-0.207,0.407463473,-0.884380602,0.191,0.342,-0.408,-0.069,0.068,-0.495,P48776,Tdo2,P48776_Tdo2,P48776,Tdo2,1,82,22,22,P48776|C5NSA7,MOUSE,47926.7,50.7,417,417.1,307.41,307.41,,406,"Tryptophan 2,3-dioxygenase",,tryptophan catabolic process to kynurenine|tryptophan catabolic process to acetyl-CoA|oxidation-reduction process|,"tryptophan 2,3-dioxygenase activity|amino acid binding|oxygen binding|heme binding|metal ion binding|",22,82,38100000000,50.7%
P19324,0.190353342,-0.009666667,16.28802639,0.343333333,0.023507008,2.926898269,-0.26,-0.241,-0.043,0.064,0.076,0.346,P19324,Serpinh1,P19324_Serpinh1,P19324,Serpinh1,1,64,19,19,P19324,MOUSE,46646.9,57.3,418,418.1,307.33,307.33,,417,Serpin H1,cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|membrane raft|extracellular exosome|extracellular space|,chondrocyte development involved in endochondral bone morphogenesis|negative regulation of endopeptidase activity|collagen fibril organization|collagen biosynthetic process|protein maturation|,serine-type endopeptidase inhibitor activity|protein binding|collagen binding|poly(A) RNA binding|unfolded protein binding|,19,64,94000000000,57.3%
Q921F2,0.57548373,-0.004833333,6.877726742,-0.155666667,0.205223611,-1.403658882,0.157,0.191,-0.129,-0.079,-0.044,-0.125,Q921F2,Tardbp,Q921F2_Tardbp,Q921F2,Tardbp,1,57,20,20,Q921F2|Q6VYI5|Q6VYI4|Q8BLD4|Q8R0B4|A0A087WRZ5|A0A087WP57,MOUSE,44946.3,54.5,419,419.1,307.14,307.14,,414,TAR DNA-binding protein 43,nucleus|nucleoplasm|perichromatin fibrils|cytoplasm|nuclear speck|interchromatin granule|,negative regulation of protein phosphorylation|transcription from RNA polymerase II promoter|mRNA processing|RNA splicing|negative regulation of gene expression|nuclear fragmentation involved in apoptotic nuclear change|positive regulation of insulin secretion|response to endoplasmic reticulum stress|negative regulation by host of viral transcription|positive regulation of transcription from RNA polymerase II promoter|regulation of cell cycle|3'-UTR-mediated mRNA stabilization|nuclear inner membrane organization|,nucleotide binding|RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|double-stranded DNA binding|RNA binding|mRNA 3'-UTR binding|protein binding|identical protein binding|poly(A) RNA binding|,20,57,37500000000,54.5%
P17751,0.689880379,0.0015,4.702522194,0.119666667,0.338647427,1.030963928,0.034,-0.083,-0.126,-0.139,0.2,0.123,P17751,Tpi1,P17751_Tpi1,P17751,Tpi1,1,69,18,18,P17751|H7BXC3,MOUSE,32704.7,71.5,420,420.1,307.11,307.11,,299,Triosephosphate isomerase,extracellular space|nucleus|extracellular exosome|,glucose metabolic process|gluconeogenesis|glycolytic process|pentose-phosphate shunt|multicellular organismal development|glyceraldehyde-3-phosphate metabolic process|,triose-phosphate isomerase activity|isomerase activity|ubiquitin protein ligase binding|,18,69,27300000000,71.5%
Q60649,0.91325,-0.009166667,1.371547703,-0.034333333,0.729197599,-0.361027931,0.064,0.09,-0.13,0.017,-0.065,-0.031,Q60649,Clpb,Q60649_Clpb,Q60649,Clpb,1,52,24,24,Q8CCN6|Q60649|E9PY58,MOUSE,76401.7,43.4,421,421.1,306.88,306.88,,677,Caseinolytic peptidase B protein homolog,mitochondrion|,metabolic process|cellular response to heat|,ATP binding|ATPase activity|,24,52,17500000000,43.4%
Q8R2Q4,0.961523652,-0.027333333,0.532395064,-0.022666667,0.884627617,-0.150796919,0.114,0.169,-0.331,0.059,-0.05,-0.125,Q8R2Q4,Gfm2,Q8R2Q4_Gfm2,Q8R2Q4,Gfm2,1,63,21,21,Q8R2Q4|Q8R2Q4-2|Q8R2Q4-3|E9Q7N5|Q8C1C2,MOUSE,86905.9,37.2,422,422.1,305.74,305.74,,779,"Ribosome-releasing factor 2, mitochondrial",mitochondrion|,mitochondrial translation|ribosome disassembly|,GTPase activity|GTP binding|,21,63,11800000000,37.2%
P13439,0.648073376,-0.028166667,5.350056973,0.156333333,0.291738874,1.145454597,0.068,-0.049,-0.338,0.206,0.018,-0.074,P13439,Umps,P13439_Umps,P13439,Umps,1,62,22,22,P13439|D6RJ62,MOUSE,52805,60.7,423,423.1,305.72,305.72,,481,Uridine 5'-monophosphate synthase,nucleus|cytoplasm|,'de novo' pyrimidine nucleobase biosynthetic process|UMP biosynthetic process|female pregnancy|lactation|cellular response to drug|'de novo' UMP biosynthetic process|,orotate phosphoribosyltransferase activity|orotidine-5'-phosphate decarboxylase activity|,22,62,30200000000,60.7%
Q8BFP9,0.963376742,-0.035,0.496373496,-0.025333333,0.891995473,-0.141090488,0.258,0.101,-0.426,0.01,-0.049,-0.104,Q8BFP9,Pdk1,Q8BFP9_Pdk1,Q8BFP9,Pdk1,1,67,22,19,Q8BFP9,MOUSE,49336.5,56.4,424,424.1,305.23,275.4,,434,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",mitochondrion|plasma membrane|mitochondrial pyruvate dehydrogenase complex|,glucose metabolic process|protein phosphorylation|cell proliferation|intrinsic apoptotic signaling pathway in response to oxidative stress|regulation of acetyl-CoA biosynthetic process from pyruvate|regulation of glucose metabolic process|intracellular signal transduction|hypoxia-inducible factor-1alpha signaling pathway|activation of mitophagy in response to mitochondrial depolarization|,protein kinase activity|pyruvate dehydrogenase (acetyl-transferring) kinase activity|ATP binding|,22,67,20900000000,56.4%
Q9JK42,0.773512169,-0.012,3.534829023,-0.167333333,0.443115659,-0.815535401,0.402,0.185,-0.372,-0.059,0.028,-0.256,Q9JK42,Pdk2,Q9JK42_Pdk2,Q9JK42,Pdk2,1,24,10,7,Q9JK42,MOUSE,46268,31.6,424,424.2,136.25,106.42,,407,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial",nucleoplasm|cytoplasm|mitochondrion|mitochondrial pyruvate dehydrogenase complex|,glucose metabolic process|regulation of gluconeogenesis|protein phosphorylation|regulation of pH|insulin receptor signaling pathway|regulation of acetyl-CoA biosynthetic process from pyruvate|regulation of cellular ketone metabolic process|regulation of glucose metabolic process|cellular response to nutrient|cellular response to reactive oxygen species|glucose homeostasis|intrinsic apoptotic signaling pathway by p53 class mediator|,pyruvate dehydrogenase (acetyl-transferring) kinase activity|protein binding|ATP binding|protein homodimerization activity|,7,24,3700000000,27.7%
P42227,0.522251937,0.121833333,7.773080737,-0.371,0.166990562,-1.552219107,0.039,0.002,0.881,-0.015,-0.167,-0.009,P42227,Stat3,P42227_Stat3,P42227,Stat3,1,43,20,20,P42227|B7ZC18|P42227-2|P42227-3,MOUSE,88851,39.6,425,425.1,304.64,304.64,,770,Signal transducer and activator of transcription 3,nuclear chromatin|nucleus|nucleoplasm|cytoplasm|mitochondrial inner membrane|cytosol|plasma membrane|,"temperature homeostasis|eye photoreceptor cell differentiation|regulation of transcription, DNA-templated|transcription from RNA polymerase II promoter|protein import into nucleus|acute-phase response|JAK-STAT cascade|aging|cell proliferation|negative regulation of cell proliferation|negative regulation of hydrogen peroxide biosynthetic process|phosphorylation|cytokine-mediated signaling pathway|stem cell maintenance|sexual reproduction|intracellular receptor signaling pathway|response to estradiol|cellular response to hormone stimulus|regulation of multicellular organism growth|response to drug|glucose homeostasis|eating behavior|negative regulation of apoptotic process|response to ethanol|positive regulation of Notch signaling pathway|negative regulation of glycolytic process|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|regulation of mitochondrial membrane permeability|astrocyte differentiation|radial glial cell differentiation|growth hormone receptor signaling pathway|JAK-STAT cascade involved in growth hormone signaling pathway|interleukin-6-mediated signaling pathway|negative regulation of neuron death|positive regulation of growth factor dependent skeletal muscle satellite cell proliferation|positive regulation of ATP biosynthetic process|negative regulation of neuron migration|",RNA polymerase II core promoter proximal region sequence-specific DNA binding|sequence-specific DNA binding RNA polymerase II transcription factor activity|RNA polymerase II repressing transcription factor binding|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|DNA binding|signal transducer activity|ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity|protein binding|transcription factor binding|protein kinase binding|protein phosphatase binding|CCR5 chemokine receptor binding|glucocorticoid receptor binding|sequence-specific DNA binding|transcription regulatory region DNA binding|protein dimerization activity|,20,43,7100000000,39.6%
Q61586,0.911411213,-0.020666667,1.430174189,-0.040666667,0.719420123,-0.374808136,0.081,0.089,-0.171,0.051,-0.046,-0.128,Q61586,Gpam,Q61586_Gpam,Q61586,Gpam,1,61,21,21,Q61586,MOUSE,94729.8,34.3,426,426.1,304.63,304.63,,827,"Glycerol-3-phosphate acyltransferase 1, mitochondrial",mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|plasma membrane|integral component of membrane|,fatty acid metabolic process|acyl-CoA metabolic process|triglyceride metabolic process|glycerophospholipid metabolic process|response to glucose|CDP-diacylglycerol biosynthetic process|triglyceride biosynthetic process|positive regulation of multicellular organism growth|positive regulation of activated T cell proliferation|regulation of cytokine secretion|defense response to virus|fatty acid homeostasis|phospholipid homeostasis|negative regulation of activation-induced cell death of T cells|interleukin-2 secretion|,glycerol-3-phosphate O-acyltransferase activity|,21,61,12000000000,34.3%
O35452,0.042592507,-0.043333333,24.47228769,0.539333333,0.003570847,4.409662864,-0.324,-0.122,-0.493,0.129,0.34,0.21,O35452,NotFound,O35452_NotFound,O35452,Tnxb,1,47,31,31,O35452|E9Q2T3,MOUSE,442488.3,9.2,427,427.1,303.71,303.71,,4006,Tenascin X,extracellular region|proteinaceous extracellular matrix|extracellular space|intracellular|extracellular exosome|fibrillar collagen trimer|extracellular matrix|,lipid metabolic process|fatty acid metabolic process|triglyceride metabolic process|cell-matrix adhesion|single organismal cell-cell adhesion|extracellular matrix organization|collagen fibril organization|collagen metabolic process|extracellular fibril organization|regulation of JUN kinase activity|elastic fiber assembly|phospholipid metabolic process|positive regulation of cell adhesion|,collagen binding|heparin binding|,31,47,2340000000,9.2%
Q60766-2,0.764377317,-0.0055,3.650117124,-0.096333333,0.431507439,-0.837299037,0.157,-0.044,0.015,0.119,-0.075,-0.205,Q60766,Irgm1,Q60766-2_Irgm1,Q60766-2,Irgm1,1,63,22,22,Q60766-2|Q60766,MOUSE,45400.6,64.1,428,428.1,303.39,303.39,,409,Isoform 2 of Immunity-related GTPase family M protein 1,Golgi membrane|autophagosome membrane|phagocytic cup|lysosome|lysosomal membrane|late endosome|endoplasmic reticulum|phagocytic vesicle membrane|late endosome membrane|cell projection|,autophagy|defense response|innate immune response|,GTP binding|hydrolase activity|,22,63,29000000000,64.1%
Q9JJ28,0.841746758,-0.009666667,2.501758466,-0.053333333,0.562113678,-0.609784743,0.054,0.058,-0.061,0.039,-0.056,-0.092,Q9JJ28,Flii,Q9JJ28_Flii,Q9JJ28,Flii,1,50,24,24,Q9JJ28,MOUSE,146226.9,28.9,429,429.1,303.38,303.38,,1271,Protein flightless-1 homolog,nucleoplasm|cytoplasm|microtubule organizing center|brush border|focal adhesion|,"transcription, DNA-templated|regulation of transcription, DNA-templated|multicellular organismal development|actin cytoskeleton organization|actin filament severing|",actin binding|protein binding|,24,50,9590000000,28.9%
A2A839,0.985313675,-0.015166667,0.233272076,0.009666667,0.947704172,0.068116865,0.023,0.22,-0.303,-0.059,0.016,0.012,A2A839,NotFound,A2A839_NotFound,A2A839,Epb41,1,62,22,21,A2A839|A2A841|P48193|P48193-2|A2A842|Q9Z2H5|A2AUK5,MOUSE,72879.1,39.5,430,430.1,303.1,288.57,,639,Protein 4.1,nucleus|Golgi apparatus|plasma membrane|actin cytoskeleton|membrane|extrinsic component of membrane|cortical cytoskeleton|intracellular membrane-bounded organelle|protein complex|,regulation of cell shape|actin cytoskeleton organization|cortical actin cytoskeleton organization|positive regulation of protein binding|,actin binding|structural molecule activity|1-phosphatidylinositol binding|spectrin binding|,22,62,19000000000,39.5%
Q811U4,0.928683702,-0.021833333,1.031131896,0.029,0.788654545,0.279031135,0.049,0.023,-0.181,0.094,-0.02,-0.096,Q811U4,Mfn1,Q811U4_Mfn1,Q811U4,Mfn1,1,49,24,24,Q811U4,MOUSE,84580.2,38.8,431,431.1,303,303,,741,Mitofusin-1,mitochondrion|mitochondrial outer membrane|integral component of membrane|,multicellular organismal development|mitochondrial fusion|metabolic process|,GTPase activity|protein binding|GTP binding|,24,49,18300000000,38.8%
Q9CWK8,0.436783765,-0.001,9.650799194,-0.194,0.108372747,-1.852441685,-0.018,0.133,0.173,-0.242,-0.038,-0.014,Q9CWK8,Snx2,Q9CWK8_Snx2,Q9CWK8,Snx2,1,75,21,19,Q9CWK8,MOUSE,58584.2,40.4,432,432.1,301.77,276.74,,519,Sorting nexin-2,cytoplasm|endosome|endosome membrane|membrane|extrinsic component of membrane|lamellipodium|retromer complex|early endosome membrane|intracellular membrane-bounded organelle|protein complex|extracellular exosome|,"intracellular protein transport|endocytosis|vesicle organization|early endosome to Golgi transport|retrograde transport, endosome to Golgi|protein oligomerization|lamellipodium morphogenesis|",epidermal growth factor receptor binding|insulin receptor binding|phosphatidylinositol binding|transferrin receptor binding|leptin receptor binding|,21,75,52100000000,40.4%
Q9WV80,0.884566234,0.01,1.846344816,-0.04,0.653680483,-0.469401143,-0.002,-0.033,0.125,-0.025,-0.007,0.002,Q9WV80,Snx1,Q9WV80_Snx1,Q9WV80,Snx1,1,11,10,8,Q9WV80|Q6NZD2,MOUSE,59065.2,20.6,432,432.2,127.5,102.47,,522,Sorting nexin-1,cytoplasm|endosome|Golgi apparatus|endosome membrane|membrane|extrinsic component of membrane|lamellipodium|retromer complex|early endosome membrane|intracellular membrane-bounded organelle|protein complex|,"intracellular protein transport|endocytosis|vesicle organization|receptor internalization|early endosome to Golgi transport|retrograde transport, endosome to Golgi|lamellipodium morphogenesis|",epidermal growth factor receptor binding|insulin receptor binding|phosphatidylinositol binding|identical protein binding|transferrin receptor binding|leptin receptor binding|,8,11,1630000000,16.6%
Q8QZY1,0.815369272,-0.175166667,2.871223866,-0.266333333,0.516270861,-0.685560981,-0.778,0.279,0.373,-0.938,-0.116,0.129,Q8QZY1,Eif3l,Q8QZY1_Eif3l,Q8QZY1,Eif3l,1,69,22,22,Q8QZY1,MOUSE,66839.9,44.6,433,433.1,301.13,301.13,,564,Eukaryotic translation initiation factor 3 subunit L,fibrillar center|nucleoplasm|nucleolus|eukaryotic translation initiation factor 3 complex|membrane|eukaryotic 43S preinitiation complex|eukaryotic 48S preinitiation complex|,formation of translation preinitiation complex|translational initiation|regulation of translational initiation|,poly(A) RNA binding|translation initiation factor activity|,22,69,15900000000,44.6%
P63037,0.87311559,-0.028833333,2.069285305,0.061,0.620971216,0.518462866,0.026,0.083,-0.287,-0.006,0.029,-0.018,P63037,Dnaja1,P63037_Dnaja1,P63037,Dnaja1,1,83,24,24,P63037,MOUSE,45609.1,55.6,434,434.1,301.01,301.01,,397,DnaJ homolog subfamily A member 1,nucleus|mitochondrion|endoplasmic reticulum|cytosol|membrane|perinuclear region of cytoplasm|extracellular exosome|ubiquitin ligase complex|,"spermatogenesis|response to heat|sperm motility|androgen receptor signaling pathway|negative regulation of protein ubiquitination|protein refolding|DNA damage response, detection of DNA damage|positive regulation of apoptotic process|negative regulation of apoptotic process|negative regulation of JUN kinase activity|regulation of protein transport|protein localization to mitochondrion|toxin transport|",G-protein coupled receptor binding|ATP binding|Hsp70 protein binding|ubiquitin protein ligase binding|metal ion binding|low-density lipoprotein particle receptor binding|unfolded protein binding|chaperone binding|C3HC4-type RING finger domain binding|,24,83,30800000000,55.6%
Q8C0C7,0.379681653,0.021833333,10.84778911,-0.196333333,0.082266134,-2.042294246,-0.007,0.184,0.183,-0.004,-0.146,-0.079,Q8C0C7,Farsa,Q8C0C7_Farsa,Q8C0C7,Farsa,1,91,21,21,Q8C0C7|E9PWY9|D6RIJ2,MOUSE,57711.9,43.5,435,435.1,300.94,300.94,,508,Phenylalanine--tRNA ligase alpha subunit,cytoplasm|phenylalanine-tRNA ligase complex|membrane|,phenylalanyl-tRNA aminoacylation|,tRNA binding|phenylalanine-tRNA ligase activity|ATP binding|poly(A) RNA binding|,21,91,64300000000,43.5%
P47856,0.6812202,0.0355,4.848293384,-0.131666667,0.327469353,-1.057196612,-0.005,-0.024,0.333,0.039,-0.133,0.003,P47856,Gfpt1,P47856_Gfpt1,P47856,Gfpt1,1,59,22,22,P47856|P47856-2|Q9Z2Z9|D3YYD9,MOUSE,79336.5,40.6,436,436.1,300.72,300.72,,697,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1,extracellular exosome|,carbohydrate metabolic process|UDP-N-acetylglucosamine biosynthetic process|glutamine metabolic process|circadian regulation of gene expression|,glutamine-fructose-6-phosphate transaminase (isomerizing) activity|carbohydrate binding|,22,59,29800000000,40.6%
A2AS89,0.798949474,-0.114833333,3.08321899,0.169,0.491674971,0.727790298,0.006,0.119,-0.723,0.123,0.006,-0.22,A2AS89,Agmat,A2AS89_Agmat,A2AS89,Agmat,1,101,18,18,A2AS89,MOUSE,38767.7,73.1,437,437.1,300.59,300.59,,358,"Agmatinase, mitochondrial",mitochondrion|extracellular exosome|,spermidine biosynthetic process|putrescine biosynthetic process from arginine|,agmatinase activity|metal ion binding|,18,101,1.51E+11,73.1%
Q9QXD6,0.430679683,-0.006,9.718844079,0.28,0.106688005,1.866135216,-0.212,-0.31,0.084,-0.073,0.333,0.142,Q9QXD6,Fbp1,Q9QXD6_Fbp1,Q9QXD6,Fbp1,1,78,19,19,Q9QXD6|E9Q0T7,MOUSE,37311.2,65,438,438.1,299.34,299.34,,338,"Fructose-1,6-bisphosphatase 1",cytoplasm|cytosol|extracellular exosome|,fructose 6-phosphate metabolic process|gluconeogenesis|regulation of gluconeogenesis|dephosphorylation|negative regulation of cell growth|cellular response to drug|negative regulation of glycolytic process|negative regulation of Ras protein signal transduction|protein homotetramerization|cellular response to magnesium ion|,"AMP binding|fructose 1,6-bisphosphate 1-phosphatase activity|identical protein binding|metal ion binding|monosaccharide binding|",19,78,50800000000,65.0%
P70333,0.111560109,0.005666667,19.3866026,-0.302666667,0.01151701,-3.446207076,0.118,0.109,0.244,-0.176,-0.186,-0.075,P70333,Hnrnph2,P70333_Hnrnph2,P70333,Hnrnph2,1,98,20,8,P70333,MOUSE,49564,51,439,439.1,299.04,145.82,,449,Heterogeneous nuclear ribonucleoprotein H2,nucleoplasm|membrane|ribonucleoprotein complex|,,nucleotide binding|poly(A) RNA binding|,20,98,75400000000,51.0%
Q9Z2,0.915850537,-0.020333333,1.308774396,0.044666667,0.739814025,0.346367066,0.185,-0.066,-0.247,0.091,-0.009,-0.076,Q9Z2,NotFound,Q9Z2_NotFound,Q9Z2,Hnrnpf,1,48,20,17,Q9Z2|Q9Z2-2,MOUSE,46071.4,58,439,439.2,287.45,240.32,,415,Heterogeneous nuclear ribonucleoprotein F,nucleoplasm|membrane|catalytic step 2 spliceosome|,mRNA processing|RNA splicing|regulation of RNA splicing|,nucleotide binding|single-stranded RNA binding|poly(A) RNA binding|,17,48,35300000000,48.6%
Q8C2Q7,0.447044692,0.009833333,9.467400891,-0.159666667,0.113047226,-1.822698933,0.006,0.106,0.157,-0.093,-0.113,-0.004,Q8C2Q7,Hnrnph1,Q8C2Q7_Hnrnph1,Q8C2Q7,Hnrnph1,1,12,20,7,Q8C2Q7|O35737,MOUSE,51502.2,46.6,439,439.3,266.56,89.47,,472,Heterogeneous nuclear ribonucleoprotein H,membrane|catalytic step 2 spliceosome|,regulation of RNA splicing|,nucleotide binding|RNA binding|poly(A) RNA binding|,7,12,4150000000,20.7%
Q91VA7,0.916751802,-0.0335,1.286662072,-0.067,0.743590432,-0.341109881,0.276,0.167,-0.443,-0.01,0.007,-0.198,Q91VA7,Idh3b,Q91VA7_Idh3b,Q91VA7,Idh3b,1,93,21,21,Q91VA7,MOUSE,42479.2,45,440,440.1,299.01,299.01,,384,"Isocitrate dehydrogenase [NAD] subunit, mitochondrial",nucleus|mitochondrion|,tricarboxylic acid cycle|isocitrate metabolic process|2-oxoglutarate metabolic process|NADH metabolic process|,magnesium ion binding|isocitrate dehydrogenase (NAD+) activity|NAD binding|,21,93,69800000000,45.0%
Q9D9V3,0.91325,-0.034,1.385606085,0.044,0.726840957,0.364510939,0.011,0.105,-0.284,0.039,-0.01,-0.065,Q9D9V3,Echdc1,Q9D9V3_Echdc1,Q9D9V3,Echdc1,1,60,20,20,Q9D9V3|Q9D9V3-2,MOUSE,35808.8,66.7,441,441.1,298.31,298.31,,322,Ethylmalonyl-CoA decarboxylase,cytosol|extracellular exosome|,metabolic process|,methylmalonyl-CoA decarboxylase activity|carboxy-lyase activity|,20,60,46000000000,66.7%
Q61102,0.820260214,-0.014333333,2.790480684,-0.077333333,0.525959049,-0.669160861,0.115,0.125,-0.167,0.029,-0.021,-0.167,Q61102,Abcb7,Q61102_Abcb7,Q61102,Abcb7,1,75,20,20,Q61102,MOUSE,82921.7,28.1,442,442.1,297.52,297.52,,752,"ATP-binding cassette sub-family B member 7, mitochondrial",mitochondrion|mitochondrial inner membrane|integral component of membrane|,cellular iron ion homeostasis|metabolic process|transmembrane transport|,"ATP binding|ATPase activity, coupled to transmembrane movement of substances|",20,75,1.27E+11,28.1%
Q8BGD9,0.001221941,-0.009166667,43.54175807,1.473666667,4.42409E-05,9.444005393,-0.754,-0.713,-0.771,0.475,0.645,1.063,Q8BGD9,Eif4b,Q8BGD9_Eif4b,Q8BGD9,Eif4b,1,56,24,24,Q8BGD9,MOUSE,69009.9,37.4,443,443.1,297.06,297.06,,611,Eukaryotic translation initiation factor 4B,,translational initiation|,nucleotide binding|translation initiation factor activity|poly(A) RNA binding|,24,56,10500000000,37.4%
Q60605-2,0.638017803,-0.204833333,5.600266899,0.457666667,0.275405945,1.188812048,0.066,0.023,-1.39,0.013,0.174,-0.115,Q60605,Myl6,Q60605-2_Myl6,Q60605-2,Myl6,1,182,18,1,Q60605-2|A0A1W2P7Q9|A0A1W2P6F6|A0A1W2P6G5|P09542|P05977|E9PWG4|P05977-2|A0A0G2JDM3|A0A087WRZ7|Q8CI43,MOUSE,17132,96,444,444.1,296.77,26.85,,151,Isoform Smooth muscle of Myosin light polypeptide 6,brush border|membrane|myosin complex|unconventional myosin complex|vesicle|extracellular exosome|,muscle contraction|skeletal muscle tissue development|muscle filament sliding|,motor activity|calcium ion binding|protein binding|structural constituent of muscle|actin-dependent ATPase activity|,18,182,1.15E+12,96.0%
Q9D2R0,0.165076439,-0.01,17.09848635,0.597333333,0.019505243,3.065005931,-0.049,-0.196,-0.681,0.432,0.029,0.405,Q9D2R0,Aacs,Q9D2R0_Aacs,Q9D2R0,Aacs,1,64,22,22,Q9D2R0,MOUSE,75712.4,35.7,445,445.1,296.39,296.39,,672,Acetoacetyl-CoA synthetase,cytosol|,liver development|fatty acid metabolic process|response to nutrient|response to purine-containing compound|positive regulation of insulin secretion|response to oleic acid|response to drug|response to starvation|response to ethanol|white fat cell differentiation|adipose tissue development|cellular response to glucose stimulus|cellular response to testosterone stimulus|cellular response to cholesterol|,ATP binding|acetoacetate-CoA ligase activity|butyrate-CoA ligase activity|,22,64,28200000000,35.7%
B2RXS4,0.002686697,-0.054,38.84551104,0.639333333,0.000130451,7.841245738,-0.406,-0.38,-0.335,0.215,0.321,0.261,B2RXS4,Plxnb2,B2RXS4_Plxnb2,B2RXS4,Plxnb2,1,44,24,24,B2RXS4,MOUSE,209079.3,16.6,446,446.1,295.82,295.82,,1842,Plexin-B2,integral component of plasma membrane|cell surface|extracellular exosome|,neural tube closure|regulation of protein phosphorylation|neuroblast proliferation|brain development|regulation of cell shape|regulation of GTPase activity|positive regulation of axonogenesis|semaphorin-plexin signaling pathway|regulation of neuron migration|,protein binding|semaphorin receptor activity|,24,44,5250000000,16.6%
P47911,0.733444091,0.036833333,4.051881216,-0.138333333,0.39337964,-0.912796111,-0.136,0.423,0.031,-0.089,0.025,-0.033,P47911,Rpl6,P47911_Rpl6,P47911,Rpl6,1,93,22,22,P47911,MOUSE,33566.1,50,447,447.1,295.65,295.65,,296,60S ribosomal protein L6,nucleus|nucleolus|cytoplasm|focal adhesion|membrane|cytosolic large ribosomal subunit|cytoplasmic ribonucleoprotein granule|,translation|,structural constituent of ribosome|poly(A) RNA binding|,22,93,1.76E+11,50.0%
P62827,0.332192581,0.001333333,11.85436445,-0.229333333,0.065247452,-2.202940008,0.005,0.167,0.176,-0.254,-0.076,-0.01,P62827,Ran,P62827_Ran,P62827,Ran,1,74,19,19,P62827|Q14AA6|Q61820,MOUSE,24593.8,73.6,448,448.1,295.32,295.32,,216,GTP-binding nuclear protein Ran,nucleus|nuclear envelope|nucleoplasm|nucleolus|cytoplasm|centriole|membrane|midbody|melanosome|RNA nuclear export complex|recycling endosome|extracellular exosome|chromatin|,"ribosomal subunit export from nucleus|ribosomal large subunit export from nucleus|ribosomal small subunit export from nucleus|protein import into nucleus, translocation|protein import into nucleus|protein export from nucleus|mitotic nuclear division|small GTPase mediated signal transduction|metabolic process|actin cytoskeleton organization|positive regulation of protein binding|cellular protein localization|cellular protein complex localization|cell division|protein localization to nucleolus|",GTPase activity|protein binding|GTP binding|GDP binding|poly(A) RNA binding|pre-miRNA binding|,19,74,1.23E+11,73.6%
Q9Z1Q9,0.954887447,-0.011833333,0.66605538,-0.023666667,0.857816631,-0.186263808,-0.231,0.214,0.017,-0.075,-0.002,0.006,Q9Z1Q9,Vars,Q9Z1Q9_Vars,Q9Z1Q9,Vars,1,51,21,21,Q9Z1Q9,MOUSE,141525.1,22.3,449,449.1,294.78,294.78,,1263,Valine--tRNA ligase,mitochondrion|cytosol|,valyl-tRNA aminoacylation|regulation of translational fidelity|,aminoacyl-tRNA editing activity|valine-tRNA ligase activity|ATP binding|,21,51,7700000000,22.3%
Q9EQ06,0.993378838,-0.025,0.108854269,0.004666667,0.975246888,0.032219406,0.158,0.083,-0.323,-0.025,0.072,-0.115,Q9EQ06,Hsd17b11,Q9EQ06_Hsd17b11,Q9EQ06,Hsd17b11,1,70,20,20,Q9EQ06|Q9EQ06-2,MOUSE,33165.3,62.7,450,450.1,294.77,294.77,,298,Estradiol 17-beta-dehydrogenase 11,extracellular region|cytoplasm|lipid particle|,steroid biosynthetic process|androgen catabolic process|oxidation-reduction process|,estradiol 17-beta-dehydrogenase activity|steroid dehydrogenase activity|,20,70,73100000000,62.7%
Q99L45,0.99327985,-0.035666667,0.122567135,-0.004666667,0.972172398,-0.036223159,0.066,0.104,-0.27,0.076,-0.052,-0.138,Q99L45,Eif2s2,Q99L45_Eif2s2,Q99L45,Eif2s2,1,49,19,19,Q99L45,MOUSE,38433.7,57.7,451,451.1,294.67,294.67,,331,Eukaryotic translation initiation factor 2 subunit 2,cytoplasm|,in utero embryonic development|male germ cell proliferation|translational initiation|male gonad development|,translation initiation factor activity|protein binding|poly(A) RNA binding|metal ion binding|,19,49,21900000000,57.7%
P42669,0.287502731,-0.0055,13.19387402,-0.206333333,0.04793057,-2.415880053,0.118,0.112,0.063,-0.089,-0.04,-0.197,P42669,Pura,P42669_Pura,P42669,Pura,1,90,22,19,P42669,MOUSE,34997.2,63.2,452,452.1,294.03,264.6,,321,Transcriptional activator protein Pur-alpha,nucleus|DNA replication factor A complex|cytoplasm|dendrite|neuronal cell body|,"DNA unwinding involved in DNA replication|transcription, DNA-templated|apoptotic process|mitotic cell cycle checkpoint|nervous system development|cell proliferation|positive regulation of cell proliferation|negative regulation of translation|cell differentiation|negative regulation of transcription, DNA-templated|","translation repressor activity, nucleic acid binding|DNA binding|double-stranded DNA binding|double-stranded telomeric DNA binding|single-stranded DNA binding|sequence-specific DNA binding transcription factor activity|protein binding|transcription factor binding|purine-rich negative regulatory element binding|poly(A) RNA binding|SMAD binding|",22,90,90400000000,63.2%
O35295,0.574833895,-0.004333333,6.898397484,-0.128,0.204249147,-1.406482881,0.035,0.106,0.038,0.05,-0.142,-0.113,O35295,Purb,O35295_Purb,O35295,Purb,1,53,19,16,O35295,MOUSE,34014.9,73.4,452,452.2,270.87,241.44,,324,Transcriptional activator protein Pur-beta,nucleus|nucleoplasm|DNA replication factor A complex|,"negative regulation of transcription from RNA polymerase II promoter|DNA unwinding involved in DNA replication|transcription, DNA-templated|apoptotic process|cell proliferation|cell differentiation|negative regulation of transcription, DNA-templated|",RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription|double-stranded DNA binding|double-stranded telomeric DNA binding|single-stranded DNA binding|sequence-specific DNA binding transcription factor activity|RNA binding|mRNA binding|protein binding|transcription factor binding|poly(A) RNA binding|SMAD binding|,16,53,12200000000,68.8%
Q9QYG0,0.604209631,-0.0285,6.282387129,0.139666667,0.235375517,1.303970644,-0.02,0.005,-0.28,0.014,0.109,0.001,Q9QYG0,Ndrg2,Q9QYG0_Ndrg2,Q9QYG0,Ndrg2,1,72,19,19,Q9QYG0|Q9QYG0-2,MOUSE,41130.8,60.6,453,453.1,293.96,293.96,,371,Protein NDRG2,nucleus|nucleoplasm|cytoplasm|Golgi apparatus|centrosome|microtubule organizing center|growth cone|perinuclear region of cytoplasm|extracellular exosome|,negative regulation of cytokine production|signal transduction|regulation of vascular endothelial growth factor production|Wnt signaling pathway|substantia nigra development|cell differentiation|negative regulation of smooth muscle cell proliferation|negative regulation of ERK1 and ERK2 cascade|regulation of platelet-derived growth factor production|,,19,72,46300000000,60.6%
Q6NZR5,0.712762463,-0.0045,4.338172139,-0.077,0.368283945,-0.964580969,0.03,0.058,0.014,-0.009,-0.097,-0.023,Q6NZR5,Skiv2l,Q6NZR5_Skiv2l,Q6NZR5,Skiv2l,1,42,23,23,Q6NZR5,MOUSE,138377.3,25,454,454.1,293.59,293.59,,1244,Superkiller viralicidic activity 2-like (S. cerevisiae),nucleus|nucleoplasm|Ski complex|,RNA catabolic process|,RNA binding|RNA helicase activity|ATP binding|,23,42,1.14E+11,25.0%
Q9DCM2,0.647450828,-0.014,5.400321052,-0.216,0.288381831,-1.154197247,0.2,0.352,-0.27,-0.172,0.099,-0.293,Q9DCM2,Gstk1,Q9DCM2_Gstk1,Q9DCM2,Gstk1,1,133,19,19,Q9DCM2|A0A0N4SVE5,MOUSE,25817.7,74.7,455,455.1,293.33,293.33,,226,Glutathione S-transferase kappa 1,intracellular|mitochondrion|mitochondrial inner membrane|mitochondrial matrix|peroxisome|membrane|intracellular membrane-bounded organelle|extracellular exosome|,glutathione metabolic process|epithelial cell differentiation|oxidation-reduction process|,glutathione transferase activity|glutathione peroxidase activity|receptor binding|protein disulfide oxidoreductase activity|,19,133,1.71E+11,74.7%
O55222,0.639572826,0.000833333,5.561548628,-0.108333333,0.277872224,-1.180915324,0.159,-0.013,0.019,0.019,-0.063,-0.116,O55222,Ilk,O55222_Ilk,O55222,Ilk,1,89,23,23,O55222|A0A1B0GRF6,MOUSE,51885.8,45.5,456,456.1,293.07,293.07,,452,Integrin-linked protein kinase,stress fiber|nucleoplasm|cytoplasm|plasma membrane|cell-cell junction|focal adhesion|membrane|sarcomere|lamellipodium|cell junction|extracellular matrix|neuronal cell body|costamere|terminal bouton|dendritic shaft|protein complex|,"branching involved in ureteric bud morphogenesis|positive regulation of cell-matrix adhesion|outflow tract morphogenesis|protein phosphorylation|negative regulation of protein kinase activity|cell cycle arrest|integrin-mediated signaling pathway|cell aging|positive regulation of cell proliferation|negative regulation of cardiac muscle cell apoptotic process|fibroblast migration|Schwann cell development|negative regulation of smooth muscle cell migration|peptidyl-serine phosphorylation|nerve development|myelination in peripheral nervous system|cell projection organization|positive regulation of cell migration|positive regulation of BMP signaling pathway|myelin assembly|regulation of actin cytoskeleton organization|substrate adhesion-dependent cell spreading|positive regulation of phosphorylation|extracellular fibril organization|positive regulation of MAP kinase activity|protein kinase B signaling|negative regulation of neuron apoptotic process|establishment or maintenance of epithelial cell apical/basal polarity|positive regulation of myoblast differentiation|positive regulation of osteoblast differentiation|positive regulation of axon extension|positive regulation of transcription, DNA-templated|negative regulation of smooth muscle cell proliferation|neuron projection morphogenesis|positive regulation of dendrite morphogenesis|protein heterooligomerization|positive regulation of protein kinase B signaling|platelet aggregation|positive regulation of canonical Wnt signaling pathway|negative regulation of neural precursor cell proliferation|",protein serine/threonine kinase activity|signal transducer activity|integrin binding|protein binding|ATP binding|SH3 domain binding|protein kinase binding|,23,89,40500000000,45.5%
O55137,0.6812202,-0.055666667,4.847709417,0.192666667,0.327513388,1.057092783,0.081,0.013,-0.55,-0.067,0.183,0.006,O55137,Acot1,O55137_Acot1,O55137,Acot1,1,86,19,3,O55137|Q32Q92|Q32Q92-2|Q6Q2Z6|Q91YQ6,MOUSE,46363.4,54.1,457,457.1,292.67,51.86,,419,Acyl-coenzyme A thioesterase 1,cytoplasm|mitochondrion|,long-chain fatty acid metabolic process|acyl-CoA metabolic process|,palmitoyl-CoA hydrolase activity|acyl-CoA hydrolase activity|carboxylic ester hydrolase activity|,20,86,65600000000,54.1%
Q9QYR9,0.802488898,-0.035166667,3.039681958,0.098333333,0.496628689,0.719175419,0.04,0.012,-0.305,-0.114,0.202,-0.046,Q9QYR9,Acot2,Q9QYR9_Acot2,Q9QYR9,Acot2,1,17,15,4,Q9QYR9,MOUSE,49884.3,40.8,457,457.2,219.89,64.45,,453,"Acyl-coenzyme A thioesterase 2, mitochondrial",mitochondrion|mitochondrial matrix|extracellular exosome|,very long-chain fatty acid metabolic process|long-chain fatty acid metabolic process|acyl-CoA metabolic process|,receptor binding|palmitoyl-CoA hydrolase activity|acyl-CoA hydrolase activity|carboxylic ester hydrolase activity|,4,17,2980000000,14.7%
Q9QYR7,0.195354513,-0.076333333,16.1068485,0.261333333,0.024508411,2.889206422,-0.108,-0.21,-0.303,0.043,0.107,0.013,Q9QYR7,Acot3,Q9QYR7_Acot3,Q9QYR7,Acot3,1,6,12,5,Q9QYR7|Q9QYR7-2|A0A1Y7VMZ4,MOUSE,47716.8,37.9,457,457.3,155.3,54.81,,432,Acyl-coenzyme A thioesterase 3,peroxisome|cytosol|,very long-chain fatty acid metabolic process|long-chain fatty acid metabolic process|acyl-CoA metabolic process|saturated monocarboxylic acid metabolic process|unsaturated monocarboxylic acid metabolic process|,palmitoyl-CoA hydrolase activity|acyl-CoA hydrolase activity|carboxylic ester hydrolase activity|,5,6,731000000,17.3%
Q8BWN8,0.961523652,-0.036166667,0.536190023,0.025666667,0.883854948,0.151815762,0.112,-0.203,-0.056,-0.356,0.068,0.218,Q8BWN8,Acot4,Q8BWN8_Acot4,Q8BWN8,Acot4,1,2,8,2,Q8BWN8,MOUSE,46822,20.4,457,457.4,106.07,28.36,,421,Acyl-coenzyme A thioesterase 4,peroxisome|,very long-chain fatty acid metabolic process|long-chain fatty acid metabolic process|succinyl-CoA metabolic process|acyl-CoA metabolic process|saturated monocarboxylic acid metabolic process|unsaturated monocarboxylic acid metabolic process|dicarboxylic acid metabolic process|dicarboxylic acid catabolic process|short-chain fatty acid metabolic process|,succinyl-CoA hydrolase activity|receptor binding|palmitoyl-CoA hydrolase activity|acyl-CoA hydrolase activity|carboxylic ester hydrolase activity|,2,2,135000000,8.5%
Q922I7,0.336787221,0.0285,11.75037923,-0.287,0.066828556,-2.190521344,0.206,0.362,-0.052,-0.179,0.017,-0.183,Q922I7,Ptbp1,Q922I7_Ptbp1,Q922I7,Ptbp1,1,82,19,15,Q922I7|Q8BGJ5|Q8CB58|P17225|E9QMW9|E9Q279,MOUSE,59491.7,45,458,458.1,292.12,236.18,,555,"MCG13402, isoform CRA_c",nucleus|membrane|extracellular exosome|,"regulation of alternative mRNA splicing, via spliceosome|mRNA processing|negative regulation of RNA splicing|positive regulation of transcription from RNA polymerase II promoter|negative regulation of mRNA splicing, via spliceosome|negative regulation of muscle cell differentiation|",nucleotide binding|protein binding|pre-mRNA binding|poly(A) RNA binding|,19,82,87200000000,45.0%
P26150,0.875832617,-0.020833333,2.008540638,-0.079666667,0.629717752,-0.505321202,0.079,0.269,-0.291,-0.029,0.038,-0.191,P26150,Hsd3b3,P26150_Hsd3b3,P26150,Hsd3b3,1,92,20,19,P26150|E9PXG7|O35469|P26149|P24815,MOUSE,42372.7,45,459,459.1,291.75,265.5,,373,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 3,mitochondrial inner membrane|mitochondrial intermembrane space|endoplasmic reticulum membrane|integral component of membrane|,steroid biosynthetic process|oxidation-reduction process|,3-beta-hydroxy-delta5-steroid dehydrogenase activity|steroid delta-isomerase activity|,21,92,58700000000,45.0%
Q99LF4,0.91325,-0.004166667,1.358592852,0.035666667,0.731376017,0.357979165,0.106,-0.134,-0.038,0.103,-0.028,-0.034,Q99LF4,Rtcb,Q99LF4_Rtcb,Q99LF4,Rtcb,1,66,23,23,Q99LF4,MOUSE,55761.8,48.7,460,460.1,291.69,291.69,,505,tRNA-splicing ligase RtcB homolog,nucleus|nuclear envelope|cytoplasm|endoplasmic reticulum membrane|tRNA-splicing ligase complex|,"in utero embryonic development|placenta development|tRNA splicing, via endonucleolytic cleavage and ligation|",RNA ligase (ATP) activity|ATP binding|vinculin binding|poly(A) RNA binding|metal ion binding|,23,66,33100000000,48.7%
Q8R0F9,0.480593503,-0.069166667,8.534223793,-0.207,0.140145004,-1.67579625,0.002,0.092,0.009,-0.33,0.068,-0.256,Q8R0F9,Sec14l4,Q8R0F9_Sec14l4,Q8R0F9,Sec14l4,1,84,20,20,Q8R0F9,MOUSE,46451.7,52.3,461,461.1,291.52,291.52,,403,SEC14-like protein 4,intracellular|integral component of membrane|,transport|,transporter activity|lipid binding|,20,84,35700000000,52.3%
Q8R180,0.00014877,-0.310666667,60.57082268,2.104,8.76835E-07,17.45988268,-1.402,-1.169,-1.517,0.643,0.72,0.861,Q8R180,Ero1l,Q8R180_Ero1l,Q8R180,Ero1a,1,61,21,20,Q8R180,MOUSE,54939.2,55.8,462,462.1,290.93,270.33,,464,ERO1-like protein alpha,endoplasmic reticulum|membrane|integral component of endoplasmic reticulum membrane|,protein folding|4-hydroxyproline metabolic process|protein maturation by protein folding|extracellular matrix organization|endoplasmic reticulum unfolded protein response|response to endoplasmic reticulum stress|cell redox homeostasis|brown fat cell differentiation|chaperone mediated protein folding requiring cofactor|release of sequestered calcium ion into cytosol|oxidation-reduction process|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress|,"protein disulfide isomerase activity|protein disulfide oxidoreductase activity|oxidoreductase activity|oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor|",21,61,16600000000,55.8%
Q8R2E9,0.00070612,-0.192166667,46.77365213,1.417666667,2.10201E-05,10.63683778,-0.876,-0.672,-1.155,0.485,0.518,0.547,Q8R2E9,Ero1lb,Q8R2E9_Ero1lb,Q8R2E9,Ero1b,1,11,7,6,A0A1Y7VNF4|A0A1Y7VJM4|Q8R2E9,MOUSE,54315.8,14.5,462,462.2,86.18,65.58,,467,ERO1-like protein beta,endoplasmic reticulum membrane|membrane|,4-hydroxyproline metabolic process|protein maturation by protein folding|insulin processing|extracellular matrix organization|glucose homeostasis|cell redox homeostasis|oxidation-reduction process|,"protein disulfide isomerase activity|protein disulfide oxidoreductase activity|oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor|",6,11,903000000,12.2%
Q9CZN7,0.919618833,0.017333333,1.166811083,0.03,0.764396855,0.312181932,-0.064,-0.022,0.093,-0.061,0.016,0.142,Q9CZN7,Shmt2,Q9CZN7_Shmt2,Q9CZN7,Shmt2,1,50,25,24,Q9CZN7|Q3TFD0,MOUSE,56271.2,58.5,463,463.1,289.89,281.45,,504,Serine hydroxymethyltransferase,mitochondrion|mitochondrial inner membrane|mitochondrial intermembrane space|mitochondrial matrix|microtubule cytoskeleton|mitochondrial nucleoid|extracellular exosome|,L-serine biosynthetic process|one-carbon metabolic process|positive regulation of cell proliferation|glycine biosynthetic process from serine|tetrahydrofolate interconversion|protein homotetramerization|,chromatin binding|glycine hydroxymethyltransferase activity|L-allo-threonine aldolase activity|amino acid binding|pyridoxal phosphate binding|identical protein binding|,25,50,6480000000,58.5%
P50431,0.209459289,-0.0265,15.59543355,0.409666667,0.027571262,2.813624782,-0.066,-0.11,-0.518,0.042,0.274,0.219,P50431,Shmt1,P50431_Shmt1,P50431,Shmt1,1,18,11,11,P50431,MOUSE,53170.5,25.7,463,463.2,109.84,109.84,,478,"Serine hydroxymethyltransferase, cytosolic",nucleus|nucleoplasm|cytoplasm|mitochondrion|cytosol|extracellular exosome|,L-serine catabolic process|purine nucleobase biosynthetic process|glycine biosynthetic process from serine|tetrahydrofolate interconversion|folic acid metabolic process|protein tetramerization|protein homotetramerization|,glycine hydroxymethyltransferase activity|L-allo-threonine aldolase activity|amino acid binding|pyridoxal phosphate binding|protein homodimerization activity|,11,18,5390000000,25.7%
Q8K2B3,0.983717661,0.029333333,0.257674832,-0.012666667,0.94239401,-0.075047775,0.042,0.299,-0.234,-0.108,0.259,-0.082,Q8K2B3,Sdha,Q8K2B3_Sdha,Q8K2B3,Sdha,1,64,21,21,Q8K2B3,MOUSE,73668.1,38.5,464,464.1,289.59,289.59,,664,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial","mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)|myelin sheath|",tricarboxylic acid cycle|succinate metabolic process|nervous system development|respiratory electron transport chain|oxidation-reduction process|,succinate dehydrogenase (ubiquinone) activity|flavin adenine dinucleotide binding|succinate dehydrogenase activity|,21,64,22200000000,38.5%
Q3UNX5-2,0.711236799,0.000833333,4.359289268,-0.171,0.366497548,-0.969236173,0.147,0.355,-0.243,-0.187,0.128,-0.195,Q3UNX5,Acsm3,Q3UNX5-2_Acsm3,Q3UNX5-2,Acsm3,1,82,20,20,Q3UNX5-2|Q3UNX5,MOUSE,70921.8,33.9,465,465.1,289.46,289.46,,580,"Isoform 2 of Acyl-coenzyme A synthetase ACSM3, mitochondrial",mitochondrion|mitochondrial matrix|,fatty acid biosynthetic process|,ATP binding|fatty acid ligase activity|metal ion binding|butyrate-CoA ligase activity|,20,82,1E+11,33.9%
Q3U0V1,0.715866402,0.015333333,4.272374694,-0.087333333,0.373906083,-0.952585558,-0.003,-0.003,0.183,-0.026,-0.067,0.008,Q3U0V1,Khsrp,Q3U0V1_Khsrp,Q3U0V1,Khsrp,1,75,20,20,Q3U0V1,MOUSE,77230.5,35.2,466,466.1,289.41,289.41,,748,Far upstream element-binding protein 2,nucleoplasm|cytosol|cytoplasmic stress granule|membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|mRNA processing|mRNA catabolic process|RNA splicing|mRNA transport|regulation of miRNA metabolic process|",mRNA binding|poly(A) RNA binding|,20,75,11000000000,35.1%
Q91VD9,0.513722705,-0.0345,7.973319351,0.221666667,0.159465987,1.584859273,-0.351,0.108,-0.193,0.212,-0.014,0.031,Q91VD9,Ndufs1,Q91VD9_Ndufs1,Q91VD9,Ndufs1,1,43,21,21,Q91VD9,MOUSE,80802.4,34.1,467,467.1,289.3,289.3,,727,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial",mitochondrion|mitochondrial respiratory chain complex I|mitochondrial intermembrane space|myelin sheath|,apoptotic mitochondrial changes|ATP synthesis coupled electron transport|cellular respiration|ATP metabolic process|regulation of mitochondrial membrane potential|reactive oxygen species metabolic process|,"NADH dehydrogenase (ubiquinone) activity|electron carrier activity|metal ion binding|iron-sulfur cluster binding|2 iron, 2 sulfur cluster binding|4 iron, 4 sulfur cluster binding|NADH dehydrogenase (ubiquinone) activity|",21,43,5930000000,34.1%
P42125,0.993050549,-0.032666667,0.141396834,0.007333333,0.967966476,0.041701417,0.268,0.028,-0.405,0.028,0.022,-0.137,P42125,Eci1,P42125_Eci1,P42125,Eci1,1,136,18,18,P42125,MOUSE,32535.1,60.8,468,468.1,289.28,289.28,,289,"Enoyl-CoA delta isomerase 1, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial matrix|extracellular exosome|,fatty acid beta-oxidation|,dodecenoyl-CoA delta-isomerase activity|identical protein binding|,18,136,3.82E+11,60.8%
Q810B6,0.662925276,-0.009666667,5.128672998,-0.116,0.306995988,-1.105840501,0.125,0.144,-0.124,-0.046,-0.021,-0.136,Q810B6,Ankfy1,Q810B6_Ankfy1,Q810B6,Ankfy1,1,58,23,23,Q810B6|Q810B6-2,MOUSE,130304.8,26.1,469,469.1,289.12,289.12,,1169,Rabankyrin-5,early endosome|endosome membrane|membrane|cytoplasmic membrane-bounded vesicle|macropinosome|extracellular exosome|retromer complex|,"endocytosis|endosome localization|endosomal vesicle fusion|retrograde transport, endosome to Golgi|positive regulation of pinocytosis|Golgi to lysosome transport|",Rab GTPase binding|metal ion binding|phosphatidylinositol phosphate binding|,23,58,45900000000,26.1%
Q99LE6,0.51414471,-0.013666667,7.938131914,-0.141333333,0.160763262,-1.576850617,0.057,0.094,0.02,0.013,-0.184,-0.082,Q99LE6,Abcf2,Q99LE6_Abcf2,Q99LE6,Abcf2,1,42,24,24,Q99LE6,MOUSE,72351,36.6,470,470.1,288.63,288.63,,628,ATP-binding cassette sub-family F member 2,mitochondrion|membrane|,metabolic process|,ATP binding|ATPase activity|,24,42,15800000000,36.6%
Q8R050,0.933608247,-0.010833333,0.960491409,0.025,0.801587358,0.261471231,0.029,0.061,-0.16,0.057,-0.017,-0.035,Q8R050,Gspt1,Q8R050_Gspt1,Q8R050,Gspt1,1,57,23,23,Q8R050|Q8R050-2|Q149F3,MOUSE,69423,43.7,471,471.1,288.53,288.53,,636,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A,,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|translational termination|protein methylation|",translation release factor activity|GTPase activity|GTP binding|poly(A) RNA binding|,23,57,46600000000,43.7%
A0A1B0GSU0,0.324514679,0.007166667,12.13858957,0.254333333,0.061114047,2.250045503,0,-0.147,-0.213,0.298,0.107,-0.002,A0A1B0GSU0,Aldh16a1,A0A1B0GSU0_Aldh16a1,A0A1B0GSU0,Aldh16a1,1,63,22,22,A0A1B0GSU0|Q571I9|D3Z0B9,MOUSE,85595.1,34.6,472,472.1,288.21,288.21,,802,Aldehyde dehydrogenase family 16 member A1,,,,22,63,22900000000,34.6%
O89079,0.685093743,-0.010166667,4.779715183,-0.099666667,0.33268137,-1.044040862,-0.032,0.087,0.064,-0.179,-0.044,0.043,O89079,Cope,O89079_Cope,O89079,Cope,1,77,22,22,O89079|E9Q6I5,MOUSE,34794.7,65.9,473,473.1,287.97,287.97,,308,Coatomer subunit epsilon,nucleoplasm|Golgi apparatus|COPI vesicle coat|COPI-coated vesicle|,"ER to Golgi vesicle-mediated transport|retrograde vesicle-mediated transport, Golgi to ER|intra-Golgi vesicle-mediated transport|protein transport|",structural molecule activity|,22,77,30800000000,65.9%
Q6ZWN5,0.454052388,0.014833333,9.297491883,-0.175666667,0.117557627,-1.795567198,0.075,0.241,-0.008,-0.038,-0.048,-0.133,Q6ZWN5,Rps9,Q6ZWN5_Rps9,Q6ZWN5,Rps9,1,109,24,24,Q6ZWN5|Q9CXW7|D3YWH9|D3Z673,MOUSE,22648.1,65.9,474,474.1,287.55,287.55,,194,40S ribosomal protein S9,nucleus|nucleolus|cytoplasm|focal adhesion|membrane|cytosolic small ribosomal subunit|ribonucleoprotein complex|extracellular exosome|,translation|positive regulation of cell proliferation|positive regulation of translational fidelity|,structural constituent of ribosome|rRNA binding|poly(A) RNA binding|translation regulator activity|,24,109,1.48E+11,65.9%
Q99K01-2,0.790620052,-0.021,3.259965359,-0.085333333,0.472066807,-0.762208018,0.111,-0.022,-0.024,0.127,-0.181,-0.137,Q99K01,Pdxdc1,Q99K01-2_Pdxdc1,Q99K01-2,Pdxdc1,1,57,20,1,A0A0R4J034|Q99K01-2|Q99K01-3|D3YZA7|Q99K01-5,MOUSE,88234.9,30.7,475,475.1,287.33,17.99,,787,Isoform 2 of Pyridoxal-dependent decarboxylase domain-containing protein 1,Golgi apparatus|intracellular membrane-bounded organelle|,carboxylic acid metabolic process|,carboxy-lyase activity|pyridoxal phosphate binding|,20,57,26100000000,30.7%
Q9JKY5,0.430366134,-0.0365,9.78000107,-0.344333333,0.105196161,-1.875919041,0.028,0.032,0.347,-0.006,-0.583,-0.037,Q9JKY5,Hip1r,Q9JKY5_Hip1r,Q9JKY5,Hip1r,1,43,23,22,Q9JKY5,MOUSE,120051.9,27.9,476,476.1,287.23,276.19,,1068,Huntingtin-interacting protein 1-related protein,cytoplasm|cytoskeleton|coated pit|clathrin-coated vesicle|clathrin-coated vesicle membrane|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|,receptor-mediated endocytosis|apoptotic process|clathrin-mediated endocytosis|,actin binding|protein binding|clathrin binding|phosphatidylinositol binding|,23,43,5150000000,27.9%
Q8VD75,0.960219778,-0.030166667,0.598394707,-0.023,0.871285586,-0.168416051,-0.244,0.144,0.044,0.114,-0.193,-0.046,Q8VD75,Hip1,Q8VD75_Hip1,Q8VD75,Hip1,1,3,4,3,Q8VD75,MOUSE,116170,5.8,476,476.2,37.39,26.35,,1029,Huntingtin-interacting protein 1,nucleus|cytoplasm|Golgi apparatus|clathrin-coated vesicle|clathrin-coated vesicle membrane|intracellular membrane-bounded organelle|,"transcription, DNA-templated|regulation of transcription, DNA-templated|endocytosis|apoptotic process|activation of cysteine-type endopeptidase activity involved in apoptotic process|cell differentiation|regulation of apoptotic process|positive regulation of receptor-mediated endocytosis|clathrin coat assembly|clathrin-mediated endocytosis|apoptotic signaling pathway|",actin binding|protein binding|clathrin binding|phosphatidylinositol binding|,3,3,299000000,4.8%
P46935,0.998411609,-0.012166667,0.013002567,0.000333333,0.997010526,0.003888749,-0.029,0.076,-0.084,-0.037,-0.023,0.024,P46935,Nedd4,P46935_Nedd4,P46935,Nedd4,1,54,21,19,P46935|Q3V335|V9GXK3,MOUSE,103217.8,24.8,477,477.1,286.94,260.66,,887,E3 ubiquitin-protein ligase NEDD4,ubiquitin ligase complex|chromatin|cytoplasm|Golgi apparatus|cytosol|plasma membrane|cell cortex|membrane|perinuclear region of cytoplasm|extracellular exosome|,negative regulation of transcription from RNA polymerase II promoter|adaptive immune response|outflow tract morphogenesis|endocardial cushion development|protein monoubiquitination|protein targeting to lysosome|neuromuscular junction development|negative regulation of sodium ion transport|negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage|positive regulation of phosphatidylinositol 3-kinase signaling|protein ubiquitination|transmission of virus|negative regulation of vascular endothelial growth factor receptor signaling pathway|neuron projection development|receptor internalization|receptor catabolic process|T cell activation|regulation of membrane potential|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|glucocorticoid receptor signaling pathway|ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway|development involved in symbiotic interaction|positive regulation of protein catabolic process|positive regulation of nucleocytoplasmic transport|blood vessel morphogenesis|regulation of dendrite morphogenesis|regulation of synapse organization|progesterone receptor signaling pathway|protein K63-linked ubiquitination|regulation of potassium ion transmembrane transporter activity|,protein binding|ligase activity|sodium channel inhibitor activity|protein domain specific binding|beta-2 adrenergic receptor binding|ubiquitin binding|phosphoserine binding|phosphothreonine binding|ubiquitin protein ligase activity|RNA polymerase binding|proline-rich region binding|,21,54,21800000000,24.8%
Q8CFI0,0.154742556,0.023333333,17.42070002,-0.301333333,0.018110482,-3.108645804,0.167,0.082,0.273,-0.102,-0.231,-0.049,Q8CFI0,NotFound,Q8CFI0_NotFound,Q8CFI0,Nedd4l,1,8,7,5,Q8CFI0|Q8CFI0-3|E9PXB7|Q8CFI0-2|G3X9H8|A0A286YCM8,MOUSE,115816.2,7.9,477,477.2,77.76,51.48,,1004,E3 ubiquitin-protein ligase NEDD4-like,cytoplasm|extracellular exosome|plasma membrane|,negative regulation of systemic arterial blood pressure|regulation of membrane depolarization|response to salt stress|response to metal ion|positive regulation of sodium ion transport|negative regulation of sodium ion transport|protein ubiquitination|regulation of ion transmembrane transport|regulation of membrane potential|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway|regulation of membrane repolarization|protein K48-linked ubiquitination|regulation of potassium ion transmembrane transporter activity|negative regulation of potassium ion transmembrane transporter activity|negative regulation of potassium ion transmembrane transport|negative regulation of sodium ion transmembrane transport|positive regulation of dendrite extension|negative regulation of protein localization to cell surface|negative regulation of sodium ion transmembrane transporter activity|regulation of bicellular tight junction assembly|positive regulation of cation channel activity|,protein binding|potassium channel regulator activity|ligase activity|sodium channel regulator activity|potassium channel inhibitor activity|sodium channel inhibitor activity|ion channel binding|ubiquitin protein ligase activity|,5,8,852000000,6.2%
Q61635,0.544541259,0.022666667,7.384171257,-0.282,0.182634523,-1.488508939,0.198,-0.159,0.452,0.082,-0.378,-0.059,Q61635,Ifi47,Q61635_Ifi47,Q61635,Ifi47,1,60,20,20,Q61635,MOUSE,47126.3,59.5,478,478.1,286.52,286.52,,420,GTP-binding protein,endoplasmic reticulum|membrane|,defense response|,GTP binding|,20,60,1.2E+11,59.5%
Q99LX0,0.912007214,0.0005,1.406927512,-0.042333333,0.72328132,-0.369452603,0.177,0.065,-0.177,-0.016,0.04,-0.086,Q99LX0,Park7,Q99LX0_Park7,Q99LX0,Park7,1,73,18,18,Q99LX0|A2A813,MOUSE,20249.2,96.2,479,479.1,285.9,285.9,,189,Protein/nucleic acid deglycase DJ-1,chromatin|nucleus|cytoplasm|mitochondrion|mitochondrial intermembrane space|mitochondrial matrix|endoplasmic reticulum|cytosol|plasma membrane|PML body|neuron projection|cell body|membrane raft|extracellular exosome|mitochondrial respiratory chain complex I|,"negative regulation of protein phosphorylation|synaptic transmission, dopaminergic|negative regulation of protein kinase activity|proteolysis|protein deglycosylation|autophagy|inflammatory response|mitochondrion organization|single fertilization|cell proliferation|adult locomotory behavior|detoxification of copper ion|positive regulation of gene expression|negative regulation of gene expression|enzyme active site formation via L-cysteine sulfinic acid|methylglyoxal catabolic process to D-lactate|lactate biosynthetic process|negative regulation of protein ubiquitination|negative regulation of protein binding|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of interleukin-8 production|positive regulation of peptidyl-serine phosphorylation|negative regulation of protein sumoylation|cellular response to oxidative stress|cellular response to reactive oxygen species|cellular response to glyoxal|negative regulation of protein catabolic process|response to hydrogen peroxide|hydrogen peroxide metabolic process|negative regulation of apoptotic process|regulation of neuron apoptotic process|negative regulation of neuron apoptotic process|positive regulation of transcription from RNA polymerase II promoter|glycolate biosynthetic process|negative regulation of protein export from nucleus|regulation of inflammatory response|detoxification of mercury ion|protein stabilization|positive regulation of sequence-specific DNA binding transcription factor activity|negative regulation of ubiquitin-protein transferase activity|dopamine uptake involved in synaptic transmission|regulation of mitochondrial membrane potential|membrane depolarization|membrane hyperpolarization|negative regulation of cell death|regulation of androgen receptor signaling pathway|cellular response to hydrogen peroxide|positive regulation of protein homodimerization activity|positive regulation of protein localization to nucleus|negative regulation of neuron death|positive regulation of superoxide dismutase activity|negative regulation of protein acetylation|positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|positive regulation of mitochondrial electron transport, NADH to ubiquinone|negative regulation of protein K48-linked deubiquitination|negative regulation of TRAIL-activated apoptotic signaling pathway|positive regulation of pyrroline-5-carboxylate reductase activity|positive regulation of tyrosine 3-monooxygenase activity|positive regulation of dopamine biosynthetic process|glyoxal catabolic process|positive regulation of L-dopa biosynthetic process|positive regulation of L-dopa decarboxylase activity|negative regulation of oxidative stress-induced cell death|negative regulation of oxidative stress-induced neuron death|negative regulation of hydrogen peroxide-induced cell death|negative regulation of hydrogen peroxide-induced neuron death|negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway|negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway|positive regulation of reactive oxygen species biosynthetic process|negative regulation of ubiquitin-specific protease activity|positive regulation of oxidative phosphorylation uncoupler activity|positive regulation of transcription regulatory region DNA binding|positive regulation of androgen receptor activity|negative regulation of extrinsic apoptotic signaling pathway|negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|","transcription coactivator activity|RNA binding|mRNA binding|receptor binding|copper ion binding|protein binding|transcription factor binding|peptidase activity|superoxide dismutase copper chaperone activity|oxidoreductase activity, acting on peroxide as acceptor|glyoxalase III activity|enzyme binding|kinase binding|cytokine binding|tyrosine 3-monooxygenase activator activity|L-dopa decarboxylase activator activity|identical protein binding|protein homodimerization activity|small protein activating enzyme binding|ubiquitin-like protein conjugating enzyme binding|mercury ion binding|androgen receptor binding|peroxiredoxin activity|repressing transcription factor binding|scaffold protein binding|cupric ion binding|cuprous ion binding|ubiquitin-specific protease binding|glyoxalase (glycolic acid-forming) activity|",18,73,74000000000,96.2%
Q80U63,0.979892713,-0.050833333,0.309503406,0.014333333,0.931214349,0.08965368,0.144,0.036,-0.354,0.116,-0.02,-0.227,Q80U63,Mfn2,Q80U63_Mfn2,Q80U63,Mfn2,1,54,23,23,Q80U63|Q80U63-2,MOUSE,86928,33.8,480,480.1,285.48,285.48,,757,Mitofusin-2,mitochondrion|cytosol|microtubule cytoskeleton|integral component of membrane|intrinsic component of mitochondrial outer membrane|,blastocyst formation|protein targeting to mitochondrion|autophagy|apoptotic process|response to unfolded protein|mitochondrial membrane organization|mitochondrial fusion|protein localization to pre-autophagosomal structure|negative regulation of Ras protein signal transduction|camera-type eye morphogenesis|negative regulation of smooth muscle cell proliferation|mitochondrion localization|cell cycle arrest|,GTPase activity|protein binding|GTP binding|ubiquitin protein ligase binding|,23,54,11200000000,33.8%
Q8K2C7,0.000555999,-0.117166667,48.47700712,1.829666667,1.42004E-05,11.3185273,-1.024,-0.897,-1.175,0.505,0.811,1.077,Q8K2C7,Os9,Q8K2C7_Os9,Q8K2C7,Os9,1,48,23,23,Q8K2C7|Q8K2C7-2,MOUSE,76562.9,42.1,481,481.1,283.93,283.93,,672,Protein OS-9,endoplasmic reticulum lumen|,"protein targeting|protein retention in ER lumen|protein ubiquitination|ER-associated ubiquitin-dependent protein catabolic process|response to endoplasmic reticulum stress|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|negative regulation of retrograde protein transport, ER to cytosol|",glycoprotein binding|protease binding|carbohydrate binding|,23,48,7740000000,42.1%
Q8R164,0.771800617,-0.069166667,3.566850424,-0.255,0.439860494,-0.821652141,-0.598,0.431,0.342,-0.601,-0.04,0.051,Q8R164,Bphl,Q8R164_Bphl,Q8R164,Bphl,1,117,21,21,Q8R164,MOUSE,33078.5,73.1,482,482.1,283.73,283.73,,291,Valacyclovir hydrolase,mitochondrion|extracellular exosome|,metabolic process|,hydrolase activity|,21,117,1.57E+11,73.1%
Q8R151,0.57548373,0.015666667,6.863277532,-0.133333333,0.205907538,-1.400663304,0.028,0.027,0.192,0.002,-0.149,-0.006,Q8R151,Znfx1,Q8R151_Znfx1,Q8R151,Znfx1,1,41,26,26,Q8R151|A2A5R6,MOUSE,223787.8,17.7,483,483.1,283.62,283.62,,1909,NF-type zinc finger-containing protein 1,,,poly(A) RNA binding|metal ion binding|,26,41,3810000000,17.7%
Q9DBC0,0.695431326,-0.041833333,4.620793118,0.139666667,0.345080714,1.016534456,0.009,0.027,-0.371,0.162,-0.003,-0.075,Q9DBC0,Selenoo,Q9DBC0_Selenoo,Q9DBC0,Selenoo,1,40,23,23,Q9DBC0|S4R1U9,MOUSE,75118.9,37.9,484,484.1,283.51,283.51,,667,Selenoprotein O,,,,23,40,10100000000,37.9%
Q9CZW5,0.888797538,-0.030833333,1.773157659,0.071666667,0.664789627,0.453339424,0.151,-0.037,-0.314,0.19,0.036,-0.211,Q9CZW5,Tomm70a,Q9CZW5_Tomm70a,Q9CZW5,Tomm70,1,57,21,21,Q9CZW5,MOUSE,68330.7,38.2,485,485.1,282.43,282.43,,611,Mitochondrial import receptor subunit TOM70,mitochondrion|mitochondrial outer membrane|membrane|integral component of membrane|extracellular exosome|,,protein binding|,21,57,16600000000,38.2%
Q9QYJ0,0.956491812,-0.010166667,0.626048468,0.015,0.865755289,0.175658176,-0.044,0.076,-0.085,-0.024,0.011,0.005,Q9QYJ0,Dnaja2,Q9QYJ0_Dnaja2,Q9QYJ0,Dnaja2,1,60,21,21,Q9QYJ0,MOUSE,46372.4,56.3,486,486.1,282.17,282.17,,412,DnaJ homolog subfamily A member 2,nucleus|cytosol|membrane|extracellular exosome|,response to heat|carbon tetrachloride metabolic process|protein refolding|,glycoprotein binding|ATP binding|heat shock protein binding|metal ion binding|unfolded protein binding|chaperone binding|,21,60,11500000000,56.3%
Q9D6M3,0.847271066,-0.022666667,2.384696146,-0.110666667,0.577471274,-0.585728426,0.324,0.145,-0.371,0.027,-0.029,-0.232,Q9D6M3,Slc25a22,Q9D6M3_Slc25a22,Q9D6M3,Slc25a22,1,107,18,18,Q9D6M3|E9Q6M6|E9Q579|Q80X52|A0A0J9YUJ4|Q9DB41|Q9DB41-2,MOUSE,35126.2,68.1,487,487.1,282.04,282.04,,323,Mitochondrial glutamate carrier 1,nucleoplasm|mitochondrion|mitochondrial inner membrane|integral component of membrane|,L-glutamate transport|L-glutamate transmembrane transport|,L-glutamate transmembrane transporter activity|symporter activity|,18,107,1.44E+11,68.1%
Q8VIJ6,0.815095629,0.0005,2.877181122,-0.116333333,0.515563173,-0.686757521,-0.23,0.152,0.254,-0.248,-0.11,0.185,Q8VIJ6,Sfpq,Q8VIJ6_Sfpq,Q8VIJ6,Sfpq,1,62,22,22,Q8VIJ6,MOUSE,75554.5,34.4,488,488.1,281.46,281.46,,699,"Splicing factor, proline- and glutamine-rich",chromatin|nucleus|nucleoplasm|cytoplasm|nuclear matrix|paraspeckles|RNA polymerase II transcription factor complex|,"negative regulation of transcription from RNA polymerase II promoter|alternative mRNA splicing, via spliceosome|double-strand break repair via homologous recombination|transcription, DNA-templated|cellular response to DNA damage stimulus|regulation of circadian rhythm|negative regulation of circadian rhythm|positive regulation of sister chromatid cohesion|negative regulation of transcription, DNA-templated|rhythmic process|chromosome organization|regulation of cell cycle|histone H3 deacetylation|positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|",nucleotide binding|transcription regulatory region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|core promoter binding|chromatin binding|protein binding|histone deacetylase binding|transcription regulatory region DNA binding|poly(A) RNA binding|,22,62,16400000000,34.4%
Q99K48,0.461918472,0.049333333,9.078377609,-0.274,0.123640923,-1.763457729,-0.066,0.437,0.188,-0.242,-0.112,0.091,Q99K48,Nono,Q99K48_Nono,Q99K48,Nono,1,74,23,23,Q99K48|Q99K48-2,MOUSE,54654.1,50.5,489,489.1,281.17,281.17,,473,Non-POU domain-containing octamer-binding protein,nucleus|nucleoplasm|nucleolus|membrane|nuclear matrix|nuclear speck|paraspeckles|RNA polymerase II transcription factor complex|,"DNA repair|DNA recombination|transcription, DNA-templated|mRNA processing|circadian rhythm|RNA splicing|regulation of circadian rhythm|negative regulation of transcription, DNA-templated|negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway|",nucleotide binding|RNA polymerase II distal enhancer sequence-specific DNA binding|core promoter binding|chromatin binding|protein binding|identical protein binding|poly(A) RNA binding|,23,74,23300000000,50.5%
P14869,0.884566234,0.007333333,1.865769589,-0.167333333,0.650763282,-0.47395662,-0.467,-0.076,0.816,-0.524,0.06,0.235,P14869,Rplp0,P14869_Rplp0,P14869,Rplp0,1,82,17,17,P14869,MOUSE,34387,57,490,490.1,280.83,280.83,,317,60S acidic ribosomal protein P0,nucleus|cytoplasm|focal adhesion|membrane|cytosolic large ribosomal subunit|dendrite|ribonucleoprotein complex|cytoplasmic ribonucleoprotein granule|extracellular exosome|,ribosome biogenesis|cellular response to interleukin-4|,poly(A) RNA binding|,17,82,21300000000,57.0%
Q8C2Q3,0.884484678,-0.014166667,1.874098713,0.045,0.649516411,0.475546352,0.005,0.061,-0.176,0.029,-0.008,0.004,Q8C2Q3,Rbm14,Q8C2Q3_Rbm14,Q8C2Q3,Rbm14,1,83,18,15,Q8C2Q3|Q8C2Q3-2|E9QL13|J3QN51|J3QPT3,MOUSE,69618.6,31.8,491,491.1,279.56,229.39,,669,RNA-binding protein 14,nucleoplasm|transcription factor complex|nucleolus|,"transcription, DNA-templated|histone deacetylation|positive regulation of transcription from RNA polymerase II promoter|negative regulation of centriole replication|SMAD protein signal transduction|",nucleotide binding|ligand-dependent nuclear receptor transcription coactivator activity|poly(A) RNA binding|,18,83,28800000000,31.8%
F7BGR7,0.875832617,-0.021166667,2.006595855,-0.047666667,0.629999804,-0.504621533,0.033,-0.018,-0.007,-0.126,-0.104,0.095,F7BGR7,Gm21992,F7BGR7_Gm21992,F7BGR7,Gm21992,1,2,5,2,F7BGR7|B0LM42|Q8C7Q4|Q8VE92,MOUSE,53475,12.3,491,491.2,61.57,11.4,,477,Predicted gene 21992,,,nucleotide binding|nucleic acid binding|zinc ion binding|,2,2,463000000,4.4%
P21271-3,0.318411535,-0.060166667,12.29870461,0.389666667,0.058901932,2.278239089,-0.045,-0.085,-0.635,0.032,0.2,0.172,P21271,NotFound,P21271-3_NotFound,P21271-3,Myo5b,1,49,25,22,P21271-3|G3X9Y9|P21271|G5E8G6|E9Q1F5|A0A1L1SUF0,MOUSE,215088.1,15.5,492,492.1,279.06,252.3,,1818,Isoform 3 of Unconventional myosin-Vb,brush border|myosin complex|protein complex|apical cortex|extracellular exosome|,metabolic process|protein transport|vesicle-mediated transport|endosome localization|,motor activity|actin binding|calmodulin binding|ATP binding|Rab GTPase binding|,26,49,15400000000,15.5%
Q61285,0.516682924,-0.102666667,7.864693749,0.312666667,0.163504845,1.567165361,0.072,-0.144,-0.705,0.131,0.077,-0.047,Q61285,Abcd2,Q61285_Abcd2,Q61285,Abcd2,1,49,21,20,Q61285|A0A0R4J0U5,MOUSE,84166.6,28.2,493,493.1,278.86,267.89,,741,ATP-binding cassette sub-family D member 2,mitochondrion|peroxisome|peroxisomal membrane|integral component of membrane|intracellular membrane-bounded organelle|,very long-chain fatty acid metabolic process|fatty acid beta-oxidation|positive regulation of fatty acid beta-oxidation|very long-chain fatty acid catabolic process|transmembrane transport|,"ATP binding|ATPase activity, coupled to transmembrane movement of substances|protein homodimerization activity|",21,49,25800000000,28.2%
P48410,0.880641665,0.0155,1.92910726,0.056333333,0.641341398,0.487854979,0.017,-0.042,-0.013,0.264,-0.045,-0.088,P48410,Abcd1,P48410_Abcd1,P48410,Abcd1,1,18,9,8,P48410|A2ALN0,MOUSE,82370.9,19,493,493.2,125.13,114.16,,736,ATP-binding cassette sub-family D member 1,cytoplasm|mitochondrion|peroxisome|peroxisomal membrane|integral component of peroxisomal membrane|membrane|perinuclear region of cytoplasm|,fatty acid beta-oxidation|peroxisome organization|peroxisomal long-chain fatty acid import|long-chain fatty acid catabolic process|very long-chain fatty acid catabolic process|transmembrane transport|,"peroxisomal fatty-acyl-CoA transporter activity|protein binding|ATP binding|ATPase activity|enzyme binding|ATPase activity, coupled to transmembrane movement of substances|identical protein binding|protein homodimerization activity|",8,18,19000000000,16.7%
Q76MZ3,0.712762463,-0.005833333,4.339797587,0.088333333,0.368146132,0.964876768,0.037,-0.162,-0.025,0.04,0.087,-0.012,Q76MZ3,Ppp2r1a,Q76MZ3_Ppp2r1a,Q76MZ3,Ppp2r1a,1,51,20,16,Q76MZ3|G3UXQ1|H3BJ83,MOUSE,66120.2,47.7,494,494.1,278.2,226.08,,589,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,"protein phosphatase type 2A complex|chromosome, centromeric region|cytosol|extracellular exosome|","protein complex assembly|chromosome segregation|female meiotic division|regulation of protein phosphatase type 2A activity|meiotic spindle elongation|mitotic sister chromatid separation|meiotic sister chromatid cohesion, centromeric|peptidyl-serine dephosphorylation|regulation of meiotic cell cycle process involved in oocyte maturation|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand|",antigen binding|protein serine/threonine phosphatase activity|protein binding|protein phosphatase type 2A regulator activity|protein heterodimerization activity|,20,51,10000000000,47.7%
G3UWS4,0.009105377,-0.2205,32.68235457,1.579,0.000539218,6.231476029,-0.64,-0.8,-1.59,0.382,0.736,0.589,G3UWS4,Ppp2r1b,G3UWS4_Ppp2r1b,G3UWS4,Ppp2r1b,1,2,6,2,G3UWS4|H3BKU1|Q3TTF6|Q7TNP2|H3BLQ0|H3BLE7|H3BIV7,MOUSE,76804.9,10,494,494.2,67.73,15.61,,694,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform,membrane raft|extracellular exosome|,protein complex assembly|regulation of protein phosphatase type 2A activity|apoptotic process involved in morphogenesis|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand|,protein phosphatase type 2A regulator activity|,2,2,75200000,2.8%
P62242,0.635598413,-0.007833333,5.660674957,-0.105,0.271601713,-1.197970084,0.047,0.11,-0.023,-0.022,-0.018,-0.141,P62242,Rps8,P62242_Rps8,P62242,Rps8,1,108,20,20,P62242,MOUSE,24490,62,495,495.1,278.15,278.15,,208,40S ribosomal protein S8,nucleus|cytoplasm|focal adhesion|membrane|cytosolic small ribosomal subunit|ribonucleoprotein complex|extracellular exosome|,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|translation|",structural constituent of ribosome|poly(A) RNA binding|,20,108,3.19E+11,62.0%
Q05D44,0.926033297,-0.001166667,1.08305962,-0.026333333,0.779280911,-0.291785765,-0.02,0.125,-0.069,0.029,-0.029,-0.043,Q05D44,Eif5b,Q05D44_Eif5b,Q05D44,Eif5b,1,50,25,25,Q05D44,MOUSE,138069.9,29,496,496.1,278,278,,1216,Eukaryotic translation initiation factor 5B,cytoplasm|,translational initiation|regulation of translational initiation|,translation initiation factor activity|GTPase activity|GTP binding|poly(A) RNA binding|,25,50,11900000000,29.0%
Q8BH95,0.821409751,-0.0275,2.754961393,-0.121,0.530278307,-0.662090089,-0.194,0.035,0.258,-0.412,0.161,-0.013,Q8BH95,Echs1,Q8BH95_Echs1,Q8BH95,Echs1,1,72,18,18,Q8BH95,MOUSE,31873.2,72,497,497.1,276.49,276.49,,290,"Enoyl-CoA hydratase, mitochondrial",mitochondrion|mitochondrial matrix|extracellular exosome|,fatty acid beta-oxidation|,enoyl-CoA hydratase activity|,18,72,52300000000,72.0%
A2A5R2,0.88044681,-0.0255,1.936452849,0.055,0.64025756,0.48941637,0.055,0.009,-0.223,0.128,-0.071,-0.051,A2A5R2,Arfgef2,A2A5R2_Arfgef2,A2A5R2,Arfgef2,1,41,23,15,A2A5R2,MOUSE,204689.4,13.8,498,498.1,276.19,183.05,,1792,Brefeldin A-inhibited guanine nucleotide-exchange protein 2,Golgi membrane|trans-Golgi network|microtubule organizing center|cytosol|axonemal microtubule|membrane|cytoplasmic membrane-bounded vesicle|cell junction|cytoplasmic vesicle|asymmetric synapse|symmetric synapse|dendritic spine|perinuclear region of cytoplasm|recycling endosome|,receptor recycling|exocytosis|Golgi to plasma membrane transport|endosome organization|endomembrane system organization|protein transport|vesicle-mediated transport|regulation of ARF protein signal transduction|positive regulation of tumor necrosis factor production|intracellular signal transduction|positive regulation of GTPase activity|,guanyl-nucleotide exchange factor activity|ARF guanyl-nucleotide exchange factor activity|myosin binding|protein kinase A regulatory subunit binding|GABA receptor binding|,23,41,3150000000,13.8%
G3X9K3,0.99327985,-0.007,0.123740809,0.003333333,0.971909706,0.036549484,0.056,0.024,-0.106,0.077,-0.039,-0.054,G3X9K3,Arfgef1,G3X9K3_Arfgef1,G3X9K3,Arfgef1,1,24,23,15,G3X9K3|D3YYK9,MOUSE,210664.2,14,498,498.2,272.46,179.32,,1846,Brefeldin A-inhibited guanine nucleotide-exchange protein 1,Golgi membrane|nucleoplasm|nucleolus|cytoplasm|Golgi apparatus|trans-Golgi network|cytosol|nuclear matrix|small nuclear ribonucleoprotein complex|perinuclear region of cytoplasm|,Golgi organization|endomembrane system organization|protein transport|vesicle-mediated transport|negative regulation of actin filament polymerization|neuron projection development|regulation of ARF protein signal transduction|negative regulation of GTPase activity|positive regulation of GTPase activity|positive regulation of protein kinase B signaling|positive regulation of protein glycosylation in Golgi|positive regulation of wound healing|regulation of establishment of cell polarity|,guanyl-nucleotide exchange factor activity|ARF guanyl-nucleotide exchange factor activity|myosin binding|protein kinase A regulatory subunit binding|,15,24,3600000000,10.2%
Q923B6,0.443938694,0.1685,9.517003793,-0.658333333,0.111763404,-1.833822625,0.055,0.053,1.385,-0.036,-0.319,-0.127,Q923B6,Steap4,Q923B6_Steap4,Q923B6,Steap4,1,64,17,17,Q923B6,MOUSE,53563.6,36.5,499,499.1,275.34,275.34,,470,Metalloreductase STEAP4,Golgi membrane|endosome|plasma membrane|integral component of plasma membrane|extracellular exosome|,copper ion import|fat cell differentiation|iron ion homeostasis|oxidation-reduction process|ferric iron import into cell|,cupric reductase activity|metal ion binding|ferric-chelate reductase (NADPH) activity|,17,64,28000000000,36.5%
J3QML2,0.927777432,-0.060333333,1.037902315,0.049333333,0.787426032,0.280814048,0.124,0.094,-0.473,-0.019,0.063,-0.151,J3QML2,Abcc3,J3QML2_Abcc3,J3QML2,Abcc3,1,45,22,22,J3QML2|A0A0R4J015|B2R2|B2R2-2|B2R2-3|O35379,MOUSE,170646,17.7,500,500.1,275.11,275.11,,1523,Canalicular multispecific organic anion transporter 2,integral component of plasma membrane|,metabolic process|canalicular bile acid transport|transmembrane transport|,"ATP binding|ATPase activity, coupled to transmembrane movement of substances|",22,45,18100000000,17.7%
P32921,0.400494909,-0.005833333,10.36935976,-0.170333333,0.091846799,-1.966294941,0.044,0.091,0.103,-0.009,-0.181,-0.083,P32921,Wars,P32921_Wars,P32921,Wars,1,73,19,19,P32921|P32921-2|E0CXQ4|E0CXX4,MOUSE,54927.5,46.3,501,501.1,274.86,274.86,,481,"Tryptophan--tRNA ligase, cytoplasmic",nucleus|cytoplasm|extracellular exosome|,angiogenesis|tryptophanyl-tRNA aminoacylation|regulation of angiogenesis|,tryptophan-tRNA ligase activity|ATP binding|,19,73,29300000000,46.3%
Q569Z5,0.876086294,-0.0065,1.99967803,-0.041666667,0.631004123,-0.503113968,0.048,0.014,-0.019,0.043,-0.044,-0.081,Q569Z5,Ddx46,Q569Z5_Ddx46,Q569Z5,Ddx46,1,45,24,24,Q569Z5|F8WHR6|Q569Z5-2,MOUSE,117959.7,27.6,502,502.1,274.08,274.08,,1032,Probable ATP-dependent RNA helicase DDX46,nucleus|Cajal body|nuclear speck|,"mRNA splicing, via spliceosome|regulation of gene expression|RNA secondary structure unwinding|",ATP-dependent RNA helicase activity|ATP binding|poly(A) RNA binding|,24,45,4360000000,27.6%
Q9CQT1,0.771800617,-0.001333333,3.566623964,-0.065333333,0.439883431,-0.821010083,0.078,0.019,-0.003,-0.015,-0.066,-0.021,Q9CQT1,Mri1,Q9CQT1_Mri1,Q9CQT1,Mri1,1,64,18,18,Q9CQT1,MOUSE,39695.5,67.4,503,503.1,274.05,274.05,,369,Methylthioribose-1-phosphate isomerase,nucleolus|cytoplasm|,L-methionine biosynthetic process from S-adenosylmethionine|L-methionine biosynthetic process from methylthioadenosine|,identical protein binding|S-methyl-5-thioribose-1-phosphate isomerase activity|,18,64,38700000000,67.4%
Q63932,0.884566234,0.002,1.844248556,-0.040666667,0.653996079,-0.468936203,0.099,-0.002,-0.03,0.051,-0.07,-0.036,Q63932,Map2k2,Q63932_Map2k2,Q63932,Map2k2,1,61,20,12,Q63932|Q91YS7|M0QWN2,MOUSE,44686.5,48.1,504,504.1,272.82,164.19,,401,Dual specificity mitogen-activated protein kinase kinase 2,nucleus|cytoplasm|mitochondrion|early endosome|late endosome|peroxisomal membrane|endoplasmic reticulum|Golgi apparatus|cytosol|microtubule|cell-cell junction|focal adhesion|cell cortex|cytoplasmic side of plasma membrane|perinuclear region of cytoplasm|,activation of MAPK activity|regulation of protein phosphorylation|peptidyl-tyrosine phosphorylation|regulation of stress-activated MAPK cascade|peptidyl-serine autophosphorylation|regulation of axon regeneration|positive regulation of axonogenesis|lung morphogenesis|trachea formation|epithelial cell proliferation involved in lung morphogenesis|ERK1 and ERK2 cascade|positive regulation of protein serine/threonine kinase activity|regulation of Golgi inheritance|positive regulation of cell motility|regulation of early endosome to late endosome transport|,protein serine/threonine kinase activity|MAP kinase kinase activity|protein serine/threonine/tyrosine kinase activity|protein tyrosine kinase activity|protein binding|ATP binding|PDZ domain binding|protein complex scaffold|protein serine/threonine kinase activator activity|scaffold protein binding|,20,61,22000000000,48.1%
P31938,0.496866931,0.001833333,8.273758635,-0.128333333,0.148807266,-1.631189256,0.054,0.038,0.106,-0.036,-0.07,-0.081,P31938,Map2k1,P31938_Map2k1,P31938,Map2k1,1,17,18,10,P31938,MOUSE,43815.6,44,504,504.2,226.17,117.54,,393,Dual specificity mitogen-activated protein kinase kinase 1,nucleus|cytoplasm|mitochondrion|early endosome|late endosome|endoplasmic reticulum|Golgi apparatus|microtubule organizing center|cytosol|microtubule|plasma membrane|focal adhesion|cell cortex|axon|dendrite cytoplasm|perikaryon|perinuclear region of cytoplasm|extracellular exosome|,activation of MAPK activity|regulation of protein phosphorylation|regulation of vascular smooth muscle contraction|protein phosphorylation|response to oxidative stress|cell cycle arrest|mitotic nuclear division|negative regulation of cell proliferation|positive regulation of gene expression|peptidyl-tyrosine phosphorylation|neuron differentiation|keratinocyte differentiation|positive regulation of cell migration|melanosome transport|regulation of stress-activated MAPK cascade|positive regulation of transcription elongation from RNA polymerase II promoter|negative regulation of homotypic cell-cell adhesion|positive regulation of GTPase activity|positive regulation of cell differentiation|positive regulation of Ras protein signal transduction|vesicle transport along microtubule|Golgi inheritance|response to axon injury|regulation of axon regeneration|neuron projection morphogenesis|cell motility|positive regulation of axonogenesis|protein heterooligomerization|response to glucocorticoid|lung morphogenesis|trachea formation|epithelial cell proliferation involved in lung morphogenesis|placenta blood vessel development|labyrinthine layer development|ERK1 and ERK2 cascade|positive regulation of protein serine/threonine kinase activity|regulation of Golgi inheritance|cellular senescence|activation of mitophagy in response to mitochondrial depolarization|regulation of early endosome to late endosome transport|,protein serine/threonine kinase activity|MAP kinase kinase activity|protein serine/threonine/tyrosine kinase activity|protein tyrosine kinase activity|receptor signaling protein tyrosine phosphatase activity|protein binding|ATP binding|protein C-terminus binding|Ras GTPase binding|mitogen-activated protein kinase kinase kinase binding|protein serine/threonine kinase activator activity|protein N-terminus binding|,10,17,5120000000,27.2%
P35123,0.953420192,-0.014,0.691093697,0.016666667,0.852885302,0.192728572,0.036,0.023,-0.126,0.01,-0.013,-0.014,P35123,Usp4,P35123_Usp4,P35123,Usp4,1,36,21,20,P35123|A0A0A6YW28|A0A0A6YVY7|Q99K46,MOUSE,109767.3,32.8,505,505.1,272.55,261.15,,962,Ubiquitin carboxyl-terminal hydrolase 4,nucleus|cytoplasm|plasma membrane|,spliceosomal tri-snRNP complex assembly|protein deubiquitination|negative regulation of protein ubiquitination|regulation of protein stability|protein localization to cell surface|proteasome-mediated ubiquitin-dependent protein catabolic process|regulation of proteasomal protein catabolic process|,cysteine-type endopeptidase activity|ubiquitin-specific protease activity|protein binding|adenosine receptor binding|identical protein binding|metal ion binding|,21,36,3570000000,32.8%
Q8R5H1,0.744748173,-0.019833333,3.89259924,-0.073666667,0.408075082,-0.882480242,0.043,-0.058,0.066,-0.086,-0.015,-0.069,Q8R5H1,Usp15,Q8R5H1_Usp15,Q8R5H1,Usp15,1,8,8,7,Q8R5H1|Q8R5H1-2|Q8R5H1-5|Q8R5H1-4|Q8R5H1-3,MOUSE,113578,9.7,505,505.2,92.41,81.01,,981,Ubiquitin carboxyl-terminal hydrolase 15,nucleus|cytoplasm|,transforming growth factor beta receptor signaling pathway|protein deubiquitination|BMP signaling pathway|monoubiquitinated protein deubiquitination|histone H2B conserved C-terminal lysine deubiquitination|proteasome-mediated ubiquitin-dependent protein catabolic process|pathway-restricted SMAD protein phosphorylation|regulation of proteasomal protein catabolic process|,cysteine-type endopeptidase activity|ubiquitin-specific protease activity|transforming growth factor beta receptor binding|identical protein binding|SMAD binding|ubiquitinated histone binding|,7,8,421000000,8.7%
P27786,0.87311559,0.005,2.069515836,-0.205333333,0.620938254,-0.518568235,0.32,0.822,-0.819,0.114,-0.107,-0.3,P27786,Cyp17a1,P27786_Cyp17a1,P27786,Cyp17a1,1,53,21,21,P27786,MOUSE,58036.2,44.9,506,506.1,272.44,272.44,,507,"Steroid 17-alpha-hydroxylase/17,20 lyase",mitochondrion|membrane|axon|neuronal cell body|,glucocorticoid biosynthetic process|steroid metabolic process|hormone biosynthetic process|progesterone metabolic process|oxidation-reduction process|,steroid 17-alpha-monooxygenase activity|iron ion binding|heme binding|17-alpha-hydroxyprogesterone aldolase activity|,21,53,21300000000,44.9%
P24369,0.043922217,-0.105333333,24.28347264,0.838666667,0.003729518,4.372332933,-0.916,-0.239,-0.419,0.156,0.281,0.505,P24369,Ppib,P24369_Ppib,P24369,Ppib,1,93,20,20,P24369,MOUSE,23713,61.1,507,507.1,271.72,271.72,,216,Peptidyl-prolyl cis-trans isomerase B,nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|focal adhesion|membrane|macromolecular complex|endoplasmic reticulum chaperone complex|melanosome|perinuclear region of cytoplasm|extracellular exosome|,protein peptidyl-prolyl isomerization|positive regulation of multicellular organism growth|positive regulation by host of viral process|positive regulation by host of viral genome replication|protein stabilization|bone development|chaperone-mediated protein folding|,peptidyl-prolyl cis-trans isomerase activity|protein complex binding|peptide binding|poly(A) RNA binding|RNA polymerase binding|collagen binding|,20,93,1.11E+11,61.1%
Q8BX70,0.570662736,0.022333333,6.967896406,-0.136666667,0.201006619,-1.417985123,-0.023,0.108,0.187,0.028,-0.128,-0.038,Q8BX70,Vps13c,Q8BX70_Vps13c,Q8BX70,Vps13c,1,35,23,22,Q8BX70|Q8BX70-3|Q8BX70-2|A0A1L1SUY8|O88935-3,MOUSE,422420.4,7.6,508,508.1,271.39,266.14,,3748,Vacuolar protein sorting-associated protein 13C,intracellular|cell|extrinsic component of membrane|extracellular exosome|,protein targeting to vacuole|protein retention in Golgi apparatus|,,23,35,1570000000,7.6%
Q9CY64,0.342671556,0.038666667,11.62024743,-0.237333333,0.068861306,-2.166093625,0.082,0.036,0.354,-0.115,-0.038,-0.087,Q9CY64,Blvra,Q9CY64_Blvra,Q9CY64,Blvra,1,57,18,18,Q9CY64|A2ASB8,MOUSE,33695.1,58.9,509,509.1,270.95,270.95,,295,Biliverdin reductase A,cytoplasm|extracellular exosome|,heme catabolic process|oxidation-reduction process|,nucleotide binding|biliverdin reductase activity|zinc ion binding|,18,57,17500000000,58.9%
P27046,0.001531196,-0.0435,42.33246225,0.909,5.84459E-05,8.930319649,-0.444,-0.419,-0.631,0.385,0.518,0.33,P27046,Man2a1,P27046_Man2a1,P27046,Man2a1,1,38,21,21,P27046,MOUSE,132370.8,23.2,510,510.1,270.54,270.54,,1150,Alpha-mannosidase 2,Golgi membrane|Golgi apparatus|cis-Golgi network|membrane|integral component of membrane|extracellular exosome|,in utero embryonic development|liver development|mannose metabolic process|N-glycan processing|mitochondrion organization|vacuole organization|respiratory gaseous exchange|lung alveolus development|positive regulation of neurogenesis|retina morphogenesis in camera-type eye|,"mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity|zinc ion binding|mannosidase activity|hydrolase activity, hydrolyzing N-glycosyl compounds|carbohydrate binding|",21,38,2560000000,23.2%
Q9Z1J3,0.81292793,-0.002333333,2.904519595,-0.064,0.512327939,-0.691794861,0.069,0.11,-0.09,0.006,-0.018,-0.091,Q9Z1J3,Nfs1,Q9Z1J3_Nfs1,Q9Z1J3,Nfs1,1,67,21,21,Q9Z1J3|A6QRH3,MOUSE,50968.5,55.3,511,511.1,268.78,268.78,,459,"Cysteine desulfurase, mitochondrial",nucleus|nucleoplasm|nucleolus|cytoplasm|mitochondrion|mitochondrial matrix|cytosol|intracellular membrane-bounded organelle|,cysteine metabolic process|Mo-molybdopterin cofactor biosynthetic process|iron incorporation into metallo-sulfur cluster|,pyridoxal phosphate binding|cysteine desulfurase activity|protein homodimerization activity|metal ion binding|iron-sulfur cluster binding|,21,67,26900000000,55.3%
Q3TDN2,0.843952565,-8.67362E-19,2.447440141,-0.052,0.569188328,-0.598496797,0.018,0.122,-0.062,-0.013,-0.034,-0.031,Q3TDN2,Faf2,Q3TDN2_Faf2,Q3TDN2,Faf2,1,46,20,20,Q3TDN2|Q3TDN2-2|D6RE51,MOUSE,52812.7,55.2,512,512.1,268.65,268.65,,445,FAS-associated factor 2,endoplasmic reticulum|lipid particle|VCP-NPL4-UFD1 AAA ATPase complex|intracellular membrane-bounded organelle|,"response to unfolded protein|ER-associated ubiquitin-dependent protein catabolic process|retrograde protein transport, ER to cytosol|lipid particle organization|negative regulation of catalytic activity|",ubiquitin protein ligase binding|lipase binding|ubiquitin binding|lipase inhibitor activity|,20,46,8980000000,55.2%
P47757-2,0.430366134,-0.034666667,9.791597397,0.405333333,0.104915646,1.877773883,-0.217,0.111,-0.606,-0.137,0.386,0.255,P47757,Capzb,P47757-2_Capzb,P47757-2,Capzb,1,64,21,21,P47757-2|P47757-4|A2AMW0|P47757,MOUSE,30970.5,69.1,513,513.1,268.57,268.57,,277,Isoform 2 of F-actin-capping protein subunit beta,actin filament|brush border|F-actin capping protein complex|intercalated disc|membrane|Z disc|lamellipodium|cortical cytoskeleton|cytoskeletal calyx|extracellular exosome|WASH complex|acrosomal vesicle|,cell morphogenesis|cytoskeleton organization|regulation of lamellipodium assembly|regulation of cell morphogenesis|cell projection organization|lamellipodium assembly|actin cytoskeleton organization|negative regulation of microtubule polymerization|neuron projection development|muscle fiber development|barbed-end actin filament capping|negative regulation of filopodium assembly|regulation of protein kinase C signaling|,protein binding|beta-tubulin binding|protein binding|actin filament binding|,21,64,21400000000,69.1%
Q8K370,0.858120828,-0.011666667,2.232906594,-0.074666667,0.598011231,-0.553650458,0.085,0.234,-0.242,-0.062,0.007,-0.092,Q8K370,Acad10,Q8K370_Acad10,Q8K370,Acad10,1,38,20,20,Q8K370|D3Z7X0|D3Z2B3,MOUSE,119889.9,23.5,514,514.1,268.16,268.16,,1069,Acyl-CoA dehydrogenase family member 10,mitochondrion|,oxidation-reduction process|,acyl-CoA dehydrogenase activity|hydrolase activity|flavin adenine dinucleotide binding|,20,38,4350000000,23.5%
Q00897,0.252386245,-0.004166667,14.11762814,0.409666667,0.03874692,2.571450634,-0.183,-0.03,-0.414,0.025,0.096,0.481,Q00897,Serpina1d,Q00897_Serpina1d,Q00897,Serpina1d,1,65,19,5,Q00897|Q00898,MOUSE,46168.7,46.2,515,515.1,267.94,78.1,,413,Alpha-1-antitrypsin 1-4,extracellular region|extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|identical protein binding|,19,65,31400000000,46.2%
P22599,0.034283912,0.035,25.63407114,0.727333333,0.002732706,4.643345872,-0.292,-0.191,-0.503,0.112,0.462,0.622,P22599,Serpina1b,P22599_Serpina1b,P22599,Serpina1b,1,17,15,3,P22599,MOUSE,46145,31.9,515,515.2,201.14,48.13,,413,Alpha-1-antitrypsin 1-2,extracellular region|extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,in utero embryonic development|protein N-linked glycosylation|acute-phase response|negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|protein binding|identical protein binding|,3,17,6930000000,9.6%
A0A0A0MQA3,0.683428593,-0.0355,4.815364608,0.157,0.329961705,1.051337618,0.012,0.034,-0.388,0.032,-0.112,0.209,A0A0A0MQA3,Serpina1a,A0A0A0MQA3_Serpina1a,A0A0A0MQA3,Serpina1a,1,12,14,4,A0A0A0MQA3|P07758,MOUSE,49023.3,33.7,515,515.3,206.14,68.36,,436,Alpha-1-antitrypsin 1-1,extracellular region|extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,protein N-linked glycosylation|negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|protein binding|identical protein binding|,4,12,4210000000,16.9%
Q8VEM8,0.956385108,-0.074333333,0.638891311,-0.036666667,0.863198881,-0.179123979,0.199,0.14,-0.507,0.012,-0.011,-0.279,Q8VEM8,Slc25a3,Q8VEM8_Slc25a3,Q8VEM8,Slc25a3,1,104,18,18,Q8VEM8|G5E902,MOUSE,40088,53.2,516,516.1,265.97,265.97,,357,"Phosphate carrier protein, mitochondrial",mitochondrion|mitochondrial inner membrane|membrane|integral component of membrane|myelin sheath|extracellular exosome|,transmembrane transport|,symporter activity|protein complex binding|,18,104,2.58E+11,53.2%
Q9JHJ0,0.318107191,-0.021,12.32079337,0.709333333,0.05860311,2.281777353,-0.221,0.084,-0.99,-0.103,0.507,0.597,Q9JHJ0,Tmod3,Q9JHJ0_Tmod3,Q9JHJ0,Tmod3,1,75,18,18,Q9JHJ0|A0A1L1SQ12,MOUSE,39616.1,62.2,517,517.1,264.89,264.89,,352,Tropomodulin-3,ruffle|cytoskeleton|striated muscle thin filament|myofibril|lamellipodium|filamentous actin|,muscle contraction|actin filament organization|actin cytoskeleton organization|myofibril assembly|erythrocyte development|negative regulation of cellular component movement|pointed-end actin filament capping|positive regulation of mitotic cell cycle phase transition|,actin binding|tropomyosin binding|microtubule minus-end binding|,18,75,33900000000,62.2%
P47754,0.512197848,-0.053333333,7.998025603,0.301333333,0.158561388,1.58887957,-0.117,0.081,-0.576,-0.123,0.219,0.196,P47754,Capza2,P47754_Capza2,P47754,Capza2,1,45,18,15,P47754|D6RCW7,MOUSE,33137.6,68.8,518,518.1,264.21,235.84,,286,F-actin-capping protein subunit alpha-2,brush border|F-actin capping protein complex|membrane|cortical cytoskeleton|extracellular exosome|,barbed-end actin filament capping|,actin binding|protein binding|,18,45,23200000000,68.8%
Q5RKN9,0.578909417,-0.016333333,6.777328539,0.231333333,0.210023139,1.388111841,-0.123,0.165,-0.438,-0.057,0.19,0.165,Q5RKN9,Capza1,Q5RKN9_Capza1,Q5RKN9,Capza1,1,32,15,12,Q5RKN9|P47753,MOUSE,33124.3,61.1,518,518.2,186.92,158.55,,286,"Capping protein (Actin filament) muscle Z-line, alpha 1",cell-cell junction|F-actin capping protein complex|membrane|cortical cytoskeleton|extracellular exosome|WASH complex|,barbed-end actin filament capping|,protein binding|protein binding|actin filament binding|,12,32,16100000000,53.4%
A2AJ72,0.473411328,-0.0075,8.681989704,-0.144333333,0.135456868,-1.69695367,0.037,0.08,0.077,-0.024,-0.172,-0.043,A2AJ72,Fubp3,A2AJ72_Fubp3,A2AJ72,Fubp3,1,52,20,20,A2AJ72|Q3TIX6|A0A0A6YX76,MOUSE,61731.5,44.8,519,519.1,263.99,263.99,,569,Far upstream element (FUSE)-binding protein 3,nucleus|cytoplasm|membrane|,"transcription, DNA-templated|transcription from RNA polymerase II promoter|positive regulation of gene expression|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|",RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|single-stranded DNA binding|poly(A) RNA binding|,20,52,9320000000,44.8%
Q9QXD1,0.927777432,0.005833333,1.038584257,-0.049,0.787302398,-0.280982372,0.024,0.368,-0.301,0.082,-0.014,-0.124,Q9QXD1,Acox2,Q9QXD1_Acox2,Q9QXD1,Acox2,1,60,22,22,Q9QXD1,MOUSE,77546,29.8,520,520.1,263.63,263.63,,681,Peroxisomal acyl-coenzyme A oxidase 2,peroxisome|,fatty acid beta-oxidation|,"acyl-CoA dehydrogenase activity|acyl-CoA oxidase activity|receptor binding|fatty acid binding|3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity|flavin adenine dinucleotide binding|",22,60,10600000000,29.8%
Q9D172,0.904214516,-0.045,1.55321347,-0.082,0.699324354,-0.403457565,0.185,0.254,-0.451,0.094,-0.14,-0.212,Q9D172,D10Jhu81e,Q9D172_D10Jhu81e,Q9D172,D10Jhu81e,1,66,15,15,Q9D172,MOUSE,28432.3,64.2,521,521.1,263.39,263.39,,266,"ES1 protein homolog, mitochondrial",mitochondrion|,,,15,66,88100000000,64.2%
P52479-2,0.4461014,0.005833333,9.48139727,-0.167666667,0.112683486,-1.824932478,0.052,0.207,0.01,-0.022,-0.104,-0.108,P52479,Usp10,P52479-2_Usp10,P52479-2,Usp10,1,40,19,19,P52479-2|P52479,MOUSE,87776.2,34,522,522.1,263.29,263.29,,792,Isoform 2 of Ubiquitin carboxyl-terminal hydrolase 10,nucleus|cytoplasm|early endosome|,"DNA repair|autophagy|regulation of autophagy|protein deubiquitination|DNA damage response, signal transduction by p53 class mediator|proteasome-mediated ubiquitin-dependent protein catabolic process|regulation of proteasomal protein catabolic process|",p53 binding|cysteine-type endopeptidase activity|ubiquitin-specific protease activity|ion channel binding|poly(A) RNA binding|,19,40,11300000000,34.0%
Q9CQQ7,0.791316333,-0.011833333,3.251371734,-0.091,0.473001836,-0.760796871,0.093,0.172,-0.164,-0.038,0.04,-0.174,Q9CQQ7,Atp5f1,Q9CQQ7_Atp5f1,Q9CQQ7,Atp5f1,1,135,19,19,Q9CQQ7,MOUSE,29062.4,53.1,523,523.1,263.28,263.28,,256,"ATP synthase F(0) complex subunit B1, mitochondrial","mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)|nucleus|nucleoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial proton-transporting ATP synthase complex|membrane|myelin sheath|extracellular exosome|",ATP synthesis coupled proton transport|substantia nigra development|,"ATPase activity|proton-transporting ATP synthase activity, rotational mechanism|",19,135,2.54E+11,53.1%
E9Q9C3,0.894455479,0.0075,1.663273281,0.040333333,0.681824609,0.428364476,-0.07,0.034,-0.002,-0.064,-0.005,0.152,E9Q9C3,Afdn,E9Q9C3_Afdn,E9Q9C3,Afdn,1,42,23,23,E9Q9C3|Q9QZQ1|Q9QZQ1-2|E9Q852|E9PYX7,MOUSE,208278.9,15.2,524,524.1,263.09,263.09,,1827,Afadin,nucleoplasm|cytoplasm|plasma membrane|cell-cell junction|adherens junction|cell-cell adherens junction|cell junction|apical part of cell|,signal transduction|positive regulation of GTPase activity|establishment of endothelial intestinal barrier|,protein binding|Ras GTPase binding|,23,42,2440000000,15.2%
Q91YP3,0.318107191,-0.0355,12.34222506,0.377666667,0.058314626,2.285210758,0.01,-0.143,-0.54,0.302,0.179,-0.021,Q91YP3,Dera,Q91YP3_Dera,Q91YP3,Dera,1,63,21,21,Q91YP3|A0A0N4SV34|A0A0N4SVW1,MOUSE,35317.1,70.7,525,525.1,263.05,263.05,,318,Deoxyribose-phosphate aldolase,nucleus|cytoplasm|extracellular exosome|,deoxyribonucleotide catabolic process|carbohydrate catabolic process|deoxyribonucleoside catabolic process|deoxyribose phosphate catabolic process|,deoxyribose-phosphate aldolase activity|,21,63,12100000000,70.7%
Q1HFZ0,0.934571417,0.0115,0.940649524,0.027,0.805257999,0.256527421,0.061,0.012,-0.079,0.182,-0.107,0,Q1HFZ0,Nsun2,Q1HFZ0_Nsun2,Q1HFZ0,Nsun2,1,45,18,18,Q1HFZ0|H3BKN0|Q1HFZ0-2,MOUSE,86305.9,30.6,526,526.1,262.98,262.98,,757,tRNA (cytosine(34)-C(5))-methyltransferase,nucleus|nucleolus|cytoplasm|spindle|chromatoid body|,mitotic nuclear division|spermatid development|tRNA methylation|meiotic cell cycle checkpoint|cell division|,tRNA binding|tRNA (cytosine-5-)-methyltransferase activity|poly(A) RNA binding|,18,45,15800000000,30.6%
Q9Z1N5,0.13182316,0.039666667,18.35227008,-0.406,0.014614131,-3.279475823,0.098,0.492,0.138,-0.142,-0.191,-0.157,Q9Z1N5,Ddx39b,Q9Z1N5_Ddx39b,Q9Z1N5,Ddx39b,1,63,22,12,Q9Z1N5,MOUSE,49491,56,527,527.1,262.49,158.05,,428,Spliceosome RNA helicase Ddx39b,transcription export complex|nucleus|nucleoplasm|spliceosomal complex|nuclear speck|U4 snRNP|U6 snRNP|cytoplasm|,"spliceosomal complex assembly|mRNA splicing, via spliceosome|mRNA export from nucleus|cellular response to DNA damage stimulus|RNA splicing|regulation of gene expression|RNA secondary structure unwinding|positive regulation of DNA-templated transcription, elongation|viral mRNA export from host cell nucleus|negative regulation of DNA damage checkpoint|",ATP-dependent RNA helicase activity|ATP binding|RNA-dependent ATPase activity|U6 snRNA binding|U4 snRNA binding|ATP-dependent protein binding|poly(A) RNA binding|,22,63,32200000000,56.0%
Q8VDW0,0.222758524,0.003666667,15.07830707,-0.22,0.0310577,-2.720284391,0.12,0.119,0.102,-0.098,-0.169,-0.052,Q8VDW0,Ddx39,Q8VDW0_Ddx39,Q8VDW0,Ddx39a,1,28,19,9,Q8VDW0|Q8VDW0-2|D6RHT5,MOUSE,49580,47,527,527.2,222.93,118.49,,427,ATP-dependent RNA helicase DDX39A,nucleus|spliceosomal complex|membrane|cytoplasm|,"mRNA splicing, via spliceosome|mRNA export from nucleus|cellular response to DNA damage stimulus|regulation of gene expression|RNA secondary structure unwinding|",ATP-dependent RNA helicase activity|ATP binding|poly(A) RNA binding|,9,28,9490000000,29.9%
Q00PI9,0.247096783,-0.003333333,14.30594949,-0.264,0.03710266,-2.594879521,0.008,0.208,0.17,-0.211,-0.182,-0.013,Q00PI9,Hnrnpul2,Q00PI9_Hnrnpul2,Q00PI9,Hnrnpul2,1,58,20,20,Q00PI9,MOUSE,85566.3,30.6,528,528.1,262.39,262.39,,745,Heterogeneous nuclear ribonucleoprotein U-like protein 2,nucleus|membrane|,,protein binding|poly(A) RNA binding|,20,58,10500000000,30.6%
Q69ZS7,0.991556352,-0.016166667,0.161213944,0.005,0.963559651,0.047425453,0.06,0.048,-0.164,0.095,-0.111,-0.025,Q69ZS7,Hbs1l,Q69ZS7_Hbs1l,Q69ZS7,Hbs1l,1,50,21,21,Q69ZS7|Q3TGM7|Q69ZS7-2|L7N209|Q69ZS7-3|J3KMK0,MOUSE,75669.7,45,529,529.1,262.35,262.35,,682,HBS1-like protein,membrane|extracellular exosome|,translational elongation|,translation elongation factor activity|GTPase activity|GTP binding|,21,50,8670000000,45.0%
E9QN99,0.857449938,-0.008333333,2.266110915,-0.060666667,0.593456524,-0.560462727,0.096,0.129,-0.159,0.008,-0.006,-0.118,E9QN99,Abhd14b,E9QN99_Abhd14b,E9QN99,Abhd14b,1,105,15,15,E9QN99|Q8VCR7|A0A1L1SU,MOUSE,22564.5,95.7,530,530.1,262.2,262.2,,210,Protein ABHD14B,nucleus|nucleolus|cytoplasm|cytosol|extracellular exosome|,metabolic process|positive regulation of transcription from RNA polymerase II promoter|,hydrolase activity|,15,105,3.37E+11,95.7%
Q5U458,0.835456306,-0.114833333,2.590090644,-0.163666667,0.5507962,-0.62840269,-0.515,0.245,0.171,-0.606,-0.076,0.092,Q5U458,Dnajc11,Q5U458_Dnajc11,Q5U458,Dnajc11,1,45,21,21,Q5U458|E9Q8B3,MOUSE,63574.2,43.1,531,531.1,261.82,261.82,,559,DnaJ homolog subfamily C member 11,mitochondrion|mitochondrial inner membrane|extracellular exosome|,,,21,45,25400000000,43.1%
P14824,0.218091343,0.1075,15.22981316,0.709666667,0.029992916,2.753296448,-0.527,-0.274,0.059,-0.061,0.626,0.822,P14824,Anxa6,P14824_Anxa6,P14824,Anxa6,1,47,21,21,P14824|F8WIT2,MOUSE,76340.4,34.1,532,532.1,261.55,261.55,,673,Annexin A6,mitochondrion|lysosomal membrane|cytosol|focal adhesion|membrane|late endosome membrane|melanosome|perinuclear region of cytoplasm|extracellular exosome|,calcium ion transport|regulation of muscle contraction|ion transmembrane transport|protein homooligomerization|mitochondrial calcium ion homeostasis|apoptotic signaling pathway|,calcium ion binding|GTP binding|calcium-dependent phospholipid binding|lipid binding|ligand-gated ion channel activity|cholesterol binding|protein homodimerization activity|calcium-dependent protein binding|,21,47,9290000000,34.1%
P46978,0.741296456,0.004333333,3.946942777,-0.102,0.403000627,-0.893045098,-0.108,0.138,0.136,0.073,-0.181,-0.032,P46978,Stt3a,P46978_Stt3a,P46978,Stt3a,1,81,20,20,P46978,MOUSE,81166.7,23.9,533,533.1,260.11,260.11,,705,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A,oligosaccharyltransferase complex|membrane|integral component of membrane|,protein N-linked glycosylation via asparagine|co-translational protein modification|,dolichyl-diphosphooligosaccharide-protein glycotransferase activity|dolichyl-diphosphooligosaccharide-protein glycotransferase activity|,20,81,46800000000,23.9%
O09158,0.140457009,0.023666667,17.96817383,-0.523333333,0.015965503,-3.213267087,0.22,0.594,0.042,-0.241,-0.082,-0.391,O09158,Cyp3a25,O09158_Cyp3a25,O09158,Cyp3a25,1,65,20,20,O09158|D3Z2W7|D3YYZ0|D6RJM4|A0A0G2JE14|D3Z707,MOUSE,58406.4,36.9,534,534.1,260.07,260.07,,503,Cytochrome P450 3A25,endoplasmic reticulum membrane|,oxidation-reduction process|,iron ion binding|heme binding|aromatase activity|,20,65,31900000000,36.9%
Q91Z40,0.821409751,-0.022166667,2.75011046,0.085666667,0.530870942,0.661105783,0.126,-0.208,-0.113,0.147,-0.158,0.073,Q91Z40,Gbp7,Q91Z40_Gbp7,Q91Z40,Gbp7,1,34,21,20,Q91Z40|Q61107,MOUSE,73233.1,36.3,535,535.1,259.91,253.22,,638,Gbp6 protein,symbiont-containing vacuole membrane|cytoplasmic vesicle|,metabolic process|defense response to protozoan|adhesion of symbiont to host|defense response to Gram-positive bacterium|cellular response to interferon-gamma|,GTPase activity|GTP binding|,21,34,21600000000,36.3%
L7N1X8,0.956385108,-0.021166667,0.640618806,-0.022333333,0.862855595,-0.17957905,0.173,-0.046,-0.157,0.025,-0.194,0.072,L7N1X8,NotFound,L7N1X8_NotFound,L7N1X8,Gm43302,1,12,15,10,A0A0G2JDV3|L7N1X8|Q000W5|A9YVJ5,MOUSE,71007,32.5,535,535.2,161.75,105.82,,611,Predicted gene 43302,,immune response|metabolic process|defense response to bacterium|cellular response to interferon-gamma|,GTPase activity|GTP binding|,10,12,780000000,23.2%
Q8BTS3,0.708523608,-0.010166667,4.412267897,0.089,0.362053884,0.978039177,0.037,-0.145,-0.056,0.06,-0.038,0.081,Q8BTS3,Gbp9,Q8BTS3_Gbp9,Q8BTS3,Gbp9,1,5,10,5,Q8BTS3,MOUSE,71967.9,17.1,535,535.3,100.82,44.89,,619,Guanylate-binding protein 9,symbiont-containing vacuole membrane|cytoplasmic vesicle|extracellular exosome|,metabolic process|defense response to protozoan|adhesion of symbiont to host|defense response to Gram-positive bacterium|cellular response to interferon-gamma|,GTPase activity|GTP binding|,5,5,372000000,10.0%
Q3TCH7,0.919416995,-0.004833333,1.250103432,0.035,0.74987635,0.332246555,0.086,0.028,-0.181,0.067,0.053,-0.082,Q3TCH7,Cul4a,Q3TCH7_Cul4a,Q3TCH7,Cul4a,1,41,22,12,Q3TCH7|E9PXT5,MOUSE,88265.3,26.4,536,536.1,259.53,144.11,,759,Cullin-4A,Cul4A-RING E3 ubiquitin ligase complex|Cul4-RING E3 ubiquitin ligase complex|,in utero embryonic development|DNA repair|ubiquitin-dependent protein catabolic process|positive regulation of cell proliferation|viral process|hemopoiesis|negative regulation of granulocyte differentiation|somatic stem cell maintenance|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|positive regulation of protein catabolic process|regulation of protein metabolic process|positive regulation of G1/S transition of mitotic cell cycle|regulation of DNA damage checkpoint|regulation of nucleotide-excision repair|,protein binding|ubiquitin protein ligase binding|ubiquitin protein ligase activity|,22,41,6150000000,26.4%
A2A432,0.931624461,-0.018,0.985599766,-0.024666667,0.796966421,-0.26772767,0.073,0.038,-0.128,-0.036,0.015,-0.07,A2A432,Cul4b,A2A432_Cul4b,A2A432,Cul4b,1,12,16,6,A2A432|A2A432-2|E9PXY1|J3QJX0,MOUSE,111382.1,14.8,536,536.2,184.55,69.13,,970,Cullin-4B,nucleoplasm|cytoplasm|cytosol|plasma membrane|Cul4B-RING E3 ubiquitin ligase complex|extracellular exosome|,cell cycle|neuron projection development|histone H2A monoubiquitination|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of protein catabolic process|UV-damage excision repair|positive regulation of G1/S transition of mitotic cell cycle|,ubiquitin protein ligase binding|damaged DNA binding|ubiquitin protein ligase activity|,6,12,921000000,7.5%
Q9ERK4,0.774891394,-0.012666667,3.462849967,0.097333333,0.450520963,0.801737641,0.101,-0.035,-0.25,0.159,0.02,-0.071,Q9ERK4,Cse1l,Q9ERK4_Cse1l,Q9ERK4,Cse1l,1,40,20,20,Q9ERK4|E9Q1T9|E9QAX7,MOUSE,111251.3,25.9,537,537.1,259.26,259.26,,971,Exportin-2,nucleoplasm|cytoplasm|membrane|extracellular exosome|,intracellular protein transport|,protein binding|Ran GTPase binding|,20,40,18300000000,25.9%
Q9QXF8,0.737891985,-0.035166667,3.973665596,0.149,0.400528515,0.898279558,0.048,0.039,-0.416,-0.057,0.263,-0.088,Q9QXF8,Gnmt,Q9QXF8_Gnmt,Q9QXF8,Gnmt,1,101,17,17,Q9QXF8,MOUSE,33131.1,65.5,538,538.1,259.25,259.25,,293,Glycine N-methyltransferase,cytoplasm|,glycogen metabolic process|regulation of gluconeogenesis|methionine metabolic process|one-carbon metabolic process|methylation|S-adenosylmethionine metabolic process|protein homotetramerization|,folic acid binding|glycine binding|glycine N-methyltransferase activity|,17,101,2.03E+11,65.5%
Q8K440,0.915850537,0.0015,1.306124518,-0.033,0.740265566,-0.345570025,0.094,0.083,-0.123,0.031,-0.038,-0.038,Q8K440,Abca8b,Q8K440_Abca8b,Q8K440,Abca8b,1,32,23,23,Q8K440|Q8K440-2,MOUSE,184462.1,18.1,539,539.1,259.14,259.14,,1620,ATP-binding cassette sub-family A member 8-B,mitochondrial inner membrane|plasma membrane|integral component of membrane|intracellular membrane-bounded organelle|,transport|lipid transport|metabolic process|transmembrane transport|,"ATP binding|ATPase activity, coupled to transmembrane movement of substances|",23,32,3590000000,18.1%
Q3TWV4,0.336787221,0.015666667,11.73001987,-0.338666667,0.067142578,-2.187268025,-0.084,0.323,0.316,-0.372,-0.068,-0.021,Q3TWV4,Ap2m1,Q3TWV4_Ap2m1,Q3TWV4,Ap2m1,1,72,21,21,Q3TWV4|P84091,MOUSE,49730.8,46.4,540,540.1,258.41,258.41,,433,AP-2 complex subunit mu,mitochondrion|clathrin adaptor complex|secretory granule|extracellular exosome|,intracellular protein transport|vesicle-mediated transport|negative regulation of protein localization to plasma membrane|,signal sequence binding|,21,72,33600000000,46.4%
Q6P4T2,0.853517287,-0.006,2.341045351,-0.076666667,0.583304685,-0.57655236,-0.219,0.165,0.151,-0.095,-0.119,0.081,Q6P4T2,Snrnp200,Q6P4T2_Snrnp200,Q6P4T2,Snrnp200,1,32,23,23,Q6P4T2,MOUSE,246196.8,13.2,541,541.1,258.09,258.09,,2136,U5 small nuclear ribonucleoprotein 200 kDa helicase,nucleus|nucleoplasm|spliceosomal complex|U5 snRNP|membrane|catalytic step 2 spliceosome|,"mRNA splicing, via spliceosome|osteoblast differentiation|",ATP-dependent RNA helicase activity|ATP binding|ATP-dependent helicase activity|identical protein binding|poly(A) RNA binding|,23,32,1580000000,13.2%
Q9CX34,0.868452057,-0.002833333,2.116694336,-0.044333333,0.614229352,-0.528464644,0.023,0.069,-0.034,-0.004,-0.091,0.02,Q9CX34,Sugt1,Q9CX34_Sugt1,Q9CX34,Sugt1,1,52,19,19,Q9CX34,MOUSE,38443.5,60.7,542,542.1,258.01,258.01,,336,Protein SGT1 homolog,nucleus|cytoplasm|,positive regulation by host of symbiont catalytic activity|,,19,52,15900000000,60.7%
Q61584-3,0.51414471,0.005666667,7.930450846,-0.142666667,0.161047844,-1.575603827,0.169,0.06,0.002,0,-0.137,-0.06,Q61584,Fxr1,Q61584-3_Fxr1,Q61584-3,Fxr1,1,56,19,17,Q61584-3|Q61584|Q61584-4|A0A0G2JEP0|Q61584-7|Q61584-6|Q61584-5|Q61584-2|A0A0H2UH27,MOUSE,76605.1,31,543,543.1,257.4,232.73,,677,Isoform B of Fragile X mental retardation syndrome-related protein 1,nucleus|cytoplasm|polysome|membrane|axon|dendrite|ribonucleoprotein granule|costamere|dendritic spine|perinuclear region of cytoplasm|,muscle organ development|negative regulation of translation|cell differentiation|,G-quadruplex RNA binding|mRNA 3'-UTR binding|protein binding|poly(A) RNA binding|G-quadruplex RNA binding|,19,56,14400000000,31.0%
Q6P5B5,0.929826523,-0.025833333,1.001119398,-0.029666667,0.794123522,-0.27161221,0.108,-0.016,-0.125,0.11,-0.108,-0.124,Q6P5B5,Fxr2,Q6P5B5_Fxr2,Q6P5B5,Fxr2,1,16,10,8,Q6P5B5|Q9WVR4,MOUSE,74594.3,20.1,543,543.2,118.62,93.95,,674,Fragile X mental retardation syndrome-related protein 2,nucleus|cytoplasm|polysome|membrane|dendrite|extracellular exosome|,positive regulation of defense response to virus by host|negative regulation of translation|,mRNA binding|identical protein binding|poly(A) RNA binding|,8,16,1060000000,17.0%
P00375,0.586445778,0.004333333,6.566384139,-0.130666667,0.220476135,-1.351264891,0.19,0.035,-0.016,-0.032,-0.001,-0.15,P00375,Dhfr,P00375_Dhfr,P00375,Dhfr,1,92,18,18,P00375,MOUSE,21662.7,78.6,544,544.1,256.95,256.95,,187,Dihydrofolate reductase,cytosol|,glycine biosynthetic process|one-carbon metabolic process|nucleotide biosynthetic process|response to methotrexate|response to nicotine|dihydrofolate metabolic process|tetrahydrofolate metabolic process|tetrahydrofolate biosynthetic process|oxidation-reduction process|,mRNA binding|dihydrofolate reductase activity|drug binding|NADP binding|dihydrofolic acid binding|,18,92,1.16E+11,78.6%
Q3URE1,0.997585215,-0.0295,0.023187002,-0.001,0.994675223,-0.006929577,0.089,0.16,-0.336,0.028,-0.037,-0.081,Q3URE1,Acsf3,Q3URE1_Acsf3,Q3URE1,Acsf3,1,56,20,20,Q3URE1|A0A1D5RMC8|Q3URE1-2,MOUSE,65474.9,40.8,545,545.1,256.77,256.77,,583,"Acyl-CoA synthetase family member 3, mitochondrial",mitochondrion|,fatty acid metabolic process|fatty acid biosynthetic process|malonate catabolic process|,ATP binding|acid-thiol ligase activity|malonyl-CoA synthetase activity|,20,56,28600000000,40.8%
Q9QYB1,0.322071891,-0.032333333,12.22349471,-0.249333333,0.059930863,-2.262168523,0.064,0.163,0.05,-0.35,-0.054,-0.067,Q9QYB1,Clic4,Q9QYB1_Clic4,Q9QYB1,Clic4,1,64,17,17,Q9QYB1,MOUSE,28956.7,73.5,546,546.1,255.91,255.91,,253,Chloride intracellular channel protein 4,intracellular|cytoplasm|mitochondrion|centrosome|cytosol|plasma membrane|microvillus|cell-cell junction|cell surface|nuclear matrix|midbody|cytoplasmic vesicle membrane|chloride channel complex|apical part of cell|perinuclear region of cytoplasm|extracellular exosome|microtubule cytoskeleton|,angiogenesis|endothelial cell morphogenesis|chloride transport|apoptotic process|vacuolar acidification|fertilization|keratinocyte differentiation|negative regulation of cell migration|regulation of ion transmembrane transport|multicellular organism growth|branching morphogenesis of an epithelial tube|retina vasculature morphogenesis in camera-type eye|cellular response to calcium ion|chloride transmembrane transport|,voltage-gated ion channel activity|chloride channel activity|protein binding|,17,64,30400000000,73.5%
Q91XD4,0.659328697,0.000833333,5.194617915,0.137666667,0.302369658,1.118309403,-0.05,0.037,-0.191,-0.095,0.267,0.037,Q91XD4,Ftcd,Q91XD4_Ftcd,Q91XD4,Ftcd,1,57,19,19,Q91XD4,MOUSE,59565.1,48.7,547,547.1,255.46,255.46,,541,Formimidoyltransferase-cyclodeaminase,Golgi apparatus|centriole|extracellular exosome|,histidine catabolic process|cytoskeleton organization|histidine catabolic process to glutamate and formamide|histidine catabolic process to glutamate and formate|tetrahydrofolate interconversion|,folic acid binding|glutamate formimidoyltransferase activity|formimidoyltetrahydrofolate cyclodeaminase activity|,19,57,5990000000,48.7%
O54734,0.841111302,0.034333333,2.525806558,-0.082666667,0.5590097,-0.615133488,-0.11,0.353,-0.016,-0.048,0.022,0.005,O54734,Ddost,O54734_Ddost,O54734,Ddost,1,76,18,18,O54734,MOUSE,49255.2,45.3,548,548.1,254.16,254.16,,441,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit,endoplasmic reticulum|oligosaccharyltransferase complex|membrane|integral component of membrane|intracellular membrane-bounded organelle|protein complex|,protein glycosylation|protein N-linked glycosylation|protein N-linked glycosylation via asparagine|response to cytokine|T cell activation|,oligosaccharyl transferase activity|dolichyl-diphosphooligosaccharide-protein glycotransferase activity|,18,76,68600000000,45.3%
P08752,0.69806825,0.004333333,4.577419888,-0.093333333,0.348544321,-1.007852045,0.139,0.016,-0.002,0.034,-0.021,-0.14,P08752,Gnai2,P08752_Gnai2,P08752,Gnai2,1,47,17,11,P08752|B2RSH2|P18872-2|P50149|Q3V3I2|P20612|Q66L47|Q8CGK7|P18872,MOUSE,41058.8,56.9,549,549.1,254,163.75,,355,Guanine nucleotide-binding protein G(i) subunit alpha-2,nucleoplasm|cytoplasm|centrosome|cytosol|heterotrimeric G-protein complex|plasma membrane|membrane|midbody|membrane raft|extracellular exosome|extracellular vesicle|,activation of MAPKK activity|adenosine receptor signaling pathway|cell cycle|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway|G-protein coupled acetylcholine receptor signaling pathway|gamma-aminobutyric acid signaling pathway|metabolic process|cell proliferation|positive regulation of cell proliferation|intracellular signal transduction|negative regulation of synaptic transmission|cell division|regulation of calcium ion transport|regulation of heart contraction|,G-protein coupled receptor binding|GTPase activity|signal transducer activity|protein binding|GTP binding|G-protein beta/gamma-subunit complex binding|metal ion binding|,17,47,15400000000,56.9%
P27601,0.390864183,0.008833333,10.60002462,-0.161666667,0.087095865,-2.002943514,0.038,0.087,0.144,-0.088,-0.085,-0.043,P27601,Gna13,P27601_Gna13,P27601,Gna13,1,31,16,15,P27601|Q9D034,MOUSE,44396.2,38.1,549,549.2,185.02,166.27,,377,Guanine nucleotide-binding protein subunit alpha-13,nucleus|cytosol|heterotrimeric G-protein complex|plasma membrane|focal adhesion|membrane|brush border membrane|melanosome|extracellular exosome|,angiogenesis|patterning of blood vessels|in utero embryonic development|G-protein coupled receptor signaling pathway|adenylate cyclase-activating G-protein coupled receptor signaling pathway|positive regulation of cytosolic calcium ion concentration|Rho protein signal transduction|metabolic process|regulation of cell shape|cell differentiation|platelet activation|regulation of cell migration|activation of phospholipase D activity|intracellular signal transduction|,GTPase activity|signal transducer activity|protein binding|GTP binding|G-protein beta/gamma-subunit complex binding|type 1 angiotensin receptor binding|D5 dopamine receptor binding|metal ion binding|,15,31,4120000000,35.2%
Q6R0H7,0.733613685,0.027666667,4.0432213,-0.088666667,0.394164829,-0.910468119,-0.01,0.002,0.224,0.004,-0.053,-0.001,Q6R0H7,Gnas,Q6R0H7_Gnas,Q6R0H7,Gnas,1,31,14,14,Q6R0H7|P63094|Q6R0H7-4|P63094-3|P63094-2|Z4YKV1|A2A610|Q6R0H7-2|Q6R0H7-3,MOUSE,122587,13.5,549,549.3,179.42,166.04,,1133,Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas,nucleus|cytoplasm|cytosol|heterotrimeric G-protein complex|membrane|dendrite|intrinsic component of membrane|trans-Golgi network membrane|perinuclear region of cytoplasm|extracellular exosome|,skeletal system development|tissue homeostasis|endochondral ossification|energy reserve metabolic process|DNA methylation|G-protein coupled receptor signaling pathway|adenylate cyclase-activating G-protein coupled receptor signaling pathway|adenylate cyclase-activating dopamine receptor signaling pathway|sensory perception of chemical stimulus|post-embryonic development|regulation of signal transduction|positive regulation of cAMP biosynthetic process|embryonic hindlimb morphogenesis|multicellular organism growth|post-embryonic body morphogenesis|response to drug|positive regulation of GTPase activity|skin development|positive regulation of cAMP-mediated signaling|positive regulation of osteoblast differentiation|positive regulation of osteoclast differentiation|developmental growth|embryonic cranial skeleton morphogenesis|cognition|cartilage development|bone development|hair follicle placode formation|platelet aggregation|response to parathyroid hormone|genetic imprinting|adenylate cyclase-activating adrenergic receptor signaling pathway|,GTPase activity|signal transducer activity|insulin-like growth factor receptor binding|protein binding|GTP binding|G-protein beta/gamma-subunit complex binding|beta-2 adrenergic receptor binding|D1 dopamine receptor binding|mu-type opioid receptor binding|ionotropic glutamate receptor binding|metal ion binding|corticotropin-releasing hormone receptor 1 binding|,14,31,6450000000,12.6%
Q9DC51,0.855191835,-0.0775,2.307193001,0.083,0.58786919,0.569409269,0.063,0.004,-0.424,0.002,0.018,-0.128,Q9DC51,Gnai3,Q9DC51_Gnai3,Q9DC51,Gnai3,1,18,13,7,Q9DC51,MOUSE,41108,41.5,549,549.4,185.05,94.8,,354,Guanine nucleotide-binding protein G(k) subunit alpha,cytoplasm|lysosomal membrane|Golgi apparatus|centrosome|heterotrimeric G-protein complex|plasma membrane|membrane|midbody|zymogen granule|membrane raft|extracellular exosome|,vesicle fusion|cell cycle|G-protein coupled receptor signaling pathway|adenylate cyclase-modulating G-protein coupled receptor signaling pathway|metabolic process|cell division|regulation of heart contraction|,GTPase activity|signal transducer activity|protein binding|GTP binding|protein domain specific binding|G-protein beta/gamma-subunit complex binding|G-protein coupled serotonin receptor binding|GTPase activating protein binding|metal ion binding|,7,18,8870000000,26.5%
P27600,0.938054337,-0.04,0.871068165,-0.023333333,0.818263508,-0.238987239,-0.001,-0.069,-0.015,-0.006,0.051,-0.2,P27600,Gna12,P27600_Gna12,P27600,Gna12,1,2,3,2,P27600,MOUSE,44265.4,7.3,549,549.5,36.08,17.33,,379,Guanine nucleotide-binding protein subunit alpha-12,heterotrimeric G-protein complex|focal adhesion|brush border membrane|,in utero embryonic development|G-protein coupled receptor signaling pathway|adenylate cyclase-modulating G-protein coupled receptor signaling pathway|Rho protein signal transduction|metabolic process|regulation of cell shape|regulation of fibroblast migration|cell differentiation|regulation of TOR signaling|regulation of proteasomal ubiquitin-dependent protein catabolic process|intracellular signal transduction|response to drug|embryonic digit morphogenesis|,GTPase activity|signal transducer activity|GTP binding|G-protein beta/gamma-subunit complex binding|D5 dopamine receptor binding|metal ion binding|,2,2,134000000,4.4%
O35286,0.400494909,0.017166667,10.3694137,-0.186333333,0.091845658,-1.966303513,0.038,0.23,0.063,-0.157,-0.032,-0.039,O35286,Dhx15,O35286_Dhx15,O35286,Dhx15,1,43,25,25,O35286|Q497W9|A0A0G2JG10|A2A4P0|G3X8X0|Q05BH3,MOUSE,91804.1,29,550,550.1,253.52,253.52,,795,Pre-mRNA-splicing factor ATP-dependent RNA helicase DH5,nucleus|nucleoplasm|spliceosomal complex|U12-type spliceosomal complex|nucleolus|cytoplasm|U2-type post-mRNA release spliceosomal complex|,RNA processing|mRNA processing|RNA splicing|,double-stranded RNA binding|ATP-dependent RNA helicase activity|protein binding|ATP binding|poly(A) RNA binding|,25,43,6150000000,29.0%
O54774,0.777827379,-0.009166667,3.425042216,-0.070333333,0.45446012,-0.793898798,0.04,0.074,-0.036,0.04,-0.127,-0.046,O54774,Ap3d1,O54774_Ap3d1,O54774,Ap3d1,1,39,18,18,O54774,MOUSE,136277,17.3,551,551.1,253.37,253.37,,1199,AP-3 complex subunit delta-1,Golgi membrane|nucleoplasm|lysosomal membrane|trans-Golgi network|endosome membrane|membrane|membrane coat|axon|terminal bouton|,"zinc II ion transport|intracellular protein transport|anterograde axon cargo transport|vesicle-mediated transport|antigen processing and presentation|protein localization to organelle|endosome to melanosome transport|antigen processing and presentation, exogenous lipid antigen via MHC class Ib|anterograde synaptic vesicle transport|synaptic vesicle membrane organization|positive regulation of NK T cell differentiation|regulation of sequestering of zinc ion|protein localization to membrane|",,18,39,8180000000,17.3%
Q8JZZ0,0.080167564,-0.125833333,21.17617435,0.993,0.007627506,3.781897289,-0.313,-0.318,-1.236,0.575,0.277,0.26,Q8JZZ0,Ugt3a2,Q8JZZ0_Ugt3a2,Q8JZZ0,Ugt3a2,1,91,19,16,Q8JZZ0,MOUSE,59842.7,32.1,552,552.1,253.32,211.36,,523,UDP-glucuronosyltransferase 3A2,integral component of membrane|intracellular membrane-bounded organelle|,flavonoid biosynthetic process|cellular response to hormone stimulus|flavonoid glucuronidation|cellular response to genistein|,UDP-glycosyltransferase activity|glucuronosyltransferase activity|,19,91,1.27E+11,32.1%
Q3UP75,0.875541631,-0.091833333,2.022053665,0.113666667,0.627761437,0.508264426,0.083,0.126,-0.655,0.125,-0.026,-0.204,Q3UP75,Ugt3a1,Q3UP75_Ugt3a1,Q3UP75,Ugt3a1,1,16,10,7,Q3UP75,MOUSE,59868.5,19.6,552,552.2,107.41,65.45,,523,UDP-glucuronosyltransferase 3A1,integral component of membrane|intracellular membrane-bounded organelle|UDP-N-acetylglucosamine transferase complex|,flavonoid biosynthetic process|cellular response to hormone stimulus|flavonoid glucuronidation|cellular response to genistein|,UDP-glycosyltransferase activity|glucuronosyltransferase activity|,7,16,3820000000,12.2%
Q3UZZ6,0.885511519,-0.081,1.818676658,-0.120666667,0.657858263,-0.463500316,0.183,0.305,-0.55,-0.175,0.181,-0.43,Q3UZZ6,Sult1d1,Q3UZZ6_Sult1d1,Q3UZZ6,Sult1d1,1,49,16,16,Q3UZZ6,MOUSE,35253.8,51.8,553,553.1,253.04,253.04,,295,Sulfotransferase 1 family member D1,cytoplasm|,sulfate assimilation|catecholamine metabolic process|lipid metabolic process|,aryl sulfotransferase activity|,16,49,47300000000,51.8%
P62082,0.78242277,-0.000166667,3.369814248,-0.065666667,0.46027626,-0.783251059,-0.013,0.053,0.058,-0.106,0.025,-0.018,P62082,Rps7,P62082_Rps7,P62082,Rps7,1,49,16,16,P62082|F6SVV1,MOUSE,22126.4,67,554,554.1,252.33,252.33,,194,40S ribosomal protein S7,nucleus|nucleolus|cytoplasm|microtubule organizing center|ribosome|focal adhesion|membrane|cytosolic small ribosomal subunit|ribonucleoprotein complex|90S preribosome|small-subunit processome|extracellular exosome|,neural tube closure|rRNA processing|translation|cell differentiation|ribosomal small subunit biogenesis|,structural constituent of ribosome|poly(A) RNA binding|,16,49,32600000000,67.0%
Q9DCE9,0.862898798,-0.0235,2.187971935,-0.090333333,0.604230727,-0.54406108,0.236,-0.219,0.048,0.155,-0.317,-0.044,Q9DCE9,Igtp,Q9DCE9_Igtp,Q9DCE9,Igtp,1,76,17,14,Q9DCE9,MOUSE,48778,47.5,555,555.1,251.7,204.66,,423,Interferon gamma-induced GTPase,cytosol|membrane|,cellular response to interferon-beta|,GTPase activity|GTP binding|,17,76,53900000000,47.5%
Q9Z1M2,0.637273847,0.013666667,5.613813468,-0.167333333,0.274548233,-1.191148125,0.083,-0.115,0.324,0.072,-0.063,-0.219,Q9Z1M2,Irgm2,Q9Z1M2_Irgm2,Q9Z1M2,Irgm2,1,14,9,6,A0A140LIF8|Q9Z1M2,MOUSE,45489.3,27.3,555,555.2,126.82,79.78,,395,Immunity-related GTPase family M member 2,Golgi apparatus|membrane|symbiont-containing vacuole|,response to interferon-gamma|defense response to bacterium|defense response to protozoan|,GTPase activity|GTP binding|,6,14,1000000000,16.2%
Q9DB20,0.987495629,-0.012166667,0.216068372,-0.011,0.951465757,-0.063209481,0.087,0.222,-0.329,-0.074,0.203,-0.182,Q9DB20,Atp5o,Q9DB20_Atp5o,Q9DB20,Atp5o,1,97,16,16,Q9DB20,MOUSE,23420.2,65.2,556,556.1,250.62,250.62,,213,"ATP synthase subunit O, mitochondrial","mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)|nucleus|mitochondrion|mitochondrial proton-transporting ATP synthase complex|plasma membrane|myelin sheath|extracellular exosome|",mitochondrial ATP synthesis coupled proton transport|,"steroid binding|drug binding|protein complex binding|proton-transporting ATP synthase activity, rotational mechanism|ATPase activity|",16,97,2.4E+11,65.2%
Q921G7,0.919416995,-0.041166667,1.241294045,0.076333333,0.75139897,0.330273041,0.093,0.178,-0.509,-0.219,0.353,-0.143,Q921G7,Etfdh,Q921G7_Etfdh,Q921G7,Etfdh,1,63,17,17,Q921G7|Q6PF96|Q2KIG0,MOUSE,68945.5,32.7,557,557.1,249.51,249.51,,616,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial",mitochondrion|mitochondrial inner membrane|membrane|mitochondrial electron transfer flavoprotein complex|integral component of mitochondrial inner membrane|mitochondrial membrane|,response to oxidative stress|electron transport chain|fatty acid beta-oxidation using acyl-CoA dehydrogenase|,"electron-transferring-flavoprotein dehydrogenase activity|electron carrier activity|oxidoreductase activity|oxidoreductase activity, oxidizing metal ions with flavin as acceptor|metal ion binding|quinone binding|ubiquinone binding|4 iron, 4 sulfur cluster binding|",17,63,12600000000,32.7%
Q3ULF4,0.960763421,-0.010666667,0.587884145,-0.015333333,0.873396778,-0.165550713,0.071,0.044,-0.124,0.041,-0.051,-0.045,Q3ULF4,Spg7,Q3ULF4_Spg7,Q3ULF4,Spg7,1,37,19,19,Q3ULF4|D3YZN4|D3YXB7,MOUSE,86222.9,34.4,558,558.1,249.49,249.49,,781,Paraplegin,mitochondrion|integral component of membrane|mitochondrial membrane|,proteolysis|mitochondrion organization|cell adhesion|anterograde axon cargo transport|regulation of cell adhesion|,metalloendopeptidase activity|ATP binding|zinc ion binding|,19,37,4690000000,34.4%
Q14DH7,0.777827379,-0.077833333,3.427756812,0.171,0.454176144,0.794985928,0.138,0.029,-0.657,0.13,0.012,-0.119,Q14DH7,Acss3,Q14DH7_Acss3,Q14DH7,Acss3,1,44,20,20,Q14DH7|Q14DH7-2,MOUSE,75144.2,31,559,559.1,247.97,247.97,,682,"Acyl-CoA synthetase short-chain family member 3, mitochondrial",mitochondrion|,metabolic process|,acetate-CoA ligase activity|ATP binding|,20,44,8070000000,31.0%
Q8R081,0.173252876,0.2025,16.81691602,-0.892333333,0.02081174,-3.017468572,-0.002,1.021,0.927,-0.578,-0.123,-0.03,Q8R081,Hnrnpl,Q8R081_Hnrnpl,Q8R081,Hnrnpl,1,55,18,18,Q8R081|G3UY38,MOUSE,64590.1,41.6,560,560.1,247.79,247.79,,586,Heterogeneous nuclear ribonucleoprotein L,nucleus|nucleoplasm|cytoplasm|membrane|ribonucleoprotein complex|pronucleus|extracellular exosome|,mRNA processing|,nucleotide binding|transcription regulatory region DNA binding|poly(A) RNA binding|,18,55,14900000000,41.6%
P58710,0.791316333,-0.0475,3.242141039,0.091666667,0.474008245,0.758995693,0.028,0.013,-0.321,0.024,0.053,-0.082,P58710,Gulo,P58710_Gulo,P58710,Gulo,1,63,19,19,P58710,MOUSE,51104.9,44.3,561,561.1,247.17,247.17,,440,L-gulonolactone oxidase,endoplasmic reticulum membrane|integral component of membrane|,L-ascorbic acid biosynthetic process|oxidation-reduction process|,"D-arabinono-1,4-lactone oxidase activity|UDP-N-acetylmuramate dehydrogenase activity|L-gulonolactone oxidase activity|flavin adenine dinucleotide binding|",19,63,25700000000,44.3%
P62918,0.502661212,0.014666667,8.163131872,-0.156,0.152646487,-1.613307797,0.003,0.225,0.05,-0.044,-0.012,-0.134,P62918,Rpl8,P62918_Rpl8,P62918,Rpl8,1,105,17,17,P62918,MOUSE,28252.4,52.9,562,562.1,247.15,247.15,,257,60S ribosomal protein L8,nucleolus|cytoplasm|focal adhesion|membrane|cytosolic large ribosomal subunit|,translation|,structural constituent of ribosome|protein binding|rRNA binding|poly(A) RNA binding|,17,105,1.09E+11,52.9%
Q9CQ73,0.578909417,-0.006833333,6.810870068,-0.112333333,0.208407332,-1.391969996,0.082,0.07,-0.004,-0.104,-0.04,-0.045,Q9CQ73,Pkp2,Q9CQ73_Pkp2,Q9CQ73,Pkp2,1,54,20,20,Q9CQ73|E0CXK9|E0CX59,MOUSE,88615.8,28.6,563,563.1,246.74,246.74,,795,Plakophilin 2,nucleoplasm|intermediate filament|plasma membrane|cell-cell junction|adherens junction|intercalated disc|cell junction|desmosome|,desmosome assembly|heart development|single organismal cell-cell adhesion|intermediate filament bundle assembly|maintenance of organ identity|ventricular cardiac muscle tissue morphogenesis|cardiac muscle cell action potential involved in contraction|ventricular cardiac muscle cell action potential|cell-cell signaling involved in cardiac conduction|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|establishment of protein localization to plasma membrane|regulation of ventricular cardiac muscle cell action potential|,protein kinase C binding|protein binding|intermediate filament binding|protein complex scaffold|alpha-catenin binding|,20,54,13600000000,28.6%
Q99LI2,0.000234521,-0.168666667,56.01850053,1.542666667,2.50121E-06,14.64907787,-0.895,-0.858,-1.067,0.473,0.705,0.63,Q99LI2,Clcc1,Q99LI2_Clcc1,Q99LI2,Clcc1,1,54,19,19,A2AEM2|Q99LI2,MOUSE,61418.9,42.8,564,564.1,246.61,246.61,,539,Chloride channel CLIC-like protein 1,nucleus|endoplasmic reticulum|Golgi apparatus|membrane|chloride channel complex|intracellular membrane-bounded organelle|,chloride transmembrane transport|,chloride channel activity|,19,54,11400000000,42.8%
Q9CR68,0.895548983,-0.004166667,1.642006257,-0.058333333,0.685171633,-0.423756053,0.006,0.26,-0.191,-0.153,0.088,-0.035,Q9CR68,Uqcrfs1,Q9CR68_Uqcrfs1,Q9CR68,Uqcrfs1,1,66,18,18,Q9CR68,MOUSE,29652.4,66.7,565,565.1,246.48,246.48,,274,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex III|myelin sheath|,response to hormone|response to drug|response to antibiotic|oxidation-reduction process|hydrogen ion transmembrane transport|,"protein binding|ubiquinol-cytochrome-c reductase activity|protein complex binding|metal ion binding|2 iron, 2 sulfur cluster binding|",18,66,69700000000,66.7%
Q99JB2,0.904214516,0.014166667,1.571421727,-0.041,0.696398501,-0.407433388,-0.015,0.196,-0.077,0.019,-0.044,0.006,Q99JB2,Stoml2,Q99JB2_Stoml2,Q99JB2,Stoml2,1,52,19,19,Q99JB2,MOUSE,38498.3,59.7,566,566.1,246.18,246.18,,353,"Stomatin-like protein 2, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial intermembrane space|extrinsic component of plasma membrane|membrane raft|immunological synapse|COP9 signalosome|actin cytoskeleton|T cell receptor complex|,"mitochondrial calcium ion transport|cellular calcium ion homeostasis|mitochondrion organization|lipid localization|positive regulation of mitochondrial membrane potential|interleukin-2 production|mitochondrial protein processing|CD4-positive, alpha-beta T cell activation|mitochondrial ATP synthesis coupled proton transport|T cell receptor signaling pathway|protein oligomerization|positive regulation of mitochondrial DNA replication|positive regulation of cardiolipin metabolic process|stress-induced mitochondrial fusion|mitochondrion localization|",GTPase binding|cardiolipin binding|,19,52,10600000000,59.7%
P61222,0.866518,0.0045,2.143710671,-0.041666667,0.610420251,-0.534273081,-0.007,0.033,0.05,-0.025,-0.031,0.007,P61222,Abce1,P61222_Abce1,P61222,Abce1,1,44,18,18,P61222,MOUSE,68283,39.3,567,567.1,245.29,245.29,,599,ATP-binding cassette sub-family E member 1,cytoplasm|mitochondrion|membrane|,metabolic process|,ATP binding|ATPase activity|iron-sulfur cluster binding|,18,44,15800000000,39.3%
P46467,0.919416995,-0.001,1.226713861,-0.033333333,0.753925814,-0.326620022,0.146,-0.059,-0.04,0.099,-0.077,-0.075,P46467,Vps4b,P46467_Vps4b,P46467,Vps4b,1,37,18,14,P46467|Q8BPY9,MOUSE,49646.6,44.3,568,568.1,245.19,192.26,,444,Vacuolar protein sorting-associated protein 4B,spindle pole|nucleus|cytoplasm|lysosome|endosome|early endosome|vacuolar membrane|centrosome|cytosol|endosome membrane|late endosome membrane|extracellular exosome|Flemming body|,cell separation after cytokinesis|potassium ion transport|nucleus organization|endosome organization|vacuole organization|mitotic metaphase plate congression|regulation of centrosome duplication|positive regulation of G2/M transition of mitotic cell cycle|protein transport|endosomal transport|viral release from host cell|cholesterol transport|intracellular cholesterol transport|endosome to lysosome transport via multivesicular body sorting pathway|response to lipid|viral budding via host ESCRT complex|ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway|positive regulation of viral process|regulation of viral process|protein depolymerization|negative regulation of cell death|ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway|regulation of mitotic spindle assembly|positive regulation of viral release from host cell|negative regulation of exosomal secretion|positive regulation of exosomal secretion|positive regulation of centriole elongation|positive regulation of viral life cycle|cytoplasmic microtubule organization|,"protein binding|ATP binding|protein C-terminus binding|ATPase activity|ATPase activity, coupled|identical protein binding|protein homodimerization activity|microtubule-severing ATPase activity|",18,37,11500000000,44.3%
Q8VEJ9,0.894042447,-0.000166667,1.680276563,-0.035666667,0.679160382,-0.432213637,0.037,-0.037,0.053,0.04,-0.037,-0.057,Q8VEJ9,Vps4a,Q8VEJ9_Vps4a,Q8VEJ9,Vps4a,1,8,7,4,Q8VEJ9,MOUSE,49191.3,15.3,568,568.2,88.41,48.34,,437,Vacuolar protein sorting-associated protein 4A,spindle pole|nucleus|cytoplasm|lysosome|endosome|early endosome|late endosome|vacuolar membrane|centrosome|cytosol|plasma membrane|midbody|late endosome membrane|perinuclear region of cytoplasm|extracellular exosome|Flemming body|ESCRT III complex|,cell separation after cytokinesis|membrane budding|nucleus organization|vacuole organization|mitotic metaphase plate congression|abscission|protein transport|vesicle-mediated transport|endosomal transport|viral release from host cell|intracellular cholesterol transport|negative regulation of cytokinesis|regulation of protein localization|endosomal vesicle fusion|viral budding via host ESCRT complex|ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway|positive regulation of viral process|cell division|vesicle uncoating|ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway|positive regulation of viral release from host cell|regulation of protein localization to plasma membrane|positive regulation of exosomal secretion|positive regulation of viral budding via host ESCRT complex|positive regulation of viral life cycle|cytoplasmic microtubule organization|,protein binding|ATP binding|protein C-terminus binding|ATPase activity|protein domain specific binding|microtubule-severing ATPase activity|,4,8,1900000000,12.3%
E9Q3L2,0.994928853,-0.015666667,0.07372506,-0.002666667,0.983167455,-0.021907409,0.154,0.029,-0.226,0.074,-0.025,-0.1,E9Q3L2,Pi4ka,E9Q3L2_Pi4ka,E9Q3L2,Pi4ka,1,40,21,21,E9Q3L2|A0A140T8I9|D6RJ66,MOUSE,239719,12.5,569,569.1,245.18,245.18,,2105,Phosphatidylinositol 4-kinase alpha,cytoplasm|plasma membrane|focal adhesion|membrane|extracellular exosome|,phosphatidylinositol phosphorylation|phosphatidylinositol-mediated signaling|,1-phosphatidylinositol 4-kinase activity|,21,40,2980000000,12.5%
Q9D819,0.442986563,-0.005,9.540877501,-0.31,0.111150712,-1.837646493,-0.015,0.025,0.44,-0.398,0.042,-0.124,Q9D819,Ppa1,Q9D819_Ppa1,Q9D819,Ppa1,1,49,16,16,Q9D819,MOUSE,33122.9,66.4,570,570.1,244.73,244.73,,289,Inorganic pyrophosphatase,cytoplasm|extracellular exosome|,phosphate-containing compound metabolic process|,magnesium ion binding|inorganic diphosphatase activity|pyrophosphatase activity|,16,49,38900000000,66.4%
Q8BGC4,0.915900752,-0.007833333,1.294429445,-0.047,0.742261706,-0.342958394,0.126,0.196,-0.275,-0.029,-0.018,-0.047,Q8BGC4,Zadh2,Q8BGC4_Zadh2,Q8BGC4,Zadh2,1,56,17,17,Q8BGC4,MOUSE,40813.4,60.2,571,571.1,243.59,243.59,,377,Prostaglandin reductase-3,mitochondrion|peroxisome|,oxidation-reduction process|,zinc ion binding|oxidoreductase activity|,17,56,35600000000,60.2%
Q9DCN2,0.961523652,0.0255,0.561771017,0.025,0.878664132,0.158665132,0.089,-0.03,-0.02,-0.109,0.384,-0.161,Q9DCN2,Cyb5r3,Q9DCN2_Cyb5r3,Q9DCN2,Cyb5r3,1,44,15,15,Q9DCN2|Q9DCN2-2|F2Z456,MOUSE,34355.3,64.1,572,572.1,243.5,243.5,,301,NADH-cytochrome b5 reductase 3,mitochondrial outer membrane|mitochondrial inner membrane|endoplasmic reticulum membrane|lipid particle|cytosol|extracellular exosome|,cholesterol biosynthetic process|oxidation-reduction process|,"cytochrome-b5 reductase activity, acting on NAD(P)H|protein binding|AMP binding|ADP binding|NAD binding|FAD binding|",15,44,14400000000,64.1%
Q921F4,0.332019767,0.011,11.9294696,-0.173333333,0.064128789,-2.214148027,0.069,0.12,0.104,-0.108,-0.066,-0.053,Q921F4,Hnrnpll,Q921F4_Hnrnpll,Q921F4,Hnrnpll,1,35,17,17,Q921F4|V9GXB6|Q921F4-4,MOUSE,64979.5,38.7,573,573.1,243.41,243.41,,591,Heterogeneous nuclear ribonucleoprotein L-like,nucleus|membrane|ribonucleoprotein complex|,mRNA processing|positive regulation of RNA splicing|,nucleotide binding|mRNA binding|poly(A) RNA binding|,17,35,7670000000,38.7%
Q01279,0.953420192,0.059,0.687407939,0.054666667,0.853609434,0.19185243,-0.219,-0.202,0.516,0.124,-0.377,0.512,Q01279,Egfr,Q01279_Egfr,Q01279,Egfr,1,40,23,23,Q01279|Q9WVF5|Q61527|Q61527-2|Q61527-3|P70424,MOUSE,138274.2,22.2,574,574.1,243.19,243.19,,1210,Epidermal growth factor receptor,"Golgi membrane|intracellular|nucleus|cytoplasm|endosome|endoplasmic reticulum membrane|plasma membrane|focal adhesion|cell surface|endosome membrane|membrane|integral component of membrane|basolateral plasma membrane|endocytic vesicle|early endosome membrane|nuclear membrane|receptor complex|membrane raft|perinuclear region of cytoplasm|multivesicular body, internal vesicle lumen|",cell morphogenesis|embryonic placenta development|positive regulation of protein phosphorylation|hair follicle development|signal transduction|cell surface receptor signaling pathway|epidermal growth factor receptor signaling pathway|salivary gland morphogenesis|learning or memory|cell proliferation|positive regulation of cell proliferation|epidermis development|single organismal cell-cell adhesion|peptidyl-tyrosine phosphorylation|cerebral cortex cell migration|signal transduction by protein phosphorylation|positive regulation of cell migration|positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle|positive regulation of catenin import into nucleus|regulation of cell proliferation|negative regulation of protein catabolic process|positive regulation of phosphorylation|negative regulation of apoptotic process|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of DNA repair|positive regulation of DNA replication|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|positive regulation of fibroblast proliferation|digestive tract morphogenesis|positive regulation of epithelial cell proliferation|regulation of peptidyl-tyrosine phosphorylation|regulation of nitric-oxide synthase activity|positive regulation of protein kinase B signaling|morphogenesis of an epithelial fold|response to UV-A|positive regulation of ERK1 and ERK2 cascade|cellular response to amino acid stimulus|cellular response to epidermal growth factor stimulus|cellular response to estradiol stimulus|,chromatin binding|protein tyrosine kinase activity|receptor signaling protein tyrosine kinase activity|signal transducer activity|transmembrane signaling receptor activity|epidermal growth factor-activated receptor activity|protein binding|ATP binding|kinase activity|enzyme binding|protein phosphatase binding|ubiquitin protein ligase binding|identical protein binding|protein heterodimerization activity|actin filament binding|nitric-oxide synthase regulator activity|,23,40,7190000000,22.2%
D4AFX7,0.623895097,0.0055,5.89558878,-0.117,0.257300791,-1.238151511,-0.014,0.051,0.155,0.035,-0.147,-0.047,D4AFX7,Dnajc13,D4AFX7_Dnajc13,D4AFX7,Dnajc13,1,40,21,21,D4AFX7|G3X922,MOUSE,257344.1,11.7,575,575.1,242.58,242.58,,2248,DnaJ heat shock protein family (Hsp40) member C13,lysosomal membrane|endosome membrane|membrane|early endosome membrane|extracellular exosome|WASH complex|,osteoblast differentiation|endosome organization|regulation of early endosome to recycling endosome transport|regulation of early endosome to late endosome transport|,,21,40,1990000000,11.7%
Q9EP69,0.977544159,-0.006166667,0.331069591,0.019666667,0.92660159,0.095686327,0.059,0.311,-0.418,0.245,-0.094,-0.14,Q9EP69,Sacm1l,Q9EP69_Sacm1l,Q9EP69,Sacm1l,1,54,18,18,Q9EP69|A0A1L1SR59,MOUSE,67513.1,30.8,576,576.1,241.9,241.9,,587,Phosphatidylinositide phosphatase SAC1,endoplasmic reticulum membrane|Golgi apparatus|integral component of endoplasmic reticulum membrane|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex|,phosphatidylinositol dephosphorylation|,phosphatidylinositol-3-phosphatase activity|phosphatase activity|phosphatidylinositol bisphosphate phosphatase activity|phosphatidylinositol-4-phosphate phosphatase activity|,18,54,29400000000,30.8%
A2ATU0,0.99327985,0.018166667,0.128846041,-0.008333333,0.970767875,-0.038052418,-0.028,0.486,-0.391,-0.017,0.151,-0.092,A2ATU0,Dhtkd1,A2ATU0_Dhtkd1,A2ATU0,Dhtkd1,1,28,17,17,A2ATU0,MOUSE,103533.3,30.9,577,577.1,241.77,241.77,,921,"Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial",mitochondrion|oxoglutarate dehydrogenase complex|cytosol|,hematopoietic progenitor cell differentiation|generation of precursor metabolites and energy|glycolytic process|tricarboxylic acid cycle|,oxoglutarate dehydrogenase (succinyl-transferring) activity|thiamine pyrophosphate binding|,17,28,2840000000,30.9%
Q7TSH2,0.933608247,-0.018,0.961733078,-0.025333333,0.801358213,-0.261781201,0.102,0.032,-0.15,-0.002,-0.06,-0.03,Q7TSH2,Phkb,Q7TSH2_Phkb,Q7TSH2,Phkb,1,44,20,20,Q7TSH2|E0CZ55,MOUSE,125028.2,22,578,578.1,240.42,240.42,,1085,Phosphorylase b kinase regulatory subunit beta,plasma membrane|phosphorylase kinase complex|,glycogen metabolic process|protein phosphorylation|,calmodulin binding|phosphorylase kinase activity|,20,44,6870000000,22.0%
Q91W43,0.963376742,-0.004,0.507195484,-0.016666667,0.889775517,-0.143994756,0.117,0.1,-0.204,-0.039,0.071,-0.069,Q91W43,Gldc,Q91W43_Gldc,Q91W43,Gldc,1,43,21,21,Q91W43,MOUSE,114634.8,25,579,579.1,240.35,240.35,,1025,"Glycine dehydrogenase (decarboxylating), mitochondrial",mitochondrion|,glycine decarboxylation via glycine cleavage system|oxidation-reduction process|,glycine dehydrogenase (decarboxylating) activity|lyase activity|protein homodimerization activity|,21,43,7260000000,25.0%
O08573,0.267487135,0.0185,13.73233818,0.356333333,0.042341494,2.508967855,-0.127,-0.045,-0.307,0.464,0.075,0.051,O08573,Lgals9,O08573_Lgals9,O08573,Lgals9,1,95,15,15,O08573|G3X9T7|B1AQR8|O08573-2|O08573-3,MOUSE,40434.5,58.3,580,580.1,240,240,,353,Galectin-9,extracellular region|nucleus|cytoplasm|,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|female pregnancy|negative regulation of gene expression|negative regulation of interferon-gamma production|negative regulation of natural killer cell activation|regulation of natural killer cell differentiation|negative regulation of natural killer cell degranulation|maintenance of protein location|positive regulation of oxidoreductase activity|cellular response to virus|negative regulation of interferon-gamma secretion|positive regulation of T cell migration|regulation of T cell chemotaxis|,galactoside binding|enzyme binding|carbohydrate binding|,15,95,64100000000,58.3%
P05202,0.92551138,-0.135166667,1.096056753,0.083666667,0.776952243,0.295106485,-0.643,-0.08,0.192,-0.595,0.135,0.18,P05202,Got2,P05202_Got2,P05202,Got2,1,57,17,17,P05202,MOUSE,47809.9,41.8,581,581.1,240,240,,430,"Aspartate aminotransferase, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial matrix|plasma membrane|cell surface|perikaryon|myelin sheath|protein complex|extracellular exosome|,2-oxoglutarate metabolic process|oxaloacetate metabolic process|aspartate metabolic process|aspartate biosynthetic process|aspartate catabolic process|glutamate metabolic process|fatty acid transport|glutamate catabolic process to aspartate|glutamate catabolic process to 2-oxoglutarate|response to ethanol|L-kynurenine metabolic process|,L-aspartate:2-oxoglutarate aminotransferase activity|phospholipid binding|kynurenine-oxoglutarate transaminase activity|amino acid binding|enzyme binding|pyridoxal phosphate binding|protein homodimerization activity|poly(A) RNA binding|L-phenylalanine:2-oxoglutarate aminotransferase activity|,17,57,25400000000,41.8%
Q9DBB8,0.773512169,0.047833333,3.492952098,-0.155666667,0.447409076,-0.807516165,0.041,0.554,-0.218,-0.072,0.01,-0.028,Q9DBB8,Dhdh,Q9DBB8_Dhdh,Q9DBB8,Dhdh,1,61,14,14,Q9DBB8|A0A1B0GSH8,MOUSE,36642.5,29.7,582,582.1,239.6,239.6,,333,"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase",cytosol|,D-xylose catabolic process|oxidation-reduction process|,"trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity|D-xylose 1-dehydrogenase (NADP+) activity|",14,61,42700000000,29.7%
P35585,0.712762463,-0.011166667,4.343216186,-0.152333333,0.367856455,-0.96630836,-0.151,0.306,0.04,-0.324,0.015,0.047,P35585,Ap1m1,P35585_Ap1m1,P35585,Ap1m1,1,51,17,17,P35585|A0A0R4J1L4|Q9WVP1-2|A0A0R4IZX6|Q9WVP1|A0A1D5RMJ1|A0A1D5RLL9,MOUSE,48713.1,46,583,583.1,239.13,239.13,,423,AP-1 complex subunit mu-1,trans-Golgi network|membrane|clathrin adaptor complex|clathrin-coated vesicle membrane|extracellular exosome|,intracellular protein transport|vesicle-mediated transport|melanosome organization|endosome to melanosome transport|,protein binding|,17,51,13300000000,46.0%
P97351,0.961523652,0.01,0.557052443,-0.018,0.879619312,-0.157378282,-0.14,0.004,0.193,-0.099,0.084,0.018,P97351,Rps3a1,P97351_Rps3a1,P97351,Rps3a,1,60,17,17,P97351,MOUSE,30112.6,50.7,584,584.1,237.88,237.88,,264,40S ribosomal protein S3a,nucleus|nucleolus|cytosol|focal adhesion|cytosolic small ribosomal subunit|ribonucleoprotein complex|extracellular exosome|,translation|cell differentiation|negative regulation of apoptotic process|,structural constituent of ribosome|protein binding|poly(A) RNA binding|,17,60,21100000000,50.7%
Q8BJY1,0.894042447,0.002166667,1.675272173,0.033666667,0.679943432,0.431081579,-0.015,-0.027,-0.002,0.049,0.027,-0.019,Q8BJY1,Psmd5,Q8BJY1_Psmd5,Q8BJY1,Psmd5,1,49,18,18,Q8BJY1,MOUSE,56370.5,48,585,585.1,237.76,237.76,,504,26S proteasome non-ATPase regulatory subunit 5,"proteasome accessory complex|proteasome regulatory particle, base subcomplex|",proteasome assembly|,,18,49,17600000000,48.0%
Q2EMV9,0.79544854,0.022666667,3.201815621,-0.136666667,0.478430037,-0.751112658,-0.02,-0.162,0.455,0.11,-0.239,-0.008,Q2EMV9,Parp14,Q2EMV9_Parp14,Q2EMV9,Parp14,1,30,25,25,Q2EMV9|Q2EMV9-2,MOUSE,205737.6,16.5,586,586.1,237.67,237.67,,1817,Poly [ADP-ribose] polymerase 14,nucleus|cytoplasm|plasma membrane|membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",nucleic acid binding|NAD+ ADP-ribosyltransferase activity|protein binding|,25,30,2250000000,16.5%
Q8R4H7,0.915850537,-0.020333333,1.305987302,-0.058666667,0.740288955,-0.345705318,0.202,0.171,-0.346,0.104,-0.081,-0.172,Q8R4H7,Nags,Q8R4H7_Nags,Q8R4H7,Nags,1,47,18,18,Q8R4H7|Q8R4H7-2,MOUSE,58058.1,37,587,587.1,237.5,237.5,,527,"N-acetylglutamate synthase, mitochondrial",mitochondrion|mitochondrial matrix|,urea cycle|arginine biosynthetic process|glutamate metabolic process|,acetyl-CoA:L-glutamate N-acetyltransferase activity|,18,47,12800000000,37.0%
Q9QZW0,0.991556352,-0.023,0.161410683,-0.006,0.963516002,-0.04749978,-0.263,0.116,0.087,-0.117,0.028,0.011,Q9QZW0,Atp11c,Q9QZW0_Atp11c,Q9QZW0,Atp11c,1,46,18,18,Q9QZW0|F6Q8D3|E9QKK8|Q9QZW0-2|P98197|E9Q3G7,MOUSE,130835.2,20,588,588.1,236.79,236.79,,1129,Phospholipid-transporting ATPase 11C,lysosomal membrane|endoplasmic reticulum|endoplasmic reticulum membrane|plasma membrane|integral component of membrane|recycling endosome|,pre-B cell differentiation|metabolic process|phospholipid translocation|positive regulation of B cell differentiation|,magnesium ion binding|phospholipid-translocating ATPase activity|ATP binding|,19,46,5600000000,20.0%
Q9DCG6,0.919416995,0.006,1.21123347,0.039333333,0.756617972,0.323054507,0.027,0.073,-0.141,-0.019,0.224,-0.128,Q9DCG6,Pbld1,Q9DCG6_Pbld1,Q9DCG6,Pbld1,1,45,16,8,K3W4L7|Q9DCG6|A0A1W2P6V3|A0A1W2P6P6,MOUSE,32218.1,59.3,589,589.1,236.36,116.2,,288,Phenazine biosynthesis-like domain-containing protein 1,cytoplasm|extracellular exosome|,biosynthetic process|negative regulation of epithelial cell migration|negative regulation of epithelial to mesenchymal transition|maintenance of gastrointestinal epithelium|negative regulation of transforming growth factor beta receptor signaling pathway|negative regulation of epithelial cell proliferation|negative regulation of SMAD protein import into nucleus|negative regulation of pathway-restricted SMAD protein phosphorylation|,isomerase activity|,16,45,14500000000,59.3%
Q9CXN7,0.617054235,-0.027833333,6.010053916,0.211666667,0.250607814,1.259002459,0.057,0.016,-0.474,-0.018,0.259,-0.007,Q9CXN7,Pbld2,Q9CXN7_Pbld2,Q9CXN7,Pbld2,1,14,13,6,Q9CXN7,MOUSE,32211,45.4,589,589.2,179.29,71.64,,288,Phenazine biosynthesis-like domain-containing protein 2,cytoplasm|extracellular exosome|,biosynthetic process|negative regulation of epithelial cell migration|negative regulation of epithelial to mesenchymal transition|maintenance of gastrointestinal epithelium|negative regulation of transforming growth factor beta receptor signaling pathway|negative regulation of epithelial cell proliferation|negative regulation of SMAD protein import into nucleus|negative regulation of pathway-restricted SMAD protein phosphorylation|,isomerase activity|,6,14,1860000000,29.5%
Q6ZWV3,0.911333788,0.002166667,1.445152526,-0.031,0.716943196,-0.378257251,-0.034,0.069,0.018,-0.015,0.03,-0.055,Q6ZWV3,Rpl10,Q6ZWV3_Rpl10,Q6ZWV3,Rpl10,1,68,18,18,Q6ZWV3|P86048,MOUSE,25059.9,58.8,590,590.1,235.74,235.74,,214,60S ribosomal protein L10,ribosome|,translation|,structural constituent of ribosome|,18,68,79000000000,58.8%
Q922Q1,0.856747233,-0.019166667,2.275058509,-0.087666667,0.592235108,-0.562606659,0.196,0.177,-0.299,-0.116,0.07,-0.143,Q922Q1,Marc2,Q922Q1_Marc2,Q922Q1,Marc2,1,57,17,17,Q922Q1,MOUSE,38821.2,40.5,591,591.1,235.58,235.58,,338,Mitochondrial amidoxime reducing component 2,mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|peroxisome|extracellular exosome|,nitrate metabolic process|oxidation-reduction process|,nitrate reductase activity|molybdenum ion binding|pyridoxal phosphate binding|molybdopterin cofactor binding|,17,57,21600000000,40.5%
Q8BFW7,0.422611235,-0.000833333,9.927133726,0.153666667,0.101691962,1.895964954,-0.038,-0.092,-0.103,0.039,0.056,0.133,Q8BFW7,Lpp,Q8BFW7_Lpp,Q8BFW7,Lpp,1,44,18,18,Q8BFW7|Q8BFW7-4|Q8BFW7-5|Q8BFW7-2|Q8BFW7-3,MOUSE,67430,40.6,592,592.1,235.24,235.24,,613,Lipoma-preferred partner homolog,nucleus|cytoplasm|focal adhesion|,cell adhesion|,protein binding|zinc ion binding|,18,44,9580000000,40.6%
Q8K2C9,0.708523608,0.003,4.416962527,-0.095333333,0.361662723,-0.978890119,0.172,0.011,-0.031,0.026,-0.024,-0.136,Q8K2C9,Hacd3,Q8K2C9_Hacd3,Q8K2C9,Hacd3,1,59,17,17,Q8K2C9,MOUSE,43301.8,38.1,593,593.1,235.15,235.15,,362,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3,endoplasmic reticulum|endoplasmic reticulum membrane|focal adhesion|integral component of membrane|,I-kappaB kinase/NF-kappaB signaling|JNK cascade|Rho protein signal transduction|fatty acid elongation|very long-chain fatty acid biosynthetic process|positive regulation of viral genome replication|positive regulation by virus of viral protein levels in host cell|,protein binding|3-hydroxyacyl-CoA dehydratase activity|enzyme binding|,17,59,58200000000,38.1%
P54729,0.754807511,-0.001666667,3.773144192,-0.076666667,0.419455198,-0.86010165,0.107,-0.008,0.011,0.048,-0.116,-0.052,P54729,Nub1,P54729_Nub1,P54729,Nub1,1,29,22,22,A0A0G2JGQ4|P54729,MOUSE,70989.9,38.4,594,594.1,234.79,234.79,,614,NEDD8 ultimate buster 1,nucleus|nucleolus|cytoplasm|,ubiquitin-dependent protein catabolic process|protein ubiquitination|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|,,22,29,18100000000,38.4%
Q9Z0N1,0.53869457,0.019666667,7.463885357,-0.14,0.179312871,-1.499567445,0.013,0.227,0.029,-0.032,-0.053,-0.066,Q9Z0N1,Eif2s3x,Q9Z0N1_Eif2s3x,Q9Z0N1,Eif2s3x,1,54,18,18,Q9Z0N1|Q9Z0N2|A2AAW9,MOUSE,51635.1,47,595,595.1,234.73,234.73,,472,"Eukaryotic translation initiation factor 2 subunit 3, X-linked",cytoplasm|extracellular exosome|,translational initiation|,"translation initiation factor activity|GTPase activity|GTP binding|translation factor activity, RNA binding|",18,54,17600000000,47.0%
P08249,0.866627606,-0.017,2.138896907,-0.108,0.611097222,-0.533537738,0.034,0.367,-0.29,-0.097,0.2,-0.316,P08249,Mdh2,P08249_Mdh2,P08249,Mdh2,1,45,17,17,P08249,MOUSE,36067.2,63.3,596,596.1,234.51,234.51,,338,"Malate dehydrogenase, mitochondrial",nucleus|nucleoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial matrix|plasma membrane|membrane|myelin sheath|extracellular exosome|,carbohydrate metabolic process|tricarboxylic acid cycle|oxaloacetate metabolic process|malate metabolic process|internal protein amino acid acetylation|NADH metabolic process|,malate dehydrogenase activity|L-malate dehydrogenase activity|protein self-association|poly(A) RNA binding|malate dehydrogenase (NADP+) activity|,17,45,12400000000,63.3%
Q8BYL4,0.873222165,-0.036666667,2.04832672,0.064,0.623975199,0.513974636,0.049,0.066,-0.321,0.024,-0.029,-0.009,Q8BYL4,Yars2,Q8BYL4_Yars2,Q8BYL4,Yars2,1,39,17,17,Q8BYL4|E9PX65,MOUSE,52938.8,40.6,597,597.1,234.37,234.37,,472,"Tyrosine--tRNA ligase, mitochondrial",mitochondrion|mitochondrial matrix|cytosol|,tRNA aminoacylation|mitochondrial tyrosyl-tRNA aminoacylation|,tRNA binding|tyrosine-tRNA ligase activity|ATP binding|protein homodimerization activity|poly(A) RNA binding|tyrosine binding|,17,39,49000000000,40.6%
P50172,0.000498463,-0.254833333,49.86790704,2.179,1.03088E-05,11.9044894,-1.233,-1.126,-1.674,0.736,1.099,0.669,P50172,Hsd11b1,P50172_Hsd11b1,P50172,Hsd11b1,1,57,19,19,P50172|Q3TJI8,MOUSE,32534.6,40.4,598,598.1,233.97,233.97,,292,Corticosteroid 11-beta-dehydrogenase isozyme 1,endoplasmic reticulum membrane|membrane|integral component of membrane|,steroid metabolic process|lung development|oxidation-reduction process|,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity|11-beta-hydroxysteroid dehydrogenase (NADP+) activity|,19,57,32200000000,40.4%
Q99KI0,0.913467169,0.091166667,1.346050216,-0.091,0.733491319,-0.355193371,-0.006,0.644,-0.228,-0.134,0.396,-0.125,Q99KI0,Aco2,Q99KI0_Aco2,Q99KI0,Aco2,1,43,17,17,Q99KI0,MOUSE,86203.6,28,599,599.1,233.9,233.9,,780,"Aconitate hydratase, mitochondrial",nucleus|mitochondrion|myelin sheath|,tricarboxylic acid cycle|citrate metabolic process|isocitrate metabolic process|,"aconitate hydratase activity|iron ion binding|3 iron, 4 sulfur cluster binding|4 iron, 4 sulfur cluster binding|",17,43,8070000000,28.0%
Q8K1M3,0.821409751,0.001666667,2.754135884,-0.062,0.530379112,-0.661507759,0.033,-0.018,0.083,-0.118,0.095,-0.065,Q8K1M3,Prkar2a,Q8K1M3_Prkar2a,Q8K1M3,Prkar2a,1,37,16,16,Q8K1M3|A0A0A6YX73|P12367|P31324|H3BK84,MOUSE,45930.9,52.7,600,600.1,233.88,233.88,,402,"Protein kinase, cAMP dependent regulatory, type II alpha",cytoplasm|centrosome|plasma membrane|focal adhesion|cAMP-dependent protein kinase complex|membrane|AMP-activated protein kinase complex|extracellular exosome|,phosphorylation|negative regulation of cAMP-dependent protein kinase activity|,cAMP-dependent protein kinase inhibitor activity|cAMP-dependent protein kinase regulator activity|kinase activity|ubiquitin protein ligase binding|protein kinase A catalytic subunit binding|,16,37,6440000000,52.7%
Q3U186,0.714714682,0.003166667,4.290498239,-0.098333333,0.372348987,-0.955946855,0.138,0.12,-0.101,0.022,-0.132,-0.028,Q3U186,Rars2,Q3U186_Rars2,Q3U186,Rars2,1,41,20,20,Q3U186,MOUSE,65905.3,33.3,601,601.1,233.88,233.88,,578,"Probable arginine--tRNA ligase, mitochondrial",cytoplasm|mitochondrion|mitochondrial matrix|,arginyl-tRNA aminoacylation|mitochondrial translation|,arginine-tRNA ligase activity|ATP binding|poly(A) RNA binding|,20,41,4190000000,33.3%
Q920L1,0.875832617,-0.037333333,2.009119143,0.102666667,0.629633875,0.505447292,0.265,-0.053,-0.478,0.059,-0.198,0.181,Q920L1,Fads1,Q920L1_Fads1,Q920L1,Fads1,1,66,15,15,Q920L1,MOUSE,52550,31.7,602,602.1,233.7,233.7,,447,Fatty acid desaturase 1,nucleus|mitochondrion|endoplasmic reticulum membrane|membrane|integral component of membrane|,unsaturated fatty acid biosynthetic process|aging|cellular response to starvation|response to sucrose|response to organic cyclic compound|arachidonic acid metabolic process|response to insulin|response to vitamin A|response to isolation stress|long-chain fatty acid biosynthetic process|oxidation-reduction process|,linoleoyl-CoA desaturase activity|oxidoreductase activity|,15,66,35200000000,31.7%
O70503,0.983717661,-0.023333333,0.252014459,0.01,0.943623079,0.07344322,0.135,0.066,-0.286,0.107,-0.052,-0.11,O70503,Hsd17b12,O70503_Hsd17b12,O70503,Hsd17b12,1,94,18,18,O70503|O70503-2,MOUSE,34969.4,61.2,603,603.1,233.16,233.16,,312,Very-long-chain 3-oxoacyl-CoA reductase,proteinaceous extracellular matrix|endoplasmic reticulum membrane|integral component of membrane|,fatty acid biosynthetic process|estrogen biosynthetic process|positive regulation of cell-substrate adhesion|extracellular matrix organization|oxidation-reduction process|,fibronectin binding|estradiol 17-beta-dehydrogenase activity|collagen binding|heparin binding|,18,94,97700000000,61.2%
Q9WV68,0.911411213,-0.007,1.420139752,0.065333333,0.721084275,0.372605309,0.337,-0.097,-0.359,0.044,0.036,-0.003,Q9WV68,Decr2,Q9WV68_Decr2,Q9WV68,Decr2,1,73,14,14,Q9WV68,MOUSE,31642.1,59.5,604,604.1,232.73,232.73,,292,"Peroxisomal 2,4-dienoyl-CoA reductase",peroxisome|,unsaturated fatty acid biosynthetic process|oxidation-reduction process|,"receptor binding|2,4-dienoyl-CoA reductase (NADPH) activity|trans-2-enoyl-CoA reductase (NADPH) activity|",14,73,45500000000,59.5%
Q9CQC9,0.917704244,-0.120833333,1.274645142,0.091,0.745650796,0.338246122,0.227,0.061,-0.787,0.018,0.047,-0.291,Q9CQC9,Sar1b,Q9CQC9_Sar1b,Q9CQC9,Sar1b,1,48,16,11,Q9CQC9,MOUSE,22495.5,63.6,605,605.1,232.57,169.07,,198,GTP-binding protein SAR1b,endoplasmic reticulum membrane|Golgi cisterna membrane|,intracellular protein transport|vesicle-mediated transport|,GTP binding|metal ion binding|,16,48,52400000000,63.6%
Q99JZ4,0.934957223,-0.0505,0.933202183,0.050333333,0.806640051,0.254760933,0.208,0.078,-0.513,0.116,-0.044,-0.148,Q99JZ4,Sar1a,Q99JZ4_Sar1a,Q99JZ4,Sar1a,1,26,13,8,Q99JZ4|P36536,MOUSE,22512.6,61.1,605,605.2,179.55,116.05,,198,GTP-binding protein SAR1a,endoplasmic reticulum|Golgi apparatus|sarcoplasmic reticulum|extracellular exosome|,intracellular protein transport|vesicle-mediated transport|regulation of cargo loading into COPII-coated vesicle|negative regulation of cargo loading into COPII-coated vesicle|,GTP binding|,8,26,7720000000,45.9%
Q80UG5,0.461918472,0.009833333,9.067994322,0.203,0.123936883,1.760928607,-0.198,-0.106,0.029,0.051,-0.006,0.289,Q80UG5,Sept9,Q80UG5_Sept9,Q80UG5,Sept9,1,37,19,19,Q80UG5|Q80UG5-3|A2A6U3|Q80UG5-2,MOUSE,65916.1,35.5,606,606.1,232.05,232.05,,583,Septin-9,stress fiber|microtubule|actin cytoskeleton|perinuclear region of cytoplasm|,cell cycle|protein heterooligomerization|cell division|,GTP binding|,19,37,7200000000,35.5%
Q80W22,0.419278528,-0.033666667,9.983641695,0.375333333,0.100377374,1.908477727,0.016,-0.084,-0.596,0.422,0.064,-0.024,Q80W22,Thnsl2,Q80W22_Thnsl2,Q80W22,Thnsl2,1,44,16,16,Q80W22,MOUSE,54985.8,36.6,607,607.1,231.54,231.54,,483,Threonine synthase-like 2,cytoplasm|,serine family amino acid catabolic process|dephosphorylation|2-oxobutyrate biosynthetic process|threonine biosynthetic process|,pyridoxal phosphate binding|serine binding|threonine synthase activity|,16,44,40600000000,36.6%
Q8BX02,0.676059904,-0.027166667,4.938206721,0.116333333,0.320759352,1.072388018,0.002,0.02,-0.278,0.027,0.077,-0.011,Q8BX02,Kank2,Q8BX02_Kank2,Q8BX02,Kank2,1,39,18,16,Q8BX02|Q8BX02-2,MOUSE,91042.6,26.4,608,608.1,231.5,215.99,,843,KN motif and ankyrin repeat domain-containing protein 2,cytoplasm|mitochondrion|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|apoptotic process|negative regulation of cell proliferation|negative regulation of intracellular estrogen receptor signaling pathway|negative regulation of programmed cell death|negative regulation of stress fiber assembly|negative regulation of vitamin D receptor signaling pathway|negative regulation of G1/S transition of mitotic cell cycle|",,18,39,4160000000,26.4%
E9Q238,0.993445046,-0.048166667,0.104798631,-0.006333333,0.976158043,-0.031032972,0.274,0.086,-0.495,0.044,0.005,-0.203,E9Q238,Kank1,E9Q238_Kank1,E9Q238,Kank1,1,4,6,4,E9Q238,MOUSE,150191.5,7.7,608,608.2,52.34,36.83,,1360,KN motif and ankyrin repeat domains 1,nucleus|cytoplasm|ruffle membrane|,negative regulation of neuron projection development|positive regulation of Wnt signaling pathway|negative regulation of cell migration|negative regulation of actin filament polymerization|negative regulation of Rho protein signal transduction|positive regulation of catenin import into nucleus|negative regulation of insulin receptor signaling pathway|positive regulation of wound healing|negative regulation of substrate adhesion-dependent cell spreading|negative regulation of ruffle assembly|regulation of establishment of cell polarity|negative regulation of lamellipodium morphogenesis|,beta-catenin binding|,4,4,114000000,5.8%
P40142,0.116705641,-0.029166667,19.11852371,0.466333333,0.012250326,3.412989016,-0.137,-0.134,-0.516,0.13,0.132,0.35,P40142,Tkt,P40142_Tkt,P40142,Tkt,1,45,18,18,P40142|E0CY51,MOUSE,68313.9,35.7,609,609.1,231.43,231.43,,623,Transketolase,nucleus|nucleoplasm|vesicle|myelin sheath|extracellular exosome|,regulation of growth|glyceraldehyde-3-phosphate biosynthetic process|,transketolase activity|protein homodimerization activity|metal ion binding|cofactor binding|,18,45,4810000000,35.7%
Q03311,0.000372555,-0.3205,52.38463688,1.985666667,5.77479E-06,13.03648025,-1.194,-1.189,-1.557,0.509,0.903,0.605,Q03311,Bche,Q03311_Bche,Q03311,Bche,1,46,15,15,Q03311,MOUSE,68974.5,33.6,610,610.1,231.33,231.33,,603,Cholinesterase,nuclear envelope lumen|endoplasmic reticulum|endoplasmic reticulum lumen|membrane|blood microparticle|,learning|negative regulation of cell proliferation|neuroblast differentiation|choline metabolic process|response to drug|response to alkaloid|negative regulation of synaptic transmission|response to glucocorticoid|response to folic acid|,acetylcholinesterase activity|cholinesterase activity|choline binding|identical protein binding|,15,46,10800000000,33.6%
Q9CY27,0.581377911,-0.049166667,6.700357628,0.251,0.213778604,1.375278755,-0.018,0.049,-0.555,0.265,0.007,-0.043,Q9CY27,Tecr,Q9CY27_Tecr,Q9CY27,Tecr,1,116,18,18,Q9CY27|Q52L67|G3UWE1|Q3TAN8,MOUSE,36489.1,30.8,611,611.1,231.1,231.1,,308,Very-long-chain enoyl-CoA reductase,nucleus|endoplasmic reticulum|integral component of endoplasmic reticulum membrane|,steroid biosynthetic process|fatty acid elongation|very long-chain fatty acid biosynthetic process|oxidation-reduction process|,"oxidoreductase activity, acting on the CH-CH group of donors|",18,116,1.48E+11,30.8%
Q8VCC1,0.588823742,-0.166666667,6.51565838,0.406,0.223066402,1.344383178,-0.022,0.033,-1.12,0.057,0.058,-0.006,Q8VCC1,Hpgd,Q8VCC1_Hpgd,Q8VCC1,Hpgd,1,68,15,15,Q8VCC1,MOUSE,29408.5,62.4,612,612.1,230.68,230.68,,269,15-hydroxyprostaglandin dehydrogenase [NAD(+)],cytoplasm|basolateral plasma membrane|extracellular exosome|,prostaglandin metabolic process|transforming growth factor beta receptor signaling pathway|female pregnancy|parturition|ovulation|negative regulation of cell cycle|oxidation-reduction process|thrombin receptor signaling pathway|ductus arteriosus closure|,catalytic activity|prostaglandin E receptor activity|15-hydroxyprostaglandin dehydrogenase (NAD+) activity|NAD binding|NAD+ binding|,15,68,30300000000,62.4%
Q3TEA8,0.763881819,-0.011333333,3.658097121,-0.070666667,0.430715289,-0.838389432,0.028,0.087,-0.043,-0.038,-0.005,-0.097,Q3TEA8,Hp1bp3,Q3TEA8_Hp1bp3,Q3TEA8,Hp1bp3,1,43,20,20,Q3TEA8|Z4YKB8|Q3TEA8-2|Q3TEA8-3|Z4YKA3,MOUSE,61093.7,36.4,613,613.1,230.01,230.01,,554,Heterochromatin protein 1-binding protein 3,nucleosome|nucleus|chromosome|,"nucleosome assembly|regulation of transcription, DNA-templated|regulation of cell proliferation|heterochromatin organization|cellular response to hypoxia|regulation of nucleus size|",DNA binding|nucleosome binding|,20,43,8930000000,36.4%
P62830,0.856747233,-0.0235,2.281060388,-0.071666667,0.591417214,-0.563878849,0.089,0.168,-0.22,-0.055,0.037,-0.16,P62830,Rpl23,P62830_Rpl23,P62830,Rpl23,1,81,14,14,P62830,MOUSE,14979.3,77.1,614,614.1,229.81,229.81,,140,60S ribosomal protein L23,nucleolus|cytoplasm|focal adhesion|membrane|cytosolic large ribosomal subunit|cytosolic ribosome|extracellular exosome|,translation|,structural constituent of ribosome|protein binding|poly(A) RNA binding|,14,81,98300000000,77.1%
Q9D1G1,0.680162369,0.005333333,4.869876056,-0.091333333,0.325846,-1.060059157,0.129,0.053,-0.029,-0.048,0.005,-0.078,Q9D1G1,Rab1b,Q9D1G1_Rab1b,Q9D1G1,Rab1b,1,77,16,10,Q9D1G1|S4R1W7|Q3TYH2|Q8K386|A2A7Z6|Q9CZT8|H3BLG3|Q504M8|Q544E8|Q9JKM7|Q8BQX0|Q923S9|D3YWS1|Q8BNU1|D3YTZ8,MOUSE,22357.9,81.5,615,615.1,211.75,112.09,,201,Ras-related protein Rab-1B,Golgi membrane|mitochondrion|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|pre-autophagosomal structure membrane|extracellular exosome|,intracellular protein transport|ER to Golgi vesicle-mediated transport|autophagy|virion assembly|Rab protein signal transduction|positive regulation of glycoprotein metabolic process|regulation of autophagosome assembly|,GTPase activity|GTP binding|,22,77,29600000000,81.5%
Q91V41,0.575882301,0.011666667,6.85537486,-0.120666667,0.206282561,-1.399353116,0.141,0.097,-0.022,-0.08,-0.018,-0.048,Q91V41,Rab14,Q91V41_Rab14,Q91V41,Rab14,1,47,15,13,Q91V41|A2AL34|P62823|A0A286YDR2|P63011|P35276|Q9CXS2|D3YW33|Q8BHD0|Q8BHC1,MOUSE,24124.7,59.5,615,615.2,229.65,196.71,,215,Ras-related protein Rab-14,Golgi membrane|intracellular|lysosomal membrane|early endosome|trans-Golgi network|apical plasma membrane|transport vesicle|phagocytic vesicle membrane|early endosome membrane|intracellular membrane-bounded organelle|phagocytic vesicle|recycling endosome|extracellular exosome|alveolar lamellar body|,intracellular protein transport|Golgi to endosome transport|body fluid secretion|metabolic process|fibroblast growth factor receptor signaling pathway|embryo development|endocytic recycling|Rab protein signal transduction|regulation of protein localization|defense response to bacterium|apical protein localization|phagolysosome assembly involved in apoptotic cell clearance|,glycoprotein binding|GTPase activity|protein binding|GTP binding|GDP binding|myosin V binding|,13,47,13100000000,53.4%
P62821,0.634404848,-0.128833333,5.688600363,0.307,0.2698609,1.204024845,0.041,0.014,-0.902,-0.014,0.115,-0.027,P62821,Rab1a,P62821_Rab1a,P62821,Rab1A,1,19,15,6,P62821,MOUSE,22905.6,64.3,615,615.3,204.79,91.22,,205,Ras-related protein Rab-1A,Golgi membrane|early endosome|endoplasmic reticulum membrane|Golgi apparatus|cytosol|melanosome|extracellular exosome|,autophagosome assembly|intracellular protein transport|ER to Golgi vesicle-mediated transport|endocytosis|autophagy|Golgi organization|cell migration|virion assembly|growth hormone secretion|melanosome transport|Rab protein signal transduction|substrate adhesion-dependent cell spreading|defense response to bacterium|vesicle transport along microtubule|interleukin-8 secretion|cargo loading into COPII-coated vesicle|positive regulation of glycoprotein metabolic process|,GTPase activity|protein binding|GTP binding|,6,19,4970000000,26.8%
P61027,0.419278528,0.021,9.985997725,-0.211333333,0.100322935,-1.906496194,0.33,0.006,0.044,-0.062,-0.069,-0.123,P61027,Rab10,P61027_Rab10,P61027,Rab10,1,21,13,9,P61027|P61028,MOUSE,22768.7,62.5,615,615.4,171.58,108.31,,200,Ras-related protein Rab-10,endosome|endoplasmic reticulum membrane|Golgi apparatus|trans-Golgi network|focal adhesion|endosome membrane|phagocytic vesicle membrane|insulin-responsive compartment|perinuclear region of cytoplasm|recycling endosome|recycling endosome membrane|extracellular exosome|endoplasmic reticulum tubular network|primary cilium|exocyst|plasma membrane|,intracellular protein transport|Golgi to plasma membrane transport|vesicle docking involved in exocytosis|axonogenesis|protein secretion|vesicle-mediated transport|endosomal transport|regulation of exocytosis|antigen processing and presentation|polarized epithelial cell differentiation|Rab protein signal transduction|cellular response to insulin stimulus|Golgi to plasma membrane protein transport|establishment of neuroblast polarity|basolateral protein localization|cellular response to antibiotic|endoplasmic reticulum tubular network organization|protein localization to plasma membrane|establishment of protein localization to membrane|establishment of protein localization to endoplasmic reticulum membrane|,GTPase activity|protein binding|GTP binding|GDP binding|myosin V binding|,9,21,13300000000,47.0%
P35279,0.953420192,0.007666667,0.703092171,-0.018,0.850532245,-0.195856389,0.017,0.129,-0.096,-0.026,0.005,0.017,P35279,Rab6a,P35279_Rab6a,P35279,Rab6a,1,21,12,11,P35279|P35279-2|D3YV69|P61294|A0A1L1SRS6,MOUSE,23703.5,49.5,615,615.5,116.45,99.03,,208,Ras-related protein Rab-6A,Golgi membrane|Golgi apparatus|trans-Golgi network|cytosol|membrane|cytoplasmic vesicle|extracellular exosome|endosome to plasma membrane transport vesicle|,"protein targeting to Golgi|intracellular protein transport|retrograde vesicle-mediated transport, Golgi to ER|intra-Golgi vesicle-mediated transport|peptidyl-cysteine methylation|antigen processing and presentation|Rab protein signal transduction|positive regulation of ATPase activity|protein localization to Golgi apparatus|early endosome to Golgi transport|retrograde transport, endosome to Golgi|",ATPase activator activity|GTPase activity|protein binding|GTP binding|protein domain specific binding|myosin V binding|ATPase binding|,11,21,2720000000,44.2%
P55258,0.998411609,-0.020666667,0.014194139,-0.000666667,0.996737014,-0.004246371,0.226,0.074,-0.361,0.016,-0.03,-0.049,P55258,Rab8a,P55258_Rab8a,P55258,Rab8a,1,13,10,4,P55258,MOUSE,23838.9,41.5,615,615.6,144.07,50.02,,207,Ras-related protein Rab-8A,nucleus|nucleoplasm|nucleolus|centrosome|plasma membrane|cilium|synaptic vesicle|postsynaptic density|trans-Golgi network transport vesicle|dendrite|secretory granule membrane|phagocytic vesicle membrane|nonmotile primary cilium|ciliary basal body|neuronal cell body|phagocytic vesicle|recycling endosome|recycling endosome membrane|extracellular exosome|primary cilium|cilium|,intracellular protein transport|vesicle docking involved in exocytosis|axonogenesis|metabolic process|protein secretion|synaptic vesicle exocytosis|regulation of exocytosis|Rab protein signal transduction|cellular response to insulin stimulus|cilium assembly|regulation of long-term neuronal synaptic plasticity|Golgi vesicle fusion to target membrane|regulation of protein transport|protein localization to plasma membrane|,GTPase activity|protein binding|GTP binding|Rab GTPase binding|GDP binding|protein kinase binding|myosin V binding|,4,13,9360000000,18.8%
Q6PHN9,0.797447147,-0.005833333,3.152904592,-0.063,0.483848658,-0.741018817,0.026,0.077,-0.026,-0.014,-0.112,0.014,Q6PHN9,Rab35,Q6PHN9_Rab35,Q6PHN9,Rab35,1,11,10,5,Q6PHN9,MOUSE,23310.1,47.7,615,615.7,129.5,65.13,,201,Ras-related protein Rab-35,mitochondrion|plasma membrane|coated pit|endosome membrane|cell projection membrane|melanosome|intercellular bridge|clathrin-coated endocytic vesicle|extracellular exosome|Golgi membrane|endoplasmic reticulum membrane|,cytokinesis|intracellular protein transport|ER to Golgi vesicle-mediated transport|protein localization|metabolic process|endosomal transport|antigen processing and presentation|neuron projection development|endocytic recycling|Rab protein signal transduction|protein localization to endosome|plasma membrane to endosome transport|cellular response to nerve growth factor stimulus|,"GTPase activity|protein binding|GTP binding|phosphatidylinositol-4,5-bisphosphate binding|GDP binding|",5,11,2520000000,30.3%
Q8CG50,0.964822261,0.016,0.479800591,-0.012,0.895405878,-0.136542743,0.131,-0.037,-0.028,0.038,-0.004,-0.004,Q8CG50,Rab43,Q8CG50_Rab43,Q8CG50,Rab43,1,18,10,9,Q8CG50|Q91Z34|D3Z444,MOUSE,23491,64.2,615,615.8,127.39,109.97,,210,Ras-related protein Rab-43,endosome|Golgi apparatus|phagocytic vesicle membrane|phagocytic vesicle|extracellular exosome|,"intracellular protein transport|Golgi organization|metabolic process|virion assembly|Rab protein signal transduction|retrograde transport, plasma membrane to Golgi|phagosome maturation|toxin transport|",GTPase activity|GTP binding|,9,18,5150000000,59.0%
P56371,0.904214516,0.014,1.555321079,-0.039333333,0.698985058,-0.403737926,-0.056,-0.021,0.178,-0.018,0.049,-0.048,P56371,Rab4a,P56371_Rab4a,P56371,Rab4a,1,4,5,4,P56371|Q91ZR1,MOUSE,24693.5,28.8,615,615.9,67.93,50.51,,218,Ras-related protein Rab-4A,cytoplasm|endosome|cytosol|plasma membrane|cytoplasmic vesicle membrane|vesicle|insulin-responsive compartment|perinuclear region of cytoplasm|recycling endosome|extracellular exosome|,intracellular protein transport|metabolic process|protein transport|antigen processing and presentation|regulation of endocytosis|Rab protein signal transduction|positive regulation of ATPase activity|,ATPase activator activity|GTPase activity|GTP binding|protein transporter activity|GDP binding|syntaxin binding|ionotropic glutamate receptor binding|ATPase binding|,4,4,306000000,23.8%
A2CG35,0.671041558,-0.002,4.994986917,-0.106666667,0.316593,-1.082185754,0.154,0.007,-0.007,0.058,-0.068,-0.156,A2CG35,NotFound,A2CG35_NotFound,A2CG35,Rab12,1,3,4,3,A2CG35|P35283,MOUSE,32694,14.4,615,615.1,52.73,35.31,,291,Ras-related protein Rab-12,Golgi apparatus|insulin-responsive compartment|,intracellular protein transport|vesicle docking involved in exocytosis|protein secretion|regulation of exocytosis|Rab protein signal transduction|protein localization to plasma membrane|cellular response to insulin stimulus|,GTPase activity|GTP binding|GDP binding|,3,3,485000000,10.6%
Q3U125,0.494183327,-0.008166667,8.315743952,0.471666667,0.147375606,1.640454303,-0.023,0.004,-0.713,0.424,0.563,-0.304,Q3U125,Fam213a,Q3U125_Fam213a,Q3U125,Fam213a,1,58,17,17,Q3U125|Q9CYH2,MOUSE,25795.7,50.2,616,616.1,229.2,229.2,,229,Redox-regulatory protein FAM213A,cytoplasm|mitochondrion|extracellular exosome|,regulation of osteoclast differentiation|oxidation-reduction process|,antioxidant activity|,17,58,26200000000,50.2%
Q99MZ7,0.715744889,0.0395,4.275446225,-0.195,0.373641733,-0.953936228,0.053,0.577,-0.219,-0.173,0.073,-0.074,Q99MZ7,Pecr,Q99MZ7_Pecr,Q99MZ7,Pecr,1,71,14,14,Q99MZ7|Q3UXD9|D6RHN4|D6RIP0,MOUSE,32694.9,63.6,617,617.1,228.64,228.64,,303,Peroxisomal trans-2-enoyl-CoA reductase,mitochondrion|peroxisome|peroxisomal membrane|intracellular membrane-bounded organelle|,fatty acid elongation|phytol metabolic process|oxidation-reduction process|,receptor binding|trans-2-enoyl-CoA reductase (NADPH) activity|,14,71,66800000000,63.6%
Q6ZQI3,0.701372679,-0.020333333,4.539044049,0.164666667,0.351637833,1.001814999,-0.408,-0.06,0.16,-0.074,0.031,0.229,Q6ZQI3,Mlec,Q6ZQI3_Mlec,Q6ZQI3,Mlec,1,45,17,17,Q6ZQI3,MOUSE,32512.6,50.8,618,618.1,228.17,228.17,,291,Malectin,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,carbohydrate metabolic process|,enzyme binding|carbohydrate binding|,17,45,13800000000,50.8%
Q9D6Y7,0.836873322,-0.011,2.570756848,-0.077333333,0.553253685,-0.624420023,0.097,-0.085,0.071,-0.265,0.115,0.001,Q9D6Y7,Msra,Q9D6Y7_Msra,Q9D6Y7,Msra,1,69,18,18,Q9D6Y7|Q9D6Y7-2|Q9D6Y7-4|A0A1B0GT40|Q9D6Y7-3,MOUSE,26216.1,77.2,619,619.1,227.38,227.38,,233,Mitochondrial peptide methionine sulfoxide reductase,nucleoplasm|cytoplasm|mitochondrion|actin cytoskeleton|membrane|extracellular exosome|,response to oxidative stress|protein repair|oxidation-reduction process|,peptide-methionine (S)-S-oxide reductase activity|,18,69,17400000000,77.2%
P13020,0.332019767,-0.012166667,11.9243266,0.433666667,0.064204777,2.21832671,-0.021,-0.103,-0.563,-0.084,0.233,0.465,P13020,Gsn,P13020_Gsn,P13020,Gsn,1,59,17,17,P13020|P13020-2,MOUSE,86339.4,23.7,620,620.1,227.19,227.19,,780,Gelsolin,ruffle|podosome|extracellular region|extracellular space|cytoplasm|cytosol|plasma membrane|focal adhesion|sarcoplasm|lamellipodium|actin cap|cortical actin cytoskeleton|myelin sheath|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|nucleus|focal adhesion|cortical actin cytoskeleton|,"phagocytosis, engulfment|aging|positive regulation of gene expression|oligodendrocyte development|striated muscle atrophy|vesicle-mediated transport|actin filament polymerization|protein destabilization|tissue regeneration|sequestering of actin monomers|actin nucleation|response to ethanol|negative regulation of viral entry into host cell|phosphatidylinositol-mediated signaling|actin filament severing|barbed-end actin filament capping|positive regulation of actin nucleation|response to folic acid|actin filament capping|cilium morphogenesis|cellular response to cadmium ion|regulation of podosome assembly|actin filament reorganization|renal protein absorption|hepatocyte apoptotic process|positive regulation of keratinocyte apoptotic process|regulation of wound healing, spreading of epidermal cells|regulation of establishment of T cell polarity|regulation of plasma membrane raft polarization|regulation of receptor clustering|positive regulation of protein processing in phagocytic vesicle|amyloid fibril formation|positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|",actin binding|calcium ion binding|protein binding|protein domain specific binding|myosin II binding|,17,59,21800000000,23.7%
Q60931,0.868452057,-0.020833333,2.117283931,-0.117666667,0.614145971,-0.528886228,-0.469,0.213,0.37,-0.235,0.014,-0.018,Q60931,Vdac3,Q60931_Vdac3,Q60931,Vdac3,1,48,22,20,Q60931|J3QMG3,MOUSE,31094.5,73.8,621,621.1,226.26,201.92,,283,Voltage-dependent anion-selective channel protein 3,nucleus|mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|pore complex|extracellular exosome|,behavioral fear response|anion transport|synaptic transmission|neuron-neuron synaptic transmission|learning|transmembrane transport|regulation of cilium assembly|regulation of anion transmembrane transport|,nucleotide binding|voltage-gated anion channel activity|porin activity|,22,48,56200000000,73.8%
Q60932-2,0.961523652,0.012833333,0.548477127,0.027666667,0.881357871,0.155109656,-0.301,-0.087,0.385,0.106,0.027,-0.053,Q60932,Vdac1,Q60932-2_Vdac1,Q60932-2,Vdac1,1,38,15,13,Q60932-2|Q60932|F2Z471,MOUSE,30869,67.4,621,621.2,208.46,184.12,,296,Isoform Mt-VDAC1 of Voltage-dependent anion-selective channel protein 1,nucleus|mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|plasma membrane|membrane|mitochondrial nucleoid|myelin sheath|pore complex|extracellular exosome|,behavioral fear response|mitochondrial calcium ion transport|apoptotic process|synaptic transmission|neuron-neuron synaptic transmission|learning|epithelial cell differentiation|anion transmembrane transport|regulation of anion transmembrane transport|,nucleotide binding|protein binding|voltage-gated anion channel activity|porin activity|protein kinase binding|protein complex binding|,13,38,12000000000,61.8%
A0A0R4J038,0.00070612,-0.060333333,46.67396665,1.256,2.15082E-05,10.58971798,-0.618,-0.67,-0.777,0.394,0.544,0.765,A0A0R4J038,Kng1,A0A0R4J038_Kng1,A0A0R4J038,Kng1,1,48,16,15,A0A0R4J038|O08677|D3YTY9|O08677-3|O08677-2,MOUSE,74183.9,31.9,622,622.1,226.19,214.92,,661,Kininogen-1,,,,16,48,10300000000,31.9%
Q6S9I0,0.047215298,0.0285,23.92011662,0.541666667,0.004054976,4.30098927,-0.317,-0.186,-0.224,0.054,0.397,0.447,Q6S9I0,Kng2,Q6S9I0_Kng2,Q6S9I0,Kng2,1,4,4,3,Q6S9I0|Q6S9I3|Q6S9I2|E0CYI5,MOUSE,48970.3,10.1,622,622.2,34.85,23.58,,433,Kininogen 2,extracellular space|cytosol|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|,cysteine-type endopeptidase inhibitor activity|receptor binding|,3,4,468000000,7.8%
P62281,0.354656702,-0.008166667,11.38229705,-0.172333333,0.072739497,-2.127180204,0.069,0.098,0.067,-0.049,-0.074,-0.16,P62281,Rps11,P62281_Rps11,P62281,Rps11,1,95,17,17,P62281|A0A1B0GRR3,MOUSE,18601.6,65.1,623,623.1,225.41,225.41,,158,40S ribosomal protein S11,nucleolus|cytoplasm|focal adhesion|membrane|cytosolic small ribosomal subunit|extracellular exosome|,osteoblast differentiation|translation|,structural constituent of ribosome|rRNA binding|poly(A) RNA binding|,17,95,2.57E+11,65.1%
Q9JLB0,0.998411609,-0.000166667,0.013963846,-0.000333333,0.996789869,-0.004175784,0,0.052,-0.052,0.004,-0.006,0.001,Q9JLB0,Mpp6,Q9JLB0_Mpp6,Q9JLB0,Mpp6,1,44,19,19,Q9JLB0|Q9JLB0-2|E9Q2R8,MOUSE,62914.9,39.7,624,624.1,224.98,224.98,,553,MAGUK p55 subfamily member 6,plasma membrane|integral component of membrane|extracellular exosome|,nucleotide phosphorylation|,guanylate kinase activity|protein binding|,19,44,10700000000,39.7%
Q91ZW3,0.282551234,0.032833333,13.32080513,-0.277666667,0.046549979,-2.439688585,0.073,0.065,0.377,-0.113,-0.167,-0.038,Q91ZW3,Smarca5,Q91ZW3_Smarca5,Q91ZW3,Smarca5,1,36,19,14,Q91ZW3|Q8BS67,MOUSE,122366.6,19.6,625,625.1,224.41,172.85,,1051,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,condensed chromosome|nucleus|nucleoplasm|chromatin silencing complex|nucleolus|NURF complex|ISWI-type complex|RSF complex|nuclear replication fork|,"chromatin silencing at rDNA|double-strand break repair|chromatin assembly or disassembly|nucleosome assembly|chromatin remodeling|DNA-templated transcription, initiation|nucleosome positioning|ATP-dependent chromatin remodeling|positive regulation of transcription, DNA-templated|",DNA binding|helicase activity|protein binding|ATP binding|ATPase activity|nucleosome binding|histone binding|,19,36,7410000000,19.6%
Q6PGB8-2,0.093250908,0.006,20.41833276,-0.306666667,0.009081691,-3.628477533,0.219,0.172,0.087,-0.182,-0.095,-0.165,Q6PGB8,Smarca1,Q6PGB8-2_Smarca1,Q6PGB8-2,Smarca1,1,5,7,3,Q6PGB8-2|Q6PGB8,MOUSE,124147.2,5,625,625.2,62.5,18.68,,1046,Isoform 2 of Probable global transcription activator SNF2L1,nuclear chromatin|nucleus|NURF complex|CERF complex|,"DNA strand renaturation|chromatin remodeling|transcription, DNA-templated|regulation of transcription, DNA-templated|brain development|neuron differentiation|ATP-dependent chromatin remodeling|positive regulation of transcription, DNA-templated|regulation of neural precursor cell proliferation|",DNA binding|helicase activity|ATP binding|nucleosome binding|annealing helicase activity|DNA-dependent ATPase activity|nucleosome-dependent ATPase activity|,3,5,1770000000,1.9%
E9PZD8,0.000643619,-0.095,47.65463175,1.056,1.71608E-05,10.84339405,-0.673,-0.673,-0.523,0.358,0.389,0.552,E9PZD8,Cp,E9PZD8_Cp,E9PZD8,Cp,1,41,19,19,E9PZD8|G3X8Q5|Q61147|G3X9T8,MOUSE,125007.5,23.8,626,626.1,224.35,224.35,,1086,Ceruloplasmin,extracellular space|lysosomal membrane|extracellular exosome|blood microparticle|,copper ion transport|cellular iron ion homeostasis|oxidation-reduction process|,ferroxidase activity|copper ion binding|chaperone binding|,19,41,3100000000,23.8%
Q9ESB3,0.012787486,0.060833333,30.94782618,1.077666667,0.000803928,5.810594622,-0.546,-0.58,-0.308,0.243,0.936,0.62,Q9ESB3,Hrg,Q9ESB3_Hrg,Q9ESB3,Hrg,1,51,16,16,A0A0R4J039|Q9ESB3,MOUSE,60131.6,28.5,627,627.1,224.07,224.07,,525,Histidine-rich glycoprotein,extracellular region|vesicle|endolysosome|phagolysosome membrane|,angiogenesis|positive regulation of immune response to tumor cell|chemotaxis|negative regulation of cell adhesion|negative regulation of cell proliferation|regulation of gene expression|regulation of platelet activation|negative regulation of lamellipodium assembly|negative regulation of endopeptidase activity|response to organic cyclic compound|heme transport|negative regulation of angiogenesis|platelet activation|regulation of blood coagulation|negative regulation of cell growth|regulation of actin cytoskeleton organization|negative regulation of cell adhesion mediated by integrin|regulation of transcription from RNA polymerase II promoter in response to iron|fibrinolysis|positive regulation of apoptotic process|regulation of protein complex assembly|negative regulation of blood vessel endothelial cell migration|regulation of peptidyl-tyrosine phosphorylation|defense response to fungus|positive regulation of focal adhesion assembly|negative regulation of fibrinolysis|heme export|negative regulation of vascular endothelial growth factor signaling pathway|positive regulation of blood vessel remodeling|negative regulation of endothelial cell chemotaxis|,serine-type endopeptidase inhibitor activity|cysteine-type endopeptidase inhibitor activity|receptor binding|protein binding|heparin binding|zinc ion binding|immunoglobulin binding|heme binding|heparan sulfate proteoglycan binding|metal ion binding|,16,51,22000000000,28.5%
Q8R4U0,0.001827436,-0.062,41.14421621,0.916666667,7.68384E-05,8.564839056,-0.585,-0.51,-0.466,0.577,0.292,0.32,Q8R4U0,Stab2,Q8R4U0_Stab2,Q8R4U0,Stab2,1,33,19,19,Q8R4U0,MOUSE,289109.6,11.6,628,628.1,223.78,223.78,,2559,Stabilin-2,cytoplasm|integral component of plasma membrane|external side of plasma membrane|,endocytosis|receptor-mediated endocytosis|cell adhesion|regulation of gene expression|regulation of blood coagulation|defense response to bacterium|,low-density lipoprotein receptor activity|scavenger receptor activity|hyaluronic acid binding|low-density lipoprotein particle binding|,19,33,1150000000,11.6%
Q9Z2M7,0.797128744,0.0075,3.160347101,-0.063,0.483020196,-0.742479142,0.015,0.127,-0.025,-0.007,-0.011,-0.054,Q9Z2M7,Pmm2,Q9Z2M7_Pmm2,Q9Z2M7,Pmm2,1,61,16,16,Q9Z2M7|O35621|Q91W01,MOUSE,27998.4,66.9,629,629.1,223.54,223.54,,242,Phosphomannomutase 2,cytoplasm|neuronal cell body|extracellular exosome|,GDP-mannose biosynthetic process|mannose biosynthetic process|,phosphomannomutase activity|,16,61,1.07E+11,66.9%
O88962,0.942504874,-0.0175,0.82543244,-0.037,0.826907167,-0.227491479,0.234,0.075,-0.306,0.118,-0.203,-0.023,O88962,Cyp8b1,O88962_Cyp8b1,O88962,Cyp8b1,1,46,17,17,O88962|A0A0R4J0N7,MOUSE,58218.8,27.6,630,630.1,223.32,223.32,,500,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,lipid metabolic process|oxidation-reduction process|,iron ion binding|sterol 12-alpha-hydroxylase activity|heme binding|7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity|,17,46,36500000000,27.6%
O55029,0.581351655,0.000666667,6.720993176,0.108666667,0.212765242,1.377035377,-0.08,-0.065,-0.016,0.089,0.034,0.042,O55029,Copb2,O55029_Copb2,O55029,Copb2,1,33,18,18,O55029,MOUSE,103303.2,24.1,631,631.1,223.11,223.11,,905,Coatomer subunit beta',Golgi apparatus|cytosol|COPI vesicle coat|,intracellular protein transport|intra-Golgi vesicle-mediated transport|toxin transport|,structural molecule activity|,18,33,3600000000,24.1%
Q9JI78,0.647960318,-0.017,5.388702881,0.098,0.289154338,1.151027337,-0.025,-0.012,-0.161,0.05,0.014,0.032,Q9JI78,Ngly1,Q9JI78_Ngly1,Q9JI78,Ngly1,1,34,19,19,Q9JI78|A0A286YCI0,MOUSE,75243.7,37.9,632,632.1,222.3,222.3,,651,Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase,nucleus|cytoplasm|,glycoprotein catabolic process|,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity|protein binding|metal ion binding|,19,34,2100000000,37.9%
Q925N2,0.565040651,0.033333333,7.0435111,-0.219333333,0.197537198,-1.432312373,0.316,0.284,-0.171,-0.029,0.01,-0.21,Q925N2,Sfxn2,Q925N2_Sfxn2,Q925N2,Sfxn2,1,69,17,17,Q925N2,MOUSE,36540.2,51.8,633,633.1,221.88,221.88,,322,Sideroflexin-2,mitochondrion|mitochondrial inner membrane|integral component of membrane|,ion transmembrane transport|iron ion homeostasis|,ion transmembrane transporter activity|,17,69,69900000000,51.8%
P84084,0.692956416,-0.017333333,4.661812896,-0.136666667,0.341836718,-1.023898338,0.162,0.205,-0.214,-0.053,-0.024,-0.18,P84084,Arf5,P84084_Arf5,P84084,Arf5,1,54,14,7,P84084|E9Q2C2,MOUSE,20643.4,77.2,634,634.1,221.65,112.18,,180,ADP-ribosylation factor 5,cytoplasm|Golgi apparatus|plasma membrane|perinuclear region of cytoplasm|extracellular exosome|,small GTPase mediated signal transduction|protein transport|vesicle-mediated transport|,protein binding|GTP binding|,14,54,36300000000,77.2%
P84078,0.91325,-0.1555,1.359663375,0.119,0.731195757,0.358405616,0.21,0.167,-1.022,0.068,-0.079,-0.277,P84078,Arf1,P84078_Arf1,P84078,Arf1,1,11,14,3,P84078|P61205,MOUSE,20753.5,60.7,634,634.2,214.82,47.69,,181,ADP-ribosylation factor 1,Golgi membrane|late endosome|peroxisomal membrane|Golgi apparatus|trans-Golgi network|cytosol|focal adhesion|endomembrane system|postsynaptic density|sarcomere|COPI-coated vesicle|cell leading edge|neuron projection|postsynaptic membrane|perinuclear region of cytoplasm|extracellular exosome|,regulation of receptor internalization|cellular copper ion homeostasis|actin filament organization|small GTPase mediated signal transduction|protein transport|vesicle-mediated transport|regulation of Arp2/3 complex-mediated actin nucleation|very-low-density lipoprotein particle assembly|positive regulation of catalytic activity|positive regulation of endocytosis|positive regulation of calcium ion-dependent exocytosis|positive regulation of protein secretion|Golgi to transport vesicle transport|long term synaptic depression|positive regulation of dendritic spine development|synaptic vesicle budding|dendritic spine organization|lysosomal membrane organization|positive regulation of sodium ion transmembrane transport|positive regulation of late endosome to lysosome transport|positive regulation of ER to Golgi vesicle-mediated transport|regulation of phospholipid metabolic process|,magnesium ion binding|protein binding|GTP binding|GDP binding|poly(A) RNA binding|phospholipase D activator activity|,3,11,4260000000,23.2%
P61750,0.631972503,-0.006833333,5.77102559,-0.131,0.264787477,-1.217169342,0.143,0.159,-0.126,-0.006,-0.104,-0.107,P61750,Arf4,P61750_Arf4,P61750,Arf4,1,26,13,7,P61750|E9Q798,MOUSE,20510.4,77.2,634,634.3,199.62,109.17,,180,ADP-ribosylation factor 4,cytoplasm|Golgi apparatus|cytosol|plasma membrane|membrane|ruffle membrane|dendritic spine|extracellular exosome|,protein ADP-ribosylation|epidermal growth factor receptor signaling pathway|small GTPase mediated signal transduction|brain development|learning|protein transport|vesicle-mediated transport|cell migration|activation of phospholipase D activity|negative regulation of apoptotic process|apical protein localization|establishment or maintenance of epithelial cell apical/basal polarity|positive regulation of transcription from RNA polymerase II promoter|response to axon injury|dendritic spine development|protein localization to cilium|regulation of reactive oxygen species metabolic process|,epidermal growth factor receptor binding|protein binding|GTP binding|,7,26,12200000000,43.8%
P32261,0.035840685,-0.088166667,25.38047037,1.035,0.00289703,4.591738482,-0.335,-0.336,-1.146,0.427,0.361,0.5,P32261,Serpinc1,P32261_Serpinc1,P32261,Serpinc1,1,36,18,18,P32261|A0A0A6YX49|A0A0A6YXS8,MOUSE,52516.1,44.9,635,635.1,221.33,221.33,,465,Antithrombin-III,extracellular space|extracellular exosome|blood microparticle|,"response to nutrient|blood coagulation|negative regulation of endopeptidase activity|negative regulation of inflammatory response|regulation of blood coagulation, intrinsic pathway|",protease binding|serine-type endopeptidase inhibitor activity|heparin binding|,18,36,8310000000,44.9%
Q8CI51,0.797504707,-0.051333333,3.117597125,0.108666667,0.487798306,0.734572458,-0.029,0.129,-0.417,0.02,0.027,-0.038,Q8CI51,Pdlim5,Q8CI51_Pdlim5,Q8CI51,Pdlim5,1,44,18,3,Q8CI51|D9J300|D9J2Z9|Q8CI51-2|F8WJI6|E9Q8P5|Q8CI51-3|D9J303|Q9CRA2,MOUSE,64553.3,36.8,636,636.1,220.64,33,,591,PDZ and LIM domain protein 5,cytosol|postsynaptic density|actin cytoskeleton|Z disc|cell junction|neuron projection|postsynaptic membrane|,regulation of synapse assembly|regulation of dendritic spine morphogenesis|,actin binding|protein kinase C binding|protein binding|zinc ion binding|actinin binding|protein N-terminus binding|,18,44,8330000000,36.8%
Q07113,0.000122452,-0.1575,62.52632214,1.620333333,5.58943E-07,18.37002237,-1.019,-0.93,-0.954,0.614,0.753,0.591,Q07113,Igf2r,Q07113_Igf2r,Q07113,Igf2r,1,47,19,19,Q07113,MOUSE,280828.2,9.5,637,637.1,220.6,220.6,,2483,Cation-independent mannose-6-phosphate receptor,nucleus|nuclear envelope lumen|lysosomal membrane|endosome|early endosome|late endosome|trans-Golgi network|focal adhesion|cell surface|membrane|integral component of membrane|endocytic vesicle|trans-Golgi network transport vesicle|extracellular exosome|,transport|,glycoprotein binding|transporter activity|insulin-like growth factor binding|mannose binding|identical protein binding|phosphoprotein binding|,19,47,2810000000,9.5%
Q9Z1F9,0.507593286,0.007,8.068858339,-0.13,0.155996253,-1.598047407,0.126,0.075,0.015,-0.03,-0.089,-0.055,Q9Z1F9,Uba2,Q9Z1F9_Uba2,Q9Z1F9,Uba2,1,35,18,18,Q9Z1F9,MOUSE,71252.3,34.7,638,638.1,220.44,220.44,,638,SUMO-activating enzyme subunit 2,nucleus|nucleoplasm|cytosol|SUMO activating enzyme complex|,protein sumoylation|,protein binding|ATP binding|transcription factor binding|SUMO activating enzyme activity|metal ion binding|protein heterodimerization activity|,18,35,5550000000,34.7%
P25911,0.237542896,0.0395,14.56742489,-0.301666667,0.03493474,-2.641906362,0.137,0.036,0.398,-0.11,-0.075,-0.149,P25911,Lyn,P25911_Lyn,P25911,Lyn,1,43,17,17,P25911|P25911-2|P16277,MOUSE,59267.6,35.9,639,639.1,220.31,220.31,,512,Tyrosine-protein kinase Lyn,nucleus|cytoplasm|mitochondrial intermembrane space|Golgi apparatus|cytosol|plasma membrane|cell-cell adherens junction|postsynaptic density|mitochondrial crista|extrinsic component of cytoplasmic side of plasma membrane|integrin alpha2-beta1 complex|mast cell granule|membrane raft|perinuclear region of cytoplasm|extracellular exosome|,B cell homeostasis|regulation of cytokine production|negative regulation of protein phosphorylation|Fc receptor mediated stimulatory signaling pathway|tolerance induction to self antigen|histamine secretion by mast cell|platelet degranulation|negative regulation of myeloid leukocyte differentiation|immune response-regulating cell surface receptor signaling pathway|Fc receptor mediated inhibitory signaling pathway|regulation of B cell apoptotic process|protein phosphorylation|cellular response to DNA damage stimulus|response to sterol depletion|signal transduction|transmembrane receptor protein tyrosine kinase signaling pathway|positive regulation of cell proliferation|negative regulation of cell proliferation|response to toxic substance|response to hormone|response to carbohydrate|positive regulation of neuron projection development|oligodendrocyte development|response to organic cyclic compound|peptidyl-tyrosine phosphorylation|hemopoiesis|erythrocyte differentiation|positive regulation of cell migration|negative regulation of B cell proliferation|neuron projection development|lipopolysaccharide-mediated signaling pathway|cellular response to extracellular stimulus|response to insulin|regulation of mast cell activation|regulation of cell adhesion mediated by integrin|negative regulation of toll-like receptor 2 signaling pathway|negative regulation of toll-like receptor 4 signaling pathway|cellular response to heat|intracellular signal transduction|peptidyl-tyrosine autophosphorylation|response to drug|positive regulation of tyrosine phosphorylation of STAT protein|hemoglobin biosynthetic process|response to amino acid|regulation of mast cell degranulation|negative regulation of MAP kinase activity|positive regulation of phosphatidylinositol 3-kinase activity|innate immune response|regulation of erythrocyte differentiation|protein autophosphorylation|response to axon injury|cytokine secretion|regulation of cytokine secretion|regulation of inflammatory response|positive regulation of peptidyl-tyrosine phosphorylation|B cell receptor signaling pathway|regulation of B cell receptor signaling pathway|positive regulation of B cell receptor signaling pathway|positive regulation of cellular component movement|regulation of release of sequestered calcium ion into cytosol|positive regulation of glial cell proliferation|positive regulation of Fc receptor mediated stimulatory signaling pathway|positive regulation of stress-activated protein kinase signaling cascade|regulation of ERK1 and ERK2 cascade|negative regulation of ERK1 and ERK2 cascade|positive regulation of oligodendrocyte progenitor proliferation|negative regulation of mast cell proliferation|positive regulation of mast cell proliferation|cellular response to retinoic acid|cellular response to peptide hormone stimulus|regulation of monocyte chemotaxis|regulation of platelet aggregation|dendritic cell differentiation|negative regulation of intracellular signal transduction|positive regulation of dendritic cell apoptotic process|,protein kinase activity|protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|erythropoietin receptor binding|platelet-derived growth factor receptor binding|integrin binding|protein binding|ATP binding|SH3 domain binding|enzyme binding|ubiquitin protein ligase binding|protein complex binding|gamma-tubulin binding|glycosphingolipid binding|ion channel binding|phosphoprotein binding|,17,43,13300000000,35.9%
P70302,0.000891947,-0.100833333,45.18691241,1.385666667,3.02907E-05,10.03540115,-0.699,-0.675,-1.007,0.397,0.631,0.748,P70302,Stim1,P70302_Stim1,P70302,Stim1,1,42,20,20,A0A1B0GRA5|P70302|A0A1B0GR78,MOUSE,77850.5,30.3,640,640.1,220.17,220.17,,685,Stromal interaction molecule 1,endoplasmic reticulum|microtubule|integral component of plasma membrane|integral component of endoplasmic reticulum membrane|cortical endoplasmic reticulum|protein complex|,store-operated calcium entry|detection of calcium ion|cation transport|myotube differentiation|activation of store-operated calcium channel activity|regulation of calcium ion transport|enamel mineralization|,protease binding|calcium channel regulator activity|calcium ion binding|protein binding|identical protein binding|microtubule plus-end binding|,20,42,9350000000,30.3%
Q6P5F9,0.708523608,-0.009833333,4.413662806,-0.083666667,0.361937614,-0.978292038,0.017,0.043,0.036,0.029,-0.043,-0.141,Q6P5F9,Xpo1,Q6P5F9_Xpo1,Q6P5F9,Xpo1,1,34,15,15,Q6P5F9,MOUSE,124231.5,16.6,641,641.1,220.16,220.16,,1071,Exportin-1,kinetochore|nucleus|annulate lamellae|nucleoplasm|nucleolus|cytoplasm|Cajal body|membrane|ribonucleoprotein complex|nuclear membrane|intracellular membrane-bounded organelle|,ribosomal large subunit export from nucleus|ribosomal small subunit export from nucleus|negative regulation of transcription from RNA polymerase II promoter|protein export from nucleus|regulation of centrosome duplication|protein localization to nucleus|regulation of protein catabolic process|response to drug|regulation of protein export from nucleus|mRNA transport|,RNA binding|nucleocytoplasmic transporter activity|protein binding|Ran GTPase binding|protein transporter activity|protein domain specific binding|,15,34,10100000000,16.6%
P58871,0.012481381,-0.009666667,31.07716554,0.562666667,0.000780339,5.798254261,-0.218,-0.264,-0.391,0.234,0.196,0.385,P58871,Tnks1bp1,P58871_Tnks1bp1,P58871,Tnks1bp1,1,29,20,20,P58871|Z4YJL4,MOUSE,183133.9,17.9,642,642.1,220.04,220.04,,1720,182 kDa tankyrase-1-binding protein,nucleoplasm|chromosome|cytoplasm|cytoskeleton|plasma membrane|CCR4-NOT complex|,,,20,29,5020000000,17.9%
O08715-4,0.841746758,-0.023666667,2.511202367,0.067333333,0.560892668,0.611827175,0.025,0.051,-0.248,-0.034,0.084,-0.02,O08715,Akap1,O08715-4_Akap1,O08715-4,Akap1,1,37,16,16,O08715-4|O08715|O08715-6|O08715-3|O08715-5|O08715-2,MOUSE,96907.2,22.6,643,643.1,219.63,219.63,,857,"Isoform 4 of A-kinase anchor protein 1, mitochondrial",mitochondrion|mitochondrial outer membrane|mitochondrial matrix|endoplasmic reticulum|lipid particle|membrane|integral component of membrane|mitochondrial crista|neuromuscular junction|postsynaptic membrane|,negative regulation of cardiac muscle hypertrophy|negative regulation of protein dephosphorylation|negative regulation of NFAT protein import into nucleus|cellular response to cAMP|cellular response to peptide hormone stimulus|,protein binding|microtubule binding|protein kinase binding|protein domain specific binding|protein phosphatase 2B binding|protein complex scaffold|protein kinase A regulatory subunit binding|poly(A) RNA binding|beta-tubulin binding|,16,37,4700000000,22.6%
Q78IK4,0.884566234,0.004833333,1.846988745,-0.037666667,0.653583569,-0.469543941,-0.006,0.085,-0.008,-0.029,-0.014,0.001,Q78IK4,Apool,Q78IK4_Apool,Q78IK4,Apool,1,39,14,14,Q78IK4|B1AV14,MOUSE,29374.3,69,644,644.1,219.4,219.4,,265,MICOS complex subunit Mic27,mitochondrion|mitochondrial inner membrane|integral component of membrane|,,,14,39,20600000000,69.0%
Q8BW75,0.480593503,0.036333333,8.540596124,0.275333333,0.139939522,1.676825681,-0.098,0.046,-0.252,-0.083,0.486,0.119,Q8BW75,Maob,Q8BW75_Maob,Q8BW75,Maob,1,47,17,17,Q8BW75|E9Q3X6|E9PVL9,MOUSE,59070.2,33.8,645,645.1,219.01,219.01,,520,Amine oxidase [flavin-containing] B,mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|integral component of membrane|extracellular exosome|,response to toxic substance|response to aluminum ion|response to selenium ion|negative regulation of serotonin secretion|substantia nigra development|response to lipopolysaccharide|response to drug|response to ethanol|positive regulation of dopamine metabolic process|response to corticosterone|oxidation-reduction process|,oxidoreductase activity|protein homodimerization activity|flavin adenine dinucleotide binding|,17,47,8930000000,33.8%
E9PV45,0.95383876,0.004,0.683162884,0.016,0.854444211,0.19065757,-0.008,0.041,-0.045,0.079,-0.051,0.008,E9PV45,NotFound,E9PV45_NotFound,E9PV45,Usp24,1,26,23,23,E9PV45|B1AY13|B1AY13-2,MOUSE,297090.7,11.7,646,646.1,218.36,218.36,,2618,Ubiquitin carboxyl-terminal hydrolase 24,,protein deubiquitination|proteasome-mediated ubiquitin-dependent protein catabolic process|regulation of proteasomal protein catabolic process|,cysteine-type endopeptidase activity|ubiquitin-specific protease activity|,23,26,3030000000,11.7%
E9QP62,0.933608247,0.000666667,0.958997964,-0.020666667,0.801863054,-0.261098328,0.04,-0.009,0.002,0.035,-0.026,-0.038,E9QP62,Lims1,E9QP62_Lims1,E9QP62,Lims1,1,61,15,10,E9QP62|A0A0R4J005|Q99JW4|Q9D7B2,MOUSE,46336.3,47,647,647.1,218.32,144.41,,387,LIM and senescent cell antigen-like-containing domain protein,cell-cell junction|focal adhesion|perinuclear region of cytoplasm|focal adhesion|,"cell-matrix adhesion|establishment or maintenance of cell polarity|positive regulation of gene expression|positive regulation of cell-substrate adhesion|single organismal cell-cell adhesion|chordate embryonic development|negative regulation of apoptotic process|positive regulation of GTPase activity|establishment of protein localization|cell-cell junction organization|negative regulation of transcription, DNA-templated|negative regulation of epithelial cell proliferation|positive regulation of focal adhesion assembly|positive regulation of substrate adhesion-dependent cell spreading|negative regulation of neural precursor cell proliferation|negative regulation of hepatocyte proliferation|positive regulation of integrin-mediated signaling pathway|",protein binding|zinc ion binding|protein kinase binding|,15,61,16700000000,47.0%
Q91XD2,0.780167159,0.017333333,3.394818712,-0.074666667,0.457633838,-0.788076951,0.152,0.014,-0.002,0.087,-0.066,-0.081,Q91XD2,Lims2,Q91XD2_Lims2,Q91XD2,Lims2,1,19,12,7,Q91XD2,MOUSE,40970.5,42.2,647,647.2,163.11,89.2,,341,LIM and senescent cell antigen-like-containing domain protein 2,plasma membrane|focal adhesion|,single organismal cell-cell adhesion|negative regulation of apoptotic process|cell-cell junction organization|negative regulation of epithelial cell proliferation|negative regulation of neural precursor cell proliferation|negative regulation of hepatocyte proliferation|positive regulation of integrin-mediated signaling pathway|,zinc ion binding|,7,19,4660000000,28.4%
H7BX95,0.91325,-0.011833333,1.359848915,-0.048333333,0.731164519,-0.358449356,-0.233,0.136,0.134,-0.028,-0.169,0.089,H7BX95,NotFound,H7BX95_NotFound,H7BX95,Srsf1,1,50,18,17,H7BX95|Q6PDM2|Q6PDM2-2|Q6PDM2-3,MOUSE,28442.8,58.1,648,648.1,218.18,212.07,,253,Serine/arginine-rich-splicing factor 1,nucleus|nucleoplasm|nuclear speck|extracellular exosome|catalytic step 2 spliceosome|exon-exon junction complex|,"mRNA 5'-splice site recognition|in utero embryonic development|regulation of transcription, DNA-templated|regulation of translation|RNA splicing|regulation of mRNA stability|regulation of mRNA splicing, via spliceosome|cardiac muscle contraction|",nucleotide binding|RNA binding|mRNA binding|poly(A) RNA binding|RS domain binding|,17,50,15800000000,57.3%
Q99PU8,0.791316333,-0.007333333,3.240320204,-0.063333333,0.474207021,-0.758119628,0.043,0.042,-0.012,0.039,-0.063,-0.093,Q99PU8,Dhx30,Q99PU8_Dhx30,Q99PU8,Dhx30,1,30,19,19,Q99PU8|Q99PU8-3|Q99PU8-2|A0A0G2JGL8,MOUSE,137806.9,20.7,649,649.1,218.03,218.03,,1217,Putative ATP-dependent RNA helicase DHX30,cytoplasm|mitochondrion|mitochondrial nucleoid|,RNA processing|,chromatin binding|double-stranded RNA binding|ATP-dependent RNA helicase activity|ATP binding|poly(A) RNA binding|,19,30,3420000000,20.7%
P11531,0.841746758,-0.011833333,2.502972755,0.070333333,0.561956533,0.610294207,0.055,0.009,-0.205,0.178,-0.071,-0.037,P11531,Dmd,P11531_Dmd,P11531,Dmd,1,56,19,19,P11531|A2A9Z2|A2A9Z1,MOUSE,427934.9,5.3,650,650.1,217.63,217.63,,3678,Dystrophin,nucleus|cytoskeleton|plasma membrane|cell surface|dystrophin-associated glycoprotein complex|Z disc|cell-substrate junction|filopodium|filopodium membrane|sarcolemma|costamere|protein complex|neuron projection terminus|membrane raft|synapse|postsynaptic membrane|,"positive regulation of cell-matrix adhesion|regulation of heart rate|regulation of transcription, DNA-templated|muscle organ development|skeletal muscle tissue development|establishment of blood-nerve barrier|regulation of gene expression|regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum|regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion|positive regulation of neuron projection development|regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion|regulation of skeletal muscle contraction|myotube cell development|muscle attachment|olfactory nerve structural organization|negative regulation of peptidyl-serine phosphorylation|cellular protein localization|response to muscle stretch|regulation of membrane potential|peptide biosynthetic process|cellular protein complex assembly|neurotransmitter receptor metabolic process|positive regulation of neuron differentiation|muscle cell cellular homeostasis|muscle fiber development|nucleus localization|cardiac muscle contraction|regulation of ryanodine-sensitive calcium-release channel activity|establishment of glial blood-brain barrier|negative regulation of ERK1 and ERK2 cascade|cardiac muscle cell action potential|regulation of cellular response to growth factor stimulus|regulation of voltage-gated calcium channel activity|negative regulation of peptidyl-cysteine S-nitrosylation|positive regulation of sodium ion transmembrane transporter activity|",dystroglycan binding|actin binding|structural constituent of cytoskeleton|protein binding|zinc ion binding|structural constituent of muscle|myosin binding|vinculin binding|nitric-oxide synthase binding|,19,56,6640000000,5.3%
Q7TMB8,0.293761754,0.006166667,12.98490735,-0.212333333,0.0502932,-2.382435987,0.037,0.098,0.202,-0.04,-0.161,-0.099,Q7TMB8,Cyfip1,Q7TMB8_Cyfip1,Q7TMB8,Cyfip1,1,50,18,18,Q7TMB8|Q7TMB8-2|A0A0R4J119|Q5SQX6,MOUSE,146893.4,17.6,651,651.1,217.45,217.45,,1253,Cytoplasmic FMR1-interacting protein 1,ruffle|mRNA cap binding complex|focal adhesion|lamellipodium|SCAR complex|neuron projection|synapse|perinuclear region of cytoplasm|extracellular exosome|,regulation of cell shape|Rac protein signal transduction|lamellipodium assembly|ruffle organization|axon extension|cognition|positive regulation of Arp2/3 complex-mediated actin nucleation|,protein binding|profilin binding|protein complex binding|Rac GTPase binding|actin filament binding|Rac GTPase binding|,19,50,12800000000,17.6%
G3X977,0.013624043,-0.033,30.59574966,0.766,0.000871816,5.727741046,-0.273,-0.317,-0.658,0.229,0.34,0.481,G3X977,Itih2,G3X977_Itih2,G3X977,Itih2,1,37,16,16,G3X977|Q61703,MOUSE,106758.8,24.9,652,652.1,216.08,216.08,,950,"Inter-alpha trypsin inhibitor, heavy chain 2",extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,16,37,8500000000,24.9%
Q9R008,0.733613685,-0.028166667,4.041796198,0.163666667,0.394294192,0.910928059,0.19,-0.039,-0.481,0.197,-0.027,-0.009,Q9R008,Mvk,Q9R008_Mvk,Q9R008,Mvk,1,50,13,13,Q9R008|Q3UEB4|A0A0G2JEG0|A0A0G2JFX8,MOUSE,42333.1,45.3,653,653.1,215.69,215.69,,395,Mevalonate kinase,cytosol|extracellular exosome|,"cholesterol biosynthetic process|isoprenoid biosynthetic process|phosphorylation|isopentenyl diphosphate biosynthetic process, mevalonate pathway|negative regulation of inflammatory response|",mevalonate kinase activity|ATP binding|identical protein binding|,13,50,22700000000,45.3%
P30416,0.369537427,-0.023333333,11.04488186,0.244,0.078616158,2.077050394,0.018,-0.128,-0.326,0.208,0.008,0.08,P30416,Fkbp4,P30416_Fkbp4,P30416,Fkbp4,1,40,17,17,P30416,MOUSE,51970.8,42.3,654,654.1,215.67,215.67,,458,Peptidyl-prolyl cis-trans isomerase FKBP4,nucleus|nucleoplasm|cytoplasm|mitochondrion|endoplasmic reticulum membrane|cytosol|microtubule|neuronal cell body|axonal growth cone|perinuclear region of cytoplasm|extracellular exosome|,protein peptidyl-prolyl isomerization|steroid hormone receptor complex assembly|copper ion transport|embryo implantation|negative regulation of neuron projection development|androgen receptor signaling pathway|prostate gland development|negative regulation of microtubule polymerization or depolymerization|negative regulation of microtubule polymerization|protein complex localization|male sex differentiation|reproductive structure development|chaperone-mediated protein folding|,peptidyl-prolyl cis-trans isomerase activity|protein binding|ATP binding|GTP binding|FK506 binding|heat shock protein binding|copper-dependent protein binding|glucocorticoid receptor binding|poly(A) RNA binding|tau protein binding|phosphoprotein binding|,17,40,7700000000,42.3%
Q9DC69,0.926554478,0.013333333,1.055038817,-0.034666667,0.784325109,-0.285038599,-0.094,0.269,-0.083,0.052,-0.036,-0.028,Q9DC69,Ndufa9,Q9DC69_Ndufa9,Q9DC69,Ndufa9,1,52,15,15,Q9DC69|A0A0R3P9C8,MOUSE,42638.5,44,655,655.1,215.46,215.46,,377,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial",nucleus|mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex I|mitochondrial matrix|mitochondrial membrane|,response to glucose|oxidation-reduction process|ubiquinone-6 biosynthetic process|,NADH dehydrogenase activity|protein complex binding|,15,52,15300000000,44.0%
P09055,0.000122452,-0.294333333,62.69403315,1.958,5.3777E-07,18.53058831,-1.236,-1.132,-1.452,0.697,0.67,0.687,P09055,Itgb1,P09055_Itgb1,P09055,Itgb1,1,56,16,16,P09055|P09055-2|Q9Z0T9|B1AYG6,MOUSE,91481.9,21.8,656,656.1,215.28,215.28,,798,Integrin beta-1,cytoplasm|plasma membrane|focal adhesion|external side of plasma membrane|cell surface|intercalated disc|membrane|lamellipodium|filopodium|neuromuscular junction|integrin alpha1-beta1 complex|integrin alpha2-beta1 complex|integrin alpha3-beta1 complex|integrin alpha7-beta1 complex|integrin alpha10-beta1 complex|integrin alpha11-beta1 complex|myelin sheath abaxonal region|sarcolemma|melanosome|dendritic spine|receptor complex|membrane raft|synapse|recycling endosome|extracellular exosome|invadopodium membrane|synaptic membrane|plasma membrane|cytoplasmic vesicle|ruffle membrane|perinuclear region of cytoplasm|,G1/S transition of mitotic cell cycle|in utero embryonic development|cell fate specification|cell migration involved in sprouting angiogenesis|leukocyte cell-cell adhesion|cell-matrix adhesion|calcium-independent cell-matrix adhesion|integrin-mediated signaling pathway|positive regulation of cell proliferation|germ cell migration|visual learning|regulation of collagen catabolic process|cell migration|formation of radial glial scaffolds|neuron projection development|cell-substrate adhesion|cell-cell adhesion mediated by integrin|heterotypic cell-cell adhesion|negative regulation of Rho protein signal transduction|positive regulation of apoptotic process|sarcomere organization|negative regulation of cell differentiation|mesodermal cell differentiation|axon extension|cardiac muscle tissue development|dendrite morphogenesis|leukocyte tethering or rolling|regulation of cell cycle|cardiac muscle cell differentiation|positive regulation of establishment of protein localization to plasma membrane|negative regulation of anoikis|transforming growth factor beta receptor signaling pathway|stress fiber assembly|,fibronectin binding|protease binding|actin binding|receptor activity|integrin binding|protein binding|metal ion binding|protein heterodimerization activity|cell adhesion molecule binding|collagen binding involved in cell-matrix adhesion|laminin binding|,16,56,14200000000,21.8%
O09110,0.978001068,-0.034166667,0.323028899,0.010333333,0.928318724,0.093411131,0.06,0.038,-0.216,0.06,-0.021,-0.126,O09110,Map2k3,O09110_Map2k3,O09110,Map2k3,1,49,17,14,O09110|O09110-2|A0A0R4J1Q6,MOUSE,39638,59.3,657,657.1,214.78,176.49,,347,Dual specificity mitogen-activated protein kinase kinase 3,cytoplasm|membrane|,"MAPK cascade|activation of MAPK activity|inflammatory response|regulation of mitotic cell cycle|peptidyl-tyrosine phosphorylation|stress-activated protein kinase signaling cascade|regulation of cytokine biosynthetic process|regulation of apoptotic process|positive regulation of protein kinase activity|positive regulation of transcription, DNA-templated|cardiac muscle contraction|",protein serine/threonine kinase activity|MAP kinase kinase activity|protein tyrosine kinase activity|protein binding|ATP binding|protein kinase binding|,17,49,16600000000,59.3%
P70236,0.82510431,-0.113,2.698189819,0.129333333,0.537255683,0.650544835,0.068,0.027,-0.628,0.025,0.021,-0.191,P70236,Map2k6,P70236_Map2k6,P70236,Map2k6,1,12,6,4,P70236|A2AGS2,MOUSE,37773.9,21.2,657,657.2,70.13,40.27,,334,Dual specificity mitogen-activated protein kinase kinase 6,nucleus|cytoplasm|cytosol|cytoskeleton|,"MAPK cascade|activation of MAPK activity|response to ischemia|transcription, DNA-templated|regulation of transcription, DNA-templated|protein phosphorylation|apoptotic process|regulation of mitotic cell cycle|peptidyl-tyrosine phosphorylation|ovulation cycle process|stress-activated protein kinase signaling cascade|positive regulation of prostaglandin secretion|response to drug|regulation of apoptotic process|positive regulation of apoptotic process|positive regulation of nitric-oxide synthase biosynthetic process|cardiac muscle contraction|cellular response to sorbitol|",protein serine/threonine kinase activity|MAP kinase kinase activity|protein tyrosine kinase activity|protein binding|ATP binding|protein kinase binding|,4,12,999000000,16.4%
Q8R1Q8,0.841972349,0.004333333,2.490296098,-0.058,0.563599229,-0.607407495,0.143,-0.029,-0.014,0.074,-0.086,-0.062,Q8R1Q8,Dync1li1,Q8R1Q8_Dync1li1,Q8R1Q8,Dync1li1,1,46,19,19,Q8R1Q8,MOUSE,56898.5,44.3,658,658.1,214.65,214.65,,523,Cytoplasmic dynein 1 light intermediate chain 1,kinetochore|condensed chromosome kinetochore|spindle pole|cytoplasm|centrosome|cytoplasmic dynein complex|microtubule|plasma membrane|membrane|,transport|microtubule-based movement|mitotic nuclear division|metabolic process|cell division|positive regulation of mitotic cell cycle spindle assembly checkpoint|,microtubule motor activity|ATP binding|poly(A) RNA binding|,19,46,7350000000,44.3%
P35550,0.055332396,0.045166667,23.13292008,-0.425666667,0.004860803,-4.129450391,0.092,0.361,0.321,-0.22,-0.173,-0.11,P35550,Fbl,P35550_Fbl,P35550,Fbl,1,42,16,16,P35550|Q80WS3,MOUSE,34420.3,49.2,659,659.1,214.5,214.5,,327,rRNA 2'-O-methyltransferase fibrillarin,dense fibrillar component|granular component|nucleus|nucleolus|Cajal body|membrane|box C/D snoRNP complex|small-subunit processome|extracellular exosome|,box C/D snoRNA 3'-end processing|osteoblast differentiation|tRNA processing|snoRNA metabolic process|rRNA methylation|histone glutamine methylation|,RNA binding|rRNA methyltransferase activity|poly(A) RNA binding|histone-glutamine methyltransferase activity|,17,42,14500000000,49.2%
Q920E5,0.388522744,-0.004,10.64222891,0.284,0.086253576,2.013633787,0.031,-0.223,-0.246,-0.096,0.33,0.18,Q920E5,Fdps,Q920E5_Fdps,Q920E5,Fdps,1,63,15,15,Q920E5|A0A0G2JEA5,MOUSE,40923.1,42.4,660,660.1,214.48,214.48,,353,Farnesyl pyrophosphate synthase,nucleoplasm|cytoplasm|mitochondrion|,cholesterol biosynthetic process|geranyl diphosphate biosynthetic process|farnesyl diphosphate biosynthetic process|,dimethylallyltranstransferase activity|geranyltranstransferase activity|poly(A) RNA binding|metal ion binding|,15,63,41400000000,42.4%
Q8K2I3,0.919618833,-0.019,1.182414887,-0.046666667,0.761655375,-0.316105197,0.012,0.263,-0.262,-0.161,0.033,0.001,Q8K2I3,Fmo2,Q8K2I3_Fmo2,Q8K2I3,Fmo2,1,49,18,18,Q8K2I3,MOUSE,61429.8,39.2,661,661.1,214.39,214.39,,535,Dimethylaniline monooxygenase [N-oxide-forming] 2,endoplasmic reticulum membrane|membrane|integral component of membrane|,organic acid metabolic process|NADP metabolic process|xenobiotic metabolic process|toxin metabolic process|drug metabolic process|oxidation-reduction process|NADPH oxidation|oxygen metabolic process|,"monooxygenase activity|N,N-dimethylaniline monooxygenase activity|flavin adenine dinucleotide binding|NADP binding|",18,49,19900000000,39.2%
Q3UW66,0.449719411,0.016333333,9.412669022,-0.281333333,0.114480917,-1.817104633,0.077,0.432,-0.038,-0.31,-0.1,0.037,Q3UW66,Mpst,Q3UW66_Mpst,Q3UW66,Mpst,1,41,15,15,Q3UW66|Q99J99,MOUSE,33324.9,51.1,662,662.1,213.92,213.92,,297,Sulfurtransferase,mitochondrion|mitochondrial inner membrane|cytosol|extracellular exosome|,kidney development|liver development|transsulfuration|spinal cord development|,thiosulfate sulfurtransferase activity|3-mercaptopyruvate sulfurtransferase activity|identical protein binding|,15,41,6140000000,51.1%
Q9D1Q6,0.000230546,-0.159,56.44990325,1.599333333,2.26469E-06,14.89021283,-0.964,-0.881,-1.031,0.555,0.551,0.816,Q9D1Q6,Erp44,Q9D1Q6_Erp44,Q9D1Q6,Erp44,1,53,19,19,Q9D1Q6,MOUSE,47251.5,35.2,663,663.1,213.29,213.29,,406,Endoplasmic reticulum resident protein 44,endoplasmic reticulum lumen|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|cell surface|extracellular exosome|,protein folding|response to unfolded protein|glycoprotein metabolic process|response to endoplasmic reticulum stress|cell redox homeostasis|,protein disulfide isomerase activity|protein binding|,19,53,21700000000,35.2%
P63242,0.754762238,-0.023833333,3.777793717,-0.101,0.419006373,-0.861502068,0.137,0.094,-0.151,-0.119,0.067,-0.171,P63242,Eif5a,P63242_Eif5a,P63242,Eif5a,1,55,12,12,P63242|J3QPS8|Q8BGY2,MOUSE,17060.2,72,664,664.1,213.05,213.05,,154,Eukaryotic translation initiation factor 5A-1,nucleus|annulate lamellae|nuclear pore|cytoplasm|endoplasmic reticulum membrane|membrane|dendrite|neuronal cell body|extracellular exosome|,mRNA export from nucleus|translational frameshifting|protein export from nucleus|apoptotic process|aging|positive regulation of cell proliferation|positive regulation of apoptotic process|negative regulation of apoptotic process|positive regulation of translational elongation|positive regulation of translational termination|positive regulation of muscle cell differentiation|,RNA binding|translation elongation factor activity|U6 snRNA binding|ribosome binding|poly(A) RNA binding|protein N-terminus binding|,12,55,35100000000,72.0%
Q91YR7,0.530524264,-0.005333333,7.604120203,-0.134666667,0.173615294,-1.522487396,0.052,0.097,0.037,-0.009,-0.182,-0.027,Q91YR7,Prpf6,Q91YR7_Prpf6,Q91YR7,Prpf6,1,29,20,20,Q91YR7|Q91YR7-2,MOUSE,107518.6,25.8,665,665.1,213,213,,941,Pre-mRNA-processing factor 6,nucleus|nucleoplasm|U5 snRNP|membrane|nuclear speck|U4/U6 x U5 tri-snRNP complex|U4/U6 snRNP|catalytic step 2 spliceosome|,spliceosomal tri-snRNP complex assembly|RNA localization|positive regulation of transcription from RNA polymerase II promoter|,transcription coactivator activity|RNA binding|ribonucleoprotein complex binding|poly(A) RNA binding|androgen receptor binding|,20,29,6490000000,25.8%
P19253,0.987391128,-0.029166667,0.218727999,-0.007,0.950883256,-0.063948061,0.029,0.068,-0.174,0.017,0.053,-0.168,P19253,Rpl13a,P19253_Rpl13a,P19253,Rpl13a,1,76,19,19,P19253|A0A1B0GS68|A0A1B0GSB2|A0A140T8K2|A0A1B0GSF0|A0A1B0GRH1|A0A1B0GSL5,MOUSE,23577.9,56.6,666,666.1,212.25,212.25,,203,60S ribosomal protein L13a,nucleus|nucleolus|cytoplasm|focal adhesion|membrane|cytosolic large ribosomal subunit|ribonucleoprotein complex|GAIT complex|GAIT complex|,translation|negative regulation of translation|response to lipopolysaccharide|regulation of homeostatic process|macrophage chemotaxis|lung morphogenesis|cellular response to interferon-gamma|negative regulation of formation of translation preinitiation complex|,mRNA binding|structural constituent of ribosome|poly(A) RNA binding|,19,76,81700000000,56.6%
Q8BWY3,0.576085848,0.020333333,6.847475815,-0.137333333,0.206658093,-1.398054736,0.007,0.243,0.017,-0.079,-0.007,-0.059,Q8BWY3,Etf1,Q8BWY3_Etf1,Q8BWY3,Etf1,1,40,17,17,Q8BWY3,MOUSE,49258.2,45.3,667,667.1,212.03,212.03,,437,Eukaryotic peptide chain release factor subunit 1,cytoplasm|cytosol|translation release factor complex|,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|translational termination|regulation of translational termination|protein methylation|viral process|","translation release factor activity|translation release factor activity, codon specific|ribosome binding|poly(A) RNA binding|",17,40,23000000000,45.3%
Q3UNZ8,0.891806269,-0.036833333,1.729246288,-0.065666667,0.671545389,-0.443485993,0.13,0.157,-0.299,0.033,-0.037,-0.205,Q3UNZ8,Cryzl2,Q3UNZ8_Cryzl2,Q3UNZ8,,1,51,13,13,Q3UNZ8|A0A0A6YWV6|Q3UNZ8-2,MOUSE,38321.6,54,668,668.1,211.33,211.33,,350,Quinone oxidoreductase-like protein 2,,oxidation-reduction process|,zinc ion binding|oxidoreductase activity|,13,51,26500000000,54.0%
Q64378,0.905664235,-0.029166667,1.53741411,-0.063,0.701873086,-0.399822076,0.044,0.236,-0.273,0.135,-0.152,-0.165,Q64378,Fkbp5,Q64378_Fkbp5,Q64378,Fkbp5,1,35,16,16,Q64378,MOUSE,51535.7,36.1,669,669.1,211.31,211.31,,456,Peptidyl-prolyl cis-trans isomerase FKBP5,nucleoplasm|cytoplasm|endoplasmic reticulum membrane|membrane|extracellular exosome|,protein peptidyl-prolyl isomerization|chaperone-mediated protein folding|,peptidyl-prolyl cis-trans isomerase activity|protein binding|FK506 binding|heat shock protein binding|,16,35,9000000000,36.1%
E9QJW0,0.609221717,0.0325,6.187463489,-0.180333333,0.240576749,-1.289104378,-0.032,0.411,-0.011,-0.139,0.019,-0.053,E9QJW0,Mgst1,E9QJW0_Mgst1,E9QJW0,Mgst1,1,182,14,14,E9QJW0|Q91VS7|D3YU60|A0A0N4SV17|A0A0N4SVZ0,MOUSE,25963.8,38.4,670,670.1,211.22,211.22,,229,Microsomal glutathione S-transferase 1,mitochondrion|mitochondrial inner membrane|,glutathione metabolic process|oxidation-reduction process|cellular response to lipid hydroperoxide|,glutathione transferase activity|glutathione peroxidase activity|,14,182,1.71E+12,38.4%
Q64FW2,0.586445778,0.079666667,6.573273794,-0.302,0.220126648,-1.354036547,0.694,0.219,-0.221,0.036,-0.103,-0.147,Q64FW2,Retsat,Q64FW2_Retsat,Q64FW2,Retsat,1,50,15,15,Q64FW2|H3BJ51|H3BKK1,MOUSE,67789.7,36.2,671,671.1,209.51,209.51,,609,"All-trans-retinol 13,14-reductase",nuclear outer membrane|endoplasmic reticulum membrane|membrane|nuclear membrane|,retinol metabolic process|oxidation-reduction process|,"oxidoreductase activity|all-trans-retinol 13,14-reductase activity|",15,50,12100000000,36.2%
Q8C0D5,0.771800617,-0.018666667,3.572926558,0.083333333,0.439245524,0.822215226,0.029,0.007,-0.217,0.091,-0.029,0.007,Q8C0D5,Efl1,Q8C0D5_Efl1,Q8C0D5,Efl1,1,35,20,20,Q8C0D5|A0A140LHB7,MOUSE,127201.1,23.1,672,672.1,209.02,209.02,,1127,Elongation factor-like GTPase 1,,translational elongation|mature ribosome assembly|,translation elongation factor activity|GTPase activity|GTP binding|ribosome binding|,20,35,11000000000,23.1%
Q9D8N0,0.612622361,-0.0785,6.13334467,-0.289,0.243593409,-1.279938937,-0.185,0.152,0.231,-0.698,0.096,-0.067,Q9D8N0,Eef1g,Q9D8N0_Eef1g,Q9D8N0,Eef1g,1,68,16,16,Q9D8N0,MOUSE,50402.1,36.1,673,673.1,209,209,,437,Elongation factor 1-gamma,nucleus|cytoplasm|membrane|extracellular exosome|endoplasmic reticulum|,translational elongation|response to virus|,translation elongation factor activity|,16,68,43700000000,36.1%
Q9JIK5,0.21736368,-0.007333333,15.2680572,-0.22,0.029729957,-2.751279065,0.103,0.103,0.102,-0.057,-0.158,-0.137,Q9JIK5,Ddx21,Q9JIK5_Ddx21,Q9JIK5,Ddx21,1,34,18,18,Q9JIK5,MOUSE,94177,29.9,674,674.1,208.77,208.77,,851,Nucleolar RNA helicase 2,nucleus|nucleoplasm|nucleolus|membrane|,osteoblast differentiation|rRNA processing|transcription from RNA polymerase II promoter|response to virus|RNA secondary structure unwinding|response to exogenous dsRNA|,RNA binding|RNA helicase activity|double-stranded RNA binding|ATP-dependent RNA helicase activity|protein binding|ATP binding|rRNA binding|snoRNA binding|poly(A) RNA binding|7SK snRNA binding|,18,34,4170000000,29.9%
P51410,0.536434852,0.014,7.493140915,-0.128,0.178109018,-1.504353926,0.03,0.164,0.04,-0.02,-0.036,-0.094,P51410,Rpl9,P51410_Rpl9,P51410,Rpl9,1,64,15,15,P51410|A0A140T8T4|D3Z629|D3YZT0|S4R1R7,MOUSE,21995.1,75.5,675,675.1,208.49,208.49,,192,60S ribosomal protein L9,nucleus|nucleolus|cytoplasm|focal adhesion|membrane|cytosolic large ribosomal subunit|,translation|,structural constituent of ribosome|rRNA binding|,15,64,75500000000,75.5%
B1AX58,0.773512169,-0.01,3.524180673,-0.136,0.444203456,-0.81349844,0.026,-0.03,0.178,-0.407,0.219,-0.046,B1AX58,Pls3,B1AX58_Pls3,B1AX58,Pls3,1,34,15,13,B1AX58|Q99K51,MOUSE,72258.3,32.8,676,676.1,208.12,179.44,,639,Plastin-3,cytoplasm|,bone development|,actin binding|calcium ion binding|,15,34,6410000000,32.8%
Q61233,0.971644043,0.000666667,0.405621633,0.019333333,0.91083107,0.116343117,-0.096,-0.147,0.216,0.226,-0.285,0.09,Q61233,Lcp1,Q61233_Lcp1,Q61233,Lcp1,1,3,4,2,Q61233,MOUSE,70775.6,8.7,676,676.2,55.32,26.64,,627,Plastin-2,ruffle|phagocytic cup|podosome|extracellular space|cytoplasm|cytosol|actin filament|plasma membrane|focal adhesion|actin cytoskeleton|filopodium|actin filament bundle|ruffle membrane|extracellular exosome|stress fiber|actin filament|,T cell activation involved in immune response|response to wounding|protein kinase A signaling|cell migration|extracellular matrix disassembly|regulation of intracellular protein transport|actin filament bundle assembly|positive regulation of podosome assembly|,calcium ion binding|protein binding|identical protein binding|actin filament binding|GTPase binding|,2,3,24300000,5.2%
P50285,0.554595587,-0.054,7.172287054,0.322,0.191765861,1.453602205,0.016,-0.002,-0.659,0.147,0.344,-0.17,P50285,Fmo1,P50285_Fmo1,P50285,Fmo1,1,28,15,15,P50285|Q8C9C1,MOUSE,60483.9,36.2,677,677.1,206.7,206.7,,532,Dimethylaniline monooxygenase [N-oxide-forming] 1,endoplasmic reticulum membrane|integral component of membrane|,organic acid metabolic process|response to osmotic stress|toxin metabolic process|drug metabolic process|response to lipopolysaccharide|NADPH oxidation|,"monooxygenase activity|N,N-dimethylaniline monooxygenase activity|flavin adenine dinucleotide binding|NADP binding|",15,28,8100000000,36.2%
G3X972,0.713417662,0.0125,4.323447845,-0.113,0.369534691,-0.962548364,-0.102,0.28,0.029,-0.077,-0.066,0.011,G3X972,Sec24c,G3X972_Sec24c,G3X972,Sec24c,1,36,17,17,G3X972|A0A286YDI8,MOUSE,120119.5,21.6,678,678.1,206.61,206.61,,1096,"SEC24 related gene family, member C (S. cerevisiae), isoform CRA_a",COPII vesicle coat|,intracellular protein transport|ER to Golgi vesicle-mediated transport|,zinc ion binding|,17,36,7240000000,21.6%
Q8QZR5,0.894042447,-0.001666667,1.678580173,0.056666667,0.679425719,0.432052774,0.041,-0.055,-0.076,-0.211,0.249,0.042,Q8QZR5,Gpt,Q8QZR5_Gpt,Q8QZR5,Gpt,1,44,17,17,Q8QZR5,MOUSE,55940.4,31.8,679,679.1,205.99,205.99,,496,Alanine aminotransferase 1,cytoplasm|extracellular exosome|,biosynthetic process|L-alanine catabolic process|,L-alanine:2-oxoglutarate aminotransferase activity|pyridoxal phosphate binding|,17,44,10800000000,31.8%
P62717,0.550359036,-0.011,7.276794886,-0.143333333,0.187206322,-1.468893058,0.037,0.176,-0.031,0.006,-0.088,-0.166,P62717,Rpl18a,P62717_Rpl18a,P62717,Rpl18a,1,86,16,16,P62717|A0A1D5RLW5|A0A1D5RM79|A0A1D5RMC7,MOUSE,21017.2,65.9,680,680.1,205.81,205.81,,176,60S ribosomal protein L18a,membrane|cytosolic large ribosomal subunit|,translation|,structural constituent of ribosome|poly(A) RNA binding|,16,86,1.31E+11,65.9%
F8VQN6,0.919416995,-0.004666667,1.246157688,0.028666667,0.750557953,0.331278599,0.05,-0.017,-0.09,0.07,0.006,-0.047,F8VQN6,Arhgef12,F8VQN6_Arhgef12,F8VQN6,Arhgef12,1,28,20,20,F8VQN6|Q8R4H2,MOUSE,173671.7,16.7,681,681.1,205.73,205.73,,1544,Rho guanine nucleotide exchange factor 12,cytoplasm|extracellular exosome|,G-protein coupled receptor signaling pathway|regulation of Rho protein signal transduction|intracellular signal transduction|termination of G-protein coupled receptor signaling pathway|positive regulation of GTPase activity|,G-protein coupled receptor binding|Rho guanyl-nucleotide exchange factor activity|,20,28,3620000000,16.7%
A0A0A0MQN4,0.590366796,0.001333333,6.487546036,-0.121333333,0.224515018,-1.338083754,0.086,0.141,-0.041,-0.057,-0.118,-0.003,A0A0A0MQN4,Atg7,A0A0A0MQN4_Atg7,A0A0A0MQN4,Atg7,1,38,17,17,A0A0A0MQN4|Q9D906|S4R2T5|S4R2D5,MOUSE,83530.5,29.2,682,682.1,205.61,205.61,,741,Ubiquitin-like modifier-activating enzyme ATG7,pre-autophagosomal structure|cytoplasm|cytosol|,liver development|protein lipidation|C-terminal protein lipidation|cellular amino acid metabolic process|autophagy|cellular response to nitrogen starvation|organelle organization|mitochondrion organization|adult walking behavior|cellular response to starvation|post-embryonic development|positive regulation of autophagy|macroautophagy|positive regulation of macroautophagy|cerebellar Purkinje cell layer development|pyramidal neuron development|central nervous system neuron axonogenesis|cerebral cortex development|protein catabolic process|neuron projection development|regulation of protein ubiquitination|positive regulation of protein modification process|protein modification by small protein conjugation|piecemeal microautophagy of nucleus|suppression by virus of host autophagy|negative stranded viral RNA replication|response to starvation|positive regulation of apoptotic process|negative regulation of apoptotic process|late nucleophagy|positive regulation of protein catabolic process|neurological system process|defense response to virus|cardiac muscle cell development|membrane organization|positive regulation of mucus secretion|cellular response to hyperoxia|regulation of mitochondrion degradation|negative regulation of histone H4-K16 acetylation|,protein binding|transcription factor binding|Atg12 activating enzyme activity|Atg8 activating enzyme activity|protein homodimerization activity|,17,38,5540000000,29.2%
Q9QYY9,0.775451947,0.036166667,3.452428308,-0.315666667,0.451603365,-0.799734281,-0.616,0.187,1.011,-0.41,-0.122,0.167,Q9QYY9,Adh4,Q9QYY9_Adh4,Q9QYY9,Adh4,1,31,14,14,Q9QYY9,MOUSE,41351.1,63.1,683,683.1,205.56,205.56,,377,Alcohol dehydrogenase 4,cytoplasm|,retinoid metabolic process|alcohol metabolic process|ethanol metabolic process|ethanol oxidation|cellular aldehyde metabolic process|retinol metabolic process|alcohol catabolic process|quinone metabolic process|,"NADPH:quinone reductase activity|alcohol dehydrogenase (NAD) activity|alcohol dehydrogenase activity, zinc-dependent|alditol:NADP+ 1-oxidoreductase activity|retinol dehydrogenase activity|all-trans retinal binding|zinc ion binding|oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor|benzaldehyde dehydrogenase activity|retinol binding|ethanol binding|NAD binding|",14,31,9840000000,63.1%
O70152,0.318107191,-0.004833333,12.31501768,-0.199666667,0.058681098,-2.275520038,0.129,0.11,0.046,-0.01,-0.124,-0.18,O70152,Dpm1,O70152_Dpm1,O70152,Dpm1,1,38,15,15,O70152|A2BDX2,MOUSE,29231.2,49.6,684,684.1,205.33,205.33,,260,Dolichol-phosphate mannosyltransferase subunit 1,endoplasmic reticulum membrane|,GPI anchor biosynthetic process|protein mannosylation|protein O-linked mannosylation|,dolichyl-phosphate-mannose-protein mannosyltransferase activity|dolichyl-phosphate beta-D-mannosyltransferase activity|,15,38,10300000000,49.6%
P42208,0.529771506,0.008,7.625210985,0.128,0.172774204,1.525929364,-0.098,-0.03,-0.04,0.05,0.017,0.149,P42208,Sept2,P42208_Sept2,P42208,Sept2,1,33,14,14,P42208|E9Q3V6,MOUSE,41753,52.9,685,685.1,205.1,205.1,,361,Septin-2,exocyst|condensed chromosome kinetochore|nucleus|nucleoplasm|nucleolus|cytoplasm|actomyosin contractile ring|spindle microtubule|plasma membrane|cell cortex|cell surface|actin cytoskeleton|microtubule cytoskeleton|midbody|cleavage furrow|ciliary transition zone|cell projection|myelin sheath|synapse|perinuclear region of cytoplasm|ciliary membrane|extracellular exosome|cell cortex|,cytokinesis|regulation of L-glutamate transport|mitotic nuclear division|smoothened signaling pathway|neuron projection development|regulation of protein localization|cilium assembly|regulation of catalytic activity|protein polymerization|,GTPase activity|protein binding|GTP binding|enzyme regulator activity|protein complex scaffold|identical protein binding|,14,33,7510000000,52.9%
Q9QUI0,0.956385108,-0.010333333,0.63678283,0.018,0.863618062,0.178489302,0.113,-0.009,-0.162,-0.032,0.06,-0.032,Q9QUI0,Rhoa,Q9QUI0_Rhoa,Q9QUI0,Rhoa,1,44,14,5,Q9QUI0|H3BL56|Q9CR99|P62746,MOUSE,22124.1,80.3,686,686.1,204.75,67.47,,193,Transforming protein RhoA,nucleus|mitochondrion|endosome|cytosol|cytoskeleton|plasma membrane|focal adhesion|cell cortex|lamellipodium|axon|midbody|vesicle|cleavage furrow|ruffle membrane|apical junction complex|extracellular exosome|,"cell morphogenesis|response to hypoxia|alpha-beta T cell lineage commitment|regulation of transcription from RNA polymerase II promoter|cytoskeleton organization|cell adhesion|cell-matrix adhesion|integrin-mediated signaling pathway|Rho protein signal transduction|skeletal muscle tissue development|response to mechanical stimulus|response to glucose|regulation of neuron projection development|cerebral cortex cell migration|forebrain radial glial cell differentiation|actin cytoskeleton organization|cell differentiation|positive regulation of cell growth|regulation of cell migration|positive regulation of cell migration|androgen receptor signaling pathway|positive regulation of actin filament polymerization|stress-activated protein kinase signaling cascade|positive regulation of cytokinesis|regulation of actin cytoskeleton organization|negative regulation of intracellular steroid hormone receptor signaling pathway|regulation of osteoblast proliferation|cleavage furrow formation|apolipoprotein A-I-mediated signaling pathway|response to drug|positive regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of I-kappaB kinase/NF-kappaB signaling|stress fiber assembly|response to amino acid|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|apical junction assembly|beta selection|negative regulation of neuron apoptotic process|positive regulation of neuron apoptotic process|ossification involved in bone maturation|wound healing, spreading of cells|response to ethanol|negative regulation of neuron differentiation|positive regulation of neuron differentiation|positive regulation of translation|positive regulation of vasoconstriction|positive regulation of smooth muscle contraction|positive regulation of alpha-beta T cell differentiation|neuron projection morphogenesis|regulation of dendrite development|negative chemotaxis|response to glucocorticoid|positive regulation of stress fiber assembly|regulation of calcium ion transport|positive regulation of lipase activity|trabecula morphogenesis|regulation of microtubule cytoskeleton organization|positive regulation of podosome assembly|mitotic spindle assembly|negative regulation of oxidative phosphorylation|skeletal muscle satellite cell migration|negative regulation of reactive oxygen species biosynthetic process|regulation of neural precursor cell proliferation|",GTPase activity|protein binding|GTP binding|myosin binding|GDP binding|protein domain specific binding|Rho GDP-dissociation inhibitor binding|,14,44,29400000000,80.3%
Q91VT4,0.811763387,0.022666667,2.919544039,-0.119333333,0.5105586,-0.6952495,0.219,0.329,-0.301,0.034,-0.044,-0.101,Q91VT4,Cbr4,Q91VT4_Cbr4,Q91VT4,Cbr4,1,44,15,15,Q91VT4,MOUSE,25585.4,58,687,687.1,204.4,204.4,,236,Carbonyl reductase family member 4,mitochondrion|mitochondrial matrix|,fatty acid biosynthetic process|daunorubicin metabolic process|doxorubicin metabolic process|protein homotetramerization|oxidation-reduction process|,NAD(P)H dehydrogenase (quinone) activity|NADPH dehydrogenase (quinone) activity|quinone binding|NADPH binding|,15,44,26700000000,58.0%
Q8BY87-2,0.922247203,-0.018333333,1.146509293,0.031333333,0.767978516,0.307261794,0.066,0.036,-0.204,0.029,-0.001,-0.036,Q8BY87,Usp47,Q8BY87-2_Usp47,Q8BY87-2,Usp47,1,29,18,18,A0A1L1SV73|Q8BY87-2|Q8BY87,MOUSE,156207.9,16.3,688,688.1,204.07,204.07,,1376,Isoform 2 of Ubiquitin carboxyl-terminal hydrolase 47,nucleus|cytoplasm|SCF ubiquitin ligase complex|,"base-excision repair|cellular response to DNA damage stimulus|negative regulation of G2/M transition of mitotic cell cycle|protein deubiquitination|positive regulation of cell growth|cellular response to UV|monoubiquitinated protein deubiquitination|response to drug|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|proteasome-mediated ubiquitin-dependent protein catabolic process|negative regulation of transcription, DNA-templated|regulation of proteasomal protein catabolic process|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage|",cysteine-type endopeptidase activity|ubiquitin-specific protease activity|WD40-repeat domain binding|,18,29,3420000000,16.3%
P60670,0.930129154,-0.022833333,0.995426661,-0.043,0.795165143,-0.270295272,0.093,0.233,-0.33,0.014,0.02,-0.167,P60670,Nploc4,P60670_Nploc4,P60670,Nploc4,1,32,17,17,P60670|P60670-2,MOUSE,68985.8,26.4,689,689.1,203.67,203.67,,608,Nuclear protein localization protein 4 homolog,nucleus|endoplasmic reticulum|cytosol|VCP-NPL4-UFD1 AAA ATPase complex|UFD1-NPL4 complex|nuclear outer membrane-endoplasmic reticulum membrane network|,"ubiquitin-dependent protein catabolic process|Golgi organization|ER-associated ubiquitin-dependent protein catabolic process|retrograde protein transport, ER to cytosol|",zinc ion binding|ubiquitin protein ligase binding|ubiquitin binding|,17,32,6180000000,26.4%
O35887,0.000302562,-0.423666667,54.68941742,2.415333333,3.39671E-06,14.1605305,-1.414,-1.473,-2.007,0.677,0.811,0.864,O35887,Calu,O35887_Calu,O35887,Calu,1,34,14,3,O35887|G3UWR0|G3UWV3|G3V004,MOUSE,37177.2,48.2,690,690.1,203.65,45.81,,315,Calumenin,extracellular region|endoplasmic reticulum|endoplasmic reticulum lumen|membrane|sarcoplasmic reticulum lumen|melanosome|,peripheral nervous system axon regeneration|response to organic cyclic compound|negative regulation of catalytic activity|,enzyme inhibitor activity|calcium ion binding|enzyme binding|,14,34,22300000000,48.2%
Q6XLQ8,0.000249709,-0.386333333,55.63316714,2.52,2.73327E-06,14.6466313,-1.724,-1.316,-1.899,0.677,0.977,0.967,Q6XLQ8,Calu,Q6XLQ8_Calu,Q6XLQ8,Calu,1,5,13,2,Q6XLQ8,MOUSE,37231.2,46.6,690,690.2,177.1,19.26,,315,Calumenin,endoplasmic reticulum|membrane|,,calcium ion binding|,2,5,900000000,6.9%
Q9DBF1,0.578909417,0.009,6.804033683,0.188,0.208735651,1.392558698,0.055,-0.084,-0.226,-0.002,0.34,-0.029,Q9DBF1,Aldh7a1,Q9DBF1_Aldh7a1,Q9DBF1,Aldh7a1,1,33,14,14,Q9DBF1|Q9DBF1-2|G3UYR8,MOUSE,59373.9,38.7,691,691.1,203.23,203.23,,539,Alpha-aminoadipic semialdehyde dehydrogenase,nucleus|cytoplasm|mitochondrion|cytosol|extracellular exosome|,glycine betaine biosynthetic process from choline|oxidation-reduction process|,aldehyde dehydrogenase (NAD) activity|L-aminoadipate-semialdehyde dehydrogenase activity|betaine-aldehyde dehydrogenase activity|,14,33,11400000000,38.7%
Q91XU0,0.933608247,-0.0015,0.956053241,0.027,0.802406939,0.260379937,0.135,-0.037,-0.143,0.059,-0.07,0.047,Q91XU0,Wrnip1,Q91XU0_Wrnip1,Q91XU0,Wrnip1,1,31,15,15,Q91XU0|Q91XU0-2,MOUSE,72591.3,27.7,692,692.1,202.45,202.45,,660,ATPase WRNIP1,nucleus|membrane|perinuclear region of cytoplasm|,DNA synthesis involved in DNA repair|DNA replication|regulation of DNA-dependent DNA replication initiation|,DNA binding|protein binding|ATP binding|ATPase activity|identical protein binding|,15,31,4610000000,27.7%
O88342,0.991556352,0.005833333,0.169681789,0.012333333,0.961682739,0.049888794,-0.516,0.07,0.445,-0.099,-0.109,0.244,O88342,Wdr1,O88342_Wdr1,O88342,Wdr1,1,41,15,15,O88342|A0A0J9YU05,MOUSE,67090.1,37.1,693,693.1,202.41,202.41,,606,WD repeat-containing protein 1,podosome|cytoplasm|actin cytoskeleton|cell junction|cell projection|myelin sheath|extracellular exosome|actin filament|,sensory perception of sound|actin cytoskeleton organization|positive regulation of actin filament depolymerization|sarcomere organization|regulation of oligodendrocyte differentiation|regulation of ventricular cardiac muscle cell membrane repolarization|,actin binding|,15,41,20200000000,37.1%
G3X9W0,0.108483191,0.111666667,19.60019903,-0.65,0.010964279,-3.497942858,0.056,0.698,0.556,-0.405,-0.159,-0.076,G3X9W0,Hnrnpd,G3X9W0_Hnrnpd,G3X9W0,Hnrnpd,1,53,15,13,G3X9W0|G5E8G0|Q60668|Q60668-2|Q60668-3|Q60668-4,MOUSE,36378.4,38,694,694.1,181.09,151.89,,336,"Heterogeneous nuclear ribonucleoprotein D, isoform CRA_a",nucleoplasm|viral nucleocapsid|ribonucleoprotein complex|extracellular exosome|,regulation of circadian rhythm|regulation of mRNA stability|positive regulation of translation|circadian regulation of translation|,nucleotide binding|RNA binding|telomeric DNA binding|poly(A) RNA binding|,15,53,33700000000,38.0%
Q20BD0,0.121158537,0.163166667,18.90970003,-0.794333333,0.012853754,-3.376408703,0.101,1.064,0.516,-0.312,-0.287,-0.103,Q20BD0,Hnrnpab,Q20BD0_Hnrnpab,Q20BD0,Hnrnpab,1,40,14,13,Q20BD0|Q80XR6|Q99020,MOUSE,36324.2,34.9,694,694.2,201.76,188.41,,332,Heterogeneous nuclear ribonucleoprotein A/B,nucleoplasm|viral nucleocapsid|ribonucleoprotein complex|,negative regulation of transcription from RNA polymerase II promoter|,nucleotide binding|RNA binding|poly(A) RNA binding|,13,40,42600000000,31.9%
D3YTQ3,0.335858884,0.109833333,11.791514,-0.488333333,0.066198569,-2.197095142,-0.094,0.361,0.795,-0.149,-0.265,0.011,D3YTQ3,Hnrnpdl,D3YTQ3_Hnrnpdl,D3YTQ3,Hnrnpdl,1,7,7,5,D3YTQ3|Q9Z130,MOUSE,46440.6,12.3,694,694.3,72.99,43.79,,420,Heterogeneous nuclear ribonucleoprotein D-like,nucleus|nucleoplasm|extracellular exosome|,regulation of gene expression|mRNA metabolic process|,nucleotide binding|DNA binding|double-stranded DNA binding|single-stranded DNA binding|RNA binding|poly(A) binding|poly(G) binding|poly(A) RNA binding|,5,7,1160000000,10.4%
P58735,0.805121368,-0.027666667,3.019431645,0.098,0.49894978,0.715158429,0.066,0.056,-0.352,0.124,-0.028,-0.032,P58735,Slc26a1,P58735_Slc26a1,P58735,Slc26a1,1,42,15,15,P58735|G5E8U1,MOUSE,76870.4,20.8,695,695.1,201.34,201.34,,704,Sulfate anion transporter 1,integral component of plasma membrane|,chloride transport|sulfate transport|oxalate transport|anion transmembrane transport|sulfate transmembrane transport|chloride transmembrane transport|,secondary active sulfate transmembrane transporter activity|chloride transmembrane transporter activity|sulfate transmembrane transporter activity|anion:anion antiporter activity|oxalate transmembrane transporter activity|,15,42,14800000000,20.8%
Q99JX7,0.539675052,0.001,7.452327614,-0.120666667,0.179790706,-1.497675755,0.074,0.102,0.008,-0.069,-0.085,-0.024,Q99JX7,Nxf1,Q99JX7_Nxf1,Q99JX7,Nxf1,1,25,18,18,Q99JX7|V9GXF3|V9GXW3|V9GX96,MOUSE,70868.8,35.5,696,696.1,201.17,201.17,,618,Nuclear RNA export factor 1,cytoplasm|nuclear speck|transcription export complex|,mRNA export from nucleus|,RNA binding|poly(A) RNA binding|,18,25,31200000000,35.5%
Q9DBP5,0.948067141,-0.022666667,0.78462209,0.019333333,0.834714179,0.216941411,0.014,0.027,-0.138,-0.006,0.03,-0.063,Q9DBP5,Cmpk1,Q9DBP5_Cmpk1,Q9DBP5,Cmpk1,1,53,13,13,Q9DBP5|A0A0R4J093,MOUSE,22393.1,56.1,697,697.1,200.94,200.94,,196,UMP-CMP kinase,nucleus|nucleoplasm|nucleolus|cytoplasm|extracellular exosome|,nucleoside diphosphate phosphorylation|'de novo' pyrimidine nucleobase biosynthetic process|pyrimidine nucleotide biosynthetic process|nucleoside triphosphate biosynthetic process|,cytidylate kinase activity|nucleoside diphosphate kinase activity|ATP binding|uridylate kinase activity|,13,53,37900000000,56.1%
O08547,0.919416995,0.007,1.236392861,0.032,0.752247432,0.328940062,0.019,0.049,-0.095,0.152,-0.044,-0.039,O08547,Sec22b,O08547_Sec22b,O08547,Sec22b,1,54,13,13,O08547|E9Q6R3|A0A0G2JF08,MOUSE,24911.3,56.2,698,698.1,200.85,200.85,,215,Vesicle-trafficking protein SEC22b,Golgi membrane|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|integral component of membrane|SNARE complex|endoplasmic reticulum-Golgi intermediate compartment membrane|melanosome|,ER to Golgi vesicle-mediated transport|protein transport|vesicle-mediated transport|regulation of organelle organization|positive regulation of protein catabolic process|vesicle fusion with Golgi apparatus|exocytosis|,SNARE binding|SNAP receptor activity|syntaxin binding|,13,54,17200000000,56.2%
Q8K268,0.669054973,-0.002333333,5.015620625,-0.1,0.315092407,-1.085815481,0.093,0.015,0.035,0.053,-0.163,-0.047,Q8K268,Abcf3,Q8K268_Abcf3,Q8K268,Abcf3,1,32,16,16,Q8K268,MOUSE,80262.7,24.2,699,699.1,200.09,200.09,,709,ATP-binding cassette sub-family F member 3,membrane|,metabolic process|defense response to virus|,protein binding|ATP binding|ATPase activity|,16,32,16700000000,24.2%
P47963,0.585175913,-0.003833333,6.612112524,-0.143666667,0.218166843,-1.359149036,-0.015,0.204,0.015,-0.051,0.023,-0.199,P47963,Rpl13,P47963_Rpl13,P47963,Rpl13,1,59,18,18,P47963,MOUSE,24362.1,60.6,700,700.1,199.91,199.91,,211,60S ribosomal protein L13,nucleus|nucleolus|cytoplasm|membrane|cytosolic large ribosomal subunit|,translation|,structural constituent of ribosome|poly(A) RNA binding|,18,59,58300000000,60.6%
Q91X52,0.876086294,-0.0335,1.997043173,0.053666667,0.631387068,0.502598542,0.02,0.038,-0.239,-0.03,0.065,-0.055,Q91X52,Dcxr,Q91X52_Dcxr,Q91X52,Dcxr,1,81,14,14,Q91X52|A2AC16,MOUSE,25973.6,68,701,701.1,199.83,199.83,,244,L-xylulose reductase,nucleus|cytoplasmic microtubule|microvillus|brush border|apical plasma membrane|extracellular exosome|,xylulose metabolic process|glucose metabolic process|NADP metabolic process|D-xylose metabolic process|protein homotetramerization|oxidation-reduction process|,"oxidoreductase activity, acting on CH-OH group of donors|oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor|L-xylulose reductase (NADP+) activity|",14,81,51800000000,68.0%
Q60823,0.773512169,-0.010166667,3.519591094,-0.077666667,0.444673133,-0.81203283,0.061,-0.02,0.045,0.059,-0.181,-0.025,Q60823,Akt2,Q60823_Akt2,Q60823,Akt2,1,32,16,11,Q60823|F8WHG5|Q9WUA6|Q9WUA6-2,MOUSE,56140.1,34.5,702,702.1,199.79,128.13,,481,RAC-beta serine/threonine-protein kinase,nucleus|cytosol|plasma membrane|cell cortex|ruffle membrane|insulin-responsive compartment|,positive regulation of protein phosphorylation|glycogen biosynthetic process|glucose metabolic process|regulation of translation|protein phosphorylation|response to osmotic stress|insulin receptor signaling pathway|carbohydrate transport|positive regulation of signal transduction|negative regulation of plasma membrane long-chain fatty acid transport|positive regulation of sodium ion transport|positive regulation of glucose metabolic process|response to muscle activity|positive regulation of cell migration|positive regulation of vesicle fusion|response to nutrient levels|positive regulation of fatty acid beta-oxidation|peripheral nervous system myelin maintenance|cellular response to insulin stimulus|negative regulation of RNA splicing|positive regulation of peptidyl-serine phosphorylation|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|protein kinase B signaling|positive regulation of nitric oxide biosynthetic process|positive regulation of glycogen biosynthetic process|positive regulation of transcription from RNA polymerase II promoter|positive regulation of glucose import|positive regulation of positive chemotaxis|intracellular protein transmembrane transport|cellular response to organic cyclic compound|protein localization to plasma membrane|positive regulation of protein targeting to membrane|activation of GTPase activity|positive regulation of cell motility|positive regulation of glucose import in response to insulin stimulus|,protein kinase activity|protein serine/threonine kinase activity|protein kinase C binding|protein binding|ATP binding|,16,32,9600000000,34.5%
P31750,0.6812202,-0.004166667,4.856394729,-0.095,0.32685906,-1.057668218,0.066,-0.005,0.069,-0.01,-0.163,0.018,P31750,Akt1,P31750_Akt1,P31750,Akt1,1,12,15,10,P31750|D3Z783,MOUSE,56105.7,34.3,702,702.2,169.36,97.7,,480,RAC-alpha serine/threonine-protein kinase,nucleus|nucleoplasm|cytoplasm|mitochondrion|spindle|cytosol|plasma membrane|cell-cell junction|microtubule cytoskeleton|ciliary basal body|protein complex|,"protein import into nucleus, translocation|osteoblast differentiation|maternal placenta development|positive regulation of protein phosphorylation|positive regulation of endothelial cell proliferation|glycogen metabolic process|glycogen biosynthetic process|regulation of glycogen biosynthetic process|glucose metabolic process|translation|regulation of translation|protein phosphorylation|negative regulation of protein kinase activity|activation-induced cell death of T cells|inflammatory response|response to oxidative stress|cytoskeleton organization|germ cell development|aging|insulin receptor signaling pathway|apoptotic mitochondrial changes|response to hormone|negative regulation of autophagy|negative regulation of gene expression|negative regulation of plasma membrane long-chain fatty acid transport|positive regulation of fibroblast migration|positive regulation of sodium ion transport|positive regulation of glucose metabolic process|negative regulation of endopeptidase activity|regulation of neuron projection development|glucose transport|phosphorylation|protein ubiquitination|peptidyl-serine phosphorylation|cell projection organization|protein catabolic process|hyaluronan metabolic process|positive regulation of cell growth|regulation of cell migration|endocrine pancreas development|regulation of myelination|positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle|lipopolysaccharide-mediated signaling pathway|negative regulation of fatty acid beta-oxidation|response to food|peripheral nervous system myelin maintenance|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|cellular response to insulin stimulus|regulation of protein localization|positive regulation of peptidyl-serine phosphorylation|response to fluid shear stress|intracellular signal transduction|cellular response to vascular endothelial growth factor stimulus|cellular response to decreased oxygen levels|glucose homeostasis|positive regulation of apoptotic process|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|protein kinase B signaling|positive regulation of blood vessel endothelial cell migration|positive regulation of nitric oxide biosynthetic process|positive regulation of fat cell differentiation|positive regulation of glycogen biosynthetic process|negative regulation of cell size|negative regulation of proteolysis|positive regulation of vasoconstriction|positive regulation of transcription from RNA polymerase II promoter|positive regulation of glucose import|negative regulation of JNK cascade|positive regulation of lipid biosynthetic process|insulin-like growth factor receptor signaling pathway|positive regulation of nitric-oxide synthase activity|positive regulation of sequence-specific DNA binding transcription factor activity|striated muscle cell differentiation|response to growth hormone|glycogen cell differentiation involved in embryonic placenta development|labyrinthine layer blood vessel development|response to UV-A|cellular response to mechanical stimulus|cellular response to growth factor stimulus|cellular response to epidermal growth factor stimulus|cellular response to prostaglandin E stimulus|cellular response to organic cyclic compound|cellular response to hypoxia|positive regulation of establishment of protein localization to plasma membrane|negative regulation of release of cytochrome c from mitochondria|cellular response to granulocyte macrophage colony-stimulating factor stimulus|execution phase of apoptosis|cellular response to peptide|response to insulin-like growth factor stimulus|","protein kinase activity|protein serine/threonine kinase activity|protein serine/threonine/tyrosine kinase activity|protein kinase C binding|protein binding|ATP binding|phosphatidylinositol-3,4,5-trisphosphate binding|kinase activity|protein kinase binding|nitric-oxide synthase regulator activity|identical protein binding|phosphatidylinositol-3,4-bisphosphate binding|protein phosphatase 2A binding|14-3-3 protein binding|",10,12,1870000000,22.9%
Q059N0,0.926554478,-0.062,1.064450182,0.103333333,0.78262728,0.287354088,0.186,0.035,-0.562,0.659,-0.693,0.003,Q059N0,Sult3a1,Q059N0_Sult3a1,Q059N0,Sult3a1,1,51,16,16,Q059N0|O35403|G5E904|O35400-2|A0A1B0GST5|A0A1B0GR49|O35400,MOUSE,35229.6,42.3,703,703.1,199.6,199.6,,293,Sulfotransferase,,metabolic process|,sulfotransferase activity|,16,51,31100000000,42.3%
Q9DCX2,0.919618833,-0.014333333,1.16921614,0.044,0.763973661,0.312912853,0.073,0.032,-0.214,-0.149,0.251,-0.079,Q9DCX2,Atp5h,Q9DCX2_Atp5h,Q9DCX2,Atp5h,1,69,14,14,Q9DCX2|G3X9L6,MOUSE,18806.2,82.6,704,704.1,199.53,199.53,,161,"ATP synthase subunit d, mitochondrial","mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)|nucleoplasm|cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial proton-transporting ATP synthase complex|myelin sheath|extracellular exosome|",ATP synthesis coupled proton transport|,hydrogen ion transmembrane transporter activity|ATPase activity|,14,69,89000000000,82.6%
Q8BVE3,0.73101227,-0.0075,4.09371274,-0.083666667,0.389608772,-0.919795062,0.101,0.024,-0.022,0.056,-0.112,-0.092,Q8BVE3,Atp6v1h,Q8BVE3_Atp6v1h,Q8BVE3,Atp6v1h,1,53,13,13,Q8BVE3|A0A0A6Y8|A0A0A6YWP6,MOUSE,56310.4,38.7,705,705.1,198.96,198.96,,483,V-type proton ATPase subunit H,"vacuolar proton-transporting V-type ATPase, V1 domain|lysosomal membrane|extracellular exosome|",endocytosis|ATP hydrolysis coupled proton transport|,"proton-transporting ATPase activity, rotational mechanism|",13,53,21400000000,38.7%
P14733,0.6987191,0.041166667,4.570932046,-0.211666667,0.349065394,-1.007563662,-0.266,0.153,0.554,-0.097,-0.196,0.099,P14733,Lmnb1,P14733_Lmnb1,P14733,Lmnb1,1,29,18,18,P14733,MOUSE,67012.7,37.4,706,706.1,198.64,198.64,,588,Lamin-B1,nucleus|nuclear envelope|nuclear inner membrane|lamin filament|nucleoplasm|membrane|nuclear matrix|nuclear membrane|,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle|positive regulation of JNK cascade|,structural molecule activity|JUN kinase binding|phospholipase binding|,18,29,16300000000,37.4%
Q9Z204,0.220866248,0.214,15.15721366,-0.842666667,0.030498511,-2.741351767,0.047,1.334,0.525,-0.193,-0.346,-0.083,Q9Z204,Hnrnpc,Q9Z204_Hnrnpc,Q9Z204,Hnrnpc,1,43,18,17,Q9Z204|Q9Z204-2|Q9Z204-5|Q9Z204-3|Q9Z204-4,MOUSE,34441.2,54.3,707,707.1,198.61,185.32,,313,Heterogeneous nuclear ribonucleoproteins C1/C2,nuclear chromatin|nucleus|nucleoplasm|spliceosomal complex|cytosol|membrane|protein complex|pronucleus|extracellular exosome|catalytic step 2 spliceosome|,"mRNA splicing, via spliceosome|osteoblast differentiation|ATP-dependent chromatin remodeling|3'-UTR-mediated mRNA stabilization|",nucleotide binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|mRNA binding|mRNA 3'-UTR binding|poly(U) RNA binding|nucleosomal DNA binding|identical protein binding|poly(A) RNA binding|N6-methyladenosine-containing RNA binding|,18,43,12100000000,54.3%
A2BDX3,0.994928853,-0.005,0.086809646,0.002666667,0.980209789,0.025748155,0.074,-0.008,-0.085,0.148,-0.112,-0.047,A2BDX3,Mocs3,A2BDX3_Mocs3,A2BDX3,Mocs3,1,22,11,10,A2BDX3,MOUSE,50344,27.6,707,707.2,154.61,141.32,,460,Adenylyltransferase and sulfurtransferase MOCS3,cytosol|,tRNA wobble uridine modification|tRNA wobble position uridine thiolation|Mo-molybdopterin cofactor biosynthetic process|protein adenylylation|enzyme active site formation via L-cysteine persulfide|protein urmylation|tRNA thio-modification|,thiosulfate sulfurtransferase activity|ATP binding|nucleotidyltransferase activity|sulfurtransferase activity|URM1 activating enzyme activity|metal ion binding|molybdopterin-synthase sulfurtransferase activity|molybdopterin-synthase adenylyltransferase activity|protein adenylyltransferase activity|,10,22,2300000000,25.6%
Q9CZM2,0.192839981,-0.004333333,16.19795167,-0.312,0.023999646,-2.906310736,0.065,0.284,0.106,-0.177,-0.03,-0.274,Q9CZM2,Rpl15,Q9CZM2_Rpl15,Q9CZM2,Rpl15,1,70,15,15,Q9CZM2|E9QAZ2,MOUSE,24259.7,57.8,708,708.1,198.12,198.12,,204,60S ribosomal protein L15,nucleus|cytosolic large ribosomal subunit|extracellular exosome|,translation|,structural constituent of ribosome|poly(A) RNA binding|,15,70,1.7E+11,57.8%
Q04857,0.960763421,0.013333333,0.589011454,-0.020666667,0.873170098,-0.165923921,-0.101,0.029,0.143,0.208,-0.146,-0.053,Q04857,Col6a1,Q04857_Col6a1,Q04857,Col6a1,1,40,14,14,Q04857,MOUSE,109628.6,17.3,709,709.1,197.9,197.9,,1025,Collagen alpha-1(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|lysosomal membrane|membrane|extracellular matrix|sarcolemma|protein complex|extracellular exosome|extracellular matrix|,osteoblast differentiation|cell adhesion|endodermal cell differentiation|protein heterotrimerization|cellular response to amino acid stimulus|,platelet-derived growth factor binding|,14,40,11600000000,17.3%
P24668,4.99445E-05,-0.614333333,69.40113979,3.009333333,1.14785E-07,23.84194448,-1.992,-1.988,-2.377,0.92,0.884,0.867,P24668,M6pr,P24668_M6pr,P24668,M6pr,1,39,13,13,P24668,MOUSE,31685.3,47.1,710,710.1,197.86,197.86,,278,Cation-dependent mannose-6-phosphate receptor,lysosomal membrane|endosome|late endosome|membrane|integral component of membrane|perinuclear region of cytoplasm|,intracellular protein transport|mannose transport|,mannose transmembrane transporter activity|,13,39,40100000000,47.1%
Q8VBT9,0.991556352,-0.030333333,0.156698629,-0.005333333,0.964561975,-0.046131001,0.094,0.058,-0.235,0.028,-0.013,-0.114,Q8VBT9,Aspscr1,Q8VBT9_Aspscr1,Q8VBT9,Aspscr1,1,39,14,14,Q8VBT9|Q8VBT9-2|Q8VBT9-3|E9PWZ4|E9Q779,MOUSE,60079.9,34,711,711.1,197.74,197.74,,550,Tether containing UBX domain for GLUT4,nucleoplasm|cytosol|plasma membrane|cytoplasmic side of plasma membrane|endomembrane system|vesicle membrane|extrinsic component of membrane|cytoplasmic vesicle membrane|endoplasmic reticulum-Golgi intermediate compartment membrane|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|,intracellular protein transport|glucose homeostasis|regulation of glucose import|,protein binding|,14,39,5920000000,34.0%
Q8BRK8,0.647214152,-0.013,5.440390945,0.102,0.285733332,1.15998555,0.002,-0.028,-0.166,0.079,0.034,0.001,Q8BRK8,Prkaa2,Q8BRK8_Prkaa2,Q8BRK8,Prkaa2,1,39,16,12,Q8BRK8,MOUSE,62648.8,38.9,712,712.1,197.73,140.6,,552,5'-AMP-activated protein kinase catalytic subunit alpha-2,nucleus|nucleoplasm|cytoplasm|cytosol|AMP-activated protein kinase complex|,"transcription, DNA-templated|regulation of transcription, DNA-templated|protein phosphorylation|fatty acid biosynthetic process|cholesterol biosynthetic process|autophagy|response to stress|lipid biosynthetic process|regulation of gene expression|positive regulation of autophagy|response to muscle activity|Wnt signaling pathway|regulation of macroautophagy|cellular response to nutrient levels|negative regulation of TOR signaling|histone-serine phosphorylation|intracellular signal transduction|cellular response to drug|cellular response to glucose starvation|glucose homeostasis|regulation of circadian rhythm|negative regulation of apoptotic process|positive regulation of glycolytic process|rhythmic process|fatty acid homeostasis|cellular response to prostaglandin E stimulus|regulation of energy homeostasis|",chromatin binding|protein serine/threonine kinase activity|AMP-activated protein kinase activity|protein serine/threonine/tyrosine kinase activity|protein binding|ATP binding|histone serine kinase activity|metal ion binding|[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity|[acetyl-CoA carboxylase] kinase activity|,16,39,7410000000,38.9%
Q5EG47,0.356052463,0.004666667,11.35197853,-0.168,0.073249075,-2.122364321,0.1,0.113,0.053,-0.055,-0.064,-0.119,Q5EG47,Prkaa1,Q5EG47_Prkaa1,Q5EG47,Prkaa1,1,16,14,10,Q5EG47,MOUSE,64555.6,31.1,712,712.2,178.76,121.63,,559,5'-AMP-activated protein kinase catalytic subunit alpha-1,nucleus|nucleoplasm|cytoplasm|apical plasma membrane|AMP-activated protein kinase complex|,"activation of MAPK activity|glucose metabolic process|transcription, DNA-templated|regulation of transcription, DNA-templated|protein phosphorylation|fatty acid biosynthetic process|cholesterol biosynthetic process|autophagy|positive regulation of cell proliferation|lipid biosynthetic process|response to UV|cold acclimation|response to gamma radiation|positive regulation of autophagy|positive regulation of gene expression|response to activity|Wnt signaling pathway|fatty acid oxidation|response to caffeine|cellular response to nutrient levels|negative regulation of TOR signaling|regulation of peptidyl-serine phosphorylation|histone-serine phosphorylation|intracellular signal transduction|cellular response to glucose starvation|response to hydrogen peroxide|glucose homeostasis|regulation of circadian rhythm|negative regulation of apoptotic process|positive regulation of glycolytic process|rhythmic process|positive regulation of skeletal muscle tissue development|negative regulation of lipid catabolic process|protein heterooligomerization|fatty acid homeostasis|regulation of vesicle-mediated transport|cellular response to hydrogen peroxide|cellular response to ethanol|cellular response to prostaglandin E stimulus|cellular response to organonitrogen compound|cellular response to hypoxia|response to camptothecin|regulation of energy homeostasis|negative regulation of glucose import in response to insulin stimulus|",chromatin binding|protein kinase activity|AMP-activated protein kinase activity|protein binding|ATP binding|protein C-terminus binding|kinase binding|histone serine kinase activity|metal ion binding|[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity|tau-protein kinase activity|[acetyl-CoA carboxylase] kinase activity|,10,16,3940000000,22.8%
P26043,0.019386137,-0.089166667,28.60518771,0.573,0.001378736,5.247956894,-0.523,-0.187,-0.417,0.162,0.201,0.229,P26043,Rdx,P26043_Rdx,P26043,Rdx,1,33,16,11,P26043|Q7TSG6|P26040,MOUSE,68655.7,28.9,713,713.1,197.68,138.9,,583,Radixin,ruffle|extracellular space|cytoplasm|cytoskeleton|plasma membrane|microvillus|focal adhesion|extrinsic component of membrane|lamellipodium|filopodium|cleavage furrow|stereocilium|myelin sheath|apical part of cell|extracellular exosome|cell periphery|focal adhesion|,positive regulation of gene expression|microvillus assembly|apical protein localization|actin filament capping|establishment of endothelial barrier|regulation of organelle assembly|positive regulation of protein localization to early endosome|positive regulation of cellular protein catabolic process|positive regulation of early endosome to late endosome transport|,actin binding|protein binding|poly(A) RNA binding|,16,33,3870000000,28.9%
P26041,0.961115261,0.04,0.580934003,0.03,0.87479562,0.163775236,-0.242,-0.079,0.396,0.159,-0.139,0.145,P26041,Msn,P26041_Msn,P26041,Msn,1,8,12,7,P26041,MOUSE,67879.9,21.6,713,713.2,119.79,61.01,,577,Moesin,uropod|extracellular space|nucleus|cytoplasm|cytoskeleton|plasma membrane|microvillus|focal adhesion|basolateral plasma membrane|apical plasma membrane|extrinsic component of membrane|filopodium|microvillus membrane|vesicle|myelin sheath|apical part of cell|extracellular exosome|cell periphery|blood microparticle|focal adhesion|,leukocyte cell-cell adhesion|positive regulation of gene expression|membrane to membrane docking|leukocyte migration|establishment of endothelial barrier|regulation of organelle assembly|positive regulation of protein localization to early endosome|positive regulation of cellular protein catabolic process|regulation of lymphocyte migration|positive regulation of early endosome to late endosome transport|,double-stranded RNA binding|actin binding|receptor binding|protein kinase binding|cell adhesion molecule binding|,7,8,240000000,12.8%
Q99J08,0.956385108,0.0065,0.635582437,0.027,0.8638568,0.178251942,-0.009,0.227,-0.239,-0.065,0.223,-0.098,Q99J08,Sec14l2,Q99J08_Sec14l2,Q99J08,Sec14l2,1,44,16,16,Q99J08,MOUSE,46755.9,47.6,714,714.1,197.2,197.2,,403,SEC14-like protein 2,nucleus|cytosol|integral component of membrane|extracellular exosome|,"transcription, DNA-templated|regulation of transcription, DNA-templated|transport|positive regulation of catalytic activity|positive regulation of cholesterol biosynthetic process|","transporter activity|enzyme activator activity|lipid binding|transferase activity, transferring alkyl or aryl (other than methyl) groups|",16,44,9190000000,47.6%
Q61578,0.505436633,-0.0115,8.108086678,-0.171,0.154593536,-1.604841971,-0.015,0.111,0.126,-0.264,0.016,-0.043,Q61578,Fdxr,Q61578_Fdxr,Q61578,Fdxr,1,38,16,16,Q61578,MOUSE,54600.4,38,715,715.1,196.97,196.97,,494,"NADPH:adrenodoxin oxidoreductase, mitochondrial",cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial matrix|,ubiquinone biosynthetic process|cholesterol metabolic process|NADPH oxidation|,NADPH-adrenodoxin reductase activity|NADPH binding|,16,38,8890000000,38.0%
Q00623,0.000791519,-0.017166667,46.04136519,1.837,2.48808E-05,10.35536693,-0.885,-0.913,-1.009,0.502,1.038,1.164,Q00623,Apoa1,Q00623_Apoa1,Q00623,Apoa1,1,62,16,16,Q00623,MOUSE,30615,48.4,716,716.1,196.8,196.8,,264,Apolipoprotein A-I,extracellular region|extracellular space|nucleus|cytosol|cell surface|endocytic vesicle|cytoplasmic vesicle|very-low-density lipoprotein particle|high-density lipoprotein particle|discoidal high-density lipoprotein particle|spherical high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|extracellular vesicle|,regulation of protein phosphorylation|endothelial cell proliferation|negative regulation of cytokine secretion involved in immune response|phospholipid metabolic process|phosphatidylcholine biosynthetic process|cholesterol biosynthetic process|G-protein coupled receptor signaling pathway|integrin-mediated signaling pathway|response to nutrient|cholesterol metabolic process|glucocorticoid metabolic process|negative regulation of tumor necrosis factor-mediated signaling pathway|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|negative regulation of very-low-density lipoprotein particle remodeling|protein oxidation|peptidyl-methionine modification|triglyceride catabolic process|lipid storage|regulation of intestinal cholesterol absorption|cholesterol transport|adrenal gland development|organ regeneration|regulation of Cdc42 protein signal transduction|cholesterol efflux|phospholipid efflux|negative regulation of heterotypic cell-cell adhesion|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|positive regulation of Rho protein signal transduction|lipoprotein biosynthetic process|response to drug|cholesterol homeostasis|blood vessel endothelial cell migration|response to estrogen|reverse cholesterol transport|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|negative regulation of interleukin-1 beta secretion|negative regulation of inflammatory response|protein stabilization|negative chemotaxis|positive regulation of lipoprotein lipase activity|vitamin transport|positive regulation of hydrolase activity|negative regulation of hydrolase activity|positive regulation of stress fiber assembly|phospholipid homeostasis|negative regulation of lipase activity|negative regulation of cell adhesion molecule production|negative regulation of response to cytokine stimulus|triglyceride homeostasis|cholesterol import|positive regulation of substrate adhesion-dependent cell spreading|protein localization|axon regeneration|,beta-amyloid binding|lipid transporter activity|protein binding|phospholipid binding|phospholipid transporter activity|high-density lipoprotein particle binding|lipid binding|cholesterol binding|cholesterol transporter activity|enzyme binding|phosphatidylcholine binding|apolipoprotein receptor binding|apolipoprotein A-I receptor binding|identical protein binding|chemorepellent activity|lipase inhibitor activity|phosphatidylcholine-sterol O-acyltransferase activator activity|high-density lipoprotein particle receptor binding|lipoprotein particle binding|cholesterol transporter activity|,16,62,12000000000,48.4%
Q80YQ1,0.687405839,-0.019666667,4.746433681,-0.118,0.335240617,-1.038612036,0.074,-0.015,0.059,0.129,-0.214,-0.151,Q80YQ1,Thbs1,Q80YQ1_Thbs1,Q80YQ1,Thbs1,1,33,17,17,Q80YQ1|P35441,MOUSE,133681.8,15.9,717,717.1,196.71,196.71,,1171,Thrombospondin-1,fibrinogen complex|extracellular space|external side of plasma membrane|cell surface|secretory granule|extracellular matrix|platelet alpha granule|extracellular exosome|extracellular matrix|,activation of MAPK activity|negative regulation of endothelial cell proliferation|negative regulation of cell-matrix adhesion|sprouting angiogenesis|chronic inflammatory response|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|negative regulation of dendritic cell antigen processing and presentation|outflow tract morphogenesis|endocardial cushion development|growth plate cartilage development|inflammatory response|immune response|cell cycle arrest|cell adhesion|response to glucose|positive regulation of endothelial cell migration|negative regulation of endothelial cell migration|negative regulation of plasma membrane long-chain fatty acid transport|negative regulation of nitric oxide mediated signal transduction|negative regulation of cGMP-mediated signaling|negative regulation of plasminogen activation|positive regulation of fibroblast migration|positive regulation of cell-substrate adhesion|cell migration|negative regulation of angiogenesis|peptide cross-linking|positive regulation of blood coagulation|positive regulation of cell migration|positive regulation of transforming growth factor beta receptor signaling pathway|regulation of cGMP metabolic process|response to magnesium ion|negative regulation of interleukin-12 production|negative regulation of fibroblast growth factor receptor signaling pathway|positive regulation of phosphorylation|response to drug|positive regulation of tumor necrosis factor biosynthetic process|positive regulation of macrophage activation|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of blood vessel endothelial cell migration|negative regulation of blood vessel endothelial cell migration|engulfment of apoptotic cell|positive regulation of translation|positive regulation of angiogenesis|blood vessel morphogenesis|positive regulation of chemotaxis|response to calcium ion|positive regulation of protein kinase B signaling|negative regulation of fibrinolysis|cellular response to nitric oxide|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors|positive regulation of endothelial cell apoptotic process|positive regulation of reactive oxygen species metabolic process|negative regulation of endothelial cell chemotaxis|,phosphatidylserine binding|fibronectin binding|integrin binding|calcium ion binding|heparin binding|fibroblast growth factor binding|low-density lipoprotein particle binding|laminin binding|extracellular matrix binding|fibrinogen binding|collagen V binding|,17,33,4110000000,15.9%
O09173,0.780105238,0.027833333,3.397241885,0.082333333,0.457378569,0.788627466,-0.011,-0.031,0.002,-0.066,0.244,0.029,O09173,Hgd,O09173_Hgd,O09173,Hgd,1,36,17,17,O09173,MOUSE,50757.8,42.4,718,718.1,196.17,196.17,,445,"Homogentisate 1,2-dioxygenase",extracellular exosome|,cellular amino acid metabolic process|L-phenylalanine catabolic process|tyrosine catabolic process|oxidation-reduction process|,"homogentisate 1,2-dioxygenase activity|metal ion binding|",17,36,6470000000,42.4%
Q9D031,0.862027405,-0.003166667,2.201646417,-0.043,0.602331198,-0.546674495,0.024,0.012,0.019,-0.024,0.017,-0.067,Q9D031,Rsu1,Q9D031_Rsu1,Q9D031,Rsu1,1,44,14,14,Q9D031|A2AUR7|Q01730|A0A0A6YWZ2|E0CXG5,MOUSE,31460.6,59.9,719,719.1,195.97,195.97,,277,Ras suppressor protein 1,intracellular|focal adhesion|extracellular exosome|,Ras protein signal transduction|positive regulation of cell-substrate adhesion|positive regulation of GTPase activity|positive regulation of neural precursor cell proliferation|,,14,44,16100000000,59.9%
Q3TMX5,0.000108653,-0.527833333,64.2973112,2.861666667,3.71765E-07,19.91980274,-2.071,-1.708,-2.097,0.782,0.838,1.089,Q3TMX5,Manf,Q3TMX5_Manf,Q3TMX5,Manf,1,61,13,13,Q3TMX5|Q80ZP8|Q9CXI5,MOUSE,20843.8,49.7,720,720.1,195.89,195.89,,179,"Arginine-rich, mutated in early stage tumors, isoform CRA_b",extracellular space|nucleus|endoplasmic reticulum|perinuclear region of cytoplasm|,vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure|,poly(A) RNA binding|,13,61,56900000000,49.7%
O35226-2,0.904214516,-0.0115,1.572601455,-0.035,0.696209355,-0.407702278,0.076,0.014,-0.072,0.024,-0.045,-0.066,O35226,Psmd4,O35226-2_Psmd4,O35226-2,Psmd4,1,41,12,1,O35226-2|O35226-3|O35226-5,MOUSE,41273.6,36.4,721,721.1,195.87,20.49,,376,Isoform Rpn10B of 26S proteasome non-ATPase regulatory subunit 4,"proteasome complex|nucleoplasm|cytoplasm|proteasome regulatory particle, base subcomplex|proteasome accessory complex|",ubiquitin-dependent protein catabolic process|,transcription factor binding|identical protein binding|poly(A) RNA binding|,12,41,18400000000,36.4%
Q9D2G2,0.622281343,0.028,5.916950721,-0.155333333,0.256038296,-1.243138739,0.275,0.174,-0.132,-0.052,0.016,-0.113,Q9D2G2,Dlst,Q9D2G2_Dlst,Q9D2G2,Dlst,1,37,17,17,Q9D2G2|Q9D2G2-2,MOUSE,49336,39.4,722,722.1,195.73,195.73,,454,"Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial",nucleus|mitochondrion|plasma membrane|membrane|myelin sheath|oxoglutarate dehydrogenase complex|extracellular exosome|,tricarboxylic acid cycle|2-oxoglutarate metabolic process|NADH metabolic process|L-lysine catabolic process to acetyl-CoA via saccharopine|,dihydrolipoyllysine-residue succinyltransferase activity|heat shock protein binding|chaperone binding|,17,37,11700000000,39.4%
E9Q8I0,0.005409154,-0.0205,35.26430422,1.246333333,0.000297557,6.899805827,-0.772,-0.68,-0.479,0.493,0.338,0.977,E9Q8I0,Cfh,E9Q8I0_Cfh,E9Q8I0,Cfh,1,35,16,13,E9Q8I0|P06909|E9Q8H9|D6RGQ0|A0A0A6YVP8,MOUSE,145947.1,17,723,723.1,195.7,155.42,,1252,Complement factor H,extracellular exosome|blood microparticle|,regulation of complement activation|,complement component C3b binding|heparin binding|heparan sulfate proteoglycan binding|,16,35,3090000000,17.0%
Q9DB77,0.914963302,0.040833333,1.331359609,0.057666667,0.735976655,0.351720229,-0.102,0.252,-0.114,-0.145,0.342,0.012,Q9DB77,Uqcrc2,Q9DB77_Uqcrc2,Q9DB77,Uqcrc2,1,31,14,14,Q9DB77,MOUSE,48291.1,35.7,724,724.1,195.7,195.7,,453,"Cytochrome b-c1 complex subunit 2, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex III|myelin sheath|extracellular exosome|,"mitochondrial electron transport, ubiquinol to cytochrome c|aerobic respiration|protein processing|",metalloendopeptidase activity|zinc ion binding|protein complex binding|,14,31,16600000000,35.7%
Q78JT3,0.816757276,-0.007166667,2.854222478,0.075,0.518295875,0.681809167,0.012,-0.216,0.07,-0.077,0.078,0.09,Q78JT3,Haao,Q78JT3_Haao,Q78JT3,Haao,1,57,17,17,Q78JT3,MOUSE,32974.9,61.5,725,725.1,195.49,195.49,,286,"3-hydroxyanthranilate 3,4-dioxygenase",cytosol|extracellular exosome|,tryptophan catabolic process|response to zinc ion|quinolinate biosynthetic process|'de novo' NAD biosynthetic process from tryptophan|anthranilate metabolic process|response to cadmium ion|oxidation-reduction process|neuron cellular homeostasis|,"3-hydroxyanthranilate 3,4-dioxygenase activity|ferrous iron binding|",17,57,16000000000,61.5%
A0A0R4J140,0.961523652,0.008666667,0.534089851,0.016666667,0.884282469,0.151200808,-0.044,-0.151,0.196,0.001,0.029,0.021,A0A0R4J140,Cluh,A0A0R4J140_Cluh,A0A0R4J140,Cluh,1,25,18,18,A0A0R4J140|Z4YLI8|Q5SW19|Q5SW19-3|Q5SW19-2,MOUSE,153317.3,18.4,726,726.1,195.17,195.17,,1353,Clustered mitochondria protein homolog,,,,18,25,1450000000,18.4%
Q8BJ71,0.32412071,0.003166667,12.15034238,-0.199666667,0.060948885,-2.249294911,0.073,0.13,0.106,-0.045,-0.209,-0.036,Q8BJ71,Nup93,Q8BJ71_Nup93,Q8BJ71,Nup93,1,28,16,16,Q8BJ71|Q8BJ71-2|A0A1D5RLQ0,MOUSE,93792.9,24.4,727,727.1,194.85,194.85,,819,Nuclear pore complex protein Nup93,nuclear pore|membrane|nuclear membrane|nuclear periphery|,positive regulation of defense response to virus by host|protein import into nucleus|poly(A)+ mRNA export from nucleus|nuclear pore complex assembly|activation of mitophagy in response to mitochondrial depolarization|,structural constituent of nuclear pore|,16,28,3030000000,24.4%
Q3UER8,0.801983355,-0.007,3.044388774,0.196,0.496090742,0.720108184,-0.3,-0.558,0.543,0.124,-0.009,0.158,Q3UER8,Fgg,Q3UER8_Fgg,Q3UER8,Fgg,1,77,14,14,Q3UER8|Q8VCM7|P12799|F1MGU7|Q3SZZ9,MOUSE,51033.2,40.1,728,728.1,194.36,194.36,,443,Fibrinogen gamma chain,fibrinogen complex|extracellular space|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|,"cell-matrix adhesion|signal transduction|protein secretion|plasminogen activation|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|cellular protein complex assembly|positive regulation of vasoconstriction|positive regulation of exocytosis|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of endothelial cell apoptotic process|","receptor binding|structural molecule activity|protein binding, bridging|cell adhesion molecule binding|",14,77,34400000000,40.1%
Q9ERE7,4.99445E-05,-0.4075,73.62899009,2.509666667,4.33612E-08,27.03480811,-1.648,-1.78,-1.559,0.808,0.889,0.845,Q9ERE7,Mesd,Q9ERE7_Mesd,Q9ERE7,Mesd,1,48,13,13,Q9ERE7,MOUSE,25320.3,45.5,729,729.1,194.32,194.32,,224,LRP chaperone MESD,endoplasmic reticulum|plasma membrane|,protein folding|mesoderm development|Wnt signaling pathway|protein localization to cell surface|,protein binding|low-density lipoprotein particle receptor binding|,13,48,46900000000,45.5%
P97366,0.954887447,-0.0015,0.6696235,-0.019,0.857112147,-0.187115995,0.134,0.013,-0.123,0.076,-0.037,-0.072,P97366,NotFound,P97366_NotFound,P97366,Evi5,1,31,16,16,P97366|F8VPT6,MOUSE,93682.9,21.6,730,730.1,194.26,194.26,,809,Ecotropic viral integration site 5 protein,nucleus|Golgi apparatus|microtubule organizing center|spindle|cytosol|intracellular membrane-bounded organelle|,"cell cycle|retrograde transport, endosome to Golgi|positive regulation of GTPase activity|cell division|",GTPase activator activity|Rab GTPase binding|,16,31,1770000000,21.6%
E9Q3C1,0.894455479,-0.070666667,1.665970524,0.072666667,0.681401284,0.429196462,0.121,0.009,-0.451,0.086,0.011,-0.2,E9Q3C1,C2cd2,E9Q3C1_C2cd2,E9Q3C1,C2cd2,1,36,13,13,E9Q3C1,MOUSE,77105.2,30.6,731,731.1,193.6,193.6,,696,C2 domain-containing protein 2,nucleus|cytosol|,,,13,36,12100000000,30.6%
P35293,0.97545852,-0.001666667,0.361889812,0.008,0.920049129,0.104217201,0.011,-0.005,-0.023,0.007,0.004,-0.004,P35293,Rab18,P35293_Rab18,P35293,Rab18,1,46,13,13,P35293,MOUSE,23320,69.9,732,732.1,193.14,193.14,,206,Ras-related protein Rab-18,intracellular|Golgi apparatus|basal plasma membrane|apical plasma membrane|extracellular exosome|endoplasmic reticulum tubular network|,eye development|intracellular protein transport|brain development|Rab protein signal transduction|lipid particle organization|endoplasmic reticulum tubular network organization|,GTPase activity|GTP binding|GDP binding|,13,46,24800000000,69.9%
P99029,0.919618833,-0.0135,1.177415324,-0.042333333,0.762532691,-0.31489668,0.086,0.08,-0.143,-0.209,0.199,-0.094,P99029,Prdx5,P99029_Prdx5,P99029,Prdx5,1,60,12,12,P99029|P99029-2|H3BJQ7|G3UZJ4,MOUSE,22239.4,60.4,733,733.1,192.17,192.17,,210,"Peroxiredoxin-5, mitochondrial",extracellular space|nucleus|cytoplasm|mitochondrion|peroxisome|peroxisomal matrix|cytosol|cytoplasmic vesicle|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|extracellular exosome|,apoptotic process|response to oxidative stress|negative regulation of transcription from RNA polymerase III promoter|positive regulation of collagen biosynthetic process|cellular response to reactive oxygen species|hydrogen peroxide catabolic process|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|negative regulation of oxidoreductase activity|regulation of apoptosis involved in tissue homeostasis|NADPH oxidation|reactive nitrogen species metabolic process|,RNA polymerase III regulatory region DNA binding|peroxidase activity|receptor binding|antioxidant activity|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|protein dimerization activity|peroxiredoxin activity|peroxynitrite reductase activity|,12,60,50300000000,60.4%
P41105,0.892575628,0.001,1.715799961,-0.042,0.673627803,-0.440229885,-0.087,0.152,0.001,-0.001,0.01,-0.069,P41105,Rpl28,P41105_Rpl28,P41105,Rpl28,1,62,15,15,P41105,MOUSE,15790.3,58.3,734,734.1,192.11,192.11,,137,60S ribosomal protein L28,cytoplasm|membrane|cytosolic large ribosomal subunit|dendrite|cytoplasmic ribonucleoprotein granule|cell body|extracellular exosome|,translation|regulation of mitochondrion degradation|positive regulation of protein targeting to mitochondrion|,structural constituent of ribosome|poly(A) RNA binding|,15,62,4.8E+11,58.3%
Q9D394-2,0.82082884,-0.003333333,2.781071954,0.057333333,0.527099743,0.666960841,-0.003,-0.007,-0.086,0.112,-0.022,-0.014,Q9D394,Rufy3,Q9D394-2_Rufy3,Q9D394-2,Rufy3,1,34,16,16,A0A0G2JFT8|Q9D394-2|Q9D394-4|Q9D394-3|Q9D394,MOUSE,75085,28.8,735,735.1,192.08,192.08,,469,Isoform 2 of Protein RUFY3,axon|dendrite|neuronal cell body|,regulation of axonogenesis|positive regulation of axonogenesis|,protein binding|,16,34,3520000000,28.8%
O08759,0.788999579,-0.018833333,3.277890566,0.074333333,0.470122399,0.765435391,0.035,0.005,-0.208,0.036,-0.008,0.027,O08759,Ube3a,O08759_Ube3a,O08759,Ube3a,1,27,13,13,O08759|O08759-2|O08759-3,MOUSE,100787.6,21.2,736,736.1,191.99,191.99,,870,Ubiquitin-protein ligase E3A,proteasome complex|nucleus|cytoplasm|cytosol|,ovarian follicle development|ubiquitin-dependent protein catabolic process|positive regulation of phosphatidylinositol 3-kinase signaling|protein ubiquitination|androgen receptor signaling pathway|positive regulation of protein ubiquitination|sperm entry|regulation of circadian rhythm|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of transcription from RNA polymerase II promoter|protein autoubiquitination|prostate gland growth|protein K48-linked ubiquitination|regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|,transcription coactivator activity|ubiquitin-protein transferase activity|protein binding|ligase activity|metal ion binding|ubiquitin protein ligase activity|,13,27,10900000000,21.2%
Q8BL66,0.936982455,-0.016166667,0.89266807,0.030333333,0.814203927,0.244559663,-0.033,-0.227,0.166,0.082,-0.107,0.022,Q8BL66,Eea1,Q8BL66_Eea1,Q8BL66,Eea1,1,26,17,17,Q8BL66,MOUSE,162052.8,14.1,737,737.1,191.5,191.5,,1411,Early endosome antigen 1,endosome|early endosome|cytosol|serine-pyruvate aminotransferase complex|extrinsic component of plasma membrane|cytoplasmic vesicle|early endosome membrane|axonal spine|extracellular exosome|,endocytosis|vesicle fusion|,protein binding|1-phosphatidylinositol binding|GTP-dependent protein binding|protein homodimerization activity|metal ion binding|,17,26,20800000000,14.1%
P15208,0.000552294,-0.056833333,48.72081707,0.874333333,1.34251E-05,11.2681978,-0.496,-0.494,-0.492,0.381,0.411,0.349,P15208,Insr,P15208_Insr,P15208,Insr,1,31,17,15,P15208,MOUSE,158288.9,13.4,738,738.1,191.39,171.51,,1372,Insulin receptor,plasma membrane|integral component of plasma membrane|insulin receptor complex|caveola|membrane|intracellular membrane-bounded organelle|receptor complex|extracellular exosome|,"activation of MAPK activity|positive regulation of protein phosphorylation|heart morphogenesis|regulation of transcription, DNA-templated|G-protein coupled receptor signaling pathway|positive regulation of cell proliferation|insulin receptor signaling pathway|epidermis development|male gonad development|organ morphogenesis|peptidyl-tyrosine phosphorylation|transformation of host cell by virus|signal transduction by protein phosphorylation|male sex determination|adrenal gland development|positive regulation of cell migration|exocrine pancreas development|activation of protein kinase activity|activation of protein kinase B activity|cellular response to insulin stimulus|peptidyl-tyrosine autophosphorylation|glucose homeostasis|positive regulation of MAPK cascade|positive regulation of nitric oxide biosynthetic process|positive regulation of glycogen biosynthetic process|positive regulation of DNA replication|positive regulation of glycolytic process|positive regulation of mitotic nuclear division|positive regulation of transcription, DNA-templated|regulation of embryonic development|positive regulation of glucose import|protein autophosphorylation|positive regulation of developmental growth|protein heterotetramerization|positive regulation of meiotic cell cycle|positive regulation of protein kinase B signaling|positive regulation of respiratory burst|cellular response to growth factor stimulus|regulation of female gonad development|",protein tyrosine kinase activity|receptor signaling protein tyrosine kinase activity|insulin-activated receptor activity|insulin-like growth factor receptor binding|protein binding|ATP binding|GTP binding|insulin-like growth factor I binding|insulin-like growth factor II binding|phosphatidylinositol 3-kinase binding|insulin binding|insulin receptor substrate binding|PTB domain binding|,17,31,8360000000,13.4%
P26231,0.378011992,0.0145,10.87874322,0.251,0.081681871,2.051372526,-0.204,-0.102,-0.027,0.002,0.055,0.363,P26231,Ctnna1,P26231_Ctnna1,P26231,Ctnna1,1,33,18,18,P26231|E0CXB9|Q61301|Q61301-3|Q61301-2|Q8BS72,MOUSE,100789.2,23.7,739,739.1,191.3,191.3,,906,Catenin alpha-1,acrosomal vesicle|cytosol|plasma membrane|cell-cell junction|adherens junction|cell-cell adherens junction|zonula adherens|focal adhesion|intercalated disc|actin cytoskeleton|catenin complex|flotillin complex|lamellipodium|,ovarian follicle development|actin filament organization|establishment or maintenance of cell polarity|negative regulation of neuroblast proliferation|aging|male gonad development|gap junction assembly|axon regeneration|cellular protein localization|regulation of cell proliferation|odontogenesis of dentin-containing tooth|negative regulation of apoptotic process|apical junction assembly|response to estrogen|positive regulation of smoothened signaling pathway|protein heterooligomerization|cellular response to indole-3-methanol|epithelial cell-cell adhesion|negative regulation of cell motility|negative regulation of integrin-mediated signaling pathway|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand|,structural molecule activity|protein binding|beta-catenin binding|vinculin binding|poly(A) RNA binding|gamma-catenin binding|cadherin binding|actin filament binding|,18,33,10900000000,23.7%
D3YTN4,0.614629659,0.011,6.087066615,-0.122,0.246202999,-1.270672697,0.11,-0.043,0.149,0.044,-0.107,-0.087,D3YTN4,Gimap4,D3YTN4_Gimap4,D3YTN4,Gimap4,1,31,15,15,D3YTN4|D3YWB5|Q99JY3|D3Z7Q4|D6RGS2|D3Z3F3,MOUSE,38386.1,46.6,740,740.1,191.06,191.06,,328,GTPase IMAP family member 4,cytosol|,,GTP binding|,15,31,22400000000,46.6%
Q3TL44,0.817484327,0.013333333,2.833874516,-0.064,0.52072994,-0.677614451,0.147,0.062,-0.073,0.041,-0.025,-0.072,Q3TL44,Nlrx1,Q3TL44_Nlrx1,Q3TL44,Nlrx1,1,29,15,15,Q3TL44,MOUSE,108856.1,16.5,741,741.1,190.94,190.94,,975,NLR family member ,mitochondrion|mitochondrial outer membrane|,viral process|negative regulation of interferon-beta production|negative regulation of interleukin-6 production|negative regulation of RIG-I signaling pathway|negative regulation of I-kappaB kinase/NF-kappaB signaling|innate immune response|negative regulation of innate immune response|negative regulation of inflammatory response|,protein binding|ATP binding|,15,29,4030000000,16.5%
Q6PGC1,0.985063154,-0.007,0.237414754,-0.006,0.9468006,-0.069265898,0.007,0.028,-0.047,0.076,-0.09,-0.016,Q6PGC1,Dhx29,Q6PGC1_Dhx29,Q6PGC1,Dhx29,1,20,15,15,Q6PGC1|Q8BN72,MOUSE,155113.5,15,742,742.1,190.76,190.76,,1365,ATP-dependent RNA helicase DHX29,cytoplasm|mitochondrion|eukaryotic 43S preinitiation complex|,RNA processing|translational initiation|,translation initiation factor activity|ATP-dependent RNA helicase activity|ATP binding|ribosomal small subunit binding|poly(A) RNA binding|,15,20,16000000000,15.0%
Q9Z0R9,0.710993264,-0.087166667,4.367878713,0.265666667,0.365773408,0.970799783,0.3,-0.144,-0.816,0.152,-0.146,0.131,Q9Z0R9,Fads2,Q9Z0R9_Fads2,Q9Z0R9,Fads2,1,64,13,13,Q9Z0R9,MOUSE,52500.5,26.1,743,743.1,190.73,190.73,,444,Fatty acid desaturase 2,endoplasmic reticulum membrane|membrane|integral component of membrane|,unsaturated fatty acid biosynthetic process|oxidation-reduction process|,stearoyl-CoA 9-desaturase activity|,13,64,55900000000,26.1%
P51150,0.931448019,-0.009333333,0.987847449,0.022666667,0.796554059,0.268286555,0.042,0.007,-0.111,0.016,-0.007,-0.003,P51150,Rab7,P51150_Rab7,P51150,Rab7a,1,56,13,13,P51150|A0A0N4SVR6,MOUSE,23774.6,81.1,744,744.1,190.67,190.67,,207,Ras-related protein Rab-7a,cytoplasm|lysosome|late endosome|vacuolar membrane|Golgi apparatus|phagocytic vesicle membrane|pre-autophagosomal structure membrane|melanosome|terminal bouton|intracellular membrane-bounded organelle|phagocytic vesicle|extracellular exosome|alveolar lamellar body|lysosome|late endosome|retromer complex|,"protein targeting to lysosome|intracellular protein transport|epidermal growth factor catabolic process|endosome to lysosome transport|viral release from host cell|protein to membrane docking|Rab protein signal transduction|retrograde transport, endosome to Golgi|early endosome to late endosome transport|bone resorption|positive regulation of protein catabolic process|positive regulation of viral process|phagosome acidification|phagosome-lysosome fusion|positive regulation of exosomal secretion|regulation of autophagosome assembly|",GTPase activity|protein binding|GTP binding|GDP binding|Rac GTPase binding|,13,56,28400000000,81.1%
Q8VCA4,0.449536571,-0.0695,9.419225965,0.311,0.114308205,1.818155607,-0.033,-0.029,-0.613,0.089,0.147,0.022,Q8VCA4,Cyp4f15,Q8VCA4_Cyp4f15,Q8VCA4,Cyp4f15,1,35,16,6,Q8VCA4|Q99N18|G3UW78|Q99N16|A0A1D5RLD0,MOUSE,61199.5,30.7,745,745.1,190.67,84.81,,527,Cyp4f15 protein,,oxidation-reduction process|,"monooxygenase activity|iron ion binding|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen|heme binding|",16,35,7960000000,30.7%
Q99N19,0.935669179,-0.018166667,0.922104498,-0.028333333,0.808703924,-0.251917259,0.027,0.145,-0.184,0.041,-0.119,-0.019,Q99N19,Cyp4f13,Q99N19_Cyp4f13,Q99N19,Cyp4f13,1,12,14,6,Q99N19|B8JK07|Q3V1F1,MOUSE,60564,26.1,745,745.2,164.26,87.05,,523,Cytochrome P450 CYP4F13,,leukotriene metabolic process|oxidation-reduction process|,"iron ion binding|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen|heme binding|",6,12,917000000,14.1%
Q9EP75,0.582708025,-1.73472E-18,6.680940633,0.24,0.214736533,1.372037586,0.026,0.016,-0.402,0.362,-0.142,0.14,Q9EP75,Cyp4f14,Q9EP75_Cyp4f14,Q9EP75,Cyp4f14,1,5,13,3,Q9EP75|G3UW81,MOUSE,60369.9,24.2,745,745.3,151.45,40.15,,524,Leukotriene-B4 omega-hydroxylase 3,endoplasmic reticulum membrane|,response to toxic substance|arachidonic acid metabolic process|leukotriene B4 catabolic process|oxidation-reduction process|,iron ion binding|arachidonic acid monooxygenase activity|heme binding|leukotriene-B4 20-monooxygenase activity|arachidonic acid binding|alpha-tocopherol omega-hydroxylase activity|,3,5,1340000000,6.4%
Q8BGU0,0.841746758,-0.010833333,2.505889883,0.068333333,0.561579197,0.610822361,0.127,-0.024,-0.238,0.024,0.021,0.025,Q8BGU0,Cyp4f39,Q8BGU0_Cyp4f39,Q8BGU0,Cyp4f39,1,4,4,3,Q8BGU0,MOUSE,62560.5,7.7,745,745.4,30.79,23.55,,532,"Cytochrome P450, family 4, subfamily f, polypeptide 39",,oxidation-reduction process|,"monooxygenase activity|iron ion binding|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen|heme binding|",3,4,824000000,6.2%
Q9JMA1,0.960902246,-0.023333333,0.585250146,0.020666667,0.873926655,0.164923763,0.048,0.135,-0.284,-0.027,0.016,-0.028,Q9JMA1,Usp14,Q9JMA1_Usp14,Q9JMA1,Usp14,1,29,13,13,Q9JMA1|E9PYI8,MOUSE,56457.4,39.9,746,746.1,190.51,190.51,,493,Ubiquitin carboxyl-terminal hydrolase 14,proteasome complex|nucleus|cytoplasm|plasma membrane|cell surface|cytoplasmic membrane-bounded vesicle|synapse|extracellular exosome|,synaptic transmission|negative regulation of endopeptidase activity|protein deubiquitination|proteasome-mediated ubiquitin-dependent protein catabolic process|regulation of chemotaxis|regulation of proteasomal protein catabolic process|negative regulation of ER-associated ubiquitin-dependent protein catabolic process|,cysteine-type endopeptidase activity|ubiquitin-specific protease activity|endopeptidase inhibitor activity|protein binding|proteasome binding|,13,29,6420000000,39.9%
Q80T06,0.926554478,-0.048833333,1.058223928,-0.056333333,0.783750096,-0.285822602,-0.341,0.08,0.199,-0.385,-0.036,0.19,Q80T06,Eef1d,Q80T06_Eef1d,Q80T06,Eef1d,1,49,16,16,Q80T06|P57776|Q91VK2|A0A0R4J1L2|A0A0R4J1E2|P57776-2|P57776-3|D3YY68,MOUSE,31405.6,70.8,747,747.1,190.5,190.5,,281,Elongation factor 1-delta,nucleolus|cytoplasm|eukaryotic translation elongation factor 1 complex|endoplasmic reticulum|,translational elongation|signal transduction|mRNA transcription|regulation of cell death|positive regulation of I-kappaB kinase/NF-kappaB signaling|cellular response to ionizing radiation|,DNA binding|translation elongation factor activity|signal transducer activity|heat shock protein binding|activating transcription factor binding|,16,49,16500000000,70.8%
Q9JIX8,0.99327985,-0.003666667,0.120628026,0.004666667,0.972606567,0.035657725,-0.237,0.067,0.152,0.017,-0.131,0.11,Q9JIX8,Acin1,Q9JIX8_Acin1,Q9JIX8,Acin1,1,29,16,16,Q9JIX8|Q9JIX8-4|B8JJ91|Q9JIX8-2|B8JJ92|Q9JIX8-3|Q52KR6,MOUSE,151115.7,12.8,748,748.1,190.3,190.3,,1338,Apoptotic chromatin condensation inducer in the nucleus,nucleus|nucleoplasm|nucleolus|cytoplasm|plasma membrane|nuclear speck|ASAP complex|exon-exon junction complex|,"positive regulation of defense response to virus by host|mRNA processing|apoptotic process|RNA splicing|regulation of autophagy|erythrocyte differentiation|apoptotic chromosome condensation|regulation of apoptotic process|positive regulation of apoptotic process|positive regulation of monocyte differentiation|negative regulation of mRNA splicing, via spliceosome|activation of mitophagy in response to mitochondrial depolarization|",nucleotide binding|poly(A) RNA binding|,16,29,2060000000,12.8%
P62331,0.254403188,0.0305,14.05141674,-0.261666667,0.039342171,-2.553759434,0.171,0.284,0.029,-0.077,-0.03,-0.194,P62331,Arf6,P62331_Arf6,P62331,Arf6,1,45,12,12,P62331|Q8BGX0|Q8BGX0-2|Q8BGX0-3,MOUSE,20195.9,76,749,749.1,190.03,190.03,,175,ADP-ribosylation factor 6,ruffle|cytoplasm|endosome|early endosome|Golgi apparatus|plasma membrane|focal adhesion|cell cortex|membrane|endocytic vesicle|midbody|filopodium membrane|cleavage furrow|myelin sheath|recycling endosome membrane|extracellular exosome|,liver development|cell cycle|small GTPase mediated signal transduction|protein transport|vesicle-mediated transport|positive regulation of actin filament polymerization|cortical actin cytoskeleton organization|ruffle organization|myeloid cell apoptotic process|regulation of toll-like receptor 4 signaling pathway|protein localization to cell surface|regulation of Rac protein signal transduction|protein localization to endosome|cell division|regulation of filopodium assembly|regulation of dendritic spine development|positive regulation of establishment of protein localization to plasma membrane|establishment of epithelial cell polarity|hepatocyte apoptotic process|negative regulation of dendrite development|,GTPase activity|protein binding|GTP binding|thioesterase binding|protein N-terminus binding|,12,45,29300000000,76.0%
Q6DFZ1,0.866627606,-0.012,2.141000395,-0.055333333,0.610801311,-0.533733647,-0.009,0.029,0.027,0.11,-0.201,-0.028,Q6DFZ1,Gbf1,Q6DFZ1_Gbf1,Q6DFZ1,Gbf1,1,28,19,19,Q6DFZ1,MOUSE,208832.4,12.1,750,750.1,189.89,189.89,,1861,Golgi-specific brefeldin A-resistance factor 1,Golgi membrane|mitochondrion|peroxisome|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|Golgi stack|cis-Golgi network|trans-Golgi network|plasma membrane|membrane|cell leading edge|trans-Golgi network|,"cell activation involved in immune response|retrograde vesicle-mediated transport, Golgi to ER|Golgi to endosome transport|Golgi organization|regulation of mitotic cell cycle|regulation of cell adhesion|neutrophil chemotaxis|regulation of ARF protein signal transduction|protein localization to Golgi apparatus|retrograde transport, endosome to Golgi|positive regulation of GTPase activity|COPI coating of Golgi vesicle|establishment of monopolar cell polarity|protein localization to endoplasmic reticulum exit site|Golgi disassembly|endoplasmic reticulum-Golgi intermediate compartment organization|reactive oxygen species biosynthetic process|protein localization to endoplasmic reticulum tubular network|regulation of protein localization to cell surface|vesicle-mediated transport|","ARF guanyl-nucleotide exchange factor activity|protein binding|phosphatidylinositol-3,4,5-trisphosphate binding|phosphatidylinositol-3,5-bisphosphate binding|",19,28,6890000000,12.1%
Q8VCQ8,0.262202412,0.0585,13.84991113,0.305666667,0.041210595,2.528009778,-0.107,-0.093,-0.083,-0.008,0.232,0.41,Q8VCQ8,Cald1,Q8VCQ8_Cald1,Q8VCQ8,Cald1,1,34,16,16,Q8VCQ8|D3Z6I7|E9QA16|E9QA15|E9Q0M9|S4R1T7,MOUSE,60565.9,33.3,751,751.1,189.85,189.85,,530,Caldesmon 1,plasma membrane|membrane|actin cap|,muscle contraction|regulation of smooth muscle contraction|response to transforming growth factor beta|,actin binding|calmodulin binding|myosin binding|,16,34,6160000000,33.3%
Q8BGS1-2,0.759852964,-0.04,3.708463449,0.115333333,0.425749018,0.848549197,0.008,0.037,-0.338,0.014,0.16,-0.121,Q8BGS1,Epb41l5,Q8BGS1-2_Epb41l5,Q8BGS1-2,Epb41l5,1,46,13,13,Q8BGS1-2|Q8BGS1|Q8BGS1-3|A2ALK6|Q9JMC8,MOUSE,58031.7,32.9,752,752.1,189.65,189.65,,731,Isoform 2 of Band 4.1-like protein 5,nucleus|cytoplasm|cytoskeleton|plasma membrane|focal adhesion|extrinsic component of membrane|cell leading edge|ruffle membrane|,"cell morphogenesis involved in differentiation|in utero embryonic development|somitogenesis|epithelial to mesenchymal transition|neural plate morphogenesis|positive regulation of cell-matrix adhesion|epithelial cell morphogenesis|apical constriction|substrate-dependent cell migration, cell attachment to substrate|ectoderm development|endoderm development|mesoderm development|mesoderm migration involved in gastrulation|unidimensional cell growth|posttranscriptional regulation of gene expression|positive regulation of epithelial cell migration|positive regulation of epithelial to mesenchymal transition|negative regulation of cell-cell adhesion|actin cytoskeleton organization|actomyosin structure organization|negative regulation of protein binding|positive regulation of protein binding|somite rostral/caudal axis specification|axial mesoderm development|axial mesoderm morphogenesis|paraxial mesoderm development|embryonic foregut morphogenesis|positive regulation of focal adhesion assembly|regulation of establishment of protein localization|left/right axis specification|cellular response to transforming growth factor beta stimulus|",protein binding|cytoskeletal protein binding|protein domain specific binding|,13,46,4590000000,32.9%
Q9DBK0,0.994928853,-0.060666667,0.090974554,0.005333333,0.979270213,0.026980918,0.086,0.215,-0.491,-0.217,0.094,-0.051,Q9DBK0,Acot12,Q9DBK0_Acot12,Q9DBK0,Acot12,1,32,14,14,Q9DBK0,MOUSE,62388.1,26.4,753,753.1,189.56,189.56,,556,Acyl-coenzyme A thioesterase 12,cytosol|,acetyl-CoA metabolic process|pyruvate metabolic process|fatty acid metabolic process|,acetyl-CoA hydrolase activity|ATP binding|lipid binding|carboxylic ester hydrolase activity|,14,32,21200000000,26.4%
Q99KV1,0.002681142,-0.044333333,38.87967546,0.856,0.000129429,7.869521777,-0.555,-0.32,-0.542,0.404,0.262,0.485,Q99KV1,Dnajb11,Q99KV1_Dnajb11,Q99KV1,Dnajb11,1,33,13,13,Q99KV1,MOUSE,40839.6,39.3,754,754.1,189.36,189.36,,358,DnaJ homolog subfamily B member 11,nucleus|cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|membrane|endoplasmic reticulum chaperone complex|,protein folding|mRNA modification|,protein binding|unfolded protein binding|,13,33,15500000000,39.3%
Q9QWG7-2,0.926033297,-0.0605,1.080146053,0.058333333,0.779803885,0.291208506,0.197,0.083,-0.549,0.073,-0.05,-0.117,Q9QWG7,Sult1b1,Q9QWG7-2_Sult1b1,Q9QWG7-2,Sult1b1,1,44,14,14,Q9QWG7-2|Q9QWG7,MOUSE,37044.1,40.1,755,755.1,189.26,189.26,,299,Isoform 2 of Sulfotransferase family cytosolic 1B member 1,cytosol|,xenobiotic metabolic process|steroid metabolic process|flavonoid metabolic process|phenol-containing compound metabolic process|epithelial cell differentiation|thyroid hormone metabolic process|sulfation|,aryl sulfotransferase activity|sulfotransferase activity|,14,44,13000000000,40.1%
Q9QZD9,0.8144483,0.025166667,2.891559943,-0.073666667,0.513859045,-0.689295242,-0.113,0.182,0.117,-0.028,-0.066,0.059,Q9QZD9,Eif3i,Q9QZD9_Eif3i,Q9QZD9,Eif3i,1,38,15,15,Q9QZD9,MOUSE,36859.5,56,756,756.1,188.84,188.84,,325,Eukaryotic translation initiation factor 3 subunit I,"eukaryotic translation initiation factor 3 complex|eukaryotic 43S preinitiation complex|eukaryotic 48S preinitiation complex|extracellular exosome|eukaryotic translation initiation factor 3 complex, eIF3m|",formation of translation preinitiation complex|translational initiation|regulation of translational initiation|,translation initiation factor activity|protein binding|translation initiation factor activity|,15,38,12000000000,56.0%
Q9WV55,0.873222165,-0.019833333,2.049833246,-0.051666667,0.623758785,-0.514020557,-0.04,0.044,0.014,-0.206,0.015,0.054,Q9WV55,Vapa,Q9WV55_Vapa,Q9WV55,Vapa,1,40,17,15,Q9WV55,MOUSE,28083,68.2,757,757.1,188.76,169.14,,249,Vesicle-associated membrane protein-associated protein A,Golgi membrane|endoplasmic reticulum|endoplasmic reticulum membrane|plasma membrane|microtubule cytoskeleton|integral component of membrane|vesicle|bicellular tight junction|perinuclear region of cytoplasm|,ER to Golgi vesicle-mediated transport|signal transduction|cell death|neuron projection development|positive regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation by host of viral release from host cell|negative regulation by host of viral genome replication|positive regulation by host of viral genome replication|protein localization to endoplasmic reticulum|COPII-coated vesicle budding|,signal transducer activity|microtubule binding|protein domain specific binding|FFAT motif binding|protein heterodimerization activity|,17,40,15200000000,68.2%
Q8BH80,0.880065349,0.009,1.961864818,0.038,0.636522146,0.494853385,-0.01,-0.028,0.008,0.026,0.033,0.025,Q8BH80,Vapb,Q8BH80_Vapb,Q8BH80,Vapb,1,17,8,5,Q8BH80|Q9QY76,MOUSE,27145.9,36.2,757,757.2,93.48,69.17,,243,"Vesicle-associated membrane protein, associated protein B and C",Golgi membrane|endoplasmic reticulum|endoplasmic reticulum membrane|Golgi apparatus|,cellular calcium ion homeostasis|ER to Golgi vesicle-mediated transport|activation of signaling protein activity involved in unfolded protein response|endoplasmic reticulum organization|modulation by virus of host morphology or physiology|endoplasmic reticulum unfolded protein response|negative regulation by host of viral release from host cell|positive regulation by host of viral release from host cell|negative regulation by host of viral genome replication|positive regulation by host of viral genome replication|positive regulation of viral genome replication|negative regulation by virus of viral protein levels in host cell|COPII-coated vesicle budding|,microtubule binding|enzyme binding|FFAT motif binding|protein homodimerization activity|protein heterodimerization activity|beta-tubulin binding|,5,17,5100000000,23.8%
P14246,0.924329621,-0.097666667,1.123459644,0.072,0.772065303,0.301798466,0.196,0.095,-0.692,-0.033,0.055,-0.207,P14246,Slc2a2,P14246_Slc2a2,P14246,Slc2a2,1,73,15,15,P14246|E9PXR7,MOUSE,57505.2,14.7,758,758.1,188.69,188.69,,523,"Solute carrier family 2, facilitated glucose transporter member 2",cytoplasm|endosome|cytosol|plasma membrane|integral component of plasma membrane|brush border|cell-cell junction|basolateral plasma membrane|brush border membrane|,carbohydrate transport|response to glucose|carbohydrate utilization|fructose transport|glucose transport|proton transport|endocrine pancreas development|response to peptide hormone|glucose import|transmembrane transport|dehydroascorbic acid transport|,insulin receptor binding|sugar:proton symporter activity|glucose transmembrane transporter activity|dehydroascorbic acid transporter activity|D-glucose transmembrane transporter activity|,15,73,56300000000,14.7%
P47962,0.681604446,0.079833333,4.840192833,-0.227666667,0.328080726,-1.055756098,-0.137,0.691,0.027,-0.135,0.067,-0.034,P47962,Rpl5,P47962_Rpl5,P47962,Rpl5,1,68,17,17,P47962,MOUSE,34628.3,48.1,759,759.1,188.42,188.42,,297,60S ribosomal protein L5,nucleus|nucleolus|cytoplasm|focal adhesion|membrane|cytosolic large ribosomal subunit|ribonucleoprotein complex|extracellular exosome|,rRNA processing|translation|ribosomal large subunit biogenesis|,structural constituent of ribosome|protein binding|5S rRNA binding|poly(A) RNA binding|,17,68,31400000000,48.1%
Q9D5T0,0.977995021,-0.008833333,0.325624784,-0.010333333,0.927764011,-0.094134308,0.11,0.085,-0.206,-0.035,0.006,-0.013,Q9D5T0,Atad1,Q9D5T0_Atad1,Q9D5T0,Atad1,1,34,12,12,Q9D5T0,MOUSE,41085.6,52.3,760,760.1,187.95,187.95,,361,ATPase family AAA domain-containing protein 1,mitochondrion|peroxisomal membrane|membrane|cell junction|postsynaptic membrane|,"positive regulation of receptor internalization|learning|memory|metabolic process|cytoplasmic microtubule organization|negative regulation of synaptic transmission, glutamatergic|",protein binding|ATP binding|microtubule-severing ATPase activity|ATPase activity|,12,34,19100000000,52.3%
P70122,0.657241764,0.008833333,5.216367087,-0.095,0.300859196,-1.121028,0.091,0.109,-0.031,-0.037,-0.008,-0.071,P70122,Sbds,P70122_Sbds,P70122,Sbds,1,41,16,16,P70122|D6REV5,MOUSE,29065.3,56.4,761,761.1,187.43,187.43,,250,Ribosome maturation protein SBDS,spindle pole|nucleus|nucleoplasm|nucleolus|cytoplasm|,inner cell mass cell proliferation|rRNA processing|cell proliferation|bone mineralization|leukocyte chemotaxis|mature ribosome assembly|mitotic spindle stabilization|bone marrow development|,RNA binding|microtubule binding|rRNA binding|ribosome binding|poly(A) RNA binding|,16,41,9950000000,56.4%
Q7TMK9-2,0.64206681,0.017666667,5.498721277,-0.113333333,0.281921289,-1.170073834,-0.028,0.196,0.055,-0.118,0.019,-0.018,Q7TMK9,Syncrip,Q7TMK9-2_Syncrip,Q7TMK9-2,Syncrip,1,30,16,10,Q7TMK9-2|A0A0R4J259|G3UZI2|Q7TMK9|G3V018|G3UZ48|G3UXJ6|G3UXU5|G3UYK7,MOUSE,62899.3,34.1,762,762.1,187.24,115.35,,623,Isoform 2 of Heterogeneous nuclear ribonucleoprotein Q,cytoplasm|membrane|ribonucleoprotein complex|CRD-mediated mRNA stability complex|catalytic step 2 spliceosome|histone pre-mRNA 3'end processing complex|GAIT complex|,osteoblast differentiation|mRNA processing|RNA splicing|negative regulation of translation|CRD-mediated mRNA stabilization|cellular response to interferon-gamma|,nucleotide binding|poly(A) binding|poly(A) RNA binding|,16,30,3470000000,34.1%
Q07076,0.919618833,0.008333333,1.182155869,-0.063333333,0.761700802,-0.316042607,-0.329,0.038,0.411,0.153,-0.215,-0.008,Q07076,Anxa7,Q07076_Anxa7,Q07076,Anxa7,1,41,16,16,A0A2C9F2D2|Q07076,MOUSE,50209.7,34.5,763,763.1,187.17,187.17,,463,Annexin A7,nucleus|nuclear envelope|endoplasmic reticulum membrane|cytosol|plasma membrane|membrane|vesicle|extracellular exosome|chromaffin granule membrane|,cellular calcium ion homeostasis|autophagy|hemostasis|cell proliferation|regulation of cell shape|response to salt stress|cellular water homeostasis|negative regulation of gene expression|response to organic cyclic compound|epithelial cell differentiation|social behavior|response to calcium ion|membrane fusion|,integrin binding|calcium ion binding|protein binding|calcium-dependent phospholipid binding|poly(A) RNA binding|calcium-dependent protein binding|,16,41,7570000000,34.5%
Q99MR6,0.982507762,0.008833333,0.27585315,-0.007666667,0.938457663,-0.080153386,-0.035,-0.041,0.114,0.078,-0.102,0.039,Q99MR6,Srrt,Q99MR6_Srrt,Q99MR6,Srrt,1,28,17,17,Q99MR6|Q99MR6-2|Q99MR6-4|Q99MR6-3|A0A0G2JDN3,MOUSE,100906.9,21.8,764,764.1,187.05,187.05,,875,Serrate RNA effector molecule homolog,nucleus|nucleoplasm|cytoplasm|,"transcription, DNA-templated|regulation of transcription, DNA-templated|cell proliferation|primary miRNA processing|positive regulation of neurogenesis|neuronal stem cell maintenance|",DNA binding|protein binding|poly(A) RNA binding|,17,28,4800000000,21.8%
P16015,0.351106168,0.093166667,11.45440742,0.557666667,0.0715417,2.143245929,-0.046,-0.187,-0.324,0.133,0.987,-0.004,P16015,Car3,P16015_Car3,P16015,Ca3,1,31,14,14,P16015,MOUSE,29651,63.4,765,765.1,186.87,186.87,,260,Carbonic anhydrase 3,cytosol|,one-carbon metabolic process|response to oxidative stress|dephosphorylation|response to ethanol|,carbonate dehydratase activity|zinc ion binding|nickel cation binding|phosphatase activity|,14,31,29200000000,63.4%
Q8BFZ9,0.000169989,-0.181,59.0642092,1.665333333,1.24045E-06,16.27196136,-0.961,-0.939,-1.141,0.616,0.569,0.77,Q8BFZ9,Erlin2,Q8BFZ9_Erlin2,Q8BFZ9,Erlin2,1,44,13,10,Q8BFZ9,MOUSE,38100.1,38.2,766,766.1,186.5,140.37,,340,Erlin-2,cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|plasma membrane|integral component of membrane|protein complex|membrane raft|extracellular exosome|,cholesterol metabolic process|ER-associated ubiquitin-dependent protein catabolic process|SREBP signaling pathway|negative regulation of cholesterol biosynthetic process|negative regulation of fatty acid biosynthetic process|,protein binding|ubiquitin protein ligase binding|,13,44,17100000000,38.2%
Q91X78,0.003208146,-0.170166667,37.95141647,1.221666667,0.000160272,7.653908302,-0.782,-0.485,-1.076,0.402,0.362,0.558,Q91X78,Erlin1,Q91X78_Erlin1,Q91X78,Erlin1,1,13,11,8,A0A0R4J1G5|Q91X78,MOUSE,39107.1,37.8,766,766.2,139.16,93.03,,346,Erlin-1,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|protein complex|,cholesterol metabolic process|ER-associated ubiquitin-dependent protein catabolic process|SREBP signaling pathway|negative regulation of cholesterol biosynthetic process|negative regulation of fatty acid biosynthetic process|,cholesterol binding|,8,13,4450000000,28.9%
Q9CXI0,0.885307507,-0.028,1.825599733,0.062666667,0.656810409,0.465041022,0.104,0.052,-0.334,0.051,0.032,-0.073,Q9CXI0,Coq5,Q9CXI0_Coq5,Q9CXI0,Coq5,1,25,12,12,Q9CXI0,MOUSE,37734.3,54.1,767,767.1,186.24,186.24,,327,"2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial",mitochondrion|mitochondrial inner membrane|,ubiquinone biosynthetic process|methylation|,S-adenosylmethionine-dependent methyltransferase activity|,12,25,25500000000,54.1%
P10649,0.744748173,0.084833333,3.91119026,0.296333333,0.406331952,0.886636353,-0.408,0.075,0.143,-0.256,0.984,-0.029,P10649,Gstm1,P10649_Gstm1,P10649,Gstm1,1,32,13,10,A2AE89|P10649|Q8R5I6|A2AE91|F6Y363|P48774|E9PV63|A0A087WNU8,MOUSE,26083.6,43.5,768,768.1,186.18,140.13,,218,Glutathione S-transferase Mu 1,cytoplasm|myelin sheath|,glutathione metabolic process|cellular response to drug|,glutathione transferase activity|protein binding|protein homodimerization activity|protein heterodimerization activity|,14,32,13400000000,43.5%
P50171-2,0.662925276,-0.008333333,5.133624267,-0.169333333,0.30664619,-1.107611313,0.177,0.301,-0.249,-0.037,-0.076,-0.166,P50171,H2-Ke6,P50171-2_H2-Ke6,P50171-2,Hsd17b8,1,41,11,11,P50171-2|P50171|G3UX44,MOUSE,28567,59.8,769,769.1,186.12,186.12,,259,Isoform Long of Estradiol 17-beta-dehydrogenase 8,mitochondrion|mitochondrial envelope|mitochondrial matrix|plasma membrane|membrane|,fatty acid biosynthetic process|estrogen biosynthetic process|androgen metabolic process|estrogen metabolic process|oxidation-reduction process|,3-hydroxyacyl-CoA dehydrogenase activity|estradiol 17-beta-dehydrogenase activity|testosterone dehydrogenase (NAD+) activity|,11,41,16900000000,59.8%
Q9DCD0,0.544296199,0.003333333,7.389761939,0.193333333,0.182399568,1.489427996,-0.247,-0.097,0.064,-0.032,0.3,0.032,Q9DCD0,Pgd,Q9DCD0_Pgd,Q9DCD0,Pgd,1,25,15,14,Q9DCD0,MOUSE,53759.7,33.9,770,770.1,185.79,171.84,,483,"6-phosphogluconate dehydrogenase, decarboxylating",nucleus|cytoplasm|extracellular exosome|,"pentose-phosphate shunt|pentose-phosphate shunt, oxidative branch|pentose biosynthetic process|D-gluconate metabolic process|oxidation-reduction process|",phosphogluconate dehydrogenase (decarboxylating) activity|NADP binding|,15,25,4370000000,33.9%
Q9DAW9,0.737344112,-0.044,3.979426602,0.18,0.399997558,0.899351042,-0.053,0.169,-0.518,-0.144,0.284,-0.002,Q9DAW9,Cnn3,Q9DAW9_Cnn3,Q9DAW9,Cnn3,1,41,13,12,Q9DAW9|A0A0G2JDV8,MOUSE,36599.2,51.5,771,771.1,185.57,168.68,,330,Calponin-3,cytoplasm|focal adhesion|postsynaptic density|actin cytoskeleton|neuronal cell body|dendritic spine|,epithelial cell differentiation|actomyosin structure organization|negative regulation of ATPase activity|,actin binding|protein binding|calmodulin binding|microtubule binding|,13,41,4420000000,51.5%
Q08093,0.348915423,0.003666667,11.48757649,0.2,0.070997385,2.143904909,-0.157,-0.139,0.007,0.088,0.033,0.19,Q08093,Cnn2,Q08093_Cnn2,Q08093,Cnn2,1,3,4,3,Q08093|D3Z7R6,MOUSE,33611.4,16.7,771,771.2,35.8,18.91,,305,Calponin-2,stress fiber|focal adhesion|membrane|extracellular exosome|,positive regulation of gene expression|hemopoiesis|negative regulation of cell migration|actomyosin structure organization|regulation of actin filament-based process|wound healing|regulation of cell proliferation|negative regulation of phagocytosis|cellular response to mechanical stimulus|,actin binding|calmodulin binding|,3,3,427000000,13.1%
Q9Z1Q5,0.365990558,-0.015,11.13864123,-0.340666667,0.076937111,-2.092843467,0.03,0.036,0.4,-0.463,-0.027,-0.066,Q9Z1Q5,Clic1,Q9Z1Q5_Clic1,Q9Z1Q5,Clic1,1,37,13,13,Q9Z1Q5,MOUSE,27354.6,63.9,772,772.1,185.39,185.39,,241,Chloride intracellular channel protein 1,extracellular space|nucleus|nuclear envelope|cytoplasm|mitochondrion|plasma membrane|membrane|nuclear membrane|vesicle|chloride channel complex|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|,chloride transport|regulation of ion transmembrane transport|positive regulation of osteoblast differentiation|regulation of cell cycle|regulation of mitochondrial membrane potential|platelet aggregation|chloride transmembrane transport|,chloride channel activity|,13,37,11200000000,63.9%
Q8C5H8,0.973888257,-0.002666667,0.381322654,-0.008666667,0.915941495,-0.109595638,0.028,0.019,-0.042,-0.025,0.023,-0.019,Q8C5H8,Nadk2,Q8C5H8_Nadk2,Q8C5H8,Nadk2,1,37,16,16,Q8C5H8|Q8C5H8-3|Q8C5H8-4|Z4YK42|Q8C5H8-2,MOUSE,51371.1,39.3,773,773.1,185.03,185.03,,452,"NAD kinase 2, mitochondrial",mitochondrion|,NADP biosynthetic process|phosphorylation|NAD metabolic process|,NAD+ kinase activity|ATP binding|protein homodimerization activity|,16,37,5550000000,39.3%
P97364,0.929192436,-0.015666667,1.012736258,-0.028,0.792002175,-0.274463156,0.03,0.129,-0.164,-0.054,0.001,-0.036,P97364,Sephs2,P97364_Sephs2,P97364,Sephs2,1,49,14,14,P97364,MOUSE,48218.5,56.8,774,774.1,184.72,184.72,,452,"Selenide, water dikinase 2",,selenium compound metabolic process|selenocysteine biosynthetic process|phosphorylation|,"selenide, water dikinase activity|ATP binding|",14,49,18100000000,56.8%
Q8VEH8,0.001091865,-0.140333333,44.13276141,1.514,3.86121E-05,9.652809206,-0.746,-0.757,-1.189,0.422,0.676,0.752,Q8VEH8,Erlec1,Q8VEH8_Erlec1,Q8VEH8,Erlec1,1,35,13,13,Q8VEH8,MOUSE,55704,39.7,775,775.1,184.71,184.71,,483,Endoplasmic reticulum lectin 1,endoplasmic reticulum lumen|,"ER-associated ubiquitin-dependent protein catabolic process|negative regulation of retrograde protein transport, ER to cytosol|",glycoprotein binding|,13,35,7050000000,39.7%
P47199,0.632582508,-0.010166667,5.759594584,-0.123666667,0.265485338,-1.214938752,-0.013,0.155,0.013,-0.204,0.033,-0.045,P47199,Cryz,P47199_Cryz,P47199,Cryz,1,31,12,12,P47199|V9GXY8|A0A0G2JFU5,MOUSE,35553.2,52.2,776,776.1,183.71,183.71,,331,Quinone oxidoreductase,cytoplasm|Golgi apparatus|cytosol|intracellular membrane-bounded organelle|extracellular exosome|,xenobiotic catabolic process|protein homotetramerization|oxidation-reduction process|,mRNA 3'-UTR binding|NADPH:quinone reductase activity|zinc ion binding|NADP binding|NADPH binding|NADH binding|,12,31,12800000000,52.2%
Q8R4N0,0.71078078,0.023833333,4.371546776,-0.171,0.365464605,-0.971467298,0.08,0.433,-0.185,-0.188,0.133,-0.13,Q8R4N0,Clybl,Q8R4N0_Clybl,Q8R4N0,Clybl,1,28,13,13,Q8R4N0,MOUSE,37890.2,51.7,777,777.1,183.54,183.54,,338,"Citramalyl-CoA lyase, mitochondrial",mitochondrion|,metabolic process|,magnesium ion binding|malate synthase activity|,13,28,4030000000,51.7%
P43883,0.669575465,0.052333333,5.009655947,-0.269333333,0.315525458,-1.08578376,0.726,0.134,-0.299,-0.011,-0.21,-0.026,P43883,Plin2,P43883_Plin2,P43883,Plin2,1,44,13,13,P43883,MOUSE,46930.5,44.4,778,778.1,183.49,183.49,,425,Perilipin-2,nucleus|cytoplasm|lipid particle|cytosol|plasma membrane|,response to organic cyclic compound|long-chain fatty acid transport|lipid storage|response to drug|,protein binding|,13,44,12200000000,44.4%
P62245,0.328224622,0.0105,12.03774891,-0.213,0.062549682,-2.231374523,0.145,0.193,0.013,-0.044,-0.046,-0.198,P62245,Rps15a,P62245_Rps15a,P62245,Rps15a,1,56,14,14,P62245,MOUSE,14953.4,83,779,779.1,182.97,182.97,,130,40S ribosomal protein S15a,membrane|cytosolic small ribosomal subunit|extracellular exosome|,translation|positive regulation of cell proliferation|response to virus|positive regulation of cell cycle|,structural constituent of ribosome|poly(A) RNA binding|,14,56,79200000000,83.0%
P35486,0.961523652,0.008666667,0.53208029,-0.018,0.884691737,-0.150712379,-0.031,0.055,0.029,-0.176,0.219,-0.044,P35486,Pdha1,P35486_Pdha1,P35486,Pdha1,1,30,15,15,P35486,MOUSE,43915.5,51,780,780.1,182.49,182.49,,390,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial",nucleus|mitochondrion|mitochondrial matrix|myelin sheath|pyruvate dehydrogenase complex|,glucose metabolic process|acetyl-CoA biosynthetic process from pyruvate|glycolytic process|tricarboxylic acid cycle|,pyruvate dehydrogenase activity|pyruvate dehydrogenase (acetyl-transferring) activity|,15,30,2790000000,51.0%
Q9DCL9,0.785249508,-0.024666667,3.327395107,0.132,0.464793975,0.775585385,-0.042,0.165,-0.395,-0.128,0.243,0.009,Q9DCL9,Paics,Q9DCL9_Paics,Q9DCL9,Paics,1,30,13,13,Q9DCL9|D6RCU8,MOUSE,47746.9,35.5,781,781.1,181.89,181.89,,425,Multifunctional protein ADE2,membrane|extracellular exosome|,'de novo' IMP biosynthetic process|,phosphoribosylaminoimidazole carboxylase activity|phosphoribosylaminoimidazolesuccinocarboxamide synthase activity|ATP binding|identical protein binding|,13,30,6740000000,35.5%
Q6XPS7,0.496866931,0.029833333,8.261919516,-0.189666667,0.149213476,-1.631256833,0.054,0.038,0.282,0.096,-0.121,-0.17,Q6XPS7,Tha1,Q6XPS7_Tha1,Q6XPS7,Tha1,1,36,13,13,Q6XPS7,MOUSE,44008.7,44.2,782,782.1,181.88,181.88,,400,L-threonine aldolase,cytosol|,glycine biosynthetic process|threonine catabolic process|,L-allo-threonine aldolase activity|,13,36,7320000000,44.2%
Q9CQA3,0.93595046,0.008166667,0.903234752,0.051666667,0.812225322,0.247225323,0.007,0.349,-0.409,-0.084,0.277,-0.091,Q9CQA3,Sdhb,Q9CQA3_Sdhb,Q9CQA3,Sdhb,1,61,12,12,Q9CQA3,MOUSE,32612.1,46.4,783,783.1,181.62,181.62,,282,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial","mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)|respiratory chain complex II|extracellular exosome|",tricarboxylic acid cycle|succinate metabolic process|respiratory electron transport chain|,"succinate dehydrogenase (ubiquinone) activity|electron carrier activity|metal ion binding|ubiquinone binding|2 iron, 2 sulfur cluster binding|3 iron, 4 sulfur cluster binding|4 iron, 4 sulfur cluster binding|",12,61,12100000000,46.4%
Q925N0,0.924103984,-0.044333333,1.126080097,0.04,0.771599594,0.302436987,0.06,0.072,-0.325,-0.036,0.067,-0.104,Q925N0,Sfxn5,Q925N0_Sfxn5,Q925N0,Sfxn5,1,37,13,13,Q925N0|Q8BRQ9|D3YXH5,MOUSE,37499,47.3,784,784.1,181.61,181.61,,342,Sideroflexin-5,mitochondrion|mitochondrial inner membrane|integral component of membrane|,citrate transport|ion transmembrane transport|iron ion homeostasis|,citrate transmembrane transporter activity|,13,37,9990000000,47.3%
Q9DC23,0.000440715,-0.123833333,50.75149165,1.192333333,8.41106E-06,12.12072037,-0.815,-0.622,-0.723,0.386,0.449,0.582,Q9DC23,Dnajc10,Q9DC23_Dnajc10,Q9DC23,Dnajc10,1,25,15,15,Q9DC23,MOUSE,91950.7,21.4,785,785.1,180.81,180.81,,793,DnaJ homolog subfamily C member 10,endoplasmic reticulum|endoplasmic reticulum lumen|membrane|endoplasmic reticulum chaperone complex|,negative regulation of protein phosphorylation|ER-associated ubiquitin-dependent protein catabolic process|positive regulation of ATPase activity|protein folding in endoplasmic reticulum|response to endoplasmic reticulum stress|cell redox homeostasis|oxidation-reduction process|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress|,"ATPase activator activity|protein binding|protein disulfide oxidoreductase activity|disulfide oxidoreductase activity|oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor|Hsp70 protein binding|chaperone binding|ATPase binding|misfolded protein binding|",15,25,1450000000,21.4%
Q810J8,0.904214516,0.000666667,1.561241085,-0.037333333,0.698032899,-0.405097027,0.07,0.064,-0.076,0.075,-0.073,-0.056,Q810J8,Zfyve1,Q810J8_Zfyve1,Q810J8,Zfyve1,1,32,14,14,Q810J8,MOUSE,89335.1,21.8,786,786.1,180.74,180.74,,777,Zinc finger FYVE domain-containing protein 1,pre-autophagosomal structure|autophagosome|endoplasmic reticulum|Golgi stack|ER-mitochondrion membrane contact site|perinuclear region of cytoplasm|extrinsic component of omegasome membrane|,negative regulation of phosphatase activity|,"1-phosphatidylinositol binding|phosphatidylinositol-3,4,5-trisphosphate binding|phosphatidylinositol-3,4-bisphosphate binding|metal ion binding|",14,32,2680000000,21.8%
Q9CXA2,0.944159632,0.002333333,0.810873267,0.018666667,0.82968392,0.22366923,0.029,-0.091,0.041,0.012,0.031,-0.008,Q9CXA2,L3hypdh,Q9CXA2_L3hypdh,Q9CXA2,L3hypdh,1,38,12,12,Q9CXA2,MOUSE,38374,44.9,787,787.1,180.72,180.72,,354,Trans-L-3-hydroxyproline dehydratase,,metabolic process|,hydro-lyase activity|trans-L-3-hydroxyproline dehydratase activity|proline racemase activity|,12,38,7500000000,44.9%
P19157,0.898147912,0.013166667,1.623053107,0.053,0.688168341,0.419441977,-0.117,0.081,-0.004,-0.136,0.261,-0.006,P19157,Gstp1,P19157_Gstp1,P19157,Gstp1,1,46,11,11,P19157|P46425|Q8VC73|F6RWR5,MOUSE,23779.9,57.6,788,788.1,180.65,180.65,,210,Glutathione S-transferase P 1,extracellular space|intracellular|nucleus|cytoplasm|mitochondrion|cytosol|plasma membrane|vesicle|protein complex|extracellular exosome|TRAF2-GSTP1 complex|,response to reactive oxygen species|negative regulation of acute inflammatory response|glutathione metabolic process|xenobiotic metabolic process|response to toxic substance|negative regulation of biosynthetic process|oligodendrocyte development|organ regeneration|response to nutrient levels|response to estradiol|negative regulation of interleukin-1 beta production|negative regulation of tumor necrosis factor production|cellular response to insulin stimulus|regulation of stress-activated MAPK cascade|negative regulation of stress-activated MAPK cascade|positive regulation of superoxide anion generation|response to L-ascorbic acid|common myeloid progenitor cell proliferation|negative regulation of apoptotic process|negative regulation of I-kappaB kinase/NF-kappaB signaling|response to amino acid|negative regulation of MAP kinase activity|negative regulation of JUN kinase activity|response to ethanol|negative regulation of fibroblast proliferation|negative regulation of nitric-oxide synthase biosynthetic process|regulation of ERK1 and ERK2 cascade|negative regulation of ERK1 and ERK2 cascade|negative regulation of leukocyte proliferation|cellular response to lipopolysaccharide|cellular response to epidermal growth factor stimulus|cellular response to glucocorticoid stimulus|cellular response to cell-matrix adhesion|negative regulation of monocyte chemotactic protein-1 production|negative regulation of neutrophil aggregation|negative regulation of peroxidase activity|negative regulation of extrinsic apoptotic signaling pathway|,glutathione transferase activity|protein binding|drug binding|JUN kinase binding|kinase regulator activity|S-nitrosoglutathione binding|dinitrosyl-iron complex binding|,11,46,30900000000,57.6%
Q9CQM8,0.753743834,-0.016333333,3.790249501,-0.084,0.417806363,-0.863316322,-0.011,0.115,-0.027,0.004,0.007,-0.186,Q9CQM8,Rpl21,Q9CQM8_Rpl21,Q9CQM8,Rpl21,1,71,17,17,Q9CQM8|O09167,MOUSE,18635.6,61.8,789,789.1,180.45,180.45,,160,60S ribosomal protein L21,nucleolus|cytoplasm|membrane|cytosolic large ribosomal subunit|,translation|,structural constituent of ribosome|poly(A) RNA binding|,17,71,79100000000,61.8%
P68254,0.808688512,0.0065,2.974859899,-0.069,0.504096881,-0.705832966,-0.05,0.168,0.005,-0.102,0.051,-0.033,P68254,Ywhaq,P68254_Ywhaq,P68254,Ywhaq,1,36,13,8,P68254|P68254-2|O70456,MOUSE,28063.1,60,790,790.1,180.44,126.59,,245,14-3-3 protein theta,cytoplasm|cytosol|focal adhesion|membrane|cytoplasmic vesicle membrane|protein complex|extracellular exosome|,"protein targeting|signal transduction|small GTPase mediated signal transduction|substantia nigra development|negative regulation of ion transmembrane transport|negative regulation of transcription, DNA-templated|",protein binding|protein C-terminus binding|protein domain specific binding|ion channel binding|protein N-terminus binding|14-3-3 protein binding|,13,36,11600000000,60.0%
P61982,0.332103046,-0.038,11.91064916,0.398,0.064407299,2.216139727,-0.031,-0.074,-0.606,0.168,0.328,-0.013,P61982,Ywhag,P61982_Ywhag,P61982,Ywhag,1,7,10,5,P61982,MOUSE,28473.3,46.1,790,790.2,120.6,69.62,,247,14-3-3 protein gamma,cytosol|focal adhesion|membrane|cytoplasmic vesicle membrane|myelin sheath|extracellular exosome|,protein targeting|regulation of neuron differentiation|regulation of synaptic plasticity|,actin binding|protein kinase C binding|insulin-like growth factor receptor binding|protein binding|protein domain specific binding|poly(A) RNA binding|,5,7,1030000000,32.7%
Q9CQV8,0.884566234,0.044333333,1.843048457,-0.101333333,0.654176825,-0.468918748,-0.153,0.607,-0.169,0.009,-0.095,0.067,Q9CQV8,Ywhab,Q9CQV8_Ywhab,Q9CQV8,Ywhab,1,11,9,4,Q9CQV8|Q9CQV8-2,MOUSE,28200,39.8,790,790.3,107.22,53.37,,246,14-3-3 protein beta/alpha,nucleus|cytoplasm|cytosol|focal adhesion|membrane|transcriptional repressor complex|cytoplasmic vesicle membrane|melanosome|perinuclear region of cytoplasm|extracellular exosome|,"protein targeting|negative regulation of protein dephosphorylation|positive regulation of catalytic activity|negative regulation of transcription, DNA-templated|cytoplasmic sequestering of protein|protein heterooligomerization|",transcription corepressor activity|protein binding|protein C-terminus binding|enzyme binding|protein domain specific binding|protein complex binding|histone deacetylase binding|phosphoserine binding|phosphoprotein binding|,4,11,866000000,22.7%
P63101,0.663391411,0.000833333,5.119433667,0.100333333,0.307649797,1.104062193,-0.128,0.01,-0.03,0.141,0.039,-0.027,P63101,Ywhaz,P63101_Ywhaz,P63101,Ywhaz,1,10,9,5,P63101,MOUSE,27941.8,37.5,790,790.4,104.08,55.36,,245,14-3-3 protein zeta/delta,extracellular space|nucleus|mitochondrion|cytosol|focal adhesion|cytoplasmic vesicle membrane|melanosome|extracellular exosome|blood microparticle|,protein targeting|regulation of cell death|establishment of Golgi localization|Golgi reassembly|,protein binding|transcription factor binding|protein kinase binding|protein domain specific binding|ubiquitin protein ligase binding|identical protein binding|poly(A) RNA binding|,5,10,1110000000,23.6%
P62259,0.363205691,-0.028,11.19506905,0.231333333,0.075943935,2.098471831,-0.281,0.017,-0.167,-0.018,0.112,0.169,P62259,Ywhae,P62259_Ywhae,P62259,Ywhae,1,7,7,4,P62259|D6REF3,MOUSE,29344.6,25.4,790,790.5,72.09,33.22,,255,14-3-3 protein epsilon,mitochondrion|cytosol|kinesin complex|focal adhesion|membrane|axon|cytoplasmic vesicle membrane|melanosome|extracellular exosome|,neuron migration|protein targeting|substantia nigra development|hippocampus development|cerebral cortex development|negative regulation of protein dephosphorylation|regulation of membrane repolarization|regulation of potassium ion transmembrane transporter activity|negative regulation of peptidyl-serine dephosphorylation|,protein binding|potassium channel regulator activity|enzyme binding|protein domain specific binding|MHC class II protein complex binding|ubiquitin protein ligase binding|histone deacetylase binding|ion channel binding|poly(A) RNA binding|protein heterodimerization activity|phosphoserine binding|phosphoprotein binding|,4,7,886000000,15.6%
P41241,0.470874264,0.058333333,8.837145767,-0.202,0.13070296,-1.724113744,-0.048,0.18,0.346,-0.042,-0.067,-0.019,P41241,Csk,P41241_Csk,P41241,Csk,1,27,15,15,P41241,MOUSE,51286,38.2,791,791.1,180.43,180.43,,450,Tyrosine-protein kinase CSK,cytoplasm|plasma membrane|cell-cell junction|extrinsic component of cytoplasmic side of plasma membrane|membrane raft|extracellular exosome|,regulation of cytokine production|morphogenesis of an epithelium|protein phosphorylation|transmembrane receptor protein tyrosine kinase signaling pathway|brain development|negative regulation of cell proliferation|negative regulation of low-density lipoprotein particle clearance|cell migration|cell differentiation|negative regulation of interleukin-6 production|negative regulation of kinase activity|adherens junction organization|intracellular signal transduction|peptidyl-tyrosine autophosphorylation|negative regulation of Golgi to plasma membrane protein transport|positive regulation of MAP kinase activity|innate immune response|negative regulation of bone resorption|oligodendrocyte differentiation|negative regulation of phagocytosis|regulation of T cell activation|regulation of Fc receptor mediated stimulatory signaling pathway|negative regulation of ERK1 and ERK2 cascade|cellular response to peptide hormone stimulus|,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|receptor binding|protein binding|ATP binding|transferase activity|protein phosphatase binding|identical protein binding|proline-rich region binding|,15,27,4020000000,38.2%
P28653,0.586445778,-0.034166667,6.58348833,0.129666667,0.219609522,1.354120932,-0.102,0.03,-0.225,0.012,0.024,0.056,P28653,Bgn,P28653_Bgn,P28653,Bgn,1,35,12,12,P28653,MOUSE,42094.9,40.1,792,792.1,180.08,180.08,,369,Biglycan,proteinaceous extracellular matrix|intracellular|cell surface|transport vesicle|sarcolemma|extracellular exosome|extracellular matrix|,blood vessel remodeling|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|,glycosaminoglycan binding|extracellular matrix binding|,12,35,5830000000,40.1%
Q8C6B0,0.91325,-0.007666667,1.375513655,-0.078,0.728532003,-0.362138325,0.264,0.304,-0.474,-0.082,0.066,-0.124,Q8C6B0,Mettl7a1,Q8C6B0_Mettl7a1,Q8C6B0,Mettl7a1,1,62,11,11,Q8C6B0|Q76I26|Q76I24|Q5I0W6|H3BJI7|G3X9G9,MOUSE,28665.9,51.2,793,793.1,179.99,179.99,,244,"MCG20149, isoform CRA_a",extracellular exosome|,methylation|,S-adenosylmethionine-dependent methyltransferase activity|,11,62,2.87E+11,51.2%
Q5XG73-3,0.204708202,-0.029,15.76038604,0.432666667,0.026543696,2.840940404,-0.173,-0.047,-0.516,0.026,0.177,0.359,Q5XG73,Acbd5,Q5XG73-3_Acbd5,Q5XG73-3,Acbd5,1,31,14,14,Q5XG73-3|Q5XG73-2|E9QNH7|Q5XG73,MOUSE,52696.2,35.5,794,794.1,179.94,179.94,,508,Isoform 3 of Acyl-CoA-binding domain-containing protein 5,nucleus|nucleoplasm|peroxisome|peroxisomal membrane|membrane|integral component of membrane|intracellular membrane-bounded organelle|,transport|peroxisome degradation|,fatty-acyl-CoA binding|lipid binding|,14,31,20700000000,35.5%
Q9DCH4,0.639638704,-0.027166667,5.554976715,-0.211,0.278293029,-1.180993601,-0.224,0.319,0.14,-0.391,-0.062,0.055,Q9DCH4,Eif3f,Q9DCH4_Eif3f,Q9DCH4,Eif3f,1,33,12,12,Q9DCH4,MOUSE,38097.7,44,795,795.1,179.91,179.91,,361,Eukaryotic translation initiation factor 3 subunit F,"eukaryotic translation initiation factor 3 complex|membrane|eukaryotic 43S preinitiation complex|eukaryotic 48S preinitiation complex|eukaryotic translation initiation factor 3 complex, eIF3m|",formation of translation preinitiation complex|translational initiation|regulation of translational initiation|protein deubiquitination|,ubiquitin-specific protease activity|protein binding|translation initiation factor binding|translation initiation factor activity|,12,33,18000000000,44.0%
Q61081,0.875541631,-0.0075,2.021481169,0.046333333,0.627844195,0.507861578,0.023,0.015,-0.13,0.098,-0.02,-0.031,Q61081,Cdc37,Q61081_Cdc37,Q61081,Cdc37,1,38,14,14,Q61081,MOUSE,45106.1,38.7,796,796.1,179.49,179.49,,379,Hsp90 co-chaperone Cdc37,cytoplasm|cytosol|ruffle membrane|extracellular exosome|HSP90-CDC37 chaperone complex|,protein folding|posttranscriptional regulation of gene expression|regulation of protein kinase activity|protein stabilization|regulation of cell cycle|regulation of interferon-gamma-mediated signaling pathway|regulation of type I interferon-mediated signaling pathway|activation of mitophagy in response to mitochondrial depolarization|,protein C-terminus binding|kinase binding|heat shock protein binding|mitogen-activated protein kinase kinase kinase binding|protein kinase B binding|unfolded protein binding|chaperone binding|Hsp90 protein binding|protein kinase regulator activity|,14,38,18300000000,38.7%
D3YU17,0.886708184,0.0115,1.796435511,-0.047666667,0.661235937,-0.458337047,0.136,0.104,-0.134,0.054,-0.05,-0.041,D3YU17,Ncln,D3YU17_Ncln,D3YU17,Ncln,1,44,12,1,D3YU17,MOUSE,63007.1,24.5,797,797.1,179.37,22.89,,562,Nicalin,endoplasmic reticulum membrane|membrane|,regulation of signal transduction|protein destabilization|regulation of protein complex assembly|,,12,44,12600000000,24.5%
Q8VCM8,0.943116533,0.008833333,0.821225829,-0.021,0.827708504,-0.226314432,0.013,0.038,0.007,0.133,-0.079,-0.059,Q8VCM8,Ncln,Q8VCM8_Ncln,Q8VCM8,Ncln,1,6,12,2,Q8VCM8,MOUSE,63135.2,24.6,797,797.2,173.37,30.56,,563,Nicalin,endoplasmic reticulum membrane|membrane|integral component of membrane|,regulation of signal transduction|protein destabilization|regulation of protein complex assembly|,,2,6,1410000000,8.1%
P01901,0.286140671,-0.0035,13.24384219,0.193666667,0.047382261,2.423884679,-0.114,-0.117,-0.07,0.13,0.042,0.108,P01901,H2-K1,P01901_H2-K1,P01901,H2-K1,1,39,13,9,P01901|Q3TH01|P04223|P04223-2|P03991|P14426|A0A0B4J1G3,MOUSE,41700.5,43,798,798.1,179.29,127.56,,369,"H-2 class I histocompatibility antigen, K-B alpha chain",endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|external side of plasma membrane|cell surface|membrane|phagocytic vesicle membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|integral component of lumenal side of endoplasmic reticulum membrane|,"positive regulation of T cell mediated cytotoxicity|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent|immune response|antigen processing and presentation of exogenous peptide antigen via MHC class I|defense response to bacterium|inner ear development|",receptor binding|protein binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,13,39,27500000000,43.0%
P01899,0.713417662,-0.0255,4.326167562,0.120333333,0.369303347,0.963200139,-0.167,-0.251,0.161,0.048,-0.011,0.067,P01899,H2-D1,P01899_H2-D1,P01899,H2-D1,1,18,13,7,P01899|P01897|Q8HWB2|G3UXE9|E9Q0G4|A7VMS6|O19441|E9PX63|P14427|V9GXR0|V9GXI4|Q05A75|G3UZL7,MOUSE,41120.7,43.9,798,798.2,176.44,81.86,,362,"H-2 class I histocompatibility antigen, D-B alpha chain",endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|plasma membrane|external side of plasma membrane|cell surface|membrane|phagocytic vesicle membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|integral component of lumenal side of endoplasmic reticulum membrane|,"positive regulation of T cell mediated cytotoxicity|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent|immune response|",receptor binding|protein binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,7,18,2260000000,27.3%
P06339,0.291379851,-0.025166667,13.07759814,0.279666667,0.049231173,2.402121446,0.016,-0.276,-0.235,0.228,-0.007,0.123,P06339,H2-T23,P06339_H2-T23,P06339,H2-T23,1,4,5,2,P06339,MOUSE,41216.8,17,798,798.5,66.01,33.16,,357,"H-2 class I histocompatibility antigen, D-37 alpha chain",plasma membrane|cell surface|phagocytic vesicle membrane|MHC class Ib protein complex|MHC class I protein complex|extracellular exosome|integral component of lumenal side of endoplasmic reticulum membrane|,"positive regulation of T cell mediated cytotoxicity|adaptive immune response|antigen processing and presentation of peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen via MHC class Ib|antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent|regulation of natural killer cell mediated immunity|positive regulation of natural killer cell mediated immunity|antibacterial humoral response|positive regulation of interleukin-13 production|positive regulation of interleukin-4 production|positive regulation of TRAIL production|positive regulation of tumor necrosis factor production|CD8-positive, alpha-beta T cell activation|protection from natural killer cell mediated cytotoxicity|inner ear development|defense response to Gram-positive bacterium|positive regulation of immunoglobulin secretion|positive regulation of CD8-positive, alpha-beta T cell proliferation|",receptor binding|beta-2-microglobulin binding|MHC class I protein binding|peptide antigen binding|natural killer cell lectin-like receptor binding|,2,4,29100000,7.2%
P39447,0.744748173,0.009333333,3.903373444,0.087333333,0.407063962,0.884495543,-0.129,0.056,-0.03,-0.025,0.011,0.173,P39447,Tjp1,P39447_Tjp1,P39447,Tjp1,1,23,17,17,P39447|B9EHJ3|A0A0U1RPW2,MOUSE,195137.3,12,799,799.1,179.05,179.05,,1745,Tight junction protein ZO-1,nucleus|cytoplasm|plasma membrane|cell-cell junction|adherens junction|cell-cell adherens junction|gap junction|bicellular tight junction|cell surface|intercalated disc|membrane|basolateral plasma membrane|apical plasma membrane|apicolateral plasma membrane|cell junction|I band|apical junction complex|apical part of cell|intercellular canaliculus|,blastocyst formation|sensory perception of sound|establishment of endothelial intestinal barrier|,protein binding|calmodulin binding|protein domain specific binding|,17,23,1260000000,12.0%
P70372,0.472645993,0.02,8.738715746,-0.155333333,0.133699082,-1.706067022,0.077,0.215,0.001,-0.053,-0.084,-0.036,P70372,Elavl1,P70372_Elavl1,P70372,Elavl1,1,48,14,14,P70372,MOUSE,36339.5,48.1,800,800.1,178.97,178.97,,326,ELAV-like protein 1,nucleus|cytoplasm|membrane|,positive regulation of translation|mRNA stabilization|3'-UTR-mediated mRNA stabilization|regulation of stem cell maintenance|,nucleotide binding|RNA binding|double-stranded RNA binding|mRNA 3'-UTR binding|protein binding|AU-rich element binding|protein kinase binding|mRNA 3'-UTR AU-rich region binding|poly(A) RNA binding|,14,48,33800000000,48.1%
Q5FWK3,0.615860336,0.0105,6.024657405,-0.109666667,0.249766541,-1.260094717,0.019,0.01,0.167,-0.02,-0.08,-0.033,Q5FWK3,Arhgap1,Q5FWK3_Arhgap1,Q5FWK3,Arhgap1,1,31,15,15,Q5FWK3|A2AH25,MOUSE,50523.8,43,801,801.1,178.86,178.86,,439,Rho GTPase-activating protein 1,ruffle|cytoplasm|plasma membrane|cell leading edge|extracellular exosome|,small GTPase mediated signal transduction|regulation of GTPase activity|positive regulation of GTPase activity|,GTPase activator activity|protein binding|SH3 domain binding|,15,31,30000000000,43.0%
Q8R307,0.956068722,0.003,0.65393733,-0.018666667,0.860213526,-0.183001698,0.057,0.006,-0.026,0.157,-0.123,-0.053,Q8R307,Vps18,Q8R307_Vps18,Q8R307,Vps18,1,22,15,15,Q8R307,MOUSE,111643,22.4,802,802.1,178.79,178.79,,973,Vacuolar protein sorting-associated protein 18 homolog,lysosome|lysosomal membrane|early endosome|late endosome|actin filament|HOPS complex|late endosome membrane|,intracellular protein transport|vesicle docking involved in exocytosis|endosome organization|lysosome organization|regulation of SNARE complex assembly|viral entry into host cell|,"actin binding|protein binding|syntaxin binding|protein binding, bridging|metal ion binding|",15,22,789000000,22.4%
Q8BFY9-2,0.634404848,-0.035666667,5.699907015,0.205333333,0.269159243,1.20596868,0.108,-0.079,-0.444,0.259,0.066,-0.124,Q8BFY9,Tnpo1,Q8BFY9-2_Tnpo1,Q8BFY9-2,Tnpo1,1,20,12,8,Q8BFY9-2|Q8BFY9,MOUSE,102793.4,18.4,803,803.1,178.42,121.44,,898,Isoform 2 of Transportin-1,nucleus|cytoplasm|extracellular exosome|,intracellular protein transport|,protein binding|Ran GTPase binding|poly(A) RNA binding|,12,20,1950000000,18.4%
Q99LG2,0.744748173,-0.129833333,3.905200304,0.239,0.406892767,0.885517757,0.086,0.06,-0.894,-0.017,-0.153,0.139,Q99LG2,Tnpo2,Q99LG2_Tnpo2,Q99LG2,Tnpo2,1,2,6,2,Q99LG2|E9PV58,MOUSE,101994.8,7.4,803,803.2,85.32,28.34,,887,Transportin-2,nucleus|cytoplasm|,protein import into nucleus|negative regulation of muscle cell differentiation|,protein binding|Ran GTPase binding|,2,2,175000000,3.1%
A2ASZ8,0.295762578,0.035333333,12.8918195,-0.280666667,0.051382834,-2.372631006,0.295,0.27,-0.038,-0.013,-0.168,-0.134,A2ASZ8,Slc25a25,A2ASZ8_Slc25a25,A2ASZ8,Slc25a25,1,36,15,15,A2ASZ8|A2ASZ8-3|A2ASZ8-5|A2ASZ8-2|A2ASZ8-4,MOUSE,53019.5,36.6,804,804.1,178.38,178.38,,469,Calcium-binding mitochondrial carrier protein SCaMC-2,mitochondrion|mitochondrial inner membrane|integral component of membrane|intracellular membrane-bounded organelle|extracellular exosome|,response to dietary excess|response to activity|response to food|multicellular organism growth|camera-type eye development|cellular respiration|ATP metabolic process|adipose tissue development|calcium ion transmembrane transport|,calcium ion binding|,15,36,4060000000,36.6%
Q9EQ32,0.723381109,-0.0115,4.190286971,0.093666667,0.381040644,0.937565621,0.088,-0.159,-0.104,0.108,0.008,-0.01,Q9EQ32,Pik3ap1,Q9EQ32_Pik3ap1,Q9EQ32,Pik3ap1,1,28,13,13,Q9EQ32|Q9EQ32-2|Q9EQ32-3,MOUSE,91839.5,18.8,805,805.1,178.02,178.02,,811,Phosphoinositide 3-kinase adapter protein 1,cytoplasm|cytosol|plasma membrane|membrane|nucleus|,positive regulation of phosphatidylinositol 3-kinase signaling|negative regulation of toll-like receptor signaling pathway|positive regulation of toll-like receptor signaling pathway|toll-like receptor 2 signaling pathway|toll-like receptor 4 signaling pathway|toll-like receptor 7 signaling pathway|toll-like receptor 9 signaling pathway|regulation of inflammatory response|regulation of I-kappaB kinase/NF-kappaB signaling|regulation of MAPK cascade|,protein binding|phosphatidylinositol 3-kinase regulatory subunit binding|identical protein binding|,13,28,3630000000,18.8%
E9Q616,0.708523608,0.0105,4.402194316,0.090333333,0.362894652,0.976212553,-0.128,0.027,-0.003,-0.027,0.054,0.14,E9Q616,Ahnak,E9Q616_Ahnak,E9Q616,Ahnak,1,26,20,19,E9Q616,MOUSE,605040.9,4.9,806,806.1,177.98,166.45,,5656,AHNAK nucleoprotein (desmoyokin),nucleus|cytoplasm|lysosomal membrane|cytosol|plasma membrane|cell-cell junction|focal adhesion|actin cytoskeleton|membrane|vesicle|sarcolemma|costamere|cell-cell contact zone|extracellular exosome|T-tubule|membrane raft|,regulation of RNA splicing|protein oligomerization|regulation of voltage-gated calcium channel activity|,S100 protein binding|poly(A) RNA binding|structural molecule activity conferring elasticity|,19,26,6410000000,4.5%
Q8R0V5,0.717934984,-0.053166667,4.249841799,0.127,0.375851095,0.949250182,0.03,0.005,-0.385,0.052,0.06,-0.081,Q8R0V5,Ido2,Q8R0V5_Ido2,Q8R0V5,Ido2,1,34,14,14,Q8R0V5,MOUSE,45539.8,43.7,807,807.1,177.96,177.96,,405,"Indoleamine 2,3-dioxygenase 2",cytoplasm|,tryptophan catabolic process to kynurenine|oxidation-reduction process|,"tryptophan 2,3-dioxygenase activity|heme binding|indoleamine 2,3-dioxygenase activity|metal ion binding|",14,34,23300000000,43.7%
Q9DCT2,0.904214516,-0.030666667,1.578892639,0.050666667,0.695201557,0.409351024,-0.194,0.19,-0.164,0.036,-0.053,0.001,Q9DCT2,Ndufs3,Q9DCT2_Ndufs3,Q9DCT2,Ndufs3,1,33,12,12,Q9DCT2,MOUSE,30319.9,42.5,808,808.1,177.68,177.68,,263,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial",nucleus|mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex I|mitochondrial membrane|myelin sheath|,substantia nigra development|negative regulation of cell growth|oxidation-reduction process|reactive oxygen species metabolic process|negative regulation of intrinsic apoptotic signaling pathway|,NADH dehydrogenase activity|NADH dehydrogenase (ubiquinone) activity|,12,33,42000000000,42.5%
Q8K0D5,0.588470288,-0.006166667,6.524013898,-0.167666667,0.22263765,-1.345784036,0.041,0.26,-0.068,-0.209,0.07,-0.131,Q8K0D5,Gfm1,Q8K0D5_Gfm1,Q8K0D5,Gfm1,1,31,17,17,Q8K0D5,MOUSE,84289.7,28.3,809,809.1,177.56,177.56,,751,"Elongation factor G, mitochondrial",mitochondrion|,mitochondrial translational elongation|,translation elongation factor activity|GTPase activity|GTP binding|poly(A) RNA binding|,17,31,3740000000,28.3%
P50295,0.430679683,-0.004,9.725041388,-0.196666667,0.106535871,-1.864280848,0.179,0.161,-0.057,-0.014,-0.087,-0.206,P50295,Nat2,P50295_Nat2,P50295,Nat2,1,35,12,12,P50295|P50296|P50294|A0A1D5RLG2,MOUSE,33929,48.9,810,810.1,177.54,177.54,,290,Arylamine N-acetyltransferase 2,cytosol|,metabolic process|response to xenobiotic stimulus|response to lipopolysaccharide|digestive tract development|,arylamine N-acetyltransferase activity|,12,35,11600000000,48.9%
Q3UKN6,0.001198319,-0.007833333,43.69439775,1.864333333,4.2713E-05,9.49754899,-1.041,-0.908,-0.871,1.144,0.47,1.159,Q3UKN6,NotFound,Q3UKN6_NotFound,Q3UKN6,Nucb2,1,26,12,12,Q3UKN6|P81117,MOUSE,50466.8,39,811,811.1,177.52,177.52,,420,Nucleobindin-2,extracellular space|nucleus|nuclear outer membrane|cytoplasm|endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|extracellular exosome|,cellular calcium ion homeostasis|,calcium ion binding|,12,26,6890000000,39.0%
O55111,0.065865965,0.033333333,22.26649731,0.416666667,0.005934037,3.967899139,-0.133,-0.175,-0.217,0.064,0.357,0.304,O55111,Dsg2,O55111_Dsg2,O55111,Dsg2,1,28,15,15,O55111|Q811I1|Q8VCE3,MOUSE,123181.5,17.2,812,812.1,176.99,176.99,,1122,Desmoglein-2,plasma membrane|cell surface|intercalated disc|integral component of membrane|apical plasma membrane|lateral plasma membrane|desmosome|extracellular exosome|,desmosome organization|Purkinje myocyte development|cell adhesion|homophilic cell adhesion via plasma membrane adhesion molecules|response to progesterone|maternal process involved in female pregnancy|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|regulation of ventricular cardiac muscle cell action potential|,calcium ion binding|cell adhesion molecule binding|,15,28,3980000000,17.2%
Q60930,0.99327985,-0.0725,0.126854019,-0.006333333,0.971213249,-0.037472345,-0.412,0.052,0.152,-0.239,0.059,-0.047,Q60930,Vdac2,Q60930_Vdac2,Q60930,Vdac2,1,28,12,12,Q60930|G3UX26,MOUSE,32359.9,53.5,813,813.1,176.91,176.91,,295,Voltage-dependent anion-selective channel protein 2,nucleus|mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|mitochondrial nucleoid|myelin sheath|membrane raft|pore complex|extracellular exosome|,anion transport|negative regulation of protein polymerization|transmembrane transport|regulation of anion transmembrane transport|negative regulation of intrinsic apoptotic signaling pathway|,nucleotide binding|protein binding|voltage-gated anion channel activity|porin activity|,12,28,6850000000,53.5%
P60229,0.73101227,-0.035333333,4.114856522,-0.178,0.387716557,-0.92443673,-0.304,0.178,0.287,-0.39,-0.053,0.07,P60229,Eif3e,P60229_Eif3e,P60229,Eif3e,1,35,13,13,P60229,MOUSE,52619.2,32.1,814,814.1,176.77,176.77,,445,Eukaryotic translation initiation factor 3 subunit E,nucleus|cytoplasm|eukaryotic translation initiation factor 3 complex|membrane|eukaryotic 43S preinitiation complex|eukaryotic 48S preinitiation complex|extracellular exosome|PML body|,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|formation of translation preinitiation complex|translational initiation|regulation of translational initiation|",poly(A) RNA binding|protein N-terminus binding|translation initiation factor activity|,13,35,19100000000,32.1%
Q9D5V5,0.471902671,-0.003,8.798098273,-0.166666667,0.131883412,-1.715601207,0.065,0.199,-0.023,-0.089,-0.01,-0.16,Q9D5V5,Cul5,Q9D5V5_Cul5,Q9D5V5,Cul5,1,23,15,15,Q9D5V5|G3X914|E9PV12|E9Q6Z0,MOUSE,91543.2,22.4,815,815.1,176.71,176.71,,780,Cullin-5,Cul5-RING ubiquitin ligase complex|,protein ubiquitination|cerebral cortex radially oriented cell migration|radial glia guided migration of Purkinje cell|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|,protein binding|ubiquitin protein ligase binding|protein heterodimerization activity|ubiquitin protein ligase activity|,15,23,2940000000,22.4%
Q80X81,0.590601398,-0.006333333,6.482616623,0.114666667,0.224769996,1.337258663,-0.108,0.027,-0.11,0.011,0.088,0.054,Q80X81,Acat3,Q80X81_Acat3,Q80X81,Acat3,1,29,13,13,Q80X81|Q8CAY6|F2Z459|G3XA25,MOUSE,41925.7,50.1,816,816.1,176.59,176.59,,397,Acetyl-Coenzyme A acetyltransferase 3,nucleus|nucleoplasm|nucleolus|cytoplasm|mitochondrion|extracellular exosome|,metabolic process|,acetyl-CoA C-acetyltransferase activity|,13,29,4620000000,50.1%
O55201,0.815266576,-0.025833333,2.873696384,-0.070333333,0.515977022,-0.685623876,-0.061,0.114,-0.025,0.032,-0.2,-0.015,O55201,Supt5,O55201_Supt5,O55201,Supt5h,1,22,15,15,O55201|O55201-2,MOUSE,121061.4,22.8,817,817.1,176.41,176.41,,1082,Transcription elongation factor SPT5,nucleus|nucleoplasm|DSIF complex|,"negative regulation of transcription from RNA polymerase II promoter|DNA-templated transcription, elongation|transcription elongation from RNA polymerase II promoter|positive regulation of macroautophagy|negative regulation of DNA-templated transcription, elongation|positive regulation of DNA-templated transcription, elongation|positive regulation of transcription from RNA polymerase II promoter|negative regulation of mRNA polyadenylation|",chromatin binding|enzyme binding|poly(A) RNA binding|protein heterodimerization activity|,15,22,1920000000,22.8%
Q8K297,0.00527087,-0.038333333,35.46632301,0.635333333,0.000284032,6.893560142,-0.386,-0.414,-0.268,0.181,0.34,0.317,Q8K297,Colgalt1,Q8K297_Colgalt1,Q8K297,Colgalt1,1,40,14,14,Q8K297,MOUSE,71401.6,22.6,818,818.1,176.29,176.29,,617,Procollagen galactosyltransferase 1,endoplasmic reticulum lumen|membrane|,metabolic process|,procollagen galactosyltransferase activity|,14,40,11500000000,22.6%
Q8VC81,4.99445E-05,-0.612666667,68.99085644,3.276,1.26158E-07,23.5005978,-2.287,-2.35,-2.115,0.851,1.287,0.938,Q8VC81,Pla2g12b,Q8VC81_Pla2g12b,Q8VC81,Pla2g12b,1,35,11,11,Q8VC81|Q99P27,MOUSE,22577.4,71.7,819,819.1,176.24,176.24,,195,Group XIIB phospholipase A2-like protein,extracellular region|,lipid catabolic process|cholesterol homeostasis|triglyceride homeostasis|,phospholipase A2 activity|calcium ion binding|,11,35,14800000000,71.7%
P29758,0.954161889,-0.005833333,0.675869855,-0.017,0.855880269,-0.188750602,0.039,0.018,-0.049,-0.022,0.086,-0.107,P29758,Oat,P29758_Oat,P29758,Oat,1,41,13,13,P29758,MOUSE,48753.1,35,820,820.1,176.14,176.14,,439,"Ornithine aminotransferase, mitochondrial",mitochondrion|mitochondrial matrix|,protein hexamerization|L-proline biosynthetic process|,ornithine-oxo-acid transaminase activity|pyridoxal phosphate binding|,13,41,7520000000,35.0%
Q9CXS4,0.470565279,-0.01,8.856825277,-0.195333333,0.130112036,-1.726441149,-0.002,0.219,0.046,-0.266,-0.081,0.024,Q9CXS4,Cenpv,Q9CXS4_Cenpv,Q9CXS4,Cenpv,1,46,14,14,Q9CXS4|Q9CXS4-2,MOUSE,27997,69.4,821,821.1,176.04,176.04,,252,Centromere protein V,kinetochore|condensed chromosome kinetochore|nucleus|nucleoplasm|cytoplasm|microtubule cytoskeleton|spindle midzone|,ameboidal-type cell migration|mitotic nuclear division|metabolic process|pericentric heterochromatin assembly|positive regulation of cytokinesis|regulation of chromosome organization|centromere complex assembly|cell division|,carbon-sulfur lyase activity|,14,46,15400000000,69.4%
Q02053,0.758301307,0.001333333,3.739947739,0.102666667,0.422673701,0.854495849,-0.111,0.023,-0.062,-0.141,0.252,0.047,Q02053,Uba1,Q02053_Uba1,Q02053,Uba1,1,24,15,15,Q02053|P31254,MOUSE,119004.9,20.5,822,822.1,175.77,175.77,,1058,Ubiquitin-like modifier-activating enzyme 1,nucleus|cytoplasm|mitochondrion|cytosol|extracellular exosome|heterochromatin|lysosomal membrane|endosome membrane|desmosome|rough endoplasmic reticulum membrane|,cellular response to DNA damage stimulus|protein ubiquitination|modification-dependent protein catabolic process|,ubiquitin activating enzyme activity|ubiquitin-protein transferase activity|protein binding|ATP binding|poly(A) RNA binding|,15,24,2750000000,20.5%
Q3TDQ1,0.183032349,-0.050333333,16.52800073,0.356666667,0.022243336,2.968913632,-0.216,-0.043,-0.427,0.037,0.178,0.169,Q3TDQ1,Stt3b,Q3TDQ1_Stt3b,Q3TDQ1,Stt3b,1,31,17,17,A0A0R4J0D3|Q3TDQ1,MOUSE,93814.5,18.3,823,823.1,175.71,175.71,,823,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B,endoplasmic reticulum|oligosaccharyltransferase complex|membrane|integral component of membrane|,glycoprotein catabolic process|response to unfolded protein|protein N-linked glycosylation via asparagine|ER-associated ubiquitin-dependent protein catabolic process|co-translational protein modification|post-translational protein modification|,dolichyl-diphosphooligosaccharide-protein glycotransferase activity|dolichyl-diphosphooligosaccharide-protein glycotransferase activity|,17,31,4910000000,18.3%
Q91X91,0.938054337,-0.021833333,0.874833347,0.049666667,0.81755441,0.240050257,-0.472,0.065,0.267,-0.164,-0.045,0.218,Q91X91,Qprt,Q91X91_Qprt,Q91X91,Qprt,1,49,12,12,Q91X91,MOUSE,31872,42.1,824,824.1,175.48,175.48,,299,Nicotinate-nucleotide pyrophosphorylase [carboxylating],cytoplasm|extracellular exosome|,NAD biosynthetic process|quinolinate catabolic process|protein oligomerization|,nicotinate-nucleotide diphosphorylase (carboxylating) activity|protein homodimerization activity|,12,49,22800000000,42.1%
Q9WUQ2,0.91325,-0.010666667,1.379012011,-0.034,0.727945388,-0.362782876,-0.109,0.056,0.072,-0.093,-0.035,0.045,Q9WUQ2,Preb,Q9WUQ2_Preb,Q9WUQ2,Preb,1,30,12,12,Q9WUQ2|D3Z3S1,MOUSE,46007.1,41.9,825,825.1,175.25,175.25,,417,Prolactin regulatory element-binding protein,nucleus|endoplasmic reticulum|membrane|integral component of membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|protein transport|vesicle-mediated transport|",DNA binding|sequence-specific DNA binding transcription factor activity|,12,30,8100000000,41.9%
G3X8Y3,0.717934984,0.026333333,4.254770342,-0.090666667,0.375424807,-0.94936892,-0.06,0.187,0.088,-0.038,-0.038,0.019,G3X8Y3,Naa15,G3X8Y3_Naa15,G3X8Y3,Naa15,1,34,17,15,G3X8Y3|Q80UM3|A0A0A6YW80,MOUSE,102405.6,21,826,826.1,175.19,148.96,,865,"N-alpha-acetyltransferase 15, NatA auxiliary subunit",nucleus|transcription factor complex|cytoplasm|membrane|NatA complex|,"N-terminal protein amino acid acetylation|negative regulation of apoptotic process|positive regulation of transcription, DNA-templated|protein stabilization|",protein binding|N-acetyltransferase activity|ribosome binding|poly(A) RNA binding|acetyltransferase activity|ribosome binding|,17,34,9150000000,21.0%
Q9DBB4,0.907855509,-0.018333333,1.485241851,0.048666667,0.71035561,0.387764988,0.109,0.055,-0.292,0.048,0.018,-0.048,Q9DBB4,Naa16,Q9DBB4_Naa16,Q9DBB4,Naa16,1,2,4,2,Q9DBB4|E9PZ53,MOUSE,102366.1,5.9,826,826.2,49.24,23.01,,864,"N-alpha-acetyltransferase 16, NatA auxiliary subunit",cytoplasm|NatA complex|extracellular exosome|,N-terminal protein amino acid acetylation|negative regulation of apoptotic process|protein stabilization|,ribosome binding|peptide alpha-N-acetyltransferase activity|,2,2,120000000,3.5%
Q9CQ60,0.90651412,-0.003666667,1.518226015,-0.030666667,0.704980977,-0.39519849,0.018,0.035,-0.018,-0.006,-0.015,-0.036,Q9CQ60,Pgls,Q9CQ60_Pgls,Q9CQ60,Pgls,1,38,11,11,Q9CQ60|Q8CBG6|D3Z4,MOUSE,27482.1,66.9,827,827.1,175.15,175.15,,257,6-phosphogluconolactonase,cytoplasm|extracellular exosome|,"carbohydrate metabolic process|pentose-phosphate shunt|pentose-phosphate shunt, oxidative branch|",6-phosphogluconolactonase activity|monosaccharide binding|,11,38,10300000000,66.9%
Q9D051,0.713417662,-0.01,4.321875121,-0.112666667,0.369668536,-0.96226154,-0.026,0.05,0.115,-0.256,0.116,-0.059,Q9D051,Pdhb,Q9D051_Pdhb,Q9D051,Pdhb,1,49,13,13,Q9D051,MOUSE,39278.7,40.3,828,828.1,174.9,174.9,,359,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial",nucleus|nucleoplasm|mitochondrion|mitochondrial matrix|pyruvate dehydrogenase complex|extracellular exosome|,glucose metabolic process|acetyl-CoA biosynthetic process from pyruvate|tricarboxylic acid cycle|,pyruvate dehydrogenase activity|pyruvate dehydrogenase (acetyl-transferring) activity|,13,49,15200000000,40.3%
P14576,0.70831983,-0.008333333,4.428813335,-0.098666667,0.360677181,-0.981043248,0.049,0.164,-0.09,-0.011,-0.02,-0.142,P14576,Srp54a,P14576_Srp54a,P14576,Srp54,1,36,13,13,P14576|E9PXC0|A0A1Y7VJJ0|P14576-2,MOUSE,56005.1,37.8,829,829.1,174.76,174.76,,504,Signal recognition particle 54 kDa protein,"signal recognition particle, endoplasmic reticulum targeting|nuclear speck|",SRP-dependent cotranslational protein targeting to membrane|metabolic process|,GTPase activity|GTP binding|7S RNA binding|,13,36,4340000000,37.8%
P85094,0.894455479,-0.027833333,1.664633778,0.052333333,0.68161105,0.428893409,0.06,0.03,-0.252,-0.111,0.136,-0.03,P85094,Isoc2a,P85094_Isoc2a,P85094,Isoc2a,1,35,12,12,P85094,MOUSE,22759.2,88.8,830,830.1,174.51,174.51,,206,Isochorismatase domain-containing protein 2A,nucleus|cytoplasm|mitochondrion|,metabolic process|protein destabilization|,catalytic activity|,12,35,23900000000,88.8%
P30115,0.820260214,0.157166667,2.792751525,0.235,0.525684107,0.669744234,-0.112,0.31,-0.079,-0.254,1.103,-0.025,P30115,Gsta3,P30115_Gsta3,P30115,Gsta3,1,51,12,12,P30115|P13745|Q6P8Q0|P10648|E9Q6L7,MOUSE,25417.1,56.1,831,831.1,174.47,174.47,,221,Glutathione S-transferase A3,cytoplasm|extracellular exosome|,ureteric bud development|glutathione metabolic process|aflatoxin catabolic process|,glutathione transferase activity|,12,51,24700000000,56.1%
Q9JIL4,0.597505754,-0.065666667,6.392829517,0.218,0.229465315,1.323753877,0.079,-0.084,-0.519,0.143,0.05,-0.063,Q9JIL4,Pdzk1,Q9JIL4_Pdzk1,Q9JIL4,Pdzk1,1,26,14,14,Q9JIL4|A0A0R4J1V0,MOUSE,56897,39.3,832,832.1,174.14,174.14,,519,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,cytoplasm|plasma membrane|brush border membrane|extracellular exosome|,transport|carnitine transport|positive regulation of ion transmembrane transport|regulation of anion transport|establishment of protein localization to plasma membrane|positive regulation of protein targeting to membrane|,protein binding|PDZ domain binding|,14,26,4610000000,39.3%
P62267,0.904214516,-0.027,1.551075813,-0.059333333,0.699668656,-0.402966107,0.104,0.197,-0.293,0.013,-0.003,-0.18,P62267,Rps23,P62267_Rps23,P62267,Rps23,1,66,11,11,P62267,MOUSE,15978.4,53.8,833,833.1,174.03,174.03,,143,40S ribosomal protein S23,nucleolus|cytoplasm|membrane|cytosolic small ribosomal subunit|,translation|,structural constituent of ribosome|poly(A) RNA binding|,11,66,78800000000,53.8%
O08914,0.988090676,0.0055,0.210922799,0.008333333,0.952593733,0.061738265,-0.017,0.209,-0.188,-0.132,0.166,-0.005,O08914,Faah,O08914_Faah,O08914,Faah,1,33,13,13,O08914,MOUSE,64247.3,37.4,834,834.1,173.85,173.85,,579,Fatty-acid amide hydrolase 1,Golgi membrane|endoplasmic reticulum membrane|integral component of membrane|organelle membrane|,fatty acid catabolic process|,"carbon-nitrogen ligase activity, with glutamine as amido-N-donor|fatty acid amide hydrolase activity|acylglycerol lipase activity|",13,33,13100000000,37.4%
Q62318,0.8541792,0.000333333,2.334113016,0.055333333,0.584236517,0.574758156,0.06,-0.031,-0.111,0.141,-0.048,-0.009,Q62318,Trim28,Q62318_Trim28,Q62318,Trim28,1,36,16,16,Q62318|Q62318-2,MOUSE,90614.2,26.6,835,835.1,173.74,173.74,,834,Transcription intermediary factor 1-beta,chromatin|nucleus|nucleoplasm|nuclear euchromatin|nuclear heterochromatin|RNA polymerase II transcription factor complex|nucleolus|,"negative regulation of transcription from RNA polymerase II promoter|in utero embryonic development|epithelial to mesenchymal transition|DNA repair|transcription, DNA-templated|protein phosphorylation|embryo implantation|protein ubiquitination|protein sumoylation|positive regulation of transcription factor import into nucleus|DNA methylation involved in embryo development|innate immune response|positive regulation of DNA repair|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|protein autophosphorylation|protein oligomerization|convergent extension involved in axis elongation|embryonic placenta morphogenesis|negative regulation of DNA demethylation|negative regulation of viral release from host cell|regulation of genetic imprinting|",DNA binding|transcription coactivator activity|transcription corepressor activity|protein kinase activity|ubiquitin-protein transferase activity|protein binding|zinc ion binding|ligase activity|ubiquitin protein ligase binding|Krueppel-associated box domain binding|poly(A) RNA binding|chromo shadow domain binding|sequence-specific DNA binding transcription factor activity|sequence-specific DNA binding|,16,36,18400000000,26.6%
Q91VS8,0.470565279,0.009833333,8.866215296,-0.161666667,0.12983102,-1.726530522,0.135,0.178,-0.041,-0.036,-0.108,-0.069,Q91VS8,Farp2,Q91VS8_Farp2,Q91VS8,Farp2,1,27,15,15,Q91VS8|D3Z4C0,MOUSE,122248.2,18,836,836.1,173.42,173.42,,1065,"FERM, ARHGEF and pleckstrin domain-containing protein 2",cytoplasm|cytosol|cytoskeleton|extrinsic component of membrane|,cell adhesion|neuron remodeling|Rac protein signal transduction|osteoclast differentiation|actin cytoskeleton reorganization|regulation of integrin activation|regulation of Rho protein signal transduction|positive regulation of GTPase activity|semaphorin-plexin signaling pathway|podosome assembly|,Rho guanyl-nucleotide exchange factor activity|cytoskeletal protein binding|Rac guanyl-nucleotide exchange factor activity|,15,27,2370000000,18.0%
P18242,0.001221941,-0.171,43.57546172,1.583333333,4.38989E-05,9.455805221,-0.806,-0.758,-1.324,0.691,0.678,0.493,P18242,Ctsd,P18242_Ctsd,P18242,Ctsd,1,45,11,11,P18242|F8WIR1,MOUSE,45409.4,32.9,837,837.1,173.22,173.22,,410,Cathepsin D,extracellular space|mitochondrion|lysosome|melanosome|membrane raft|extracellular exosome|extracellular matrix|,autophagosome assembly|proteolysis|autophagy|protein catabolic process|epithelial tube branching involved in lung morphogenesis|,aspartic-type endopeptidase activity|peptidase activity|peptide binding|,11,45,14400000000,32.9%
E9QMK9,0.904214516,-0.029,1.566085271,0.072,0.697254736,0.406414063,0.067,0.188,-0.45,0.136,-0.066,-0.049,E9QMK9,Dglucy,E9QMK9_Dglucy,E9QMK9,Dglucy,1,38,14,14,E9QMK9|Q8BH86|Q8BH86-2,MOUSE,70890.5,26.5,838,838.1,172.56,172.56,,647,"D-glutamate cyclase, mitochondrial",mitochondrion|,,,14,38,6430000000,26.5%
Q921T2,0.777608966,-0.015333333,3.434090197,0.074666667,0.453514294,0.795639287,0.037,-0.007,-0.188,-0.001,0.015,0.052,Q921T2,Tor1aip1,Q921T2_Tor1aip1,Q921T2,Tor1aip1,1,39,13,1,Q921T2|Q921T2-3|J3QQ40|Q3UE61,MOUSE,67065.3,30,839,839.1,172.5,14.59,,595,Torsin-1A-interacting protein 1,nucleus|nuclear envelope|nuclear inner membrane|integral component of membrane|,positive regulation of ATPase activity|protein localization to nucleus|nuclear membrane organization|,ATPase activator activity|protein binding|lamin binding|cytoskeletal protein binding|ATPase binding|,13,39,3610000000,30.0%
Q8BYU6,0.69223202,0.006666667,4.685260893,-0.092,0.339996081,-1.027187511,0.092,-0.023,0.089,0.051,-0.06,-0.109,Q8BYU6,Tor1aip2,Q8BYU6_Tor1aip2,Q8BYU6,Tor1aip2,1,19,10,9,Q8BYU6,MOUSE,54836.9,21.9,839,839.3,125.44,118.78,,502,Torsin-1A-interacting protein 2,nucleus|nuclear envelope|cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|intracellular membrane-bounded organelle|,endoplasmic reticulum organization|positive regulation of ATPase activity|protein localization to nuclear envelope|,ATPase activator activity|protein binding|ATPase binding|,9,19,5910000000,19.9%
Q8R5F7,0.822408388,0.017833333,2.733043581,-0.072333333,0.53296126,-0.657324899,0.1,-0.122,0.184,0.072,-0.085,-0.042,Q8R5F7,Ifih1,Q8R5F7_Ifih1,Q8R5F7,Ifih1,1,23,16,16,Q8R5F7|Q8R5F7-2,MOUSE,117281.6,16.8,840,840.1,171.88,171.88,,1025,Interferon-induced helicase C domain-containing protein 1,nucleus|cytoplasm|,response to virus|protein sumoylation|positive regulation of interferon-alpha production|positive regulation of interferon-beta production|MDA-5 signaling pathway|regulation of apoptotic process|innate immune response|,DNA binding|double-stranded RNA binding|single-stranded RNA binding|helicase activity|protein binding|ATP binding|zinc ion binding|ribonucleoprotein complex binding|,16,23,10700000000,16.8%
O70325,0.538677779,-0.0455,7.467684116,0.199666667,0.179156095,1.502227542,-0.016,-0.01,-0.41,0.137,0.053,-0.027,O70325,Gpx4,O70325_Gpx4,O70325,Gpx4,1,44,15,15,F7A8H6|O70325|O70325-2|S4R1E5|Q91XR9,MOUSE,22785.2,54.8,841,841.1,171.72,171.72,,197,"Phospholipid hydroperoxide glutathione peroxidase, mitochondrial",nucleus|nuclear envelope|mitochondrion|mitochondrial inner membrane|cytosol|extracellular exosome|,chromatin organization|response to oxidative stress|multicellular organismal development|spermatogenesis|oxidation-reduction process|,glutathione peroxidase activity|phospholipid-hydroperoxide glutathione peroxidase activity|,15,44,17800000000,54.8%
H3BKH6,0.150805016,0.12,17.56399694,0.69,0.017522671,3.144087551,-0.402,-0.226,-0.047,0.024,0.868,0.503,H3BKH6,Esd,H3BKH6_Esd,H3BKH6,Esd,1,28,11,11,H3BKH6|Q9R0P3|H3BJL6|H3BLJ9|H3BK43,MOUSE,33399.4,48.4,842,842.1,171.72,171.72,,295,S-formylglutathione hydrolase,nucleoplasm|cytoplasm|Golgi apparatus|plasma membrane|extracellular exosome|,formaldehyde catabolic process|,"hydrolase activity, acting on ester bonds|S-formylglutathione hydrolase activity|",11,28,20700000000,48.4%
B2RY56,0.863857851,0.011333333,2.170862322,-0.05,0.60661587,-0.54009422,-0.085,0.061,0.133,-0.002,-0.056,0.017,B2RY56,Rbm25,B2RY56_Rbm25,B2RY56,Rbm25,1,29,15,15,B2RY56|S4R2F7|S4R1X9,MOUSE,99892.4,21.9,843,843.1,171.49,171.49,,838,RNA-binding protein 25,spliceosomal complex|cytoplasm|nuclear speck|,"regulation of alternative mRNA splicing, via spliceosome|mRNA processing|apoptotic process|RNA splicing|regulation of apoptotic process|",nucleotide binding|mRNA binding|,15,29,5790000000,21.9%
Q9DBA8,0.936982455,-0.012666667,0.886458585,-0.023333333,0.815368898,-0.242879744,0.061,0.07,-0.134,-0.095,0.018,0.004,Q9DBA8,Amdhd1,Q9DBA8_Amdhd1,Q9DBA8,Amdhd1,1,25,12,12,Q9DBA8,MOUSE,47115.4,42.9,844,844.1,171.47,171.47,,426,Probable imidazolonepropionase,cytoplasm|,histidine catabolic process to glutamate and formamide|histidine catabolic process to glutamate and formate|,metal ion binding|imidazolonepropionase activity|,12,25,3050000000,42.9%
Q9WVM8,0.357097349,0.067333333,11.28625291,-0.322666667,0.074366049,-2.116401851,0.333,0.444,-0.091,-0.113,-0.001,-0.168,Q9WVM8,Aadat,Q9WVM8_Aadat,Q9WVM8,Aadat,1,47,14,14,Q9WVM8|Q3UNS8,MOUSE,47882.3,42.3,845,845.1,170.98,170.98,,425,"Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial",mitochondrion|,2-oxoglutarate metabolic process|glutamate metabolic process|biosynthetic process|tryptophan catabolic process to kynurenine|L-lysine catabolic process to acetyl-CoA via saccharopine|kynurenine metabolic process|L-kynurenine metabolic process|,kynurenine-oxoglutarate transaminase activity|pyridoxal phosphate binding|protein homodimerization activity|2-aminoadipate transaminase activity|,14,47,14700000000,42.3%
Q8C7H1,0.829508454,-0.061,2.647081211,0.109333333,0.54361556,0.640102486,0.098,0.047,-0.492,0.088,0,-0.107,Q8C7H1,Mmaa,Q8C7H1_Mmaa,Q8C7H1,Mmaa,1,38,12,12,Q8C7H1|A0A1B0GSL6,MOUSE,46388,31.3,846,846.1,170.66,170.66,,415,"Methylmalonic aciduria type A homolog, mitochondrial",mitochondrion|,cobalamin biosynthetic process|,GTP binding|hydrolase activity|,12,38,10100000000,31.3%
Q8K310,0.692956416,0.011333333,4.660910315,-0.092,0.341907768,-1.022830386,-0.03,0.149,0.053,-0.041,-0.089,0.026,Q8K310,Matr3,Q8K310_Matr3,Q8K310,Matr3,1,33,16,16,Q8K310|A0A087WQZ1|A0A087WSP7|A0A087WQ54|A0A087WSF8,MOUSE,95142.1,19.1,847,847.1,170.11,170.11,,846,Matrin-3,nucleoplasm|membrane|nuclear matrix|,posttranscriptional regulation of gene expression|,nucleotide binding|zinc ion binding|poly(A) RNA binding|,16,33,5370000000,19.1%
Q62425,0.553672549,0.034166667,7.205759402,-0.253,0.190293546,-1.459126536,0.417,0.273,-0.208,-0.053,0,-0.224,Q62425,Ndufa4,Q62425_Ndufa4,Q62425,Ndufa4,1,64,11,11,Q62425|A0A0N4SVQ1,MOUSE,9326.6,65.8,848,848.1,169.99,169.99,,82,Cytochrome c oxidase subunit NDUFA4,mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex IV|extracellular exosome|mitochondrial respiratory chain complex I|,oxidation-reduction process|hydrogen ion transmembrane transport|,protein complex binding|cytochrome-c oxidase activity|,11,64,1.61E+11,65.8%
Q9Z2G6,0.00070612,-0.210166667,46.91737375,1.481666667,2.03359E-05,10.69288311,-0.817,-0.82,-1.216,0.522,0.416,0.654,Q9Z2G6,Sel1l,Q9Z2G6_Sel1l,Q9Z2G6,Sel1l,1,33,11,11,Q9Z2G6|Q9Z2G6-2|J3QJX3,MOUSE,88852.3,23.2,849,849.1,169.76,169.76,,790,Protein sel-1 homolog 1,endoplasmic reticulum membrane|integral component of membrane|,"Notch signaling pathway|retrograde protein transport, ER to cytosol|response to endoplasmic reticulum stress|",,11,33,9720000000,23.2%
Q91VM5,0.956385108,-0.0325,0.634877689,-0.033,0.863996993,-0.178066143,-0.288,0.175,0.065,-0.327,-0.07,0.25,Q91VM5,Rbmxl1,Q91VM5_Rbmxl1,Q91VM5,Rbmxl1,1,45,18,18,Q91VM5|Q9WV02|A2AFI3|Q9WV02-2|S4R1F6,MOUSE,42160.9,41.7,850,850.1,169.68,169.68,,388,"RNA binding motif protein, X-linked-like-1",nucleus|nuclear euchromatin|supraspliceosomal complex|extracellular exosome|catalytic step 2 spliceosome|,"regulation of alternative mRNA splicing, via spliceosome|transcription from RNA polymerase II promoter|mRNA processing|membrane protein ectodomain proteolysis|RNA splicing|positive regulation of transcription from RNA polymerase II promoter|negative regulation of mRNA splicing, via spliceosome|positive regulation of mRNA splicing, via spliceosome|protein homooligomerization|cellular response to interleukin-1|",nucleotide binding|core promoter binding|chromatin binding|RNA binding|mRNA binding|protein binding|,20,45,6760000000,41.7%
O54950,0.797504707,-0.008,3.133615017,-0.062666667,0.486002494,-0.73723009,0.047,0.068,-0.045,-0.032,0.015,-0.101,O54950,Prkag1,O54950_Prkag1,O54950,Prkag1,1,28,13,10,O54950,MOUSE,37690.8,42.4,851,851.1,169.54,120.77,,330,5'-AMP-activated protein kinase subunit gamma-1,nucleus|nucleoplasm|cytosol|membrane|AMP-activated protein kinase complex|extracellular exosome|,protein phosphorylation|fatty acid biosynthetic process|positive regulation of gene expression|,protein kinase activity|AMP-activated protein kinase activity|ATP binding|AMP binding|protein kinase binding|ADP binding|AMP-activated protein kinase activity|,13,28,3780000000,42.4%
O35465,0.267825397,-0.0055,13.71147635,0.321,0.042545376,2.505591312,-0.014,-0.173,-0.311,0.355,0.086,0.024,O35465,Fkbp8,O35465_Fkbp8,O35465,Fkbp8,1,30,12,1,O35465,MOUSE,43984.5,46.5,852,852.1,169.19,11.54,,402,Peptidyl-prolyl cis-trans isomerase FKBP8,cytoplasm|mitochondrion|mitochondrial envelope|endoplasmic reticulum membrane|membrane|integral component of endoplasmic reticulum membrane|mitochondrial membrane|,protein peptidyl-prolyl isomerization|cell fate specification|apoptotic process|smoothened signaling pathway|dorsal/ventral pattern formation|regulation of gene expression|dorsal/ventral neural tube patterning|neural tube development|regulation of BMP signaling pathway|positive regulation of BMP signaling pathway|multicellular organism growth|camera-type eye development|negative regulation of apoptotic process|chaperone-mediated protein folding|,peptidyl-prolyl cis-trans isomerase activity|FK506 binding|identical protein binding|,12,30,5180000000,46.5%
O35465-2,0.47899797,-0.075666667,8.582234842,0.387333333,0.13860424,1.683550454,0.027,-0.058,-0.777,0.32,0.11,-0.076,O35465,Fkbp8,O35465-2_Fkbp8,O35465-2,Fkbp8,1,5,12,2,O35465-2,MOUSE,44071.6,46.6,852,852.2,166.8,21.92,,402,Isoform 2 of Peptidyl-prolyl cis-trans isomerase FKBP8,cytoplasm|mitochondrion|mitochondrial envelope|endoplasmic reticulum membrane|membrane|integral component of endoplasmic reticulum membrane|mitochondrial membrane|,protein peptidyl-prolyl isomerization|cell fate specification|apoptotic process|smoothened signaling pathway|dorsal/ventral pattern formation|regulation of gene expression|dorsal/ventral neural tube patterning|neural tube development|regulation of BMP signaling pathway|positive regulation of BMP signaling pathway|multicellular organism growth|camera-type eye development|negative regulation of apoptotic process|chaperone-mediated protein folding|,peptidyl-prolyl cis-trans isomerase activity|FK506 binding|identical protein binding|,2,5,1730000000,5.9%
P35278,0.607189465,0.002666667,6.232951882,-0.112666667,0.238070077,-1.295320362,0.153,0.057,-0.033,-0.057,-0.06,-0.044,P35278,Rab5c,P35278_Rab5c,P35278,Rab5c,1,36,11,9,P35278|Q8C266,MOUSE,23640.3,58.7,853,853.1,169.05,137.77,,216,Ras-related protein Rab-5C,lysosomal membrane|early endosome|lipid particle|plasma membrane|endocytic vesicle|early endosome membrane|melanosome|intracellular membrane-bounded organelle|extracellular exosome|,intracellular protein transport|endosome organization|regulation of endocytosis|Rab protein signal transduction|plasma membrane to endosome transport|,GTPase activity|protein binding|GTP binding|GDP binding|,11,36,8170000000,58.7%
Q9CQD1,0.991556352,-0.081333333,0.165877328,0.009333333,0.962525551,0.048790444,0.114,0.165,-0.537,-0.07,-0.082,-0.078,Q9CQD1,Rab5a,Q9CQD1_Rab5a,Q9CQD1,Rab5a,1,9,7,4,Q9CQD1,MOUSE,23826.4,46,853,853.2,99.85,64.14,,215,Ras-related protein Rab-5A,ruffle|cytoplasm|endosome|early endosome|cytosol|plasma membrane|synaptic vesicle|actin cytoskeleton|endocytic vesicle|axon|dendrite|somatodendritic compartment|melanosome|neuronal cell body|terminal bouton|axon terminus|membrane raft|phagocytic vesicle|extracellular exosome|cytoplasmic side of early endosome membrane|,intracellular protein transport|endocytosis|regulation of endocytosis|Rab protein signal transduction|synaptic vesicle recycling|early endosome to late endosome transport|positive regulation of exocytosis|regulation of endosome size|regulation of filopodium assembly|receptor internalization involved in canonical Wnt signaling pathway|regulation of synaptic vesicle exocytosis|,GTPase activity|protein binding|GTP binding|guanyl nucleotide binding|GDP binding|,4,9,2960000000,33.0%
P61021,0.90770516,0.009833333,1.490458188,0.033,0.70950291,0.388779696,0.027,-0.03,-0.017,0.106,-0.049,0.022,P61021,Rab5b,P61021_Rab5b,P61021,Rab5b,1,8,7,4,P61021,MOUSE,23934.6,40.4,853,853.3,92.74,57.03,,215,Ras-related protein Rab-5B,intracellular|endosome|early endosome|plasma membrane|endocytic vesicle|early endosome membrane|melanosome|extracellular exosome|,intracellular protein transport|endosome organization|antigen processing and presentation|regulation of endocytosis|Rab protein signal transduction|plasma membrane to endosome transport|,GTPase activity|protein binding|GTP binding|GDP binding|GTP-dependent protein binding|,4,8,12200000000,27.4%
P29351-2,0.639352439,0.038666667,5.577430296,-0.165333333,0.276857932,-1.184871358,-0.044,0.417,-0.009,0.003,-0.094,-0.041,P29351,Ptpn6,P29351-2_Ptpn6,P29351-2,Ptpn6,1,30,16,16,P29351-2|P29351|P29351-3,MOUSE,68058.2,30.3,854,854.1,168.91,168.91,,595,Isoform 2 of Tyrosine-protein phosphatase non-receptor type 6,nucleus|nucleolus|cytoplasm|cytosol|cell-cell junction|alpha-beta T cell receptor complex|extracellular exosome|,hematopoietic progenitor cell differentiation|negative regulation of humoral immune response mediated by circulating immunoglobulin|protein dephosphorylation|cell proliferation|positive regulation of cell proliferation|positive regulation of phosphatidylinositol 3-kinase signaling|peptidyl-tyrosine phosphorylation|cytokine-mediated signaling pathway|cell differentiation|platelet formation|abortive mitotic cell cycle|positive regulation of cell adhesion mediated by integrin|peptidyl-tyrosine dephosphorylation|intracellular signal transduction|megakaryocyte development|negative regulation of T cell proliferation|natural killer cell mediated cytotoxicity|negative regulation of MAP kinase activity|negative regulation of MAPK cascade|regulation of B cell differentiation|negative regulation of peptidyl-tyrosine phosphorylation|B cell receptor signaling pathway|negative regulation of B cell receptor signaling pathway|negative regulation of T cell receptor signaling pathway|regulation of release of sequestered calcium ion into cytosol|regulation of ERK1 and ERK2 cascade|platelet aggregation|regulation of G1/S transition of mitotic cell cycle|,phosphotyrosine binding|protein tyrosine phosphatase activity|transmembrane receptor protein tyrosine phosphatase activity|protein binding|SH3 domain binding|protein kinase binding|SH2 domain binding|,16,30,5160000000,30.3%
P62900,0.811763387,-0.000666667,2.919445063,-0.058,0.510570236,-0.69478029,-0.007,0.109,-0.017,-0.026,-0.003,-0.06,P62900,Rpl31,P62900_Rpl31,P62900,Rpl31,1,65,14,14,P62900|A0A0A6YX26|A0A0A6YXL3,MOUSE,14462.6,59.2,855,855.1,168.88,168.88,,125,60S ribosomal protein L31,focal adhesion|membrane|cytosolic large ribosomal subunit|extracellular exosome|,translation|,structural constituent of ribosome|poly(A) RNA binding|,14,65,52900000000,59.2%
Q9Z1D1,0.614629659,0.003666667,6.08878982,-0.167333333,0.246105329,-1.272382033,-0.126,0.195,0.193,-0.224,-0.096,0.08,Q9Z1D1,Eif3g,Q9Z1D1_Eif3g,Q9Z1D1,Eif3g,1,42,13,13,Q9Z1D1,MOUSE,35922.7,35,856,856.1,168.79,168.79,,320,Eukaryotic translation initiation factor 3 subunit G,nucleus|cytoplasm|eukaryotic translation initiation factor 3 complex|eukaryotic 43S preinitiation complex|eukaryotic 48S preinitiation complex|perinuclear region of cytoplasm|,formation of translation preinitiation complex|translational initiation|regulation of translational initiation|,nucleotide binding|protein binding|poly(A) RNA binding|translation initiation factor activity|,13,42,12000000000,35.0%
Q8BG67-2,0.863857851,-0.024833333,2.173347839,0.069666667,0.606268796,0.540930729,0.102,0.004,-0.285,0.131,-0.001,-0.1,Q8BG67,Efr3a,Q8BG67-2_Efr3a,Q8BG67-2,Efr3a,1,27,12,12,A0A1D5RLL3|Q8BG67-2|Q8BG67,MOUSE,94201.1,18.7,857,857.1,168.62,168.62,,819,Isoform 2 of Protein EFR3 homolog A,cornified envelope|intracellular|plasma membrane|extracellular exosome|,single organismal cell-cell adhesion|,protein homodimerization activity|,12,27,11800000000,18.7%
Q9D1P4,0.655748724,0.028,5.247393728,-0.148,0.298717473,-1.127544742,0.034,0.367,-0.095,-0.055,-0.056,-0.027,Q9D1P4,Chordc1,Q9D1P4_Chordc1,Q9D1P4,Chordc1,1,30,15,15,Q9D1P4|A0A1L1STZ1|A0A1L1SSG7|A0A1L1STQ1,MOUSE,38091.6,56.7,858,858.1,168.61,168.61,,331,Cysteine and histidine-rich domain-containing protein 1,,regulation of centrosome duplication|chaperone-mediated protein folding|regulation of cellular response to heat|negative regulation of Rho-dependent protein serine/threonine kinase activity|,zinc ion binding|Hsp90 protein binding|calcium ion binding|,15,30,5210000000,56.7%
Q9CSH3,0.891701906,-0.013333333,1.735826624,-0.042,0.670528648,-0.444734116,0.078,0.015,-0.07,0.044,-0.147,0,Q9CSH3,Dis3,Q9CSH3_Dis3,Q9CSH3,Dis3,1,24,13,13,Q9CSH3,MOUSE,109805.5,19.5,859,859.1,167.99,167.99,,958,Exosome complex exonuclease RRP44,nuclear exosome (RNase complex)|cytoplasmic exosome (RNase complex)|nucleoplasm|nucleolus|membrane|,"rRNA processing|mRNA catabolic process|rRNA catabolic process|positive regulation of GTPase activity|CUT catabolic process|nucleic acid phosphodiester bond hydrolysis|RNA phosphodiester bond hydrolysis, exonucleolytic|",3'-5'-exoribonuclease activity|RNA binding|endonuclease activity|guanyl-nucleotide exchange factor activity|,13,24,4000000000,19.5%
Q8R0X7,0.000222149,-0.2345,56.97307573,1.743666667,2.00767E-06,15.27086306,-1.061,-0.983,-1.275,0.614,0.763,0.535,Q8R0X7,Sgpl1,Q8R0X7_Sgpl1,Q8R0X7,Sgpl1,1,41,14,14,Q8R0X7|D6REF7,MOUSE,64303.7,32.7,860,860.1,167.6,167.6,,568,Sphingosine-1-phosphate lyase 1,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,luteinization|vasculogenesis|kidney development|fatty acid metabolic process|ceramide metabolic process|nitrogen compound metabolic process|spermatogenesis|androgen metabolic process|estrogen metabolic process|female gonad development|post-embryonic development|fibroblast migration|hemopoiesis|sphingolipid catabolic process|Leydig cell differentiation|regulation of multicellular organism growth|platelet-derived growth factor receptor signaling pathway|skeletal system morphogenesis|palate development|face morphogenesis|apoptotic signaling pathway|,sphinganine-1-phosphate aldolase activity|carboxy-lyase activity|pyridoxal phosphate binding|,14,41,15500000000,32.7%
Q61792,0.589223895,0.001,6.508801224,0.146666667,0.223418884,1.342012396,-0.189,-0.024,-0.004,0.098,-0.079,0.204,Q61792,Lasp1,Q61792_Lasp1,Q61792,Lasp1,1,40,13,13,Q61792|Q9DC07,MOUSE,30393.3,45.6,861,861.1,167.47,167.47,,263,LIM and SH3 domain protein 1,cytoplasm|focal adhesion|cortical actin cytoskeleton|extracellular exosome|,ion transport|ion transmembrane transport|,protein binding|zinc ion binding|ion transmembrane transporter activity|actin filament binding|,13,40,11700000000,45.6%
A0JNY3,0.400003744,0.001833333,10.39538466,0.173,0.091298057,1.970430767,-0.041,-0.185,-0.028,0.042,0.096,0.127,A0JNY3,Gphn,A0JNY3_Gphn,A0JNY3,Gphn,1,26,13,13,A0JNY3|Q8BUV3,MOUSE,84349,23.1,862,862.1,167.39,167.39,,772,Gephyrin,intracellular|cytoplasm|extrinsic component of plasma membrane|inhibitory synapse|,Mo-molybdopterin cofactor biosynthetic process|establishment of synaptic specificity at neuromuscular junction|molybdenum incorporation into molybdenum-molybdopterin complex|glycine receptor clustering|,cytoskeletal protein binding|molybdopterin adenylyltransferase activity|molybdopterin molybdotransferase activity|,13,26,2310000000,23.1%
Q9JKC8,0.514798568,-0.001333333,7.896263487,-0.137333333,0.162320604,-1.570052697,0.053,0.158,-0.009,-0.026,-0.068,-0.116,Q9JKC8,Ap3m1,Q9JKC8_Ap3m1,Q9JKC8,Ap3m1,1,40,13,13,Q9JKC8|H7BWY2|A0A286YDZ6|Q8R2R9|D6RI63,MOUSE,47277.6,44.9,863,863.1,167.27,167.27,,418,AP-3 complex subunit mu-1,lysosomal membrane|Golgi apparatus|clathrin adaptor complex|cytoplasmic vesicle membrane|,intracellular protein transport|anterograde axon cargo transport|anterograde synaptic vesicle transport|,Rab GTPase binding|,13,40,7390000000,44.9%
Q9EQH3,0.318411535,0.048333333,12.29283095,-0.322,0.058981648,-2.277298291,-0.062,0.31,0.38,-0.243,-0.088,-0.007,Q9EQH3,Vps35,Q9EQH3_Vps35,Q9EQH3,Vps35,1,26,13,13,Q9EQH3,MOUSE,92510.1,20.9,864,864.1,167.06,167.06,,796,Vacuolar protein sorting-associated protein 35,lysosomal membrane|endosome|early endosome|late endosome|cytosol|integral component of membrane|retromer complex|extracellular exosome|tubular endosome|neuronal postsynaptic density|,"vacuolar protein processing|intracellular protein transport|retrograde transport, endosome to Golgi|transcytosis|negative regulation of late endosome to lysosome transport|retrograde transport, endosome to plasma membrane|",protein binding|protein transporter activity|,13,26,7320000000,20.9%
Q9WVJ2,0.984402059,-0.014833333,0.24490235,0.006333333,0.945169644,0.0713935,0.08,-0.031,-0.103,0.013,0.012,-0.06,Q9WVJ2,Psmd13,Q9WVJ2_Psmd13,Q9WVJ2,Psmd13,1,39,13,13,Q9WVJ2|E9Q5I9|E9Q0U1,MOUSE,43150.9,30,865,865.1,167.01,167.01,,376,26S proteasome non-ATPase regulatory subunit 13,proteasome complex|nucleus|proteasome regulatory particle|membrane|proteasome accessory complex|extracellular exosome|,proteolysis|meiosis I|,endopeptidase activity|,13,39,13100000000,30.0%
Q9CR57,0.919577834,1.59016E-18,1.203233817,-0.038,0.758012938,-0.32110956,-0.012,0.225,-0.156,-0.007,0.038,-0.088,Q9CR57,Rpl14,Q9CR57_Rpl14,Q9CR57,Rpl14,1,66,13,13,Q9CR57,MOUSE,23677.8,41,866,866.1,166.84,166.84,,217,60S ribosomal protein L14,cytoplasm|membrane|cytosolic large ribosomal subunit|extracellular exosome|,rRNA processing|translation|ribosomal large subunit biogenesis|,structural constituent of ribosome|poly(A) RNA binding|,13,66,56300000000,41.0%
G5E829,0.811165008,-0.011166667,2.947914281,-0.060333333,0.507234251,-0.700464743,0.025,0.063,-0.031,0.03,-0.121,-0.033,G5E829,Atp2b1,G5E829_Atp2b1,G5E829,Atp2b1,1,29,15,12,G5E829|F8WHB1|Q9R0K7|Q3UHH0|S4R1C4|Q0VF55|A2ALL9|Q8C048,MOUSE,135714.3,15.9,867,867.1,166.79,131.5,,1220,Plasma membrane calcium-transporting ATPase 1,nucleus|plasma membrane|integral component of plasma membrane|cytoplasmic side of plasma membrane|membrane|basolateral plasma membrane|apical plasma membrane|cell junction|dendrite membrane|dendritic spine membrane|neuronal cell body membrane|membrane raft|synapse|extracellular exosome|,neural retina development|calcium ion transport|brain development|aging|metabolic process|response to cold|calcium ion transmembrane transport|cellular response to vitamin D|cellular response to corticosterone stimulus|calcium ion export|,calcium-transporting ATPase activity|protein binding|calmodulin binding|ATP binding|PDZ domain binding|metal ion binding|,15,29,2240000000,15.9%
E9Q828,0.994928853,-0.030666667,0.084094293,-0.003333333,0.98082284,-0.024959589,0.042,0.123,-0.252,0.112,-0.179,-0.03,E9Q828,Atp2b4,E9Q828_Atp2b4,E9Q828,Atp2b4,1,4,7,4,E9Q828|F7AAP4,MOUSE,130395.4,8,867,867.2,79.97,44.68,,1172,Calcium-transporting ATPase,plasma membrane|integral component of plasma membrane|membrane|Z disc|T-tubule|,regulation of transcription from RNA polymerase II promoter|calcium ion transport|cellular calcium ion homeostasis|metabolic process|negative regulation of nitric oxide mediated signal transduction|positive regulation of peptidyl-serine phosphorylation|negative regulation of nitric oxide biosynthetic process|negative regulation of nitric-oxide synthase activity|response to hydrostatic pressure|calcium ion transmembrane transport|negative regulation of calcineurin-NFAT signaling cascade|cellular response to epinephrine stimulus|negative regulation of the force of heart contraction|negative regulation of arginine catabolic process|negative regulation of adrenergic receptor signaling pathway involved in heart process|regulation of cell cycle G1/S phase transition|negative regulation of cardiac muscle hypertrophy in response to stress|negative regulation of citrulline biosynthetic process|positive regulation of cAMP-dependent protein kinase activity|,calcium-transporting ATPase activity|calmodulin binding|ATP binding|protein phosphatase 2B binding|nitric-oxide synthase inhibitor activity|metal ion binding|nitric-oxide synthase binding|nitric-oxide synthase inhibitor activity|,4,4,481000000,4.5%
P35505,0.59743348,0.010166667,6.400755664,0.158333333,0.229046908,1.325087165,0.019,-0.029,-0.197,0.021,0.285,-0.038,P35505,Fah,P35505_Fah,P35505,Fah,1,24,13,13,P35505,MOUSE,46517.3,50.5,868,868.1,166.66,166.66,,419,Fumarylacetoacetase,extracellular exosome|,arginine catabolic process|L-phenylalanine catabolic process|tyrosine catabolic process|,fumarylacetoacetase activity|metal ion binding|,13,24,6890000000,50.5%
Q922Y1,0.821142881,-0.029,2.776447614,0.105333333,0.527661294,0.666444989,0.171,-0.022,-0.394,0.152,-0.013,-0.068,Q922Y1,Ubxn1,Q922Y1_Ubxn1,Q922Y1,Ubxn1,1,40,13,13,Q922Y1,MOUSE,33686.1,54.2,869,869.1,166.64,166.64,,297,UBX domain-containing protein 1,nucleus|cytoplasm|dendrite|VCP-NPL4-UFD1 AAA ATPase complex|neuronal cell body|proteasome complex|,negative regulation of protein ubiquitination|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|,polyubiquitin binding|ubiquitin protein ligase binding|ubiquitin binding|ATPase binding|K6-linked polyubiquitin binding|,13,40,8150000000,54.2%
Q922B1,0.809816893,-0.021666667,2.959038302,-0.078666667,0.505936684,-0.702909497,0.111,0.062,-0.12,-0.073,0.082,-0.192,Q922B1,Macrod1,Q922B1_Macrod1,Q922B1,Macrod1,1,45,12,12,Q922B1,MOUSE,35864.6,38,870,870.1,166.45,166.45,,323,O-acetyl-ADP-ribose deacetylase MACROD1,nucleus|mitochondrion|,cellular response to DNA damage stimulus|purine nucleoside metabolic process|protein de-ADP-ribosylation|,"hydrolase activity, acting on glycosyl bonds|deacetylase activity|",12,45,20600000000,38.0%
Q91WD5,0.728662979,-0.018666667,4.13517217,0.092666667,0.385907113,0.92743885,-0.14,0.094,-0.149,0.067,0.035,-0.019,Q91WD5,Ndufs2,Q91WD5_Ndufs2,Q91WD5,Ndufs2,1,27,14,14,Q91WD5|D3YXT0,MOUSE,53024.1,39.5,871,871.1,165.97,165.97,,463,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial",nucleoplasm|mitochondrion|mitochondrial respiratory chain complex I|,response to oxidative stress|oxidation-reduction process|,"NADH dehydrogenase (ubiquinone) activity|ubiquitin protein ligase binding|metal ion binding|quinone binding|NAD binding|4 iron, 4 sulfur cluster binding|NADH dehydrogenase activity|",14,27,8800000000,39.5%
Q8R0N6,0.855191835,-0.0195,2.307761249,-0.102333333,0.587792276,-0.569529369,0.282,0.174,-0.361,-0.029,0.018,-0.201,Q8R0N6,Adhfe1,Q8R0N6_Adhfe1,Q8R0N6,Adhfe1,1,24,12,12,Q8R0N6|Q8R0N6-2,MOUSE,50392.8,36.3,872,872.1,165.87,165.87,,465,"Hydroxyacid-oxoacid transhydrogenase, mitochondrial",mitochondrion|,molecular hydrogen transport|oxidation-reduction process|,metal ion binding|hydroxyacid-oxoacid transhydrogenase activity|,12,24,3260000000,36.3%
Q8BWJ3,0.709080076,0.008,4.391443485,-0.093333333,0.3637941,-0.974262066,0.16,0.085,-0.081,-0.016,-0.015,-0.085,Q8BWJ3,Phka2,Q8BWJ3_Phka2,Q8BWJ3,Phka2,1,38,13,13,Q8BWJ3|A2AHQ7|Q6PE66,MOUSE,139630.9,11.1,873,873.1,165.49,165.49,,1235,"Phosphorylase b kinase regulatory subunit alpha, liver isoform",plasma membrane|phosphorylase kinase complex|,glycogen metabolic process|protein phosphorylation|,calmodulin binding|phosphorylase kinase activity|,13,38,5370000000,11.1%
P61022,0.332192581,0.0105,11.88405371,-0.221666667,0.064802928,-2.206960175,0.194,0.187,-0.017,-0.157,-0.004,-0.14,P61022,Chp1,P61022_Chp1,P61022,Chp1,1,32,12,12,P61022|B0R091,MOUSE,22431.7,68.7,874,874.1,165.38,165.38,,195,Calcineurin B homologous protein 1,Golgi membrane|nucleus|cytoplasm|endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|cytosol|plasma membrane|focal adhesion|microtubule cytoskeleton|transport vesicle|extracellular exosome|,microtubule bundle formation|negative regulation of protein phosphorylation|negative regulation of protein kinase activity|protein export from nucleus|negative regulation of phosphatase activity|calcium ion-dependent exocytosis|membrane docking|cytoplasmic microtubule organization|negative regulation of protein ubiquitination|negative regulation of protein autophosphorylation|negative regulation of NF-kappaB transcription factor activity|positive regulation of sodium:proton antiporter activity|negative regulation of protein import into nucleus|protein stabilization|positive regulation of protein transport|protein oligomerization|regulation of intracellular pH|positive regulation of protein glycosylation|membrane organization|membrane fusion|negative regulation of calcineurin-NFAT signaling cascade|cellular response to acidic pH|positive regulation of protein targeting to membrane|regulation of neuron death|negative regulation of cyclin-dependent protein kinase activity|,protein kinase inhibitor activity|transporter activity|calcium ion binding|microtubule binding|kinase binding|calcium-dependent protein binding|,12,32,6510000000,68.7%
Q8BYC6,0.617256008,-0.001666667,6.001356406,-0.113333333,0.251110203,-1.256140004,0.07,0.142,-0.047,-0.002,-0.075,-0.098,Q8BYC6,Taok3,Q8BYC6_Taok3,Q8BYC6,Taok3,1,27,14,13,Q8BYC6|Q3V3K3,MOUSE,105790.3,18.8,875,875.1,164.88,153.06,,898,Serine/threonine-protein kinase TAO3,nucleus|cytoplasm|,MAPK cascade|activation of MAPKK activity|DNA repair|protein phosphorylation|cellular response to DNA damage stimulus|mitotic G2 DNA damage checkpoint|regulation of mitotic cell cycle|signal transduction by protein phosphorylation|stress-activated protein kinase signaling cascade|positive regulation of stress-activated MAPK cascade|regulation of apoptotic process|positive regulation of JUN kinase activity|negative regulation of JNK cascade|positive regulation of JNK cascade|protein autophosphorylation|,protein serine/threonine kinase activity|MAP kinase kinase kinase activity|ATP binding|transferase activity|,14,27,3040000000,18.8%
Q9CZ13,0.493441063,-0.006833333,8.336694827,0.219,0.146666361,1.643847498,-0.258,0.108,-0.199,-0.008,0.267,0.049,Q9CZ13,Uqcrc1,Q9CZ13_Uqcrc1,Q9CZ13,Uqcrc1,1,25,12,12,Q9CZ13,MOUSE,53478.4,34.5,876,876.1,164.88,164.88,,480,"Cytochrome b-c1 complex subunit 1, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex III|myelin sheath|,"mitochondrial electron transport, ubiquinol to cytochrome c|aerobic respiration|response to activity|protein processing|response to alkaloid|",metalloendopeptidase activity|protein binding|zinc ion binding|ubiquitin protein ligase binding|protein complex binding|,12,25,8270000000,34.5%
O35857,0.680162369,0.061333333,4.867682065,-0.206,0.326010654,-1.060642349,0.045,0.604,-0.156,0.011,-0.027,-0.109,O35857,Timm44,O35857_Timm44,O35857,Timm44,1,34,13,13,O35857,MOUSE,51432.7,34.2,877,877.1,164.75,164.75,,452,Mitochondrial import inner membrane translocase subunit TIM44,mitochondrion|mitochondrial inner membrane|mitochondrial matrix|,protein import into mitochondrial matrix|,ATP binding|P-P-bond-hydrolysis-driven protein transmembrane transporter activity|chaperone binding|,13,34,4860000000,34.2%
Q06890,0.926033297,0.007,1.072322289,0.044666667,0.781209959,0.289288364,-0.089,-0.268,0.311,0.034,-0.018,0.072,Q06890,Clu,Q06890_Clu,Q06890,Clu,1,28,13,13,Q06890,MOUSE,52282.3,32.8,878,878.1,164.74,164.74,,448,Clusterin,extracellular space|intracellular|nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|cytosol|extracellular matrix|mitochondrial membrane|spherical high-density lipoprotein particle|chromaffin granule|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|neurofibrillary tangle|apical dendrite|extracellular matrix|,cell morphogenesis|microglial cell activation|response to virus|protein import|central nervous system myelin maintenance|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|negative regulation of protein homooligomerization|positive regulation of tumor necrosis factor production|positive regulation of apoptotic process|positive regulation of nitric oxide biosynthetic process|protein stabilization|positive regulation of NF-kappaB transcription factor activity|chaperone-mediated protein complex assembly|response to misfolded protein|chaperone-mediated protein folding|microglial cell proliferation|intrinsic apoptotic signaling pathway|regulation of beta-amyloid clearance|regulation of neuron death|positive regulation of neuron death|positive regulation of beta-amyloid formation|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage|negative regulation of beta-amyloid formation|regulation of neuronal signal transduction|positive regulation of tau-protein kinase activity|positive regulation of neurofibrillary tangle assembly|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of intrinsic apoptotic signaling pathway|,protein binding|ubiquitin protein ligase binding|misfolded protein binding|ATPase activity|,13,28,3740000000,32.8%
Q91YT0,0.580760484,-0.0455,6.732453105,0.203666667,0.212204549,1.380632858,-0.352,0.12,-0.21,0.206,-0.083,0.046,Q91YT0,Ndufv1,Q91YT0_Ndufv1,Q91YT0,Ndufv1,1,39,13,13,Q91YT0|D3YUM1|D3Z1U9|D6RG60,MOUSE,51517.9,42.8,879,879.1,164.64,164.64,,464,"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex I|,oxidation-reduction process|,"protein binding|NADH dehydrogenase (ubiquinone) activity|FMN binding|metal ion binding|NAD binding|4 iron, 4 sulfur cluster binding|",13,39,4780000000,42.8%
P62814,0.833338863,0.011666667,2.610365795,-0.052,0.548230787,-0.632185895,-0.009,0.006,0.116,-0.021,-0.007,-0.015,P62814,Atp6v1b2,P62814_Atp6v1b2,P62814,Atp6v1b2,1,36,14,14,P62814|Q91YH6,MOUSE,56892.1,36.7,880,880.1,164.58,164.58,,511,"V-type proton ATPase subunit B, brain isoform","ruffle|cytoplasm|lysosomal membrane|cytosol|plasma membrane|microvillus|endomembrane system|integral component of membrane|proton-transporting V-type ATPase, V1 domain|melanosome|myelin sheath|intracellular membrane-bounded organelle|extracellular exosome|",ATP hydrolysis coupled proton transport|ATP metabolic process|,"ATP binding|hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances|",15,36,82200000000,36.7%
Q6ZQ08-4,0.891701906,-0.015166667,1.733359128,0.035666667,0.670909725,0.444179727,-0.007,-0.015,-0.077,0.023,-0.044,0.029,Q6ZQ08,Cnot1,Q6ZQ08-4_Cnot1,Q6ZQ08-4,Cnot1,1,20,15,15,Q6ZQ08-4|Q6ZQ08|Q6ZQ08-2|A0A1D5RMJ8|B7ZWL1|A0A1D5RMD8|A0A1D5RM03|Q6ZQ08-3,MOUSE,269241.3,7.9,881,881.1,164.51,164.51,,2375,Isoform 4 of CCR4-NOT transcription complex subunit 1,cytoplasmic mRNA processing body|extracellular space|nucleoplasm|peroxisomal membrane|membrane|CCR4-NOT complex|,"negative regulation of transcription from RNA polymerase II promoter|trophectodermal cell differentiation|transcription, DNA-templated|positive regulation of cytoplasmic mRNA processing body assembly|negative regulation of translation|negative regulation of intracellular estrogen receptor signaling pathway|gene silencing by miRNA|negative regulation of retinoic acid receptor signaling pathway|positive regulation of nuclear-transcribed mRNA poly(A) tail shortening|positive regulation of mRNA catabolic process|RNA phosphodiester bond hydrolysis, exonucleolytic|positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|regulation of stem cell maintenance|",protein binding|protein domain specific binding|estrogen receptor binding|protein complex scaffold|retinoic acid receptor binding|poly(A) RNA binding|armadillo repeat domain binding|poly(A)-specific ribonuclease activity|,15,20,1200000000,7.9%
A2AS98,0.400003744,-0.018166667,10.39127361,-0.172333333,0.091384521,-1.969777465,0.038,0.098,0.068,-0.067,-0.208,-0.038,A2AS98,Nckap1,A2AS98_Nckap1,A2AS98,Nckap1,1,32,14,14,A2AS98|P28660|P28660-2,MOUSE,130820.7,14.9,882,882.1,164.19,164.19,,1134,Nck-associated protein 1,focal adhesion|lamellipodium|SCAR complex|extracellular exosome|,"in utero embryonic development|somitogenesis|neural tube closure|zygotic determination of anterior/posterior axis, embryo|endoderm development|mesodermal cell migration|embryonic body morphogenesis|positive regulation of lamellipodium assembly|Rac protein signal transduction|lamellipodium assembly|notochord development|establishment or maintenance of actin cytoskeleton polarity|regulation of protein localization|embryonic heart tube development|cell migration involved in gastrulation|basal protein localization|apical protein localization|paraxial mesoderm development|paraxial mesoderm morphogenesis|notochord morphogenesis|embryonic foregut morphogenesis|protein stabilization|positive regulation of Arp2/3 complex-mediated actin nucleation|",protein complex binding|Rac GTPase binding|,14,32,23800000000,14.9%
P52430,0.121985139,-0.049,18.85524585,0.420666667,0.013015936,3.366894125,-0.202,-0.078,-0.498,0.13,0.135,0.219,P52430,Pon1,P52430_Pon1,P52430,Pon1,1,50,11,5,P52430,MOUSE,39735.6,30.7,883,883.1,164.16,70.56,,355,Serum paraoxonase/arylesterase 1,extracellular space|high-density lipoprotein particle|spherical high-density lipoprotein particle|intracellular membrane-bounded organelle|extracellular exosome|blood microparticle|,blood circulation|cholesterol metabolic process|response to toxic substance|positive regulation of cholesterol efflux|dephosphorylation|aromatic compound catabolic process|response to nutrient levels|positive regulation of transporter activity|carboxylic acid catabolic process|organophosphate catabolic process|phosphatidylcholine metabolic process|positive regulation of binding|response to fatty acid|response to fluoride|,aryldialkylphosphatase activity|arylesterase activity|calcium ion binding|phospholipid binding|high-density lipoprotein particle binding|protein homodimerization activity|,11,50,33400000000,30.7%
Q9JK53,0.797487413,-0.009333333,3.149126379,0.059333333,0.484269773,0.740277163,0.004,-0.021,-0.1,0.028,0.016,0.017,Q9JK53,Prelp,Q9JK53_Prelp,Q9JK53,Prelp,1,26,15,15,Q9JK53,MOUSE,43634,38.8,884,884.1,163.74,163.74,,378,Prolargin,proteinaceous extracellular matrix|extracellular exosome|extracellular vesicle|extracellular matrix|,cell aging|,extracellular matrix structural constituent|heparin binding|,15,26,17100000000,38.8%
Q0VBL3,0.64745161,-0.009,5.397580092,-0.103333333,0.288563895,-1.152567139,-0.002,0.09,0.04,-0.037,-0.165,0.02,Q0VBL3,Rbm15,Q0VBL3_Rbm15,Q0VBL3,Rbm15,1,21,14,14,Q0VBL3,MOUSE,105948,17.5,885,885.1,163.7,163.7,,962,RNA-binding motif protein 15,nucleus|nucleoplasm|,negative regulation of transcription from RNA polymerase II promoter|patterning of blood vessels|positive regulation of transcription of Notch receptor target|negative regulation of myeloid cell differentiation|spleen development|ventricular septum morphogenesis|placenta blood vessel development|,nucleotide binding|protein binding|poly(A) RNA binding|,14,21,1870000000,17.5%
Q7TNC4,0.518316033,-0.014166667,7.833747527,0.132333333,0.164674081,1.559893842,-0.152,-0.095,0.006,0.066,0.063,0.027,Q7TNC4,Luc7l2,Q7TNC4_Luc7l2,Q7TNC4,Luc7l2,1,37,12,7,Q7TNC4|Q7TNC4-4|Q7TNC4-3|Q7TNC4-2|Q05CX5|E9Q715,MOUSE,46981.6,33.4,886,886.1,163.66,97.96,,392,Putative RNA-binding protein Luc7-like 2,U1 snRNP|nuclear speck|,mRNA splice site selection|,mRNA binding|enzyme binding|poly(A) RNA binding|,12,37,8910000000,33.4%
Q9CYI4,0.430679683,-0.013666667,9.71733022,0.196666667,0.1067252,1.863051401,0.053,-0.116,-0.273,0.09,0.093,0.071,Q9CYI4,Luc7l,Q9CYI4_Luc7l,Q9CYI4,Luc7l,1,8,9,4,Q9CYI4|A0A0R4J047|Q9CYI4-2|D6RGP6|D6REI1,MOUSE,44332.8,25,886,886.2,123.15,57.45,,371,Putative RNA-binding protein Luc7-like 1,nucleus|U1 snRNP|,mRNA splice site selection|negative regulation of striated muscle tissue development|,mRNA binding|protein binding|identical protein binding|RS domain binding|,4,8,579000000,11.3%
Q91VE0,0.667069025,-0.000833333,5.045729724,0.111,0.312915465,1.091123347,0.044,-0.027,-0.186,0.162,-0.013,0.015,Q91VE0,Slc27a4,Q91VE0_Slc27a4,Q91VE0,Slc27a4,1,30,12,12,Q91VE0,MOUSE,73173,26.4,887,887.1,163.23,163.23,,643,Long-chain fatty acid transport protein 4,endoplasmic reticulum|endoplasmic reticulum membrane|plasma membrane|microvillus|membrane|integral component of membrane|brush border membrane|,very long-chain fatty acid metabolic process|medium-chain fatty acid transport|long-chain fatty acid metabolic process|fatty acid metabolic process|response to nutrient|long-chain fatty acid transport|very long-chain fatty acid catabolic process|skin development|long-chain fatty acid import|,nucleotide binding|long-chain fatty acid-CoA ligase activity|very long-chain fatty acid-CoA ligase activity|,12,30,4430000000,26.4%
Q9QYC7,0.759504567,0.016666667,3.723089357,0.081333333,0.424317618,0.850674686,-0.097,-0.035,0.06,-0.003,0,0.175,Q9QYC7,Ggcx,Q9QYC7_Ggcx,Q9QYC7,Ggcx,1,45,12,12,Q9QYC7|A0A0U1RPT2,MOUSE,87763.6,14.7,888,888.1,163.16,163.16,,757,Vitamin K-dependent gamma-carboxylase,endoplasmic reticulum membrane|integral component of membrane|,peptidyl-glutamic acid carboxylation|,gamma-glutamyl carboxylase activity|,12,45,15200000000,14.7%
Q60770,0.634404848,-0.029333333,5.704480763,-0.122666667,0.268875929,-1.20549677,0.046,0.155,-0.105,-0.005,-0.12,-0.147,Q60770,Stxbp3,Q60770_Stxbp3,Q60770,Stxbp3,1,23,12,12,Q60770|Q60770-2|A0A0G2JEQ3|A2AEC9,MOUSE,68854.1,24.6,889,889.1,163.15,163.15,,592,Syntaxin-binding protein 3,cytosol|plasma membrane|basolateral plasma membrane|apical plasma membrane|platelet alpha granule|specific granule|extracellular exosome|tertiary granule|,exocytosis|vesicle docking involved in exocytosis|brain development|glucose transport|protein to membrane docking|insulin secretion|response to insulin|neutrophil degranulation|negative regulation of calcium ion-dependent exocytosis|protein heterooligomerization|platelet aggregation|,protein binding|syntaxin-1 binding|syntaxin binding|,12,23,3160000000,24.6%
Q8R0Y8,0.662343866,-0.002,5.14273662,-0.174,0.306003461,-1.109211294,0.278,0.217,-0.24,0.011,-0.061,-0.217,Q8R0Y8,Slc25a42,Q8R0Y8_Slc25a42,Q8R0Y8,Slc25a42,1,53,10,10,Q8R0Y8,MOUSE,35297.3,39.9,890,890.1,162.5,162.5,,318,Mitochondrial coenzyme A transporter SLC25A42,nucleus|mitochondrion|mitochondrial inner membrane|integral component of membrane|,metabolic process|ADP transport|ATP transport|coenzyme A transmembrane transport|AMP transport|,ATP transmembrane transporter activity|ADP transmembrane transporter activity|coenzyme A transmembrane transporter activity|adenosine-diphosphatase activity|AMP transmembrane transporter activity|,10,53,27300000000,39.9%
Q8R570,0.919618833,-0.0075,1.184435716,-0.032333333,0.761301049,-0.316443545,-0.016,0.067,-0.025,0.12,-0.024,-0.167,Q8R570,Snap47,Q8R570_Snap47,Q8R570,Snap47,1,28,12,12,Q8R570|Q8R570-2|B2FDF6,MOUSE,46751.7,41.8,892,892.1,162.01,162.01,,413,Synaptosomal-associated protein 47,plasma membrane|endomembrane system|membrane|dendrite|SNARE complex|neuronal cell body|perinuclear region of cytoplasm|BLOC-1 complex|,exocytosis|synaptic vesicle priming|synaptic vesicle fusion to presynaptic membrane|long-term synaptic potentiation|,SNAP receptor activity|syntaxin binding|,12,28,3880000000,41.8%
O88544,0.919257874,-0.029833333,1.261202155,0.035,0.747962431,0.334899409,-0.007,0.067,-0.202,0.035,0.032,-0.104,O88544,Cops4,O88544_Cops4,O88544,Cops4,1,24,13,13,O88544,MOUSE,46569.3,46,893,893.1,161.82,161.82,,406,COP9 signalosome complex subunit 4,nucleus|nucleoplasm|synaptic vesicle|COP9 signalosome|cell junction|extracellular exosome|,protein deneddylation|cullin deneddylation|,protein binding|,13,24,2250000000,46.0%
Q5RKZ7,0.52769863,0.001,7.660964965,-0.176,0.171357652,-1.533190509,0.115,0.228,-0.076,0.007,-0.052,-0.216,Q5RKZ7,Mocs1,Q5RKZ7_Mocs1,Q5RKZ7,Mocs1,1,30,13,13,Q5RKZ7|Q5RKZ7-2|G3UYX9|G3UWH1|Q5RKZ7-3,MOUSE,70713.5,25.9,894,894.1,161.26,161.26,,636,Molybdenum cofactor biosynthesis protein 1,molybdopterin synthase complex|,Mo-molybdopterin cofactor biosynthetic process|molybdopterin cofactor biosynthetic process|,"GTP binding|metal ion binding|4 iron, 4 sulfur cluster binding|cyclic pyranopterin monophosphate synthase activity|",13,30,11100000000,25.9%
Q9CXJ1,0.805699632,0.018666667,2.998174034,-0.098,0.501397999,-0.710934744,0.26,0.108,-0.165,0.131,-0.113,-0.109,Q9CXJ1,Ears2,Q9CXJ1_Ears2,Q9CXJ1,Ears2,1,23,14,14,Q9CXJ1,MOUSE,58724.7,34,895,895.1,160.66,160.66,,523,"Probable glutamate--tRNA ligase, mitochondrial",mitochondrion|mitochondrial matrix|,glutamyl-tRNA aminoacylation|tRNA aminoacylation for mitochondrial protein translation|,tRNA binding|glutamate-tRNA ligase activity|ATP binding|glutamate-tRNA(Gln) ligase activity|,14,23,4030000000,34.0%
Q8BMF4,0.648073376,-0.0405,5.379048885,-0.149666667,0.289797818,-1.150499344,0.044,0.108,-0.049,-0.358,0.078,-0.066,Q8BMF4,Dlat,Q8BMF4_Dlat,Q8BMF4,Dlat,1,42,12,12,Q8BMF4,MOUSE,68511,26.7,896,896.1,160.57,160.57,,642,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",mitochondrion|mitochondrial pyruvate dehydrogenase complex|myelin sheath|pyruvate dehydrogenase complex|,glucose metabolic process|acetyl-CoA biosynthetic process from pyruvate|tricarboxylic acid cycle|sleep|,dihydrolipoyllysine-residue acetyltransferase activity|,12,42,8480000000,26.7%
Q9QYF1,0.507052147,-0.080166667,8.077458743,0.389,0.155687637,1.601795325,0.026,-0.031,-0.819,0.347,0.025,-0.029,Q9QYF1,Rdh11,Q9QYF1_Rdh11,Q9QYF1,Rdh11,1,38,13,13,Q9QYF1|Q9R1R8,MOUSE,35546.6,34.1,897,897.1,160.18,160.18,,316,Retinol dehydrogenase 11,photoreceptor inner segment|intracellular|endoplasmic reticulum membrane|integral component of membrane|photoreceptor outer segment membrane|,adaptation of rhodopsin mediated signaling|retinol metabolic process|retinal metabolic process|oxidation-reduction process|,retinol dehydrogenase activity|NADP-retinol dehydrogenase activity|,13,38,16900000000,34.1%
Q8C2E7,0.64206681,0.017,5.49987497,-0.121333333,0.281846407,-1.170442582,0.103,0.013,0.117,0.124,-0.149,-0.106,Q8C2E7,Washc5,Q8C2E7_Washc5,Q8C2E7,Washc5,1,20,14,14,Q8C2E7|Q8C2E7-2,MOUSE,134963.8,13.8,898,898.1,160.12,160.12,,1159,WASH complex subunit 5,endosome|early endosome|endoplasmic reticulum|cytosol|WASH complex|,oocyte maturation|protein transport|endosomal transport|polar body extrusion after meiotic divisions|spindle assembly involved in meiosis|,,14,20,1560000000,13.8%
P61255,0.489597778,-0.02,8.403736682,-0.144666667,0.144419665,-1.652164478,0.077,0.024,0.056,-0.019,-0.062,-0.196,P61255,Rpl26,P61255_Rpl26,P61255,Rpl26,1,61,15,15,P61255|B1ARA5,MOUSE,17257.9,51.7,899,899.1,159.4,159.4,,145,60S ribosomal protein L26,membrane|cytosolic large ribosomal subunit|extracellular exosome|,rRNA processing|translation|ribosomal large subunit biogenesis|,structural constituent of ribosome|protein binding|poly(A) RNA binding|,15,61,42300000000,51.7%
Q8R404,0.886698259,-0.041166667,1.801583986,-0.071666667,0.66045252,-0.459691127,0.121,0.181,-0.318,-0.015,0.015,-0.231,Q8R404,2410015M20Rik,Q8R404_2410015M20Rik,Q8R404,Mic13,1,45,10,10,Q8R404,MOUSE,13430.3,91.5,900,900.1,158.96,158.96,,119,MICOS complex subunit MIC13,mitochondrion|mitochondrial inner membrane|mitochondrial crista junction|MICOS complex|,cristae formation|,,10,45,33100000000,91.5%
Q99L13,0.741564845,-0.018833333,3.943129162,-0.152333333,0.403354665,-0.892594036,0.071,0.297,-0.196,-0.217,0.176,-0.244,Q99L13,Hibadh,Q99L13_Hibadh,Q99L13,Hibadh,1,24,13,13,Q99L13,MOUSE,35838.7,48,901,901.1,158.96,158.96,,335,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",mitochondrion|,valine catabolic process|oxidation-reduction process|,phosphogluconate dehydrogenase (decarboxylating) activity|3-hydroxyisobutyrate dehydrogenase activity|NAD binding|,13,24,4690000000,48.0%
P56959,0.791316333,-0.020333333,3.236611702,0.244666667,0.474612126,0.757916173,-0.558,-0.364,0.494,-0.363,0.219,0.45,P56959,Fus,P56959_Fus,P56959,Fus,1,46,11,8,P56959|Q8CFQ9|Q91VQ2,MOUSE,52900.5,19.4,902,902.1,158.93,118.1,,518,RNA-binding protein FUS,nucleus|nucleoplasm|cytoplasm|polysome|perikaryon|dendritic spine head|perinuclear region of cytoplasm|,cellular response to calcium ion|regulation of nucleic acid-templated transcription|,nucleotide binding|DNA binding|transcription coactivator activity|zinc ion binding|estrogen receptor binding|myosin V binding|ionotropic glutamate receptor binding|identical protein binding|poly(A) RNA binding|retinoid X receptor binding|thyroid hormone receptor binding|,11,46,12600000000,19.4%
Q8BQ46,0.564845247,0.017166667,7.050659635,0.559,0.197212317,1.433495749,-0.715,-0.251,0.179,-0.54,0.675,0.755,Q8BQ46,Taf15,Q8BQ46_Taf15,Q8BQ46,Taf15,1,12,11,7,Q8BQ46,MOUSE,58827.9,25.4,902,902.2,121.8,74.76,,557,"TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor",nucleus|nucleoplasm|cytoplasm|,,nucleotide binding|zinc ion binding|poly(A) RNA binding|,7,12,971000000,20.4%
Q9WU19,0.927777432,-0.025333333,1.04383032,-0.05,0.78635195,-0.282276677,-0.249,0.298,-0.05,-0.31,0.09,0.069,Q9WU19,Hao1,Q9WU19_Hao1,Q9WU19,Hao1,1,25,12,12,Q9WU19,MOUSE,41285.9,36.7,903,903.1,158.84,158.84,,370,Hydroxyacid oxidase 1,peroxisome|,fatty acid alpha-oxidation|response to oxidative stress|glycolate catabolic process|,(S)-2-hydroxy-acid oxidase activity|receptor binding|glycolate oxidase activity|FMN binding|very-long-chain-(S)-2-hydroxy-acid oxidase activity|long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity|medium-chain-(S)-2-hydroxy-acid oxidase activity|,12,25,4250000000,36.7%
Q8R059,0.821409751,-0.002833333,2.758291336,0.059,0.529871873,0.662349829,-0.021,-0.002,-0.074,0.051,-0.079,0.108,Q8R059,Gale,Q8R059_Gale,Q8R059,Gale,1,31,12,12,Q8R059,MOUSE,38566.2,37.4,904,904.1,158.73,158.73,,347,UDP-glucose 4-epimerase,extracellular exosome|,galactose metabolic process|galactose catabolic process|,UDP-N-acetylglucosamine 4-epimerase activity|UDP-glucose 4-epimerase activity|protein homodimerization activity|coenzyme binding|,12,31,10500000000,37.4%
Q8K0G8,0.951421295,-0.028166667,0.740666216,0.023,0.843205398,0.205655851,0.092,0.022,-0.233,0.042,-0.004,-0.088,Q8K0G8,Esrp2,Q8K0G8_Esrp2,Q8K0G8,Esrp2,1,22,14,14,Q8K0G8|F8WGU3|Q3US41|Q3US41-5|Z4YJI3|Q3US41-2|Q3US41-3|Q3US41-4,MOUSE,78158.2,26.9,905,905.1,158.6,158.6,,717,Epithelial splicing regulatory protein 2,nucleus|nucleoplasm|,mRNA processing|RNA splicing|regulation of RNA splicing|,nucleotide binding|mRNA binding|poly(A) RNA binding|,15,22,5700000000,26.9%
Q9D880,0.973520289,0.004,0.385556678,0.014666667,0.915048961,0.110813202,0.148,0.1,-0.258,0.118,-0.014,-0.07,Q9D880,Timm50,Q9D880_Timm50,Q9D880,Timm50,1,40,11,11,Q9D880,MOUSE,40003.9,30.3,906,906.1,158.57,158.57,,353,Mitochondrial import inner membrane translocase subunit TIM50,nucleoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial inner membrane presequence translocase complex|integral component of membrane|nuclear speck|,release of cytochrome c from mitochondria|protein dephosphorylation|mitochondrial membrane organization|protein transport|peptidyl-tyrosine dephosphorylation|,phosphoprotein phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|interleukin-2 receptor binding|ribonucleoprotein complex binding|,11,40,33100000000,30.3%
P97855,0.762989784,-0.043,3.665333908,0.134,0.429998172,0.840383619,0.085,0.05,-0.465,0.086,-0.016,0.002,P97855,G3bp1,P97855_G3bp1,P97855,G3bp1,1,27,12,12,P97855,MOUSE,51884.9,32.9,907,907.1,158.36,158.36,,465,Ras GTPase-activating protein-binding protein 1,nucleus|cytoplasm|cytosol|plasma membrane|focal adhesion|cytoplasmic stress granule|,transport|negative regulation of canonical Wnt signaling pathway|nucleic acid phosphodiester bond hydrolysis|,DNA binding|mRNA binding|helicase activity|endonuclease activity|protein binding|ATP binding|poly(A) RNA binding|,12,27,3820000000,32.9%
Q923D2,0.817484327,-0.009666667,2.833552718,-0.057333333,0.520768526,-0.677549667,-0.046,0.086,0.017,-0.013,-0.008,-0.094,Q923D2,Blvrb,Q923D2_Blvrb,Q923D2,Blvrb,1,35,11,11,Q923D2|E9PZC3|E9PZC4|A0A0U1RPU7,MOUSE,22311,65.5,908,908.1,158.17,158.17,,206,Flavin reductase (NADPH),nucleoplasm|cytoplasm|cytosol|plasma membrane|extracellular exosome|,heme catabolic process|oxidation-reduction process|,biliverdin reductase activity|riboflavin reductase (NADPH) activity|,11,35,12900000000,65.5%
Q9CQC6,0.771416168,-0.000166667,3.578876445,-0.083,0.438644164,-0.823348407,0.137,-0.062,0.049,0.071,-0.05,-0.146,Q9CQC6,Bzw1,Q9CQC6_Bzw1,Q9CQC6,Bzw1,1,33,13,13,A0A087WQS2|Q9CQC6|A0A087WS48,MOUSE,48213.5,26.2,909,909.1,158.03,158.03,,419,Basic leucine zipper and W2 domain-containing protein 1,cytoplasm|membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",poly(A) RNA binding|,13,33,65900000000,26.2%
Q61210-5,0.847271066,-0.0065,2.38595511,-0.047,0.577303897,-0.58564957,0.04,0.011,0,0.013,-0.087,-0.016,Q61210,Arhgef1,Q61210-5_Arhgef1,Q61210-5,Arhgef1,1,34,15,15,Q61210-5|E9PUF7|Q61210|Q61210-2|Q61210-4|Q61210-3,MOUSE,109874.4,17.5,910,910.1,158.02,158.02,,920,Isoform 5 of Rho guanine nucleotide exchange factor 1,cytoplasm|plasma membrane|,regulation of Rho protein signal transduction|termination of G-protein coupled receptor signaling pathway|positive regulation of GTPase activity|,Rho guanyl-nucleotide exchange factor activity|GTPase activator activity|protein binding|poly(A) RNA binding|,15,34,6670000000,17.5%
Q9EPC1,0.816757276,-0.0115,2.854744805,-0.098333333,0.518233543,-0.682248035,0.181,0.177,-0.245,0.033,-0.017,-0.198,Q9EPC1,Parva,Q9EPC1_Parva,Q9EPC1,Parva,1,37,11,11,Q9EPC1|Q3UF75|D6RHM9,MOUSE,42386.1,34.4,911,911.1,157.9,157.9,,372,Alpha-parvin,nucleus|cytoplasm|plasma membrane|focal adhesion|actin cytoskeleton|Z disc|lamellipodium|,sprouting angiogenesis|outflow tract septum morphogenesis|cell adhesion|establishment or maintenance of cell polarity|regulation of cell shape|actin cytoskeleton reorganization|heterotypic cell-cell adhesion|substrate adhesion-dependent cell spreading|cilium morphogenesis|actin-mediated cell contraction|smooth muscle cell chemotaxis|,actin binding|protein binding|,11,37,6220000000,34.4%
Q9CXR1,0.512341124,-0.0295,7.99287532,0.171666667,0.158749537,1.586271656,-0.066,0.012,-0.292,0.121,0.063,-0.015,Q9CXR1,Dhrs7,Q9CXR1_Dhrs7,Q9CXR1,Dhrs7,1,36,13,13,Q9CXR1,MOUSE,38566.1,42.3,912,912.1,157.71,157.71,,338,Dehydrogenase/reductase SDR family member 7,membrane|,oxidation-reduction process|,oxidoreductase activity|,13,36,16700000000,42.3%
Q8R086,0.818423797,-0.006666667,2.815758212,0.055333333,0.522906667,0.673964582,-0.075,-0.052,0.024,-0.027,0.032,0.058,Q8R086,Suox,Q8R086_Suox,Q8R086,Suox,1,34,14,14,Q8R086,MOUSE,61268.2,28,913,913.1,157.57,157.57,,546,"Sulfite oxidase, mitochondrial",mitochondrion|mitochondrial intermembrane space|cytosol|,sulfur compound metabolic process|response to nutrient|nitrate assimilation|oxidation-reduction process|,sulfite oxidase activity|heme binding|molybdenum ion binding|molybdopterin cofactor binding|,14,34,2340000000,28.0%
Q6ZWQ9,0.410633762,-0.104,10.1563571,0.579333333,0.096463783,1.936072055,-0.066,-0.022,-1.093,-0.069,0.3,0.326,Q6ZWQ9,Myl12a,Q6ZWQ9_Myl12a,Q6ZWQ9,Myl12a,1,36,11,4,Q6ZWQ9|Q3THE2,MOUSE,19952,48.8,914,914.1,156.37,63.1,,172,MCG5400,stress fiber|myosin II complex|Z disc|extracellular exosome|,regulation of cell shape|platelet aggregation|protein targeting to plasma membrane|,calcium ion binding|protein binding|glutamate receptor binding|,11,36,29100000000,48.8%
Q9CQ19,0.289929066,-0.153166667,13.11372816,0.978333333,0.048823306,2.409106521,-0.31,-0.015,-1.602,0.015,0.52,0.473,Q9CQ19,Myl9,Q9CQ19_Myl9,Q9CQ19,Myl9,1,10,9,3,Q9CQ19,MOUSE,19910.9,54.6,914,914.2,127.1,50.75,,172,Myosin regulatory light polypeptide 9,stress fiber|myosin II complex|Z disc|,platelet aggregation|,calcium ion binding|myosin heavy chain binding|,3,10,1870000000,28.4%
O55022,0.696322589,-0.045,4.595623767,0.158666667,0.347086421,1.012008818,0.016,0.051,-0.44,0.025,0.175,-0.097,O55022,Pgrmc1,O55022_Pgrmc1,O55022,Pgrmc1,1,49,13,11,O55022,MOUSE,21807.9,57.4,915,915.1,155.67,130.25,,195,Membrane-associated progesterone receptor component 1,nucleolus|endoplasmic reticulum|endoplasmic reticulum membrane|endomembrane system|membrane|integral component of membrane|extracellular exosome|,axon guidance|,steroid binding|heme binding|,13,49,38100000000,57.4%
Q80UU9,0.002109954,-0.113833333,40.26145683,1.285,9.41574E-05,8.355008717,-0.606,-0.619,-1.044,0.431,0.718,0.437,Q80UU9,Pgrmc2,Q80UU9_Pgrmc2,Q80UU9,Pgrmc2,1,22,11,9,Q80UU9,MOUSE,23447.8,43.3,915,915.2,136.63,111.21,,217,Membrane-associated progesterone receptor component 2,endomembrane system|membrane|integral component of membrane|,,steroid binding|heme binding|,9,22,10900000000,40.5%
Q8CG76,0.674607544,-0.0455,4.953921867,0.154333333,0.319600767,1.075932763,0.044,0.017,-0.429,-0.012,0.095,0.012,Q8CG76,Akr7a5,Q8CG76_Akr7a5,Q8CG76,Akr7a2,1,34,13,13,Q8CG76,MOUSE,41067.8,40.5,916,916.1,155.62,155.62,,367,Aflatoxin B1 aldehyde reductase member 2,mitochondrion|Golgi apparatus|extracellular exosome|,daunorubicin metabolic process|doxorubicin metabolic process|oxidation-reduction process|,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor|phenanthrene-9,10-epoxide hydrolase activity|",13,34,10400000000,40.5%
D3Z780,0.978001068,-0.016833333,0.323786539,-0.009,0.92815679,-0.093611198,0.032,0.049,-0.118,0.076,-0.11,-0.03,D3Z780,NotFound,D3Z780_NotFound,D3Z780,Eif2b4,1,29,11,11,D3Z780|Q61749-2|Q61749,MOUSE,63036.1,30,917,917.1,155.15,155.15,,566,Translation initiation factor eIF-2B subunit delta,cytoplasm|eukaryotic translation initiation factor 2B complex|,ovarian follicle development|translational initiation|oligodendrocyte development|myelination|positive regulation of GTPase activity|negative regulation of translational initiation|L-methionine biosynthetic process from methylthioadenosine|,guanyl-nucleotide exchange factor activity|S-methyl-5-thioribose-1-phosphate isomerase activity|translation initiation factor activity|guanyl-nucleotide exchange factor activity|,11,29,3600000000,30.0%
Q91VA6,0.785249508,-0.039666667,3.327315694,0.096,0.464802474,0.775569979,0.066,-0.002,-0.327,0.015,0.064,-0.054,Q91VA6,Poldip2,Q91VA6_Poldip2,Q91VA6,Poldip2,1,31,12,12,Q91VA6,MOUSE,42097.6,38.5,918,918.1,154.88,154.88,,368,Polymerase delta-interacting protein 2,nucleus|mitochondrion|mitochondrial nucleoid|,mitochondrion morphogenesis|,"DNA binding|protein binding, bridging|",12,31,8890000000,38.5%
Q99KY4,0.719204842,-0.033833333,4.231216134,0.111,0.377466476,0.945686804,0.032,-0.058,-0.242,0.165,0.021,-0.121,Q99KY4,Gak,Q99KY4_Gak,Q99KY4,Gak,1,22,13,13,A0A0R4J0F6|Q99KY4|Q99KY4-2|D6RHK5|A0A0G2JEW6|A0A0G2JGP6,MOUSE,145121.3,12.2,919,919.1,154.86,154.86,,1305,Cyclin-G-associated kinase,Golgi apparatus|focal adhesion|membrane|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|,protein phosphorylation|endoplasmic reticulum organization|Golgi organization|cell cycle|epidermal cell differentiation|intrahepatic bile duct development|cell development|forebrain morphogenesis|establishment of skin barrier|clathrin coat disassembly|clathrin-mediated endocytosis|positive regulation of neural precursor cell proliferation|,protein serine/threonine kinase activity|protein binding|ATP binding|,13,22,7020000000,12.2%
A0A0R4J083,0.847271066,-0.048833333,2.387097354,-0.093,0.577152079,-0.586232079,-0.174,0.159,0.008,-0.383,0.13,-0.033,A0A0R4J083,Acadl,A0A0R4J083_Acadl,A0A0R4J083,Acadl,1,39,12,12,A0A0R4J083|P51174,MOUSE,48295.4,33.2,920,920.1,154.82,154.82,,430,"Long-chain-specific acyl-CoA dehydrogenase, mitochondrial",,,,12,39,14500000000,33.2%
Q60597-3,0.92990033,-0.000166667,0.997921236,0.024333333,0.794708533,0.27078902,0.004,-0.068,0.027,-0.095,0.081,0.05,Q60597,Ogdh,Q60597-3_Ogdh,Q60597-3,Ogdh,1,29,14,14,Q60597-3|Q60597-4|Q60597|Z4YJV4|Q60597-2|E9Q7L0,MOUSE,119375.1,15.5,921,921.1,154.73,154.73,,1023,"Isoform 3 of 2-oxoglutarate dehydrogenase, mitochondrial",mitochondrion|mitochondrial matrix|mitochondrial membrane|oxoglutarate dehydrogenase complex|cytosol|,generation of precursor metabolites and energy|glycolytic process|tricarboxylic acid cycle|cerebellar cortex development|striatum development|hippocampus development|thalamus development|pyramidal neuron development|tangential migration from the subventricular zone to the olfactory bulb|olfactory bulb mitral cell layer development|,oxoglutarate dehydrogenase (succinyl-transferring) activity|thiamine pyrophosphate binding|oxoglutarate dehydrogenase (NAD+) activity|metal ion binding|,14,29,17600000000,15.5%
Q9JII5,0.469727509,0.004333333,8.891871361,-0.143333333,0.129066301,-1.730645066,0.047,0.14,0.041,-0.12,-0.037,-0.045,Q9JII5,Dazap1,Q9JII5_Dazap1,Q9JII5,Dazap1,1,43,10,10,Q9JII5|Q3UGB5|Q9JII5-2,MOUSE,43441.6,36.2,922,922.1,154.63,154.63,,406,DAZ-associated protein 1,nucleus|nucleoplasm|cytoplasm|polysome|,"maternal placenta development|spermatogenesis|cell proliferation|cell differentiation|positive regulation of mRNA splicing, via spliceosome|",nucleotide binding|RNA binding|RNA stem-loop binding|poly(A) RNA binding|,10,43,23900000000,36.2%
Q9D0S9,0.885307507,0.001333333,1.824769359,-0.062666667,0.656936003,-0.46485629,-0.166,0.248,0.016,-0.178,-0.004,0.092,Q9D0S9,Hint2,Q9D0S9_Hint2,Q9D0S9,Hint2,1,49,9,9,Q9D0S9,MOUSE,17376.8,47.8,923,923.1,154.37,154.37,,163,"Histidine triad nucleotide-binding protein 2, mitochondrial",nucleolus|mitochondrion|,steroid biosynthetic process|apoptotic process|,nucleotide binding|hydrolase activity|,9,49,93000000000,47.8%
Q7TNE1,0.774891394,0.001166667,3.47059265,-0.095666667,0.449718481,-0.803225093,0.234,-0.007,-0.08,0.027,0.021,-0.188,Q7TNE1,Sugct,Q7TNE1_Sugct,Q7TNE1,Sugct,1,33,12,12,Q7TNE1,MOUSE,48202.9,39.9,924,924.1,154.34,154.34,,436,Succinate--hydroxymethylglutarate CoA-transferase,mitochondrion|,metabolic process|,succinate-hydroxymethylglutarate CoA-transferase activity|,12,33,11400000000,39.9%
Q544X6,0.637521424,0.000833333,5.609298227,-0.121666667,0.274833822,-1.189147125,-0.052,0.203,0.034,-0.15,0.005,-0.035,Q544X6,Fech,Q544X6_Fech,Q544X6,Fech,1,31,13,13,Q544X6|P22315,MOUSE,47991.4,38.3,925,925.1,154,154,,422,Ferrochelatase,mitochondrion|mitochondrial inner membrane|,porphyrin-containing compound biosynthetic process|heme biosynthetic process|cholesterol metabolic process|response to light stimulus|detection of UV|response to lead ion|regulation of gene expression|regulation of eIF2 alpha phosphorylation by heme|response to insecticide|erythrocyte differentiation|very-low-density lipoprotein particle assembly|response to drug|response to ethanol|protoporphyrinogen IX metabolic process|response to arsenic-containing substance|regulation of hemoglobin biosynthetic process|response to methylmercury|iron ion homeostasis|response to platinum ion|cellular response to dexamethasone stimulus|,ferrochelatase activity|iron ion binding|heme binding|iron-responsive element binding|tetrapyrrole binding|,13,31,2800000000,38.3%
Q9WUR9,0.773512169,-0.025666667,3.509891333,0.116,0.4456674,0.810762683,0.168,-0.104,-0.315,0.103,0.101,-0.107,Q9WUR9,Ak4,Q9WUR9_Ak4,Q9WUR9,Ak4,1,34,10,10,Q9WUR9,MOUSE,25175.4,56,926,926.1,153.51,153.51,,223,"Adenylate kinase 4, mitochondrial",mitochondrion|mitochondrial matrix|extracellular exosome|,liver development|nucleoside diphosphate phosphorylation|ADP biosynthetic process|brain development|nucleoside triphosphate biosynthetic process|response to drug|AMP metabolic process|ATP metabolic process|GTP metabolic process|,adenylate kinase activity|nucleoside diphosphate kinase activity|ATP binding|GTP binding|nucleoside triphosphate adenylate kinase activity|,10,34,10400000000,56.0%
Q570Y9,0.55391814,-0.0765,7.185505995,0.245,0.191183056,1.455784339,0.009,-0.044,-0.562,0.086,0.133,-0.081,Q570Y9,Deptor,Q570Y9_Deptor,Q570Y9,Deptor,1,21,12,12,Q570Y9|Q570Y9-3|B2ZRS5|Q570Y9-2,MOUSE,46632.2,39.8,927,927.1,153.49,153.49,,409,DEP domain-containing mTOR-interacting protein,intracellular|,negative regulation of protein kinase activity|negative regulation of TOR signaling|intracellular signal transduction|negative regulation of cell size|regulation of extrinsic apoptotic signaling pathway|,,12,21,2240000000,39.8%
Q9Z2I0,0.951421295,-0.076333333,0.747800884,0.05,0.841821303,0.207548439,0.067,0.269,-0.64,0.129,-0.055,-0.228,Q9Z2I0,Letm1,Q9Z2I0_Letm1,Q9Z2I0,Letm1,1,25,13,13,Q9Z2I0,MOUSE,83671.8,28,928,928.1,153.32,153.32,,738,Mitochondrial proton/calcium exchanger protein,mitochondrion|mitochondrial inner membrane|integral component of membrane|,cristae formation|,metal ion binding|,13,25,2430000000,28.0%
Q8BTI8,0.911411213,0.002333333,1.433381827,0.04,0.718888965,0.375547962,-0.163,0.106,0.004,-0.011,-0.053,0.131,Q8BTI8,Srrm2,Q8BTI8_Srrm2,Q8BTI8,Srrm2,1,28,14,14,Q8BTI8|Q8BTI8-3|Q8BTI8-2,MOUSE,295691.1,7.8,929,929.1,153.31,153.31,,2703,Serine/arginine repetitive matrix protein 2,Cajal body|nuclear speck|catalytic step 2 spliceosome|,RNA splicing|,poly(A) RNA binding|protein N-terminus binding|C2H2 zinc finger domain binding|,14,28,7410000000,7.8%
Q8K1N2-2,0.647295927,-0.016333333,5.437082199,0.12,0.285951106,1.159542959,0.04,-0.049,-0.22,0.11,-0.051,0.072,Q8K1N2,Phldb2,Q8K1N2-2_Phldb2,Q8K1N2-2,Phldb2,1,24,14,14,Q8K1N2-2|Q8K1N2,MOUSE,148252.5,13.2,930,930.1,153.06,153.06,,1249,Isoform 2 of Pleckstrin homology-like domain family B member 2,cytoplasm|plasma membrane|cell leading edge|intermediate filament cytoskeleton|basal cortex|focal adhesion|,"microtubule cytoskeleton organization|regulation of gastrulation|regulation of epithelial to mesenchymal transition|establishment of protein localization|negative regulation of stress fiber assembly|negative regulation of focal adhesion assembly|regulation of microtubule cytoskeleton organization|negative regulation of wound healing, spreading of epidermal cells|positive regulation of basement membrane assembly involved in embryonic body morphogenesis|",,14,24,8000000000,13.2%
Q60960,0.966996144,-0.012333333,0.448607386,0.016666667,0.901860283,0.128118221,0.019,0.186,-0.267,0.054,-0.009,-0.057,Q60960,Kpna1,Q60960_Kpna1,Q60960,Kpna1,1,23,11,5,Q60960|G3UZK5|G3UXT6,MOUSE,60923.2,26.3,931,931.1,153.01,71.8,,538,Importin subunit alpha-5,nucleus|nucleoplasm|cytoplasm|dendrite|,protein import into nucleus|positive regulation of protein import into nucleus|,protein binding|protein transporter activity|,11,23,3790000000,26.3%
P15116,0.001821256,-0.0575,41.24127405,0.863,7.51402E-05,8.57670677,-0.489,-0.37,-0.608,0.301,0.352,0.469,P15116,Cdh2,P15116_Cdh2,P15116,Cdh2,1,41,12,12,P15116|D3YYT0|P39038,MOUSE,100251,19.3,932,932.1,152.95,152.95,,906,Cadherin-2,cell-cell junction|adherens junction|cell-cell adherens junction|fascia adherens|focal adhesion|intercalated disc|membrane|integral component of membrane|basolateral plasma membrane|apical plasma membrane|catenin complex|lamellipodium|plasma membrane raft|synapse|extracellular exosome|cortical actin cytoskeleton|,cell adhesion|homophilic cell adhesion via plasma membrane adhesion molecules|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|glial cell differentiation|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|cell migration|regulation of myelination|regulation of Rho protein signal transduction|positive regulation of MAPK cascade|cell-cell adhesion mediated by cadherin|blood vessel morphogenesis|regulation of axonogenesis|striated muscle cell differentiation|protein heterooligomerization|establishment of protein localization to plasma membrane|negative regulation of canonical Wnt signaling pathway|neuroligin clustering involved in postsynaptic membrane assembly|neuronal stem cell maintenance|regulation of postsynaptic density protein 95 clustering|positive regulation of synaptic vesicle clustering|,calcium ion binding|protein binding|beta-catenin binding|enzyme binding|protein kinase binding|protein phosphatase binding|protein complex binding|alpha-catenin binding|gamma-catenin binding|nitric-oxide synthase binding|,12,41,5940000000,19.3%
P70404,0.497381785,0.046666667,8.23913147,-0.184,0.149998478,-1.626832253,0.16,0.306,-0.05,-0.094,0.014,-0.056,P70404,Idh3g,P70404_Idh3g,P70404,Idh3g,1,27,11,11,P70404,MOUSE,43184.1,36.8,933,933.1,152.92,152.92,,393,"Isocitrate dehydrogenase [NAD] subunit gamma 1, mitochondrial",nucleoplasm|nucleolus|mitochondrion|,tricarboxylic acid cycle|isocitrate metabolic process|2-oxoglutarate metabolic process|NADH metabolic process|negative regulation of growth|,magnesium ion binding|isocitrate dehydrogenase (NAD+) activity|ATP binding|NAD binding|,11,27,5090000000,36.8%
Q91X34,0.919618833,-0.0635,1.172072998,0.045,0.763471272,0.313604348,-0.282,0.102,-0.078,-0.261,0.045,0.093,Q91X34,Baat,Q91X34_Baat,Q91X34,Baat,1,23,11,11,Q91X34,MOUSE,46766.1,36.1,934,934.1,152.75,152.75,,420,Bile acid-CoA:amino acid N-acyltransferase,peroxisome|cytosol|,liver development|bile acid conjugation|glycine metabolic process|fatty acid metabolic process|acyl-CoA metabolic process|bile acid biosynthetic process|bile acid metabolic process|taurine metabolic process|organ regeneration|,receptor binding|palmitoyl-CoA hydrolase activity|N-acyltransferase activity|glycine N-choloyltransferase activity|carboxylic ester hydrolase activity|medium-chain acyl-CoA hydrolase activity|long-chain acyl-CoA hydrolase activity|very long chain acyl-CoA hydrolase activity|,11,23,7210000000,36.1%
Q61510,0.447813439,-0.0395,9.445502687,-0.157,0.113618678,-1.819203986,0.051,0.06,0.006,-0.215,-0.054,-0.085,Q61510,Trim25,Q61510_Trim25,Q61510,Trim25,1,23,12,12,Q61510|Q5SU71|Q5SU72,MOUSE,73265.5,24.2,935,935.1,152.41,152.41,,634,E3 ubiquitin/ISG15 ligase TRIM25,nucleoplasm|cytoplasm|,protein ubiquitination|positive regulation of I-kappaB kinase/NF-kappaB signaling|innate immune response|regulation of viral entry into host cell|negative regulation of viral entry into host cell|positive regulation of sequence-specific DNA binding transcription factor activity|positive regulation of NF-kappaB transcription factor activity|defense response to virus|regulation of viral release from host cell|negative regulation of viral release from host cell|,zinc ion binding|acid-amino acid ligase activity|poly(A) RNA binding|,12,23,3470000000,24.2%
P21107-2,0.316451715,-0.011,12.38595012,0.258,0.057730456,2.289552944,-0.038,-0.057,-0.325,0.05,0.225,0.079,P21107,Tpm3,P21107-2_Tpm3,P21107-2,Tpm3,1,27,14,10,P21107-2|D3Z2H9|D3Z6I8|E9Q7Q3|E9Q5J9|A0A0R4J1P2|P21107|F8WID5|E9Q454|E9Q450|Q8BP43|E9Q448|P58771-2|Q8BSH3|P58771|B7ZNL3|E9Q452|A2AIM4|P58774-2|P58774|S4R2U0,MOUSE,29248.3,51.6,936,936.1,152.39,99.34,,285,Isoform 2 of Tropomyosin alpha-3 chain,stress fiber|podosome|cytoplasm|growth cone|cortical cytoskeleton|neuron projection|extracellular exosome|filamentous actin|cleavage furrow|,,actin binding|protein binding|,15,27,12500000000,51.6%
A2RSQ0,0.995757571,0.000333333,0.055451488,0.001333333,0.98731299,0.016504249,0.041,-0.02,-0.022,0.053,-0.011,-0.039,A2RSQ0,Dennd5b,A2RSQ0_Dennd5b,A2RSQ0,Dennd5b,1,28,15,15,A2RSQ0,MOUSE,146109.9,13.8,937,937.1,152.36,152.36,,1274,DENN domain-containing protein 5B,membrane|integral component of membrane|,positive regulation of GTPase activity|detection of mechanical stimulus|calcium ion transmembrane transport|,calcium channel activity|Rab guanyl-nucleotide exchange factor activity|,15,28,2310000000,13.8%
O88696,0.960763421,-0.024333333,0.589441537,0.018666667,0.873083632,0.166001874,0.109,0.027,-0.237,-0.055,0.025,-0.015,O88696,Clpp,O88696_Clpp,O88696,Clpp,1,56,11,11,O88696,MOUSE,30085.2,38.2,938,938.1,152.25,152.25,,272,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",mitochondrion|mitochondrial matrix|endopeptidase Clp complex|,misfolded or incompletely synthesized protein catabolic process|protein homooligomerization|proteolysis involved in cellular protein catabolic process|,serine-type endopeptidase activity|protein binding|identical protein binding|,11,56,38900000000,38.2%
P61161,0.919416995,-0.016666667,1.220800971,0.033333333,0.754952979,0.325200454,-0.119,0.008,0.011,-0.141,0.015,0.126,P61161,Actr2,P61161_Actr2,P61161,Actr2,1,41,12,12,P61161,MOUSE,45045.2,29.4,939,939.1,152.19,152.19,,394,Actin-related protein 2,cytoplasm|Arp2/3 protein complex|focal adhesion|cell cortex|membrane|actin cap|cell projection|extracellular exosome|,establishment or maintenance of cell polarity|asymmetric cell division|meiotic chromosome movement towards spindle pole|cytoplasmic transport|actin cytoskeleton organization|meiotic cytokinesis|Arp2/3 complex-mediated actin nucleation|cilium assembly|meiotic cell cycle|spindle localization|,structural constituent of cytoskeleton|ATP binding|actin filament binding|,12,41,18100000000,29.4%
P62751,0.991656487,-0.01,0.152502652,-0.004,0.965494346,-0.044902632,-0.001,0.079,-0.102,-0.026,0.042,-0.052,P62751,Rpl23a,P62751_Rpl23a,P62751,Rpl23a,1,43,11,11,A0A140T8M7|P62751|D3YTY6,MOUSE,17694.7,55.1,940,940.1,151.8,151.8,,156,60S ribosomal protein L23a,nucleus|nucleolus|cytosolic large ribosomal subunit|extracellular exosome|TORC2 complex|,translation|cell proliferation|,nucleotide binding|structural constituent of ribosome|protein binding|rRNA binding|poly(A) RNA binding|,11,43,29400000000,55.1%
Q9D6Y9,0.246705091,-0.042166667,14.33726079,0.289666667,0.036836124,2.603033671,-0.268,-0.001,-0.292,0.197,0.07,0.041,Q9D6Y9,Gbe1,Q9D6Y9_Gbe1,Q9D6Y9,Gbe1,1,35,12,12,Q9D6Y9|F6ZHD8|G3UW30,MOUSE,80818.6,21.6,941,941.1,151.78,151.78,,702,"1,4-alpha-glucan-branching enzyme",extracellular exosome|,glycogen biosynthetic process|,"1,4-alpha-glucan branching enzyme activity|hydrolase activity, hydrolyzing O-glycosyl compounds|cation binding|",12,35,8090000000,21.6%
P57759,0.000426615,-0.531,51.15600224,2.570666667,7.66302E-06,12.47193548,-1.617,-1.526,-2.306,0.729,0.757,0.777,P57759,Erp29,P57759_Erp29,P57759,Erp29,1,34,12,12,P57759|D6RG87|F8WIM7|F8WJI4,MOUSE,28879.8,48,942,942.1,151.59,151.59,,262,Endoplasmic reticulum resident protein 29,endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|cell surface|membrane|transport vesicle|melanosome|extracellular exosome|,activation of MAPK activity|positive regulation of protein phosphorylation|ER to Golgi vesicle-mediated transport|protein secretion|positive regulation of gene expression|negative regulation of gene expression|negative regulation of protein secretion|regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|,protein homodimerization activity|chaperone binding|,12,34,14000000000,48.0%
Q61129,0.003315407,-0.0505,37.76006514,0.907666667,0.000167492,7.598094747,-0.486,-0.398,-0.629,0.326,0.286,0.598,Q61129,Cfi,Q61129_Cfi,Q61129,Cfi,1,36,12,12,Q61129,MOUSE,69541.5,24.2,943,943.1,151.33,151.33,,603,Complement factor I,extracellular space|membrane|extracellular exosome|,"proteolysis|receptor-mediated endocytosis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|scavenger receptor activity|metal ion binding|,12,36,5070000000,24.2%
Q6ZPE2-2,0.842967796,-0.000833333,2.468806928,-0.049666667,0.566394865,-0.60294389,0.052,0.002,0.018,0,-0.099,0.022,Q6ZPE2,Sbf1,Q6ZPE2-2_Sbf1,Q6ZPE2-2,Sbf1,1,16,11,11,Q6ZPE2-2|Q6ZPE2|D6RG52,MOUSE,213477.8,8.6,944,944.1,151.3,151.3,,1867,Isoform 2 of Myotubularin-related protein 5,nucleus|,regulation of cell growth|spermatogenesis|negative regulation of catalytic activity|positive regulation of GTPase activity|,pseudophosphatase activity|Rab guanyl-nucleotide exchange factor activity|,11,16,2980000000,8.6%
A2A5S3,0.797504707,-0.041833333,3.142591047,0.089666667,0.484999058,0.739492133,-0.048,0.101,-0.313,-0.019,0.029,-0.001,A2A5S3,Stau1,A2A5S3_Stau1,A2A5S3,Stau1,1,32,11,1,A2A5S3|V9GX87,MOUSE,55197.2,29.6,945,945.1,150.99,14.37,,495,Double-stranded RNA-binding protein Staufen homolog 1,cytoplasm|endoplasmic reticulum|plasma membrane|membrane|dendrite|ribonucleoprotein complex|cytoplasmic ribonucleoprotein granule|neuronal cell body|cell body|extracellular exosome|,intracellular mRNA localization|positive regulation of viral genome replication|positive regulation by virus of viral protein levels in host cell|,RNA binding|double-stranded RNA binding|protein binding|protein phosphatase 1 binding|poly(A) RNA binding|,11,32,4930000000,29.6%
Q3U487,0.905087052,-0.013166667,1.542163884,0.037,0.701105883,0.400713687,0.017,-0.009,-0.103,0.117,-0.036,-0.065,Q3U487,Hectd3,Q3U487_Hectd3,Q3U487,Hectd3,1,21,14,14,Q3U487|Q3U487-2,MOUSE,98429.3,19.8,946,946.1,150.56,150.56,,861,E3 ubiquitin-protein ligase HECTD3,cytoplasm|perinuclear region of cytoplasm|,protein ubiquitination involved in ubiquitin-dependent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|,ubiquitin-protein transferase activity|ligase activity|syntaxin binding|,14,21,1650000000,19.8%
Q8VC19,0.961523652,0.0135,0.533369244,0.021,0.884429206,0.151058527,-0.092,-0.169,0.27,0.126,-0.096,0.042,Q8VC19,Alas1,Q8VC19_Alas1,Q8VC19,Alas1,1,19,12,12,Q8VC19|A0A0R4J0X2|D6RGR8,MOUSE,71872.1,20.4,947,947.1,150.52,150.52,,642,"5-aminolevulinate synthase, nonspecific, mitochondrial",nucleoplasm|cytoplasm|mitochondrion|mitochondrial matrix|,protoporphyrinogen IX biosynthetic process|,5-aminolevulinate synthase activity|pyridoxal phosphate binding|,12,19,2560000000,20.4%
Q8VCH6,0.967029453,-0.010833333,0.445835576,0.011,0.902436063,0.127305969,-0.064,0.058,-0.043,0.057,-0.004,-0.069,Q8VCH6,Dhcr24,Q8VCH6_Dhcr24,Q8VCH6,Dhcr24,1,27,12,12,Q8VCH6,MOUSE,60852.9,20.1,948,948.1,150.49,150.49,,516,Delta(24)-sterol reductase,Golgi membrane|nucleus|cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|cytosol|cytoskeleton|membrane|integral component of membrane|,cholesterol biosynthetic process|response to oxidative stress|Ras protein signal transduction|protein localization|cholesterol metabolic process|negative regulation of cell proliferation|response to hormone|tissue development|sterol metabolic process|male genitalia development|plasminogen activation|amyloid precursor protein catabolic process|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|skin development|oxidation-reduction process|membrane organization|,"delta24(24-1) sterol reductase activity|UDP-N-acetylmuramate dehydrogenase activity|oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor|enzyme binding|peptide antigen binding|delta24-sterol reductase activity|flavin adenine dinucleotide binding|",12,27,10000000000,20.1%
Q8K3W0,0.951421295,-0.0035,0.740930366,-0.018333333,0.843154114,-0.205678199,-0.043,0.115,-0.055,0.022,-0.057,-0.003,Q8K3W0,Babam2,Q8K3W0_Babam2,Q8K3W0,Babam2,1,30,11,11,Q8K3W0|Q8K3W0-1|Q8K3W0-5|Q8K3W0-6|D3Z7P0|Q8K3W0-4|E9Q0U3|E9Q8Q1,MOUSE,44000.3,27.1,949,949.1,150.47,150.47,,383,BRISC and BRCA1-A complex member 2,nuclear ubiquitin ligase complex|nucleus|cytoplasm|BRCA1-A complex|BRISC complex|,double-strand break repair|apoptotic process|cellular response to DNA damage stimulus|response to ionizing radiation|chromatin modification|G2 DNA damage checkpoint|positive regulation of DNA repair|,tumor necrosis factor receptor binding|polyubiquitin binding|,11,30,9480000000,27.1%
B1ASP2,0.647450828,0.035333333,5.422332511,-0.15,0.286923916,-1.158020516,0.001,-0.033,0.363,0.046,-0.117,-0.048,B1ASP2,Jak1,B1ASP2_Jak1,B1ASP2,Jak1,1,26,14,13,B1ASP2|P52332,MOUSE,135233.7,13,950,950.1,150.35,138.1,,1153,Tyrosine-protein kinase,nucleus|cytoplasm|cytoskeleton|focal adhesion|extrinsic component of cytoplasmic side of plasma membrane|,enzyme linked receptor protein signaling pathway|transmembrane receptor protein tyrosine kinase signaling pathway|cell migration|peptidyl-tyrosine phosphorylation|cytokine-mediated signaling pathway|cell differentiation|intracellular signal transduction|peptidyl-tyrosine autophosphorylation|interleukin-2-mediated signaling pathway|regulation of cell proliferation|innate immune response|response to antibiotic|,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|growth hormone receptor binding|protein binding|ATP binding|protein phosphatase binding|CCR5 chemokine receptor binding|,14,26,3470000000,13.0%
E9QJS1,0.199620765,-0.057666667,15.94554254,0.342,0.02543582,2.87167722,-0.343,-0.307,-0.036,0.229,-0.006,0.117,E9QJS1,Tyk2,E9QJS1_Tyk2,E9QJS1,Tyk2,1,3,4,3,E9QJS1|Q3TXE3|Q9R117,MOUSE,138009.7,3.8,950,950.2,33.54,21.29,,1207,Tyrosine-protein kinase,nucleus|cytoplasm|cytoskeleton|extrinsic component of cytoplasmic side of plasma membrane|extracellular exosome|,transmembrane receptor protein tyrosine kinase signaling pathway|cell migration|cell differentiation|intracellular signal transduction|peptidyl-tyrosine autophosphorylation|regulation of cell proliferation|innate immune response|,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|growth hormone receptor binding|ATP binding|type 1 angiotensin receptor binding|hormone receptor binding|,3,3,44800000,2.9%
Q91WJ2,0.701917801,-0.009,4.505604753,-0.123333333,0.354355783,-0.995776897,0.183,0.018,-0.043,0.132,-0.229,-0.115,Q91WJ2,Slc22a26,Q91WJ2_Slc22a26,Q91WJ2,Slc22a26,1,62,11,9,Q91WJ2|E9Q6M5,MOUSE,62158,16.6,951,951.1,150.3,124.54,,552,"MCG14908, isoform CRA_b",integral component of plasma membrane|,sodium-independent organic anion transport|anion transmembrane transport|,inorganic anion exchanger activity|sodium-independent organic anion transmembrane transporter activity|,11,62,81800000000,16.6%
Q96LX3,0.797504707,-0.0845,3.122368729,0.258333333,0.487262655,0.735512398,-0.252,0.567,-0.956,0.099,-0.011,0.046,Q96LX3,Slc22a30,Q96LX3_Slc22a30,Q96LX3,Slc22a30,1,9,7,5,Q96LX3|E9PVA5|Q3V3G0|B2RT89|Q8VCA0,MOUSE,62823.8,16.1,951,951.2,81.83,57.2,,552,"Solute carrier family 22, member 30",integral component of plasma membrane|,sodium-independent organic anion transport|anion transmembrane transport|,inorganic anion exchanger activity|sodium-independent organic anion transmembrane transporter activity|,5,9,933000000,12.6%
Q62376,0.997585215,-0.007833333,0.026312851,0.001666667,0.993959559,0.00786095,-0.459,0.102,0.331,-0.095,-0.117,0.191,Q62376,Snrnp70,Q62376_Snrnp70,Q62376,Snrnp70,1,28,12,12,Q62376|Q62376-2|A0A1B0GRV8,MOUSE,52048.2,31.4,952,952.1,150.26,150.26,,448,U1 small nuclear ribonucleoprotein 70 kDa,nucleus|nucleoplasm|spliceosomal complex|U1 snRNP|nuclear speck|,"mRNA splicing, via spliceosome|regulation of RNA splicing|positive regulation of mRNA splicing, via spliceosome|",nucleotide binding|RNA binding|poly(A) RNA binding|,13,28,7280000000,31.4%
Q7M6Y3-5,0.463450011,0.022,9.018987342,-0.374666667,0.125343341,-1.753912076,0.102,0.659,-0.133,-0.374,-0.06,-0.062,Q7M6Y3,Picalm,Q7M6Y3-5_Picalm,Q7M6Y3-5,Picalm,1,22,11,1,Q7M6Y3-5|Q7M6Y3-3|Q7M6Y3-2|E9QLK9|Q61548|Q61548-2|E9QQ05|Q61548-3|E9Q9A3|Q3TWS4,MOUSE,71151.7,24.2,953,953.1,150.08,21.05,,660,Isoform 5 of Phosphatidylinositol-binding clathrin assembly protein,intracellular|nucleus|Golgi apparatus|coated pit|membrane|vesicle|neuronal cell body|intracellular membrane-bounded organelle|neurofibrillary tangle|AP-2 adaptor complex|clathrin coat of coated pit|perinuclear region of cytoplasm|,"receptor-mediated endocytosis|axonogenesis|cell proliferation|negative regulation of gene expression|synaptic vesicle maturation|endosomal transport|hemopoiesis|regulation of endocytosis|receptor internalization|regulation of protein localization|cargo loading into vesicle|positive regulation of transcription, DNA-templated|negative regulation of receptor-mediated endocytosis|clathrin coat assembly|dendrite morphogenesis|iron ion homeostasis|clathrin-mediated endocytosis|iron ion import into cell|positive regulation of neuron death|positive regulation of beta-amyloid formation|regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process|positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process|negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process|",1-phosphatidylinositol binding|clathrin binding|clathrin heavy chain binding|clathrin adaptor activity|,11,22,5850000000,24.2%
Q91ZW2,0.001826563,-0.082333333,41.19919444,1.062666667,7.58718E-05,8.654661768,-0.488,-0.503,-0.85,0.483,0.372,0.492,Q91ZW2,Pofut1,Q91ZW2_Pofut1,Q91ZW2,Pofut1,1,28,10,10,Q91ZW2|A2AMC3|Q3UXG7|E9Q686|E9PZ15,MOUSE,45144.1,37.4,954,954.1,149.71,149.71,,393,GDP-fucose protein O-fucosyltransferase 1,endoplasmic reticulum|membrane|,angiogenesis|somitogenesis|fucose metabolic process|protein O-linked glycosylation|Notch signaling pathway|nervous system development|heart development|protein O-linked fucosylation|,fucosyltransferase activity|peptide-O-fucosyltransferase activity|,10,28,4210000000,37.4%
G3X928,0.255844821,0.001833333,13.99546209,0.299666667,0.039852337,2.550269305,-0.299,-0.176,0.031,0.247,0.03,0.178,G3X928,Sec23ip,G3X928_Sec23ip,G3X928,Sec23ip,1,37,13,13,G3X928|Q6NZC7,MOUSE,111388.8,19.4,955,955.1,149.59,149.59,,998,SEC23-interacting protein,cis-Golgi network|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|endoplasmic reticulum exit site|perinuclear endoplasmic reticulum|,acrosome assembly|spermatid development|single fertilization|,poly(A) RNA binding|metal ion binding|,13,37,82800000000,19.4%
P60122,0.706444596,0.038333333,4.445795219,-0.138,0.359269606,-0.984951817,-0.095,0.032,0.385,-0.083,-0.076,0.067,P60122,Ruvbl1,P60122_Ruvbl1,P60122,Ruvbl1,1,17,11,11,P60122,MOUSE,50555.4,30.2,956,956.1,149.53,149.53,,456,RuvB-like 1,Swr1 complex|nucleus|nucleoplasm|cytoplasm|Golgi apparatus|ribonucleoprotein complex|Ino80 complex|NuA4 histone acetyltransferase complex|intracellular membrane-bounded organelle|extracellular exosome|MLL1 complex|,"DNA repair|DNA recombination|transcription, DNA-templated|regulation of transcription, DNA-templated|mitotic nuclear division|DNA duplex unwinding|regulation of growth|histone H4 acetylation|histone H2A acetylation|cell division|regulation of mitochondrion degradation|positive regulation of protein targeting to mitochondrion|",DNA helicase activity|ATP binding|ATP-dependent 5'-3' DNA helicase activity|,11,17,1400000000,30.2%
Q8K0Z7,0.586445778,0.012833333,6.555363076,-0.181666667,0.221036346,-1.351037192,0.188,0.265,-0.142,-0.032,0.013,-0.215,Q8K0Z7,Taco1,Q8K0Z7_Taco1,Q8K0Z7,Taco1,1,30,11,11,Q8K0Z7,MOUSE,32770,42.5,957,957.1,149.35,149.35,,294,Translational activator of cytochrome c oxidase 1,nucleus|nucleoplasm|mitochondrion|,regulation of translation|,,11,30,23800000000,42.5%
Q3TCU5,0.336787221,-0.011833333,11.73710478,0.205,0.067033134,2.183559479,-0.225,-0.017,-0.101,0.077,0.035,0.16,Q3TCU5,Tapbp,Q3TCU5_Tapbp,Q3TCU5,Tapbp,1,24,14,14,Q3TCU5|Q9R233|Q9R233-2,MOUSE,50119.8,35.8,958,958.1,149.33,149.33,,466,Tapasin,Golgi membrane|endoplasmic reticulum membrane|integral component of plasma membrane|TAP complex|,"MHC class I protein complex assembly|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent|defense response|antigen processing and presentation of endogenous peptide antigen via MHC class I|",protein binding|TAP1 binding|TAP2 binding|,14,24,3190000000,35.8%
Q99N93,0.726796323,0.004833333,4.160408006,-0.095,0.383671199,-0.93207955,0.004,0.218,-0.065,-0.072,-0.006,-0.05,Q99N93,Mrpl16,Q99N93_Mrpl16,Q99N93,Mrpl16,1,25,12,12,Q99N93,MOUSE,28917.4,43.8,959,959.1,149.18,149.18,,251,"39S ribosomal protein L16, mitochondrial",mitochondrion|mitochondrial large ribosomal subunit|,translation|mitochondrial translation|,structural constituent of ribosome|rRNA binding|,12,25,4530000000,43.8%
P34927,0.000844502,-0.145333333,45.61440099,1.885333333,2.74511E-05,10.19435925,-1.014,-1.023,-1.227,0.633,1.206,0.553,P34927,Asgr1,P34927_Asgr1,P34927,Asgr1,1,32,10,10,P34927|B1AR34,MOUSE,33161.5,31.6,960,960.1,148.87,148.87,,284,Asialoglycoprotein receptor 1,integral component of membrane|,receptor-mediated endocytosis|cellular response to extracellular stimulus|,asialoglycoprotein receptor activity|carbohydrate binding|protein homodimerization activity|metal ion binding|,10,32,21700000000,31.6%
Q922E4,0.072213408,-0.012333333,21.7468404,0.421333333,0.006688303,3.873253935,-0.218,-0.107,-0.344,0.126,0.124,0.345,Q922E4,Pcyt2,Q922E4_Pcyt2,Q922E4,Pcyt2,1,29,11,11,Q922E4|A2ABY3,MOUSE,45690.6,28.2,961,961.1,148.65,148.65,,404,Ethanolamine-phosphate cytidylyltransferase,,phosphatidylethanolamine biosynthetic process|,ethanolamine-phosphate cytidylyltransferase activity|,11,29,9020000000,28.2%
Q91V12-4,0.470565279,-0.004666667,8.87412655,-0.218666667,0.129594731,-1.730607961,0.172,0.225,-0.083,-0.134,0.049,-0.257,Q91V12,Acot7,Q91V12-4_Acot7,Q91V12-4,Acot7,1,44,12,12,Q91V12-4|Q91V12-2|E9PYH2|Q91V12|Q91V12-3,MOUSE,42071.5,38.7,962,962.1,148.35,148.35,,381,Isoform D of Cytosolic acyl coenzyme A thioester hydrolase,nucleoplasm|cytoplasm|cytosol|neuron projection|cell body|extracellular exosome|,fatty acid catabolic process|coenzyme A biosynthetic process|medium-chain fatty-acyl-CoA catabolic process|long-chain fatty-acyl-CoA catabolic process|medium-chain fatty acid biosynthetic process|palmitic acid biosynthetic process|,fatty-acyl-CoA binding|palmitoyl-CoA hydrolase activity|long-chain fatty acyl-CoA binding|protein homodimerization activity|carboxylic ester hydrolase activity|,12,44,12000000000,38.7%
O08917,0.600763538,0.0225,6.331406624,-0.179,0.232733734,-1.313411752,0.019,-0.036,0.353,0.073,-0.068,-0.206,O08917,Flot1,O08917_Flot1,O08917,Flot1,1,23,14,14,O08917|G3UYU4,MOUSE,47797.9,33.4,963,963.1,148.31,148.31,,428,Flotillin-1,uropod|lysosomal membrane|endosome|early endosome|microtubule organizing center|plasma membrane|caveola|cell-cell adherens junction|focal adhesion|membrane|basolateral plasma membrane|flotillin complex|lamellipodium|cytoplasmic vesicle|centriolar satellite|sarcolemma|melanosome|cell-cell contact zone|plasma membrane raft|membrane raft|extracellular exosome|COP9 signalosome|cortical actin cytoskeleton|,"membrane raft assembly|positive regulation of cytokine production|positive regulation of protein phosphorylation|regulation of receptor internalization|endocytosis|axonogenesis|axon guidance|extracellular matrix disassembly|positive regulation of protein binding|positive regulation of synaptic transmission, dopaminergic|positive regulation of interferon-beta production|dsRNA transport|positive regulation of heterotypic cell-cell adhesion|positive regulation of toll-like receptor 3 signaling pathway|response to endoplasmic reticulum stress|regulation of Rho protein signal transduction|plasma membrane raft assembly|positive regulation of endocytosis|positive regulation of skeletal muscle tissue development|protein homooligomerization|positive regulation of cell adhesion molecule production|protein kinase C signaling|cellular response to exogenous dsRNA|protein localization to plasma membrane|establishment of protein localization to plasma membrane|positive regulation of myoblast fusion|positive regulation of cell junction assembly|protein localization to membrane raft|positive regulation of cell-cell adhesion mediated by cadherin|",protease binding|protein binding|protein heterodimerization activity|,14,23,51900000000,33.4%
Q9DB30,0.88153149,0.008166667,1.914376394,0.041,0.643520462,0.484430272,0.063,-0.005,-0.095,0.039,0.042,0.005,Q9DB30,Phkg2,Q9DB30_Phkg2,Q9DB30,Phkg2,1,25,11,11,Q9DB30|D6RG71|D6RGU6|A0A0U1RPC7,MOUSE,46971,35.2,964,964.1,148.24,148.24,,406,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",phosphorylase kinase complex|,glycogen biosynthetic process|protein phosphorylation|,phosphorylase kinase activity|calmodulin binding|ATP binding|enzyme binding|,11,25,4420000000,35.2%
Q80X73,0.942504874,-0.000333333,0.826105582,-0.021333333,0.826779009,-0.227559705,0.031,0.028,-0.028,0.111,-0.123,-0.021,Q80X73,Pelo,Q80X73_Pelo,Q80X73,Pelo,1,35,14,14,Q80X73,MOUSE,43804.7,29.3,965,965.1,148.18,148.18,,385,Protein pelota homolog,nucleus|cytoplasm|,"cell cycle|cell proliferation|chromosome organization|cell division|nuclear-transcribed mRNA catabolic process, non-stop decay|nuclear-transcribed mRNA catabolic process, no-go decay|RNA surveillance|nucleic acid phosphodiester bond hydrolysis|",endonuclease activity|metal ion binding|,14,35,4090000000,29.3%
Q9DB29,0.837702479,0.0085,2.55998081,0.059,0.554628164,0.621821114,0.049,-0.001,-0.111,0.044,0.131,-0.061,Q9DB29,Iah1,Q9DB29_Iah1,Q9DB29,Iah1,1,27,12,12,Q9DB29|A0A1Y7VLY5,MOUSE,28430.1,50.2,966,966.1,148.18,148.18,,249,Isoamyl acetate-hydrolyzing esterase 1 homolog,extracellular exosome|,lipid catabolic process|,"hydrolase activity, acting on ester bonds|",12,27,5690000000,50.2%
Q6P1F6,0.593471457,-0.013833333,6.44263891,0.130333333,0.226848603,1.330563041,0.003,-0.012,-0.228,0.099,0.05,0.005,Q6P1F6,Ppp2r2a,Q6P1F6_Ppp2r2a,Q6P1F6,Ppp2r2a,1,21,13,10,Q6P1F6|Q9CWU3|Q6ZWR4-2|Q6ZWR4|Q6ZWR4-3|A0A286YDJ9|Q8BG02,MOUSE,52204.6,38.7,967,967.1,148.1,97.46,,447,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform,protein phosphatase type 2A complex|,protein dephosphorylation|signal transduction|regulation of protein phosphatase type 2A activity|response to morphine|,protein serine/threonine phosphatase activity|protein phosphatase type 2A regulator activity|protein complex binding|tau protein binding|protein phosphatase 2A binding|,13,21,2610000000,38.7%
Q8CGF7,0.933608247,-0.004166667,0.95078176,0.021,0.803381495,0.259045239,-0.018,0.038,-0.064,-0.028,0.008,0.039,Q8CGF7,Tcerg1,Q8CGF7_Tcerg1,Q8CGF7,Tcerg1,1,20,13,13,Q8CGF7|Q8CGF7-2|Q8CGF7-3|Q3B807|Q3B807-3,MOUSE,124014,13.5,968,968.1,148.01,148.01,,1100,Transcription elongation regulator 1,nucleus|nucleolus|actin cytoskeleton|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|",RNA polymerase II repressing transcription factor binding|RNA polymerase II transcription corepressor activity|sequence-specific DNA binding transcription factor activity|poly(A) RNA binding|proline-rich region binding|,13,20,990000000,13.5%
Q9QXB9,0.838820082,-0.0395,2.548671097,-0.092333333,0.556074385,-0.619861947,0.185,0.147,-0.312,-0.016,-0.081,-0.16,Q9QXB9,Drg2,Q9QXB9_Drg2,Q9QXB9,Drg2,1,25,12,12,Q9QXB9,MOUSE,41117,45.8,969,969.1,148.01,148.01,,364,Developmentally-regulated GTP-binding protein 2,cytoplasm|mitochondrion|membrane|,,GTP binding|,12,25,6410000000,45.8%
P61620,0.35633016,-0.004,11.30145032,-0.206666667,0.074106272,-2.114338711,0.143,0.163,-0.008,0.004,-0.189,-0.137,P61620,Sec61a1,P61620_Sec61a1,P61620,Sec61a1,1,41,10,10,P61620|Q9JLR1|Q9CYJ6|A2ATT9,MOUSE,52720.2,19.3,970,970.1,147.81,147.81,,476,Protein transport protein Sec61 subunit alpha isoform 1,endoplasmic reticulum membrane|rough endoplasmic reticulum|membrane|integral component of membrane|phagocytic vesicle membrane|,SRP-dependent cotranslational protein targeting to membrane|posttranslational protein targeting to membrane|endoplasmic reticulum organization|cell growth|response to interferon-gamma|,ribosome binding|,10,41,37900000000,19.3%
Q80ZX0,0.734218406,0.005166667,4.022371715,-0.073,0.396061683,-0.906608764,0.013,0.057,0.055,0,-0.091,-0.003,Q80ZX0,Sec24b,Q80ZX0_Sec24b,Q80ZX0,Sec24b,1,27,14,14,Q80ZX0,MOUSE,136689.5,11.7,971,971.1,147.74,147.74,,1251,"Sec24-related gene family, member B (S. cerevisiae)",COPII vesicle coat|ER to Golgi transport vesicle|,neural tube closure|auditory receptor cell morphogenesis|outflow tract morphogenesis|intracellular protein transport|ER to Golgi vesicle-mediated transport|cochlear nucleus development|aorta morphogenesis|auditory receptor cell stereocilium organization|lung morphogenesis|lung lobe morphogenesis|coronary artery morphogenesis|pulmonary artery morphogenesis|cardiovascular system development|regulation of establishment of planar polarity involved in neural tube closure|regulation of cargo loading into COPII-coated vesicle|,protein binding|zinc ion binding|,14,27,1840000000,11.7%
Q9CQE8,0.905664235,0.006166667,1.536249305,0.034333333,0.702061358,0.399352552,0.051,-0.078,-0.006,0.093,-0.017,-0.006,Q9CQE8,Rtraf,Q9CQE8_Rtraf,Q9CQE8,RTRAF,1,38,10,10,Q9CQE8,MOUSE,28265.8,42.2,972,972.1,147.74,147.74,,244,"RNA transcription, translation and transport factor protein",nucleus|nucleoplasm|cytoplasm|microtubule organizing center|cytosol|perinuclear region of cytoplasm|tRNA-splicing ligase complex|,"transcription, DNA-templated|tRNA splicing, via endonucleolytic cleavage and ligation|positive regulation of transcription from RNA polymerase II promoter|",RNA polymerase II core binding|RNA binding|identical protein binding|poly(A) RNA binding|,10,38,8190000000,42.2%
Q9CPR4,0.799710496,-0.001,3.074485015,-0.063333333,0.49266476,-0.725581271,-0.011,0.109,-0.006,-0.08,0.043,-0.061,Q9CPR4,NotFound,Q9CPR4_NotFound,Q9CPR4,Rpl17,1,35,11,11,Q9CPR4|Q6ZWZ7|B2RY53,MOUSE,21651,42.3,973,973.1,147.68,147.68,,184,60S ribosomal protein L17,nucleus|cytosolic large ribosomal subunit|,translation|,structural constituent of ribosome|poly(A) RNA binding|,11,35,24400000000,42.3%
I1E4X8,0.041329984,-0.0025,24.67203255,0.526333333,0.003410333,4.446416444,-0.167,-0.171,-0.459,0.24,0.158,0.384,I1E4X8,NotFound,I1E4X8_NotFound,I1E4X8,Stim2,1,20,12,12,I1E4X8|P83093,MOUSE,85625.2,18.9,974,974.1,147.68,147.68,,754,Stromal interaction molecule 2,endoplasmic reticulum|plasma membrane|integral component of membrane|,cellular calcium ion homeostasis|activation of store-operated calcium channel activity|positive regulation of calcium ion transport|calcium ion transmembrane transport|,calcium channel regulator activity|calcium ion binding|store-operated calcium channel activity|,12,20,2910000000,18.9%
O54988,0.918194884,0.014166667,1.270823963,0.027666667,0.746307152,0.337171567,-0.034,-0.005,0.04,0.092,-0.013,0.005,O54988,Slk,O54988_Slk,O54988,Slk,1,18,15,15,O54988|O54988-2|O55098,MOUSE,142138.8,14.1,975,975.1,147.5,147.5,,1233,STE20-like serine/threonine-protein kinase,cytoplasm|extracellular exosome|,apoptotic process|regulation of mitotic cell cycle|signal transduction by protein phosphorylation|stress-activated protein kinase signaling cascade|activation of protein kinase activity|regulation of apoptotic process|protein autophosphorylation|,protein serine/threonine kinase activity|ATP binding|identical protein binding|protein homodimerization activity|,15,18,2740000000,14.1%
Q9DBH5,0.000222149,-0.2755,57.11825205,1.867,1.94167E-06,15.44371537,-1.12,-1.066,-1.441,0.61,0.646,0.718,Q9DBH5,Lman2,Q9DBH5_Lman2,Q9DBH5,Lman2,1,34,10,10,Q9DBH5,MOUSE,40771.4,36.5,976,976.1,147.5,147.5,,358,Vesicular integral-membrane protein VIP36,Golgi membrane|extracellular space|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|integral component of plasma membrane|cell surface|extracellular exosome|,"retrograde vesicle-mediated transport, Golgi to ER|protein transport|positive regulation of phagocytosis|",glycoprotein binding|mannose binding|carbohydrate binding|heat shock protein binding|metal ion binding|,10,34,22200000000,36.5%
Q6ZWZ6,0.97545852,0.035,0.361385033,-0.02,0.920156073,-0.104122653,-0.201,-0.1,0.436,-0.195,0.1,0.17,Q6ZWZ6,Rps12,Q6ZWZ6_Rps12,Q6ZWZ6,Rps12-ps3,1,45,10,10,F7AEH4|Q6ZWZ6|A0A1W2P7A1|P63323,MOUSE,14914.1,78.7,977,977.1,147.14,147.14,,132,40S ribosomal protein S12,membrane|cytosolic small ribosomal subunit|,translation|,structural constituent of ribosome|poly(A) RNA binding|,10,45,35700000000,78.7%
P21614,0.001667629,-0.0925,41.79369496,1.237666667,6.61653E-05,8.849360694,-0.472,-0.723,-0.939,0.406,0.53,0.643,P21614,Gc,P21614_Gc,P21614,Gc,1,17,12,12,P21614,MOUSE,55196.9,34,978,978.1,146.55,146.55,,476,Vitamin D-binding protein,extracellular space|cytosol|axon|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|,female pregnancy|lactation|response to nutrient levels|response to estradiol|vitamin D metabolic process|vitamin transport|,actin binding|vitamin transporter activity|calcidiol binding|,12,17,3550000000,34.0%
Q99JY9,0.847271066,-0.013833333,2.385118845,0.092333333,0.577415071,0.585817095,-0.308,-0.087,0.215,-0.147,0.079,0.165,Q99JY9,Actr3,Q99JY9_Actr3,Q99JY9,Actr3,1,22,12,10,Q99JY9|A0A087WPR6|Q641P0-2,MOUSE,47812.7,39.4,979,979.1,146.52,128.05,,418,Actin-related protein 3,cytoplasm|Arp2/3 protein complex|brush border|cell-cell junction|focal adhesion|membrane|lamellipodium|extracellular exosome|,establishment or maintenance of cell polarity|asymmetric cell division|meiotic chromosome movement towards spindle pole|meiotic cytokinesis|Arp2/3 complex-mediated actin nucleation|meiotic cell cycle|spindle localization|cilium morphogenesis|,structural constituent of cytoskeleton|protein binding|ATP binding|actin filament binding|,12,22,1090000000,39.4%
O08553,0.977544159,0.0225,0.328912456,0.011,0.927061946,0.095071922,-0.095,-0.06,0.206,-0.061,0.002,0.143,O08553,Dpysl2,O08553_Dpysl2,O08553,Dpysl2,1,23,11,11,O08553|Q6P1J1|P97427,MOUSE,62675.8,25.3,980,980.1,146.32,146.32,,572,Dihydropyrimidinase-related protein 2,mitochondrion|cytosol|axon|dendrite|growth cone|neuronal cell body|terminal bouton|myelin sheath|extracellular exosome|microtubule|membrane|,response to amphetamine|endocytosis|cytoskeleton organization|axon guidance|metabolic process|regulation of neuron projection development|positive regulation of glutamate secretion|spinal cord development|olfactory bulb development|regulation of axon extension|response to cocaine|response to drug|synaptic vesicle transport|,"protein binding|microtubule binding|hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds|protein kinase binding|",11,23,1640000000,25.3%
E9Q411,0.885307507,0.006833333,1.831654119,-0.047666667,0.655895405,-0.466142237,0.095,0.035,-0.038,0.137,-0.062,-0.126,E9Q411,Nbas,E9Q411_Nbas,E9Q411,Nbas,1,19,16,16,E9Q411,MOUSE,269022.1,7.6,981,981.1,146.23,146.23,,2356,Neuroblastoma-amplified sequence,nucleolus|cytoplasm|endoplasmic reticulum|Golgi apparatus|membrane|nuclear membrane|Dsl1p complex|,"nuclear-transcribed mRNA catabolic process|retrograde vesicle-mediated transport, Golgi to ER|negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|",SNARE binding|,16,19,868000000,7.6%
Q9CQI3,0.546002425,0.005166667,7.351364535,-0.129666667,0.184019373,-1.481132771,0.171,0.043,-0.004,-0.051,-0.033,-0.095,Q9CQI3,Gmfb,Q9CQI3_Gmfb,Q9CQI3,Gmfb,1,23,10,8,Q9CQI3,MOUSE,16894,77.4,982,982.1,146.08,115.04,,142,Glia maturation factor beta,intracellular|,learning|locomotory behavior|negative regulation of Arp2/3 complex-mediated actin nucleation|,actin binding|growth factor activity|Arp2/3 complex binding|,10,23,6960000000,77.4%
Q9ERL7,0.531143183,-0.0245,7.573061983,-0.243,0.17486134,-1.519507614,0.021,-0.085,0.355,0.079,-0.347,-0.17,Q9ERL7,Gmfg,Q9ERL7_Gmfg,Q9ERL7,Gmfg,1,9,7,5,Q9ERL7|D3YY16,MOUSE,16919.2,71.8,982,982.2,82.57,51.53,,142,Glia maturation factor gamma,intracellular|,negative regulation of Arp2/3 complex-mediated actin nucleation|regulation of actin cytoskeleton reorganization|,actin binding|growth factor activity|Arp2/3 complex binding|,5,9,1030000000,46.4%
Q62418,0.693804058,0.042666667,4.645730824,0.148666667,0.343104898,1.02101301,-0.137,-0.106,0.148,-0.025,-0.005,0.381,Q62418,Dbnl,Q62418_Dbnl,Q62418,Dbnl,1,20,13,13,Q62418|Q62418-2|Q62418-3,MOUSE,48984,36.4,983,983.1,146,146,,436,Drebrin-like protein,Golgi membrane|ruffle|podosome|cytoplasm|cytosol|plasma membrane|cell cortex|postsynaptic density|lamellipodium|cell junction|dendrite|clathrin-coated vesicle membrane|extracellular exosome|,immune system process|receptor-mediated endocytosis|synapse assembly|Rac protein signal transduction|neuron projection morphogenesis|podosome assembly|ruffle assembly|actin filament severing|barbed-end actin filament capping|actin filament bundle assembly|,actin binding|protein binding|protein C-terminus binding|protein domain specific binding|actin filament binding|,13,20,1640000000,36.4%
E9QMC1,0.198650353,-0.021833333,15.98051318,0.407666667,0.025231826,2.877491648,-0.384,0.004,-0.297,-0.007,0.331,0.222,E9QMC1,Cgn,E9QMC1_Cgn,E9QMC1,Cgn,1,21,14,14,E9QMC1|P59242|D3YUW7|P59242-2|A0A0G2JEK8|A0A0G2JFG0,MOUSE,136771.8,15.6,984,984.1,145.87,145.87,,1192,Cingulin,bicellular tight junction|myosin complex|apical junction complex|,microtubule cytoskeleton organization|epithelial cell morphogenesis|metabolic process|bicellular tight junction assembly|,motor activity|protein binding|microtubule binding|,14,21,1520000000,15.6%
P62264,0.634404848,-0.032666667,5.719766421,0.116666667,0.267931242,1.208108161,-0.043,0.01,-0.24,0.041,0.024,0.012,P62264,Rps14,P62264_Rps14,P62264,Rps14,1,55,9,9,P62264,MOUSE,16443.6,41,985,985.1,145.86,145.86,,151,40S ribosomal protein S14,nucleolus|cytoplasm|mitochondrion|focal adhesion|membrane|cytosolic small ribosomal subunit|extracellular exosome|,ribosomal small subunit assembly|negative regulation of transcription from RNA polymerase II promoter|translation|regulation of translation|erythrocyte differentiation|maturation of SSU-rRNA|,RNA binding|structural constituent of ribosome|poly(A) RNA binding|translation regulator activity|mRNA 5'-UTR binding|,9,55,59200000000,41.0%
Q9DBD0,0.036043561,-0.0015,25.31095144,0.549666667,0.002943777,4.577650666,-0.226,-0.172,-0.431,0.222,0.149,0.449,Q9DBD0,1300017J02Rik,Q9DBD0_1300017J02Rik,Q9DBD0,Ica,1,25,13,13,Q9DBD0|D3YY36,MOUSE,78761.2,20.5,986,986.1,145.79,145.79,,700,Inhibitor of carbonic anhydrase,extracellular space|,negative regulation of catalytic activity|,enzyme inhibitor activity|iron ion binding|,13,25,2120000000,20.5%
Q0GNC1,0.911411213,-0.012666667,1.439298977,-0.037333333,0.717910164,-0.376894536,0.022,-0.116,0.112,0.026,-0.126,0.006,Q0GNC1,Inf2,Q0GNC1_Inf2,Q0GNC1,Inf2,1,23,14,14,Q0GNC1|E9QLA5|Q0GNC1-3,MOUSE,139698.8,16.4,987,987.1,145.74,145.74,,1273,Inverted formin-2,nucleus|cytoplasm|endoplasmic reticulum|perinuclear region of cytoplasm|,actin cytoskeleton organization|regulation of cellular component size|regulation of mitochondrial fission|,actin binding|Rho GTPase binding|,14,23,3370000000,16.4%
Q8CGY8,0.635598413,-0.014166667,5.657286338,0.108333333,0.271813715,1.197388071,-0.078,0.005,-0.132,0.137,-0.004,-0.013,Q8CGY8,Ogt,Q8CGY8_Ogt,Q8CGY8,Ogt,1,18,13,13,Q8CGY8|Q8CGY8-2,MOUSE,118204.8,15.3,988,988.1,145.63,145.63,,1046,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,histone acetyltransferase complex|intracellular|nucleus|nucleoplasm|cytoplasm|microtubule organizing center|cytosol|plasma membrane|MLL5-L complex|,regulation of glycolytic process|protein O-linked glycosylation|apoptotic process|positive regulation of granulocyte differentiation|negative regulation of protein ubiquitination|response to insulin|circadian regulation of gene expression|regulation of Rac protein signal transduction|positive regulation of catalytic activity|histone H4-K5 acetylation|histone H4-K8 acetylation|histone H4-K16 acetylation|positive regulation of proteolysis|positive regulation of transcription from RNA polymerase II promoter|regulation of insulin receptor signaling pathway|phosphatidylinositol-mediated signaling|positive regulation of histone H3-K4 methylation|positive regulation of histone H3-K27 methylation|cellular response to retinoic acid|histone H3-K4 trimethylation|regulation of gluconeogenesis involved in cellular glucose homeostasis|,"catalytic activity|protein binding|phosphatidylinositol-3,4,5-trisphosphate binding|enzyme activator activity|N-acetyltransferase activity|protein N-acetylglucosaminyltransferase activity|protein O-GlcNAc transferase activity|histone acetyltransferase activity (H4-K5 specific)|histone acetyltransferase activity (H4-K8 specific)|histone acetyltransferase activity (H4-K16 specific)|",13,18,3430000000,15.3%
P53994,0.581377911,-0.003166667,6.700128091,-0.127,0.213789903,-1.373563499,0.159,0.066,-0.044,-0.102,0,-0.098,P53994,Rab2a,P53994_Rab2a,P53994,Rab2a,1,48,12,12,P53994|P59279|Q3TEG7|G3V022|G3UXQ7,MOUSE,23718.3,53.7,989,989.1,145.47,145.47,,212,Ras-related protein Rab-2A,Golgi membrane|nucleus|lysosomal membrane|endoplasmic reticulum membrane|Golgi apparatus|endoplasmic reticulum-Golgi intermediate compartment membrane|melanosome|extracellular exosome|,intracellular protein transport|Golgi organization|metabolic process|vesicle-mediated transport|Rab protein signal transduction|,GTPase activity|GTP binding|GDP binding|,12,48,30000000000,53.7%
Q61171,0.407768607,-0.0225,10.22847504,0.196333333,0.094875154,1.943927156,0.031,-0.201,-0.192,0.003,0.139,0.085,Q61171,Prdx2,Q61171_Prdx2,Q61171,Prdx2,1,39,9,9,Q61171,MOUSE,21949.4,40.9,990,990.1,144.94,144.94,,198,Peroxiredoxin-2,mitochondrion|myelin sheath|extracellular exosome|,activation of MAPK activity|respiratory burst involved in inflammatory response|response to oxidative stress|regulation of hydrogen peroxide metabolic process|removal of superoxide radicals|positive regulation of blood coagulation|negative regulation of lipopolysaccharide-mediated signaling pathway|negative regulation of NF-kappaB transcription factor activity|response to lipopolysaccharide|cellular response to oxidative stress|T cell proliferation|hydrogen peroxide metabolic process|hydrogen peroxide catabolic process|regulation of apoptotic process|negative regulation of T cell differentiation|thymus development|homeostasis of number of cells|oxidation-reduction process|negative regulation of reactive oxygen species metabolic process|negative regulation of extrinsic apoptotic signaling pathway|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand|,peroxidase activity|protein binding|thioredoxin peroxidase activity|selenium binding|antioxidant activity|,9,39,18400000000,40.9%
Q9EPS3,0.000533208,-0.190833333,49.16434316,1.456333333,1.21218E-05,11.60469908,-0.787,-0.868,-1.102,0.415,0.49,0.707,Q9EPS3,Glce,Q9EPS3_Glce,Q9EPS3,Glce,1,22,13,13,Q9EPS3,MOUSE,70429.9,21.5,991,991.1,144.91,144.91,,618,D-glucuronyl C5-epimerase,Golgi membrane|Golgi apparatus|integral component of membrane|,heparan sulfate proteoglycan biosynthetic process|heparin biosynthetic process|,"racemase and epimerase activity, acting on carbohydrates and derivatives|heparosan-N-sulfate-glucuronate 5-epimerase activity|UDP-glucuronate 5'-epimerase activity|",13,22,30400000000,21.5%
Q3U2K8,0.786484674,-0.0035,3.314316445,-0.078333333,0.466195799,-0.772513037,0.121,0.106,-0.12,0.011,-0.025,-0.114,Q3U2K8,Agfg2,Q3U2K8_Agfg2,Q3U2K8,Agfg2,1,29,12,12,Q3U2K8|Q80WC7|Q80WC7-2,MOUSE,50594.9,21,992,992.1,144.77,144.77,,490,Arf-GAP domain and FG repeat-containing protein 2,membrane|,positive regulation of GTPase activity|,GTPase activator activity|,12,29,5330000000,21.0%
Q9JKX3,0.732367555,0.0365,4.06053359,-0.137666667,0.392596697,-0.91439793,0.033,-0.127,0.41,0.024,-0.136,0.015,Q9JKX3,Tfr2,Q9JKX3_Tfr2,Q9JKX3,Tfr2,1,23,12,12,Q9JKX3|Q9JKX3-3|Q9JKX3-2,MOUSE,88742.8,17.5,993,993.1,144.71,144.71,,798,Transferrin receptor protein 2,cytoplasm|integral component of membrane|HFE-transferrin receptor complex|,cellular iron ion homeostasis|receptor-mediated endocytosis|iron ion homeostasis|,glycoprotein binding|transferrin receptor activity|co-receptor binding|,12,23,5380000000,17.5%
E9Q1T1,0.549735936,-0.024333333,7.313960675,-0.152666667,0.185611095,-1.475214627,-0.018,0.031,0.143,0.049,-0.206,-0.145,E9Q1T1,Camk2d,E9Q1T1_Camk2d,E9Q1T1,Camk2d,1,27,11,8,E9Q1T1|A0A0G2JGS4|E9Q1W0|Q6PHZ2-5|Q6PHZ2|Q6PHZ2-4|Q6PHZ2-2|E9Q1V9|Q8CCM0|Q5SVJ0|Q5SVI1|Q68EG2|P28652|Q5SVI2|Q5SVI3|Q5SVI0|Q5SVJ1|F8WIS9|Q5SVI9|P11798|D6RDQ8|E9QAJ4,MOUSE,60631.1,27.2,994,994.1,144.68,104.07,,533,Calcium/calmodulin-dependent protein kinase type II subunit delta,nucleus|cytoplasm|intercalated disc|membrane|sarcoplasmic reticulum|T-tubule|neuromuscular junction|neuronal cell body|axon initial segment|,G1/S transition of mitotic cell cycle|regulation of sodium ion transport|regulation of membrane depolarization|protein phosphorylation|calcium ion transport|positive regulation of cardiac muscle hypertrophy|peptidyl-serine phosphorylation|peptidyl-threonine phosphorylation|protein autophosphorylation|protein oligomerization|cardiac muscle contraction|regulation of cellular localization|regulation of relaxation of cardiac muscle|negative regulation of sodium ion transmembrane transport|negative regulation of sodium ion transmembrane transporter activity|,protein serine/threonine kinase activity|calmodulin-dependent protein kinase activity|protein binding|calmodulin binding|ATP binding|sodium channel inhibitor activity|titin binding|protein homodimerization activity|ion channel binding|,11,27,5060000000,27.2%
Q923T9,0.681954507,-0.036833333,4.832901235,-0.095666667,0.32863202,-1.053498093,0.033,0.002,-0.002,0.039,-0.164,-0.129,Q923T9,Camk2g,Q923T9_Camk2g,Q923T9,Camk2g,1,6,8,5,Q923T9|Q923T9-2|Q923T9-3,MOUSE,60290.4,20.9,994,994.2,73.12,32.51,,529,Calcium/calmodulin-dependent protein kinase type II subunit gamma,membrane|sarcoplasmic reticulum membrane|neuronal postsynaptic density|,G1/S transition of mitotic cell cycle|calcium ion transport|nervous system development|cell differentiation|protein autophosphorylation|protein oligomerization|regulation of relaxation of cardiac muscle|,protein serine/threonine kinase activity|calmodulin-dependent protein kinase activity|calmodulin binding|ATP binding|protein homodimerization activity|,5,6,4090000000,13.9%
G3UXL2,0.979892713,0.027833333,0.311247203,-0.012333333,0.930840519,-0.090142439,-0.116,-0.05,0.268,-0.142,0.056,0.151,G3UXL2,Prps1l3,G3UXL2_Prps1l3,G3UXL2,Prps1l3,1,34,12,7,Q9D7G0|G3UXL2|Q8C5R8,MOUSE,35337.1,38.9,995,995.1,144.61,85.6,,318,Phosphoribosyl pyrophosphate synthetase 1-like 3,ribose phosphate diphosphokinase complex|,AMP biosynthetic process|nervous system development|organ regeneration|urate biosynthetic process|hypoxanthine biosynthetic process|,magnesium ion binding|ribose phosphate diphosphokinase activity|ATP binding|AMP binding|GDP binding|carbohydrate binding|protein homodimerization activity|ADP binding|,12,34,9330000000,38.9%
Q9CS42,0.512755428,0.014333333,7.985432781,-0.252,0.159021821,-1.586830603,-0.093,0.04,0.474,-0.215,-0.089,-0.031,Q9CS42,Prps2,Q9CS42_Prps2,Q9CS42,Prps2,1,2,7,2,Q9CS42,MOUSE,35184.9,27.9,995,995.2,76.2,17.19,,318,Ribose-phosphate pyrophosphokinase 2,extracellular exosome|,5-phosphoribose 1-diphosphate biosynthetic process|ribonucleoside monophosphate biosynthetic process|nucleotide biosynthetic process|phosphorylation|,magnesium ion binding|ribose phosphate diphosphokinase activity|ATP binding|kinase activity|identical protein binding|protein homodimerization activity|,2,2,40900000,7.2%
Q569Z6,0.035408051,-0.030333333,25.44831904,0.404666667,0.002852122,4.579313074,-0.279,-0.264,-0.155,0.113,0.149,0.254,Q569Z6,Thrap3,Q569Z6_Thrap3,Q569Z6,Thrap3,1,26,15,15,Q569Z6|Q8BZN7,MOUSE,108233.3,19.4,996,996.1,144.53,144.53,,951,Thyroid hormone receptor-associated protein 3,nucleus|nucleoplasm|mediator complex|extracellular exosome|exon-exon junction complex|,"regulation of alternative mRNA splicing, via spliceosome|nuclear-transcribed mRNA catabolic process|transcription from RNA polymerase II promoter|transcription initiation from RNA polymerase II promoter|mRNA processing|circadian rhythm|RNA splicing|intracellular steroid hormone receptor signaling pathway|androgen receptor signaling pathway|positive regulation of circadian rhythm|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of mRNA splicing, via spliceosome|mRNA stabilization|",core promoter sequence-specific DNA binding|RNA polymerase II transcription cofactor activity|transcription cofactor activity|transcription coactivator activity|receptor activity|protein binding|ATP binding|poly(A) RNA binding|thyroid hormone receptor binding|phosphoprotein binding|,15,26,1820000000,19.4%
P84099,0.919416995,-0.0285,1.21373208,0.041,0.756182795,0.323655677,0.094,0.049,-0.29,0.051,0.03,-0.105,P84099,Rpl19,P84099_Rpl19,P84099,Rpl19,1,53,11,11,P84099|A2A547,MOUSE,23579.7,32.6,997,997.1,144.37,144.37,,196,60S ribosomal protein L19,nucleolus|cytoplasm|focal adhesion|membrane|cytosolic large ribosomal subunit|,translation|,structural constituent of ribosome|poly(A) RNA binding|,11,53,19000000000,32.6%
Q8VC28,0.73101227,-0.014666667,4.085723958,0.142,0.390326111,0.919056929,-0.207,-0.241,0.191,-0.151,0.172,0.148,Q8VC28,Akr1c13,Q8VC28_Akr1c13,Q8VC28,Akr1c13,1,20,11,2,Q8VC28|D6RGB1,MOUSE,37627.6,41.4,998,998.1,144.34,27.42,,323,Aldo-keto reductase family 1 member C13,,xenobiotic metabolic process|oxidation-reduction process|,aldo-keto reductase (NADP) activity|,11,20,3450000000,41.4%
G3X9Y6,0.223683903,-0.027333333,15.04277723,0.255333333,0.031312827,2.714488742,-0.037,-0.231,-0.197,0.057,0.177,0.067,G3X9Y6,Akr1c19,G3X9Y6_Akr1c19,G3X9Y6,Akr1c19,1,8,8,5,G3X9Y6,MOUSE,37558.4,36.5,998,998.3,92.68,53.95,,323,"Aldo-keto reductase family 1, member C19",,oxidation-reduction process|,oxidoreductase activity|,5,8,4280000000,26.0%
Q9R190,0.430366134,-0.0005,9.779595783,-0.155666667,0.105205979,-1.872472627,0.017,0.101,0.114,-0.074,-0.132,-0.029,Q9R190,Mta2,Q9R190_Mta2,Q9R190,Mta2,1,24,14,13,Q9R190|Q924K8|Q3UII8|E9Q794|Q3U3A7|Q924K8-2,MOUSE,75770.4,24.4,999,999.1,144.32,130.15,,668,Metastasis-associated protein MTA2,histone deacetylase complex|nuclear chromatin|nucleus|nucleoplasm|transcription factor complex|membrane|NuRD complex|protein complex|,"negative regulation of transcription from RNA polymerase II promoter|DNA methylation|DNA packaging|chromatin remodeling|regulation of fibroblast migration|histone deacetylation|ATP-dependent chromatin remodeling|negative regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|",transcription factor binding transcription factor activity|RNA polymerase II transcription factor binding|RNA polymerase II repressing transcription factor binding|sequence-specific DNA binding transcription factor activity|histone deacetylase activity|protein binding|zinc ion binding|transcription regulatory region DNA binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|,14,24,2680000000,24.4%
P61089,0.461918472,0.031666667,9.054318856,-0.238,0.124327762,-1.759591405,0.098,0.407,-0.053,-0.092,0.001,-0.171,P61089,Ube2n,P61089_Ube2n,P61089,Ube2n,1,37,11,11,P61089|A0A1W2P7Z3,MOUSE,17194.6,60.5,1000,1000.1,144.3,144.3,,152,Ubiquitin-conjugating enzyme E2 N,ubiquitin ligase complex|nucleus|cytoplasm|UBC13-MMS2 complex|UBC13-UEV1A complex|protein complex|extracellular exosome|,double-strand break repair via homologous recombination|DNA double-strand break processing|postreplication repair|ubiquitin-dependent protein catabolic process|protein ubiquitination|histone ubiquitination|positive regulation of histone modification|regulation of histone ubiquitination|positive regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of DNA repair|T cell receptor signaling pathway|positive regulation of NF-kappaB transcription factor activity|positive regulation of ubiquitin-protein transferase activity|protein K63-linked ubiquitination|,ubiquitin-protein transferase activity|protein binding|ATP binding|ligase activity|ubiquitin protein ligase binding|ubiquitin binding|poly(A) RNA binding|ubiquitin protein ligase activity|ubiquitin conjugating enzyme activity|,11,37,14200000000,60.5%
Q7TMC8,0.585102109,-0.028,6.617132358,0.197333333,0.217914819,1.361375307,-0.007,-0.002,-0.371,0.27,0.007,-0.065,Q7TMC8,Fuk,Q7TMC8_Fuk,Q7TMC8,Fuk,1,15,11,11,Q7TMC8|Q7TMC8-2|A0A1D5RMI1,MOUSE,120862.7,15,1001,1001.1,144.2,144.2,,1090,L-fucose kinase,cytoplasm|,phosphorylation|,ATP binding|fucokinase activity|,11,15,1400000000,15.0%
P34152,0.91325,0.002166667,1.375996698,-0.031,0.728450977,-0.362074153,-0.011,-0.027,0.091,0.017,-0.081,0.024,P34152,Ptk2,P34152_Ptk2,P34152,Ptk2,1,21,13,13,P34152|P34152-2|P34152-4|P34152-3|P34152-5|P34152-6|P34152-7|P34152-9|A0A087WPV9|Q9DA74|P34152-8,MOUSE,124447.5,15.4,1002,1002.1,143.84,143.84,,1090,Focal adhesion kinase 1,stress fiber|nucleus|cytoplasm|microtubule organizing center|cytosol|plasma membrane|focal adhesion|apical plasma membrane|lamellipodium|extrinsic component of cytoplasmic side of plasma membrane|perinuclear region of cytoplasm|,microtubule cytoskeleton organization|angiogenesis|blood vessel development|vasculogenesis|neuron migration|regulation of protein phosphorylation|positive regulation of protein phosphorylation|cell adhesion|signal complex assembly|epidermal growth factor receptor signaling pathway|transforming growth factor beta receptor signaling pathway|integrin-mediated signaling pathway|positive regulation of cell proliferation|regulation of cell shape|regulation of epithelial cell migration|positive regulation of phosphatidylinositol 3-kinase signaling|peptidyl-tyrosine phosphorylation|central nervous system neuron axonogenesis|negative regulation of cell-cell adhesion|regulation of cell adhesion|extracellular matrix organization|positive regulation of cell migration|regulation of cell adhesion mediated by integrin|peptidyl-tyrosine autophosphorylation|establishment of nucleus localization|regulation of cell proliferation|negative regulation of apoptotic process|endothelial cell migration|innate immune response|regulation of osteoblast differentiation|positive regulation of protein kinase activity|negative regulation of organ growth|protein autophosphorylation|ephrin receptor signaling pathway|negative regulation of axonogenesis|regulation of focal adhesion assembly|positive regulation of protein kinase B signaling|negative regulation of synapse assembly|growth hormone receptor signaling pathway|cellular response to transforming growth factor beta stimulus|regulation of substrate adhesion-dependent cell spreading|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|negative regulation of anoikis|,actin binding|protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|signal transducer activity|receptor binding|protein binding|ATP binding|JUN kinase binding|protein kinase binding|SH2 domain binding|,13,21,1730000000,15.4%
Q60634-2,0.629307568,-0.0015,5.824168115,-0.125666667,0.261567143,-1.225978605,0.025,-0.009,0.168,0.021,-0.011,-0.203,Q60634,Flot2,Q60634-2_Flot2,Q60634-2,Flot2,1,28,11,11,Q60634-2|Q5SS83|Q60634|Q60634-3,MOUSE,47585.8,29.4,1003,1003.1,143.64,143.64,,428,Isoform 2 of Flotillin-2,uropod|acrosomal membrane|endosome|plasma membrane|caveola|cell-cell adherens junction|focal adhesion|membrane|basolateral plasma membrane|flotillin complex|lamellipodium|endocytic vesicle|cytoplasmic vesicle|vesicle|cell-cell contact zone|membrane raft|perinuclear region of cytoplasm|extracellular exosome|cortical actin cytoskeleton|,membrane raft assembly|cell adhesion|negative regulation of gene expression|protein localization to plasma membrane raft|regulation of myoblast differentiation|protein stabilization|establishment of protein localization to plasma membrane|negative regulation of amyloid precursor protein catabolic process|positive regulation of establishment of T cell polarity|,protease binding|ionotropic glutamate receptor binding|protein heterodimerization activity|,11,28,3820000000,29.4%
P21958,0.530752353,0.048166667,7.585090014,-0.249666667,0.174377721,-1.521477905,-0.026,0.035,0.51,0.026,-0.234,-0.022,P21958,Tap1,P21958_Tap1,P21958,Tap1,1,25,10,10,P21958|Q3TBA3,MOUSE,79262,21.1,1004,1004.1,143.61,143.61,,724,Antigen peptide transporter 1,mitochondrion|membrane|integral component of membrane|integral component of endoplasmic reticulum membrane|phagocytic vesicle membrane|TAP complex|host cell|,defense response|metabolic process|peptide transport|intracellular transport of viral protein in host cell|antigen processing and presentation of endogenous peptide antigen via MHC class I|protection from natural killer cell mediated cytotoxicity|cytosol to ER transport|transmembrane transport|,"ATP binding|peptide transporter activity|peptide-transporting ATPase activity|MHC class Ib protein binding|MHC class I protein binding|peptide antigen binding|ATPase activity, coupled to transmembrane movement of substances|ADP binding|TAP2 binding|tapasin binding|protein heterodimerization activity|peptide transporter activity|",10,25,2710000000,21.1%
Q78ZM0,0.550838715,0.005166667,7.261406177,-0.245,0.187870842,-1.468302173,0.15,0.384,-0.151,0.074,-0.111,-0.315,Q78ZM0,Snx3,Q78ZM0_Snx3,Q78ZM0,Snx3,1,28,11,11,Q78ZM0|O70492|D3Z6Z0|D3Z789,MOUSE,18819.1,61.1,1005,1005.1,143.41,143.41,,162,"Sorting nexin 3, isoform CRA_b",cytoplasm|endosome|early endosome|cytosol|endosome membrane|extrinsic component of membrane|clathrin-coated vesicle|early endosome membrane|early phagosome|intracellular membrane-bounded organelle|extracellular exosome|retromer complex|,heme biosynthetic process|endocytosis|response to bacterium|membrane invagination|vesicle organization|protein to membrane docking|regulation of Wnt signaling pathway|regulation of cellular protein metabolic process|regulation of intracellular protein transport|transferrin transport|negative regulation of protein catabolic process|hemoglobin biosynthetic process|negative regulation of viral entry into host cell|negative regulation of phagocytosis|negative regulation of protein transport|intralumenal vesicle formation|negative regulation of early endosome to late endosome transport|,protein binding|protein phosphatase binding|phosphatidylinositol-3-phosphate binding|,11,28,13500000000,61.1%
O09172,0.934957223,-0.000666667,0.933401367,-0.022,0.806603056,-0.254693456,0.058,0.062,-0.089,0.008,-0.044,0.001,O09172,Gclm,O09172_Gclm,O09172,Gclm,1,38,10,10,O09172,MOUSE,30876.6,49.6,1006,1006.1,142.89,142.89,,274,Glutamate--cysteine ligase regulatory subunit,glutamate-cysteine ligase complex|,cysteine metabolic process|glutamate metabolic process|glutathione metabolic process|glutathione biosynthetic process|response to oxidative stress|apoptotic mitochondrial changes|positive regulation of glutamate-cysteine ligase activity|response to drug|negative regulation of neuron apoptotic process|regulation of blood vessel size|response to nitrosative stress|regulation of mitochondrial depolarization|negative regulation of extrinsic apoptotic signaling pathway|,enzyme regulator activity|glutamate-cysteine ligase catalytic subunit binding|protein heterodimerization activity|glutamate-cysteine ligase activity|,10,38,32500000000,49.6%
Q00612,0.550359036,0.156833333,7.282523759,-0.512333333,0.186959537,-1.471781561,0.062,-0.069,1.246,-0.025,-0.347,0.074,Q00612,G6pdx,Q00612_G6pdx,Q00612,G6pdx,1,20,12,12,Q00612|P97324|G3UWD6,MOUSE,59717.9,28.1,1007,1007.1,142.73,142.73,,515,Glucose-6-phosphate 1-dehydrogenase X,cytoplasm|centrosome|microtubule organizing center|cytosol|cytoplasmic side of plasma membrane|membrane|intracellular membrane-bounded organelle|extracellular exosome|,"cytokine production|angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure|vasodilation by angiotensin involved in regulation of systemic arterial blood pressure|glucose metabolic process|pentose-phosphate shunt|cholesterol biosynthetic process|NADP metabolic process|NADPH regeneration|NADP biosynthetic process|glutathione metabolic process|response to oxidative stress|pentose-phosphate shunt, oxidative branch|negative regulation of protein glutathionylation|pentose biosynthetic process|interleukin-10 production|interleukin-12 production|cellular response to oxidative stress|regulation of multicellular organism growth|erythrocyte maturation|ribose phosphate biosynthetic process|erythrocyte development|glucose 6-phosphate metabolic process|oxidation-reduction process|",glucose-6-phosphate dehydrogenase activity|glucose binding|identical protein binding|protein homodimerization activity|NADP binding|,12,20,1680000000,28.1%
Q8CEE7,0.995757571,-0.015333333,0.051460047,-0.002,0.988220811,-0.015329791,0.158,0.07,-0.271,0.063,-0.054,-0.058,Q8CEE7,Rdh13,Q8CEE7_Rdh13,Q8CEE7,Rdh13,1,25,11,11,Q8CEE7|A0A0R4J1N8,MOUSE,36748.7,27.2,1008,1008.1,142.51,142.51,,334,Retinol dehydrogenase 13,mitochondrion|,response to high light intensity|retina layer formation|eye photoreceptor cell development|oxidation-reduction process|,oxidoreductase activity|,11,25,6510000000,27.2%
Q61941,0.578909417,0.330666667,6.80241928,-0.807333333,0.208813259,-1.392289953,0.326,2.169,-0.292,-0.066,-0.117,-0.036,Q61941,NotFound,Q61941_NotFound,Q61941,Nnt,1,21,12,12,Q61941|Q8BGK0|Q8C9V5|E9Q8F4,MOUSE,114521,13.6,1009,1009.1,142.46,142.46,,1086,"NAD(P) transhydrogenase, mitochondrial",mitochondrion|mitochondrial inner membrane|integral component of membrane|,proton transport|cell redox homeostasis|oxidation-reduction process|reactive oxygen species metabolic process|,NAD(P)+ transhydrogenase (AB-specific) activity|NADP binding|,12,21,2070000000,13.6%
P36371,0.539869532,-0.0035,7.444440373,-0.312333333,0.180117522,-1.498411477,-0.025,0.008,0.475,0.071,-0.538,-0.012,P36371,Tap2,P36371_Tap2,P36371,Tap2,1,24,11,11,P36371,MOUSE,77899.8,19.5,1010,1010.1,142.42,142.42,,702,Antigen peptide transporter 2,membrane|integral component of membrane|integral component of endoplasmic reticulum membrane|TAP complex|host cell|,"positive regulation of T cell mediated cytotoxicity|response to molecule of bacterial origin|antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent|antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent|positive regulation of antigen processing and presentation of peptide antigen via MHC class I|metabolic process|intracellular transport of viral protein in host cell|antigen processing and presentation of endogenous peptide antigen via MHC class I|cytosol to ER transport|peptide antigen transport|transmembrane transport|","protein binding|ATP binding|peptide antigen-transporting ATPase activity|MHC class Ib protein binding|ATPase activity, coupled to transmembrane movement of substances|TAP1 binding|tapasin binding|peptide transporter activity|",11,24,5040000000,19.5%
P14131,0.655748724,-0.0075,5.24492343,-0.099666667,0.298887434,-1.126013225,0.067,0.053,0.007,-0.048,0.033,-0.157,P14131,Rps16,P14131_Rps16,P14131,Rps16,1,50,11,11,P14131,MOUSE,16559.1,50,1011,1011.1,142.22,142.22,,146,40S ribosomal protein S16,focal adhesion|small ribosomal subunit|membrane|cytosolic small ribosomal subunit|extracellular exosome|,rRNA processing|translation|ribosomal small subunit biogenesis|,RNA binding|structural constituent of ribosome|poly(A) RNA binding|,11,50,39600000000,50.0%
E9QL80,0.386623778,0.027,10.70376813,-0.231333333,0.085039987,-2.021956627,0.137,-0.011,0.302,0.03,-0.186,-0.11,E9QL80,Lpgat1,E9QL80_Lpgat1,E9QL80,Lpgat1,1,24,13,13,E9QL80|Q91YX5,MOUSE,47399.4,35.2,1012,1012.1,141.9,141.9,,409,Acyl-CoA:lysophosphatidylglycerol acyltransferase 1,cytoplasm|membrane|,metabolic process|,"transferase activity, transferring acyl groups|",13,24,7430000000,35.2%
P10639,0.382438943,-0.013833333,10.79228869,0.165666667,0.083324196,2.03348032,-0.074,-0.05,-0.166,0.053,0.088,0.066,P10639,Txn1,P10639_Txn1,P10639,Txn,1,41,10,10,P10639,MOUSE,12017.6,66.6,1013,1013.1,141.73,141.73,,105,Thioredoxin,nucleus|cytoplasm|mitochondrion|cytosol|extracellular exosome|,"sulfate assimilation|negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|protein folding|glycerol ether metabolic process|response to radiation|positive regulation of peptidyl-serine phosphorylation|regulation of protein import into nucleus, translocation|cellular response to oxidative stress|positive regulation of DNA binding|cell redox homeostasis|negative regulation of protein export from nucleus|oxidation-reduction process|negative regulation of hydrogen peroxide-induced cell death|","protein binding|protein disulfide oxidoreductase activity|peptide disulfide oxidoreductase activity|oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor|poly(A) RNA binding|",10,41,35500000000,66.6%
A5D6P2,0.70184245,-0.013,4.516695889,0.089333333,0.353451974,0.996919223,-0.045,0.02,-0.148,0.051,-0.038,0.082,A5D6P2,Pard3,A5D6P2_Pard3,A5D6P2,Pard3,1,17,11,11,A5D6P2|Q99NH2|G3XA13|B7ZNY3|E0CXL4|E0CY24|Q99NH2-2|Q99NH2-3|E9PYJ2|A0A0R4J1Y4|Q99NH2-4|Q99NH2-5,MOUSE,149768,10.5,1014,1014.1,141.27,141.27,,1334,Par-3 (Partitioning defective 3) homolog (C. elegans),cytoplasm|spindle|cell-cell junction|adherens junction|cell-cell adherens junction|bicellular tight junction|cell cortex|cell junction|protein complex|apical part of cell|,"microtubule cytoskeleton organization|apical constriction|single organismal cell-cell adhesion|regulation of actin filament-based process|wound healing, spreading of cells|centrosome localization|",protein kinase C binding|protein binding|,11,17,1280000000,10.5%
A2ARD6,0.951421295,-0.003333333,0.733778681,-0.030666667,0.84454371,-0.20391849,-0.292,0.284,0.044,-0.013,-0.032,-0.011,A2ARD6,Kynu,A2ARD6_Kynu,A2ARD6,Kynu,1,25,12,12,A2ARD6|Q9CXF0|Q6NSV5|A2ARD7,MOUSE,52912,23.4,1015,1015.1,141.19,141.19,,465,Kynureninase,nucleoplasm|cytoplasm|mitochondrion|cytosol|,tryptophan catabolic process|tryptophan catabolic process to kynurenine|tryptophan catabolic process to acetyl-CoA|quinolinate biosynthetic process|response to interferon-gamma|'de novo' NAD biosynthetic process from tryptophan|response to vitamin B6|anthranilate metabolic process|L-kynurenine catabolic process|,pyridoxal phosphate binding|kynureninase activity|protein homodimerization activity|,12,25,3430000000,23.4%
O35386,0.322381947,-0.037333333,12.19331613,-0.198,0.060348765,-2.256136798,0.039,0.111,0.035,-0.192,-0.036,-0.181,O35386,Phyh,O35386_Phyh,O35386,Phyh,1,25,12,12,O35386,MOUSE,39063.1,34.6,1016,1016.1,141.18,141.18,,338,"Phytanoyl-CoA dioxygenase, peroxisomal",mitochondrion|peroxisome|,fatty acid alpha-oxidation|isoprenoid metabolic process|methyl-branched fatty acid metabolic process|,catalytic activity|protein binding|L-ascorbic acid binding|metal ion binding|cofactor binding|phytanoyl-CoA dioxygenase activity|,12,25,2030000000,34.6%
O88736,0.598120507,-0.05,6.37673018,0.185333333,0.230317523,1.321044848,0.049,-0.041,-0.436,0.102,0.022,0.004,O88736,Hsd17b7,O88736_Hsd17b7,O88736,Hsd17b7,1,32,10,10,O88736|Q8C5N9,MOUSE,37658.5,26,1017,1017.1,141.13,141.13,,334,3-keto-steroid reductase,endoplasmic reticulum|plasma membrane|integral component of membrane|,cholesterol biosynthetic process|estrogen biosynthetic process|oxidation-reduction process|,3-keto sterol reductase activity|estradiol 17-beta-dehydrogenase activity|prolactin receptor binding|,10,32,15500000000,26.0%
O89017,0.548710608,0.03,7.325679982,-0.145333333,0.185110904,-1.476931975,0.081,-0.015,0.242,0.012,-0.054,-0.086,O89017,Lgmn,O89017_Lgmn,O89017,Lgmn,1,49,10,10,O89017,MOUSE,49771.5,17.4,1018,1018.1,140.74,140.74,,435,Legumain,lysosome|late endosome|apical part of cell|extracellular exosome|,renal system process|proteolysis|response to acidic pH|receptor catabolic process|negative regulation of multicellular organism growth|negative regulation of neuron apoptotic process|proteolysis involved in cellular protein catabolic process|negative regulation of ERBB signaling pathway|,cysteine-type endopeptidase activity|peptidase activity|,10,49,24000000000,17.4%
Q8CHQ9,0.198470228,0.032666667,15.99943912,-0.327333333,0.025122109,-2.876546757,0.087,0.095,0.407,-0.083,-0.183,-0.127,Q8CHQ9,Nat8f2,Q8CHQ9_Nat8f2,Q8CHQ9,Cml2,1,37,11,11,Q8CHQ9,MOUSE,26594.7,42.8,1019,1019.1,140.6,140.6,,238,Probable N-acetyltransferase CML2,endoplasmic reticulum|Golgi apparatus|integral component of membrane|extracellular space|,gastrulation with mouth forming second|negative regulation of cell adhesion|metabolic process|,N-acetyltransferase activity|,11,37,46800000000,42.8%
Q61133,0.744748173,-0.0375,3.891041325,-0.123666667,0.408221494,-0.882872033,0.085,0.138,-0.15,-0.298,0.126,-0.126,Q61133,Gstt2,Q61133_Gstt2,Q61133,Gstt2,1,44,10,10,Q61133|A0A1W2P6L1,MOUSE,27747.8,36.8,1020,1020.1,140.29,140.29,,244,Glutathione S-transferase theta-2,nucleus|cytosol|extracellular exosome|,glutathione metabolic process|,glutathione transferase activity|,10,44,16500000000,36.8%
E9Q0J5,0.977234082,-0.003,0.339932149,0.008666667,0.924712621,0.098115118,-0.011,0.089,-0.1,0.037,-0.012,-0.021,E9Q0J5,NotFound,E9Q0J5_NotFound,E9Q0J5,Kif21a,1,21,13,13,E9Q0J5|Q9QXL2|F8WGN6|Q9QXL2-4|Q9QXL2-2|Q9QXL2-3|Q9QXL1|E9Q0A4|F8VQE2|Q7M6Z4,MOUSE,188059.6,13.3,1021,1021.1,140.07,131.02,,1672,Kinesin-like protein KIF21A,kinesin complex|microtubule|,microtubule-based movement|metabolic process|,microtubule motor activity|ATP binding|microtubule binding|ATPase activity|,14,21,432000000,13.3%
O35711,0.915850537,0.0085,1.31314486,-0.028333333,0.739069898,-0.34723538,0.079,0.015,-0.026,0.037,-0.028,-0.026,O35711,Ppfibp2,O35711_Ppfibp2,O35711,Ppfibp2,1,24,13,10,O35711|G3X957|O35711-2|O35711-4|O35711-3,MOUSE,99378.6,19.1,1022,1022.1,139.89,108.65,,882,Liprin-beta-2,extracellular space|,,,13,24,616000000,19.1%
Q8C8U0-3,0.57548373,0.012166667,6.864032567,0.155,0.205871744,1.401288977,0.024,0.001,-0.221,0.223,-0.001,0.047,Q8C8U0,Ppfibp1,Q8C8U0-3_Ppfibp1,Q8C8U0-3,Ppfibp1,1,9,12,9,Q8C8U0-3|Q8C8U0|Q8C8U0-2,MOUSE,110519.7,12.8,1022,1022.2,122.55,91.31,,969,Isoform 3 of Liprin-beta-1,focal adhesion|,,,9,9,310000000,9.8%
P68181,0.369537427,-0.003,11.04833288,-0.206,0.078553712,-2.074171504,0.034,0.077,0.189,-0.239,-0.064,-0.015,P68181,Prkacb,P68181_Prkacb,P68181,Prkacb,1,19,12,8,P68181|P68181-4|P68181-3|P68181-2,MOUSE,40878.2,33,1023,1023.1,139.83,87.31,,351,cAMP-dependent protein kinase catalytic subunit beta,nucleus|centrosome|cytosol|plasma membrane|cAMP-dependent protein kinase complex|perinuclear region of cytoplasm|extracellular exosome|ciliary base|,neural tube closure|protein phosphorylation|adenylate cyclase-modulating G-protein coupled receptor signaling pathway|negative regulation of meiotic cell cycle|regulation of protein processing|response to clozapine|negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning|,magnesium ion binding|cAMP-dependent protein kinase activity|ATP binding|ubiquitin protein ligase binding|,12,19,3840000000,33.0%
P05132,0.744748173,0.0345,3.896263502,-0.138333333,0.407730922,-0.883848103,-0.068,-0.054,0.433,-0.16,0.026,0.03,P05132,Prkaca,P05132_Prkaca,P05132,Prkaca,1,6,9,5,P05132|P05132-2,MOUSE,40684,30.4,1023,1023.2,101.85,49.33,,351,cAMP-dependent protein kinase catalytic subunit alpha,nucleus|nucleoplasm|cytoplasm|mitochondrion|Golgi apparatus|centrosome|cytosol|plasma membrane|cAMP-dependent protein kinase complex|AMP-activated protein kinase complex|neuromuscular junction|neuron projection|perinuclear region of cytoplasm|extracellular exosome|sperm midpiece|ciliary base|membrane|,"mesoderm formation|neural tube closure|protein phosphorylation|positive regulation of cell proliferation|peptidyl-serine phosphorylation|peptidyl-threonine phosphorylation|regulation of cellular respiration|regulation of osteoblast differentiation|protein autophosphorylation|positive regulation of protein export from nucleus|sperm capacitation|regulation of synaptic transmission|negative regulation of meiotic cell cycle|regulation of synaptic transmission, glutamatergic|regulation of proteasomal protein catabolic process|regulation of protein processing|positive regulation of cell cycle arrest|cellular response to glucose stimulus|cellular response to parathyroid hormone stimulus|negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning|regulation of bicellular tight junction assembly|",protein kinase activity|protein serine/threonine kinase activity|cAMP-dependent protein kinase activity|protein serine/threonine/tyrosine kinase activity|protein binding|ATP binding|protein kinase binding|ubiquitin protein ligase binding|protein complex binding|protein kinase A regulatory subunit binding|,5,6,279000000,17.6%
F8WJ05,0.00070612,-0.063333333,46.65511072,0.809333333,2.16017E-05,10.45837146,-0.451,-0.479,-0.474,0.344,0.364,0.316,F8WJ05,Itih1,F8WJ05_Itih1,F8WJ05,Itih1,1,16,13,13,F8WJ05|Q61702,MOUSE,102089.1,19.9,1024,1024.1,139.59,139.59,,911,Inter-alpha-trypsin inhibitor heavy chain H1,extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,13,16,3130000000,19.9%
Q9CQM9,1,-0.019,1.92865E-15,4.53247E-17,1,4.84094E-16,0.051,0.024,-0.132,-0.099,0.035,0.007,Q9CQM9,Glrx3,Q9CQM9_Glrx3,Q9CQM9,Glrx3,1,24,12,12,Q9CQM9|A0A1B0GS58|A0A1B0GSD3,MOUSE,38063,43,1025,1025.1,139.57,139.57,,337,Glutaredoxin-3,nucleus|cell cortex|Z disc|dendrite|extracellular exosome|,regulation of the force of heart contraction|negative regulation of cardiac muscle hypertrophy|cell redox homeostasis|oxidation-reduction process|,protein kinase C binding|protein binding|electron carrier activity|protein disulfide oxidoreductase activity|poly(A) RNA binding|metal ion binding|iron-sulfur cluster binding|,12,24,7230000000,43.0%
Q99K28-2,0.527575483,-0.031166667,7.688333771,0.161,0.170281169,1.53654414,-0.077,0.017,-0.275,0.021,0.008,0.119,Q99K28,Arfgap2,Q99K28-2_Arfgap2,Q99K28-2,Arfgap2,1,25,14,14,Q99K28-2|Q99K28,MOUSE,58508.5,31.2,1026,1026.1,139.36,139.36,,520,Isoform 2 of ADP-ribosylation factor GTPase-activating protein 2,Golgi membrane|nucleolus|cytoplasm|Golgi apparatus|plasma membrane|,protein transport|vesicle-mediated transport|positive regulation of GTPase activity|,GTPase activator activity|metal ion binding|,14,25,5010000000,31.2%
F8VPK0,0.689880379,0.003,4.704170832,-0.083333333,0.338518897,-1.030567621,0.064,0.077,-0.007,0.001,-0.04,-0.077,F8VPK0,Ttc37,F8VPK0_Ttc37,F8VPK0,Ttc37,1,14,11,11,F8VPK0,MOUSE,176278.4,11.1,1027,1027.1,139.2,139.2,,1563,Tetratricopeptide repeat domain 37,nucleus|nucleoplasm|cytoplasm|transcriptionally active chromatin|Ski complex|,,,11,14,1100000000,11.1%
Q9CRC8,0.868023996,0.006833333,2.125734545,-0.057,0.612952112,-0.530473899,0.151,0.001,-0.046,0.133,-0.114,-0.084,Q9CRC8,Lrrc40,Q9CRC8_Lrrc40,Q9CRC8,Lrrc40,1,24,11,11,Q9CRC8|A0A0R4J0W6|D6RHB1,MOUSE,68587.9,21.9,1028,1028.1,139.06,139.06,,602,Leucine-rich repeat-containing protein 40,membrane|,,,11,24,12200000000,21.9%
Q64442,0.564678113,0.154333333,7.058932714,0.444,0.196836996,1.434865053,-0.103,0.06,-0.16,-0.069,1.133,0.065,Q64442,Sord,Q64442_Sord,Q64442,Sord,1,29,10,10,Q64442,MOUSE,38819.3,37.5,1029,1029.1,138.59,138.59,,357,Sorbitol dehydrogenase,mitochondrion|membrane|motile cilium|mitochondrial membrane|extracellular exosome|,sorbitol metabolic process|sorbitol catabolic process|response to osmotic stress|response to hormone|sperm motility|response to nutrient levels|response to drug|fructose biosynthetic process|response to cadmium ion|response to copper ion|L-xylitol catabolic process|L-xylitol metabolic process|oxidation-reduction process|,L-iditol 2-dehydrogenase activity|zinc ion binding|identical protein binding|NAD binding|,10,29,40400000000,37.5%
P53798,0.251008093,0.052333333,14.17245858,0.588666667,0.038260808,2.580362236,-0.04,-0.163,-0.523,0.628,-0.122,0.534,P53798,Fdft1,P53798_Fdft1,P53798,Fdft1,1,24,10,10,P53798|A0A286YD20,MOUSE,48838.1,33.8,1030,1030.1,138.27,138.27,,416,Squalene synthase,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,cholesterol biosynthetic process|isoprenoid biosynthetic process|farnesyl diphosphate metabolic process|oxidation-reduction process|,farnesyl-diphosphate farnesyltransferase activity|oxidoreductase activity|squalene synthase activity|,10,24,2430000000,33.8%
O70378,0.001332403,-0.051166667,43.1214699,1.705666667,4.87364E-05,9.2979416,-0.98,-0.886,-0.846,0.38,0.989,1.036,O70378,Emc8,O70378_Emc8,O70378,Emc8,1,32,9,9,O70378|M0QWC9|M0QWE2|M0QWS0,MOUSE,23804.5,56.5,1031,1031.1,138.25,138.25,,207,ER membrane protein complex subunit 8,cytoplasm|mitochondrion|membrane|ER membrane protein complex|,,,9,32,10100000000,56.5%
Q9CSU0,0.770893564,-0.003,3.588255198,-0.076,0.437697917,-0.825129383,0.04,0.038,0.027,0.057,-0.168,-0.012,Q9CSU0,Rprd1b,Q9CSU0_Rprd1b,Q9CSU0,Rprd1b,1,32,10,10,Q9CSU0|A0A0R4J195|Q9CSU0-2|Q9CSU0-3,MOUSE,36997.2,34.3,1032,1032.1,138.16,138.16,,326,Regulation of nuclear pre-mRNA domain-containing protein 1B,"nucleus|DNA-directed RNA polymerase II, holoenzyme|","transcription, DNA-templated|positive regulation of cell proliferation|regulation of cell cycle process|positive regulation of transcription from RNA polymerase II promoter|dephosphorylation of RNA polymerase II C-terminal domain|",RNA polymerase II core binding|,10,32,5310000000,34.3%
G3X8T3,0.000122452,-0.203333333,62.33402294,1.65,5.84249E-07,18.24683391,-0.965,-0.979,-1.141,0.591,0.676,0.598,G3X8T3,Ctsa,G3X8T3_Ctsa,G3X8T3,Ctsa,1,34,12,12,G3X8T3|P16675,MOUSE,56352.8,22.9,1033,1033.1,138.13,138.13,,492,Carboxypeptidase,nucleoplasm|mitochondrion|membrane|intracellular membrane-bounded organelle|extracellular exosome|,proteolysis|,serine-type carboxypeptidase activity|protein binding|,12,34,11600000000,22.9%
Q9CQI6,0.397021072,0.032833333,10.48827896,-0.215666667,0.089365956,-1.986095935,0.095,0.013,0.314,-0.007,-0.157,-0.061,Q9CQI6,Cotl1,Q9CQI6_Cotl1,Q9CQI6,Cotl1,1,34,12,12,Q9CQI6|A0A1D5RLP1,MOUSE,16057.7,69,1034,1034.1,138.12,138.12,,142,Coactosin-like protein,cytoplasm|cytoskeleton|nuclear membrane|extracellular exosome|,leukotriene biosynthetic process|defense response to fungus|,actin binding|protein binding|enzyme binding|,12,34,20400000000,69.0%
Q9QY81,0.012175452,-0.044833333,31.21938464,0.606333333,0.000755199,5.838057532,-0.333,-0.213,-0.498,0.182,0.287,0.306,Q9QY81,Nup210,Q9QY81_Nup210,Q9QY81,Nup210,1,21,13,13,Q9QY81|A0A0R4J1I6,MOUSE,205066.8,9.9,1035,1035.1,137.93,137.93,,1886,Nuclear pore membrane glycoprotein 210,nuclear envelope|nuclear pore|endoplasmic reticulum membrane|membrane|nuclear membrane|,protein transport|mRNA transport|,protein dimerization activity|,13,21,3910000000,9.9%
Q60866,0.846769943,-0.012,2.407077287,0.080666667,0.574502961,0.590418391,-0.266,0.057,0.052,-0.132,0.005,0.212,Q60866,Pter,Q60866_Pter,Q60866,Pter,1,28,11,11,Q60866|Q60866-2,MOUSE,39559.8,32.3,1036,1036.1,137.86,137.86,,349,Phosphotriesterase-related protein,extracellular exosome|,catabolic process|epithelial cell differentiation|,"zinc ion binding|hydrolase activity, acting on ester bonds|",11,28,3270000000,32.3%
E9PUW7,0.884484678,-0.0245,1.871828771,0.055666667,0.649855985,0.475248838,0.068,0.002,-0.227,0.148,-0.071,-0.067,E9PUW7,NotFound,E9PUW7_NotFound,E9PUW7,Xpo7,1,25,11,11,E9PUW7|Q9EPK7|Q9EPK7-2,MOUSE,125321.5,11.8,1037,1037.1,137.77,137.77,,1088,Exportin-7,nucleus|nuclear pore|cytoplasm|,protein export from nucleus|nucleocytoplasmic transport|,nuclear export signal receptor activity|protein binding|Ran GTPase binding|,11,25,8900000000,11.8%
Q8BRH0,0.001975071,-0.138166667,40.7154163,1.253666667,8.48122E-05,8.498946959,-0.773,-0.515,-1.007,0.33,0.58,0.556,Q8BRH0,Tmtc3,Q8BRH0_Tmtc3,Q8BRH0,Tmtc3,1,18,11,11,G5E8C4|Q8BRH0|A0A0R4J173|Q8BRH0-2,MOUSE,105108.6,13.8,1038,1038.1,137.47,137.47,,920,Transmembrane and TPR repeat-containing protein 3,integral component of membrane|,post-embryonic development|regulation of gene expression|cell differentiation|lung development|lung alveolus development|muscle fiber development|bud outgrowth involved in lung branching|,,11,18,7490000000,13.8%
Q8BWW4,0.578909417,-0.008833333,6.813321942,0.177666667,0.208289705,1.394104683,0.01,0.015,-0.318,0.221,-0.02,0.039,Q8BWW4,Larp4,Q8BWW4_Larp4,Q8BWW4,Larp4,1,20,11,11,Q8BWW4|G3X9Q6|E9Q066,MOUSE,80503.7,19.8,1039,1039.1,137.39,137.39,,719,La-related protein 4,membrane|,cytoskeleton organization|regulation of cell morphogenesis|,poly(A) RNA binding|,11,20,3700000000,19.8%
Q91XD6,0.714714682,-0.026333333,4.297604317,0.105333333,0.371740234,0.9573762,0.005,0.026,-0.268,0.084,0.044,-0.049,Q91XD6,Vps36,Q91XD6_Vps36,Q91XD6,Vps36,1,25,12,12,Q91XD6,MOUSE,44020,38.3,1040,1040.1,137.35,137.35,,386,Vacuolar protein-sorting-associated protein 36,nucleus|lysosome|endosome|late endosome|cytosol|late endosome membrane|extracellular exosome|,"transcription, DNA-templated|regulation of transcription, DNA-templated|protein transport|endosomal transport|",protein C-terminus binding|phosphatidylinositol-3-phosphate binding|ubiquitin binding|,12,25,3940000000,38.3%
Q60992,0.81687669,0.000166667,2.84974765,-0.058333333,0.518830185,-0.680807854,0.061,-0.004,0.031,0.06,-0.098,-0.049,Q60992,Vav2,Q60992_Vav2,Q60992,Vav2,1,16,13,13,Q60992|Q7TSI6,MOUSE,101225.9,17.8,1041,1041.1,137.2,137.2,,868,Guanine nucleotide exchange factor VAV2,cytoplasm|cytosol|plasma membrane|,angiogenesis|small GTPase mediated signal transduction|regulation of gene expression|cell migration|cell projection assembly|lamellipodium assembly|regulation of blood coagulation|regulation of Rho protein signal transduction|positive regulation of GTPase activity|positive regulation of phosphatidylinositol 3-kinase activity|,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|epidermal growth factor receptor binding|protein binding|metal ion binding|,13,16,1180000000,17.8%
Q9CX86,0.403228566,-0.001333333,10.32450678,-0.17,0.092800288,-1.95916634,0.033,0.158,0.06,-0.159,-0.066,-0.034,Q9CX86,Hnrnpa0,Q9CX86_Hnrnpa0,Q9CX86,Hnrnpa0,1,25,12,12,Q9CX86,MOUSE,30701,35.4,1042,1042.1,137.18,137.18,,305,Heterogeneous nuclear ribonucleoprotein A0,nucleoplasm|ribonucleoprotein complex|,inflammatory response|response to lipopolysaccharide|3'-UTR-mediated mRNA stabilization|,nucleotide binding|AU-rich element binding|protein kinase binding|poly(A) RNA binding|,12,25,7040000000,35.4%
E9Q8B5,0.005446557,-0.0365,35.21227573,1.464333333,0.000301143,6.885814308,-0.704,-0.455,-1.147,0.609,0.999,0.479,E9Q8B5,Gm4788,E9Q8B5_Gm4788,E9Q8B5,Gm4788,1,24,12,12,E9Q8B5|E9PUM5|E9Q8B6,MOUSE,102688.5,18.8,1043,1043.1,136.96,136.96,,879,Predicted gene 4788,,,,12,24,2440000000,18.8%
Q9D892,0.884566234,-0.000833333,1.852228304,-0.036333333,0.652795526,-0.470705477,0.019,0.035,-0.002,-0.018,-0.037,-0.002,Q9D892,Itpa,Q9D892_Itpa,Q9D892,Itpa,1,23,9,9,Q9D892,MOUSE,22238.9,72.7,1044,1044.1,136.85,136.85,,198,Inosine triphosphate pyrophosphatase,cytoplasm|,ITP catabolic process|deoxyribonucleoside triphosphate catabolic process|chromosome organization|,nucleotide binding|dITP diphosphatase activity|ITP diphosphatase activity|XTP diphosphatase activity|metal ion binding|nucleoside-triphosphate diphosphatase activity|,9,23,14100000000,72.7%
E9QKW2,0.000653657,-0.1475,47.54194559,1.425,1.76119E-05,10.939556,-1.013,-0.828,-0.739,0.347,0.699,0.649,E9QKW2,Smoc1,E9QKW2_Smoc1,E9QKW2,Smoc1,1,22,12,12,A0A0R4J1E4|E9QKW2|D3Z3A3|Q8BLY1|Q8BLY1-2,MOUSE,51031.9,35.3,1045,1045.1,136.83,136.83,,452,SPARC-related modular calcium-binding protein 1,basement membrane|,eye development|signal transduction|positive regulation of cell-substrate adhesion|extracellular matrix organization|regulation of osteoblast differentiation|limb development|,calcium ion binding|extracellular matrix binding|,12,22,2180000000,35.3%
P42232,0.702124706,-0.004333333,4.500437105,-0.103333333,0.35477768,-0.994114271,0.036,0.189,-0.083,0.031,-0.072,-0.127,P42232,Stat5b,P42232_Stat5b,P42232,Stat5b,1,21,12,3,P42232,MOUSE,90514,18,1046,1046.1,136.82,36.3,,786,Signal transducer and activator of transcription 5B,nucleus|nucleoplasm|cytoplasm|cytosol|,allantoin metabolic process|luteinization|natural killer cell differentiation|citrate metabolic process|2-oxoglutarate metabolic process|succinate metabolic process|oxaloacetate metabolic process|regulation of transcription from RNA polymerase II promoter|transcription from RNA polymerase II promoter|isoleucine metabolic process|valine metabolic process|creatine metabolic process|fatty acid metabolic process|JAK-STAT cascade|sex differentiation|female pregnancy|lactation|positive regulation of cell proliferation|regulation of steroid metabolic process|cytokine-mediated signaling pathway|taurine metabolic process|lipid storage|regulation of cell adhesion|regulation of epithelial cell differentiation|response to estradiol|positive regulation of natural killer cell proliferation|positive regulation of natural killer cell differentiation|cellular response to hormone stimulus|T cell differentiation in thymus|prolactin signaling pathway|regulation of multicellular organism growth|positive regulation of multicellular organism growth|positive regulation of activated T cell proliferation|progesterone metabolic process|T cell homeostasis|negative regulation of apoptotic process|positive regulation of interleukin-2 biosynthetic process|positive regulation of B cell differentiation|positive regulation of gamma-delta T cell differentiation|positive regulation of lymphocyte differentiation|negative regulation of erythrocyte differentiation|positive regulation of mitotic cell cycle|positive regulation of transcription from RNA polymerase II promoter|positive regulation of natural killer cell mediated cytotoxicity|creatinine metabolic process|development of secondary female sexual characteristics|development of secondary male sexual characteristics|Peyer's patch development|positive regulation of inflammatory response|JAK-STAT cascade involved in growth hormone signaling pathway|response to interleukin-2|response to interleukin-4|response to interleukin-15|cellular response to growth factor stimulus|cellular response to epidermal growth factor stimulus|mast cell migration|,RNA polymerase II core promoter sequence-specific DNA binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|DNA binding|chromatin binding|signal transducer activity|protein binding|protein phosphatase binding|glucocorticoid receptor binding|protein dimerization activity|,12,21,3060000000,18.0%
P42230,0.076694599,-0.111333333,21.42782284,0.725333333,0.007198097,3.828141535,-0.301,-0.213,-0.908,0.239,0.177,0.338,P42230,Stat5a,P42230_Stat5a,P42230,Stat5a,1,3,12,3,P42230|B2C3G8,MOUSE,91400.2,17.5,1046,1046.2,116.19,15.67,,793,Signal transducer and activator of transcription 5A,nucleus|nucleoplasm|cytoplasm|cytosol|,"allantoin metabolic process|luteinization|natural killer cell differentiation|citrate metabolic process|2-oxoglutarate metabolic process|succinate metabolic process|oxaloacetate metabolic process|transcription, DNA-templated|regulation of transcription from RNA polymerase II promoter|isoleucine metabolic process|valine metabolic process|creatine metabolic process|fatty acid metabolic process|JAK-STAT cascade|female pregnancy|lactation|positive regulation of cell proliferation|peptidyl-tyrosine phosphorylation|regulation of steroid metabolic process|cytokine-mediated signaling pathway|taurine metabolic process|lipid storage|regulation of cell adhesion|regulation of epithelial cell differentiation|mammary gland development|positive regulation of natural killer cell differentiation|negative regulation of mast cell apoptotic process|T cell differentiation in thymus|prolactin signaling pathway|regulation of multicellular organism growth|positive regulation of multicellular organism growth|positive regulation of activated T cell proliferation|T cell homeostasis|negative regulation of apoptotic process|response to peptide hormone|positive regulation of interleukin-2 biosynthetic process|positive regulation of B cell differentiation|positive regulation of gamma-delta T cell differentiation|positive regulation of lymphocyte differentiation|negative regulation of erythrocyte differentiation|positive regulation of mitotic cell cycle|positive regulation of transcription from RNA polymerase II promoter|positive regulation of natural killer cell mediated cytotoxicity|creatinine metabolic process|development of secondary female sexual characteristics|development of secondary male sexual characteristics|Peyer's patch development|positive regulation of inflammatory response|positive regulation of mast cell differentiation|JAK-STAT cascade involved in growth hormone signaling pathway|prostate gland epithelium morphogenesis|epithelial cell differentiation involved in prostate gland development|mammary gland epithelium development|positive regulation of mast cell proliferation|cellular response to granulocyte macrophage colony-stimulating factor stimulus|",RNA polymerase II core promoter sequence-specific DNA binding|DNA binding|sequence-specific DNA binding transcription factor activity|signal transducer activity|protein binding|protein phosphatase binding|,3,3,62700000,4.1%
P24547,0.929192436,-0.013166667,1.02105493,0.023666667,0.79048659,0.276521108,-0.001,-0.118,0.044,0.006,-0.027,0.017,P24547,Impdh2,P24547_Impdh2,P24547,Impdh2,1,24,10,10,P24547,MOUSE,56213.4,24.3,1047,1047.1,136.8,136.8,,514,Inosine-5'-monophosphate dehydrogenase 2,nucleus|cytoplasm|peroxisomal membrane|membrane|extracellular exosome|,purine nucleotide biosynthetic process|GMP biosynthetic process|lymphocyte proliferation|protein homotetramerization|oxidation-reduction process|retina development in camera-type eye|cellular response to interleukin-4|,nucleotide binding|DNA binding|RNA binding|IMP dehydrogenase activity|metal ion binding|,10,24,2980000000,24.3%
Q148V8,0.226782822,-0.0025,14.9205515,0.223,0.032206598,2.694569959,-0.083,-0.141,-0.118,0.178,0.048,0.101,Q148V8,Fam83h,Q148V8_Fam83h,Q148V8,Fam83h,1,20,14,14,Q148V8,MOUSE,131683.4,15.7,1048,1048.1,136.6,136.6,,1209,Protein FAM83H,,biomineral tissue development|,,14,20,2040000000,15.7%
Z4YJT3,0.64621906,0.000166667,5.449835174,-0.123666667,0.285112647,-1.161839082,-0.042,0.02,0.208,0.004,-0.181,-0.008,Z4YJT3,NotFound,Z4YJT3_NotFound,Z4YJT3,Larp1,1,29,10,10,Z4YJT3|Q6ZQ58,MOUSE,121548.9,17.7,1049,1049.1,136.01,136.01,,1072,La-related protein 1,nucleoplasm|cytoplasm|membrane|TORC1 complex|,translational initiation|cell proliferation|positive regulation of macroautophagy|TOR signaling|positive regulation of translation|,RNA cap binding|mRNA 3'-UTR binding|eukaryotic initiation factor 4E binding|translation activator activity|translation initiation factor binding|poly(A) RNA binding|mRNA 5'-UTR binding|,10,29,1590000000,17.7%
Q8CBB7,0.430679683,0.004166667,9.717007345,-0.259,0.106733135,-1.865841332,-0.094,0.272,0.223,-0.295,-0.119,0.038,Q8CBB7,Ap1g1,Q8CBB7_Ap1g1,Q8CBB7,Ap1g1,1,22,13,13,Q8CBB7|P22892,MOUSE,92576.1,17.8,1050,1050.1,135.23,135.23,,825,AP-1 complex subunit gamma-1,cytoplasm|Golgi apparatus|trans-Golgi network|membrane|clathrin adaptor complex|clathrin-coated vesicle|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|recycling endosome|,intracellular protein transport|vesicle-mediated transport|endosome to melanosome transport|positive regulation of natural killer cell degranulation|positive regulation of natural killer cell mediated cytotoxicity|Golgi to lysosome transport|,protein transporter activity|Rab GTPase binding|kinesin binding|GTP-dependent protein binding|,13,22,2620000000,17.8%
Q8CH18,0.777827379,-0.0025,3.420348818,0.091666667,0.454951518,0.79339309,-0.233,0.025,0.063,-0.004,-0.034,0.168,Q8CH18,Ccar1,Q8CH18_Ccar1,Q8CH18,Ccar1,1,14,11,11,Q8CH18|Q8CH18-3|Q8CH18-2,MOUSE,132742.5,11.8,1051,1051.1,134.9,134.9,,1146,Cell division cycle and apoptosis regulator protein 1,nuclear envelope lumen|perinuclear region of cytoplasm|,"transcription, DNA-templated|regulation of transcription, DNA-templated|apoptotic process|cell cycle|positive regulation of cell proliferation|positive regulation of cell migration|positive regulation of apoptotic process|negative regulation of nucleic acid-templated transcription|",core promoter binding|transcription coactivator activity|transcription corepressor activity|protein binding|ligand-dependent nuclear receptor transcription coactivator activity|poly(A) RNA binding|,11,14,1890000000,11.8%
Q6AW69,0.428327067,-0.040333333,9.825224113,0.295333333,0.104106438,1.883151934,-0.171,0.078,-0.471,-0.048,0.182,0.188,Q6AW69,Cgnl1,Q6AW69_Cgnl1,Q6AW69,Cgnl1,1,22,15,15,Q6AW69|Q6AW69-4|B2RSU6|Q6AW69-5|D3Z3H4|Q6AW69-3|Q6AW69-2,MOUSE,148969.6,14.2,1052,1052.1,134.78,134.78,,1298,Cingulin-like protein 1,bicellular tight junction|actin cytoskeleton|myosin complex|apical junction complex|,metabolic process|,motor activity|,15,22,853000000,14.2%
P70671,0.919416995,-0.030166667,1.219432848,-0.041666667,0.755190843,-0.325026494,0.107,0.127,-0.262,-0.007,-0.012,-0.134,P70671,Irf3,P70671_Irf3,P70671,Irf3,1,12,9,9,P70671,MOUSE,47079.5,43.4,1053,1053.1,134.7,134.7,,419,Interferon regulatory factor 3,nucleus|cytoplasm|cytosol|,"transcription, DNA-templated|regulation of transcription, DNA-templated|response to bacterium|lipopolysaccharide-mediated signaling pathway|response to lipopolysaccharide|positive regulation of interferon-alpha production|positive regulation of interferon-beta production|positive regulation of I-kappaB kinase/NF-kappaB signaling|response to exogenous dsRNA|innate immune response|type I interferon biosynthetic process|positive regulation of cytokine secretion|defense response to virus|positive regulation of type I interferon-mediated signaling pathway|cellular response to lipopolysaccharide|cellular response to dsRNA|programmed necrotic cell death|",regulatory region DNA binding|sequence-specific DNA binding transcription factor activity|identical protein binding|protein homodimerization activity|,9,12,1710000000,43.4%
Q60598,0.168149552,0.018666667,16.96710508,0.326,0.020104325,3.034620518,-0.132,-0.023,-0.278,0.054,0.234,0.257,Q60598,Cttn,Q60598_Cttn,Q60598,Cttn,1,24,13,13,Q60598|Q921L6,MOUSE,61419.8,24.5,1054,1054.1,134.53,134.53,,546,Src substrate cortactin,ruffle|podosome|cytoplasm|cytosol|coated pit|focal adhesion|cell cortex|lamellipodium|cell junction|cortical cytoskeleton|dendritic spine|extracellular exosome|mitotic spindle midzone|actin filament|focal adhesion|voltage-gated potassium channel complex|growth cone|,"intracellular protein transport|receptor-mediated endocytosis|substrate-dependent cell migration, cell extension|actin filament polymerization|regulation of axon extension|positive regulation of actin filament polymerization|actin cytoskeleton reorganization|positive regulation of smooth muscle contraction|focal adhesion assembly|neuron projection morphogenesis|cell motility|dendritic spine maintenance|lamellipodium organization|regulation of mitochondrion degradation|negative regulation of extrinsic apoptotic signaling pathway|",protein binding|profilin binding|,13,24,3930000000,24.5%
P70295,0.81132483,-0.027166667,2.944632062,0.071,0.507617743,0.699813313,0.025,0.008,-0.221,0.077,-0.03,-0.022,P70295,NotFound,P70295_NotFound,P70295,Aup1,1,26,10,10,P70295|Q3U3K9,MOUSE,46519.8,29,1055,1055.1,134.49,134.49,,410,Ancient ubiquitous protein 1,endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular exosome|,"retrograde protein transport, ER to cytosol|","transferase activity, transferring acyl groups|",10,26,8830000000,29.0%
A8DUK4,0.620776556,-0.0115,5.941089239,0.287666667,0.254619157,1.24725619,0.32,-0.497,-0.289,-0.05,0.049,0.398,A8DUK4,Hbb-bs,A8DUK4_Hbb-bs,A8DUK4,Hbb-bs,1,57,9,3,A8DUK4|P02081|D4QBB3|P02070|P02104|P06642|P06643,MOUSE,15804.8,76.8,1056,1056.1,134.48,47.01,,147,Beta-globin,hemoglobin complex|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,9,57,1.14E+11,76.8%
P02088,0.546002425,-0.132833333,7.359105799,0.549666667,0.183691652,1.484387187,0.489,-0.775,-0.937,-0.012,0.061,0.377,P02088,Hbb-b1,P02088_Hbb-b1,P02088,Hbb-b1,1,21,8,3,P02088,MOUSE,15954,68.7,1056,1056.2,117.19,50.5,,147,Hemoglobin subunit beta-1,hemoglobin complex|myelin sheath|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,3,21,37400000000,27.8%
Q7TQI3,0.856746862,0.027833333,2.290887415,-0.074333333,0.590080494,-0.565960206,-0.121,0.323,-0.007,-0.081,0.013,0.04,Q7TQI3,Otub1,Q7TQI3_Otub1,Q7TQI3,Otub1,1,24,9,9,Q7TQI3|D3YWF6,MOUSE,31497.7,35,1057,1057.1,134.25,134.25,,271,Ubiquitin thioesterase OTUB1,nucleus|cytoplasm|extracellular exosome|,immune system process|DNA repair|cellular response to DNA damage stimulus|protein K48-linked deubiquitination|cellular response to interleukin-1|negative regulation of histone H2A K63-linked ubiquitination|negative regulation of double-strand break repair|,ubiquitin-specific protease activity|NEDD8-specific protease activity|ubiquitin protein ligase binding|ubiquitin binding|,9,24,2500000000,35.0%
Q60864,0.55391814,0.022666667,7.184651233,0.136666667,0.191220688,1.453742832,-0.051,-0.056,-0.03,-0.049,0.176,0.146,Q60864,Stip1,Q60864_Stip1,Q60864,Stip1,1,24,12,12,Q60864,MOUSE,63208.6,26.7,1058,1058.1,134.08,134.08,,543,Stress-induced-phosphoprotein 1,nucleus|cytosol|myelin sheath|protein complex|,,protein binding|protein C-terminus binding|Hsp70 protein binding|poly(A) RNA binding|chaperone binding|,12,24,13900000000,26.7%
Q8VBW8,0.225866106,-0.003333333,14.97261041,0.235333333,0.031822842,2.703050325,-0.055,-0.156,-0.152,0.029,0.165,0.149,Q8VBW8,Ttc36,Q8VBW8_Ttc36,Q8VBW8,Ttc36,1,31,10,10,Q8VBW8,MOUSE,20189.2,53.2,1059,1059.1,134.03,134.03,,186,Tetratricopeptide repeat protein 36,,,,10,31,26200000000,53.2%
Q9D023,0.905087052,-0.026333333,1.543096145,-0.093333333,0.700955399,-0.401130369,0.345,0.233,-0.517,-0.14,0.092,-0.171,Q9D023,Mpc2,Q9D023_Mpc2,Q9D023,Mpc2,1,50,10,10,Q9D023|A0A0A6YY89,MOUSE,14342.7,51.1,1060,1060.1,134.01,134.01,,127,Mitochondrial pyruvate carrier 2,nucleus|mitochondrion|mitochondrial inner membrane|integral component of membrane|,pyruvate metabolic process|mitochondrial pyruvate transport|pyruvate transmembrane transport|,pyruvate transmembrane transporter activity|,10,50,1.82E+11,51.1%
P97371,0.598421022,-0.012666667,6.371384435,0.158,0.230601197,1.320145054,-0.047,-0.287,0.059,-0.022,0.037,0.184,P97371,Psme1,P97371_Psme1,P97371,Psme1,1,31,12,10,P97371|G3UXY0|G3X9K9,MOUSE,28843.6,46.5,1061,1061.1,133.85,108.67,,249,Proteasome activator complex subunit 1,proteasome activator complex|extracellular exosome|,positive regulation of endopeptidase activity|antigen processing and presentation of exogenous antigen|,protein binding|endopeptidase activator activity|,12,31,4660000000,46.5%
P97372,0.291555338,0.011333333,13.06498482,0.208666667,0.049374364,2.395246168,-0.048,-0.183,-0.048,0.143,0.055,0.149,P97372,Psme2,P97372_Psme2,P97372,Psme2,1,14,7,5,P97372|G3X9V0,MOUSE,27285,29.2,1061,1061.2,91.42,66.24,,239,Proteasome activator complex subunit 2,proteasome activator complex|,,,5,14,2690000000,24.6%
E9QP,0.000673669,-0.156333333,47.32143503,1.798,1.85292E-05,10.85188343,-1.011,-0.884,-1.271,0.453,0.81,0.965,E9QP,NotFound,E9QP_NotFound,E9QP,Col18a1,1,28,10,10,E9QP|P39061|P39061-1|P39061-2,MOUSE,183320.5,6.8,1062,1062.1,133.72,133.72,,1774,Collagen alpha-1(XVIII) chain,collagen trimer|basement membrane|extracellular space|extracellular matrix|extracellular exosome|extracellular matrix|,angiogenesis|endothelial cell morphogenesis|cell adhesion|positive regulation of cell proliferation|extracellular matrix organization|positive regulation of cell migration|positive regulation of endothelial cell apoptotic process|,structural molecule activity|identical protein binding|,10,28,6920000000,6.8%
Q8BSE0,0.961523652,-0.015166667,0.560882662,0.019,0.878843882,0.158427808,-0.047,0.111,-0.138,0.039,0.132,-0.188,Q8BSE0,Rmdn2,Q8BSE0_Rmdn2,Q8BSE0,Rmdn2,1,23,12,12,Q8BSE0,MOUSE,47528.7,36,1063,1063.1,133.67,133.67,,410,Regulator of microtubule dynamics protein 2,spindle pole|cytoplasm|mitochondrion|microtubule|integral component of membrane|,,,12,23,28200000000,36.0%
P35980,0.961624579,-0.004833333,0.528040365,-0.019,0.885515084,-0.149626925,-0.108,0.245,-0.123,0.043,0.033,-0.119,P35980,Rpl18,P35980_Rpl18,P35980,Rpl18,1,47,10,10,P35980|A0A1B0GQU8|A0A1B0GSF7|A0A1B0GSS8,MOUSE,21701.2,45.7,1064,1064.1,132.76,132.76,,188,60S ribosomal protein L18,nucleus|nucleolus|cytoplasm|focal adhesion|membrane|cytosolic large ribosomal subunit|,translation|,structural constituent of ribosome|,10,47,49600000000,45.7%
A2ACM0,0.894042447,0.006,1.675060386,-0.041333333,0.67997659,-0.431033655,0.12,-0.002,-0.038,0.092,-0.029,-0.107,A2ACM0,Rptor,A2ACM0_Rptor,A2ACM0,Rptor,1,19,12,12,A2ACM0|Q8K4Q0|Q8K4Q0-4|E9PXZ5|Q8K4Q0-5|Q8K4Q0-2|Q8K4Q0-3,MOUSE,151320.4,11,1065,1065.1,132.36,132.36,,1335,Putative uncharacterized protein,nucleoplasm|cytoplasm|lysosome|lysosomal membrane|dendrite|TORC1 complex|neuronal cell body|intracellular membrane-bounded organelle|,positive regulation of endothelial cell proliferation|regulation of cell size|cell growth|cellular response to nutrient levels|TOR signaling|positive regulation of TOR signaling|positive regulation of transcription from RNA polymerase III promoter|cellular response to amino acid stimulus|positive regulation of protein serine/threonine kinase activity|,RNA polymerase III type 1 promoter DNA binding|RNA polymerase III type 2 promoter DNA binding|RNA polymerase III type 3 promoter DNA binding|TFIIIC-class transcription factor binding|protein kinase binding|protein complex binding|14-3-3 protein binding|,12,19,1180000000,11.0%
A3KGB4,0.963376742,-0.000833333,0.499672292,-0.011,0.891318192,-0.141919531,0.018,0.006,-0.01,-0.018,-0.025,0.024,A3KGB4,Tbc1d8b,A3KGB4_Tbc1d8b,A3KGB4,Tbc1d8b,1,23,11,11,A3KGB4|Q9Z1A9|A0A0A6YWY1|A0A0A6YXU3,MOUSE,129088.5,11.7,1066,1066.1,132.15,132.15,,1114,TBC1 domain family member 8B,,positive regulation of GTPase activity|,GTPase activator activity|calcium ion binding|,11,23,7920000000,11.7%
Q9R1Z8,0.974362931,-0.012666667,0.376592482,-0.01,0.916939648,-0.108288353,-0.075,0.047,0.005,-0.114,-0.022,0.083,Q9R1Z8,Sorbs3,Q9R1Z8_Sorbs3,Q9R1Z8,Sorbs3,1,21,11,11,Q9R1Z8,MOUSE,82632.7,19.3,1067,1067.1,132.12,132.12,,733,Vinexin,nucleus|cytoplasm|cytoskeleton|focal adhesion|focal adhesion|,negative regulation of transcription from RNA polymerase II promoter|actin filament organization|cell-substrate adhesion|positive regulation of MAPK cascade|positive regulation of stress fiber assembly|,transcription factor binding|vinculin binding|,11,21,1680000000,19.3%
Q03160,0.726796323,-0.027666667,4.15245741,0.092666667,0.384374226,0.930618199,-0.036,0.046,-0.232,0.027,0.006,0.023,Q03160,Grb7,Q03160_Grb7,Q03160,Grb7,1,26,9,9,Q03160,MOUSE,60871,21.6,1068,1068.1,131.87,131.87,,535,Growth factor receptor-bound protein 7,cytosol|plasma membrane|focal adhesion|cytoplasmic stress granule|cell projection|,signal transduction|positive regulation of signal transduction|negative regulation of translation|positive regulation of cell migration|stress granule assembly|,RNA binding|SH3/SH2 adaptor activity|protein binding|protein kinase binding|phosphatidylinositol binding|identical protein binding|,9,26,3890000000,21.6%
Q9DCY0,0.919416995,-0.032333333,1.212305811,0.071333333,0.756431174,0.32331254,-0.021,0.364,-0.547,0.077,-0.028,-0.039,Q9DCY0,Keg1,Q9DCY0_Keg1,Q9DCY0,Keg1,1,21,11,11,Q9DCY0,MOUSE,34178.8,45,1069,1069.1,131.75,131.75,,295,Glycine N-acyltransferase-like protein Keg1,mitochondrion|microtubule organizing center|microtubule|,metabolic process|,glycine N-acyltransferase activity|,11,21,3040000000,45.0%
Q8C4C9,0.461918472,0.000333333,9.114074579,0.242666667,0.122628818,1.76919293,0.048,-0.043,-0.368,0.156,-0.023,0.232,Q8C4C9,NotFound,Q8C4C9_NotFound,Q8C4C9,Dnajb12,1,20,11,11,Q8C4C9|Q9QYI4|D6RHR9,MOUSE,42659.8,26.1,1070,1070.1,131.31,131.31,,378,"DnaJ (Hsp40) homolog, subfamily B, member 12, isoform CRA_d",membrane|,,,11,20,611000000,26.1%
Q99JR6,0.970532223,-0.043166667,0.415798212,-0.017666667,0.908699269,-0.119139582,0.159,0.051,-0.313,0.017,0.04,-0.213,Q99JR6,Nmnat3,Q99JR6_Nmnat3,Q99JR6,Nmnat3,1,27,11,11,Q99JR6|Q3V3C7|Q3V3F1,MOUSE,27873.4,56.3,1071,1071.1,131.25,131.25,,245,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3,mitochondrion|,NAD biosynthetic process|response to wounding|,nicotinamide-nucleotide adenylyltransferase activity|nicotinate-nucleotide adenylyltransferase activity|ATP binding|,11,27,10100000000,56.3%
Q8BJS4,0.332192581,0.005666667,11.86579197,0.204666667,0.065075993,2.204020392,-0.124,-0.155,-0.011,0.19,0.01,0.124,Q8BJS4,Sun2,Q8BJS4_Sun2,Q8BJS4,Sun2,1,19,11,11,Q8BJS4|Q8BJS4-2|Q8BJS4-3,MOUSE,81775.1,18.1,1072,1072.1,131.19,131.19,,731,SUN domain-containing protein 2,"nuclear chromosome, telomeric region|condensed nuclear chromosome|nuclear envelope|nuclear inner membrane|integral component of nuclear inner membrane|endosome membrane|nuclear membrane|LINC complex|",nuclear envelope organization|positive regulation of cell migration|nuclear migration along microfilament|centrosome localization|cytoskeletal anchoring at nuclear membrane|nuclear matrix anchoring at nuclear membrane|,protein binding|lamin binding|identical protein binding|,11,19,1920000000,18.1%
Q91YR1,0.252165464,0.032333333,14.12937573,-0.275333333,0.038642252,-2.567812773,0.009,0.315,0.186,-0.177,-0.102,-0.037,Q91YR1,Twf1,Q91YR1_Twf1,Q91YR1,Twf1,1,29,10,10,Q91YR1,MOUSE,40306.9,32.8,1073,1073.1,131.16,131.16,,350,Twinfilin-1,cytoplasm|cell-cell junction|focal adhesion|actin cytoskeleton|myofibril|filopodium|perinuclear region of cytoplasm|ruffle membrane|,peptidyl-tyrosine phosphorylation|negative regulation of actin filament polymerization|sequestering of actin monomers|regulation of actin phosphorylation|barbed-end actin filament capping|,"actin monomer binding|protein tyrosine kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate binding|protein complex binding|",10,29,7390000000,32.8%
Q3TXZ6,0.582708025,0.016333333,6.673343262,0.123333333,0.215112513,1.369103912,-0.03,-0.016,-0.09,0.193,0.016,0.025,Q3TXZ6,Pde2a,Q3TXZ6_Pde2a,Q3TXZ6,Pde2a,1,15,10,10,F7D3W5|A0A1B0GRJ9|Q3TXZ6|Q5PR72|Q922S4,MOUSE,107328.5,18.5,1074,1074.1,130.91,130.91,,939,Phosphodiesterase,nucleus|cytosol|plasma membrane|membrane raft|perinuclear region of cytoplasm|,"negative regulation of transcription from RNA polymerase II promoter|cAMP catabolic process|cAMP-mediated signaling|cGMP-mediated signaling|monocyte differentiation|negative regulation of protein import into nucleus, translocation|cellular response to drug|cellular response to macrophage colony-stimulating factor stimulus|negative regulation of vascular permeability|positive regulation of vascular permeability|cGMP catabolic process|cellular response to cGMP|cellular response to transforming growth factor beta stimulus|cellular response to granulocyte macrophage colony-stimulating factor stimulus|",cGMP-stimulated cyclic-nucleotide phosphodiesterase activity|drug binding|cAMP binding|cGMP binding|TPR domain binding|protein homodimerization activity|metal ion binding|,10,15,1720000000,18.5%
O08529,0.543949462,-0.0125,7.399935635,0.149,0.181972783,1.489109689,-0.238,-0.054,0.031,0.02,0.055,0.111,O08529,Capn2,O08529_Capn2,O08529,Capn2,1,24,11,11,O08529,MOUSE,80726.5,17,1075,1075.1,130.89,130.89,,700,Calpain-2 catalytic subunit,chromatin|nucleus|cytoplasm|lysosome|endoplasmic reticulum|Golgi apparatus|cytosol|plasma membrane|focal adhesion|dendrite|pseudopodium|membrane raft|extracellular exosome|perinuclear endoplasmic reticulum|membrane raft|,response to hypoxia|blastocyst development|proteolysis|myoblast fusion|protein autoprocessing|regulation of cytoskeleton organization|cellular response to amino acid stimulus|,calcium-dependent cysteine-type endopeptidase activity|calcium ion binding|cytoskeletal protein binding|peptidase activity|protein heterodimerization activity|,11,24,4670000000,17.0%
Q61029,0.167761897,0.009333333,16.99756636,0.340666667,0.019963807,3.042666677,-0.165,-0.093,-0.225,-0.018,0.287,0.27,Q61029,Tmpo,Q61029_Tmpo,Q61029,Tmpo,1,21,9,5,Q61029|Q61029-3|Q61029-2|Q61029-4|Q61033-2,MOUSE,50428.9,31.8,1076,1076.1,130.57,65.6,,452,"Lamina-associated polypeptide 2, isoforms beta/delta/epsilon/gamma",chromatin|nucleus|nuclear envelope|nuclear inner membrane|membrane|integral component of membrane|nuclear membrane|,"regulation of transcription, DNA-templated|",DNA binding|protein binding|,9,21,3860000000,31.8%
Q61033,0.185890557,-0.036166667,16.43072005,0.346333333,0.022747203,2.950728168,-0.235,-0.379,-0.014,0.226,0.078,0.107,Q61033,Tmpo,Q61033_Tmpo,Q61033,Tmpo,1,2,6,2,Q61033,MOUSE,75851.6,13.8,1076,1076.2,84.41,19.44,,693,"Lamina-associated polypeptide 2, isoforms alpha/zeta",chromatin|nucleus|nuclear envelope|nuclear inner membrane|membrane|nuclear membrane|,"regulation of transcription, DNA-templated|",DNA binding|protein binding|,2,2,82200000,2.7%
Q542V3,0.817688571,0.024166667,2.826284593,-0.085,0.521640786,-0.676515751,-0.141,0.104,0.237,-0.003,-0.14,0.088,Q542V3,Srsf4,Q542V3_Srsf4,Q542V3,Srsf4,1,25,11,7,Q542V3|Q8VE97,MOUSE,56361.9,20.5,1077,1077.1,130.56,86.04,,491,Serine/arginine-rich-splicing factor 4,nucleoplasm|,"hematopoietic progenitor cell differentiation|negative regulation of mRNA splicing, via spliceosome|",nucleotide binding|poly(A) RNA binding|,11,25,8060000000,20.5%
Q3TWW8,0.88044681,0.004333333,1.937761115,0.054,0.640064718,0.489635065,-0.193,0.095,0.03,0.028,-0.062,0.128,Q3TWW8,Srsf6,Q3TWW8_Srsf6,Q3TWW8,Srsf6,1,16,11,7,Q3TWW8,MOUSE,39138.7,24.1,1077,1077.2,119.5,74.98,,339,Serine/arginine-rich splicing factor 6,nucleoplasm|nuclear speck|,"alternative mRNA splicing, via spliceosome|regulation of alternative mRNA splicing, via spliceosome|mRNA splice site selection|regulation of keratinocyte proliferation|negative regulation of keratinocyte differentiation|negative regulation of mRNA splicing, via spliceosome|positive regulation of epithelial cell proliferation involved in lung morphogenesis|negative regulation of cell death|regulation of wound healing|",nucleotide binding|RNA binding|pre-mRNA binding|poly(A) RNA binding|,7,16,3890000000,19.4%
O35326,0.963376742,-0.002,0.508466805,0.014,0.889515089,0.14429275,-0.002,-0.009,-0.016,0.138,-0.13,0.007,O35326,Srsf5,O35326_Srsf5,O35326,Srsf5,1,19,9,8,Q9D8S5|O35326,MOUSE,31005,31.9,1077,1077.3,113.57,100.58,,269,Serine/arginine-rich splicing factor 5,nucleolus|cytoplasm|nuclear speck|,"transcription, DNA-templated|regulation of transcription, DNA-templated|mRNA processing|RNA splicing|response to wounding|regulation of cell cycle|",nucleotide binding|protein binding|poly(A) RNA binding|RS domain binding|,8,19,3030000000,28.6%
Q8QZS1,0.91325,-0.053833333,1.392414737,-0.113666667,0.725702345,-0.366109767,-0.497,-0.088,0.594,-0.552,0.126,0.094,Q8QZS1,Hibch,Q8QZS1_Hibch,Q8QZS1,Hibch,1,16,9,9,Q8QZS1|E0C9,MOUSE,43322.1,32.7,1078,1078.1,130.45,130.45,,385,"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial",mitochondrion|extracellular exosome|,valine catabolic process|,3-hydroxyisobutyryl-CoA hydrolase activity|,9,16,1950000000,32.7%
F8VPU2,0.994928853,0.0015,0.087749168,0.002333333,0.97999776,0.026022487,-0.021,-0.015,0.037,0.053,-0.113,0.068,F8VPU2,Farp1,F8VPU2_Farp1,F8VPU2,Farp1,1,18,12,12,F8VPU2,MOUSE,119671.9,13.9,1079,1079.1,130.21,130.21,,1048,"FERM, ARHGEF and pleckstrin domain-containing protein 1",cytoplasm|cytosol|cytoskeleton|cell junction|filopodium|dendrite|extrinsic component of cytoplasmic side of plasma membrane|dendritic spine|synapse|,synapse assembly|negative regulation of phosphatase activity|regulation of Rho protein signal transduction|positive regulation of GTPase activity|dendrite morphogenesis|,cytoskeletal protein binding|Rac guanyl-nucleotide exchange factor activity|Rac GTPase binding|,12,18,1500000000,13.9%
Q9CQ62,0.911411213,-0.012,1.418523466,0.055333333,0.721352686,0.372227293,0.072,0.109,-0.3,-0.083,0.216,-0.086,Q9CQ62,Decr1,Q9CQ62_Decr1,Q9CQ62,Decr1,1,26,12,12,Q9CQ62,MOUSE,36498.4,44.4,1080,1080.1,130.2,130.2,,335,"2,4-dienoyl-CoA reductase, mitochondrial",nucleus|nucleoplasm|cytoplasm|mitochondrion|extracellular exosome|,fatty acid beta-oxidation|protein homotetramerization|,"2,4-dienoyl-CoA reductase (NADPH) activity|NADPH binding|",12,26,3310000000,44.4%
Q99KG5,0.028766834,0.021666667,26.53591068,0.773333333,0.002220286,4.82967471,-0.282,-0.266,-0.547,0.371,0.157,0.697,Q99KG5,Lsr,Q99KG5_Lsr,Q99KG5,Lsr,1,25,10,10,Q99KG5|Q99KG5-2|Q99KG5-3,MOUSE,67304.9,24.2,1081,1081.1,130.19,130.19,,594,Lipolysis-stimulated lipoprotein receptor,plasma membrane|integral component of membrane|very-low-density lipoprotein particle|low-density lipoprotein particle|chylomicron|extracellular exosome|,liver development|receptor-mediated endocytosis|regulation of lipid metabolic process|lipoprotein transport|,low-density lipoprotein particle binding|lipoprotein particle receptor activity|,10,25,5700000000,24.2%
Q91XE0,0.241932648,0.061833333,14.43845473,-0.401666667,0.035987736,-2.623668576,0.089,0.601,0.098,-0.181,-0.145,-0.091,Q91XE0,Glyat,Q91XE0_Glyat,Q91XE0,Glyat,1,26,11,11,Q91XE0|Q91XE0-2,MOUSE,34382.9,42.9,1082,1082.1,130.12,130.12,,296,Glycine N-acyltransferase,mitochondrion|extracellular exosome|,glycine metabolic process|response to toxic substance|monocarboxylic acid metabolic process|,glycine N-acyltransferase activity|glycine N-benzoyltransferase activity|,11,26,4630000000,42.9%
Q68FH4,0.910359106,-0.007666667,1.45289973,0.050666667,0.71566541,0.380249902,0.126,-0.01,-0.215,0.211,-0.032,-0.126,Q68FH4,Galk2,Q68FH4_Galk2,Q68FH4,Galk2,1,29,10,10,Q68FH4|Q8BUU7,MOUSE,51472.3,29.9,1083,1083.1,130.11,130.11,,458,N-acetylgalactosamine kinase,cytoplasm|,galactose metabolic process|carbohydrate phosphorylation|,galactokinase activity|ATP binding|N-acetylgalactosamine kinase activity|,10,29,6210000000,29.9%
Q6PB44,0.587827992,0.022,6.533306236,0.126,0.222161795,1.345737904,-0.113,0.06,-0.07,0.084,0.004,0.167,Q6PB44,Ptpn23,Q6PB44_Ptpn23,Q6PB44,Ptpn23,1,19,13,13,Q6PB44|Q6PB44-2,MOUSE,186068.9,10.6,1084,1084.1,130.03,130.03,,1692,Tyrosine-protein phosphatase non-receptor type 23,nucleus|nucleoplasm|cytoplasm|endosome|early endosome|cytoplasmic membrane-bounded vesicle|ciliary basal body|extracellular exosome|,negative regulation of epithelial cell migration|protein transport|peptidyl-tyrosine dephosphorylation|ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway|cilium morphogenesis|positive regulation of homophilic cell adhesion|positive regulation of adherens junction organization|positive regulation of early endosome to late endosome transport|,protein tyrosine phosphatase activity|protein kinase binding|,13,19,1290000000,10.6%
Q6ZWX6,0.873144039,0.0175,2.062056865,-0.070333333,0.622005627,-0.516952382,-0.078,0.333,-0.097,0.059,-0.051,-0.061,Q6ZWX6,Eif2s1,Q6ZWX6_Eif2s1,Q6ZWX6,Eif2s1,1,20,10,10,Q6ZWX6,MOUSE,36392.8,38,1085,1085.1,129.99,129.99,,315,Eukaryotic translation initiation factor 2 subunit 1,nucleus|cytoplasm|ribosome|eukaryotic translation initiation factor 2 complex|eukaryotic translation initiation factor 2B complex|cytoplasmic stress granule|membrane|eukaryotic 48S preinitiation complex|multi-eIF complex|extracellular exosome|eukaryotic translation initiation factor 2B complex|,positive regulation of defense response to virus by host|translation|translational initiation|regulation of translational initiation in response to stress|protein autophosphorylation|activation of mitophagy in response to mitochondrial depolarization|,translation initiation factor activity|protein binding|ribosome binding|poly(A) RNA binding|,10,20,1840000000,38.0%
P54116,0.578909417,0.021666667,6.769354399,-0.147333333,0.21040912,-1.385393928,0.014,0.011,0.261,-0.019,-0.147,0.01,P54116,Stom,P54116_Stom,P54116,Stom,1,26,11,11,P54116,MOUSE,31545.9,35.5,1086,1086.1,129.88,129.88,,284,Erythrocyte band 7 integral membrane protein,extracellular space|cytoplasm|mitochondrion|endoplasmic reticulum|cytoskeleton|integral component of plasma membrane|membrane|vesicle|melanosome|membrane raft|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|,positive regulation of defense response to virus by host|regulation of ion transmembrane transport|positive regulation by host of viral genome replication|positive regulation of viral process|protein homooligomerization|positive regulation of protein targeting to membrane|activation of mitophagy in response to mitochondrial depolarization|regulation of acid-sensing ion channel activity|,protein binding|identical protein binding|protein homodimerization activity|RNA polymerase binding|,11,26,4620000000,35.5%
P21619,0.41441163,0.083666667,10.09587891,-0.311333333,0.097816498,-1.926411416,-0.112,0.401,0.429,-0.119,-0.131,0.034,P21619,Lmnb2,P21619_Lmnb2,P21619,Lmnb2,1,22,12,12,A0A0R4J0Q5|P21619|P21619-2,MOUSE,67431,23.9,1087,1087.1,129.33,129.33,,596,Lamin-B2,nucleus|nuclear envelope|nuclear inner membrane|lamin filament|,,structural molecule activity|,12,22,15700000000,23.9%
A2AJL3,0.470565279,-0.003833333,8.856069645,0.155,0.130134676,1.724903141,-0.037,-0.029,-0.178,0.052,0.147,0.022,A2AJL3,Fggy,A2AJL3_Fggy,A2AJL3,Fggy,1,15,9,9,A2AJL3|A2AJL3-2|A2AJL4|D6RHR3,MOUSE,61020,21.9,1088,1088.1,129.32,129.32,,552,FGGY carbohydrate kinase domain-containing protein,cytoplasm|,carbohydrate phosphorylation|neuron cellular homeostasis|,"kinase activity|phosphotransferase activity, alcohol group as acceptor|",9,15,1110000000,21.9%
Q61550,0.216645849,0.001833333,15.33458506,-0.270333333,0.029278006,-2.762163309,0.13,0.183,0.098,-0.097,-0.278,-0.025,Q61550,Rad21,Q61550_Rad21,Q61550,Rad21,1,11,10,10,Q61550,MOUSE,72367,17.6,1089,1089.1,129.32,129.32,,635,Double-strand-break repair protein rad21 homolog,"chromosome, centromeric region|chromatin|condensed nuclear chromosome|nucleoplasm|cohesin complex|membrane|nuclear meiotic cohesin complex|",DNA repair|regulation of transcription from RNA polymerase II promoter|transcription from RNA polymerase II promoter|apoptotic process|chromosome segregation|mitotic nuclear division|positive regulation of transcription from RNA polymerase II promoter|cell division|protein localization to chromatin|,RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|protein binding|,10,11,449000000,17.6%
Q9EPK6,0.002846478,-0.185833333,38.54469961,1.570333333,0.000139807,7.829108382,-0.656,-0.836,-1.421,0.488,0.61,0.7,Q9EPK6,Sil1,Q9EPK6_Sil1,Q9EPK6,Sil1,1,20,9,9,Q9EPK6,MOUSE,52771.3,27.9,1090,1090.1,129.19,129.19,,465,Nucleotide exchange factor SIL1,extracellular space|endoplasmic reticulum|endoplasmic reticulum lumen|,protein transport|,,9,20,2780000000,27.9%
Q920R0,0.826689065,-0.014166667,2.67117708,0.052333333,0.540607781,0.644633444,-0.013,-0.104,-0.004,0.028,-0.02,0.028,Q920R0,Als2,Q920R0_Als2,Q920R0,Als2,1,23,11,11,Q920R0|Q920R0-2,MOUSE,184331.7,7.3,1091,1091.1,129,129,,1651,Alsin,ruffle|nucleus|cytoplasm|early endosome|centrosome|cytosol|postsynaptic density|membrane|lamellipodium|axon|dendrite|growth cone|vesicle|neuronal cell body|dendritic spine|protein complex|centrosome|,"behavioral fear response|in utero embryonic development|receptor recycling|response to oxidative stress|endosome organization|lysosomal transport|axonogenesis|neuromuscular junction development|locomotory behavior|protein localization|cell death|vesicle organization|endosomal transport|Rac protein signal transduction|regulation of Rho protein signal transduction|synaptic transmission, glutamatergic|regulation of GTPase activity|positive regulation of GTPase activity|positive regulation of protein kinase activity|neuron projection morphogenesis|regulation of endosome size|protein homooligomerization|positive regulation of protein serine/threonine kinase activity|",GTPase activator activity|protein binding|Rab guanyl-nucleotide exchange factor activity|Rab GTPase binding|Rac guanyl-nucleotide exchange factor activity|identical protein binding|protein homodimerization activity|protein serine/threonine kinase activator activity|Rac GTPase binding|guanyl-nucleotide exchange factor activity|,11,23,2060000000,7.3%
Q9D832,0.515087795,0.010666667,7.885481216,-0.147333333,0.1627241,-1.56830131,0.038,0.2,0.015,-0.12,0.015,-0.084,Q9D832,Dnajb4,Q9D832_Dnajb4,Q9D832,Dnajb4,1,16,11,10,Q9D832,MOUSE,37952.3,38.5,1092,1092.1,128.99,120.98,,337,DnaJ homolog subfamily B member 4,nucleoplasm|cytoplasm|cytosol|plasma membrane|extracellular exosome|,protein folding|,unfolded protein binding|chaperone binding|,11,16,4620000000,38.5%
Q9QYJ3,0.472782242,-0.03,8.72012451,-0.175333333,0.134272647,-1.703308983,0.006,0.173,-0.006,-0.161,-0.208,0.016,Q9QYJ3,Dnajb1,Q9QYJ3_Dnajb1,Q9QYJ3,Dnajb1,1,10,8,7,Q9QYJ3|Q3TYL7,MOUSE,38337.7,27.6,1092,1092.2,77.23,69.22,,340,DnaJ homolog subfamily B member 1,nucleus|nucleolus|cytosol|extracellular exosome|,positive regulation of ATPase activity|chaperone mediated protein folding requiring cofactor|chaperone cofactor-dependent protein refolding|negative regulation of inclusion body assembly|,ATPase activator activity|Hsp70 protein binding|unfolded protein binding|chaperone binding|ATPase binding|,7,10,4710000000,24.1%
Q9JI39,0.788130842,-0.0055,3.292565408,-0.087666667,0.468536533,-0.768622006,0.056,0.184,-0.125,0.053,-0.036,-0.165,Q9JI39,Abcb10,Q9JI39_Abcb10,Q9JI39,Abcb10,1,21,11,11,Q9JI39,MOUSE,77528.9,18,1093,1093.1,128.99,128.99,,715,"ATP-binding cassette sub-family B member 10, mitochondrial",mitochondrion|mitochondrial inner membrane|integral component of membrane|integral component of mitochondrial membrane|,metabolic process|transmembrane transport|,"transporter activity|protein binding|ATP binding|ATPase activity, coupled to transmembrane movement of substances|protein homodimerization activity|",11,21,5710000000,18.0%
Q6PAR5-4,0.99327985,-0.006,0.133497662,0.003333333,0.969728666,0.039388954,-0.021,0.048,-0.05,0.055,-0.073,0.005,Q6PAR5,Gapvd1,Q6PAR5-4_Gapvd1,Q6PAR5-4,Gapvd1,1,20,10,10,Q6PAR5-4|Q6PAR5|Q6PAR5-6|Q6PAR5-2|Q6PAR5-5|Q6PAR5-3,MOUSE,164340.2,8.8,1094,1094.1,128.9,128.9,,1458,Isoform 4 of GTPase-activating protein and VPS9 domain-containing protein 1,endosome|cytosol|membrane|,endocytosis|signal transduction|positive regulation of GTPase activity|regulation of protein transport|,guanyl-nucleotide exchange factor activity|GTPase activator activity|protein binding|GTPase activating protein binding|,10,20,1310000000,8.8%
Q3U7R1,0.61379227,0.016833333,6.10305646,-0.128333333,0.245298196,-1.273389775,-0.039,0.243,0.039,-0.036,-0.032,-0.074,Q3U7R1,Esyt1,Q3U7R1_Esyt1,Q3U7R1,Esyt1,1,19,12,12,Q3U7R1|Q3U7R1-2,MOUSE,121779.6,15,1095,1095.1,128.89,128.89,,1092,Extended synaptotagmin-1,endoplasmic reticulum|plasma membrane|membrane|integral component of endoplasmic reticulum membrane|intrinsic component of endoplasmic reticulum membrane|organelle membrane contact site|,lipid transport|,phospholipid binding|metal ion binding|,12,19,2200000000,15.0%
Q8BVW3,0.681323599,-0.019,4.844515729,-0.095333333,0.327754322,-1.055560239,0.036,-0.003,0.053,0.027,-0.179,-0.048,Q8BVW3,Trim14,Q8BVW3_Trim14,Q8BVW3,Trim14,1,21,9,9,Q8BVW3|Q8BVW3-2|Q8BVW3-3,MOUSE,50381.5,25.2,1096,1096.1,128.66,128.66,,440,Tripartite motif-containing protein 14,cytoplasm|,negative regulation of viral transcription|innate immune response|positive regulation of sequence-specific DNA binding transcription factor activity|positive regulation of NF-kappaB transcription factor activity|,zinc ion binding|,9,21,2520000000,25.2%
Q9EQZ6,0.87311559,-0.019666667,2.075360872,-0.098666667,0.620103115,-0.519833565,0.244,0.221,-0.376,0.034,-0.258,0.017,Q9EQZ6,Rapgef4,Q9EQZ6_Rapgef4,Q9EQZ6,Rapgef4,1,24,10,10,Q9EQZ6|Q9EQZ6-3|A2ASW8|Q9EQZ6-2,MOUSE,116516.4,12.2,1097,1097.1,128.4,128.4,,1011,Rap guanine nucleotide exchange factor 4,cytosol|cAMP-dependent protein kinase complex|membrane|,small GTPase mediated signal transduction|calcium ion-dependent exocytosis|regulation of exocytosis|cAMP-mediated signaling|insulin secretion|positive regulation of GTPase activity|regulation of protein kinase activity|,guanyl-nucleotide exchange factor activity|Ras guanyl-nucleotide exchange factor activity|protein binding|cAMP-dependent protein kinase regulator activity|Ras GTPase binding|cAMP binding|,10,24,1150000000,12.2%
Q6P3A8,0.578909417,-0.037,6.808350752,-0.226666667,0.208528263,-1.393277295,0.005,-0.021,0.245,-0.479,-0.007,0.035,Q6P3A8,Bckdhb,Q6P3A8_Bckdhb,Q6P3A8,Bckdhb,1,37,8,8,Q6P3A8|Q6P3A8-2,MOUSE,43678.3,41.5,1098,1098.1,128.32,128.32,,390,"2-oxoisovalerate dehydrogenase subunit beta, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial alpha-ketoglutarate dehydrogenase complex|,cellular amino acid catabolic process|branched-chain amino acid catabolic process|oxidation-reduction process|,alpha-ketoacid dehydrogenase activity|3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity|,8,37,40100000000,41.5%
B1AUN2,0.92551138,-0.010166667,1.096823476,0.029666667,0.776815088,0.295156013,0.032,0.05,-0.157,0.109,-0.06,-0.035,B1AUN2,Eif2b3,B1AUN2_Eif2b3,B1AUN2,Eif2b3,1,15,10,10,B1AUN2|Q3UKV0|B1AUN3,MOUSE,51172.4,29.2,1099,1099.1,128.01,128.01,,452,"Eukaryotic translation initiation factor 2B, subunit 3",cytoplasm|eukaryotic translation initiation factor 2B complex|,translational initiation|response to heat|response to glucose|oligodendrocyte development|negative regulation of translational initiation in response to stress|response to peptide hormone|positive regulation of GTPase activity|,"nucleotidyltransferase activity|translation initiation factor activity|guanyl-nucleotide exchange factor activity|translation factor activity, RNA binding|",10,15,813000000,29.2%
Q9DAU1,0.000151804,-0.494333333,60.07881802,2.678666667,9.82015E-07,17.15788601,-1.832,-1.544,-2.125,0.769,0.821,0.945,Q9DAU1,Cnpy3,Q9DAU1_Cnpy3,Q9DAU1,Cnpy3,1,31,7,7,Q9DAU1|Q9DAU1-2,MOUSE,30936.7,31.1,1100,1100.1,127.62,127.62,,276,Protein canopy homolog 3,endoplasmic reticulum|,innate immune response|,receptor binding|,7,31,18700000000,31.1%
Q9WTX2,0.869880514,-0.002,2.102668695,-0.046,0.616216227,-0.525442692,0.022,0.021,0.02,0.07,-0.023,-0.122,Q9WTX2,Prkra,Q9WTX2_Prkra,Q9WTX2,Prkra,1,23,10,10,Q9WTX2,MOUSE,34827,35.1,1101,1101.1,127.61,127.61,,313,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,intracellular|nucleoplasm|cytoplasm|membrane|perinuclear region of cytoplasm|,protein phosphorylation|production of siRNA involved in RNA interference|pre-miRNA processing|cellular response to oxidative stress|production of miRNAs involved in gene silencing by miRNA|outer ear morphogenesis|middle ear morphogenesis|skeletal system morphogenesis|positive regulation of intrinsic apoptotic signaling pathway|,double-stranded RNA binding|protein binding|enzyme binding|identical protein binding|protein homodimerization activity|poly(A) RNA binding|,10,23,1780000000,35.1%
Q7TPM9,0.863414132,-0.003333333,2.183520886,-0.044666667,0.604850315,-0.542802572,-0.014,0.049,0.022,0.033,-0.089,-0.021,Q7TPM9,Mtmr10,Q7TPM9_Mtmr10,Q7TPM9,Mtmr10,1,18,9,9,Q7TPM9|A0A0U1RQ60,MOUSE,89222.6,15.3,1102,1102.1,127.45,127.45,,771,Myotubularin-related protein 10,,,,9,18,672000000,15.3%
P54823,0.63071819,0.048,5.796704573,-0.181333333,0.26322646,-1.22257924,-0.072,0.452,0.036,-0.098,0.029,-0.059,P54823,Ddx6,P54823_Ddx6,P54823,Ddx6,1,18,11,11,P54823,MOUSE,54590,30,1103,1103.1,127.44,127.44,,483,Probable ATP-dependent RNA helicase DDX6,cytoplasmic mRNA processing body|cytoplasm|cytoplasmic stress granule|membrane|RISC complex|intracellular membrane-bounded organelle|,regulation of translation|RNA secondary structure unwinding|viral RNA genome packaging|stem cell maintenance|cytoplasmic mRNA processing body assembly|negative regulation of neuron differentiation|,ATP-dependent RNA helicase activity|ATP binding|protein domain specific binding|poly(A) RNA binding|,11,18,2470000000,30.0%
G3XA17,0.427450846,-0.047666667,9.839135337,0.224,0.1037735,1.885308949,-0.049,-0.036,-0.394,0.066,0.043,0.084,G3XA17,NotFound,G3XA17_NotFound,G3XA17,Eif4g2,1,20,11,11,G3XA17|F7CBP1|Q62448|Q62448-2,MOUSE,102612.2,14.4,1104,1104.1,127.39,127.39,,906,Eukaryotic translation initiation factor 4 gamma 2,cytoplasm|membrane|eukaryotic translation initiation factor 4F complex|,translational initiation|regulation of translational initiation|,"translation initiation factor activity|protein binding|translation factor activity, RNA binding|poly(A) RNA binding|",11,20,1530000000,14.4%
P53996-3,0.915850537,-0.023166667,1.314992683,0.063,0.738755508,0.34784258,0.169,0.058,-0.391,0.242,-0.034,-0.183,P53996,Cnbp,P53996-3_Cnbp,P53996-3,Cnbp,1,38,9,1,P53996-3|P53996-2|A0A0N4SVS6,MOUSE,20717.6,59.8,1105,1105.1,127.18,18.42,,178,Isoform 3 of Cellular nucleic acid-binding protein,nucleus|endoplasmic reticulum|cytosol|nucleus|,"transcription, DNA-templated|positive regulation of cell proliferation|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|",single-stranded DNA binding|single-stranded RNA binding|zinc ion binding|poly(A) RNA binding|,9,38,10700000000,59.8%
P53996,0.926554478,-0.1225,1.055091125,0.065,0.784315662,0.285051478,0.15,0.055,-0.67,0.031,-0.018,-0.283,P53996,Cnbp,P53996_Cnbp,P53996,Cnbp,1,8,9,2,P53996,MOUSE,20846.7,60.1,1105,1105.2,122.31,31.22,,178,Cellular nucleic acid-binding protein,nucleus|endoplasmic reticulum|cytosol|nucleus|,"transcription, DNA-templated|positive regulation of cell proliferation|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|",single-stranded DNA binding|single-stranded RNA binding|zinc ion binding|poly(A) RNA binding|,2,8,3230000000,16.8%
Q9CZW4,0.954887447,-0.003,0.668881194,0.019333333,0.857258659,0.186929373,0.001,-0.103,0.064,0.143,-0.12,-0.003,Q9CZW4,Acsl3,Q9CZW4_Acsl3,Q9CZW4,Acsl3,1,26,11,11,Q9CZW4|E9PUC2,MOUSE,81517.9,20.4,1106,1106.1,127.13,127.13,,720,Long-chain-fatty-acid--CoA ligase 3,mitochondrial outer membrane|peroxisomal membrane|endoplasmic reticulum|endoplasmic reticulum membrane|Golgi apparatus|lipid particle|membrane|integral component of membrane|perinuclear region of cytoplasm|,long-chain fatty acid metabolic process|fatty acid biosynthetic process|brain development|response to nutrient|response to organic cyclic compound|very-low-density lipoprotein particle assembly|positive regulation of Golgi to plasma membrane protein transport|long-chain fatty acid import|positive regulation of secretion|positive regulation of phosphatidylcholine biosynthetic process|,long-chain fatty acid-CoA ligase activity|ATP binding|protein kinase binding|protein domain specific binding|,11,26,78000000000,20.4%
Q9R0M6,0.994928853,-0.0295,0.072716317,-0.003666667,0.983395844,-0.021610109,0.264,0.039,-0.386,0.017,0.006,-0.117,Q9R0M6,Rab9,Q9R0M6_Rab9,Q9R0M6,Rab9a,1,30,9,9,Q9R0M6|A2AFP5,MOUSE,23194.5,48.7,1107,1107.1,127.06,127.06,,201,Ras-related protein Rab-9A,lysosome|late endosome|plasma membrane|phagocytic vesicle membrane|phagocytic vesicle|extracellular exosome|vacuolar membrane|,"intracellular protein transport|metabolic process|Rab protein signal transduction|regulation of protein localization|retrograde transport, endosome to Golgi|positive regulation of exocytosis|negative regulation by host of symbiont molecular function|phagosome-lysosome fusion|",GTPase activity|GTP binding|GDP binding|,9,30,10600000000,48.7%
Q91YP0,0.961523652,-0.001,0.548404292,0.012666667,0.881372652,0.155021546,-0.036,0.023,-0.009,-0.047,0.068,-0.005,Q91YP0,L2hgdh,Q91YP0_L2hgdh,Q91YP0,L2hgdh,1,23,11,11,Q91YP0,MOUSE,51582.3,28.2,1108,1108.1,127,127,,464,"L-2-hydroxyglutarate dehydrogenase, mitochondrial",mitochondrion|integral component of membrane|,cellular protein metabolic process|oxidation-reduction process|,2-hydroxyglutarate dehydrogenase activity|,11,23,5960000000,28.2%
Q9ERR7,0.002449274,-0.317166667,39.42670354,1.987,0.000114112,8.095713493,-1.219,-0.862,-1.851,0.55,0.651,0.828,Q9ERR7,Selenof,Q9ERR7_Selenof,Q9ERR7,Selenof,1,26,8,8,Q9ERR7|A0A0R4J0K1|A0A1C7ZMY4,MOUSE,18191.8,53,1109,1109.1,126.64,126.64,,162,Selenoprotein F,endoplasmic reticulum lumen|extracellular exosome|,'de novo' posttranslational protein folding|,protein binding|selenium binding|,8,26,10400000000,53.0%
E9Q6H8,0.830342985,0.013,2.638995889,-0.054666667,0.544628559,-0.638054594,0.081,0.04,0,0.068,-0.085,-0.026,E9Q6H8,Plekha5,E9Q6H8_Plekha5,E9Q6H8,Plekha5,1,21,12,12,E9Q6H8|A0A0N4SW19|A0A0N4SUV0|A0A0N4SWC0,MOUSE,145547.1,12.4,1110,1110.1,126.59,126.59,,1269,"Pleckstrin homology domain-containing, family A member 5",cytosol|membrane|,reproductive system development|,"phosphatidylinositol-5-phosphate binding|phosphatidylinositol-3-phosphate binding|phosphatidylinositol-4-phosphate binding|phosphatidylinositol-3,5-bisphosphate binding|",12,21,1110000000,12.4%
Q8CDG3,0.891135171,0.03,1.745881114,0.049333333,0.668978081,0.447052051,-0.027,-0.081,0.124,0.217,-0.056,0.003,Q8CDG3,Vcpip1,Q8CDG3_Vcpip1,Q8CDG3,Vcpip1,1,22,12,12,Q8CDG3|A0A0R4J0M9|Q8CDG3-2,MOUSE,135755.7,15,1111,1111.1,126.59,126.59,,1220,Deubiquitinating protein VCIP135,cytoplasm|endoplasmic reticulum|Golgi stack|,protein ubiquitination|protein K11-linked deubiquitination|protein K48-linked deubiquitination|,ubiquitin-specific protease activity|,12,22,800000000,15.0%
F8WHU5,0.336787221,0.016333333,11.75110789,-0.184,0.066817344,-2.18578556,0.163,0.131,0.031,-0.03,-0.102,-0.095,F8WHU5,Pds5b,F8WHU5_Pds5b,F8WHU5,Pds5b,1,18,13,11,F8WHU5|Q4VA53-3|Q4VA53|Q4VA53-2,MOUSE,166013.7,11.9,1112,1112.1,126.55,110.83,,1449,Sister chromatid cohesion protein PDS5 homolog B,chromatin|nucleoplasm|,mitotic sister chromatid cohesion|negative regulation of cell proliferation|regulation of cell proliferation|,DNA binding|,13,18,2330000000,11.9%
Q6A026,0.481746078,-0.013666667,8.507668106,0.144,0.14100457,1.668911331,-0.041,-0.048,-0.168,0.117,0.008,0.05,Q6A026,NotFound,Q6A026_NotFound,Q6A026,Pds5a,1,12,11,9,Q6A026|E9QPI5,MOUSE,151865.3,9,1112,1112.2,80.12,64.4,,1332,Sister chromatid cohesion protein PDS5 homolog A,nucleus|,mitotic nuclear division|negative regulation of DNA replication|cell division|,,9,12,311000000,7.6%
Q8BGG9,0.842967796,-0.012,2.471732483,-0.051333333,0.56601345,-0.603552096,-0.048,0.092,-0.003,-0.068,-0.058,0.013,Q8BGG9,Acnat2,Q8BGG9_Acnat2,Q8BGG9,Acnat2,1,21,10,2,Q8BGG9|Q8BGG9-2,MOUSE,46993.6,30,1113,1113.1,126.5,20.46,,420,Acyl-coenzyme A amino acid N-acyltransferase 2,peroxisome|,fatty acid metabolic process|acyl-CoA metabolic process|,N-acyltransferase activity|thiolester hydrolase activity|,10,21,3340000000,30.0%
Q9JKV1,0.471902671,-0.026333333,8.797040482,-0.168,0.131915538,-1.715431425,0.003,0.12,0.05,-0.252,-0.059,-0.02,Q9JKV1,Adrm1,Q9JKV1_Adrm1,Q9JKV1,Adrm1,1,22,10,10,A0A0A6YVU8|Q9JKV1|D3YUD8,MOUSE,42401.7,22.8,1114,1114.1,126.49,126.49,,407,Proteasomal ubiquitin receptor ADRM1,proteasome complex|nucleoplasm|cytoplasm|plasma membrane|,ovarian follicle development|transcription elongation from RNA polymerase II promoter|spermatid development|positive regulation of endopeptidase activity|regulation of T cell differentiation in thymus|follicle-stimulating hormone signaling pathway|proteasome assembly|oogenesis|thymus development|Sertoli cell development|positive regulation of growth hormone receptor signaling pathway|adipose tissue development|seminiferous tubule development|,protease binding|endopeptidase activator activity|proteasome binding|,10,22,2340000000,22.8%
Q99KI3,0.000797375,-0.091666667,45.97074899,1.668,2.52886E-05,10.32858132,-1.079,-0.717,-0.981,0.45,0.932,0.845,Q99KI3,Emc3,Q99KI3_Emc3,Q99KI3,Emc3,1,32,10,10,Q99KI3,MOUSE,29979.5,47.1,1115,1115.1,126.32,126.32,,261,ER membrane protein complex subunit 3,integral component of membrane|ER membrane protein complex|,protein folding in endoplasmic reticulum|,,10,32,17200000000,47.1%
Q80U72-3,0.941437739,-0.002333333,0.844267699,-0.018,0.823328654,-0.232185795,0.008,0.034,-0.022,-0.021,0.001,-0.014,Q80U72,Scrib,Q80U72-3_Scrib,Q80U72-3,Scrib,1,15,10,10,Q80U72-3|Q80U72-2|Q80U72-4|Q80U72|Q80VQ1|Q80VQ1-3,MOUSE,181001.7,9.1,1116,1116.1,126.2,126.2,,1612,Isoform 3 of Protein scribble homolog,nucleoplasm|cytosol|plasma membrane|cell-cell junction|cell-cell adherens junction|basolateral plasma membrane|lamellipodium|Scrib-APC-beta-catenin complex|myelin sheath abaxonal region|extracellular exosome|plasma membrane|cell leading edge|presynaptic membrane|postsynaptic membrane|,neural tube closure|positive regulation of receptor recycling|auditory receptor cell morphogenesis|asymmetric protein localization|cell proliferation|synaptic vesicle targeting|morphogenesis of embryonic epithelium|single organismal cell-cell adhesion|cell migration|cochlear nucleus development|establishment of apical/basal cell polarity|wound healing|positive regulation of apoptotic process|astrocyte cell migration|negative regulation of mitotic cell cycle|synaptic vesicle endocytosis|positive chemotaxis|auditory receptor cell stereocilium organization|apoptotic process involved in morphogenesis|mammary gland duct morphogenesis|protein localization to adherens junction|activation of GTPase activity|,protein binding|,10,15,1270000000,9.1%
Q9CRB3,0.857449938,-0.013333333,2.252073536,-0.054,0.595377813,-0.557409171,0.006,-0.032,0.067,-0.181,0.007,0.053,Q9CRB3,Urah,Q9CRB3_Urah,Q9CRB3,Urah,1,32,7,7,Q9CRB3|A0A0A0MQC3,MOUSE,13730.4,87.2,1117,1117.1,126.11,126.11,,118,5-hydroxyisourate hydrolase,mitochondrion|peroxisome|,purine nucleobase metabolic process|urate catabolic process|,hydrolase activity|hydroxyisourate hydrolase activity|,7,32,62400000000,87.2%
F6RQA2,0.799875932,-0.001333333,3.068383853,0.068,0.493357364,0.724376292,-0.123,-0.082,0.099,0.036,-0.001,0.063,F6RQA2,NotFound,F6RQA2_NotFound,F6RQA2,Rps6ka1,1,19,10,6,F6RQA2|Q505N6|P18653|E9PWV3|G3UZI3|Q9WUT3|E9QK39|A2CEE7|E9PUP0|Q7TPS0|Q7TPS0-3|A2CEE5|A2CEE6|Q7TPS0-2,MOUSE,83649.6,18.2,1118,1118.1,125.97,73.66,,736,Ribosomal protein S6 kinase,nucleus|cytoplasm|spindle|,regulation of translation|protein phosphorylation|intracellular signal transduction|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of transcription from RNA polymerase II promoter|positive regulation of hepatic stellate cell activation|,magnesium ion binding|protein serine/threonine kinase activity|ribosomal protein S6 kinase activity|protein serine/threonine/tyrosine kinase activity|ATP binding|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|,10,19,1640000000,18.2%
P18654,0.894455479,0.026166667,1.663511892,0.041666667,0.681787149,0.428418547,-0.031,-0.049,0.096,0.173,-0.025,-0.007,P18654,Rps6ka3,P18654_Rps6ka3,P18654,Rps6ka3,1,9,8,4,P18654|B1AXN9,MOUSE,84034.7,12.2,1118,1118.2,98.31,46,,740,Ribosomal protein S6 kinase alpha-3,nucleus|cytoplasm|,toll-like receptor signaling pathway|regulation of translation|protein phosphorylation|cell cycle|response to lipopolysaccharide|intracellular signal transduction|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of transcription from RNA polymerase II promoter|,magnesium ion binding|protein serine/threonine kinase activity|ribosomal protein S6 kinase activity|ATP binding|protein kinase binding|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|,4,9,2060000000,5.4%
P40336,0.522251937,0.056333333,7.768155791,-0.179333333,0.167180039,-1.550770671,-0.073,0.269,0.242,-0.078,0.006,-0.028,P40336,Vps26a,P40336_Vps26a,P40336,Vps26a,1,21,10,10,P40336|P40336-2|A0A1W2P7R7,MOUSE,38227.2,42.2,1119,1119.1,125.95,125.95,,327,Vacuolar protein sorting-associated protein 26A,endosome|early endosome|cytosol|endosome membrane|retromer complex|vesicle|intracellular membrane-bounded organelle|extracellular exosome|tubular endosome|,"intracellular protein transport|retrograde transport, endosome to Golgi|retrograde transport, endosome to plasma membrane|",protein binding|protein transporter activity|,10,21,3340000000,42.2%
Q8VD65,0.791316333,0.006333333,3.244434487,-0.065333333,0.473757994,-0.758921753,0.079,0.063,-0.025,0.052,-0.08,-0.051,Q8VD65,Pik3r4,Q8VD65_Pik3r4,Q8VD65,Pik3r4,1,15,12,12,Q8VD65|A0A0R4J2C7,MOUSE,153908.4,10.8,1120,1120.1,125.39,125.39,,1358,Phosphoinositide 3-kinase regulatory subunit 4,"nuclear pore|late endosome|autophagosome|axoneme|membrane|cytoplasmic vesicle|phosphatidylinositol 3-kinase complex, class III, type I|phosphatidylinositol 3-kinase complex, class III, type II|phosphatidylinositol 3-kinase complex, class III|nucleus-vacuole junction|",protein phosphorylation|protein targeting to vacuole|macroautophagy|peroxisome degradation|regulation of cytokinesis|receptor catabolic process|cellular response to glucose starvation|positive regulation of phosphatidylinositol 3-kinase activity|late endosome to vacuole transport|,protein serine/threonine kinase activity|ATP binding|,12,15,1760000000,10.8%
Q9CRD2,0.00070612,-0.158333333,46.78446282,1.858666667,2.09678E-05,10.64104424,-0.927,-0.972,-1.364,0.478,0.947,0.888,Q9CRD2,Emc2,Q9CRD2_Emc2,Q9CRD2,Emc2,1,24,9,9,Q9CRD2,MOUSE,35105.2,38.7,1121,1121.1,125.38,125.38,,297,ER membrane protein complex subunit 2,nucleolus|cytoplasm|mitochondrion|endoplasmic reticulum|ER membrane protein complex|,,,9,24,7930000000,38.7%
Q7TQG1,0.624901635,-0.003,5.878014144,0.14,0.258344123,1.235831983,0.036,-0.031,-0.224,-0.057,0.055,0.203,Q7TQG1,Plekha6,Q7TQG1_Plekha6,Q7TQG1,Plekha6,1,17,14,14,Q7TQG1|E9PX43|A0A087WRB7,MOUSE,131767.2,14.2,1122,1122.1,125.36,125.36,,1173,Pleckstrin homology domain-containing family A member 6,,,,14,17,1520000000,14.2%
O08966,0.735115384,-0.012666667,4.010295773,0.108,0.3971645,0.905086213,0.127,-0.092,-0.235,0.081,-0.067,0.11,O08966,Slc22a1,O08966_Slc22a1,O08966,Slc22a1,1,29,9,9,O08966|O70577|O70577-2,MOUSE,62432.8,12.5,1123,1123.1,125.32,125.32,,556,Solute carrier family 22 member 1,integral component of plasma membrane|basolateral plasma membrane|,cation transport|neurotransmitter transport|drug transmembrane transport|establishment or maintenance of transmembrane electrochemical gradient|organic cation transport|quaternary ammonium group transport|dopamine transport|norepinephrine transport|epinephrine transport|protein homooligomerization|ammonium transmembrane transport|acetate ester transport|,acetylcholine transmembrane transporter activity|dopamine transmembrane transporter activity|norepinephrine transmembrane transporter activity|secondary active organic cation transmembrane transporter activity|organic cation transmembrane transporter activity|quaternary ammonium group transmembrane transporter activity|protein homodimerization activity|,9,29,18800000000,12.5%
P52623,0.866008635,-0.0615,2.15139266,0.109,0.609341467,0.536222299,0.135,0.089,-0.572,0.153,-0.055,-0.119,P52623,Uck1,P52623_Uck1,P52623,Uck1,1,19,10,10,P52623|A2AN37,MOUSE,31296,55.2,1124,1124.1,125,125,,277,Uridine-cytidine kinase 1,,phosphorylation|UMP salvage|CTP salvage|,uridine kinase activity|ATP binding|nucleoside kinase activity|,10,19,4610000000,55.2%
O35593,0.590090752,-0.006833333,6.495992175,-0.132333333,0.224078806,-1.339508606,0.127,0.111,-0.06,-0.143,0.035,-0.111,O35593,Psmd14,O35593_Psmd14,O35593,Psmd14,1,32,9,9,O35593,MOUSE,34747.6,33.8,1125,1125.1,124.95,124.95,,310,26S proteasome non-ATPase regulatory subunit 14,"proteasome complex|nucleus|proteasome regulatory particle, lid subcomplex|proteasome accessory complex|cytosolic proteasome complex|extracellular exosome|",double-strand break repair via homologous recombination|double-strand break repair via nonhomologous end joining|positive regulation of endopeptidase activity|response to ethanol|regulation of proteasomal protein catabolic process|protein K63-linked deubiquitination|,endopeptidase activity|protein binding|metallopeptidase activity|metal ion binding|endopeptidase activator activity|proteasome binding|,9,32,9260000000,33.8%
O70585-2,0.954161889,0.009833333,0.678445157,-0.024333333,0.855372895,-0.189509116,0.181,0.106,-0.221,0.097,-0.07,-0.034,O70585,Dtnb,O70585-2_Dtnb,O70585-2,Dtnb,1,11,10,7,O70585-2|Q8C8Z9|O70585|G3UYM7|G3UZ87|Q8K0N0|G3UY34|G3UXK0|G3UZJ3,MOUSE,70434.5,20.9,1126,1126.1,124.88,95.33,,659,Isoform 2 of Dystrobrevin beta,cytoplasm|synapse|,,protein binding|zinc ion binding|,10,11,1080000000,20.9%
Q9CYA0,0.000394445,-0.129333333,51.77677958,2.257333333,6.64235E-06,12.75426776,-1.122,-1.407,-1.245,0.754,0.874,1.37,Q9CYA0,Creld2,Q9CYA0_Creld2,Q9CYA0,Creld2,1,26,11,11,Q9CYA0,MOUSE,40386.9,40,1127,1127.1,124.87,124.87,,350,Cysteine-rich with EGF-like domain protein 2,extracellular space|endoplasmic reticulum|Golgi apparatus|,,calcium ion binding|,11,26,6970000000,40.0%
P14115,0.597715057,-0.018333333,6.382841715,-0.139333333,0.229993641,-1.320764023,0,0.115,0.039,0,0,-0.264,P14115,Rpl27a,P14115_Rpl27a,P14115,Rpl27a,1,47,9,9,P14115,MOUSE,16719.3,40.5,1128,1128.1,124.85,124.85,,148,60S ribosomal protein L27a,membrane|cytosolic large ribosomal subunit|,translation|,structural constituent of ribosome|poly(A) RNA binding|,9,47,1.2E+11,40.5%
Q5BLK4,0.933153013,0.000166667,0.971330331,-0.021666667,0.799589287,-0.26417504,0.046,-0.018,0.005,0.053,-0.063,-0.022,Q5BLK4,Tut7,Q5BLK4_Tut7,Q5BLK4,Zcchc6,1,18,10,10,Q5BLK4|E9PUA2|A0A286YD79,MOUSE,171381.6,8.2,1129,1129.1,124.39,124.39,,1491,Terminal uridylyltransferase 7,cytoplasm|,RNA 3'-end processing|histone mRNA catabolic process|,zinc ion binding|poly(A) RNA binding|RNA uridylyltransferase activity|,10,18,3750000000,8.2%
P62983,0.782023331,-0.035666667,3.374120851,-0.107333333,0.459820061,-0.784634827,-0.153,0.013,0.194,-0.268,-0.102,0.102,P62983,Rps27a,P62983_Rps27a,P62983,Rps27a,1,39,9,3,P62983|P62984|A0A0A6YW67|E9QNP0|D3YYZ2,MOUSE,18292.9,57,1130,1130.1,123.94,45.82,,156,Ubiquitin-40S ribosomal protein S27a,nucleoplasm|nucleolus|cytoplasm|cytosol|small ribosomal subunit|membrane|cytosolic small ribosomal subunit|myelin sheath|extracellular exosome|,translation|circadian rhythm|,structural constituent of ribosome|poly(A) RNA binding|metal ion binding|,9,39,34300000000,57.0%
P98203,0.956068722,-0.002166667,0.655458093,-0.015,0.859912359,-0.183400482,0.056,-0.024,-0.016,-0.016,0.042,-0.055,P98203,Arvcf,P98203_Arvcf,P98203,Arvcf,1,14,10,10,P98203|P98203-2|P98203-3|P98203-5|P98203-4,MOUSE,105634.4,14.3,1131,1131.1,123.69,123.69,,962,Armadillo repeat protein deleted in velo-cardio-facial syndrome homolog,nucleus|nucleoplasm|cytoplasm|plasma membrane|cell junction|,multicellular organismal development|single organismal cell-cell adhesion|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|,protein binding|,10,14,885000000,14.3%
Q8BL97-2,0.459323034,0.046166667,9.163054032,-0.279666667,0.121253587,-1.777059435,-0.14,0.252,0.446,-0.111,-0.157,-0.013,Q8BL97,Srsf7,Q8BL97-2_Srsf7,Q8BL97-2,Srsf7,1,28,12,11,Q8BL97-2|Q8BL97-4|Q8BL97-3|Q8BL97,MOUSE,27605.3,36.1,1132,1132.1,123.63,110.47,,267,Isoform 2 of Serine/arginine-rich splicing factor 7,nucleoplasm|cytoplasm|extracellular exosome|,"mRNA processing|RNA splicing|negative regulation of mRNA splicing, via spliceosome|mRNA transport|",nucleotide binding|protein binding|zinc ion binding|poly(A) RNA binding|,12,28,8420000000,36.1%
P84104,0.790620052,0.012,3.258763737,-0.102,0.472197438,-0.76223839,-0.196,0.174,0.211,-0.043,-0.136,0.062,P84104,Srsf3,P84104_Srsf3,P84104,Srsf3,1,37,11,10,P84104|P84104-2|A2A4X6,MOUSE,19557.5,41.4,1132,1132.2,118.46,105.3,,164,Serine/arginine-rich splicing factor 3,cytoplasm|nuclear speck|,mRNA processing|insulin receptor signaling pathway|RNA splicing|mRNA transport|,nucleotide binding|RNA binding|phospholipase binding|poly(A) RNA binding|,10,37,23700000000,41.4%
Q64727,0.964565918,0.026166667,0.487068408,-0.018333333,0.89390869,-0.138572547,-0.095,0.164,0.037,-0.045,-0.149,0.245,Q64727,Vcl,Q64727_Vcl,Q64727,Vcl,1,16,13,13,Q64727,MOUSE,117285.9,13.6,1133,1133.1,123.58,123.58,,1066,Vinculin,cytoplasm|plasma membrane|brush border|cell-cell junction|adherens junction|cell-cell adherens junction|zonula adherens|fascia adherens|focal adhesion|costamere|protein complex|membrane raft|extracellular exosome|outer dense plaque of desmosome|inner dense plaque of desmosome|extracellular vesicle|terminal web|,morphogenesis of an epithelium|cell adhesion|cell-matrix adhesion|lamellipodium assembly|regulation of cell migration|adherens junction assembly|protein localization to cell surface|apical junction assembly|axon extension|platelet aggregation|epithelial cell-cell adhesion|,dystroglycan binding|structural molecule activity|protein binding|ubiquitin protein ligase binding|alpha-catenin binding|actin filament binding|,13,16,3440000000,13.6%
P67984,0.399466839,0.051166667,10.43159458,-0.222333333,0.090540011,-1.978125379,0.018,0.368,0.101,-0.048,-0.04,-0.092,P67984,Rpl22,P67984_Rpl22,P67984,Rpl22,1,36,9,9,P67984,MOUSE,14815.7,62.5,1134,1134.1,123.51,123.51,,128,60S ribosomal protein L22,nucleus|cytoplasm|ribosome|focal adhesion|cytosolic large ribosomal subunit|ribonucleoprotein complex|extracellular exosome|,translation|alpha-beta T cell differentiation|,structural constituent of ribosome|heparin binding|poly(A) RNA binding|,9,36,28400000000,62.5%
Q8CJH3,0.000397983,-0.071,51.6662127,1.303333333,6.81363E-06,12.54905696,-0.742,-0.752,-0.674,0.415,0.714,0.613,Q8CJH3,Plxnb1,Q8CJH3_Plxnb1,Q8CJH3,Plxnb1,1,25,13,13,Q8CJH3,MOUSE,234738.4,7.2,1135,1135.1,123.47,123.47,,2119,Plexin-B1,semaphorin receptor complex|integral component of plasma membrane|,negative regulation of cell adhesion|regulation of cell shape|positive regulation of phosphatidylinositol 3-kinase signaling|negative regulation of osteoblast proliferation|positive regulation of GTPase activity|ossification involved in bone maturation|neuron projection morphogenesis|positive regulation of axonogenesis|regulation of cytoskeleton organization|semaphorin-plexin signaling pathway|semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis|,protein binding|semaphorin receptor activity|GTPase activating protein binding|,13,25,8980000000,7.2%
Q9CZY3,0.73101227,0.008166667,4.089658541,-0.088333333,0.389972647,-0.919047156,0.046,0.181,-0.07,-0.068,0.004,-0.044,Q9CZY3,Ube2v1,Q9CZY3_Ube2v1,Q9CZY3,Ube2v1,1,43,10,5,Q9CZY3|E9PY39|B7ZBY7|Q9CZY3-2|B2KF55,MOUSE,16468.6,60.5,1136,1136.1,123.43,65.67,,147,Ubiquitin-conjugating enzyme E2 variant 1,ubiquitin ligase complex|nucleus|cytoplasm|ubiquitin conjugating enzyme complex|UBC13-UEV1A complex|protein complex|extracellular exosome|,error-free postreplication DNA repair|positive regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of NF-kappaB transcription factor activity|protein K63-linked ubiquitination|,protein binding|ubiquitin conjugating enzyme binding|ubiquitin protein ligase binding|ubiquitin protein ligase activity|ubiquitin conjugating enzyme activity|,10,43,17300000000,60.5%
Q9D2M8,0.550838715,-0.0175,7.258577905,-0.220333333,0.18799323,-1.467836067,0.016,0.278,-0.016,-0.268,0.149,-0.264,Q9D2M8,Ube2v2,Q9D2M8_Ube2v2,Q9D2M8,Ube2v2,1,3,7,2,Q9D2M8|Q9D2M8-2|A6X925,MOUSE,16423.5,43.4,1136,1136.2,79.17,21.41,,145,Ubiquitin-conjugating enzyme E2 variant 2,nucleus|cytoplasm|UBC13-MMS2 complex|extracellular exosome|,DNA double-strand break processing|positive regulation of neuron projection development|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|error-free postreplication DNA repair|negative regulation of neuron apoptotic process|positive regulation of DNA repair|positive regulation of synapse assembly|protein K63-linked ubiquitination|,protein binding|ubiquitin protein ligase binding|ubiquitin protein ligase activity|ubiquitin conjugating enzyme activity|,2,3,20500000,17.9%
H3BLH0,0.909718781,-0.008333333,1.4668226,-0.041333333,0.713374761,-0.383342604,0.108,0.014,-0.085,0.102,-0.178,-0.011,H3BLH0,Smarca2,H3BLH0_Smarca2,H3BLH0,Smarca2,1,18,10,8,H3BLH0|F2Z4A9|Q6DIC0|H3BJK2|E9QAB8|A0A140LHP6|H3BK47|A0A140LIM0|H3BKJ3|Q9D007,MOUSE,183417.3,7.8,1137,1137.1,122.99,93.81,,1601,Probable global transcription activator SNF2L2,nuclear chromatin|nucleus|nucleoplasm|SWI/SNF complex|intracellular membrane-bounded organelle|intermediate filament cytoskeleton|npBAF complex|nBAF complex|BAF-type complex|,"chromatin organization|nucleosome assembly|chromatin remodeling|metabolic process|negative regulation of cell proliferation|negative regulation of cell growth|aortic smooth muscle cell differentiation|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|",RNA polymerase II transcription coactivator activity|protein binding|ATP binding|ATPase activity|histone binding|transcription regulatory region DNA binding|,10,18,13800000000,7.8%
Q3TKT4-2,0.611607456,-0.0335,6.158160376,-0.125,0.242205479,-1.282697763,0.019,0.074,-0.006,0.027,-0.231,-0.084,Q3TKT4,Smarca4,Q3TKT4-2_Smarca4,Q3TKT4-2,Smarca4,1,8,6,4,A0A0R4J170|Q3TKT4-2|Q3TKT4,MOUSE,182024.5,5.2,1137,1137.2,68.58,39.4,,1613,Isoform 2 of Transcription activator BRG1,nuclear chromatin|heterochromatin|extracellular space|nucleus|nuclear euchromatin|perichromatin fibrils|membrane|SWI/SNF complex|protein complex|npBAF complex|nBAF complex|BAF-type complex|nucleolus|,"negative regulation of transcription from RNA polymerase II promoter|cell morphogenesis|blood vessel development|vasculogenesis|in utero embryonic development|blastocyst growth|blastocyst hatching|liver development|outflow tract morphogenesis|nucleosome assembly|nucleosome disassembly|chromatin remodeling|methylation-dependent chromatin silencing|transcription, DNA-templated|nervous system development|glial cell fate determination|heart development|positive regulation of cell proliferation|DNA methylation on cytosine within a CG sequence|stem cell maintenance|neurogenesis|positive regulation of Wnt signaling pathway|extracellular matrix organization|keratinocyte differentiation|negative regulation of cell growth|regulation of cell migration|forebrain development|hindbrain development|embryonic hindlimb morphogenesis|aortic smooth muscle cell differentiation|ATP-dependent chromatin remodeling|negative regulation of apoptotic process|positive regulation of DNA binding|positive regulation by host of viral transcription|histone H3 acetylation|positive regulation of cell differentiation|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|embryonic organ morphogenesis|epidermis morphogenesis|positive regulation of sequence-specific DNA binding transcription factor activity|definitive erythrocyte differentiation|heart trabecula formation|negative regulation of androgen receptor signaling pathway|pharyngeal arch artery morphogenesis|lens fiber cell development|positive regulation of pri-miRNA transcription from RNA polymerase II promoter|",RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II transcription coactivator activity|p53 binding|chromatin binding|transcription coactivator activity|transcription corepressor activity|helicase activity|protein binding|ATP binding|DNA-dependent ATPase activity|transcription factor binding|ATPase activity|Tat protein binding|protein N-terminus binding|androgen receptor binding|DNA polymerase binding|lysine-acetylated histone binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|,4,8,3630000000,3.4%
P36916,0.951421295,-0.016833333,0.744885015,-0.017666667,0.842386694,-0.206701077,0.047,0.03,-0.101,0.001,-0.021,-0.057,P36916,Gnl1,P36916_Gnl1,P36916,Gnl1,1,17,11,11,P36916|P36916-2,MOUSE,69397.4,23.8,1138,1138.1,122.46,122.46,,607,Guanine nucleotide-binding protein-like 1,nucleus|,cellular response to DNA damage stimulus|ribosome biogenesis|,GTPase activity|GTP binding|,11,17,8760000000,23.8%
Q9CWD8,0.73101227,-0.015833333,4.091610697,-0.108333333,0.389797393,-0.920001908,0.159,0.132,-0.176,0.015,-0.094,-0.131,Q9CWD8,Nubpl,Q9CWD8_Nubpl,Q9CWD8,Nubpl,1,30,8,8,Q9CWD8,MOUSE,34423.6,32.6,1139,1139.1,122.39,122.39,,319,Iron-sulfur protein NUBPL,mitochondrion|,mitochondrial respiratory chain complex I assembly|mitochondrion morphogenesis|,"ATP binding|metal ion binding|4 iron, 4 sulfur cluster binding|",8,30,5670000000,32.6%
Q9D6J6,0.677287369,-0.036,4.909003249,0.172,0.322923518,1.067975932,-0.3,0.122,-0.188,0.285,-0.173,0.038,Q9D6J6,Ndufv2,Q9D6J6_Ndufv2,Q9D6J6,Ndufv2,1,19,9,9,Q9D6J6|Q9D6J6-2,MOUSE,27627.2,52.4,1140,1140.1,122.16,122.16,,248,"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial",mitochondrion|mitochondrial respiratory chain complex I|myelin sheath|plasma membrane respiratory chain complex I|,"mitochondrial electron transport, NADH to ubiquinone|nervous system development|cardiac muscle tissue development|","NADH dehydrogenase (ubiquinone) activity|metal ion binding|2 iron, 2 sulfur cluster binding|",9,19,3350000000,52.4%
Q8CFI7,0.91325,-0.000333333,1.384563447,-0.040666667,0.727015475,-0.364175776,-0.001,-0.011,0.072,0.144,-0.208,0.002,Q8CFI7,Polr2b,Q8CFI7_Polr2b,Q8CFI7,Polr2b,1,13,11,11,Q8CFI7,MOUSE,135334.6,11.6,1141,1141.1,122.1,122.1,,1174,DNA-directed RNA polymerase II subunit RPB2,"nucleus|nucleoplasm|DNA-directed RNA polymerase II, core complex|membrane|",transcription from RNA polymerase II promoter|,DNA binding|chromatin binding|ribonucleoside binding|poly(A) RNA binding|metal ion binding|RNA polymerase II activity|,11,13,1630000000,11.6%
A6H8H2-2,0.915900752,-0.000666667,1.299945232,-0.033333333,0.74131959,-0.344102853,0.027,0.14,-0.119,0.013,-0.05,-0.015,A6H8H2,Dennd4c,A6H8H2-2_Dennd4c,A6H8H2-2,Dennd4c,1,18,14,14,A6H8H2-2|A6H8H2|E9Q449,MOUSE,218961.5,7.9,1142,1142.1,122.06,122.06,,1906,Isoform 2 of DENN domain-containing protein 4C,cytosol|plasma membrane|cytoplasmic vesicle membrane|retromer complex|insulin-responsive compartment|,protein transport|cellular response to insulin stimulus|positive regulation of GTPase activity|protein localization to plasma membrane|,Rab guanyl-nucleotide exchange factor activity|,14,18,1090000000,7.9%
Q9D5J6,0.687405839,-0.048166667,4.740533571,0.128333333,0.335696368,1.03799008,-0.174,0.116,-0.279,0.066,0.052,-0.07,Q9D5J6,Shpk,Q9D5J6_Shpk,Q9D5J6,Shpk,1,31,9,9,Q9D5J6|D6RJM2,MOUSE,51815.2,28.5,1143,1143.1,121.99,121.99,,476,Sedoheptulokinase,cytoplasm|,"carbohydrate metabolic process|pentose-phosphate shunt, non-oxidative branch|phosphorylation|cellular response to interleukin-13|regulation of macrophage activation|carbohydrate phosphorylation|regulation of inflammatory response|cellular response to lipopolysaccharide|cellular response to interleukin-4|",ATP binding|sedoheptulokinase activity|,9,31,3680000000,28.5%
S4R2S8,0.834860518,0.007166667,2.599890331,-0.055666667,0.549554751,-0.630034842,-0.02,0.142,-0.017,-0.063,-0.001,0.002,S4R2S8,NotFound,S4R2S8_NotFound,S4R2S8,Ank3,1,21,11,3,S4R2S8|G5E8K5|G5E8K3|G5E8K2|G5E8K5-3|S4R1S2|A0A1W2P812|G5E8K5-2|G3X971|Q8C8R3-4|S4R2F3|Q8C8R3-2|Q8C8R3|S4R2R5|Q8C8R3-5|Q8C8R3-3,MOUSE,218331.9,7,1144,1144.1,121.97,35.59,,1985,Ankyrin-3,intracellular|intercalated disc|membrane|basolateral plasma membrane|lateral plasma membrane|axon|paranode region of axon|sarcolemma|axon initial segment|synapse|bicellular tight junction|basal plasma membrane|,mitotic cytokinesis|plasma membrane organization|signal transduction|axon guidance|Golgi to plasma membrane protein transport|establishment of protein localization|synapse organization|membrane assembly|protein localization to plasma membrane|maintenance of protein location in plasma membrane|protein targeting to plasma membrane|,structural constituent of cytoskeleton|protein binding|,12,21,6860000000,7.0%
Q9D665,0.543949462,0.027166667,7.396933022,-0.208333333,0.182098638,-1.490606713,0.406,0.022,-0.034,0.045,-0.134,-0.142,Q9D665,Sdr42e1,Q9D665_Sdr42e1,Q9D665,Sdr42e1,1,19,7,7,Q9D665,MOUSE,44293,26.3,1145,1145.1,121.92,121.92,,394,Short-chain dehydrogenase/reductase family 42E member 1,integral component of membrane|,steroid biosynthetic process|oxidation-reduction process|,3-beta-hydroxy-delta5-steroid dehydrogenase activity|,7,19,1870000000,26.3%
Q9D517,0.641900554,-0.009333333,5.526176787,-0.104666667,0.280144642,-1.174814659,0.053,0.127,-0.051,-0.106,-0.006,-0.073,Q9D517,Agpat3,Q9D517_Agpat3,Q9D517,Agpat3,1,27,10,10,Q9D517,MOUSE,43979.7,23.4,1146,1146.1,121.67,121.67,,376,1-acyl-sn-glycerol-3-phosphate acyltransferase gamma,nuclear envelope|endoplasmic reticulum|endoplasmic reticulum membrane|plasma membrane|membrane|integral component of membrane|,CDP-diacylglycerol biosynthetic process|,1-acylglycerol-3-phosphate O-acyltransferase activity|lysophosphatidic acid acyltransferase activity|,10,27,11800000000,23.4%
P70266,0.982112023,-0.013,0.28687113,0.014666667,0.936079829,0.083294578,0.113,0.246,-0.42,0.034,-0.016,-0.035,P70266,Pfkfb1,P70266_Pfkfb1,P70266,Pfkfb1,1,19,10,10,P70266|P70266-2|Q6DTY7|Q6DTY7-5|Q6DTY7-6|Q6DTY7-2,MOUSE,55419,22.9,1147,1147.1,121.59,121.59,,471,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1","6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex|","fructose metabolic process|fructose 2,6-bisphosphate metabolic process|dephosphorylation|organ regeneration|response to insulin|positive regulation of glucokinase activity|response to glucagon|response to starvation|carbohydrate phosphorylation|response to glucocorticoid|response to cAMP|","6-phosphofructo-2-kinase activity|fructose-2,6-bisphosphate 2-phosphatase activity|ATP binding|kinase binding|identical protein binding|fructose-6-phosphate binding|",10,19,1150000000,22.9%
Q61234,0.702124706,-0.007666667,4.498878543,-0.104,0.354905023,-0.993832926,0.183,0.069,-0.119,-0.002,-0.091,-0.086,Q61234,NotFound,Q61234_NotFound,Q61234,Snta1,1,29,10,10,Q61234|A2AKD7,MOUSE,54120.5,24.4,1148,1148.1,121.53,121.53,,503,Alpha-1-syntrophin,intracellular|cytoplasm|cytoskeleton|cell junction|sarcolemma|protein complex|postsynaptic membrane|,regulation of heart rate|regulation of vasoconstriction by circulating norepinephrine|neuromuscular junction development|regulation of ventricular cardiac muscle cell membrane repolarization|ventricular cardiac muscle cell action potential|negative regulation of peptidyl-cysteine S-nitrosylation|regulation of sodium ion transmembrane transport|,actin binding|structural molecule activity|protein binding|calmodulin binding|ion channel binding|nitric-oxide synthase binding|ATPase binding|sodium channel regulator activity|,10,29,8140000000,24.4%
Q811D0-3,0.02832934,0.016833333,26.618288,0.635,0.002178568,4.846917734,-0.376,-0.248,-0.278,0.215,0.19,0.598,Q811D0,Dlg1,Q811D0-3_Dlg1,Q811D0-3,Dlg1,1,21,12,12,Q811D0-3|E9Q9H0|Q811D0|Q811D0-2|H7BWY4|D3Z3B8|S4R2T8|Q91XM9-7|Q91XM9-4|E9Q2L2|Q91XM9-2|Q91XM9-8|Q91XM9|Q91XM9-6|Q91XM9-3|D3YUZ8|Q91XM9-5,MOUSE,103383.1,16.2,1149,1149.1,121.35,121.35,,905,Isoform 3 of Disks large homolog 1,immunological synapse|basal lamina|nucleus|cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|Golgi apparatus|microtubule|plasma membrane|cell-cell junction|cell-cell adherens junction|bicellular tight junction|cytoplasmic side of plasma membrane|postsynaptic density|basolateral plasma membrane|lateral plasma membrane|cell junction|cell projection membrane|neuromuscular junction|node of Ranvier|myelin sheath abaxonal region|lateral loop|membrane raft|synapse|postsynaptic membrane|perinuclear region of cytoplasm|extracellular exosome|MPP7-DLG1-LIN7 complex|ionotropic glutamate receptor complex|,ureteric bud development|branching involved in ureteric bud morphogenesis|immunological synapse formation|endothelial cell proliferation|lens development in camera-type eye|T cell cytokine production|actin filament organization|synaptic transmission|nervous system development|protein localization|positive regulation of cell proliferation|single organismal cell-cell adhesion|peristalsis|positive regulation of actin filament polymerization|cortical actin cytoskeleton organization|membrane raft organization|regulation of myelination|activation of protein kinase activity|positive regulation of multicellular organism growth|T cell activation|negative regulation of T cell proliferation|regulation of membrane potential|amyloid precursor protein metabolic process|receptor clustering|positive regulation of potassium ion transport|establishment or maintenance of epithelial cell apical/basal polarity|negative regulation of mitotic cell cycle|nucleotide phosphorylation|reproductive structure development|positive regulation of developmental growth|embryonic skeletal system morphogenesis|tissue morphogenesis|smooth muscle tissue development|negative regulation of epithelial cell proliferation|negative regulation of protein kinase B signaling|hard palate development|bicellular tight junction assembly|protein localization to plasma membrane|positive regulation of establishment of protein localization to plasma membrane|receptor localization to synapse|,guanylate kinase activity|protein binding|protein C-terminus binding|potassium channel regulator activity|kinase binding|protein kinase binding|phosphatase binding|mitogen-activated protein kinase kinase binding|protein complex scaffold|ionotropic glutamate receptor binding|ion channel binding|L27 domain binding|,12,21,9120000000,16.2%
Q6PDG5,0.648073376,-0.000666667,5.363947165,0.092666667,0.290807286,1.146730523,-0.065,-0.065,-0.011,0.062,-0.011,0.086,Q6PDG5,Smarcc2,Q6PDG5_Smarcc2,Q6PDG5,Smarcc2,1,21,10,10,Q6PDG5|Q3UID0|Q6PDG5-2|P97496|Q3UNN4|P97496-2|Q3UZD0,MOUSE,133001,10.3,1150,1150.1,121.22,121.22,,1213,SWI/SNF complex subunit SMARCC2,nuclear chromatin|nucleoplasm|SWI/SNF complex|protein complex|npBAF complex|nBAF complex|BAF-type complex|transcriptional repressor complex|,"negative regulation of transcription from RNA polymerase II promoter|nucleosome disassembly|chromatin remodeling|transcription, DNA-templated|regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment|ATP-dependent chromatin remodeling|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|",chromatin binding|protein binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|,10,21,10300000000,10.3%
Q9R1T2,0.277283754,-0.039,13.44458069,-0.221333333,0.045242014,-2.456072722,0.123,0.084,0.008,-0.048,-0.182,-0.219,Q9R1T2,Sae1,Q9R1T2_Sae1,Q9R1T2,Sae1,1,16,11,11,Q9R1T2|Q9R1T2-2,MOUSE,39075.8,34.5,1151,1151.1,121.12,121.12,,350,SUMO-activating enzyme subunit 1,nucleus|nucleoplasm|cytosol|SUMO activating enzyme complex|intracellular membrane-bounded organelle|,regulation of mitotic cell cycle|protein sumoylation|positive regulation of protein targeting to mitochondrion|,protein C-terminus binding|SUMO activating enzyme activity|ATP-dependent protein binding|protein heterodimerization activity|SUMO activating enzyme activity|,11,16,2700000000,34.5%
Q5U5V2,0.886698259,-0.033,1.80825646,-0.063333333,0.659438584,-0.461179017,-0.143,0.002,0.137,-0.309,0.086,0.029,Q5U5V2,Hykk,Q5U5V2_Hykk,Q5U5V2,Hykk,1,27,10,10,Q5U5V2|Q5U5V2-2,MOUSE,42584,36.1,1152,1152.1,121.08,121.08,,376,Hydroxylysine kinase,cytoplasm|,phosphorylation|,hydroxylysine kinase activity|,10,27,6250000000,36.1%
P08226,0.076694599,-0.041833333,21.42006234,0.715,0.007210971,3.82671154,-0.247,-0.161,-0.79,0.276,0.17,0.501,P08226,Apoe,P08226_Apoe,P08226,Apoe,1,22,11,11,P08226,MOUSE,35923,29.2,1153,1153.1,121.04,121.04,,311,Apolipoprotein E,extracellular region|extracellular space|nucleus|endoplasmic reticulum|Golgi apparatus|cytosol|membrane|extracellular matrix|very-low-density lipoprotein particle|low-density lipoprotein particle|intermediate-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|extracellular vesicle|,negative regulation of endothelial cell proliferation|response to dietary excess|lipid metabolic process|triglyceride metabolic process|cholesterol biosynthetic process|cholesterol catabolic process|cellular calcium ion homeostasis|receptor-mediated endocytosis|response to oxidative stress|G-protein coupled receptor signaling pathway|nitric oxide mediated signal transduction|cholesterol metabolic process|regulation of gene expression|negative regulation of platelet activation|positive regulation of cholesterol esterification|positive regulation of cholesterol efflux|long-chain fatty acid transport|protein import|virion assembly|triglyceride catabolic process|cGMP-mediated signaling|negative regulation of blood coagulation|regulation of axon extension|positive regulation of cGMP biosynthetic process|regulation of cholesterol transport|regulation of Cdc42 protein signal transduction|positive regulation of low-density lipoprotein particle receptor catabolic process|cholesterol efflux|phospholipid efflux|very-low-density lipoprotein particle remodeling|low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|chylomicron remnant clearance|high-density lipoprotein particle clearance|very-low-density lipoprotein particle clearance|lipoprotein metabolic process|lipoprotein biosynthetic process|lipoprotein catabolic process|vasodilation|cholesterol homeostasis|negative regulation of MAP kinase activity|negative regulation of neuron apoptotic process|negative regulation of blood vessel endothelial cell migration|reverse cholesterol transport|positive regulation by host of viral process|negative regulation of cholesterol biosynthetic process|positive regulation of lipid biosynthetic process|artery morphogenesis|negative regulation of inflammatory response|positive regulation of nitric-oxide synthase activity|positive regulation of membrane protein ectodomain proteolysis|negative regulation of lipid biosynthetic process|maintenance of location in cell|lipid homeostasis|fatty acid homeostasis|positive regulation of dendritic spine development|negative regulation of dendritic spine development|cardiovascular system development|negative regulation of cholesterol efflux|alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering|N-methyl-D-aspartate receptor clustering|regulation of beta-amyloid clearance|regulation of neuron death|negative regulation of neuron death|positive regulation of neuron death|negative regulation of postsynaptic membrane organization|positive regulation of postsynaptic membrane organization|negative regulation of presynaptic membrane organization|positive regulation of presynaptic membrane organization|positive regulation of beta-amyloid formation|negative regulation of beta-amyloid formation|regulation of tau-protein kinase activity|negative regulation of dendritic spine maintenance|positive regulation of dendritic spine maintenance|positive regulation of phospholipid efflux|positive regulation of neurofibrillary tangle assembly|negative regulation of phospholipid efflux|negative regulation of lipid transport across blood brain barrier|positive regulation of lipid transport across blood brain barrier|protein localization|axon regeneration|,beta-amyloid binding|lipid transporter activity|protein binding|phospholipid binding|heparin binding|lipid binding|cholesterol binding|antioxidant activity|cholesterol transporter activity|identical protein binding|protein homodimerization activity|metal chelating activity|tau protein binding|low-density lipoprotein particle receptor binding|phosphatidylcholine-sterol O-acyltransferase activator activity|very-low-density lipoprotein particle receptor binding|lipoprotein particle binding|,11,22,3710000000,29.2%
Q3V384,0.93292639,-0.0435,0.976686047,-0.041,0.798603842,-0.265632471,0.113,0.163,-0.345,-0.062,0.042,-0.172,Q3V384,Afg1l,Q3V384_Afg1l,Q3V384,Afg1l,1,17,10,10,Q3V384|E9Q4K2,MOUSE,54825.7,24.3,1154,1154.1,121.02,121.02,,480,AFG1-like ATPase,mitochondrion|,,ATP binding|,10,17,1900000000,24.3%
Q9WUP7-2,0.998487544,-0.000166667,0.010493588,0.000333333,0.997586679,0.003139531,-0.078,0.186,-0.109,0.015,0.023,-0.038,Q9WUP7,Uchl5,Q9WUP7-2_Uchl5,Q9WUP7-2,Uchl5,1,14,9,9,Q9WUP7-2|Q9WUP7,MOUSE,37772.4,41.1,1155,1155.1,120.98,120.98,,329,Isoform 2 of Ubiquitin carboxyl-terminal hydrolase isozyme L5,proteasome complex|nucleus|cytoplasm|cytosol|Ino80 complex|Ino80 complex|,"DNA repair|DNA recombination|transcription, DNA-templated|regulation of transcription, DNA-templated|ubiquitin-dependent protein catabolic process|negative regulation of endopeptidase activity|protein deubiquitination|lateral ventricle development|midbrain development|forebrain morphogenesis|regulation of proteasomal protein catabolic process|",ubiquitin-specific protease activity|endopeptidase inhibitor activity|omega peptidase activity|poly(A) RNA binding|proteasome binding|,9,14,1400000000,41.1%
A2ADY9,0.773512169,0.033333333,3.514151575,0.089333333,0.445230433,0.811129663,-0.092,-0.067,0.125,-0.014,0.018,0.23,A2ADY9,Ddi2,A2ADY9_Ddi2,A2ADY9,Ddi2,1,28,9,9,A2ADY9|Q9DAF3,MOUSE,45046.3,34.5,1156,1156.1,120.97,120.97,,399,Protein DDI1 homolog 2,,proteolysis|,aspartic-type endopeptidase activity|,10,28,5570000000,34.5%
Q9Z0U1,0.07838657,0.003,21.29944263,0.410666667,0.007414054,3.791275387,-0.255,-0.078,-0.274,0.155,0.109,0.361,Q9Z0U1,Tjp2,Q9Z0U1_Tjp2,Q9Z0U1,Tjp2,1,23,13,13,Q9Z0U1,MOUSE,131505.8,14.3,1157,1157.1,120.88,120.88,,1167,Tight junction protein ZO-2,nucleus|cytoplasm|plasma membrane|gap junction|bicellular tight junction|cell surface|cell junction|,response to organic substance|intestinal absorption|establishment of endothelial intestinal barrier|regulation of membrane permeability|,"protein binding|protein C-terminus binding|protein domain specific binding|protein binding, bridging|",13,23,742000000,14.3%
Q9CPY7,0.936982455,0.012166667,0.884124715,0.041666667,0.81580719,0.242401134,-0.014,0.248,-0.26,-0.061,0.297,-0.137,Q9CPY7,Lap3,Q9CPY7_Lap3,Q9CPY7,Lap3,1,14,10,10,Q9CPY7|Q9CPY7-2,MOUSE,56539.7,26.7,1158,1158.1,120.79,120.79,,519,Cytosol aminopeptidase,nucleus|nucleoplasm|cytoplasm|mitochondrion|trans-Golgi network|focal adhesion|extracellular exosome|,proteolysis|,aminopeptidase activity|peptidase activity|metalloexopeptidase activity|manganese ion binding|,10,14,653000000,26.7%
P35951,0.036043561,0.004166667,25.31154961,0.717,0.002943371,4.577771776,-0.255,-0.236,-0.572,0.246,0.639,0.203,P35951,Ldlr,P35951_Ldlr,P35951,Ldlr,1,21,12,12,P35951|A0A1L1SRE8,MOUSE,98425.9,22.2,1160,1160.1,120.35,120.35,,862,Low-density lipoprotein receptor,lysosome|endosome|early endosome|late endosome|Golgi apparatus|plasma membrane|coated pit|external side of plasma membrane|cell surface|membrane|integral component of membrane|basolateral plasma membrane|low-density lipoprotein particle|receptor complex|apical part of cell|,lipid metabolic process|receptor-mediated endocytosis|cholesterol metabolic process|positive regulation of triglyceride biosynthetic process|regulation of phosphatidylcholine catabolic process|phospholipid transport|intestinal cholesterol absorption|cholesterol transport|low-density lipoprotein particle clearance|lipoprotein metabolic process|lipoprotein catabolic process|cholesterol homeostasis|cholesterol import|regulation of cholesterol homeostasis|,glycoprotein binding|low-density lipoprotein receptor activity|calcium ion binding|protein binding|low-density lipoprotein particle binding|very-low-density lipoprotein particle receptor activity|,12,21,822000000,22.2%
Q8CHT1,0.863857851,-0.0755,2.176981213,0.101,0.605761794,0.541708905,0.139,0.037,-0.554,0.045,-0.038,-0.082,Q8CHT1,Ngef,Q8CHT1_Ngef,Q8CHT1,Ngef,1,19,10,10,E9QK62|Q8CHT1|Q8CHT1-2,MOUSE,82711,22.3,1161,1161.1,120.1,120.1,,710,Ephexin-1,cytosol|membrane|growth cone|,cellular process|regulation of Rho protein signal transduction|regulation of GTPase activity|positive regulation of GTPase activity|ephrin receptor signaling pathway|negative regulation of dendritic spine morphogenesis|,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|protein binding|ephrin receptor binding|,10,19,1970000000,22.3%
P98083,0.623895097,-0.019166667,5.890915767,0.129666667,0.257577796,1.237555275,-0.108,0.057,-0.201,-0.004,-0.013,0.154,P98083,Shc1,P98083_Shc1,P98083,Shc1,1,21,8,8,P98083|P98083-2|P98083-3|Q8BMC3|Q61120,MOUSE,63120.3,22.7,1162,1162.1,119.52,119.52,,579,SHC-transforming protein 1,nucleus|mitochondrial matrix|cytosol|plasma membrane|endosome membrane|,MAPK cascade|activation of MAPK activity|angiogenesis|response to hypoxia|epidermal growth factor receptor signaling pathway|heart development|aging|insulin receptor signaling pathway|response to toxic substance|single organismal cell-cell adhesion|organ regeneration|neuron projection development|actin cytoskeleton reorganization|response to nicotine|regulation of growth|regulation of cell proliferation|response to hydrogen peroxide|positive regulation of vasoconstriction|positive regulation of smooth muscle cell proliferation|response to glucocorticoid|,phosphotyrosine binding|insulin receptor binding|insulin-like growth factor receptor binding|neurotrophin TRKA receptor binding|protein binding|protein kinase binding|receptor tyrosine kinase binding|ephrin receptor binding|protein phosphatase 2A binding|,8,21,1050000000,22.7%
P06684,0.580023145,-0.001333333,6.754305224,0.296,0.211139495,1.384275772,-0.211,-0.509,0.272,0.065,-0.008,0.383,P06684,Hc,P06684_Hc,P06684,C5,1,25,13,13,P06684|A0A0J9YUU3,MOUSE,190586.2,8.5,1163,1163.1,119.43,119.43,,1680,Complement C5,membrane attack complex|extracellular space|extracellular exosome|,"in utero embryonic development|inflammatory response|complement activation, alternative pathway|complement activation, classical pathway|positive regulation of vascular endothelial growth factor production|negative regulation of macrophage chemotaxis|negative regulation of endopeptidase activity|cytolysis|positive regulation of angiogenesis|positive regulation of chemokine secretion|activation of mitophagy in response to mitochondrial depolarization|",endopeptidase inhibitor activity|,13,25,3810000000,8.5%
Q91V89,0.994928853,-0.0155,0.068864459,0.001666667,0.984268427,0.020465428,0.012,0.026,-0.087,-0.013,-0.031,0,Q91V89,Ppp2r5d,Q91V89_Ppp2r5d,Q91V89,Ppp2r5d,1,18,11,11,Q91V89|Q60996|Q60996-4|Q60996-3|Q60996-2,MOUSE,69335.6,20.8,1164,1164.1,119.4,119.4,,594,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit,protein phosphatase type 2A complex|,regulation of protein phosphorylation|signal transduction|positive regulation of neuron projection development|regulation of protein autophosphorylation|regulation of protein phosphatase type 2A activity|positive regulation of transcription from RNA polymerase II promoter|positive regulation of neurotrophin TRK receptor signaling pathway|cellular response to growth factor stimulus|,protein binding|protein phosphatase type 2A regulator activity|,11,18,1170000000,20.8%
E9Q394,0.493441063,-0.0195,8.332746691,0.229666667,0.146799755,1.643208129,0.033,-0.044,-0.392,0.247,0.015,0.024,E9Q394,Akap13,E9Q394_Akap13,E9Q394,Akap13,1,17,13,13,A0A140LJJ5|E9Q394|E9Q394-2,MOUSE,307621.8,6.9,1165,1165.1,119.39,119.39,,2776,A-kinase anchor protein 13,cytoplasm|membrane|perinuclear region of cytoplasm|,protein phosphorylation|regulation of cardiac muscle hypertrophy|regulation of Rho protein signal transduction|intracellular signal transduction|positive regulation of GTPase activity|regulation of protein kinase activity|nuclear export|regulation of glucocorticoid mediated signaling pathway|,cAMP-dependent protein kinase activity|Rho guanyl-nucleotide exchange factor activity|Rho GTPase binding|protein complex scaffold|metal ion binding|protein kinase A binding|,13,17,976000000,6.9%
P14206,0.91325,-0.002333333,1.355964141,0.03,0.73181884,0.357358365,-0.071,-0.033,0.052,-0.037,0.055,0.02,P14206,Rpsa,P14206_Rpsa,P14206,Rpsa,1,18,9,9,P14206|A0A1L1SUK3,MOUSE,32951.6,38.6,1166,1166.1,119.31,119.31,,295,40S ribosomal protein SA,basement membrane|nucleus|cytoplasm|plasma membrane|small ribosomal subunit|membrane|cytosolic small ribosomal subunit|90S preribosome|neuronal cell body|extracellular exosome|,"ribosomal small subunit assembly|endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|rRNA export from nucleus|translation|single organismal cell-cell adhesion|epithelial cell differentiation|",structural constituent of ribosome|laminin receptor activity|ribosome binding|laminin binding|poly(A) RNA binding|,9,18,4600000000,38.6%
Q9CX56,0.885307507,-0.102666667,1.82295999,0.095333333,0.657209755,0.464453701,0.141,0.004,-0.596,0.04,0.04,-0.245,Q9CX56,Psmd8,Q9CX56_Psmd8,Q9CX56,Psmd8,1,14,9,9,Q9CX56|Q9CPS5|Q3TG45,MOUSE,40214.8,30.8,1167,1167.1,119.29,119.29,,353,26S proteasome non-ATPase regulatory subunit 8,proteasome complex|nucleus|proteasome regulatory particle|proteasome accessory complex|extracellular exosome|,proteolysis|regulation of protein stability|positive regulation of protein targeting to mitochondrion|,,9,14,2290000000,30.8%
P26450,0.826177557,0.017,2.676553181,0.055333333,0.53993898,0.645730671,-0.044,-0.03,0.042,0.13,-0.002,0.006,P26450,Pik3r1,P26450_Pik3r1,P26450,Pik3r1,1,16,12,12,P26450|Q80UI5|A0A1L1ST33|Q64143|B1AUG0|O08908,MOUSE,83972.2,16.4,1168,1168.1,119.16,119.16,,724,Phosphatidylinositol 3-kinase regulatory subunit alpha,"nucleus|cytoplasm|cis-Golgi network|cytosol|cell-cell junction|phosphatidylinositol 3-kinase complex|phosphatidylinositol 3-kinase complex, class IA|membrane|perinuclear endoplasmic reticulum membrane|",cellular glucose homeostasis|negative regulation of cell-matrix adhesion|protein phosphorylation|negative regulation of cell adhesion|insulin receptor signaling pathway|extrinsic apoptotic signaling pathway via death domain receptors|intrinsic apoptotic signaling pathway in response to DNA damage|phosphatidylinositol 3-kinase signaling|B cell differentiation|positive regulation of cell migration|positive regulation of tumor necrosis factor production|cellular response to insulin stimulus|positive regulation of RNA splicing|cellular response to UV|response to endoplasmic reticulum stress|phosphatidylinositol-3-phosphate biosynthetic process|positive regulation of transcription factor import into nucleus|negative regulation of apoptotic process|regulation of phosphatidylinositol 3-kinase activity|negative regulation of osteoclast differentiation|positive regulation of transcription from RNA polymerase II promoter|phosphatidylinositol phosphorylation|insulin-like growth factor receptor signaling pathway|protein stabilization|regulation of stress fiber assembly|NFAT protein import into nucleus|growth hormone receptor signaling pathway|regulation of establishment of protein localization to plasma membrane|positive regulation of endoplasmic reticulum unfolded protein response|positive regulation of glucose import in response to insulin stimulus|,insulin receptor binding|insulin-like growth factor receptor binding|neurotrophin TRKA receptor binding|protein binding|transcription factor binding|1-phosphatidylinositol-3-kinase activity|protein phosphatase binding|phosphatidylinositol 3-kinase regulator activity|phosphatidylinositol 3-kinase regulatory subunit binding|ErbB-3 class receptor binding|insulin binding|insulin receptor substrate binding|1-phosphatidylinositol-3-kinase regulator activity|protein heterodimerization activity|,12,16,3800000000,16.4%
Q924Z4,0.52769863,-0.0235,7.66708232,0.157,0.171116452,1.532774164,-0.002,-0.046,-0.258,0.132,0.001,0.032,Q924Z4,Cers2,Q924Z4_Cers2,Q924Z4,Cers2,1,39,7,7,Q924Z4,MOUSE,45194.7,12.3,1169,1169.1,119.15,119.15,,380,Ceramide synthase 2,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|nuclear membrane|,sphingolipid biosynthetic process|ceramide biosynthetic process|,DNA binding|sphingosine N-acyltransferase activity|,7,39,25800000000,12.3%
Q8R0J8,0.837702479,-0.07,2.561462963,0.107333333,0.554438913,0.622503055,0.089,0.056,-0.516,0.002,0.031,-0.082,Q8R0J8,Idnk,Q8R0J8_Idnk,Q8R0J8,Idnk,1,15,8,8,Q8R0J8|D3Z4J6|A0A286YD91,MOUSE,20152.1,51,1170,1170.1,119.14,119.14,,184,Probable gluconokinase,,phosphorylation|D-gluconate catabolic process|,ATP binding|gluconokinase activity|,8,15,3880000000,51.0%
K3W4R4,0.000498463,-0.0525,49.73964285,0.949666667,1.06178E-05,11.68825037,-0.501,-0.515,-0.566,0.419,0.476,0.372,K3W4R4,NotFound,K3W4R4_NotFound,K3W4R4,Col14a1,1,18,12,12,K3W4R4|Q809|B7ZNH7|Q809-2,MOUSE,194335.4,7.5,1171,1171.1,119.04,119.04,,1798,Collagen alpha-1(XIV) chain,interstitial matrix|extracellular space|extracellular exosome|extracellular matrix|,ventricular cardiac muscle tissue development|collagen fibril organization|homeostasis of number of cells within a tissue|regulation of cell growth involved in cardiac muscle cell development|,poly(A) RNA binding|,12,18,893000000,7.5%
Q9QZS5,0.771416168,-0.063666667,3.5795668,0.182666667,0.438574442,0.824077611,0.24,-0.057,-0.648,0.096,0.081,-0.094,Q9QZS5,Sgk2,Q9QZS5_Sgk2,Q9QZS5,Sgk2,1,20,9,9,Q9QZS5|Q9QZS5-2,MOUSE,41757.7,28,1172,1172.1,118.97,118.97,,367,Serine/threonine-protein kinase Sgk2,nucleus|cytoplasm|,protein phosphorylation|,protein serine/threonine kinase activity|ATP binding|potassium channel regulator activity|,9,20,5650000000,28.0%
Q9D154,0.037157479,0.011833333,25.1490196,-0.536333333,0.003055611,-4.540749635,0.317,0.376,0.147,-0.179,-0.146,-0.444,Q9D154,Serpinb1a,Q9D154_Serpinb1a,Q9D154,Serpinb1a,1,24,11,10,Q9D154|Q8VHP7|Q5SV42|I7HJI5|Q9DAV6|Q9D6A7,MOUSE,42745.3,29.5,1173,1173.1,118.74,102.63,,379,Leukocyte elastase inhibitor A,extracellular space|cytoplasm|membrane|extracellular exosome|,negative regulation of endopeptidase activity|regulation of protein catabolic process|,serine-type endopeptidase inhibitor activity|,11,24,7200000000,29.5%
Q9JK88,0.647450828,0.5005,5.408595138,-1.041666667,0.287832935,-1.155634785,0.045,3.321,-0.302,-0.051,-0.095,0.085,Q9JK88,Serpini2,Q9JK88_Serpini2,Q9JK88,Serpini2,1,8,4,3,Q9JK88,MOUSE,45888.8,9.8,1173,1173.2,56.31,40.2,,405,Serpin I2,extracellular space|extracellular exosome|,negative regulation of endopeptidase activity|regulation of cell adhesion|,serine-type endopeptidase inhibitor activity|,3,8,283000000,7.4%
Q9DB05,0.797504707,-0.005166667,3.108832369,-0.058333333,0.488783755,-0.732354265,0.029,0.05,-0.007,-0.003,-0.018,-0.082,Q9DB05,Napa,Q9DB05_Napa,Q9DB05,Napa,1,17,9,9,Q9DB05|P28663,MOUSE,33645.5,42.7,1174,1174.1,118.72,118.72,,295,Alpha-soluble NSF attachment protein,vacuolar membrane|membrane|terminal bouton|myelin sheath|synaptobrevin 2-SNAP-25-syntaxin-1a complex|extracellular exosome|,"intracellular protein transport|brain development|regulation of synaptic vesicle priming|neuron differentiation|synaptic transmission, glutamatergic|SNARE complex disassembly|apical protein localization|membrane fusion|",SNARE binding|soluble NSF attachment protein activity|protein binding|syntaxin binding|,9,17,1760000000,42.7%
B9EJ54,0.758840764,0.003666667,3.730303865,-0.083333333,0.423613326,-0.852035261,0.165,0.043,-0.072,0.037,-0.098,-0.053,B9EJ54,Nup205,B9EJ54_Nup205,B9EJ54,Nup205,1,20,9,9,A0A0J9YUD5|B9EJ54|E9Q880,MOUSE,229743.5,5.6,1175,1175.1,118.71,118.71,,2008,"MCG21756, isoform CRA_b",nuclear pore|nucleoplasm|cytoplasm|membrane|nuclear membrane|nuclear periphery|,nuclear pore complex assembly|,structural constituent of nuclear pore|,9,20,920000000,5.6%
Q8K1B8,0.430655636,0.087333333,9.756776339,-0.438666667,0.105760225,-1.87220392,0.015,0.055,0.85,-0.057,-0.304,-0.035,Q8K1B8,Fermt3,Q8K1B8_Fermt3,Q8K1B8,Fermt3,1,16,11,11,Q8K1B8,MOUSE,76203.7,23.3,1176,1176.1,118.71,118.71,,665,Fermitin family homolog 3,podosome|membrane|cell junction|cell projection|extracellular exosome|,leukocyte cell-cell adhesion|integrin-mediated signaling pathway|integrin activation|regulation of cell-cell adhesion mediated by integrin|substrate adhesion-dependent cell spreading|platelet aggregation|,integrin binding|protein binding|,11,16,1490000000,23.3%
Q80W54,0.000587272,-0.334,48.09848478,1.997333333,1.54936E-05,11.16369857,-1.149,-1.12,-1.729,0.683,0.545,0.766,Q80W54,Zmpste24,Q80W54_Zmpste24,Q80W54,Zmpste24,1,27,9,9,Q80W54,MOUSE,55018.7,16.2,1177,1177.1,118.67,118.67,,475,CAAX prenyl protease 1 homolog,nuclear inner membrane|endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular exosome|,nuclear envelope organization|prenylated protein catabolic process|CAAX-box protein processing|,metalloendopeptidase activity|metal ion binding|,9,27,16800000000,16.2%
Q8BZ20,0.830342985,-0.001166667,2.640332722,-0.055,0.544460939,-0.638328258,0.023,-0.01,0.066,0.052,-0.028,-0.11,Q8BZ20,Parp12,Q8BZ20_Parp12,Q8BZ20,Parp12,1,21,11,11,Q8BZ20,MOUSE,81341.6,22.7,1178,1178.1,118.36,118.36,,711,Poly [ADP-ribose] polymerase 12,nucleus|,metabolic process|,NAD+ ADP-ribosyltransferase activity|poly(A) RNA binding|metal ion binding|,11,21,2210000000,22.7%
Q9D6R2,0.777827379,-0.044,3.424254084,0.13,0.4545426,0.794311124,0.119,0.011,-0.457,0.14,-0.025,-0.052,Q9D6R2,Idh3a,Q9D6R2_Idh3a,Q9D6R2,Idh3a,1,22,10,10,A0A1L1STE6|Q9D6R2|Q9D6R2-2,MOUSE,40094.5,33.6,1179,1179.1,118.28,118.28,,366,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",nucleus|mitochondrion|myelin sheath|,tricarboxylic acid cycle|,magnesium ion binding|isocitrate dehydrogenase (NAD+) activity|NAD binding|,10,22,9700000000,33.6%
Q8VE38,0.785249508,0.000166667,3.339361783,-0.077,0.463515031,-0.777366014,0.075,0.096,-0.055,-0.136,0.089,-0.068,Q8VE38,Oxnad1,Q8VE38_Oxnad1,Q8VE38,Oxnad1,1,20,9,9,Q8VE38|Q8VE38-2|E9Q690,MOUSE,35182.8,34.4,1180,1180.1,118.18,118.18,,311,Oxidoreductase NAD-binding domain-containing protein 1,mitochondrion|,oxidation-reduction process|,oxidoreductase activity|,9,20,1570000000,34.4%
Q9DBE8,0.805699632,0.009666667,3.002487392,-0.065333333,0.500900264,-0.711325036,0.123,0.004,0,0.081,-0.085,-0.065,Q9DBE8,Alg2,Q9DBE8_Alg2,Q9DBE8,Alg2,1,21,13,13,Q9DBE8,MOUSE,48031.7,30.8,1181,1181.1,118.16,118.16,,415,"Alpha-1,3/1,6-mannosyltransferase ALG2",nucleus|cytoplasm|endoplasmic reticulum|membrane|integral component of membrane|perinuclear region of cytoplasm|,dolichol-linked oligosaccharide biosynthetic process|protein glycosylation in endoplasmic reticulum|response to calcium ion|mannosylation|,"alpha-1,3-mannosyltransferase activity|GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity|glycolipid 6-alpha-mannosyltransferase activity|protein heterodimerization activity|protein N-terminus binding|calcium-dependent protein binding|",13,21,5370000000,30.8%
Q9JLI6,0.970354469,0.009833333,0.417895737,-0.011666667,0.908260498,-0.11966286,0.01,-0.07,0.107,-0.114,0.05,0.076,Q9JLI6,Scly,Q9JLI6_Scly,Q9JLI6,Scly,1,19,9,9,A0A0R4J069|Q9JLI6|Q9JLI6-2|M0QWF1,MOUSE,47629.5,35.1,1182,1182.1,117.67,117.67,,432,Selenocysteine lyase,cytosol|,selenium compound metabolic process|lipid metabolic process|response to insulin|negative regulation of cellular response to oxidative stress|,selenocysteine lyase activity|transferase activity|,9,19,984000000,35.1%
Q80UJ7,0.497302739,-0.038166667,8.2523384,0.261,0.149543024,1.630179581,-0.032,0.005,-0.479,0.279,-0.012,0.01,Q80UJ7,Rab3gap1,Q80UJ7_Rab3gap1,Q80UJ7,Rab3gap1,1,18,10,10,Q80UJ7|A0A1D5RLG3,MOUSE,111450.8,14.2,1183,1183.1,117.33,117.33,,981,Rab3 GTPase-activating protein catalytic subunit,cytoplasm|protein complex|extracellular exosome|endoplasmic reticulum tubular network|,brain development|positive regulation of gene expression|regulation of synaptic vesicle priming|hypothalamus development|regulation of Rab protein signal transduction|lipid particle organization|camera-type eye development|regulation of GTPase activity|positive regulation of GTPase activity|regulation of short-term neuronal synaptic plasticity|synaptic vesicle transport|protein stabilization|regulation of excitatory postsynaptic membrane potential|face morphogenesis|positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization|establishment of protein localization to endoplasmic reticulum membrane|regulation of calcium ion-dependent exocytosis of neurotransmitter|positive regulation of endoplasmic reticulum tubular network organization|,GTPase activator activity|Rab GTPase binding|Rab guanyl-nucleotide exchange factor activity|,10,18,604000000,14.2%
H9KV00,0.993050549,-0.026833333,0.141986227,0.005,0.96783512,0.041872533,-0.213,0.009,0.116,0.076,-0.156,0.007,H9KV00,Son,H9KV00_Son,H9KV00,Son,1,18,10,10,H9KV00|Q9QX47|Q9QX47-3|H9KV15|H9KV01|Q9QX47-4|Q9QX47-2|H9KV02,MOUSE,269331.1,4.4,1184,1184.1,116.97,116.97,,2477,Protein SON,nucleoplasm|nuclear speck|,microtubule cytoskeleton organization|mRNA processing|negative regulation of apoptotic process|regulation of RNA splicing|regulation of cell cycle|,RNA binding|protein binding|poly(A) RNA binding|RS domain binding|,10,18,782000000,4.4%
B1AR13,0.70184245,0.021333333,4.512698579,-0.176666667,0.353777446,-0.997058664,0.071,0.479,-0.221,-0.097,0.004,-0.108,B1AR13,Cisd3,B1AR13_Cisd3,B1AR13,Cisd3,1,32,11,11,B1AR13|B2RWE3|Z4YKM2,MOUSE,16075.3,58.3,1185,1185.1,116.83,116.83,,137,"CDGSH iron-sulfur domain-containing protein 3, mitochondrial",mitochondrion|,,"metal ion binding|2 iron, 2 sulfur cluster binding|",11,32,12300000000,58.3%
O88967,0.612170052,-0.0095,6.143047918,0.177666667,0.243049767,1.281583348,0.063,-0.021,-0.337,0.248,0.029,-0.039,O88967,Yme1l1,O88967_Yme1l1,O88967,Yme1l1,1,21,8,8,O88967,MOUSE,80197.7,15.3,1186,1186.1,116.78,116.78,,715,ATP-dependent zinc metalloprotease YME1L1,mitochondrion|mitochondrial inner membrane|membrane|integral component of membrane|,misfolded or incompletely synthesized protein catabolic process|mitochondrion organization|cell proliferation|,metalloendopeptidase activity|ATP binding|metal ion binding|,8,21,4370000000,15.3%
F8VQC7,0.472645993,-0.016666667,8.750858795,0.144666667,0.133325776,1.708017143,-0.094,-0.013,-0.16,0.063,0.016,0.088,F8VQC7,Ktn1,F8VQC7_Ktn1,F8VQC7,Ktn1,1,11,9,9,F8VQC7|A0A087WPX0|A0A087WP14|A0A087WP85|A0A087WQQ5|A0A087WRS1|A0A087WQ25|A0A087WS23|A0A087WPW5|A0A087WQI3|A0A087WQD0|A0A087WNW3|A0A087WQG4|A0A087WS29|A0A087WS04|A0A087WP48|A0A087WQF8|Q61595|Q61595-11|Q61595-7|Q61595-10|Q61595-5|Q61595-15|Q61595-13|Q61595-8|Q61595-9|Q61595-4|Q61595-6|Q61595-14|Q61595-3|Q61595-16|Q61595-12|Q61595-2|A0A087WPY8,MOUSE,153111.2,11,1187,1187.1,116.65,116.65,,1327,Kinectin,endoplasmic reticulum|membrane|,microtubule-based movement|,kinesin binding|poly(A) RNA binding|,9,11,182000000,11.0%
Q9CRB9,0.514657719,0.085333333,7.905233441,0.380666667,0.161985692,1.573772296,-0.275,0.087,-0.127,0.823,-0.063,0.067,Q9CRB9,Chchd3,Q9CRB9_Chchd3,Q9CRB9,Chchd3,1,29,8,8,Q9CRB9|Q9D9P1|S4R238,MOUSE,26562.3,30.3,1188,1188.1,116.64,116.64,,227,MICOS complex subunit Mic19,nucleus|cytoplasm|mitochondrion|mitochondrial inner membrane|extracellular exosome|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|inner mitochondrial membrane organization|mitochondrial fusion|",RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription|protein binding|phosphatase binding|protein complex scaffold|,8,29,11100000000,30.3%
Q9CQR4,0.638602797,0.0625,5.592791123,-0.309,0.275880426,-1.187522381,0.123,0.771,-0.243,-0.277,0.136,-0.135,Q9CQR4,Acot13,Q9CQR4_Acot13,Q9CQR4,Acot13,1,29,9,9,Q9CQR4,MOUSE,15296.7,60.7,1189,1189.1,116.56,116.56,,140,Acyl-coenzyme A thioesterase 13,nucleus|mitochondrion|spindle|cytosol|extracellular exosome|,metabolic process|protein homotetramerization|,acyl-CoA hydrolase activity|,9,29,8790000000,60.7%
P47809,0.935669179,-0.016,0.921923373,0.023333333,0.808737652,0.251813006,-0.012,0.033,-0.104,0.105,-0.056,-0.062,P47809,Map2k4,P47809_Map2k4,P47809,Map2k4,1,27,9,9,P47809|M0QWG5|M0QWR0,MOUSE,44569.2,31.4,1190,1190.1,116.4,116.4,,397,Dual specificity mitogen-activated protein kinase kinase 4,nucleus|cytosol|,MAPK cascade|apoptotic process|JNK cascade|activation of JUN kinase activity|peptidyl-tyrosine phosphorylation|cellular response to mechanical stimulus|,protein serine/threonine kinase activity|protein tyrosine kinase activity|protein binding|ATP binding|JUN kinase kinase activity|,9,27,2100000000,31.4%
Q99JX4,0.473411328,0.002833333,8.679770045,-0.349666667,0.135526117,-1.699290556,-0.078,0.56,0.051,-0.472,-0.044,0,Q99JX4,Eif3m,Q99JX4_Eif3m,Q99JX4,Eif3m,1,16,9,9,Q99JX4|A2A702,MOUSE,42972.6,34.2,1191,1191.1,116.3,116.3,,374,Eukaryotic translation initiation factor 3 subunit M,"eukaryotic translation initiation factor 3 complex|eukaryotic 43S preinitiation complex|eukaryotic 48S preinitiation complex|eukaryotic translation initiation factor 3 complex, eIF3m|",formation of translation preinitiation complex|cytoplasmic translational initiation|translation|regulation of translational initiation|,translation initiation factor activity|translation initiation factor binding|,9,16,1740000000,34.2%
Q3U0S6,0.873222165,0.018333333,2.05102639,0.045333333,0.623587442,0.514277218,-0.006,-0.004,-0.003,0.155,-0.018,-0.014,Q3U0S6,Rasip1,Q3U0S6_Rasip1,Q3U0S6,Rasip1,1,20,10,10,Q3U0S6,MOUSE,104298.4,14.4,1192,1192.1,116.2,116.2,,961,Ras-interacting protein 1,Golgi apparatus|Golgi stack|perinuclear region of cytoplasm|,angiogenesis|vasculogenesis|signal transduction|positive regulation of cell proliferation|negative regulation of autophagy|regulation of GTPase activity|branching morphogenesis of an epithelial tube|,protein binding|Ras GTPase binding|,10,20,1290000000,14.4%
Q9QZS3,0.70184245,0.037333333,4.528159009,-0.098666667,0.352520274,-0.998991804,0.021,-0.005,0.244,-0.026,-0.034,0.024,Q9QZS3,Numb,Q9QZS3_Numb,Q9QZS3,Numb,1,22,10,10,Q9QZS3|Q9QZS3-2|Q9QZS3-3|Q9QZS3-4|Q05BE7|O08919|F8WJ71,MOUSE,71439.2,14,1193,1193.1,116.17,116.17,,653,Protein numb homolog,nucleus|cytoplasm|early endosome|plasma membrane|focal adhesion|cytoplasmic membrane-bounded vesicle|basolateral plasma membrane|extrinsic component of plasma membrane|clathrin-coated vesicle|apical part of cell|apical plasma membrane|,nervous system development|neuroblast proliferation|axonogenesis|lateral ventricle development|neuroblast division in subventricular zone|positive regulation of cell migration|positive regulation of polarized epithelial cell differentiation|forebrain development|adherens junction organization|negative regulation of Notch signaling pathway|positive regulation of neurogenesis|lung epithelial cell differentiation|negative regulation of protein localization to plasma membrane|,protein binding|beta-catenin binding|alpha-catenin binding|cadherin binding|,10,22,2210000000,14.0%
O55125,0.936982455,-0.019333333,0.892619093,0.022666667,0.81421311,0.24443515,-0.013,0.044,-0.123,0.057,0.019,-0.1,O55125,Nipsnap1,O55125_Nipsnap1,O55125,Nipsnap1,1,26,9,9,O55125,MOUSE,33590.8,47.5,1194,1194.1,116.1,116.1,,284,Protein NipSnap homolog 1,mitochondrion|mitochondrial inner membrane|membrane|synaptic membrane|,sensory perception of pain|,protein binding|neurotransmitter binding|,9,26,9430000000,47.5%
Q8VDC0,0.966362666,-0.031166667,0.454068033,0.015,0.900727032,0.129590426,0.072,0.005,-0.193,0.125,-0.048,-0.148,Q8VDC0,Lars2,Q8VDC0_Lars2,Q8VDC0,Lars2,1,25,11,11,Q8VDC0|A0A1L1SSW1,MOUSE,102619.3,11.1,1195,1195.1,115.9,115.9,,902,"Probable leucine--tRNA ligase, mitochondrial",mitochondrion|mitochondrial matrix|cytosol|,leucyl-tRNA aminoacylation|regulation of translational fidelity|,aminoacyl-tRNA editing activity|leucine-tRNA ligase activity|ATP binding|,11,25,3110000000,11.1%
Q99LM2,0.571046339,-0.016166667,6.954638294,0.156333333,0.201621189,1.416257576,-0.053,-0.255,0.025,0.179,-0.025,0.032,Q99LM2,Cdk5rap3,Q99LM2_Cdk5rap3,Q99LM2,Cdk5rap3,1,22,10,10,Q99LM2|F2Z486|D6RJ46|D6RII4,MOUSE,57389.1,21.2,1196,1196.1,115.79,115.79,,503,CDK5 regulatory subunit-associated protein 3,nucleus|cytoplasm|centrosome|endomembrane system|membrane|protein complex|,regulation of cyclin-dependent protein serine/threonine kinase activity|negative regulation of protein phosphorylation|mitotic G2 DNA damage checkpoint|regulation of mitotic cell cycle|cell proliferation|positive regulation of protein ubiquitination|negative regulation of NF-kappaB transcription factor activity|mitotic G2/M transition checkpoint|positive regulation of transcription from RNA polymerase II promoter|protein ufmylation|negative regulation of protein serine/threonine kinase activity|positive regulation of protein localization to nucleus|positive regulation of signal transduction by p53 class mediator|negative regulation of cellular protein catabolic process|,protein binding|protein kinase binding|cyclin binding|ubiquitin-like protein ligase binding|NF-kappaB binding|MDM2/MDM4 family protein binding|,10,22,7840000000,21.2%
A11112,0.000524182,-0.11,49.29244022,1.766666667,1.17694E-05,11.65875951,-0.919,-0.911,-1.15,0.482,0.86,0.978,A11112,NotFound,A11112_NotFound,A11112,,1,18,11,11,A11112,MOUSE,26302.5,67.2,1197,1197.1,115.42,115.42,,,mKate2,,,,11,18,1700000000,67.2%
Q99P88,0.654538688,0.011,5.27170481,-0.111333333,0.297049974,-1.13069065,0.206,0.018,-0.024,0.022,-0.045,-0.111,Q99P88,Nup155,Q99P88_Nup155,Q99P88,Nup155,1,27,10,10,Q99P88,MOUSE,156655.6,8.7,1198,1198.1,115.4,115.4,,1391,Nuclear pore complex protein Nup155,nuclear envelope|nuclear pore|membrane|nuclear membrane|,mRNA export from nucleus|protein import into nucleus|nuclear envelope organization|atrial cardiac muscle cell action potential|,structural constituent of nuclear pore|,10,27,10600000000,8.7%
Q99JY4,0.836873322,-0.031666667,2.577675879,0.082,0.552372962,0.625846106,0.007,0.107,-0.332,0.081,-0.026,-0.027,Q99JY4,Trabd,Q99JY4_Trabd,Q99JY4,Trabd,1,17,9,9,Q99JY4|E9Q8R5|E9PXM1,MOUSE,42530.7,32.4,1199,1199.1,115.07,115.07,,376,TraB domain-containing protein,,,,9,17,10100000000,32.4%
Q8K3K7,0.822248694,-0.015666667,2.736977263,-0.056666667,0.532478741,-0.658027519,0.006,0.059,-0.027,-0.093,0.046,-0.085,Q8K3K7,Agpat2,Q8K3K7_Agpat2,Q8K3K7,Agpat2,1,36,9,9,Q8K3K7,MOUSE,31352.4,37,1200,1200.1,115.06,115.06,,278,1-acyl-sn-glycerol-3-phosphate acyltransferase beta,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,positive regulation of cytokine production|phosphatidic acid biosynthetic process|epidermis development|phospholipid biosynthetic process|CDP-diacylglycerol biosynthetic process|,1-acylglycerol-3-phosphate O-acyltransferase activity|,9,36,9330000000,37.0%
Q8BQ47,0.000222149,-0.078833333,56.86658229,1.521666667,2.05751E-06,15.06013739,-0.854,-0.78,-0.885,0.614,0.591,0.841,Q8BQ47,Cnpy4,Q8BQ47_Cnpy4,Q8BQ47,Cnpy4,1,16,8,8,Q8BQ47,MOUSE,28492.6,36.7,1201,1201.1,114.86,114.86,,245,Protein canopy homolog 4,extracellular region|,regulation of protein localization|,receptor binding|,8,16,1560000000,36.7%
Q6P9Q6-2,0.619364398,0.020666667,5.970065914,0.124,0.252925961,1.25083449,-0.13,-0.046,0.052,0.017,0.023,0.208,Q6P9Q6,Fkbp15,Q6P9Q6-2_Fkbp15,Q6P9Q6-2,Fkbp15,1,16,10,10,Q6P9Q6-2|Q6P9Q6|Q80YW9|Q80YW6|Q80YW7,MOUSE,137952.3,11.3,1202,1202.1,114.78,114.78,,1216,Isoform B of FK506-binding protein 15,early endosome|membrane|axon|growth cone|actin filament|,protein folding|endocytosis|negative regulation of phosphatase activity|,actin binding|peptidyl-prolyl cis-trans isomerase activity|,10,16,570000000,11.3%
P35282,0.386623778,-0.008666667,10.70211199,-0.166666667,0.085072423,-2.019158644,0.086,0.106,0.032,-0.151,-0.092,-0.033,P35282,Rab21,P35282_Rab21,P35282,Rab21,1,23,9,9,P35282|A0A1W2P6Z4,MOUSE,24505.3,41.4,1203,1203.1,114.46,114.46,,222,Ras-related protein Rab-21,endosome|early endosome|endoplasmic reticulum membrane|trans-Golgi network|focal adhesion|cytoplasmic side of plasma membrane|vesicle membrane|cytoplasmic vesicle membrane|Golgi cisterna membrane|neuron projection|extracellular exosome|cytoplasmic side of early endosome membrane|,intracellular protein transport|anterograde axon cargo transport|metabolic process|regulation of exocytosis|regulation of endocytosis|regulation of axon extension|Rab protein signal transduction|positive regulation of receptor-mediated endocytosis|positive regulation of dendrite morphogenesis|positive regulation of early endosome to late endosome transport|,GTPase activity|protein binding|GTP binding|GDP binding|,9,23,6950000000,41.4%
Q8BZ09,0.961523652,-0.012833333,0.551535185,-0.025,0.880737487,-0.155928302,0.162,0.193,-0.356,0.012,0.011,-0.099,Q8BZ09,Slc25a21,Q8BZ09_Slc25a21,Q8BZ09,Slc25a21,1,26,11,11,Q8BZ09|B6CI26|Q80V31,MOUSE,33342.4,37.2,1204,1204.1,114.38,114.38,,298,Mitochondrial 2-oxodicarboxylate carrier,mitochondrion|mitochondrial inner membrane|integral component of membrane|,transport|,,11,26,7260000000,37.2%
Q9CXW4,0.924329621,-0.0005,1.120642581,-0.025666667,0.772566268,-0.300969474,-0.019,0.094,-0.038,0.004,0.022,-0.066,Q9CXW4,Rpl11,Q9CXW4_Rpl11,Q9CXW4,Rpl11,1,34,9,9,E9PYL9|Q9CXW4|E9PZB3,MOUSE,20480.2,44.3,1205,1205.1,114.28,114.28,,178,60S ribosomal protein L11,nucleolus|cytoplasm|membrane|cytosolic large ribosomal subunit|extracellular exosome|,rRNA processing|translation|protein targeting|protein localization to nucleus|ribosomal large subunit biogenesis|,structural constituent of ribosome|protein binding|rRNA binding|poly(A) RNA binding|,9,34,1.38E+11,44.3%
P29699,0.20713013,0.013666667,15.67186628,0.536,0.027090272,2.826274043,0.001,-0.242,-0.522,0.327,-0.024,0.542,P29699,Ahsg,P29699_Ahsg,P29699,Ahsg,1,22,7,7,P29699,MOUSE,38123.7,34.2,1206,1206.1,114.13,114.13,,345,Alpha-2-HS-glycoprotein,extracellular space|extracellular exosome|blood microparticle|,ossification|acute-phase response|negative regulation of endopeptidase activity|negative regulation of bone mineralization|regulation of inflammatory response|positive regulation of phagocytosis|,cysteine-type endopeptidase inhibitor activity|,7,22,3880000000,34.2%
Q8CFE4,0.73101227,0.004833333,4.094562084,-0.100333333,0.389532584,-0.920124251,0.215,0.029,-0.079,0.024,-0.011,-0.149,Q8CFE4,Scyl2,Q8CFE4_Scyl2,Q8CFE4,Scyl2,1,17,9,9,Q8CFE4|G5E8J9|Q8CFE4-2,MOUSE,104000,13.7,1207,1207.1,114.03,114.03,,930,SCY1-like protein 2,Golgi apparatus|endosome membrane|clathrin-coated vesicle|perinuclear region of cytoplasm|,positive regulation of receptor internalization|protein phosphorylation|endosome to lysosome transport|negative regulation of canonical Wnt signaling pathway|receptor internalization involved in canonical Wnt signaling pathway|positive regulation of clathrin-mediated endocytosis|,protein kinase activity|receptor binding|protein binding|ATP binding|,9,17,1680000000,13.7%
Q6ZQB6,0.686505935,-0.062166667,4.763701493,0.142333333,0.333910327,1.042127451,0.006,0.019,-0.425,0.019,-0.012,0.02,Q6ZQB6,Ppip5k2,Q6ZQB6_Ppip5k2,Q6ZQB6,Ppip5k2,1,18,12,12,E9Q9J4|Q6ZQB6|Q6ZQB6-3|Q6ZQB6-2|A2ARP1|A2ARP1-2|A2ARP1-3|A2ARP1-7|A2ARP1-6|A2ARP1-5,MOUSE,129565.5,14.7,1208,1208.1,113.7,113.7,,1129,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2,cytosol|,inositol metabolic process|phosphorylation|dephosphorylation|,"inositol-1,3,4,5,6-pentakisphosphate kinase activity|inositol hexakisphosphate 5-kinase activity|acid phosphatase activity|ATP binding|diphosphoinositol-pentakisphosphate kinase activity|inositol hexakisphosphate 1-kinase activity|inositol hexakisphosphate 3-kinase activity|",12,18,3630000000,14.7%
Q5D0E0,0.800946828,0.003833333,3.057894558,0.058333333,0.494550385,0.722303321,-0.039,-0.002,-0.035,0.097,0.001,0.001,Q5D0E0,Ikbkb,Q5D0E0_Ikbkb,Q5D0E0,Ikbkb,1,19,13,13,Q5D0E0|O88351|A0A0R4J0T4|Q3U141,MOUSE,87925.8,17.1,1209,1209.1,113.39,113.39,,757,Ikbkb protein,cytoplasm|IkappaB kinase complex|intracellular membrane-bounded organelle|,B cell homeostasis|skeletal muscle contraction|protein phosphorylation|I-kappaB phosphorylation|positive regulation of cell proliferation|response to toxic substance|positive regulation of sodium ion transport|signal transduction by protein phosphorylation|neuron projection development|response to drug|serine phosphorylation of STAT protein|positive regulation of transcription from RNA polymerase II promoter|positive regulation of NF-kappaB transcription factor activity|response to fatty acid|cellular response to tumor necrosis factor|positive regulation of neuron death|positive regulation of cation channel activity|,protein kinase activity|receptor signaling protein serine/threonine kinase activity|protein binding|ATP binding|IkappaB kinase activity|protein kinase binding|protein homodimerization activity|protein heterodimerization activity|scaffold protein binding|,13,19,946000000,17.1%
Q8BX90,0.809975056,0.017666667,2.956239606,-0.070666667,0.506262826,-0.702127873,-0.027,-0.028,0.214,-0.002,-0.07,0.019,Q8BX90,Fndc3a,Q8BX90_Fndc3a,Q8BX90,Fndc3a,1,19,12,12,Q8BX90,MOUSE,133895.8,12.5,1210,1210.1,113.35,113.35,,1198,Fibronectin type-III domain-containing protein 3A,Golgi membrane|acrosomal vesicle|Golgi apparatus|cytosol|vesicle membrane|membrane|integral component of membrane|cytoplasmic vesicle|,spermatid development|fertilization|single organismal cell-cell adhesion|Sertoli cell development|,poly(A) RNA binding|,12,19,2230000000,12.5%
E9Q9F5,0.427450846,0.000666667,9.840546353,0.197333333,0.10373979,1.882690653,-0.168,-0.149,0.023,0.056,0.005,0.237,E9Q9F5,NotFound,E9Q9F5_NotFound,E9Q9F5,Sept7,1,25,8,7,E9Q9F5|E9Q1G8|O55131|Q9DA97|S4R2P6,MOUSE,51079.5,29.9,1211,1211.1,113.05,99.06,,437,Septin-7,stress fiber|nucleus|nucleolus|cytoplasm|plasma membrane|cell cortex|actin cytoskeleton|microtubule cytoskeleton|septin complex|axon terminus|synapse|extracellular exosome|,protein heterooligomerization|,protein binding|GTP binding|identical protein binding|,8,25,7220000000,29.9%
Q8C650,0.693581167,0.000333333,4.649658751,0.090666667,0.342794721,1.020815382,-0.076,-0.1,0.041,-0.012,0.028,0.121,Q8C650,Sept10,Q8C650_Sept10,Q8C650,Sept10,1,11,7,6,A0A1W2P6J7|Q8C650|A0A0R4J233|Q8C650-2,MOUSE,53220,17.9,1211,1211.2,96.93,82.94,,452,Septin-10,cytoplasm|cytoskeleton|,cell cycle|cell division|,GTP binding|,6,11,1060000000,15.9%
Q8C1B7,0.404061957,-0.0645,10.30496042,0.318333333,0.093218897,1.959802475,-0.464,-0.282,0.075,-0.022,0.022,0.284,Q8C1B7,Sept11,Q8C1B7_Sept11,Q8C1B7,Sept11,1,6,5,4,A0A0J9YUL3|Q8C1B7|Q8C1B7-2|A0A0J9YTY0|Q8C1B7-3|B1AQZ0|B1AQY9|B7ZC46|Q8CHH9-2|Q8CHH9|Q9R1T4|Q9R1T4-3|Q9R1T4-2,MOUSE,50036.1,14.1,1211,1211.3,59.57,45.58,,431,Septin-11,stress fiber|cytoplasm|cell junction|axon|dendritic spine|synapse|extracellular exosome|,cell cycle|protein heterooligomerization|cell division|,GTP binding|,4,6,1870000000,12.0%
P54310-2,0.745264968,-0.000833333,3.881362645,-0.089,0.40913227,-0.880387062,0.045,0.104,-0.018,-0.091,-0.152,0.107,P54310,Lipe,P54310-2_Lipe,P54310-2,Lipe,1,17,10,10,P54310-2|E9Q4M2|P54310,MOUSE,88766.9,15.2,1212,1212.1,112.97,112.97,,759,Isoform 2 of Hormone-sensitive lipase,nucleus|cytoplasm|mitochondrion|lipid particle|cytosol|caveola|,transcription initiation from RNA polymerase I promoter|termination of RNA polymerase I transcription|cholesterol metabolic process|lipid catabolic process|triglyceride catabolic process|long-chain fatty acid catabolic process|diacylglycerol catabolic process|,triglyceride lipase activity|protein binding|protein kinase binding|hormone-sensitive lipase activity|rRNA primary transcript binding|,10,17,557000000,15.2%
P68037,0.70184245,0.002166667,4.518322443,-0.112333333,0.353319621,-0.997649106,-0.111,0.093,0.193,-0.172,0.008,0.002,P68037,Ube2l3,P68037_Ube2l3,P68037,Ube2l3,1,22,9,9,P68037|D3YZS3,MOUSE,18032.4,70.7,1213,1213.1,112.88,112.88,,154,Ubiquitin-conjugating enzyme E2 L3,nucleus|cytoplasm|,"protein polyubiquitination|transcription, DNA-templated|regulation of transcription, DNA-templated|cell proliferation|protein ubiquitination|cell cycle phase transition|protein K11-linked ubiquitination|cellular response to steroid hormone stimulus|cellular response to glucocorticoid stimulus|",transcription coactivator activity|ubiquitin-protein transferase activity|protein binding|ATP binding|ligase activity|,9,22,9830000000,70.7%
Q9DCS3,0.935853609,-0.026833333,0.912390854,0.031666667,0.810514735,0.249531513,-0.056,0.179,-0.251,0.014,0.045,-0.092,Q9DCS3,Mecr,Q9DCS3_Mecr,Q9DCS3,Mecr,1,18,9,9,Q9DCS3,MOUSE,40570.2,38.6,1214,1214.1,112.83,112.83,,373,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",nucleus|mitochondrion|cytosol|,fatty acid metabolic process|fatty acid biosynthetic process|oxidation-reduction process|,zinc ion binding|ligand-dependent nuclear receptor binding|trans-2-enoyl-CoA reductase (NADPH) activity|,9,18,1750000000,38.6%
Q9DCC4,0.634404848,-0.036666667,5.687169026,0.224666667,0.269949854,1.203778716,0.043,0.036,-0.526,0.298,-0.064,-0.007,Q9DCC4,Pycrl,Q9DCC4_Pycrl,Q9DCC4,Pycr3,1,36,9,9,Q9DCC4,MOUSE,29177.2,43,1215,1215.1,112.61,112.61,,274,Pyrroline-5-carboxylate reductase 3,,cytidine deamination|oxidation-reduction process|L-proline biosynthetic process|,cytidine deaminase activity|pyrroline-5-carboxylate reductase activity|protein binding|identical protein binding|,9,36,11100000000,43.0%
Q8BKZ9,0.818605458,-0.002,2.811874666,-0.068,0.523374469,-0.673184509,0.052,0.167,-0.123,-0.062,-0.011,-0.035,Q8BKZ9,Pdhx,Q8BKZ9_Pdhx,Q8BKZ9,Pdhx,1,22,10,10,Q8BKZ9|A2AWH8,MOUSE,54283.3,20.5,1216,1216.1,112.54,112.54,,501,"Pyruvate dehydrogenase protein X component, mitochondrial",mitochondrion|mitochondrial matrix|pyruvate dehydrogenase complex|,metabolic process|,"transferase activity, transferring acyl groups|",10,22,24600000000,20.5%
Q9JK38,0.904274672,-0.011666667,1.549211937,-0.044,0.699969,-0.40238183,0.067,0.058,-0.094,-0.124,0.14,-0.117,Q9JK38,Gnpnat1,Q9JK38_Gnpnat1,Q9JK38,Gnpnat1,1,19,7,7,Q9JK38,MOUSE,21133.1,45.6,1217,1217.1,112.53,112.53,,184,Glucosamine 6-phosphate N-acetyltransferase,Golgi membrane|late endosome|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|endosome membrane|,UDP-N-acetylglucosamine biosynthetic process|,glucosamine 6-phosphate N-acetyltransferase activity|identical protein binding|,7,19,1920000000,45.6%
Q6P8,0.56608042,0.025166667,7.022587468,-0.193,0.198491198,-1.428847586,-0.111,0.132,0.344,-0.188,-0.023,-0.003,Q6P8,NotFound,Q6P8_NotFound,Q6P8,Snx6,1,13,10,10,Q6P8|A0A1W2P701,MOUSE,46933.2,29.3,1218,1218.1,112.43,112.43,,406,Sorting nexin-6,nucleus|cytoplasm|endosome|cytoplasmic membrane-bounded vesicle|extrinsic component of membrane|retromer complex|early endosome membrane|tubular endosome|,"intracellular protein transport|endocytosis|vesicle organization|negative regulation of transforming growth factor beta receptor signaling pathway|retrograde transport, endosome to Golgi|negative regulation of transcription, DNA-templated|",dynactin binding|type I transforming growth factor beta receptor binding|phosphatidylinositol binding|protein homodimerization activity|,10,13,664000000,29.3%
P29788,0.994928853,0.044666667,0.066964932,-0.002666667,0.984699022,-0.019913769,-0.159,-0.003,0.3,0.067,-0.044,0.107,P29788,Vtn,P29788_Vtn,P29788,Vtn,1,16,8,8,P29788,MOUSE,55646.8,24,1219,1219.1,112.15,112.15,,478,Vitronectin,proteinaceous extracellular matrix|extracellular space|extracellular matrix|extracellular exosome|blood microparticle|extracellular matrix|,receptor-mediated endocytosis|immune response|cell-matrix adhesion|positive regulation of cell-substrate adhesion|negative regulation of endopeptidase activity|positive regulation of smooth muscle cell migration|extracellular matrix organization|positive regulation of protein binding|cell adhesion mediated by integrin|endodermal cell differentiation|positive regulation of receptor-mediated endocytosis|oligodendrocyte differentiation|positive regulation of peptidyl-tyrosine phosphorylation|smooth muscle cell-matrix adhesion|,scavenger receptor activity|integrin binding|heparin binding|polysaccharide binding|extracellular matrix binding|,8,16,1590000000,24.0%
P61164,0.991594045,-0.017,0.155280706,-0.004,0.964876945,-0.045706701,0.029,0.035,-0.109,-0.071,0.03,-0.016,P61164,Actr1a,P61164_Actr1a,P61164,Actr1a,1,26,10,4,P61164,MOUSE,42727.1,34,1220,1220.1,112.12,39.78,,376,Alpha-centractin,cytoplasm|centrosome|dynactin complex|myelin sheath|extracellular exosome|,,ATP binding|,10,26,15600000000,34.0%
Q8R5C5,0.964565918,0.037166667,0.487595797,-0.015666667,0.893800144,-0.138685252,-0.034,0.012,0.157,-0.048,-0.075,0.211,Q8R5C5,Actr1b,Q8R5C5_Actr1b,Q8R5C5,Actr1b,1,9,9,4,Q8R5C5,MOUSE,42394.7,33.5,1220,1220.2,103.3,45.01,,376,Beta-centractin,cytoplasm|centrosome|dynactin complex|membrane|extracellular exosome|,,ATP binding|,4,9,986000000,15.1%
P08103,0.416525979,0.067833333,10.05137815,-0.323,0.098823945,-1.91930176,0.112,0.002,0.574,0.057,-0.224,-0.114,P08103,Hck,P08103_Hck,P08103,Hck,1,30,10,9,P08103|F6UND7|P08103-2|P05480|F8WI90|E9Q696|P06240,MOUSE,59584.7,22.1,1221,1221.1,111.95,83.97,,524,Tyrosine-protein kinase HCK,nucleus|lysosome|Golgi apparatus|cytosol|caveola|focal adhesion|transport vesicle|extrinsic component of cytoplasmic side of plasma membrane|cell projection|actin filament|,exocytosis|phagocytosis|inflammatory response|transmembrane receptor protein tyrosine kinase signaling pathway|positive regulation of cell proliferation|regulation of cell shape|peptidyl-tyrosine phosphorylation|cell differentiation|peptidyl-tyrosine autophosphorylation|regulation of cell proliferation|negative regulation of apoptotic process|innate immune response|protein autophosphorylation|regulation of phagocytosis|defense response to Gram-positive bacterium|regulation of sequence-specific DNA binding transcription factor activity|cellular response to peptide hormone stimulus|regulation of podosome assembly|positive regulation of actin cytoskeleton reorganization|,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|receptor binding|protein binding|ATP binding|,12,30,6040000000,22.1%
Q04736,0.844723818,-0.0085,2.435152592,-0.049666667,0.57080102,-0.595935321,0.076,0,-0.027,0.018,-0.087,-0.031,Q04736,Yes1,Q04736_Yes1,Q04736,Yes1,1,14,9,6,Q04736|P39688|P39688-2|D3YZ57,MOUSE,61085.3,19.9,1221,1221.2,105.76,65.49,,541,Tyrosine-protein kinase Yes,cytoplasm|Golgi apparatus|microtubule organizing center|cytosol|actin filament|plasma membrane|focal adhesion|extrinsic component of cytoplasmic side of plasma membrane|extracellular exosome|,transmembrane receptor protein tyrosine kinase signaling pathway|glucose transport|cell differentiation|cellular response to platelet-derived growth factor stimulus|peptidyl-tyrosine autophosphorylation|regulation of cell proliferation|innate immune response|positive regulation of transcription from RNA polymerase II promoter|positive regulation of peptidyl-tyrosine phosphorylation|cellular response to retinoic acid|cellular response to peptide hormone stimulus|cellular response to transforming growth factor beta stimulus|,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|receptor binding|epidermal growth factor receptor binding|protein binding|ATP binding|enzyme binding|ion channel binding|,6,14,1670000000,15.1%
Q3UMB9,0.634404848,-0.001833333,5.723547721,-0.107,0.267698062,-1.208756188,0.095,0.051,0.009,0.028,-0.152,-0.042,Q3UMB9,Washc4,Q3UMB9_Washc4,Q3UMB9,Washc4,1,18,11,11,Q3UMB9|A0A1W2P6V9,MOUSE,137394.7,10.9,1222,1222.1,111.95,111.95,,1173,WASH complex subunit 4,nucleoplasm|endosome|early endosome|WASH complex|BLOC-1 complex|,endosome organization|protein transport|endosomal transport|,,11,18,2790000000,10.9%
Q80WQ2,0.64206681,-0.0005,5.494485425,0.141666667,0.282196392,1.170530904,0.009,-0.036,-0.187,0.279,-0.067,-0.001,Q80WQ2,Vac14,Q80WQ2_Vac14,Q80WQ2,Vac14,1,23,8,8,Q80WQ2|A0A1D5RLY2|A0A1D5RLN5,MOUSE,89073,11.2,1223,1223.1,111.7,111.7,,782,Protein VAC14 homolog,vacuolar membrane|endoplasmic reticulum|endosome membrane|PAS complex|,response to osmotic stress|positive regulation of phosphorylation|regulation of lipid kinase activity|,kinase activator activity|,8,23,1100000000,11.2%
Q9DCS2,0.926554478,-0.0165,1.056023219,0.033666667,0.784147348,0.285259068,0.033,0.047,-0.18,-0.169,0.14,0.03,Q9DCS2,Mettl26,Q9DCS2_Mettl26,Q9DCS2,Mettl26,1,24,9,9,Q9DCS2|G5E8|E9Q7K5|E9Q5B2|D3YZM4,MOUSE,23029.1,48,1224,1224.1,111.49,111.49,,204,Methyltransferase-like 26,,,,9,24,18100000000,48.0%
P51175,0.893374005,-0.008,1.707074555,0.050666667,0.674982549,0.438424523,-0.005,0.069,-0.164,0.195,-0.073,-0.07,P51175,Ppox,P51175_Ppox,P51175,Ppox,1,17,10,10,P51175,MOUSE,51269,31.2,1225,1225.1,111.41,111.41,,477,Protoporphyrinogen oxidase,mitochondrion|intrinsic component of mitochondrial inner membrane|integral component of mitochondrial inner membrane|mitochondrial membrane|,porphyrin-containing compound biosynthetic process|protoporphyrinogen IX biosynthetic process|heme biosynthetic process|response to drug|oxidation-reduction process|,oxygen-dependent protoporphyrinogen oxidase activity|,10,17,1760000000,31.2%
Q8BM72,0.002101511,-0.292166667,40.30627033,1.882333333,9.31908E-05,8.369125089,-1.097,-0.859,-1.744,0.544,0.633,0.77,Q8BM72,Hspa13,Q8BM72_Hspa13,Q8BM72,Hspa13,1,28,8,8,Q8BM72|D3Z0Y0|Q8BM72-2,MOUSE,51765.4,21,1226,1226.1,111.21,111.21,,471,Heat shock 70 kDa protein 13,endoplasmic reticulum|extracellular exosome|,,ATP binding|,8,28,10500000000,21.0%
A2A7S7,0.991556352,-0.015,0.160613879,-0.006,0.963692795,-0.047269409,-0.218,0.153,0.029,-0.156,0.011,0.091,A2A7S7,Yars,A2A7S7_Yars,A2A7S7,Yars,1,20,9,9,A2A7S7|Q91WQ3,MOUSE,63400,15.4,1227,1227.1,111.15,111.15,,564,Tyrosine--tRNA ligase,nucleus|cytoplasm|cytosol|,tyrosyl-tRNA aminoacylation|isoleucyl-tRNA aminoacylation|,tRNA binding|tyrosine-tRNA ligase activity|ATP binding|poly(A) RNA binding|isoleucine-tRNA ligase activity|,9,20,8440000000,15.4%
Q8K2C8,0.925061327,-0.004666667,1.110774319,-0.038,0.774323729,-0.298703981,0.098,0.179,-0.234,0.045,-0.036,-0.08,Q8K2C8,Gpat4,Q8K2C8_Gpat4,Q8K2C8,Gpat4,1,20,8,7,Q8K2C8,MOUSE,52636.8,22.3,1228,1228.1,111.12,95.7,,456,Glycerol-3-phosphate acyltransferase 4,endoplasmic reticulum|membrane|integral component of endoplasmic reticulum membrane|,glandular epithelial cell maturation|fatty acid metabolic process|acyl-CoA metabolic process|triglyceride metabolic process|phosphatidylcholine biosynthetic process|lactation|lipid biosynthetic process|CDP-diacylglycerol biosynthetic process|triglyceride biosynthetic process|mammary gland development|regulation of multicellular organism growth|diacylglycerol metabolic process|,glycerol-3-phosphate O-acyltransferase activity|,8,20,17000000000,22.3%
Q8C0N2,0.252149878,0.044333333,14.13760558,-0.276,0.038569094,-2.569143489,0.332,0.035,0.18,-0.009,-0.1,-0.172,Q8C0N2,Gpat3,Q8C0N2_Gpat3,Q8C0N2,Gpat3,1,10,6,5,Q8C0N2,MOUSE,49512.9,18.2,1228,1228.2,91.03,75.61,,438,Glycerol-3-phosphate acyltransferase 3,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,CDP-diacylglycerol biosynthetic process|triglyceride biosynthetic process|regulation of TOR signaling|,1-acylglycerol-3-phosphate O-acyltransferase activity|glycerol-3-phosphate O-acyltransferase activity|,5,10,3690000000,16.2%
Q924C1,0.752869277,0.0355,3.799691624,0.098333333,0.416898985,0.865442869,0.034,-0.031,-0.044,0.297,-0.014,-0.029,Q924C1,Xpo5,Q924C1_Xpo5,Q924C1,Xpo5,1,14,10,10,Q924C1|Q924C1-2|Q924C1-3,MOUSE,139138.7,11.1,1229,1229.1,111.09,111.09,,1204,Exportin-5,nucleus|nucleoplasm|cytoplasm|RNA nuclear export complex|,protein export from nucleus|pre-miRNA export from nucleus|positive regulation of RNA interference|,tRNA binding|mRNA binding|Ran GTPase binding|protein transporter activity|poly(A) RNA binding|pre-miRNA binding|pre-miRNA binding|,10,14,1780000000,11.1%
P19221,0.02787994,-0.0005,26.70361336,0.509,0.002136184,4.83976518,-0.188,-0.266,-0.311,0.191,0.146,0.425,P19221,F2,P19221_F2,P19221,F2,1,21,12,12,P19221|H7BX99,MOUSE,71693.8,18.7,1230,1230.1,110.97,110.97,,618,Prothrombin,extracellular space|cytosol|extracellular matrix|extracellular exosome|blood microparticle|,positive regulation of protein phosphorylation|proteolysis|acute-phase response|cell surface receptor signaling pathway|positive regulation of cell proliferation|regulation of cell shape|response to wounding|regulation of gene expression|positive regulation of phosphatidylinositol 3-kinase signaling|response to inactivity|platelet activation|positive regulation of blood coagulation|positive regulation of cell growth|positive regulation of collagen biosynthetic process|fibrinolysis|negative regulation of proteolysis|negative regulation of astrocyte differentiation|positive regulation of release of sequestered calcium ion into cytosol|cytosolic calcium ion homeostasis|thrombin receptor signaling pathway|cellular response to mechanical stimulus|positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway|positive regulation of reactive oxygen species metabolic process|,serine-type endopeptidase activity|receptor binding|calcium ion binding|protein binding|peptidase activity|thrombospondin receptor activity|,12,21,6370000000,18.7%
Q99K41,0.007714627,-0.032166667,33.59016263,0.667,0.000437506,6.415761751,-0.419,-0.447,-0.231,0.421,0.264,0.219,Q99K41,Emilin1,Q99K41_Emilin1,Q99K41,Emilin1,1,18,10,10,Q99K41,MOUSE,108895,13.6,1231,1231.1,110.96,110.96,,1017,EMILIN-1,extracellular region|proteinaceous extracellular matrix|collagen trimer|extracellular matrix|extracellular exosome|extracellular matrix|,cell adhesion|positive regulation of cell-substrate adhesion|extracellular matrix organization|,protein binding|extracellular matrix constituent conferring elasticity|identical protein binding|,10,18,558000000,13.6%
Q05915,0.87311559,-0.018166667,2.069506706,0.049666667,0.62093956,0.518279844,0.046,0.016,-0.191,-0.008,0.02,0.008,Q05915,Gch1,Q05915_Gch1,Q05915,Gch1,1,15,9,9,Q05915,MOUSE,27184.8,37.7,1232,1232.1,110.93,110.93,,241,GTP cyclohydrolase 1,nucleus|nucleoplasm|cytoplasm|cytosol|cytoplasmic vesicle|nuclear membrane|protein complex|,"tetrahydrobiopterin biosynthetic process|regulation of blood pressure|regulation of lung blood pressure|response to lipopolysaccharide|response to interferon-gamma|response to tumor necrosis factor|7,8-dihydroneopterin 3'-triphosphate biosynthetic process|vasodilation|dopamine biosynthetic process|pteridine-containing compound biosynthetic process|negative regulation of blood pressure|tetrahydrofolate biosynthetic process|response to pain|neuromuscular process controlling posture|positive regulation of nitric-oxide synthase activity|protein homooligomerization|protein heterooligomerization|",GTP cyclohydrolase I activity|calcium ion binding|GTP binding|zinc ion binding|GTP-dependent protein binding|protein homodimerization activity|coenzyme binding|,9,15,2920000000,37.7%
P27546,0.102183391,0.0075,19.94660804,0.495,0.010123698,3.559552492,-0.253,-0.04,-0.427,0.077,0.265,0.423,P27546,Map4,P27546_Map4,P27546,Map4,1,21,10,10,P27546|P27546-2|P27546-3|A0A140T8T5|E9PZ43|A0A0G2JDN7|P27546-4,MOUSE,117997.7,12.5,1233,1233.1,110.92,110.92,,1125,Microtubule-associated protein 4,cytoplasm|microtubule|plasma membrane|microtubule cytoskeleton|extracellular exosome|mitotic spindle|neuronal postsynaptic density|,mitotic spindle organization|microtubule sliding|establishment of spindle orientation|cell division|,microtubule binding|poly(A) RNA binding|,10,21,1730000000,12.5%
Q9JK92,0.895491675,0.029,1.64387763,-0.046,0.684876457,-0.424014838,-0.045,-0.02,0.221,-0.052,-0.041,0.111,Q9JK92,Hspb8,Q9JK92_Hspb8,Q9JK92,Hspb8,1,22,8,8,Q9JK92,MOUSE,21704.1,48.9,1234,1234.1,110.79,110.79,,196,Heat shock protein beta-8,intracellular|nucleus|nucleoplasm|cytoplasm|Golgi apparatus|,,protein binding|identical protein binding|,8,22,9490000000,48.9%
P39039,0.000818215,-0.2245,45.82043563,1.604333333,2.61792E-05,10.2717724,-0.734,-1.035,-1.311,0.474,0.593,0.666,P39039,Mbl1,P39039_Mbl1,P39039,Mbl1,1,19,10,9,P39039|P39039-2|A0A2C9F2B6,MOUSE,25852,31.7,1235,1235.1,93.05,88.04,,239,Mannose-binding protein A,collagen trimer|extracellular space|,"complement activation, lectin pathway|complement activation, classical pathway|negative regulation of growth of symbiont in host|positive regulation of phagocytosis|defense response to Gram-positive bacterium|protein homotetramerization|killing by host of symbiont cells|protein homotrimerization|",protease binding|calcium ion binding|mannose binding|polysaccharide binding|protein homodimerization activity|calcium-dependent protein binding|phosphatidylinositol-4-phosphate binding|,10,19,3940000000,31.7%
P41317,0.002263704,-0.280833333,39.82152278,1.715666667,0.000104195,8.217495107,-0.944,-0.84,-1.632,0.637,0.541,0.553,P41317,Mbl2,P41317_Mbl2,P41317,Mbl2,1,19,9,8,P41317,MOUSE,26356,50,1235,1235.2,110.76,105.75,,244,Mannose-binding protein C,collagen trimer|extracellular space|,"complement activation, lectin pathway|complement activation, classical pathway|negative regulation of growth of symbiont in host|innate immune response|negative regulation of viral process|positive regulation of phagocytosis|defense response to Gram-positive bacterium|killing by host of symbiont cells|",receptor binding|calcium ion binding|mannose binding|calcium-dependent protein binding|,8,19,6290000000,45.4%
P31725,0.34703809,0.341333333,11.52589628,-1.988,0.070373698,-2.154661316,0.294,0.128,3.584,-0.531,-1.336,-0.091,P31725,S100a9,P31725_S100a9,P31725,S100a9,1,25,10,10,P31725,MOUSE,13219.8,55.7,1236,1236.1,110.72,110.72,,113,Protein S100-A9,extracellular space|nucleus|cytoplasm|cytoskeleton|plasma membrane|extracellular exosome|,leukocyte migration involved in inflammatory response|chronic inflammatory response|positive regulation of peptide secretion|regulation of translation|autophagy|activation of cysteine-type endopeptidase activity involved in apoptotic process|response to zinc ion|peptidyl-cysteine S-nitrosylation|positive regulation of blood coagulation|neutrophil chemotaxis|leukocyte chemotaxis|actin cytoskeleton reorganization|response to lipopolysaccharide|peptidyl-cysteine S-trans-nitrosylation|innate immune response|regulation of integrin biosynthetic process|response to ethanol|positive regulation of inflammatory response|neutrophil aggregation|positive regulation of intrinsic apoptotic signaling pathway|,calcium ion binding|microtubule binding|zinc ion binding|antioxidant activity|Toll-like receptor 4 binding|arachidonic acid binding|RAGE receptor binding|,10,25,5370000000,55.7%
Q922Q8,0.936982455,0.0265,0.885323412,0.029,0.81558205,0.24270417,-0.115,-0.054,0.205,-0.061,0.016,0.168,Q922Q8,Lrrc59,Q922Q8_Lrrc59,Q922Q8,Lrrc59,1,20,9,9,Q922Q8,MOUSE,35333.2,34.5,1237,1237.1,110.62,110.62,,307,Leucine-rich repeat-containing protein 59,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|mitochondrial nucleoid|,,poly(A) RNA binding|,9,20,43300000000,34.5%
Q8VH51,0.95383876,-0.02,0.682779734,0.017333333,0.854519596,0.190557445,0.02,0.022,-0.128,0.028,0.03,-0.092,Q8VH51,Rbm39,Q8VH51_Rbm39,Q8VH51,Rbm39,1,29,8,8,Q8VH51|Q8VH51-2|E9Q8F0|Q8VH51-3,MOUSE,59690.8,20.7,1238,1238.1,110.45,110.45,,530,RNA-binding protein 39,nucleus|nucleoplasm|microtubule organizing center|microtubule cytoskeleton|,"transcription, DNA-templated|regulation of transcription, DNA-templated|mRNA processing|RNA splicing|",nucleotide binding|transcription coactivator activity|protein binding|poly(A) RNA binding|,8,29,4010000000,20.7%
P56399,0.846769943,0.003,2.401095844,0.065333333,0.575294756,0.588940051,-0.188,0.005,0.094,-0.023,-0.031,0.161,P56399,Usp5,P56399_Usp5,P56399,Usp5,1,19,10,10,P56399|Q3U4W8,MOUSE,96744.4,15,1239,1239.1,110.35,110.35,,858,Ubiquitin carboxyl-terminal hydrolase 5,lysosome|,protein deubiquitination|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|regulation of proteasomal protein catabolic process|protein K48-linked deubiquitination|,cysteine-type endopeptidase activity|ubiquitin-specific protease activity|protein binding|omega peptidase activity|zinc ion binding|ubiquitin binding|,10,19,587000000,15.0%
Q9QXT0,0.000552294,-0.280833333,48.55402785,1.776333333,1.39507E-05,11.35027044,-1.022,-0.968,-1.517,0.61,0.566,0.646,Q9QXT0,Cnpy2,Q9QXT0_Cnpy2,Q9QXT0,Cnpy2,1,28,7,7,Q9QXT0,MOUSE,21109.3,45,1240,1240.1,110.22,110.22,,182,Protein canopy homolog 2,endoplasmic reticulum|,negative regulation of gene expression|regulation of low-density lipoprotein particle clearance|positive regulation of low-density lipoprotein particle receptor biosynthetic process|,,7,28,7020000000,45.0%
Q8BH04,0.683824379,0.064333333,4.795789048,-0.213333333,0.331452344,-1.047850385,-0.107,0.641,-0.021,0.054,-0.037,-0.144,Q8BH04,Pck2,Q8BH04_Pck2,Q8BH04,Pck2,1,13,10,10,A0A0R4J0G0|Q8BH04,MOUSE,71382.5,21,1241,1241.1,109.79,109.79,,640,"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial",mitochondrion|extracellular exosome|,gluconeogenesis|,phosphoenolpyruvate carboxykinase (GTP) activity|GTP binding|metal ion binding|,10,13,1190000000,21.0%
O88343,0.683475429,0.014166667,4.810597688,-0.100333333,0.330324078,-1.049535033,0.154,0.092,-0.053,0.045,-0.056,-0.097,O88343,Slc4a4,O88343_Slc4a4,O88343,Slc4a4,1,16,7,7,O88343|A7E1Z5|E9Q8N8|O88343-2|O88343-3,MOUSE,122394.3,15.5,1242,1242.1,109.41,109.41,,1079,Electrogenic sodium bicarbonate cotransporter 1,integral component of plasma membrane|basolateral plasma membrane|extracellular exosome|,sodium ion transport|regulation of pH|bicarbonate transport|sodium ion transmembrane transport|regulation of intracellular pH|anion transmembrane transport|,inorganic anion exchanger activity|protein binding|sodium:bicarbonate symporter activity|,7,16,1590000000,15.5%
Q8VE47,0.88044681,-0.045333333,1.939953559,0.074666667,0.639741676,0.490315568,-0.009,0.122,-0.361,0.171,-0.114,-0.081,Q8VE47,Uba5,Q8VE47_Uba5,Q8VE47,Uba5,1,16,8,8,Q8VE47|D6RH76|F6VRI6,MOUSE,45302.5,33.9,1244,1244.1,109.33,109.33,,403,Ubiquitin-like modifier-activating enzyme 5,nucleus|cytoplasm|cytosol|intracellular membrane-bounded organelle|,regulation of intracellular estrogen receptor signaling pathway|response to endoplasmic reticulum stress|protein ufmylation|protein K69-linked ufmylation|,ATP binding|metal ion binding|UFM1 activating enzyme activity|,8,16,3040000000,33.9%
Q8K2T1,0.824484026,-0.001166667,2.703328279,-0.052333333,0.536620392,-0.651187615,0.043,0.024,0.008,0.001,-0.089,0.006,Q8K2T1,Nmral1,Q8K2T1_Nmral1,Q8K2T1,Nmral1,1,22,8,8,Q8K2T1|D3YU12|G5E8S7|Q8K2T1-2|Q8K2T1-3,MOUSE,34546.7,35.5,1245,1245.1,109.26,109.26,,309,NmrA-like family domain-containing protein 1,nucleus|cytoplasm|perinuclear region of cytoplasm|,,,8,22,5250000000,35.5%
P52019,0.450260828,-0.019,9.393102639,0.374,0.114997854,1.813968181,-0.051,-0.029,-0.538,0.381,-0.195,0.318,P52019,Sqle,P52019_Sqle,P52019,Sqle,1,23,9,9,P52019|Q3TSS7,MOUSE,64225.2,17.4,1246,1246.1,109.24,109.24,,572,Squalene monooxygenase,endoplasmic reticulum membrane|integral component of membrane|,cellular aromatic compound metabolic process|cholesterol metabolic process|response to organic substance|oxidation-reduction process|,squalene monooxygenase activity|flavin adenine dinucleotide binding|,9,23,10300000000,17.4%
Q9DB25,0.773512169,0.003666667,3.514448895,-0.114666667,0.445199954,-0.811635535,0.082,0.298,-0.197,-0.155,0.034,-0.04,Q9DB25,Alg5,Q9DB25_Alg5,Q9DB25,Alg5,1,29,8,8,Q9DB25|D6RCG2,MOUSE,37189.6,27.1,1247,1247.1,109.21,109.21,,324,Dolichyl-phosphate beta-glucosyltransferase,endoplasmic reticulum membrane|membrane|integral component of membrane|,protein glycosylation|determination of left/right symmetry|,dolichyl-phosphate beta-glucosyltransferase activity|,8,29,3440000000,27.1%
Q02788,0.894042447,-0.016333333,1.682123355,-0.062666667,0.678871637,-0.432854585,-0.056,0.062,0.039,0.25,-0.269,-0.124,Q02788,Col6a2,Q02788_Col6a2,Q02788,Col6a2,1,24,10,10,Q02788|D3Z7D5,MOUSE,111473.4,11.3,1248,1248.1,109.11,109.11,,1034,Collagen alpha-2(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|extracellular space|extracellular matrix|sarcolemma|protein complex|extracellular exosome|extracellular vesicle|extracellular matrix|,cell adhesion|response to glucose|protein heterotrimerization|,,10,24,5490000000,11.3%
Q7TQK5,0.712762463,0.011666667,4.340495824,-0.112,0.368086948,-0.965611721,-0.109,0.035,0.277,-0.033,-0.036,-0.064,Q7TQK5,Ccdc93,Q7TQK5_Ccdc93,Q7TQK5,Ccdc93,1,11,10,10,Q7TQK5|E9QAD4,MOUSE,72887,16.8,1249,1249.1,109.09,109.09,,629,Coiled-coil domain-containing protein 93,early endosome|,Golgi to plasma membrane transport|protein transport|,,10,11,1070000000,16.8%
Q9QVP9,0.953420192,-0.000166667,0.688932034,0.019,0.853309924,0.192164989,0.028,-0.076,0.019,0.146,-0.109,-0.009,Q9QVP9,Ptk2b,Q9QVP9_Ptk2b,Q9QVP9,Ptk2b,1,13,12,12,Q9QVP9|Q3UDE9|E9Q2A6,MOUSE,117104.6,16,1250,1250.1,108.98,108.98,,1009,Protein-tyrosine kinase 2-beta,nucleus|nucleoplasm|cytoplasm|cytosol|cytoskeleton|focal adhesion|cell cortex|postsynaptic density|N-methyl-D-aspartate selective glutamate receptor complex|lamellipodium|axon|dendrite|growth cone|extrinsic component of cytoplasmic side of plasma membrane|neuronal cell body|cell body|membrane raft|perinuclear region of cytoplasm|apical dendrite|,"MAPK cascade|oocyte maturation|response to hypoxia|positive regulation of cell-matrix adhesion|sprouting angiogenesis|marginal zone B cell differentiation|protein phosphorylation|cellular defense response|response to osmotic stress|cytoskeleton organization|cell adhesion|cell surface receptor signaling pathway|signal complex assembly|epidermal growth factor receptor signaling pathway|positive regulation of cytosolic calcium ion concentration|integrin-mediated signaling pathway|positive regulation of cell proliferation|negative regulation of cell proliferation|regulation of cell shape|response to mechanical stimulus|response to hormone|response to glucose|response to lithium ion|positive regulation of endothelial cell migration|negative regulation of muscle cell apoptotic process|regulation of cGMP-mediated signaling|regulation of macrophage chemotaxis|positive regulation of neuron projection development|glial cell proliferation|cell migration|peptidyl-tyrosine phosphorylation|regulation of cell adhesion|positive regulation of cell growth|positive regulation of cell migration|negative regulation of bone mineralization|regulation of cGMP biosynthetic process|positive regulation of actin filament polymerization|neuron projection development|regulation of inositol trisphosphate biosynthetic process|tumor necrosis factor-mediated signaling pathway|ionotropic glutamate receptor signaling pathway|response to immobilization stress|peptidyl-tyrosine autophosphorylation|response to cocaine|response to drug|response to hydrogen peroxide|activation of Janus kinase activity|negative regulation of apoptotic process|stress fiber assembly|negative regulation of potassium ion transport|positive regulation of JUN kinase activity|negative regulation of neuron apoptotic process|blood vessel endothelial cell migration|positive regulation of phosphatidylinositol 3-kinase activity|innate immune response|regulation of nitric oxide biosynthetic process|bone resorption|response to ethanol|negative regulation of myeloid cell differentiation|positive regulation of translation|positive regulation of angiogenesis|positive regulation of protein kinase activity|positive regulation of JNK cascade|vascular endothelial growth factor receptor signaling pathway|focal adhesion assembly|positive regulation of peptidyl-tyrosine phosphorylation|regulation of calcium-mediated signaling|positive regulation of nitric-oxide synthase activity|regulation of release of sequestered calcium ion into cytosol|response to cAMP|response to calcium ion|positive regulation of synaptic transmission, glutamatergic|long-term synaptic potentiation|chemokine-mediated signaling pathway|positive regulation of ERK1 and ERK2 cascade|cellular response to retinoic acid|cellular response to fluid shear stress|activation of GTPase activity|regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|regulation of establishment of cell polarity|regulation of actin cytoskeleton reorganization|regulation of N-methyl-D-aspartate selective glutamate receptor activity|positive regulation of reactive oxygen species metabolic process|positive regulation of excitatory postsynaptic membrane potential|positive regulation of B cell chemotaxis|",protein kinase activity|calmodulin-dependent protein kinase activity|non-membrane spanning protein tyrosine kinase activity|receptor binding|protein binding|ATP binding|protein complex binding|3-phosphoinositide-dependent protein kinase binding|N-methyl-D-aspartate selective glutamate receptor activity|,12,13,540000000,16.0%
O70570,0.0058955,-0.014166667,34.82442128,0.652333333,0.000329274,6.724326946,-0.312,-0.279,-0.43,0.196,0.33,0.41,O70570,Pigr,O70570_Pigr,O70570,Pigr,1,17,9,9,O70570,MOUSE,86309.5,15.5,1251,1251.1,108.93,108.93,,771,Polymeric immunoglobulin receptor,extracellular space|plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,detection of chemical stimulus involved in sensory perception of bitter taste|retina homeostasis|immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor|epidermal growth factor receptor signaling pathway|Fc receptor signaling pathway|receptor clustering|,polymeric immunoglobulin receptor activity|,9,17,967000000,15.5%
Q9D1D4,0.000366358,-0.2475,52.71906561,2.176333333,5.34679E-06,13.19422191,-1.494,-1.03,-1.483,0.63,0.889,1.003,Q9D1D4,Tmed10,Q9D1D4_Tmed10,Q9D1D4,Tmed10,1,35,7,7,Q9D1D4|A0A1Y7VM54|Q9D1D4-2,MOUSE,25081.5,35.6,1252,1252.1,108.84,108.84,,219,Transmembrane emp24 domain-containing protein 10,Golgi membrane|endoplasmic reticulum|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|cis-Golgi network|plasma membrane|integral component of membrane|COPI-coated vesicle|trans-Golgi network transport vesicle|transport vesicle membrane|secretory granule membrane|endoplasmic reticulum-Golgi intermediate compartment membrane|melanosome|zymogen granule membrane|extracellular exosome|gamma-secretase complex|,"kidney development|intracellular protein transport|retrograde vesicle-mediated transport, Golgi to ER|Golgi organization|COPI-coated vesicle budding|response to alkaloid|regulated secretory pathway|vesicle targeting, to, from or within Golgi|protein oligomerization|regulation of beta-amyloid formation|",syntaxin binding|protein complex binding|,7,35,15600000000,35.6%
P59017,0.530752353,0.001,7.583258679,-0.184,0.174451269,-1.521177945,0.008,0.292,-0.021,-0.157,0.047,-0.163,P59017,Bcl2l13,P59017_Bcl2l13,P59017,Bcl2l13,1,21,7,7,P59017,MOUSE,46889.7,26.4,1253,1253.1,108.7,108.7,,434,Bcl-2-like protein 13,mitochondrion|integral component of membrane|mitochondrial membrane|,apoptotic process|regulation of apoptotic process|,,7,21,4180000000,26.4%
Q3TC93,0.982930903,-0.018166667,0.267712317,-0.007,0.940218448,-0.077854712,0.023,0.062,-0.129,0.004,-0.06,-0.009,Q3TC93,Hs1bp3,Q3TC93_Hs1bp3,Q3TC93,Hs1bp3,1,14,8,8,Q3TC93,MOUSE,43804.6,31.8,1254,1254.1,108.62,108.62,,395,HCLS1-binding protein 3,,cell surface receptor signaling pathway|T cell differentiation|,protein binding|phosphatidylinositol binding|,8,14,1100000000,31.8%
Q9WTM5,0.821142881,0.114166667,2.775616079,-0.178333333,0.527762334,-0.666276598,-0.185,-0.025,0.82,-0.066,-0.101,0.242,Q9WTM5,Ruvbl2,Q9WTM5_Ruvbl2,Q9WTM5,Ruvbl2,1,20,10,10,Q9WTM5,MOUSE,51282.8,27.8,1255,1255.1,108.59,108.59,,463,RuvB-like 2,Swr1 complex|intracellular|nucleus|nucleoplasm|nuclear euchromatin|cytoplasm|ribonucleoprotein complex|Ino80 complex|NuA4 histone acetyltransferase complex|extracellular exosome|MLL1 complex|,"DNA repair|DNA recombination|chromatin remodeling|transcription, DNA-templated|DNA duplex unwinding|cellular response to UV|positive regulation of histone acetylation|histone H4 acetylation|histone H2A acetylation|positive regulation of transcription from RNA polymerase II promoter|establishment of protein localization to chromatin|cellular response to estradiol stimulus|transcriptional activation by promoter-enhancer looping|negative regulation of estrogen receptor binding|",RNA polymerase II core promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA helicase activity|damaged DNA binding|ATP binding|chromatin DNA binding|identical protein binding|ATP-dependent 5'-3' DNA helicase activity|ATPase activity|,10,20,2530000000,27.8%
Q8VBZ3,0.033517537,-0.007,25.76294612,0.593333333,0.002652805,4.669702666,-0.476,-0.097,-0.338,0.201,0.429,0.239,Q8VBZ3,Clptm1,Q8VBZ3_Clptm1,Q8VBZ3,Clptm1,1,17,7,7,Q8VBZ3,MOUSE,75631.6,16.5,1256,1256.1,108.33,108.33,,664,Cleft lip and palate transmembrane protein 1 homolog,external side of plasma membrane|membrane|integral component of membrane|,multicellular organismal development|cell differentiation|regulation of T cell differentiation in thymus|,,7,17,2350000000,16.5%
O35382,0.666246069,-0.011333333,5.078115306,-0.102666667,0.310590716,-1.096809534,-0.006,0.019,0.107,0.032,-0.177,-0.043,O35382,Exoc4,O35382_Exoc4,O35382,Exoc4,1,15,11,11,O35382|Q8C391|Q9CXE1,MOUSE,111341.8,13.9,1257,1257.1,108.22,108.22,,975,Exocyst complex component 4,exocyst|cytoplasm|plasma membrane|membrane|growth cone membrane|myelin sheath abaxonal region|,vesicle docking involved in exocytosis|protein transport|,protein binding|Ral GTPase binding|PDZ domain binding|protein N-terminus binding|,11,15,888000000,13.9%
D3Z5I1,0.561710094,-0.034333333,7.095733694,-0.154,0.195176098,-1.439495089,0.023,0.104,0.001,-0.022,-0.295,-0.017,D3Z5I1,Zc3hav1,D3Z5I1_Zc3hav1,D3Z5I1,Zc3hav1,1,17,10,10,D3Z5I1|Q3UPF5|Q3UPF5-2|G3X9X5,MOUSE,114071.9,9.5,1258,1258.1,107.74,107.74,,996,Zinc finger CCCH-type antiviral protein 1,nucleus|cytoplasm|lysosome|late endosome|Golgi apparatus|,metabolic process|response to virus|positive regulation of type I interferon production|positive regulation of interferon-alpha production|positive regulation of interferon-beta production|positive regulation of ATPase activity|suppression by virus of host molecular function|positive regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of viral genome replication|positive regulation of mRNA catabolic process|cellular response to exogenous dsRNA|positive regulation of RIG-I signaling pathway|,NAD+ ADP-ribosyltransferase activity|DEAD/H-box RNA helicase binding|poly(A) RNA binding|metal ion binding|,10,17,376000000,9.5%
Q8C754,0.50495704,-0.0325,8.130947521,-0.205,0.153781909,-1.610484238,0.199,0.047,-0.036,0.035,-0.093,-0.347,Q8C754,Vps52,Q8C754_Vps52,Q8C754,Vps52,1,9,7,7,Q8C754|Q8C754-2,MOUSE,82384.9,13.4,1259,1259.1,107.6,107.6,,723,Vacuolar protein sorting-associated protein 52 homolog,Golgi apparatus|endosome membrane|perinuclear region of cytoplasm|recycling endosome|EARP complex|,ectodermal cell differentiation|protein transport|endocytic recycling|embryonic ectodermal digestive tract development|,syntaxin binding|,7,9,555000000,13.4%
Q91YM2,0.881050168,0.015833333,1.921489445,0.049666667,0.642467341,0.485996881,-0.049,-0.064,0.086,0.129,-0.106,0.099,Q91YM2,Arhgap35,Q91YM2_Arhgap35,Q91YM2,Arhgap35,1,11,9,9,Q91YM2,MOUSE,171930.2,6.8,1260,1260.1,107.22,107.22,,1499,Rho GTPase-activating protein 35,nucleus|cytoplasm|actin cytoskeleton|,"negative regulation of transcription from RNA polymerase II promoter|neural tube closure|transcription, DNA-templated|integrin-mediated signaling pathway|small GTPase mediated signal transduction|regulation of cell shape|positive regulation of neuron projection development|forebrain development|negative regulation of Rho protein signal transduction|camera-type eye development|negative regulation of vascular permeability|positive regulation of GTPase activity|negative regulation of transcription, DNA-templated|",RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription|GTPase activator activity|GTP binding|,9,11,430000000,6.8%
Q8C863,0.946747465,-0.020333333,0.794671809,0.020666667,0.832784856,0.219520479,-0.056,0.054,-0.09,0.046,-0.123,0.047,Q8C863,Itch,Q8C863_Itch,Q8C863,Itch,1,15,9,8,Q8C863|Q8C863-2,MOUSE,99733.4,12.9,1261,1261.1,106.96,96,,864,E3 ubiquitin-protein ligase Itchy,ubiquitin ligase complex|nucleus|cytoplasm|cytosol|plasma membrane|cell cortex|membrane|cytoplasmic vesicle|extracellular exosome|,protein polyubiquitination|positive regulation of T cell anergy|ubiquitin-dependent protein catabolic process|apoptotic process|protein ubiquitination|negative regulation of NF-kappaB transcription factor activity|protein K29-linked ubiquitination|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|negative regulation of apoptotic process|innate immune response|positive regulation of protein catabolic process|negative regulation of JNK cascade|negative regulation of alpha-beta T cell proliferation|negative regulation of defense response to virus|defense response to virus|protein K63-linked ubiquitination|protein K48-linked ubiquitination|regulation of protein deubiquitination|,ubiquitin-protein transferase activity|protein binding|ligase activity|ribonucleoprotein complex binding|CXCR chemokine receptor binding|ubiquitin protein ligase activity|,9,15,2620000000,12.9%
P55264,0.378340838,0.019,10.86878223,0.197333333,0.081869432,2.04562805,-0.084,-0.078,-0.077,-0.001,0.26,0.094,P55264,Adk,P55264_Adk,P55264,Adk,1,18,9,9,P55264|P55264-2,MOUSE,40490.3,33.2,1262,1262.1,106.75,106.75,,361,Adenosine kinase,nucleus|nucleoplasm|cytoplasm|cytosol|,purine ribonucleoside salvage|dATP biosynthetic process|phosphorylation|AMP salvage|,"adenosine kinase activity|ATP binding|phosphotransferase activity, alcohol group as acceptor|poly(A) RNA binding|metal ion binding|",9,18,4830000000,33.2%
Q924Y0,0.773512169,-0.030166667,3.51319522,0.148333333,0.445328488,0.811395462,-0.333,-0.165,0.185,-0.256,0.182,0.206,Q924Y0,Bbox1,Q924Y0_Bbox1,Q924Y0,Bbox1,1,15,8,8,Q924Y0,MOUSE,45211.5,27.9,1263,1263.1,106.7,106.7,,387,Gamma-butyrobetaine dioxygenase,mitochondrion|extracellular exosome|,carnitine biosynthetic process|oxidation-reduction process|,iron ion binding|zinc ion binding|gamma-butyrobetaine dioxygenase activity|,8,15,1090000000,27.9%
Q9QZH6,0.846769943,-0.079,2.412219809,0.118,0.573823089,0.591494594,0.059,0.13,-0.603,0.062,-0.035,-0.087,Q9QZH6,Ecsit,Q9QZH6_Ecsit,Q9QZH6,Ecsit,1,17,10,10,Q9QZH6|A0A0R4J174,MOUSE,50083.4,27.1,1264,1264.1,106.64,106.64,,435,"Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial",nucleus|nucleoplasm|transcription factor complex|cytoplasm|mitochondrion|,mesoderm formation|regulation of transcription from RNA polymerase II promoter|transmembrane receptor protein serine/threonine kinase signaling pathway|BMP signaling pathway|innate immune response|regulation of oxidoreductase activity|oxidation-reduction process|,"sequence-specific DNA binding transcription factor activity|signal transducer activity|protein binding|oxidoreductase activity, acting on NAD(P)H|",10,17,3660000000,27.1%
Q69ZR2,0.966713786,-0.002666667,0.451182824,-0.01,0.901325623,-0.128764096,-0.002,0.034,-0.025,0,-0.002,-0.021,Q69ZR2,NotFound,Q69ZR2_NotFound,Q69ZR2,Hectd1,1,14,12,12,Q69ZR2|F8WIE5,MOUSE,293047.8,5.9,1265,1265.1,106.57,106.57,,2618,E3 ubiquitin-protein ligase HECTD1,cytoplasm|,natural killer cell differentiation|neural tube closure|embryonic placenta development|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|protein autoubiquitination|trophoblast giant cell differentiation|spongiotrophoblast differentiation|protein K63-linked ubiquitination|negative regulation of protein localization to plasma membrane|,protein binding|ligase activity|metal ion binding|ubiquitin protein ligase activity|,12,14,543000000,5.9%
Q8BSF4,0.993378838,-0.026166667,0.114150946,-0.003666667,0.974058197,-0.033756129,0.1,-0.003,-0.17,0.065,-0.004,-0.145,Q8BSF4,Pisd,Q8BSF4_Pisd,Q8BSF4,Pisd,1,21,9,9,F6TVX7|Q8BSF4|E9PX91|D3YY63,MOUSE,46382.2,24.1,1266,1266.1,106.47,106.47,,406,"Phosphatidylserine decarboxylase proenzyme, mitochondrial",nucleus|mitochondrion|,phosphatidylethanolamine biosynthetic process|,phosphatidylserine decarboxylase activity|,9,21,2990000000,24.1%
Q3TXS7,0.35633016,0.0015,11.31001933,0.203666667,0.073960198,2.115699727,-0.111,-0.175,-0.015,0.22,0.021,0.069,Q3TXS7,Psmd1,Q3TXS7_Psmd1,Q3TXS7,Psmd1,1,12,10,10,Q3TXS7|J3QN38,MOUSE,106755.2,17.2,1267,1267.1,106.33,106.33,,953,26S proteasome non-ATPase regulatory subunit 1,proteasome complex|membrane|proteasome accessory complex|extracellular exosome|,regulation of protein catabolic process|regulation of catalytic activity|,protein binding|enzyme regulator activity|,10,12,1740000000,17.2%
Q9CQC7,0.961523652,0.020833333,0.561763445,-0.035,0.878665664,-0.158663109,-0.277,0.568,-0.176,-0.007,0.019,-0.002,Q9CQC7,Ndufb4,Q9CQC7_Ndufb4,Q9CQC7,Ndufb4,1,35,8,8,Q9CQC7,MOUSE,15081,54.2,1268,1268.1,106.26,106.26,,129,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4,nucleoplasm|mitochondrial respiratory chain complex I|integral component of membrane|nuclear membrane|extracellular exosome|,response to oxidative stress|oxidation-reduction process|,NADH dehydrogenase (ubiquinone) activity|,8,35,12200000000,54.2%
Q60854,0.773512169,0.048,3.505986842,-0.123333333,0.446068253,-0.810014692,-0.026,-0.03,0.385,-0.201,0.021,0.139,Q60854,Serpinb6a,Q60854_Serpinb6a,Q60854,Serpinb6,1,18,9,9,Q60854|F8WIV2|W4VSP4,MOUSE,42940.5,29.1,1269,1269.1,106.02,106.02,,378,Serpin B6,extracellular space|intracellular|cytoplasm|protein complex|extracellular exosome|,sensory perception of sound|gonad development|negative regulation of endopeptidase activity|cellular response to osmotic stress|,protease binding|serine-type endopeptidase inhibitor activity|protein binding|,9,18,6880000000,29.1%
Q99KF1,0.000366358,-0.435666667,52.98981294,2.478,5.02364E-06,13.32323243,-1.62,-1.341,-2.063,0.703,0.797,0.91,Q99KF1,Tmed9,Q99KF1_Tmed9,Q99KF1,Tmed9,1,27,8,7,Q99KF1|A0A286YDS5,MOUSE,27240.8,29.7,1270,1270.1,105.98,88.16,,235,Transmembrane emp24 domain-containing protein 9,Golgi membrane|endoplasmic reticulum|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|integral component of membrane|endoplasmic reticulum-Golgi intermediate compartment membrane|extracellular exosome|,Golgi organization|positive regulation of organelle organization|protein transport|COPI coating of Golgi vesicle|,syntaxin binding|,8,27,9490000000,29.7%
Q8R1V4,0.001332403,-0.494333333,43.09908824,2.679333333,4.89882E-05,9.290219059,-1.616,-1.374,-2.512,0.664,0.915,0.957,Q8R1V4,Tmed4,Q8R1V4_Tmed4,Q8R1V4,Tmed4,1,13,6,5,Q8R1V4,MOUSE,26249.7,31.2,1270,1270.2,81.98,64.16,,227,Transmembrane emp24 domain-containing protein 4,endoplasmic reticulum membrane|integral component of membrane|extracellular exosome|,signal transduction|protein transport|positive regulation of I-kappaB kinase/NF-kappaB signaling|,signal transducer activity|,5,13,1890000000,23.7%
Q91V55,0.900317884,-0.035166667,1.604626147,0.067,0.691094418,0.415238013,0.005,0.201,-0.412,-0.016,0.057,-0.046,Q91V55,Rps5,Q91V55_Rps5,Q91V55,Rps5,1,18,9,9,Q91V55|P97461,MOUSE,23047.2,47,1271,1271.1,105.88,105.88,,204,40S ribosomal protein S5,focal adhesion|membrane|cytosolic small ribosomal subunit|ribonucleoprotein complex|extracellular exosome|,translation|regulation of translational fidelity|,mRNA binding|structural constituent of ribosome|poly(A) RNA binding|,9,18,3230000000,47.0%
Z4YJY0,0.863857851,0.001666667,2.171776111,-0.059333333,0.606488247,-0.540360949,0.016,0.215,-0.137,-0.025,-0.042,-0.017,Z4YJY0,Abraxas2,Z4YJY0_Abraxas2,Z4YJY0,Abraxas2,1,21,8,8,Z4YJY0|Q3TCJ1,MOUSE,48160.4,19.3,1272,1272.1,105.79,105.79,,424,BRISC complex subunit Abraxas 2,nucleus|cytoplasm|BRISC complex|,cellular response to freezing|,protein binding|polyubiquitin binding|,8,21,1070000000,19.3%
Q9D8,0.773512169,-0.045333333,3.49783811,-0.096,0.446906004,-0.8084389,-0.134,0.101,0.041,-0.28,0.023,-0.023,Q9D8,NotFound,Q9D8_NotFound,Q9D8,Cutc,1,19,7,7,Q9D8|F8WHX2,MOUSE,29402.5,39.7,1273,1273.1,105.35,105.35,,272,Copper homeostasis protein cutC homolog,nucleus|nucleoplasm|nucleolus|cytoplasm|,protein tetramerization|copper ion homeostasis|,copper ion binding|,7,19,2210000000,39.7%
Q6PFA2,0.550913932,0.063666667,7.249847216,-0.293333333,0.188371536,-1.466397062,-0.154,0.173,0.612,-0.248,-0.046,0.045,Q6PFA2,Clta,Q6PFA2_Clta,Q6PFA2,Clta,1,24,8,8,Q6PFA2|B1AWE0|B1AWD9|B1AWD8|O08585|B1AWE1,MOUSE,23689.4,33.4,1274,1274.1,105.23,105.23,,218,Clathrin light chain,membrane|clathrin vesicle coat|clathrin coat of trans-Golgi network vesicle|clathrin coat of coated pit|intracellular membrane-bounded organelle|clathrin complex|,intracellular protein transport|clathrin-mediated endocytosis|,structural molecule activity|clathrin heavy chain binding|,8,24,20700000000,33.4%
P49698,0.781242273,-0.009666667,3.382608592,-0.064666667,0.458922278,-0.785721448,0.04,0.051,-0.023,-0.001,-0.019,-0.106,P49698,Hnf4a,P49698_Hnf4a,P49698,Hnf4a,1,16,7,7,P49698|Z4YKX0|P49698-2|E9QPS1|Q059V1|Q9WUU6,MOUSE,53481.4,19.6,1275,1275.1,105.21,105.21,,474,Hepatocyte nuclear factor 4-alpha,nucleus|cytoplasm|cytosol|,"regulation of transcription, DNA-templated|regulation of transcription from RNA polymerase II promoter|transcription from RNA polymerase II promoter|ornithine metabolic process|lipid metabolic process|xenobiotic metabolic process|sex differentiation|blood coagulation|negative regulation of cell proliferation|response to glucose|regulation of gastrulation|regulation of lipid metabolic process|signal transduction involved in regulation of gene expression|negative regulation of cell growth|intracellular receptor signaling pathway|endocrine pancreas development|glucose homeostasis|steroid hormone mediated signaling pathway|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|regulation of insulin secretion|lipid homeostasis|phospholipid homeostasis|SMAD protein signal transduction|triglyceride homeostasis|positive regulation of cholesterol homeostasis|",RNA polymerase II core promoter sequence-specific DNA binding|RNA polymerase II activating transcription factor binding|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|DNA binding|sequence-specific DNA binding transcription factor activity|RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity|steroid hormone receptor activity|ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity|receptor binding|fatty acid binding|protein binding|zinc ion binding|protein homodimerization activity|sequence-specific DNA binding|transcription regulatory region DNA binding|,7,16,825000000,19.6%
Q8R010,0.634404848,-0.044833333,5.692147268,-0.161,0.269640593,-1.20463471,0.158,0.138,-0.189,0.044,-0.182,-0.238,Q8R010,Aimp2,Q8R010_Aimp2,Q8R010,Aimp2,1,16,6,6,Q8R010|Q8R3V2,MOUSE,35662.2,37.5,1276,1276.1,105.08,105.08,,320,Aminoacyl tRNA synthase complex-interacting multifunctional protein 2,nucleus|cytosol|membrane|,translation|apoptotic process|negative regulation of cell proliferation|positive regulation of protein ubiquitination|Type II pneumocyte differentiation|positive regulation of neuron death|,protein binding|,6,16,7510000000,37.5%
Q99L43,0.773512169,0.024166667,3.549480101,0.102333333,0.441623311,0.81833568,0.082,-0.121,-0.042,0.302,-0.024,-0.052,Q99L43,Cds2,Q99L43_Cds2,Q99L43,Cds2,1,16,8,8,Q99L43|Q6PBC0|A2AMQ5,MOUSE,51883.4,18,1277,1277.1,105.08,105.08,,444,Phosphatidate cytidylyltransferase 2,mitochondrial inner membrane|endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,phosphatidylglycerol biosynthetic process|phototransduction|CDP-diacylglycerol biosynthetic process|glycosylation|,phosphatidate cytidylyltransferase activity|,8,16,8260000000,18.0%
P10833,0.736844736,0.031166667,3.995581226,-0.091,0.398512435,-0.901647916,-0.015,0.005,0.24,0.008,-0.063,0.012,P10833,Rras,P10833_Rras,P10833,Rras,1,22,8,6,P10833|A0A1B0GRT5,MOUSE,23934.6,37.1,1278,1278.1,104.86,71.98,,218,Ras-related protein R-Ras,cytosol|plasma membrane|focal adhesion|extracellular exosome|,leukocyte differentiation|small GTPase mediated signal transduction|metabolic process|negative regulation of cell migration|positive regulation of angiogenesis|regulation of protein kinase B signaling|face morphogenesis|regulation of ERK1 and ERK2 cascade|,GTPase activity|GTP binding|GDP binding|protein complex binding|,9,22,1910000000,37.1%
P62071,0.312476077,0.006166667,12.48701402,-0.187666667,0.056402532,-2.302932846,0.111,0.127,0.062,-0.036,-0.144,-0.083,P62071,Rras2,P62071_Rras2,P62071,Rras2,1,4,5,2,P62071,MOUSE,23627.4,28.9,1278,1278.2,73.91,28.85,,204,Ras-related protein R-Ras2,intracellular|plasma membrane|focal adhesion|membrane|extracellular exosome|,osteoblast differentiation|Ras protein signal transduction|cellular process|positive regulation of cell migration|regulation of neuron death|,protein binding|GTP binding|,2,4,742000000,11.7%
P12710,0.12014551,0.059833333,18.95766925,0.759,0.012712562,3.384798488,-0.263,-0.175,-0.521,0.199,0.941,0.178,P12710,Fabp1,P12710_Fabp1,P12710,Fabp1,1,25,8,8,P12710,MOUSE,14302.4,63.7,1279,1279.1,104.79,104.79,,127,"Fatty acid-binding protein, liver",nucleus|cytoplasm|peroxisomal matrix|cytosol|apical cortex|extracellular exosome|,positive regulation of defense response to virus by host|positive regulation of cell proliferation|long-chain fatty acid transport|positive regulation of fatty acid beta-oxidation|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|intestinal absorption|positive regulation of hydrolase activity|cellular response to hydrogen peroxide|cellular response to hypoxia|activation of mitophagy in response to mitochondrial depolarization|,chromatin binding|long-chain fatty acid transporter activity|fatty acid binding|phospholipid binding|drug binding|antioxidant activity|bile acid binding|,8,25,3890000000,63.7%
A0JNU3,0.894042447,-0.006666667,1.684211485,0.044666667,0.678545308,0.433124585,-0.062,-0.164,0.139,-0.007,0.03,0.024,A0JNU3,Aspg,A0JNU3_Aspg,A0JNU3,Aspg,1,20,9,9,A0JNU3,MOUSE,61164.1,25,1280,1280.1,104.67,104.67,,564,60 kDa lysophospholipase,,cellular amino acid metabolic process|lipid catabolic process|,1-alkyl-2-acetylglycerophosphocholine esterase activity|asparaginase activity|lysophospholipase activity|,9,20,6710000000,25.0%
P28650-2,0.590090752,-0.007333333,6.496323248,-0.111333333,0.224061725,-1.339552621,0.061,0.022,0.062,0.007,-0.063,-0.133,P28650,Adssl1,P28650-2_Adssl1,P28650-2,Adssl1,1,19,9,9,P28650-2|J3QN31|P28650,MOUSE,53121.8,25.6,1281,1281.1,104.66,104.66,,457,Isoform 2 of Adenylosuccinate synthetase isozyme 1,cytoplasm|membrane|,purine nucleotide metabolic process|AMP biosynthetic process|aspartate metabolic process|glutamine metabolic process|response to muscle activity|cellular response to drug|response to starvation|'de novo' AMP biosynthetic process|IMP metabolic process|cellular response to electrical stimulus|,magnesium ion binding|GTPase activity|adenylosuccinate synthase activity|protein binding|GTP binding|protein homodimerization activity|actin filament binding|,9,19,1540000000,25.6%
P09405,0.390884549,-0.055166667,10.58854251,0.485,0.087326439,2.00506667,-0.824,-0.052,-0.017,-0.033,0.165,0.43,P09405,Ncl,P09405_Ncl,P09405,Ncl,1,13,10,10,P09405,MOUSE,76778.7,16.1,1282,1282.1,104.52,104.52,,707,Nucleolin,fibrillar center|dense fibrillar component|nucleus|nucleoplasm|nucleolus|cell cortex|cell surface|membrane|ribonucleoprotein complex|cytoplasmic ribonucleoprotein granule|extracellular exosome|,angiogenesis|endocytosis|spermatogenesis|positive regulation of tumor necrosis factor production|negative regulation of apoptotic process|positive regulation of transcription from RNA polymerase II promoter|cellular response to lipopolysaccharide|liver regeneration|positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter|regulation of rRNA processing|positive regulation of interleukin-6 secretion|,nucleotide binding|single-stranded DNA binding|RNA binding|calcium ion binding|protein binding|protein C-terminus binding|selenocysteine insertion sequence binding|rRNA primary transcript binding|telomeric DNA binding|histone binding|identical protein binding|laminin binding|poly(A) RNA binding|ErbB-4 class receptor binding|,10,13,2300000000,16.1%
P62996,0.497562458,0.052,8.219467733,-0.286,0.150679173,-1.624849597,-0.125,0.218,0.492,-0.163,-0.216,0.106,P62996,Tra2b,P62996_Tra2b,P62996,Tra2b,1,31,9,8,P62996|F8WJG3,MOUSE,33779.2,32.2,1283,1283.1,104.42,90.67,,288,Transformer-2 protein homolog beta,nucleus|,"regulation of alternative mRNA splicing, via spliceosome|mRNA splicing, via spliceosome|cerebral cortex regionalization|positive regulation of mRNA splicing, via spliceosome|",nucleotide binding|mRNA binding|poly(A) RNA binding|,9,31,2950000000,32.2%
E9QP00,0.856747233,-0.005333333,2.279647343,-0.097333333,0.591609672,-0.5635794,-0.213,0.102,0.241,0.202,-0.31,-0.054,E9QP00,Tra2a,E9QP00_Tra2a,E9QP00,Tra2a,1,2,3,2,E9QP00|Q6PFR5|A0A0N4SVC2,MOUSE,32635,10.6,1283,1283.2,33.06,19.31,,282,Transformer-2 protein homolog alpha,nucleus|nucleolus|intracellular membrane-bounded organelle|,"mRNA splicing, via spliceosome|",nucleotide binding|RNA binding|poly(A) RNA binding|,2,2,8350000000,7.0%
O88783,0.001346067,-0.100166667,42.95644399,0.871666667,5.06239E-05,9.137383211,-0.499,-0.433,-0.676,0.328,0.315,0.364,O88783,F5,O88783_F5,O88783,F5,1,12,9,9,O88783,MOUSE,248366.9,5.4,1284,1284.1,104.33,104.33,,2183,Coagulation factor V,extracellular space|membrane|platelet alpha granule|extracellular vesicle|,blood coagulation|blood circulation|platelet activation|,copper ion binding|,9,12,651000000,5.4%
P49615,0.923393626,-0.0075,1.138187523,-0.026333333,0.769451495,-0.305239333,0.038,0.028,-0.049,0.06,-0.03,-0.092,P49615,Cdk5,P49615_Cdk5,P49615,Cdk5,1,25,10,10,P49615|A0A0G2JDL3,MOUSE,33744.3,43.8,1285,1285.1,104.26,104.26,,292,Cyclin-dependent-like kinase 5,nucleus|cytoplasm|cytosol|cytoskeleton|postsynaptic density|membrane|cyclin-dependent protein kinase 5 holoenzyme complex|lamellipodium|cell junction|filopodium|axon|dendrite|growth cone|neuromuscular junction|neuronal cell body|perikaryon|postsynaptic membrane|nucleolus|,"neuron migration|synaptic transmission, dopaminergic|protein phosphorylation|intracellular protein transport|nucleocytoplasmic transport|apoptotic process|cell cycle|cell-matrix adhesion|axonogenesis|synapse assembly|skeletal muscle tissue development|motor neuron axon guidance|associative learning|visual learning|response to wounding|Schwann cell development|phosphorylation|cell migration|peptidyl-serine phosphorylation|peptidyl-threonine phosphorylation|sensory perception of pain|telencephalon development|cerebellum development|cerebellar cortex development|cerebellar cortex formation|hippocampus development|layer formation in cerebral cortex|central nervous system neuron development|cerebral cortex development|corpus callosum development|neuron differentiation|regulation of cell migration|negative regulation of axon extension|cortical actin cytoskeleton organization|forebrain development|neuron projection development|negative regulation of protein ubiquitination|negative regulation of synaptic plasticity|positive regulation of protein binding|receptor catabolic process|serine phosphorylation of STAT3 protein|synaptic transmission, glutamatergic|protein localization to synapse|response to cocaine|receptor clustering|positive regulation of neuron apoptotic process|regulated secretory pathway|negative regulation of cell cycle|positive regulation of protein kinase activity|negative regulation of proteolysis|negative regulation of transcription, DNA-templated|positive regulation of calcium ion-dependent exocytosis|protein autophosphorylation|negative regulation of protein export from nucleus|behavioral response to cocaine|regulation of synaptic plasticity|synaptic vesicle endocytosis|rhythmic process|oligodendrocyte differentiation|dendrite morphogenesis|cell division|neuron apoptotic process|regulation of postsynaptic membrane potential|regulation of excitatory postsynaptic membrane potential|regulation of dendritic spine morphogenesis|calcium ion import|positive regulation of protein targeting to membrane|negative regulation of neuron death|positive regulation of receptor activity|",p53 binding|protein kinase activity|protein serine/threonine kinase activity|cyclin-dependent protein serine/threonine kinase activity|ErbB-2 class receptor binding|protein binding|ATP binding|cytoskeletal protein binding|kinase activity|protein kinase binding|acetylcholine receptor activator activity|ErbB-3 class receptor binding|ephrin receptor binding|tau-protein kinase activity|,10,25,10100000000,43.8%
Q99N57-2,0.956735569,0.002666667,0.62359539,-0.014,0.866244442,-0.175010566,-0.028,0.003,0.054,0.002,-0.041,0.026,Q99N57,Raf1,Q99N57-2_Raf1,Q99N57-2,Raf1,1,21,10,8,Q99N57-2|Q99N57|P28028|P28028-2,MOUSE,76062.4,19.9,1286,1286.1,103.97,72.28,,648,Isoform 2 of RAF proto-oncogene serine/threonine-protein kinase,nucleus|cytoplasm|mitochondrion|Golgi apparatus|cytosol|plasma membrane|pseudopodium|plasma membrane|,MAPK cascade|activation of MAPKK activity|response to hypoxia|cellular glucose homeostasis|positive regulation of protein phosphorylation|heart development|negative regulation of cell proliferation|cell differentiation|negative regulation of protein complex assembly|positive regulation of peptidyl-serine phosphorylation|somatic stem cell maintenance|intracellular signal transduction|insulin secretion involved in cellular response to glucose stimulus|response to muscle stretch|negative regulation of apoptotic process|intermediate filament cytoskeleton organization|positive regulation of transcription from RNA polymerase II promoter|neurotrophin TRK receptor signaling pathway|death-inducing signaling complex assembly|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|,protein kinase activity|protein serine/threonine kinase activity|MAP kinase kinase kinase activity|protein binding|ATP binding|Ras GTPase binding|mitogen-activated protein kinase kinase binding|identical protein binding|metal ion binding|protein heterodimerization activity|,10,21,1590000000,19.9%
E9Q0P8,0.318107191,0.166333333,12.32681305,-0.739333333,0.058521937,-2.28274168,0.744,1.03,-0.166,0.132,-0.505,-0.237,E9Q0P8,NotFound,E9Q0P8_NotFound,E9Q0P8,Araf,1,5,4,2,E9Q0P8,MOUSE,46767.4,8.3,1286,1286.3,40.31,8.98,,419,Serine/threonine-protein kinase A-Raf,mitochondrion|,protein phosphorylation|regulation of TOR signaling|regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of peptidyl-serine phosphorylation|intracellular signal transduction|negative regulation of apoptotic process|,protein serine/threonine kinase activity|receptor signaling protein activity|protein binding|ATP binding|metal ion binding|,2,5,323000000,3.1%
Q6GQS1,0.982507762,-0.008666667,0.274564933,-0.007333333,0.938736073,-0.079789896,0.049,0.059,-0.123,0.046,-0.053,-0.03,Q6GQS1,Slc25a23,Q6GQS1_Slc25a23,Q6GQS1,Slc25a23,1,22,11,11,Q6GQS1,MOUSE,52724.3,31.2,1287,1287.1,103.94,103.94,,467,Calcium-binding mitochondrial carrier protein SCaMC-3,mitochondrion|mitochondrial inner membrane|integral component of membrane|,regulation of oxidative phosphorylation|regulation of cellular respiration|regulation of sequestering of calcium ion|adenine nucleotide transport|transmembrane transport|cellular response to calcium ion|urea homeostasis|,calcium ion binding|,11,22,5100000000,31.2%
P70290,0.797128744,0.023666667,3.163477456,0.084,0.482672165,0.743347945,0.151,-0.096,-0.11,0.199,0.004,-0.006,P70290,Mpp1,P70290_Mpp1,P70290,Mpp1,1,17,9,9,P70290|A2AN84|B7ZCL8,MOUSE,52511.5,27.2,1288,1288.1,103.67,103.67,,466,55 kDa erythrocyte membrane protein,intracellular|membrane|cortical cytoskeleton|stereocilium|,regulation of neutrophil chemotaxis|,protein binding|,9,17,906000000,27.2%
Q99PV0,0.657693172,0.047,5.210723349,-0.143333333,0.301250423,-1.121129807,-0.117,0.137,0.336,-0.038,-0.05,0.014,Q99PV0,Prpf8,Q99PV0_Prpf8,Q99PV0,Prpf8,1,15,10,10,Q99PV0,MOUSE,274923.6,4.1,1289,1289.1,103.67,103.67,,2335,Pre-mRNA-processing-splicing factor 8,nucleus|U5 snRNP|membrane|nuclear speck|catalytic step 2 spliceosome|,"spliceosomal tri-snRNP complex assembly|mRNA splicing, via spliceosome|",second spliceosomal transesterification activity|U6 snRNA binding|U1 snRNA binding|U2 snRNA binding|U5 snRNA binding|poly(A) RNA binding|K63-linked polyubiquitin binding|pre-mRNA intronic binding|,10,15,558000000,4.1%
Q9D8L3,0.140351716,0.023333333,17.99293049,-0.306666667,0.015874752,-3.205682021,0.14,0.318,0.072,-0.131,-0.153,-0.106,Q9D8L3,Ssr4,Q9D8L3_Ssr4,Q9D8L3,Ssr4,1,42,8,8,Q9D8L3|Q62186,MOUSE,19235.5,34.1,1290,1290.1,103.55,103.55,,173,"Signal sequence receptor, delta",Sec61 translocon complex|integral component of membrane|extracellular exosome|,,,8,42,38400000000,34.1%
E9PZF0,0.731162978,-0.0335,4.07712293,-0.177666667,0.391099902,-0.917466908,0.185,0.297,-0.316,-0.212,0.135,-0.29,E9PZF0,NotFound,E9PZF0_NotFound,E9PZF0,Gm20390,1,17,9,9,E9PZF0|Q01768|P15532|Q5NC79,MOUSE,30370.6,36.7,1291,1291.1,103.14,103.14,,267,Nucleoside diphosphate kinase,intracellular|cytosol|,purine nucleotide metabolic process|nucleoside diphosphate phosphorylation|GTP biosynthetic process|pyrimidine nucleotide metabolic process|UTP biosynthetic process|CTP biosynthetic process|nucleoside triphosphate biosynthetic process|regulation of apoptotic process|,nucleoside diphosphate kinase activity|ATP binding|,9,17,3810000000,36.7%
Q9CPQ8,0.663574238,0.022333333,5.100799191,-0.180666667,0.308972681,-1.101842751,0.15,0.382,-0.194,-0.112,0.094,-0.186,Q9CPQ8,Atp5l,Q9CPQ8_Atp5l,Q9CPQ8,Atp5l,1,35,7,7,Q9CPQ8,MOUSE,11424.3,61.1,1292,1292.1,103.09,103.09,,103,"ATP synthase subunit g, mitochondrial","mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)|mitochondrial proton-transporting ATP synthase complex|",ATP synthesis coupled proton transport|,hydrogen ion transmembrane transporter activity|,7,35,71900000000,61.1%
Q9CQ45,0.00070612,-0.245833333,46.70556234,2.174333333,2.13523E-05,10.61037835,-1.588,-1.452,-0.959,0.579,0.835,1.11,Q9CQ45,Nenf,Q9CQ45_Nenf,Q9CQ45,Nenf,1,16,7,7,Q9CQ45,MOUSE,18904.1,50.2,1293,1293.1,102.9,102.9,,171,Neudesin,extracellular space|nucleus|nucleoplasm|endomembrane system|membrane|,negative regulation of appetite|positive regulation of MAPK cascade|,growth factor activity|heme binding|metal ion binding|,7,16,3510000000,50.2%
Q8BHC4,0.993378838,-0.022666667,0.114768345,-0.004,0.973919733,-0.033945,0.115,0.048,-0.225,0.079,-0.076,-0.077,Q8BHC4,Dcakd,Q8BHC4_Dcakd,Q8BHC4,Dcakd,1,23,9,9,Q8BHC4,MOUSE,26589.7,51.5,1294,1294.1,102.81,102.81,,231,Dephospho-CoA kinase domain-containing protein,mitochondrion|membrane|,coenzyme A biosynthetic process|phosphorylation|,dephospho-CoA kinase activity|ATP binding|,9,23,8080000000,51.5%
G3X9Q0,0.961523652,-0.040666667,0.548483816,-0.019333333,0.881356513,-0.155111447,0.059,0.12,-0.272,0.023,-0.1,-0.074,G3X9Q0,Mbnl1,G3X9Q0_Mbnl1,G3X9Q0,Mbnl1,1,16,9,3,G3X9Q0|Q9JKP5|A0A0A6YXE3|A0A0A6YVV8|A0A0A6YWB0|Q3U581|Q3U570|Q8R003|S4R267,MOUSE,41692.3,30.4,1295,1295.1,102.79,32.03,,381,"Muscleblind-like 1 (Drosophila), isoform CRA_a",nucleus|nucleoplasm|cytoplasm|centrosome|cytoplasmic stress granule|,"alternative mRNA splicing, via spliceosome|regulation of alternative mRNA splicing, via spliceosome|mRNA splice site selection|skeletal muscle tissue development|RNA splicing|regulation of RNA splicing|",RNA binding|double-stranded RNA binding|poly(A) RNA binding|metal ion binding|,9,16,2530000000,30.4%
Q8C181-4,0.868703705,0.0105,2.113713029,-0.059666667,0.614651148,-0.527971623,0.033,-0.012,0.1,0.175,-0.058,-0.175,Q8C181,Mbnl2,Q8C181-4_Mbnl2,Q8C181-4,Mbnl2,1,4,8,2,Q8C181-4|Q8C181|Q8C181-2|Q8C181-3,MOUSE,42335.7,21.8,1295,1295.2,87.28,16.52,,373,Isoform 4 of Muscleblind-like protein 2,nucleus|cytoplasm|,"regulation of alternative mRNA splicing, via spliceosome|mRNA processing|RNA splicing|regulation of RNA splicing|",poly(A) RNA binding|metal ion binding|,2,4,101000000,5.2%
Q8VCN5,0.016870959,-0.028166667,29.3728622,0.606333333,0.001155351,5.427578932,-0.395,-0.193,-0.406,0.121,0.388,0.316,Q8VCN5,Cth,Q8VCN5_Cth,Q8VCN5,Cth,1,21,9,9,Q8VCN5,MOUSE,44194,31.6,1296,1296.1,102.79,102.79,,398,Cystathionine gamma-lyase,nucleus|nucleoplasm|cytoplasm|extracellular exosome|,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine|cysteine biosynthetic process|negative regulation of apoptotic process|positive regulation of I-kappaB kinase/NF-kappaB signaling|protein sulfhydration|positive regulation of NF-kappaB transcription factor activity|protein homotetramerization|hydrogen sulfide biosynthetic process|negative regulation of apoptotic signaling pathway|,cystathionine gamma-lyase activity|protein binding|calmodulin binding|pyridoxal phosphate binding|L-cystine L-cysteine-lyase (deaminating)|L-cysteine desulfhydrase activity|,9,21,2060000000,31.6%
P45878,0.000552294,-0.1705,48.64749123,1.421666667,1.36537E-05,11.38889947,-0.852,-0.684,-1.108,0.601,0.534,0.486,P45878,Fkbp2,P45878_Fkbp2,P45878,Fkbp2,1,18,7,7,P45878,MOUSE,15514.8,57.8,1297,1297.1,102.53,102.53,,140,Peptidyl-prolyl cis-trans isomerase FKBP2,cytoplasm|endoplasmic reticulum membrane|extracellular exosome|,protein peptidyl-prolyl isomerization|chaperone-mediated protein folding|,peptidyl-prolyl cis-trans isomerase activity|FK506 binding|,7,18,2830000000,57.8%
P14094,0.904214516,-0.0005,1.564480114,0.059666667,0.69751249,0.406045638,-0.076,0.209,-0.224,-0.157,0.188,0.057,P14094,Atp1b1,P14094_Atp1b1,P14094,Atp1b1,1,26,9,9,P14094,MOUSE,35593.3,26.3,1298,1298.1,102.47,102.47,,304,Sodium/potassium-transporting ATPase subunit beta-1,intracellular|plasma membrane|sodium:potassium-exchanging ATPase complex|caveola|intercalated disc|basolateral plasma membrane|apical plasma membrane|sarcolemma|myelin sheath|extracellular exosome|extracellular vesicle|,response to hypoxia|positive regulation of defense response to virus by host|cellular calcium ion homeostasis|cellular sodium ion homeostasis|cell adhesion|potassium ion import|regulation of gene expression|regulation of cardiac muscle contraction by calcium ion signaling|cellular potassium ion homeostasis|positive regulation of ATPase activity|sodium ion export from cell|protein stabilization|relaxation of cardiac muscle|cardiac muscle contraction|protein localization to plasma membrane|membrane repolarization|activation of mitophagy in response to mitochondrial depolarization|positive regulation of potassium ion transmembrane transporter activity|regulation of calcium ion transmembrane transport|positive regulation of sodium ion export from cell|positive regulation of calcium:sodium antiporter activity|positive regulation of potassium ion import|,ATPase activator activity|protein binding|protein C-terminus binding|MHC class II protein complex binding|ATPase binding|sodium:potassium-exchanging ATPase activity|,9,26,4300000000,26.3%
Q8C0K5,0.997585215,-0.0305,0.027832768,-0.001,0.993611761,-0.008313582,0.065,0.088,-0.243,-0.003,0.048,-0.138,Q8C0K5,Slc25a16,Q8C0K5_Slc25a16,Q8C0K5,Slc25a16,1,19,9,9,Q8C0K5|Q8C0K5-2,MOUSE,36561.3,23.7,1299,1299.1,102.13,102.13,,332,Graves disease carrier protein homolog,mitochondrion|mitochondrial inner membrane|integral component of membrane|,transmembrane transport|,,9,19,1410000000,23.7%
Q3TVK3,0.71486516,0.001666667,4.28312301,0.085333333,0.37298185,0.954547965,-0.081,-0.078,0.036,0.049,-0.038,0.122,Q3TVK3,Dnpep,Q3TVK3_Dnpep,Q3TVK3,Dnpep,1,22,8,8,Q3TVK3|Q9Z2W0|Q8BPW9,MOUSE,53035.8,20.2,1300,1300.1,101.56,101.56,,475,Aspartyl aminopeptidase,nucleus|nucleoplasm|cytoplasm|blood microparticle|,proteolysis|,aminopeptidase activity|metallopeptidase activity|zinc ion binding|,8,22,1260000000,20.2%
Q61425,0.884899108,0.0845,1.839766592,0.085666667,0.654671358,0.468189993,0.008,0.252,-0.135,-0.025,0.49,-0.083,Q61425,Hadh,Q61425_Hadh,Q61425,Hadh,1,22,10,10,Q61425,MOUSE,34634.4,34.3,1301,1301.1,101.49,101.49,,314,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",nucleoplasm|cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial matrix|,fatty acid beta-oxidation|response to activity|response to insulin|response to drug|negative regulation of insulin secretion|,3-hydroxyacyl-CoA dehydrogenase activity|NAD+ binding|,10,22,4990000000,34.3%
Q9D883,0.973888257,0.003333333,0.382191177,0.009333333,0.915758339,0.109835541,-0.097,0.054,0.039,-0.001,0.016,0.009,Q9D883,U2af1,Q9D883_U2af1,Q9D883,U2af1,1,14,7,7,Q9D883|G3UW94|Q8BGJ9|E9Q1I7|E9PUZ3|E9Q5Y2|Q8BGJ9-3|E9Q5J3|Q8BGJ9-2|F8WH71|Q8BGJ9-4|E9Q809|E9PWM2|E9PWX6|A0A140LII6,MOUSE,28328,35.9,1302,1302.1,101.47,101.47,,239,Splicing factor U2AF 35 kDa subunit,spliceosomal complex|nuclear speck|,mRNA processing|RNA splicing|,nucleotide binding|RNA binding|protein binding|metal ion binding|RS domain binding|,7,14,1330000000,35.9%
Q9JMD3,0.609221717,0.033833333,6.188216341,0.247,0.240535048,1.289231776,-0.085,0.132,-0.316,-0.029,0.529,-0.028,Q9JMD3,Stard10,Q9JMD3_Stard10,Q9JMD3,Stard10,1,24,9,9,Q9JMD3|E9PVP0|G3UY59,MOUSE,33350.2,35,1303,1303.1,101.31,101.31,,291,START domain-containing protein 10,cytosol|microvillus|membrane|motile cilium|intercellular canaliculus|,bile acid secretion|positive regulation of peroxisome proliferator activated receptor signaling pathway|,lipid binding|,9,24,6760000000,35.0%
Q99LD9,0.982507762,-0.003166667,0.27362716,0.006333333,0.938938796,0.079525228,0.026,-0.053,0.008,0.034,-0.017,-0.017,Q99LD9,Eif2b2,Q99LD9_Eif2b2,Q99LD9,Eif2b2,1,20,8,8,Q99LD9,MOUSE,39125.1,21,1304,1304.1,101.06,101.06,,351,Translation initiation factor eIF-2B subunit beta,cytoplasm|eukaryotic translation initiation factor 2B complex|,ovarian follicle development|translational initiation|regulation of translational initiation|central nervous system development|oligodendrocyte development|myelination|positive regulation of GTPase activity|cellular response to stimulus|L-methionine biosynthetic process from methylthioadenosine|,guanyl-nucleotide exchange factor activity|ATP binding|GTP binding|S-methyl-5-thioribose-1-phosphate isomerase activity|translation initiation factor activity|guanyl-nucleotide exchange factor activity|,8,20,1500000000,21.0%
Q64324,0.57548373,0.032333333,6.862725874,-0.170666667,0.205933695,-1.402322013,-0.086,0.134,0.305,-0.046,-0.138,0.025,Q64324,Stxbp2,Q64324_Stxbp2,Q64324,Stxbp2,1,14,10,10,Q64324,MOUSE,66812.7,27.3,1305,1305.1,100.99,100.99,,593,Syntaxin-binding protein 2,cytosol|plasma membrane|apical plasma membrane|specific granule|azurophil granule|cytolytic granule|extracellular exosome|tertiary granule|SNARE complex|,leukocyte mediated cytotoxicity|exocytosis|vesicle docking involved in exocytosis|protein transport|neutrophil degranulation|,syntaxin-1 binding|syntaxin binding|syntaxin-3 binding|,10,14,1270000000,27.3%
Q8BKC5,0.576085848,-0.0165,6.841186462,0.199666667,0.206957588,1.398740551,0.012,0.011,-0.372,0.261,-0.011,0,Q8BKC5,Ipo5,Q8BKC5_Ipo5,Q8BKC5,Ipo5,1,15,9,9,Q8BKC5|Q8BKC5-2,MOUSE,125072.3,11.5,1306,1306.1,100.97,100.97,,1097,Importin-5,nucleus|nucleoplasm|cytoplasm|Golgi apparatus|membrane|nuclear membrane|intracellular membrane-bounded organelle|,NLS-bearing protein import into nucleus|ribosomal protein import into nucleus|positive regulation of protein import into nucleus|cellular response to amino acid stimulus|,protein binding|Ran GTPase binding|protein transporter activity|poly(A) RNA binding|,9,15,3870000000,11.5%
Q64374,0.677954323,0.093333333,4.894007399,0.262666667,0.324040475,1.065316066,-0.083,0.152,-0.183,0.063,0.779,-0.168,Q64374,Rgn,Q64374_Rgn,Q64374,Rgn,1,21,10,10,Q64374,MOUSE,33919.7,39.4,1307,1307.1,100.87,100.87,,299,Regucalcin,nucleus|nucleoplasm|cytoplasm|cytosol|,kidney development|negative regulation of protein kinase activity|cellular calcium ion homeostasis|spermatogenesis|aging|positive regulation of triglyceride biosynthetic process|positive regulation of glucose metabolic process|positive regulation of phosphatase activity|L-ascorbic acid biosynthetic process|negative regulation of phosphoprotein phosphatase activity|positive regulation of ATPase activity|negative regulation of GTPase activity|negative regulation of apoptotic process|positive regulation of GTPase activity|negative regulation of nitric oxide biosynthetic process|positive regulation of fatty acid biosynthetic process|negative regulation of epithelial cell proliferation|regulation of calcium-mediated signaling|negative regulation of cyclic-nucleotide phosphodiesterase activity|liver regeneration|negative regulation of sperm motility|positive regulation of superoxide dismutase activity|positive regulation of calcium-transporting ATPase activity|negative regulation of RNA biosynthetic process|negative regulation of bone development|positive regulation of proteolysis involved in cellular protein catabolic process|negative regulation of calcium-dependent ATPase activity|negative regulation of DNA catabolic process|positive regulation of dUTP diphosphatase activity|negative regulation of leucine-tRNA ligase activity|negative regulation of DNA biosynthetic process|,gluconolactonase activity|calcium ion binding|zinc ion binding|enzyme regulator activity|,10,21,1780000000,39.4%
P28474,0.862027405,0.026166667,2.203706863,-0.107,0.602045499,-0.547423997,-0.146,-0.119,0.504,-0.209,0.099,0.028,P28474,Adh5,P28474_Adh5,P28474,Adh5,1,22,8,8,P28474|A0A0G2JGS3|Q64437,MOUSE,40345.8,22.7,1308,1308.1,100.6,100.6,,374,Alcohol dehydrogenase class-3,mitochondrion|extracellular exosome|,retinoid metabolic process|respiratory system process|ethanol oxidation|peptidyl-cysteine S-nitrosylation|response to lipopolysaccharide|positive regulation of blood pressure|formaldehyde catabolic process|response to nitrosative stress|response to redox state|,alcohol dehydrogenase (NAD) activity|fatty acid binding|zinc ion binding|formaldehyde dehydrogenase activity|protein homodimerization activity|S-(hydroxymethyl)glutathione dehydrogenase activity|,8,22,4390000000,22.7%
Q61037,0.911496676,0.037166667,1.415037235,0.045666667,0.721931973,0.37141166,0.012,0.042,-0.011,0.301,-0.109,-0.012,Q61037,NotFound,Q61037_NotFound,Q61037,Tsc2,1,13,8,8,Q61037|Q61037-5|Q61037-6|Q61037-2|Q61037-3|Q61037-4|Q7TT21|Q61037-7,MOUSE,204520.7,6.5,1309,1309.1,100.28,100.28,,1814,Tuberin,cytoplasm|cytosol|membrane|TSC1-TSC2 complex|perinuclear region of cytoplasm|cytoplasm|,response to hypoxia|neural tube closure|negative regulation of protein kinase activity|protein import into nucleus|heart development|protein localization|negative regulation of cell proliferation|phosphatidylinositol 3-kinase signaling|negative regulation of phosphatidylinositol 3-kinase signaling|cell projection organization|regulation of endocytosis|negative regulation of Wnt signaling pathway|negative regulation of TOR signaling|cellular response to insulin stimulus|protein kinase B signaling|positive regulation of GTPase activity|protein transport into plasma membrane raft|negative regulation of cell size|positive regulation of transcription from RNA polymerase II promoter|glucose import|regulation of insulin receptor signaling pathway|negative regulation of insulin receptor signaling pathway|insulin-like growth factor receptor signaling pathway|positive chemotaxis|regulation of small GTPase mediated signal transduction|regulation of cell cycle|negative regulation of protein kinase B signaling|,GTPase activator activity|protein binding|phosphatase binding|protein homodimerization activity|14-3-3 protein binding|,8,13,536000000,6.5%
P10605,0.956385108,0.036333333,0.639131928,0.028666667,0.863151058,0.179187373,-0.134,-0.121,0.321,-0.118,0.236,0.034,P10605,Ctsb,P10605_Ctsb,P10605,Ctsb,1,17,7,7,P10605,MOUSE,38192,20.9,1310,1310.1,100.24,100.24,,339,Cathepsin B,extracellular space|nucleolus|mitochondrion|lysosome|caveola|external side of plasma membrane|apical plasma membrane|sarcolemma|melanosome|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|extracellular exosome|,proteolysis|autophagy|spermatogenesis|skeletal muscle tissue development|response to wounding|response to glucose|response to organic cyclic compound|response to amine|collagen catabolic process|epithelial cell differentiation|response to peptide hormone|response to ethanol|decidualization|viral entry into host cell|regulation of catalytic activity|proteolysis involved in cellular protein catabolic process|negative regulation of cell death|response to interleukin-4|cellular response to mechanical stimulus|cellular response to thyroid hormone stimulus|,cysteine-type endopeptidase activity|collagen binding|peptidase activity|cysteine-type peptidase activity|kininogen binding|peptide binding|proteoglycan binding|protein self-association|,7,17,5230000000,20.9%
Q3B7Z2,0.977544159,-0.0245,0.33167068,0.008333333,0.926473351,0.095812342,0.013,0.034,-0.133,-0.023,0.002,-0.04,Q3B7Z2,Osbp,Q3B7Z2_Osbp,Q3B7Z2,Osbp,1,13,7,7,Q3B7Z2|Q3B7Z2-2|Q5QNQ6,MOUSE,89650.8,7.7,1311,1311.1,100.11,100.11,,805,Oxysterol-binding protein 1,Golgi membrane|nucleus|nucleoplasm|nucleolus|cytoplasm|Golgi apparatus|membrane|cell junction|,lipid transport|positive regulation of growth of symbiont in host|,lipid binding|protein domain specific binding|,7,13,1320000000,7.7%
B1AQF4,0.93595046,-0.042166667,0.905141489,-0.033,0.811868799,-0.247705859,0.138,0.07,-0.285,0.023,-0.044,-0.155,B1AQF4,NotFound,B1AQF4_NotFound,B1AQF4,Dusp3,1,37,6,6,B1AQF4|Q9D7X3|H3BKL8|Q3V2Y9,MOUSE,23565.4,41.4,1312,1312.1,100.05,100.05,,210,Dual-specificity protein phosphatase 3,immunological synapse|nucleus|nucleoplasm|cytoplasm|cytosol|extracellular exosome|,inactivation of MAPK activity|protein dephosphorylation|peptidyl-tyrosine dephosphorylation|negative regulation of MAPK cascade|positive regulation of mitotic cell cycle|negative regulation of JNK cascade|negative regulation of T cell receptor signaling pathway|negative regulation of T cell activation|negative regulation of ERK1 and ERK2 cascade|,phosphoprotein phosphatase activity|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity|protein kinase binding|MAP kinase phosphatase activity|,6,37,22900000000,41.4%
Q99N87,0.606990596,0.0435,6.241976933,-0.387,0.237575858,-1.298321847,-0.288,0.838,0.161,-0.491,0.085,-0.044,Q99N87,Mrps5,Q99N87_Mrps5,Q99N87,Mrps5,1,21,9,9,Q99N87,MOUSE,48719.1,23.6,1313,1313.1,100.01,100.01,,432,"28S ribosomal protein S5, mitochondrial",mitochondrion|mitochondrial small ribosomal subunit|,translation|,structural constituent of ribosome|poly(A) RNA binding|,9,21,2560000000,23.6%
P70168,0.436783765,-0.020166667,9.641975508,0.171,0.108593155,1.850543093,-0.086,-0.034,-0.197,-0.029,0.115,0.11,P70168,Kpnb1,P70168_Kpnb1,P70168,Kpnb1,1,22,9,9,P70168,MOUSE,98437.6,12.6,1314,1314.1,99.63,99.63,,876,Importin subunit beta-1,nuclear envelope|nucleoplasm|cytoplasm|membrane|nuclear membrane|protein complex|extracellular exosome|endoplasmic reticulum tubular network|,protein import into nucleus|ribosomal protein import into nucleus|,protein binding|Ran GTPase binding|protein transporter activity|enzyme binding|protein domain specific binding|poly(A) RNA binding|,9,22,2630000000,12.6%
P52503,0.636050842,-0.035,5.638496265,0.168,0.272992285,1.195401731,-0.378,0.111,-0.09,0.15,-0.041,0.038,P52503,Ndufs6,P52503_Ndufs6,P52503,Ndufs6,1,14,6,6,P52503|A0A1Y7VM38|A0A1Y7VKP8,MOUSE,13190.7,65.5,1315,1315.1,99.61,99.61,,116,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",mitochondrion|mitochondrial respiratory chain complex I|,fatty acid metabolic process|muscle contraction|multicellular organismal aging|respiratory electron transport chain|multicellular organism growth|reproductive system development|mitochondrion morphogenesis|cardiovascular system development|,,6,14,1930000000,65.5%
P23492,0.450471993,-0.053166667,9.38153189,0.187,0.115304647,1.809300045,-0.05,-0.317,-0.073,0.037,0.092,-0.008,P23492,Pnp,P23492_Pnp,P23492,Pnp,1,17,7,7,P23492|Q543K9|Q9D8C9,MOUSE,32561.8,28.7,1316,1316.1,99.56,99.56,,289,Purine nucleoside phosphorylase,intracellular|cytoplasm|cytosol|cytoskeleton|extracellular exosome|,positive regulation of T cell mediated cytotoxicity|inosine catabolic process|deoxyinosine catabolic process|deoxyguanosine catabolic process|GTP biosynthetic process|intrinsic apoptotic signaling pathway in response to DNA damage|apoptotic mitochondrial changes|response to gamma radiation|urate biosynthetic process|positive regulation of T cell proliferation|purine nucleoside metabolic process|purine-containing compound salvage|positive regulation of B cell differentiation|positive regulation of DNA repair|dGTP metabolic process|guanosine catabolic process|positive regulation of alpha-beta T cell differentiation|negative regulation of T cell apoptotic process|,nucleoside binding|purine nucleobase binding|purine-nucleoside phosphorylase activity|drug binding|phosphate ion binding|,7,17,702000000,28.7%
E9PZJ8,0.331544957,-0.000833333,11.94502847,-0.179666667,0.063899455,-2.216622926,0.112,0.031,0.124,-0.123,-0.055,-0.094,E9PZJ8,Ascc3,E9PZJ8_Ascc3,E9PZJ8,Ascc3,1,12,11,11,E9PZJ8|E9PZJ8-2,MOUSE,252149.9,6.1,1317,1317.1,99.38,99.38,,2198,Activating signal cointegrator 1 complex subunit 3,intracellular|nucleus|cytoplasm|Golgi apparatus|membrane|,"DNA dealkylation involved in DNA repair|transcription, DNA-templated|regulation of transcription, DNA-templated|cell proliferation|DNA duplex unwinding|",ATP binding|ATP-dependent 3'-5' DNA helicase activity|poly(A) RNA binding|,11,12,2000000000,6.1%
P97379,0.572571882,-0.021333333,6.922387317,0.162666667,0.203124013,1.411710188,-0.014,0.019,-0.313,0.132,0.013,0.035,P97379,G3bp2,P97379_G3bp2,P97379,G3bp2,1,17,8,8,P97379|P97379-2,MOUSE,54144.2,20.1,1318,1318.1,99.26,99.26,,482,Ras GTPase-activating protein-binding protein 2,cytoplasm|,small GTPase mediated signal transduction|mRNA transport|,nucleotide binding|poly(A) RNA binding|,8,17,4260000000,20.1%
Q920A5,0.693366972,-0.002666667,4.655868322,-0.083333333,0.342304941,-1.021927568,0.029,-0.003,0.091,-0.028,-0.012,-0.093,Q920A5,Scpep1,Q920A5_Scpep1,Q920A5,Scpep1,1,19,8,8,Q920A5,MOUSE,51249,18.1,1319,1319.1,99.25,99.25,,452,Retinoid-inducible serine carboxypeptidase,cytosol|extracellular exosome|,proteolysis|retinoic acid metabolic process|negative regulation of blood pressure|positive regulation of vasodilation|,,8,19,7720000000,18.1%
Q80ZK9,0.93595046,-0.0015,0.909197375,-0.020333333,0.811110946,-0.248613242,0.065,0.018,-0.057,-0.031,0.014,-0.018,Q80ZK9,Wdtc1,Q80ZK9_Wdtc1,Q80ZK9,Wdtc1,1,16,10,10,Q80ZK9|A2AE98|Q8BX46|Q8BX46-2|D3YX64|E9Q4Z6|Q8C008,MOUSE,76815.2,17.5,1320,1320.1,99.2,99.2,,677,WD and tetratricopeptide repeats protein 1,nucleus|cytosol|,negative regulation of transcription from RNA polymerase II promoter|in utero embryonic development|glucose metabolic process|regulation of cell size|protein ubiquitination|cellular response to insulin stimulus|multicellular organism growth|negative regulation of catalytic activity|negative regulation of fatty acid biosynthetic process|cellular chemical homeostasis|,enzyme inhibitor activity|histone binding|histone deacetylase binding|,10,16,380000000,17.5%
D3Z0M9,0.977234082,-0.010166667,0.337973993,-0.009666667,0.925129651,-0.097569955,-0.146,0.102,0.028,-0.008,-0.08,0.043,D3Z0M9,Ddx23,D3Z0M9_Ddx23,D3Z0M9,Ddx23,1,13,12,12,D3Z0M9,MOUSE,95835.2,17,1321,1321.1,99.18,99.18,,819,DEAD (Asp-Glu-Ala-Asp) box polypeptide 23,nucleus|nucleoplasm|U5 snRNP|nucleolus|mitochondrion|plasma membrane|U4/U6 x U5 tri-snRNP complex|extracellular exosome|catalytic step 2 spliceosome|,"RNA splicing, via transesterification reactions|RNA secondary structure unwinding|",ATP-dependent RNA helicase activity|ATP binding|poly(A) RNA binding|,12,13,4100000000,17.0%
B8JJM5,0.025499102,-0.061666667,27.18779672,0.68,0.001910822,4.967174765,-0.466,-0.325,-0.414,0.186,0.094,0.555,B8JJM5,Cfb,B8JJM5_Cfb,B8JJM5,Cfb,1,22,11,11,B8JJN0|B8JJM5|P04186|B8JJM6|F6XQ00,MOUSE,86604.6,14.1,1322,1322.1,99.12,99.12,,763,Complement factor B,extracellular space|extracellular exosome|blood microparticle|,"proteolysis|complement activation, alternative pathway|cell proliferation|",serine-type endopeptidase activity|,11,22,3840000000,14.1%
P62301,0.530752353,-4.62593E-18,7.587798377,-0.186666667,0.174269009,-1.5219215,-0.067,0.103,0.244,-0.194,0.077,-0.163,P62301,Rps13,P62301_Rps13,P62301,Rps13,1,21,8,8,P62301|Q921R2|A0A0U1RQ71,MOUSE,17222,52.3,1323,1323.1,98.89,98.89,,151,40S ribosomal protein S13,nucleus|nucleolus|focal adhesion|membrane|cytosolic small ribosomal subunit|extracellular exosome|,translation|negative regulation of RNA splicing|,mRNA binding|structural constituent of ribosome|poly(A) RNA binding|small ribosomal subunit rRNA binding|,8,21,1800000000,52.3%
Q9Z0E6,0.222758524,0.091833333,15.07625102,-0.639666667,0.031072407,-2.728044154,0.068,0.22,0.947,-0.292,-0.34,-0.052,Q9Z0E6,Gbp2,Q9Z0E6_Gbp2,Q9Z0E6,Gbp2,1,17,6,6,Q9Z0E6,MOUSE,67308.8,17.8,1324,1324.1,98.46,98.46,,589,Guanylate-binding protein 2,Golgi membrane|nucleus|symbiont-containing vacuole membrane|cytoplasmic vesicle|,metabolic process|cellular response to interferon-beta|defense response to protozoan|adhesion of symbiont to host|defense response to Gram-positive bacterium|cellular response to lipopolysaccharide|cellular response to interferon-gamma|,GTPase activity|GTP binding|,6,17,1460000000,17.8%
P14152,0.56608042,0.059666667,7.016803792,0.393333333,0.198755713,1.427889574,-0.363,0.024,-0.072,-0.188,0.878,0.079,P14152,Mdh1,P14152_Mdh1,P14152,Mdh1,1,22,7,7,P14152,MOUSE,36681.7,25.4,1325,1325.1,98.43,98.43,,334,"Malate dehydrogenase, cytoplasmic",extracellular space|cytoplasm|mitochondrion|centrosome|cytosol|myelin sheath|extracellular exosome|,positive regulation of defense response to virus by host|carbohydrate metabolic process|tricarboxylic acid cycle|oxaloacetate metabolic process|malate metabolic process|NADH metabolic process|activation of mitophagy in response to mitochondrial depolarization|,L-malate dehydrogenase activity|NAD binding|,7,22,2030000000,25.4%
Q9R0X4,0.227949059,-0.004833333,14.86407843,-0.252333333,0.032628128,-2.685376375,0.087,0.05,0.227,-0.088,-0.223,-0.082,Q9R0X4,Acot9,Q9R0X4_Acot9,Q9R0X4,Acot9,1,17,9,9,Q9R0X4|Q32MW3,MOUSE,50844.8,22.7,1326,1326.1,98.33,98.33,,439,"Acyl-coenzyme A thioesterase 9, mitochondrial",mitochondrion|,acyl-CoA metabolic process|,acetyl-CoA hydrolase activity|protein binding|acyl-CoA hydrolase activity|carboxylic ester hydrolase activity|,9,17,1200000000,22.7%
Q8BJ64,0.609221717,-0.020333333,6.191199032,-0.106666667,0.240369908,-1.288277199,0.069,0.035,-0.005,-0.134,-0.076,-0.011,Q8BJ64,Chdh,Q8BJ64_Chdh,Q8BJ64,Chdh,1,14,10,10,Q8BJ64,MOUSE,67098,21.4,1327,1327.1,98.06,98.06,,596,"Choline dehydrogenase, mitochondrial",mitochondrion|mitochondrial inner membrane|,glycine betaine biosynthetic process from choline|oxidation-reduction process|,choline dehydrogenase activity|flavin adenine dinucleotide binding|,10,14,1090000000,21.4%
Q4VBD2,0.888791421,0.009166667,1.774817477,-0.051,0.664535601,-0.453593523,-0.002,0.067,0.039,0.18,-0.179,-0.05,Q4VBD2,Tapt1,Q4VBD2_Tapt1,Q4VBD2,Tapt1,1,13,8,8,Q4VBD2|A0A0G2JGM7,MOUSE,64520.5,23.4,1328,1328.1,97.98,97.98,,564,Transmembrane anterior posterior transformation protein 1,integral component of membrane|,in utero embryonic development|post-embryonic development|embryonic skeletal system development|,,8,13,4210000000,23.4%
Q8C5W3-2,0.52769863,-0.071,7.676243173,0.28,0.170755886,1.536396049,0.015,-0.033,-0.615,0.203,0.001,0.003,Q8C5W3,Tbcel,Q8C5W3-2_Tbcel,Q8C5W3-2,Tbcel,1,14,10,10,Q8C5W3-2|Q8C5W3,MOUSE,50436.5,32.3,1329,1329.1,97.97,97.97,,424,Isoform 2 of Tubulin-specific chaperone cofactor E-like protein,cytoplasm|cytoskeleton|,,,10,14,692000000,32.3%
Q8BP67,0.936980315,-0.041166667,0.89565046,-0.029666667,0.813644989,-0.245312486,0.045,0.081,-0.205,0.01,0.04,-0.218,Q8BP67,Rpl24,Q8BP67_Rpl24,Q8BP67,Rpl24,1,36,7,7,Q8BP67,MOUSE,17892.7,33.7,1330,1330.1,97.68,97.68,,157,60S ribosomal protein L24,membrane|cytosolic large ribosomal subunit|extracellular exosome|,ribosomal large subunit assembly|translation|mitotic cell cycle checkpoint|exit from mitosis|optic nerve development|retinal ganglion cell axon guidance|retina development in camera-type eye|,structural constituent of ribosome|poly(A) RNA binding|,7,36,59800000000,33.7%
Q8BM55,0.69642685,-0.007833333,4.59252888,-0.106333333,0.347333851,-1.010699334,0.006,0.089,0.041,0.12,-0.158,-0.145,Q8BM55,Tmem214,Q8BM55_Tmem214,Q8BM55,Tmem214,1,18,9,9,Q8BM55|D3Z6S1|Q8BM55-2|Q8BM55-3,MOUSE,77455.5,12.9,1331,1331.1,97.64,97.64,,687,Transmembrane protein 214,cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|Golgi apparatus|cytoplasmic microtubule|integral component of membrane|,apoptotic process|,,9,18,3250000000,12.9%
Q3TLP8,0.733613685,0.003833333,4.044125168,-0.082333333,0.394082803,-0.910635323,-0.02,0.022,0.133,-0.123,0.011,0,Q3TLP8,Rac1,Q3TLP8_Rac1,Q3TLP8,Rac1,1,30,10,3,Q3TLP8|P63001,MOUSE,23888.4,36.9,1332,1332.1,97.63,30.31,,211,"RAS-related C3 botulinum substrate 1, isoform CRA_a",cytoplasm|trans-Golgi network|focal adhesion|membrane|cytoplasmic membrane-bounded vesicle|extrinsic component of plasma membrane|lamellipodium|cytoplasmic ribonucleoprotein granule|cell projection|extracellular exosome|actin filament|,"positive regulation of protein phosphorylation|auditory receptor cell morphogenesis|epithelial cell morphogenesis|endocytosis|hyperosmotic response|cytoskeleton organization|cell adhesion|G-protein coupled receptor signaling pathway|small GTPase mediated signal transduction|axon guidance|positive regulation of lamellipodium assembly|positive regulation of cell-substrate adhesion|regulation of neuron maturation|dendrite development|cell migration|cerebral cortex radially oriented cell migration|embryonic olfactory bulb interneuron precursor migration|cerebral cortex GABAergic interneuron development|regulation of cell morphogenesis|lamellipodium assembly|actin cytoskeleton organization|actin filament polymerization|regulation of cell migration|positive regulation of actin filament polymerization|ruffle organization|negative regulation of interleukin-23 production|substrate adhesion-dependent cell spreading|positive regulation of phosphatidylinositol 3-kinase activity|cell-cell junction organization|anatomical structure arrangement|dendrite morphogenesis|cell motility|homeostasis of number of cells within a tissue|positive regulation of stress fiber assembly|localization within membrane|positive regulation of focal adhesion assembly|synaptic transmission, GABAergic|Wnt signaling pathway, planar cell polarity pathway|regulation of respiratory burst|dopaminergic neuron differentiation|protein localization to plasma membrane|positive regulation of neutrophil chemotaxis|cochlea morphogenesis|positive regulation of substrate adhesion-dependent cell spreading|",GTPase activity|protein binding|GTP binding|enzyme binding|thioesterase binding|,10,30,12200000000,36.9%
Q05144,0.672056103,0.068,4.978103876,-0.312,0.317826139,-1.080209856,0.083,-0.293,0.882,0.097,-0.18,-0.181,Q05144,Rac2,Q05144_Rac2,Q05144,Rac2,1,15,8,4,Q05144,MOUSE,21839.8,32.8,1332,1332.2,89.98,46.37,,192,Ras-related C3 botulinum toxin substrate 2,nuclear envelope|cytoplasm|cytosol|focal adhesion|membrane|lamellipodium|extracellular exosome|actin filament|,chemotaxis|actin filament organization|G-protein coupled receptor signaling pathway|small GTPase mediated signal transduction|positive regulation of cell proliferation|positive regulation of lamellipodium assembly|regulation of cell-substrate adhesion|cell projection assembly|actin cytoskeleton organization|regulation of T cell proliferation|regulation of mast cell degranulation|bone resorption|regulation of protein kinase activity|regulation of respiratory burst|regulation of mast cell chemotaxis|lymphocyte aggregation|positive regulation of neutrophil chemotaxis|regulation of neutrophil migration|positive regulation of protein targeting to mitochondrion|,GTPase activity|GTP binding|protein kinase regulator activity|,4,15,1680000000,16.1%
O70251,0.637906964,-0.025666667,5.603846118,0.268,0.275179063,1.189429386,-0.469,-0.123,0.113,-0.319,0.291,0.353,O70251,Eef1b2,O70251_Eef1b2,O70251,Eef1b,1,21,6,6,O70251|A0A087WS46|G3UX43|M0QWH8|M0QWK5,MOUSE,24864.4,27.5,1333,1333.1,97.38,97.38,,225,Elongation factor 1-beta,cytoplasm|eukaryotic translation elongation factor 1 complex|endoplasmic reticulum|,translational elongation|,translation elongation factor activity|protein binding|,6,21,65100000000,27.5%
Q8CI59-2,0.218091343,-0.068166667,15.23767065,0.497,0.0299387,2.754589899,-0.118,-0.122,-0.71,0.321,0.062,0.158,Q8CI59,Steap3,Q8CI59-2_Steap3,Q8CI59-2,Steap3,1,12,7,7,Q8CI59-2|E9QN92|Q8CI59|A0A0R4J1G9,MOUSE,59099.6,16.5,1334,1334.1,97.15,97.15,,488,Isoform 2 of Metalloreductase STEAP3,endosome|multivesicular body|plasma membrane|integral component of plasma membrane|endosome membrane|,iron ion transport|apoptotic process|cell cycle|protein secretion|copper ion import|iron ion homeostasis|oxidation-reduction process|ferric iron import into cell|positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator|exosomal secretion|,ferric-chelate reductase activity|cupric reductase activity|metal ion binding|ferric-chelate reductase (NADPH) activity|,7,12,635000000,16.5%
Q8K3G9,0.974566906,-0.008666667,0.371822107,0.012,0.917947386,0.106992168,-0.212,0.094,0.074,-0.074,0.004,0.062,Q8K3G9,Appl2,Q8K3G9_Appl2,Q8K3G9,Appl2,1,9,7,7,Q8K3G9|D6RFR7,MOUSE,74423,19.3,1335,1335.1,96.98,96.98,,662,DCC-interacting protein 13-beta,nucleus|cytoplasm|endosome membrane|early endosome membrane|extracellular exosome|NuRD complex|,cell cycle|cell proliferation|,Rab GTPase binding|,7,9,288000000,19.3%
P17742,0.701565636,0.122333333,4.533799995,0.273333333,0.352062688,1.00086875,-0.013,0.051,-0.081,-0.033,0.928,-0.118,P17742,Ppia,P17742_Ppia,P17742,Ppia,1,24,8,8,P17742|A0A1L1SST0|F8VPN3|V9GX31|V9GXC1|A0A1L1SRX5,MOUSE,18142.2,53.6,1336,1336.1,96.89,96.89,,164,Peptidyl-prolyl cis-trans isomerase A,extracellular space|nucleus|cytosol|focal adhesion|membrane|myelin sheath|extracellular exosome|,protein peptidyl-prolyl isomerization|protein folding|neuron differentiation|lipid particle organization|regulation of viral genome replication|positive regulation of viral genome replication|positive regulation of protein secretion|,peptidyl-prolyl cis-trans isomerase activity|peptide binding|poly(A) RNA binding|,8,24,5300000000,53.6%
P57784,0.759852964,-0.135833333,3.707688624,-0.231666667,0.425824983,-0.848402701,-0.446,0.198,0.188,-0.772,-0.042,0.059,P57784,Snrpa1,P57784_Snrpa1,P57784,Snrpa1,1,11,8,8,P57784|G5E883|A0A0U1RNZ6,MOUSE,28471.1,40.7,1337,1337.1,96.49,96.49,,255,U2 small nuclear ribonucleoprotein A',nucleoplasm|spliceosomal complex|catalytic step 2 spliceosome|,mRNA processing|RNA splicing|,poly(A) RNA binding|,8,11,2080000000,40.7%
P62835,0.919416995,0.0095,1.253026206,0.041666667,0.749371858,0.333082032,0.216,-0.112,-0.138,0.089,0.089,-0.087,P62835,Rap1a,P62835_Rap1a,P62835,Rap1a,1,23,8,3,P62835|A0A0G2JDL9|A0A0G2JE52,MOUSE,21329.1,39.1,1338,1338.1,96.43,43.74,,184,Ras-related protein Rap-1A,cytoplasm|early endosome|late endosome|plasma membrane|cell junction|guanyl-nucleotide exchange factor complex|neuron projection|myelin sheath|perinuclear region of cytoplasm|extracellular exosome|,small GTPase mediated signal transduction|positive regulation of neuron projection development|protein transport|Rap protein signal transduction|nerve growth factor signaling pathway|positive regulation of GTPase activity|positive regulation of protein kinase activity|establishment of endothelial barrier|positive regulation of ERK1 and ERK2 cascade|cellular response to cAMP|regulation of cell junction assembly|cellular response to nerve growth factor stimulus|negative regulation of synaptic vesicle exocytosis|positive regulation of vasculogenesis|,GTPase activity|protein binding|GTP binding|protein transporter activity|Ras GTPase binding|Rap guanyl-nucleotide exchange factor activity|protein complex binding|,8,23,6640000000,39.1%
Q99JI6,0.968866595,-0.014833333,0.429772075,0.014333333,0.905780137,0.122960167,0.147,-0.236,0.023,-0.019,0.025,-0.029,Q99JI6,Rap1b,Q99JI6_Rap1b,Q99JI6,Rap1b,1,11,7,2,Q99JI6,MOUSE,21052.6,35.3,1338,1338.2,89.79,37.1,,184,Ras-related protein Rap-1b,intracellular|lipid particle|cytosol|plasma membrane|cell-cell junction|extracellular exosome|,small GTPase mediated signal transduction|metabolic process|cell proliferation|Rap protein signal transduction|negative regulation of calcium ion-dependent exocytosis|establishment of endothelial barrier|positive regulation of ERK1 and ERK2 cascade|cellular response to cAMP|regulation of cell junction assembly|regulation of establishment of cell polarity|negative regulation of synaptic vesicle exocytosis|,GTPase activity|protein binding|GTP binding|GDP binding|protein complex binding|,2,11,1240000000,15.2%
Q9ES74,0.811763387,0.013666667,2.921090642,-0.07,0.510376813,-0.695112447,0.168,0.033,-0.055,0.088,-0.067,-0.085,Q9ES74,Nek7,Q9ES74_Nek7,Q9ES74,Nek7,1,21,9,9,Q9ES74|Q3TN15,MOUSE,34992.7,34.7,1339,1339.1,96.04,96.04,,302,Serine/threonine-protein kinase Nek7,spindle pole|nucleoplasm|cytoplasm|microtubule organizing center|,protein phosphorylation|,protein serine/threonine kinase activity|ATP binding|metal ion binding|,9,21,3090000000,34.7%
P62849,0.634404848,-0.006666667,5.680461748,-0.117333333,0.270367089,-1.201367172,0.064,0.157,-0.065,-0.049,0.004,-0.151,P62849,Rps24,P62849_Rps24,P62849,Rps24,1,53,7,7,P62849|P62849-3|P62849-2|A0A286YEB7,MOUSE,15422.9,40.6,1340,1340.1,95.76,95.76,,133,40S ribosomal protein S24,nucleus|cytoplasm|small ribosomal subunit|membrane|cytosolic small ribosomal subunit|,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|rRNA processing|translation|erythrocyte homeostasis|ribosomal small subunit biogenesis|",nucleotide binding|structural constituent of ribosome|poly(A) RNA binding|,7,53,68000000000,40.6%
Q921M3,0.525341433,0.027166667,7.721895507,-0.161666667,0.168970329,-1.542015166,-0.041,0.136,0.229,0.02,-0.035,-0.146,Q921M3,Sf3b3,Q921M3_Sf3b3,Q921M3,Sf3b3,1,10,8,8,Q921M3|Q921M3-2,MOUSE,136631.9,9,1341,1341.1,95.66,95.66,,1217,Splicing factor 3B subunit 3,U12-type spliceosomal complex|catalytic step 2 spliceosome|,"mRNA splicing, via spliceosome|negative regulation of protein catabolic process|",RNA binding|,8,10,959000000,9.0%
Q8R1G2,0.636050842,-0.031833333,5.630652254,0.194333333,0.273485796,1.19405037,-0.004,0.069,-0.452,-0.014,0.242,-0.032,Q8R1G2,Cmbl,Q8R1G2_Cmbl,Q8R1G2,Cmbl,1,14,7,7,Q8R1G2,MOUSE,28243.7,27.7,1342,1342.1,95.65,95.65,,245,Carboxymethylenebutenolidase homolog,cytosol|extracellular exosome|,metabolic process|,hydrolase activity|,7,14,1360000000,27.7%
G5E8R4,0.811763387,-0.001833333,2.922507096,0.055666667,0.510210381,0.695392316,-0.089,-0.012,0.012,0.033,0.032,0.013,G5E8R4,Ppp6r3,G5E8R4_Ppp6r3,G5E8R4,Ppp6r3,1,9,8,8,G5E8R4|Q922D4|Q922D4-2|Q922D4-3|Q922D4-4,MOUSE,98774.3,9.8,1343,1343.1,95.61,95.61,,873,"SAPS domain family, member 3, isoform CRA_c",nucleoplasm|cytoplasm|plasma membrane|,regulation of phosphoprotein phosphatase activity|,protein phosphatase binding|,8,9,498000000,9.8%
P97819,0.886698259,-0.014166667,1.799754413,-0.045666667,0.66073081,-0.459042859,0.058,0.117,-0.149,-0.053,-0.002,-0.056,P97819,Pla2g6,P97819_Pla2g6,P97819,Pla2g6,1,13,9,9,P97819|P97819-2,MOUSE,90585.2,16.3,1344,1344.1,95.57,95.57,,807,85/88 kDa calcium-independent phospholipase A2,cytoplasm|microtubule organizing center|membrane|,chemotaxis|lipid catabolic process|cardiolipin biosynthetic process|,phospholipase A2 activity|calmodulin binding|,9,13,7170000000,16.3%
P62911,0.834860518,0.020166667,2.59503807,-0.085,0.550169098,-0.629420723,-0.023,0.329,-0.118,0.001,0.045,-0.113,P62911,Rpl32,P62911_Rpl32,P62911,Rpl32,1,30,8,8,P62911,MOUSE,15973.6,51.8,1345,1345.1,95.51,95.51,,135,60S ribosomal protein L32,centrosome|membrane|cytosolic large ribosomal subunit|,translation|,structural constituent of ribosome|poly(A) RNA binding|,8,30,9600000000,51.8%
Q9DBJ3,0.991124742,0.0115,0.190028319,0.005,0.95718783,0.055723618,-0.067,0.128,-0.034,0.024,0.023,-0.005,Q9DBJ3,Baiap2l1,Q9DBJ3_Baiap2l1,Q9DBJ3,Baiap2l1,1,11,9,9,Q9DBJ3,MOUSE,57529.4,25,1346,1346.1,95.46,95.46,,514,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1,nucleoplasm|cytoplasm|cytosol|plasma membrane|actin cytoskeleton|extracellular exosome|actin cytoskeleton|,plasma membrane organization|insulin receptor signaling pathway|response to bacterium|positive regulation of actin filament polymerization|regulation of insulin receptor signaling pathway|actin filament bundle assembly|actin crosslink formation|positive regulation of actin cytoskeleton reorganization|,actin binding|cytoskeletal adaptor activity|proline-rich region binding|,9,11,191000000,25.0%
Q99J39,0.533820102,0.039333333,7.529070935,-0.153333333,0.176641566,-1.510243631,0.031,0.286,0.031,-0.005,-0.047,-0.06,Q99J39,Mlycd,Q99J39_Mlycd,Q99J39,Mlycd,1,14,8,8,Q99J39|Q99J39-2,MOUSE,55305.6,21.9,1347,1347.1,95.45,95.45,,492,"Malonyl-CoA decarboxylase, mitochondrial",cytoplasm|mitochondrion|mitochondrial matrix|peroxisome|peroxisomal matrix|cytosol|,response to ischemia|acetyl-CoA biosynthetic process|fatty acid biosynthetic process|regulation of glucose metabolic process|fatty acid oxidation|regulation of fatty acid beta-oxidation|positive regulation of fatty acid oxidation|malonyl-CoA catabolic process|,receptor binding|protein binding|malonyl-CoA decarboxylase activity|,8,14,1450000000,21.9%
P70441,0.791316333,0.022666667,3.241100458,0.089333333,0.474121832,0.758691715,-0.129,-0.059,0.122,-0.051,0.012,0.241,P70441,Slc9a3r1,P70441_Slc9a3r1,P70441,Slc9a3r1,1,13,6,6,P70441,MOUSE,38884.7,25.9,1348,1348.1,95.41,95.41,,355,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,ruffle|cytoplasm|centrosome|plasma membrane|microvillus|endomembrane system|membrane|apical plasma membrane|filopodium|brush border membrane|microvillus membrane|vesicle|stereocilium|stereocilium bundle tip|intracellular membrane-bounded organelle|membrane raft|apical part of cell|extracellular exosome|cell periphery|sperm midpiece|,renal sodium ion transport|adenylate cyclase-activating dopamine receptor signaling pathway|sensory perception of sound|negative regulation of cell proliferation|negative regulation of platelet-derived growth factor receptor signaling pathway|negative regulation of sodium ion transport|negative regulation of phosphatidylinositol 3-kinase signaling|Wnt signaling pathway|cAMP-mediated signaling|microvillus assembly|actin cytoskeleton organization|negative regulation of cell migration|cellular phosphate ion homeostasis|negative regulation of sodium:proton antiporter activity|bile acid secretion|cellular protein localization|glutathione transport|regulation of excretion|regulation of protein kinase activity|negative regulation of protein kinase B signaling|auditory receptor cell stereocilium organization|phospholipase C-activating dopamine receptor signaling pathway|renal absorption|negative regulation of ERK1 and ERK2 cascade|renal phosphate ion absorption|negative regulation of cell motility|positive regulation of intrinsic apoptotic signaling pathway|,receptor binding|protein binding|beta-catenin binding|chloride channel regulator activity|phosphatase binding|PDZ domain binding|beta-2 adrenergic receptor binding|protein complex binding|protein complex scaffold|protein self-association|dopamine receptor binding|growth factor receptor binding|,6,13,1830000000,25.9%
Q9D4H8,0.69541277,0.012666667,4.630745799,0.106666667,0.344290802,1.01755979,0.021,-0.053,-0.09,0.235,0.018,-0.055,Q9D4H8,Cul2,Q9D4H8_Cul2,Q9D4H8,Cul2,1,12,10,10,Q9D4H8|Q9D4H8-2,MOUSE,87503,15.8,1349,1349.1,95.34,95.34,,745,Cullin-2,nucleoplasm|nucleolus|Cul2-RING ubiquitin ligase complex|,protein catabolic process|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|,protein binding|ubiquitin protein ligase binding|ubiquitin protein ligase activity|,10,12,14500000000,15.8%
P53986,0.306010717,0.026666667,12.62296561,-0.35,0.054664256,-2.330224042,0.071,0.032,0.502,-0.037,-0.283,-0.125,P53986,Slc16a1,P53986_Slc16a1,P53986,Slc16a1,1,22,6,6,P53986,MOUSE,53893.8,12.7,1350,1350.1,94.95,94.95,,493,Monocarboxylate transporter 1,mitochondrion|centrosome|plasma membrane|integral component of plasma membrane|membrane|extracellular exosome|,lipid metabolic process|response to food|plasma membrane lactate transport|glucose homeostasis|regulation of insulin secretion|centrosome organization|behavioral response to nutrient|cellular response to organic cyclic compound|,lactate transmembrane transporter activity|symporter activity|protein homodimerization activity|organic cyclic compound binding|,6,22,4200000000,12.7%
Q9D0F9,0.774891394,0.103166667,3.459756827,0.209666667,0.450841948,0.801143195,-0.059,0.195,-0.141,-0.096,0.82,-0.1,Q9D0F9,Pgm2,Q9D0F9_Pgm2,Q9D0F9,Pgm1,1,15,8,8,Q9D0F9|A2CEK3|Q8BZF8,MOUSE,61702.3,18.8,1351,1351.1,94.89,94.89,,562,Phosphoglucomutase-1,cytosol|actin cytoskeleton|extracellular exosome|,glycogen biosynthetic process|glucose metabolic process|response to radiation|galactose catabolic process|,magnesium ion binding|phosphoglucomutase activity|,8,15,603000000,18.8%
Q9JIZ0,0.634404848,0.0085,5.711054333,-0.095666667,0.268469261,-1.206614786,0.003,0.094,0.072,-0.032,-0.045,-0.041,Q9JIZ0,Nat8f1,Q9JIZ0_Nat8f1,Q9JIZ0,Cml1,1,31,8,1,Q9JIZ0|E0CYC6,MOUSE,25241.4,28.8,1352,1352.1,94.85,15.88,,222,Probable N-acetyltransferase CML1,mitochondrial inner membrane|endoplasmic reticulum|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|integral component of membrane|endoplasmic reticulum-Golgi intermediate compartment membrane|extracellular space|,gastrulation with mouth forming second|negative regulation of cell adhesion|positive regulation of gene expression|peptidyl-lysine N6-acetylation|negative regulation of apoptotic process|beta-amyloid metabolic process|,"lysine N-acetyltransferase activity, acting on acetyl phosphate as donor|N-acetyltransferase activity|",8,31,44600000000,28.8%
E9PUL7,0.537027183,0.030833333,7.484678504,-0.132333333,0.178456409,-1.50296967,0,0.104,0.187,-0.008,-0.067,-0.031,E9PUL7,Nat8f1,E9PUL7_Nat8f1,E9PUL7,Nat8f1,1,15,8,2,E9PUL7,MOUSE,26443.7,28.8,1352,1352.2,92.02,30.03,,232,N-acetyltransferase 8 (GCN5-related) family member 1,mitochondrial inner membrane|endoplasmic reticulum|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|endoplasmic reticulum-Golgi intermediate compartment membrane|extracellular space|,negative regulation of cell adhesion|positive regulation of gene expression|peptidyl-lysine N6-acetylation|negative regulation of apoptotic process|beta-amyloid metabolic process|,"lysine N-acetyltransferase activity, acting on acetyl phosphate as donor|",2,15,8960000000,8.6%
Q99M87,0.291596612,0.034,13.05277973,-0.454,0.049513318,-2.399295011,0.162,0.646,-0.025,-0.364,-0.021,-0.194,Q99M87,Dnaja3,Q99M87_Dnaja3,Q99M87,Dnaja3,1,17,8,8,Q99M87|Q99M87-3|Q99M87-2,MOUSE,53127.2,25,1353,1353.1,94.49,94.49,,480,"DnaJ homolog subfamily A member 3, mitochondrial",nucleus|cytoplasm|mitochondrion|mitochondrial matrix|cytosol|extrinsic component of plasma membrane|cell junction|neuromuscular junction|mitochondrial nucleoid|intracellular membrane-bounded organelle|postsynaptic membrane|actin filament|IkappaB kinase complex|I-kappaB/NF-kappaB complex|,negative regulation of transcription from RNA polymerase II promoter|mitochondrial DNA replication|protein folding|negative regulation of protein kinase activity|apoptotic process|activation of cysteine-type endopeptidase activity involved in apoptotic process|activation-induced cell death of T cells|mitochondrion organization|small GTPase mediated signal transduction|neuromuscular junction development|cell aging|negative regulation of cell proliferation|response to heat|positive regulation of protein ubiquitination|negative regulation of NF-kappaB transcription factor activity|T cell differentiation in thymus|response to interferon-gamma|protein refolding|positive regulation of T cell proliferation|regulation of apoptotic process|positive regulation of apoptotic process|negative regulation of apoptotic process|negative regulation of programmed cell death|negative regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|protein stabilization|negative regulation of interferon-gamma-mediated signaling pathway|skeletal muscle acetylcholine-gated channel clustering|,interferon-gamma receptor binding|protein binding|ATP binding|transcription factor binding|protein kinase binding|GTPase regulator activity|receptor tyrosine kinase binding|heat shock protein binding|metal ion binding|NF-kappaB binding|unfolded protein binding|chaperone binding|,8,17,5850000000,25.0%
S4R1M2,0.708523608,0.024333333,4.400506922,-0.109333333,0.363035678,-0.976316485,-0.039,0.197,0.079,-0.093,-0.129,0.131,S4R1M2,Safb,S4R1M2_Safb,S4R1M2,Safb,1,14,9,7,S4R1M2|D3YXK2,MOUSE,105828.6,13.7,1354,1354.1,94.43,69.34,,939,Scaffold attachment factor B1,nucleoplasm|,intracellular estrogen receptor signaling pathway|growth|hormone metabolic process|,nucleotide binding|protein binding|poly(A) RNA binding|,9,14,822000000,13.7%
Q80YR5,0.797128744,0.047333333,3.164546935,0.127333333,0.482553318,0.743806148,-0.3,-0.11,0.361,0.081,0.102,0.15,Q80YR5,Safb2,Q80YR5_Safb2,Q80YR5,Safb2,1,3,5,3,Q80YR5,MOUSE,112464,7.6,1354,1354.2,44.24,19.15,,991,Scaffold attachment factor B2,nucleoplasm|cytoplasm|intracellular membrane-bounded organelle|extracellular exosome|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",nucleotide binding|DNA binding|identical protein binding|poly(A) RNA binding|,3,3,98700000,3.9%
Q3U0V2,0.933153013,0.015833333,0.96993927,-0.026333333,0.79984544,-0.263829167,0.04,-0.061,0.108,0.137,-0.065,-0.064,Q3U0V2,Tradd,Q3U0V2_Tradd,Q3U0V2,Tradd,1,15,9,9,Q3U0V2,MOUSE,35147.3,46.4,1355,1355.1,94.3,94.3,,310,Tumor necrosis factor receptor type 1-associated DEATH domain protein,nucleus|cytoplasm|cytoskeleton|receptor complex|membrane raft|,apoptotic process|regulation of apoptotic process|positive regulation of I-kappaB kinase/NF-kappaB signaling|protein heterooligomerization|positive regulation of hair follicle development|extrinsic apoptotic signaling pathway|,"signal transducer activity|tumor necrosis factor receptor binding|protein binding|kinase binding|protein complex binding|identical protein binding|binding, bridging|death domain binding|",9,15,1420000000,46.4%
Q7TMF3,0.636050842,-0.055333333,5.641405545,0.200666667,0.272809472,1.195902845,-0.453,0.2,-0.214,0.096,0.035,0.004,Q7TMF3,Ndufa12,Q7TMF3_Ndufa12,Q7TMF3,Ndufa12,1,16,7,7,Q7TMF3|A0A0R4J275,MOUSE,17143.1,59.3,1356,1356.1,94.02,94.02,,145,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12,cytoplasm|mitochondrion|mitochondrial respiratory chain complex I|,response to oxidative stress|oxidation-reduction process|,NADH dehydrogenase (ubiquinone) activity|electron carrier activity|,7,16,1660000000,59.3%
Q99KD5,0.866518,0.013,2.14364512,0.056666667,0.610429464,0.534314824,0.06,-0.063,-0.043,0.198,-0.104,0.03,Q99KD5,Unc45a,Q99KD5_Unc45a,Q99KD5,Unc45a,1,14,8,8,Q99KD5|D6RIN1,MOUSE,104643.5,10.9,1357,1357.1,93.78,93.78,,944,Protein unc-45 homolog A,nucleoplasm|cytoplasm|Golgi apparatus|perinuclear region of cytoplasm|,muscle organ development|cell differentiation|chaperone-mediated protein folding|,protein binding|Hsp90 protein binding|,8,14,2170000000,10.9%
G3X8T2,0.887422221,-0.013,1.790396988,0.042666667,0.662155973,0.456953626,0.007,0.032,-0.142,0.089,-0.06,-0.004,G3X8T2,Zc3h18,G3X8T2_Zc3h18,G3X8T2,Zc3h18,1,15,8,8,G3X8T2|H3BIW0|Q0P678|Q0P678-2,MOUSE,108457.2,11.4,1358,1358.1,93.76,93.76,,972,"RIKEN cDNA 5830416A07, isoform CRA_c",nucleoplasm|,,poly(A) RNA binding|,8,15,1130000000,11.4%
O54782,0.000365132,-0.068,53.17268128,1.217333333,4.8165E-06,13.21225745,-0.665,-0.774,-0.591,0.584,0.578,0.46,O54782,Man2b2,O54782_Man2b2,O54782,Man2b2,1,12,8,8,O54782,MOUSE,115835.7,12,1359,1359.1,93.72,93.72,,1018,Epididymis-specific alpha-mannosidase,extracellular exosome|,mannose metabolic process|,alpha-mannosidase activity|zinc ion binding|carbohydrate binding|,8,12,3600000000,12.0%
P59325,0.021127546,0,28.08665472,0.414666667,0.001553583,5.127479998,-0.239,-0.164,-0.219,0.237,0.155,0.23,P59325,Eif5,P59325_Eif5,P59325,Eif5,1,15,7,7,P59325|Q8BVV6|A0A1Y7VLQ0,MOUSE,49424,15.8,1360,1360.1,93.4,93.4,,429,Eukaryotic translation initiation factor 5,cytoplasm|plasma membrane|,translational initiation|regulation of translational initiation|,translation initiation factor activity|GTP binding|poly(A) RNA binding|,7,15,6010000000,15.8%
Q64213,0.602936373,-0.016333333,6.304082479,0.161333333,0.234202622,1.3088053,-0.19,0.019,-0.12,0.043,-0.113,0.263,Q64213,NotFound,Q64213_NotFound,Q64213,Sf1,1,11,8,8,Q64213|D3YZD0|Q64213-3|D3YZC9|E9Q4Q2|Q64213-2|F8WHF9|D6RDB7,MOUSE,70858.2,18.9,1361,1361.1,93.36,93.36,,653,Splicing factor 1,nucleus|nucleoplasm|spliceosomal complex|cytoplasm|,"mRNA splicing, via spliceosome|transcription, DNA-templated|regulation of transcription, DNA-templated|male sex determination|Leydig cell differentiation|negative regulation of smooth muscle cell proliferation|regulation of steroid biosynthetic process|",zinc ion binding|poly(A) RNA binding|pre-mRNA branch point binding|,8,11,1680000000,18.9%
Q8BGV0,0.444995195,-0.022166667,9.501841645,-0.165666667,0.112154276,-1.828194618,0.026,0.102,0.054,-0.067,-0.221,-0.027,Q8BGV0,Nars2,Q8BGV0_Nars2,Q8BGV0,Nars2,1,10,8,8,Q8BGV0|D3YV21|A0A0U1RPY0,MOUSE,54588.4,24.5,1362,1362.1,93.26,93.26,,477,"Probable asparagine--tRNA ligase, mitochondrial",mitochondrion|mitochondrial matrix|,asparaginyl-tRNA aminoacylation|,nucleic acid binding|asparagine-tRNA ligase activity|ATP binding|,8,10,403000000,24.5%
Q8K0L9,0.701917801,0.0285,4.506343006,-0.103666667,0.354295552,-0.995180176,-0.079,0.143,0.177,-0.024,-0.1,0.054,Q8K0L9,Zbtb20,Q8K0L9_Zbtb20,Q8K0L9,Zbtb20,1,10,7,7,Q8K0L9|Q8K0L9-2,MOUSE,82174,14.4,1363,1363.1,93.24,93.24,,741,Zinc finger and BTB domain-containing protein 20,nucleus|nucleoplasm|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|negative regulation of gene expression|positive regulation of interferon-beta production|positive regulation of interleukin-6 production|positive regulation of tumor necrosis factor production|negative regulation of transcription, DNA-templated|",RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription|DNA binding|metal ion binding|,7,10,310000000,14.4%
Q3UZ09,0.000372555,-0.098333333,52.09773745,1.068666667,6.16916E-06,12.71631479,-0.562,-0.627,-0.709,0.468,0.418,0.422,Q3UZ09,C1rl,Q3UZ09_C1rl,Q3UZ09,C1rl,1,14,8,7,Q3UZ09,MOUSE,54233.1,17,1364,1364.1,93.21,88.63,,482,Complement C1r subcomponent-like protein,extracellular space|extracellular exosome|,"proteolysis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|,8,14,931000000,17.0%
Q3TZZ7,0.97512547,0.0175,0.366250717,0.009666667,0.919125739,0.105425958,-0.071,0.132,-0.023,0.011,0.068,-0.012,Q3TZZ7,Esyt2,Q3TZZ7_Esyt2,Q3TZZ7,Esyt2,1,14,10,10,Q3TZZ7|Q3TZZ7-2|A0A1Y7VM39,MOUSE,94594,16.6,1365,1365.1,93.06,93.06,,845,Extended synaptotagmin-2,endoplasmic reticulum|integral component of plasma membrane|membrane|intrinsic component of endoplasmic reticulum membrane|extrinsic component of cytoplasmic side of plasma membrane|organelle membrane contact site|,lipid transport|endocytosis|,calcium ion binding|phospholipid binding|calcium-dependent phospholipid binding|phosphatidylethanolamine binding|phosphatidylcholine binding|phosphatidylinositol binding|identical protein binding|,10,14,854000000,16.6%
Q9ERA6,0.982507762,-0.016833333,0.279109737,0.008333333,0.937754218,0.081074186,0.052,-0.019,-0.096,0.043,-0.167,0.086,Q9ERA6,Tfip11,Q9ERA6_Tfip11,Q9ERA6,Tfip11,1,9,8,8,Q9ERA6,MOUSE,96588.6,11.5,1366,1366.1,93.01,93.01,,838,Tuftelin-interacting protein 11,proteinaceous extracellular matrix|intracellular|nucleus|spliceosomal complex|cytoplasm|nuclear speck|U2-type post-mRNA release spliceosomal complex|catalytic step 2 spliceosome|,"spliceosomal complex disassembly|regulation of transcription, DNA-templated|cell differentiation|extracellular matrix organization|biomineral tissue development|",DNA binding|protein binding|,8,9,506000000,11.5%
Q5SSK3,0.938634393,-0.003166667,0.865886863,-0.020333333,0.819240311,-0.237674625,-0.007,0.069,-0.041,0.044,0.001,-0.085,Q5SSK3,Tefm,Q5SSK3_Tefm,Q5SSK3,Tefm,1,15,7,7,Q5SSK3,MOUSE,42272.3,27.4,1367,1367.1,92.87,92.87,,364,"Transcription elongation factor, mitochondrial",mitochondrion|mitochondrial matrix|ribonucleoprotein complex|mitochondrial nucleoid|,"oxidative phosphorylation|DNA metabolic process|regulation of transcription, DNA-templated|transcription from mitochondrial promoter|",DNA polymerase processivity factor activity|poly(A) RNA binding|,7,15,2130000000,27.4%
Q9CRB8,0.614629659,0.013166667,6.084741019,-0.219666667,0.246334873,-1.271694813,0.039,0.433,-0.103,-0.326,0.074,-0.038,Q9CRB8,Mtfp1,Q9CRB8_Mtfp1,Q9CRB8,Mtfp1,1,26,7,7,Q9CRB8,MOUSE,18370.8,33.7,1368,1368.1,92.53,92.53,,166,Mitochondrial fission process protein 1,mitochondrion|mitochondrial inner membrane|integral component of membrane|,mitochondrial fission|apoptotic process|mitochondrial membrane organization|,,7,26,51300000000,33.7%
O88291,0.708523608,-0.043166667,4.410831532,0.131,0.362173647,0.978608373,0.053,-0.024,-0.355,0.091,-0.112,0.088,O88291,Zfp326,O88291_Zfp326,O88291,Znf326,1,17,7,7,O88291|A0A0R4J098|O88291-2,MOUSE,65680.5,15,1369,1369.1,92.47,92.47,,580,DBIRD complex subunit ZNF326,nucleus|nucleoplasm|nuclear matrix|intracellular membrane-bounded organelle|DBIRD complex|spliceosomal complex|,"transcription, DNA-templated|mRNA processing|RNA splicing|regulation of DNA-templated transcription, elongation|positive regulation of transcription, DNA-templated|",RNA polymerase II core binding|DNA binding|zinc ion binding|poly(A) RNA binding|,7,17,1920000000,15.0%
Q8BU33,0.552744811,0.016333333,7.222199422,-0.117333333,0.189574561,-1.459920014,0.016,0.128,0.081,-0.041,-0.041,-0.045,Q8BU33,Ilvbl,Q8BU33_Ilvbl,Q8BU33,Ilvbl,1,17,7,7,Q8BU33|A0A1W2P8E1|A0A1W2P727|Q8BU33-2|Q8BU33-3,MOUSE,68782.6,18.1,1370,1370.1,92.3,92.3,,632,Acetolactate synthase-like protein,membrane|integral component of membrane|,metabolic process|,magnesium ion binding|transferase activity|thiamine pyrophosphate binding|,7,17,1220000000,18.1%
Q61508,0.008593293,-0.044166667,32.95436932,0.623666667,0.000506481,6.249783937,-0.225,-0.43,-0.413,0.367,0.238,0.198,Q61508,Ecm1,Q61508_Ecm1,Q61508,Ecm1,1,12,8,8,Q61508|F8WI14|Q61508-2,MOUSE,64485.6,18.9,1371,1371.1,92.2,92.2,,559,Extracellular matrix protein 1,proteinaceous extracellular matrix|extracellular space|extracellular matrix|extracellular exosome|,ossification|angiogenesis|positive regulation of endothelial cell proliferation|negative regulation of cytokine-mediated signaling pathway|regulation of type 2 immune response|regulation of transcription from RNA polymerase II promoter|inflammatory response|signal transduction|negative regulation of peptidase activity|negative regulation of bone mineralization|biomineral tissue development|positive regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of angiogenesis|regulation of T cell migration|,protease binding|signal transducer activity|interleukin-2 receptor binding|protein C-terminus binding|enzyme binding|laminin binding|,8,12,1460000000,18.9%
Q91V76,0.607857354,-0.0505,6.220593504,0.162333333,0.238748499,1.294707958,0.046,-0.089,-0.352,-0.075,0.1,0.067,Q91V76,4931406C07Rik,Q91V76_4931406C07Rik,Q91V76,,1,14,9,9,Q91V76|A0A1L1SSF8,MOUSE,35451.7,26.9,1372,1372.1,92.18,92.18,,315,Ester hydrolase C11orf54 homolog,nucleus|extracellular exosome|,metabolic process|,"zinc ion binding|hydrolase activity, acting on ester bonds|",9,14,2190000000,26.9%
P29391,0.965021617,-0.005666667,0.477132795,-0.014,0.895956079,-0.135824401,0.018,0.029,-0.043,-0.031,0.146,-0.153,P29391,NotFound,P29391_NotFound,P29391,Ftl1,1,15,9,9,P29391|Q9CPX4|A0A1B0GR60|P49945|A0A1B0GRH4|A0A1Y7VNT9|O46415,MOUSE,20859.1,55.1,1373,1373.1,92.13,92.13,,183,Ferritin light chain 1,extracellular region|intracellular ferritin complex|endocytic vesicle lumen|,iron ion transport|cellular iron ion homeostasis|,iron ion binding|protein binding|ferric iron binding|,9,15,949000000,55.1%
Q8BIW1,0.64206681,-0.039666667,5.494438439,0.136666667,0.282199446,1.170292466,0.039,-0.033,-0.33,0.025,-0.001,0.062,Q8BIW1,Prune1,Q8BIW1_Prune1,Q8BIW1,Prune1,1,13,7,7,Q8BIW1,MOUSE,50923.3,20.7,1374,1374.1,92.09,92.09,,454,Exopolyphosphatase PRUNE1,nucleus|cytoplasm|focal adhesion|,polyphosphate catabolic process|,exopolyphosphatase activity|inorganic diphosphatase activity|metal ion binding|,7,13,2060000000,20.7%
A6X935,0.036766769,-0.114833333,25.20977505,0.994333333,0.003013162,4.557192711,-0.851,-0.801,-0.184,0.154,0.321,0.672,A6X935,Itih4,A6X935_Itih4,A6X935,Itih4,1,12,8,8,A6X935|E9PVD2|E9Q5L2|A6X935-2|A0A0R4J1N1,MOUSE,104828.7,8.5,1375,1375.1,91.98,91.98,,942,"Inter alpha-trypsin inhibitor, heavy chain 4",cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,acute-phase response|negative regulation of endopeptidase activity|hyaluronan metabolic process|response to cytokine|,serine-type endopeptidase inhibitor activity|protein binding|calcium ion binding|hyaluronic acid binding|,8,12,1500000000,8.5%
Q9QUJ7,0.852602346,0.013,2.352843404,-0.05,0.581722229,-0.578699507,-0.031,0.044,0.101,0.016,-0.083,0.031,Q9QUJ7,Acsl4,Q9QUJ7_Acsl4,Q9QUJ7,Acsl4,1,17,9,9,Q9QUJ7|Q9QUJ7-2,MOUSE,80273.7,14.6,1376,1376.1,91.87,91.87,,711,Long-chain-fatty-acid--CoA ligase 4,cytoplasm|mitochondrion|mitochondrial outer membrane|peroxisomal membrane|lipid particle|membrane|integral component of membrane|neuronal cell body|ER-mitochondrion membrane contact site|extracellular exosome|,long-chain fatty acid metabolic process|lipid metabolic process|triglyceride metabolic process|response to nutrient|lipid biosynthetic process|fatty acid transport|regulation of fatty acid metabolic process|neuron differentiation|positive regulation of cell growth|negative regulation of prostaglandin secretion|embryonic process involved in female pregnancy|dendritic spine development|response to interleukin-15|,long-chain fatty acid-CoA ligase activity|ATP binding|very long-chain fatty acid-CoA ligase activity|arachidonate-CoA ligase activity|,9,17,620000000,14.6%
Q9CR09,0.592842015,-0.009166667,6.462970003,-0.133,0.225789114,-1.33398037,-0.069,0.112,0.129,-0.182,-0.011,-0.034,Q9CR09,Ufc1,Q9CR09_Ufc1,Q9CR09,Ufc1,1,20,8,8,Q9CR09|M0QWS4,MOUSE,19652.2,41.9,1377,1377.1,91.8,91.8,,167,Ubiquitin-fold modifier-conjugating enzyme 1,extracellular exosome|,response to endoplasmic reticulum stress|protein ufmylation|protein K69-linked ufmylation|,UFM1 transferase activity|,8,20,1870000000,41.9%
Q99LP6,0.990223955,-0.033333333,0.197460942,-0.006,0.955551076,-0.057860241,-0.152,0.027,0.034,0.055,-0.168,0.004,Q99LP6,Grpel1,Q99LP6_Grpel1,Q99LP6,Grpel1,1,14,7,7,Q99LP6,MOUSE,24534.8,35,1378,1378.1,91.65,91.65,,217,"GrpE protein homolog 1, mitochondrial",mitochondrion|mitochondrial matrix|,protein folding|regulation of catalytic activity|,adenyl-nucleotide exchange factor activity|protein homodimerization activity|unfolded protein binding|chaperone binding|,7,14,1450000000,35.0%
P62962,0.911275302,0.01,1.446980914,0.048,0.716641425,0.378871166,0.035,0.083,-0.16,-0.006,0.237,-0.129,P62962,Pfn1,P62962_Pfn1,P62962,Pfn1,1,13,7,7,P62962|Q5SX49|J3QMC2,MOUSE,15128.1,65.7,1379,1379.1,91.55,91.55,,140,Profilin-1,extracellular region|nucleus|cytoplasm|cytosol|cytoskeleton|focal adhesion|cell cortex|membrane|neuron projection|synapse|extracellular exosome|blood microparticle|,neural tube closure|regulation of transcription from RNA polymerase II promoter|regulation of actin polymerization or depolymerization|positive regulation of epithelial cell migration|actin cytoskeleton organization|negative regulation of actin filament polymerization|positive regulation of actin filament polymerization|negative regulation of actin filament bundle assembly|positive regulation of ATPase activity|sequestering of actin monomers|positive regulation of transcription from RNA polymerase II promoter|positive regulation of viral transcription|protein stabilization|positive regulation of DNA metabolic process|positive regulation of stress fiber assembly|negative regulation of stress fiber assembly|cellular response to growth factor stimulus|positive regulation of ruffle assembly|,"adenyl-nucleotide exchange factor activity|actin binding|actin monomer binding|receptor binding|protein binding|phosphatidylinositol-4,5-bisphosphate binding|Rho GTPase binding|poly(A) RNA binding|proline-rich region binding|",7,13,2800000000,65.7%
Q91VB8,0.68325953,-0.016833333,4.819542479,0.252333333,0.329644438,1.052081469,0.236,-0.517,-0.148,-0.206,0.065,0.469,Q91VB8,Hba-a1,Q91VB8_Hba-a1,Q91VB8,Hba-a1,1,31,6,6,Q91VB8|P01942|P01966,MOUSE,15169,52.1,1380,1380.1,91.48,91.48,,142,Alpha globin 1,hemoglobin complex|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,6,31,60200000000,52.1%
Q9JIA7,0.956385108,0.005333333,0.632343968,0.023333333,0.864501206,0.177397966,0.19,0.043,-0.252,0.112,-0.026,-0.035,Q9JIA7,Sphk2,Q9JIA7_Sphk2,Q9JIA7,Sphk2,1,14,6,6,Q9JIA7,MOUSE,66244.6,14.2,1381,1381.1,91.37,91.37,,617,Sphingosine kinase 2,lysosomal membrane|cytosol|membrane|,blood vessel development|sphingosine-1-phosphate signaling pathway|sphinganine-1-phosphate biosynthetic process|sphingosine metabolic process|brain development|female pregnancy|cell proliferation|positive regulation of cell proliferation|negative regulation of apoptotic process|sphingosine biosynthetic process|lipid phosphorylation|,protein binding|ATP binding|sphinganine kinase activity|D-erythro-sphingosine kinase activity|sphingosine-1-phosphate receptor activity|,6,14,1720000000,14.2%
D3YYS6,0.892090805,-0.019,1.722196238,0.076,0.672636416,0.441899235,0.015,0.243,-0.429,-0.014,0.064,0.007,D3YYS6,NotFound,D3YYS6_NotFound,D3YYS6,Mgll,1,15,6,6,D3YYS6|E9Q3B9|O35678|Q3UFN1|O35678-2|A0A0N4SUZ2,MOUSE,36996,26.2,1382,1382.1,91.16,91.16,,331,Monoglyceride lipase,nucleoplasm|axon|varicosity|synapse|,regulation of axon extension|acylglycerol catabolic process|long term synaptic depression|,protein homodimerization activity|acylglycerol lipase activity|,6,15,5780000000,26.2%
Q9CQE7-2,0.00980792,-0.2505,32.29825152,1.526333333,0.000589081,6.136408605,-0.707,-0.711,-1.623,0.499,0.509,0.53,Q9CQE7,Ergic3,Q9CQE7-2_Ergic3,Q9CQE7-2,Ergic3,1,21,8,8,Q9CQE7-2|Q9CQE7,MOUSE,45028.6,21.8,1383,1383.1,91.14,91.14,,383,Isoform 2 of Endoplasmic reticulum-Golgi intermediate compartment protein 3,endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|membrane|integral component of membrane|endoplasmic reticulum-Golgi intermediate compartment membrane|,ER to Golgi vesicle-mediated transport|,,8,21,75800000000,21.8%
B1ATZ1,0.857830933,0.012666667,2.244395473,0.062,0.596431336,0.555927426,-0.096,-0.088,0.129,-0.056,-0.004,0.191,B1ATZ1,NotFound,B1ATZ1_NotFound,B1ATZ1,Hgs,1,12,9,9,B1ATZ1|B1ATZ0|Q3UMA3|Q99LI8,MOUSE,86932.2,15.1,1384,1384.1,91.12,91.12,,767,Hepatocyte growth factor-regulated tyrosine kinase substrate,cytoplasm|endosome|early endosome|intracellular membrane-bounded organelle|extracellular exosome|,protein targeting to lysosome|membrane invagination|positive regulation of gene expression|regulation of MAP kinase activity|negative regulation of JAK-STAT cascade|protein localization to membrane|positive regulation of exosomal secretion|,protein domain specific binding|metal ion binding|,9,12,889000000,15.1%
F7C846,0.855039332,0.0225,2.316189865,-0.085,0.586652619,-0.571309979,0.009,0.349,-0.163,0.064,0.029,-0.153,F7C846,Mtx1,F7C846_Mtx1,F7C846,Mtx1,1,19,8,8,F7C846|P47802|D3YVW0,MOUSE,51854.4,18,1385,1385.1,91.05,91.05,,461,Metaxin-1,mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|,protein targeting to mitochondrion|,,8,19,3280000000,18.0%
Q9R0E1,0.002528295,-0.0695,39.18318513,0.965666667,0.000120693,8.021358708,-0.36,-0.557,-0.74,0.314,0.464,0.462,Q9R0E1,Plod3,Q9R0E1_Plod3,Q9R0E1,Plod3,1,9,8,8,Q9R0E1,MOUSE,85491.3,17,1386,1386.1,91.04,91.04,,741,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",rough endoplasmic reticulum membrane|extracellular exosome|,in utero embryonic development|endothelial cell morphogenesis|protein localization|neural tube development|collagen fibril organization|cellular response to hormone stimulus|vasodilation|epidermis morphogenesis|oxidation-reduction process|lung morphogenesis|basement membrane assembly|,iron ion binding|procollagen-lysine 5-dioxygenase activity|L-ascorbic acid binding|procollagen glucosyltransferase activity|,8,9,1740000000,17.0%
D3YTS1,0.326803699,-0.070333333,12.06940191,0.512666667,0.062095454,2.241531341,-0.791,-0.237,0.048,-0.056,0.234,0.38,D3YTS1,NotFound,D3YTS1_NotFound,D3YTS1,Sec11a,1,21,8,8,D3YTS1|D3Z569|Q9R0P6|D3YWT0,MOUSE,28044.9,25.1,1387,1387.1,90.94,90.94,,247,Signal peptidase complex catalytic subunit SEC11,endoplasmic reticulum membrane|integral component of membrane|extracellular exosome|,signal peptide processing|,serine-type peptidase activity|,8,21,4840000000,25.1%
G5E8J3,0.929192436,-0.0015,1.009110925,-0.022333333,0.792663586,-0.273564149,-0.064,0.055,0.038,-0.006,-0.021,-0.011,G5E8J3,Wdr11,G5E8J3_Wdr11,G5E8J3,Wdr11,1,15,10,10,G5E8J3|Q8K1,MOUSE,137847.3,11.6,1388,1388.1,90.91,90.91,,1223,"Bromodomain and WD repeat domain containing 2, isoform CRA_a",cytoplasm|lysosomal membrane|cilium|microtubule cytoskeleton|membrane|,,,10,15,909000000,11.6%
P61211,0.73101227,0.007833333,4.093517954,-0.123666667,0.389626246,-0.920497087,0.252,0.142,-0.185,0.044,-0.055,-0.151,P61211,Arl1,P61211_Arl1,P61211,Arl1,1,14,7,7,P61211,MOUSE,20525.3,46.4,1389,1389.1,90.77,90.77,,181,ADP-ribosylation factor-like protein 1,Golgi membrane|cytoplasm|Golgi apparatus|trans-Golgi network|extracellular exosome|,"Golgi organization|small GTPase mediated signal transduction|toxin metabolic process|activation of phospholipase D activity|protein localization to Golgi apparatus|retrograde transport, endosome to Golgi|Golgi vesicle transport|",GTPase activity|GTP binding|enzyme activator activity|protein domain specific binding|metal ion binding|,7,14,9410000000,46.4%
G5E896,0.929192436,0.014666667,1.010385368,-0.023333333,0.792431012,-0.273879918,-0.009,0.052,0.036,0.092,-0.057,-0.026,G5E896,Edc4,G5E896_Edc4,G5E896,Edc4,1,11,9,9,G5E896|A0A0R4J1Q0|D6RE33|Q3UJB9|Q3UJB9-2,MOUSE,153850.4,10.8,1390,1390.1,90.7,90.7,,1406,"Enhancer of mRNA decapping 4, isoform CRA_b",cytoplasmic mRNA processing body|nucleus|nucleoplasm|membrane|intracellular membrane-bounded organelle|,,protein binding|,9,11,372000000,10.8%
A0A0R4J0B5,0.618717314,0.004166667,5.977809483,0.113666667,0.25247539,1.252140567,-0.102,0.011,-0.067,0.084,-0.042,0.141,A0A0R4J0B5,BC017158,A0A0R4J0B5_BC017158,A0A0R4J0B5,BC017158,1,20,8,2,A0A0R4J0B5|D6RDS0|Q91W34-2,MOUSE,50928.7,19.7,1391,1391.1,90.25,37.39,,466,cDNA sequence BC017158,,,,8,20,1860000000,19.7%
Q9CRA5,0.771800617,-0.032,3.571537428,0.112666667,0.439386043,0.822546359,0.031,0.014,-0.31,0.209,-0.021,-0.115,Q9CRA5,Golph3,Q9CRA5_Golph3,Q9CRA5,Golph3,1,11,8,8,Q9CRA5|H3BJ07|Q8R088|K3W4Q3|Q8R088-3|Q9CRA5-2,MOUSE,34037.2,40.9,1392,1392.1,90.18,90.18,,298,Golgi phosphoprotein 3,nucleoplasm|mitochondrion|mitochondrial intermembrane space|endosome|Golgi apparatus|trans-Golgi network|cytosol|plasma membrane|Golgi cisterna|Golgi cisterna membrane|,Golgi organization|cell proliferation|glycoprotein biosynthetic process|protein secretion|gene expression|regulation of mitochondrion organization|cell migration|lamellipodium assembly|positive regulation of TOR signaling|Golgi to plasma membrane protein transport|negative regulation of apoptotic process|protein retention in Golgi apparatus|Golgi vesicle budding|positive regulation of protein secretion|leukocyte tethering or rolling|cell adhesion molecule production|Golgi ribbon formation|asymmetric Golgi ribbon formation|,enzyme binding|phosphatidylinositol-4-phosphate binding|,8,11,1690000000,40.9%
Q61249,0.070011167,0.005333333,21.93430904,0.366666667,0.006405737,3.903540712,-0.123,-0.102,-0.309,0.165,0.16,0.241,Q61249,Igbp1,Q61249_Igbp1,Q61249,Igbp1,1,12,8,8,Q61249|A0A0B4J1F7|Q9QZ29,MOUSE,39141.4,29.4,1393,1393.1,89.96,89.96,,340,Immunoglobulin-binding protein 1,cytoplasm|cytosol|microtubule|,negative regulation of transcription from RNA polymerase II promoter|negative regulation of stress-activated MAPK cascade|regulation of protein phosphatase type 2A activity|response to tumor necrosis factor|positive regulation of dephosphorylation|negative regulation of protein dephosphorylation|B cell activation|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of transcription from RNA polymerase II promoter|regulation of microtubule-based movement|response to interleukin-1|negative regulation of apoptotic signaling pathway|,protein binding|protein phosphatase type 2A regulator activity|protein domain specific binding|mitogen-activated protein kinase kinase binding|protein complex binding|protein phosphatase 2A binding|,8,12,10000000000,29.4%
P60867,0.774891394,-0.001,3.463818292,-0.068666667,0.450420523,-0.801350152,-0.033,0.12,0.013,-0.079,-0.01,-0.017,P60867,Rps20,P60867_Rps20,P60867,Rps20,1,39,7,7,P60867,MOUSE,13486.6,36.9,1394,1394.1,89.85,89.85,,119,40S ribosomal protein S20,cytoplasm|membrane|cytosolic small ribosomal subunit|extracellular exosome|,translation|,structural constituent of ribosome|poly(A) RNA binding|,7,39,26300000000,36.9%
P62858,0.817863006,-0.017333333,2.823447979,0.064,0.521981609,0.675514506,0.04,0.002,-0.19,0.043,-0.002,0.003,P62858,Rps28,P62858_Rps28,P62858,Rps28,1,21,7,7,P62858,MOUSE,7898,68.1,1395,1395.1,89.83,89.83,,69,40S ribosomal protein S28,cytoplasm|small ribosomal subunit|cytosolic small ribosomal subunit|extracellular exosome|,rRNA processing|rRNA export from nucleus|translation|ribosome biogenesis|ribosomal small subunit biogenesis|,structural constituent of ribosome|poly(A) RNA binding|,7,21,14800000000,68.1%
Q3UJD6,0.863857851,0.018166667,2.177832297,-0.053666667,0.605643095,-0.541588101,-0.033,0.2,-0.032,-0.01,-0.053,0.037,Q3UJD6,Usp19,Q3UJD6_Usp19,Q3UJD6,Usp19,1,13,8,8,Q3UJD6|J3KMM1|Q3UJD6-2|E9Q9M5|A0A0A6YW,MOUSE,152314.5,8.2,1396,1396.1,89.68,89.68,,1360,Ubiquitin carboxyl-terminal hydrolase 19,cytoplasm|endoplasmic reticulum membrane|cytosol|integral component of membrane|,protein deubiquitination|ER-associated ubiquitin-dependent protein catabolic process|regulation of protein stability|response to endoplasmic reticulum stress|negative regulation of skeletal muscle tissue development|regulation of proteasomal protein catabolic process|positive regulation of cell cycle process|regulation of cellular response to hypoxia|,cysteine-type endopeptidase activity|ubiquitin-specific protease activity|protein binding|metal ion binding|Hsp90 protein binding|,8,13,1450000000,8.2%
F6ZDS4,0.532990931,0.011166667,7.539507127,0.239666667,0.176217602,1.514008809,-0.242,-0.25,0.166,0.056,-0.019,0.356,F6ZDS4,Tpr,F6ZDS4_Tpr,F6ZDS4,Tpr,1,13,9,9,F6ZDS4|Q7M739,MOUSE,274384.7,4.8,1397,1397.1,89.42,89.42,,2431,Nucleoprotein TPR,kinetochore|nucleus|nuclear envelope|nuclear pore|cytoplasm|cytoplasmic dynein complex|extrinsic component of membrane|nuclear membrane|nuclear periphery|nuclear inclusion body|nuclear pore nuclear basket|mitotic spindle|kinetochore|,negative regulation of transcription from RNA polymerase II promoter|MAPK import into nucleus|RNA import into nucleus|RNA export from nucleus|nuclear pore organization|mitotic nuclear division|mitotic spindle assembly checkpoint|regulation of mitotic sister chromatid separation|positive regulation of heterochromatin assembly|mRNA export from nucleus in response to heat stress|cellular response to heat|cellular response to interferon-alpha|positive regulation of protein import into nucleus|negative regulation of translational initiation|positive regulation of protein export from nucleus|negative regulation of RNA export from nucleus|cell division|response to epidermal growth factor|positive regulation of mitotic cell cycle spindle assembly checkpoint|positive regulation of intracellular protein transport|regulation of mitotic spindle assembly|protein import into nucleus|protein export from nucleus|nuclear pore organization|regulation of protein stability|regulation of protein import into nucleus|nuclear matrix organization|nuclear pore complex assembly|,chromatin binding|mRNA binding|nucleocytoplasmic transporter activity|protein binding|tubulin binding|heat shock protein binding|protein homodimerization activity|poly(A) RNA binding|mitogen-activated protein kinase binding|dynein complex binding|transporter activity|protein anchor|,9,13,1370000000,4.8%
Q922Q9,0.002244301,-0.129166667,39.88547207,1.254333333,0.000102672,8.237364607,-0.765,-0.512,-0.992,0.423,0.378,0.693,Q922Q9,Chid1,Q922Q9_Chid1,Q922Q9,Chid1,1,11,7,7,A0A0R4J242|Q922Q9|A0A0R4J058|Q922Q9-2|A0A1B0GSH5,MOUSE,45075.9,16.5,1398,1398.1,89.38,89.38,,393,Chitinase domain-containing protein 1,extracellular region|extracellular space|nucleus|lysosome|late endosome|trans-Golgi network|membrane|extracellular exosome|,carbohydrate metabolic process|chitin catabolic process|innate immune response|negative regulation of cytokine production involved in inflammatory response|,chitinase activity|chitin binding|oligosaccharide binding|,7,11,665000000,16.5%
Q8CDN6,0.939288356,0.014,0.859772955,-0.026,0.820394433,-0.23614956,-0.011,-0.088,0.18,-0.126,0.087,0.042,Q8CDN6,Txnl1,Q8CDN6_Txnl1,Q8CDN6,Txnl1,1,8,6,6,Q8CDN6,MOUSE,32636.1,28.7,1399,1399.1,89.15,89.15,,289,Thioredoxin-like protein 1,proteasome complex|nucleus|cytoplasm|extracellular exosome|,sulfate assimilation|protein folding|glycerol ether metabolic process|cellular response to oxidative stress|cell redox homeostasis|oxidation-reduction process|,"protein disulfide oxidoreductase activity|disulfide oxidoreductase activity|oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor|",6,8,1480000000,28.7%
P61358,0.894042447,-0.010666667,1.684195047,-0.063333333,0.678547876,-0.433323244,-0.14,0.253,-0.05,0.047,0.084,-0.258,P61358,Rpl27,P61358_Rpl27,P61358,Rpl27,1,17,8,8,P61358,MOUSE,15797.4,53.6,1400,1400.1,89.1,89.1,,136,60S ribosomal protein L27,nucleus|focal adhesion|membrane|cytosolic large ribosomal subunit|extracellular exosome|,translation|,structural constituent of ribosome|poly(A) RNA binding|,8,17,3610000000,53.6%
Q8BJW6,0.508093395,0.006833333,8.052699329,0.245666667,0.156577757,1.597771069,-0.349,-0.153,0.154,-0.041,0.162,0.268,Q8BJW6,Eif2a,Q8BJW6_Eif2a,Q8BJW6,Eif2a,1,15,7,7,Q8BJW6|Q8BJW6-2,MOUSE,64915.6,16.5,1401,1401.1,88.98,88.98,,581,Eukaryotic translation initiation factor 2A,extracellular space|cytoplasm|eukaryotic translation initiation factor 2 complex|blood microparticle|,translation|translational initiation|regulation of translation|protein phosphorylation|positive regulation of signal transduction|SREBP signaling pathway|ribosome assembly|,tRNA binding|translation initiation factor activity|ribosome binding|,7,15,875000000,16.5%
Q9Z1G4,0.965288537,-0.007666667,0.468027071,-0.018,0.897836574,-0.133406285,-0.255,0.216,0.043,-0.044,-0.071,0.065,Q9Z1G4,Atp6v0a1,Q9Z1G4_Atp6v0a1,Q9Z1G4,Atp6v0a1,1,14,7,7,Q9Z1G4|K3W4T3|Q9Z1G4-2|Q9Z1G4-3,MOUSE,97263.9,10.8,1402,1402.1,88.72,88.72,,839,V-type proton ATPase 116 kDa subunit a isoform 1,"vacuolar proton-transporting V-type ATPase, V0 domain|nucleoplasm|cytoplasm|Golgi apparatus|plasma membrane|integral component of membrane|vacuolar proton-transporting V-type ATPase complex|cytoplasmic vesicle membrane|melanosome|intracellular membrane-bounded organelle|extracellular exosome|",vacuolar acidification|ATP synthesis coupled proton transport|ATP hydrolysis coupled proton transport|vacuolar proton-transporting V-type ATPase complex assembly|toxin transport|,"protein binding|proton-transporting ATPase activity, rotational mechanism|ATPase binding|",7,14,3250000000,10.8%
Q9D0M5,0.759852964,-0.008666667,3.707081956,-0.124,0.425884471,-0.848287993,0.129,0.208,-0.177,-0.212,0.146,-0.146,Q9D0M5,Dynll2,Q9D0M5_Dynll2,Q9D0M5,Dynll2,1,22,6,5,Q9D0M5|D6RIN4|Q80ZS7,MOUSE,10463.8,51.6,1403,1403.1,88.72,73.61,,89,"Dynein light chain 2, cytoplasmic",nucleus|cytoplasm|centrosome|microtubule|membrane|myosin complex|dynein complex|,microtubule-based process|synaptic target recognition|metabolic process|intracellular transport|,motor activity|protein binding|cytoskeletal protein binding|,6,22,10900000000,51.6%
P63168,0.862898798,0.127166667,2.187854085,-0.143666667,0.604247123,-0.544035872,-0.094,-0.092,0.783,0.03,-0.18,0.316,P63168,Dynll1,P63168_Dynll1,P63168,Dynll1,1,2,3,2,P63168,MOUSE,10536.9,51.6,1403,1403.2,46.8,31.69,,89,"Dynein light chain 1, cytoplasmic",kinetochore|nucleus|cytoplasm|mitochondrion|centrosome|cytosol|cytoskeleton|cytoplasmic dynein complex|microtubule|cilium|membrane|extracellular exosome|mitotic spindle|COP9 signalosome|,"transcription, DNA-templated|regulation of transcription, DNA-templated|apoptotic process|microtubule-based movement|substantia nigra development|intraciliary retrograde transport|negative regulation of phosphorylation|negative regulation of catalytic activity|negative regulation of nitric oxide biosynthetic process|cilium morphogenesis|",motor activity|enzyme inhibitor activity|protein binding|protein C-terminus binding|protein domain specific binding|,2,2,575000000,39.3%
Q60953,0.734493028,-0.020666667,4.016230768,-0.101333333,0.396622112,-0.905826608,0.008,-0.022,0.104,0.026,-0.269,0.029,Q60953,Pml,Q60953_Pml,Q60953,Pml,1,12,8,8,Q60953|Q60953-2|D3YXR5|D3Z3A6,MOUSE,100180.2,11.8,1404,1404.1,88.68,88.68,,885,Protein PML,nucleus|nucleoplasm|nucleolus|cytoplasm|cytosol|nuclear matrix|PML body|early endosome membrane|nuclear membrane|extrinsic component of endoplasmic reticulum membrane|PML body|,"response to hypoxia|regulation of protein phosphorylation|positive regulation of defense response to virus by host|transcription, DNA-templated|regulation of transcription, DNA-templated|protein complex assembly|protein targeting|apoptotic process|activation of cysteine-type endopeptidase activity involved in apoptotic process|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|cell cycle arrest|transforming growth factor beta receptor signaling pathway|common-partner SMAD protein phosphorylation|SMAD protein import into nucleus|cell aging|negative regulation of cell proliferation|intrinsic apoptotic signaling pathway in response to DNA damage|intrinsic apoptotic signaling pathway in response to oxidative stress|response to UV|response to gamma radiation|regulation of calcium ion transport into cytosol|fibroblast migration|viral process|negative regulation of angiogenesis|myeloid cell differentiation|regulation of cell adhesion|negative regulation of cell growth|PML body organization|positive regulation of histone deacetylation|negative regulation of telomere maintenance via telomerase|endoplasmic reticulum calcium ion homeostasis|circadian regulation of gene expression|negative regulation of translation in response to oxidative stress|response to cytokine|regulation of circadian rhythm|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator|entrainment of circadian clock by photoperiod|proteasome-mediated ubiquitin-dependent protein catabolic process|innate immune response|cell fate commitment|regulation of MHC class I biosynthetic process|negative regulation of transcription, DNA-templated|negative regulation of mitotic cell cycle|positive regulation of fibroblast proliferation|retinoic acid receptor signaling pathway|negative regulation of interleukin-1 secretion|negative regulation of interleukin-1 beta secretion|protein stabilization|maintenance of protein location in nucleus|defense response to virus|negative regulation of telomerase activity|positive regulation of apoptotic process involved in mammary gland involution|branching involved in mammary gland duct morphogenesis|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress|cellular response to interleukin-4|intrinsic apoptotic signaling pathway by p53 class mediator|cellular senescence|extrinsic apoptotic signaling pathway|negative regulation of viral release from host cell|negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|regulation of double-strand break repair|positive regulation of apoptotic signaling pathway|positive regulation of extrinsic apoptotic signaling pathway|",DNA binding|transcription coactivator activity|protein binding|zinc ion binding|ubiquitin protein ligase binding|SUMO binding|protein homodimerization activity|SMAD binding|protein heterodimerization activity|cobalt ion binding|,8,12,525000000,11.8%
P46664,0.877964074,0.029333333,1.97577355,-0.049333333,0.634486878,-0.497897773,0.151,0.036,-0.025,0.125,-0.09,-0.021,P46664,Adss,P46664_Adss,P46664,Adss,1,14,7,7,P46664,MOUSE,50419.5,21.2,1405,1405.1,88.67,88.67,,456,Adenylosuccinate synthetase isozyme 2,cytoplasm|cytosol|plasma membrane|extracellular exosome|,purine nucleotide biosynthetic process|AMP biosynthetic process|aspartate metabolic process|response to purine-containing compound|'de novo' AMP biosynthetic process|IMP metabolic process|response to ammonium ion|cellular response to electrical stimulus|,magnesium ion binding|adenylosuccinate synthase activity|GTP binding|,7,14,1740000000,21.2%
Q99JB8,0.70184245,-0.006666667,4.514722743,0.088666667,0.353612595,0.996563417,-0.031,0.013,-0.135,-0.025,0.111,0.027,Q99JB8,Pacsin3,Q99JB8_Pacsin3,Q99JB8,Pacsin3,1,12,7,7,Q99JB8,MOUSE,48926.4,21.6,1406,1406.1,88.56,88.56,,424,Protein kinase C and casein kinase II substrate protein 3,nucleoplasm|cytoplasm|endosome|plasma membrane|membrane|membrane-bounded vesicle|extracellular exosome|trans-Golgi network|,endocytosis|cytoskeleton organization|negative regulation of endocytosis|positive regulation of membrane protein ectodomain proteolysis|negative regulation of calcium ion transport|membrane tubulation|,protein binding|phospholipid binding|cytoskeletal protein binding|lipid binding|calcium channel inhibitor activity|,7,12,8010000000,21.6%
D3Z3N4,0.430655636,-0.005833333,9.758332794,-0.181666667,0.105722329,-1.869085496,0.053,0.125,0.077,0.017,-0.238,-0.069,D3Z3N4,Hnrnph3,D3Z3N4_Hnrnph3,D3Z3N4,Hnrnph3,1,18,8,8,D3Z3N4|D3YWT1,MOUSE,36925.9,20.8,1407,1407.1,88.52,88.52,,346,Heterogeneous nuclear ribonucleoprotein H3,nucleus|nucleoplasm|,epithelial cell differentiation|,nucleotide binding|poly(A) RNA binding|,8,18,3700000000,20.8%
P40124,0.318107191,-0.064833333,12.3304513,0.357,0.058472932,2.283324527,-0.512,-0.269,0.051,-0.01,0.134,0.217,P40124,Cap1,P40124_Cap1,P40124,Cap1,1,10,7,7,P40124,MOUSE,51906.2,22.1,1408,1408.1,88.52,88.52,,474,Adenylyl cyclase-associated protein 1,extracellular region|cytoplasm|cytosol|plasma membrane|focal adhesion|cortical actin cytoskeleton|extracellular exosome|,cell morphogenesis|ameboidal-type cell migration|receptor-mediated endocytosis|actin cytoskeleton organization|,actin binding|protein binding|,7,10,691000000,22.1%
Q9JLM9,0.842967796,-0.039333333,2.469333019,-0.077333333,0.566326258,-0.603411904,0.105,0.134,-0.241,-0.023,-0.02,-0.191,Q9JLM9,Grb14,Q9JLM9_Grb14,Q9JLM9,Grb14,1,13,8,8,Q9JLM9,MOUSE,61199.5,18.9,1409,1409.1,88.47,88.47,,538,Growth factor receptor-bound protein 14,Golgi membrane|cytoplasm|plasma membrane|endosome membrane|intracellular membrane-bounded organelle|,signal transduction|positive regulation of signal transduction|,SH3/SH2 adaptor activity|protein binding|,8,13,4510000000,18.9%
P17918,0.799875932,-0.015,3.065789072,-0.07,0.493652218,-0.72386365,0.054,-0.03,0.036,0.063,-0.185,-0.028,P17918,Pcna,P17918_Pcna,P17918,Pcna,1,19,6,6,A0A140T8V5|P17918,MOUSE,29126.7,35.2,1410,1410.1,88.45,88.45,,261,Proliferating cell nuclear antigen,cyclin-dependent protein kinase holoenzyme complex|intracellular|nucleus|nuclear lamina|nucleoplasm|replication fork|cytoplasm|centrosome|nuclear replication fork|PCNA complex|extracellular exosome|PCNA-p21 complex|,"negative regulation of transcription from RNA polymerase II promoter|leading strand elongation|base-excision repair, gap-filling|mismatch repair|translesion synthesis|positive regulation of deoxyribonuclease activity|cellular response to UV|positive regulation of DNA repair|positive regulation of DNA replication|cellular response to xenobiotic stimulus|",purine-specific mismatch base pair DNA N-glycosylase activity|chromatin binding|damaged DNA binding|protein binding|DNA polymerase processivity factor activity|receptor tyrosine kinase binding|dinucleotide insertion or deletion binding|MutLalpha complex binding|histone acetyltransferase binding|identical protein binding|DNA polymerase binding|,6,19,2110000000,35.2%
Q9DCJ5,0.423692625,-0.012166667,9.902664663,0.228333333,0.102266533,1.895534233,-0.276,-0.018,-0.085,0.286,-0.007,0.027,Q9DCJ5,Ndufa8,Q9DCJ5_Ndufa8,Q9DCJ5,Ndufa8,1,17,8,8,Q9DCJ5,MOUSE,20448.1,43,1411,1411.1,88.34,88.34,,172,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8,mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex I|mitochondrial intermembrane space|,oxidation-reduction process|,protein complex binding|,8,17,12600000000,43.0%
Q60749,0.695646919,-0.007333333,4.616381816,-0.119333333,0.345431404,-1.015568867,-0.037,-0.029,0.223,-0.179,-0.105,0.083,Q60749,Khdrbs1,Q60749_Khdrbs1,Q60749,Khdrbs1,1,18,8,8,Q60749|Q9WU01|Q9WU01-2|A0A087WSL3|A0A087WR32,MOUSE,48540.9,13,1412,1412.1,88.32,88.32,,443,"KH domain-containing, RNA-binding, signal transduction-associated protein 1",nucleus|nucleoplasm|cytoplasm|membrane|Grb2-Sos complex|,"transcription, DNA-templated|cell cycle|cell surface receptor signaling pathway|positive regulation of signal transduction|negative regulation of transcription, DNA-templated|positive regulation of translational initiation|regulation of RNA export from nucleus|positive regulation of RNA export from nucleus|",RNA binding|SH3/SH2 adaptor activity|protein binding|poly(A) binding|poly(U) RNA binding|SH3 domain binding|protein complex binding|identical protein binding|poly(A) RNA binding|,9,18,5760000000,13.0%
Q8BG81,0.694574197,-0.018,4.638448644,0.096666667,0.343680693,1.018806711,-0.076,0.052,-0.175,0.074,-0.031,0.048,Q8BG81,Poldip3,Q8BG81_Poldip3,Q8BG81,Poldip3,1,9,7,7,Q8BG81|Q3UDD3,MOUSE,46359.9,23.3,1413,1413.1,88.04,88.04,,420,Polymerase delta-interacting protein 3,nucleoplasm|cytoplasm|nuclear speck|intracellular membrane-bounded organelle|transcription export complex|exon-exon junction complex|,poly(A)+ mRNA export from nucleus|positive regulation of translation|,nucleotide binding|poly(A) RNA binding|,7,9,257000000,23.3%
Q9CQU0,0.000987574,-0.181166667,44.6650649,2.243,3.41581E-05,9.844353021,-1.162,-1.083,-1.663,0.612,1.327,0.882,Q9CQU0,Txndc12,Q9CQU0_Txndc12,Q9CQU0,Txndc12,1,19,6,6,Q9CQU0,MOUSE,19219.4,40.5,1414,1414.1,88.01,88.01,,170,Thioredoxin domain-containing protein 12,endoplasmic reticulum lumen|,cell redox homeostasis|oxidation-reduction process|,protein-disulfide reductase (glutathione) activity|,6,19,8620000000,40.5%
Q6IRU5-2,0.522251937,0.063833333,7.766501181,-0.321666667,0.167243744,-1.551144828,-0.173,0.209,0.638,-0.262,-0.02,-0.009,Q6IRU5,Cltb,Q6IRU5-2_Cltb,Q6IRU5-2,Cltb,1,16,9,9,Q6IRU5-2|Q6IRU5|Q6IRU5-3,MOUSE,23288,34.1,1415,1415.1,87.89,87.89,,229,Isoform 2 of Clathrin light chain B,cytoplasm|trans-Golgi network|plasma membrane|clathrin coat|clathrin vesicle coat|clathrin coat of trans-Golgi network vesicle|clathrin coat of coated pit|intracellular membrane-bounded organelle|ciliary membrane|,intracellular protein transport|clathrin-mediated endocytosis|,structural molecule activity|clathrin heavy chain binding|peptide binding|,9,16,5470000000,34.1%
P56389,0.994928853,-0.007666667,0.06618337,-0.002,0.984876246,-0.019674649,0.069,-0.153,0.064,-0.01,-0.089,0.073,P56389,Cda,P56389_Cda,P56389,Cda,1,22,5,5,P56389,MOUSE,16530.5,52,1416,1416.1,87.79,87.79,,146,Cytidine deaminase,,cytidine deamination|negative regulation of cell growth|negative regulation of nucleotide metabolic process|protein homotetramerization|,nucleoside binding|cytidine deaminase activity|zinc ion binding|identical protein binding|protein homodimerization activity|,5,22,3500000000,52.0%
Q9D6Z1,0.406418919,0.0535,10.26829769,-0.246333333,0.094009173,-1.953948669,-0.077,0.33,0.277,-0.113,-0.058,-0.038,Q9D6Z1,Nop56,Q9D6Z1_Nop56,Q9D6Z1,Nop56,1,19,8,8,Q9D6Z1|E0CXZ0,MOUSE,64919.6,14.6,1417,1417.1,87.79,87.79,,580,Nucleolar protein 56,nucleoplasm|nucleolus|small nucleolar ribonucleoprotein complex|cytoplasm|membrane|box C/D snoRNP complex|small-subunit processome|pre-snoRNP complex|,rRNA modification|,snoRNA binding|poly(A) RNA binding|,8,19,975000000,14.6%
Q8CCF0,0.43686978,0.0155,9.625620576,-0.155,0.109002872,-1.847935815,0.036,0.154,0.089,-0.014,-0.115,-0.057,Q8CCF0,Prpf31,Q8CCF0_Prpf31,Q8CCF0,Prpf31,1,11,9,9,Q8CCF0|Q8CCF0-2,MOUSE,55657.2,24.6,1418,1418.1,87.78,87.78,,499,U4/U6 small nuclear ribonucleoprotein Prp31,nucleus|spliceosomal complex|U4 snRNP|Cajal body|nuclear speck|U4/U6 x U5 tri-snRNP complex|MLL1 complex|,"spliceosomal tri-snRNP complex assembly|mRNA splicing, via spliceosome|",ribonucleoprotein complex binding|poly(A) RNA binding|snRNP binding|,9,11,28200000000,24.6%
Q64726,0.332192581,0.039833333,11.89400623,0.268333333,0.064654592,2.213478729,-0.08,-0.065,-0.138,0.117,0.001,0.404,Q64726,Azgp1,Q64726_Azgp1,Q64726,Azgp1,1,17,8,8,Q64726,MOUSE,35559.5,32.5,1419,1419.1,87.63,87.63,,307,Zinc-alpha-2-glycoprotein,extracellular space|nucleus|plasma membrane|MHC class I protein complex|extracellular exosome|,detection of chemical stimulus involved in sensory perception of bitter taste|retina homeostasis|antigen processing and presentation of peptide antigen via MHC class I|immune response|cell adhesion|regulation of multicellular organism growth|,glycoprotein binding|peptide antigen binding|,8,17,2950000000,32.5%
Q8BL63,0.017411913,-0.159166667,29.18272369,1.095,0.001207057,5.403524213,-0.469,-0.47,-1.181,0.314,0.375,0.476,Q8BL63,Pigk,Q8BL63_Pigk,Q8BL63,Pigk,1,12,7,7,Q8BL63|Q9CXY9|Q8BXX3|E9Q421|A0A0G2JEZ9,MOUSE,50126.3,24.8,1420,1420.1,87.6,87.6,,442,GPI-anchor transamidase,membrane|GPI-anchor transamidase complex|,proteolysis|attachment of GPI anchor to protein|,GPI-anchor transamidase activity|peptidase activity|,7,12,3790000000,24.8%
Q9EQC5,0.917704244,-0.030333333,1.276228789,0.036,0.745378945,0.338490648,0.004,-0.053,-0.096,0.102,-0.193,0.054,Q9EQC5,Scyl1,Q9EQC5_Scyl1,Q9EQC5,Scyl1,1,11,9,9,Q9EQC5,MOUSE,89785.7,17.2,1421,1421.1,87.46,87.46,,806,N-terminal kinase-like protein,cytoplasm|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|cis-Golgi network|microtubule organizing center|membrane|COPI vesicle coat|,"protein phosphorylation|retrograde vesicle-mediated transport, Golgi to ER|",protein kinase activity|protein binding|ATP binding|,9,11,868000000,17.2%
Q9CPX6,0.676059904,-0.075333333,4.932842801,0.200666667,0.321155763,1.0722008,0.048,0.023,-0.598,0.148,-0.023,-0.05,Q9CPX6,Atg3,Q9CPX6_Atg3,Q9CPX6,Atg3,1,17,8,8,Q9CPX6,MOUSE,36252.1,27.3,1422,1422.1,87.29,87.29,,314,Ubiquitin-like-conjugating enzyme ATG3,cytoplasmic ubiquitin ligase complex|cytosol|,autophagosome assembly|mitochondrion degradation|cellular protein modification process|protein transport|protein ubiquitination|mitochondrial fragmentation involved in apoptotic process|nucleophagy|regulation of cilium assembly|,protein binding|ligase activity|Atg8 ligase activity|Atg12 transferase activity|ubiquitin-like protein transferase activity|enzyme binding|,8,17,3390000000,27.3%
Q9QYI3,0.457736715,-0.009166667,9.200297346,0.235,0.120218212,1.783038981,0.068,-0.114,-0.334,0.26,0.027,0.038,Q9QYI3,Dnajc7,Q9QYI3_Dnajc7,Q9QYI3,Dnajc7,1,17,8,8,Q9QYI3,MOUSE,57273.6,19,1423,1423.1,87.24,87.24,,494,DnaJ homolog subfamily C member 7,nucleoplasm|cytoplasm|cytoskeleton|membrane|extracellular exosome|,chaperone cofactor-dependent protein refolding|,heat shock protein binding|,8,17,1120000000,19.0%
Q9CZU3,0.815606851,-0.003333333,2.866110196,-0.102666667,0.51687911,-0.684533412,-0.224,0.044,0.324,-0.158,0.009,-0.015,Q9CZU3,Mtrex,Q9CZU3_Mtrex,Q9CZU3,Skiv2l2,1,11,9,9,Q9CZU3,MOUSE,118661.3,10,1424,1424.1,87.03,87.03,,1040,Superkiller viralicidic activity 2-like 2,nucleus|nucleoplasm|nucleolus|catalytic step 2 spliceosome|exosome (RNase complex)|,maturation of 5.8S rRNA|mRNA processing|RNA catabolic process|RNA splicing|,RNA helicase activity|ATP binding|poly(A) RNA binding|,9,11,285000000,10.0%
Q8K0C4,0.587827992,-0.040666667,6.531979638,0.177333333,0.222229667,1.347119258,0.022,-0.037,-0.373,0.094,-0.078,0.128,Q8K0C4,Cyp51,Q8K0C4_Cyp51,Q8K0C4,Cyp51a1,1,12,9,9,Q8K0C4,MOUSE,57174,17.2,1425,1425.1,86.93,86.93,,503,Lanosterol 14-alpha demethylase,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,"steroid biosynthetic process|cholesterol biosynthetic process|cholesterol biosynthetic process via 24,25-dihydrolanosterol|oxidation-reduction process|demethylation|",iron ion binding|sterol 14-demethylase activity|heme binding|,9,12,1680000000,17.2%
Q9CPQ3,0.913467169,-0.0485,1.347277899,-0.079,0.733284002,-0.355483305,0.104,0.373,-0.504,-0.032,-0.004,-0.228,Q9CPQ3,Tomm22,Q9CPQ3_Tomm22,Q9CPQ3,Tomm22,1,10,6,6,Q9CPQ3,MOUSE,15536.5,66.1,1426,1426.1,86.89,86.89,,142,Mitochondrial import receptor subunit TOM22 homolog,mitochondrion|mitochondrial outer membrane translocase complex|mitochondrial inner membrane|membrane|integral component of membrane|,protein import into mitochondrial outer membrane|,protein binding|protein transmembrane transporter activity|,6,10,2330000000,66.1%
Q8VC77,0.982258276,0.025833333,0.284945787,-0.023666667,0.93649491,-0.082752258,-0.063,0.682,-0.506,0.029,0.137,-0.124,Q8VC77,Akr1c20,Q8VC77_Akr1c20,Q8VC77,Akr1c20,1,26,7,7,Q8VC77|Q9CZU0,MOUSE,37369.4,18.2,1427,1427.1,86.82,86.82,,323,Akr1c20 protein,,steroid biosynthetic process|oxidation-reduction process|,aldo-keto reductase (NADP) activity|,7,26,41400000000,18.2%
P28659,0.355298635,0.042166667,11.36711202,-0.220333333,0.072994275,-2.125413688,0.099,0.326,0.032,-0.033,-0.077,-0.094,P28659,Celf1,P28659_Celf1,P28659,Celf1,1,14,9,9,A0A0R4J0T5|P28659|P28659-3|P28659-2|P28659-4|Q9Z0H4-9|Q9Z0H4-6|Q9Z0H4-2|Q9Z0H4-8|Q9Z0H4|Q9Z0H4-4|Q9Z0H4-5|Q9Z0H4-7|E9QA47|S4R1S7|Q9Z0H4-11|S4R2U7|A0A0R4J2B0|Q9Z0H4-3,MOUSE,52505.7,18.3,1428,1428.1,86.71,86.71,,486,CUGBP Elav-like family member 1,nucleus|nucleoplasm|cytoplasm|membrane|,mRNA splice site selection|spermatid development|positive regulation of multicellular organism growth|regulation of RNA splicing|,nucleotide binding|RNA binding|mRNA binding|translation initiation factor binding|BRE binding|,9,14,2680000000,18.3%
Q62433,0.822662977,-0.063166667,2.721327514,-0.131666667,0.534400983,-0.655257004,-0.265,0.139,0.134,-0.511,-0.032,0.156,Q62433,Ndrg1,Q62433_Ndrg1,Q62433,Ndrg1,1,17,7,7,Q62433|E9Q7V2|E9Q7G8|E9PZC7|E9Q0J8,MOUSE,43464.4,27.6,1429,1429.1,86.65,86.65,,394,Protein NDRG1,nucleus|cytoplasm|centrosome|cytosol|microtubule|plasma membrane|cell-cell adherens junction|microtubule cytoskeleton|myelin sheath|perinuclear region of cytoplasm|recycling endosome membrane|extracellular exosome|,"signal transduction|negative regulation of cell proliferation|DNA damage response, signal transduction by p53 class mediator|peripheral nervous system myelin maintenance|mast cell activation|cellular response to hypoxia|positive regulation of spindle checkpoint|",microtubule binding|Rab GTPase binding|gamma-tubulin binding|cadherin binding|,7,17,2630000000,27.6%
Q8CFA2,0.408707826,0.023,10.19165056,-0.274666667,0.095683035,-1.941708926,0.091,0.436,-0.046,-0.199,-0.01,-0.134,Q8CFA2,Amt,Q8CFA2_Amt,Q8CFA2,Amt,1,15,8,8,Q8CFA2,MOUSE,44464.6,21,1430,1430.1,86.63,86.63,,403,"Aminomethyltransferase, mitochondrial",mitochondrion|,glycine catabolic process|methylation|,aminomethyltransferase activity|transaminase activity|,8,15,4600000000,21.0%
Q99KC8,0.931666785,0.0005,0.983977853,0.027,0.797264111,0.267325151,-0.114,0.155,-0.08,0.001,0.001,0.04,Q99KC8,Vwa5a,Q99KC8_Vwa5a,Q99KC8,Vwa5a,1,12,8,8,Q99KC8,MOUSE,87882.9,13.3,1431,1431.1,86.6,86.6,,793,von Willebrand factor A domain-containing protein 5A,nucleus|nucleoplasm|,,,8,12,1960000000,13.3%
Q64433,0.615860336,-0.001,6.033076748,0.372,0.249282806,1.262918101,-0.483,-0.522,0.444,-0.034,0.035,0.554,Q64433,Hspe1,Q64433_Hspe1,Q64433,Hspe1,1,24,6,6,Q64433,MOUSE,10962.5,54.9,1432,1432.1,86.51,86.51,,102,"10 kDa heat shock protein, mitochondrial",mitochondrion|mitochondrial matrix|membrane|extracellular exosome|,osteoblast differentiation|protein folding|,ATP binding|poly(A) RNA binding|chaperone binding|,6,24,19800000000,54.9%
Q8C854,0.571733416,-0.012166667,6.942517012,0.118333333,0.202184705,1.413786925,-0.069,0.003,-0.148,0.051,0.059,0.031,Q8C854,Myef2,Q8C854_Myef2,Q8C854,Myef2,1,12,7,7,Q8C854|Q8C854-3|A2ATP6|A2ATP5|Q8C854-2|Q8C854-1,MOUSE,63521.7,14.2,1433,1433.1,86.33,86.33,,591,Myelin expression factor 2,nucleus|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|",nucleotide binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription|RNA binding|,7,12,1190000000,14.2%
P46737,0.900174519,0.032,1.60745693,-0.045333333,0.690644101,-0.41572208,0.012,0.239,-0.087,0.066,-0.007,-0.031,P46737,Brcc3,P46737_Brcc3,P46737,Brcc3,1,15,7,7,P46737|P46737-2,MOUSE,33738.9,31.9,1434,1434.1,86.12,86.12,,291,Lys-63-specific deubiquitinase BRCC36,ubiquitin ligase complex|nuclear ubiquitin ligase complex|nucleus|nucleoplasm|BRCA1-A complex|BRISC complex|,double-strand break repair|response to X-ray|response to ionizing radiation|G2 DNA damage checkpoint|positive regulation of DNA repair|regulation of catalytic activity|protein K63-linked deubiquitination|histone H2A K63-linked deubiquitination|,ubiquitin-specific protease activity|protein binding|metallopeptidase activity|enzyme regulator activity|polyubiquitin binding|metal ion binding|,7,15,2050000000,31.9%
Q923Q2,0.919577834,0.028166667,1.203662155,-0.028333333,0.75793818,-0.321077916,-0.021,0.051,0.097,0.044,-0.076,0.074,Q923Q2,Stard13,Q923Q2_Stard13,Q923Q2,Stard13,1,10,8,8,F8WIY7|Q923Q2|A0A0J9YU82,MOUSE,126256.4,8.1,1435,1435.1,86.11,86.11,,1113,StAR-related lipid transfer protein 13,lipid particle|mitochondrial membrane|,cell cycle|signal transduction|positive regulation of GTPase activity|,GTPase activator activity|lipid binding|,8,10,1200000000,8.1%
Q3T9X0,0.726796323,-0.004333333,4.151196134,-0.134,0.384485872,-0.931135068,0.307,0.06,-0.179,-0.008,0.008,-0.214,Q3T9X0,Slc2a9,Q3T9X0_Slc2a9,Q3T9X0,Slc2a9,1,11,6,6,Q3T9X0|B9EHN5|Q7TSK9|Q99JJ2|D6REU9,MOUSE,59076.8,12.2,1436,1436.1,86.06,86.06,,538,"Solute carrier family 2 (facilitated glucose transporter), member 9",plasma membrane|integral component of membrane|,glucose transport|proton transport|glucose import|urate metabolic process|transmembrane transport|,sugar:proton symporter activity|glucose transmembrane transporter activity|,6,11,4130000000,12.2%
Q9DC50,0.410633762,-0.026833333,10.15655357,-0.267,0.096459419,-1.936103435,0.268,-0.093,0.145,-0.364,-0.024,-0.093,Q9DC50,Crot,Q9DC50_Crot,Q9DC50,Crot,1,14,10,10,Q9DC50,MOUSE,71176,21.8,1437,1437.1,86.02,86.02,,612,Peroxisomal carnitine O-octanoyltransferase,mitochondrion|peroxisome|intracellular membrane-bounded organelle|,generation of precursor metabolites and energy|fatty acid metabolic process|fatty acid beta-oxidation|carnitine metabolic process|fatty acid transport|coenzyme A metabolic process|medium-chain fatty acid metabolic process|,receptor binding|carnitine O-octanoyltransferase activity|,10,14,420000000,21.8%
Q9Z1A1,0.938634393,0.130166667,0.8655897,0.075,0.819296369,0.237707964,-0.256,-0.265,0.799,0.078,-0.08,0.505,Q9Z1A1,Tfg,Q9Z1A1_Tfg,Q9Z1A1,Tfg,1,20,9,9,Q9Z1A1|B8JJG6,MOUSE,43076.8,20.9,1438,1438.1,85.93,85.93,,397,TFG protein,extracellular exosome|,signal transduction|positive regulation of I-kappaB kinase/NF-kappaB signaling|,signal transducer activity|,9,20,3940000000,20.9%
Q9WVB0-2,0.648073376,0.001333333,5.372768195,-0.122,0.290217222,-1.148475511,0.175,0.105,-0.093,-0.119,0.044,-0.104,Q9WVB0,Rbpms,Q9WVB0-2_Rbpms,Q9WVB0-2,Rbpms,1,9,7,5,Q9WVB0-2|Q9WVB0|T1ECW4,MOUSE,24461.5,31.8,1439,1439.1,85.85,66.29,,197,Isoform 2 of RNA-binding protein with multiple splicing,nucleoplasm|cytoplasm|,"transcription, DNA-templated|regulation of transcription, DNA-templated|positive regulation of pathway-restricted SMAD protein phosphorylation|positive regulation of SMAD protein import into nucleus|",nucleotide binding|transcription coactivator activity|poly(A) binding|poly(A) RNA binding|,7,9,1560000000,31.8%
Q8VC52,0.875832617,-0.054666667,2.007334501,0.081333333,0.629892663,0.505058289,0.068,0.081,-0.435,0.121,-0.073,-0.09,Q8VC52,Rbpms2,Q8VC52_Rbpms2,Q8VC52,Rbpms2,1,15,7,5,Q8VC52|Q9CWY6,MOUSE,22576.3,31.5,1439,1439.2,76.68,57.12,,206,RNA-binding protein with multiple splicing 2,,,nucleotide binding|nucleic acid binding|,5,15,2130000000,26.6%
G5E8T9,0.734072404,-0.016666667,4.029132621,0.090666667,0.395445591,0.907865918,-0.104,0.093,-0.175,0.005,0.007,0.074,G5E8T9,Hagh,G5E8T9_Hagh,G5E8T9,Hagh,1,20,7,7,G5E8T9|Q99KB8|A0A0R4J052|Q99KB8-2,MOUSE,34559,30,1440,1440.1,85.84,85.84,,309,Hydroxyacyl glutathione hydrolase,cytoplasm|mitochondrion|mitochondrial matrix|extracellular exosome|,carbohydrate metabolic process|glutathione biosynthetic process|,hydroxyacylglutathione hydrolase activity|zinc ion binding|,7,20,1240000000,30.0%
Q99KK2,0.683428593,-0.027,4.813418072,-0.106666667,0.330109629,-1.050043252,0.022,-0.077,0.134,-0.164,0.04,-0.117,Q99KK2,Cmas,Q99KK2_Cmas,Q99KK2,Cmas,1,13,6,6,Q99KK2|A0A0R4J0B4|Q99KK2-2|A0A0N4SW65,MOUSE,48684.7,18.9,1441,1441.1,85.75,85.75,,432,N-acylneuraminate cytidylyltransferase,nucleus|membrane|,N-acetylneuraminate metabolic process|CMP-N-acetylneuraminate biosynthetic process|,N-acylneuraminate cytidylyltransferase activity|,6,13,3740000000,18.9%
O09174,0.798009538,0.001,3.091653625,-0.098,0.490720993,-0.729455949,0.036,0.29,-0.176,-0.044,-0.132,0.032,O09174,Amacr,O09174_Amacr,O09174,Amacr,1,12,8,8,O09174,MOUSE,42045.6,25.1,1442,1442.1,85.71,85.71,,381,Alpha-methylacyl-CoA racemase,cytoplasm|mitochondrion|peroxisome|,fatty acid metabolic process|bile acid biosynthetic process|bile acid metabolic process|isoprenoid catabolic process|,receptor binding|alpha-methylacyl-CoA racemase activity|,8,12,2440000000,25.1%
Q8BMS4,0.590334558,0.014833333,6.490989503,-0.134333333,0.224337073,-1.338671428,0.18,0.139,-0.073,0.007,-0.067,-0.097,Q8BMS4,Coq3,Q8BMS4_Coq3,Q8BMS4,Coq3,1,40,5,5,Q8BMS4,MOUSE,41412.2,18.3,1443,1443.1,85.64,85.64,,370,"Ubiquinone biosynthesis O-methyltransferase, mitochondrial",mitochondrion|mitochondrial inner membrane|,glycerol metabolic process|ubiquinone biosynthetic process|methylation|,"hexaprenyldihydroxybenzoate methyltransferase activity|O-methyltransferase activity|2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity|3-demethylubiquinone-9 3-O-methyltransferase activity|",5,40,19900000000,18.3%
P59729,0.805699632,-0.002833333,2.998060274,0.055,0.501411133,0.710445781,-0.014,-0.06,-0.017,0.03,0.01,0.034,P59729,Rin3,P59729_Rin3,P59729,Rin3,1,11,6,6,P59729|Q3U332,MOUSE,108188.4,7.8,1444,1444.1,85.6,85.6,,980,Ras and Rab interactor 3,early endosome|cytoplasmic membrane-bounded vesicle|cytoplasmic vesicle|,signal transduction|positive regulation of GTPase activity|,GTPase activator activity|Rab guanyl-nucleotide exchange factor activity|Rab GTPase binding|,6,11,472000000,7.8%
Q9R060,0.661323193,-0.035166667,5.169263162,0.105,0.3041401,1.112792115,-0.097,0.039,-0.205,0.043,0.004,0.005,Q9R060,Nubp1,Q9R060_Nubp1,Q9R060,Nubp1,1,9,7,7,Q9R060,MOUSE,34711.9,29,1445,1445.1,85.58,85.58,,320,Cytosolic Fe-S cluster assembly factor NUBP1,cytoplasm|cytosol|plasma membrane|extracellular exosome|,cellular iron ion homeostasis|negative regulation of centrosome duplication|cell growth|iron-sulfur cluster assembly|centrosome localization|protein localization to cell cortex|,"protein binding|ATP binding|metal ion binding|iron-sulfur cluster binding|4 iron, 4 sulfur cluster binding|",7,9,3440000000,29.0%
Q9JIG7,0.917674517,-0.016833333,1.279288617,0.031666667,0.744853973,0.339189166,0.1,-0.063,-0.135,-0.002,0.002,-0.003,Q9JIG7,Ccdc22,Q9JIG7_Ccdc22,Q9JIG7,Ccdc22,1,9,8,8,Q9JIG7,MOUSE,71298.7,18,1446,1446.1,85.53,85.53,,627,Coiled-coil domain-containing protein 22,endosome|,cellular copper ion homeostasis|Golgi to plasma membrane transport|cytoplasmic sequestering of NF-kappaB|protein transport|positive regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|,protein binding|cullin family protein binding|,8,9,4390000000,18.0%
Q9JI99,0.904214516,-0.008333333,1.55434598,-0.042,0.699142015,-0.403544442,-0.028,-0.028,0.094,0.027,-0.191,0.076,Q9JI99,Sgpp1,Q9JI99_Sgpp1,Q9JI99,Sgpp1,1,17,7,7,Q9JI99|A0A1W2P6K9,MOUSE,48313.9,15.3,1447,1447.1,85.35,85.35,,430,Sphingosine-1-phosphate phosphatase 1,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|mitochondrion|Golgi apparatus|actin cytoskeleton|,sphingolipid metabolic process|sphinganine-1-phosphate metabolic process|sphingosine metabolic process|dephosphorylation|extrinsic apoptotic signaling pathway|intrinsic apoptotic signaling pathway|,sphingosine-1-phosphate phosphatase activity|,7,17,1250000000,15.3%
Q80YV4-2,0.904214516,-0.0255,1.569493424,0.043,0.696707776,0.407021548,0.078,-0.028,-0.191,0.044,0.054,-0.11,Q80YV4,Pank4,Q80YV4-2_Pank4,Q80YV4-2,Pank4,1,9,8,8,Q80YV4-2|Q80YV4|Q80YV4-3,MOUSE,87105.8,14.2,1448,1448.1,85.26,85.26,,820,Isoform 2 of Pantothenate kinase 4,cytoplasm|,coenzyme A biosynthetic process|phosphorylation|,pantothenate kinase activity|ATP binding|,8,9,874000000,14.2%
P32883,0.909861937,0.0005,1.46147859,0.031666667,0.714253112,0.382056208,0.023,0.029,-0.098,0.022,0.005,0.022,P32883,Kras,P32883_Kras,P32883,Kras,1,17,6,2,P32883|P32883-2|Q9D091|P08556|C0H5X4|A0A0N4SVY1|E9PVD5|E9Q8V2,MOUSE,21940.7,55,1449,1449.1,85.04,33.49,,189,GTPase KRas,cytoplasm|mitochondrion|plasma membrane|focal adhesion|membrane|extrinsic component of cytoplasmic side of plasma membrane|membrane raft|,"positive regulation of protein phosphorylation|Ras protein signal transduction|positive regulation of cell proliferation|visual learning|positive regulation of gene expression|cytokine-mediated signaling pathway|actin cytoskeleton organization|regulation of synaptic transmission, GABAergic|positive regulation of Rac protein signal transduction|social behavior|endocrine signaling|positive regulation of MAP kinase activity|negative regulation of neuron apoptotic process|negative regulation of cell differentiation|regulation of long-term neuronal synaptic plasticity|homeostasis of number of cells within a tissue|positive regulation of nitric-oxide synthase activity|positive regulation of NF-kappaB transcription factor activity|striated muscle cell differentiation|response to glucocorticoid|response to mineralocorticoid|epithelial tube branching involved in lung morphogenesis|",GTPase activity|protein binding|GTP binding|GMP binding|GDP binding|LRR domain binding|protein complex binding|,6,17,1900000000,55.0%
Q60865,0.332192581,0.032833333,11.89024471,0.321666667,0.064710615,2.212877333,-0.277,-0.128,0.021,0.011,0.114,0.456,Q60865,Caprin1,Q60865_Caprin1,Q60865,Caprin1,1,20,6,6,Q60865,MOUSE,78338.7,12.8,1450,1450.1,85.04,85.04,,707,Caprin-1,cytoplasmic mRNA processing body|cytoplasm|cytosol|cytoplasmic stress granule|membrane|dendrite|,negative regulation of translation|positive regulation of dendrite morphogenesis|positive regulation of dendritic spine morphogenesis|,RNA binding|poly(A) RNA binding|,6,20,5650000000,12.8%
P52196,0.842577616,-0.016166667,2.476263287,0.068333333,0.565423261,0.604676042,0.072,-0.034,-0.189,0.075,0.113,-0.134,P52196,Tst,P52196_Tst,P52196,Tst,1,13,9,9,P52196,MOUSE,33693.5,28.2,1451,1451.1,84.96,84.96,,297,Thiosulfate sulfurtransferase,extracellular space|mitochondrion|mitochondrial inner membrane|mitochondrial matrix|extracellular exosome|,metabolic process|epithelial cell differentiation|rRNA import into mitochondrion|rRNA transport|,thiosulfate sulfurtransferase activity|5S rRNA binding|,9,13,5350000000,28.2%
Q8VCF0,0.247122038,-0.022,14.29581388,0.292,0.037189352,2.596853283,-0.107,-0.038,-0.359,0.043,0.136,0.193,Q8VCF0,Mavs,Q8VCF0_Mavs,Q8VCF0,Mavs,1,21,8,8,Q8VCF0|S4R1W6,MOUSE,53854.4,20.4,1452,1452.1,84.88,84.88,,503,Mitochondrial antiviral-signaling protein,mitochondrion|mitochondrial outer membrane|peroxisome|peroxisomal membrane|integral component of membrane|mitochondrial membrane|,"positive regulation of protein phosphorylation|activation of innate immune response|positive regulation of defense response to virus by host|signal transduction|positive regulation of type I interferon production|positive regulation of interferon-alpha production|positive regulation of interferon-beta production|positive regulation of interleukin-8 production|positive regulation of tumor necrosis factor production|positive regulation of protein import into nucleus, translocation|RIG-I signaling pathway|defense response to bacterium|positive regulation of transcription factor import into nucleus|positive regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of viral genome replication|innate immune response|positive regulation of transcription from RNA polymerase II promoter|positive regulation of sequence-specific DNA binding transcription factor activity|defense response to virus|positive regulation of type I interferon-mediated signaling pathway|cellular response to exogenous dsRNA|positive regulation of chemokine (C-C motif) ligand 5 production|positive regulation of IP-10 production|regulation of peroxisome organization|",signal transducer activity|protein binding|protein kinase binding|CARD domain binding|,8,21,1230000000,20.4%
G5E870,0.969116546,0.000333333,0.427348211,0.010666667,0.906285807,0.122253223,-0.009,0.009,-0.015,0.111,-0.025,-0.069,G5E870,Trip12,G5E870_Trip12,G5E870,Trip12,1,11,9,9,G5E870|A0A087WNZ7,MOUSE,226235,5.4,1453,1453.1,84.84,84.84,,2025,E3 ubiquitin-protein ligase TRIP12,nucleus|nucleoplasm|cytoplasm|,DNA repair|cellular response to DNA damage stimulus|embryo development|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|negative regulation of histone H2A K63-linked ubiquitination|negative regulation of double-strand break repair|,ubiquitin-protein transferase activity|ligase activity|thyroid hormone receptor binding|,9,11,261000000,5.4%
Q9WU84,0.862898798,0.0135,2.187911152,-0.059,0.604239183,-0.543812833,0.23,-0.106,0.005,-0.016,-0.04,0.008,Q9WU84,Ccs,Q9WU84_Ccs,Q9WU84,Ccs,1,16,8,8,Q9WU84,MOUSE,29481.6,40.1,1454,1454.1,84.67,84.67,,274,Copper chaperone for superoxide dismutase,nucleus|cytoplasm|,removal of superoxide radicals|metal ion transport|positive regulation of oxidoreductase activity|oxidation-reduction process|,superoxide dismutase activity|copper ion binding|zinc ion binding|,8,16,1620000000,40.1%
Q8CFJ7,0.838820082,0.027833333,2.550215825,-0.127666667,0.555876632,-0.620181046,0.338,0.332,-0.395,0.038,-0.059,-0.087,Q8CFJ7,Slc25a45,Q8CFJ7_Slc25a45,Q8CFJ7,Slc25a45,1,17,7,7,Q8CFJ7|Q8CFJ7-2,MOUSE,32031.4,26,1455,1455.1,84.6,84.6,,288,Solute carrier family 25 member 45,mitochondrion|mitochondrial inner membrane|integral component of membrane|,transmembrane transport|,,7,17,4260000000,26.0%
Q3UXS0,0.923890139,-0.008,1.132853948,-0.028666667,0.770397039,-0.303942479,-0.04,0.021,0.038,0.056,-0.157,0.034,Q3UXS0,Scamp3,Q3UXS0_Scamp3,Q3UXS0,Scamp3,1,21,5,5,Q3UXS0|O35609|E9Q855,MOUSE,38984.9,19.1,1456,1456.1,84.56,84.56,,350,Secretory carrier-associated membrane protein,Golgi membrane|integral component of membrane|extracellular exosome|,intracellular protein transport|response to organic substance|response to retinoic acid|,ubiquitin protein ligase binding|,5,21,5840000000,19.1%
Q8K3H0,0.93595046,-0.009333333,0.906630932,0.020666667,0.81159041,0.247967164,-0.097,0.029,0.009,-0.016,0.038,-0.019,Q8K3H0,Appl1,Q8K3H0_Appl1,Q8K3H0,Appl1,1,11,8,8,Q8K3H0,MOUSE,80011.4,10.6,1457,1457.1,84.5,84.5,,707,DCC-interacting protein 13-alpha,nucleus|cytosol|endosome membrane|vesicle membrane|early endosome membrane|extracellular exosome|NuRD complex|,cell cycle|cell proliferation|regulation of glucose import|regulation of establishment of protein localization to plasma membrane|,identical protein binding|protein kinase B binding|,8,11,1530000000,10.6%
A2AWA9,0.469507952,0.008833333,8.913915297,0.174333333,0.128412846,1.734199791,-0.055,-0.043,-0.137,0.194,-0.061,0.155,A2AWA9,Rabgap1,A2AWA9_Rabgap1,A2AWA9,Rabgap1,1,12,9,7,A2AWA9|A2AWA9-2|A2AWA9-3,MOUSE,122107.8,10.1,1458,1458.1,84.49,60.98,,1064,Rab GTPase-activating protein 1,microtubule organizing center|cytosol|,cell cycle|positive regulation of GTPase activity|,GTPase activator activity|Rab GTPase binding|,9,12,870000000,10.1%
A6H6A9-3,0.485595784,-0.014833333,8.451796325,0.229,0.142830306,1.662473483,0.012,-0.043,-0.357,0.194,-0.087,0.192,A6H6A9,Rabgap1l,A6H6A9-3_Rabgap1l,A6H6A9-3,Rabgap1l,1,9,5,5,A6H6A9-3|A6H6A9|A6H6A9-4,MOUSE,43152.6,15.6,1458,1458.2,54.41,50.37,,815,Isoform 3 of Rab GTPase-activating protein 1-like,nucleus|early endosome|Golgi apparatus|,regulation of protein localization|megakaryocyte development|positive regulation of GTPase activity|,GTPase activator activity|Rab GTPase binding|,5,9,1990000000,11.3%
Q9R0Q7,0.820260214,-0.034833333,2.795141379,0.081,0.525394911,0.670227461,0.03,0.028,-0.284,-0.014,0.121,-0.09,Q9R0Q7,Ptges3,Q9R0Q7_Ptges3,Q9R0Q7,Ptges3,1,12,8,8,Q9R0Q7|D3Z7C6,MOUSE,19006.4,52.5,1459,1459.1,84.31,84.31,,160,Prostaglandin E synthase 3,nucleus|nucleoplasm|telomerase holoenzyme complex|cytoplasm|extracellular exosome|,prostaglandin biosynthetic process|glycogen biosynthetic process|RNA-dependent DNA replication|cell proliferation|glucocorticoid receptor signaling pathway|skin development|lung saccule development|chaperone cofactor-dependent protein refolding|,telomerase activity|prostaglandin-E synthase activity|unfolded protein binding|,8,12,6110000000,52.5%
P35922-3,0.844723818,0.002166667,2.437254011,-0.047666667,0.570524894,-0.596373596,0.007,0.08,-0.009,-0.049,-0.007,-0.009,P35922,NotFound,P35922-3_NotFound,P35922-3,Fmr1,1,23,7,7,P35922-3|E9QAT0|E9QAS9|P35922-9|E9QAS8|P35922|Q6AXB7|P35922-2|P35922-7|E9QNF5|D3Z6U8|P35922-8|P35922-6|P35922-12|P35922-4|P35922-5|P35922-10|P35922-11,MOUSE,66553.5,13.2,1460,1460.1,84.14,84.14,,614,Isoform 3 of Synaptic functional regulator FMR1,nucleus|nucleolus|cytoplasm|polysome|mRNA cap binding complex|cytoplasmic stress granule|membrane|dendrite|cytoplasmic ribonucleoprotein granule|cell body|neuronal ribonucleoprotein granule|microtubule|,central nervous system development|positive regulation of translation|negative regulation of translational initiation|mRNA transport|dendritic spine development|,RNA binding|mRNA binding|protein binding|microtubule binding|poly(A) RNA binding|,7,23,10500000000,13.2%
Q8C1E7,0.760357786,0.0195,3.700591868,-0.267,0.426521387,-0.847060578,-0.589,0.38,0.668,-0.309,-0.068,0.035,Q8C1E7,Tmem120a,Q8C1E7_Tmem120a,Q8C1E7,Tmem120a,1,16,6,6,Q8C1E7,MOUSE,41207.1,17.2,1461,1461.1,83.92,83.92,,343,Transmembrane protein 120A,integral component of membrane|,,,6,16,5980000000,17.2%
Q7TMK6,0.977234082,0.017166667,0.34427508,0.009666667,0.923788373,0.099324135,0.032,0.041,-0.036,0.17,-0.062,-0.042,Q7TMK6,Hook2,Q7TMK6_Hook2,Q7TMK6,Hook2,1,12,8,8,Q7TMK6|A0A1B0GT78|A0A1B0GSU8,MOUSE,83934.7,14.2,1462,1462.1,83.9,83.9,,716,Protein Hook homolog 2,centrosome|microtubule|FHF complex|HOPS complex|,endosome organization|lysosome organization|endosome to lysosome transport|protein transport|early endosome to late endosome transport|,identical protein binding|,9,12,2050000000,14.2%
Q3UVT7,0.660104829,-0.031666667,5.184196129,0.139333333,0.303096127,1.116483345,-0.04,0.077,-0.341,0.051,0.079,-0.016,Q3UVT7,Palmd,Q3UVT7_Palmd,Q3UVT7,Palmd,1,11,8,8,Q3UVT7|A0A0R4J0J0|Q9JHU2,MOUSE,62958,19.4,1463,1463.1,83.76,83.76,,551,Palmdelphin,cytoplasm|membrane|,regulation of cell shape|,,8,11,512000000,19.4%
Q791V5,0.797504707,-0.0765,3.113817544,0.141666667,0.488223012,0.733827691,-0.566,0.031,0.093,-0.185,0.091,0.077,Q791V5,Mtch2,Q791V5_Mtch2,Q791V5,Mtch2,1,16,7,7,Q791V5|Q9D050|A2AFW6|D6RCZ1,MOUSE,34126.1,33,1464,1464.1,83.69,83.69,,303,Mitochondrial carrier homolog 2,nucleus|mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|membrane|integral component of membrane|extracellular exosome|,protein localization to mitochondrion|hepatocyte apoptotic process|regulation of mitochondrial membrane permeability involved in apoptotic process|,,7,16,2430000000,33.0%
P47955,0.651971232,0.017,5.296607288,-0.154,0.295351561,-1.136139188,0.085,0.29,-0.093,0.043,0.023,-0.246,P47955,Rplp1,P47955_Rplp1,P47955,Rplp1,1,21,4,4,P47955|E9Q3T0,MOUSE,11588.8,94.7,1465,1465.1,83.68,83.68,,114,60S acidic ribosomal protein P1,ribosome|,translational elongation|regulation of translation|,structural constituent of ribosome|,4,21,19600000000,94.7%
Q9CY58,0.701372679,-0.013833333,4.537424251,0.135,0.351769009,1.001522745,-0.134,0.119,-0.229,-0.144,0.142,0.163,Q9CY58,Serbp1,Q9CY58_Serbp1,Q9CY58,Serbp1,1,15,9,9,Q9CY58|Q3UMP4|Q9CY58-2|Q9CY58-3|A0A0N4SV32|A0A0N4SWH2|Q9CY58-4|A0A0N4SUN8|A0A0N4SUQ1,MOUSE,44827.4,26.5,1466,1466.1,83.68,83.68,,407,Plasminogen activator inhibitor 1 RNA-binding protein,nucleus|cytoplasm|plasma membrane|membrane|perinuclear region of cytoplasm|extracellular exosome|,regulation of apoptotic process|,mRNA 3'-UTR binding|poly(A) RNA binding|,9,15,980000000,26.5%
P61924,0.452728444,0.037166667,9.329418349,-0.189666667,0.11669659,-1.801129027,-0.017,0.288,0.125,-0.071,0.004,-0.106,P61924,Copz1,P61924_Copz1,P61924,Copz1,1,19,5,5,P61924,MOUSE,20254.9,34.4,1467,1467.1,83.68,83.68,,177,Coatomer subunit zeta-1,COPI vesicle coat|,intracellular protein transport|intra-Golgi vesicle-mediated transport|toxin transport|,,5,19,2830000000,34.4%
Q80VI1,0.841705581,0.0205,2.517240614,0.064333333,0.560113369,0.613046633,-0.037,-0.005,0.007,0.227,-0.087,0.018,Q80VI1,Trim56,Q80VI1_Trim56,Q80VI1,Trim56,1,6,6,6,A0A0R4J0Q6|Q80VI1,MOUSE,81223.1,10.6,1468,1468.1,83.63,83.63,,734,E3 ubiquitin-protein ligase TRIM56,cytoplasm|,interferon-beta production|response to type I interferon|innate immune response|negative regulation of viral entry into host cell|defense response to virus|protein K63-linked ubiquitination|negative regulation of viral release from host cell|,ubiquitin-protein transferase activity|protein binding|zinc ion binding|ligase activity|poly(A) RNA binding|ubiquitin protein ligase activity|,6,6,528000000,10.6%
G3X973,0.408707826,-0.005833333,10.18716393,0.282333333,0.095781935,1.94099238,-0.02,-0.16,-0.261,0.421,-0.035,0.02,G3X973,Stab1,G3X973_Stab1,G3X973,Stab1,1,11,8,8,G3X973|Q8R4Y4|Q8R4Y4-2,MOUSE,288107,5.4,1469,1469.1,83.63,83.63,,2571,"Stabilin 1, isoform CRA_a",cytoplasm|integral component of plasma membrane|,receptor-mediated endocytosis|cell adhesion|cell-cell signaling|negative regulation of angiogenesis|defense response to bacterium|,low-density lipoprotein receptor activity|scavenger receptor activity|hyaluronic acid binding|low-density lipoprotein particle binding|,8,11,314000000,5.4%
Q9R049,0.760472992,0.010166667,3.691106377,0.130333333,0.427453977,0.845265752,-0.128,0.135,-0.172,0.328,-0.17,0.068,Q9R049,Amfr,Q9R049_Amfr,Q9R049,Amfr,1,12,7,7,Q9R049|Q9R049-2,MOUSE,73959.7,17.1,1470,1470.1,83.51,83.51,,643,E3 ubiquitin-protein ligase AMFR,Hrd1p ubiquitin ligase complex|endoplasmic reticulum membrane|integral component of plasma membrane|membrane|integral component of endoplasmic reticulum membrane|protein complex|perinuclear region of cytoplasm|BAT3 complex|,protein polyubiquitination|ubiquitin-dependent protein catabolic process|cellular process|ER-associated ubiquitin-dependent protein catabolic process|endoplasmic reticulum unfolded protein response|positive regulation of protein binding|protein oligomerization|protein K48-linked ubiquitination|,"nucleotide binding|ubiquitin-protein transferase activity|receptor activity|protein binding|zinc ion binding|ligase activity|protein binding, bridging|protein complex binding|chaperone binding|ubiquitin protein ligase activity|ubiquitin-specific protease binding|",7,12,879000000,17.1%
E9PXY8,0.600763538,-0.0675,6.328767001,0.177,0.232875232,1.312966905,-0.073,-0.015,-0.38,0.078,0.137,-0.152,E9PXY8,Usp7,E9PXY8_Usp7,E9PXY8,Usp7,1,9,8,7,E9PXY8|Q6A4J8-2|Q6A4J8|F8VP|Q6A4J8-3,MOUSE,133986.1,10.1,1471,1471.1,83.46,78.97,,1143,Ubiquitin carboxyl-terminal hydrolase 7,nucleus|cytoplasm|cytosol|nuclear body|,"transcription-coupled nucleotide-excision repair|regulation of transcription, DNA-templated|maintenance of DNA methylation|histone deubiquitination|protein deubiquitination|negative regulation of NF-kappaB transcription factor activity|proteasome-mediated ubiquitin-dependent protein catabolic process|regulation of sequence-specific DNA binding transcription factor activity|regulation of proteasomal protein catabolic process|",p53 binding|cysteine-type endopeptidase activity|ubiquitin-specific protease activity|protein C-terminus binding|transcription factor binding|ubiquitin protein ligase binding|,8,9,128000000,10.1%
Q6GQT6,0.717079575,-0.026,4.262687932,0.149333333,0.374740996,0.951602051,0.001,0.082,-0.385,0.24,0.017,-0.111,Q6GQT6,Scap,Q6GQT6_Scap,Q6GQT6,Scap,1,4,4,4,Q6GQT6,MOUSE,141490.9,3.9,1471,1471.2,30.69,30.69,,1276,Sterol regulatory element-binding protein cleavage-activating protein,Golgi membrane|endoplasmic reticulum membrane|ER to Golgi transport vesicle membrane|integral component of membrane|protein complex|,response to hypoxia|aging|cholesterol metabolic process|regulation of fatty acid metabolic process|response to insulin|SREBP signaling pathway|regulation of fatty acid biosynthetic process|regulation of cholesterol biosynthetic process|,cholesterol binding|protein complex binding|,4,4,108000000,3.9%
Q9CZX9,0.004131972,-0.1135,36.61500655,1.640333333,0.000218022,7.270995689,-1.339,-0.814,-0.648,0.363,0.804,0.953,Q9CZX9,Emc4,Q9CZX9_Emc4,Q9CZX9,Emc4,1,17,6,6,Q9CZX9,MOUSE,20287.5,34.4,1472,1472.1,83.43,83.43,,183,ER membrane protein complex subunit 4,integral component of membrane|ER membrane protein complex|,apoptotic process|,,6,17,3050000000,34.4%
P12815,0.403991273,0.039833333,10.31100682,-0.182333333,0.093089204,-1.957020586,0.068,0.233,0.092,-0.108,0.04,-0.086,P12815,Pdcd6,P12815_Pdcd6,P12815,Pdcd6,1,16,6,6,P12815|P12815-2,MOUSE,21924.1,52.3,1473,1473.1,83.36,83.36,,191,Programmed cell death protein 6,nucleus|cytoplasm|endosome|endoplasmic reticulum|endoplasmic reticulum membrane|cytoplasmic vesicle|nuclear membrane|extracellular exosome|endoplasmic reticulum exit site|,angiogenesis|positive regulation of endothelial cell proliferation|intracellular protein transport|apoptotic process|activation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of endothelial cell migration|negative regulation of vascular endothelial growth factor receptor signaling pathway|negative regulation of TOR signaling|cellular response to heat|vascular endothelial growth factor receptor-2 signaling pathway|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of angiogenesis|response to calcium ion|negative regulation of protein kinase B signaling|,"calcium-dependent cysteine-type endopeptidase activity|calcium ion binding|protein binding|identical protein binding|protein homodimerization activity|protein anchor|protein dimerization activity|calcium-dependent protein binding|binding, bridging|",6,16,3310000000,52.3%
Q8R2Y0,0.676059904,-0.004333333,4.932307101,-0.122666667,0.32119538,-1.071737309,0.043,0.212,-0.084,0.068,-0.166,-0.099,Q8R2Y0,Abhd6,Q8R2Y0_Abhd6,Q8R2Y0,Abhd6,1,12,6,6,Q8R2Y0|Q8R2Y0-2,MOUSE,38603.2,27.6,1474,1474.1,83.29,83.29,,336,Monoacylglycerol lipase ABHD6,mitochondrion|integral component of membrane|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex|extracellular exosome|,phospholipid catabolic process|negative regulation of cell migration|acylglycerol catabolic process|positive regulation of lipid biosynthetic process|long term synaptic depression|regulation of endocannabinoid signaling pathway|,phospholipase activity|acylglycerol lipase activity|,6,12,908000000,27.6%
Q8R1K1,0.461918472,-0.026833333,9.099708597,0.173,0.123035132,1.763958852,-0.057,-0.044,-0.239,0.138,-0.03,0.071,Q8R1K1,Ubac2,Q8R1K1_Ubac2,Q8R1K1,Ubac2,1,18,6,6,Q8R1K1,MOUSE,39398.2,20,1475,1475.1,83.28,83.28,,345,Ubiquitin-associated domain-containing protein 2,endoplasmic reticulum|integral component of membrane|,"protein localization to endoplasmic reticulum|negative regulation of retrograde protein transport, ER to cytosol|",,6,18,10000000000,20.0%
G3X8U3,0.796085917,0.078333333,3.192261634,-0.171333333,0.479483687,-0.749241539,-0.124,-0.078,0.694,-0.103,-0.074,0.155,G3X8U3,2210016F16Rik,G3X8U3_2210016F16Rik,G3X8U3,2210016F16Rik,1,13,7,7,G3X8U3,MOUSE,39013.8,23,1476,1476.1,83.19,83.19,,338,MCG6895,,,,7,13,1850000000,23.0%
B1B1A8,0.956385108,0.004333333,0.631922923,0.016666667,0.864585022,0.177207882,-0.016,0.116,-0.112,0.062,-0.027,0.003,B1B1A8,Mylk,B1B1A8_Mylk,B1B1A8,Mylk,1,14,8,8,B1B1A8|Q6PDN3|Q6PDN3-3|Q6PDN3-2,MOUSE,216229.9,5.1,1477,1477.1,83.18,83.18,,1950,"Myosin light chain kinase, smooth muscle",stress fiber|cytoplasm|cell-cell junction|lamellipodium|cleavage furrow|extracellular exosome|,positive regulation of defense response to virus by host|protein phosphorylation|actin filament organization|positive regulation of cell migration|bleb assembly|positive regulation of calcium ion transport|aorta smooth muscle tissue morphogenesis|cellular hypotonic response|positive regulation of wound healing|activation of mitophagy in response to mitochondrial depolarization|,calmodulin-dependent protein kinase activity|myosin light chain kinase activity|ATP binding|,8,14,7460000000,5.1%
Q711T7,0.497381785,-0.0365,8.231736007,0.156333333,0.150254123,1.624400048,-0.074,-0.015,-0.255,0.058,-0.004,0.071,Q711T7,Nadsyn1,Q711T7_Nadsyn1,Q711T7,Nadsyn1,1,12,9,9,Q711T7|G5E8V4,MOUSE,82792.1,13.2,1478,1478.1,83.14,83.14,,725,Glutamine-dependent NAD(+) synthetase,cytoplasm|,NAD biosynthetic process|,"NAD+ synthase (glutamine-hydrolyzing) activity|ATP binding|NAD+ synthase activity|hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds|",9,12,829000000,13.2%
Q3UYI5,0.811763387,0.023166667,2.931474917,0.057666667,0.509157925,0.697183892,-0.027,0.015,-0.005,0.114,-0.021,0.063,Q3UYI5,Rgl3,Q3UYI5_Rgl3,Q3UYI5,Rgl3,1,11,9,9,Q3UYI5|Q3UYI5-2,MOUSE,78457.2,16.7,1479,1479.1,82.85,82.85,,709,Ral guanine nucleotide dissociation stimulator-like 3,intracellular|,small GTPase mediated signal transduction|positive regulation of GTPase activity|,protein binding|Ral guanyl-nucleotide exchange factor activity|Ras GTPase binding|,9,11,2730000000,16.7%
P48024,0.156075038,-0.002333333,17.37306092,-0.246666667,0.018310235,-3.100609445,0.115,0.14,0.108,-0.131,-0.076,-0.17,P48024,Eif1,P48024_Eif1,P48024,Eif1,1,7,6,6,P48024|Q9CXU9,MOUSE,12860.4,81.4,1480,1480.1,82.81,82.81,,113,Eukaryotic translation initiation factor 1,nucleus|cytoplasm|,translational initiation|regulation of translational initiation|dosage compensation by inactivation of X chromosome|,translation initiation factor activity|poly(A) RNA binding|,6,7,1300000000,81.4%
E9Q512,0.606990596,-0.012833333,6.24059652,0.163666667,0.237651384,1.29808862,-0.197,-0.156,0.069,0.138,-0.128,0.197,E9Q512,Trip11,E9Q512_Trip11,E9Q512,Trip11,1,8,8,8,E9Q512,MOUSE,227022.1,4.7,1481,1481.1,82.73,82.73,,1976,Thyroid hormone receptor interactor 11,inner acrosomal membrane|acrosomal membrane|outer acrosomal membrane|nucleus|Golgi apparatus|cis-Golgi network|,protein targeting to Golgi|ventricular septum development|,protein binding|,8,8,433000000,4.7%
O35250,0.998411609,0.014166667,0.014037624,-0.000333333,0.996772936,-0.004197811,0.005,-0.018,0.056,0.014,-0.017,0.045,O35250,Exoc7,O35250_Exoc7,O35250,Exoc7,1,10,8,8,O35250|A2AAN0|O35250-2,MOUSE,80186.9,15.2,1482,1482.1,82.68,82.68,,697,Exocyst complex component 7,exocyst|microtubule organizing center|cytosol|plasma membrane|membrane|growth cone membrane|centriolar satellite|,exocytosis|protein transport|regulation of entry of bacterium into host cell|,protein binding|,8,10,333000000,15.2%
Q3UIA2,0.842315612,-0.0045,2.479614657,-0.061,0.564987103,-0.605192514,0.113,-0.087,0.052,0.057,-0.151,-0.011,Q3UIA2,Arhgap17,Q3UIA2_Arhgap17,Q3UIA2,Arhgap17,1,12,8,8,Q3UIA2|E9QAJ9|Q3UIA2-2|Q3UIA2-3|Q3UIA2-4|A0A0U1RNM6,MOUSE,92656.9,11.1,1483,1483.1,82.47,82.47,,846,Rho GTPase-activating protein 17,cytoplasm|plasma membrane|bicellular tight junction|,actin filament organization|signal transduction|calcium ion-dependent exocytosis|positive regulation of GTPase activity|,GTPase activator activity|SH3 domain binding|,8,12,3320000000,11.1%
O55142,0.572571882,0.047166667,6.924096233,-0.194333333,0.203044101,-1.412516516,0.011,0.433,-0.011,-0.048,0.003,-0.105,O55142,Rpl35a,O55142_Rpl35a,O55142,Rpl35a,1,22,8,8,O55142,MOUSE,12667.6,49,1484,1484.1,82.43,82.43,,110,60S ribosomal protein L35a,mitochondrion|membrane|cytosolic large ribosomal subunit|extracellular exosome|,rRNA processing|translation|ribosomal large subunit biogenesis|,structural constituent of ribosome|poly(A) RNA binding|,8,22,17400000000,49.0%
P49935,0.000586434,-0.085,48.15113694,0.925333333,1.53069E-05,11.03937426,-0.497,-0.636,-0.51,0.369,0.39,0.374,P49935,Ctsh,P49935_Ctsh,P49935,Ctsh,1,19,6,6,P49935,MOUSE,37740.2,25.5,1485,1485.1,82.27,82.27,,333,Pro-cathepsin H,extracellular space|lysosome|cytosol|extracellular exosome|alveolar lamellar body|,metanephros development|T cell mediated cytotoxicity|immune response-regulating signaling pathway|proteolysis|apoptotic process|activation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of cell proliferation|positive regulation of gene expression|positive regulation of epithelial cell migration|neuropeptide catabolic process|bradykinin catabolic process|positive regulation of peptidase activity|positive regulation of cell migration|zymogen activation|protein destabilization|response to retinoic acid|membrane protein proteolysis|negative regulation of apoptotic process|surfactant homeostasis|positive regulation of angiogenesis|proteolysis involved in cellular protein catabolic process|dichotomous subdivision of terminal units involved in lung branching|ERK1 and ERK2 cascade|cellular response to thyroid hormone stimulus|positive regulation of apoptotic signaling pathway|,endopeptidase activity|aminopeptidase activity|cysteine-type endopeptidase activity|serine-type endopeptidase activity|peptidase activity|cysteine-type peptidase activity|cysteine-type endopeptidase activator activity involved in apoptotic process|peptidase activator activity involved in apoptotic process|HLA-A specific activating MHC class I receptor activity|thyroid hormone binding|,6,19,1520000000,25.5%
Q9R078,0.614913894,-0.030166667,6.073618829,0.185666667,0.24696654,1.269806557,0.014,0.002,-0.385,0.24,0.025,-0.077,Q9R078,Prkab1,Q9R078_Prkab1,Q9R078,Prkab1,1,15,6,6,Q9R078|S4R2R1|Q6PAM0,MOUSE,30421.8,34.4,1486,1486.1,82.24,82.24,,270,5'-AMP-activated protein kinase subunit beta-1,nucleus|cytosol|AMP-activated protein kinase complex|,protein phosphorylation|fatty acid biosynthetic process|signal transduction|positive regulation of gene expression|regulation of protein kinase activity|protein heterooligomerization|,protein kinase activity|AMP-activated protein kinase activity|protein binding|protein kinase binding|,6,15,3740000000,34.4%
Q9D1M0,0.719871588,-0.005166667,4.224870016,-0.072333333,0.378018451,-0.943898501,0.027,0.04,0.026,-0.051,-0.046,-0.027,Q9D1M0,Sec13,Q9D1M0_Sec13,Q9D1M0,Sec13,1,22,5,5,Q9D1M0,MOUSE,36078.5,22,1487,1487.1,82.15,82.15,,322,Protein SEC13 homolog,nuclear envelope|endoplasmic reticulum|endoplasmic reticulum membrane|ER to Golgi transport vesicle membrane|nuclear pore outer ring|GATOR2 complex|extracellular exosome|kinetochore|,ER to Golgi vesicle-mediated transport|protein transport|positive regulation of TOR signaling|mRNA transport|,,5,22,14500000000,22.0%
Q8BH35,0.019347247,0.035833333,28.65730763,0.986333333,0.001362289,5.286244952,-0.685,-0.226,-0.461,0.603,0.196,0.788,Q8BH35,C8b,Q8BH35_C8b,Q8BH35,C8b,1,18,8,8,Q8BH35|Q8BH35-2,MOUSE,68053.9,20.3,1488,1488.1,82.11,82.11,,589,Complement component C8 beta chain,membrane attack complex|extracellular space|extracellular exosome|extracellular vesicle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",protein complex binding|,8,18,843000000,20.3%
Q8BXA1,0.009928326,-0.056166667,32.22501327,0.965,0.000599099,6.118404441,-0.733,-0.641,-0.242,0.246,0.466,0.567,Q8BXA1,Golim4,Q8BXA1_Golim4,Q8BXA1,Golim4,1,7,6,6,D3YVW2|Q8BXA1,MOUSE,76840.5,12.6,1489,1489.1,82.01,82.01,,655,Golgi integral membrane protein 4,nucleoplasm|Golgi apparatus|endosome membrane|membrane|integral component of membrane|Golgi cisterna membrane|,transport|,,6,7,179000000,12.6%
E9QK41,0.514125584,0.022333333,7.954236281,0.284,0.160168228,1.581752982,-0.214,-0.249,0.104,-0.113,0.113,0.493,E9QK41,Ablim1,E9QK41_Ablim1,E9QK41,Ablim1,1,11,7,7,E9QK41|Q8K4G5|E9Q9C2|E9Q9C1|E9Q9C0|Q8K4G5-2|E9Q9C4|E9Q9C7|Q8K4G5-4|E9Q030|Q8K4G5-3|E9Q9D2|E9Q9D1|E9Q9Q7|Q8K4G5-5,MOUSE,98715.9,10.3,1490,1490.1,82,82,,861,Actin-binding LIM protein 1,stress fiber|actin cytoskeleton|lamellipodium|neuronal postsynaptic density|,cytoskeleton organization|axon guidance|lamellipodium assembly|cilium assembly|positive regulation of transcription from RNA polymerase II promoter|,actin binding|zinc ion binding|,7,11,574000000,10.3%
P16301,0.019113951,-0.09,28.74265997,0.658,0.001335777,5.305179219,-0.337,-0.274,-0.646,0.192,0.181,0.344,P16301,Lcat,P16301_Lcat,P16301,Lcat,1,17,6,6,P16301,MOUSE,50088.2,16.2,1491,1491.1,81.9,81.9,,438,Phosphatidylcholine-sterol acyltransferase,extracellular space|high-density lipoprotein particle|extracellular exosome|,phospholipid metabolic process|phosphatidylcholine biosynthetic process|cholesterol metabolic process|cholesterol transport|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|cholesterol esterification|lipoprotein biosynthetic process|cholesterol homeostasis|reverse cholesterol transport|response to copper ion|response to glucocorticoid|regulation of high-density lipoprotein particle assembly|,phosphatidylcholine-sterol O-acyltransferase activity|phospholipase A2 activity|apolipoprotein A-I binding|,6,17,2140000000,16.2%
Q5I012,0.122124581,0.0185,18.77905428,0.359,0.0132463,3.343386973,-0.293,-0.124,-0.066,0.176,0.089,0.329,Q5I012,Slc38a10,Q5I012_Slc38a10,Q5I012,Slc38a10,1,18,9,9,Q5I012|J3QNE8|Q5I012-2|Q5I012-3|Q5I012-4,MOUSE,117762.2,12.4,1492,1492.1,81.86,81.86,,1090,Putative sodium-coupled neutral amino acid transporter 10,Golgi apparatus|integral component of membrane|,amino acid transmembrane transport|sodium ion transport|bone development|,amino acid transmembrane transporter activity|,9,18,6700000000,12.4%
Q9WTL7,0.066132928,-0.000833333,22.23542197,0.386333333,0.00597665,3.959275784,-0.151,-0.195,-0.236,0.156,0.085,0.336,Q9WTL7,Lypla2,Q9WTL7_Lypla2,Q9WTL7,Lypla2,1,16,6,6,Q9WTL7,MOUSE,25135.9,36.7,1493,1493.1,81.86,81.86,,231,Acyl-protein thioesterase 2,cytoplasm|extracellular exosome|,fatty acid metabolic process|,hydrolase activity|,6,16,3920000000,36.7%
Q8C5W0,0.844185634,-0.022333333,2.444434019,0.071333333,0.569582448,0.59822432,-0.014,0.121,-0.281,0,0.033,0.007,Q8C5W0,Clmn,Q8C5W0_Clmn,Q8C5W0,Clmn,1,10,7,7,Q8C5W0|Q8C5W0-4|Q8C5W0-3|Q8C5W0-2,MOUSE,117738.3,10.8,1494,1494.1,81.74,81.74,,1052,Calmin,cytoplasm|membrane|integral component of membrane|,negative regulation of cell proliferation|neuron projection development|,actin binding|,7,10,730000000,10.8%
O54998,0.000319249,-0.2615,54.14218162,1.749,3.85285E-06,13.88568266,-1.082,-1.035,-1.291,0.463,0.566,0.81,O54998,Fkbp7,O54998_Fkbp7,O54998,Fkbp7,1,15,7,7,O54998|H3BJI5,MOUSE,25198,29.3,1495,1495.1,81.64,81.64,,218,Peptidyl-prolyl cis-trans isomerase FKBP7,cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|,protein peptidyl-prolyl isomerization|chaperone-mediated protein folding|,peptidyl-prolyl cis-trans isomerase activity|calcium ion binding|protein binding|FK506 binding|,7,15,1250000000,29.3%
Q8JZN7,0.791316333,-0.082166667,3.245635833,0.165666667,0.473626961,0.759677772,0.119,0.076,-0.69,0.002,0.022,-0.022,Q8JZN7,Rhot2,Q8JZN7_Rhot2,Q8JZN7,Rhot2,1,13,7,5,Q8JZN7|H3BKJ1,MOUSE,70153.9,16.1,1496,1496.1,81.63,52.27,,620,Mitochondrial Rho GTPase 2,mitochondrion|mitochondrial inner membrane|membrane|integral component of mitochondrial outer membrane|extracellular exosome|,small GTPase mediated signal transduction|metabolic process|cellular homeostasis|mitochondrion transport along microtubule|mitochondrial outer membrane permeabilization|,GTPase activity|calcium ion binding|GTP binding|,7,13,1500000000,16.1%
Q8BG51-4,0.336787221,0.025166667,11.72958372,-0.223,0.067149321,-2.182398526,0.115,0.28,0.015,-0.015,-0.084,-0.16,Q8BG51,Rhot1,Q8BG51-4_Rhot1,Q8BG51-4,Rhot1,1,5,5,3,Q8BG51-4|Q8BG51-3|Q8BG51-2|Q8BG51,MOUSE,82195.7,7.1,1496,1496.2,56.69,27.33,,631,Isoform 4 of Mitochondrial Rho GTPase 1,mitochondrion|membrane|integral component of mitochondrial outer membrane|,small GTPase mediated signal transduction|metabolic process|cellular homeostasis|mitochondrion transport along microtubule|mitochondrial outer membrane permeabilization|,GTPase activity|calcium ion binding|GTP binding|,3,5,242000000,4.2%
E9PVB5,0.014006693,-0.0635,30.38124286,0.767,0.000915958,5.677673664,-0.241,-0.407,-0.693,0.251,0.275,0.434,E9PVB5,Ttc17,E9PVB5_Ttc17,E9PVB5,Ttc17,1,12,7,7,E9PVB5|E9PVB5-2|A2AFY7|A2AGG1,MOUSE,136716.5,7.7,1497,1497.1,81.6,81.6,,1198,Tetratricopeptide repeat protein 17,cytoplasm|plasma membrane|actin cytoskeleton|,actin filament polymerization|cilium organization|,,7,12,1500000000,7.7%
Q9D8T7,0.798949474,0.016666667,3.081053582,-0.058,0.491920183,-0.726877925,0.063,0.054,0.02,-0.066,0.02,0.009,Q9D8T7,Slirp,Q9D8T7_Slirp,Q9D8T7,Slirp,1,18,6,6,Q9D8T7|Q9D8T7-2,MOUSE,12662.1,72.3,1498,1498.1,81.58,81.58,,112,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",acrosomal vesicle|nucleus|cytoplasm|mitochondrion|ribonucleoprotein complex|sperm flagellum|perinuclear region of cytoplasm|,"negative regulation of mitochondrial RNA catabolic process|transcription, DNA-templated|regulation of transcription, DNA-templated|spermatid development|single fertilization|sperm motility|mitochondrion morphogenesis|",nucleotide binding|poly(A) RNA binding|,6,18,12100000000,72.3%
Q3UCV8,0.929192436,0.020666667,1.011550928,0.028,0.792218367,0.274169572,0.051,0.018,-0.049,0.189,-0.094,0.009,Q3UCV8,Otulin,Q3UCV8_Otulin,Q3UCV8,Otulin,1,17,8,8,Q3UCV8,MOUSE,40718.7,23.8,1499,1499.1,81.53,81.53,,352,Ubiquitin thioesterase otulin,cytoplasm|LUBAC complex|,sprouting angiogenesis|negative regulation of NF-kappaB transcription factor activity|innate immune response|negative regulation of inflammatory response|canonical Wnt signaling pathway|nucleotide-binding oligomerization domain containing 2 signaling pathway|protein linear deubiquitination|,ubiquitin-specific protease activity|cysteine-type peptidase activity|,8,17,5400000000,23.8%
Q9ER39,0.919416995,-0.016333333,1.241645997,0.038,0.751338079,0.330306584,0.099,0.05,-0.255,0.013,0.017,-0.022,Q9ER39,Tor1a,Q9ER39_Tor1a,Q9ER39,Tor1a,1,13,6,6,Q9ER39,MOUSE,38228.6,21.6,1500,1500.1,81.5,81.5,,333,Torsin-1A,nucleus|nuclear envelope|cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|cytoskeleton|synaptic vesicle|membrane|cell junction|transport vesicle|secretory granule|growth cone|cytoplasmic vesicle membrane|nuclear membrane|extrinsic component of endoplasmic reticulum membrane|intracellular membrane-bounded organelle|extracellular exosome|,"protein deneddylation|response to oxidative stress|organelle organization|nuclear envelope organization|cell adhesion|neuron projection development|protein localization to nucleus|wound healing, spreading of cells|intermediate filament cytoskeleton organization|synaptic vesicle transport|chaperone mediated protein folding requiring cofactor|protein homooligomerization|regulation of dopamine uptake involved in synaptic transmission|chaperone-mediated protein folding|ER-associated misfolded protein catabolic process|nuclear membrane organization|chaperone-mediated protein transport|positive regulation of synaptic vesicle endocytosis|regulation of protein localization to cell surface|",protein binding|ATP binding|cytoskeletal protein binding|ATPase activity|kinesin binding|unfolded protein binding|misfolded protein binding|,6,13,4370000000,21.6%
Q8BUK6,0.228674286,-0.046,14.84177591,0.340666667,0.032796116,2.689579846,-0.037,-0.38,-0.232,0.291,0.013,0.069,Q8BUK6,Hook3,Q8BUK6_Hook3,Q8BUK6,Hook3,1,9,8,8,Q8BUK6,MOUSE,83615.8,12.9,1501,1501.1,81.4,81.4,,718,Protein Hook homolog 3,pericentriolar material|cytoplasm|Golgi apparatus|cis-Golgi network|centrosome|microtubule organizing center|microtubule|centriolar satellite|FHF complex|HOPS complex|,endosome organization|lysosome organization|endosome to lysosome transport|protein transport|interkinetic nuclear migration|cytoplasmic microtubule organization|microtubule anchoring at centrosome|early endosome to late endosome transport|negative regulation of neurogenesis|Golgi localization|protein localization to centrosome|neuronal stem cell maintenance|,protein binding|microtubule binding|identical protein binding|,8,9,529000000,12.9%
E9PVN6,0.773512169,-0.007666667,3.50311678,-0.085333333,0.446363138,-0.808968712,0.081,0.148,-0.124,0.043,-0.102,-0.092,E9PVN6,Gm20498,E9PVN6_Gm20498,E9PVN6,Gm20498,1,12,6,6,E9PVN6|Q9D6K5-4|Q9D6K5|Q9D6K5-2|Q9D6K5-3|Q9CR63|E9PVQ9,MOUSE,20499.7,48.9,1502,1502.1,81.39,81.39,,182,Predicted gene 20498,mitochondrial membrane|,,,6,12,2740000000,48.9%
Q80U78,0.754778221,-0.029166667,3.775506679,0.079,0.419227084,0.860545847,-0.02,0.006,-0.192,0.045,0.017,-0.031,Q80U78,Pum1,Q80U78_Pum1,Q80U78,Pum1,1,12,8,5,Q80U78|Q80U78-3|Q80U78-2|Q3TTW5|E9Q6M7|Q80U78-4,MOUSE,127301.8,8.1,1503,1503.1,81.35,43.74,,1189,Pumilio homolog 1,cytoplasmic mRNA processing body|cytoplasm|cytoplasmic stress granule|,spermatogenesis|adult locomotory behavior|posttranscriptional gene silencing|stem cell differentiation|regulation of cell cycle|mRNA destabilization|positive regulation of RIG-I signaling pathway|positive regulation of gene silencing by miRNA|,mRNA 3'-UTR binding|poly(A) RNA binding|,8,12,11900000000,8.1%
Q6PGB6-4,0.648073376,-0.0025,5.36872832,-0.105,0.290487312,-1.147560703,0.084,0.126,-0.06,-0.032,-0.013,-0.12,Q6PGB6,Naa50,Q6PGB6-4_Naa50,Q6PGB6-4,Naa50,1,28,7,7,Q6PGB6-4|Q6PGB6|Q6PGB6-2|Q6PGB6-3|Q6PGB6-5,MOUSE,20271.8,36.5,1504,1504.1,81.33,81.33,,169,Isoform 4 of N-alpha-acetyltransferase 50,cytoplasm|protein acetyltransferase complex|extracellular exosome|NatA complex|,"N-terminal protein amino acid acetylation|histone H4 acetylation|mitotic sister chromatid cohesion, centromeric|","peptide alpha-N-acetyltransferase activity|protein binding|H4 histone acetyltransferase activity|peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor|",7,28,18800000000,36.5%
K3W4R5,0.926554478,0.027333333,1.064984812,0.027333333,0.782530942,0.287350717,-0.043,0.05,0.034,0.176,-0.032,-0.021,K3W4R5,Ckap5,K3W4R5_Ckap5,K3W4R5,Ckap5,1,13,9,9,K3W4R5|A2AGT5|A0A0R4J0K2|A2AGT5-3|Z4YL78|A2AGT5-2|A0A0U1RPM3|Q9Z0S9,MOUSE,227286.2,5.7,1505,1505.1,81,81,,2032,Cytoskeleton-associated protein 5,spindle pole|cytoplasm|centrosome|membrane|protein complex|gamma-tubulin complex|microtubule plus-end|,spindle organization|establishment or maintenance of microtubule cytoskeleton polarity|centrosome organization|,microtubule binding|ribonucleoprotein complex binding|,9,13,2700000000,5.7%
Q8BGA8,0.826064255,-0.035333333,2.687103644,0.101333333,0.53862888,0.6482837,-0.09,0.185,-0.353,0.119,0.075,-0.148,Q8BGA8,Acsm5,Q8BGA8_Acsm5,Q8BGA8,Acsm5,1,11,10,10,Q8BGA8|A0A140LHR8|Q8BGA8-2|Q6P8J0,MOUSE,65183.1,29.2,1506,1506.1,80.98,80.98,,578,"Acyl-coenzyme A synthetase ACSM5, mitochondrial",mitochondrial matrix|,fatty acid metabolic process|,ATP binding|metal ion binding|butyrate-CoA ligase activity|,10,11,1070000000,29.2%
P63073,0.241192428,0.011,14.47641538,-0.320666667,0.035674547,-2.629859161,0.074,0.324,0.116,-0.327,-0.122,0.001,P63073,Eif4e,P63073_Eif4e,P63073,Eif4e,1,13,6,6,P63073|A0A0G2JH04|A0A0G2JFB4,MOUSE,25281,26.7,1507,1507.1,80.88,80.88,,217,Eukaryotic translation initiation factor 4E,cytoplasmic mRNA processing body|cytoplasm|mRNA cap binding complex|cytoplasmic stress granule|eukaryotic translation initiation factor 4F complex|RISC complex|chromatoid body|perinuclear region of cytoplasm|extracellular exosome|,G1/S transition of mitotic cell cycle|behavioral fear response|translational initiation|regulation of translation|negative regulation of translation|stem cell maintenance|negative regulation of neuron differentiation|positive regulation of mitotic cell cycle|,translation initiation factor activity|protein binding|enzyme binding|eukaryotic initiation factor 4G binding|poly(A) RNA binding|repressing transcription factor binding|,6,13,3490000000,26.7%
P47811-3,0.471902671,0.031166667,8.809917522,-0.187,0.131524981,-1.718145164,0.007,0.182,0.185,0.061,-0.032,-0.216,P47811,Mapk14,P47811-3_Mapk14,P47811-3,Mapk14,1,15,7,7,P47811-3|P47811|P47811-4|B2KF35|P47811-2,MOUSE,41714.9,21.3,1508,1508.1,80.83,80.83,,360,Isoform 3 of Mitogen-activated protein kinase 14,spindle pole|cell|nucleus|nucleoplasm|cytoplasm|mitochondrion|cytosol|extracellular exosome|,"DNA damage checkpoint|cell morphogenesis|cartilage condensation|angiogenesis|placenta development|chondrocyte differentiation|glucose metabolic process|transcription, DNA-templated|regulation of transcription, DNA-templated|regulation of transcription from RNA polymerase II promoter|protein phosphorylation|apoptotic process|cellular response to DNA damage stimulus|transmembrane receptor protein serine/threonine kinase signaling pathway|skeletal muscle tissue development|response to glucose|positive regulation of gene expression|positive regulation of myotube differentiation|myoblast differentiation involved in skeletal muscle regeneration|peptidyl-serine phosphorylation|fatty acid oxidation|osteoclast differentiation|positive regulation of cyclase activity|lipopolysaccharide-mediated signaling pathway|response to muramyl dipeptide|response to lipopolysaccharide|intracellular signal transduction|cellular response to vascular endothelial growth factor stimulus|response to muscle stretch|p38MAPK cascade|positive regulation of protein import into nucleus|signal transduction in response to DNA damage|positive regulation of erythrocyte differentiation|positive regulation of myoblast differentiation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of glucose import|protein autophosphorylation|vascular endothelial growth factor receptor signaling pathway|striated muscle cell differentiation|positive regulation of cardiac muscle cell proliferation|cellular response to lipopolysaccharide|cellular response to ionizing radiation|negative regulation of canonical Wnt signaling pathway|positive regulation of brown fat cell differentiation|stress-induced premature senescence|regulation of cytokine production involved in inflammatory response|positive regulation of myoblast fusion|positive regulation of reactive oxygen species metabolic process|",protein kinase activity|protein serine/threonine kinase activity|MAP kinase activity|protein binding|ATP binding|protein C-terminus binding|kinase activity|NFAT protein binding|,7,15,987000000,21.3%
E9PWG2,0.949474693,-0.014166667,0.771175077,-0.021666667,0.837302701,-0.21348442,-0.162,0.024,0.128,-0.053,-0.028,0.006,E9PWG2,Trappc8,E9PWG2_Trappc8,E9PWG2,Trappc8,1,15,9,9,E9PWG2|A0A286YCX6|E9PY51,MOUSE,162562.6,8.4,1509,1509.1,80.78,80.78,,1437,Trafficking protein particle complex 8,pre-autophagosomal structure|cytoplasmic vesicle|TRAPPIII protein complex|,autophagosome assembly|ER to Golgi vesicle-mediated transport|peroxisome degradation|CVT pathway|protein localization to pre-autophagosomal structure|nucleophagy|,,9,15,1460000000,8.4%
Q8VDG5,0.919416995,0.025166667,1.230073731,-0.051,0.753342774,-0.327582261,-0.054,0.373,-0.167,-0.12,0.066,0.053,Q8VDG5,Ppcs,Q8VDG5_Ppcs,Q8VDG5,Ppcs,1,12,8,8,Q8VDG5|Q8VDG5-2,MOUSE,33850.5,29.5,1510,1510.1,80.76,80.76,,311,Phosphopantothenate--cysteine ligase,extracellular exosome|,coenzyme A biosynthetic process|,phosphopantothenate--cysteine ligase activity|,8,12,12400000000,29.5%
Q99LB6,0.926033297,-0.000833333,1.073923149,-0.029666667,0.780922049,-0.289546407,0.125,0.055,-0.138,-0.017,0.055,-0.085,Q99LB6,Mat2b,Q99LB6_Mat2b,Q99LB6,Mat2b,1,10,6,6,Q99LB6|Q99LB6-2|E0CYU5,MOUSE,37791.3,23.3,1511,1511.1,80.75,80.75,,334,Methionine adenosyltransferase 2 subunit beta,nucleus|mitochondrion|methionine adenosyltransferase complex|extracellular exosome|,S-adenosylmethionine biosynthetic process|one-carbon metabolic process|regulation of catalytic activity|,enzyme binding|methionine adenosyltransferase regulator activity|,6,10,3480000000,23.3%
Q9Z1G3,0.647606275,0.029833333,5.39380877,-0.141666667,0.288814586,-1.153065486,-0.131,0.181,0.252,-0.122,0.008,-0.009,Q9Z1G3,Atp6v1c1,Q9Z1G3_Atp6v1c1,Q9Z1G3,Atp6v1c1,1,13,8,8,Q9Z1G3,MOUSE,44057.9,20.6,1512,1512.1,80.69,80.69,,382,V-type proton ATPase subunit C 1,"lysosomal membrane|plasma membrane|cytoplasmic vesicle|proton-transporting V-type ATPase, V1 domain|apical part of cell|extracellular exosome|",ATP hydrolysis coupled proton transport|,"hydrogen-exporting ATPase activity, phosphorylative mechanism|",8,13,1190000000,20.6%
Q9JJI8,0.621229204,0.031,5.933196325,-0.196666667,0.255082325,-1.2459102,-0.138,0.417,0.109,-0.191,0.075,-0.086,Q9JJI8,Rpl38,Q9JJI8_Rpl38,Q9JJI8,Rpl38,1,24,6,6,Q9JJI8,MOUSE,8260.8,52.8,1513,1513.1,80.56,80.56,,70,60S ribosomal protein L38,focal adhesion|cytosolic large ribosomal subunit|eukaryotic 80S initiation complex|,skeletal system development|ossification|translation|regulation of translation|sensory perception of sound|90S preribosome assembly|middle ear morphogenesis|axial mesoderm development|,structural constituent of ribosome|,6,24,15200000000,52.8%
Q61211-2,0.965296689,-0.037166667,0.464465547,-0.014333333,0.898573166,-0.132393334,0.085,-0.011,-0.164,0.082,-0.064,-0.151,Q61211,Eif2d,Q61211-2_Eif2d,Q61211-2,Eif2d,1,9,6,6,Q61211-2|A0A0R4J298|Q61211|E9PUG7|Q8C8I3,MOUSE,65423.2,16,1514,1514.1,80.48,80.48,,570,Isoform 2 of Eukaryotic translation initiation factor 2D,nucleus|nucleoplasm|cytoplasm|cytosolic small ribosomal subunit|,formation of translation preinitiation complex|IRES-dependent translational initiation|ribosome disassembly|,translation initiation factor activity|,6,9,227000000,16.0%
P84244,0.744718456,0.083666667,3.917981699,-0.166,0.405697032,-0.887904137,-0.051,0.534,0.017,-0.166,-0.064,0.232,P84244,H3f3a,P84244_H3f3a,P84244,H3f3a,1,21,6,1,P84244|P02301|P68433|F8WI35,MOUSE,15384.7,47.7,1515,1515.1,80.47,27.59,,136,Histone H3.3,nuclear nucleosome|nucleoplasm|extracellular exosome|,chromatin silencing at rDNA|DNA replication-independent nucleosome assembly|brain development|response to hormone|positive regulation of cell growth|,RNA polymerase II core promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|histone binding|protein heterodimerization activity|,6,21,46000000000,47.7%
P28658,0.963376742,-0.052166667,0.497812658,-0.017666667,0.891699933,-0.141479532,0.097,-0.029,-0.198,0.102,-0.227,-0.058,P28658,Atxn10,P28658_Atxn10,P28658,Atxn10,1,13,7,7,P28658,MOUSE,54333.5,19.1,1516,1516.1,80.34,80.34,,475,Ataxin-10,extracellular space|cytoplasm|cytosol|plasma membrane|membrane|dendrite|neuronal cell body|perinuclear region of cytoplasm|,nervous system development|neuron projection development|protein homotrimerization|,protein binding|enzyme binding|identical protein binding|,7,13,2680000000,19.1%
Q9CT10,0.975683513,-0.043166667,0.357799887,0.013666667,0.920915985,0.103127599,0.021,0.142,-0.313,-0.101,-0.013,0.005,Q9CT10,Ranbp3,Q9CT10_Ranbp3,Q9CT10,Ranbp3,1,13,6,6,Q9CT10,MOUSE,52857.1,16.9,1517,1517.1,80.32,80.32,,491,Ran-binding protein 3,nucleus|nucleoplasm|cytoplasm|,protein transport|intracellular transport|,R-SMAD binding|,6,13,673000000,16.9%
Q9WVA3,0.953420192,0.031166667,0.695906875,0.029,0.851940594,0.19407112,-0.148,-0.134,0.332,0.032,-0.035,0.14,Q9WVA3,Bub3,Q9WVA3_Bub3,Q9WVA3,Bub3,1,18,7,7,Q9WVA3|A0A140LHA2|A0A140LIM5|A0A140LI47,MOUSE,37353.2,22.6,1518,1518.1,80.29,80.29,,326,Mitotic checkpoint protein BUB3,kinetochore|condensed chromosome kinetochore|nucleoplasm|,mitotic sister chromatid segregation|chromosome segregation|attachment of spindle microtubules to kinetochore|cell division|meiotic cell cycle|regulation of chromosome segregation|spindle assembly checkpoint|,,7,18,762000000,22.6%
O35969-2,0.536434852,-0.0265,7.498560357,0.171666667,0.177886899,1.506453183,-0.125,0.053,-0.265,0.006,0.178,-0.006,O35969,Gamt,O35969-2_Gamt,O35969-2,Gamt,1,11,7,7,O35969-2|O35969,MOUSE,28254.7,38.4,1519,1519.1,80.27,80.27,,236,Isoform 2 of Guanidinoacetate N-methyltransferase,microvillus|extracellular exosome|,creatine biosynthetic process|spermatogenesis|organ morphogenesis|methylation|regulation of multicellular organism growth|S-adenosylhomocysteine metabolic process|S-adenosylmethionine metabolic process|embryonic liver development|,guanidinoacetate N-methyltransferase activity|protein homodimerization activity|,7,11,3190000000,38.4%
Q8CIN4,0.918513912,-0.022333333,1.267676409,0.05,0.746848235,0.336583209,-0.335,0.039,0.154,-0.131,0.021,0.118,Q8CIN4,Pak2,Q8CIN4_Pak2,Q8CIN4,Pak2,1,14,7,7,Q8CIN4|Q61036|Q61036-2|O88643|G5E884,MOUSE,58214.6,17.3,1520,1520.1,80.27,80.27,,524,Serine/threonine-protein kinase PAK 2,nucleoplasm|cytoplasm|membrane|perinuclear region of cytoplasm|,protein phosphorylation|Rho protein signal transduction|regulation of mitotic cell cycle|phosphorylation|cell migration|peptidyl-serine phosphorylation|signal transduction by protein phosphorylation|actin cytoskeleton organization|stress-activated protein kinase signaling cascade|activation of protein kinase activity|regulation of growth|negative regulation of apoptotic process|regulation of MAPK cascade|protein autophosphorylation|positive regulation of peptidyl-tyrosine phosphorylation|dendritic spine development|positive regulation of protein tyrosine kinase activity|cellular response to organic cyclic compound|positive regulation of extrinsic apoptotic signaling pathway|negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis|,protein kinase activity|protein serine/threonine kinase activity|protein binding|ATP binding|protein kinase binding|protein tyrosine kinase activator activity|identical protein binding|Rac GTPase binding|,7,14,3130000000,17.3%
P26516,0.687405839,-0.025333333,4.742554485,0.113333333,0.335540194,1.037637042,-0.007,0.027,-0.266,-0.05,0.066,0.078,P26516,Psmd7,P26516_Psmd7,P26516,Psmd7,1,10,6,6,P26516,MOUSE,36596.2,25.5,1521,1521.1,80.14,80.14,,321,26S proteasome non-ATPase regulatory subunit 7,proteasome complex|nucleus|nucleoplasm|proteasome regulatory particle|membrane|extracellular exosome|,,protein homodimerization activity|,6,10,2200000000,25.5%
E9PYF4,0.706061876,-0.017,4.455344935,0.091333333,0.358480475,0.985839518,0.056,-0.082,-0.162,0.062,-0.017,0.041,E9PYF4,Lmo7,E9PYF4_Lmo7,E9PYF4,Lmo7,1,13,8,8,E9PYF4|E9PYI7,MOUSE,193804.7,5.4,1522,1522.1,80.11,80.11,,1699,LIM domain only 7,focal adhesion|,regulation of signaling|regulation of cell adhesion|,zinc ion binding|,8,13,929000000,5.4%
O70400,0.47841582,0.045166667,8.617103332,0.299666667,0.137495874,1.689179408,-0.245,-0.264,0.195,0.027,0.081,0.477,O70400,Pdlim1,O70400_Pdlim1,O70400,Pdlim1,1,10,7,7,O70400,MOUSE,36230.2,35.4,1523,1523.1,80.06,80.06,,327,PDZ and LIM domain protein 1,transcription factor complex|cytoplasm|cytoskeleton|focal adhesion|,"response to hypoxia|regulation of transcription, DNA-templated|",transcription coactivator activity|protein binding|zinc ion binding|,7,10,528000000,35.4%
P62317,0.99327985,-0.024666667,0.120432276,-0.007333333,0.972650406,-0.035600632,-0.467,0.127,0.277,-0.155,-0.089,0.159,P62317,Snrpd2,P62317_Snrpd2,P62317,Snrpd2,1,13,7,7,P62317,MOUSE,13640.8,63.5,1524,1524.1,79.83,79.83,,118,Small nuclear ribonucleoprotein Sm D2,U1 snRNP|U4 snRNP|U12-type spliceosomal complex|cytosol|methylosome|pICln-Sm protein complex|SMN-Sm protein complex|extracellular exosome|catalytic step 2 spliceosome|,spliceosomal snRNP assembly|,poly(A) RNA binding|,7,13,4900000000,63.5%
Q8BLF1,0.387241291,-0.059666667,10.68725586,0.317333333,0.085363932,2.020818733,-0.011,-0.09,-0.554,0.201,0.037,0.059,Q8BLF1,Nceh1,Q8BLF1_Nceh1,Q8BLF1,Nceh1,1,11,6,6,Q8BLF1|Q8BYQ0,MOUSE,45967,22.3,1525,1525.1,79.62,79.62,,408,Neutral cholesterol ester hydrolase 1,endoplasmic reticulum|membrane|integral component of membrane|,protein dephosphorylation|xenobiotic metabolic process|lipid catabolic process|SMAD protein signal transduction|,serine hydrolase activity|phosphate ion binding|carboxylic ester hydrolase activity|,6,11,953000000,22.3%
P32233,0.836873322,0.008833333,2.576213421,-0.099,0.552559001,-0.625544753,-0.175,0.393,-0.043,-0.141,0.007,0.012,P32233,Drg1,P32233_Drg1,P32233,Drg1,1,11,7,7,P32233,MOUSE,40796.6,23.1,1526,1526.1,79.49,79.49,,367,Developmentally-regulated GTP-binding protein 1,cytoplasm|polysome|membrane|,,GTP binding|identical protein binding|,7,11,19000000000,23.1%
P26369,0.852968656,0.012333333,2.345621761,-0.056666667,0.582690347,-0.577182946,-0.08,0.182,0.02,-0.059,0.022,-0.011,P26369,U2af2,P26369_U2af2,P26369,U2af2,1,15,8,8,P26369|Q80XR5|Q3KQM4,MOUSE,53858.4,32,1527,1527.1,79.42,79.42,,475,Splicing factor U2AF 65 kDa subunit,nucleoplasm|spliceosomal complex|nuclear speck|Prp19 complex|,"mRNA processing|RNA splicing|positive regulation of RNA splicing|negative regulation of mRNA splicing, via spliceosome|regulation of mitochondrion degradation|positive regulation of protein targeting to mitochondrion|",nucleotide binding|protein binding|enzyme binding|poly(A) RNA binding|C2H2 zinc finger domain binding|,8,15,27600000000,32.0%
Q9JJK5,0.919416995,0.0065,1.217054893,0.049666667,0.755604456,0.324454822,-0.239,-0.095,0.279,0.175,-0.071,-0.01,Q9JJK5,Herpud1,Q9JJK5_Herpud1,Q9JJK5,Herpud1,1,18,7,7,Q9JJK5|Q8C4N0,MOUSE,44020.4,27.1,1528,1528.1,79.21,79.21,,391,Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|Lewy body core|calcium channel complex|,"ubiquitin-dependent protein catabolic process|endoplasmic reticulum unfolded protein response|retrograde protein transport, ER to cytosol|regulation of protein ubiquitination|positive regulation of protein binding|endoplasmic reticulum calcium ion homeostasis|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|regulation of ER-associated ubiquitin-dependent protein catabolic process|positive regulation of ER-associated ubiquitin-dependent protein catabolic process|negative regulation of intrinsic apoptotic signaling pathway|",protein binding|ion channel binding|,7,18,2430000000,27.1%
Q8R0G9,0.454052388,0.001333333,9.269234431,-0.150666667,0.118325012,-1.791051616,0.046,0.08,0.104,-0.032,-0.159,-0.031,Q8R0G9,Nup133,Q8R0G9_Nup133,Q8R0G9,Nup133,1,10,6,6,Q8R0G9,MOUSE,129815.9,9.4,1529,1529.1,79.21,79.21,,1155,Nuclear pore complex protein Nup133,nuclear pore|membrane|nuclear pore outer ring|nuclear membrane|condensed chromosome kinetochore|condensed chromosome outer kinetochore|,mRNA export from nucleus|nuclear pore organization|protein transport|paraxial mesoderm development|,nucleocytoplasmic transporter activity|,6,10,509000000,9.4%
Q70FJ1,0.967029453,-0.0115,0.443515608,0.010333333,0.902918267,0.126672882,0.016,0.009,-0.075,-0.018,-0.039,0.038,Q70FJ1,Akap9,Q70FJ1_Akap9,Q70FJ1,Akap9,1,8,8,8,Q70FJ1|Q70FJ1-2|E9QQ10|Q70FJ1-3,MOUSE,439405.6,2.9,1530,1530.1,79.2,79.2,,3797,A-kinase anchor protein 9,pericentriolar material|cytoplasm|Golgi apparatus|centrosome|ciliary basal body|,signal transduction|spermatogenesis|Sertoli cell development|,protein binding|protein complex scaffold|,8,8,225000000,2.9%
D3Z7W0,0.751736923,-0.0265,3.812297244,0.119,0.415690669,0.868116487,-0.007,0.079,-0.33,0.189,-0.055,-0.035,D3Z7W0,NotFound,D3Z7W0_NotFound,D3Z7W0,Iscu,1,14,5,5,D3Z7W0|Q9D7P6,MOUSE,22451.5,30.6,1531,1531.1,79.12,79.12,,209,"Iron-sulfur cluster assembly enzyme ISCU, mitochondrial",cytoplasm|mitochondrion|mitochondrial matrix|cytosol|,cellular iron ion homeostasis|[2Fe-2S] cluster assembly|protein maturation by iron-sulfur cluster transfer|,"ferrous iron binding|protein complex scaffold|iron-sulfur transferase activity|2 iron, 2 sulfur cluster binding|4 iron, 4 sulfur cluster binding|",5,14,2890000000,30.6%
Q8C0Z1,0.857449938,-0.0185,2.264124536,0.065666667,0.593728022,0.560225008,0.05,0.069,-0.273,0.065,-0.041,0.019,Q8C0Z1,Fam234a,Q8C0Z1_Fam234a,Q8C0Z1,Fam234a,1,8,6,6,Q8C0Z1,MOUSE,61145.3,14.7,1532,1532.1,79.06,79.06,,555,Protein FAM234A,cell surface|integral component of membrane|extracellular exosome|,,,6,8,1590000000,14.7%
P70349,0.996081204,-0.018333333,0.046405145,0.004666667,0.989371704,0.013831867,-0.453,-0.13,0.521,-0.61,0.12,0.442,P70349,Hint1,P70349_Hint1,P70349,Hint1,1,28,7,7,P70349|B0R1E3,MOUSE,13890.8,48.4,1533,1533.1,79.05,79.05,,126,Histidine triad nucleotide-binding protein 1,histone deacetylase complex|nucleus|cytoplasm|plasma membrane|extracellular exosome|,"transcription, DNA-templated|regulation of transcription, DNA-templated|purine ribonucleotide catabolic process|positive regulation of calcium-mediated signaling|intrinsic apoptotic signaling pathway by p53 class mediator|",nucleotide binding|hydrolase activity|,7,28,28400000000,48.4%
A2A8L5,0.821409751,-0.0185,2.763459439,0.065666667,0.5292417,0.663399677,-0.21,0.016,0.04,-0.02,0.026,0.037,A2A8L5,Ptprf,A2A8L5_Ptprf,A2A8L5,Ptprf,1,13,9,9,A2A8L5|Q64487-6|Q64487-7|Q64487|Q64487-5|Q64487-8|Q64487-10|Q64487-9|Q64487-11|Q64487-1|G3UY75|G3UX60|B9EJA3|E9PVW8|G3UWK6|E9Q7I7|Q64487-12|G3UYU6|Q64487-3|B0V2N1|B0V2N1-2|B0V2N1-6|B0V2N1-3|B0V2N1-4|Q64487-2|Q5SPA9|B0V2N1-5,MOUSE,212569.5,5.2,1534,1534.1,79,79,,1898,Receptor-type tyrosine-protein phosphatase F,integral component of membrane|neuron projection|neuronal cell body|extracellular exosome|,cell adhesion|regulation of neuron projection development|cell migration|neuron projection regeneration|peptidyl-tyrosine dephosphorylation|regulation of axon regeneration|negative regulation of receptor binding|,phosphoprotein phosphatase activity|protein tyrosine phosphatase activity|heparin binding|protein complex binding|chondroitin sulfate proteoglycan binding|,10,13,817000000,5.2%
P43006,0.935669179,-0.0335,0.921427818,0.053,0.808829939,0.251804412,0.004,0.333,-0.517,-0.109,0.041,0.047,P43006,Slc1a2,P43006_Slc1a2,P43006,Slc1a2,1,13,5,5,P43006|P43006-2|A2APL5|P43006-3,MOUSE,62542.6,10.3,1535,1535.1,78.98,78.98,,572,Excitatory amino acid transporter 2,integral component of plasma membrane|cell surface|axon|axolemma|,nervous system development|visual behavior|response to light stimulus|response to wounding|multicellular organismal aging|L-glutamate transport|telencephalon development|adult behavior|cellular response to extracellular stimulus|multicellular organism growth|response to drug|response to amino acid|positive regulation of glucose import|L-glutamate import|D-aspartate import|L-glutamate transmembrane transport|,L-glutamate transmembrane transporter activity|glutamate:sodium symporter activity|sodium:dicarboxylate symporter activity|,5,13,3210000000,10.3%
P09671,0.864103982,-0.0435,2.167048479,0.088333333,0.607148816,0.539580877,0.055,0.135,-0.453,0.063,-0.032,-0.029,P09671,Sod2,P09671_Sod2,P09671,Sod2,1,15,8,8,P09671,MOUSE,24830.7,41.8,1536,1536.1,78.97,78.97,,222,"Superoxide dismutase [Mn], mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial nucleoid|myelin sheath|extracellular exosome|,response to reactive oxygen species|response to superoxide|age-dependent response to oxidative stress|age-dependent response to reactive oxygen species|response to hypoxia|release of cytochrome c from mitochondria|liver development|detection of oxygen|vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure|regulation of transcription from RNA polymerase II promoter|glutathione metabolic process|superoxide metabolic process|response to oxidative stress|mitochondrion organization|heart development|locomotory behavior|regulation of blood pressure|negative regulation of cell proliferation|intrinsic apoptotic signaling pathway in response to DNA damage|intrinsic apoptotic signaling pathway in response to oxidative stress|apoptotic mitochondrial changes|response to cold|post-embryonic development|response to manganese ion|response to zinc ion|response to selenium ion|response to gamma radiation|response to activity|removal of superoxide radicals|respiratory electron transport chain|hemopoiesis|oxygen homeostasis|response to lipopolysaccharide|response to L-ascorbic acid|response to silicon dioxide|response to isolation stress|response to immobilization stress|vasodilation|response to drug|response to hydrogen peroxide|superoxide anion generation|negative regulation of neuron apoptotic process|positive regulation of nitric oxide biosynthetic process|negative regulation of fat cell differentiation|response to cadmium ion|negative regulation of fibroblast proliferation|neuron development|response to axon injury|erythrophore differentiation|hydrogen peroxide biosynthetic process|regulation of catalytic activity|protein homotetramerization|response to electrical stimulus|regulation of mitochondrial membrane potential|iron ion homeostasis|response to hyperoxia|response to magnetism|cellular response to ethanol|negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|sensory perception of sound|,DNA binding|superoxide dismutase activity|protein binding|oxidoreductase activity|oxygen binding|manganese ion binding|identical protein binding|,8,15,2360000000,41.8%
Q9CZR8,0.998487544,-0.008833333,0.010231728,0.000333333,0.997646831,0.003061341,-0.005,0.154,-0.176,0.04,0.003,-0.069,Q9CZR8,Tsfm,Q9CZR8_Tsfm,Q9CZR8,Tsfm,1,6,5,5,Q9CZR8|Q9CX33,MOUSE,35733.2,40.7,1537,1537.1,78.94,78.94,,324,"Elongation factor Ts, mitochondrial",nucleus|nucleoplasm|mitochondrion|mitochondrial matrix|,mitochondrial translational elongation|,translation elongation factor activity|poly(A) RNA binding|,5,6,206000000,40.7%
A2ADH1,0.961523652,-0.038333333,0.553007385,0.023333333,0.880438979,0.156322249,-0.208,0.19,-0.132,-0.247,0.05,0.117,A2ADH1,Magt1,A2ADH1_Magt1,A2ADH1,Magt1,1,26,7,7,A2ADH1|Q9CQY5|Q9CQY5-3|Q9CQY5-2,MOUSE,42036.4,16,1538,1538.1,78.93,78.93,,368,Magnesium transporter protein 1,oligosaccharyltransferase complex|membrane|,magnesium ion transport|cell redox homeostasis|cognition|,magnesium ion transmembrane transporter activity|,7,26,9400000000,16.0%
P56135,0.963376742,-0.013833333,0.500727445,-0.024333333,0.891101666,-0.142267159,0.068,0.245,-0.318,-0.05,0.169,-0.197,P56135,Atp5j2,P56135_Atp5j2,P56135,Atp5j2,1,32,6,6,P56135|F8WHP8,MOUSE,10401.1,38.6,1539,1539.1,78.81,78.81,,88,"ATP synthase subunit f, mitochondrial","mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)|nucleus|mitochondrion|mitochondrial inner membrane|mitochondrial proton-transporting ATP synthase complex|integral component of membrane|extracellular exosome|",ATP biosynthetic process|proton transport|,ATPase activity|,6,32,57700000000,38.6%
Q14CH1,0.470565279,-0.0555,8.867172866,0.214333333,0.129802397,1.729488522,-0.097,-0.341,-0.05,0.141,-0.125,0.139,Q14CH1,Mocos,Q14CH1_Mocos,Q14CH1,Mocos,1,10,8,8,Q14CH1,MOUSE,96380.2,11.3,1540,1540.1,78.77,78.77,,862,Molybdenum cofactor sulfurase,,Mo-molybdopterin cofactor biosynthetic process|molybdopterin cofactor metabolic process|,Mo-molybdopterin cofactor sulfurase activity|transferase activity|lyase activity|molybdenum ion binding|pyridoxal phosphate binding|,8,10,183000000,11.3%
Q60872,0.770893564,0.019333333,3.588939585,-0.072,0.437628948,-0.825259616,0.081,-0.048,0.133,-0.012,-0.003,-0.035,Q60872,Eif1a,Q60872_Eif1a,Q60872,Eif1a,1,18,6,1,Q60872|Q3TQZ4|A0A1Y7VJE9|Q3UTA4|A0A1Y7VK80|J3QP87|J3QNT6|Q8BX20|A0A1Y7VLT7|J3QQ02|A0A1Y7VNG9|J3QPI8|J3QMW5|Q3UT53|F6YNI8,MOUSE,16616.3,38.8,1541,1541.1,78.63,14.4,,144,Eukaryotic translation initiation factor 1A,,translational initiation|,translation initiation factor activity|poly(A) RNA binding|,6,18,3950000000,38.8%
Q8BMJ3,0.748207831,0.001666667,3.855265321,-0.076,0.411598201,-0.875503831,0.133,-0.027,0.013,-0.08,0,-0.029,Q8BMJ3,Eif1ax,Q8BMJ3_Eif1ax,Q8BMJ3,Eif1ax,1,6,6,2,Q8BMJ3,MOUSE,16574.2,38.8,1541,1541.2,77.32,29.66,,144,"Eukaryotic translation initiation factor 1A, X-chromosomal",,translational initiation|,translation initiation factor activity|poly(A) RNA binding|,2,6,615000000,18.7%
P55292,0.013719524,-0.006,30.50041982,0.538,0.000891165,5.664468402,-0.247,-0.252,-0.326,0.155,0.39,0.244,P55292,Dsc2,P55292_Dsc2,P55292,Dsc2,1,9,7,7,P55292|P55292-2,MOUSE,101100.7,9.9,1542,1542.1,78.59,78.59,,902,Desmocollin-2,plasma membrane|cell-cell adherens junction|intercalated disc|integral component of membrane|desmosome|cytoplasmic vesicle|extracellular exosome|,homophilic cell adhesion via plasma membrane adhesion molecules|cellular response to starvation|cardiac muscle cell-cardiac muscle cell adhesion|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|regulation of ventricular cardiac muscle cell action potential|,calcium ion binding|,7,9,273000000,9.9%
Q8CH25,0.420547369,0.029,9.960347869,-0.178,0.100917205,-1.901251346,0.049,0.201,0.104,-0.038,-0.163,0.021,Q8CH25,Sltm,Q8CH25_Sltm,Q8CH25,Sltm,1,18,9,9,Q8CH25|Q8CH25-2|A0A1L1STF9,MOUSE,117145.5,9,1543,1543.1,78.44,78.44,,1031,SAFB-like transcription modulator,nucleoplasm|,"transcription, DNA-templated|regulation of transcription, DNA-templated|apoptotic process|",nucleotide binding|poly(A) RNA binding|,9,18,708000000,9.0%
G3UXW9,0.797504707,-0.006666667,3.128733525,-0.062666667,0.486549071,-0.736270419,-0.065,0.049,0.09,-0.047,-0.009,-0.058,G3UXW9,Gps1,G3UXW9_Gps1,G3UXW9,Gps1,1,10,7,7,G3UXW9|Q3MIA8|A0A140LJB7|Q99LD4|B1ATU4|Q99LD4-2,MOUSE,59487.6,15.9,1544,1544.1,78.42,78.42,,526,COP9 signalosome complex subunit 1,nucleus|cytoplasm|COP9 signalosome|,cullin deneddylation|,protein binding|,7,10,1070000000,15.9%
Q8R2Y8,0.822567717,0.0285,2.729369763,-0.111,0.533412297,-0.656892667,0.007,0.439,-0.194,-0.129,0.054,-0.006,Q8R2Y8,Ptrh2,Q8R2Y8_Ptrh2,Q8R2Y8,Ptrh2,1,9,5,5,Q8R2Y8,MOUSE,19754.4,37.5,1545,1545.1,78.4,78.4,,181,"Peptidyl-tRNA hydrolase 2, mitochondrial",mitochondrion|cytosol|membrane|,metabolic process|negative regulation of gene expression|positive regulation of anoikis|negative regulation of anoikis|,aminoacyl-tRNA hydrolase activity|,5,9,1480000000,37.5%
O35309,0.647450828,0.055166667,5.416039047,0.229,0.287340005,1.156927702,-0.048,-0.217,0.087,0.594,-0.131,0.046,O35309,Nmi,O35309_Nmi,O35309,Nmi,1,9,7,7,O35309,MOUSE,35691.6,28.3,1546,1546.1,78.17,78.17,,314,N-myc-interactor,nucleoplasm|cytoplasm|,negative regulation of type I interferon production|negative regulation of interferon-alpha biosynthetic process|negative regulation of interferon-beta biosynthetic process|negative regulation of innate immune response|positive regulation of protein K48-linked ubiquitination|,protein binding|,7,9,1300000000,28.3%
Q91VW5,0.915689908,0.004666667,1.324596507,0.045333333,0.737123657,0.350118967,-0.089,-0.084,0.119,0.194,-0.197,0.085,Q91VW5,Golga4,Q91VW5_Golga4,Q91VW5,Golga4,1,9,9,9,Q91VW5,MOUSE,258985.5,4.8,1547,1547.1,78.05,78.05,,2238,Golgin subfamily A member 4,Golgi membrane|nucleoplasm|cytoplasm|Golgi apparatus|intracellular membrane-bounded organelle|extracellular exosome|,protein targeting to Golgi|Golgi to plasma membrane protein transport|positive regulation of axon extension|,GTPase binding|,9,9,1080000000,4.8%
Q6DFW4,0.192839981,0.080833333,16.20721687,-0.375666667,0.0239485,-2.915256816,0.006,0.381,0.419,-0.065,-0.152,-0.104,Q6DFW4,Nop58,Q6DFW4_Nop58,Q6DFW4,Nop58,1,12,6,6,Q6DFW4|A0A0A0MQ76,MOUSE,60855.4,16.6,1548,1548.1,77.88,77.88,,536,Nucleolar protein 58,nucleus|nucleolus|small nucleolar ribonucleoprotein complex|cytoplasm|Cajal body|membrane|box C/D snoRNP complex|small-subunit processome|pre-snoRNP complex|,rRNA modification|snRNP protein import into nucleus|,snoRNA binding|poly(A) RNA binding|,6,12,1140000000,16.6%
Q8K0D0,0.614913894,8.67362E-19,6.075106401,-0.103333333,0.246881962,-1.268647111,0.112,0.002,0.041,-0.017,-0.075,-0.063,Q8K0D0,Cdk17,Q8K0D0_Cdk17,Q8K0D0,Cdk17,1,15,7,4,Q8K0D0|Q8K0D0-2|Q04735|Q04735-2,MOUSE,59790.3,15.2,1549,1549.1,72.79,32.02,,523,Cyclin-dependent kinase 17,,protein phosphorylation|regulation of cell cycle|,cyclin-dependent protein serine/threonine kinase activity|ATP binding|,7,15,3110000000,15.2%
Q04899,0.919577834,-0.085166667,1.20558422,0.070333333,0.757602812,0.321694499,0.174,0.085,-0.62,0.086,-0.042,-0.194,Q04899,Cdk18,Q04899_Cdk18,Q04899,Cdk18,1,3,6,3,Q04899,MOUSE,52074.8,16.1,1549,1549.2,77.76,36.99,,451,Cyclin-dependent kinase 18,,protein phosphorylation|regulation of cell cycle|,cyclin-dependent protein serine/threonine kinase activity|ATP binding|,3,3,476000000,8.8%
P43274,0.994928853,-0.142333333,0.076757949,-0.008,0.982481101,-0.022800867,-0.866,0.109,0.342,-0.575,-0.117,0.253,P43274,Hist1h1e,P43274_Hist1h1e,P43274,Hist1h1e,1,15,8,4,P43274|I7HFT9|Q07133|P43276|P43275,MOUSE,21976.9,33.3,1550,1550.1,77.72,45.06,,219,Histone H1.4,nucleosome|nucleus|nuclear heterochromatin|extracellular exosome|nucleolus|,negative regulation of transcription from RNA polymerase II promoter|nucleosome assembly|nucleosome positioning|,DNA binding|protein binding|chromatin DNA binding|poly(A) RNA binding|,8,15,2570000000,33.3%
P43277,0.87311559,0.0605,2.065948302,-0.094333333,0.621448537,-0.517795552,-0.174,0.024,0.473,-0.126,-0.026,0.192,P43277,Hist1h1d,P43277_Hist1h1d,P43277,Hist1h1d,1,3,6,2,P43277|P15864,MOUSE,22099.1,23.9,1550,1550.2,45.78,13.12,,221,Histone H1.3,nucleosome|nuclear chromatin|nuclear euchromatin|,negative regulation of transcription from RNA polymerase II promoter|nucleosome assembly|nucleosome positioning|,DNA binding|protein binding|chromatin DNA binding|poly(A) RNA binding|,2,3,449000000,5.8%
Q9ERS2,0.915850537,0.018666667,1.320852431,0.061333333,0.737759409,0.349231867,-0.17,0.35,-0.216,0.219,0.03,-0.101,Q9ERS2,Ndufa13,Q9ERS2_Ndufa13,Q9ERS2,Ndufa13,1,16,6,6,Q9ERS2,MOUSE,16859.3,49.3,1551,1551.1,77.71,77.71,,144,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13,nucleoplasm|cytoplasm|mitochondrion|mitochondrial respiratory chain|integral component of membrane|,"negative regulation of cell growth|negative regulation of transcription, DNA-templated|oxidation-reduction process|apoptotic signaling pathway|",NADH dehydrogenase (ubiquinone) activity|,6,16,3150000000,49.3%
Q920Q4,0.398597711,-0.0075,10.46024973,-0.179666667,0.089944586,-1.980737873,0.107,0.037,0.103,0.018,-0.132,-0.178,Q920Q4,NotFound,Q920Q4_NotFound,Q920Q4,Vps16,1,14,7,7,Q920Q4|G3X8X7|Q920Q4-2,MOUSE,96010.5,9.8,1552,1552.1,77.68,77.68,,839,Vacuolar protein sorting-associated protein 16 homolog,lysosome|lysosomal membrane|early endosome|late endosome|actin filament|HOPS complex|late endosome membrane|recycling endosome|,"intracellular protein transport|vacuole organization|endosomal transport|regulation of vacuole fusion, non-autophagic|regulation of SNARE complex assembly|viral entry into host cell|",actin binding|protein binding|,7,14,733000000,9.8%
Q80SY4,0.996072918,-0.011333333,0.047668615,-0.001333333,0.989083913,-0.014200302,0.028,-0.028,-0.032,0.059,-0.148,0.053,Q80SY4,Mib1,Q80SY4_Mib1,Q80SY4,Mib1,1,11,7,7,Q80SY4,MOUSE,112482.2,7.4,1553,1553.1,77.58,77.58,,1006,E3 ubiquitin-protein ligase MIB1,cytoplasm|centrosome|plasma membrane|postsynaptic density|cytoplasmic vesicle|,blood vessel development|in utero embryonic development|somitogenesis|neural tube formation|heart looping|endocytosis|Notch signaling pathway|heart development|protein ubiquitination|negative regulation of neuron differentiation|positive regulation of endocytosis|,ubiquitin-protein transferase activity|protein binding|zinc ion binding|ligase activity|,7,11,639000000,7.4%
Q9D1H8,0.919618833,-0.017666667,1.163297662,0.036666667,0.765015499,0.311450724,0.012,0.136,-0.256,0.013,-0.016,0.005,Q9D1H8,Mrpl53,Q9D1H8_Mrpl53,Q9D1H8,Mrpl53,1,12,6,6,Q9D1H8,MOUSE,12908.6,50.8,1554,1554.1,77.54,77.54,,118,"39S ribosomal protein L53, mitochondrial",mitochondrion|ribosome|,,,6,12,661000000,50.8%
Q9DBL2-2,0.641900554,0.003333333,5.528150546,0.107333333,0.280017353,1.175155288,-0.042,-0.02,-0.089,0.17,0.043,-0.042,Q9DBL2,Gdap2,Q9DBL2-2_Gdap2,Q9DBL2-2,Gdap2,1,12,7,7,Q9DBL2-2|Q9DBL2,MOUSE,61985.4,16.1,1555,1555.1,77.53,77.53,,498,Isoform 2 of Ganglioside-induced differentiation-associated protein 2,lysosomal membrane|,response to retinoic acid|,,7,12,5540000000,16.1%
A0A0A0MQ68,0.639352439,-0.034333333,5.575585728,0.164,0.276975546,1.184552917,-0.011,0.053,-0.391,-0.047,0.144,0.046,A0A0A0MQ68,Gcdh,A0A0A0MQ68_Gcdh,A0A0A0MQ68,Gcdh,1,17,7,7,A0A0A0MQ68|Q60759,MOUSE,50082.7,19.9,1556,1556.1,77.49,77.49,,447,"Glutaryl-CoA dehydrogenase, mitochondrial",mitochondrion|mitochondrial inner membrane|,fatty acid oxidation|fatty-acyl-CoA biosynthetic process|,fatty-acyl-CoA binding|glutaryl-CoA dehydrogenase activity|flavin adenine dinucleotide binding|,7,17,31600000000,19.9%
A0A140LIS8,0.984402059,-0.069166667,0.245521908,-0.011666667,0.945034817,-0.071600456,0.168,0.071,-0.429,-0.052,-0.068,-0.105,A0A140LIS8,NotFound,A0A140LIS8_NotFound,A0A140LIS8,Gm4756,1,11,5,5,A0A140LIS8|A0A140LJG4|A0A140LJ41|A0A140LIU7,MOUSE,38238.8,20,1557,1557.1,77.48,77.48,,335,Predicted gene 4756,,,,5,11,8380000000,20.0%
P27048,0.857830933,-0.007833333,2.239624387,-0.082333333,0.597086925,-0.555080348,-0.245,0.202,0.143,-0.174,-0.087,0.114,P27048,Snrpb,P27048_Snrpb,P27048,Snrpb,1,13,8,8,P27048|P63163|A0A0G2JGN4,MOUSE,23826.7,24.2,1558,1558.1,77.45,77.45,,231,Small nuclear ribonucleoprotein-associated protein B,nucleus|U5 snRNP|U7 snRNP|U1 snRNP|U2 snRNP|U4 snRNP|U12-type spliceosomal complex|cytoplasm|cytosol|methylosome|SMN-Sm protein complex|U4/U6 x U5 tri-snRNP complex|extracellular exosome|U2-type prespliceosome|catalytic step 2 spliceosome|histone pre-mRNA 3'end processing complex|,"spliceosomal snRNP assembly|mRNA splicing, via spliceosome|positive regulation of defense response to virus by host|protein methylation|activation of mitophagy in response to mitochondrial depolarization|",poly(A) RNA binding|histone pre-mRNA DCP binding|,8,13,3810000000,24.2%
Q6PD03,0.659390583,-0.011333333,5.191553249,0.102,0.302583105,1.11669141,0.022,-0.061,-0.148,0.123,0.012,-0.016,Q6PD03,Ppp2r5a,Q6PD03_Ppp2r5a,Q6PD03,Ppp2r5a,1,16,6,6,Q6PD03,MOUSE,56745.3,15.4,1559,1559.1,77.4,77.4,,486,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,"protein phosphatase type 2A complex|chromosome, centromeric region|nucleus|cytoplasm|cytosol|Z disc|M band|membrane|",signal transduction|regulation of protein phosphatase type 2A activity|positive regulation of protein dephosphorylation|negative regulation of establishment of protein localization to plasma membrane|negative regulation of lipid kinase activity|,protein binding|protein phosphatase type 2A regulator activity|kinase binding|,6,16,657000000,15.4%
K3W4Q9,0.961523652,0.048166667,0.54223964,0.021,0.882624617,0.153438453,-0.029,0.252,-0.11,0.244,-0.086,0.018,K3W4Q9,NotFound,K3W4Q9_NotFound,K3W4Q9,Gopc,1,11,7,7,K3W4Q9|Q8BH60-2|Q8BH60,MOUSE,51034.6,19.8,1560,1560.1,77.3,77.3,,463,Golgi-associated PDZ and coiled-coil motif-containing protein,,,,8,11,466000000,19.8%
Q11011,0.965288537,-0.012833333,0.471591466,-0.014333333,0.897099993,-0.134328263,-0.11,0.073,0.02,-0.178,0.04,0.078,Q11011,Npepps,Q11011_Npepps,Q11011,Npepps,1,13,8,8,Q11011|E9Q039|E9Q6F4,MOUSE,104008.1,10.9,1561,1561.1,77.29,77.29,,920,Puromycin-sensitive aminopeptidase,nucleus|cytosol|extracellular exosome|,proteolysis|cellular response to hypoxia|positive regulation of protein targeting to mitochondrion|,aminopeptidase activity|metallopeptidase activity|zinc ion binding|,8,13,1730000000,10.9%
E9Q5W5,0.55391814,-0.0115,7.189607712,0.145666667,0.191002578,1.454572163,0.01,-0.025,-0.238,0.116,0.005,0.063,E9Q5W5,NotFound,E9Q5W5_NotFound,E9Q5W5,Zzef1,1,12,9,9,A0A140LJ04|E9Q5W5|Q5SSH7|Q5SSH7-2|Q5SSH7-3,MOUSE,332941.5,4.7,1562,1562.1,77.28,77.28,,2924,Zinc finger ZZ-type and EF-hand domain-containing protein 1,,,calcium ion binding|zinc ion binding|,9,12,4600000000,4.7%
P14602,0.670248403,0.047666667,5.002707528,-0.164666667,0.316030681,-1.084556922,0.267,0.325,-0.202,0.015,-0.085,-0.034,P14602,Hspb1,P14602_Hspb1,P14602,Hspb1,1,12,6,6,P14602|P14602-2|P14602-3|D3YZ06,MOUSE,23070.5,38.7,1563,1563.1,77.24,77.24,,209,Heat shock protein beta-1,proteasome complex|extracellular space|intracellular|nucleus|cytoplasm|spindle|plasma membrane|focal adhesion|Z disc|contractile fiber|extracellular exosome|,retina homeostasis|negative regulation of protein kinase activity|response to unfolded protein|response to virus|positive regulation of interleukin-1 beta production|intracellular signal transduction|cellular response to vascular endothelial growth factor stimulus|positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway|positive regulation of tumor necrosis factor biosynthetic process|regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of blood vessel endothelial cell migration|positive regulation of angiogenesis|platelet aggregation|negative regulation of protein serine/threonine kinase activity|negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|positive regulation of endothelial cell chemotaxis|negative regulation of apoptotic signaling pathway|,protein kinase C binding|protein kinase C inhibitor activity|protein kinase binding|identical protein binding|ubiquitin binding|poly(A) RNA binding|,6,12,916000000,38.7%
O35075,0.63071819,0.001,5.796717338,-0.134,0.263225686,-1.22158338,0.171,0.01,0.023,0.104,-0.112,-0.19,O35075,Vps26c,O35075_Vps26c,O35075,Dscr3,1,9,6,6,O35075,MOUSE,33426.1,26.9,1564,1564.1,77.21,77.21,,297,Down syndrome critical region protein 3 homolog,nucleus|,intracellular protein transport|,protein transporter activity|,6,9,816000000,26.9%
Q8R1X6,0.430679683,-0.018666667,9.746141836,0.18,0.106019516,1.867143339,-0.042,-0.049,-0.235,0.153,0.01,0.051,Q8R1X6,Spg20,Q8R1X6_Spg20,Q8R1X6,Spart,1,11,7,7,Q8R1X6|Q8R1X6-2|D3Z3F8,MOUSE,73280.9,15.4,1565,1565.1,77.04,77.04,,671,Spartin,mitochondrial outer membrane|lipid particle|plasma membrane|midbody|synapse|,abscission|negative regulation of BMP signaling pathway|lipid particle organization|negative regulation of collateral sprouting in absence of injury|neuromuscular process|cell division|regulation of mitochondrial membrane potential|adipose tissue development|,protein binding|ubiquitin protein ligase binding|,7,11,438000000,15.4%
P61202-2,0.919416995,-0.030666667,1.20991232,0.033333333,0.756848175,0.322596988,0.018,0.04,-0.2,0.035,0.032,-0.109,P61202,Cops2,P61202-2_Cops2,P61202-2,Cops2,1,12,7,7,P61202-2|P61202|A2AQE4,MOUSE,52746,22.6,1566,1566.1,76.93,76.93,,443,Isoform 2 of COP9 signalosome complex subunit 2,nucleus|cytoplasm|COP9 signalosome|,"cell proliferation|cullin deneddylation|skeletal muscle cell differentiation|negative regulation of transcription, DNA-templated|",transcription corepressor activity|protein binding|,7,12,494000000,22.6%
Q9JJL3-2,0.281360675,-0.111,13.34654809,0.390666667,0.046274868,2.446629066,-0.411,0.038,-0.546,0.156,0.077,0.02,Q9JJL3,Slco1b2,Q9JJL3-2_Slco1b2,Q9JJL3-2,Slco1b2,1,11,6,6,Q9JJL3-2|Q9JJL3|A0A0N4SUN2,MOUSE,80128.8,11.2,1567,1567.1,76.89,76.89,,689,Isoform 2 of Solute carrier organic anion transporter family member 1B2,plasma membrane|integral component of plasma membrane|basolateral plasma membrane|,liver development|drug transmembrane transport|oligopeptide transport|bile acid and bile salt transport|response to lipopolysaccharide|response to cytokine|response to peptide hormone|response to antibiotic|response to glucocorticoid|,organic anion transmembrane transporter activity|bile acid transmembrane transporter activity|oligopeptide transporter activity|drug transmembrane transporter activity|,6,11,1830000000,11.2%
P51863,0.951421295,0.0245,0.728816796,-0.039,0.845509167,-0.20263193,-0.304,-0.018,0.454,0.025,-0.098,0.088,P51863,Atp6v0d1,P51863_Atp6v0d1,P51863,Atp6v0d1,1,14,7,7,P51863,MOUSE,40756.8,18.8,1568,1568.1,76.86,76.86,,351,V-type proton ATPase subunit d 1,"lysosomal membrane|early endosome|synaptic vesicle|membrane|apical plasma membrane|vacuolar proton-transporting V-type ATPase complex|proton-transporting V-type ATPase, V0 domain|axon terminus|extracellular exosome|centrosome|",brain development|ATP hydrolysis coupled proton transport|cilium assembly|,"hydrogen-exporting ATPase activity, phosphorylative mechanism|protein complex binding|",7,14,1100000000,18.8%
Q9CZU6,0.856747233,-0.049833333,2.277737409,0.087666667,0.591869907,0.563174586,-0.013,0.151,-0.419,0.018,0.055,-0.091,Q9CZU6,Cs,Q9CZU6_Cs,Q9CZU6,Cs,1,12,6,6,Q9CZU6|Q80X68,MOUSE,52021,12.9,1569,1569.1,76.6,76.6,,464,"Citrate synthase, mitochondrial",nucleus|mitochondrion|mitochondrial matrix|extracellular exosome|,carbohydrate metabolic process|tricarboxylic acid cycle|cellular carbohydrate metabolic process|,"citrate (Si)-synthase activity|poly(A) RNA binding|transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer|",6,12,6540000000,12.9%
P70362,0.974183286,-0.027,0.378711384,0.016,0.916492387,0.108921686,0.059,0.186,-0.35,-0.034,-0.003,-0.02,P70362,Ufd1,P70362_Ufd1,P70362,Ufd1,1,10,7,7,P70362,MOUSE,34766,26,1570,1570.1,76.59,76.59,,307,Ubiquitin recognition factor in ER-associated degradation protein 1,nucleus|cytoplasm|cytosol|VCP-NPL4-UFD1 AAA ATPase complex|UFD1-NPL4 complex|,"retrograde protein transport, ER to cytosol|ER-associated misfolded protein catabolic process|",receptor binding|protein complex binding|K48-linked polyubiquitin binding|,7,10,890000000,26.0%
P63276,0.579174934,-0.102,6.764010627,0.29,0.210668177,1.385893115,-0.007,0.007,-0.741,-0.018,0.129,0.018,P63276,Rps17,P63276_Rps17,P63276,Rps17,1,15,5,5,P63276,MOUSE,15580.9,51.8,1571,1571.1,76.56,76.56,,135,40S ribosomal protein S17,focal adhesion|membrane|cytosolic small ribosomal subunit|extracellular exosome|,ribosomal small subunit assembly|rRNA processing|translation|erythrocyte homeostasis|ribosomal small subunit biogenesis|,structural constituent of ribosome|poly(A) RNA binding|,5,15,6700000000,51.8%
Q9Z1P6,0.656833435,-0.0745,5.227761227,0.179666667,0.300070898,1.124111504,-0.258,0.183,-0.418,0.058,0.006,-0.018,Q9Z1P6,Ndufa7,Q9Z1P6_Ndufa7,Q9Z1P6,Ndufa7,1,20,6,6,Q9Z1P6,MOUSE,12632.4,59.2,1572,1572.1,76.42,76.42,,113,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7,mitochondrion|mitochondrial respiratory chain complex I|mitochondrial ribosome|,mitochondrial translation|ATP synthesis coupled electron transport|,structural constituent of ribosome|NADH dehydrogenase (ubiquinone) activity|,6,20,4320000000,59.2%
Q9D881,0.919618833,-0.0175,1.176041462,0.028333333,0.762773952,0.314414608,-0.106,0.082,-0.071,-0.019,-0.032,0.041,Q9D881,Cox5b,Q9D881_Cox5b,Q9D881,Gm11273,1,26,7,7,Q9D881|P19536,MOUSE,14131.9,42.6,1573,1573.1,76.4,76.4,,129,"Cytochrome c oxidase subunit 5B, mitochondrial",mitochondrial envelope|,hydrogen ion transmembrane transport|,cytochrome-c oxidase activity|,7,26,4060000000,42.6%
Q9CQ69,0.977289428,0.062666667,0.335188445,-0.024666667,0.925723216,-0.096835526,-0.171,0.624,-0.228,-0.235,0.269,0.117,Q9CQ69,Uqcrq,Q9CQ69_Uqcrq,Q9CQ69,Uqcrq,1,17,6,6,Q9CQ69|I7HPX6,MOUSE,9768.1,56,1574,1574.1,76.31,76.31,,82,Cytochrome b-c1 complex subunit 8,mitochondrion|mitochondrial inner membrane|respiratory chain|,subthalamus development|pons development|cerebellar Purkinje cell layer development|hippocampus development|thalamus development|hypothalamus development|pyramidal neuron development|midbrain development|oxidation-reduction process|hydrogen ion transmembrane transport|,ubiquinol-cytochrome-c reductase activity|,6,17,17300000000,56.0%
Q91WS0,0.962232805,-0.005666667,0.523503245,0.024666667,0.886440674,0.148406921,-0.05,0.326,-0.33,0.021,0.014,-0.015,Q91WS0,Cisd1,Q91WS0_Cisd1,Q91WS0,Cisd1,1,19,5,5,Q91WS0,MOUSE,12267.9,42.5,1575,1575.1,76.24,76.24,,108,CDGSH iron-sulfur domain-containing protein 1,mitochondrion|mitochondrial outer membrane|integral component of membrane|extracellular exosome|,regulation of cellular respiration|,"iron ion binding|2 iron, 2 sulfur cluster binding|",5,19,5250000000,42.5%
Q9D0L4,0.906772524,0.0235,1.504289236,0.038333333,0.707246939,0.391979735,0.056,0.017,-0.06,0.183,-0.05,-0.005,Q9D0L4,Adck1,Q9D0L4_Adck1,Q9D0L4,Adck1,1,14,5,5,Q9D0L4|Q9D0L4-2,MOUSE,60305.4,13.9,1576,1576.1,76.17,76.17,,525,Uncharacterized aarF domain-containing protein kinase 1,extracellular region|mitochondrion|,protein phosphorylation|,protein serine/threonine kinase activity|ATP binding|,5,14,322000000,13.9%
Q8CIM3,0.019380777,-0.1475,28.63044094,1.579666667,0.001370743,5.280294282,-0.532,-0.655,-1.625,0.675,0.864,0.388,Q8CIM3,D2hgdh,Q8CIM3_D2hgdh,Q8CIM3,D2hgdh,1,9,5,5,E9QN44|Q8CIM3,MOUSE,59373.3,15.8,1577,1577.1,76.11,76.11,,535,"D-2-hydroxyglutarate dehydrogenase, mitochondrial",mitochondrion|,response to manganese ion|response to zinc ion|response to cobalt ion|cellular protein metabolic process|oxidation-reduction process|response to magnesium ion|response to calcium ion|,UDP-N-acetylmuramate dehydrogenase activity|flavin adenine dinucleotide binding|(R)-2-hydroxyglutarate dehydrogenase activity|,5,9,1440000000,15.8%
Q6PHQ8,0.954887447,0.005,0.668066657,0.02,0.857419457,0.186725565,-0.021,-0.121,0.127,0.143,-0.072,-0.026,Q6PHQ8,Naa35,Q6PHQ8_Naa35,Q6PHQ8,Naa35,1,9,7,7,Q6PHQ8,MOUSE,84331.3,10,1578,1578.1,75.65,75.65,,725,"N-alpha-acetyltransferase 35, NatC auxiliary subunit",cytoplasm|NatC complex|polysome|,negative regulation of apoptotic process|smooth muscle cell proliferation|,protein binding|,7,9,546000000,10.0%
P07356,0.626292064,0.067166667,5.859525562,-0.205666667,0.259446277,-1.233330428,-0.1,0.492,0.118,-0.171,0.111,-0.047,P07356,Anxa2,P07356_Anxa2,P07356,Anxa2,1,14,6,6,P07356,MOUSE,38960.8,26.8,1579,1579.1,75.61,75.61,,339,Annexin A2,ruffle|basement membrane|extracellular space|nucleus|cytoplasm|lysosomal membrane|endosome|early endosome|lipid particle|cytosol|plasma membrane|cell cortex|cell surface|membrane|basolateral plasma membrane|extrinsic component of plasma membrane|midbody|late endosome membrane|vesicle|myelin sheath adaxonal region|sarcolemma|melanosome|Schmidt-Lanterman incisure|macropinosome|perinuclear region of cytoplasm|extracellular exosome|PCSK9-AnxA2 complex|membrane raft|,angiogenesis|membrane raft assembly|positive regulation of protein phosphorylation|negative regulation of receptor internalization|membrane budding|body fluid secretion|collagen fibril organization|positive regulation of vesicle fusion|negative regulation of low-density lipoprotein particle receptor catabolic process|osteoclast development|fibrinolysis|negative regulation of catalytic activity|positive regulation of fibroblast proliferation|positive regulation of binding|protein heterotetramerization|protein targeting to plasma membrane|negative regulation of receptor binding|positive regulation of receptor activity|,"calcium ion binding|protein binding|calcium-dependent phospholipid binding|phosphatidylinositol-4,5-bisphosphate binding|cytoskeletal protein binding|Rab GTPase binding|phospholipase A2 inhibitor activity|S100 protein binding|poly(A) RNA binding|calcium-dependent protein binding|receptor activator activity|",6,14,626000000,26.8%
G3X9Y5,0.876461947,-0.069666667,1.989806807,0.086666667,0.632439984,0.501233725,0.124,0.028,-0.491,0.082,-0.039,-0.122,G3X9Y5,Ube4a,G3X9Y5_Ube4a,G3X9Y5,Ube4a,1,7,6,6,G3X9Y5|E9Q735|E9Q442|Q8VDS1|D6RGN7,MOUSE,125601.4,8.2,1580,1580.1,75.53,75.53,,1085,Ubiquitin conjugation factor E4 A,ubiquitin ligase complex|cytoplasm|,protein polyubiquitination|ubiquitin-dependent protein catabolic process|,ligase activity|ubiquitin-ubiquitin ligase activity|ubiquitin protein ligase activity|,6,7,981000000,8.2%
Q5ND34,0.99327985,-0.002166667,0.129094265,0.003,0.970712391,0.03810821,0.018,-0.03,0.001,-0.036,-0.001,0.035,Q5ND34,Wdr81,Q5ND34_Wdr81,Q5ND34,Wdr81,1,7,7,7,Q5ND34|Q5ND34-2|Q5ND34-3,MOUSE,213881,5.8,1581,1581.1,75.53,75.53,,1934,WD repeat-containing protein 81,,negative regulation of phosphatase activity|,,7,7,595000000,5.8%
Q62093,0.951421295,-0.013833333,0.729845716,0.019,0.845308874,0.202807474,-0.145,0.087,-0.012,0.012,-0.045,0.02,Q62093,Srsf2,Q62093_Srsf2,Q62093,Srsf2,1,23,5,5,Q62093,MOUSE,25475.9,24.4,1582,1582.1,75.49,75.49,,221,Serine/arginine-rich splicing factor 2,nucleus|nucleoplasm|spliceosomal complex|cytoplasm|nuclear speck|extracellular exosome|,"regulation of alternative mRNA splicing, via spliceosome|mRNA processing|RNA splicing|",nucleotide binding|protein binding|pre-mRNA binding|poly(A) RNA binding|,5,23,18000000000,24.4%
E9QMP6,0.981973179,-0.002,0.290043586,-0.007333333,0.935396286,-0.084151125,-0.024,0.083,-0.054,0.064,-0.047,-0.034,E9QMP6,Mark2,E9QMP6_Mark2,E9QMP6,Mark2,1,12,8,8,E9QMP6|Q05512|Q05512-2|A0A0R4J0B1|Q05512-4|A0A0R4J227|Q05512-3|Q3T9A3|E9PYX3|E9Q9N6|A0A1Y7VNZ6|Q8VHJ5|Q03141|Q03141-3|Q03141-2|Q8CIP4|Q8CIP4-2,MOUSE,86753.8,13.4,1583,1583.1,75.31,75.31,,776,Non-specific serine/threonine protein kinase,nucleus|actin filament|plasma membrane|membrane|lateral plasma membrane|basal cortex|microtubule bundle|,protein phosphorylation|positive regulation of neuron projection development|establishment of cell polarity|intracellular signal transduction|establishment or maintenance of epithelial cell apical/basal polarity|regulation of axonogenesis|,magnesium ion binding|protein serine/threonine kinase activity|ATP binding|poly(A) RNA binding|,8,12,737000000,13.4%
Q9D358,0.678058757,-0.021833333,4.890789027,0.124333333,0.324280697,1.064555208,0.014,0.009,-0.275,0.163,0.004,-0.046,Q9D358,Acp1,Q9D358_Acp1,Q9D358,Acp1,1,10,8,3,Q9D358|A0A1W2P7X3,MOUSE,18647.8,58.2,1584,1584.1,75.27,21,,158,Low molecular weight phosphotyrosine protein phosphatase,cytoplasm|cytoplasmic side of plasma membrane|extracellular exosome|,peptidyl-tyrosine dephosphorylation|,acid phosphatase activity|non-membrane spanning protein tyrosine phosphatase activity|phosphatase activity|,8,10,1970000000,58.2%
Q9WUM4,0.607857354,0.0155,6.217089983,0.212333333,0.238941179,1.294115633,-0.152,-0.04,-0.08,-0.226,0.189,0.402,Q9WUM4,Coro1c,Q9WUM4_Coro1c,Q9WUM4,Coro1c,1,17,9,9,Q9WUM4|E9PX03|Q920M5-4|Q920M5-2|Q920M5|B9EIZ7|Q920M5-3,MOUSE,53804.6,19.1,1585,1585.1,75.27,75.27,,474,Coronin-1C,cytoplasm|cytoskeleton|focal adhesion|actin cytoskeleton|lateral plasma membrane|flotillin complex|lamellipodium|vesicle|,actin cortical patch assembly|neural crest cell migration|regulation of protein phosphorylation|negative regulation of protein phosphorylation|phagocytosis|regulation of epithelial cell migration|negative regulation of epithelial cell migration|regulation of fibroblast migration|actin cytoskeleton organization|negative regulation of protein kinase activity by regulation of protein phosphorylation|establishment of protein localization|regulation of focal adhesion assembly|negative regulation of focal adhesion assembly|activation of GTPase activity|regulation of substrate adhesion-dependent cell spreading|negative regulation of substrate adhesion-dependent cell spreading|regulation of ruffle assembly|positive regulation of lamellipodium morphogenesis|,Rac GTPase binding|actin filament binding|,9,17,711000000,19.1%
Q6PF93,0.926033297,0.0025,1.073963014,-0.029,0.780914881,-0.289556189,0.01,-0.008,0.049,0.15,-0.069,-0.117,Q6PF93,Pik3c3,Q6PF93_Pik3c3,Q6PF93,Pik3c3,1,8,6,6,Q6PF93|E9QLS6|Q6PF93-2|D3YZ98|E9Q824,MOUSE,102170.2,8.6,1586,1586.1,75.13,75.13,,887,Phosphatidylinositol 3-kinase catalytic subunit type 3,"pre-autophagosomal structure|cytoplasm|endosome|late endosome|peroxisome|membrane|midbody|phosphatidylinositol 3-kinase complex, class III, type I|phosphatidylinositol 3-kinase complex, class III, type II|phosphatidylinositol 3-kinase complex, class III|phagocytic vesicle|",autophagosome assembly|cytokinesis|protein phosphorylation|endocytosis|endosome organization|endosomal transport|macroautophagy|protein processing|peroxisome degradation|regulation of cytokinesis|phosphatidylinositol-3-phosphate biosynthetic process|cellular response to glucose starvation|response to leucine|early endosome to late endosome transport|phosphatidylinositol phosphorylation|phosphatidylinositol-mediated signaling|regulation of protein secretion|,protein kinase activity|protein binding|ATP binding|1-phosphatidylinositol-3-kinase activity|,6,8,615000000,8.6%
O88738,0.869880514,0.0045,2.103690094,-0.048333333,0.616071319,-0.525662912,-0.012,0.011,0.087,0.038,-0.138,0.041,O88738,Birc6,O88738_Birc6,O88738,Birc6,1,13,9,9,O88738|O88738-2|S4R2P8|O88738-3|S4R1L5,MOUSE,538664.8,2.5,1587,1587.1,75.11,75.11,,4882,Baculoviral IAP repeat-containing protein 6,spindle pole|cytoplasm|endosome|trans-Golgi network|microtubule organizing center|membrane|midbody|,placenta development|apoptotic process|mitotic nuclear division|positive regulation of cell proliferation|regulation of signal transduction|negative regulation of endopeptidase activity|protein ubiquitination|regulation of cytokinesis|regulation of cell proliferation|negative regulation of apoptotic process|cell division|labyrinthine layer development|spongiotrophoblast layer development|negative regulation of extrinsic apoptotic signaling pathway|,ubiquitin-protein transferase activity|cysteine-type endopeptidase inhibitor activity|protein binding|ligase activity|ubiquitin conjugating enzyme activity|,9,13,1010000000,2.5%
B1ATI0,0.461918472,-0.029166667,9.088177994,0.299666667,0.123362227,1.765032462,0.032,-0.069,-0.5,0.021,0.336,0.005,B1ATI0,NotFound,B1ATI0_NotFound,B1ATI0,Aldh3a2,1,13,6,6,B1ATI0|B1AV77|P47740,MOUSE,59846.1,21.6,1588,1588.1,75.09,75.09,,532,Aldehyde dehydrogenase,mitochondrion|mitochondrial inner membrane|peroxisome|integral component of membrane|intracellular membrane-bounded organelle|extracellular exosome|,cellular aldehyde metabolic process|sesquiterpenoid metabolic process|central nervous system development|peripheral nervous system development|epidermis development|phytol metabolic process|oxidation-reduction process|,3-chloroallyl aldehyde dehydrogenase activity|aldehyde dehydrogenase (NAD) activity|aldehyde dehydrogenase [NAD(P)+] activity|long-chain-alcohol oxidase activity|long-chain-aldehyde dehydrogenase activity|medium-chain-aldehyde dehydrogenase activity|,6,13,621000000,21.6%
P61079,0.494183327,-0.007,8.313944688,-0.192666667,0.147436676,-1.639681356,0.116,0.235,-0.083,-0.184,0.034,-0.16,P61079,Ube2d3,P61079_Ube2d3,P61079,Ube2d3,1,15,6,6,A0A0G2JGL0|P61079|P62838|Q6ZWY6|P61080,MOUSE,16915.1,52.3,1589,1589.1,74.95,74.95,,147,Ubiquitin-conjugating enzyme E2 D3,plasma membrane|endosome membrane|extracellular exosome|,protein polyubiquitination|DNA repair|protein monoubiquitination|apoptotic process|protein ubiquitination|proteasome-mediated ubiquitin-dependent protein catabolic process|protein autoubiquitination|protein K48-linked ubiquitination|protein K11-linked ubiquitination|positive regulation of protein targeting to mitochondrion|,ubiquitin-protein transferase activity|protein binding|ATP binding|ligase activity|ubiquitin conjugating enzyme activity|,6,15,8100000000,52.3%
Q8C7E7,0.268140406,-0.038333333,13.68341293,0.346,0.042821187,2.501050209,-0.451,-0.202,0.019,0.016,0.221,0.167,Q8C7E7,Stbd1,Q8C7E7_Stbd1,Q8C7E7,Stbd1,1,12,6,6,Q8C7E7,MOUSE,36240.5,20.4,1590,1590.1,74.94,74.94,,338,Starch-binding domain-containing protein 1,integral component of membrane|,,starch binding|,6,12,1320000000,20.4%
P63087-2,0.497381785,0.018666667,8.239024691,-0.142666667,0.150002166,-1.625577894,0.053,0.148,0.069,-0.148,-0.002,-0.008,P63087,Ppp1cc,P63087-2_Ppp1cc,P63087-2,Ppp1cc,1,14,6,1,P63087-2|P63087|A0A0G2JGC1,MOUSE,39245.3,19.5,1591,1591.1,74.76,11.08,,323,Isoform Gamma-2 of Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,condensed chromosome kinetochore|nucleolus|mitochondrion|focal adhesion|nuclear speck|midbody|cleavage furrow|dendritic spine|MLL5-L complex|PTW/PP1 phosphatase complex|,glycogen metabolic process|protein dephosphorylation|cell cycle|neuron differentiation|circadian regulation of gene expression|regulation of circadian rhythm|entrainment of circadian clock by photoperiod|cell division|,protein serine/threonine phosphatase activity|protein binding|phosphatase activity|protein kinase binding|poly(A) RNA binding|metal ion binding|,6,14,898000000,19.5%
O09106,0.390864183,0.011666667,10.59969445,-0.224,0.087102487,-2.004852077,-0.026,0.108,0.289,-0.174,-0.13,0.003,O09106,Hdac1,O09106_Hdac1,O09106,Hdac1,1,13,6,3,O09106|D3YYI8,MOUSE,55644.5,20.1,1592,1592.1,74.6,41.56,,482,Histone deacetylase 1,histone deacetylase complex|chromatin|nuclear chromatin|heterochromatin|nucleus|nucleoplasm|transcription factor complex|cytoplasm|cytosol|Sin3 complex|NuRD complex|transcriptional repressor complex|neuronal cell body|protein complex|,"negative regulation of transcription from RNA polymerase II promoter|chromatin silencing at rDNA|transcription, DNA-templated|protein deacetylation|endoderm development|circadian rhythm|positive regulation of cell proliferation|epidermal cell differentiation|negative regulation of gene expression|positive regulation of receptor biosynthetic process|chromatin modification|histone deacetylation|hippocampus development|neuron differentiation|circadian regulation of gene expression|odontogenesis of dentin-containing tooth|embryonic digit morphogenesis|ATP-dependent chromatin remodeling|negative regulation of apoptotic process|negative regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation by host of viral transcription|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of oligodendrocyte differentiation|negative regulation of androgen receptor signaling pathway|hair follicle placode formation|eyelid development in camera-type eye|fungiform papilla formation|histone H3 deacetylation|histone H4 deacetylation|negative regulation of canonical Wnt signaling pathway|negative regulation of intrinsic apoptotic signaling pathway|",transcription regulatory region sequence-specific DNA binding|core promoter binding|RNA polymerase II repressing transcription factor binding|RNA polymerase II transcription corepressor activity|DNA binding|chromatin binding|sequence-specific DNA binding transcription factor activity|transcription corepressor activity|histone deacetylase activity|protein binding|transcription factor binding|deacetylase activity|enzyme binding|NAD-dependent histone deacetylase activity (H3-K14 specific)|protein deacetylase activity|activating transcription factor binding|Krueppel-associated box domain binding|histone deacetylase binding|transcription regulatory region DNA binding|protein N-terminus binding|NF-kappaB binding|repressing transcription factor binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|,6,13,2120000000,20.1%
P70288,0.512036644,0.027833333,8.007274606,-0.157,0.158224066,-1.588083733,-0.01,0.087,0.242,-0.111,-0.051,0.01,P70288,Hdac2,P70288_Hdac2,P70288,Hdac2,1,8,5,3,A0A0R4J008|P70288|Q8BQ10,MOUSE,55871.7,13.1,1592,1592.2,55.43,29.04,,488,Histone deacetylase 2,histone deacetylase complex|nuclear chromatin|heterochromatin|nucleus|nucleoplasm|replication fork|transcription factor complex|cytoplasm|Sin3 complex|NuRD complex|transcriptional repressor complex|ESC/E(Z) complex|protein complex|RNA polymerase II transcription repressor complex|,"negative regulation of transcription from RNA polymerase II promoter|chromatin silencing at rDNA|maintenance of chromatin silencing|transcription, DNA-templated|protein deacetylation|positive regulation of cell proliferation|epidermal cell differentiation|positive regulation of receptor biosynthetic process|negative regulation of neuron projection development|dendrite development|chromatin modification|histone deacetylation|hippocampus development|neuron differentiation|circadian regulation of gene expression|odontogenesis of dentin-containing tooth|embryonic digit morphogenesis|ATP-dependent chromatin remodeling|negative regulation of apoptotic process|negative regulation of sequence-specific DNA binding transcription factor activity|positive regulation of proteolysis|negative regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of oligodendrocyte differentiation|positive regulation of sequence-specific DNA binding transcription factor activity|regulation of protein kinase B signaling|cardiac muscle cell development|negative regulation of cardiac muscle cell proliferation|regulation of sarcomere organization|hair follicle placode formation|eyelid development in camera-type eye|fungiform papilla formation|histone H3 deacetylation|histone H4 deacetylation|negative regulation of canonical Wnt signaling pathway|regulation of protein deacetylation|negative regulation of intrinsic apoptotic signaling pathway|",RNA polymerase II repressing transcription factor binding|RNA polymerase II transcription corepressor binding|chromatin binding|sequence-specific DNA binding transcription factor activity|histone deacetylase activity|protein binding|transcription factor binding|deacetylase activity|enzyme binding|chromatin DNA binding|NAD-dependent histone deacetylase activity (H3-K14 specific)|protein deacetylase activity|histone deacetylase activity (H4-K16 specific)|Krueppel-associated box domain binding|sequence-specific DNA binding|poly(A) RNA binding|NF-kappaB binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|,3,8,693000000,8.1%
Q9CPP6,0.805121368,-0.030166667,3.017521908,0.081666667,0.499169233,0.714604698,-0.263,0.116,-0.066,0.008,0.033,-0.009,Q9CPP6,Ndufa5,Q9CPP6_Ndufa5,Q9CPP6,Ndufa5,1,10,6,6,Q9CPP6|D3YTQ8,MOUSE,13416.5,64.6,1593,1593.1,74.45,74.45,,116,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,mitochondrion|mitochondrial respiratory chain complex I|respiratory chain complex I|,respiratory electron transport chain|,NADH dehydrogenase (ubiquinone) activity|,6,10,2230000000,64.6%
Q99LC8,0.722398659,-0.000333333,4.205011137,-0.082666667,0.379750965,-0.940260252,0.067,0.1,-0.044,0.03,-0.075,-0.08,Q99LC8,Eif2b1,Q99LC8_Eif2b1,Q99LC8,Eif2b1,1,16,8,8,Q99LC8|A0A0G2JEF1,MOUSE,34043.9,38.6,1594,1594.1,74.18,74.18,,305,Translation initiation factor eIF-2B subunit alpha,cytoplasm|eukaryotic translation initiation factor 2B complex|plasma membrane|membrane|,translational initiation|regulation of translational initiation|response to heat|response to glucose|oligodendrocyte development|negative regulation of translational initiation in response to stress|response to peptide hormone|positive regulation of GTPase activity|cellular response to stimulus|L-methionine biosynthetic process from methylthioadenosine|,guanyl-nucleotide exchange factor activity|protein binding|GTP binding|GDP binding|enzyme regulator activity|S-methyl-5-thioribose-1-phosphate isomerase activity|translation initiation factor activity|guanyl-nucleotide exchange factor activity|,8,16,2.52E+11,38.6%
P08030,0.17717439,0.053833333,16.70957584,-0.267,0.021332533,-2.989323633,0.196,0.109,0.257,-0.118,-0.125,0.004,P08030,Aprt,P08030_Aprt,P08030,Aprt,1,9,5,5,P08030|A0A1D5RLR6,MOUSE,19894.7,46.6,1595,1595.1,74.15,74.15,,180,Adenine phosphoribosyltransferase,nucleoplasm|cytoplasm|extracellular exosome|,purine ribonucleoside salvage|adenine salvage|lactation|grooming behavior|cellular response to insulin stimulus|AMP salvage|adenine metabolic process|grooming behavior|,adenine binding|adenine phosphoribosyltransferase activity|AMP binding|,5,9,735000000,46.6%
Q8VI75,0.919416995,-0.03,1.225349754,0.037333333,0.754162658,0.326390028,0.06,0.017,-0.223,0.102,-0.128,-0.008,Q8VI75,Ipo4,Q8VI75_Ipo4,Q8VI75,Ipo4,1,12,7,7,Q8VI75|Q5U4C5|D6RES6,MOUSE,120699,7.5,1596,1596.1,74,74,,1082,Importin-4,nuclear chromatin|cytoplasm|membrane|protein complex|,DNA replication-dependent nucleosome assembly|DNA replication-independent nucleosome assembly|ribosomal protein import into nucleus|ribosome biogenesis|,protein binding|Ran GTPase binding|,7,12,2820000000,7.5%
Q9CZ28,0.881050168,0.002666667,1.923934911,0.049333333,0.642105676,0.486534552,-0.012,-0.121,0.067,0.143,-0.089,0.028,Q9CZ28,Snf8,Q9CZ28_Snf8,Q9CZ28,Snf8,1,15,5,5,Q9CZ28|A2A6M1,MOUSE,28999.8,22.8,1597,1597.1,73.99,73.99,,258,Vacuolar-sorting protein SNF8,ESCRT II complex|nucleus|nucleoplasm|transcription factor complex|cytoplasm|cytosol|plasma membrane|endosome membrane|membrane|late endosome membrane|perinuclear region of cytoplasm|recycling endosome|extracellular exosome|,"transcription, DNA-templated|regulation of transcription from RNA polymerase II promoter|positive regulation of gene expression|regulation of multivesicular body size involved in endosome transport|endocytic recycling|regulation of protein catabolic process|protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway|early endosome to late endosome transport|positive regulation of protein catabolic process|regulation of protein complex stability|positive regulation of exosomal secretion|regulation of viral budding via host ESCRT complex|",protein C-terminus binding|transcription factor binding|channel regulator activity|protein homodimerization activity|protein N-terminus binding|,5,15,1200000000,22.8%
Q8R001,0.427208389,0.0055,9.851652545,-0.164333333,0.103474836,-1.883948283,0.048,0.108,0.107,-0.176,-0.046,-0.008,Q8R001,Mapre2,Q8R001_Mapre2,Q8R001,Mapre2,1,11,6,5,Q8R001|Q8R001-2|E9Q6X0|Q3TG90,MOUSE,37173.7,20.2,1598,1598.1,73.94,56.46,,326,Microtubule-associated protein RP/EB family member 2,cytoplasm|microtubule plus-end|,mitotic nuclear division|cell division|,protein binding|microtubule binding|,6,11,14300000000,20.2%
D3Z6G3,0.56608042,-0.006,7.018339026,-0.194666667,0.198685465,-1.428143883,0.191,0.262,-0.179,-0.196,-0.021,-0.093,D3Z6G3,Mapre3,D3Z6G3_Mapre3,D3Z6G3,Mapre3,1,3,4,3,D3Z6G3|Q6PER3,MOUSE,30649.1,19.9,1598,1598.2,43.82,26.34,,266,Microtubule-associated protein RP/EB family member 3,cytoplasm|microtubule cytoskeleton|microtubule plus-end|perinuclear region of cytoplasm|cytoplasmic microtubule|microtubule plus-end|,positive regulation of microtubule plus-end binding|,protein binding|microtubule binding|,3,3,30500000,16.1%
Q9JIY5,0.685093743,0.004333333,4.781938824,-0.122,0.332511077,-1.045198251,0.051,0.261,-0.116,-0.038,-0.009,-0.123,Q9JIY5,Htra2,Q9JIY5_Htra2,Q9JIY5,Htra2,1,11,7,7,Q9JIY5|D3YX27|D3YX28|S4R1B3|A2RT60,MOUSE,49347.5,22,1599,1599.1,73.86,73.86,,458,"Serine protease HTRA2, mitochondrial",chromatin|nucleus|mitochondrion|mitochondrial intermembrane space|cytosol|cytoskeleton|cytoplasmic side of plasma membrane|membrane|mitochondrial membrane|CD40 receptor complex|,proteolysis|ceramide metabolic process|mitochondrion organization|adult walking behavior|adult locomotory behavior|intrinsic apoptotic signaling pathway in response to DNA damage|response to herbicide|positive regulation of cell death|pentacyclic triterpenoid metabolic process|forebrain development|cellular response to heat|cellular response to interferon-beta|regulation of multicellular organism growth|positive regulation of apoptotic process|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|cellular protein catabolic process|neuron development|negative regulation of cell death|cellular response to retinoic acid|cellular response to growth factor stimulus|intrinsic apoptotic signaling pathway|positive regulation of protein targeting to mitochondrion|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand|positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|,serine-type endopeptidase activity|protein binding|peptidase activity|serine-type peptidase activity|,7,11,722000000,22.0%
Q78JE5,0.956972055,-0.029333333,0.621027487,0.018,0.866756787,0.174339736,-0.007,0.037,-0.145,0.081,0.016,-0.158,Q78JE5,Fbxo22,Q78JE5_Fbxo22,Q78JE5,Fbxo22,1,9,5,5,Q78JE5|Q3V492|D6REV6|D6RFT2,MOUSE,44886.8,13.4,1600,1600.1,73.66,73.66,,402,F-box only protein 22,nucleus|cytoplasm|Z disc|,protein polyubiquitination|nucleocytoplasmic transport|cellular response to starvation|regulation of myotube differentiation|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|regulation of skeletal muscle fiber development|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|,protein binding|,5,9,464000000,13.4%
Q61247,0.773512169,0.0155,3.49456375,0.102333333,0.447243075,0.807825209,-0.007,-0.23,0.13,0,-0.022,0.222,Q61247,Serpinf2,Q61247_Serpinf2,Q61247,Serpinf2,1,14,5,5,Q61247,MOUSE,55199.1,11.8,1601,1601.1,73.63,73.63,,491,Alpha-2-antiplasmin,fibrinogen complex|extracellular space|cell surface|extracellular exosome|blood microparticle|,regulation of blood vessel size by renin-angiotensin|acute-phase response|response to organic substance|negative regulation of plasminogen activation|negative regulation of endopeptidase activity|collagen fibril organization|positive regulation of collagen biosynthetic process|positive regulation of cell differentiation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of JNK cascade|blood vessel morphogenesis|positive regulation of smooth muscle cell proliferation|positive regulation of stress fiber assembly|negative regulation of fibrinolysis|positive regulation of ERK1 and ERK2 cascade|positive regulation of transforming growth factor beta production|,protease binding|serine-type endopeptidase inhibitor activity|protein homodimerization activity|,5,14,1490000000,11.8%
Q7TQH0-2,0.147261443,0.004666667,17.68995289,0.292,0.01702177,3.154186885,-0.179,-0.109,-0.136,0.058,0.119,0.275,Q7TQH0,Atxn2l,Q7TQH0-2_Atxn2l,Q7TQH0-2,Atxn2l,1,12,9,9,A0A0U1RPL0|Q7TQH0-2|Q7TQH0|Q7TQH0-3|Q3TGG2,MOUSE,113326.5,9.7,1602,1602.1,73.62,73.62,,1049,Isoform 2 of Ataxin-2-like protein,cytoplasm|cytoplasmic stress granule|membrane|nuclear speck|,regulation of cytoplasmic mRNA processing body assembly|stress granule assembly|,poly(A) RNA binding|,9,12,445000000,9.7%
G3X982,0.717934984,-0.002166667,4.248190668,0.081,0.375994016,0.948165902,-0.017,0.02,-0.131,0.078,0.021,0.016,G3X982,Aox3,G3X982_Aox3,G3X982,Aox3,1,15,10,8,G3X982|A0A087WQC8|Q3TYQ9,MOUSE,149067.4,11,1603,1603.1,73.56,51.5,,1335,Aldehyde oxidase 3,cytoplasm|,oxidation-reduction process|,"aldehyde oxidase activity|iron ion binding|UDP-N-acetylmuramate dehydrogenase activity|electron carrier activity|molybdenum ion binding|flavin adenine dinucleotide binding|NAD binding|2 iron, 2 sulfur cluster binding|",10,15,1320000000,11.0%
Q00519,0.936982455,-0.018,0.885598201,0.021333333,0.815530448,0.242662392,-0.107,-0.055,0.076,-0.036,0.013,0.001,Q00519,Xdh,Q00519_Xdh,Q00519,Xdh,1,9,9,7,Q00519,MOUSE,148670.7,7.6,1603,1603.2,65.45,43.39,,1335,Xanthine dehydrogenase/oxidase,extracellular space|peroxisome|cytosol|sarcoplasmic reticulum|,negative regulation of protein phosphorylation|negative regulation of endothelial cell proliferation|activation of cysteine-type endopeptidase activity involved in apoptotic process|lactation|xanthine catabolic process|negative regulation of gene expression|regulation of epithelial cell differentiation|negative regulation of endothelial cell differentiation|negative regulation of protein kinase B signaling|oxidation-reduction process|positive regulation of p38MAPK cascade|negative regulation of vascular endothelial growth factor signaling pathway|positive regulation of reactive oxygen species metabolic process|negative regulation of vasculogenesis|,"xanthine dehydrogenase activity|xanthine oxidase activity|iron ion binding|protein binding|UDP-N-acetylmuramate dehydrogenase activity|electron carrier activity|oxidoreductase activity|oxidoreductase activity, acting on the aldehyde or oxo group of donors|molybdenum ion binding|protein homodimerization activity|molybdopterin cofactor binding|flavin adenine dinucleotide binding|2 iron, 2 sulfur cluster binding|",7,9,1190000000,6.8%
P60766,0.912007214,-0.0045,1.407353635,-0.031,0.723210356,-0.369430376,0.069,-0.004,-0.032,-0.056,0.047,-0.051,P60766,Cdc42,P60766_Cdc42,P60766,Cdc42,1,21,5,5,P60766|P60766-1,MOUSE,21600.5,36.6,1604,1604.1,73.45,73.45,,191,Cell division control protein 42 homolog,Golgi membrane|storage vacuole|cytoplasm|microtubule organizing center|cytosol|plasma membrane|cell-cell junction|focal adhesion|membrane|secretory granule|filopodium|midbody|leading edge membrane|cytoplasmic ribonucleoprotein granule|cell projection|neuron projection|neuronal cell body|myelin sheath|apical part of cell|spindle midzone|extracellular exosome|cell periphery|mitotic spindle|,positive regulation of protein phosphorylation|sprouting angiogenesis|cardiac conduction system development|keratinocyte development|endocytosis|Golgi organization|regulation of mitotic nuclear division|nuclear migration|establishment or maintenance of cell polarity|Rho protein signal transduction|positive regulation of gene expression|negative regulation of gene expression|endosomal transport|single organismal cell-cell adhesion|substantia nigra development|hair follicle morphogenesis|positive regulation of pseudopodium assembly|negative regulation of protein complex assembly|keratinization|regulation of protein stability|positive regulation of cytokinesis|positive regulation of peptidyl-serine phosphorylation|adherens junction organization|cellular protein localization|establishment or maintenance of apical/basal cell polarity|multicellular organism growth|dendritic cell migration|regulation of protein catabolic process|positive regulation of MAPK cascade|regulation of protein heterodimerization activity|positive regulation of neuron apoptotic process|positive regulation of phosphatidylinositol 3-kinase activity|positive regulation of DNA replication|regulation of protein kinase activity|positive regulation of JNK cascade|filopodium assembly|positive regulation of metalloenzyme activity|neuron fate determination|epidermis morphogenesis|actin filament bundle assembly|regulation of protein metabolic process|regulation of filopodium assembly|nucleus localization|establishment of Golgi localization|positive regulation of synapse structural plasticity|regulation of attachment of spindle microtubules to kinetochore|heart contraction|canonical Wnt signaling pathway|positive regulation of epithelial cell proliferation involved in lung morphogenesis|submandibular salivary gland formation|epithelial-mesenchymal cell signaling|hair follicle placode formation|positive regulation of hair follicle cell proliferation|organelle transport along microtubule|actin filament branching|epithelial cell-cell adhesion|positive regulation of intracellular protein transport|positive regulation of substrate adhesion-dependent cell spreading|,GTPase activity|protein binding|GTP binding|protein kinase binding|GTP-dependent protein binding|mitogen-activated protein kinase kinase kinase binding|thioesterase binding|apolipoprotein A-I receptor binding|identical protein binding|,5,21,3610000000,36.6%
G3X9H5,0.877964074,0.018333333,1.975618439,0.066666667,0.63450954,0.49813246,0.043,-0.093,0.005,0.3,-0.169,0.024,G3X9H5,Htt,G3X9H5_Htt,G3X9H5,Htt,1,9,8,8,G3X9H5|P42859|P42859-2,MOUSE,348832.8,3.4,1605,1605.1,73.4,73.4,,3120,Huntingtin,nucleus|nucleoplasm|cytoplasm|mitochondrion|late endosome|autophagosome|endoplasmic reticulum|Golgi apparatus|centriole|cytosol|postsynaptic density|cytoplasmic membrane-bounded vesicle|inclusion body|clathrin-coated vesicle|axon|dendrite|cytoplasmic vesicle membrane|neuronal cell body|protein complex|neuronal ribonucleoprotein granule|,"urea cycle|citrulline metabolic process|establishment of mitotic spindle orientation|protein import into nucleus|mitochondrial transport|ER to Golgi vesicle-mediated transport|retrograde vesicle-mediated transport, Golgi to ER|apoptotic process|mitochondrion organization|endoplasmic reticulum organization|Golgi organization|dopamine receptor signaling pathway|spermatogenesis|gastrulation|central nervous system development|brain development|cell aging|learning or memory|learning|grooming behavior|locomotory behavior|axon cargo transport|associative learning|determination of adult lifespan|visual learning|anatomical structure morphogenesis|anterior/posterior pattern specification|endosomal transport|lactate biosynthetic process from pyruvate|quinolinate biosynthetic process|striatum development|olfactory lobe development|neural plate formation|neurogenesis|peptide hormone secretion|insulin secretion|positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity|regulation of protein phosphatase type 2A activity|social behavior|hormone metabolic process|negative regulation of apoptotic process|negative regulation of neuron apoptotic process|positive regulation of cilium assembly|regulation of mitochondrial membrane permeability|vesicle transport along microtubule|regulation of synaptic plasticity|paraxial mesoderm formation|neuron development|mRNA transport|neuron apoptotic process|response to calcium ion|regulation of mitochondrial membrane potential|L-glutamate import|iron ion homeostasis|protein localization to centrosome|negative regulation of neuron death|positive regulation of nonmotile primary cilium assembly|negative regulation of cysteine-type endopeptidase activity|negative regulation of extrinsic apoptotic signaling pathway|neuron development|",p53 binding|receptor binding|protein binding|profilin binding|transcription factor binding|dynactin binding|identical protein binding|ion channel binding|dynein intermediate chain binding|beta-tubulin binding|diazepam binding|,8,9,219000000,3.4%
K3W4M4,0.797504707,-0.055,3.112716053,0.097333333,0.488346855,0.733610601,-0.018,0.077,-0.37,-0.068,-0.001,0.05,K3W4M4,Naxd,K3W4M4_Naxd,K3W4M4,Naxd,1,12,7,7,K3W4M4|Q9CZ42|Q9CZ42-3|J3QMM7|Q9CZ42-2|J3QN06|J3QPU6,MOUSE,39424.6,31.7,1606,1606.1,73.26,73.26,,365,ATP-dependent (S)-NAD(P)H-hydrate dehydratase,mitochondrion|cytosol|mitochondrion|,metabolic process|,ATP binding|ATP-dependent NAD(P)H-hydrate dehydratase activity|ADP-dependent NAD(P)H-hydrate dehydratase activity|,7,12,868000000,31.7%
Q9R099,0.561710094,0.043333333,7.104828245,-0.238666667,0.194767808,-1.442456915,0.006,0.493,-0.011,0.101,-0.119,-0.21,Q9R099,Tbl2,Q9R099_Tbl2,Q9R099,Tbl2,1,16,7,7,Q9R099,MOUSE,50210.4,15.8,1607,1607.1,73.23,73.23,,442,Transducin beta-like protein 2,endoplasmic reticulum|,endoplasmic reticulum unfolded protein response|cellular response to glucose starvation|cellular response to hypoxia|,protein kinase binding|translation initiation factor binding|poly(A) RNA binding|phosphoprotein binding|,7,16,1710000000,15.8%
Q8R2P8,0.91325,-0.0055,1.367119011,-0.033666667,0.729941573,-0.359985861,0.089,0.07,-0.125,0.003,-0.023,-0.047,Q8R2P8,Kars,Q8R2P8_Kars,Q8R2P8,Kars,1,9,8,8,Q8R2P8|Q99MN1,MOUSE,71745.9,11.6,1608,1608.1,73.19,73.19,,624,Lysine--tRNA ligase,cytoplasm|mitochondrion|microtubule cytoskeleton|aminoacyl-tRNA synthetase multienzyme complex|,lysyl-tRNA aminoacylation|diadenosine tetraphosphate biosynthetic process|,tRNA binding|lysine-tRNA ligase activity|ATP binding|amino acid binding|,8,9,1070000000,11.6%
Q8R104,0.93595046,-0.007833333,0.904396177,-0.053,0.812008139,-0.247518043,0.035,0.44,-0.419,-0.154,0.087,-0.036,Q8R104,Sirt3,Q8R104_Sirt3,Q8R104,Sirt3,1,12,5,5,Q8R104|A0A1B0GRY5|Q8R104-2|A0A1B0GRF7,MOUSE,36956.2,23,1609,1609.1,73.16,73.16,,334,NAD-dependent protein deacetylase sirtuin-3,cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial matrix|membrane|,protein deacetylation|aging|aerobic respiration|positive regulation of insulin secretion|peptidyl-lysine deacetylation|negative regulation of ERK1 and ERK2 cascade|histone H3 deacetylation|negative regulation of reactive oxygen species metabolic process|negative regulation of peptidyl-lysine acetylation|,protein binding|zinc ion binding|enzyme binding|NAD-dependent histone deacetylase activity (H3-K14 specific)|NAD+ binding|NAD-dependent histone deacetylase activity (H3-K14 specific)|,5,12,978000000,23.0%
Q80X50-5,0.100417072,-0.070166667,20.04701151,0.619,0.009892336,3.577491787,-0.21,-0.197,-0.732,0.103,0.193,0.422,Q80X50,Ubap2l,Q80X50-5_Ubap2l,Q80X50-5,Ubap2l,1,12,6,6,Q80X50-5|Q80X50|Q80X50-4|Q80X50-3|A0A0G2JDV6|Q80X50-2|A0A0H2UH17,MOUSE,117446.7,8.9,1610,1610.1,73.06,73.06,,1107,Isoform 5 of Ubiquitin-associated protein 2-like,Ada2/Gcn5/Ada3 transcription activator complex|PcG protein complex|,binding of sperm to zona pellucida|hematopoietic stem cell homeostasis|,poly(A) RNA binding|,6,12,1270000000,8.9%
Q8BVQ5,0.815095629,-0.017833333,2.87907557,-0.070333333,0.515338327,-0.686700234,0.062,0.084,-0.094,0.07,-0.166,-0.063,Q8BVQ5,Ppme1,Q8BVQ5_Ppme1,Q8BVQ5,Ppme1,1,13,7,7,Q8BVQ5,MOUSE,42655,21.2,1611,1611.1,73.06,73.06,,386,Protein phosphatase methylesterase 1,,protein demethylation|,protein kinase binding|protein phosphatase binding|protein phosphatase 2A binding|protein C-terminal methylesterase activity|,7,13,460000000,21.2%
O08582,0.708523608,0.0085,4.40367888,-0.083666667,0.362770624,-0.976481807,0.08,0.113,-0.042,-0.002,-0.063,-0.035,O08582,Gtpbp1,O08582_Gtpbp1,O08582,Gtpbp1,1,10,5,5,O08582,MOUSE,72984.1,11.5,1612,1612.1,72.88,72.88,,668,GTP-binding protein 1,cytoplasmic exosome (RNase complex)|cytosol|membrane|,metabolic process|positive regulation of mRNA catabolic process|,GTPase activity|GTP binding|poly(A) RNA binding|,5,10,555000000,11.5%
Q99JR5,0.074838761,0.064166667,21.56194101,0.815,0.006979204,3.852894313,-0.071,-0.288,-0.671,0.631,0.679,0.105,Q99JR5,Tinagl1,Q99JR5_Tinagl1,Q99JR5,Tinagl1,1,10,8,8,Q99JR5|H3BJ97,MOUSE,54032.9,21.6,1613,1613.1,72.72,72.72,,466,Tubulointerstitial nephritis antigen-like,extracellular space|cytoplasm|extracellular exosome|lysosome|extracellular matrix|,receptor-mediated endocytosis|immune response|cell adhesion|proteolysis involved in cellular protein catabolic process|,scavenger receptor activity|polysaccharide binding|laminin binding|cysteine-type endopeptidase activity|,8,10,513000000,21.6%
Q80TL7,0.22436839,0.008166667,15.01707161,-0.229666667,0.031498715,-2.710297166,0.162,0.054,0.153,-0.042,-0.131,-0.147,Q80TL7,Mon2,Q80TL7_Mon2,Q80TL7,Mon2,1,10,7,7,Q80TL7|B9EKJ3|Q80TL7-2|A0A1W2P878,MOUSE,191243.1,5,1614,1614.1,72.56,72.56,,1715,Protein MON2 homolog,trans-Golgi network|extracellular exosome|,Golgi to endosome transport|protein transport|vesicle-mediated transport|positive regulation of GTPase activity|,ARF guanyl-nucleotide exchange factor activity|,7,10,2820000000,5.0%
A2AT37,0.909718781,-0.0375,1.468980147,0.045666667,0.713020449,0.383990326,0.076,0.032,-0.289,0.024,-0.003,-0.065,A2AT37,Upf2,A2AT37_Upf2,A2AT37,Upf2,1,8,7,7,A2AT37,MOUSE,148748.3,5.9,1615,1615.1,72.53,72.53,,1269,UPF2 regulator of nonsense transcripts homolog (yeast),nucleus|cytoplasm|exon-exon junction complex|perinuclear region of cytoplasm|,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|liver development|response to unfolded protein|organ regeneration|",RNA binding|,7,8,986000000,5.9%
Q9WTP6,0.880641665,0.0025,1.928792312,0.069666667,0.641387909,0.48786296,0.054,0.055,-0.206,-0.091,0.296,-0.093,Q9WTP6,Ak2,Q9WTP6_Ak2,Q9WTP6,Ak2,1,10,6,6,Q9WTP6|Q9WTP6-2,MOUSE,26753.5,38.4,1616,1616.1,72.44,72.44,,239,"Adenylate kinase 2, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial intermembrane space|sperm flagellum|extracellular exosome|sperm mitochondrial sheath|,ADP biosynthetic process|AMP metabolic process|ATP metabolic process|nucleotide phosphorylation|,adenylate kinase activity|ATP binding|,6,10,964000000,38.4%
Q8CHW4,0.748326411,-0.0035,3.848044497,-0.098333333,0.412283116,-0.874492625,0.205,0.026,-0.094,0.07,-0.095,-0.133,Q8CHW4,Eif2b5,Q8CHW4_Eif2b5,Q8CHW4,Eif2b5,1,9,7,7,Q8CHW4,MOUSE,80883.7,9.2,1617,1617.1,72.43,72.43,,717,Translation initiation factor eIF-2B subunit epsilon,nucleus|cytoplasm|eukaryotic translation initiation factor 2B complex|,ovarian follicle development|translational initiation|response to heat|response to glucose|astrocyte development|oligodendrocyte development|negative regulation of translational initiation in response to stress|response to endoplasmic reticulum stress|cellular response to drug|myelination|response to peptide hormone|positive regulation of GTPase activity|positive regulation of translational initiation|astrocyte differentiation|,guanyl-nucleotide exchange factor activity|translation initiation factor binding|translation initiation factor activity|guanyl-nucleotide exchange factor activity|,7,9,1250000000,9.2%
P62806,0.123830702,0.0525,18.66810729,0.589,0.013589055,3.334271788,-0.461,-0.114,-0.151,0.102,0.257,0.682,P62806,Hist1h4h,P62806_Hist1h4h,P62806,Hist1h4a,1,16,5,5,P62806,MOUSE,11367.1,51.4,1618,1618.1,72.29,72.29,,103,Histone H4,nuclear chromosome|nucleosome|nucleoplasm|membrane|extracellular exosome|,chromatin silencing at rDNA|nucleosome assembly|DNA replication-dependent nucleosome assembly|DNA replication-independent nucleosome assembly|negative regulation of megakaryocyte differentiation|protein heterotetramerization|,DNA binding|protein binding|histone binding|poly(A) RNA binding|protein heterodimerization activity|,5,16,5810000000,51.4%
Q9ET54,0.457962014,-0.028333333,9.191837172,0.223333333,0.120452629,1.781680822,-0.204,0.052,-0.268,-0.043,0.052,0.241,Q9ET54,Palld,Q9ET54_Palld,Q9ET54,Palld,1,8,6,6,Q9ET54|Q9ET54-6|Q9ET54-2|Q9ET54-4|Q9ET54-5|Q9ET54-3|Q5DTJ9|A0A1W2P7G1,MOUSE,153668.9,5.6,1619,1619.1,72.22,72.22,,1408,Palladin,ruffle|nucleus|cytoplasm|mitochondrion|actin filament|plasma membrane|focal adhesion|actin cytoskeleton|Z disc|lamellipodium|,keratinocyte development|epithelial cell morphogenesis|actin cytoskeleton organization|,actin binding|,6,8,337000000,5.6%
Q61545,0.578909417,0.0335,6.791272104,0.398333333,0.209349915,1.390434035,-0.378,-0.368,0.249,-0.264,0.226,0.736,Q61545,Ewsr1,Q61545_Ewsr1,Q61545,Ewsr1,1,15,6,6,Q5SUS9|Q61545|Q5SUT0,MOUSE,68746.3,11.6,1620,1620.1,72.19,72.19,,655,RNA-binding protein EWS,nucleus|nucleoplasm|nucleolus|cytoplasm|plasma membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",nucleotide binding|protein binding|calmodulin binding|zinc ion binding|identical protein binding|poly(A) RNA binding|,6,15,960000000,11.6%
Q9R1C7,0.913973354,0.0015,1.342126583,-0.041,0.734154291,-0.3542156,-0.143,0.231,-0.022,-0.059,0.022,-0.02,Q9R1C7,Prpf40a,Q9R1C7_Prpf40a,Q9R1C7,Prpf40a,1,9,6,6,Q9R1C7|A0A1B0GRU8|Q9R1C7-2,MOUSE,108764,8.1,1621,1621.1,72.16,72.16,,953,Pre-mRNA-processing factor 40 homolog A,nucleoplasm|cytoplasm|membrane|nuclear matrix|nuclear speck|,mRNA processing|cytoskeleton organization|regulation of cell shape|RNA splicing|cell migration|regulation of cytokinesis|,protein binding|poly(A) RNA binding|proline-rich region binding|,6,9,622000000,8.1%
Q5SVR0,0.841746758,-0.0105,2.510423936,0.059,0.560993212,0.611580251,0.059,-0.008,-0.171,0.086,-0.025,-0.004,Q5SVR0,Tbc1d9b,Q5SVR0_Tbc1d9b,Q5SVR0,Tbc1d9b,1,9,6,6,Q5SVR0|Q5SVR0-2,MOUSE,142803.7,7.2,1622,1622.1,71.98,71.98,,1263,TBC1 domain family member 9B,integral component of membrane|,positive regulation of GTPase activity|,GTPase activator activity|calcium ion binding|,6,9,1390000000,7.2%
P84096,0.817340245,0.0195,2.843447325,-0.067,0.5195834,-0.679543691,-0.015,-0.025,0.199,0.045,-0.074,-0.013,P84096,Rhog,P84096_Rhog,P84096,Rhog,1,19,7,7,P84096,MOUSE,21764.5,46,1623,1623.1,71.96,71.96,,191,Rho-related GTP-binding protein RhoG,intracellular|plasma membrane|focal adhesion|extracellular exosome|,"Rho protein signal transduction|metabolic process|Rac protein signal transduction|actin cytoskeleton organization|positive regulation of transcription, DNA-templated|cell chemotaxis|positive regulation of establishment of protein localization to plasma membrane|activation of GTPase activity|regulation of ruffle assembly|",GTPase activity|protein binding|GTP binding|,7,19,1450000000,46.0%
Q9JI11,0.855039332,0.015166667,2.319761566,-0.045,0.586170345,-0.571733364,0.02,0.013,0.08,0.015,-0.029,-0.008,Q9JI11,Stk4,Q9JI11_Stk4,Q9JI11,Stk4,1,11,7,7,Q9JI11|Q9JI10|Q9JI10-2|Q8CDG4,MOUSE,55768.4,18.6,1624,1624.1,71.82,77.78,,487,Serine/threonine-protein kinase 4,nucleus|nucleoplasm|cytoplasm|,MAPK cascade|activation of MAPKK activity|cell morphogenesis|patterning of blood vessels|neural tube formation|endocardium development|protein phosphorylation|apoptotic process|regulation of mitotic cell cycle|central nervous system development|negative regulation of cell proliferation|peptidyl-serine phosphorylation|signal transduction by protein phosphorylation|keratinocyte differentiation|stress-activated protein kinase signaling cascade|positive regulation of protein binding|hippo signaling|intracellular signal transduction|positive regulation of apoptotic process|positive regulation of fat cell differentiation|negative regulation of organ growth|protein autophosphorylation|primitive hemopoiesis|cell differentiation involved in embryonic placenta development|regulation of cell differentiation involved in embryonic placenta development|negative regulation of canonical Wnt signaling pathway|hepatocyte apoptotic process|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors|,magnesium ion binding|protein serine/threonine kinase activity|MAP kinase kinase kinase activity|protein binding|ATP binding|transcription factor binding|identical protein binding|protein homodimerization activity|protein dimerization activity|,8,11,2320000000,18.6%
E9QNE9,0.2052132,0.035833333,15.74029057,0.419,0.026666802,2.837609304,-0.138,-0.115,-0.268,-0.059,0.338,0.457,E9QNE9,NotFound,E9QNE9_NotFound,E9QNE9,Map4k3,1,2,3,2,E9QNE9|Q99JP0,MOUSE,102533.2,4.2,1624,1624.2,17.86,11.76,,896,Mitogen-activated protein kinase kinase kinase kinase,intracellular|cytoplasm|,MAPK cascade|activation of MAPKKK activity|protein phosphorylation|regulation of mitotic cell cycle|response to UV|stress-activated protein kinase signaling cascade|activation of protein kinase activity|response to tumor necrosis factor|intracellular signal transduction|regulation of apoptotic process|,protein serine/threonine kinase activity|ATP binding|MAP kinase kinase kinase kinase activity|,2,2,18600000,3.0%
Q9CQ54,0.977113723,0.0065,0.34885641,0.013,0.922814392,0.100642273,-0.21,0.224,-0.014,-0.065,0.001,0.103,Q9CQ54,Ndufc2,Q9CQ54_Ndufc2,Q9CQ54,Ndufc2,1,19,6,6,Q9CQ54|A0A0U1RPJ5,MOUSE,14220.5,35.8,1625,1625.1,71.73,71.73,,120,NADH dehydrogenase [ubiquinone] 1 subunit C2,cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex I|integral component of membrane|,"mitochondrial electron transport, NADH to ubiquinone|",NADH dehydrogenase (ubiquinone) activity|,6,19,5590000000,35.8%
Q505D1,0.636050842,-0.038333333,5.641317234,0.159333333,0.27281502,1.195887634,0.032,0.012,-0.398,0.073,0.019,0.032,Q505D1,Ankrd28,Q505D1_Ankrd28,Q505D1,Ankrd28,1,10,7,7,Q505D1,MOUSE,114607.3,8.1,1626,1626.1,71.7,71.7,,1053,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A,nucleoplasm|,,,7,10,387000000,8.1%
P46638,0.933608247,0.0075,0.946542545,-0.025666667,0.804166071,-0.257985755,0.12,-0.075,0.016,0.056,0.054,-0.126,P46638,Rab11b,P46638_Rab11b,P46638,Rab11b,1,12,6,6,P46638|P62492|E9Q3P9|G3UY29|G3UZD3|E9Q6B3,MOUSE,24603.1,23.8,1627,1627.1,71.52,71.52,,218,Ras-related protein Rab-11B,cytoplasm|mitochondrion|synaptic vesicle|cytoplasmic membrane-bounded vesicle|cell junction|phagocytic vesicle membrane|synaptic vesicle membrane|phagocytic vesicle|recycling endosome|recycling endosome membrane|extracellular exosome|,"receptor recycling|intracellular protein transport|melanosome transport|Rab protein signal transduction|transferrin transport|insulin secretion involved in cellular response to glucose stimulus|regulation of anion transport|constitutive secretory pathway|regulated secretory pathway|cellular response to acidic pH|establishment of protein localization to membrane|retrograde transport, endosome to plasma membrane|regulation of protein localization to cell surface|regulation of endocytic recycling|endocytosis|",GTPase activity|protein binding|GTP binding|GDP binding|myosin V binding|,6,12,5220000000,23.8%
D3YV00,0.923890139,-0.0015,1.130279046,-0.025666667,0.770853938,-0.303316031,-0.015,0.047,0.002,0.054,-0.095,-0.002,D3YV00,Atp9b,D3YV00_Atp9b,D3YV00,Atp9b,1,13,7,7,D3YV00|P98195|A0A286YCV0|P98195-2|A0A286YCT2|A2AQC3|O70228|Q8C288|Q8C4G3|E9Q8X5,MOUSE,130526.2,7.5,1628,1628.1,71.51,71.51,,1146,Phospholipid-transporting ATPase,endosome|trans-Golgi network|plasma membrane|integral component of membrane|perinuclear region of cytoplasm|,"retrograde vesicle-mediated transport, Golgi to ER|endocytosis|metabolic process|phospholipid translocation|establishment of protein localization to Golgi|",magnesium ion binding|phospholipid-translocating ATPase activity|ATP binding|,8,13,588000000,7.5%
Q6VN19,0.514657719,0.015833333,7.906181516,-0.137,0.161950334,-1.571663436,-0.003,0.108,0.148,0.008,-0.086,-0.08,Q6VN19,Ranbp10,Q6VN19_Ranbp10,Q6VN19,Ranbp10,1,7,7,6,A0A0R4J0G4|Q6VN19,MOUSE,67928.9,14.3,1629,1629.1,71.45,67.23,,620,Ran-binding protein 10,nucleus|cytoplasm|cytoplasmic microtubule|,microtubule cytoskeleton organization|positive regulation of GTPase activity|,Ran guanyl-nucleotide exchange factor activity|Ran GTPase binding|beta-tubulin binding|,7,7,401000000,14.3%
E9Q5D6,0.209459289,-0.032333333,15.59834757,0.294,0.027552768,2.806704627,-0.062,-0.336,-0.14,0.198,0.1,0.046,E9Q5D6,Ranbp9,E9Q5D6_Ranbp9,E9Q5D6,Ranbp9,1,3,4,3,E9Q5D6|P69566|P69566-2,MOUSE,76679.7,6.9,1629,1629.2,24.83,20.61,,710,Ran-binding protein 9,nucleus|cytoplasm|centrosome|,negative regulation of ERK1 and ERK2 cascade|,protein binding|Ran GTPase binding|enzyme binding|,3,3,32600000,4.5%
Q9D0D3,0.90651412,-0.006333333,1.51020192,0.039333333,0.706284716,0.393347412,0.07,0.03,-0.178,0.077,-0.005,-0.032,Q9D0D3,Mtpap,Q9D0D3_Mtpap,Q9D0D3,Mtpap,1,9,5,5,Q9D0D3,MOUSE,66026.9,14.1,1630,1630.1,71.43,71.43,,585,"Poly(A) RNA polymerase, mitochondrial",mitochondrion|intracellular membrane-bounded organelle|,"transcription, DNA-templated|mRNA polyadenylation|histone mRNA catabolic process|",magnesium ion binding|UTP binding|polynucleotide adenylyltransferase activity|ATP binding|manganese ion binding|identical protein binding|protein homodimerization activity|poly(A) RNA binding|,5,9,454000000,14.1%
Q8K2K6,0.584741827,-0.035,6.632561964,0.158,0.217141985,1.363508762,-0.151,0.082,-0.273,0.002,-0.001,0.131,Q8K2K6,Agfg1,Q8K2K6_Agfg1,Q8K2K6,Agfg1,1,12,8,8,Q8K2K6|Q8K2K6-1|A0A087WSR7|Q8K2K6-3|A0A087WNV1|Q8K2K6-2,MOUSE,58327.1,20.6,1631,1631.1,71.4,71.4,,561,Arf-GAP domain and FG repeat-containing protein 1,nucleus|cytoplasmic membrane-bounded vesicle|cell projection|neuronal cell body|intracellular membrane-bounded organelle|,acrosome assembly|transport|multicellular organismal development|spermatid nucleus differentiation|positive regulation of GTPase activity|intermediate filament organization|,DNA binding|GTPase activator activity|metal ion binding|,8,12,760000000,20.6%
Q9JLI8,0.763908281,-0.0045,3.655785468,-0.085,0.43094461,-0.837955974,-0.093,0.118,0.089,-0.024,-0.153,0.036,Q9JLI8,Sart3,Q9JLI8_Sart3,Q9JLI8,Sart3,1,8,7,7,Q9JLI8|Q9JLI8-2,MOUSE,110472.7,8.9,1632,1632.1,71.38,71.38,,962,Squamous cell carcinoma antigen recognized by T-cells 3,nucleus|nucleoplasm|cytoplasm|Cajal body|nuclear speck|U4/U6 x U5 tri-snRNP complex|U4atac/U6atac snRNP|U6atac snRNP|U4/U6 snRNP|,"spliceosomal tri-snRNP complex assembly|spliceosomal snRNP assembly|mRNA splicing, via spliceosome|cell morphogenesis|nucleosome assembly|regulation of gene expression|homeostasis of number of cells|hematopoietic stem cell proliferation|positive regulation of histone deubiquitination|",nucleotide binding|RNA binding|U6 snRNA binding|U4 snRNA binding|U6atac snRNA binding|histone binding|poly(A) RNA binding|ubiquitin-specific protease binding|,7,8,1100000000,8.9%
E9PUR6,0.336787221,-0.011833333,11.7314009,0.227,0.067121231,2.183374416,-0.116,0.023,-0.283,0.139,0.106,0.06,E9PUR6,Nr3c1,E9PUR6_Nr3c1,E9PUR6,Nr3c1,1,12,6,6,E9PUR6|P06537|P06537-3|P06537-5|E9PYV1|P06537-2|P06537-4|A3KN90|D3Z473|D6RIL1,MOUSE,88303.3,8.7,1633,1633.1,71.32,71.32,,792,Glucocorticoid receptor,intracellular|nucleus|nucleoplasm|cytoplasm|cytosol|membrane|,"regulation of gluconeogenesis|regulation of transcription, DNA-templated|transcription from RNA polymerase II promoter|glucocorticoid metabolic process|adrenal gland development|regulation of glucocorticoid biosynthetic process|maternal behavior|glucocorticoid receptor signaling pathway|glucocorticoid mediated signaling pathway|positive regulation of neuron apoptotic process|positive regulation of transcription from RNA polymerase II promoter|mammary gland duct morphogenesis|cellular response to steroid hormone stimulus|negative regulation of glucocorticoid mediated signaling pathway|",RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|DNA binding|sequence-specific DNA binding transcription factor activity|glucocorticoid receptor activity|steroid binding|protein binding|zinc ion binding|glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity|sequence-specific DNA binding|protein dimerization activity|steroid hormone binding|,6,12,388000000,8.7%
Q9JLJ4,0.593471457,-0.113,6.449157669,0.319333333,0.226508359,1.333222778,0.013,0.02,-0.851,0.077,-0.038,0.101,Q9JLJ4,Elovl2,Q9JLJ4_Elovl2,Q9JLJ4,Elovl2,1,44,4,4,Q9JLJ4|A0A0R4J1P7,MOUSE,34491.9,10.9,1634,1634.1,71.32,71.32,,292,Elongation of very long chain fatty acids protein 2,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,"very long-chain fatty acid metabolic process|unsaturated fatty acid biosynthetic process|fatty acid elongation, polyunsaturated fatty acid|very long-chain fatty acid biosynthetic process|","fatty acid elongase activity|transferase activity, transferring acyl groups other than amino-acyl groups|",4,44,24700000000,10.9%
B9EJ86,0.677899899,-0.081666667,4.896906977,0.18,0.323824201,1.065830512,-0.024,0.047,-0.538,0.013,0.112,-0.1,B9EJ86,Osbpl8,B9EJ86_Osbpl8,B9EJ86,Osbpl8,1,8,6,6,B9EJ86|A0A0R4J150,MOUSE,101837.3,9.6,1635,1635.1,71.14,71.14,,889,Oxysterol-binding protein-related protein 8,membrane|nuclear membrane|,lipid transport|negative regulation of sequestering of triglyceride|negative regulation of cell migration|activation of protein kinase B activity|fat cell differentiation|positive regulation of insulin receptor signaling pathway|positive regulation of protein kinase B signaling|protein localization to nuclear pore|positive regulation of glucose import in response to insulin stimulus|,protein binding|cholesterol binding|,6,8,424000000,9.6%
P97494,0.417403507,-0.010666667,10.02863877,0.249333333,0.099342738,1.915668387,-0.251,0.076,-0.231,-0.055,0.224,0.173,P97494,Gclc,P97494_Gclc,P97494,Gclc,1,8,6,6,P97494,MOUSE,73368.8,14.1,1636,1636.1,71.02,71.02,,637,Glutamate--cysteine ligase catalytic subunit,cytosol|glutamate-cysteine ligase complex|,"cysteine metabolic process|glutamate metabolic process|glutathione metabolic process|glutathione biosynthetic process|response to oxidative stress|apoptotic mitochondrial changes|response to heat|response to xenobiotic stimulus|response to hormone|L-ascorbic acid metabolic process|negative regulation of protein ubiquitination|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|negative regulation of apoptotic process|negative regulation of neuron apoptotic process|cell redox homeostasis|negative regulation of transcription, DNA-templated|response to arsenic-containing substance|regulation of blood vessel size|response to nitrosative stress|regulation of mitochondrial depolarization|negative regulation of extrinsic apoptotic signaling pathway|",magnesium ion binding|glutamate-cysteine ligase activity|ATP binding|glutamate binding|ADP binding|protein heterodimerization activity|coenzyme binding|,6,8,481000000,14.1%
P20108,0.996544943,-0.0035,0.041930059,-0.001,0.990391705,-0.01249894,0.018,0.02,-0.047,-0.015,0.038,-0.035,P20108,Prdx3,P20108_Prdx3,P20108,Prdx3,1,23,4,4,P20108,MOUSE,28354.7,26,1637,1637.1,70.98,70.98,,257,"Thioredoxin-dependent peroxide reductase, mitochondrial",cytoplasm|mitochondrion|early endosome|cytosol|myelin sheath|extracellular exosome|IkappaB kinase complex|,maternal placenta development|apoptotic process|response to oxidative stress|mitochondrion organization|positive regulation of cell proliferation|peptidyl-cysteine oxidation|myeloid cell differentiation|response to lipopolysaccharide|negative regulation of kinase activity|cellular response to oxidative stress|cellular response to reactive oxygen species|response to hydrogen peroxide|hydrogen peroxide catabolic process|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of NF-kappaB transcription factor activity|regulation of mitochondrial membrane potential|,protein C-terminus binding|thioredoxin peroxidase activity|kinase binding|protein kinase binding|identical protein binding|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|,4,23,3120000000,26.0%
Q8CFV9,0.872151671,0.011666667,2.087169878,-0.051333333,0.618419268,-0.522100044,0.175,0.038,-0.101,-0.01,-0.001,-0.031,Q8CFV9,Rfk,Q8CFV9_Rfk,Q8CFV9,Rfk,1,14,6,6,Q8CFV9,MOUSE,17493.7,38.7,1638,1638.1,70.93,70.93,,155,Riboflavin kinase,mitochondrion|,apoptotic process|riboflavin biosynthetic process|FMN biosynthetic process|phosphorylation|positive regulation of NAD(P)H oxidase activity|reactive oxygen species metabolic process|,protein binding|ATP binding|riboflavin kinase activity|metal ion binding|,6,14,6960000000,38.7%
E9PX59,0.884566234,-0.018,1.853946423,0.040666667,0.652537324,0.471086208,0.002,-0.083,-0.034,0.084,-0.002,-0.075,E9PX59,Samd9l,E9PX59_Samd9l,E9PX59,Samd9l,1,9,7,7,E9PX59|Q69Z37,MOUSE,184076.8,5.3,1639,1639.1,70.89,70.89,,1579,Sterile alpha motif domain-containing protein 9-like,early endosome|,hematopoietic progenitor cell differentiation|stem cell division|endosomal vesicle fusion|common myeloid progenitor cell proliferation|regulation of protein catabolic process|spleen development|,,7,9,3200000000,5.3%
Q80YE7,0.975683513,-0.018166667,0.358400617,-0.009,0.92078861,-0.103249316,0.038,0.026,-0.105,0.033,-0.034,-0.067,Q80YE7,Dapk1,Q80YE7_Dapk1,Q80YE7,Dapk1,1,11,7,7,Q80YE7|Q80YE7-2,MOUSE,163321.4,5.7,1640,1640.1,70.89,70.89,,1442,Death-associated protein kinase 1,cytoplasm|cytosol|plasma membrane|actin cytoskeleton|,protein phosphorylation|apoptotic process|extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of translation|intracellular signal transduction|negative regulation of apoptotic process|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|protein autophosphorylation|cellular response to interferon-gamma|apoptotic signaling pathway|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|regulation of N-methyl-D-aspartate selective glutamate receptor activity|,protein kinase activity|calmodulin-dependent protein kinase activity|protein binding|calmodulin binding|ATP binding|GTP binding|syntaxin-1 binding|identical protein binding|,7,11,449000000,5.7%
Q8C3X4,0.809729234,-0.0255,2.961459881,0.101,0.505654658,0.703623223,0.018,0.127,-0.373,0.103,-0.001,-0.027,Q8C3X4,Guf1,Q8C3X4_Guf1,Q8C3X4,Guf1,1,15,7,7,Q8C3X4|Q8C3X4-2|A0A0J9YUM0,MOUSE,72803.8,16.4,1641,1641.1,70.82,70.82,,651,"Translation factor Guf1, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial matrix|,translation|positive regulation of translation|,GTPase activity|GTP binding|ribosome binding|,7,15,2020000000,16.4%
Q6PFD9,0.620776556,-0.041666667,5.940567147,0.124666667,0.254649768,1.245818522,-0.004,-0.045,-0.263,0.008,-0.012,0.066,Q6PFD9,Nup98,Q6PFD9_Nup98,Q6PFD9,Nup98,1,7,7,7,A0A1B0GSX7|Q6PFD9|A0A140T8J8|B2RQL0|A0A1B0GRA7|A0A1B0GRB5,MOUSE,198435.1,5.2,1642,1642.1,70.71,70.71,,1816,Nuclear pore complex protein Nup98-Nup96,nucleus|nuclear envelope|nuclear pore|nuclear pore outer ring|nuclear membrane|nuclear periphery|nuclear inclusion body|nuclear pore nuclear basket|kinetochore|,DNA replication|protein transport|mRNA transport|nuclear pore complex assembly|,structural constituent of nuclear pore|,7,7,287000000,5.2%
Q8K2I4,0.000232962,-0.103,56.28227892,1.628,2.35381E-06,14.80648313,-1.036,-0.796,-0.919,0.671,0.605,0.857,Q8K2I4,Manba,Q8K2I4_Manba,Q8K2I4,Manba,1,8,6,6,A0A0R4J092|Q8K2I4|D6RGR1,MOUSE,101513.6,8,1643,1643.1,70.64,70.64,,879,Beta-mannosidase,lysosome|intracellular membrane-bounded organelle|,carbohydrate metabolic process|glycoprotein catabolic process|mannan catabolic process|,beta-mannosidase activity|,6,8,107000000,8.0%
Q8BGX2,0.855683036,-0.0085,2.299824345,-0.080333333,0.588867472,-0.567851289,-0.026,0.271,-0.15,-0.228,0.041,0.041,Q8BGX2,Timm29,Q8BGX2_Timm29,Q8BGX2,Timm29,1,14,5,5,Q8BGX2,MOUSE,29757.2,28.9,1644,1644.1,70.63,70.63,,266,Mitochondrial import inner membrane translocase subunit Tim29,,,,5,14,1010000000,28.9%
Q05186,0.000498463,-0.029666667,49.77942474,1.188666667,1.0521E-05,11.70608855,-0.674,-0.549,-0.649,0.524,0.455,0.715,Q05186,Rcn1,Q05186_Rcn1,Q05186,Rcn1,1,7,5,5,Q05186,MOUSE,38112.4,20,1645,1645.1,70.57,70.57,,325,Reticulocalbin-1,endoplasmic reticulum|endoplasmic reticulum lumen|,in utero embryonic development|camera-type eye development|,calcium ion binding|,5,7,1140000000,20.0%
Q9R1J0,0.51414471,-0.036333333,7.931663824,0.211333333,0.16100287,1.578077537,-0.134,0.065,-0.357,-0.026,0.021,0.213,Q9R1J0,Nsdhl,Q9R1J0_Nsdhl,Q9R1J0,Nsdhl,1,12,5,5,Q9R1J0,MOUSE,40970.4,20.4,1646,1646.1,70.53,70.53,,362,"Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating",endoplasmic reticulum|endoplasmic reticulum membrane|lipid particle|integral component of membrane|intracellular membrane-bounded organelle|,hair follicle development|cholesterol biosynthetic process|smoothened signaling pathway|cholesterol metabolic process|oxidation-reduction process|labyrinthine layer blood vessel development|,3-beta-hydroxy-delta5-steroid dehydrogenase activity|sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity|,5,12,1020000000,20.4%
Q9CYN2,0.430679683,-0.054166667,9.717414245,0.445666667,0.106723135,1.865906437,-0.806,-0.064,0.039,-0.067,0.262,0.311,Q9CYN2,Spcs2,Q9CYN2_Spcs2,Q9CYN2,Spcs2,1,10,6,6,Q9CYN2|A0A140LHG8|A0A140LHR3|A0A140LJG6|A0A140LIK0|A0A140LHW5,MOUSE,25205.4,30.9,1647,1647.1,70.51,70.51,,226,Signal peptidase complex subunit 2,signal peptidase complex|integral component of membrane|,signal peptide processing|,peptidase activity|,6,10,6970000000,30.9%
Q5D073,0.522251937,-0.063,7.776743951,-0.21,0.166849767,-1.552817169,0.01,0.133,-0.017,-0.44,-0.01,-0.054,Q5D073,Pxmp2,Q5D073_Pxmp2,Q5D073,Pxmp2,1,7,4,4,Q5D073|D6REH1|P42925,MOUSE,22110,22.7,1648,1648.1,70.49,70.49,,193,Peroxisomal membrane protein 2,cytoplasm|mitochondrion|peroxisomal membrane|membrane|integral component of membrane|protein complex|,,,4,7,873000000,22.7%
Q9Z2A7,0.816639535,0.018833333,2.858691902,0.099666667,0.517762759,0.683041968,0.013,0.041,-0.147,0.366,-0.106,-0.054,Q9Z2A7,Dgat1,Q9Z2A7_Dgat1,Q9Z2A7,Dgat1,1,14,5,5,Q9Z2A7,MOUSE,57245.5,14.4,1649,1649.1,70.49,70.49,,498,Diacylglycerol O-acyltransferase 1,endoplasmic reticulum membrane|membrane|integral component of membrane|intracellular membrane-bounded organelle|,triglyceride biosynthetic process|lipid storage|very-low-density lipoprotein particle assembly|long-chain fatty-acyl-CoA metabolic process|retinol metabolic process|diacylglycerol metabolic process|fatty acid homeostasis|,2-acylglycerol O-acyltransferase activity|diacylglycerol O-acyltransferase activity|retinol O-fatty-acyltransferase activity|,5,14,5850000000,14.4%
Q8VCU2,0.086773686,-0.002,20.78133656,0.386666667,0.008353459,3.695962389,-0.135,-0.239,-0.212,0.196,0.038,0.34,Q8VCU2,Gpld1,Q8VCU2_Gpld1,Q8VCU2,Gpld1,1,7,6,6,Q8VCU2|O70362,MOUSE,94192.4,7.6,1650,1650.1,70.43,70.43,,842,Glycosylphosphatidylinositol specific phospholipase D1,proteinaceous extracellular matrix|extracellular space|intracellular|cytoplasm|lysosomal membrane|intracellular membrane-bounded organelle|extracellular exosome|,cell migration involved in sprouting angiogenesis|complement receptor mediated signaling pathway|GPI anchor release|negative regulation of cell proliferation|insulin receptor signaling pathway|response to glucose|positive regulation of endothelial cell migration|cellular response to insulin stimulus|cellular response to drug|positive regulation of apoptotic process|positive regulation of cytolysis|positive regulation of membrane protein ectodomain proteolysis|cellular response to calcium ion|cellular response to cholesterol|cellular response to triglyceride|cellular response to pH|regulation of cellular response to insulin stimulus|,glycosylphosphatidylinositol phospholipase D activity|phospholipase D activity|protein binding|,6,7,1020000000,7.6%
Q91YJ5,0.890116428,0.001833333,1.763459902,-0.080333333,0.666275755,-0.451167689,0.28,0.167,-0.321,0.149,-0.107,-0.157,Q91YJ5,Mtif2,Q91YJ5_Mtif2,Q91YJ5,Mtif2,1,11,6,6,Q91YJ5,MOUSE,81800.5,9.9,1651,1651.1,70.25,70.25,,727,"Translation initiation factor IF-2, mitochondrial",nucleoplasm|mitochondrion|,ribosome disassembly|mitochondrial translational initiation|,"translation initiation factor activity|GTPase activity|GTP binding|translation factor activity, RNA binding|ribosomal small subunit binding|poly(A) RNA binding|",6,11,3530000000,9.9%
Q8BYZ7,0.786206023,-0.016166667,3.317912226,-0.064333333,0.465809967,-0.773206456,0.011,-0.01,0.047,0.011,-0.123,-0.033,Q8BYZ7,Elmo3,Q8BYZ7_Elmo3,Q8BYZ7,Elmo3,1,9,8,8,Q8BYZ7|A0A1D5RMK9|Q8BYZ7-2,MOUSE,82555.7,15.4,1652,1652.1,70.2,70.2,,720,Engulfment and cell motility protein 3,cytoplasm|,phagocytosis|apoptotic process|cell migration|,protein binding|SH3 domain binding|,8,9,1070000000,15.4%
Q7TT37,0.96097128,0.064333333,0.582924033,0.022,0.874394861,0.164304895,0.001,0.021,0.138,0.344,-0.09,-0.028,Q7TT37,Elp1,Q7TT37_Elp1,Q7TT37,Elp1,1,12,7,7,Q7TT37,MOUSE,151292.7,5.5,1653,1653.1,70.19,70.19,,1333,Elongator complex protein 1,histone acetyltransferase complex|nucleolus|cytoplasm|transcription elongation factor complex|Elongator holoenzyme complex|,"transcription, DNA-templated|regulation of transcription from RNA polymerase II promoter|positive regulation of cell migration|regulation of protein kinase activity|",phosphorylase kinase regulator activity|RNA polymerase II core binding|,7,12,1270000000,5.5%
Q3UN02,0.997585215,-0.007,0.027410139,-0.000666667,0.993708457,-0.008184206,0.018,-0.001,-0.037,0.044,-0.069,0.003,Q3UN02,Lclat1,Q3UN02_Lclat1,Q3UN02,Lclat1,1,21,6,6,Q3UN02,MOUSE,44855.5,15.4,1654,1654.1,70.14,70.14,,376,Lysocardiolipin acyltransferase 1,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,multicellular organismal development|CDP-diacylglycerol biosynthetic process|,"1-acylglycerol-3-phosphate O-acyltransferase activity|transferase activity, transferring acyl groups|",6,21,4190000000,15.4%
Q3UIL6-2,0.79133184,0.006666667,3.234494811,0.078,0.474843523,0.757027119,-0.103,0.001,0.005,0.042,-0.095,0.19,Q3UIL6,Plekha7,Q3UIL6-2_Plekha7,Q3UIL6-2,Plekha7,1,11,9,9,Q3UIL6-2|Q3UIL6-6|Q3UIL6-4|Q3UIL6|Q3UIL6-5|Q3UIL6-3,MOUSE,144441.5,8.6,1655,1655.1,70.11,70.11,,1118,Isoform 2 of Pleckstrin homology domain-containing family A member 7,cytoplasm|centrosome|zonula adherens|cell junction|extracellular exosome|,zonula adherens maintenance|epithelial cell-cell adhesion|,delta-catenin binding|,9,11,491000000,8.6%
Q9DCT8,0.925206453,-0.047,1.107783504,0.055333333,0.774857158,0.297973553,0.02,0.226,-0.47,0.115,-0.049,-0.124,Q9DCT8,Crip2,Q9DCT8_Crip2,Q9DCT8,Crip2,1,23,4,4,Q9DCT8|A0A0G2JF37,MOUSE,23525.3,37,1656,1656.1,70.11,70.11,,208,Cysteine-rich protein 2,cell cortex|extracellular matrix|,positive regulation of cell proliferation|hemopoiesis|,protein binding|zinc ion binding|,4,23,3450000000,37.0%
Q8K4Z3,0.52944394,-0.0015,7.632049442,0.143666667,0.172502366,1.527045106,-0.068,-0.183,0.031,0.027,0.044,0.14,Q8K4Z3,Naxe,Q8K4Z3_Naxe,Q8K4Z3,Naxe,1,10,5,5,Q8K4Z3,MOUSE,31314.6,23.4,1657,1657.1,69.81,69.81,,282,NAD(P)H-hydrate epimerase,extracellular region|extracellular space|nucleus|nucleoplasm|cytoplasm|mitochondrion|cytosol|cilium|intracellular membrane-bounded organelle|cell body|extracellular exosome|,NADH metabolic process|NADP metabolic process|protein homotetramerization|,nucleotide binding|protein homodimerization activity|metal ion binding|NADHX epimerase activity|NADPHX epimerase activity|,5,10,605000000,23.4%
P46061,0.640988657,-0.044333333,5.54073761,0.163333333,0.279206959,1.178532858,0.008,0.028,-0.414,-0.011,0.115,0.008,P46061,Rangap1,P46061_Rangap1,P46061,Rangap1,1,11,6,6,P46061,MOUSE,64043.3,12.2,1658,1658.1,69.8,69.8,,589,Ran GTPase-activating protein 1,condensed chromosome kinetochore|cytoplasm|cytosol|dendrite|nuclear membrane|nuclear pore cytoplasmic filaments|perinuclear region of cytoplasm|mitotic spindle|kinetochore|,signal transduction|positive regulation of GTPase activity|negative regulation of protein export from nucleus|response to axon injury|cellular response to peptide hormone stimulus|,GTPase activator activity|Ran GTPase binding|ubiquitin protein ligase binding|,6,11,1190000000,12.2%
Q9CR00,0.344160393,-0.030833333,11.58065599,0.288333333,0.069491934,2.163406774,0.015,-0.144,-0.396,0.246,0.107,-0.013,Q9CR00,Psmd9,Q9CR00_Psmd9,Q9CR00,Psmd9,1,10,6,6,Q9CR00,MOUSE,24890.6,33.3,1659,1659.1,69.77,69.77,,222,26S proteasome non-ATPase regulatory subunit 9,"nucleus|cytoplasm|proteasome regulatory particle, base subcomplex|proteasome regulatory particle, base subcomplex|","positive regulation of insulin secretion|positive regulation of transcription, DNA-templated|negative regulation of insulin secretion|proteasome regulatory particle assembly|",transcription coactivator activity|bHLH transcription factor binding|,6,10,998000000,33.3%
P70460,0.744919453,0.024333333,3.887819473,-0.08,0.408524449,-0.881587956,-0.019,0.077,0.135,0.074,-0.058,-0.063,P70460,Vasp,P70460_Vasp,P70460,Vasp,1,14,7,7,P70460,MOUSE,39837.1,24.2,1660,1660.1,69.74,69.74,,375,Vasodilator-stimulated phosphoprotein,cytoplasm|cytosol|cytoskeleton|plasma membrane|bicellular tight junction|focal adhesion|lamellipodium|filopodium|lamellipodium membrane|filopodium membrane|extracellular exosome|,neural tube closure|axon guidance|actin polymerization or depolymerization|actin cytoskeleton organization|positive regulation of actin filament polymerization|protein homotetramerization|,actin binding|protein binding|profilin binding|SH3 domain binding|,7,14,2340000000,24.2%
Q9CZE3,0.41100279,0.0495,10.14209092,-0.241666667,0.096781179,-1.933793373,0.1,0,0.411,-0.061,-0.132,-0.021,Q9CZE3,Rab32,Q9CZE3_Rab32,Q9CZE3,Rab32,1,11,6,6,Q9CZE3|A0A1Y7VIZ0,MOUSE,25296.2,39.4,1661,1661.1,69.69,69.69,,223,Ras-related protein Rab-32,mitochondrion|early endosome|trans-Golgi network|membrane|phagocytic vesicle membrane|melanosome|phagocytic vesicle|,intracellular protein transport|metabolic process|antigen processing and presentation|melanosome organization|Rab protein signal transduction|endosome to melanosome transport|phagosome maturation|melanosome assembly|,GTPase activity|protein binding|GTP binding|GTP-dependent protein binding|AP-1 adaptor complex binding|AP-3 adaptor complex binding|BLOC-2 complex binding|,6,11,2420000000,39.4%
Q80SU7,0.470565279,0.117666667,8.877987252,-0.569333333,0.129479578,-1.731229445,0.189,-0.116,1.134,-0.103,-0.483,0.085,Q80SU7,Gm4070,Q80SU7_Gm4070,Q80SU7,Gvin1,1,10,8,8,Q80SU7|L7N451,MOUSE,283433.9,3.8,1662,1662.1,69.63,69.63,,2427,Interferon-induced very large GTPase 1,nucleus|cytosol|,,GTP binding|,8,10,1140000000,3.8%
Q8VDP4,0.226782822,-0.0495,14.93922441,0.239666667,0.03206842,2.697611167,-0.082,-0.147,-0.279,0.086,0.052,0.073,Q8VDP4,Ccar2,Q8VDP4_Ccar2,Q8VDP4,Ccar2,1,9,6,6,Q8VDP4,MOUSE,103628,9.8,1663,1663.1,69.6,69.6,,922,Cell cycle and apoptosis regulator protein 2,nuclear chromatin|nucleus|cytoplasm|mitochondrial matrix|DBIRD complex|spliceosomal complex|,"transcription, DNA-templated|mRNA processing|cellular response to DNA damage stimulus|cell cycle|RNA splicing|response to UV|Wnt signaling pathway|negative regulation of cell growth|regulation of protein stability|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|regulation of DNA-templated transcription, elongation|regulation of circadian rhythm|positive regulation of apoptotic process|negative regulation of catalytic activity|mitochondrial fragmentation involved in apoptotic process|negative regulation of transcription, DNA-templated|rhythmic process|positive regulation of canonical Wnt signaling pathway|regulation of protein deacetylation|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage|positive regulation of DNA damage checkpoint|",RNA polymerase II core binding|enzyme inhibitor activity|protein binding|enzyme binding|poly(A) RNA binding|,6,9,305000000,9.8%
Q9QZX7,0.951421295,0.008,0.742719465,0.035333333,0.842806844,0.206234,0.295,-0.037,-0.287,0.203,0.029,-0.155,Q9QZX7,Srr,Q9QZX7_Srr,Q9QZX7,Srr,1,13,5,5,Q9QZX7|Q9QZX7-2|Q9QZX7-3,MOUSE,36757.6,23,1664,1664.1,69.38,69.38,,339,Serine racemase,cytoplasm|plasma membrane|neuronal cell body|apical part of cell|,L-serine metabolic process|brain development|aging|serine family amino acid metabolic process|response to lipopolysaccharide|response to drug|pyruvate biosynthetic process|response to morphine|protein homotetramerization|D-serine metabolic process|D-serine biosynthetic process|,magnesium ion binding|L-serine ammonia-lyase activity|calcium ion binding|protein binding|ATP binding|D-serine ammonia-lyase activity|glycine binding|threonine racemase activity|PDZ domain binding|pyridoxal phosphate binding|serine racemase activity|protein homodimerization activity|,5,13,3280000000,23.0%
Q6NXL1,1,0.051666667,2.89298E-15,-2.96027E-16,1,-8.58392E-16,-0.544,-0.134,0.833,-0.182,0.023,0.314,Q6NXL1,Sec24d,Q6NXL1_Sec24d,Q6NXL1,Sec24d,1,11,9,9,Q6NXL1,MOUSE,114157.4,9.8,1665,1665.1,69.35,69.35,,1032,"Sec24-related gene family, member D (S. cerevisiae)",COPII vesicle coat|,in utero embryonic development|intracellular protein transport|ER to Golgi vesicle-mediated transport|,zinc ion binding|,9,11,449000000,9.8%
Q3UHQ6,0.461918472,0.031166667,9.063747378,0.155666667,0.124058139,1.758183245,-0.038,-0.074,-0.028,0.22,0.037,0.07,Q3UHQ6,Dop1b,Q3UHQ6_Dop1b,Q3UHQ6,Dopey2,1,9,6,6,Q3UHQ6|Q3UHQ6-2,MOUSE,260274.3,3.3,1666,1666.1,69.16,69.16,,2295,Protein dopey-2,extracellular exosome|,protein transport|cognition|,,6,9,279000000,3.3%
P61082,0.773512169,0.008166667,3.545837814,-0.099666667,0.441993842,-0.817639782,-0.144,0.259,0.059,-0.121,-0.005,0.001,P61082,Ube2m,P61082_Ube2m,P61082,Ube2m,1,12,6,6,P61082|G5E919,MOUSE,21184.9,32.7,1667,1667.1,69.16,69.16,,183,NEDD8-conjugating enzyme Ubc12,cytoplasm|extracellular exosome|,cellular protein modification process|protein ubiquitination|positive regulation of neuron apoptotic process|protein neddylation|,ubiquitin-protein transferase activity|ATP binding|ribosomal S6-glutamic acid ligase activity|NEDD8 transferase activity|ubiquitin protein ligase binding|ubiquitin protein ligase activity|,6,12,1090000000,32.7%
Q8BUR4,0.586445778,-0.020666667,6.562378892,0.129333333,0.220679561,1.350595913,-0.005,-0.035,-0.216,0.113,0.023,-0.004,Q8BUR4,Dock1,Q8BUR4_Dock1,Q8BUR4,Dock1,1,13,9,9,Q8BUR4|Q8BUR4-2|A0A1B0GSI1,MOUSE,216051.5,5.6,1668,1668.1,69.05,69.05,,1865,Dedicator of cytokinesis protein 1,nucleus|nucleoplasm|cytoplasm|membrane|,hematopoietic progenitor cell differentiation|phagocytosis|apoptotic process|cytoskeleton organization|small GTPase mediated signal transduction|cell migration|positive regulation of GTPase activity|,guanyl-nucleotide exchange factor activity|GTPase activator activity|protein binding|SH3 domain binding|,9,13,1030000000,5.6%
Q8C7R4,0.971528421,-0.001333333,0.407438932,-0.01,0.910450014,-0.11679177,0.044,0.062,-0.095,0.003,-0.001,-0.021,Q8C7R4,Uba6,Q8C7R4_Uba6,Q8C7R4,Uba6,1,12,7,7,Q8C7R4|D3Z061,MOUSE,119504.2,9.5,1669,1669.1,69.04,69.04,,1053,Ubiquitin-like modifier-activating enzyme 6,cytoplasm|cytosol|,ubiquitin-dependent protein catabolic process|learning|locomotory behavior|protein ubiquitination|amygdala development|hippocampus development|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|dendritic spine development|,ubiquitin activating enzyme activity|protein binding|ATP binding|FAT10 activating enzyme activity|,7,12,573000000,9.5%
Q9QY36,0.674404166,0.009,4.958241191,-0.104,0.319283063,-1.075695064,-0.062,0.13,0.115,-0.012,-0.133,0.016,Q9QY36,Naa10,Q9QY36_Naa10,Q9QY36,Naa10,1,11,5,3,Q9QY36|B1AUY7|B1AUY8|Q3V4D5|B1AUZ1|B1AUY9|Q3UX61,MOUSE,26690.4,27.6,1670,1670.1,69,36.36,,235,N-alpha-acetyltransferase 10,intracellular|nucleus|nucleolus|cytoplasm|membrane|cytosolic ribosome|NatA complex|,N-terminal protein amino acid acetylation|internal protein amino acid acetylation|N-terminal peptidyl-serine acetylation|N-terminal peptidyl-glutamic acid acetylation|,protein binding|N-acetyltransferase activity|peptide-serine-N-acetyltransferase activity|peptide-glutamate-N-acetyltransferase activity|peptide alpha-N-acetyltransferase activity|acetyltransferase activity|ribosome binding|,5,11,1020000000,27.6%
Q3UVL4,0.919618833,-0.019333333,1.180732532,-0.032,0.76195048,-0.315549242,-0.029,-0.01,0.029,0.115,-0.178,-0.043,Q3UVL4,Vps51,Q3UVL4_Vps51,Q3UVL4,Vps51,1,9,6,6,Q3UVL4|Q3UVL4-2|Q3UVL4-3,MOUSE,87098.7,9.5,1671,1671.1,68.92,68.92,,782,Vacuolar protein sorting-associated protein 51 homolog,GARP complex|Golgi apparatus|recycling endosome|EARP complex|,"lipid transport|autophagy|protein transport|endocytic recycling|retrograde transport, endosome to Golgi|",,6,9,966000000,9.5%
O88455,0.445249759,-0.028,9.494524373,0.238666667,0.1123434,1.830221577,-0.313,0.019,-0.148,0.251,-0.085,0.108,O88455,Dhcr7,O88455_Dhcr7,O88455,Dhcr7,1,17,6,6,A0A140LIT2|O88455,MOUSE,54659.4,11.4,1672,1672.1,68.74,68.74,,471,7-dehydrocholesterol reductase,nuclear outer membrane|endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,blood vessel development|cholesterol biosynthetic process|post-embryonic development|sterol biosynthetic process|cell differentiation|lung development|multicellular organism growth|regulation of cell proliferation|regulation of cholesterol biosynthetic process|oxidation-reduction process|,7-dehydrocholesterol reductase activity|,6,17,16700000000,11.4%
Q148V7,0.801983355,-0.004333333,3.044501207,0.074,0.496077899,0.719685453,0.087,-0.078,-0.133,0.147,0.006,-0.055,Q148V7,Relch,Q148V7_Relch,Q148V7,Kiaa1468,1,7,7,7,Q148V7|G3X9J4|E9QM90|Q148V7-2|A0A087WSS1|Q148V7-3|A0A087WRM8,MOUSE,135440.1,7,1673,1673.1,68.59,68.59,,1216,LisH domain and HEAT repeat-containing protein KIAA1468,,,,7,7,748000000,7.0%
Q9JHI5,0.672056103,0.037833333,4.983598921,0.103,0.317424254,1.080170718,-0.002,-0.029,-0.01,-0.029,0.224,0.073,Q9JHI5,Ivd,Q9JHI5_Ivd,Q9JHI5,Ivd,1,9,7,7,Q9JHI5,MOUSE,46724,16.5,1674,1674.1,68.59,68.59,,424,"Isovaleryl-CoA dehydrogenase, mitochondrial",nucleoplasm|mitochondrion|mitochondrial matrix|mitochondrial membrane|,leucine catabolic process|oxidation-reduction process|,isovaleryl-CoA dehydrogenase activity|flavin adenine dinucleotide binding|,7,9,3510000000,16.5%
Q9WUU7,0.001667629,-0.087166667,41.73566187,0.943666667,6.70554E-05,8.756922776,-0.421,-0.53,-0.726,0.464,0.367,0.323,Q9WUU7,Ctsz,Q9WUU7_Ctsz,Q9WUU7,Ctsz,1,21,5,5,Q9WUU7,MOUSE,34680.3,22.2,1675,1675.1,68.55,68.55,,306,Cathepsin Z,extracellular space|lysosome|endoplasmic reticulum|intracellular membrane-bounded organelle|extracellular exosome|,proteolysis involved in cellular protein catabolic process|epithelial tube branching involved in lung morphogenesis|,cysteine-type endopeptidase activity|,5,21,6390000000,22.2%
Q9DBC7,0.819870651,-0.034833333,2.80192553,0.063,0.524574828,0.671173988,-0.018,0.02,-0.201,-0.009,-0.032,0.031,Q9DBC7,Prkar1a,Q9DBC7_Prkar1a,Q9DBC7,Prkar1a,1,7,7,7,Q9DBC7|A2AI69|P12849|D3Z0V6,MOUSE,43469.6,18.8,1676,1676.1,68.52,68.52,,381,cAMP-dependent protein kinase type I-alpha regulatory subunit,cytoplasm|plasma membrane|cAMP-dependent protein kinase complex|membrane|AMP-activated protein kinase complex|neuromuscular junction|protein complex|,mesoderm formation|protein phosphorylation|negative regulation of protein kinase activity|female meiotic division|heart development|cell proliferation|organ morphogenesis|sarcomere organization|negative regulation of meiotic nuclear division|cardiac muscle cell proliferation|negative regulation of cAMP-dependent protein kinase activity|,cAMP-dependent protein kinase inhibitor activity|protein binding|cAMP-dependent protein kinase regulator activity|cAMP binding|ubiquitin protein ligase binding|protein kinase A catalytic subunit binding|,7,7,614000000,18.8%
Q9QY06-2,0.881050168,-0.003666667,1.919543917,0.038,0.642755214,0.48556715,-0.058,0.017,-0.027,0.019,0.006,0.021,Q9QY06,NotFound,Q9QY06-2_NotFound,Q9QY06-2,Myo9b,1,9,6,6,Q9QY06-2|E9PZW8|Q9QY06|E9PWZ6|A0A1D5RLD1|Q9QY06-3|E9QKV6,MOUSE,243831.1,4.5,1677,1677.1,68.36,68.36,,2114,Isoform 2 of Unconventional myosin-IXb,ruffle|cytoplasm|cell cortex|membrane|myosin complex|lamellipodium|filamentous actin|filopodium tip|perinuclear region of cytoplasm|,monocyte chemotaxis|Rho protein signal transduction|metabolic process|establishment of cell polarity|actin-myosin filament sliding|positive regulation of GTPase activity|macrophage chemotaxis|lamellipodium morphogenesis|,microfilament motor activity|motor activity|actin binding|GTPase activator activity|calmodulin binding|ATP binding|ATPase activity|actin-dependent ATPase activity|ADP binding|metal ion binding|actin filament binding|,6,9,115000000,4.5%
Q6P9R2,0.841705581,-0.050666667,2.517273046,0.089333333,0.560109186,0.613366195,-0.005,0.115,-0.396,-0.08,0.068,-0.006,Q6P9R2,Oxsr1,Q6P9R2_Oxsr1,Q6P9R2,Oxsr1,1,19,5,5,Q6P9R2,MOUSE,58497.7,13.2,1678,1678.1,68.32,68.32,,527,Serine/threonine-protein kinase OSR1,cytoplasm|extracellular exosome|,protein phosphorylation|response to oxidative stress|regulation of mitotic cell cycle|peptidyl-threonine phosphorylation|signal transduction by protein phosphorylation|stress-activated protein kinase signaling cascade|activation of protein kinase activity|intracellular signal transduction|regulation of apoptotic process|cellular hypotonic response|negative regulation of potassium ion transmembrane transporter activity|negative regulation of potassium ion transmembrane transport|negative regulation of rubidium ion transport|negative regulation of rubidium ion transmembrane transporter activity|,magnesium ion binding|protein serine/threonine kinase activity|receptor signaling protein serine/threonine kinase activity|protein binding|ATP binding|,5,19,1980000000,13.2%
Q6P069,0.925061327,0.09,1.112330645,-0.107333333,0.774046294,-0.299083946,-0.24,-0.192,0.863,-0.476,0.133,0.452,Q6P069,Sri,Q6P069_Sri,Q6P069,Sri,1,15,5,5,Q6P069|Q6P069-2,MOUSE,21912.2,25.7,1679,1679.1,68.17,68.17,,198,Sorcin,intracellular|nucleoplasm|cytoplasm|mitochondrion|endoplasmic reticulum membrane|smooth endoplasmic reticulum|cytosol|plasma membrane|membrane|Z disc|T-tubule|vesicle|sarcoplasmic reticulum membrane|axon terminus|dendritic spine neck|extracellular exosome|chromaffin granule membrane|,proteolysis|calcium ion transport|heart development|negative regulation of heart rate|positive regulation of insulin secretion involved in cellular response to glucose stimulus|cytoplasmic sequestering of transcription factor|positive regulation of release of sequestered calcium ion into cytosol|regulation of calcium ion transport|negative regulation of ryanodine-sensitive calcium-release channel activity|regulation of cardiac muscle cell contraction|regulation of relaxation of muscle|regulation of high voltage-gated calcium channel activity|regulation of cell communication by electrical coupling involved in cardiac conduction|negative regulation of transcription regulatory region DNA binding|,protease binding|calcium-dependent cysteine-type endopeptidase activity|calcium ion binding|protein binding|protein heterodimerization activity|repressing transcription factor binding|,5,15,650000000,25.7%
E9QKE4,0.764663191,-0.018833333,3.641616912,0.079,0.432352833,0.835266009,0.046,-0.08,-0.141,0.108,-0.052,0.006,E9QKE4,Rab3gap2,E9QKE4_Rab3gap2,E9QKE4,Rab3gap2,1,7,7,7,E9QKE4|A0A0A6YWM5|Q8BMG7|Q8BMG7-2,MOUSE,156234.9,5.7,1680,1680.1,68.1,68.1,,1387,Rab3 GTPase-activating protein non-catalytic subunit,cytoplasm|plasma membrane|protein complex|,positive regulation of GTPase activity|establishment of protein localization to endoplasmic reticulum membrane|positive regulation of endoplasmic reticulum tubular network organization|,Rab GTPase binding|Rab guanyl-nucleotide exchange factor activity|,7,7,340000000,5.7%
Q8C079,0.929650705,-0.020166667,1.003368095,0.023666667,0.793712446,0.272140478,0.067,-0.052,-0.111,0.017,-0.018,-0.024,Q8C079,Strip1,Q8C079_Strip1,Q8C079,Strip1,1,9,7,7,Q8C079|Q8C079-3|Q8C079-4|Q8C079-2,MOUSE,96324.8,13,1681,1681.1,67.94,67.94,,837,Striatin-interacting protein 1,nucleus|cytoplasm|extracellular exosome|,regulation of cell morphogenesis|cortical actin cytoskeleton organization|,,7,9,1070000000,13.0%
B1AUX2,0.063452358,-0.056,22.44218076,0.489333333,0.00569878,4.017243472,-0.259,-0.121,-0.522,0.173,0.137,0.256,B1AUX2,Hcfc1,B1AUX2_Hcfc1,B1AUX2,Hcfc1,1,11,8,8,B1AUX2|Q61191,MOUSE,216930.2,4.8,1682,1682.1,67.91,67.91,,2090,Host cell factor 1,histone acetyltransferase complex|nucleus|nucleoplasm|cytoplasm|mitochondrion|membrane|neuronal cell body|Set1C/COMPASS complex|MLL5-L complex|MLL1 complex|Ada2/Gcn5/Ada3 transcription activator complex|SAGA-type complex|,"regulation of transcription, DNA-templated|transcription from RNA polymerase II promoter|positive regulation of gene expression|regulation of protein complex assembly|histone H4-K5 acetylation|histone H4-K8 acetylation|histone H4-K16 acetylation|positive regulation of transcription from RNA polymerase II promoter|protein stabilization|",RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|chromatin binding|transcription coactivator activity|identical protein binding|histone acetyltransferase activity (H4-K5 specific)|histone acetyltransferase activity (H4-K8 specific)|histone acetyltransferase activity (H4-K16 specific)|,8,11,386000000,4.8%
Q80WJ7,0.14082599,0.002166667,17.93538601,0.349,0.016086494,3.198623327,-0.282,0.016,-0.251,0.107,0.203,0.22,Q80WJ7,Mtdh,Q80WJ7_Mtdh,Q80WJ7,Mtdh,1,11,6,6,Q80WJ7|E9PUX0,MOUSE,63958.9,17.4,1683,1683.1,67.6,67.6,,579,Protein LYRIC,nucleus|nucleolus|cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|bicellular tight junction|integral component of membrane|apical plasma membrane|nuclear body|nuclear membrane|intercellular canaliculus|perinuclear region of cytoplasm|,negative regulation of transcription from RNA polymerase II promoter|positive regulation of autophagy|lipopolysaccharide-mediated signaling pathway|negative regulation of apoptotic process|positive regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of angiogenesis|positive regulation of NF-kappaB transcription factor activity|positive regulation of protein kinase B signaling|bicellular tight junction assembly|,RNA polymerase II transcription factor binding|transcription coactivator activity|double-stranded RNA binding|protein binding|poly(A) RNA binding|NF-kappaB binding|,6,11,1060000000,17.4%
Q9JIH2,0.62765663,-0.0525,5.844192678,0.177,0.260363878,1.230708424,-0.137,0.114,-0.4,-0.068,0.097,0.079,Q9JIH2,Nup50,Q9JIH2_Nup50,Q9JIH2,Nup50,1,7,5,5,Q9JIH2,MOUSE,49940.7,16.7,1684,1684.1,67.52,67.52,,466,Nuclear pore complex protein Nup50,nuclear pore|nuclear membrane|,protein transport|intracellular transport|mRNA transport|,,5,7,411000000,16.7%
Q61187,0.612622361,-0.003666667,6.122098785,-0.108666667,0.244225002,-1.276601445,-0.008,0.144,0.016,-0.058,-0.079,-0.037,Q61187,Tsg101,Q61187_Tsg101,Q61187,Tsg101,1,9,5,5,Q61187|A0A1B0GRX2,MOUSE,44294,17.3,1685,1685.1,67.5,67.5,,391,Tumor susceptibility gene 101 protein,ESCRT I complex|nucleus|nucleolus|cytoplasm|endosome|early endosome|late endosome|plasma membrane|late endosome membrane|extracellular exosome|,"regulation of cell growth|protein monoubiquitination|cell cycle arrest|negative regulation of cell proliferation|endosome to lysosome transport|protein transport|cell differentiation|keratinocyte differentiation|ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway|regulation of MAP kinase activity|negative regulation of transcription, DNA-templated|viral budding|positive regulation of viral process|cell division|positive regulation of viral release from host cell|positive regulation of exosomal secretion|regulation of extracellular exosome assembly|regulation of viral budding via host ESCRT complex|positive regulation of viral budding via host ESCRT complex|positive regulation of ubiquitin-dependent endocytosis|",transcription corepressor activity|protein binding|ligand-dependent nuclear receptor transcription coactivator activity|ubiquitin protein ligase binding|protein homodimerization activity|ubiquitin binding|virion binding|calcium-dependent protein binding|,5,9,467000000,17.3%
E9PWB2,0.712762463,0.030333333,4.343501336,-0.099333333,0.367832303,-0.965604709,-0.087,0.18,0.147,-0.077,-0.005,0.024,E9PWB2,NotFound,E9PWB2_NotFound,E9PWB2,Csnk1a1,1,13,8,8,E9PWB2|Q8BK63|E9Q4G7|H7BXB1|Q8BK63-2|E9Q3W1|E9Q2U6,MOUSE,43800.7,20.8,1686,1686.1,67.41,67.41,,374,Casein kinase I isoform alpha,cytoplasm|centrosome|membrane|nuclear speck|ribonucleoprotein complex|mRNA cleavage and polyadenylation specificity factor complex|,cell morphogenesis|protein phosphorylation|phagocytosis|regulation of cell shape|Wnt signaling pathway|peptidyl-serine phosphorylation|,protein serine/threonine kinase activity|ATP binding|,8,13,1240000000,20.8%
Q9CQS4,0.948714266,-0.035333333,0.778890755,0.031333333,0.835816469,0.215566193,0.079,0.134,-0.366,0.001,0.001,-0.061,Q9CQS4,Slc25a46,Q9CQS4_Slc25a46,Q9CQS4,Slc25a46,1,15,5,5,Q9CQS4,MOUSE,46565.8,16.2,1687,1687.1,67.36,67.36,,418,Solute carrier family 25 member 46,mitochondrion|mitochondrial inner membrane|integral component of membrane|,transport|,,5,15,2620000000,16.2%
Q8BK03,0.522820765,-0.048833333,7.754167634,0.234333333,0.167719376,1.549130751,0.057,-0.12,-0.435,0.21,0.087,-0.092,Q8BK03,Miga2,Q8BK03_Miga2,Q8BK03,Miga2,1,12,6,6,Q8BK03|Q8BK03-2,MOUSE,66003,13.4,1688,1688.1,67.17,67.17,,593,Mitoguardin 2,integral component of membrane|,bone development|,,6,12,2450000000,13.4%
Q6PGF7,0.73101227,-0.000333333,4.108643988,0.089333333,0.388271578,0.922548041,0.001,-0.136,0,0.164,-0.045,0.014,Q6PGF7,Exoc8,Q6PGF7_Exoc8,Q6PGF7,Exoc8,1,8,6,6,Q6PGF7,MOUSE,81718.4,11.1,1689,1689.1,66.9,66.9,,716,Exocyst complex component 8,exocyst|cytoplasm|late endosome|plasma membrane|membrane|growth cone|,exocyst assembly|exocytosis|endosome organization|protein transport|extracellular matrix disassembly|exocyst localization|,Ral GTPase binding|phosphatidylinositol binding|,6,8,235000000,11.1%
Q9CQF9,0.00100159,-0.334666667,44.54215832,2.042,3.51386E-05,9.799829961,-1.068,-1.156,-1.843,0.665,0.779,0.615,Q9CQF9,Pcyox1,Q9CQF9_Pcyox1,Q9CQF9,Pcyox1,1,9,5,5,Q9CQF9|A0A0N4SWD3,MOUSE,56721.9,16.2,1690,1690.1,66.74,66.74,,505,Prenylcysteine oxidase,lysosome|vacuolar membrane|plasma membrane|very-low-density lipoprotein particle|extracellular exosome|,prenylated protein catabolic process|prenylcysteine catabolic process|oxidation-reduction process|chloride transmembrane transport|,prenylcysteine oxidase activity|chloride-transporting ATPase activity|,5,9,588000000,16.2%
P35569,0.961523652,-0.0105,0.545494495,0.025666667,0.881963375,0.15431076,0.197,0.133,-0.4,-0.032,0.044,-0.005,P35569,Irs1,P35569_Irs1,P35569,Irs1,1,11,7,7,P35569|Q543V3,MOUSE,131862.3,9.2,1691,1691.1,66.71,66.71,,1233,Insulin receptor substrate 1,nucleus|cytoplasm|cytosol|plasma membrane|caveola|ciliary basal body|,positive regulation of mesenchymal cell proliferation|insulin receptor signaling pathway|regulation of gene expression|positive regulation of glucose metabolic process|phosphatidylinositol 3-kinase signaling|lipid catabolic process|positive regulation of cell migration|mammary gland development|positive regulation of fatty acid beta-oxidation|response to insulin|cellular response to insulin stimulus|protein localization to nucleus|protein kinase B signaling|positive regulation of phosphatidylinositol 3-kinase activity|positive regulation of glycogen biosynthetic process|positive regulation of glucose import|negative regulation of insulin secretion|insulin-like growth factor receptor signaling pathway|positive regulation of glucose import in response to insulin stimulus|insulin secretion|,signal transducer activity|insulin receptor binding|insulin-like growth factor receptor binding|protein binding|protein kinase binding|SH2 domain binding|phosphatidylinositol 3-kinase binding|,7,11,1320000000,9.2%
Q9JHF5,0.846769943,-0.037666667,2.400036598,-0.118666667,0.575435088,-0.588944095,-0.302,0.044,0.323,-0.031,-0.398,0.138,Q9JHF5,Tcirg1,Q9JHF5_Tcirg1,Q9JHF5,Tcirg1,1,8,6,6,Q9JHF5,MOUSE,94142.6,6.5,1692,1692.1,66.68,66.68,,834,V-type proton ATPase subunit a,"vacuolar proton-transporting V-type ATPase, V0 domain|mitochondrion|lysosomal membrane|plasma membrane|integral component of membrane|apical plasma membrane|vacuolar proton-transporting V-type ATPase complex|",vacuolar acidification|ATP synthesis coupled proton transport|ATP hydrolysis coupled proton transport|vacuolar proton-transporting V-type ATPase complex assembly|,"proton-transporting ATPase activity, rotational mechanism|ATPase binding|",6,8,729000000,6.5%
Q9Z1K6,0.982507762,0.008833333,0.277345071,-0.008333333,0.938135333,-0.08057776,0.083,0.006,-0.05,0.162,-0.112,-0.036,Q9Z1K6,Arih2,Q9Z1K6_Arih2,Q9Z1K6,Arih2,1,14,6,6,Q9Z1K6|A0A0A6YXB0,MOUSE,59293.3,16.2,1693,1693.1,66.67,66.67,,492,E3 ubiquitin-protein ligase ARIH2,nucleus|cytoplasm|,protein polyubiquitination|ubiquitin-dependent protein catabolic process|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|developmental cell growth|protein K63-linked ubiquitination|protein K48-linked ubiquitination|hematopoietic stem cell proliferation|positive regulation of protein targeting to mitochondrion|,nucleic acid binding|ubiquitin-protein transferase activity|protein binding|zinc ion binding|ligase activity|,6,14,2750000000,16.2%
Q91Z53,0.015548689,-0.029,29.76659133,0.677333333,0.001055215,5.535907746,-0.324,-0.217,-0.562,0.202,0.286,0.441,Q91Z53,Grhpr,Q91Z53_Grhpr,Q91Z53,Grhpr,1,7,4,4,Q91Z53|D6REG4,MOUSE,35727.6,18.2,1694,1694.1,66.58,66.58,,328,Glyoxylate reductase/hydroxypyruvate reductase,cytoplasm|cytosol|extracellular exosome|,excretion|dicarboxylic acid metabolic process|protein oligomerization|oxidation-reduction process|,glycerate dehydrogenase activity|hydroxypyruvate reductase activity|glyoxylate reductase (NADP) activity|carboxylic acid binding|protein homodimerization activity|NAD binding|NADPH binding|,4,7,379000000,18.2%
P99027,0.915850537,-0.011166667,1.315877662,-0.046333333,0.738604984,-0.348052471,-0.002,0.26,-0.222,0.007,-0.049,-0.061,P99027,Rplp2,P99027_Rplp2,P99027,Rplp2,1,14,4,4,P99027,MOUSE,11650.7,70.4,1695,1695.1,66.41,66.41,,115,60S acidic ribosomal protein P2,focal adhesion|membrane|cytosolic large ribosomal subunit|extracellular exosome|,translational elongation|,structural constituent of ribosome|,4,14,8420000000,70.4%
Q9DBS5,0.399466839,-0.004666667,10.41850071,0.188,0.090813399,1.974104101,-0.052,-0.178,-0.066,0.141,-0.034,0.161,Q9DBS5,Klc4,Q9DBS5_Klc4,Q9DBS5,Klc4,1,12,8,5,Q9DBS5|Q91YS4|D3YXZ3|O88448,MOUSE,69124.9,14.5,1696,1696.1,66.38,41.76,,619,Kinesin light chain 4,cytoplasm|kinesin complex|microtubule|,metabolic process|,microtubule motor activity|,8,12,1360000000,14.5%
Q3UMR5,0.858913955,-0.017833333,2.227145718,0.051,0.598805014,0.552109499,-0.14,0.073,-0.063,-0.043,0.028,0.038,Q3UMR5,Mcu,Q3UMR5_Mcu,Q3UMR5,Mcu,1,8,6,6,Q3UMR5|Q3UMR5-2,MOUSE,40023.2,22.8,1697,1697.1,66.35,66.35,,350,"Calcium uniporter protein, mitochondrial",mitochondrion|mitochondrial inner membrane|integral component of mitochondrial inner membrane|calcium channel complex|uniplex complex|,mitochondrial calcium ion transport|calcium-mediated signaling|positive regulation of insulin secretion|protein complex oligomerization|calcium ion transmembrane import into mitochondrion|glucose homeostasis|positive regulation of mitochondrial calcium ion concentration|,calcium channel activity|protein binding|uniporter activity|identical protein binding|,6,8,1210000000,22.8%
P70335,0.799875932,0.019666667,3.06799181,-0.095333333,0.493401902,-0.724780528,-0.095,-0.009,0.306,0.084,-0.143,-0.025,P70335,Rock1,P70335_Rock1,P70335,Rock1,1,9,8,8,P70335|P70335-2,MOUSE,159137.6,6.8,1698,1698.1,66.34,66.34,,1354,Rho-associated protein kinase 1,Golgi membrane|ruffle|centriole|cytoskeleton|plasma membrane|lamellipodium|bleb|,apical constriction|protein phosphorylation|apoptotic process|leukocyte cell-cell adhesion|Rho protein signal transduction|negative regulation of angiogenesis|membrane to membrane docking|actin cytoskeleton organization|bleb assembly|negative regulation of protein binding|regulation of actin filament-based process|negative regulation of neuron apoptotic process|regulation of keratinocyte differentiation|leukocyte migration|leukocyte tethering or rolling|myoblast migration|regulation of stress fiber assembly|positive regulation of focal adhesion assembly|regulation of establishment of cell polarity|,protein serine/threonine kinase activity|protein binding|ATP binding|GTP-Rho binding|metal ion binding|,8,9,1990000000,6.8%
P10854,0.586322047,0.010666667,6.598279563,-0.296666667,0.218862847,-1.358221723,-0.273,0.349,0.401,-0.437,-0.012,0.036,P10854,Hist1h2bm,P10854_Hist1h2bm,P10854,Hist1h2bm,1,20,5,5,P10854|Q64478|Q64525|Q6ZWY9|Q8CGP2-2|Q8CBB6|Q8CGP2|Q64475|P10853|Q8CGP1|Q9D2U9|Q64524|Q8CGP0|P70696,MOUSE,13935.9,37.3,1699,1699.1,66.25,66.25,,126,Histone H2B type 1-M,nuclear nucleosome|nucleus|nucleoplasm|extracellular exosome|,nucleosome assembly|,DNA binding|protein heterodimerization activity|,5,20,25200000000,37.3%
O88712,0.797504707,-0.004833333,3.100352495,-0.068333333,0.489739068,-0.730683777,0.081,-0.082,0.089,0.01,-0.004,-0.123,O88712,Ctbp1,O88712_Ctbp1,O88712,Ctbp1,1,10,6,4,O88712|O88712-2|A0A0J9YU62|A0A0J9YUM4|O88712-3|A0A0J9YU66,MOUSE,48200.1,14.9,1700,1700.1,66.17,41.66,,441,C-terminal-binding protein 1,nucleus|nucleoplasm|transcription factor complex|cytoplasm|transcriptional repressor complex|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|positive regulation of histone deacetylation|negative regulation of histone acetylation|negative regulation of transcription, DNA-templated|white fat cell differentiation|regulation of cell cycle|oxidation-reduction process|negative regulation of histone H4 acetylation|negative regulation of transcription from RNA polymerase II promoter by histone modification|","RNA polymerase II transcription corepressor activity|sequence-specific DNA binding transcription factor activity|protein binding|transcription factor binding|oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor|protein domain specific binding|protein homodimerization activity|NAD binding|repressing transcription factor binding|",6,10,63300000000,14.9%
Q99KN2,0.919416995,-0.019666667,1.233233431,0.042666667,0.75279488,0.328340429,-0.078,0.104,-0.149,0.225,-0.141,-0.079,Q99KN2,Ciao1,Q99KN2_Ciao1,Q99KN2,Ciao1,1,9,4,4,Q99KN2|G3UYR5|G3UYN9,MOUSE,38659,20.6,1701,1701.1,66.14,66.14,,339,Probable cytosolic iron-sulfur protein assembly protein CIAO1,MMXD complex|CIA complex|,regulation of transcription from RNA polymerase II promoter|chromosome segregation|iron-sulfur cluster assembly|,sequence-specific DNA binding transcription factor activity|,4,9,970000000,20.6%
O35445,0.526056,-0.055833333,7.704638156,0.320333333,0.169643094,1.541038395,-0.013,0.014,-0.649,0.35,-0.023,-0.014,O35445,Rnf5,O35445_Rnf5,O35445,Rnf5,1,12,6,6,O35445,MOUSE,20236.4,23.8,1702,1702.1,66,66,,180,E3 ubiquitin-protein ligase RNF5,endoplasmic reticulum membrane|membrane|integral component of membrane|mitochondrial membrane|,response to bacterium|negative regulation of autophagy|protein ubiquitination|ER-associated ubiquitin-dependent protein catabolic process|protein destabilization|ERAD pathway|cellular protein catabolic process|protein K63-linked ubiquitination|protein K48-linked ubiquitination|ER-associated misfolded protein catabolic process|regulation of autophagosome assembly|,ubiquitin-protein transferase activity|protein binding|zinc ion binding|ligase activity|,6,12,3240000000,23.8%
G3UVW1,0.172940035,0.072833333,16.83492404,-0.579,0.020725623,-3.020502368,0.192,0.77,0.125,-0.385,-0.049,-0.216,G3UVW1,Mpv17,G3UVW1_Mpv17,G3UVW1,Mpv17,1,9,5,5,G3UVW1|P19258|F8WHT5|E9Q1I6|D3YWI4,MOUSE,20169.4,29.2,1703,1703.1,65.98,65.98,,178,"Mpv17 transgene, kidney disease mutant, isoform CRA_b",mitochondrion|mitochondrial inner membrane|peroxisome|integral component of membrane|,mitochondrial genome maintenance|homeostatic process|reactive oxygen species metabolic process|,,5,9,9150000000,29.2%
P59481,0.000234521,-0.3705,56.09284177,2.169666667,2.45876E-06,14.8890782,-1.332,-1.263,-1.771,0.686,0.75,0.707,P59481,Lman2l,P59481_Lman2l,P59481,Lman2l,1,19,6,6,D3Z4P2|P59481|J3QNZ7,MOUSE,40051.5,17.8,1704,1704.1,65.97,65.97,,347,VIP36-like protein,Golgi membrane|endoplasmic reticulum membrane|Golgi apparatus|integral component of membrane|,protein transport|,carbohydrate binding|metal ion binding|,6,19,2430000000,17.8%
H7BWY3,0.876461947,0.005,1.991488723,-0.052666667,0.632195103,-0.501368672,-0.034,0.108,0.02,-0.164,0.126,-0.026,H7BWY3,Agxt2,H7BWY3_Agxt2,H7BWY3,Agxt2,1,9,7,7,H7BWY3|Q3UEG6,MOUSE,61240.5,13.3,1705,1705.1,65.92,65.92,,541,"Alanine--glyoxylate aminotransferase 2, mitochondrial",mitochondrion|,"glyoxylate catabolic process|glycine biosynthetic process, by transamination of glyoxylate|L-alanine catabolic process, by transamination|positive regulation of nitric oxide biosynthetic process|",alanine-glyoxylate transaminase activity|beta-alanine-pyruvate transaminase activity|pyridoxal phosphate binding|(R)-3-amino-2-methylpropionate-pyruvate transaminase activity|,7,9,1600000000,13.3%
Q9D1R9,0.572571882,0.0885,6.92727292,-0.273,0.202895637,-1.413043818,-0.088,0.647,0.116,0.079,-0.083,-0.14,Q9D1R9,Rpl34,Q9D1R9_Rpl34,Q9D1R9,Rpl34,1,10,7,7,Q9D1R9|A0A0G2JEY6,MOUSE,13520.9,45.2,1706,1706.1,65.76,65.76,,117,60S ribosomal protein L34,nucleolus|cytosolic large ribosomal subunit|extracellular exosome|,translation|,structural constituent of ribosome|,7,10,7550000000,45.2%
O70305,0.505436633,-0.043166667,8.117771225,0.244333333,0.154249185,1.608344442,-0.205,0.098,-0.389,-0.106,0.171,0.172,O70305,Atxn2,O70305_Atxn2,O70305,Atxn2,1,10,7,7,O70305|E9QM77|O70305-2|O70305-3,MOUSE,137338.5,8.1,1707,1707.1,65.67,65.67,,1285,Ataxin-2,nucleoplasm|cytoplasm|Golgi apparatus|trans-Golgi network|polysome|cytoplasmic stress granule|membrane|ribonucleoprotein complex|perinuclear region of cytoplasm|,negative regulation of receptor internalization|regulation of cytoplasmic mRNA processing body assembly|cerebellar Purkinje cell differentiation|cytoplasmic mRNA processing body assembly|stress granule assembly|negative regulation of multicellular organism growth|neuron projection morphogenesis|homeostasis of number of cells|neuromuscular process|,epidermal growth factor receptor binding|protein C-terminus binding|poly(A) RNA binding|DBD domain binding|,7,10,629000000,8.1%
Q9CXF4,0.991556352,0.0025,0.160909878,-0.004333333,0.963627116,-0.047334514,-0.049,-0.059,0.122,0.031,-0.057,0.027,Q9CXF4,Tbc1d15,Q9CXF4_Tbc1d15,Q9CXF4,Tbc1d15,1,7,6,6,Q9CXF4,MOUSE,77495.7,10.4,1708,1708.1,65.59,65.59,,671,TBC1 domain family member 15,extracellular region|cytoplasm|mitochondrion|extracellular exosome|,regulation of GTPase activity|positive regulation of GTPase activity|,GTPase activator activity|,6,7,4500000000,10.4%
Q01339,0.000498463,-0.094166667,49.66262173,1.301666667,1.08078E-05,11.71809586,-0.714,-0.638,-0.883,0.49,0.473,0.707,Q01339,Apoh,Q01339_Apoh,Q01339,Apoh,1,12,7,7,Q01339,MOUSE,39930.4,25.7,1709,1709.1,65.54,65.54,,345,Beta-2-glycoprotein 1,extracellular space|cell surface|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|extracellular matrix|,"negative regulation of endothelial cell proliferation|triglyceride metabolic process|blood coagulation, intrinsic pathway|negative regulation of endothelial cell migration|negative regulation of angiogenesis|regulation of blood coagulation|negative regulation of blood coagulation|organ regeneration|plasminogen activation|negative regulation of myeloid cell apoptotic process|negative regulation of smooth muscle cell apoptotic process|positive regulation of lipoprotein lipase activity|regulation of fibrinolysis|negative regulation of fibrinolysis|",glycoprotein binding|phospholipid binding|heparin binding|lipid binding|identical protein binding|lipoprotein lipase activator activity|,7,12,715000000,25.7%
Q91WJ8-2,0.925061327,0.027833333,1.109956618,-0.035,0.774469534,-0.298477044,-0.081,-0.023,0.24,-0.076,-0.017,0.124,Q91WJ8,Fubp1,Q91WJ8-2_Fubp1,Q91WJ8-2,Fubp1,1,13,6,6,Q3UUU2|Q91WJ8-2|A0A0G2JFY5|Q91WJ8|A0A0G2JGW9|Q3TUE1|A0A0G2JG00,MOUSE,71041,7.2,1710,1710.1,65.53,65.53,,651,Isoform 2 of Far upstream element-binding protein 1,nucleus|nucleoplasm|,transcription from RNA polymerase II promoter|positive regulation of gene expression|positive regulation of transcription from RNA polymerase II promoter|,RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|DNA binding|protein binding|poly(A) RNA binding|,6,13,3080000000,7.2%
Q9DC70,0.873144039,-0.003333333,2.060672282,0.095333333,0.622203961,0.516652295,-0.197,0.374,-0.33,0.064,0.055,0.014,Q9DC70,Ndufs7,Q9DC70_Ndufs7,Q9DC70,Ndufs7,1,19,5,5,Q9DC70,MOUSE,24967.7,26.7,1711,1711.1,65.35,65.35,,224,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex I|neuron projection|neuronal cell body|synaptic membrane|,mitochondrial respiratory chain complex I assembly|oxidation-reduction process|,"protease binding|NADH dehydrogenase (ubiquinone) activity|metal ion binding|quinone binding|4 iron, 4 sulfur cluster binding|NADH dehydrogenase activity|",5,19,1410000000,26.7%
Q9Z277,0.748207831,-0.006333333,3.853159792,-0.136666667,0.411797799,-0.875782408,-0.166,-0.003,0.355,-0.004,-0.243,0.023,Q9Z277,Baz1b,Q9Z277_Baz1b,Q9Z277,Baz1b,1,7,7,7,Q9Z277|Q9Z277-2,MOUSE,172302.1,6.2,1712,1712.1,65.3,65.3,,1479,Tyrosine-protein kinase BAZ1B,condensed chromosome|nucleus|pericentric heterochromatin|nuclear replication fork|,"heart morphogenesis|double-strand break repair|chromatin assembly or disassembly|chromatin remodeling|transcription, DNA-templated|regulation of transcription, DNA-templated|cellular response to DNA damage stimulus|histone phosphorylation|peptidyl-tyrosine phosphorylation|chromatin-mediated maintenance of transcription|positive regulation of receptor activity|",chromatin binding|protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|protein binding|ATP binding|zinc ion binding|histone kinase activity|histone binding|lysine-acetylated histone binding|vitamin D receptor activator activity|,7,7,234000000,6.2%
Q9QXK7,0.403228566,-0.011833333,10.3255766,-0.182333333,0.09277743,-1.959336379,0.196,0.053,-0.011,-0.108,-0.155,-0.046,Q9QXK7,Cpsf3,Q9QXK7_Cpsf3,Q9QXK7,Cpsf3,1,6,5,5,Q9QXK7|P79101|A0A1Y7VLY3,MOUSE,78131.2,8.9,1713,1713.1,65.2,65.2,,684,Cleavage and polyadenylation specificity factor subunit 3,mRNA cleavage and polyadenylation specificity factor complex|ribonucleoprotein complex|,"histone mRNA 3'-end processing|nucleic acid phosphodiester bond hydrolysis|RNA phosphodiester bond hydrolysis, endonucleolytic|",RNA binding|endoribonuclease activity|5'-3' exonuclease activity|metal ion binding|,5,6,2430000000,8.9%
Q8BHS3,0.983717661,-0.018333333,0.256464474,-0.008,0.942656687,-0.074679399,0.06,0.101,-0.204,0.005,-0.015,-0.057,Q8BHS3,Rbm22,Q8BHS3_Rbm22,Q8BHS3,Rbm22,1,8,6,6,Q8BHS3,MOUSE,47636.5,17.3,1714,1714.1,65.05,65.05,,420,Pre-mRNA-splicing factor RBM22,nucleus|nucleoplasm|cytoplasm|catalytic step 2 spliceosome|,"protein import into nucleus, translocation|positive regulation of RNA splicing|cellular response to drug|mRNA cis splicing, via spliceosome|positive regulation of intracellular protein transport|",nucleotide binding|nucleocytoplasmic transporter activity|snRNA binding|pre-mRNA binding|poly(A) RNA binding|metal ion binding|calcium-dependent protein binding|,6,8,613000000,17.3%
Q8B0,0.846087297,-0.0295,2.420233441,-0.058333333,0.572765243,-0.592823551,0.006,-0.006,-0.001,0.028,-0.219,0.015,Q8B0,NotFound,Q8B0_NotFound,Q8B0,Pgam5,1,11,6,6,Q8B0|Q8B0-2,MOUSE,32164.9,20.4,1715,1715.1,65.04,65.04,,288,"Serine/threonine-protein phosphatase PGAM5, mitochondrial",mitochondrion|mitochondrial outer membrane|integral component of membrane|,dephosphorylation|intracellular signal transduction|positive regulation of GTPase activity|necroptotic process|,GTPase activator activity|receptor signaling protein serine/threonine phosphatase activity|phosphatase activity|protein complex binding|,6,11,1370000000,20.4%
P16294,0.108483191,0.007166667,19.57882656,0.461666667,0.01101837,3.494155952,-0.031,-0.272,-0.368,0.313,0.046,0.355,P16294,F9,P16294_F9,P16294,F9,1,12,5,5,P16294,MOUSE,54289.1,13.5,1716,1716.1,64.95,64.95,,471,Coagulation factor IX,extracellular space|extracellular exosome|,proteolysis|blood coagulation|zymogen activation|,endopeptidase activity|serine-type endopeptidase activity|calcium ion binding|peptidase activity|,5,12,1180000000,13.5%
A2AEX6,0.996670041,-0.015333333,0.039442926,-0.002,0.990959048,-0.011765948,-0.327,0.092,0.192,0.212,-0.121,-0.14,A2AEX6,NotFound,A2AEX6_NotFound,A2AEX6,Fhl1,1,10,7,7,A2AEX6|A2AEX8|P97447|A2AEY2|A2AEX7|P97447-2,MOUSE,37019.8,21.3,1717,1717.1,64.82,64.82,,309,Four and a half LIM domains protein 1,nucleus|cytoplasm|plasma membrane|focal adhesion|,regulation of membrane depolarization|negative regulation of G2/M transition of mitotic cell cycle|negative regulation of cell growth|positive regulation of potassium ion transport|regulation of potassium ion transmembrane transporter activity|negative regulation of G1/S transition of mitotic cell cycle|,zinc ion binding|ion channel binding|,7,10,2500000000,21.3%
Q6ZPJ0,0.631972503,-0.061,5.776163469,0.164666667,0.264474408,1.219058934,0.007,-0.007,-0.43,0.019,0.044,0.001,Q6ZPJ0,Tex2,Q6ZPJ0_Tex2,Q6ZPJ0,Tex2,1,7,7,7,Q6ZPJ0|B1ATR2,MOUSE,125793.8,8.3,1718,1718.1,64.71,64.71,,1128,Testis-expressed protein 2,integral component of membrane|,,,7,7,357000000,8.3%
P34022,0.80820754,0.0105,2.979399502,-0.057,0.503570233,-0.706736225,0.039,-0.012,0.09,-0.044,-0.022,0.012,P34022,Ranbp1,P34022_Ranbp1,P34022,Ranbp1,1,13,5,5,P34022|H7BX22,MOUSE,23767.2,26.6,1719,1719.1,64.63,64.63,,203,Ran-specific GTPase-activating protein,nucleus|cytoplasm|centrosome|cell projection cytoplasm|,spindle organization|positive regulation of neuron projection development|cellular response to drug|positive regulation of GTPase activity|positive regulation of mitotic centrosome separation|intracellular transport|response to calcium ion|cellular response to leptomycin B|,GTPase activator activity|,5,13,3110000000,26.6%
P35831,0.697395065,0.0095,4.584051956,-0.089,0.348012469,-1.009044093,0.037,-0.007,0.132,0.029,-0.108,-0.026,P35831,Ptpn12,P35831_Ptpn12,P35831,Ptpn12,1,12,6,6,P35831,MOUSE,87266.6,8.1,1720,1720.1,64.57,64.57,,775,Tyrosine-protein phosphatase non-receptor type 12,podosome|cytoplasm|cytosol|plasma membrane|cell junction|cell projection|,protein dephosphorylation|peptidyl-tyrosine dephosphorylation|tissue regeneration|,phosphoprotein phosphatase activity|protein tyrosine phosphatase activity|protein binding|SH3 domain binding|,6,12,417000000,8.1%
Q810A7,0.953420192,-0.001166667,0.688382073,0.039,0.853417988,0.192106898,-0.151,0.44,-0.351,0.111,-0.052,-0.004,Q810A7,Ddx42,Q810A7_Ddx42,Q810A7,Ddx42,1,11,6,6,Q810A7|Q810A7-2,MOUSE,102248.4,9.5,1721,1721.1,64.57,64.57,,929,ATP-dependent RNA helicase DDX42,nucleus|nucleoplasm|cytoplasm|Cajal body|membrane|nuclear speck|,protein localization|RNA secondary structure unwinding|,ATP-dependent RNA helicase activity|ATP binding|poly(A) RNA binding|,6,11,213000000,9.5%
Q9DCM0,0.726796323,-0.084333333,4.150917463,0.140666667,0.384510544,0.931083753,-0.007,0.02,-0.477,-0.109,0.031,0.036,Q9DCM0,Ethe1,Q9DCM0_Ethe1,Q9DCM0,Ethe1,1,12,5,5,Q9DCM0,MOUSE,28251.8,19.6,1722,1722.1,64.45,64.45,,254,"Persulfide dioxygenase ETHE1, mitochondrial",nucleoplasm|cytoplasm|mitochondrion|mitochondrial matrix|,glutathione metabolic process|oxidation-reduction process|hydrogen sulfide metabolic process|,iron ion binding|sulfur dioxygenase activity|,5,12,7430000000,19.6%
P35979,0.759504567,-0.039166667,3.720464044,0.098333333,0.424574196,0.850629763,-0.299,-0.026,0.06,-0.043,0.062,0.011,P35979,Rpl12,P35979_Rpl12,P35979,Rpl12,1,9,6,6,P35979|F8VQK7,MOUSE,17975.4,48.4,1723,1723.1,64.43,64.43,,165,60S ribosomal protein L12,focal adhesion|membrane|cytosolic large ribosomal subunit|extracellular exosome|,translation|,structural constituent of ribosome|poly(A) RNA binding|,6,9,1250000000,48.4%
Q62468,0.013650805,-0.167333333,30.54929714,1.435333333,0.000881191,5.716872388,-0.672,-0.51,-1.473,0.546,0.689,0.416,Q62468,Vil1,Q62468_Vil1,Q62468,Vil1,1,10,7,7,Q62468,MOUSE,93286.9,9.5,1724,1724.1,64.43,64.43,,827,Villin-1,ruffle|cytoplasm|microvillus|brush border|lamellipodium|filopodium|actin filament bundle|filopodium tip|extracellular exosome|,intestinal D-glucose absorption|epidermal growth factor receptor signaling pathway|regulation of cell shape|response to bacterium|positive regulation of epithelial cell migration|actin filament polymerization|actin filament depolymerization|positive regulation of cell migration|positive regulation of actin filament depolymerization|epithelial cell differentiation|positive regulation of actin filament bundle assembly|regulation of microvillus length|cellular response to hepatocyte growth factor stimulus|positive regulation of multicellular organism growth|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|actin nucleation|actin filament severing|barbed-end actin filament capping|regulation of actin nucleation|actin filament capping|cytoplasmic actin-based contraction involved in cell motility|regulation of wound healing|cellular response to epidermal growth factor stimulus|positive regulation of establishment of protein localization to plasma membrane|terminal web assembly|regulation of lamellipodium morphogenesis|positive regulation of lamellipodium morphogenesis|microvillus assembly|,"calcium ion binding|protein binding|phosphatidylinositol-4,5-bisphosphate binding|lysophosphatidic acid binding|identical protein binding|protein homodimerization activity|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|actin filament binding|",7,10,920000000,9.5%
Q9JIM1,0.467222102,-0.004666667,8.968659693,0.268,0.126804315,1.745819197,-0.233,0.158,-0.341,0.266,-0.014,0.136,Q9JIM1,Slc29a1,Q9JIM1_Slc29a1,Q9JIM1,Slc29a1,1,13,4,4,Q9JIM1|Q9JIM1-2|E9PXM6,MOUSE,51047.2,6.5,1725,1725.1,64.36,64.36,,460,Equilibrative nucleoside transporter 1,integral component of plasma membrane|membrane|basolateral plasma membrane|apical plasma membrane|,lactation|nucleoside transport|uridine transport|sleep|regulation of excitatory postsynaptic membrane potential|cellular response to glucose stimulus|cellular response to hypoxia|nucleoside transmembrane transport|,nucleoside transmembrane transporter activity|,4,13,1940000000,6.5%
Q9CQW2,0.982930903,0.082333333,0.266658319,-0.021333333,0.940446659,-0.077590508,0.559,0.051,-0.331,0.51,-0.089,-0.206,Q9CQW2,Arl8b,Q9CQW2_Arl8b,Q9CQW2,Arl8b,1,11,5,5,Q9CQW2|A0A0N4SVB8|Q8VEH3,MOUSE,21766.9,31.1,1726,1726.1,64.32,64.32,,186,ADP-ribosylation factor-like protein 8B,cytoplasm|lysosomal membrane|membrane|midbody|late endosome membrane|spindle midzone|extracellular exosome|,chromosome segregation|mitotic nuclear division|small GTPase mediated signal transduction|cell division|,GTP binding|GDP binding|alpha-tubulin binding|beta-tubulin binding|,5,11,1130000000,31.1%
Q8VHK9,0.593471457,-0.001833333,6.437536116,-0.112333333,0.227115298,-1.329707876,0.105,-0.014,0.072,-0.025,-0.119,-0.03,Q8VHK9,Dhx36,Q8VHK9_Dhx36,Q8VHK9,Dhx36,1,8,6,6,Q8VHK9,MOUSE,114737.1,10.9,1727,1727.1,64.25,64.25,,1001,ATP-dependent RNA helicase DHX36,"chromosome, telomeric region|nucleus|cytoplasm|extracellular exosome|","ossification|transcription, DNA-templated|RNA processing|response to virus|RNA secondary structure unwinding|positive regulation of telomere maintenance|response to exogenous dsRNA|positive regulation of transcription from RNA polymerase II promoter|",core promoter binding|G-quadruplex RNA binding|double-stranded RNA binding|ATP-dependent RNA helicase activity|protein binding|ATP binding|DNA-dependent ATPase activity|histone deacetylase binding|transcription regulatory region DNA binding|poly(A) RNA binding|G-quadruplex DNA binding|,6,8,449000000,10.9%
Q3U9N9,0.042592507,-0.015833333,24.5090204,-0.467666667,0.003540772,-4.397451108,0.284,0.121,0.249,-0.182,-0.154,-0.413,Q3U9N9,Slc16a10,Q3U9N9_Slc16a10,Q3U9N9,Slc16a10,1,12,5,5,Q3U9N9|Q3U9N9-2,MOUSE,56003.9,8.2,1728,1728.1,64.22,64.22,,512,Monocarboxylate transporter 10,integral component of plasma membrane|integral component of membrane|basolateral plasma membrane|,aromatic amino acid transport|ion transmembrane transport|thyroid hormone transport|,transporter activity|aromatic amino acid transmembrane transporter activity|thyroid hormone transmembrane transporter activity|,5,12,6190000000,8.2%
P03930,0.688055485,-0.004333333,4.731442104,-0.174666667,0.336399847,-1.036365287,0.132,0.347,-0.23,-0.188,0.1,-0.187,P03930,ATP8,P03930_ATP8,P03930,Mtatp8,1,21,6,6,P03930,MOUSE,7766.1,40.2,1729,1729.1,64.15,64.15,,67,ATP synthase protein 8,"mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)|mitochondrion|mitochondrial proton-transporting ATP synthase complex|integral component of membrane|",ATP synthesis coupled proton transport|response to hyperoxia|,hydrogen ion transmembrane transporter activity|,6,21,83700000000,40.2%
Q8BVY0,0.90651412,0.006833333,1.52728538,0.059,0.703511923,0.397487589,-0.114,0.275,-0.229,-0.076,0.134,0.051,Q8BVY0,Rsl1d1,Q8BVY0_Rsl1d1,Q8BVY0,Rsl1d1,1,8,6,6,Q8BVY0,MOUSE,50648.6,13.2,1730,1730.1,64.12,64.12,,452,Ribosomal L1 domain-containing protein 1,nucleolus|membrane|,osteoblast differentiation|regulation of protein localization|regulation of apoptotic process|regulation of cellular senescence|,protein binding|poly(A) RNA binding|,6,8,436000000,13.2%
O35691,0.956385108,-0.049,0.632272202,-0.023333333,0.864515491,-0.177379036,-0.178,0.02,0.046,0.011,-0.293,0.1,O35691,Pnn,O35691_Pnn,O35691,Pnn,1,11,6,6,Q3TUQ5|O35691,MOUSE,82605.4,8.6,1731,1731.1,64,64,,725,Pinin,nucleoplasm|cytoplasm|membrane|nuclear speck|desmosome|catalytic step 2 spliceosome|exon-exon junction complex|,"transcription, DNA-templated|regulation of transcription, DNA-templated|mRNA processing|RNA splicing|single organismal cell-cell adhesion|",DNA binding|poly(A) RNA binding|,6,11,705000000,8.6%
Q65Z40,0.606068848,0.020333333,6.264736423,-0.182666667,0.236334083,-1.302165835,0.195,0.278,-0.138,0.095,-0.165,-0.143,Q65Z40,Wapl,Q65Z40_Wapl,Q65Z40,Wapl,1,5,5,5,Q65Z40|B7ZP47,MOUSE,135721.8,7.4,1732,1732.1,63.97,63.97,,1200,Wings apart-like protein homolog,chromatin|synaptonemal complex|nucleus|nucleoplasm|cytoplasm|cohesin complex|microtubule cytoskeleton|intracellular membrane-bounded organelle|,mitotic nuclear division|negative regulation of DNA replication|response to toxic substance|negative regulation of chromatin binding|negative regulation of sister chromatid cohesion|positive regulation of fibroblast proliferation|cell division|regulation of chromosome segregation|regulation of chromosome condensation|protein localization to chromatin|regulation of cohesin localization to chromatin|,,5,5,236000000,7.4%
P56395,0.267576236,-0.043166667,13.72319834,0.301666667,0.042430697,2.507488467,-0.124,-0.048,-0.41,0.047,0.203,0.073,P56395,Cyb5a,P56395_Cyb5a,P56395,Cyb5a,1,11,4,4,P56395|G5E850|E0CY88,MOUSE,15240.7,32,1733,1733.1,63.97,63.97,,134,Cytochrome b5,mitochondrion|endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular exosome|,fatty acid metabolic process|response to cadmium ion|oxidation-reduction process|,stearoyl-CoA 9-desaturase activity|enzyme binding|heme binding|metal ion binding|,4,11,7640000000,32.0%
P83870,0.57510913,-0.0195,6.889463069,-0.132333333,0.204669766,-1.405002856,-0.039,0.141,0.038,0.005,-0.162,-0.1,P83870,Phf5a,P83870_Phf5a,P83870,Phf5a,1,15,5,5,P83870,MOUSE,13146.9,54.5,1734,1734.1,63.83,63.83,,110,PHD finger-like domain-containing protein 5A,nucleoplasm|U2 snRNP|U12-type spliceosomal complex|nuclear matrix|nuclear speck|nucleolus|,"mRNA splicing, via spliceosome|transcription, DNA-templated|positive regulation of transcription, DNA-templated|",DNA binding|sequence-specific DNA binding transcription factor activity|protein binding|poly(A) RNA binding|,5,15,1030000000,54.5%
P28700,0.624237536,-0.053666667,5.885581326,0.140666667,0.257894374,1.237187799,-0.006,-0.027,-0.339,0.051,-0.007,0.006,P28700,Rxra,P28700_Rxra,P28700,Rxra,1,5,5,5,P28700|Q6LC96|P28705|E9Q9V9|Q3TWJ1|P28704|Q8VCR0|P28704-2,MOUSE,51957.6,9.4,1735,1735.1,63.79,63.79,,467,Retinoic acid receptor RXR-alpha,nuclear chromatin|nucleus|nucleoplasm|axon|receptor complex|RNA polymerase II transcription factor complex|,"negative regulation of transcription from RNA polymerase II promoter|in utero embryonic development|liver development|placenta development|maternal placenta development|heart morphogenesis|transcription, DNA-templated|regulation of transcription, DNA-templated|regulation of transcription from RNA polymerase II promoter|inflammatory response|midgut development|heart development|embryo implantation|aging|negative regulation of cell proliferation|response to selenium ion|negative regulation of gene expression|modulation by virus of host morphology or physiology|axon regeneration|regulation of myelination|response to retinoic acid|cellular response to insulin stimulus|response to vitamin A|response to vitamin D|peroxisome proliferator activated receptor signaling pathway|camera-type eye development|positive regulation of apoptotic process|steroid hormone mediated signaling pathway|response to ethanol|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of translational initiation by iron|retinoic acid receptor signaling pathway|protein homotetramerization|response to glucocorticoid|cardiac muscle cell differentiation|ventricular cardiac muscle tissue morphogenesis|ventricular cardiac muscle cell differentiation|cardiac muscle cell proliferation|mesenchyme development|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development|regulation of branching involved in prostate gland morphogenesis|angiogenesis involved in coronary vascular morphogenesis|visceral serous pericardium development|positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus|",RNA polymerase II regulatory region sequence-specific DNA binding|DNA binding|double-stranded DNA binding|sequence-specific DNA binding transcription factor activity|steroid hormone receptor activity|ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity|9-cis retinoic acid receptor activity|protein binding|transcription factor binding|zinc ion binding|enzyme binding|protein domain specific binding|chromatin DNA binding|protein complex binding|vitamin D receptor binding|retinoic acid receptor binding|sequence-specific DNA binding|retinoic acid-responsive element binding|protein heterodimerization activity|ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity|transcription regulatory region DNA binding|vitamin D response element binding|,5,5,95400000,9.4%
Q8R2U0,0.483459336,-0.044166667,8.487553724,0.179666667,0.141659149,1.666275125,-0.043,-0.042,-0.317,0.111,-0.016,0.042,Q8R2U0,Seh1l,Q8R2U0_Seh1l,Q8R2U0,Seh1l,1,5,4,4,Q8R2U0|Q8R2U0-2,MOUSE,40344.6,20,1736,1736.1,63.77,63.77,,360,Nucleoporin SEH1,condensed chromosome kinetochore|nuclear pore outer ring|GATOR2 complex|kinetochore|,cytokine production involved in inflammatory response|nuclear pore organization|mitotic metaphase plate congression|protein transport|positive regulation of TOR signaling|cellular response to amino acid starvation|cellular protein complex localization|defense response to Gram-positive bacterium|mRNA transport|cell division|attachment of mitotic spindle microtubules to kinetochore|,,4,5,216000000,20.0%
P06802,0.360876246,-0.007333333,11.2288459,0.316,0.075355579,2.107239287,-0.301,-0.309,0.114,0.262,-0.029,0.219,P06802,Enpp1,P06802_Enpp1,P06802,Enpp1,1,11,5,5,P06802|A0A0R4J1Q7|P06802-2|G3X9S2|E9QQ26,MOUSE,105227.6,7.1,1737,1737.1,63.6,63.6,,906,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,extracellular space|lysosomal membrane|plasma membrane|integral component of plasma membrane|cell surface|integral component of membrane|basolateral plasma membrane|,generation of precursor metabolites and energy|phosphate-containing compound metabolic process|receptor-mediated endocytosis|immune response|nucleoside triphosphate catabolic process|negative regulation of ossification|negative regulation of cell growth|inorganic diphosphate transport|cellular phosphate ion homeostasis|sequestering of triglyceride|biomineral tissue development|negative regulation of protein autophosphorylation|cellular response to insulin stimulus|negative regulation of fat cell differentiation|negative regulation of glycogen biosynthetic process|negative regulation of glucose import|negative regulation of insulin receptor signaling pathway|bone remodeling|3'-phosphoadenosine 5'-phosphosulfate metabolic process|nucleic acid phosphodiester bond hydrolysis|,nucleic acid binding|phosphodiesterase I activity|nucleotide diphosphatase activity|scavenger receptor activity|insulin receptor binding|calcium ion binding|ATP binding|zinc ion binding|polysaccharide binding|NADH pyrophosphatase activity|protein homodimerization activity|nucleoside-triphosphate diphosphatase activity|,5,11,1320000000,7.1%
Q9ER35,0.661323193,-0.046,5.166281718,0.220666667,0.304348964,1.11334265,0.003,0.135,-0.607,0.036,0.175,-0.018,Q9ER35,Fn3k,Q9ER35_Fn3k,Q9ER35,Fn3k,1,12,5,5,Q9ER35|Q7TQJ3|Q6P264,MOUSE,35259.6,22.3,1738,1738.1,63.47,63.47,,309,Fructosamine-3-kinase,cytosol|,phosphorylation|fructosamine metabolic process|epithelial cell differentiation|,fructosamine-3-kinase activity|,5,12,1580000000,22.3%
Q9EP89,0.912007214,0.027333333,1.406453914,0.049333333,0.723360198,0.369401915,-0.051,0.25,-0.191,0.018,0.161,-0.023,Q9EP89,Lactb,Q9EP89_Lactb,Q9EP89,Lactb,1,9,6,6,Q9EP89|A0A1L1SVF9,MOUSE,60932.6,15,1739,1739.1,63.43,63.43,,551,"Serine beta-lactamase-like protein LACTB, mitochondrial",cytoplasm|mitochondrion|,metabolic process|,hydrolase activity|,6,9,1170000000,15.0%
Q8R238,0.983717661,-0.013333333,0.253063467,0.006666667,0.943395181,0.07370873,-0.127,0.051,0.026,0.048,-0.041,-0.037,Q8R238,Sdsl,Q8R238_Sdsl,Q8R238,Sdsl,1,13,7,7,Q8R238,MOUSE,35187.8,25.2,1740,1740.1,63.23,63.23,,329,Serine dehydratase-like,cytoplasm|mitochondrion|extracellular exosome|,L-serine catabolic process|threonine catabolic process|,L-serine ammonia-lyase activity|L-threonine ammonia-lyase activity|pyridoxal phosphate binding|,7,13,2370000000,25.2%
Q3U9G9,0.993214096,0.023333333,0.13818139,0.005333333,0.968683408,0.04076751,-0.225,0.078,0.209,-0.007,-0.036,0.121,Q3U9G9,Lbr,Q3U9G9_Lbr,Q3U9G9,Lbr,1,12,8,8,Q3U9G9,MOUSE,72009.4,13.5,1741,1741.1,63.13,63.13,,626,Lamin-B receptor,nuclear envelope|nuclear inner membrane|nuclear lamina|membrane|integral component of membrane|nuclear membrane|,oxidation-reduction process|,"DNA binding|oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor|poly(A) RNA binding|chromo shadow domain binding|",8,12,3670000000,13.5%
P08775,0.472136605,-0.002333333,8.765901818,-0.152666667,0.132864763,-1.710432636,0.089,0.037,0.096,0.025,-0.09,-0.171,P08775,Polr2a,P08775_Polr2a,P08775,Polr2a,1,10,8,8,P08775|A0A0R4J0V5,MOUSE,218541.6,4,1742,1742.1,63.04,63.04,,1970,DNA-directed RNA polymerase II subunit RPB1,"nucleus|nucleoplasm|DNA-directed RNA polymerase II, core complex|nuclear euchromatin|nucleolus|Prp19 complex|",transcription from RNA polymerase II promoter|response to organic cyclic compound|positive regulation of RNA splicing|cellular response to oxygen levels|,core promoter binding|DNA binding|protein binding|ubiquitin protein ligase binding|poly(A) RNA binding|metal ion binding|RNA polymerase II activity|,8,10,2280000000,4.0%
Q9CWX2,0.83266067,-0.057166667,2.623175488,0.092333333,0.54661614,0.635202013,0.042,0.063,-0.415,-0.051,0.057,-0.039,Q9CWX2,Ndufaf1,Q9CWX2_Ndufaf1,Q9CWX2,Ndufaf1,1,7,6,6,A0A0R4J081|Q9CWX2|A2AQ17,MOUSE,37923.3,18.9,1743,1743.1,63.03,63.03,,328,"Complex I intermediate-associated protein 30, mitochondrial",cytoplasm|mitochondrion|,,,6,7,392000000,18.9%
Q8VEH6,0.919416995,-0.026,1.211462983,0.044666667,0.756577988,0.323109737,0.013,0.116,-0.274,0.172,-0.141,-0.042,Q8VEH6,Cbwd1,Q8VEH6_Cbwd1,Q8VEH6,Cbwd1,1,7,5,5,Q8VEH6|Q8VEH6-2,MOUSE,44227.6,18.5,1744,1744.1,62.97,62.97,,393,COBW domain-containing protein 1,,,ATP binding|,5,7,93900000,18.5%
Q91ZH7,0.35633016,0.008166667,11.31660197,0.221,0.073848181,2.117416954,-0.106,0.012,-0.213,-0.012,0.184,0.184,Q91ZH7,Abhd3,Q91ZH7_Abhd3,Q91ZH7,Abhd3,1,11,5,5,Q91ZH7|Q91ZH7-2|D3Z6Y2|D3YU06,MOUSE,46801.9,15.3,1745,1745.1,62.93,62.93,,411,Phospholipase ABHD3,integral component of membrane|,phosphatidylcholine metabolic process|,phospholipase A2 activity|phosphatidylcholine 1-acylhydrolase activity|phosphatidylserine 1-acylhydrolase activity|1-acyl-2-lysophosphatidylserine acylhydrolase activity|,5,11,3830000000,15.3%
Q8K411,0.90770516,-0.001166667,1.491174295,0.035666667,0.70938593,0.388945519,0.071,0.002,-0.13,0.027,0.061,-0.038,Q8K411,Pitrm1,Q8K411_Pitrm1,Q8K411,Pitrm1,1,9,6,6,Q8K411|Q8K411-2|Q8K411-3,MOUSE,118510.7,7.6,1746,1746.1,62.92,62.92,,1036,"Presequence protease, mitochondrial",mitochondrion|mitochondrial matrix|,proteolysis|protein processing|,metalloendopeptidase activity|zinc ion binding|,6,9,200000000,7.6%
Q99KH8,0.994928853,-0.0195,0.072120626,-0.003,0.983530738,-0.021434515,0.182,0.067,-0.303,0.043,-0.014,-0.092,Q99KH8,Stk24,Q99KH8_Stk24,Q99KH8,Stk24,1,9,5,2,Q99KH8|Q99JT2|A2AD84,MOUSE,48238,14.3,1747,1747.1,62.68,15.99,,431,Serine/threonine-protein kinase 24,nucleus|nucleolus|cytoplasm|membrane|extracellular exosome|,protein phosphorylation|regulation of mitotic cell cycle|intrinsic apoptotic signaling pathway in response to oxidative stress|signal transduction by protein phosphorylation|negative regulation of cell migration|stress-activated protein kinase signaling cascade|activation of protein kinase activity|response to hydrogen peroxide|regulation of apoptotic process|protein autophosphorylation|regulation of axon regeneration|execution phase of apoptosis|,protein serine/threonine kinase activity|ATP binding|metal ion binding|,5,9,1200000000,14.3%
Q9Z2W1,0.797128744,-0.016,3.183142685,-0.128666667,0.480491525,-0.747454379,0.293,0.154,-0.302,0.053,-0.055,-0.239,Q9Z2W1,Stk25,Q9Z2W1_Stk25,Q9Z2W1,Stk25,1,2,4,2,Q9Z2W1,MOUSE,48385.1,11.9,1747,1747.2,55.8,22.36,,426,Serine/threonine-protein kinase 25,Golgi membrane|cytoplasm|extracellular exosome|Golgi apparatus|,protein phosphorylation|establishment or maintenance of cell polarity|regulation of mitotic cell cycle|signal transduction by protein phosphorylation|stress-activated protein kinase signaling cascade|activation of protein kinase activity|positive regulation of stress-activated MAPK cascade|intrinsic apoptotic signaling pathway in response to hydrogen peroxide|response to hydrogen peroxide|regulation of apoptotic process|protein autophosphorylation|positive regulation of axonogenesis|Golgi localization|establishment of Golgi localization|Golgi reassembly|,protein serine/threonine kinase activity|protein binding|ATP binding|protein homodimerization activity|metal ion binding|,2,2,359000000,4.4%
Q8BIJ7,0.953420192,0.023833333,0.688623732,-0.023666667,0.853370502,-0.192170019,0.089,-0.109,0.127,0.213,-0.111,-0.066,Q8BIJ7,Rufy1,Q8BIJ7_Rufy1,Q8BIJ7,Rufy1,1,6,5,5,Q8BIJ7,MOUSE,81516.2,8,1748,1748.1,62.65,62.65,,712,RUN and FYVE domain-containing protein 1,nucleus|cytoplasm|early endosome membrane|intracellular membrane-bounded organelle|late endosome|cytosol|,endocytosis|protein transport|regulation of endocytosis|,protein binding|lipid binding|protein transporter activity|metal ion binding|,5,6,1320000000,8.0%
Q7TPD0,0.648073376,-0.040166667,5.350124825,0.131666667,0.291734316,1.14510278,0.056,-0.145,-0.229,0.104,0.092,-0.119,Q7TPD0,Ints3,Q7TPD0_Ints3,Q7TPD0,Ints3,1,5,5,5,Q7TPD0|A0A0G2JFJ6|Q7TPD0-2,MOUSE,119476,6.4,1749,1749.1,62.62,62.62,,1041,Integrator complex subunit 3,nucleus|integrator complex|SOSS complex|,DNA repair|cellular response to DNA damage stimulus|mitotic cell cycle checkpoint|response to ionizing radiation|snRNA processing|,,5,5,198000000,6.4%
Q9DBA6,0.573899096,-0.0055,6.908897563,-0.130333333,0.203755924,-1.408221867,0.056,-0.01,0.133,0.017,-0.168,-0.061,Q9DBA6,Tysnd1,Q9DBA6_Tysnd1,Q9DBA6,Tysnd1,1,11,5,5,Q9DBA6,MOUSE,59977.5,14.7,1750,1750.1,62.59,62.59,,568,Peroxisomal leader peptide-processing protease,peroxisome|membrane|,proteolysis|protein processing|regulation of fatty acid beta-oxidation|protein homooligomerization|,protease binding|serine-type endopeptidase activity|identical protein binding|,5,11,519000000,14.7%
Q9Z1R2,0.372565587,0.001166667,10.98798031,0.200333333,0.079652969,2.064556791,-0.062,-0.148,-0.087,-0.014,0.081,0.237,Q9Z1R2,Bag6,Q9Z1R2_Bag6,Q9Z1R2,Bag6,1,9,7,7,Q9Z1R2|Q3UF95|G3UZT6|G3UYQ2,MOUSE,121548.8,7.7,1751,1751.1,62.45,62.45,,1154,Large proline-rich protein BAG6,nucleus|nucleoplasm|cytoplasm|cytosol|membrane|intracellular membrane-bounded organelle|BAT3 complex|,kidney development|antigen processing and presentation of peptide antigen via MHC class I|ubiquitin-dependent protein catabolic process|transport|apoptotic process|synaptonemal complex assembly|spermatogenesis|brain development|embryo development|chromatin modification|internal peptidyl-lysine acetylation|cell differentiation|lung development|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|regulation of cell proliferation|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator|regulation of apoptotic process|negative regulation of apoptotic process|negative regulation of proteolysis|protein stabilization|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress|tail-anchored membrane protein insertion into ER membrane|regulation of ER-associated ubiquitin-dependent protein catabolic process|positive regulation of ER-associated ubiquitin-dependent protein catabolic process|,protein binding|Hsp70 protein binding|polyubiquitin binding|ubiquitin protein ligase binding|ribosome binding|misfolded protein binding|proteasome binding|ubiquitin-specific protease binding|,7,9,182000000,7.7%
Q8BWF0,0.977234082,-0.003166667,0.343623009,-0.010333333,0.923927086,-0.099149135,-0.032,-0.023,0.061,-0.133,0.159,-0.051,Q8BWF0,Aldh5a1,Q8BWF0_Aldh5a1,Q8BWF0,Aldh5a1,1,8,5,5,Q8BWF0,MOUSE,56537.7,15.6,1752,1752.1,62.45,62.45,,523,"Succinate-semialdehyde dehydrogenase, mitochondrial",mitochondrion|,glucose metabolic process|acetate metabolic process|succinate metabolic process|glutamate metabolic process|glutamine metabolic process|glycerophospholipid metabolic process|glucosylceramide metabolic process|galactosylceramide metabolic process|glutathione metabolic process|central nervous system development|gamma-aminobutyric acid metabolic process|gamma-aminobutyric acid catabolic process|post-embryonic development|respiratory electron transport chain|neurotransmitter catabolic process|short-chain fatty acid metabolic process|protein homotetramerization|oxidation-reduction process|,aldehyde dehydrogenase (NAD) activity|succinate-semialdehyde dehydrogenase (NAD+) activity|succinate-semialdehyde dehydrogenase [NAD(P)+] activity|carboxylic acid binding|NAD binding|,5,8,854000000,15.6%
P50462,0.677899899,0.0345,4.898867641,0.193,0.32367804,1.066178338,0.036,0.072,-0.294,0.481,-0.085,-0.003,P50462,Csrp3,P50462_Csrp3,P50462,Csrp3,1,15,4,4,P50462,MOUSE,21807.3,29.3,1753,1753.1,62.44,62.44,,194,Cysteine and glycine-rich protein 3,nucleus|cytoplasm|cytoskeleton|Z disc|,blood vessel remodeling|regulation of the force of heart contraction|cardiac muscle hypertrophy|cellular calcium ion homeostasis|muscle organ development|positive regulation of myotube differentiation|protein localization to organelle|detection of muscle stretch|positive regulation of transcription from RNA polymerase II promoter|cardiac muscle tissue development|positive regulation of sequence-specific DNA binding transcription factor activity|cardiac myofibril assembly|cardiac muscle contraction|,protein binding|zinc ion binding|structural constituent of muscle|telethonin binding|actinin binding|MRF binding|RNA polymerase II sequence-specific DNA binding transcription factor binding|,4,15,2740000000,29.3%
Q6ZWQ7,0.01880646,-0.027166667,28.8305709,1.466333333,0.00130901,5.324728429,-1.296,-0.458,-0.527,0.294,0.846,0.978,Q6ZWQ7,Spcs3,Q6ZWQ7_Spcs3,Q6ZWQ7,Spcs3,1,14,6,6,Q6ZWQ7,MOUSE,20370.1,26.6,1754,1754.1,62.39,62.39,,180,Signal peptidase complex subunit 3,endoplasmic reticulum|signal peptidase complex|integral component of membrane|,signal peptide processing|,peptidase activity|,6,14,4350000000,26.6%
Q9R1P4,0.47899797,0.009,8.59767909,0.148,0.138112215,1.683398068,0.026,-0.093,-0.128,0.098,0.022,0.129,Q9R1P4,Psma1,Q9R1P4_Psma1,Q9R1P4,Psma1,1,10,6,6,Q9R1P4|A0A1B0GS70,MOUSE,29831.3,37.2,1755,1755.1,62.06,62.06,,263,Proteasome subunit alpha type-1,"proteasome complex|nucleus|nucleoplasm|cytoplasm|centrosome|cytosol|proteasome core complex|proteasome core complex, alpha-subunit complex|extracellular exosome|",immune system process|negative regulation of inflammatory response to antigenic stimulus|proteasomal ubiquitin-independent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|,lipopolysaccharide binding|endopeptidase activity|threonine-type endopeptidase activity|protein binding|,6,10,780000000,37.2%
Q8VCM3,0.60945322,-0.0035,6.180076342,0.117666667,0.240986307,1.286399464,-0.036,0.026,-0.177,0.106,0.031,0.029,Q8VCM3,Zfyve21,Q8VCM3_Zfyve21,Q8VCM3,Zfyve21,1,10,4,4,A0A1Y7VNH4|Q8VCM3|A0A1Y7VLE1,MOUSE,26902.4,26.4,1756,1756.1,61.97,61.97,,234,Zinc finger FYVE domain-containing protein 21,endosome|focal adhesion|cytoplasmic membrane-bounded vesicle|,,metal ion binding|,4,10,644000000,26.4%
P62270,0.956385108,0.0135,0.636188361,0.016333333,0.863736284,0.178332115,-0.112,0.064,0.064,-0.025,0.075,0.015,P62270,Rps18,P62270_Rps18,P62270,Rps18,1,6,5,5,A0A1Y7VKY1|P62270|F6YVP7|S4R1N6,MOUSE,17718.4,26.9,1757,1757.1,61.82,61.82,,152,40S ribosomal protein S18,nucleus|cytoplasm|focal adhesion|small ribosomal subunit|membrane|cytosolic small ribosomal subunit|extracellular exosome|,translation|,structural constituent of ribosome|protein binding|rRNA binding|poly(A) RNA binding|,5,6,911000000,26.9%
Q8BWQ6,0.505436633,-0.037166667,8.108890668,-0.150333333,0.15456492,-1.604530145,0.048,0.086,-0.02,-0.029,-0.072,-0.236,Q8BWQ6,Vps35l,Q8BWQ6_Vps35l,Q8BWQ6,,1,6,5,5,Q8BWQ6|Q8BWQ6-2|I1E4X5|Q8BWQ6-3,MOUSE,110444.1,6.3,1758,1758.1,61.81,61.81,,963,UPF0505 protein C16orf62 homolog,early endosome|integral component of membrane|,Golgi to plasma membrane transport|protein transport|,,5,6,325000000,6.3%
Q9DAW6,0.817376822,0.001,2.839419839,-0.077333333,0.520065466,-0.678978296,-0.153,0.137,0.135,-0.048,-0.122,0.057,Q9DAW6,Prpf4,Q9DAW6_Prpf4,Q9DAW6,Prpf4,1,11,5,5,Q9DAW6,MOUSE,59053.7,13.4,1759,1759.1,61.77,61.77,,521,U4/U6 small nuclear ribonucleoprotein Prp4,nucleoplasm|spliceosomal complex|Cajal body|nuclear speck|U4/U6 x U5 tri-snRNP complex|U4/U6 snRNP|,"mRNA splicing, via spliceosome|",U6 snRNA binding|U4 snRNA binding|,5,11,1140000000,13.4%
Q8BWU8,0.791332991,0.02,3.229268389,0.129333333,0.475415308,0.756481824,-0.09,0.277,-0.321,-0.03,0.268,0.016,Q8BWU8,Etnppl,Q8BWU8_Etnppl,Q8BWU8,Etnppl,1,11,7,7,Q8BWU8|E9PYH3,MOUSE,56066,14.6,1760,1760.1,61.67,61.67,,499,Ethanolamine-phosphate phospho-lyase,mitochondrion|,metabolic process|,transaminase activity|pyridoxal phosphate binding|ethanolamine-phosphate phospho-lyase activity|,7,11,919000000,14.6%
Q9DCP2,0.852864363,-0.029833333,2.349722842,-0.114333333,0.582140368,-0.578379584,-0.409,0.221,0.27,-0.254,-0.039,0.032,Q9DCP2,Slc38a3,Q9DCP2_Slc38a3,Q9DCP2,Slc38a3,1,21,4,4,Q9DCP2,MOUSE,56104,9.5,1761,1761.1,61.61,61.61,,505,Sodium-coupled neutral amino acid transporter 3,plasma membrane|integral component of plasma membrane|membrane|,sodium ion transport|asparagine transport|glutamine transport|L-alanine transport|histidine transport|cellular response to potassium ion starvation|positive regulation of transcription from RNA polymerase II promoter in response to acidic pH|L-histidine transmembrane transport|,L-histidine transmembrane transporter activity|L-alanine transmembrane transporter activity|L-asparagine transmembrane transporter activity|L-glutamine transmembrane transporter activity|symporter activity|antiporter activity|,4,21,10600000000,9.5%
P43247,0.854957327,-0.035666667,2.324815573,-0.062,0.585488599,-0.572876584,0.104,-0.039,-0.079,0.089,-0.098,-0.191,P43247,Msh2,P43247_Msh2,P43247,Msh2,1,5,5,5,P43247,MOUSE,104948.2,6.9,1762,1762.1,61.52,61.52,,935,DNA mismatch repair protein Msh2,nuclear chromosome|nucleus|membrane|MutSalpha complex|MutSbeta complex|,meiotic mismatch repair|in utero embryonic development|somatic recombination of immunoglobulin genes involved in immune response|oxidative phosphorylation|DNA repair|mismatch repair|postreplication repair|double-strand break repair|meiotic gene conversion|cellular response to DNA damage stimulus|cell cycle arrest|reciprocal meiotic recombination|germ cell development|determination of adult lifespan|male gonad development|intrinsic apoptotic signaling pathway in response to DNA damage|response to X-ray|response to UV-B|somatic hypermutation of immunoglobulin genes|somatic recombination of immunoglobulin gene segments|B cell mediated immunity|B cell differentiation|intra-S DNA damage checkpoint|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator|negative regulation of neuron apoptotic process|maintenance of DNA repeat elements|negative regulation of reciprocal meiotic recombination|isotype switching|negative regulation of DNA recombination|positive regulation of helicase activity|in utero embryonic development|somatic hypermutation of immunoglobulin genes|,four-way junction DNA binding|Y-form DNA binding|heteroduplex DNA loop binding|double-strand/single-strand DNA junction binding|DNA binding|damaged DNA binding|protein C-terminus binding|DNA-dependent ATPase activity|ATPase activity|centromeric DNA binding|enzyme binding|protein kinase binding|mismatched DNA binding|guanine/thymine mispair binding|single base insertion or deletion binding|protein homodimerization activity|magnesium ion binding|four-way junction DNA binding|double-stranded DNA binding|single-stranded DNA binding|ATP binding|ATPase activity|mismatched DNA binding|guanine/thymine mispair binding|dinucleotide insertion or deletion binding|single guanine insertion binding|single thymine insertion binding|dinucleotide repeat insertion binding|oxidized purine DNA binding|MutLalpha complex binding|ADP binding|,5,5,213000000,6.9%
Q61771,0.700566953,-0.015,4.549713253,-0.084,0.350775033,-1.002867817,0.017,0.04,0.024,0.015,-0.137,-0.049,Q61771,Kif3b,Q61771_Kif3b,Q61771,Kif3b,1,10,6,6,Q61771|O35066|L0N7N1|E9Q3T3|O35231|Q8C0X6|Q3V3Y6|Q9WV04|E9PWU7|O35231-2|A0A1D5RLM0|Q14BL9,MOUSE,85400.9,10.1,1763,1763.1,61.5,63.52,,747,Kinesin-like protein KIF3B,centrosome|spindle|cytosol|microtubule|cilium|microtubule cytoskeleton|membrane|kinesin II complex|midbody|extracellular exosome|intraciliary transport particle|,microtubule-based movement|metabolic process|cytoskeleton-dependent intracellular transport|positive regulation of cytokinesis|mitotic spindle assembly|,microtubule motor activity|protein binding|ATP binding|microtubule binding|ATPase activity|Rho GTPase binding|,7,10,1550000000,10.1%
P48760-4,0.868452057,0.005,2.119993483,-0.06,0.613762926,-0.529324337,0.188,0.012,-0.095,0.015,-0.162,0.072,P48760,Fpgs,P48760-4_Fpgs,P48760-4,Fpgs,1,8,6,6,P48760-4|P48760-5|P48760-3|P48760|P48760-2|A0A0A6YX96,MOUSE,65768,13.8,1764,1764.1,61.43,61.43,,587,"Isoform 4 of Folylpolyglutamate synthase, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial matrix|,liver development|one-carbon metabolic process|brain development|organ regeneration|tetrahydrofolylpolyglutamate biosynthetic process|,tetrahydrofolylpolyglutamate synthase activity|ATP binding|,6,8,1570000000,13.8%
Q91YD9,0.676367666,-0.011666667,4.924632819,0.138666667,0.321763456,1.070746321,0.047,0.036,-0.326,-0.048,0.148,0.073,Q91YD9,Wasl,Q91YD9_Wasl,Q91YD9,Wasl,1,7,5,5,Q91YD9|Q9CXQ9,MOUSE,54672.6,18.1,1765,1765.1,61.42,61.42,,501,Neural Wiskott-Aldrich syndrome protein,Golgi membrane|nucleus|cytoplasm|cytosol|cytoplasmic membrane-bounded vesicle|lamellipodium|actin cap|extracellular exosome|,"transcription, DNA-templated|regulation of transcription, DNA-templated|membrane budding|mitotic nuclear division|response to bacterium|vesicle organization|actin cytoskeleton organization|vesicle transport along actin filament|regulation of protein localization|cellular protein complex localization|actin nucleation|cell division|positive regulation of filopodium assembly|spindle localization|negative regulation of membrane tubulation|positive regulation of clathrin-mediated endocytosis|negative regulation of lymphocyte migration|positive regulation of Arp2/3 complex-mediated actin nucleation|cell projection assembly|",actin binding|protein binding|,5,7,265000000,18.1%
Q9D071,0.961523652,0.036333333,0.565553519,0.022666667,0.87789919,0.1596752,0.018,0.075,-0.018,0.347,-0.149,-0.055,Q9D071,Mms19,Q9D071_Mms19,Q9D071,Mms19,1,5,4,4,Q9D071|Q9D071-3|Q9D071-2|E9PW47|E9Q5T0,MOUSE,114741.4,6.8,1766,1766.1,61.37,61.37,,1031,MMS19 nucleotide excision repair protein homolog,nucleus|nucleoplasm|cytoplasm|spindle|membrane|MMXD complex|CIA complex|,"DNA metabolic process|DNA repair|transcription, DNA-templated|cellular response to DNA damage stimulus|chromosome segregation|iron-sulfur cluster assembly|positive regulation of transcription, DNA-templated|",transcription coactivator activity|estrogen receptor binding|,4,5,835000000,6.8%
P97384,0.564678113,0.033166667,7.059295747,0.261,0.196820543,1.434925134,-0.332,-0.107,0.147,0.024,-0.019,0.486,P97384,Anxa11,P97384_Anxa11,P97384,Anxa11,1,11,7,7,P97384|D3Z7U0,MOUSE,54420.7,16.3,1767,1767.1,61.34,61.34,,503,Annexin A11,nuclear envelope|nucleoplasm|cytoplasm|spindle|membrane|midbody|melanosome|specific granule|azurophil granule|phagocytic vesicle|extracellular exosome|,phagocytosis|cell cycle|cell division|response to calcium ion|,calcium ion binding|calcium-dependent phospholipid binding|phosphatidylethanolamine binding|MHC class II protein complex binding|S100 protein binding|poly(A) RNA binding|calcium-dependent protein binding|,7,11,920000000,16.3%
Q9JKX6,0.91325,-0.012833333,1.362636399,0.033,0.730695378,0.358930471,0.013,0.037,-0.138,0.073,-0.055,-0.007,Q9JKX6,Nudt5,Q9JKX6_Nudt5,Q9JKX6,Nudt5,1,8,6,6,Q9JKX6,MOUSE,24269.1,38.9,1768,1768.1,61.31,61.31,,218,ADP-sugar pyrophosphatase,nucleus|extracellular exosome|,nucleobase-containing compound metabolic process|ribonucleoside diphosphate catabolic process|,magnesium ion binding|nucleoside-diphosphatase activity|ADP-sugar diphosphatase activity|snoRNA binding|ADP-ribose diphosphatase activity|m7G(5')pppN diphosphatase activity|,6,8,1240000000,38.9%
Q8VCS9,0.855191835,-0.011666667,2.305861925,-0.081333333,0.588049395,-0.569127919,0.163,0.203,-0.279,-0.019,-0.045,-0.093,Q8VCS9,Slc6a12,Q8VCS9_Slc6a12,Q8VCS9,Slc6a12,1,12,5,5,Q8VCS9|G5E8Z4|P31651|E9PXG1|E9Q5U8,MOUSE,72417.2,10.6,1769,1769.1,61.27,61.27,,628,Transporter,integral component of plasma membrane|,neurotransmitter transport|gamma-aminobutyric acid transport|transmembrane transport|,neurotransmitter:sodium symporter activity|gamma-aminobutyric acid:sodium symporter activity|,5,12,37900000000,10.6%
Q9CWE0,0.584741827,-0.087166667,6.635749741,0.274333333,0.216982659,1.364488024,0.052,-0.039,-0.686,0.164,0.017,-0.031,Q9CWE0,Mtfr1l,Q9CWE0_Mtfr1l,Q9CWE0,Mtfr1l,1,8,5,5,Q9CWE0|D6RCX5|Q9CWE0-2,MOUSE,32182,20.7,1770,1770.1,60.96,60.96,,289,Mitochondrial fission regulator 1-like,mitochondrion|,mitochondrial fission|aerobic respiration|,,5,8,1290000000,20.7%
D3Z3L3,0.035248706,-0.0525,25.48306615,0.470333333,0.002829394,4.586478276,-0.289,-0.339,-0.235,0.109,0.09,0.349,D3Z3L3,Trim12c,D3Z3L3_Trim12c,D3Z3L3,Trim12c,1,4,4,4,D3Z3L3|E9PV98|D3YYU4|A0A0R4J1B5|Q99PQ1,MOUSE,58818.9,14,1771,1771.1,60.92,60.92,,497,Tripartite motif-containing 12C,cytoplasmic mRNA processing body|cytoplasm|,pattern recognition receptor signaling pathway|protein ubiquitination|,ubiquitin-protein transferase activity|zinc ion binding|signaling pattern recognition receptor activity|identical protein binding|protein homodimerization activity|,4,4,141000000,14.0%
Q80VD1,0.586445778,-0.036,6.566875715,0.151333333,0.22045118,1.352149605,-0.044,-0.008,-0.283,0.162,-0.033,-0.01,Q80VD1,Fam98b,Q80VD1_Fam98b,Q80VD1,Fam98b,1,7,4,3,Q80VD1,MOUSE,45918.9,16.3,1772,1772.1,60.84,52.49,,429,Protein FAM98B,nucleus|cytoplasm|tRNA-splicing ligase complex|,,poly(A) RNA binding|,4,7,355000000,16.3%
Q3TJZ6,0.805699632,-0.002833333,3.008157835,0.067666667,0.500246682,0.712450772,-0.045,0.054,-0.119,0.116,-0.067,0.044,Q3TJZ6,Fam98a,Q3TJZ6_Fam98a,Q3TJZ6,Fam98a,1,4,3,2,Q3TJZ6,MOUSE,55510.8,8.5,1772,1772.2,38.03,29.68,,515,Protein FAM98A,tRNA-splicing ligase complex|,,poly(A) RNA binding|,2,4,277000000,4.8%
Q9QXY9,0.820260214,-0.062833333,2.792899686,0.106333333,0.525666174,0.669774194,0.085,-0.005,-0.428,0.123,0.016,-0.168,Q9QXY9,Pex3,Q9QXY9_Pex3,Q9QXY9,Pex3,1,16,4,4,Q9QXY9|E9QA46|D3Z6X4|D3Z6X3,MOUSE,42565.4,16.1,1773,1773.1,60.74,60.74,,372,Peroxisomal biogenesis factor 3,nucleoplasm|peroxisome|peroxisomal membrane|integral component of peroxisomal membrane|endoplasmic reticulum|cytosol|integral component of plasma membrane|membrane|protein-lipid complex|intracellular membrane-bounded organelle|protein complex|,positive regulation of defense response to virus by host|amino acid transmembrane transport|peroxisome organization|peroxisome membrane biogenesis|protein import into peroxisome membrane|activation of mitophagy in response to mitochondrial depolarization|,lipid binding|amino acid transmembrane transporter activity|protein dimerization activity|,4,16,2280000000,16.1%
Q99J95,0.136853697,0.013166667,18.16768782,-0.249666667,0.015248644,-3.235508042,0.122,0.162,0.13,-0.096,-0.12,-0.119,Q99J95,Cdk9,Q99J95_Cdk9,Q99J95,Cdk9,1,14,7,7,Q99J95|Q99J95-2|Q99J95-3|D6RHP4,MOUSE,43160.2,22.5,1774,1774.1,60.73,60.73,,372,Cyclin-dependent kinase 9,nucleus|nucleoplasm|cytoplasm|transcription elongation factor complex|positive transcription elongation factor complex b|membrane|PML body|intracellular membrane-bounded organelle|,"DNA repair|regulation of DNA repair|transcription, DNA-templated|protein phosphorylation|positive regulation of cardiac muscle hypertrophy|regulation of histone modification|positive regulation of histone phosphorylation|response to drug|replication fork arrest|positive regulation of transcription from RNA polymerase II promoter|negative regulation of cell cycle arrest|cellular response to cytokine stimulus|negative regulation of mRNA polyadenylation|positive regulation of mRNA 3'-UTR binding|positive regulation of histone H2B ubiquitination|",DNA binding|chromatin binding|cyclin-dependent protein serine/threonine kinase activity|protein binding|ATP binding|transcription factor binding|RNA polymerase II carboxy-terminal domain kinase activity|snRNA binding|transcription regulatory region DNA binding|,7,14,3920000000,22.5%
P01872-2,0.951421295,0.155166667,0.724528944,-0.103666667,0.846344362,-0.201519264,1.472,-0.584,-0.267,0.344,-0.146,0.112,P01872,NotFound,P01872-2_NotFound,P01872-2,Ighm,1,9,5,5,P01872-2|P01872|P04221|P03988,MOUSE,53153.5,10.7,1775,1775.1,60.7,60.7,,454,Isoform 2 of Ig mu chain C region,"extracellular space|plasma membrane|external side of plasma membrane|integral component of membrane|B cell receptor complex|immunoglobulin complex, circulating|perinuclear region of cytoplasm|",activation of MAPK activity|humoral immune response mediated by circulating immunoglobulin|immunoglobulin mediated immune response|antigen processing and presentation|positive regulation of B cell proliferation|positive regulation of MAPK cascade|early endosome to late endosome transport|positive regulation of endocytosis|positive regulation of peptidyl-tyrosine phosphorylation|defense response to Gram-negative bacterium|B cell receptor signaling pathway|positive regulation of B cell activation|,antigen binding|transmembrane signaling receptor activity|protein binding|immunoglobulin receptor binding|identical protein binding|,5,9,491000000,10.7%
Q8JZX4,0.366262585,-0.0145,11.12962003,0.201,0.077097092,2.087049352,-0.151,-0.009,-0.185,0.056,0.012,0.19,Q8JZX4,Rbm17,Q8JZX4_Rbm17,Q8JZX4,Rbm17,1,6,5,5,Q8JZX4,MOUSE,45531.2,17.5,1776,1776.1,60.47,60.47,,405,Splicing factor 45,nucleoplasm|spliceosomal complex|,"RNA splicing, via transesterification reactions|alternative mRNA splicing, via spliceosome|mRNA processing|RNA splicing|",nucleotide binding|RNA binding|,5,6,316000000,17.5%
O88908,0.696311006,-0.0485,4.598142051,0.207,0.346885219,1.012461874,-0.504,0.305,-0.257,0.12,0.086,-0.041,O88908,Soat2,O88908_Soat2,O88908,Soat2,1,11,5,5,O88908,MOUSE,61395,10.6,1777,1777.1,60.44,60.44,,525,Sterol O-acyltransferase 2,endoplasmic reticulum|endoplasmic reticulum membrane|brush border|membrane|integral component of membrane|,cholesterol metabolic process|cholesterol efflux|very-low-density lipoprotein particle assembly|cholesterol esterification|cholesterol homeostasis|,fatty-acyl-CoA binding|sterol O-acyltransferase activity|cholesterol binding|cholesterol O-acyltransferase activity|,5,11,9270000000,10.6%
O88746,0.484234055,0.039666667,8.468138118,-0.198666667,0.142293869,-1.665115836,0.081,0.001,0.335,-0.181,0.029,-0.027,O88746,Tom1,O88746_Tom1,O88746,Tom1,1,9,5,5,Q3UDC3|O88746|A0A1D5RM12,MOUSE,54552.4,16,1778,1778.1,60.41,60.41,,492,Target of Myb protein 1,cytoplasm|endosome|early endosome|cytosol|membrane|extracellular exosome|,intracellular protein transport|,protein binding|clathrin binding|,5,9,407000000,16.0%
Q99J87,0.502661212,-0.002,8.169036382,-0.182,0.152439095,-1.61548049,0.044,-0.016,0.239,-0.001,-0.241,-0.037,Q99J87,Dhx58,Q99J87_Dhx58,Q99J87,Dhx58,1,7,5,5,Q99J87,MOUSE,77563,7.5,1779,1779.1,60.33,60.33,,678,Probable ATP-dependent RNA helicase DHX58,cytoplasm|,metabolic process|response to virus|negative regulation of type I interferon production|positive regulation of type I interferon production|negative regulation of MDA-5 signaling pathway|negative regulation of RIG-I signaling pathway|innate immune response|regulation of innate immune response|negative regulation of innate immune response|defense response to virus|positive regulation of MDA-5 signaling pathway|positive regulation of RIG-I signaling pathway|,DNA binding|double-stranded RNA binding|single-stranded RNA binding|helicase activity|ATP binding|zinc ion binding|,5,7,252000000,7.5%
Q99LR1,0.90651412,0.014166667,1.511280957,-0.035666667,0.706109256,-0.39359522,-0.061,0.028,0.129,0.006,-0.062,0.045,Q99LR1,Abhd12,Q99LR1_Abhd12,Q99LR1,Abhd12,1,13,6,6,Q99LR1|D6RFU2|Q99LR1-2|D6RI21,MOUSE,45668.3,19.3,1780,1780.1,60.29,60.29,,398,Monoacylglycerol lipase ABHD12,mitochondrion|integral component of membrane|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex|,phosphatidylserine catabolic process|adult walking behavior|response to auditory stimulus|acylglycerol catabolic process|,acylglycerol lipase activity|,6,13,1670000000,19.3%
Q9R0U0,0.581377911,0.020333333,6.704324454,-0.144,0.213583429,-1.374512608,0.088,0.252,-0.063,-0.042,-0.025,-0.088,Q9R0U0,Srsf10,Q9R0U0_Srsf10,Q9R0U0,Srsf10,1,9,5,5,Q9R0U0|Q9R0U0-2|Q9R0U0-3|Q3TFP0,MOUSE,31357,19.4,1781,1781.1,60.28,60.28,,262,Serine/arginine-rich splicing factor 10,nucleoplasm|nuclear speck|,"RNA splicing, via transesterification reactions|mRNA splicing, via spliceosome|regulation of transcription, DNA-templated|mRNA splice site selection|mRNA export from nucleus|cytoplasmic transport|negative regulation of mRNA splicing, via spliceosome|",nucleotide binding|RNA binding|poly(A) RNA binding|unfolded protein binding|,5,9,1410000000,19.4%
Q8R1S0,0.901083696,-0.0195,1.599345976,0.044333333,0.691935165,0.413866335,-0.146,0.115,-0.094,0.099,0.003,-0.094,Q8R1S0,Coq6,Q8R1S0_Coq6,Q8R1S0,Coq6,1,10,5,5,Q8R1S0|D3YW66|D6RG57,MOUSE,51677,11.7,1782,1782.1,60.19,60.19,,476,"Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial",mitochondrion|mitochondrial inner membrane|Golgi apparatus|cell projection|,ubiquinone biosynthetic process|secondary metabolite biosynthetic process|oxidation-reduction process|,"monooxygenase activity|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen|flavin adenine dinucleotide binding|",5,10,1210000000,11.7%
Q8VBV7,0.991556352,0.009666667,0.166424116,0.004,0.962404375,0.048927187,-0.047,-0.001,0.071,0.03,-0.02,0.025,Q8VBV7,Cops8,Q8VBV7_Cops8,Q8VBV7,Cops8,1,10,4,4,Q8VBV7,MOUSE,23312.2,30.1,1783,1783.1,60.15,60.15,,209,COP9 signalosome complex subunit 8,nucleus|nucleoplasm|cytoplasm|COP9 signalosome|perinuclear region of cytoplasm|extracellular exosome|,activation of NF-kappaB-inducing kinase activity|negative regulation of cell proliferation|cullin deneddylation|,,4,10,1650000000,30.1%
Q61823,0.313080161,-0.020166667,12.44585267,0.269,0.056939642,2.300761569,-0.058,-0.132,-0.274,0.303,0.046,-0.006,Q61823,Pdcd4,Q61823_Pdcd4,Q61823,Pdcd4,1,6,5,5,Q61823,MOUSE,52100.6,19.1,1784,1784.1,60.02,60.02,,469,Programmed cell death protein 4,nucleus|nucleoplasm|cytoplasm|cytosol|,"apoptotic process|cell aging|positive regulation of smooth muscle cell apoptotic process|negative regulation of apoptotic process|negative regulation of JUN kinase activity|negative regulation of transcription, DNA-templated|",RNA binding|protein binding|,5,6,234000000,19.1%
Q3V4B5,0.746598526,0.026833333,3.871378687,-0.107,0.410073903,-0.879194154,0.019,0.31,-0.088,-0.003,0.009,-0.086,Q3V4B5,Commd6,Q3V4B5_Commd6,Q3V4B5,Commd6,1,7,5,5,Q3V4B5|B7ZNP3,MOUSE,9852.1,68.9,1785,1785.1,60,60,,87,COMM domain-containing protein 6,nucleus|cytoplasm|,"transcription, DNA-templated|negative regulation of NF-kappaB transcription factor activity|",NF-kappaB binding|,5,7,523000000,68.9%
B2RXQ2,0.911411213,0.003,1.426430403,-0.032666667,0.720040558,-0.373890726,-0.031,0.081,0.008,0.07,-0.08,-0.03,B2RXQ2,Ppfia1,B2RXQ2_Ppfia1,B2RXQ2,Ppfia1,1,8,6,4,B2RXQ2|B2RXW8|B8QI34|F7CYX4|Q8BSS9|B8QI36|A0A087WPM2,MOUSE,143244.4,5.6,1786,1786.1,59.99,40.71,,1266,Ppfia1 protein,cytoplasm|focal adhesion|,negative regulation of stress fiber assembly|negative regulation of establishment of protein localization to plasma membrane|,protein binding|,6,8,617000000,5.6%
P60469,0.719125821,-0.1825,4.23401638,0.379,0.377223171,0.946350615,-0.006,0.259,-1.369,0.066,-0.069,0.024,P60469,Ppfia3,P60469_Ppfia3,P60469,Ppfia3,1,5,5,3,P60469|P60469-2,MOUSE,133994.5,6.1,1786,1786.2,36.47,17.19,,1194,Liprin-alpha-3,cytoplasm|cell surface|presynaptic active zone|,neurotransmitter secretion|regulation of short-term neuronal synaptic plasticity|,,3,5,389000000,4.6%
Q9CPU0,0.029353731,-0.032166667,26.41672739,0.436333333,0.002282061,4.776121956,-0.188,-0.19,-0.373,0.144,0.201,0.213,Q9CPU0,Glo1,Q9CPU0_Glo1,Q9CPU0,Glo1,1,8,5,5,Q9CPU0,MOUSE,20980.4,33.1,1787,1787.1,59.89,59.89,,184,Lactoylglutathione lyase,extracellular exosome|,carbohydrate metabolic process|regulation of transcription from RNA polymerase II promoter|glutathione metabolic process|methylglyoxal metabolic process|osteoclast differentiation|negative regulation of apoptotic process|,lactoylglutathione lyase activity|zinc ion binding|,5,8,915000000,33.1%
Q8CFQ3,0.2052132,0.008,15.72891559,-0.407333333,0.026736739,-2.83572416,0.052,0.086,0.497,-0.254,-0.267,-0.066,Q8CFQ3,Aqr,Q8CFQ3_Aqr,Q8CFQ3,Aqr,1,6,5,5,Q8CFQ3|A2AQA7,MOUSE,171546,4.3,1788,1788.1,59.85,59.85,,1481,Intron-binding protein aquarius,nucleus|nucleoplasm|membrane|catalytic step 2 spliceosome|,"mRNA splicing, via spliceosome|",poly(A) RNA binding|,5,6,246000000,4.3%
P62880,0.911833436,-0.014833333,1.411894309,-0.084333333,0.722454614,-0.370676023,-0.373,0.048,0.407,-0.243,-0.188,0.26,P62880,Gnb2,P62880_Gnb2,P62880,Gnb2,1,10,5,5,P62880|E9QKR0|D3YZX3|E9PWM7|P29387|V9GWY1|A0A0A6YVN9,MOUSE,38072.1,17.3,1789,1789.1,59.68,59.68,,340,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2,extracellular space|lysosomal membrane|heterotrimeric G-protein complex|focal adhesion|membrane|vesicle|myelin sheath|cell body|perinuclear region of cytoplasm|extracellular exosome|,G-protein coupled receptor signaling pathway|,GTPase activity|signal transducer activity|calcium channel regulator activity|protein binding|protein complex binding|GTPase binding|,5,10,4800000000,17.3%
Q3TB82,0.846769943,0.019833333,2.401586517,-0.046333333,0.575229762,-0.588922874,0.07,0.063,-0.004,0.008,-0.016,-0.002,Q3TB82,Plekhf1,Q3TB82_Plekhf1,Q3TB82,Plekhf1,1,8,4,4,Q3TB82|Q91WB4,MOUSE,31841.6,19.3,1790,1790.1,59.66,59.66,,279,Pleckstrin homology domain-containing family F member 1,mitochondrion|lysosome|perinuclear region of cytoplasm|endosome|,apoptotic process|endosome organization|positive regulation of autophagy|vesicle organization|regulation of mitochondrial membrane permeability|protein localization to plasma membrane|positive regulation of intrinsic apoptotic signaling pathway|,phosphatidylinositol-5-phosphate binding|phosphatidylinositol-3-phosphate binding|metal ion binding|phosphatidylinositol-4-phosphate binding|,4,8,544000000,19.3%
Q9ER73,0.227563079,0.006333333,14.88850308,0.299333333,0.032445143,2.692588973,-0.132,-0.091,-0.207,0.283,-0.039,0.224,Q9ER73,Elp4,Q9ER73_Elp4,Q9ER73,Elp4,1,9,4,4,Q9ER73,MOUSE,46837.8,13.5,1791,1791.1,59.64,59.64,,422,Elongator complex protein 4,histone acetyltransferase complex|nucleoplasm|cytoplasm|transcription elongation factor complex|Elongator holoenzyme complex|,"transcription, DNA-templated|regulation of transcription from RNA polymerase II promoter|histone H3 acetylation|histone H4 acetylation|regulation of protein kinase activity|",phosphorylase kinase regulator activity|RNA polymerase II core binding|histone acetyltransferase activity|,4,9,175000000,13.5%
Q9WTU6,0.635527525,0.019333333,5.665522435,-0.112666667,0.271298727,-1.198802542,0.014,0.191,0.022,0.04,-0.05,-0.101,Q9WTU6,Mapk9,Q9WTU6_Mapk9,Q9WTU6,Mapk9,1,12,6,4,Q9WTU6|Q9WTU6-4|Q9WTU6-2|Q9WTU6-3|E9QN59|Q61831|Q8C9D4|Q80W80|Q61831-2|Q80W82|Q3TQZ7|A0A0G2JGL2|A0A0G2JG69,MOUSE,48644.8,16.5,1792,1792.1,59.6,38.72,,423,Mitogen-activated protein kinase 9,nucleus|mitochondrion|cytosol|,"release of cytochrome c from mitochondria|positive regulation of protein phosphorylation|protein phosphorylation|protein targeting to mitochondrion|activation of cysteine-type endopeptidase activity involved in apoptotic process|JNK cascade|JUN phosphorylation|central nervous system development|response to mechanical stimulus|response to toxic substance|positive regulation of gene expression|positive regulation of macrophage derived foam cell differentiation|positive regulation of cell morphogenesis involved in differentiation|response to amine|neuron projection development|positive regulation of prostaglandin biosynthetic process|regulation of protein ubiquitination|positive regulation of prostaglandin secretion|positive regulation of chemokine production|cellular response to UV|response to drug|regulation of circadian rhythm|positive regulation of nitric oxide biosynthetic process|positive regulation of transcription, DNA-templated|regulation of JNK cascade|response to cadmium ion|rhythmic process|positive regulation of nitric-oxide synthase biosynthetic process|cellular response to lipopolysaccharide|cellular response to interleukin-1|cellular response to tumor necrosis factor|cellular response to growth factor stimulus|positive regulation of apoptotic signaling pathway|",JUN kinase activity|protein binding|ATP binding|transcription factor binding|cysteine-type endopeptidase activator activity involved in apoptotic process|mitogen-activated protein kinase kinase kinase binding|,6,12,1440000000,16.5%
G3X8U9,0.933153013,0.015666667,0.972509779,0.032,0.799372166,0.264591543,-0.049,0.217,-0.169,0.107,0.024,-0.036,G3X8U9,Mapk8,G3X8U9_Mapk8,G3X8U9,Mapk8,1,2,4,2,G3X8U9|A6P3E4|Q7TSJ7|Q91Y86|D3Z1Z4,MOUSE,48691.1,13.8,1792,1792.2,32.34,11.46,,427,Mitogen-activated protein kinase,nucleus|cytoplasm|mitochondrion|cytosol|,ossification|protein phosphorylation|JNK cascade|JUN phosphorylation|response to UV|regulation of gene expression|positive regulation of gene expression|peptidyl-serine phosphorylation|peptidyl-threonine phosphorylation|regulation of histone deacetylation|positive regulation of cyclase activity|negative regulation of protein binding|regulation of protein localization|negative regulation of apoptotic process|response to cadmium ion|determination of dorsal identity|positive regulation of protein metabolic process|cellular response to hydrogen peroxide|cellular response to lipopolysaccharide|cellular response to nitric oxide|positive regulation of deacetylase activity|neuronal stem cell maintenance|programmed necrotic cell death|positive regulation of determination of dorsal identity|positive regulation of apoptotic signaling pathway|,protein serine/threonine kinase activity|JUN kinase activity|protein binding|ATP binding|kinase activity|enzyme binding|histone deacetylase regulator activity|histone deacetylase binding|,2,2,61600000,9.6%
P28740-2,0.884484678,-0.024,1.886267499,-0.053333333,0.647699035,-0.478354049,0.025,0.124,-0.141,0.085,-0.08,-0.157,P28740,Kif2a,P28740-2_Kif2a,P28740-2,Kif2a,1,7,5,5,P28740-2|E0CZ72|P28740-1|P28740,MOUSE,75528.1,11.3,1793,1793.1,59.43,59.43,,705,Isoform 2 of Kinesin-like protein KIF2A,lysosome|centrosome|kinesin complex|membrane|sperm principal piece|spindle pole|spindle microtubule|,microtubule-based movement|microtubule depolymerization|mitotic spindle organization|nervous system development|metabolic process|cell differentiation|cell division|mitotic spindle assembly|,microtubule motor activity|ATP binding|microtubule binding|ATPase activity|,5,7,202000000,11.3%
Q6KAR6,0.98696829,0.015333333,0.222185028,-0.006666667,0.950126644,-0.064929745,0.01,-0.076,0.122,0.111,-0.118,0.043,Q6KAR6,Exoc3,Q6KAR6_Exoc3,Q6KAR6,Exoc3,1,7,5,5,Q6KAR6,MOUSE,87137.8,7.2,1794,1794.1,59.42,59.42,,755,Exocyst complex component 3,exocyst|secretory granule membrane|,exocytosis|protein transport|exocyst localization|,SNARE binding|,5,7,170000000,7.2%
Q9Z160,0.654663152,-0.018333333,5.260149101,0.114,0.297841417,1.128676819,-0.007,0.008,-0.227,0.007,0.117,-0.008,Q9Z160,Cog1,Q9Z160_Cog1,Q9Z160,Cog1,1,7,5,5,Q9Z160|Q810S7,MOUSE,110360.4,5.5,1795,1795.1,59.38,59.38,,980,Conserved oligomeric Golgi complex subunit 1,Golgi membrane|Golgi apparatus|Golgi transport complex|,protein transport|,,5,7,274000000,5.5%
Q9CQF3,0.615860336,-0.0305,6.028904913,0.146333333,0.249522383,1.26186262,-0.073,0.044,-0.282,-0.078,0.114,0.092,Q9CQF3,Nudt21,Q9CQF3_Nudt21,Q9CQF3,Nudt21,1,7,6,6,Q9CQF3|A0A1D5RM23,MOUSE,26296.8,34.8,1796,1796.1,59.3,59.3,,227,Cleavage and polyadenylation specificity factor subunit 5,nucleus|centrosome|mRNA cleavage factor complex|paraspeckles|,mRNA polyadenylation|mRNA cleavage|mRNA processing|protein tetramerization|,mRNA binding|hydrolase activity|AU-rich element binding|protein homodimerization activity|histone deacetylase binding|poly(A) RNA binding|RNA binding|,6,7,270000000,34.8%
Q9DBM0,0.841746758,-0.034333333,2.49822813,0.082666667,0.562570801,0.609416983,-0.002,0.129,-0.354,0.032,-0.013,0.002,Q9DBM0,Abcg8,Q9DBM0_Abcg8,Q9DBM0,Abcg8,1,9,5,5,Q9DBM0|Q9DBM0-2|Q7TSR6|E9Q0P2,MOUSE,76736.2,9.6,1797,1797.1,59.27,59.27,,673,ATP-binding cassette sub-family G member 8,apical plasma membrane|ATP-binding cassette (ABC) transporter complex|receptor complex|,response to nutrient|excretion|metabolic process|negative regulation of intestinal phytosterol absorption|phospholipid transport|sterol transport|intestinal cholesterol absorption|cholesterol efflux|response to drug|cholesterol homeostasis|negative regulation of intestinal cholesterol absorption|sterol homeostasis|,protein heterodimerization activity|ATP binding|ATPase activity|cholesterol transporter activity|,5,9,340000000,9.6%
Q4PJ,0.946922071,0.000833333,0.79125529,-0.031,0.833440251,-0.218743306,-0.241,0.067,0.223,-0.124,-0.041,0.121,Q4PJ,NotFound,Q4PJ_NotFound,Q4PJ,Odr4,1,9,5,5,Q4PJ|A0A0A0MQB0|Q4PJ-3|Q4PJ-2,MOUSE,50567.4,15.6,1798,1798.1,59.26,59.26,,447,Protein odr-4 homolog,integral component of membrane|,oxidation-reduction process|,zinc ion binding|oxidoreductase activity|,5,9,10800000000,15.6%
Q60855,0.861056825,-0.001666667,2.212828847,-0.046,0.600782281,-0.549059686,0.04,0.084,-0.06,-0.022,-0.049,-0.003,Q60855,Ripk1,Q60855_Ripk1,Q60855,Ripk1,1,9,6,6,Q60855,MOUSE,75480.7,12.5,1799,1799.1,59.26,59.26,,656,Receptor-interacting serine/threonine-protein kinase 1,cytoplasm|mitochondrion|death-inducing signaling complex|receptor complex|membrane raft|ripoptosome|,positive regulation of protein phosphorylation|apoptotic process|viral process|positive regulation of interleukin-8 production|positive regulation of tumor necrosis factor production|response to tumor necrosis factor|peptidyl-serine autophosphorylation|positive regulation of phosphorylation|positive regulation of apoptotic process|positive regulation of programmed cell death|positive regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of MAPK cascade|cellular protein catabolic process|positive regulation of macrophage differentiation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of JNK cascade|protein autophosphorylation|positive regulation of NF-kappaB transcription factor activity|protein homooligomerization|protein heterooligomerization|positive regulation of necroptotic process|T cell apoptotic process|necroptotic process|regulation of ATP:ADP antiporter activity|cellular response to tumor necrosis factor|cellular response to growth factor stimulus|extrinsic apoptotic signaling pathway|ripoptosome assembly|necroptotic signaling pathway|ripoptosome assembly involved in necroptotic process|amyloid fibril formation|regulation of reactive oxygen species metabolic process|negative regulation of extrinsic apoptotic signaling pathway|positive regulation of extrinsic apoptotic signaling pathway|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand|,protein kinase activity|protein serine/threonine kinase activity|death receptor binding|protein binding|ATP binding|ubiquitin protein ligase binding|protein complex binding|identical protein binding|death domain binding|,6,9,605000000,12.5%
Q9ES28,0.615860336,-0.010833333,6.040786564,0.111,0.248840659,1.262830496,-0.032,-0.139,-0.028,0.065,-0.038,0.107,Q9ES28,Arhgef7,Q9ES28_Arhgef7,Q9ES28,Arhgef7,1,9,5,5,Q9ES28|Q9ES28-7|Q9ES28-2|Q9ES28-3|Q9ES28-4|Q9ES28-8|A0A0R4J0X8|Q9ES28-5|Q9ES28-6|F6WMJ3|Q8K4I3|A2AFJ8,MOUSE,97795.8,6.7,1800,1800.1,59.26,59.26,,862,Rho guanine nucleotide exchange factor 7,storage vacuole|ruffle|cytosol|plasma membrane|focal adhesion|cell cortex|lamellipodium|growth cone|neuron projection|neuronal cell body|protein complex|,hematopoietic progenitor cell differentiation|small GTPase mediated signal transduction|positive regulation of fibroblast migration|lamellipodium assembly|positive regulation of protein binding|regulation of Rho protein signal transduction|positive regulation of apoptotic process|positive regulation of GTPase activity|astrocyte cell migration|focal adhesion assembly|positive regulation of growth hormone secretion|positive regulation of substrate adhesion-dependent cell spreading|positive regulation of lamellipodium morphogenesis|,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|protein binding|protein kinase binding|,5,9,136000000,6.7%
P52760,0.514798568,0.0305,7.894121807,0.312333333,0.162400671,1.571961799,-0.104,0.084,-0.357,0.062,0.576,-0.078,P52760,Rida,P52760_Rida,P52760,Rida,1,9,4,4,P52760,MOUSE,14312.2,34,1801,1801.1,59.18,59.18,,135,2-iminobutanoate/2-iminopropanoate deaminase,nucleus|mitochondrion|peroxisome|cytosol|extracellular exosome|,"kidney development|brain development|negative regulation of translation|lung development|response to lipid|negative regulation of epithelial cell proliferation|G1 to G0 transition|RNA phosphodiester bond hydrolysis, endonucleolytic|response to salt|","endoribonuclease activity, producing 3'-phosphomonoesters|deaminase activity|long-chain fatty acid binding|protein homodimerization activity|poly(A) RNA binding|transition metal ion binding|platinum binding|xenon atom binding|",4,9,8240000000,34.0%
Q9CY50,0.891701906,0.017166667,1.732796285,-0.069,0.67099668,-0.44428449,0.062,0.316,-0.223,0.14,-0.09,-0.102,Q9CY50,Ssr1,Q9CY50_Ssr1,Q9CY50,Ssr1,1,10,4,4,Q9CY50|A0A286YCG8|A0A286YCT4,MOUSE,32064.4,20.9,1802,1802.1,59.18,59.18,,286,Translocon-associated protein subunit alpha,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,,,4,10,4570000000,20.9%
Q8BP48,0.934957223,0.012833333,0.934035417,-0.021666667,0.806485305,-0.254852421,-0.044,0.092,0.023,-0.046,0.052,0,Q8BP48,Metap1,Q8BP48_Metap1,Q8BP48,Metap1,1,13,6,6,Q8BP48|A0A0G2JF71,MOUSE,44190.4,19.4,1803,1803.1,59.07,59.07,,386,Methionine aminopeptidase 1,nucleus|cytoplasm|cytosolic ribosome|,proteolysis|protein initiator methionine removal|platelet aggregation|,metal ion binding|metalloaminopeptidase activity|,6,13,371000000,19.4%
Q9Z2U0,0.461793226,-0.009833333,9.128565718,0.177666667,0.122220323,1.768578556,0.042,-0.17,-0.168,0.158,0.083,-0.004,Q9Z2U0,Psma7,Q9Z2U0_Psma7,Q9Z2U0,Psma7,1,8,4,4,Q9Z2U0|Q9CWH6,MOUSE,28025.5,20.9,1804,1804.1,58.97,58.97,,248,Proteasome subunit alpha type-7,"proteasome complex|nucleus|cytoplasm|cytosol|proteasome core complex|proteasome core complex, alpha-subunit complex|extracellular exosome|",proteasomal ubiquitin-independent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|,endopeptidase activity|threonine-type endopeptidase activity|identical protein binding|,4,8,849000000,20.9%
Q91XH5,0.951421295,0.036333333,0.73100149,-0.02,0.845083945,-0.203107653,-0.058,0.026,0.171,-0.052,0.028,0.103,Q91XH5,Spr,Q91XH5_Spr,Q91XH5,Spr,1,6,5,5,Q91XH5|G3UXX3|Q64105|G3UZ79,MOUSE,28327,25.9,1805,1805.1,58.95,58.95,,262,Sepiapterin reductase,nucleoplasm|cytoplasm|mitochondrion|extracellular exosome|,L-phenylalanine metabolic process|tetrahydrobiopterin biosynthetic process|nitric oxide biosynthetic process|pteridine metabolic process|regulation of multicellular organism growth|norepinephrine metabolic process|dopamine metabolic process|serotonin metabolic process|tetrahydrobiopterin metabolic process|cell morphogenesis involved in neuron differentiation|voluntary musculoskeletal movement|oxidation-reduction process|,sepiapterin reductase activity|,5,6,257000000,25.9%
Q8R1F1,0.686679975,0.044833333,4.75511719,-0.092333333,0.33457099,-1.039659093,0.062,0.007,0.204,-0.003,0.002,-0.003,Q8R1F1,Fam129b,Q8R1F1_Fam129b,Q8R1F1,Fam129b,1,7,7,7,Q8R1F1,MOUSE,85444.6,13,1806,1806.1,58.9,58.9,,749,Niban-like protein 1,nucleoplasm|nucleolus|cytoplasm|cytosol|plasma membrane|adherens junction|actin cytoskeleton|extracellular exosome|nucleus|,negative regulation of apoptotic process|,,7,7,347000000,13.0%
P62855,0.773512169,-0.011,3.503088327,-0.103333333,0.446366062,-0.80945929,0.061,0.228,-0.167,-0.001,0.008,-0.195,P62855,Rps26,P62855_Rps26,P62855,Rps26,1,22,4,4,P62855,MOUSE,13300.5,44.3,1807,1807.1,58.82,58.82,,115,40S ribosomal protein S26,nucleolus|membrane|cytosolic small ribosomal subunit|extracellular exosome|,translation|negative regulation of RNA splicing|,mRNA binding|structural constituent of ribosome|,4,22,62800000000,44.3%
P54751,0.701372679,-0.012,4.54153929,0.106666667,0.351435857,1.001558123,-0.202,-0.077,0.083,0.045,-0.046,0.125,P54751,St3gal1,P54751_St3gal1,P54751,St3gal1,1,5,4,4,P54751,MOUSE,39414.5,19.5,1808,1808.1,58.71,58.71,,337,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",membrane|integral component of Golgi membrane|Golgi cisterna membrane|extracellular exosome|,N-acetylneuraminate metabolic process|protein phosphorylation|protein glycosylation|protein N-linked glycosylation|sialylation|,"beta-galactoside (CMP) alpha-2,3-sialyltransferase activity|",4,5,763000000,19.5%
Q9WTX8,0.585038867,-0.016333333,6.620875786,-0.150666667,0.217727067,-1.360828797,0.039,0.05,0.088,0.102,-0.248,-0.129,Q9WTX8,Mad1l1,Q9WTX8_Mad1l1,Q9WTX8,Mad1l1,1,9,6,6,Q9WTX8|Q9WTX8-2,MOUSE,83939.4,9,1809,1809.1,58.6,58.6,,717,Mitotic spindle assembly checkpoint protein MAD1,kinetochore|condensed chromosome kinetochore|spindle pole|nucleus|cytoplasm|microtubule organizing center|actin cytoskeleton|mitotic spindle|kinetochore|nuclear pore|,mitotic nuclear division|mitotic spindle assembly checkpoint|negative regulation of T cell proliferation|thymus development|cell division|regulation of metaphase plate congression|regulation of mitotic cell cycle phase transition|,,6,9,5990000000,9.0%
O35841,0.463265233,-0.030333333,9.028110419,0.208,0.125080313,1.755165155,-0.07,0.022,-0.355,0.09,0.115,0.016,O35841,Api5,O35841_Api5,O35841,Api5,1,10,5,5,O35841,MOUSE,57126.4,19.6,1810,1810.1,58.5,58.5,,504,Apoptosis inhibitor 5,nucleus|nucleoplasm|spliceosomal complex|cytoplasm|membrane|,apoptotic process|negative regulation of apoptotic process|negative regulation of fibroblast apoptotic process|,fibroblast growth factor binding|poly(A) RNA binding|,5,10,1200000000,19.6%
Q9CXT8,0.774891394,0.0245,3.462173384,-0.075,0.450591154,-0.801034466,-0.035,0.039,0.182,-0.06,-0.02,0.041,Q9CXT8,Pmpcb,Q9CXT8_Pmpcb,Q9CXT8,Pmpcb,1,8,6,6,Q9CXT8,MOUSE,55412.3,16.1,1811,1811.1,58.48,58.48,,489,Mitochondrial-processing peptidase subunit beta,mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex III|mitochondrial matrix|,"mitochondrial electron transport, ubiquinol to cytochrome c|aerobic respiration|protein processing|",metalloendopeptidase activity|zinc ion binding|,6,8,452000000,16.1%
Q8K3J1,0.692811304,-0.046666667,4.679147113,0.178,0.340475047,1.027005835,-0.194,0.232,-0.445,0.053,0.096,-0.022,Q8K3J1,Ndufs8,Q8K3J1_Ndufs8,Q8K3J1,Ndufs8,1,8,5,5,Q8K3J1,MOUSE,24494.3,26.8,1812,1812.1,58.43,58.43,,212,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial",mitochondrion|mitochondrial respiratory chain complex I|,response to oxidative stress|mitochondrial respiratory chain complex I assembly|oxidation-reduction process|,"metal ion binding|4 iron, 4 sulfur cluster binding|NADH dehydrogenase activity|NADH dehydrogenase (ubiquinone) activity|",5,8,1210000000,26.8%
Q505D7,0.685942266,-0.031333333,4.769803706,-0.269333333,0.333441483,-1.043216456,0.414,0.333,-0.437,0.013,-0.015,-0.496,Q505D7,Opa3,Q505D7_Opa3,Q505D7,Opa3,1,6,4,4,Q505D7,MOUSE,20395.2,28.4,1813,1813.1,58.35,58.35,,179,Optic atrophy 3 protein homolog,mitochondrion|,visual perception|regulation of lipid metabolic process|growth|neuromuscular process|mitochondrion morphogenesis|,,4,6,1740000000,28.4%
Q61409,0.372565587,0.016666667,10.9810334,0.177333333,0.079780483,2.063453628,-0.113,-0.006,-0.097,0.173,0.104,0.039,Q61409,Pde3b,Q61409_Pde3b,Q61409,Pde3b,1,6,6,6,Q61409|E9QLQ3,MOUSE,123920.3,9,1814,1814.1,58.35,58.35,,1100,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",endoplasmic reticulum|Golgi apparatus|cytosol|membrane|integral component of membrane|guanyl-nucleotide exchange factor complex|,angiogenesis|negative regulation of cell adhesion|signal transduction|metabolic process|negative regulation of angiogenesis|endocrine pancreas development|cellular response to insulin stimulus|glucose homeostasis|regulation of insulin secretion|negative regulation of lipid catabolic process|,"3',5'-cyclic-nucleotide phosphodiesterase activity|protein kinase B binding|metal ion binding|",6,6,54800000,9.0%
Q9CXU4,0.5499389,0.022166667,7.301540736,-0.152333333,0.186142665,-1.473153658,0.177,0.168,-0.05,-0.032,0.022,-0.152,Q9CXU4,Timm23,Q9CXU4_Timm23,Q9CXU4,Gm10273,1,11,4,4,Q9CXU4|Q9WTQ8,MOUSE,22079.9,27.2,1815,1815.1,58.27,58.27,,209,Mitochondrial import inner membrane translocase subunit TIM23,mitochondrial inner membrane presequence translocase complex|integral component of membrane|,intracellular protein transport|protein transmembrane transport|,P-P-bond-hydrolysis-driven protein transmembrane transporter activity|,4,11,3840000000,27.2%
E9QMB7,0.581377911,-0.002333333,6.698509399,0.167333333,0.213869601,1.374970308,-0.06,-0.023,-0.175,0.286,-0.107,0.065,E9QMB7,NotFound,E9QMB7_NotFound,E9QMB7,Naa30,1,10,5,5,E9QMB7|Q8CES0|Q8CES0-2,MOUSE,40385.9,19.3,1816,1816.1,57.84,57.84,,366,N-alpha-acetyltransferase 30,cytoplasm|NatC complex|polysome|,N-terminal protein amino acid acetylation|N-terminal peptidyl-methionine acetylation|,peptide alpha-N-acetyltransferase activity|,5,10,313000000,19.3%
P97290,0.436783765,-0.050333333,9.631845539,0.322,0.108846745,1.852212042,-0.369,-0.422,0.157,0.073,-0.005,0.264,P97290,Serping1,P97290_Serping1,P97290,Serping1,1,9,4,4,P97290|A2ATR8,MOUSE,55868.8,8.9,1817,1817.1,57.72,57.72,,504,Plasma protease C1 inhibitor,extracellular space|extracellular exosome|blood microparticle|,"negative regulation of complement activation, lectin pathway|complement activation, classical pathway|aging|blood coagulation|negative regulation of endopeptidase activity|fibrinolysis|innate immune response|",serine-type endopeptidase inhibitor activity|,4,9,741000000,8.9%
Q922B9,0.289482016,-0.020333333,13.12767412,0.280666667,0.048666777,2.410174705,0.014,-0.237,-0.259,0.252,0.107,0.001,Q922B9,Itprid2,Q922B9_Itprid2,Q922B9,Ssfa2,1,7,5,5,Q922B9|A2AQD5|Q922B9-3|A2AQD6|Q922B9-2,MOUSE,138314,4.7,1818,1818.1,57.72,57.72,,1252,Sperm-specific antigen 2 homolog,nucleus|nucleoplasm|cytoplasm|plasma membrane|,,receptor binding|actin filament binding|,5,7,291000000,4.7%
Q9DCV4,0.88044681,0.045833333,1.941802364,-0.156333333,0.639469394,-0.490721537,-0.002,0.84,-0.466,-0.081,0.18,-0.196,Q9DCV4,Rmdn1,Q9DCV4_Rmdn1,Q9DCV4,Rmdn1,1,9,5,5,Q9DCV4|A2AGJ2,MOUSE,35284.8,14.7,1819,1819.1,57.6,57.6,,305,Regulator of microtubule dynamics protein 1,spindle pole|mitochondrion|centrosome|microtubule|,,,5,9,529000000,14.7%
A2A4P4,0.440784361,-0.023666667,9.567381865,0.18,0.110474441,1.838649387,-0.198,0.042,-0.185,0.044,0.061,0.094,A2A4P4,NotFound,A2A4P4_NotFound,A2A4P4,Gm27029,1,8,5,5,A2A4P4|A2A4P3|Q3THG9,MOUSE,60904.6,12.1,1820,1820.1,57.5,57.5,,543,"Predicted gene, 27029",nucleus|,alanyl-tRNA aminoacylation|,nucleic acid binding|alanine-tRNA ligase activity|ATP binding|,5,8,515000000,12.1%
Q8BU31,0.785249508,-0.016166667,3.340251073,-0.065,0.463420128,-0.777534267,-0.008,0.046,0.011,0.032,-0.075,-0.103,Q8BU31,Rap2c,Q8BU31_Rap2c,Q8BU31,Rap2c,1,10,4,3,Q8BU31|P61226|Q80ZJ1-2,MOUSE,20972.6,27.8,1821,1821.1,57.41,41.6,,183,Ras-related protein Rap-2c,cytoplasm|cytosol|plasma membrane|bicellular tight junction|membrane|cell-cell contact zone|recycling endosome|recycling endosome membrane|extracellular exosome|,negative regulation of cell migration|positive regulation of protein autophosphorylation|Rap protein signal transduction|regulation of protein tyrosine kinase activity|establishment of endothelial intestinal barrier|regulation of nucleic acid-templated transcription|,transcription coactivator activity|GTP binding|GDP binding|,4,10,233000000,27.8%
Q6P1Y9,0.506155299,-0.008333333,8.097072839,0.176,0.154986088,1.603169319,-0.002,-0.107,-0.18,0.229,0.086,-0.076,Q6P1Y9,Exoc1,Q6P1Y9_Exoc1,Q6P1Y9,Exoc1,1,4,4,4,Q6P1Y9|Q8R3S6|Q5PPR2,MOUSE,103540.2,6.4,1822,1822.1,57.28,57.28,,901,Exocyst complex component 1,exocyst|cytoplasm|plasma membrane|membrane|cytoplasmic side of apical plasma membrane|,exocytosis|Golgi to plasma membrane transport|phosphatidylinositol-mediated signaling|positive regulation of protein secretion|exocyst localization|,"phosphatidylinositol-4,5-bisphosphate binding|GTP-Rho binding|",4,4,380000000,6.4%
Q04750,0.915900752,-0.0385,1.293702178,-0.055,0.742386015,-0.3427854,-0.011,0.007,-0.029,-0.398,0.228,-0.028,Q04750,Top1,Q04750_Top1,Q04750,Top1,1,8,6,6,Q04750|Q8R4U6,MOUSE,91330.5,7.5,1823,1823.1,57.19,57.19,,767,DNA topoisomerase 1,cytoplasmic mRNA processing body|nucleus|nucleoplasm|nucleolus|cytoplasm|replication fork protection complex|perikaryon|nuclear chromosome|,DNA replication|DNA topological change|chromatin remodeling|chromosome segregation|circadian regulation of gene expression|embryonic cleavage|response to drug|,core promoter sequence-specific DNA binding|DNA binding|chromatin binding|DNA topoisomerase type I activity|DNA topoisomerase type II (ATP-hydrolyzing) activity|poly(A) RNA binding|,6,8,1260000000,7.5%
Q6P5D8,0.663598461,-0.035333333,5.098023642,-0.124666667,0.309170206,-1.100836927,0.011,-0.011,0.081,-0.085,-0.285,0.077,Q6P5D8,Smchd1,Q6P5D8_Smchd1,Q6P5D8,Smchd1,1,6,6,6,Q6P5D8,MOUSE,227640.9,4.2,1824,1824.1,57.15,57.15,,2007,Structural maintenance of chromosomes flexible hinge domain-containing protein 1,Barr body|,dosage compensation by inactivation of X chromosome|chromosome organization|inactivation of X chromosome by DNA methylation|,ATP binding|,6,6,182000000,4.2%
Q9CQ48,0.773512169,0.01,3.513281401,-0.072666667,0.445319651,-0.810826315,0.018,0.001,0.12,-0.119,-0.002,0.042,Q9CQ48,Nudcd2,Q9CQ48_Nudcd2,Q9CQ48,Nudcd2,1,14,4,4,Q9CQ48|E0CYQ2,MOUSE,17830.7,32.4,1825,1825.1,57.13,57.13,,157,NudC domain-containing protein 2,condensed chromosome kinetochore|spindle pole|intracellular|cytoplasm|microtubule organizing center|microtubule cytoskeleton|extracellular exosome|,,,4,14,1670000000,32.4%
C0HKG5,0.001966637,-0.080666667,40.76248099,0.749333333,8.38981E-05,8.42473388,-0.345,-0.492,-0.529,0.3,0.26,0.322,C0HKG5,Rnaset2b,C0HKG5_Rnaset2b,C0HKG5,Rnaset2a,1,12,5,5,C0HKG5,MOUSE,30178.8,18.1,1826,1826.1,57.11,57.11,,259,Ribonuclease T2-A,,,,5,12,1850000000,18.1%
P02802,0.279272295,0.2005,13.39517996,-2.006333333,0.045759577,-2.454475829,0.075,0.533,3.003,-0.52,-1.809,-0.079,P02802,Mt1,P02802_Mt1,P02802,Mt1,1,23,4,2,P02802,MOUSE,7159.1,68.8,1827,1827.1,56.87,23.01,,61,Metallothionein-1,nucleus|cytoplasm|lysosome|cytosol|perinuclear region of cytoplasm|,cellular metal ion homeostasis|cellular zinc ion homeostasis|nitric oxide mediated signal transduction|detoxification of copper ion|negative regulation of neuron apoptotic process|negative regulation of growth|cellular response to chromate|cellular response to zinc ion|,copper ion binding|zinc ion binding|metal ion binding|,4,23,1420000000,68.8%
A0A1D5RLN7,0.109314512,0.107666667,19.52036619,-2.398,0.011167691,-3.483805939,0.744,0.385,2.791,-0.526,-2.006,-0.742,A0A1D5RLN7,Mt1,A0A1D5RLN7_Mt1,A0A1D5RLN7,Mt1,1,5,3,2,A0A1D5RLN7,MOUSE,15012.9,31.8,1827,1827.2,38.1,17.61,,132,Metallothionein-1,,,,2,5,309000000,15.9%
Q8K1R7,0.647450828,-0.0155,5.403945896,0.111666667,0.288141233,1.153670998,-0.12,0.062,-0.156,-0.012,0.021,0.112,Q8K1R7,Nek9,Q8K1R7_Nek9,Q8K1R7,Nek9,1,6,5,5,Q8K1R7,MOUSE,108910.3,6.1,1828,1828.1,56.85,56.85,,984,Serine/threonine-protein kinase Nek9,nucleus|cytoplasm|,protein phosphorylation|mitotic nuclear division|cell division|,protein serine/threonine kinase activity|ATP binding|protein kinase binding|metal ion binding|,5,6,433000000,6.1%
O08600,0.985199576,-0.000666667,0.235042473,-0.01,0.94731792,-0.068620876,0.017,0.273,-0.277,-0.034,-0.017,0.034,O08600,Endog,O08600_Endog,O08600,Endog,1,9,6,6,O08600,MOUSE,32304.2,26.1,1829,1829.1,56.76,56.76,,294,"Endonuclease G, mitochondrial",nucleus|mitochondrion|cytosol|perikaryon|,in utero embryonic development|DNA catabolic process|apoptotic DNA fragmentation|aging|response to mechanical stimulus|response to estradiol|response to tumor necrosis factor|neuron death in response to oxidative stress|positive regulation of apoptotic process|response to antibiotic|cellular response to calcium ion|cellular response to glucose stimulus|cellular response to hypoxia|positive regulation of hydrogen peroxide-mediated programmed cell death|positive regulation of apoptotic DNA fragmentation|,nucleic acid binding|nuclease activity|endonuclease activity|deoxyribonuclease activity|metal ion binding|,6,9,1320000000,26.1%
Q9D7H3,0.254777572,-0.014166667,14.02929497,-0.205666667,0.039543081,-2.550140628,0.133,0.11,0.023,-0.121,-0.111,-0.119,Q9D7H3,Rtca,Q9D7H3_Rtca,Q9D7H3,RtcA,1,5,5,5,Q9D7H3|D6RD00|D6REI7,MOUSE,39710.2,21,1830,1830.1,56.75,56.75,,366,RNA 3'-terminal phosphate cyclase,nucleus|nucleoplasm|,RNA processing|,RNA binding|RNA-3'-phosphate cyclase activity|ATP binding|poly(A) RNA binding|,5,5,267000000,21.0%
P62743,0.64206681,-0.052166667,5.495672243,-0.232333333,0.282119286,-1.170736402,-0.251,0.284,0.159,-0.497,-0.092,0.084,P62743,Ap2s1,P62743_Ap2s1,P62743,Ap2s1,1,13,6,6,P62743|A0A0U1RQ06|A0A0U1RPS0,MOUSE,17188.5,34.5,1831,1831.1,56.67,56.67,,142,AP-2 complex subunit sigma,AP-2 adaptor complex|,intracellular protein transport|endocytosis|,protein transporter activity|,6,13,2170000000,34.5%
Q9CVB6,0.997585215,-0.001333333,0.022706108,-0.001333333,0.994785369,-0.006786231,-0.306,0.012,0.292,-0.301,0.066,0.229,Q9CVB6,Arpc2,Q9CVB6_Arpc2,Q9CVB6,Arpc2,1,8,5,5,Q9CVB6|D3YXG6,MOUSE,34470.6,18.3,1832,1832.1,56.64,56.64,,300,Actin-related protein 2/3 complex subunit 2,cytoplasm|endosome|Golgi apparatus|Arp2/3 protein complex|plasma membrane|focal adhesion|cell leading edge|neuron projection|synapse|extracellular exosome|,positive regulation of lamellipodium assembly|positive regulation of actin filament polymerization|Arp2/3 complex-mediated actin nucleation|positive regulation of substrate adhesion-dependent cell spreading|,structural constituent of cytoskeleton|protein binding|kinesin binding|AP-1 adaptor complex binding|Arp2/3 complex binding|actin filament binding|,5,8,1700000000,18.3%
Q8VHQ9,0.929192436,-0.036666667,1.006937363,0.05,0.793060398,0.273152557,0.14,0.118,-0.443,0.158,-0.012,-0.181,Q8VHQ9,Acot11,Q8VHQ9_Acot11,Q8VHQ9,Acot11,1,9,6,6,A2AVR6|Q8VHQ9|E0CYS0,MOUSE,68209.2,10.2,1833,1833.1,56.6,56.6,,594,Acyl-coenzyme A thioesterase 11,cytoplasm|extracellular exosome|,fatty acid metabolic process|response to temperature stimulus|response to cold|intracellular signal transduction|,lipid binding|acyl-CoA hydrolase activity|carboxylic ester hydrolase activity|,6,9,525000000,10.2%
Q64446,0.63071819,0.023833333,5.796694973,0.193,0.263227042,1.222577596,0.166,-0.206,-0.178,0.383,-0.036,0.014,Q64446,Atp7b,Q64446_Atp7b,Q64446,Atp7b,1,6,5,5,Q64446|B1AQ57,MOUSE,158671.1,4.9,1834,1834.1,56.41,56.41,,1462,Copper-transporting ATPase 2,late endosome|trans-Golgi network|membrane|integral component of membrane|trans-Golgi network|cytoplasmic membrane-bounded vesicle|basolateral plasma membrane|perinuclear region of cytoplasm|,copper ion transport|cellular copper ion homeostasis|cellular zinc ion homeostasis|lactation|metabolic process|copper ion import|intracellular copper ion transport|copper ion transmembrane transport|response to copper ion|sequestering of calcium ion|copper ion export|,copper-exporting ATPase activity|copper ion binding|ATP binding|copper-transporting ATPase activity|,5,6,278000000,4.9%
Q99K30,0.873387671,0.023,2.045798203,-0.055333333,0.624338591,-0.513209424,0.045,0.179,-0.072,-0.136,0.04,0.082,Q99K30,Eps8l2,Q99K30_Eps8l2,Q99K30,Eps8l2,1,11,5,5,Q99K30|Q99K30-2,MOUSE,82741.4,12.8,1835,1835.1,56.4,56.4,,729,Epidermal growth factor receptor kinase substrate 8-like protein 2,ruffle|cytoplasm|plasma membrane|vesicle|ruffle membrane|protein complex|extracellular exosome|,Rho protein signal transduction|Rac protein signal transduction|regulation of Rho protein signal transduction|positive regulation of GTPase activity|positive regulation of ruffle assembly|,actin binding|actin filament binding|Rho guanyl-nucleotide exchange factor activity|Rac guanyl-nucleotide exchange factor activity|,5,11,532000000,12.8%
Q9DCJ9,0.508093395,0.035666667,8.055623713,-0.149333333,0.156472358,-1.595903378,0.006,0.083,0.242,-0.022,-0.049,-0.046,Q9DCJ9,Npl,Q9DCJ9_Npl,Q9DCJ9,Npl,1,5,5,5,Q9DCJ9,MOUSE,35186.9,24.3,1836,1836.1,56.36,56.36,,320,N-acetylneuraminate lyase,cytoplasm|,carbohydrate metabolic process|N-acetylneuraminate catabolic process|,N-acetylneuraminate lyase activity|,5,5,260000000,24.3%
Q9D0M3,0.919618833,0.0405,1.165414515,0.056333333,0.764642703,0.311992237,-0.139,0.334,-0.158,-0.164,0.308,0.062,Q9D0M3,Cyc1,Q9D0M3_Cyc1,Q9D0M3,Cyc1,1,10,4,4,Q9D0M3|Q9D0M3-2,MOUSE,35555.2,18.4,1837,1837.1,56.12,56.12,,325,"Cytochrome c1, heme protein, mitochondrial",nucleus|mitochondrion|mitochondrial inner membrane|membrane|integral component of membrane|respiratory chain|,response to glucagon|oxidation-reduction process|,protein binding|electron carrier activity|heme binding|metal ion binding|,4,10,1100000000,18.4%
Q8C142,0.662343866,-0.043,5.140387042,0.128666667,0.306169056,1.108534656,-0.029,0.037,-0.33,0.026,0.031,0.007,Q8C142,Ldlrap1,Q8C142_Ldlrap1,Q8C142,Ldlrap1,1,7,4,4,Q8C142,MOUSE,34203,12.6,1838,1838.1,56.11,56.11,,308,Low density lipoprotein receptor adapter protein 1,cytoplasm|early endosome|cytosol|neurofilament|cytoplasmic side of plasma membrane|basal plasma membrane|axon|recycling endosome|AP-1 adaptor complex|AP-2 adaptor complex|,receptor-mediated endocytosis|cholesterol metabolic process|positive regulation of signal transduction|receptor internalization|cholesterol homeostasis|amyloid precursor protein metabolic process|regulation of protein binding|positive regulation of receptor-mediated endocytosis|regulation of establishment of protein localization to plasma membrane|receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport|,"beta-amyloid binding|phosphotyrosine binding|receptor binding|protein binding|phosphatidylinositol-4,5-bisphosphate binding|receptor signaling complex scaffold activity|clathrin binding|signaling adaptor activity|AP-2 adaptor complex binding|clathrin adaptor activity|low-density lipoprotein particle receptor binding|",4,7,228000000,12.6%
Q8BWU5,0.340515286,0.071333333,11.6658968,-0.292,0.068141285,-2.177022889,-0.045,0.397,0.3,-0.169,-0.012,-0.043,Q8BWU5,Osgep,Q8BWU5_Osgep,Q8BWU5,Osgep,1,9,6,6,A0A0R4J1Y3|Q8BWU5|E0CYN9|E9QMF4|E0CXW7,MOUSE,36813.6,20.5,1839,1839.1,56,56,,335,Probable tRNA N6-adenosine threonylcarbamoyltransferase,EKC/KEOPS complex|nucleus|cytoplasm|,tRNA processing|,"transferase activity, transferring acyl groups|metal ion binding|",6,9,770000000,20.5%
Q9JM52-3,0.857449938,0.003666667,2.258959543,0.056,0.594434553,0.558873098,0.033,0.028,-0.134,0.148,-0.071,0.018,Q9JM52,Mink1,Q9JM52-3_Mink1,Q9JM52-3,Mink1,1,14,6,4,Q9JM52-3|G3X9G2|Q5SXG3|Q5SXG1|Q9JM52|Q9JM52-2|B2RQ80|B9EKN8|E9PUL9|P83510|E0CY98|E0CXD6|P83510-2|E0CZD7|E0CZF8,MOUSE,151992.1,4.7,1840,1840.1,56,33.71,,1308,Isoform 3 of Misshapen-like kinase 1,cytoplasm|Golgi apparatus|postsynaptic density|cell junction|axon|dendrite|postsynaptic membrane|extracellular exosome|,MAPK cascade|regulation of cell-matrix adhesion|protein phosphorylation|response to stress|synaptic transmission|multicellular organismal development|regulation of mitotic cell cycle|regulation of cell-cell adhesion|regulation of cell migration|stress-activated protein kinase signaling cascade|actin cytoskeleton reorganization|activation of protein kinase activity|intracellular signal transduction|regulation of apoptotic process|negative thymic T cell selection|positive regulation of JNK cascade|protein autophosphorylation|neuron projection morphogenesis|dendrite morphogenesis|regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity|,protein serine/threonine kinase activity|ATP binding|MAP kinase kinase kinase kinase activity|,6,14,10500000000,4.7%
E9PVG7,0.139554201,-0.062666667,18.03928536,0.434,0.015706212,3.225490123,-0.269,-0.059,-0.511,0.048,0.165,0.25,E9PVG7,NotFound,E9PVG7_NotFound,E9PVG7,Map4k4,1,2,4,2,E9PVG7|A0A0A6YW53|A0A0A6YWM8|F8VPL5|A0A0A6YWR8|P97820|B2RUE8|B7ZNR9,MOUSE,147456.6,2.5,1840,1840.2,43.29,21,,1288,Mitogen-activated protein kinase kinase kinase kinase 4,cytoplasm|,MAPK cascade|protein phosphorylation|regulation of mitotic cell cycle|stress-activated protein kinase signaling cascade|activation of protein kinase activity|intracellular signal transduction|regulation of apoptotic process|negative regulation of apoptotic process|regulation of JNK cascade|neuron projection morphogenesis|,creatine kinase activity|protein serine/threonine kinase activity|ATP binding|MAP kinase kinase kinase kinase activity|,2,2,433000000,1.3%
Q8BTI9,0.826177557,-0.0405,2.678387162,0.083666667,0.539711018,0.646504355,0.054,0.03,-0.331,0.091,-0.09,0.003,Q8BTI9,Pik3cb,Q8BTI9_Pik3cb,Q8BTI9,Pik3cb,1,5,4,4,Q8BTI9|S4R1S1,MOUSE,123077.8,6.8,1841,1841.1,55.89,55.89,,1064,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",nucleus|cytoplasm|plasma membrane|phosphatidylinositol 3-kinase complex|,endothelial cell proliferation|regulation of cell-matrix adhesion|adaptive immune response|protein phosphorylation|cellular calcium ion homeostasis|endocytosis|autophagy|inflammatory response|homophilic cell adhesion via plasma membrane adhesion molecules|response to wounding|positive regulation of gene expression|phosphatidylinositol 3-kinase signaling|platelet activation|phosphatidylinositol-3-phosphate biosynthetic process|embryonic cleavage|innate immune response|phosphatidylinositol phosphorylation|angiogenesis involved in wound healing|cell chemotaxis|,"protein binding|ATP binding|1-phosphatidylinositol-3-kinase activity|1-phosphatidylinositol-4-phosphate 3-kinase activity|insulin receptor substrate binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity|",4,5,287000000,6.8%
Q31125,0.841746758,-0.088166667,2.49699218,0.126333333,0.562730924,0.609160453,-0.635,0.107,0.074,-0.104,-0.054,0.083,Q31125,Slc39a7,Q31125_Slc39a7,Q31125,Slc39a7,1,15,4,4,Q31125,MOUSE,50826.8,12.8,1842,1842.1,55.85,55.85,,476,Zinc transporter SLC39A7,nucleoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|Golgi apparatus|integral component of membrane|,zinc II ion transport|transmembrane transport|,protein binding|metal ion transmembrane transporter activity|,4,15,3150000000,12.8%
Q8CBY8,0.963376742,-0.033666667,0.503303408,-0.016,0.890573277,-0.142931131,-0.092,0.055,-0.04,0.034,-0.234,0.075,Q8CBY8,Dctn4,Q8CBY8_Dctn4,Q8CBY8,Dctn4,1,9,4,4,Q8CBY8|Q8CBY8-2,MOUSE,53911.8,12.6,1843,1843.1,55.72,55.72,,467,Dynactin subunit 4,centrosome|cytoplasmic dynein complex|dynactin complex|sarcomere|,nuclear migration|,protein N-terminus binding|,4,9,422000000,12.6%
P63030,0.926033297,-0.086166667,1.079926292,-0.071666667,0.779843346,-0.291154602,0.307,0.145,-0.603,-0.002,-0.021,-0.343,P63030,Mpc1,P63030_Mpc1,P63030,Mpc1,1,24,6,6,P63030|E9Q0V4|D3Z5S0|D3YWY6,MOUSE,12625.6,54.1,1844,1844.1,55.69,55.69,,109,Mitochondrial pyruvate carrier 1,mitochondrion|mitochondrial inner membrane|integral component of membrane|,pyruvate metabolic process|mitochondrial pyruvate transport|pyruvate transmembrane transport|,pyruvate transmembrane transporter activity|,6,24,40000000000,54.1%
P59999,0.972248418,-0.035166667,0.396997048,-0.016333333,0.912641672,-0.113968817,-0.182,-0.035,0.136,-0.295,0.056,0.109,P59999,Arpc4,P59999_Arpc4,P59999,Arpc4,1,15,5,5,P59999,MOUSE,19780.8,34.5,1845,1845.1,55.66,55.66,,168,Actin-related protein 2/3 complex subunit 4,cytoplasm|Arp2/3 protein complex|cell projection|extracellular exosome|,actin filament polymerization|Arp2/3 complex-mediated actin nucleation|,"structural constituent of cytoskeleton|enzyme binding|protein binding, bridging|actin filament binding|",5,15,1630000000,34.5%
Q8CFX3,0.686505935,-0.005833333,4.758720471,0.083666667,0.334293516,1.040301279,0.005,-0.042,-0.106,0.031,0.048,0.029,Q8CFX3,Pcdh1,Q8CFX3_Pcdh1,Q8CFX3,Pcdh1,1,13,5,4,Q8CFX3,MOUSE,112693.9,5.8,1846,1846.1,55.57,40.91,,1038,Protocadherin 1,integral component of plasma membrane|cell-cell junction|,homophilic cell adhesion via plasma membrane adhesion molecules|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|,calcium ion binding|protein binding|,5,13,1510000000,5.8%
E0CXD4,0.663574238,-0.0145,5.105025273,0.087666667,0.308672168,1.101534508,-0.042,-0.038,-0.095,-0.013,0.037,0.064,E0CXD4,NotFound,E0CXD4_NotFound,E0CXD4,Pcdh1,1,6,2,2,E0CXD4,MOUSE,39202.8,6.1,1846,1846.2,26.1,26.1,,360,Protocadherin 1,integral component of plasma membrane|cell-cell junction|,homophilic cell adhesion via plasma membrane adhesion molecules|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|,calcium ion binding|protein binding|,2,6,1050000000,6.1%
Q9D820,0.883573216,-0.019833333,1.900215941,0.055,0.645622126,0.481473609,0.047,0.072,-0.261,0.048,-0.039,0.014,Q9D820,Prorsd1,Q9D820_Prorsd1,Q9D820,Prorsd1,1,6,4,4,Q9D820|Q9D820-2,MOUSE,18975.5,31.3,1847,1847.1,55.52,55.52,,169,Prolyl-tRNA synthetase associated domain-containing protein 1,,regulation of translational fidelity|,,4,6,1780000000,31.3%
Q9D1I6,0.965296689,-0.0315,0.461477533,-0.017666667,0.899191611,-0.131624989,0.084,0.131,-0.283,-0.109,0.072,-0.084,Q9D1I6,Mrpl14,Q9D1I6_Mrpl14,Q9D1I6,Mrpl14,1,11,4,4,Q9D1I6,MOUSE,15988.3,33.1,1848,1848.1,55.51,55.51,,145,"39S ribosomal protein L14, mitochondrial",mitochondrion|ribosome|,translation|,structural constituent of ribosome|poly(A) RNA binding|,4,11,1970000000,33.1%
Q91YJ2,0.812521998,0.000166667,2.909578419,-0.115666667,0.511731508,-0.693254448,-0.121,-0.005,0.3,0.155,-0.333,0.005,Q91YJ2,Snx4,Q91YJ2_Snx4,Q91YJ2,Snx4,1,6,6,6,Q91YJ2,MOUSE,52061.9,11.7,1849,1849.1,55.48,55.48,,450,Sorting nexin-4,cytoplasm|endosome|cytoplasmic dynein complex|plasma membrane|membrane|extrinsic component of membrane|SNARE complex|early endosome membrane|protein complex|,endocytosis|protein transport|vesicle organization|endocytic recycling|positive regulation of histamine secretion by mast cell|,epidermal growth factor receptor binding|insulin receptor binding|phosphatidylinositol binding|transferrin receptor binding|leptin receptor binding|,6,6,1980000000,11.7%
Q9WUM3,0.312476077,-0.0545,12.46830769,0.394333333,0.056645998,2.305417568,-0.438,-0.39,0.073,-0.077,0.221,0.284,Q9WUM3,Coro1b,Q9WUM3_Coro1b,Q9WUM3,Coro1b,1,7,5,5,Q9WUM3,MOUSE,54538.8,16.5,1850,1850.1,55.46,55.46,,484,Coronin-1B,stress fiber|cytoplasm|cytosol|actin filament|plasma membrane|focal adhesion|actin cytoskeleton|lamellipodium|cell leading edge|perinuclear region of cytoplasm|extracellular exosome|cell periphery|,cell migration|actin cytoskeleton organization|ruffle organization|negative regulation of Arp2/3 complex-mediated actin nucleation|endothelial cell chemotaxis|cellular response to platelet-derived growth factor stimulus|wound healing|actin filament bundle assembly|negative regulation of smooth muscle cell chemotaxis|actin filament branching|protein localization to cell leading edge|positive regulation of lamellipodium morphogenesis|,protein binding|identical protein binding|actin filament binding|Arp2/3 complex binding|,5,7,469000000,16.5%
Q6P2B1-2,0.987719777,0.022833333,0.213817818,0.006333333,0.951958943,0.062539292,0.064,0.062,-0.067,0.149,-0.108,0.037,Q6P2B1,Tnpo3,Q6P2B1-2_Tnpo3,Q6P2B1-2,Tnpo3,1,9,5,5,Q6P2B1-2|Q6P2B1|Q6P2B1-3|E9Q0H8,MOUSE,106625,6.6,1851,1851.1,55.37,55.37,,923,Isoform 2 of Transportin-3,nucleus|cytoplasm|intracellular membrane-bounded organelle|,splicing factor protein import into nucleus|,identical protein binding|,5,9,338000000,6.6%
Q61335,0.000151804,-0.310666667,60.07805494,2.052666667,9.82188E-07,17.15742154,-1.355,-1.166,-1.49,0.671,0.617,0.859,Q61335,Bcap31,Q61335_Bcap31,Q61335,Bcap31,1,14,6,6,Q61335,MOUSE,28013.1,18.7,1852,1852.1,55.34,55.34,,245,B-cell receptor-associated protein 31,Golgi membrane|mitochondrion|endoplasmic reticulum|lipid particle|cytosol|integral component of plasma membrane|membrane|clathrin-coated vesicle|Golgi cisterna membrane|endoplasmic reticulum-Golgi intermediate compartment membrane|Sec61 translocon complex|,"intracellular protein transport|ER to Golgi vesicle-mediated transport|positive regulation of cytosolic calcium ion concentration|spermatogenesis|negative regulation of endoplasmic reticulum calcium ion concentration|calcium-mediated signaling using intracellular calcium source|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of mitochondrial calcium ion concentration|protein localization to endoplasmic reticulum exit site|positive regulation of ER-associated ubiquitin-dependent protein catabolic process|positive regulation of retrograde protein transport, ER to cytosol|positive regulation of intrinsic apoptotic signaling pathway|",protein binding|protein complex binding|MHC class I protein binding|,6,14,1130000000,18.7%
P31649,0.629307568,-0.094833333,5.819928463,0.263666667,0.261822614,1.226556396,-0.008,0.058,-0.73,0.15,-0.037,-0.002,P31649,Slc6a13,P31649_Slc6a13,P31649,Slc6a13,1,14,4,4,P31649,MOUSE,69653.2,9.3,1853,1853.1,55.16,55.16,,602,Sodium- and chloride-dependent GABA transporter 2,integral component of plasma membrane|extracellular exosome|,neurotransmitter transport|gamma-aminobutyric acid transport|transmembrane transport|,neurotransmitter:sodium symporter activity|gamma-aminobutyric acid:sodium symporter activity|,4,14,2180000000,9.3%
E9PUK2,0.927777432,-0.011166667,1.03794982,0.027,0.787417419,0.280694568,0.004,0.087,-0.165,-0.013,-0.013,0.033,E9PUK2,Adck5,E9PUK2_Adck5,E9PUK2,Adck5,1,11,6,6,E9PUK2|E0CXW2|Q80V03|Q80V03-2,MOUSE,67196.8,14.7,1854,1854.1,55.1,55.1,,582,Uncharacterized aarF domain-containing protein kinase 5,mitochondrion|,,,6,11,446000000,14.7%
E9Q8I7,0.677899899,0.0305,4.899521253,0.172333333,0.32362933,1.066294283,-0.107,-0.046,-0.014,0.48,-0.067,-0.063,E9Q8I7,Nfxl1,E9Q8I7_Nfxl1,E9Q8I7,Nfxl1,1,7,7,7,E9Q8I7|E9PZN0,MOUSE,107895.9,9.4,1856,1856.1,54.89,54.89,,918,"Nuclear transcription factor, X-box-binding-like 1",nucleus|membrane|,negative regulation of transcription from RNA polymerase II promoter|transcription from RNA polymerase II promoter|,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription|zinc ion binding|,7,7,134000000,9.4%
Q99M31-2,0.942471768,0.013833333,0.830066297,0.020333333,0.82602534,0.228569715,0.019,0.068,-0.076,0.025,-0.048,0.095,Q99M31,Hspa14,Q99M31-2_Hspa14,Q99M31-2,Hspa14,1,6,5,5,Q99M31-2|Q99M31,MOUSE,56566.5,13.7,1857,1857.1,54.87,54.87,,509,Isoform 2 of Heat shock 70 kDa protein 14,cytosol|membrane|ribosome|,,ATP binding|,5,6,91600000,13.7%
Q61194,0.454052388,-0.0085,9.281861945,-0.153666667,0.117981471,-1.793069633,0.039,0.115,0.051,-0.09,-0.16,-0.006,Q61194,Pik3c2a,Q61194_Pik3c2a,Q61194,Pik3c2a,1,10,7,7,Q61194|F8VPL2|Q61194-2|A0A0U1RNH9,MOUSE,192580.2,4.8,1858,1858.1,54.77,54.77,,1686,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha,nucleus|cytoplasm|Golgi apparatus|plasma membrane|phosphatidylinositol 3-kinase complex|membrane|clathrin-coated vesicle|vesicle|extracellular exosome|,adaptive immune response|protein phosphorylation|exocytosis|endocytosis|inflammatory response|phosphatidylinositol 3-kinase signaling|platelet activation|phosphatidylinositol-3-phosphate biosynthetic process|innate immune response|phosphatidylinositol phosphorylation|clathrin coat assembly|cell chemotaxis|negative regulation of zinc ion transmembrane transport|,ATP binding|1-phosphatidylinositol-3-kinase activity|1-phosphatidylinositol-4-phosphate 3-kinase activity|phosphatidylinositol binding|,7,10,255000000,4.8%
V9GXM1,0.667069025,0.111666667,5.044087742,0.248,0.313033795,1.091857772,-0.249,-0.135,0.347,0.02,0.039,0.648,V9GXM1,Arfgap1,V9GXM1_Arfgap1,V9GXM1,Arfgap1,1,8,5,5,V9GXM1|Q9EPJ9|V9GWV1|Q3TGS9|Q9EPJ9-2,MOUSE,46824,13.9,1859,1859.1,54.75,54.75,,424,ADP-ribosylation factor GTPase-activating protein 1,synapse|neuronal postsynaptic density|,regulation of endocytosis|positive regulation of GTPase activity|,GTPase activator activity|protein binding|metal ion binding|,5,8,234000000,13.9%
Q6ZWU9,0.586445778,-0.0285,6.552526213,-0.132333333,0.221180777,-1.348960554,0.085,0.065,-0.037,-0.028,-0.021,-0.235,Q6ZWU9,Rps27,Q6ZWU9_Rps27,Q6ZWU9,Rps27,1,25,4,2,Q6ZWU9|A0A0G2JG29,MOUSE,9803.3,40.4,1860,1860.1,54.63,23.06,,84,40S ribosomal protein S27,ribosome|,translation|,structural constituent of ribosome|metal ion binding|,4,25,38700000000,40.4%
Q8K4F5,0.760357786,0.0325,3.697678294,-0.168333333,0.426807626,-0.846509393,0.157,0.504,-0.311,-0.04,-0.035,-0.08,Q8K4F5,Abhd11,Q8K4F5_Abhd11,Q8K4F5,Abhd11,1,8,5,5,Q8K4F5|D3YYK0,MOUSE,33674.1,20.1,1861,1861.1,54.63,54.63,,307,Protein ABHD11,mitochondrion|,metabolic process|,hydrolase activity|,5,8,376000000,20.1%
Q3V2R3,0.399899437,-0.014,10.40309,0.208666667,0.091136218,1.972253214,-0.014,-0.049,-0.292,0.107,0.02,0.144,Q3V2R3,Chn2,Q3V2R3_Chn2,Q3V2R3,Chn2,1,10,6,6,Q3V2R3|Q80XD1|A0A0N4SVT0|Q80XD1-2|Q80XD1-3|A0A0N4SV75|A0A0N4SWG3|A0A0N4SVZ7|A0A0N4SV96|A0A0N4SVE7,MOUSE,54464.1,17,1862,1862.1,54.61,54.61,,468,Beta-chimaerin,intracellular|synapse|,intracellular signal transduction|positive regulation of GTPase activity|,GTPase activator activity|metal ion binding|,6,10,344000000,17.0%
Q8BI72,0.943277934,0.0095,0.819094028,-0.026333333,0.828114897,-0.225852905,0.096,0.103,-0.131,0.062,0.098,-0.171,Q8BI72,Cdkn2aip,Q8BI72_Cdkn2aip,Q8BI72,Cdkn2aip,1,4,4,4,Q8BI72,MOUSE,60257.1,14,1863,1863.1,54.59,54.59,,563,CDKN2A-interacting protein,granular component|nucleus|nucleoplasm|nucleolus|cytoplasm|,cellular response to DNA damage stimulus|positive regulation of signal transduction|positive regulation of cell growth|negative regulation of cell growth|regulation of protein stability|,p53 binding|RNA binding|,4,4,116000000,14.0%
P05064,0.985063154,0.030833333,0.239166767,0.007666667,0.946418723,0.069771105,-0.074,-0.068,0.223,0.063,-0.024,0.065,P05064,Aldoa,P05064_Aldoa,P05064,Aldoa,1,8,5,3,A6ZI44|P05064|P00883|P05063|A6ZI47,MOUSE,39811.6,20.6,1864,1864.1,54.58,30.56,,364,Fructose-bisphosphate aldolase A,membrane|Z disc|M band|myelin sheath|protein complex|,glycolytic process|protein homotetramerization|,protease binding|fructose-bisphosphate aldolase activity|,6,8,2890000000,20.6%
Q9CZ30,0.929192436,0.0045,1.012088744,0.047,0.792120268,0.274429645,-0.311,0.279,-0.025,-0.128,0.215,-0.003,Q9CZ30,Ola1,Q9CZ30_Ola1,Q9CZ30,Ola1,1,6,5,5,Q9CZ30|B1AYJ9|Q9CZ30-2,MOUSE,44956.9,15.4,1865,1865.1,54.52,54.52,,396,Obg-like ATPase 1,nucleolus|cytoplasm|centrosome|membrane|extracellular exosome|,ATP metabolic process|,ATP binding|GTP binding|ATPase activity|ribosome binding|ribosomal large subunit binding|metal ion binding|,6,6,1270000000,15.4%
Q9DCF9,0.167564453,0.009333333,17.01293562,-0.272666667,0.019893282,-3.040060391,0.099,0.26,0.078,-0.111,-0.103,-0.167,Q9DCF9,Ssr3,Q9DCF9_Ssr3,Q9DCF9,Ssr3,1,13,5,5,Q9DCF9|Q9DCF9-2,MOUSE,21064.1,15.6,1866,1866.1,54.46,54.46,,185,Translocon-associated protein subunit gamma,Sec61 translocon complex|integral component of endoplasmic reticulum membrane|,cotranslational protein targeting to membrane|,,5,13,26900000000,15.6%
F8WJD4,0.21692926,-0.073833333,15.29755949,0.365,0.029528681,2.764452755,-0.01,-0.351,-0.408,0.091,0.01,0.225,F8WJD4,Sympk,F8WJD4_Sympk,F8WJD4,Sympk,1,7,6,6,F8WJD4|Q80X82|S4R2Q3,MOUSE,143587.4,7.9,1867,1867.1,54.43,54.43,,1288,Symplekin,nucleoplasm|cytoplasm|plasma membrane|,mRNA polyadenylation|positive regulation of protein dephosphorylation|,,6,7,305000000,7.9%
Q505F5,0.47899797,0.003333333,8.588553612,-0.151333333,0.138402724,-1.681930075,0.01,0.044,0.183,-0.01,-0.112,-0.095,Q505F5,Lrrc47,Q505F5_Lrrc47,Q505F5,Lrrc47,1,8,5,5,Q505F5|E9PV22,MOUSE,64216.7,13.5,1868,1868.1,54.31,54.31,,581,Leucine-rich repeat-containing protein 47,phenylalanine-tRNA ligase complex|,phenylalanyl-tRNA aminoacylation|,poly(A) RNA binding|phenylalanine-tRNA ligase activity|,5,8,222000000,13.5%
Q99K23,0.994928853,-0.018666667,0.086616719,-0.003333333,0.980253334,-0.025701002,-0.255,0.065,0.139,-0.081,-0.082,0.102,Q99K23,Ufsp2,Q99K23_Ufsp2,Q99K23,Ufsp2,1,8,6,6,Q99K23|A0A1B0GSK1|A0A1B0GSM1,MOUSE,52970.7,16,1869,1869.1,54.31,54.31,,461,Ufm1-specific protease 2,nucleus|cytoplasm|endoplasmic reticulum|,proteolysis|regulation of intracellular estrogen receptor signaling pathway|,thiolester hydrolase activity|UFM1 hydrolase activity|,6,8,961000000,16.0%
P32067,0.312476077,0.058333333,12.47871919,-0.261333333,0.056510361,-2.304382346,-0.011,0.231,0.347,-0.122,-0.06,-0.035,P32067,Ssb,P32067_Ssb,P32067,Ssb,1,9,6,6,P32067|D6RI87,MOUSE,47926.8,13.4,1870,1870.1,54.29,54.29,,415,Lupus La protein homolog,nucleus|ribonucleoprotein complex|,RNA processing|,nucleotide binding|RNA binding|poly(A) RNA binding|,6,9,1140000000,13.4%
Q9Z2U1,0.647450828,0.012666667,5.407986164,0.094,0.287873298,1.154371459,-0.053,-0.033,-0.017,0.052,0.003,0.124,Q9Z2U1,Psma5,Q9Z2U1_Psma5,Q9Z2U1,Psma5,1,7,4,4,Q9Z2U1,MOUSE,26581.7,26.5,1871,1871.1,54.18,54.18,,241,Proteasome subunit alpha type-5,"proteasome complex|nucleus|nucleoplasm|cytoplasm|cytosol|proteasome core complex|proteasome core complex, alpha-subunit complex|extracellular exosome|",proteasomal ubiquitin-independent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|,endopeptidase activity|threonine-type endopeptidase activity|,4,7,149000000,26.5%
Q9ES00,0.755647062,-0.010666667,3.766123485,0.084666667,0.420133828,0.85878549,-0.112,-0.073,0.026,0.157,-0.083,0.021,Q9ES00,Ube4b,Q9ES00_Ube4b,Q9ES00,Ube4b,1,8,8,8,Q9ES00|G3UZD6|G3UZM6,MOUSE,134627.5,8,1872,1872.1,54.13,54.13,,1173,Ubiquitin conjugation factor E4 B,ubiquitin ligase complex|nucleus|cytoplasm|,protein folding|granzyme-mediated apoptotic signaling pathway|response to UV|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|,ligase activity|enzyme binding|ubiquitin-ubiquitin ligase activity|unfolded protein binding|,8,8,1540000000,8.0%
Q9R061,0.726796323,-0.0395,4.159162811,0.107,0.38378122,0.93235152,-0.036,0.033,-0.276,0.13,-0.021,-0.067,Q9R061,Nubp2,Q9R061_Nubp2,Q9R061,Nubp2,1,7,6,6,Q9R061,MOUSE,29916.8,22.5,1873,1873.1,54.12,54.12,,275,Cytosolic Fe-S cluster assembly factor NUBP2,nucleus|cytoplasm|spindle pole centrosome|,iron-sulfur cluster assembly|,"protein binding|ATP binding|metal ion binding|4 iron, 4 sulfur cluster binding|",6,7,1280000000,22.5%
E9QNL4,0.703907029,-0.015166667,4.478233144,-0.092333333,0.356596179,-0.989977068,0.122,-0.016,-0.013,0.027,-0.057,-0.154,E9QNL4,Chuk,E9QNL4_Chuk,E9QNL4,Chuk,1,8,6,6,E9QNL4|Q60680|E9Q605|Q60680-3|Q60680-2,MOUSE,85944.6,9.2,1874,1874.1,54.08,54.08,,745,Inhibitor of nuclear factor kappa-B kinase subunit alpha,nucleoplasm|cytoplasm|IkappaB kinase complex|intracellular membrane-bounded organelle|,morphogenesis of an epithelial sheet|skeletal muscle contraction|protein phosphorylation|I-kappaB phosphorylation|Rho protein signal transduction|lactation|response to toxic substance|response to acetate|signal transduction by protein phosphorylation|osteoclast differentiation|response to lipopolysaccharide|response to hydroperoxide|mammary gland epithelial cell proliferation|response to muscle stretch|odontogenesis of dentin-containing tooth|response to drug|positive regulation of I-kappaB kinase/NF-kappaB signaling|response to amino acid|positive regulation of transcription from RNA polymerase II promoter|striated muscle cell differentiation|mammary gland alveolus development|cellular response to tumor necrosis factor|,protein kinase activity|receptor signaling protein serine/threonine kinase activity|protein binding|ATP binding|IkappaB kinase activity|protein homodimerization activity|protein heterodimerization activity|scaffold protein binding|,6,8,6410000000,9.2%
Q8K2T4,0.614399379,-0.0815,6.095501896,0.263666667,0.245725264,1.273521116,0.1,-0.059,-0.681,0.187,-0.015,-0.021,Q8K2T4,Uqcc3,Q8K2T4_Uqcc3,Q8K2T4,Uqcc3,1,7,4,4,Q8K2T4,MOUSE,9583.8,28,1875,1875.1,54.03,54.03,,89,Ubiquinol-cytochrome-c reductase complex assembly factor 3,mitochondrial inner membrane|integral component of membrane|,,,4,7,767000000,28.0%
Q8BXN7,0.391635111,0.049666667,10.57000486,-0.224,0.087699984,-2.000125093,0.089,0.054,0.342,0.045,-0.095,-0.137,Q8BXN7,Ppm1k,Q8BXN7_Ppm1k,Q8BXN7,Ppm1k,1,7,4,4,Q8BXN7,MOUSE,41374.1,12.9,1876,1876.1,53.99,53.99,,372,"Protein phosphatase 1K, mitochondrial",mitochondrion|mitochondrial matrix|,protein dephosphorylation|,protein serine/threonine phosphatase activity|metal ion binding|,4,7,1410000000,12.9%
Q8CBE3,0.39291571,0.036666667,10.54426442,-0.234666667,0.088221321,-1.997241682,0.004,0.115,0.343,-0.003,-0.195,-0.044,Q8CBE3,Wdr37,Q8CBE3_Wdr37,Q8CBE3,Wdr37,1,8,4,4,Q8CBE3|Q05BF4,MOUSE,55729.6,9.6,1877,1877.1,53.97,53.97,,496,WD repeat-containing protein 37,,,,4,8,706000000,9.6%
Q9ES46,0.588823742,-0.009333333,6.514967413,-0.111333333,0.223101895,-1.342671565,0,0.085,0.054,0,-0.082,-0.113,Q9ES46,Parvb,Q9ES46_Parvb,Q9ES46,Parvb,1,4,4,4,Q9ES46,MOUSE,41725.4,16.7,1878,1878.1,53.96,53.96,,365,Beta-parvin,cytoskeleton|plasma membrane|focal adhesion|Z disc|lamellipodium|,cell adhesion|cell projection assembly|lamellipodium assembly|actin cytoskeleton reorganization|establishment or maintenance of cell polarity regulating cell shape|,actin binding|protein binding|,4,4,232000000,16.7%
Q9Z2G9,0.036043561,-0.179333333,25.3129412,0.898,0.002942428,4.578053532,-0.335,-0.462,-1.088,0.271,0.26,0.278,Q9Z2G9,Htatip2,Q9Z2G9_Htatip2,Q9Z2G9,Htatip2,1,7,5,5,Q3U816|Q9Z2G9|Q9Z2G9-2,MOUSE,27097.7,23.1,1879,1879.1,53.94,53.94,,242,Oxidoreductase HTATIP2,nuclear envelope|cytoplasm|membrane|,angiogenesis|apoptotic process|cell differentiation|positive regulation of programmed cell death|regulation of angiogenesis|positive regulation of transcription from RNA polymerase II promoter during mitosis|protein autophosphorylation|nuclear import|oxidation-reduction process|,protein serine/threonine kinase activity|oxidoreductase activity|,5,7,1440000000,23.1%
P11930,0.81132483,-0.041833333,2.941554905,0.129,0.507977539,0.699650235,-0.051,0.18,-0.448,-0.172,0.225,0.015,P11930,Nudt19,P11930_Nudt19,P11930,Nudt19,1,9,4,4,P11930,MOUSE,40832.8,15.9,1880,1880.1,53.74,53.74,,357,Nucleoside diphosphate-linked moiety X motif 19,mitochondrion|peroxisome|,metabolic process|,receptor binding|hydrolase activity|metal ion binding|,4,9,1020000000,15.9%
Q6Y7W8,0.623038428,-0.02,5.905749326,0.137333333,0.256699526,1.240266732,-0.074,0.083,-0.275,0.054,0.035,0.057,Q6Y7W8,Gigyf2,Q6Y7W8_Gigyf2,Q6Y7W8,Gigyf2,1,6,5,5,Q6Y7W8|G3UYG6|G3UWR2|Q6Y7W8-2,MOUSE,149475.4,5.8,1881,1881.1,53.72,53.72,,1291,GRB10-interacting GYF protein 2,cytoplasm|membrane|,feeding behavior|adult locomotory behavior|post-embryonic development|negative regulation of translation|spinal cord motor neuron differentiation|mitotic G1 DNA damage checkpoint|multicellular organism growth|cellular protein metabolic process|insulin-like growth factor receptor signaling pathway|homeostasis of number of cells within a tissue|musculoskeletal movement|neuromuscular process controlling balance|,protein binding|poly(A) RNA binding|,5,6,173000000,5.8%
P16056,0.297132915,0.000833333,12.83472727,0.215,0.05206277,2.358429842,-0.064,-0.041,-0.215,0.148,0.04,0.137,P16056,NotFound,P16056_NotFound,P16056,Met,1,8,6,6,P16056|F8VQL0,MOUSE,155885.1,6,1882,1882.1,53.68,53.68,,1379,Hepatocyte growth factor receptor,basal plasma membrane|cell surface|membrane|integral component of membrane|,activation of MAPK activity|endothelial cell morphogenesis|liver development|placenta development|synaptic transmission|brain development|muscle organ development|skeletal muscle tissue development|positive regulation of glucose transport|muscle cell migration|myotube differentiation|peptidyl-tyrosine phosphorylation|adult behavior|glucose homeostasis|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|hepatocyte growth factor receptor signaling pathway|branching morphogenesis of an epithelial tube|regulation of synaptic transmission|positive chemotaxis|myoblast proliferation|regulation of excitatory postsynaptic membrane potential|regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling|semaphorin-plexin signaling pathway|negative regulation of hydrogen peroxide-mediated programmed cell death|positive regulation of endothelial cell chemotaxis|,protein kinase activity|hepatocyte growth factor-activated receptor activity|protein binding|ATP binding|protein phosphatase binding|,6,8,128000000,6.0%
P62960,0.295433851,-0.040833333,12.90367091,0.379,0.051242807,2.375310027,-0.588,-0.068,-0.035,0.114,0.137,0.195,P62960,Ybx1,P62960_Ybx1,P62960,Ybx1,1,5,5,5,P62960|Q9JKB3|Q9Z2C8|B2RUF0|Q9Z2C8-2|A0A0A0MQD2|Q9JKB3-2,MOUSE,35729.3,35.7,1883,1883.1,53.67,53.67,,322,Nuclease-sensitive element-binding protein 1,nucleus|U12-type spliceosomal complex|cytoplasm|cytoplasmic stress granule|ribonucleoprotein complex|nuclear membrane|intracellular membrane-bounded organelle|extracellular exosome|CRD-mediated mRNA stability complex|histone pre-mRNA 3'end processing complex|,"negative regulation of transcription from RNA polymerase II promoter|in utero embryonic development|regulation of transcription, DNA-templated|transcription from RNA polymerase II promoter|mRNA processing|RNA splicing|positive regulation of transcription from RNA polymerase II promoter|negative regulation of striated muscle cell differentiation|positive regulation of cell division|CRD-mediated mRNA stabilization|",RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|DNA binding|chromatin binding|single-stranded DNA binding|RNA binding|protein binding|poly(A) RNA binding|GTPase binding|,5,5,175000000,35.7%
D3YZP9,0.121985139,-0.021166667,18.82310123,0.363666667,0.013112632,3.351256379,-0.189,-0.165,-0.255,0.283,-0.029,0.228,D3YZP9,Ccdc6,D3YZP9_Ccdc6,D3YZP9,Ccdc6,1,8,5,5,D3YZP9,MOUSE,53109,11.9,1884,1884.1,53.52,53.52,,469,Coiled-coil domain-containing protein 6,cytoplasm|cytoskeleton|,,SH3 domain binding|,5,8,147000000,11.9%
Q3UJU9,0.615860336,-0.03,6.025223196,0.135333333,0.249734004,1.260490524,-0.026,-0.002,-0.265,0.13,0.025,-0.042,Q3UJU9,Rmdn3,Q3UJU9_Rmdn3,Q3UJU9,Rmdn3,1,7,4,4,Q3UJU9,MOUSE,52370.2,13.8,1885,1885.1,53.38,53.38,,470,Regulator of microtubule dynamics protein 3,spindle pole|nucleus|mitochondrion|mitochondrial outer membrane|microtubule|integral component of membrane|,cellular calcium ion homeostasis|apoptotic process|cell differentiation|,,4,7,336000000,13.8%
O09012,0.586445778,-0.056333333,6.553632177,0.199333333,0.221124458,1.35074726,0.031,-0.027,-0.472,-0.027,0.063,0.094,O09012,Pex5,O09012_Pex5,O09012,Pex5,1,6,5,5,O09012|D3Z600|O09012-2,MOUSE,71096.6,11.8,1886,1886.1,53.35,53.35,,639,Peroxisomal targeting signal 1 receptor,intracellular|cytoplasm|mitochondrion|peroxisome|peroxisomal membrane|peroxisomal matrix|Golgi apparatus|cytosol|membrane|protein complex|,"very long-chain fatty acid metabolic process|neuron migration|protein targeting to peroxisome|fatty acid beta-oxidation|mitochondrion organization|mitochondrial membrane organization|endoplasmic reticulum organization|peroxisome organization|protein import into peroxisome matrix|protein import into peroxisome matrix, docking|protein import into peroxisome matrix, translocation|cerebral cortex cell migration|cerebral cortex neuron differentiation|positive regulation of multicellular organism growth|cellular lipid metabolic process|protein import into peroxisome membrane|cell development|neuromuscular process|protein tetramerization|negative regulation of protein homotetramerization|",peroxisome targeting sequence binding|peroxisome matrix targeting signal-1 binding|protein C-terminus binding|enzyme binding|small GTPase binding|protein N-terminus binding|,5,6,265000000,11.8%
Q80Y14,0.894042447,-0.067833333,1.68391263,0.077,0.678592003,0.433259363,0.098,0.072,-0.489,-0.049,0.115,-0.154,Q80Y14,Glrx5,Q80Y14_Glrx5,Q80Y14,Glrx5,1,20,4,4,Q80Y14|A0A1Y7VN70,MOUSE,16406.3,26.9,1887,1887.1,53.32,53.32,,152,"Glutaredoxin-related protein 5, mitochondrial",nucleus|mitochondrion|dendrite|neuronal cell body|,hemopoiesis|cell redox homeostasis|oxidation-reduction process|,"electron carrier activity|protein disulfide oxidoreductase activity|metal ion binding|2 iron, 2 sulfur cluster binding|",4,20,9180000000,26.9%
Q9EQQ9-3,0.873540954,-0.057333333,2.03992371,0.095333333,0.625183675,0.512150066,-0.065,0.159,-0.409,-0.296,0.149,0.118,Q9EQQ9,Mgea5,Q9EQQ9-3_Mgea5,Q9EQQ9-3,Mgea5,1,8,4,4,Q9EQQ9-3|Q9EQQ9,MOUSE,108477.4,3.9,1888,1888.1,53.26,53.26,,916,Isoform 3 of Protein O-GlcNAcase,nucleus|mitochondrion|cytosol|membrane|,N-acetylglucosamine metabolic process|protein deglycosylation|protein targeting to membrane|aging|positive regulation of calcium ion transport into cytosol|negative regulation of cardiac muscle adaptation|histone acetylation|positive regulation of cell killing|positive regulation of insulin secretion|positive regulation of protein complex disassembly|positive regulation of proteolysis|dATP metabolic process|positive regulation of glucose import|response to steroid hormone|positive regulation of DNA metabolic process|positive regulation of mitochondrial depolarization|negative regulation of protein glycosylation|positive regulation of growth hormone secretion|necrotic cell death|,histone acetyltransferase activity|beta-N-acetylglucosaminidase activity|,4,8,1580000000,3.9%
A8Y5T6,0.826064255,-0.023,2.684167214,-0.078,0.538993191,-0.647684421,0.122,0.015,-0.089,0.075,-0.266,0.005,A8Y5T6,Pars2,A8Y5T6_Pars2,A8Y5T6,Pars2,1,5,5,5,A8Y5T6|Q8CFI5,MOUSE,58762,11.7,1889,1889.1,53.24,53.24,,511,"Probable proline--tRNA ligase, mitochondrial",mitochondrion|,prolyl-tRNA aminoacylation|,proline-tRNA ligase activity|ATP binding|,5,5,332000000,11.7%
Q3UM29,0.676059904,0.010166667,4.929455829,-0.114333333,0.321406324,-1.070822154,0.15,-0.107,0.159,0.036,-0.095,-0.082,Q3UM29,Cog7,Q3UM29_Cog7,Q3UM29,Cog7,1,6,5,5,A0A0R4J0Q9|Q3UM29|Q3TR20,MOUSE,86698.7,9.4,1890,1890.1,53.14,53.14,,770,Conserved oligomeric Golgi complex subunit 7,Golgi membrane|nucleolus|Golgi apparatus|Golgi transport complex|intracellular membrane-bounded organelle|,"protein glycosylation|intracellular protein transport|retrograde vesicle-mediated transport, Golgi to ER|protein localization to organelle|protein localization to Golgi apparatus|protein stabilization|",,5,6,252000000,9.4%
Q5SUH6,0.470565279,0.024166667,8.848667953,0.258333333,0.130356654,1.726509146,-0.256,-0.127,0.068,-0.01,0.045,0.425,Q5SUH6,Clint1,Q5SUH6_Clint1,Q5SUH6,Clint1,1,11,7,7,Q5SUH6|Q5SUH7|Q99KN9|Q99KN9-2,MOUSE,69815.1,11,1891,1891.1,53.08,53.08,,641,Clathrin interactor 1,nucleoplasm|Golgi apparatus|membrane|intracellular membrane-bounded organelle|,vesicle-mediated transport|,clathrin binding|,7,11,486000000,11.0%
Q6NV83,0.893374005,0.004666667,1.709272887,0.036,0.674640969,0.438759542,-0.009,-0.065,0.034,0.001,0.075,-0.008,Q6NV83,U2surp,Q6NV83_U2surp,Q6NV83,U2surp,1,8,6,6,Q6NV83|Q6NV83-2|Q6NV83-3|A0A087WRG2,MOUSE,118715.1,6.9,1892,1892.1,53.04,53.04,,1029,U2 snRNP-associated SURP motif-containing protein,nucleus|nucleoplasm|,RNA processing|,nucleotide binding|poly(A) RNA binding|,6,8,334000000,6.9%
Q8R2V5,0.651971232,0.006,5.292273894,-0.122,0.295646411,-1.134511905,0.166,0.153,-0.118,0.006,-0.104,-0.067,Q8R2V5,Adap2,Q8R2V5_Adap2,Q8R2V5,Adap2,1,10,4,4,Q8R2V5|E9QAL8,MOUSE,44388,12.8,1893,1893.1,53.02,53.02,,381,Arf-GAP with dual PH domain-containing protein 2,cytoplasm|mitochondrial envelope|plasma membrane|,heart development|positive regulation of GTPase activity|inositol lipid-mediated signaling|,"GTPase activator activity|phosphatidylinositol-4,5-bisphosphate binding|phosphatidylinositol-3,4,5-trisphosphate binding|phosphatidylinositol-3,4-bisphosphate binding|inositol 1,3,4,5 tetrakisphosphate binding|metal ion binding|",4,10,1280000000,12.8%
O54941,0.90651412,-0.010166667,1.516493984,0.033,0.70526219,0.394798783,0.036,-0.052,-0.064,0.064,-0.041,-0.004,O54941,Smarce1,O54941_Smarce1,O54941,Smarce1,1,6,6,6,O54941,MOUSE,46694.7,13.8,1894,1894.1,53,53,,411,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1,nuclear chromatin|nucleus|nucleoplasm|SWI/SNF complex|transcriptional repressor complex|protein complex|npBAF complex|nBAF complex|BAF-type complex|,"nucleosome disassembly|chromatin remodeling|regulation of transcription, DNA-templated|nervous system development|metabolic process|ATP-dependent chromatin remodeling|negative regulation of transcription, DNA-templated|",chromatin binding|RNA binding|protein binding|N-acetyltransferase activity|ligand-dependent nuclear receptor binding|protein N-terminus binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|,6,6,254000000,13.8%
Q8CDM8,0.904214516,0.003166667,1.552464542,0.043,0.699444961,0.403123445,0.124,-0.028,-0.151,0.098,-0.082,0.058,Q8CDM8,Fam160b1,Q8CDM8_Fam160b1,Q8CDM8,Fam160b1,1,5,4,4,Q8CDM8|Q8CDM8-2,MOUSE,87157,6.6,1895,1895.1,52.97,52.97,,764,Protein FAM160B1,,,,4,5,246000000,6.6%
Q8BXQ2,0.110915145,0.059666667,19.43343885,0.433333333,0.011393473,3.468438556,-0.239,-0.049,-0.183,0.047,0.382,0.4,Q8BXQ2,Pigt,Q8BXQ2_Pigt,Q8BXQ2,Pigt,1,7,5,5,Q8BXQ2|B7ZC19,MOUSE,66388,7.2,1896,1896.1,52.95,52.95,,582,GPI transamidase component PIG-T,cytoplasm|membrane|cytoplasmic membrane-bounded vesicle|GPI-anchor transamidase complex|,attachment of GPI anchor to protein|neuron differentiation|neuron apoptotic process|,GPI-anchor transamidase activity|,5,7,921000000,7.2%
P00405,0.895444761,0.017833333,1.651650586,-0.083,0.683651768,-0.425947435,-0.3,0.008,0.47,-0.135,0.056,0.008,P00405,COX2,P00405_COX2,P00405,Mtco2,1,17,4,4,P00405,MOUSE,26147.1,19.3,1897,1897.1,52.91,52.91,,227,Cytochrome c oxidase subunit 2,mitochondrion|mitochondrial inner membrane|integral component of membrane|respiratory chain complex IV|extracellular exosome|,lactation|response to cold|electron transport chain|hydrogen ion transmembrane transport|,copper ion binding|cytochrome-c oxidase activity|,4,17,8350000000,19.3%
P26262,0.005368126,-0.158666667,35.36435811,1.250666667,0.00029078,6.926775196,-0.551,-0.608,-1.193,0.401,0.437,0.562,P26262,Klkb1,P26262_Klkb1,P26262,Klkb1,1,6,4,4,P26262,MOUSE,73492.3,8.7,1898,1898.1,52.89,52.89,,638,Plasma kallikrein,extracellular space|extracellular exosome|,inflammatory response|blood coagulation|plasminogen activation|fibrinolysis|positive regulation of fibrinolysis|liver regeneration|,serine-type endopeptidase activity|,4,6,199000000,8.7%
Q5M8N4,0.214980661,0.039333333,15.39445487,-0.290666667,0.028877162,-2.773227969,0.023,0.288,0.243,-0.194,-0.058,-0.066,Q5M8N4,Sdr39u1,Q5M8N4_Sdr39u1,Q5M8N4,Sdr39u1,1,8,5,5,Q5M8N4|Q5M8N4-2,MOUSE,33165.3,18.8,1899,1899.1,52.87,52.87,,308,Epimerase family protein SDR39U1,nucleus|,oxidation-reduction process|,oxidoreductase activity|coenzyme binding|,5,8,376000000,18.8%
Q3UHA3,0.636939506,-0.008333333,5.618922763,-0.116666667,0.274225428,-1.190794016,-0.029,0.017,0.162,0.041,-0.138,-0.103,Q3UHA3,Spg11,Q3UHA3_Spg11,Q3UHA3,Spg11,1,8,7,7,Q3UHA3|Q3UHA3-2,MOUSE,278150.9,4,1900,1900.1,52.86,52.86,,2430,Spatacsin,nucleolus|cytoplasm|lysosomal membrane|cytosol|plasma membrane|integral component of membrane|cytoplasmic vesicle|extracellular exosome|,,,7,8,1200000000,4.0%
Q8R2U6,0.683824379,0.006,4.796155429,-0.091333333,0.331424383,-1.046966653,0.026,-0.014,0.143,-0.078,-0.055,0.014,Q8R2U6,Nudt4,Q8R2U6_Nudt4,Q8R2U6,Nudt4,1,11,5,5,Q8R2U6|P0C027,MOUSE,20383.7,40.7,1901,1901.1,52.83,52.83,,179,Diphosphoinositol polyphosphate phosphohydrolase 2,cytoplasm|,metabolic process|,"diphosphoinositol-polyphosphate diphosphatase activity|snoRNA binding|metal ion binding|inositol diphosphate tetrakisphosphate diphosphatase activity|inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity|inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity|inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity|inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity|inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity|inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity|m7G(5')pppN diphosphatase activity|",5,11,1670000000,40.7%
Q9CQ26,0.736844736,-0.004833333,3.996484211,0.085,0.398429585,0.901810323,0.027,-0.014,-0.155,0.126,-0.026,0.013,Q9CQ26,Stambp,Q9CQ26_Stambp,Q9CQ26,Stambp,1,5,5,5,Q9CQ26,MOUSE,49197.4,14.3,1902,1902.1,52.59,52.59,,424,STAM-binding protein,nucleoplasm|cytoplasm|endosome|plasma membrane|cleavage furrow|extracellular exosome|,mitotic cytokinesis|negative regulation of phosphatidylinositol 3-kinase signaling|protein deubiquitination|negative regulation of neuron apoptotic process|negative regulation of Ras protein signal transduction|,ubiquitin-specific protease activity|metallopeptidase activity|protein domain specific binding|metal ion binding|,5,5,876000000,14.3%
Q3U8Y1,0.841746758,-0.017,2.509038697,-0.099333333,0.561172177,-0.611659546,-0.112,0.353,-0.143,-0.243,0.066,-0.023,Q3U8Y1,Mrps11,Q3U8Y1_Mrps11,Q3U8Y1,Mrps11,1,7,4,4,Q3U8Y1|Q9DCA2,MOUSE,20365,35,1903,1903.1,52.56,52.56,,191,"28S ribosomal protein S11, mitochondrial",mitochondrion|mitochondrial small ribosomal subunit|,translation|,structural constituent of ribosome|poly(A) RNA binding|,4,7,706000000,35.0%
O08586,0.469507952,-0.031,8.911704282,0.171333333,0.128478238,1.733845312,-0.017,-0.143,-0.19,0.176,-0.033,0.021,O08586,Pten,O08586_Pten,O08586,Pten,1,6,5,5,O08586,MOUSE,47721.9,16.3,1904,1904.1,52.44,52.44,,403,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",nucleus|nucleoplasm|cytoplasm|mitochondrion|plasma membrane|cytoplasmic side of plasma membrane|PML body|myelin sheath adaxonal region|cell projection|neuron projection|dendritic spine|Schmidt-Lanterman incisure|postsynaptic membrane|,"angiogenesis|negative regulation of protein phosphorylation|regulation of B cell apoptotic process|protein dephosphorylation|apoptotic process|activation of APC-Cdc20 complex activity|neuron-neuron synaptic transmission|synapse assembly|central nervous system development|heart development|aging|response to nutrient|learning or memory|memory|locomotory behavior|positive regulation of cell proliferation|negative regulation of cell proliferation|response to glucose|response to zinc ion|regulation of neuron projection development|cell migration|dentate gyrus development|central nervous system neuron axonogenesis|negative regulation of cell migration|adult behavior|negative regulation of myelination|regulation of protein stability|negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle|regulation of synaptic transmission, GABAergic|central nervous system myelin maintenance|response to estradiol|regulation of cellular component size|regulation of myeloid cell apoptotic process|response to ATP|multicellular organismal response to stress|social behavior|peptidyl-tyrosine dephosphorylation|cellular response to decreased oxygen levels|response to drug|maternal behavior|negative regulation of apoptotic process|protein kinase B signaling|endothelial cell migration|response to ethanol|locomotor rhythm|negative regulation of cell size|negative regulation of organ growth|response to arsenic-containing substance|inositol phosphate dephosphorylation|phosphatidylinositol dephosphorylation|platelet-derived growth factor receptor signaling pathway|regulation of axon regeneration|cardiac muscle tissue development|forebrain morphogenesis|brain morphogenesis|negative regulation of epithelial cell proliferation|negative regulation of phagocytosis|negative regulation of axonogenesis|protein stabilization|positive regulation of sequence-specific DNA binding transcription factor activity|regulation of cell cycle|negative regulation of focal adhesion assembly|negative regulation of protein kinase B signaling|rhythmic synaptic transmission|canonical Wnt signaling pathway|synapse maturation|prepulse inhibition|male mating behavior|long-term synaptic potentiation|long term synaptic depression|regulation of cellular localization|prostate gland growth|dendritic spine morphogenesis|negative regulation of dendritic spine morphogenesis|positive regulation of ERK1 and ERK2 cascade|cellular response to hypoxia|negative regulation of ribosome biogenesis|negative regulation of cell aging|negative regulation of excitatory postsynaptic membrane potential|presynaptic membrane assembly|postsynaptic density assembly|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|negative regulation of G1/S transition of mitotic cell cycle|positive regulation of excitatory postsynaptic membrane potential|negative regulation of synaptic vesicle clustering|positive regulation of apoptotic signaling pathway|","magnesium ion binding|phosphatidylinositol-3-phosphatase activity|phosphoprotein phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|platelet-derived growth factor receptor binding|protein binding|protein tyrosine/serine/threonine phosphatase activity|anaphase-promoting complex binding|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity|enzyme binding|protein kinase binding|PDZ domain binding|inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity|phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity|",5,6,874000000,16.3%
Q8R216,0.919416995,0.009666667,1.238030306,-0.040666667,0.751963861,-0.329490792,0.134,0.084,-0.128,0.17,-0.043,-0.159,Q8R216,Sirt4,Q8R216_Sirt4,Q8R216,Sirt4,1,9,5,5,Q8R216,MOUSE,38037.7,21.3,1905,1905.1,52.44,52.44,,333,"NAD-dependent protein lipoamidase sirtuin-4, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial matrix|,regulation of glutamine family amino acid metabolic process|protein ADP-ribosylation|glutamine metabolic process|cellular response to DNA damage stimulus|negative regulation of cardiac muscle cell apoptotic process|peptidyl-lysine deacetylation|negative regulation of fatty acid oxidation|negative regulation of insulin secretion|positive regulation of lipid biosynthetic process|cellular response to hypoxia|tricarboxylic acid metabolic process|negative regulation of protein processing involved in protein targeting to mitochondrion|regulation of pyruvate dehydrogenase activity|,"NAD+ ADP-ribosyltransferase activity|protein binding|zinc ion binding|hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds|NAD-dependent protein deacetylase activity|biotinidase activity|lipoamidase activity|NAD+ binding|",5,9,473000000,21.3%
Q9DBG5,0.526056,-0.043,7.709389037,0.209333333,0.169457618,1.541814907,-0.301,-0.065,-0.077,-0.168,0.1,0.253,Q9DBG5,Plin3,Q9DBG5_Plin3,Q9DBG5,Plin3,1,5,4,4,Q9DBG5,MOUSE,47375.5,15.5,1906,1906.1,52.37,52.37,,437,Perilipin-3,cytoplasm|lipid particle|endosome membrane|membrane|intracellular membrane-bounded organelle|,transport|,,4,5,67800000,15.5%
Q8R480,0.953420192,0.002166667,0.689122579,-0.023666667,0.853272486,-0.192300308,0.009,0.015,0.018,0.201,-0.231,0.001,Q8R480,Nup85,Q8R480_Nup85,Q8R480,Nup85,1,6,5,5,Q8R480,MOUSE,75916,9.7,1907,1907.1,52.34,52.34,,656,Nuclear pore complex protein Nup85,condensed chromosome kinetochore|spindle pole|cytoplasm|plasma membrane|membrane|nuclear pore outer ring|nuclear membrane|kinetochore|,chemotaxis|protein transport|cytokine-mediated signaling pathway|lamellipodium assembly|macrophage chemotaxis|mRNA transport|,CCR2 chemokine receptor binding|,5,6,67600000,9.7%
Q9Z0V7,0.933608247,0.005833333,0.950278119,-0.047666667,0.803474667,-0.259038951,-0.181,0.387,-0.117,-0.257,0.108,0.095,Q9Z0V7,Timm17b,Q9Z0V7_Timm17b,Q9Z0V7,Timm17b,1,13,4,4,Q9Z0V7,MOUSE,18522.9,33.7,1908,1908.1,52.32,52.32,,172,Mitochondrial import inner membrane translocase subunit Tim17-B,mitochondrion|mitochondrial inner membrane|mitochondrial inner membrane presequence translocase complex|integral component of mitochondrial inner membrane|,intracellular protein transport|protein transmembrane transport|,P-P-bond-hydrolysis-driven protein transmembrane transporter activity|,4,13,3030000000,33.7%
P62878,0.514657719,0.0035,7.911920597,0.155,0.161736463,1.572610265,0.004,-0.058,-0.168,0.207,0.013,0.023,P62878,Rbx1,P62878_Rbx1,P62878,Rbx1,1,11,4,4,P62878,MOUSE,12730.2,30.5,1909,1909.1,52.26,52.26,,108,E3 ubiquitin-protein ligase RB,ubiquitin ligase complex|anaphase-promoting complex|cytosol|SCF ubiquitin ligase complex|VCB complex|cullin-RING ubiquitin ligase complex|Cul2-RING ubiquitin ligase complex|Cul3-RING ubiquitin ligase complex|Cul4A-RING E3 ubiquitin ligase complex|Cul4B-RING E3 ubiquitin ligase complex|Cul5-RING ubiquitin ligase complex|Cul7-RING ubiquitin ligase complex|nuclear SCF ubiquitin ligase complex|Cul4-RING E3 ubiquitin ligase complex|,DNA repair|ubiquitin-dependent protein catabolic process|protein monoubiquitination|protein ubiquitination|protein catabolic process|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|protein neddylation|,ubiquitin-protein transferase activity|protein binding|eukaryotic initiation factor 4E binding|zinc ion binding|ligase activity|NEDD8 transferase activity|ubiquitin protein ligase binding|protein complex binding|ubiquitin-ubiquitin ligase activity|ubiquitin protein ligase activity|cullin family protein binding|ubiquitin-protein transferase activity|,4,11,1650000000,30.5%
A2AI52,0.885307507,0.018666667,1.827525509,0.050666667,0.656519226,0.465280678,-0.173,-0.006,0.159,0.006,0.104,0.022,A2AI52,Usp8,A2AI52_Usp8,A2AI52,Usp8,1,5,5,5,A2AI52|Q80U87,MOUSE,124854.8,5.8,1910,1910.1,52.16,52.16,,1091,Ubiquitin carboxyl-terminal hydrolase 8,intracellular|nucleoplasm|cytoplasm|early endosome|Golgi apparatus|cytosol|extrinsic component of plasma membrane|midbody|acrosomal vesicle|,mitotic cytokinesis|endosome organization|Ras protein signal transduction|protein deubiquitination|proteasome-mediated ubiquitin-dependent protein catabolic process|regulation of proteasomal protein catabolic process|protein K63-linked deubiquitination|protein K48-linked deubiquitination|,cysteine-type endopeptidase activity|ubiquitin-specific protease activity|protein binding|,5,5,67600000,5.8%
Q6P9Q4,0.461918472,0.0355,9.092482971,0.175,0.123240004,1.762804137,-0.028,-0.098,-0.03,0.261,-0.012,0.12,Q6P9Q4,Fhod1,Q6P9Q4_Fhod1,Q6P9Q4,Fhod1,1,7,4,4,Q6P9Q4,MOUSE,130853.3,4.7,1911,1911.1,52.09,52.09,,1197,FH1/FH2 domain-containing protein 1,stress fiber|nucleus|cytosol|membrane|bleb|,positive regulation of transcription from RNA polymerase II promoter|positive regulation of stress fiber assembly|,actin binding|identical protein binding|,4,7,101000000,4.7%
P97823,0.57548373,0.002666667,6.867201233,-0.114666667,0.205721592,-1.401313724,-0.001,0.13,0.051,-0.056,-0.056,-0.052,P97823,Lypla1,P97823_Lypla1,P97823,Lypla1,1,12,4,4,P97823|J3QP56|P97823-2|D3Z111,MOUSE,25029.6,21.3,1912,1912.1,52.08,52.08,,230,Acyl-protein thioesterase 1,mitochondrion|cytosol|extracellular exosome|,protein depalmitoylation|fatty acid metabolic process|negative regulation of Golgi to plasma membrane protein transport|,palmitoyl-(protein) hydrolase activity|lipase activity|,4,12,1170000000,21.3%
P70699,0.140580414,-0.010666667,17.95364972,0.457333333,0.016018986,3.210772524,-0.392,-0.239,-0.087,0.202,0.005,0.447,P70699,Gaa,P70699_Gaa,P70699,Gaa,1,8,4,4,P70699,MOUSE,106987.4,7.2,1913,1913.1,52.07,52.07,,953,Lysosomal alpha-glucosidase,lysosome|lysosomal membrane|membrane|extracellular exosome|,maltose metabolic process|regulation of the force of heart contraction|diaphragm contraction|heart morphogenesis|glycogen metabolic process|glycogen catabolic process|striated muscle contraction|lysosome organization|locomotory behavior|tissue development|vacuolar sequestering|muscle cell cellular homeostasis|neuromuscular process controlling posture|neuromuscular process controlling balance|cardiac muscle contraction|,"alpha-1,4-glucosidase activity|carbohydrate binding|maltose alpha-glucosidase activity|",4,8,238000000,7.2%
Q91YM4,0.991556352,-0.0375,0.165732451,0.008333333,0.962557661,0.048748601,0.137,0.168,-0.43,0.033,-0.066,-0.067,Q91YM4,Tbrg4,Q91YM4_Tbrg4,Q91YM4,Tbrg4,1,5,4,4,Q91YM4|Q91YM4-2|E9PUT1,MOUSE,72025.6,10.9,1914,1914.1,52.06,52.06,,630,Protein TBRG4,mitochondrion|,protein phosphorylation|cellular respiration|,protein kinase activity|poly(A) RNA binding|,4,5,785000000,10.9%
Q91WK2,0.797504707,-0.025833333,3.139414136,0.223666667,0.48535397,0.738867324,-0.815,0.006,0.396,-0.046,-0.025,0.329,Q91WK2,Eif3h,Q91WK2_Eif3h,Q91WK2,Eif3h,1,7,5,5,Q91WK2,MOUSE,40002.7,17,1915,1915.1,51.96,51.96,,352,Eukaryotic translation initiation factor 3 subunit H,"eukaryotic translation initiation factor 3 complex|membrane|eukaryotic 43S preinitiation complex|eukaryotic 48S preinitiation complex|extracellular exosome|eukaryotic translation initiation factor 3 complex, eIF3m|",formation of translation preinitiation complex|translational initiation|,poly(A) RNA binding|translation initiation factor activity|,5,7,57000000,17.0%
Q8BH97,0.005723664,-0.028833333,34.97476506,1.765666667,0.000318071,6.822225344,-1.042,-0.65,-1.043,0.699,0.447,1.416,Q8BH97,Rcn3,Q8BH97_Rcn3,Q8BH97,Rcn3,1,6,3,3,Q8BH97,MOUSE,38000.9,13.7,1916,1916.1,51.95,51.95,,328,Reticulocalbin-3,endoplasmic reticulum lumen|,,,3,6,559000000,13.7%
P23589,0.885511519,-0.023333333,1.819695752,0.049333333,0.657703912,0.463527878,0.095,-0.023,-0.216,0.042,0.023,-0.061,P23589,Car5a,P23589_Car5a,P23589,Ca5a,1,9,5,5,P23589,MOUSE,34471.2,19,1917,1917.1,51.86,51.86,,299,"Carbonic anhydrase 5A, mitochondrial",mitochondrion|,gluconeogenesis|one-carbon metabolic process|,carbonate dehydratase activity|zinc ion binding|,5,9,206000000,19.0%
Q9D2V7,0.02721786,-0.043166667,26.85598078,0.651666667,0.002062538,4.896884741,-0.415,-0.354,-0.338,0.062,0.247,0.539,Q9D2V7,Coro7,Q9D2V7_Coro7,Q9D2V7,Coro7,1,7,6,6,Q9D2V7,MOUSE,101666.2,9.1,1918,1918.1,51.74,51.74,,922,Coronin-7,Golgi membrane|Golgi apparatus|trans-Golgi network|cytosol|membrane|integral component of membrane|cytoplasmic membrane-bounded vesicle|,Golgi to endosome transport|protein transport|actin filament polymerization|,actin binding|,6,7,694000000,9.1%
Q80UM7,0.010780707,0.013166667,31.80712099,0.691,0.000659611,6.002698776,-0.464,-0.261,-0.272,0.458,0.179,0.439,Q80UM7,Mogs,Q80UM7_Mogs,Q80UM7,Mogs,1,7,5,5,Q80UM7,MOUSE,92000.8,8.9,1919,1919.1,51.73,51.73,,834,Mannosyl-oligosaccharide glucosidase,endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular exosome|,protein N-linked glycosylation|oligosaccharide metabolic process|,mannosyl-oligosaccharide glucosidase activity|,5,7,457000000,8.9%
Q91W63,0.933608247,-0.030333333,0.955978493,0.063333333,0.80242075,0.260464514,0.239,0.195,-0.62,-0.152,0.194,-0.038,Q91W63,Nmrk1,Q91W63_Nmrk1,Q91W63,Nmrk1,1,5,4,4,Q91W63,MOUSE,22474.1,33.8,1920,1920.1,51.69,51.69,,195,Nicotinamide riboside kinase 1,,NAD biosynthetic process|phosphorylation|,ATP binding|metal ion binding|ribosylnicotinamide kinase activity|,4,5,395000000,33.8%
Q8BFR4,0.000552294,-0.2175,48.81964446,1.851,1.31231E-05,11.46036641,-1.165,-0.834,-1.43,0.602,0.82,0.702,Q8BFR4,Gns,Q8BFR4_Gns,Q8BFR4,Gns,1,9,6,6,Q8BFR4,MOUSE,61915.5,12.3,1921,1921.1,51.56,51.56,,544,N-acetylglucosamine-6-sulfatase,lysosome|extracellular exosome|,glycosaminoglycan metabolic process|,N-acetylglucosamine-6-sulfatase activity|sulfuric ester hydrolase activity|metal ion binding|,6,9,4440000000,12.3%
Q91YE6,0.578909417,-0.042333333,6.779336231,0.180666667,0.209926071,1.388446255,0.02,-0.028,-0.39,0.129,-0.014,0.029,Q91YE6,NotFound,Q91YE6_NotFound,Q91YE6,Ipo9,1,9,5,5,Q91YE6|E9QKZ2|E0CXB2|E0CY46,MOUSE,117076.9,5.9,1922,1922.1,51.41,51.41,,1041,Importin-9,nucleus|cytoplasm|membrane|,protein import into nucleus|ribosomal protein import into nucleus|ribosome biogenesis|protein stabilization|,Ran GTPase binding|protein transporter activity|histone binding|,5,9,985000000,5.9%
P97770,0.230392003,0.038,14.79231057,-0.3,0.033171793,-2.677556475,0.116,0.058,0.39,-0.06,-0.119,-0.157,P97770,Thumpd3,P97770_Thumpd3,P97770,Thumpd3,1,8,5,5,P97770|P97770-2|P97770-3,MOUSE,57285.9,15.6,1923,1923.1,51.38,51.38,,505,THUMP domain-containing protein 3,nucleolus|cytoplasm|,methylation|,RNA binding|methyltransferase activity|,5,8,560000000,15.6%
Q921G9,0.889263733,-0.047166667,1.769250967,-0.063,0.665387907,-0.452464848,-0.004,0.173,-0.216,0.061,-0.272,-0.025,Q921G9,Tjp3,Q921G9_Tjp3,Q921G9,Tjp3,1,6,6,6,Q921G9|Q9QXY1,MOUSE,99338.7,9.8,1924,1924.1,51.38,51.38,,904,Tight junction protein 3,nucleus|nucleoplasm|bicellular tight junction|cell surface|apical plasma membrane|cell junction|,regulation of G1/S transition of mitotic cell cycle|,protein binding|,6,6,426000000,9.8%
H3BJW3,0.939705289,-0.032,0.856450306,0.027333333,0.821022331,0.23536277,-0.224,0.011,0.076,-0.151,0.028,0.068,H3BJW3,Cpsf6,H3BJW3_Cpsf6,H3BJW3,Cpsf6,1,7,6,6,H3BJW3|H3BJ30|Q6NVF9,MOUSE,63583.9,14.4,1925,1925.1,51.36,51.36,,588,Cleavage and polyadenylation-specificity factor subunit 6,nucleus|nucleoplasm|mRNA cleavage factor complex|membrane|ribonucleoprotein complex|paraspeckles|,mRNA polyadenylation|mRNA processing|protein tetramerization|,nucleotide binding|mRNA binding|poly(A) RNA binding|RNA binding|,6,7,240000000,14.4%
P54731,0.935669179,0.0125,0.926887312,-0.023666667,0.807813801,-0.253059368,-0.025,0.124,-0.026,0.026,-0.094,0.07,P54731,Faf1,P54731_Faf1,P54731,Faf1,1,8,6,6,P54731,MOUSE,74318.2,8.9,1926,1926.1,51.32,51.32,,649,FAS-associated factor 1,nucleus|nuclear envelope|cytoplasm|cytosol|VCP-NPL4-UFD1 AAA ATPase complex|perinuclear region of cytoplasm|,apoptotic process|cytoplasmic sequestering of NF-kappaB|cell death|positive regulation of cell death|regulation of cell adhesion|positive regulation of protein complex assembly|regulation of protein catabolic process|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors|,protein binding|protein kinase binding|protein domain specific binding|heat shock protein binding|ubiquitin protein ligase binding|ubiquitin binding|NF-kappaB binding|,6,8,337000000,8.9%
Q91WU5,0.020231179,-0.037166667,28.37389807,0.597666667,0.001454153,5.212362576,-0.187,-0.285,-0.536,0.185,0.298,0.302,Q91WU5,As3mt,Q91WU5_As3mt,Q91WU5,As3mt,1,8,4,4,Q91WU5,MOUSE,42477.5,13,1927,1927.1,51.31,51.31,,376,Arsenite methyltransferase,mitochondrion|cytosol|,toxin metabolic process|arsonoacetate metabolic process|methylation|response to arsenic-containing substance|,S-adenosylmethionine-dependent methyltransferase activity|arsenite methyltransferase activity|methylarsonite methyltransferase activity|,4,8,523000000,13.0%
P52293,0.647450828,-0.016333333,5.420085428,-0.136,0.287072411,-1.157405286,0.037,0.171,-0.053,0.083,-0.248,-0.088,P52293,Kpna2,P52293_Kpna2,P52293,Kpna2,1,6,6,6,P52293|A2A602|F2Z431,MOUSE,58269.4,13.9,1928,1928.1,51.29,51.29,,529,Importin subunit alpha-1,nucleus|cytoplasm|,protein import into nucleus|,protein binding|protein transporter activity|,6,6,126000000,13.9%
Q62523,0.513922711,0.0045,7.961738328,0.241666667,0.159891791,1.582974252,-0.264,-0.171,0.086,0.138,-0.114,0.352,Q62523,Zyx,Q62523_Zyx,Q62523,Zyx,1,5,4,4,Q62523|Q7TQE2,MOUSE,61857,12.7,1929,1929.1,51.18,51.18,,564,Zyxin,stress fiber|nucleus|cytoplasm|cell-cell adherens junction|focal adhesion|,cell-matrix adhesion|transforming growth factor beta receptor signaling pathway|integrin-mediated signaling pathway|stress fiber assembly|regulation of inflammatory response|,protein binding|zinc ion binding|poly(A) RNA binding|,4,5,72300000,12.7%
Q8CDA1,0.923890139,-0.004666667,1.132620172,-0.026666667,0.77043851,-0.303885613,0.036,0.046,-0.056,0.073,-0.069,-0.058,Q8CDA1,Inpp5f,Q8CDA1_Inpp5f,Q8CDA1,Inpp5f,1,6,5,5,Q8CDA1|Q8CDA1-2|Q8CDA1-3|Q8CDA1-4,MOUSE,128861.2,4.5,1930,1930.1,51.09,51.09,,1132,Phosphatidylinositide phosphatase SAC2,intracellular|,cardiac muscle hypertrophy in response to stress|phosphatidylinositol catabolic process|phosphatidylinositol-mediated signaling|regulation of protein kinase B signaling|,phosphoric ester hydrolase activity|,5,6,121000000,4.5%
Q9D7N9,0.003361304,-0.0355,37.67629519,1.031666667,0.000170754,7.573765906,-0.323,-0.585,-0.746,0.56,0.325,0.556,Q9D7N9,Apmap,Q9D7N9_Apmap,Q9D7N9,Apmap,1,13,5,5,Q9D7N9,MOUSE,46604.7,19.5,1931,1931.1,51.02,51.02,,415,Adipocyte plasma membrane-associated protein,cell surface|membrane|integral component of membrane|extracellular exosome|,biosynthetic process|,arylesterase activity|strictosidine synthase activity|,5,13,1040000000,19.5%
P48025,0.73101227,0.051666667,4.097209559,-0.210666667,0.389295196,-0.921178992,0.106,-0.198,0.563,0.281,-0.199,-0.243,P48025,Syk,P48025_Syk,P48025,Syk,1,5,5,5,P48025|E9PWE9,MOUSE,71888.5,11.7,1932,1932.1,50.96,50.96,,629,Tyrosine-protein kinase SYK,nucleus|cytoplasm|cytosol|B cell receptor complex|extrinsic component of cytoplasmic side of plasma membrane|early phagosome|T cell receptor complex|protein complex|,activation of MAPK activity|angiogenesis|serotonin secretion|lymph vessel development|positive regulation of receptor internalization|adaptive immune response|macrophage activation involved in immune response|neutrophil activation involved in immune response|leukocyte activation involved in immune response|serotonin secretion by platelet|protein phosphorylation|leukocyte cell-cell adhesion|cell surface receptor signaling pathway|enzyme linked receptor protein signaling pathway|transmembrane receptor protein tyrosine kinase signaling pathway|G-protein coupled receptor signaling pathway|integrin-mediated signaling pathway|activation of JUN kinase activity|regulation of platelet activation|regulation of tumor necrosis factor-mediated signaling pathway|cell migration|peptidyl-serine phosphorylation|peptidyl-tyrosine phosphorylation|leukotriene biosynthetic process|cell differentiation|neutrophil chemotaxis|positive regulation of type I interferon production|regulation of superoxide anion generation|positive regulation of cell adhesion mediated by integrin|intracellular signal transduction|peptidyl-tyrosine autophosphorylation|defense response to bacterium|transcription factor import into nucleus|positive regulation of mast cell degranulation|regulation of neutrophil degranulation|beta selection|innate immune response|positive regulation of interleukin-3 biosynthetic process|positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process|positive regulation of B cell differentiation|positive regulation of gamma-delta T cell differentiation|positive regulation of bone resorption|positive regulation of alpha-beta T cell differentiation|positive regulation of alpha-beta T cell proliferation|protein autophosphorylation|blood vessel morphogenesis|positive regulation of cytokine secretion|positive regulation of peptidyl-tyrosine phosphorylation|regulation of phagocytosis|positive regulation of calcium-mediated signaling|B cell receptor signaling pathway|regulation of sequence-specific DNA binding transcription factor activity|regulation of ERK1 and ERK2 cascade|cellular response to molecule of fungal origin|regulation of arachidonic acid secretion|regulation of platelet aggregation|,protein kinase activity|protein serine/threonine kinase activity|protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|receptor signaling protein tyrosine kinase activity|receptor binding|integrin binding|protein binding|ATP binding|protein kinase binding|,5,5,366000000,11.7%
D3YZZ5,0.009108093,0.1025,32.66052491,1.296333333,0.000541935,6.226043937,-0.611,-0.375,-0.651,0.287,0.925,1.04,D3YZZ5,Tmed7,D3YZZ5_Tmed7,D3YZZ5,Tmed7,1,12,4,4,D3YZZ5|E9Q7G1,MOUSE,25542.4,20.9,1933,1933.1,50.7,50.7,,224,Transmembrane p24-trafficking protein 7,endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|integral component of membrane|extracellular exosome|,transport|,,4,12,683000000,20.9%
Q9QUM9,0.709100713,0.057833333,4.388941946,0.100333333,0.364003706,0.97387721,0.013,-0.04,0.05,-0.025,0.268,0.081,Q9QUM9,Psma6,Q9QUM9_Psma6,Q9QUM9,Psma6,1,5,4,4,Q9QUM9|E0CXB1,MOUSE,27828.4,21.5,1934,1934.1,50.67,50.67,,246,Proteasome subunit alpha type-6,"proteasome complex|cytoplasmic mRNA processing body|nucleus|nucleoplasm|cytoplasm|cytosol|proteasome core complex|polysome|nuclear matrix|proteasome core complex, alpha-subunit complex|myofibril|sarcomere|extracellular exosome|",skeletal muscle tissue development|proteasomal ubiquitin-independent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|positive regulation of NF-kappaB transcription factor activity|proteolysis involved in cellular protein catabolic process|,RNA binding|endopeptidase activity|threonine-type endopeptidase activity|NF-kappaB binding|,4,5,932000000,21.5%
P16045,0.995757571,0.004333333,0.05043909,0.001333333,0.988453153,0.015020903,-0.083,0.073,0.021,0.074,-0.05,-0.009,P16045,Lgals1,P16045_Lgals1,P16045,Lgals1,1,7,3,3,P16045,MOUSE,15207.9,33.3,1935,1935.1,50.65,50.65,,135,Galectin-1,proteinaceous extracellular matrix|extracellular space|intracellular|nucleus|cytoplasm|cell surface|extracellular exosome|extracellular matrix|,plasma cell differentiation|apoptotic process|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|signal transduction|negative regulation of cell-substrate adhesion|negative regulation of neuron projection development|T cell costimulation|multicellular organismal response to stress|positive regulation of erythrocyte aggregation|response to drug|positive regulation of I-kappaB kinase/NF-kappaB signaling|myoblast differentiation|response to axon injury|cellular response to glucose stimulus|cellular response to organic cyclic compound|maintenance of protein location|,glycoprotein binding|signal transducer activity|protein binding|galactose binding|galactoside binding|carbohydrate binding|lactose binding|protein homodimerization activity|laminin binding|poly(A) RNA binding|,3,7,582000000,33.3%
Q9DCD2,0.855039332,-0.040666667,2.313996585,-0.053333333,0.586948966,-0.570517106,0.07,-0.036,-0.076,0.034,-0.153,-0.083,Q9DCD2,Xab2,Q9DCD2_Xab2,Q9DCD2,Xab2,1,4,4,4,Q9DCD2,MOUSE,100784.5,6,1936,1936.1,50.63,50.63,,855,Pre-mRNA-splicing factor SYF1,membrane|catalytic step 2 spliceosome|,"blastocyst development|transcription-coupled nucleotide-excision repair|transcription, DNA-templated|mRNA processing|RNA splicing|",,4,4,160000000,6.0%
Q60715-2,0.000366358,-0.086833333,52.75950429,1.155,5.29724E-06,13.01953549,-0.596,-0.725,-0.672,0.42,0.478,0.574,Q60715,P4ha1,Q60715-2_P4ha1,Q60715-2,P4ha1,1,6,6,6,Q60715-2|E9Q7B0|Q60715,MOUSE,61170.1,15.9,1937,1937.1,50.58,50.58,,534,Isoform 2 of Prolyl 4-hydroxylase subunit alpha-1,mitochondrion|endoplasmic reticulum|endoplasmic reticulum lumen|membrane|procollagen-proline 4-dioxygenase complex|intracellular membrane-bounded organelle|,peptidyl-proline hydroxylation to 4-hydroxy-L-proline|collagen fibril organization|oxidation-reduction process|,"procollagen-proline 4-dioxygenase activity|iron ion binding|oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen|L-ascorbic acid binding|procollagen-proline 4-dioxygenase activity|",6,6,124000000,15.9%
Q8K224,0.894042447,-0.060833333,1.688411512,-0.053,0.677889409,-0.434276733,-0.107,0.139,-0.135,0.032,-0.257,-0.037,Q8K224,Nat10,Q8K224_Nat10,Q8K224,Nat10,1,7,7,7,Q8K224,MOUSE,116329.3,10,1938,1938.1,50.58,50.58,,1024,RNA cytidine acetyltransferase,nucleolus|membrane|,metabolic process|,ATP binding|N-acetyltransferase activity|poly(A) RNA binding|,7,7,1970000000,10.0%
P11031,0.774891394,-0.006666667,3.464123172,0.074,0.450388904,0.801408659,-0.139,-0.049,0.057,0.003,-0.014,0.102,P11031,Sub1,P11031_Sub1,P11031,Sub1,1,9,4,4,P11031,MOUSE,14427.2,30.7,1939,1939.1,50.57,50.57,,127,Activated RNA polymerase II transcriptional coactivator p15,nucleus|transcription factor complex|nucleolus|extracellular exosome|,regulation of transcription from RNA polymerase II promoter|transcription from RNA polymerase II promoter|positive regulation of transcription from RNA polymerase II promoter|SMAD protein signal transduction|,RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|single-stranded DNA binding|transcription coactivator activity|poly(A) RNA binding|,4,9,1760000000,30.7%
Q9JM76,0.744748173,0.013166667,3.907018858,-0.243666667,0.406722421,-0.885857406,-0.266,-0.012,0.683,-0.479,0.022,0.131,Q9JM76,Arpc3,Q9JM76_Arpc3,Q9JM76,Arpc3,1,6,4,4,Q9JM76|H7BWZ3|D3Z2F8|D3Z2F7,MOUSE,20752.5,25.2,1940,1940.1,50.54,50.54,,178,Actin-related protein 2/3 complex subunit 3,cytoplasm|Arp2/3 protein complex|focal adhesion|membrane|lamellipodium|extracellular exosome|,Arp2/3 complex-mediated actin nucleation|,structural constituent of cytoskeleton|actin filament binding|,4,6,2670000000,25.2%
Q4LDD4,0.600763538,0.035,6.32938061,-0.105333333,0.232842331,-1.311553645,0.028,0.123,0.112,-0.023,-0.035,0.005,Q4LDD4,Arap1,Q4LDD4_Arap1,Q4LDD4,Arap1,1,9,6,6,Q4LDD4|Q4LDD4-2|Q4LDD4-3|E9PUB0,MOUSE,163927.4,5.7,1941,1941.1,50.47,50.47,,1452,"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1",Golgi apparatus|trans-Golgi network|plasma membrane|cytoplasmic vesicle|Golgi cisterna membrane|,"positive regulation of receptor recycling|transforming growth factor beta receptor signaling pathway|SMAD protein import into nucleus|regulation of cell shape|positive regulation of GTPase activity|positive regulation of transcription, DNA-templated|regulation of cellular component movement|positive regulation of filopodium assembly|negative regulation of stress fiber assembly|SMAD protein signal transduction|","sequence-specific DNA binding transcription factor activity|GTPase activator activity|phosphatidylinositol-3,4,5-trisphosphate binding|transcription factor binding|type 1 angiotensin receptor binding|transcription regulatory region DNA binding|metal ion binding|R-SMAD binding|",6,9,819000000,5.7%
O70571,0.096320331,0.132833333,20.24029813,-1.266333333,0.009461722,-3.612132668,1.627,0.348,0.323,-0.486,-0.667,-0.348,O70571,Pdk4,O70571_Pdk4,O70571,Pdk4,1,10,6,6,O70571,MOUSE,46937.9,14.3,1942,1942.1,50.42,50.42,,412,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial matrix|,positive regulation of defense response to virus by host|glucose metabolic process|acetyl-CoA biosynthetic process from pyruvate|protein phosphorylation|regulation of pH|insulin receptor signaling pathway|cellular response to starvation|regulation of acetyl-CoA biosynthetic process from pyruvate|regulation of cellular ketone metabolic process|regulation of glucose metabolic process|regulation of fatty acid biosynthetic process|glucose homeostasis|response to starvation|regulation of bone resorption|regulation of fatty acid oxidation|cellular response to fatty acid|reactive oxygen species metabolic process|negative regulation of anoikis|,protein kinase activity|protein serine/threonine/tyrosine kinase activity|pyruvate dehydrogenase (acetyl-transferring) kinase activity|ATP binding|,6,10,751000000,14.3%
Q8VI94,0.469727509,0.051666667,8.895271113,-0.24,0.128965305,-1.734011468,0.013,0.036,0.466,-0.1,-0.081,-0.024,Q8VI94,Oasl1,Q8VI94_Oasl1,Q8VI94,Oasl1,1,9,7,7,Q8VI94|Q9Z2F2,MOUSE,59886.1,18.7,1943,1943.1,50.37,50.37,,511,2'-5'-oligoadenylate synthase-like protein 1,nucleolus|cytoplasm|membrane|,metabolic process|response to virus|negative regulation of viral genome replication|innate immune response|defense response to virus|,DNA binding|double-stranded RNA binding|ATP binding|poly(A) RNA binding|2'-5'-oligoadenylate synthetase activity|,7,9,1220000000,18.7%
Q9D187,0.99327985,-0.002166667,0.125538648,0.004333333,0.97150745,0.037086072,0.16,-0.068,-0.105,0.116,0.035,-0.151,Q9D187,Ciao2b,Q9D187_Ciao2b,Q9D187,Fam96b,1,8,4,4,Q9D187|F8WHV1|A0A1D5RMI0,MOUSE,17780.8,43.5,1944,1944.1,50.35,50.35,,163,Mitotic spindle-associated MMXD complex subunit MIP18,nucleus|nucleoplasm|cytoplasm|spindle|MMXD complex|CIA complex|,chromosome segregation|iron-sulfur cluster assembly|,,4,8,748000000,43.5%
P51163,0.970060845,-0.016,0.420512515,-0.014666667,0.907713404,-0.120433187,0.154,0.048,-0.228,-0.107,-0.014,0.051,P51163,Uros,P51163_Uros,P51163,Uros,1,8,4,4,P51163|Q3TPL3,MOUSE,28902.8,30.9,1945,1945.1,50.29,50.29,,265,Uroporphyrinogen-III synthase,mitochondrion|cytosol|,porphyrin-containing compound biosynthetic process|uroporphyrinogen III biosynthetic process|protoporphyrinogen IX biosynthetic process|heme biosynthetic process|response to antibiotic|cellular response to arsenic-containing substance|cellular response to amine stimulus|,uroporphyrinogen-III synthase activity|cofactor binding|,4,8,916000000,30.9%
Q6GSS7,0.965696166,-0.015333333,0.458372316,-0.034666667,0.899834766,-0.130779685,-0.446,-0.056,0.508,-0.355,0.017,0.24,Q6GSS7,Hist2h2aa1,Q6GSS7_Hist2h2aa1,Q6GSS7,Hist2h2aa1,1,10,4,1,Q6GSS7|Q64523|Q8BFU2|Q8CGP4|Q8R1M2|A0A0N4SV66|P27661|Q64522|Q3UA95,MOUSE,14095.2,35.3,1946,1946.1,50.26,12.39,,130,Histone H2A type 2-A,nucleosome|nucleus|extracellular exosome|,nucleosome assembly|,DNA binding|protein heterodimerization activity|,4,10,5310000000,35.3%
G3UYW1,0.954887447,0.006,0.664423106,-0.014666667,0.858139098,-0.185752646,0.063,-0.023,0,-0.001,-0.009,0.006,G3UYW1,Wdfy3,G3UYW1_Wdfy3,G3UYW1,Wdfy3,1,8,6,6,G3UYW1|A0A1D5RLV7|Q6VNB8|Q6VNB8-2,MOUSE,398912.3,2,1947,1947.1,50.23,50.23,,3526,WD repeat and FYVE domain-containing protein 3,nuclear envelope|cytoplasm|autophagosome|endomembrane system|inclusion body|PML body|extrinsic component of membrane|autophagosome|Atg12-Atg5-Atg16 complex|,endosomal transport|positive regulation of macroautophagy|aggrephagy|,"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity|phospholipid binding|1-phosphatidylinositol binding|metal ion binding|",6,8,1200000000,2.0%
Q9CR86,0.913375242,-0.013166667,1.351097303,-0.044333333,0.732639399,-0.356385002,0.147,0.078,-0.198,-0.177,0.032,0.039,Q9CR86,Carhsp1,Q9CR86_Carhsp1,Q9CR86,Carhsp1,1,12,4,4,Q9CR86,MOUSE,16290.2,23.6,1948,1948.1,50.11,50.11,,148,Calcium-regulated heat stable protein 1,cytoplasmic mRNA processing body|cytosol|P granule|extracellular exosome|cytoplasmic exosome (RNase complex)|,"regulation of transcription, DNA-templated|regulation of mRNA stability|",DNA binding|mRNA 3'-UTR binding|protein binding|,4,12,5900000000,23.6%
Q9CQ56,0.707463555,0.011666667,4.437139462,-0.119333333,0.359986367,-0.983382466,0.145,-0.013,0.082,0.154,-0.237,-0.061,Q9CQ56,Use1,Q9CQ56_Use1,Q9CQ56,Use1,1,9,5,5,Q9CQ56|E9Q496|Q9CQ56-2,MOUSE,30821.3,25.1,1949,1949.1,50.1,50.1,,270,Vesicle transport protein USE1,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,endoplasmic reticulum organization|protein transport|vesicle-mediated transport|regulation of ER to Golgi vesicle-mediated transport|endoplasmic reticulum tubular network organization|,,5,9,5910000000,25.1%
Q9QWR8,0.002068715,-0.029333333,40.40538342,0.694666667,9.10881E-05,8.313359605,-0.405,-0.406,-0.319,0.297,0.383,0.274,Q9QWR8,Naga,Q9QWR8_Naga,Q9QWR8,Naga,1,8,6,6,Q9QWR8,MOUSE,47747.3,17.3,1950,1950.1,50.04,50.04,,415,Alpha-N-acetylgalactosaminidase,cytoplasm|lysosome|extracellular exosome|,oligosaccharide metabolic process|carbohydrate catabolic process|glycoside catabolic process|glycolipid catabolic process|glycosylceramide catabolic process|,alpha-galactosidase activity|alpha-N-acetylgalactosaminidase activity|protein homodimerization activity|,6,8,1040000000,17.3%
Q8R313,0.956385108,-0.0105,0.640479821,-0.023666667,0.862883209,-0.179542443,-0.026,0.247,-0.217,0.025,-0.004,-0.088,Q8R313,NotFound,Q8R313_NotFound,Q8R313,Exoc6,1,4,4,4,Q3U9D6|Q8R313,MOUSE,93930.9,7.2,1951,1951.1,50.02,50.02,,802,Exocyst complex component 6,exocyst|plasma membrane|,vesicle docking involved in exocytosis|protein transport|erythrocyte differentiation|,protein binding|,4,4,316000000,7.2%
Q91WP0,0.01701319,-0.066833333,29.31863997,0.608333333,0.001169866,5.41580457,-0.396,-0.186,-0.531,0.272,0.165,0.275,Q91WP0,Masp2,Q91WP0_Masp2,Q91WP0,Masp2,1,7,6,6,Q91WP0,MOUSE,76998.6,10.5,1952,1952.1,50.02,50.02,,685,Mannan-binding lectin serine protease 2,extracellular exosome|,"complement activation, lectin pathway|proteolysis|complement activation, classical pathway|",complement component C4b binding|serine-type endopeptidase activity|calcium ion binding|protein binding|peptidase activity|calcium-dependent protein binding|,6,7,1680000000,10.5%
P47915,0.21736368,-0.010666667,15.27753569,0.368666667,0.029665142,2.761154259,-0.22,-0.031,-0.334,0.03,0.391,0.1,P47915,Rpl29,P47915_Rpl29,P47915,Rpl29,1,15,5,5,P47915|F6QL70|W4VSN7|F6YH22,MOUSE,17643.7,30.6,1953,1953.1,49.98,49.98,,160,60S ribosomal protein L29,ribosome|,translation|,structural constituent of ribosome|,5,15,8720000000,30.6%
Q91X72,0.701917801,0.110833333,4.504984026,-0.231,0.354406434,-0.995664717,-0.056,-0.025,0.76,0.047,-0.182,0.121,Q91X72,Hpx,Q91X72_Hpx,Q91X72,Hpx,1,8,5,5,Q91X72,MOUSE,52058.5,10,1954,1954.1,49.97,49.97,,460,Hemopexin,extracellular space|extracellular exosome|blood microparticle|,positive regulation of immunoglobulin production|positive regulation of humoral immune response mediated by circulating immunoglobulin|transport|hemoglobin metabolic process|heme metabolic process|positive regulation of tyrosine phosphorylation of Stat1 protein|regulation of protein metabolic process|positive regulation of response to interferon-gamma|positive regulation of interferon-gamma-mediated signaling pathway|,heme binding|metal ion binding|,5,8,604000000,10.0%
Q3TRM4,0.818423797,-0.050333333,2.814745431,0.078,0.523028623,0.674062133,0.055,-0.012,-0.311,-0.019,-0.01,-0.005,Q3TRM4,Pnpla6,Q3TRM4_Pnpla6,Q3TRM4,Pnpla6,1,6,5,5,Q3TRM4|A0A140LI54|Q3TRM4-3|Q3TRM4-2|A0A140LHU9|Q3TRM4-4,MOUSE,150961.1,6.3,1955,1955.1,49.93,49.93,,1355,Neuropathy target esterase,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,angiogenesis|organ morphogenesis|lipid catabolic process|phosphatidylcholine metabolic process|,lysophospholipase activity|carboxylic ester hydrolase activity|,5,6,753000000,6.3%
O35387,0.494090387,-0.060666667,8.322940341,0.222666667,0.147131603,1.641619929,-0.061,0.001,-0.456,0.077,0.068,0.007,O35387,Hax1,O35387_Hax1,O35387,Hax1,1,9,4,4,O35387|A0A0G2JDP0|A0A0G2JFF9|A0A0G2JE46|A0A0G2JEE6|A0A0G2JGR0,MOUSE,31653.8,17.5,1956,1956.1,49.9,49.9,,280,HCLS1-associated protein X-1,transcription factor complex|cytoplasm|mitochondrion|mitochondrial outer membrane|mitochondrial intermembrane space|endoplasmic reticulum|actin cytoskeleton|cytoplasmic membrane-bounded vesicle|sarcoplasmic reticulum|lamellipodium|nuclear membrane|,cell surface receptor signaling pathway|positive regulation of phosphatidylinositol 3-kinase signaling|regulation of actin filament polymerization|positive regulation of granulocyte differentiation|positive regulation of peptidyl-serine phosphorylation|negative regulation of apoptotic process|positive regulation of transcription from RNA polymerase II promoter|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of protein kinase B signaling|cellular response to cytokine stimulus|positive regulation of actin cytoskeleton reorganization|,protein binding|interleukin-1 binding|protein N-terminus binding|,4,9,811000000,17.5%
Q8VCH7,0.481746078,-0.067,8.516269618,0.276666667,0.140725577,1.672895404,-0.066,-0.003,-0.547,0.212,0.064,-0.062,Q8VCH7,Rdh10,Q8VCH7_Rdh10,Q8VCH7,Rdh10,1,7,5,5,Q8VCH7,MOUSE,38759.5,18.1,1957,1957.1,49.79,49.79,,341,Retinol dehydrogenase 10,cytoplasm|endoplasmic reticulum membrane|membrane|integral component of membrane|cell body|,metanephros development|in utero embryonic development|retinoic acid biosynthetic process|visual perception|gonad development|organ morphogenesis|neural crest cell development|embryonic camera-type eye development|embryonic forelimb morphogenesis|retinol metabolic process|retinal metabolic process|ear development|nose development|embryonic organ development|embryonic viscerocranium morphogenesis|oxidation-reduction process|primary lung bud formation|bud elongation involved in lung branching|,retinol dehydrogenase activity|NADP-retinol dehydrogenase activity|,5,7,1420000000,18.1%
Q5SV02,0.617494432,0.018666667,5.9924784,0.132,0.251624057,1.254838373,0.045,-0.095,-0.092,0.23,-0.052,0.076,Q5SV02,Rad50,Q5SV02_Rad50,Q5SV02,Rad50,1,5,5,5,Q5SV02|P70388|P70388-2|E9PUJ2|P70388-4|P70388-3,MOUSE,154685.1,4.3,1958,1958.1,49.67,49.67,,1312,DNA repair protein RAD50,"nuclear chromosome, telomeric region|nucleus|nucleoplasm|membrane|Mre11 complex|site of double-strand break|pronucleus|","regulation of mitotic recombination|DNA catabolic process, endonucleolytic|DNA repair|double-strand break repair|DNA recombination|cellular response to DNA damage stimulus|telomere maintenance via telomerase|regulation of mitotic cell cycle|positive regulation of protein autophosphorylation|DNA duplex unwinding|positive regulation of kinase activity|chromosome organization|chromosome organization involved in meiosis|nucleic acid phosphodiester bond hydrolysis|","DNA binding|protein binding, bridging|single-stranded DNA endodeoxyribonuclease activity|ATP-dependent DNA helicase activity|3'-5' exonuclease activity|",5,5,416000000,4.3%
Q8R574,0.846769943,-0.0025,2.398762499,0.163,0.57560393,0.588677198,-0.521,-0.241,0.51,-0.033,-0.107,0.377,Q8R574,Prpsap2,Q8R574_Prpsap2,Q8R574,Prpsap2,1,6,4,3,Q8R574,MOUSE,41279.4,13.5,1959,1959.1,49.67,35.19,,369,Phosphoribosyl pyrophosphate synthase-associated protein 2,ribose phosphate diphosphokinase complex|,nucleotide biosynthetic process|bone development|,magnesium ion binding|ribose phosphate diphosphokinase activity|,4,6,811000000,13.5%
B1AT82,0.811763387,-0.025333333,2.928643965,-0.098666667,0.509489929,-0.697069839,0.176,-0.233,0.129,-0.24,0.029,-0.013,B1AT82,Prpsap1,B1AT82_Prpsap1,B1AT82,Prpsap1,1,3,4,3,B1AT82|Q9D0M1,MOUSE,42809.1,14.5,1959,1959.2,40.78,26.3,,385,"MCG6846, isoform CRA_c",ribose phosphate diphosphokinase complex|,nucleotide biosynthetic process|negative regulation of kinase activity|,magnesium ion binding|ribose phosphate diphosphokinase activity|kinase binding|enzyme regulator activity|,3,3,29100000,10.9%
Q8R093,0.002159674,-0.144166667,40.10601743,1.098333333,9.75884E-05,8.306201174,-0.801,-0.435,-0.844,0.378,0.504,0.333,Q8R093,Upp2,Q8R093_Upp2,Q8R093,Upp2,1,8,5,5,Q8R093|A2APN2|Q8CGR7,MOUSE,38544.7,23.6,1960,1960.1,49.63,49.63,,338,Uridine phosphorylase,cytoplasm|type III intermediate filament|,nucleotide catabolic process|UMP salvage|,uridine phosphorylase activity|,5,8,1030000000,23.6%
Q8K4K6,0.884484678,0.038,1.881158823,-0.074666667,0.648461382,-0.477361445,0.12,-0.227,0.333,0.132,-0.079,-0.051,Q8K4K6,Pank1,Q8K4K6_Pank1,Q8K4K6,Pank1,1,7,6,3,Q8K4K6|Q8K4K6-2|Q8R2W9,MOUSE,60832.1,8.7,1961,1961.1,49.55,22.5,,548,Pantothenate kinase 1,nucleus|cytosol|clathrin coat|recycling endosome|cell periphery|,coenzyme A biosynthetic process|phosphorylation|,pantothenate kinase activity|ATP binding|,6,7,403000000,8.7%
Q3U4S0,0.64206681,-0.052,5.499005766,0.204666667,0.281902822,1.171313555,-0.094,-0.479,0.11,0.25,0.012,-0.111,Q3U4S0,Pank2,Q3U4S0_Pank2,Q3U4S0,Pank2,1,2,5,2,Q3U4S0|V9GXP9|V9GX56,MOUSE,49144.1,12.8,1961,1961.2,39.91,12.86,,443,Pantothenate kinase 2,mitochondrion|cytosol|,spermatid development|aerobic respiration|coenzyme A biosynthetic process|phosphorylation|regulation of fatty acid metabolic process|regulation of mitochondrial membrane potential|mitochondrion morphogenesis|regulation of triglyceride metabolic process|regulation of bile acid metabolic process|,pantothenate kinase activity|ATP binding|,2,2,81600000,7.6%
Q91YY4,0.730301281,0.047833333,4.123117697,-0.140333333,0.386979742,-0.92596068,-0.152,0.428,0.078,-0.036,-0.028,-0.003,Q91YY4,Atpaf2,Q91YY4_Atpaf2,Q91YY4,Atpaf2,1,7,5,5,A0A0R4J1C5|Q91YY4,MOUSE,33459.6,13.4,1962,1962.1,49.54,49.54,,289,ATP synthase mitochondrial F1 complex assembly factor 2,mitochondrion|nuclear speck|,proton-transporting ATP synthase complex assembly|,,5,7,1120000000,13.4%
E9Q3X0,0.241250094,-0.082,14.46714409,0.403333333,0.035750786,2.628346966,-0.521,-0.343,0.013,0.071,0.257,0.031,E9Q3X0,Mvp,E9Q3X0_Mvp,E9Q3X0,Mvp,1,6,4,4,E9Q3X0|Q9EQK5,MOUSE,97140.9,5.5,1963,1963.1,49.5,49.5,,870,Major vault protein,nucleus|cytoplasm|cytoskeleton|membrane|perinuclear region of cytoplasm|extracellular exosome|,negative regulation of signaling|negative regulation of protein autophosphorylation|ERBB signaling pathway|negative regulation of protein tyrosine kinase activity|,protein kinase binding|protein phosphatase binding|,4,6,362000000,5.5%
Q3UVG3,0.956972055,4.33681E-19,0.615796083,0.017333333,0.867801491,0.172950235,-0.09,0.067,-0.003,0.15,-0.065,-0.059,Q3UVG3,Fam91a1,Q3UVG3_Fam91a1,Q3UVG3,Fam91a1,1,8,5,5,Q3UVG3,MOUSE,94203.5,6.9,1964,1964.1,49.49,49.49,,837,Protein FAM91A1,,,,5,8,1830000000,6.9%
P59708,0.386623778,0.016166667,10.7094341,-0.202333333,0.084929113,-2.020350496,-0.016,0.197,0.171,-0.125,-0.145,0.015,P59708,Sf3b6,P59708_Sf3b6,P59708,Sf3b6,1,12,5,5,P59708,MOUSE,14698.7,34.4,1965,1965.1,49.47,49.47,,125,Splicing factor 3B subunit 6,nucleus|nucleoplasm|U12-type spliceosomal complex|,blastocyst formation|mRNA processing|RNA splicing|,nucleotide binding|poly(A) RNA binding|,5,12,1440000000,34.4%
Q8C0S1,0.408707826,0.0345,10.18833106,-0.205,0.095756198,-1.93809207,0.01,0.128,0.273,-0.016,-0.181,-0.007,Q8C0S1,Dis3l,Q8C0S1_Dis3l,Q8C0S1,Dis3l,1,7,6,6,Q8C0S1|Q8C0S1-2,MOUSE,121594,7.5,1966,1966.1,49.44,49.44,,1053,DIS3-like exonuclease 1,nuclear exosome (RNase complex)|cytoplasmic exosome (RNase complex)|cytoplasm|centrosome|plasma membrane|,"rRNA processing|mRNA catabolic process|rRNA catabolic process|RNA phosphodiester bond hydrolysis, exonucleolytic|",3'-5'-exoribonuclease activity|RNA binding|enzyme binding|,6,7,75200000,7.5%
P53026,0.913375242,0.014166667,1.351043627,0.127666667,0.732648454,0.356372333,-0.468,-0.056,0.375,-0.563,0.749,0.048,P53026,NotFound,P53026_NotFound,P53026,Rpl10a,1,11,4,4,P53026|Q5XJF6,MOUSE,25087.1,16.1,1967,1967.1,49.37,49.37,,217,60S ribosomal protein L10a,nucleus|nucleolus|cytoplasm|mitochondrion|focal adhesion|membrane|cytosolic large ribosomal subunit|extracellular exosome|,translation|,structural constituent of ribosome|poly(A) RNA binding|,4,11,5620000000,16.1%
Q9CZ44-3,0.005373909,-0.053,35.33723814,0.905333333,0.000292601,6.919456868,-0.449,-0.661,-0.407,0.334,0.246,0.619,Q9CZ44,Nsfl1c,Q9CZ44-3_Nsfl1c,Q9CZ44-3,Nsfl1c,1,5,4,4,Q9CZ44-3|Q9CZ44|A2AT02|Q9CZ44-2,MOUSE,40952.5,13.9,1968,1968.1,49.24,49.24,,370,Isoform 3 of NSFL1 cofactor p47,nucleus|nucleoplasm|chromosome|cytoplasm|Golgi stack|cytosol|plasma membrane|intermediate filament cytoskeleton|,autophagosome assembly|Golgi organization|nuclear envelope reassembly|proteasome-mediated ubiquitin-dependent protein catabolic process|regulation of catalytic activity|membrane fusion|,protein binding|phospholipid binding|protein phosphatase type 1 regulator activity|ubiquitin binding|ATPase binding|,4,5,497000000,13.9%
Q8BH15,0.938054337,0.011333333,0.873643826,-0.020666667,0.817778366,-0.23963934,-0.008,-0.043,0.116,0.036,-0.03,-0.003,Q8BH15,Cnot10,Q8BH15_Cnot10,Q8BH15,Cnot10,1,7,5,5,Q8BH15|Q8BH15-2|Q8BH15-3|Q8BH15-4|A0A1L1SQF2|A0A1L1SS47|Q8BH15-5|A0A1L1SQA7,MOUSE,82957.8,9,1969,1969.1,49.21,49.21,,744,CCR4-NOT transcription complex subunit 10,nucleus|cytoplasm|membrane|CCR4-NOT complex|,"transcription, DNA-templated|regulation of transcription, DNA-templated|regulation of translation|gene silencing by RNA|",,5,7,102000000,9.0%
Q9CWS1,0.926033297,-0.042333333,1.086688876,0.037333333,0.778629964,0.292812556,-0.007,-0.247,0.071,0.026,-0.2,0.103,Q9CWS1,Rnf135,Q9CWS1_Rnf135,Q9CWS1,Rnf135,1,4,3,3,Q9CWS1|Q9CWS1-2,MOUSE,47259.6,9.1,1970,1970.1,49.18,49.18,,417,E3 ubiquitin-protein ligase RNF135,cytoplasm|,protein ubiquitination|positive regulation of interferon-beta production|innate immune response|regulation of innate immune response|,ubiquitin-protein transferase activity|protein binding|zinc ion binding|ligase activity|ribonucleoprotein complex binding|,3,4,132000000,9.1%
B1ART2,0.982507762,-0.0185,0.275864437,-0.009666667,0.938455224,-0.080191401,0.109,0.018,-0.168,0.135,-0.032,-0.173,B1ART2,Vps13d,B1ART2_Vps13d,B1ART2,Vps13d,1,8,4,4,B1ART2|B1ART1,MOUSE,494896.4,1.3,1971,1971.1,49.13,49.13,,4390,Vacuolar protein sorting 13D,intracellular|cell|extrinsic component of membrane|extracellular exosome|,protein targeting to vacuole|protein retention in Golgi apparatus|,,4,8,281000000,1.3%
Q8BK67,0.99643062,-0.009333333,0.043654954,-0.001333333,0.989998427,-0.013010607,-0.126,-0.008,0.108,0.061,-0.123,0.032,Q8BK67,Rcc2,Q8BK67_Rcc2,Q8BK67,Rcc2,1,6,4,4,Q8BK67,MOUSE,56724,12.3,1972,1972.1,49.11,49.11,,520,Protein RCC2,"nucleus|nucleolus|microtubule|plasma membrane|midbody|early endosome membrane|chromosome, centromeric core domain|mitotic spindle midzone|membrane|",endosome organization|mitotic nuclear division|integrin-mediated signaling pathway|regulation of fibroblast migration|positive regulation of G2/M transition of mitotic cell cycle|regulation of cell migration|negative regulation of GTPase activity|establishment of protein localization|focal adhesion assembly|cell division|negative regulation of focal adhesion assembly|positive regulation of attachment of spindle microtubules to kinetochore|chromosome passenger complex localization to kinetochore|activation of GTPase activity|negative regulation of substrate adhesion-dependent cell spreading|regulation of ruffle assembly|,microtubule binding|protein kinase binding|protein domain specific binding|small GTPase binding|poly(A) RNA binding|Rac GTPase binding|,4,6,129000000,12.3%
E9Q0N0,0.326803699,0.010833333,12.08001333,0.300333333,0.061943917,2.243229192,-0.178,-0.284,0.044,0.104,0.016,0.363,E9Q0N0,Itsn1,E9Q0N0_Itsn1,E9Q0N0,Itsn1,1,6,5,5,E9Q0N0|Q9Z0R4|E9Q3I5|Q9Z0R4-2|E9Q3I4|E9Q3I9|E9Q3I8|Q6NZJ5,MOUSE,195806.3,3.6,1973,1973.1,49.1,49.1,,1719,Intersectin-1,plasma membrane|coated pit|lamellipodium|endocytic vesicle|,small GTPase mediated signal transduction|regulation of Rho protein signal transduction|positive regulation of phosphorylation|negative regulation of neuron apoptotic process|positive regulation of GTPase activity|positive regulation of protein kinase B signaling|,Rho guanyl-nucleotide exchange factor activity|calcium ion binding|protein binding|kinase activator activity|protein complex scaffold|proline-rich region binding|,5,6,214000000,3.6%
A2AJ88,0.965288537,-0.0495,0.466751408,-0.017,0.898100337,-0.133059512,-0.01,0.15,-0.263,-0.003,-0.169,-0.002,A2AJ88,Pnpla7,A2AJ88_Pnpla7,A2AJ88,Pnpla7,1,7,5,5,A2AJ88|A2AJ88-2|A2AJ88-3|A0A0A6YWJ6,MOUSE,151860.9,4.3,1974,1974.1,49.08,49.08,,1352,Patatin-like phospholipase domain-containing protein 7,lysosomal membrane|endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|nuclear membrane|mitochondrial membrane|,lipid metabolic process|developmental process|,lysophospholipase activity|lysophospholipase activity|,5,7,274000000,4.3%
E9QJX9,0.790377854,-0.011333333,3.268265471,-0.09,0.471165468,-0.763994037,-0.018,-0.076,0.195,0.027,-0.22,0.024,E9QJX9,NotFound,E9QJX9_NotFound,E9QJX9,Stat2,1,11,5,5,E9QJX9|Q9WVL2|Q9QXJ2,MOUSE,105911.5,6,1975,1975.1,49.04,49.04,,923,Signal transducer and activator of transcription,nucleus|cytoplasm|plasma membrane|,"positive regulation of defense response to virus by host|transcription, DNA-templated|regulation of transcription, DNA-templated|signal transduction|activation of mitophagy in response to mitochondrial depolarization|",DNA binding|sequence-specific DNA binding transcription factor activity|signal transducer activity|identical protein binding|,5,11,1120000000,6.0%
Q3UFY8,0.773512169,-0.026833333,3.534892088,-0.091,0.443109225,-0.815249664,0.078,0.122,-0.144,0.025,-0.044,-0.198,Q3UFY8,Trmt10c,Q3UFY8_Trmt10c,Q3UFY8,Trmt10c,1,11,4,4,Q3UFY8,MOUSE,48727.2,12.5,1976,1976.1,49.02,49.02,,414,tRNA methyltransferase 10 homolog C,nucleoplasm|mitochondrion|mitochondrial nucleoid|,mitochondrial RNA 5'-end processing|tRNA processing|methylation|,methyltransferase activity|poly(A) RNA binding|,4,11,996000000,12.5%
Q8BYA0,0.459323034,0.010666667,9.158825315,0.168666667,0.121371709,1.773398328,-0.146,-0.071,-0.004,0.144,-0.026,0.167,Q8BYA0,Tbcd,Q8BYA0_Tbcd,Q8BYA0,Tbcd,1,8,5,5,Q8BYA0,MOUSE,135087.3,5.1,1977,1977.1,48.83,48.83,,1196,Tubulin-specific chaperone D,cytoplasm|microtubule|adherens junction|bicellular tight junction|lateral plasma membrane|,microtubule cytoskeleton organization|protein folding|post-chaperonin tubulin folding pathway|negative regulation of cell-substrate adhesion|negative regulation of microtubule polymerization|adherens junction assembly|positive regulation of GTPase activity|bicellular tight junction assembly|,GTPase activator activity|beta-tubulin binding|,5,8,1090000000,5.1%
Q60737,0.457736715,-0.0025,9.201311296,0.195666667,0.120190148,1.780895897,-0.08,0.037,-0.258,-0.003,0.099,0.19,Q60737,Csnk2a1,Q60737_Csnk2a1,Q60737,Csnk2a1,1,10,5,5,Q60737,MOUSE,45246.8,15.6,1978,1978.1,48.83,48.83,,391,Casein kinase II subunit alpha,PcG protein complex|,"transcription, DNA-templated|regulation of transcription, DNA-templated|protein phosphorylation|positive regulation of cell proliferation|Wnt signaling pathway|positive regulation of Wnt signaling pathway|positive regulation of cell growth|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of protein catabolic process|rhythmic process|mitotic spindle checkpoint|",protein serine/threonine kinase activity|ATP binding|,5,10,379000000,15.6%
Q80U95,0.488226583,-0.012666667,8.424189122,0.168,0.143741141,1.655480029,-0.007,-0.036,-0.247,0.155,0.036,0.023,Q80U95,Ube3c,Q80U95_Ube3c,Q80U95,Ube3c,1,7,5,5,Q80U95|A0A0G2JDR9,MOUSE,125114.3,6,1979,1979.1,48.83,48.83,,1083,Ubiquitin-protein ligase E3C,nucleus|cytoplasm|,protein polyubiquitination|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|,ubiquitin-protein transferase activity|ligase activity|,5,7,818000000,6.0%
Q91XT4,0.273334376,0.044,13.54221861,0.418666667,0.044236233,2.47822037,-0.22,0.007,-0.283,0.021,0.147,0.592,Q91XT4,Sec16b,Q91XT4_Sec16b,Q91XT4,Sec16b,1,8,6,6,Q91XT4,MOUSE,116081.5,5.3,1980,1980.1,48.82,48.82,,1051,Protein transport protein Sec16B,Golgi membrane|endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,endoplasmic reticulum organization|peroxisome organization|positive regulation of gene expression|protein transport|peroxisome fission|COPII vesicle coating|positive regulation of protein exit from endoplasmic reticulum|protein localization to endoplasmic reticulum|,,6,8,25900000000,5.3%
P62307,0.982930903,-0.0255,0.268786923,-0.013666667,0.939985832,-0.078192312,-0.406,0.14,0.21,-0.084,-0.093,0.08,P62307,Snrpf,P62307_Snrpf,P62307,Snrpf,1,12,4,4,P62307,MOUSE,9782.1,58.1,1981,1981.1,48.76,48.76,,86,Small nuclear ribonucleoprotein F,spliceosomal complex|U7 snRNP|U1 snRNP|U4 snRNP|U12-type spliceosomal complex|small nucleolar ribonucleoprotein complex|cytosol|small nuclear ribonucleoprotein complex|methylosome|pICln-Sm protein complex|SMN-Sm protein complex|catalytic step 2 spliceosome|,"spliceosomal snRNP assembly|mRNA splicing, via spliceosome|RNA splicing|activation of mitophagy in response to mitochondrial depolarization|",RNA binding|,4,12,3490000000,58.1%
Q80X98,0.629307568,0.0175,5.818117171,-0.131,0.261931833,-1.225218019,0.04,0.133,0.076,0.138,-0.135,-0.147,Q80X98,Dhx38,Q80X98_Dhx38,Q80X98,Dhx38,1,6,6,6,Q80X98,MOUSE,141419,6.4,1982,1982.1,48.76,48.76,,1228,DEAH (Asp-Glu-Ala-His) box polypeptide 38,spliceosomal complex|cytoplasm|membrane|catalytic step 2 spliceosome|,"mRNA splicing, via spliceosome|",ATP-dependent RNA helicase activity|ATP binding|poly(A) RNA binding|,6,6,272000000,6.4%
P84089,0.933153013,-0.008166667,0.970035213,-0.022333333,0.79982777,-0.263852207,-0.036,-0.026,0.071,-0.056,0.046,-0.048,P84089,Erh,P84089_Erh,P84089,Erh,1,13,4,4,P84089|G3UW85|A0A1W2P7T3|A0A1W2P7H9,MOUSE,12429.9,52.8,1983,1983.1,48.64,48.64,,104,Enhancer of rudimentary homolog,membrane|midbody|,osteoblast differentiation|pyrimidine nucleotide biosynthetic process|cell cycle|positive regulation of Notch signaling pathway|,poly(A) RNA binding|,4,13,1280000000,52.8%
Q6PDL0,0.367306672,-0.0005,11.10342435,0.239666667,0.07756353,2.085804087,-0.096,-0.097,-0.168,0.311,-0.065,0.112,Q6PDL0,Dync1li2,Q6PDL0_Dync1li2,Q6PDL0,Dync1li2,1,8,4,4,Q6PDL0|A0A1D5RM94,MOUSE,54502.7,12.8,1984,1984.1,48.59,48.59,,492,Cytoplasmic dynein 1 light intermediate chain 2,centrosome|cytoplasmic dynein complex|microtubule|membrane|,microtubule cytoskeleton organization|transport|microtubule-based movement|metabolic process|centrosome localization|,microtubule motor activity|protein binding|ATP binding|,4,8,175000000,12.8%
Q9D8Z1,0.907855509,0.027833333,1.484096757,-0.041666667,0.710542933,-0.387348465,0.08,0.108,-0.042,0.149,-0.15,0.022,Q9D8Z1,Ascc1,Q9D8Z1_Ascc1,Q9D8Z1,Ascc1,1,14,5,5,Q9D8Z1,MOUSE,41564.3,14.8,1985,1985.1,48.56,48.56,,356,Activating signal cointegrator 1 complex subunit 1,transcription factor complex|cytoplasm|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",RNA binding|,5,14,1130000000,14.8%
Q8C570,0.857449938,-0.011166667,2.256579624,-0.049,0.59476039,-0.558365753,0.007,-0.018,0.051,-0.025,-0.131,0.049,Q8C570,Rae1,Q8C570_Rae1,Q8C570,Rae1,1,5,4,4,Q8C570,MOUSE,41592,16.3,1986,1986.1,48.54,48.54,,368,mRNA export factor,nucleus|nucleolus|cytoplasm|,cellular response to organic cyclic compound|,,4,5,294000000,16.3%
Q9JHW2,0.606068848,-0.072666667,6.2627906,0.174,0.236439994,1.301837292,-0.152,0.066,-0.393,-0.026,-0.045,0.114,Q9JHW2,Nit2,Q9JHW2_Nit2,Q9JHW2,Nit2,1,5,4,4,Q9JHW2,MOUSE,30843.5,24.6,1987,1987.1,48.52,48.52,,276,Omega-amidase NIT2,cytoplasm|mitochondrion|centrosome|extracellular exosome|,oxaloacetate metabolic process|asparagine metabolic process|glutamine metabolic process|,omega-amidase activity|,4,5,51600000,24.6%
Q9Z1Z2,0.770893564,-0.033,3.5899324,-0.120666667,0.437528915,-0.826053192,-0.136,-0.008,0.226,-0.335,0.026,0.029,Q9Z1Z2,Strap,Q9Z1Z2_Strap,Q9Z1Z2,Strap,1,5,5,5,Q9Z1Z2,MOUSE,38726.8,17.1,1988,1988.1,48.51,48.51,,350,Serine-threonine kinase receptor-associated protein,nucleus|nucleoplasm|cytoplasm|cytosol|plasma membrane|SMN complex|SMN-Sm protein complex|,negative regulation of transcription from RNA polymerase II promoter|spliceosomal snRNP assembly|negative regulation of epithelial cell migration|negative regulation of epithelial to mesenchymal transition|maintenance of gastrointestinal epithelium|negative regulation of transforming growth factor beta receptor signaling pathway|negative regulation of epithelial cell proliferation|negative regulation of pathway-restricted SMAD protein phosphorylation|,receptor binding|protein binding|poly(A) RNA binding|,5,5,608000000,17.1%
E0CZ22,0.759504567,0.018666667,3.71778134,-0.110666667,0.424836543,-0.850310369,0.062,-0.075,0.235,0.151,-0.202,-0.059,E0CZ22,Mroh1,E0CZ22_Mroh1,E0CZ22,Mroh1,1,5,5,5,E0CZ22|G3XA21|D3Z624,MOUSE,184473.4,4.1,1989,1989.1,48.48,48.48,,1640,Maestro heat-like repeat family member 1,,,,5,5,290000000,4.1%
O55028,0.773512169,0.025833333,3.495697088,-0.124333333,0.447126378,-0.808042514,0.003,0.413,-0.152,-0.108,0.005,-0.006,O55028,Bckdk,O55028_Bckdk,O55028,Bckdk,1,9,3,3,O55028|A0A0U1RPT4|A0A0U1RNL7,MOUSE,46814.9,10.9,1990,1990.1,48.41,48.41,,412,"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial",mitochondrion|mitochondrial alpha-ketoglutarate dehydrogenase complex|,protein phosphorylation|branched-chain amino acid catabolic process|phosphorylation|,protein kinase activity|protein serine/threonine kinase activity|ATP binding|[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity|,3,9,235000000,10.9%
Q91YR5,0.991556352,0.001833333,0.15738517,0.004333333,0.964409507,0.046315489,-0.043,0.073,-0.031,0.123,-0.054,-0.057,Q91YR5,Mettl13,Q91YR5_Mettl13,Q91YR5,Mettl13,1,5,5,5,Q91YR5|Q91YR5-1|Q91YR5-2|E9PYK1,MOUSE,79439.8,6.8,1991,1991.1,48.39,48.39,,698,Methyltransferase-like protein 13,,methylation|,methyltransferase activity|,5,5,57000000,6.8%
O35218,0.979892713,0.008333333,0.309921279,0.013333333,0.931124753,0.089770819,0.011,0.005,-0.011,0.309,-0.259,-0.005,O35218,Cpsf2,O35218_Cpsf2,O35218,Cpsf2,1,5,5,5,O35218,MOUSE,89236.9,10.8,1992,1992.1,48.36,48.36,,782,Cleavage and polyadenylation specificity factor subunit 2,mRNA cleavage and polyadenylation specificity factor complex|membrane|,mRNA polyadenylation|mRNA cleavage|histone mRNA 3'-end processing|,RNA binding|,5,5,286000000,10.8%
Q8CGE8,0.352021174,0.027166667,11.43115656,-0.459,0.071925741,-2.139533627,0.059,0.081,0.63,-0.554,-0.078,0.025,Q8CGE8,Ifi205,Q8CGE8_Ifi205,Q8CGE8,Ifi205a,1,7,5,4,P0DOV1|P0DOV1-2|Q8CGE8|D0QMC3|A0A087WRA4,MOUSE,45746.1,12.6,1993,1993.1,48.31,33.9,,404,Interferon-activable protein 205-A,nucleus|nucleolus|cytoplasm|membrane|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|cellular response to interferon-beta|",RNA polymerase II core promoter proximal region sequence-specific DNA binding|core promoter binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription|double-stranded DNA binding|transcription factor binding|identical protein binding|poly(A) RNA binding|,6,7,262000000,12.6%
P0DOV2,0.042592507,-0.008166667,24.4614805,-0.782333333,0.003579744,-4.407521428,0.305,0.16,0.684,-0.642,-0.381,-0.175,P0DOV2,Ifi204,P0DOV2_Ifi204,P0DOV2,Ifi204,1,4,5,3,P0DOV2|E9Q3L4|D3Z2E7,MOUSE,70178.5,11.7,1993,1993.2,44.13,25.66,,619,Interferon-activable protein 204,,,,3,4,46300000,8.0%
Q8VDK1,0.647450828,0.004166667,5.420170387,0.105,0.287066795,1.156483178,-0.04,-0.132,0.027,-0.027,0.076,0.121,Q8VDK1,Nit1,Q8VDK1_Nit1,Q8VDK1,Nit1,1,8,4,4,Q8VDK1|Q8VDK1-2|D3YY53,MOUSE,36446.1,16.7,1994,1994.1,48.3,48.3,,323,Deaminated glutathione amidase,nucleus|mitochondrion|extracellular exosome|,nitrogen compound metabolic process|,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds|",4,8,469000000,16.7%
Q9EST5-2,0.418849198,0.044666667,10.00850444,-0.336666667,0.09980437,-1.912451011,0.032,0.026,0.581,-0.301,-0.051,-0.019,Q9EST5,Anp32b,Q9EST5-2_Anp32b,Q9EST5-2,Anp32b,1,12,4,4,Q9EST5-2|Q9EST5,MOUSE,37731.9,11.5,1995,1995.1,48.29,48.29,,272,Isoform 2 of Acidic leucine-rich nuclear phosphoprotein 32 family member B,nucleus|nucleolus|cytoplasm|extracellular exosome|,G1/S transition of mitotic cell cycle|vasculature development|nucleosome assembly|activation of cysteine-type endopeptidase activity involved in apoptotic process|ventricular system development|negative regulation of cell differentiation|positive regulation of protein export from nucleus|inner ear development|palate development|,histone binding|RNA polymerase binding|,4,12,1230000000,11.5%
E9PVZ8,0.450260828,0.027333333,9.394144639,0.184,0.114970266,1.8110276,-0.141,-0.049,-0.004,0.188,-0.034,0.204,E9PVZ8,Golgb1,E9PVZ8_Golgb1,E9PVZ8,Golgb1,1,8,7,7,E9PVZ8|E9QAH1,MOUSE,371573.7,2.9,1996,1996.1,48.27,48.27,,3238,"Golgi autoantigen, golgin subfamily b, macrogolgin 1",endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|cis-Golgi network|membrane|,,poly(A) RNA binding|,7,8,256000000,2.9%
P51859,0.480593503,0.009833333,8.534763072,0.238333333,0.140127603,1.675883372,-0.273,-0.148,0.093,0.038,-0.002,0.351,P51859,Hdgf,P51859_Hdgf,P51859,Hdgf,1,7,4,4,P51859|E0CYW7,MOUSE,26382.3,17.7,1997,1997.1,48.13,48.13,,237,Hepatoma-derived growth factor,extracellular space|nucleus|nucleoplasm|cytoplasm|transcriptional repressor complex|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|cellular process|",nucleotide binding|RNA polymerase II transcription corepressor activity|transcription corepressor binding|DNA binding|protein binding|growth factor activity|heparin binding|poly(A) RNA binding|,4,7,925000000,17.7%
Q8R0F6,0.634404848,0.014666667,5.684232928,-0.099333333,0.270132419,-1.202014356,0.109,0.089,-0.005,-0.044,0.005,-0.066,Q8R0F6,Ilkap,Q8R0F6_Ilkap,Q8R0F6,Ilkap,1,4,4,4,Q8R0F6|Q8R0F6-2,MOUSE,43344.2,14.2,1998,1998.1,48.12,48.12,,392,Integrin-linked kinase-associated serine/threonine phosphatase 2C,cytoplasm|,protein dephosphorylation|,protein serine/threonine phosphatase activity|metal ion binding|,4,4,183000000,14.2%
Q8BRG8,0.776205722,-0.006166667,3.446116333,-0.077666667,0.452260196,-0.797950964,0.043,0.131,-0.076,0.001,-0.145,0.009,Q8BRG8,Tmem209,Q8BRG8_Tmem209,Q8BRG8,Tmem209,1,10,4,4,Q8BRG8|Q8BRG8-2|F8WGT2|Q8BRG8-3|Q8C214,MOUSE,63380.1,9.2,1999,1999.1,48.09,48.09,,561,Transmembrane protein 209,integral component of membrane|,,,4,10,1590000000,9.2%
Q9R0A1,0.454052388,0.063833333,9.285651356,0.256333333,0.117878572,1.796736488,-0.103,0.086,-0.176,0.218,-0.053,0.411,Q9R0A1,Clcn2,Q9R0A1_Clcn2,Q9R0A1,Clcn2,1,5,4,4,Q9R0A1|A9C437|D6RFS3,MOUSE,100358.5,8.5,2000,2000.1,47.98,47.98,,908,Chloride channel protein 2,plasma membrane|chloride channel complex|,retina development in camera-type eye|cell differentiation involved in salivary gland development|chloride transmembrane transport|regulation of anion transmembrane transport|,voltage-gated chloride channel activity|,4,5,130000000,8.5%
Q9JLZ8,0.965296689,-0.003,0.463994774,0.014,0.898670576,0.132260866,-0.085,-0.078,0.133,0.125,-0.083,-0.03,Q9JLZ8,Sigirr,Q9JLZ8_Sigirr,Q9JLZ8,Sigirr,1,7,4,4,Q9JLZ8|Q9JLZ8-2,MOUSE,46785.6,13.2,2001,2001.1,47.95,47.95,,409,Single Ig IL-1-related receptor,membrane|integral component of membrane|,negative regulation of cytokine-mediated signaling pathway|acute-phase response|signal transduction|negative regulation of sequence-specific DNA binding transcription factor activity|negative regulation of chemokine biosynthetic process|,,4,7,583000000,13.2%
A0A1L1SSC7,0.014774397,0.019,30.07557698,0.558,0.000982748,5.567593605,-0.272,-0.205,-0.303,0.143,0.401,0.35,A0A1L1SSC7,Ttc13,A0A1L1SSC7_Ttc13,A0A1L1SSC7,Ttc13,1,5,4,4,A0A1L1SSC7|E9Q723|D3YVV0|Q3UMK4,MOUSE,95830,7.9,2002,2002.1,47.92,47.92,,844,Tetratricopeptide repeat domain 13,,,,4,5,77000000,7.9%
Q8BGH2,0.772060577,-0.037,3.562407414,0.154,0.440310719,0.820804217,-0.155,0.25,-0.437,0.225,-0.015,-0.09,Q8BGH2,Samm50,Q8BGH2_Samm50,Q8BGH2,Samm50,1,8,3,3,Q8BGH2,MOUSE,52262.4,9.1,2003,2003.1,47.89,47.89,,469,Sorting and assembly machinery component 50 homolog,mitochondrial sorting and assembly machinery complex|mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|integral component of membrane|extracellular exosome|,mitochondrial respiratory chain complex assembly|cristae formation|protein import into mitochondrial outer membrane|,protein binding|,3,8,2150000000,9.1%
Q8CJF7,0.648073376,-0.039,5.379329764,0.136666667,0.289779076,1.150525533,0.017,0,-0.339,0.058,-0.011,0.041,Q8CJF7,Ahctf1,Q8CJF7_Ahctf1,Q8CJF7,Ahctf1,1,7,5,5,Q8CJF7,MOUSE,249638.5,2.9,2004,2004.1,47.88,47.88,,2243,Protein ELYS,nucleus|nucleoplasm|cytoplasm|nuclear matrix|nuclear membrane|extracellular exosome|condensed chromosome kinetochore|chromatin|nuclear pore|nuclear pore outer ring|,"cytokinesis|transcription, DNA-templated|regulation of transcription, DNA-templated|mitotic nuclear division|protein transport|hemopoiesis|positive regulation of transcription, DNA-templated|mRNA transport|nuclear pore complex assembly|",DNA binding|sequence-specific DNA binding transcription factor activity|,5,7,1200000000,2.9%
Q5FW57,0.799875932,-0.0365,3.065679635,-0.111,0.493664658,-0.724323199,0.121,0.117,-0.181,0.092,-0.365,-0.003,Q5FW57,Gm4952,Q5FW57_Gm4952,Q5FW57,Gm4952,1,10,5,5,Q5FW57,MOUSE,34510.1,21.2,2005,2005.1,47.8,47.8,,296,Glycine N-acyltransferase-like protein,mitochondrion|,metabolic process|,glycine N-acyltransferase activity|,5,10,1020000000,21.2%
P24721,0.02721786,0.047666667,26.86175786,0.65,0.002059796,4.898103155,-0.314,-0.286,-0.232,0.484,0.098,0.536,P24721,Asgr2,P24721_Asgr2,P24721,Asgr2,1,11,4,4,P24721,MOUSE,35533.7,15.6,2006,2006.1,47.79,47.79,,301,Asialoglycoprotein receptor 2,integral component of membrane|,endocytosis|glycoprotein metabolic process|bone mineralization|regulation of protein stability|lipid homeostasis|,carbohydrate binding|,4,11,762000000,15.6%
Q8BUE4-2,0.297561895,0.002166667,12.80278862,-0.245666667,0.052447059,-2.35418831,0.11,0.205,0.06,0.022,-0.123,-0.261,Q8BUE4,Aifm2,Q8BUE4-2_Aifm2,Q8BUE4-2,Aifm2,1,10,4,4,Q8BUE4-2|Q8BUE4,MOUSE,41640.1,11.3,2007,2007.1,47.76,47.76,,373,Isoform 2 of Apoptosis-inducing factor 2,extracellular space|cytoplasm|mitochondrion|mitochondrial outer membrane|lipid particle|cytosol|integral component of membrane|,apoptotic mitochondrial changes|positive regulation of apoptotic process|oxidation-reduction process|,DNA binding|electron-transferring-flavoprotein dehydrogenase activity|NADH dehydrogenase (ubiquinone) activity|flavin adenine dinucleotide binding|,4,10,6590000000,11.3%
Q3UW53,0.884484678,0.013166667,1.880945996,-0.091,0.648493161,-0.477314398,-0.034,-0.209,0.419,0.04,-0.276,0.139,Q3UW53,Fam129a,Q3UW53_Fam129a,Q3UW53,Fam129a,1,5,5,5,Q3UW53|E9PYV4|D3Z233,MOUSE,103503,6.6,2008,2008.1,47.7,47.7,,926,Protein Niban,cytoplasm|plasma membrane|membrane|extracellular exosome|,negative regulation of protein phosphorylation|positive regulation of protein phosphorylation|response to endoplasmic reticulum stress|positive regulation of translation|,,5,5,169000000,6.6%
Q06185,0.933608247,-0.038666667,0.950547556,-0.046,0.80342482,-0.259106361,0.06,0.174,-0.281,-0.294,0.232,-0.123,Q06185,Atp5k,Q06185_Atp5k,Q06185,Atp5i,1,11,3,3,Q06185|Q8BTB6,MOUSE,8235.5,39.4,2009,2009.1,47.63,47.63,,71,"ATP synthase subunit e, mitochondrial","mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)|mitochondrion|mitochondrial proton-transporting ATP synthase complex|",ATP synthesis coupled proton transport|,hydrogen ion transmembrane transporter activity|ATPase activity|,3,11,23700000000,39.4%
Q9DCR2,0.936982455,-0.006666667,0.887031977,-0.026,0.815261253,-0.243048594,0.076,0.057,-0.114,0.123,-0.136,-0.046,Q9DCR2,Ap3s1,Q9DCR2_Ap3s1,Q9DCR2,Ap3s1,1,12,4,4,Q9DCR2|A0A286YDU3|A0A286YD58,MOUSE,21959.9,24.3,2011,2011.1,47.56,47.56,,193,AP-3 complex subunit sigma-1,trans-Golgi network|membrane|AP-3 adaptor complex|cytoplasmic vesicle membrane|,intracellular protein transport|anterograde axon cargo transport|vesicle-mediated transport|anterograde synaptic vesicle transport|,protein transporter activity|,4,12,842000000,24.3%
I1E4,0.472782242,0.0505,8.719741543,-0.216333333,0.134284487,-1.705736358,0.039,0.031,0.406,-0.143,-0.007,-0.023,I1E4,NotFound,I1E4_NotFound,I1E4,Stx5a,1,4,3,3,I1E4|Q8K1E0|Q8K1E0-2|H3BJ02|H3BKJ7|H3BJ89,MOUSE,49369.4,11.9,2012,2012.1,47.49,47.49,,442,Syntaxin 5A,Golgi membrane|nucleoplasm|Golgi apparatus|endomembrane system|integral component of membrane|SNARE complex|vesicle|,"intracellular protein transport|ER to Golgi vesicle-mediated transport|vesicle fusion|vesicle-mediated transport|early endosome to Golgi transport|retrograde transport, endosome to Golgi|positive regulation of protein catabolic process|vesicle docking|Golgi disassembly|regulation of Golgi organization|",SNARE binding|SNAP receptor activity|protein N-terminus binding|,3,4,120000000,11.9%
Q8BTW9,0.89153776,-0.027166667,1.741899714,0.055,0.669591649,0.446330578,0.089,0.048,-0.301,0.035,-0.006,-0.028,Q8BTW9,Pak4,Q8BTW9_Pak4,Q8BTW9,Pak4,1,4,4,4,Q8BTW9,MOUSE,64850,9.2,2013,2013.1,47.46,47.46,,593,Serine/threonine-protein kinase PAK 4,cytoplasm|,protein phosphorylation|apoptotic process|cell cycle|,protein serine/threonine kinase activity|ATP binding|,4,4,88000000,9.2%
G5E8J0,0.001667629,-0.118833333,41.71353821,1.762333333,6.73979E-05,8.822891443,-0.969,-0.761,-1.27,0.553,1.134,0.6,G5E8J0,Notch2,G5E8J0_Notch2,G5E8J0,Notch2,1,8,7,6,G5E8J0|O35516|O35516-2,MOUSE,279492.6,3.3,2014,2014.1,47.46,41.1,,2473,Neurogenic locus notch homolog protein 2,nucleus|integral component of plasma membrane|cell surface|receptor complex|,pulmonary valve morphogenesis|cell cycle arrest|Notch signaling pathway|negative regulation of cell proliferation|cell growth|cell differentiation|positive regulation of Ras protein signal transduction|bone remodeling|regulation of developmental process|atrial septum morphogenesis|,calcium ion binding|,7,8,490000000,3.3%
Q9Z0M5,0.000181451,-0.198833333,58.30659641,1.595666667,1.47686E-06,15.84406127,-0.984,-1.126,-0.88,0.659,0.63,0.508,Q9Z0M5,Lipa,Q9Z0M5_Lipa,Q9Z0M5,Lipa,1,11,4,4,Q9Z0M5,MOUSE,45609.9,7.5,2015,2015.1,47.41,47.41,,397,Lysosomal acid lipase/cholesteryl ester hydrolase,lysosome|extracellular exosome|,cytokine production|inflammatory response|cell proliferation|lipid catabolic process|lung development|tissue remodeling|homeostasis of number of cells within a tissue|,sterol esterase activity|lipase activity|,4,11,9080000000,7.5%
Q9CWI3,0.19117741,0.045,16.2594066,-0.353333333,0.02366243,-2.923968733,0.004,0.241,0.42,-0.111,-0.128,-0.156,Q9CWI3,Bccip,Q9CWI3_Bccip,Q9CWI3,Bccip,1,10,4,4,Q9CWI3,MOUSE,36283.8,15.1,2016,2016.1,47.38,47.38,,316,BRCA2 and CDKN1A-interacting protein,nuclear cyclin-dependent protein kinase holoenzyme complex|,regulation of cyclin-dependent protein serine/threonine kinase activity|DNA repair|cellular response to DNA damage stimulus|cell cycle|neuroendocrine cell differentiation|,kinase regulator activity|poly(A) RNA binding|,4,10,537000000,15.1%
Q99J56,0.843401516,-0.028166667,2.457142986,0.081,0.567918088,0.600873681,-0.329,0.112,0.011,-0.064,-0.013,0.114,Q99J56,Derl1,Q99J56_Derl1,Q99J56,Derl1,1,15,4,4,Q99J56,MOUSE,28948.4,16.3,2017,2017.1,47.35,47.35,,251,Derlin-1,Hrd1p ubiquitin ligase complex|early endosome|late endosome|endoplasmic reticulum|membrane|integral component of membrane|integral component of endoplasmic reticulum membrane|,"response to unfolded protein|ER-associated ubiquitin-dependent protein catabolic process|endoplasmic reticulum unfolded protein response|retrograde protein transport, ER to cytosol|positive regulation of protein ubiquitination|protein destabilization|positive regulation of protein binding|cellular response to unfolded protein|protein homooligomerization|ER-associated misfolded protein catabolic process|",protease binding|protein binding|ubiquitin protein ligase binding|MHC class I protein binding|ATPase binding|ubiquitin-specific protease binding|,4,15,11400000000,16.3%
Q8BS95,0.606563663,0.001666667,6.249883165,-0.111333333,0.23714375,-1.298173966,0.042,0.053,0.077,0.028,-0.047,-0.143,Q8BS95,Gpr89,Q8BS95_Gpr89,Q8BS95,Gpr89a,1,4,3,3,Q8BS95,MOUSE,53019,12,2018,2018.1,47.34,47.34,,455,Golgi pH regulator,integral component of membrane|Golgi-associated vesicle membrane|Golgi cisterna membrane|,signal transduction|protein transport|skin development|intracellular pH reduction|anion transmembrane transport|regulation of anion transmembrane transport|,signal transducer activity|voltage-gated anion channel activity|,3,4,924000000,12.0%
O88545,0.754688548,0.0015,3.78041393,-0.093666667,0.418753651,-0.861620998,0.011,0.228,-0.094,-0.099,0.013,-0.05,O88545,Cops6,O88545_Cops6,O88545,Cops6,1,5,4,4,O88545|D3Z0F5,MOUSE,36164.8,15.7,2019,2019.1,47.19,47.19,,324,COP9 signalosome complex subunit 6,nucleoplasm|cytoplasm|COP9 signalosome|extracellular exosome|,cullin deneddylation|,protein binding|,4,5,178000000,15.7%
G5E8I8,0.568043335,-0.007333333,6.994832827,0.132666667,0.199763766,1.422438203,-0.085,0.004,-0.14,0.079,0.143,-0.045,G5E8I8,Cherp,G5E8I8_Cherp,G5E8I8,Cherp,1,7,4,4,G5E8I8|A0A1D5RL92|Q8CGZ0,MOUSE,108011.7,4.3,2020,2020.1,47.1,47.1,,949,Calcium homeostasis endoplasmic reticulum protein,cytoplasm|membrane|sarcoplasmic reticulum membrane|perinuclear region of cytoplasm|,RNA processing|cellular calcium ion homeostasis|negative regulation of cell proliferation|release of sequestered calcium ion into cytosol|positive regulation of NFAT protein import into nucleus|,ion channel binding|poly(A) RNA binding|,4,7,321000000,4.3%
Q8K1J6,0.686505935,0.088333333,4.759190486,-0.308666667,0.334257339,-1.041322216,0.003,0.924,-0.199,-0.263,0.175,-0.11,Q8K1J6,Trnt1,Q8K1J6_Trnt1,Q8K1J6,Trnt1,1,10,4,4,Q8K1J6|Q8K1J6-2,MOUSE,50065.5,13.1,2021,2021.1,47.02,47.02,,434,"CCA tRNA nucleotidyltransferase 1, mitochondrial",intracellular|mitochondrion|,tRNA 3'-terminal CCA addition|tRNA processing|tRNA 3'-end processing|,tRNA binding|tRNA adenylyltransferase activity|ATP binding|tRNA nucleotidyltransferase activity|CTP:tRNA cytidylyltransferase activity|CTP:3'-cytidine-tRNA cytidylyltransferase activity|ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity|,4,10,3570000000,13.1%
P46412,0.107869207,-0.0115,19.65035311,-0.323,0.010838388,-3.492444979,0.24,0.101,0.109,-0.167,-0.263,-0.089,P46412,Gpx3,P46412_Gpx3,P46412,Gpx3,1,6,4,4,P46412|P21765,MOUSE,25581.2,17.6,2022,2022.1,47.01,47.01,,226,Glutathione peroxidase 3,extracellular space|extracellular exosome|,response to oxidative stress|hydrogen peroxide catabolic process|protein homotetramerization|oxidation-reduction process|,glutathione peroxidase activity|selenium binding|,4,6,438000000,17.6%
P47879,0.013650805,-0.047833333,30.56760935,0.853,0.000877484,5.721155217,-0.694,-0.258,-0.471,0.332,0.583,0.221,P47879,Igfbp4,P47879_Igfbp4,P47879,Igfbp4,1,14,4,1,P47879,MOUSE,28947.5,17.3,2023,2023.1,46.93,15.08,,254,Insulin-like growth factor-binding protein 4,extracellular space|,regulation of cell growth|inflammatory response|regulation of glucose metabolic process|regulation of growth|positive regulation of MAPK cascade|positive regulation of insulin-like growth factor receptor signaling pathway|type B pancreatic cell proliferation|,insulin-like growth factor binding|insulin-like growth factor I binding|insulin-like growth factor II binding|,4,14,782000000,17.3%
A0A0A0MQD1,0.386623778,0.019833333,10.70383617,0.203666667,0.085038655,2.019461379,-0.088,-0.22,0.062,0.169,0.083,0.113,A0A0A0MQD1,Tdrd7,A0A0A0MQD1_Tdrd7,A0A0A0MQD1,Tdrd7,1,5,4,4,A0A0A0MQD1|Q8K1H1,MOUSE,127375.4,4.8,2024,2024.1,46.91,46.91,,1119,Tudor domain-containing protein 7,mitochondrial matrix|ribonucleoprotein complex|ribonucleoprotein granule|P granule|,lens morphogenesis in camera-type eye|germ cell development|posttranscriptional regulation of gene expression|lens fiber cell differentiation|,mRNA binding|protein binding|protein N-terminus binding|,4,5,34600000,4.8%
Q8BH43,0.695646919,-0.0355,4.611127899,0.120333333,0.345849546,1.014741175,0.041,-0.029,-0.299,0.012,-0.064,0.126,Q8BH43,Wasf2,Q8BH43_Wasf2,Q8BH43,Wasf2,1,4,4,4,Q8BH43|Q8R5H6,MOUSE,54300.8,9.8,2025,2025.1,46.9,46.9,,497,Wiskott-Aldrich syndrome protein family member 2,ruffle|intracellular|early endosome|cytoskeleton|cell-cell junction|lamellipodium|SCAR complex|extracellular exosome|,angiogenesis|ameboidal-type cell migration|endocytosis|positive regulation of lamellipodium assembly|Rac protein signal transduction|lamellipodium assembly|actin cytoskeleton organization|actin filament-based movement|megakaryocyte development|negative regulation of stress fiber assembly|lamellipodium morphogenesis|,actin binding|protein binding|protein complex binding|,4,4,2590000000,9.8%
G5E881,0.797128744,0.0165,3.170122951,-0.063,0.481934154,-0.744396054,-0.032,0.126,0.05,-0.039,0.002,-0.008,G5E881,Tamm41,G5E881_Tamm41,G5E881,Tamm41,1,5,4,4,G5E881|Q3TUH1|Q3TUH1-2|D6RGT1,MOUSE,38067.4,17.2,2026,2026.1,46.81,46.81,,337,"Phosphatidate cytidylyltransferase, mitochondrial",mitochondrion|mitochondrial inner membrane|,CDP-diacylglycerol biosynthetic process|,phosphatidate cytidylyltransferase activity|,4,5,390000000,17.2%
Q99M28,0.669054973,-0.019,5.016545475,-0.122666667,0.315025314,-1.086495734,-0.051,0.199,-0.021,0.021,-0.223,-0.039,Q99M28,Rnps1,Q99M28_Rnps1,Q99M28,Rnps1,1,5,4,4,Q99M28|Q99M28-2,MOUSE,34207.7,13.7,2027,2027.1,46.79,46.79,,305,RNA-binding protein with serine-rich domain 1,nucleus|nucleoplasm|cytoplasm|nuclear speck|ASAP complex|,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|regulation of alternative mRNA splicing, via spliceosome|mRNA processing|RNA splicing|positive regulation of apoptotic process|negative regulation of mRNA splicing, via spliceosome|",nucleotide binding|mRNA 3'-UTR binding|poly(A) RNA binding|,4,5,580000000,13.7%
Q8JZN5,0.87503645,-0.0225,2.02909008,-0.075,0.626745165,-0.509795305,0.07,0.226,-0.251,0.087,-0.073,-0.194,Q8JZN5,Acad9,Q8JZN5_Acad9,Q8JZN5,Acad9,1,8,4,4,Q8JZN5|A0A0G2JDY4,MOUSE,69234.4,6.7,2028,2028.1,46.74,46.74,,625,"Acyl-CoA dehydrogenase family member 9, mitochondrial",nucleus|mitochondrion|dendrite|,mitochondrial respiratory chain complex I assembly|oxidation-reduction process|,acyl-CoA dehydrogenase activity|flavin adenine dinucleotide binding|,4,8,1620000000,6.7%
Q9DBY8,0.961523652,-0.021,0.547958058,-0.014,0.881463217,-0.154902104,0.087,-0.014,-0.115,0.004,-0.072,-0.016,Q9DBY8,Nvl,Q9DBY8_Nvl,Q9DBY8,Nvl,1,4,4,4,Q9DBY8,MOUSE,95444.2,6.6,2029,2029.1,46.74,46.74,,855,Nuclear valosin-containing protein-like,nucleus|nucleolus|cytoplasm|mitochondrion|plasma membrane|membrane|,,ATP binding|poly(A) RNA binding|,4,4,1370000000,6.6%
Q60902,0.211523046,-0.034833333,15.53365738,0.425,0.027966252,2.803410792,-0.547,-0.108,-0.087,0.082,0.119,0.332,Q60902,Eps15l1,Q60902_Eps15l1,Q60902,Eps15l1,1,7,5,5,Q60902|Q60902-3|Q60902-2|Q60902-4|A0A1D5RLS1,MOUSE,99478,8.5,2030,2030.1,46.71,46.71,,907,Epidermal growth factor receptor substrate 15-like 1,nucleus|membrane|clathrin coat of coated pit|,endocytosis|,calcium ion binding|protein binding|,5,7,3790000000,8.5%
Q9D8U8,0.696311006,0.0155,4.598666113,-0.101666667,0.346843363,-1.011675825,-0.029,0.014,0.214,-0.113,0.014,-0.007,Q9D8U8,Snx5,Q9D8U8_Snx5,Q9D8U8,Snx5,1,10,5,5,Q9D8U8,MOUSE,47081.8,13.3,2031,2031.1,46.71,46.71,,404,Sorting nexin-5,ruffle|phagocytic cup|endosome|extrinsic component of membrane|cytoplasmic vesicle membrane|retromer complex|extrinsic component of cytoplasmic side of plasma membrane|extrinsic component of endosome membrane|macropinocytic cup|tubular endosome|early endosome membrane|,"intracellular protein transport|endocytosis|pinocytosis|vesicle organization|retrograde transport, endosome to Golgi|",dynactin binding|phosphatidylinositol binding|,5,10,970000000,13.3%
D3YYY8,0.310902103,0.0225,12.52334134,-0.437666667,0.055932711,-2.314242121,-0.062,0.31,0.476,0.059,-0.48,-0.168,D3YYY8,Arhgef26,D3YYY8_Arhgef26,D3YYY8,Arhgef26,1,7,4,4,D3YYY8,MOUSE,97957.2,5,2032,2032.1,46.68,46.68,,869,Rho guanine nucleotide exchange factor (GEF) 26,,endothelial cell morphogenesis|regulation of Rho protein signal transduction|positive regulation of GTPase activity|ruffle assembly|,Rho guanyl-nucleotide exchange factor activity|,4,7,546000000,5.0%
Q9DCU9,0.386122129,0.021833333,10.73553673,-0.168333333,0.08442019,-2.02446724,0.028,0.159,0.131,-0.067,-0.086,-0.034,Q9DCU9,Hoga1,Q9DCU9_Hoga1,Q9DCU9,Hoga1,1,11,6,6,Q9DCU9|E9Q1R2,MOUSE,34985.6,17.4,2033,2033.1,46.67,46.67,,321,"4-hydroxy-2-oxoglutarate aldolase, mitochondrial",mitochondrion|extracellular exosome|,glyoxylate catabolic process|4-hydroxyproline catabolic process|oxalate metabolic process|pyruvate biosynthetic process|glyoxylate metabolic process|,4-hydroxy-2-oxoglutarate aldolase activity|protein homodimerization activity|,6,11,829000000,17.4%
Q8VDG7,0.838867494,0.022333333,2.545620082,-0.083333333,0.556465177,-0.619231557,0.161,0.212,-0.181,-0.071,0.124,-0.111,Q8VDG7,Pafah2,Q8VDG7_Pafah2,Q8VDG7,Pafah2,1,5,4,4,E9QNW6|Q8VDG7,MOUSE,44131.7,12,2034,2034.1,46.57,46.57,,390,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",cytoplasm|,lipid catabolic process|,1-alkyl-2-acetylglycerophosphocholine esterase activity|,4,5,170000000,12.0%
A0A0A6YXW6,0.536031671,0.040333333,7.50743365,0.294,0.17752382,1.50874965,-0.096,-0.261,0.037,-0.205,0.234,0.533,A0A0A6YXW6,NotFound,A0A0A6YXW6_NotFound,A0A0A6YXW6,Igha,1,6,4,4,A0A0A6YXW6|P01878,MOUSE,42869.8,14.3,2035,2035.1,46.54,46.54,,389,Immunoglobulin heavy constant alpha (Fragment),,,,4,6,119000000,14.3%
Q3TAS6,0.005397389,-0.047333333,35.29597496,1.146,0.000295395,6.908333671,-0.861,-0.361,-0.639,0.299,0.556,0.722,Q3TAS6,Emc10,Q3TAS6_Emc10,Q3TAS6,Emc10,1,5,3,3,A0A0KG67|A0A0KG66|Q3TAS6|Q3TAS6-2,MOUSE,27280.3,20.9,2036,2036.1,46.45,46.45,,258,ER membrane protein complex subunit 10,extracellular region|integral component of membrane|ER membrane protein complex|,,,3,5,308000000,20.9%
A7MCT6,0.808726229,-0.030666667,2.97270239,0.069333333,0.504347371,0.705406595,-0.201,-0.006,0.011,0.037,-0.08,0.055,A7MCT6,Etnk2,A7MCT6_Etnk2,A7MCT6,Etnk2,1,6,6,6,A7MCT6|A7MCT6-2|H9KV13,MOUSE,45308.1,15.8,2037,2037.1,46.4,46.4,,385,Ethanolamine kinase 2,,in utero embryonic development|placenta development|phosphatidylethanolamine biosynthetic process|post-embryonic development|phosphorylation|multicellular organism growth|,ethanolamine kinase activity|ATP binding|choline kinase activity|,6,6,1710000000,15.8%
O70303,0.991556352,-0.0105,0.171676133,-0.007,0.961241222,-0.050464205,0.18,0.097,-0.298,0.035,-0.046,-0.031,O70303,Cideb,O70303_Cideb,O70303,Cideb,1,6,5,5,O70303,MOUSE,24971.1,25.1,2038,2038.1,46.36,46.36,,219,Cell death activator CIDE-B,lipid particle|cytosol|perinuclear region of cytoplasm|,apoptotic process|positive regulation of cell death|regulation of apoptotic process|positive regulation of release of cytochrome c from mitochondria|execution phase of apoptosis|activation of cysteine-type endopeptidase activity|,identical protein binding|,5,6,1050000000,25.1%
Q03963,0.919618833,-0.028833333,1.178048302,0.044333333,0.762421561,0.315049734,0.168,0.01,-0.331,0.073,-0.055,-0.038,Q03963,Eif2ak2,Q03963_Eif2ak2,Q03963,Eif2ak2,1,6,3,3,Q03963,MOUSE,58792.4,9.5,2039,2039.1,46.33,46.33,,515,"Interferon-induced, double-stranded RNA-activated protein kinase",nucleus|cytoplasm|membrane|perinuclear region of cytoplasm|,"activation of MAPKK activity|positive regulation of cytokine production|transcription, DNA-templated|translation|protein phosphorylation|response to virus|negative regulation of translation|peptidyl-tyrosine phosphorylation|endoplasmic reticulum unfolded protein response|positive regulation of chemokine production|positive regulation of stress-activated MAPK cascade|negative regulation of osteoblast proliferation|response to interferon-alpha|negative regulation of apoptotic process|negative regulation of viral genome replication|innate immune response|protein autophosphorylation|positive regulation of NF-kappaB transcription factor activity|defense response to virus|regulation of NLRP3 inflammasome complex assembly|positive regulation of NIK/NF-kappaB signaling|regulation of hematopoietic progenitor cell differentiation|regulation of hematopoietic stem cell proliferation|regulation of hematopoietic stem cell differentiation|",double-stranded RNA binding|protein kinase activity|protein serine/threonine kinase activity|non-membrane spanning protein tyrosine kinase activity|protein binding|ATP binding|poly(A) RNA binding|,3,6,289000000,9.5%
Q9CQA9,0.841746758,-0.063666667,2.501400826,0.104,0.56215997,0.610075365,0.058,0.09,-0.495,0.087,-0.08,-0.042,Q9CQA9,Ntpcr,Q9CQA9_Ntpcr,Q9CQA9,Ntpcr,1,7,5,5,Q9CQA9|D3YXL1|Q8C373|D3Z2W9,MOUSE,20837.9,45.2,2040,2040.1,46.32,46.32,,190,Cancer-related nucleoside-triphosphatase homolog,membrane|extracellular exosome|,dephosphorylation|,"ATP binding|nucleoside-triphosphatase activity|poly(A) RNA binding|nucleotide phosphatase activity, acting on free nucleotides|",5,7,1750000000,45.2%
Q5HZI1,0.330672768,-0.010166667,11.9672682,0.235,0.063573069,2.220949922,-0.026,-0.106,-0.251,0.221,-0.015,0.116,Q5HZI1,Mtus1,Q5HZI1_Mtus1,Q5HZI1,Mtus1,1,7,5,5,A0A0R4J1L9|Q5HZI1,MOUSE,135575.1,4.8,2041,2041.1,46.31,46.31,,1210,Microtubule-associated tumor suppressor 1 homolog,extracellular space|nucleus|cytoplasm|mitochondrion|Golgi apparatus|plasma membrane|,cell cycle|regulation of macrophage chemotaxis|,,5,7,793000000,4.8%
Q6TCG2,0.894042447,0.0115,1.674883931,-0.063666667,0.680004218,-0.431215961,-0.048,-0.001,0.179,-0.164,-0.172,0.275,Q6TCG2,Paqr9,Q6TCG2_Paqr9,Q6TCG2,Paqr9,1,13,5,5,Q6TCG2,MOUSE,43596.2,12.8,2042,2042.1,46.31,46.31,,375,Membrane progesterone receptor epsilon,integral component of membrane|,,receptor activity|,5,13,4360000000,12.8%
Q9CQZ5,0.600763538,-0.0195,6.326130625,0.239666667,0.233016641,1.312522573,-0.474,0.166,-0.11,0.303,-0.058,0.056,Q9CQZ5,Ndufa6,Q9CQZ5_Ndufa6,Q9CQZ5,Ndufa6,1,6,3,3,Q9CQZ5,MOUSE,15282.5,25.1,2043,2043.1,46.24,46.24,,131,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6,mitochondrion|mitochondrial respiratory chain complex I|mitochondrial membrane|,response to oxidative stress|oxidation-reduction process|,,3,6,750000000,25.1%
Q8CEC0,0.888791421,0.007166667,1.775631211,0.040333333,0.664411099,0.453654969,-0.086,0.034,0.013,-0.064,0.065,0.081,Q8CEC0,Nup88,Q8CEC0_Nup88,Q8CEC0,Nup88,1,4,4,4,Q8CEC0|Q8CEC0-2|Q8CEC0-3,MOUSE,86191.4,7.1,2044,2044.1,46.23,46.23,,753,Nuclear pore complex protein Nup88,nuclear pore|nucleoplasm|,protein transport|mRNA transport|,,4,4,273000000,7.1%
O70252,0.374561053,0.001333333,10.9347741,-0.218,0.080634814,-2.056891102,-0.006,0.184,0.153,-0.025,-0.041,-0.257,O70252,Hmox2,O70252_Hmox2,O70252,Hmox2,1,6,3,3,O70252,MOUSE,35909.1,15.2,2045,2045.1,46.2,46.2,,315,Heme oxygenase 2,endoplasmic reticulum|plasma membrane|membrane|,response to hypoxia|heme oxidation|response to oxidative stress|,heme oxygenase (decyclizing) activity|metal ion binding|,3,6,148000000,15.2%
Q9WVL3,0.994928853,0.001333333,0.095299718,-0.002666667,0.978295438,-0.028237822,-0.068,-0.02,0.096,-0.007,-0.088,0.095,Q9WVL3,Slc12a7,Q9WVL3_Slc12a7,Q9WVL3,Slc12a7,1,5,5,5,Q9WVL3|Q9WVL3-2,MOUSE,120791.4,7.4,2046,2046.1,46.19,46.19,,1083,Solute carrier family 12 member 7,integral component of plasma membrane|,potassium ion transport|cell volume homeostasis|chloride transmembrane transport|,potassium:chloride symporter activity|protein kinase binding|,5,5,239000000,7.4%
Q5SPX8,0.797487413,0.000166667,3.148347288,0.071,0.484356655,0.740124203,0.057,-0.126,-0.037,0.119,-0.064,0.052,Q5SPX8,NotFound,Q5SPX8_NotFound,Q5SPX8,Tbc1d10a,1,10,5,5,Q5SPX8|P58802,MOUSE,59765.3,10.1,2047,2047.1,46.16,46.16,,534,TBC1 domain family member 10A,intracellular|plasma membrane|extracellular exosome|,"retrograde transport, endosome to Golgi|positive regulation of proteolysis|activation of cysteine-type endopeptidase activity|",PDZ domain binding|,5,10,174000000,10.1%
E9QJY0,0.90651412,-0.061166667,1.518482739,-0.067666667,0.704939305,-0.395456298,0.061,0.212,-0.355,-0.032,0.04,-0.293,E9QJY0,NotFound,E9QJY0_NotFound,E9QJY0,Slc7a2,1,9,3,3,E9QJY0|P18581|P18581-2,MOUSE,74504.8,5.7,2048,2048.1,46.15,46.15,,674,Cationic amino acid transporter 2,integral component of plasma membrane|integral component of membrane|,nitric oxide production involved in inflammatory response|nitric oxide biosynthetic process|macrophage activation|regulation of inflammatory response|L-arginine import across plasma membrane|L-lysine import across plasma membrane|L-ornithine import across plasma membrane|L-arginine transport|L-ornithine transmembrane transport|,L-ornithine transmembrane transporter activity|high-affinity arginine transmembrane transporter activity|high-affinity lysine transmembrane transporter activity|arginine transmembrane transporter activity|L-lysine transmembrane transporter activity|antiporter activity|L-arginine transmembrane transporter activity|low-affinity L-arginine transmembrane transporter activity|high-affinity L-ornithine transmembrane transporter activity|,3,9,2010000000,5.7%
Q9Z0R6,0.825727613,-0.0085,2.691963506,0.057666667,0.538026478,0.648872957,-0.1,-0.031,0.019,-0.075,0.065,0.071,Q9Z0R6,NotFound,Q9Z0R6_NotFound,Q9Z0R6,Itsn2,1,6,6,6,B2RR82|Q9Z0R6|E9QNG1|Q9Z0R6-2,MOUSE,189817.2,4.5,2049,2049.1,46.09,46.09,,1659,Intersectin-2,cytoplasm|centrosome|extracellular exosome|,endocytosis|regulation of Rho protein signal transduction|positive regulation of GTPase activity|positive regulation of dendrite extension|,Rho guanyl-nucleotide exchange factor activity|calcium ion binding|protein binding|,6,6,1470000000,4.5%
Q9QZ88,0.516682924,0.0335,7.85962914,-0.185,0.16369563,-1.56597273,-0.075,0.139,0.314,-0.031,-0.121,-0.025,Q9QZ88,Vps29,Q9QZ88_Vps29,Q9QZ88,Vps29,1,8,4,4,Q9QZ88|D3Z645|Q9QZ88-2|D3YW98,MOUSE,20666.5,26.9,2050,2050.1,46.07,46.07,,182,Vacuolar protein sorting-associated protein 29,cytoplasm|endosome|endosome membrane|retromer complex|intracellular membrane-bounded organelle|extracellular exosome|,"intracellular protein transport|Golgi to vacuole transport|retrograde transport, endosome to Golgi|retrograde transport, endosome to plasma membrane|",protein binding|zinc ion binding|protein transporter activity|,4,8,581000000,26.9%
Q80TH2-2,0.644449202,0.0085,5.47482424,-0.090333333,0.283476835,-1.165943501,0.035,0.072,0.054,-0.027,-0.063,-0.02,Q80TH2,Erbin,Q80TH2-2_Erbin,Q80TH2-2,Erbin,1,9,6,6,Q80TH2-2|B7ZNX6|Q80TH2|Q80TH2-1|B2RUJ2,MOUSE,163092.7,5,2051,2051.1,46.02,46.02,,1402,Isoform 2 of Erbin,nucleus|nucleoplasm|cytoplasm|plasma membrane|basolateral plasma membrane|cell junction|hemidesmosome|nuclear membrane|,protein targeting|positive regulation of gene expression|negative regulation of NF-kappaB transcription factor activity|response to muramyl dipeptide|response to lipopolysaccharide|negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway|cellular response to tumor necrosis factor|negative regulation of monocyte chemotactic protein-1 production|,receptor binding|integrin binding|protein binding|,6,9,500000000,5.0%
P54822,0.705177674,0.010333333,4.467995221,-0.120666667,0.3574378,-0.988973675,0.021,0.274,-0.083,-0.17,0.041,-0.021,P54822,Adsl,P54822_Adsl,P54822,Adsl,1,4,4,4,P54822|E9Q242|E9Q3T7|E9Q0A0|A0A0G2JFI8,MOUSE,55607,14.2,2052,2052.1,46.02,46.02,,484,Adenylosuccinate lyase,mitochondrion|cytosol|,response to hypoxia|AMP biosynthetic process|'de novo' IMP biosynthetic process|response to nutrient|aerobic respiration|response to muscle activity|response to starvation|'de novo' AMP biosynthetic process|protein tetramerization|,"N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity|(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity|",4,4,867000000,14.2%
P70318,0.463113208,0.011666667,9.038346192,-0.224,0.124785861,-1.757024108,-0.086,0.203,0.254,-0.253,0.01,-0.058,P70318,Tial1,P70318_Tial1,P70318,Tial1,1,4,4,4,P70318|Q921W2|D3Z3Y4|D6RGU1|P52912|D3Z4H6|Q80ZW7|G5E8L2|Q8CII5|D3YY02|A0A0N4SU|A0A0N4SVR8|A0A0U1RP00,MOUSE,43730.3,9.4,2053,2053.1,46.01,46.01,,392,Nucleolysin TIAR,nucleus|cytoplasm|cytoplasmic stress granule|extracellular exosome|,apoptotic process|germ cell development|positive regulation of cell proliferation|stem cell division|,nucleotide binding|protein binding|AU-rich element binding|poly(A) RNA binding|,4,4,476000000,9.4%
Q566J8,0.295433851,0.007833333,12.91707805,0.241666667,0.051084859,2.371632695,-0.24,0.002,-0.101,0.165,0.026,0.195,Q566J8,NotFound,Q566J8_NotFound,Q566J8,Coq8b,1,6,5,5,E9QLB8|Q566J8|A0A0R4J1,MOUSE,59972.6,12.7,2054,2054.1,45.86,45.86,,533,"Atypical kinase COQ8B, mitochondrial",mitochondrion|plasma membrane|integral component of membrane|mitochondrial membrane|,protein phosphorylation|,protein serine/threonine kinase activity|,5,6,306000000,12.7%
O35239,0.764663191,-0.017666667,3.640705872,0.097333333,0.432443539,0.835591111,0.055,0.007,-0.261,0.146,-0.028,-0.025,O35239,Ptpn9,O35239_Ptpn9,O35239,Ptpn9,1,8,4,4,O35239,MOUSE,68596.4,7.7,2055,2055.1,45.78,45.78,,593,Tyrosine-protein phosphatase non-receptor type 9,cytoplasm|,peptidyl-tyrosine dephosphorylation|,protein tyrosine phosphatase activity|protein binding|,4,8,977000000,7.7%
P27808,0.285007832,0.034,13.26843734,0.212,0.047114682,2.427825785,-0.036,-0.008,-0.172,0.098,0.163,0.159,P27808,Mgat1,P27808_Mgat1,P27808,Mgat1,1,8,4,4,P27808,MOUSE,51974.5,10.7,2056,2056.1,45.74,45.74,,447,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase",Golgi membrane|membrane|integral component of membrane|extracellular exosome|extracellular vesicle|,in utero embryonic development|UDP-N-acetylglucosamine catabolic process|protein glycosylation|,"alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity|acetylglucosaminyltransferase activity|metal ion binding|",4,8,148000000,10.7%
E9QL65,0.979995204,-0.001,0.306286905,0.018666667,0.931904287,0.088751696,0.28,0.04,-0.351,0.347,-0.1,-0.222,E9QL65,Cog3,E9QL65_Cog3,E9QL65,Cog3,1,5,4,4,E9QL65|Q8CI04,MOUSE,95056,6.6,2057,2057.1,45.73,45.73,,828,Conserved oligomeric Golgi complex subunit 3,nucleoplasm|cytoplasm|Golgi apparatus|cis-Golgi network|plasma membrane|Golgi transport complex|,"retrograde transport, vesicle recycling within Golgi|protein glycosylation|intracellular protein transport|ER to Golgi vesicle-mediated transport|retrograde vesicle-mediated transport, Golgi to ER|intra-Golgi vesicle-mediated transport|Golgi organization|protein localization to organelle|protein stabilization|",protein transporter activity|,4,5,459000000,6.6%
Q14CH7,0.99327985,-0.013333333,0.123353049,-0.004,0.971996486,-0.036440194,-0.025,0.131,-0.14,0.108,-0.114,-0.04,Q14CH7,Aars2,Q14CH7_Aars2,Q14CH7,Aars2,1,4,3,3,Q14CH7,MOUSE,107808.5,5.5,2058,2058.1,45.64,45.64,,980,"Alanine--tRNA ligase, mitochondrial",mitochondrion|,mitochondrial respiratory chain complex assembly|mitochondrial alanyl-tRNA aminoacylation|,tRNA binding|alanine-tRNA ligase activity|ATP binding|zinc ion binding|,3,4,70400000,5.5%
Q9JLV5,0.634404848,-0.011666667,5.738464842,-0.107333333,0.266780152,-1.211311805,-0.016,0.075,0.067,-0.124,0.035,-0.107,Q9JLV5,Cul3,Q9JLV5_Cul3,Q9JLV5,Cul3,1,7,4,4,Q9JLV5|E9Q4T8,MOUSE,89574.3,4,2059,2059.1,45.6,45.6,,768,Cullin-3,Golgi membrane|nucleus|cytoplasm|Golgi apparatus|polar microtubule|membrane|Cul3-RING ubiquitin ligase complex|extracellular exosome|,negative regulation of transcription from RNA polymerase II promoter|protein polyubiquitination|mitotic cell cycle|cell morphogenesis|in utero embryonic development|trophectodermal cellular morphogenesis|regulation of transcription from RNA polymerase II promoter|protein monoubiquitination|ER to Golgi vesicle-mediated transport|mitotic metaphase plate congression|integrin-mediated signaling pathway|gastrulation|negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation|Wnt signaling pathway|cell migration|protein ubiquitination|stem cell division|positive regulation of cytokinesis|negative regulation of Rho protein signal transduction|embryonic cleavage|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|stress fiber assembly|proteasome-mediated ubiquitin-dependent protein catabolic process|fibroblast apoptotic process|positive regulation of mitotic metaphase/anaphase transition|COPII vesicle coating|liver morphogenesis|,protein binding|cyclin binding|POZ domain binding|ubiquitin protein ligase binding|protein homodimerization activity|protein heterodimerization activity|ubiquitin-protein transferase activity|ubiquitin protein ligase activity|,4,7,3570000000,4.0%
O88876,0.841746758,-0.062666667,2.494283335,0.114666667,0.563082029,0.608598111,0.093,0.072,-0.525,0.172,-0.127,-0.061,O88876,Dhrs3,O88876_Dhrs3,O88876,Dhrs3,1,7,5,5,O88876|G5E8W9|O88876-2|H7BX54,MOUSE,34051.3,17.5,2060,2060.1,45.51,45.51,,302,Short-chain dehydrogenase/reductase 3,integral component of membrane|,retinoid metabolic process|outflow tract morphogenesis|regulation of ossification|retinol metabolic process|negative regulation of retinoic acid receptor signaling pathway|oxidation-reduction process|palate development|bone morphogenesis|cardiac septum morphogenesis|,retinol dehydrogenase activity|NADP-retinol dehydrogenase activity|,5,7,972000000,17.5%
Q8CCB4,0.92551138,-0.004666667,1.097598001,0.028,0.776676563,0.295344406,0.047,-0.055,-0.048,0.139,-0.059,-0.052,Q8CCB4,Vps53,Q8CCB4_Vps53,Q8CCB4,Vps53,1,8,5,5,Q8CCB4|E9PXG9|E9PYD3|Q8CCB4-2|E9Q648,MOUSE,95277.3,6.9,2061,2061.1,45.4,45.4,,832,Vacuolar protein sorting-associated protein 53 homolog,GARP complex|Golgi apparatus|endosome membrane|perinuclear region of cytoplasm|recycling endosome|EARP complex|,"protein transport|endocytic recycling|retrograde transport, endosome to Golgi|",,5,8,208000000,6.9%
Q61418,0.150000436,-0.000833333,17.59773249,-0.337666667,0.017387084,-3.141012954,0.154,0.132,0.218,-0.061,-0.358,-0.09,Q61418,Clcn4,Q61418_Clcn4,Q61418,Clcn4,1,5,4,4,Q61418|A0A1B0GT29|Q3LRV6,MOUSE,84644.8,8.4,2062,2062.1,45.39,45.39,,747,H(+)/Cl(-) exchange transporter 4,integral component of membrane|early endosome membrane|late endosome membrane|,chloride transmembrane transport|regulation of anion transmembrane transport|,voltage-gated chloride channel activity|ATP binding|antiporter activity|,4,5,1100000000,8.4%
P56382,0.862898798,0.015833333,2.191811722,-0.121666667,0.603696736,-0.544882228,0.064,0.542,-0.376,-0.061,0.053,-0.127,P56382,Atp5e,P56382_Atp5e,P56382,Atp5e,1,17,4,4,P56382,MOUSE,5894.8,57.6,2063,2063.1,45.39,45.39,,52,"ATP synthase subunit epsilon, mitochondrial","mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)|mitochondrion|mitochondrial inner membrane|mitochondrial proton-transporting ATP synthase complex|",ATP synthesis coupled proton transport|,"hydrogen-exporting ATPase activity, phosphorylative mechanism|proton-transporting ATP synthase activity, rotational mechanism|proton-transporting ATPase activity, rotational mechanism|ATPase activity|",4,17,13000000000,57.6%
Q9JKJ9,0.886698259,-0.018833333,1.811012103,-0.115666667,0.659020296,-0.461793161,0.073,0.532,-0.488,-0.227,0.07,-0.073,Q9JKJ9,Cyp39a1,Q9JKJ9_Cyp39a1,Q9JKJ9,Cyp39a1,1,13,4,4,Q9JKJ9,MOUSE,53973,9.3,2064,2064.1,45.36,45.36,,470,24-hydroxycholesterol 7-alpha-hydroxylase,endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,bile acid biosynthetic process|cholesterol catabolic process|digestion|bile acid catabolic process|oxidation-reduction process|,iron ion binding|steroid 7-alpha-hydroxylase activity|oxysterol 7-alpha-hydroxylase activity|heme binding|24-hydroxycholesterol 7alpha-hydroxylase activity|,4,13,2570000000,9.3%
Q9CYR6,0.723381109,-0.011666667,4.189843865,0.174666667,0.381079524,0.938243979,-0.328,-0.264,0.295,-0.029,-0.006,0.262,Q9CYR6,Pgm3,Q9CYR6_Pgm3,Q9CYR6,Pgm3,1,4,4,4,Q9CYR6|Q8BWW3,MOUSE,60079.2,9.2,2065,2065.1,45.27,45.27,,542,Phosphoacetylglucosamine mutase,cytosol|,UDP-N-acetylglucosamine biosynthetic process|protein N-linked glycosylation|protein O-linked glycosylation|spermatogenesis|glucose 1-phosphate metabolic process|hemopoiesis|,magnesium ion binding|phosphoacetylglucosamine mutase activity|phosphoglucomutase activity|,4,4,107000000,9.2%
Q91XD7,0.000679964,-0.183666667,47.1932965,1.428,1.9084E-05,10.80123004,-0.932,-0.66,-1.101,0.499,0.456,0.636,Q91XD7,Creld1,Q91XD7_Creld1,Q91XD7,Creld1,1,8,4,4,Q91XD7,MOUSE,47999.2,11.9,2066,2066.1,45.15,45.15,,420,Cysteine-rich with EGF-like domain protein 1,integral component of membrane|,,calcium ion binding|,4,8,1380000000,11.9%
Q5DU37,0.841746758,-0.003333333,2.505162021,0.065333333,0.561673324,0.610568896,-0.036,0.078,-0.15,0.15,-0.097,0.035,Q5DU37,Zfyve26,Q5DU37_Zfyve26,Q5DU37,Zfyve26,1,6,5,5,Q5DU37|Q5DU37-2|Q5DU37-3,MOUSE,287520.1,2.2,2067,2067.1,45.06,45.06,,2529,Zinc finger FYVE domain-containing protein 26,lysosomal membrane|centrosome|midbody|,double-strand break repair via homologous recombination|cytokinesis|,phosphatidylinositol-3-phosphate binding|metal ion binding|,5,6,625000000,2.2%
P18572,0.000679964,-0.039,47.21079011,1.078,1.90073E-05,10.67185029,-0.645,-0.542,-0.547,0.37,0.488,0.642,P18572,Bsg,P18572_Bsg,P18572,Bsg,1,6,4,4,P18572|P18572-2|K3W4Q8,MOUSE,42900.4,11.8,2068,2068.1,45.01,45.01,,389,Basigin,acrosomal membrane|mitochondrion|plasma membrane|integral component of plasma membrane|focal adhesion|membrane|sarcolemma|melanosome|membrane raft|extracellular exosome|,embryo implantation|odontogenesis of dentin-containing tooth|response to peptide hormone|response to mercury ion|decidualization|response to cAMP|protein targeting to plasma membrane|,mannose binding|,4,6,1040000000,11.8%
Q62293,0.572571882,0.026666667,6.923333694,-0.620666667,0.203079755,-1.412389936,0.095,-0.327,1.243,-0.025,-0.882,0.056,Q62293,Tgtp1,Q62293_Tgtp1,Q62293,Tgtp1,1,10,4,4,Q62293,MOUSE,47176.9,6.9,2069,2069.1,44.99,44.99,,415,T-cell-specific guanine nucleotide triphosphate-binding protein 1,intracellular|membrane|,immune response|response to virus|,GTPase activity|GTP binding|,4,10,1580000000,6.9%
Q99L48,0.911411213,0.014166667,1.436316533,0.050333333,0.718403347,0.376384295,-0.164,-0.002,0.133,0.085,-0.175,0.208,Q99L48,Nmd3,Q99L48_Nmd3,Q99L48,Nmd3,1,4,4,4,Q99L48|Q99L48-2|A0A0A6YY59,MOUSE,58751.2,10.3,2070,2070.1,44.87,44.87,,503,60S ribosomal export protein NMD3,nucleus|nucleoplasm|nucleolus|cytoplasm|membrane|,ribosomal large subunit export from nucleus|protein transport|,"protein binding, bridging|ribosomal large subunit binding|poly(A) RNA binding|",4,4,167000000,10.3%
P70170-2,0.461918472,0.047333333,9.061017995,-0.173333333,0.12413613,-1.757765472,0.122,0.243,0.037,0.066,-0.069,-0.115,P70170,Abcc9,P70170-2_Abcc9,P70170-2,Abcc9,1,7,5,5,P70170-2|P70170|E9PUE8|P70170-3,MOUSE,175766.9,4.9,2071,2071.1,44.86,44.86,,1546,Isoform SUR2B of ATP-binding cassette sub-family C member 9,plasma membrane|voltage-gated potassium channel complex|sarcomere|sarcolemma|,signal transduction|metabolic process|defense response to virus|potassium ion transmembrane transport|,"ATP binding|sulfonylurea receptor activity|ATPase activity, coupled to transmembrane movement of substances|ion channel binding|potassium channel activity|",5,7,357000000,4.9%
Q8K0U4,0.995757571,-0.0505,0.054208718,-0.001666667,0.987595559,-0.016137289,-0.004,0.059,-0.204,0.033,-0.082,-0.105,Q8K0U4,Hspa12a,Q8K0U4_Hspa12a,Q8K0U4,Hspa12a,1,4,4,4,Q8K0U4,MOUSE,75212.3,7.8,2072,2072.1,44.85,44.85,,675,Heat shock 70 kDa protein 12A,extracellular exosome|,,ATP binding|,4,4,38200000,7.8%
E9PU87,0.612622361,-0.051833333,6.120288999,-0.133666667,0.244326796,-1.276508928,-0.113,0.023,0.135,-0.173,-0.182,-0.001,E9PU87,Sik3,E9PU87_Sik3,E9PU87,Sik3,1,7,4,4,E9PU87|Q6P4S6|Q6P4S6-2,MOUSE,151911.9,3.8,2073,2073.1,44.78,44.78,,1369,Serine/threonine-protein kinase SIK3,cytoplasm|,endochondral ossification|protein phosphorylation|regulation of protein localization|limb morphogenesis|multicellular organism growth|skeletal system morphogenesis|cartilage development involved in endochondral bone morphogenesis|,magnesium ion binding|protein serine/threonine kinase activity|protein binding|ATP binding|,4,7,265000000,3.8%
Q8K0H1,0.88044681,-0.092833333,1.937015688,0.081666667,0.640174589,0.489670285,0.047,-0.016,-0.432,0.02,-0.283,0.107,Q8K0H1,Slc47a1,Q8K0H1_Slc47a1,Q8K0H1,Slc47a1,1,9,4,4,Q8K0H1|D6RGQ3|Q8K0H1-2,MOUSE,62610.8,7.7,2074,2074.1,44.78,44.78,,567,Multidrug and toxin extrusion protein 1,plasma membrane|integral component of membrane|membrane-bounded vesicle|,drug transmembrane transport|organic cation transport|hydrogen ion transmembrane transport|,monovalent cation:proton antiporter activity|drug transmembrane transporter activity|,4,9,245000000,7.7%
Q8VE19,0.956972055,0.000166667,0.617788765,0.015,0.867403407,0.173476499,0.006,-0.006,-0.022,0.055,0.064,-0.096,Q8VE19,Mios,Q8VE19_Mios,Q8VE19,Mios,1,7,4,4,Q8VE19,MOUSE,99987.9,5.9,2075,2075.1,44.77,44.77,,875,GATOR complex protein MIOS,nucleus|nucleoplasm|cytoplasm|lysosomal membrane|cell junction|GATOR2 complex|,positive regulation of TOR signaling|cellular response to amino acid starvation|cellular protein complex localization|,,4,7,84600000,5.9%
O88543,0.873472653,-0.0275,2.042997216,-0.048333333,0.624741388,-0.512535726,0.02,0.098,-0.128,-0.016,-0.034,-0.105,O88543,Cops3,O88543_Cops3,O88543,Cops3,1,9,5,5,O88543,MOUSE,48401.8,13.2,2076,2076.1,44.74,44.74,,423,COP9 signalosome complex subunit 3,nucleus|nucleoplasm|cytoplasm|COP9 signalosome|,in utero embryonic development|ubiquitin-dependent protein catabolic process|cullin deneddylation|,protein binding|,5,9,1290000000,13.2%
Q64133,0.737344112,0.0435,3.979353778,0.136333333,0.400004265,0.8993375,-0.214,-0.038,0.178,-0.133,0.187,0.281,Q64133,Maoa,Q64133_Maoa,Q64133,Maoa,1,4,3,3,Q64133,MOUSE,60171.3,5.8,2077,2077.1,44.69,44.69,,526,Amine oxidase [flavin-containing] A,mitochondrion|mitochondrial outer membrane|integral component of membrane|,neurotransmitter catabolic process|dopamine catabolic process|serotonin metabolic process|phenylethylamine metabolic process|oxidation-reduction process|,protein binding|primary amine oxidase activity|flavin adenine dinucleotide binding|serotonin binding|,3,4,933000000,5.8%
Q8C3X8,0.914063344,-0.072,1.340181811,0.082,0.734483119,0.353806798,0.14,0.188,-0.667,0.066,-0.059,-0.1,Q8C3X8,Lmf2,Q8C3X8_Lmf2,Q8C3X8,Lmf2,1,3,3,3,Q8C3X8,MOUSE,80166.8,8.4,2078,2078.1,44.62,44.62,,702,Lipase maturation factor 2,endoplasmic reticulum membrane|membrane|integral component of membrane|,,,3,3,1720000000,8.4%
Q7TN29,0.870569966,-0.025166667,2.097507596,-0.047,0.616948966,-0.524329565,-0.021,0.02,-0.004,-0.167,-0.002,0.023,Q7TN29,Smap2,Q7TN29_Smap2,Q7TN29,Smap2,1,9,5,5,Q7TN29|Q7TN29-2,MOUSE,46919.3,13,2079,2079.1,44.61,44.61,,428,Stromal membrane-associated protein 2,nucleoplasm|cytoplasm|,positive regulation of GTPase activity|,GTPase activator activity|metal ion binding|,5,9,1130000000,13.0%
A0A087WRT4,0.994928853,0.041166667,0.084665059,-0.002333333,0.980693945,-0.025116542,-0.018,-0.027,0.172,0.047,0.074,-0.001,A0A087WRT4,Fat1,A0A087WRT4_Fat1,A0A087WRT4,Fat1,1,6,5,5,A0A1L1SQU7|A0A087WRT4|F2Z4A3,MOUSE,511001.9,1.5,2080,2080.1,44.55,44.55,,4602,FAT atypical cadherin 1,nucleus|plasma membrane|cell-cell junction|focal adhesion|lamellipodium|cell junction|filopodium|perinuclear region of cytoplasm|extracellular exosome|,actin filament organization|homophilic cell adhesion via plasma membrane adhesion molecules|establishment or maintenance of cell polarity|single organismal cell-cell adhesion|,calcium ion binding|protein binding|,5,6,1240000000,1.5%
Q9DC16,0.73101227,0.004166667,4.093806608,-0.086333333,0.389600351,-0.919812376,-0.055,0.128,0.069,0.026,-0.016,-0.127,Q9DC16,Ergic1,Q9DC16_Ergic1,Q9DC16,Ergic1,1,8,4,4,Q9DC16,MOUSE,32961,12.4,2081,2081.1,44.42,44.42,,290,Endoplasmic reticulum-Golgi intermediate compartment protein 1,Golgi membrane|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|membrane|integral component of membrane|endoplasmic reticulum-Golgi intermediate compartment membrane|,ER to Golgi vesicle-mediated transport|,,4,8,708000000,12.4%
Q9CQH3,0.974362931,-0.0765,0.374025446,-0.021,0.917481795,-0.107625389,0.077,0.192,-0.467,-0.071,0.096,-0.286,Q9CQH3,Ndufb5,Q9CQH3_Ndufb5,Q9CQH3,Ndufb5,1,8,3,3,Q9CQH3|D3Z568|D3Z6W9,MOUSE,21766.8,23.2,2082,2082.1,44.4,44.4,,189,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial",nucleoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex I|integral component of membrane|,oxidation-reduction process|,,3,8,251000000,23.2%
Q9WUN2,0.662343866,0.004833333,5.144745002,-0.171,0.305861983,-1.109563852,-0.015,-0.045,0.331,0.06,-0.327,0.025,Q9WUN2,Tbk1,Q9WUN2_Tbk1,Q9WUN2,Tbk1,1,8,5,5,Q9WUN2,MOUSE,84050.8,6.9,2083,2083.1,44.34,44.34,,729,Serine/threonine-protein kinase TBK1,cytoplasm|cytosol|,activation of innate immune response|protein phosphorylation|negative regulation of gene expression|positive regulation of interferon-alpha production|positive regulation of interferon-beta production|positive regulation of I-kappaB kinase/NF-kappaB signaling|dendritic cell proliferation|innate immune response|positive regulation of interferon-beta biosynthetic process|positive regulation of transcription from RNA polymerase II promoter|defense response to Gram-positive bacterium|defense response to virus|,nucleic acid binding|protein serine/threonine kinase activity|protein binding|ATP binding|phosphoprotein binding|,5,8,376000000,6.9%
O54692,0.983717661,0.058166667,0.254296748,-0.008333333,0.94312732,-0.074074549,0.205,-0.019,0.001,0.213,-0.021,-0.03,O54692,Zw10,O54692_Zw10,O54692,Zw10,1,8,4,4,O54692,MOUSE,89202.2,5.9,2084,2084.1,44.26,44.26,,779,Centromere/kinetochore protein zw10 homolog,kinetochore|condensed chromosome kinetochore|spindle pole|nucleus|cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|kinetochore microtubule|membrane|Dsl1p complex|RZZ complex|,mitotic sister chromatid segregation|establishment of mitotic spindle orientation|protein complex assembly|ER to Golgi vesicle-mediated transport|Golgi organization|mitotic metaphase plate congression|mitotic cell cycle checkpoint|regulation of exit from mitosis|protein transport|protein localization to kinetochore|cell division|,,4,8,399000000,5.9%
Q8R326,0.620577434,-0.0445,5.9565766,0.163666667,0.253712778,1.249896283,-0.384,-0.019,0.024,-0.02,0.003,0.129,Q8R326,Pspc1,Q8R326_Pspc1,Q8R326,Pspc1,1,8,5,5,Q8R326|Q8R326-2,MOUSE,58871.6,12.4,2085,2085.1,44.26,44.26,,523,Paraspeckle component 1,nucleoplasm|nucleolus|cytoplasm|nuclear matrix|nuclear speck|paraspeckles|,"transcription, DNA-templated|regulation of circadian rhythm|negative regulation of transcription, DNA-templated|rhythmic process|",nucleotide binding|core promoter binding|RNA binding|protein binding|poly(A) RNA binding|,5,8,218000000,12.4%
Q99J36,0.452728444,0.069,9.326625298,-0.292666667,0.116771664,-1.8033089,-0.084,0.516,0.214,-0.19,0.032,-0.074,Q99J36,Thumpd1,Q99J36_Thumpd1,Q99J36,Thumpd1,1,9,4,4,Q99J36,MOUSE,39169.5,13.7,2086,2086.1,44.24,44.24,,350,THUMP domain-containing protein 1,,,poly(A) RNA binding|,4,9,3750000000,13.7%
Q922U1,0.963376742,-0.0165,0.511506336,-0.018333333,0.888892755,-0.145176097,-0.221,0.19,0.009,-0.009,-0.124,0.056,Q922U1,Prpf3,Q922U1_Prpf3,Q922U1,Prpf3,1,4,3,3,Q922U1,MOUSE,77624.6,7,2087,2087.1,44.19,44.19,,683,U4/U6 small nuclear ribonucleoprotein Prp3,nucleus|nucleoplasm|spliceosomal complex|cytoplasm|Cajal body|nuclear speck|U4/U6 x U5 tri-snRNP complex|,"spliceosomal tri-snRNP complex assembly|mRNA splicing, via spliceosome|",identical protein binding|poly(A) RNA binding|,3,4,234000000,7.0%
Q99LG0,0.708523608,-0.049166667,4.416906762,0.103,0.361667367,0.979004209,-0.058,0.036,-0.28,0.005,-0.003,0.005,Q99LG0,Usp16,Q99LG0_Usp16,Q99LG0,Usp16,1,5,4,4,Q99LG0|D3YVU1|D6RHQ6,MOUSE,94859.2,7.6,2088,2088.1,44.18,44.18,,825,Ubiquitin carboxyl-terminal hydrolase 16,nucleus|,"transcription, DNA-templated|regulation of transcription from RNA polymerase II promoter|cellular response to DNA damage stimulus|mitotic nuclear division|histone deubiquitination|monoubiquitinated histone H2A deubiquitination|proteasome-mediated ubiquitin-dependent protein catabolic process|positive regulation of transcription, DNA-templated|positive regulation of translational elongation|positive regulation of transcription from RNA polymerase II promoter|protein homotetramerization|cell division|regulation of cell cycle|regulation of proteasomal protein catabolic process|histone H2A K63-linked deubiquitination|",transcription coactivator activity|cysteine-type endopeptidase activity|ubiquitin-specific protease activity|protein binding|zinc ion binding|histone binding|ubiquitin binding|,4,5,3040000000,7.6%
Q80VP1-2,0.961523652,0.022666667,0.539634844,-0.015333333,0.883154153,-0.152672956,-0.044,-0.055,0.19,0.03,-0.038,0.053,Q80VP1,Epn1,Q80VP1-2_Epn1,Q80VP1-2,Epn1,1,11,5,5,Q80VP1-2|Q80VP1|Q91W69,MOUSE,60396.2,12.1,2089,2089.1,44.17,44.17,,575,Isoform 2 of Epsin-1,nucleus|cytoplasm|plasma membrane|coated pit|terminal bouton|,in utero embryonic development|endocytosis|Notch signaling pathway|female pregnancy|embryonic organ development|,transcription factor binding|lipid binding|ion channel binding|,6,11,388000000,12.1%
O88441,0.843083616,-0.283,2.462771388,0.3,0.56718255,0.602045993,0.155,0.203,-1.657,-0.135,0.151,-0.415,O88441,Mtx2,O88441_Mtx2,O88441,Mtx2,1,4,3,3,O88441,MOUSE,30099.9,28.1,2090,2090.1,44.14,44.14,,263,Metaxin-2,mitochondrion|mitochondrial outer membrane|,protein targeting to mitochondrion|,,3,4,352000000,28.1%
O88822,0.086491781,0.0095,20.81314559,0.482333333,0.008292499,3.71563656,-0.35,-0.014,-0.331,0.25,0.111,0.391,O88822,Sc5d,O88822_Sc5d,O88822,Sc5d,1,11,4,4,O88822,MOUSE,35175.9,10,2091,2091.1,44.11,44.11,,299,Lathosterol oxidase,endoplasmic reticulum membrane|integral component of membrane|,fatty acid biosynthetic process|cholesterol biosynthetic process via lathosterol|oxidation-reduction process|,C-5 sterol desaturase activity|iron ion binding|lathosterol oxidase activity|,4,11,705000000,10.0%
Q8VHI3,0.001827436,-0.1655,41.13882494,1.353666667,7.69339E-05,8.6350982,-0.883,-0.582,-1.062,0.444,0.368,0.722,Q8VHI3,Pofut2,Q8VHI3_Pofut2,Q8VHI3,Pofut2,1,8,5,5,Q8VHI3,MOUSE,49770.7,11.8,2092,2092.1,44.01,44.01,,429,GDP-fucose protein O-fucosyltransferase 2,endoplasmic reticulum|Golgi apparatus|,mesoderm formation|fucose metabolic process|regulation of gene expression|regulation of epithelial to mesenchymal transition|fucosylation|protein O-linked fucosylation|regulation of secretion|,fucosyltransferase activity|peptide-O-fucosyltransferase activity|,5,8,176000000,11.8%
Q78KK3,0.791316333,-0.1055,3.238612554,0.145666667,0.474393516,0.75830686,0.005,0.083,-0.623,-0.045,0.043,-0.096,Q78KK3,Slc22a18,Q78KK3_Slc22a18,Q78KK3,Slc22a18,1,11,3,3,A0A0R4J0P7|Q78KK3,MOUSE,43468.3,10,2093,2093.1,44,44,,406,Solute carrier family 22 member 18,nuclear envelope|cytoplasm|integral component of plasma membrane|membrane|apical plasma membrane|,anion transport|drug transmembrane transport|organic anion transport|drug transport|,organic anion transmembrane transporter activity|drug transmembrane transporter activity|symporter activity|ubiquitin protein ligase binding|,3,11,2370000000,10.0%
Q3USZ8,0.650605366,-0.005333333,5.314026408,0.098666667,0.294169308,1.138053204,0.004,-0.137,-0.031,0.108,0.008,0.016,Q3USZ8,1190002N15Rik,Q3USZ8_1190002N15Rik,Q3USZ8,,1,6,5,5,Q3USZ8,MOUSE,50146.7,13.7,2094,2094.1,43.96,43.96,,430,Deleted in autism protein 1 homolog,Golgi membrane|extracellular space|COPI vesicle coat|COPI-coated vesicle|,"regulation of phosphatidylinositol 3-kinase signaling|vesicle targeting, to, from or within Golgi|cardiac muscle cell proliferation|",,5,6,247000000,13.7%
O35704,0.991556352,0.0035,0.167456077,0.006333333,0.962175717,0.049246338,-0.171,-0.032,0.204,0.031,-0.137,0.126,O35704,Sptlc1,O35704_Sptlc1,O35704,Sptlc1,1,5,4,4,O35704,MOUSE,53104.3,9,2095,2095.1,43.93,43.93,,473,Serine palmitoyltransferase 1,integral component of membrane|serine C-palmitoyltransferase complex|SPOTS complex|,sphingomyelin biosynthetic process|sphinganine biosynthetic process|sphingosine biosynthetic process|ceramide biosynthetic process|,protein binding|pyridoxal phosphate binding|serine C-palmitoyltransferase activity|,4,5,50900000,9.0%
Q9D2Y4-2,0.89105666,0.0435,1.752832564,-0.088333333,0.667908151,-0.44878494,0.008,-0.193,0.448,0.239,-0.236,-0.005,Q9D2Y4,Mlkl,Q9D2Y4-2_Mlkl,Q9D2Y4-2,Mlkl,1,4,4,4,Q9D2Y4-2|Q9D2Y4,MOUSE,53945,12.5,2096,2096.1,43.91,43.91,,472,Isoform 2 of Mixed lineage kinase domain-like protein,cytoplasm|plasma membrane|,protein phosphorylation|protein homotrimerization|necroptotic process|,ATP binding|protein kinase binding|protein complex binding|protein kinase activity|,4,4,724000000,12.5%
P63325,0.963913158,0.015833333,0.492639738,0.016333333,0.892762678,0.140068724,-0.136,0.101,0.058,-0.096,0.195,-0.027,P63325,Rps10,P63325_Rps10,P63325,Rps10,1,8,4,4,P63325|Q3UW83,MOUSE,18915.4,20.6,2097,2097.1,43.84,43.84,,165,40S ribosomal protein S10,nucleolus|cytoplasm|focal adhesion|membrane|cytosolic small ribosomal subunit|extracellular exosome|,,poly(A) RNA binding|,4,8,287000000,20.6%
P28654,0.332192581,-0.0435,11.85327853,0.239,0.065263768,2.203183111,-0.344,-0.017,-0.128,0.039,0.06,0.129,P28654,Dcn,P28654_Dcn,P28654,Dcn,1,6,5,5,P28654,MOUSE,40150.6,18,2098,2098.1,43.75,43.75,,354,Decorin,collagen type VI trimer|extracellular space|extracellular matrix|,kidney development|placenta development|skeletal muscle tissue development|aging|response to mechanical stimulus|positive regulation of autophagy|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|response to lipopolysaccharide|wound healing|,collagen binding|glycosaminoglycan binding|poly(A) RNA binding|protein N-terminus binding|extracellular matrix binding|,5,6,119000000,18.0%
O55060,0.774051682,0.024,3.483361709,-0.156666667,0.448398168,-0.805676445,0.04,0.488,-0.221,-0.242,0.105,-0.026,O55060,Tpmt,O55060_Tpmt,O55060,Tpmt,1,4,4,4,O55060|A0A0R4J018|D3Z380,MOUSE,27870.4,15.8,2099,2099.1,43.56,43.56,,240,Thiopurine S-methyltransferase,cytoplasm|extracellular exosome|,methylation|,thiopurine S-methyltransferase activity|,4,4,82700000,15.8%
Q8VCB1,0.550913932,-0.044,7.247283611,0.156666667,0.188482763,1.464459721,-0.063,0.005,-0.309,0,0.043,0.06,Q8VCB1,Ndc1,Q8VCB1_Ndc1,Q8VCB1,Ndc1,1,8,4,4,Q8VCB1|J3QPB5,MOUSE,76092.6,7.7,2100,2100.1,43.55,43.55,,673,Nucleoporin NDC1,nuclear pore|cytoplasm|membrane|nuclear membrane|,synapsis|spermatogenesis|protein transport|nuclear pore distribution|mRNA transport|nuclear pore complex assembly|,structural constituent of nuclear pore|,4,8,200000000,7.7%
O54724,0.991706646,0.038833333,0.150230027,-0.005,0.965999713,-0.04425419,0.017,0.176,-0.069,0.197,-0.053,-0.035,O54724,Cavin1,O54724_Cavin1,O54724,Cavin1,1,6,4,4,O54724,MOUSE,43952.8,13.5,2101,2101.1,43.54,43.54,,392,Caveolae-associated protein 1,nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|cytosol|plasma membrane|caveola|intracellular membrane-bounded organelle|protein complex|membrane raft|,"regulation of transcription, DNA-templated|transcription initiation from RNA polymerase I promoter|termination of RNA polymerase I transcription|",rRNA primary transcript binding|poly(A) RNA binding|,4,6,1000000000,13.5%
Q8K4L3,0.312476077,0.007,12.46701586,0.198666667,0.05666285,2.29974431,-0.159,-0.084,-0.034,0.179,0.053,0.087,Q8K4L3,Svil,Q8K4L3_Svil,Q8K4L3,Svil,1,4,4,4,A0A1B0GS91|Q8K4L3|E9Q3Z5|Q8K4L2|Q8K4L3-3,MOUSE,244697.7,2.8,2102,2102.1,43.49,43.49,,2170,Supervillin,podosome|nucleus|cytoplasm|plasma membrane|focal adhesion|actin cytoskeleton|midbody|cleavage furrow|microtubule minus-end|costamere|invadopodium|,cytoskeleton organization|skeletal muscle tissue development|positive regulation of cytokinesis|,actin filament binding|,4,4,37700000,2.8%
P35821,0.600763538,0.139666667,6.338577222,-0.406666667,0.232349787,-1.314620022,0.101,-0.149,1.077,0.023,-0.253,0.039,P35821,Ptpn1,P35821_Ptpn1,P35821,Ptpn1,1,7,5,5,P35821,MOUSE,50220,10.1,2103,2103.1,43.49,43.49,,432,Tyrosine-protein phosphatase non-receptor type 1,cytoplasm|early endosome|endoplasmic reticulum|cytosol|cytoplasmic vesicle|sorting endosome|cytoplasmic side of endoplasmic reticulum membrane|plasma membrane|,protein dephosphorylation|activation of JUN kinase activity|insulin receptor signaling pathway|regulation of signal transduction|regulation of endocytosis|negative regulation of vascular endothelial growth factor receptor signaling pathway|endoplasmic reticulum unfolded protein response|actin cytoskeleton reorganization|regulation of intracellular protein transport|response to endoplasmic reticulum stress|peptidyl-tyrosine dephosphorylation|platelet-derived growth factor receptor-beta signaling pathway|IRE1-mediated unfolded protein response|negative regulation of MAP kinase activity|regulation of insulin receptor signaling pathway|positive regulation of protein tyrosine kinase activity|negative regulation of ERK1 and ERK2 cascade|regulation of hepatocyte growth factor receptor signaling pathway|negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|negative regulation of PERK-mediated unfolded protein response|peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity|positive regulation of receptor catabolic process|,protein tyrosine phosphatase activity|insulin receptor binding|zinc ion binding|enzyme binding|protein kinase binding|receptor tyrosine kinase binding|poly(A) RNA binding|ephrin receptor binding|protein phosphatase 2A binding|,5,7,187000000,10.1%
Q4FCQ7,0.974362931,0.0215,0.374495849,-0.011666667,0.917382424,-0.107719518,-0.026,-0.088,0.196,0.074,-0.083,0.056,Q4FCQ7,Ate1,Q4FCQ7_Ate1,Q4FCQ7,Ate1,1,5,4,4,Q4FCQ7|J3QNU1|A0A1L1SQ41|Q9Z2A5|Q9Z2A5-2,MOUSE,59345.5,12.1,2104,2104.1,43.48,43.48,,509,Arginyl-tRNA--protein transferase 1,nucleus|cytoplasm|,protein arginylation|,arginyltransferase activity|,4,5,164000000,12.1%
Q8BNI4,0.98696829,-0.018833333,0.22307337,0.007,0.949932317,0.065187628,-0.134,0.12,-0.053,0.048,-0.141,0.047,Q8BNI4,Derl2,Q8BNI4_Derl2,Q8BNI4,Derl2,1,13,3,3,Q8BNI4|Q3U957|Q8BNI4-2|J3QMF4|J3QMQ7,MOUSE,27753.1,19.6,2105,2105.1,43.45,43.45,,239,Derlin-2,early endosome|late endosome|endoplasmic reticulum|membrane|integral component of endoplasmic reticulum membrane|,"suckling behavior|positive regulation of cell proliferation|positive regulation of cell growth|ER-associated ubiquitin-dependent protein catabolic process|endoplasmic reticulum unfolded protein response|retrograde protein transport, ER to cytosol|negative regulation of retrograde protein transport, ER to cytosol|",,3,13,5500000000,19.6%
Q3UDR8,0.390295723,0.0295,10.61696849,0.205666667,0.086756725,2.005663402,-0.149,-0.011,-0.06,0.271,-0.002,0.128,Q3UDR8,Yipf3,Q3UDR8_Yipf3,Q3UDR8,Yipf3,1,5,3,3,Q3UDR8,MOUSE,38225.9,12.9,2106,2106.1,43.35,43.35,,347,Protein YIPF3,nucleoplasm|Golgi apparatus|plasma membrane|integral component of membrane|transport vesicle|intracellular membrane-bounded organelle|,cell differentiation|,,3,5,1530000000,12.9%
Q8R1A4,0.910011409,0.025333333,1.456274485,0.035333333,0.715109506,0.380846131,-0.04,0.008,0.055,-0.006,0.167,-0.032,Q8R1A4,NotFound,Q8R1A4_NotFound,Q8R1A4,Dock7,1,10,6,6,Q8R1A4|A2A9M4|Q8R1A4-2|A2A9M5|E9PX48|A0A0U1RNK7,MOUSE,243316.8,4.3,2107,2107.1,43.33,43.33,,2130,Dedicator of cytokinesis protein 7,focal adhesion|axon|COP9 signalosome|,microtubule cytoskeleton organization|hematopoietic progenitor cell differentiation|small GTPase mediated signal transduction|axonogenesis|interkinetic nuclear migration|neuron projection development|positive regulation of peptidyl-serine phosphorylation|pigmentation|establishment of neuroblast polarity|regulation of neurogenesis|activation of GTPase activity|,guanyl-nucleotide exchange factor activity|protein binding|Rac GTPase binding|,6,10,5350000000,4.3%
Q9WTX6,0.961523652,0.014,0.539468883,0.012666667,0.883187903,0.152627979,-0.047,0.019,0.051,-0.041,0.051,0.051,Q9WTX6,Cul1,Q9WTX6_Cul1,Q9WTX6,Cul1,1,8,5,5,Q9WTX6|A0A0N4SUW1,MOUSE,90374.5,6.1,2108,2108.1,43.31,43.31,,776,Cullin-1,SCF ubiquitin ligase complex|cullin-RING ubiquitin ligase complex|Parkin-FBXW7-Cul1 ubiquitin ligase complex|,ubiquitin-dependent protein catabolic process|protein monoubiquitination|apoptotic process|cell proliferation|organ morphogenesis|viral process|protein ubiquitination|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|,protein binding|ubiquitin protein ligase binding|ubiquitin protein ligase activity|,5,8,732000000,6.1%
Q9DC63,0.965296689,0.016,0.461495619,0.012666667,0.899187867,0.131572086,-0.003,0.012,0.02,-0.012,0.167,-0.088,Q9DC63,Fbxo3,Q9DC63_Fbxo3,Q9DC63,Fbxo3,1,8,3,3,Q9DC63|Q9DC63-2|Q9DC63-3|A2BHN6,MOUSE,56082,9.5,2109,2109.1,43.29,43.29,,480,F-box only protein 3,nucleoplasm|cytoplasm|,proteolysis|protein ubiquitination|,,3,8,545000000,9.5%
Q6PD26,0.193260113,-0.0425,16.17313581,0.358333333,0.024137174,2.909571399,-0.283,-0.016,-0.366,0.016,0.147,0.247,Q6PD26,Pigs,Q6PD26_Pigs,Q6PD26,Pigs,1,4,4,4,Q6PD26,MOUSE,61823.5,10.8,2110,2110.1,43.26,43.26,,555,GPI transamidase component PIG-S,membrane|GPI-anchor transamidase complex|,attachment of GPI anchor to protein|,GPI-anchor transamidase activity|,4,4,265000000,10.8%
Q9DC29,0.825727613,-0.013,2.69116799,-0.053333333,0.53812504,-0.648710848,0.011,0.01,0.02,-0.007,0.006,-0.118,Q9DC29,Abcb6,Q9DC29_Abcb6,Q9DC29,Abcb6,1,9,4,4,Q9DC29,MOUSE,94282.1,6.6,2111,2111.1,43.2,43.2,,842,"ATP-binding cassette sub-family B member 6, mitochondrial",mitochondrion|mitochondrial envelope|mitochondrial outer membrane|endosome|endoplasmic reticulum|Golgi apparatus|plasma membrane|integral component of membrane|integral component of mitochondrial outer membrane|extracellular exosome|,porphyrin-containing compound biosynthetic process|transport|brain development|heme transport|skin development|transmembrane transport|,"ATP binding|heme-transporting ATPase activity|efflux transmembrane transporter activity|heme binding|ATPase activity, coupled to transmembrane movement of substances|",4,9,291000000,6.6%
V9GX91,0.902549921,-0.083166667,1.589111463,0.090333333,0.693567691,0.411691015,0.199,0.062,-0.646,-0.106,0.034,-0.042,V9GX91,Nav2,V9GX91_Nav2,V9GX91,Nav2,1,12,6,6,V9GX91|E9Q842|V9GXT3,MOUSE,263026.9,3,2112,2112.1,43.16,43.16,,2432,Neuron navigator 2,proteinaceous extracellular matrix|interstitial matrix|nucleoplasm|,regulation of systemic arterial blood pressure by baroreceptor feedback|sensory perception of sound|sensory perception of smell|locomotory behavior|optic nerve development|glossopharyngeal nerve development|vagus nerve development|,heparin binding|,6,12,14300000000,3.0%
Q8BGF6,0.876086294,0.000333333,1.996739171,-0.059333333,0.631431266,-0.502702363,-0.002,-0.065,0.157,0.119,-0.209,0.002,Q8BGF6,Elmod2,Q8BGF6_Elmod2,Q8BGF6,Elmod2,1,5,5,5,Q8BGF6,MOUSE,35146,18,2113,2113.1,43.14,43.14,,293,ELMO domain-containing protein 2,membrane|,positive regulation of GTPase activity|regulation of defense response to virus|,GTPase activator activity|,5,5,585000000,18.0%
Q61937,0.913467169,-0.015333333,1.347142624,0.050666667,0.733306843,0.35545136,-0.163,-0.109,0.15,-0.233,0.144,0.119,Q61937,Npm1,Q61937_Npm1,Q61937,Npm1,1,9,5,5,Q61937|Q5SQB0|Q5SQB5|Q9DAY9,MOUSE,32730.7,19.1,2114,2114.1,43.09,43.09,,292,Nucleophosmin,granular component|nucleus|nucleoplasm|nucleolus|cytoplasm|centrosome|cytosol|focal adhesion|large ribosomal subunit|small ribosomal subunit|membrane|nuclear speck|ribonucleoprotein complex|spindle pole centrosome|,"ribosomal large subunit export from nucleus|ribosomal small subunit export from nucleus|DNA repair|nucleosome assembly|rRNA export from nucleus|cell volume homeostasis|nucleocytoplasmic transport|centrosome cycle|cell aging|protein localization|positive regulation of cell proliferation|negative regulation of cell proliferation|regulation of centrosome duplication|positive regulation of centrosome duplication|negative regulation of centrosome duplication|cell growth|positive regulation of cellular biosynthetic process|regulation of endodeoxyribonuclease activity|ribosomal large subunit biogenesis|ribosomal small subunit biogenesis|negative regulation of apoptotic process|regulation of DNA damage response, signal transduction by p53 class mediator|regulation of neuron apoptotic process|negative regulation of protein kinase activity by regulation of protein phosphorylation|positive regulation of translation|positive regulation of DNA replication|positive regulation of protein kinase activity|regulation of centriole replication|negative regulation of mRNA splicing, via spliceosome|positive regulation of NF-kappaB transcription factor activity|protein oligomerization|protein homooligomerization|regulation of cell cycle|regulation of endoribonuclease activity|regulation of eIF2 alpha phosphorylation by dsRNA|negative regulation of cyclin-dependent protein kinase activity|","DNA binding|transcription coactivator activity|RNA binding|protein kinase inhibitor activity|protein binding|phosphatidylinositol-3,4,5-trisphosphate binding|rRNA binding|protein kinase binding|Tat protein binding|histone binding|protein homodimerization activity|ribosomal large subunit binding|ribosomal small subunit binding|poly(A) RNA binding|protein heterodimerization activity|protein N-terminus binding|NF-kappaB binding|unfolded protein binding|",5,9,716000000,19.1%
Q9D8U3,0.844723818,0.455833333,2.430754658,-0.558333333,0.571379342,-0.595369127,-0.205,3.071,-0.661,0.075,0.658,-0.203,Q9D8U3,Erp27,Q9D8U3_Erp27,Q9D8U3,Erp27,1,4,4,4,Q9D8U3,MOUSE,30920.8,19.4,2115,2115.1,42.96,42.96,,272,Endoplasmic reticulum resident protein 27,endoplasmic reticulum lumen|cell surface|,protein folding|response to endoplasmic reticulum stress|,protein disulfide isomerase activity|,4,4,356000000,19.4%
Q69ZX8,0.884566234,0.007666667,1.844000611,-0.061333333,0.654033417,-0.469130127,-0.005,0.188,-0.068,-0.018,-0.222,0.171,Q69ZX8,Ablim3,Q69ZX8_Ablim3,Q69ZX8,Ablim3,1,10,7,7,Q69ZX8,MOUSE,79340.6,10.7,2116,2116.1,42.91,42.91,,682,Actin-binding LIM protein 3,stress fiber|cytoplasm|lamellipodium|,"transcription, DNA-templated|lamellipodium assembly|actin cytoskeleton organization|cilium assembly|positive regulation of transcription from RNA polymerase II promoter|positive regulation of protein targeting to mitochondrion|",actin binding|zinc ion binding|,7,10,3740000000,10.7%
Q8CIV8,0.993378838,0.001166667,0.118706087,-0.003666667,0.973037082,-0.035084166,0.065,0.061,-0.117,0.139,-0.084,-0.057,Q8CIV8,Tbce,Q8CIV8_Tbce,Q8CIV8,Tbce,1,10,5,5,Q8CIV8|E0CZ81|E0CXJ6,MOUSE,59826.4,12.7,2117,2117.1,42.91,42.91,,524,Tubulin-specific chaperone E,cytoplasm|cytoskeleton|,microtubule cytoskeleton organization|protein folding|tubulin complex assembly|post-chaperonin tubulin folding pathway|axonogenesis|adult locomotory behavior|post-embryonic development|muscle atrophy|developmental growth|peripheral nervous system neuron axonogenesis|,unfolded protein binding|,5,10,4330000000,12.7%
Q9CZX7,0.689434001,0.035333333,4.710302195,-0.145333333,0.338041313,-1.032584568,-0.028,-0.046,0.398,0.048,-0.116,-0.044,Q9CZX7,Pip4p2,Q9CZX7_Pip4p2,Q9CZX7,Pip4p2,1,7,4,4,Q9CZX7|Q3TWL2|F8WHW3|E0CZ18|E0CZF6,MOUSE,29121.4,15.1,2118,2118.1,42.87,42.87,,257,"Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase",lysosomal membrane|integral component of membrane|late endosome membrane|,metabolic process|,hydrolase activity|,4,7,235000000,15.1%
Q91VJ4,0.774891394,-0.008,3.469114437,-0.066666667,0.449871578,-0.802366327,0.005,0.075,-0.004,-0.022,-0.108,0.006,Q91VJ4,Stk38,Q91VJ4_Stk38,Q91VJ4,Stk38,1,6,5,4,Q91VJ4,MOUSE,54515.6,13.5,2119,2119.1,42.81,35.73,,465,Serine/threonine-protein kinase 38,nucleus|cytoplasm|MLL5-L complex|,cellular protein modification process|protein phosphorylation|intracellular signal transduction|negative regulation of MAP kinase activity|,magnesium ion binding|protein serine/threonine kinase activity|protein binding|ATP binding|mitogen-activated protein kinase kinase kinase binding|,5,6,1640000000,13.5%
Q7TSE6-2,0.019347247,-0.029,28.65522932,0.442,0.001362941,5.250759993,-0.25,-0.19,-0.31,0.226,0.218,0.132,Q7TSE6,Stk38l,Q7TSE6-2_Stk38l,Q7TSE6-2,Stk38l,1,4,4,3,Q7TSE6-2|Q7TSE6,MOUSE,54836.8,11.8,2119,2119.2,36.31,29.23,,464,Isoform 2 of Serine/threonine-protein kinase 38-like,cytoplasm|actin cytoskeleton|membrane|,protein phosphorylation|intracellular signal transduction|regulation of cellular component organization|,magnesium ion binding|actin binding|protein serine/threonine kinase activity|ATP binding|,3,4,163000000,9.3%
Q9D4H1,0.91325,0.0035,1.382692263,0.029,0.727328782,0.363647499,0.022,-0.034,-0.021,0.066,0.003,-0.015,Q9D4H1,Exoc2,Q9D4H1_Exoc2,Q9D4H1,Exoc2,1,6,5,5,Q9D4H1,MOUSE,104984.4,9.1,2120,2120.1,42.81,42.81,,924,Exocyst complex component 2,exocyst|plasma membrane|membrane|intracellular membrane-bounded organelle|,exocytosis|Golgi to plasma membrane transport|protein transport|positive regulation of exocytosis|regulation of entry of bacterium into host cell|,Ral GTPase binding|protein kinase binding|protein N-terminus binding|,5,6,247000000,9.1%
Q9D7J9,0.750398776,-0.010833333,3.82837713,-0.071,0.414154407,-0.870469466,0.021,0.041,0.012,0.024,-0.096,-0.067,Q9D7J9,Echdc3,Q9D7J9_Echdc3,Q9D7J9,Echdc3,1,10,4,4,Q9D7J9,MOUSE,32687,16.3,2121,2121.1,42.77,42.77,,300,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",mitochondrion|,metabolic process|,catalytic activity|,4,10,3080000000,16.3%
Q9D8C4,0.454052388,0.0415,9.272871163,0.515666667,0.118225969,1.794686089,0.066,-0.402,-0.313,0.948,-0.089,0.039,Q9D8C4,Ifi35,Q9D8C4_Ifi35,Q9D8C4,Ifi35,1,4,3,3,Q9D8C4,MOUSE,32103.3,19.2,2122,2122.1,42.77,42.77,,286,Interferon-induced 35 kDa protein homolog,nucleus|,,,3,4,466000000,19.2%
Q99P30,0.951421295,0.010166667,0.725633299,0.066333333,0.846129175,0.201805914,-0.582,0.021,0.492,0.229,-0.488,0.389,Q99P30,Nudt7,Q99P30_Nudt7,Q99P30,Nudt7,1,3,3,3,Q99P30|Q99P30-3|Q99P30-5|Q99P30-2|Q99P30-4,MOUSE,27084.5,10.5,2123,2123.1,42.71,42.71,,236,Peroxisomal coenzyme A diphosphatase NUDT7,peroxisome|,nucleoside diphosphate metabolic process|coenzyme A catabolic process|acetyl-CoA catabolic process|brown fat cell differentiation|,magnesium ion binding|acetyl-CoA hydrolase activity|receptor binding|manganese ion binding|snoRNA binding|m7G(5')pppN diphosphatase activity|,3,3,933000000,10.5%
A2AWP8,0.854501013,-0.0055,2.33069539,0.059666667,0.584696455,0.574087941,-0.035,-0.113,0.042,0.124,-0.133,0.082,A2AWP8,Arhgef10l,A2AWP8_Arhgef10l,A2AWP8,Arhgef10l,1,7,5,5,A2AWP8|A2AWP8-4|A2AWP8-2|A2AWP8-3|A2AWP6|A2AWP8-5,MOUSE,141638.8,4.9,2124,2124.1,42.7,42.7,,1280,Rho guanine nucleotide exchange factor 10-like protein,cytoplasm|,regulation of Rho protein signal transduction|positive regulation of GTPase activity|,Rho guanyl-nucleotide exchange factor activity|,5,7,85800000,4.9%
Q9D0B0,0.880641665,0.017,1.930274885,-0.093333333,0.641168993,-0.48818892,-0.169,0.143,0.217,-0.141,-0.293,0.345,Q9D0B0,Srsf9,Q9D0B0_Srsf9,Q9D0B0,Srsf9,1,9,4,4,Q9D0B0,MOUSE,25775,18.9,2125,2125.1,42.6,42.6,,222,Serine/arginine-rich splicing factor 9,nucleoplasm|nucleolus|,"mRNA processing|RNA splicing|negative regulation of mRNA splicing, via spliceosome|",nucleotide binding|poly(A) RNA binding|,4,9,2340000000,18.9%
Q61144,0.904214516,0.006,1.565037621,0.054,0.697422955,0.406173609,-0.02,-0.128,0.085,0.254,-0.184,0.029,Q61144,Psen2,Q61144_Psen2,Q61144,Psen2,1,7,3,2,Q61144|Q3U4P5|A0A0R4J1F2|Q61144-2,MOUSE,50552.8,8.9,2126,2126.1,42.53,35.24,,448,Presenilin-2,Golgi membrane|kinetochore|nucleus|nuclear inner membrane|mitochondrial inner membrane|lysosomal membrane|endoplasmic reticulum|endoplasmic reticulum membrane|Golgi apparatus|centrosome|cytosol|plasma membrane|integral component of plasma membrane|cell cortex|cell surface|membrane|apical plasma membrane|Z disc|axon|growth cone|neuromuscular junction|ciliary rootlet|ciliary basal body|neuronal cell body|dendritic shaft|protein complex|membrane raft|perinuclear region of cytoplasm|,negative regulation of transcription from RNA polymerase II promoter|cell fate specification|somitogenesis|positive regulation of receptor recycling|negative regulation of protein phosphorylation|hair follicle development|hematopoietic progenitor cell differentiation|T cell activation involved in immune response|myeloid leukocyte differentiation|membrane protein ectodomain proteolysis|negative regulation of epidermal growth factor-activated receptor activity|regulation of epidermal growth factor-activated receptor activity|Notch signaling pathway|Notch receptor processing|learning or memory|memory|protein transport|protein processing|dorsal/ventral neural tube patterning|embryonic limb morphogenesis|forebrain development|negative regulation of protein complex assembly|negative regulation of protein binding|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|endoplasmic reticulum calcium ion homeostasis|intracellular signal transduction|locomotion|amyloid precursor protein catabolic process|positive regulation of apoptotic process|positive regulation of catalytic activity|regulation of protein binding|skin morphogenesis|cellular protein metabolic process|regulation of synaptic plasticity|lung alveolus development|thymus development|brain morphogenesis|beta-amyloid metabolic process|positive regulation of coagulation|T cell receptor signaling pathway|negative regulation of ubiquitin-protein transferase activity|protein maturation|cardiac muscle contraction|neuron cellular homeostasis|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|negative regulation of apoptotic signaling pathway|,endopeptidase activity|aspartic-type endopeptidase activity|protein binding|,3,7,853000000,8.9%
P49769,0.904214516,0.071833333,1.567448176,-0.077,0.697035958,-0.406726826,-0.138,-0.002,0.471,0.199,-0.213,0.114,P49769,Psen1,P49769_Psen1,P49769,Psen1,1,4,3,2,P49769|P49769-2,MOUSE,52924.1,5.9,2126,2126.2,19.97,12.68,,467,Presenilin-1,Golgi membrane|kinetochore|intracellular|nucleus|nuclear outer membrane|mitochondrion|mitochondrial inner membrane|lysosomal membrane|endoplasmic reticulum|endoplasmic reticulum membrane|smooth endoplasmic reticulum|rough endoplasmic reticulum|Golgi apparatus|centrosome|plasma membrane|integral component of plasma membrane|cell cortex|cell surface|membrane|aggresome|apical plasma membrane|Z disc|axon|dendrite|growth cone|cytoplasmic vesicle|neuromuscular junction|nuclear membrane|ciliary rootlet|neuronal cell body|dendritic shaft|membrane-bounded organelle|membrane raft|perinuclear region of cytoplasm|gamma-secretase complex|,"autophagosome assembly|negative regulation of transcription from RNA polymerase II promoter|activation of MAPKK activity|blood vessel development|cell fate specification|somitogenesis|neuron migration|positive regulation of receptor recycling|negative regulation of protein phosphorylation|positive regulation of protein phosphorylation|heart looping|hematopoietic progenitor cell differentiation|T cell activation involved in immune response|myeloid leukocyte differentiation|neural retina development|negative regulation of protein kinase activity|protein glycosylation|membrane protein ectodomain proteolysis|calcium ion transport|mitochondrial transport|cellular calcium ion homeostasis|autophagy|cellular response to DNA damage stimulus|response to oxidative stress|negative regulation of epidermal growth factor-activated receptor activity|regulation of epidermal growth factor-activated receptor activity|Notch signaling pathway|Notch receptor processing|brain development|heart development|learning or memory|memory|post-embryonic development|protein transport|L-glutamate transport|choline transport|synaptic vesicle targeting|single organismal cell-cell adhesion|protein processing|cerebral cortex cell migration|Cajal-Retzius cell differentiation|dorsal/ventral neural tube patterning|cerebral cortex development|neurogenesis|neuron differentiation|embryonic limb morphogenesis|forebrain development|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|endoplasmic reticulum calcium ion homeostasis|beta-amyloid formation|segmentation|intracellular signal transduction|locomotion|regulation of phosphorylation|amyloid precursor protein catabolic process|myeloid dendritic cell differentiation|positive regulation of apoptotic process|negative regulation of apoptotic process|positive regulation of catalytic activity|regulation of protein binding|positive regulation of MAP kinase activity|negative regulation of neuron apoptotic process|skin morphogenesis|cellular protein metabolic process|positive regulation of protein kinase activity|positive regulation of transcription, DNA-templated|regulation of synaptic plasticity|thymus development|neuron development|skeletal system morphogenesis|brain morphogenesis|beta-amyloid metabolic process|epithelial cell proliferation|negative regulation of axonogenesis|positive regulation of coagulation|T cell receptor signaling pathway|neuron apoptotic process|negative regulation of ubiquitin-protein transferase activity|smooth endoplasmic reticulum calcium ion homeostasis|protein maturation|regulation of synaptic transmission, glutamatergic|canonical Wnt signaling pathway|regulation of resting membrane potential|positive regulation of dendritic spine development|calcium ion transmembrane transport|negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|negative regulation of apoptotic signaling pathway|",endopeptidase activity|aspartic-type endopeptidase activity|calcium channel activity|protein binding|beta-catenin binding|PDZ domain binding|cadherin binding|,2,4,24400000,4.0%
Q9EP72,0.069033632,-0.015666667,22.00871736,0.634,0.006296921,3.93589584,-0.583,-0.289,-0.126,0.056,0.384,0.464,Q9EP72,Emc7,Q9EP72_Emc7,Q9EP72,Emc7,1,8,5,5,Q9EP72,MOUSE,26309.9,22.4,2127,2127.1,42.45,42.45,,241,ER membrane protein complex subunit 7,integral component of membrane|ER membrane protein complex|,,carbohydrate binding|,5,8,3670000000,22.4%
Q9ET30,0.884566234,-0.060166667,1.851724782,-0.109666667,0.652871216,-0.470844056,-0.48,0.222,0.242,-0.419,-0.013,0.087,Q9ET30,Tm9sf3,Q9ET30_Tm9sf3,Q9ET30,Tm9sf3,1,6,4,4,Q9ET30,MOUSE,68285.3,8.5,2128,2128.1,42.45,42.45,,587,Transmembrane 9 superfamily member 3,integral component of membrane|,,,4,6,751000000,8.5%
Q3UMU9-3,0.068476727,0.024833333,22.07070305,0.494333333,0.006207685,3.947478624,-0.343,-0.182,-0.142,0.282,0.072,0.462,Q3UMU9,Hdgfl2,Q3UMU9-3_Hdgfl2,Q3UMU9-3,Hdgfl2,1,4,4,4,Q3UMU9-3|Q3UMU9|Q3UMU9-2|Q3UMU9-4,MOUSE,75472.6,7.9,2129,2129.1,42.37,42.37,,669,Isoform 3 of Hepatoma-derived growth factor-related protein 2,nucleus|nucleoplasm|mitochondrion|,"transcription, DNA-templated|positive regulation of cell growth|",chromatin binding|protein binding|chromatin binding|,4,4,157000000,7.9%
Q9D4V7,0.919618833,0.0015,1.16330996,-0.031666667,0.765013332,-0.311335351,-0.107,0.103,0.056,0.076,-0.126,0.007,Q9D4V7,Rabl3,Q9D4V7_Rabl3,Q9D4V7,Rabl3,1,6,3,3,Q9D4V7|Q9D4V7-2,MOUSE,26525.4,22.8,2130,2130.1,42.16,42.16,,236,Rab-like protein 3,intracellular|,intracellular protein transport|Rab protein signal transduction|,GTPase activity|GTP binding|,3,6,1010000000,22.8%
Q9D6T0,0.681615533,-0.01,4.837590601,-0.114,0.328277366,-1.054555712,0.022,-0.027,0.146,0.071,-0.051,-0.221,Q9D6T0,Nosip,Q9D6T0_Nosip,Q9D6T0,Nosip,1,7,4,4,Q9D6T0|Q9D6T0-2|A0A1B0GS52,MOUSE,33721.9,19.2,2131,2131.1,42.13,42.13,,301,Nitric oxide synthase-interacting protein,nucleus|nucleoplasm|cytoplasm|,negative regulation of catalytic activity|negative regulation of nitric-oxide synthase activity|,poly(A) RNA binding|,4,7,94200000,19.2%
Q71KT5,0.692956416,-0.046833333,4.666357953,0.212333333,0.34147916,1.024713377,-0.576,0.115,0.002,-0.121,-0.002,0.301,Q71KT5,Tm7sf2,Q71KT5_Tm7sf2,Q71KT5,Tm7sf2,1,10,3,3,Q71KT5|E9Q4M8,MOUSE,46805.4,6.4,2132,2132.1,42.12,42.12,,418,Delta(14)-sterol reductase,endoplasmic reticulum membrane|integral component of membrane|receptor complex|,cholesterol biosynthetic process|oxidation-reduction process|,delta14-sterol reductase activity|,3,10,7350000000,6.4%
E9Q6C2,0.042592507,0.069166667,24.45361365,0.831666667,0.003586234,4.405962984,-0.476,-0.393,-0.171,0.492,0.13,0.833,E9Q6C2,C1s1,E9Q6C2_C1s1,E9Q6C2,C1s1,1,4,4,4,E9Q6C2|Q8CG14|A0A1W2P7F1|Q8CFG8,MOUSE,79039.3,10.3,2133,2133.1,42.03,42.03,,694,"Complement component 1, s subcomponent 1",extracellular exosome|blood microparticle|,proteolysis|complement activation|,serine-type endopeptidase activity|calcium ion binding|identical protein binding|,4,4,275000000,10.3%
Q8BVR6,0.761023727,0.004333333,3.685199077,0.086666667,0.428035798,0.843555446,0.015,0.07,-0.202,0.108,-0.001,0.036,Q8BVR6,Rspry1,Q8BVR6_Rspry1,Q8BVR6,Rspry1,1,6,5,5,Q8BVR6|Q8BVR6-3|Q8BVR6-2,MOUSE,65633.5,14.7,2134,2134.1,42.02,42.02,,576,RING finger and SPRY domain-containing protein 1,extracellular region|,,zinc ion binding|,5,6,200000000,14.7%
Q9D3A8,0.631727619,0.160333333,5.780996895,-0.512,0.264180228,-1.219887499,-0.047,-0.097,1.393,0.075,-0.51,0.148,Q9D3A8,Nos1ap,Q9D3A8_Nos1ap,Q9D3A8,Nos1ap,1,6,4,4,Q9D3A8|Q9D3A8-2|E9PYK5|Q3TRB6,MOUSE,56157.6,7.9,2135,2135.1,41.96,41.96,,503,Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein,Z disc|sarcoplasmic reticulum membrane|caveola|T-tubule|,,nitric-oxide synthase binding|,4,6,20800000000,7.9%
Q60520-1,0.880297256,-0.010666667,1.95903561,-0.102666667,0.636936943,-0.494501713,-0.269,-0.083,0.474,0.013,-0.278,0.079,Q60520,Sin3a,Q60520-1_Sin3a,Q60520-1,Sin3a,1,3,3,3,Q60520-1|Q60520,MOUSE,146270.5,2.9,2136,2136.1,41.95,41.95,,1274,Isoform 2 of Paired amphipathic helix protein Sin3a,kinetochore|chromatin|nucleus|nucleoplasm|transcription factor complex|nucleolus|cytoplasm|Sin3 complex|transcriptional repressor complex|intercellular bridge|,"negative regulation of transcription from RNA polymerase II promoter|chromatin silencing at rDNA|in utero embryonic development|activation of innate immune response|positive regulation of defense response to virus by host|hematopoietic progenitor cell differentiation|DNA replication|transcription, DNA-templated|regulation of transcription, DNA-templated|protein deacetylation|positive regulation of G2/M transition of mitotic cell cycle|histone deacetylation|positive regulation of chromatin silencing|cellular protein localization|negative regulation of circadian rhythm|negative regulation of apoptotic process|negative regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|rhythmic process|response to methylglyoxal|cellular response to glucose stimulus|negative regulation of protein localization to nucleus|negative regulation of histone H3-K27 acetylation|negative regulation of transcription regulatory region DNA binding|",transcription regulatory region sequence-specific DNA binding|RNA polymerase II activating transcription factor binding|RNA polymerase II repressing transcription factor binding|RNA polymerase II transcription corepressor activity|DNA binding|chromatin binding|sequence-specific DNA binding transcription factor activity|transcription corepressor activity|protein binding|transcription factor binding|protein deacetylase activity|histone deacetylase activity|,3,3,110000000,2.9%
Q9CQ91,0.91325,-0.048666667,1.385061103,0.116666667,0.726932172,0.364382902,-0.169,0.609,-0.761,0.058,0.067,-0.096,Q9CQ91,Ndufa3,Q9CQ91_Ndufa3,Q9CQ91,Ndufa3,1,4,3,3,Q9CQ91,MOUSE,9330.7,48.8,2137,2137.1,41.91,41.91,,84,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3,mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex I|integral component of membrane|,oxidation-reduction process|,,3,4,497000000,48.8%
Q69ZP3-2,0.785249508,-0.073833333,3.332615502,0.233,0.464235609,0.776597919,0.315,0.024,-0.91,0.148,0.013,-0.033,Q69ZP3,Pnkd,Q69ZP3-2_Pnkd,Q69ZP3-2,Pnkd,1,5,3,2,Q69ZP3-2|A0A0R4J1J1,MOUSE,15699.7,30.2,2138,2138.1,41.86,28.11,,385,Isoform 2 of Probable hydrolase PNKD,nucleus|mitochondrion|membrane|,"glutathione biosynthetic process|regulation of synaptic transmission, dopaminergic|regulation of dopamine metabolic process|neuromuscular process controlling posture|",hydroxyacylglutathione hydrolase activity|zinc ion binding|,3,5,933000000,30.2%
Q69ZP3-3,0.951421295,0.008833333,0.741594836,-0.021666667,0.843025121,-0.205863986,0.015,0.144,-0.1,0.117,-0.091,-0.032,Q69ZP3,Pnkd,Q69ZP3-3_Pnkd,Q69ZP3-3,Pnkd,1,4,2,2,Q69ZP3-3|Q69ZP3|Q69ZP3-4,MOUSE,48038.9,5.6,2138,2138.2,27.93,27.93,,385,Isoform 3 of Probable hydrolase PNKD,nucleus|mitochondrion|membrane|,"glutathione biosynthetic process|regulation of synaptic transmission, dopaminergic|regulation of dopamine metabolic process|neuromuscular process controlling posture|",hydroxyacylglutathione hydrolase activity|zinc ion binding|,2,4,174000000,5.6%
Q8K3A9,0.926033297,-0.004166667,1.074030258,0.030333333,0.78090279,0.289592042,0.13,-0.05,-0.138,0.1,-0.069,0.002,Q8K3A9,Mepce,Q8K3A9_Mepce,Q8K3A9,Mepce,1,5,4,4,Q8K3A9,MOUSE,72676.7,10.3,2139,2139.1,41.85,41.85,,666,7SK snRNA methylphosphate capping enzyme,,negative regulation of transcription from RNA polymerase II promoter|RNA methylation|snRNA metabolic process|negative regulation of chromatin binding|snRNA modification|positive regulation of G1/S transition of mitotic cell cycle|,RNA methyltransferase activity|S-adenosylmethionine-dependent methyltransferase activity|poly(A) RNA binding|,4,5,78100000,10.3%
P51125,0.007812054,-0.095833333,33.49420411,0.801666667,0.00044728,6.436033525,-0.662,-0.393,-0.435,0.208,0.21,0.497,P51125,Cast,P51125_Cast,P51125,Cast,1,6,4,4,P51125|P51125-6|P51125-2|Q8CE80|P51125-3|P51125-7|Q8CE04|Q8C281|Q921U7|P51125-4|A0A1Y7VJN8|P51125-5,MOUSE,85148.4,5.8,2140,2140.1,41.79,41.79,,788,Calpastatin,cytoplasm|cytosol|membrane|,negative regulation of peptidase activity|negative regulation of endopeptidase activity|protein catabolic process|negative regulation of type B pancreatic cell apoptotic process|,cysteine-type endopeptidase inhibitor activity|poly(A) RNA binding|,4,6,152000000,5.8%
Q9ESZ8,0.620776556,0.0325,5.946634308,-0.119,0.254294267,-1.246840814,0.228,0,0.048,0,-0.002,-0.079,Q9ESZ8,Gtf2i,Q9ESZ8_Gtf2i,Q9ESZ8,Gtf2i,1,5,3,3,Q9ESZ8|Q9ESZ8-2|Q9ESZ8-6|Q9ESZ8-3|Q3UHU8|Q9ESZ8-4|Q9ESZ8-5|G3UYD0,MOUSE,112776.7,3.5,2141,2141.1,41.69,41.69,,998,General transcription factor II-I,nucleus|nucleoplasm|cytoplasm|membrane|cell projection|neuronal cell body|,"transcription, DNA-templated|regulation of transcription, DNA-templated|transition between slow and fast fiber|negative regulation of angiogenesis|",DNA binding|protein binding|mitogen-activated protein kinase binding|,3,5,207000000,3.5%
A2A9C3,0.894042447,-0.0055,1.696741516,0.035,0.676590427,0.435933394,-0.022,0.002,-0.049,0.067,-0.002,-0.029,A2A9C3,Szt2,A2A9C3_Szt2,A2A9C3,Szt2,1,7,6,6,A2A9C3|A2A9C3-2,MOUSE,381842.1,2.3,2142,2142.1,41.62,41.62,,3431,KICSTOR complex protein SZT2,peroxisome|extracellular exosome|,central nervous system development|post-embryonic development|corpus callosum morphogenesis|pigmentation|regulation of superoxide dismutase activity|,,6,7,1190000000,2.3%
O70435,0.344160393,0.1135,11.58784501,0.335666667,0.069376997,2.164554999,-0.043,-0.067,-0.053,0.602,0.004,0.238,O70435,Psma3,O70435_Psma3,O70435,Psma3,1,7,4,4,O70435|E0CYL6|F8WH02|E0CZ34,MOUSE,28632.9,14.9,2143,2143.1,41.61,41.61,,255,Proteasome subunit alpha type-3,"proteasome complex|nucleus|cytoplasm|cytosol|proteasome core complex|proteasome core complex, alpha-subunit complex|extracellular exosome|",proteasomal ubiquitin-independent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|,endopeptidase activity|threonine-type endopeptidase activity|protein binding|,4,7,248000000,14.9%
P16330,0.797504707,0.022166667,3.106268421,0.080333333,0.489072403,0.731963869,0.013,-0.097,0.03,0.248,-0.056,-0.005,P16330,Cnp,P16330_Cnp,P16330,Cnp,1,4,4,4,P16330|P16330-2,MOUSE,47521.8,9.2,2144,2144.1,41.59,41.59,,420,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",extracellular space|nucleus|nucleoplasm|cytoplasm|mitochondrial outer membrane|mitochondrial inner membrane|microtubule|plasma membrane|microvillus|membrane|pseudopodium|myelin sheath abaxonal region|myelin sheath adaxonal region|melanosome|myelin sheath|perinuclear region of cytoplasm|extracellular exosome|,microtubule cytoskeleton organization|axonogenesis|aging|adult locomotory behavior|cyclic nucleotide catabolic process|response to toxic substance|substantia nigra development|forebrain development|response to lipopolysaccharide|regulation of mitochondrial membrane permeability|oligodendrocyte differentiation|,"RNA binding|2',3'-cyclic-nucleotide 3'-phosphodiesterase activity|cyclic nucleotide binding|",4,4,321000000,9.2%
Q6PCM2,0.968866595,0.024666667,0.429784778,0.018,0.905777487,0.122974079,0.013,0.059,-0.025,-0.013,-0.216,0.33,Q6PCM2,Ints6,Q6PCM2_Ints6,Q6PCM2,Ints6,1,5,5,5,Q6PCM2|Q6PCM2-2|Q8BND4|E9PXU1|Q6PCM2-3,MOUSE,100230.1,7,2145,2145.1,41.59,41.59,,883,Integrator complex subunit 6,nucleoplasm|actin cytoskeleton|integrator complex|,snRNA processing|,,5,5,569000000,7.0%
P35822,0.019386137,-0.017833333,28.58808276,0.461666667,0.001384177,5.236101102,-0.171,-0.283,-0.292,0.132,0.236,0.271,P35822,Ptprk,P35822_Ptprk,P35822,Ptprk,1,5,4,4,A0A1W2P7Y1|P35822|B2RRF0,MOUSE,166179.6,4.1,2146,2146.1,41.57,41.57,,1457,Receptor-type tyrosine-protein phosphatase kappa,photoreceptor outer segment|cell-cell junction|cell surface|integral component of membrane|axon|dendrite|leading edge membrane|neuronal cell body|,"protein dephosphorylation|cell adhesion|signal transduction|transforming growth factor beta receptor signaling pathway|negative regulation of cell proliferation|negative regulation of keratinocyte proliferation|cell migration|negative regulation of cell migration|protein localization to cell surface|cellular response to reactive oxygen species|cellular response to UV|peptidyl-tyrosine dephosphorylation|negative regulation of cell cycle|negative regulation of transcription, DNA-templated|focal adhesion assembly|",protein tyrosine phosphatase activity|beta-catenin binding|protein kinase binding|gamma-catenin binding|,4,5,79500000,4.1%
Q6ZWZ4,0.787001391,0.0365,3.307312068,-0.109,0.466948294,-0.7716866,-0.036,0.365,-0.056,-0.01,0.097,-0.141,Q6ZWZ4,Rpl36,Q6ZWZ4_Rpl36,Q6ZWZ4,Rpl36,1,5,4,4,Q6ZWZ4|P47964|D3YX71,MOUSE,12310.6,29.5,2147,2147.1,41.56,41.56,,105,60S ribosomal protein L36,ribosome|,translation|,structural constituent of ribosome|,4,5,958000000,29.5%
P54103,0.98664507,-0.015333333,0.226140588,-0.006666667,0.949261662,-0.066056299,0.028,0.072,-0.136,0.096,-0.079,-0.073,P54103,Dnajc2,P54103_Dnajc2,P54103,Dnajc2,1,6,6,6,P54103|E9Q9H2|E9Q9H3|Q3TRX6,MOUSE,72177,13.5,2148,2148.1,41.5,41.5,,621,DnaJ homolog subfamily C member 2,nucleus|cytoplasm|cytosol|nuclear membrane|,"DNA replication|transcription, DNA-templated|chromatin modification|positive regulation of transcription, DNA-templated|negative regulation of DNA biosynthetic process|",DNA binding|chromatin binding|protein binding|Hsp70 protein binding|histone binding|ubiquitin binding|poly(A) RNA binding|,6,6,304000000,13.5%
Q9D3D9,0.886698259,0.017833333,1.800393218,-0.083,0.66063363,-0.459425478,0.055,0.424,-0.301,-0.033,0.027,-0.065,Q9D3D9,Atp5d,Q9D3D9_Atp5d,Q9D3D9,Atp5d,1,13,3,3,Q9D3D9,MOUSE,17599.7,17.2,2149,2149.1,41.49,41.49,,168,"ATP synthase subunit delta, mitochondrial","mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)|mitochondrion|mitochondrial envelope|mitochondrial inner membrane|mitochondrial proton-transporting ATP synthase complex|proton-transporting ATP synthase complex|",ATP synthesis coupled proton transport|proton transport|,"hydrogen ion transmembrane transporter activity|proton-transporting ATPase activity, rotational mechanism|ATPase activity|proton-transporting ATP synthase activity, rotational mechanism|",3,13,17900000000,17.2%
Q61646,0.473411328,0.337833333,8.693924322,1.365,0.135085137,1.701573383,-0.003,-0.15,-0.881,3.002,0.034,0.025,Q61646,Hp,Q61646_Hp,Q61646,Hp,1,10,4,4,Q61646,MOUSE,39265.1,9.5,2150,2150.1,41.48,41.48,,347,Haptoglobin,extracellular space|endoplasmic reticulum|Golgi apparatus|haptoglobin-hemoglobin complex|extracellular exosome|blood microparticle|,response to hypoxia|liver development|immune system process|acute-phase response|Notch signaling pathway|spermatogenesis|response to heat|response to X-ray|response to lead ion|positive regulation of cell death|organ regeneration|response to magnesium ion|response to lipopolysaccharide|response to cobalamin|response to L-ascorbic acid|response to drug|response to hydrogen peroxide|defense response to bacterium|negative regulation of oxidoreductase activity|response to glucocorticoid|response to electrical stimulus|response to growth hormone|negative regulation of hydrogen peroxide catabolic process|,antioxidant activity|hemoglobin binding|protein homodimerization activity|,4,10,28400000000,9.5%
Q8C7G5,0.001346067,-0.048166667,42.98731534,0.717,5.02653E-05,9.147770669,-0.382,-0.452,-0.386,0.304,0.311,0.316,Q8C7G5,Apoa5,Q8C7G5_Apoa5,Q8C7G5,Apoa5,1,7,3,3,Q8C7G5|A0A1L1SQP3,MOUSE,41318.5,9.5,2151,2151.1,41.47,41.47,,368,Apolipoprotein A-V,extracellular region|extracellular space|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|blood microparticle|,triglyceride metabolic process|cholesterol biosynthetic process|lipid transport|response to hormone|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|positive regulation of very-low-density lipoprotein particle remodeling|triglyceride catabolic process|regulation of intestinal cholesterol absorption|organ regeneration|neuron projection regeneration|cholesterol efflux|phospholipid efflux|triglyceride-rich lipoprotein particle remodeling|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|lipoprotein metabolic process|tissue regeneration|cholesterol homeostasis|reverse cholesterol transport|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|positive regulation of lipid catabolic process|positive regulation of lipoprotein lipase activity|acylglycerol homeostasis|triglyceride homeostasis|,phospholipid binding|enzyme activator activity|heparin binding|lipid binding|cholesterol binding|cholesterol transporter activity|enzyme binding|phosphatidylcholine binding|lipase binding|low-density lipoprotein particle receptor binding|phosphatidylcholine-sterol O-acyltransferase activator activity|lipase activator activity|lipoprotein lipase activator activity|lipoprotein particle receptor binding|,3,7,183000000,9.5%
Q8CD15,0.911411213,-0.0055,1.430947036,-0.057,0.71929211,-0.375130843,-0.206,0.07,0.205,-0.175,-0.129,0.202,Q8CD15,Riox2,Q8CD15_Riox2,Q8CD15,Riox2,1,5,4,4,Q8CD15|D3YTU3|Q8CCK9,MOUSE,53858.5,7.5,2152,2152.1,41.41,41.41,,465,Ribosomal oxygenase 2,nucleus|transcription factor complex|nucleolus|cytoplasm|cytosol|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|regulation of cell proliferation|ribosome biogenesis|oxidation-reduction process|",RNA polymerase II transcription factor binding transcription repressor activity|metal ion binding|dioxygenase activity|,4,5,110000000,7.5%
F6QC57,0.754358975,-0.014,3.784508202,0.143333333,0.418359061,0.862892145,-0.038,-0.073,-0.146,0.413,-0.224,-0.016,F6QC57,Ubr3,F6QC57_Ubr3,F6QC57,Ubr3,1,9,6,6,F6QC57|Q5U430|Q5U430-3|Q5U430-2,MOUSE,216662.5,3.8,2153,2153.1,41.4,41.4,,1892,E3 ubiquitin-protein ligase UBR3,ubiquitin ligase complex|cytoplasm|,in utero embryonic development|suckling behavior|protein ubiquitination|olfactory behavior|ubiquitin-dependent protein catabolic process via the N-end rule pathway|,protein binding|zinc ion binding|ubiquitin protein ligase activity|,6,9,15300000000,3.8%
O55013,0.943283966,0.025666667,0.816798591,0.020666667,0.828552708,0.225183772,0.005,-0.014,0.055,0.156,0.007,-0.055,O55013,Trappc3,O55013_Trappc3,O55013,Trappc3,1,4,3,3,O55013,MOUSE,20472.9,18.3,2154,2154.1,41.36,41.36,,180,Trafficking protein particle complex subunit 3,Golgi membrane|endoplasmic reticulum|cytosol|TRAPP complex|,ER to Golgi vesicle-mediated transport|,protein binding|,3,4,151000000,18.3%
Q3UKJ7,0.530752353,0.0185,7.580191747,-0.383,0.174574507,-1.520675579,-0.208,0.142,0.696,-0.422,-0.228,0.131,Q3UKJ7,Smu1,Q3UKJ7_Smu1,Q3UKJ7,Smu1,1,6,3,3,Q3UKJ7|Q3UKJ7-2,MOUSE,58170.5,6.8,2155,2155.1,41.36,41.36,,513,WD40 repeat-containing protein SMU1,nucleus|cytoplasm|,,,3,6,1690000000,6.8%
Q9ESP1,0.007714627,-0.0325,33.57004847,0.953,0.000439537,6.455399241,-0.754,-0.361,-0.412,0.48,0.244,0.608,Q9ESP1,Sdf2l1,Q9ESP1_Sdf2l1,Q9ESP1,Sdf2l1,1,9,3,3,Q9ESP1,MOUSE,23876.1,20.3,2156,2156.1,41.33,41.33,,221,Stromal cell-derived factor 2-like protein 1,endoplasmic reticulum|endoplasmic reticulum lumen|membrane|endoplasmic reticulum chaperone complex|,response to endoplasmic reticulum stress|regulation of apoptotic process|cellular response to misfolded protein|ER-associated misfolded protein catabolic process|,chaperone binding|ATPase binding|misfolded protein binding|,3,9,3260000000,20.3%
Q9WV32,0.91325,-0.114333333,1.356831172,0.081333333,0.731672754,0.357737798,-0.659,0.006,0.188,-0.107,-0.226,0.112,Q9WV32,Arpc1b,Q9WV32_Arpc1b,Q9WV32,Arpc1b,1,3,3,3,Q91Z25|Q9WV32,MOUSE,41861.9,12.6,2157,2157.1,41.24,41.24,,372,Actin-related protein 2/3 complex subunit 1B,cytoplasm|Arp2/3 protein complex|focal adhesion|extracellular exosome|,Arp2/3 complex-mediated actin nucleation|,structural constituent of cytoskeleton|actin filament binding|actin filament binding|,3,3,91600000,12.6%
Q7TSS3,0.765908264,-0.032166667,3.629331686,0.087,0.433577594,0.833027269,-0.058,-0.136,-0.033,0.163,-0.138,0.009,Q7TSS3,Ikbkg,Q7TSS3_Ikbkg,Q7TSS3,Ikbkg,1,6,3,3,Q7TSS3|E9Q2Y3|O88522|Q8VC91,MOUSE,50882.7,9,2158,2158.1,41.2,41.2,,430,Inhibitor of kappaB kinase gamma,ubiquitin ligase complex|spindle pole|intracellular|nucleus|cytoplasm|IkappaB kinase complex|mitotic spindle|,B cell homeostasis|cellular response to DNA damage stimulus|activation of NF-kappaB-inducing kinase activity|phosphorylation|positive regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of transcription from RNA polymerase II promoter|positive regulation of NF-kappaB transcription factor activity|establishment of vesicle localization|,protein binding|kinase activity|protein domain specific binding|ubiquitin protein ligase binding|protein homodimerization activity|peroxisome proliferator activated receptor binding|protein heterodimerization activity|K63-linked polyubiquitin binding|linear polyubiquitin binding|,3,6,2340000000,9.0%
Q9D1I5,0.780743075,-0.013166667,3.388846624,-0.079,0.458263574,-0.786929091,-0.015,0.147,-0.053,-0.148,-0.062,0.052,Q9D1I5,Mcee,Q9D1I5_Mcee,Q9D1I5,Mcee,1,4,3,3,Q9D1I5|A0A0U1RQ27,MOUSE,19130.8,21.9,2159,2159.1,41.12,41.12,,178,"Methylmalonyl-CoA epimerase, mitochondrial",mitochondrion|,L-methylmalonyl-CoA metabolic process|,methylmalonyl-CoA epimerase activity|metal ion binding|,3,4,682000000,21.9%
Q8BPM2,0.928683702,0.047,1.030790749,0.038666667,0.788716498,0.279057663,0.133,-0.06,0.01,0.342,-0.09,-0.053,Q8BPM2,Map4k5,Q8BPM2_Map4k5,Q8BPM2,Map4k5,1,11,4,4,Q8BPM2|E9PX30|Q8BPM2-2|E9Q1T3,MOUSE,96127.3,6.7,2160,2160.1,41.11,41.11,,847,Mitogen-activated protein kinase kinase kinase kinase 5,cytoplasm|plasma membrane|,MAPK cascade|activation of MAPKKK activity|protein phosphorylation|regulation of mitotic cell cycle|stress-activated protein kinase signaling cascade|activation of protein kinase activity|intracellular signal transduction|regulation of apoptotic process|,protein serine/threonine kinase activity|ATP binding|MAP kinase kinase kinase kinase activity|,4,11,4220000000,6.7%
Q149L6,0.561710094,-0.0325,7.102414194,0.151,0.1948761,1.440474362,-0.245,0.051,-0.13,0.088,-0.026,0.067,Q149L6,Dnajb14,Q149L6_Dnajb14,Q149L6,Dnajb14,1,4,4,4,Q149L6|Q149L6-2|Q149L6-3,MOUSE,42781.2,12.4,2161,2161.1,41.1,41.1,,379,DnaJ homolog subfamily B member 14,endoplasmic reticulum membrane|membrane|integral component of membrane|,,,4,4,152000000,12.4%
Q9WUK2,0.843013392,0.007166667,2.466758309,0.063,0.566662103,0.60257141,-0.031,-0.061,0.019,-0.029,-0.071,0.216,Q9WUK2,Eif4h,Q9WUK2_Eif4h,Q9WUK2,Eif4h,1,9,4,4,Q9WUK2|Q9WUK2-2,MOUSE,27397.6,12.9,2162,2162.1,41.03,41.03,,248,Eukaryotic translation initiation factor 4H,membrane|perinuclear region of cytoplasm|,translational initiation|sexual reproduction|developmental growth|,nucleotide binding|translation initiation factor activity|poly(A) RNA binding|,4,9,616000000,12.9%
P97760,0.647450828,-0.008333333,5.40482207,-0.131333333,0.288083107,-1.154464393,0.205,0.053,-0.086,0.038,-0.202,-0.058,P97760,Polr2c,P97760_Polr2c,P97760,Polr2c,1,5,3,3,A0A1D5RML8|P97760,MOUSE,31784.9,20.3,2163,2163.1,40.94,40.94,,275,DNA-directed RNA polymerase II subunit RPB3,"nucleus|nucleoplasm|DNA-directed RNA polymerase II, core complex|cytoplasm|microtubule cytoskeleton|",transcription from RNA polymerase II promoter|,DNA binding|protein binding|protein dimerization activity|RNA polymerase II activity|,3,5,201000000,20.3%
Q91Y74,0.495901013,-0.0235,8.294791989,0.261666667,0.148088318,1.637060021,-0.247,-0.34,0.124,0.312,-0.077,0.087,Q91Y74,St3gal4,Q91Y74_St3gal4,Q91Y74,St3gal4,1,9,4,4,Q91Y74,MOUSE,38285.9,14.1,2164,2164.1,40.86,40.86,,333,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4",membrane|integral component of Golgi membrane|Golgi cisterna membrane|extracellular exosome|,protein glycosylation|cognition|sialylation|,"beta-galactoside (CMP) alpha-2,3-sialyltransferase activity|monosialoganglioside sialyltransferase activity|",4,9,633000000,14.1%
Q9CX00,0.281114635,-0.034666667,13.357765,0.328666667,0.046155504,2.448438633,-0.002,-0.268,-0.327,0.332,0.047,0.01,Q9CX00,Ist1,Q9CX00_Ist1,Q9CX00,Ist1,1,9,5,5,Q9CX00,MOUSE,39638.8,11,2165,2165.1,40.84,40.84,,362,IST1 homolog,endoplasmic reticulum-Golgi intermediate compartment|centrosome|cytosol|cytoplasmic membrane-bounded vesicle|midbody|extracellular exosome|Flemming body|,cytokinesis|positive regulation of defense response to virus by host|protein localization|abscission|viral release from host cell|establishment of protein localization|positive regulation of proteolysis|viral capsid secondary envelopment|positive regulation of collateral sprouting|cell division|activation of mitophagy in response to mitochondrial depolarization|,protein binding|protein domain specific binding|protein complex binding|MIT domain binding|,5,9,3430000000,11.0%
Q66GT5,0.604209631,0.1045,6.282798441,-0.229,0.235353226,-1.305214645,0.183,0.588,-0.114,0.003,-0.026,-0.007,Q66GT5,Ptpmt1,Q66GT5_Ptpmt1,Q66GT5,Ptpmt1,1,5,4,4,Q66GT5,MOUSE,22113.3,26.4,2166,2166.1,40.8,40.8,,193,Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1,nucleus|mitochondrion|mitochondrial inner membrane|,protein dephosphorylation|cardiolipin biosynthetic process|peptidyl-tyrosine dephosphorylation|phosphatidylinositol metabolic process|inositol phosphate dephosphorylation|,"phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity|phosphatidylglycerophosphatase activity|",4,5,278000000,26.4%
P97930,0.689434001,0.0365,4.711419688,-0.125666667,0.337954343,-1.032784517,0.119,0.297,-0.118,0.015,-0.068,-0.026,P97930,Dtymk,P97930_Dtymk,P97930,Dtymk,1,7,4,4,P97930|D3Z3R3|P97930-2,MOUSE,24085.3,17.4,2167,2167.1,40.75,40.75,,212,Thymidylate kinase,cytoplasm|mitochondrial intermembrane space|mitochondrial matrix|cytosol|,dUDP biosynthetic process|dTDP biosynthetic process|dTTP biosynthetic process|nucleotide biosynthetic process|response to estrogen|myoblast differentiation|response to cadmium ion|nucleotide phosphorylation|nucleoside monophosphate phosphorylation|cellular response to growth factor stimulus|,thymidylate kinase activity|ATP binding|uridylate kinase activity|nucleoside phosphate kinase activity|,4,7,301000000,17.4%
Q8BGB8,0.711236799,-0.014166667,4.361091653,0.174333333,0.366345478,0.969564335,0.172,-0.054,-0.422,0.304,0.004,-0.089,Q8BGB8,Coq4,Q8BGB8_Coq4,Q8BGB8,Coq4,1,4,3,3,Q8BGB8|D6RJJ8,MOUSE,30254.8,13.1,2168,2168.1,40.72,40.72,,266,"Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial",mitochondrion|extrinsic component of mitochondrial inner membrane|,ubiquinone biosynthetic process|,,3,4,261000000,13.1%
Q52KI8,0.784845088,0.009833333,3.350194391,0.096333333,0.462360326,0.780004705,0.04,0.071,-0.226,0.211,0.037,-0.074,Q52KI8,Srrm1,Q52KI8_Srrm1,Q52KI8,Srrm1,1,5,4,4,Q52KI8|E9PUK6|A2A8V9|A2A8V8|E9QKA4|Q52KI8-2,MOUSE,106917.3,4.7,2169,2169.1,40.55,40.55,,946,Serine/arginine repetitive matrix protein 1,spliceosomal complex|nuclear matrix|nuclear speck|,"RNA splicing, via transesterification reactions|mRNA splicing, via spliceosome|",DNA binding|RNA binding|,4,5,697000000,4.7%
Q9WTK3,0.086491781,0.000833333,20.80814877,0.355666667,0.008302046,3.698353676,-0.236,-0.145,-0.15,0.219,0.043,0.274,Q9WTK3,Gpaa1,Q9WTK3_Gpaa1,Q9WTK3,Gpaa1,1,8,3,3,Q9WTK3|E9PW03,MOUSE,68289.7,5.9,2170,2170.1,40.55,40.55,,621,Glycosylphosphatidylinositol anchor attachment 1 protein,integral component of plasma membrane|membrane|GPI-anchor transamidase complex|,GPI anchor biosynthetic process|,GPI-anchor transamidase activity|GPI anchor binding|,3,8,1190000000,5.9%
Q9Z0W3,0.35633016,-0.014333333,11.31646346,-0.210666667,0.073850536,-2.116755505,0.165,0.062,0.046,0.015,-0.239,-0.135,Q9Z0W3,Nup160,Q9Z0W3_Nup160,Q9Z0W3,Nup160,1,6,5,5,Q9Z0W3|Q9Z0W3-2,MOUSE,160225.6,3.7,2171,2171.1,40.54,40.54,,1402,Nuclear pore complex protein Nup160,nuclear pore|nuclear pore outer ring|kinetochore|,mRNA export from nucleus|protein transport|,nucleocytoplasmic transporter activity|,5,6,390000000,3.7%
Q9Z110,0.370379022,0.19,11.02373296,-0.542666667,0.078999929,-2.074507182,-0.086,0.967,0.503,0.097,-0.265,-0.076,Q9Z110,Aldh18a1,Q9Z110_Aldh18a1,Q9Z110,Aldh18a1,1,8,4,4,Q9Z110|Q9Z110-2,MOUSE,87835.3,5.9,2172,2172.1,40.41,40.41,,795,Delta-1-pyrroline-5-carboxylate synthase,cytoplasm|mitochondrion|mitochondrial inner membrane|,glutamate metabolic process|proline biosynthetic process|ornithine biosynthetic process|cellular amino acid biosynthetic process|phosphorylation|citrulline biosynthetic process|oxidation-reduction process|L-proline biosynthetic process|,glutamate 5-kinase activity|glutamate-5-semialdehyde dehydrogenase activity|ATP binding|poly(A) RNA binding|,4,8,168000000,5.9%
P63330,0.138896564,0.0115,18.07064329,-0.293,0.015593215,-3.218934027,0.198,0.152,0.124,-0.183,-0.015,-0.207,P63330,Ppp2ca,P63330_Ppp2ca,P63330,Ppp2ca,1,6,5,5,P63330|P62715,MOUSE,36178.1,17.1,2173,2173.1,40.41,40.41,,309,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,"protein phosphatase type 2A complex|chromosome, centromeric region|spindle pole|nucleus|cytoplasm|cytosol|plasma membrane|extracellular exosome|",regulation of protein phosphorylation|protein dephosphorylation|mesoderm development|regulation of receptor activity|negative regulation of epithelial to mesenchymal transition|regulation of protein autophosphorylation|regulation of protein catabolic process|meiotic cell cycle|regulation of cell cycle|protein heterotrimerization|positive regulation of protein serine/threonine kinase activity|,protein serine/threonine phosphatase activity|protein binding|protein C-terminus binding|metal ion binding|protein heterodimerization activity|protein dimerization activity|GABA receptor binding|,5,6,39900000,17.1%
Q9DCS9,0.894042447,-0.066833333,1.698968084,0.067666667,0.676243637,0.436661818,-0.008,0.118,-0.412,0.07,-0.006,-0.163,Q9DCS9,Ndufb10,Q9DCS9_Ndufb10,Q9DCS9,Ndufb10,1,7,3,3,Q9DCS9,MOUSE,21308.7,22.7,2174,2174.1,40.36,40.36,,176,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10,mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex I|extracellular exosome|,oxidation-reduction process|,,3,7,290000000,22.7%
H3BK65,0.399466839,0.031166667,10.42434704,0.298333333,0.090691231,1.978861213,-0.28,-0.052,-0.022,0.018,0.05,0.473,H3BK65,Eps15,H3BK65_Eps15,H3BK65,Eps15,1,4,3,3,H3BK65|P42567|Q5JC28|F6W2Q5|A0A0R4J0A0|P42567-2,MOUSE,102741,5.3,2175,2175.1,40.35,40.35,,933,Epidermal growth factor receptor substrate 15,cytoplasm|plasma membrane|coated pit|membrane|aggresome|clathrin coat of coated pit|intracellular membrane-bounded organelle|ciliary membrane|,Golgi to endosome transport|receptor-mediated endocytosis of virus by host cell|viral entry into host cell|clathrin coat assembly|,calcium ion binding|protein binding|polyubiquitin binding|,3,4,141000000,5.3%
P41233,0.779080526,0.021166667,3.409191695,-0.075,0.456121801,-0.790847107,-0.056,0.168,0.064,0.03,-0.081,0.002,P41233,Abca1,P41233_Abca1,P41233,Abca1,1,4,3,3,P41233,MOUSE,256189.4,2.1,2176,2176.1,40.24,40.24,,2261,ATP-binding cassette sub-family A member 1,Golgi apparatus|plasma membrane|integral component of plasma membrane|external side of plasma membrane|endocytic vesicle|intracellular membrane-bounded organelle|membrane raft|phagocytic vesicle|perinuclear region of cytoplasm|,"peptide secretion|protein lipidation|phagocytosis, engulfment|lysosome organization|G-protein coupled receptor signaling pathway|cholesterol metabolic process|positive regulation of cholesterol efflux|endosomal transport|positive regulation of cAMP biosynthetic process|intracellular cholesterol transport|regulation of Cdc42 protein signal transduction|cholesterol efflux|phospholipid efflux|high-density lipoprotein particle assembly|response to laminar fluid shear stress|apolipoprotein A-I-mediated signaling pathway|lipoprotein metabolic process|lipoprotein biosynthetic process|cholesterol homeostasis|reverse cholesterol transport|phospholipid translocation|interleukin-1 beta secretion|transmembrane transport|phospholipid homeostasis|response to low-density lipoprotein particle|platelet dense granule organization|cellular response to lipopolysaccharide|cellular response to retinoic acid|anion transmembrane transport|response to high density lipoprotein particle|","receptor binding|protein binding|ATP binding|phospholipid transporter activity|anion transmembrane transporter activity|cholesterol transporter activity|syntaxin binding|small GTPase binding|apolipoprotein binding|apolipoprotein A-I binding|apolipoprotein A-I receptor activity|ATPase activity, coupled to transmembrane movement of substances|ATPase binding|",3,4,258000000,2.1%
Q62426,0.00240428,-0.090166667,39.53346869,0.855666667,0.00011134,8.061815938,-0.45,-0.605,-0.499,0.479,0.345,0.189,Q62426,Cstb,Q62426_Cstb,Q62426,Cstb,1,6,4,4,Q62426,MOUSE,11159.5,47.9,2177,2177.1,40.2,40.2,,98,Cystatin-B,extracellular space|nucleus|nucleolus|cytoplasm|extracellular exosome|,adult locomotory behavior|negative regulation of peptidase activity|negative regulation of endopeptidase activity|negative regulation of proteolysis|,protease binding|endopeptidase inhibitor activity|cysteine-type endopeptidase inhibitor activity|poly(A) RNA binding|,4,6,761000000,47.9%
P97348,0.919416995,-0.010666667,1.216526927,-0.029333333,0.75569632,-0.324172484,0.063,-0.023,-0.028,0.078,-0.042,-0.112,P97348,Rhod,P97348_Rhod,P97348,Rhod,1,7,4,4,P97348|G3X9Y4,MOUSE,23960.9,21.9,2178,2178.1,40.19,40.19,,210,Rho-related GTP-binding protein RhoD,early endosome|plasma membrane|,protein targeting|small GTPase mediated signal transduction|lamellipodium assembly|positive regulation of cell migration|positive regulation of cell adhesion|focal adhesion assembly|actin filament bundle assembly|regulation of focal adhesion assembly|regulation of actin cytoskeleton reorganization|,GTP binding|protein kinase binding|,4,7,139000000,21.9%
Q8K382,0.615860336,-0.013333333,6.030643387,0.184,0.249422519,1.262504376,-0.162,0.071,-0.225,-0.12,0.026,0.33,Q8K382,Dennd1a,Q8K382_Dennd1a,Q8K382,Dennd1a,1,4,4,4,Q8K382|D6RH88|D6RI65,MOUSE,112106.8,3.8,2179,2179.1,40.18,40.18,,1016,DENN domain-containing protein 1A,cell junction|clathrin-coated vesicle|dendrite|clathrin-coated vesicle membrane|presynaptic membrane|neuronal cell body|synapse|,endocytosis|protein transport|regulation of Rab protein signal transduction|positive regulation of GTPase activity|synaptic vesicle endocytosis|,protein binding|Rab guanyl-nucleotide exchange factor activity|SH3 domain binding|,4,4,62400000,3.8%
Q8JZM0,0.855191835,-0.023,2.309933797,0.062666667,0.587498308,0.56973644,-0.076,0.11,-0.197,-0.045,-0.039,0.109,Q8JZM0,Tfb1m,Q8JZM0_Tfb1m,Q8JZM0,Tfb1m,1,5,4,4,Q8JZM0,MOUSE,39246.2,12.4,2180,2180.1,40.16,40.16,,345,"Dimethyladenosine transferase 1, mitochondrial",mitochondrion|mitochondrial nucleoid|,"transcription, DNA-templated|regulation of transcription, DNA-templated|rRNA methylation|","rRNA (adenine-N6,N6-)-dimethyltransferase activity|DNA binding|poly(A) RNA binding|",4,5,105000000,12.4%
Q8VDL4,0.003636524,-0.319333333,37.23962359,1.776,0.000188815,7.44797416,-1.186,-0.726,-1.71,0.57,0.461,0.675,Q8VDL4,Adpgk,Q8VDL4_Adpgk,Q8VDL4,Adpgk,1,4,3,3,A0A1L1SSF2|Q8VDL4|Q3UDS7|Q8VDL4-3|Q8VDL4-2,MOUSE,54243.8,9.2,2181,2181.1,40.15,40.15,,496,ADP-dependent glucokinase,extracellular region|endoplasmic reticulum|membrane|,glycolytic process|phosphorylation|,ADP-specific glucokinase activity|metal ion binding|,3,4,96300000,9.2%
Q8C3J5,0.683824379,0.062166667,4.797779067,-0.219666667,0.331300502,-1.048205034,0.136,-0.181,0.561,0.213,-0.173,-0.183,Q8C3J5,Dock2,Q8C3J5_Dock2,Q8C3J5,Dock2,1,6,5,5,Q8C3J5|Q5SRI3|Q3TMS1|D6RGU3,MOUSE,213069.5,4.1,2182,2182.1,40.09,40.09,,1828,Dedicator of cytokinesis protein 2,cytoplasm|cytoskeleton|endomembrane system|membrane|extracellular exosome|,membrane raft polarization|establishment of T cell polarity|immunological synapse formation|myeloid dendritic cell activation involved in immune response|chemotaxis|cytoskeleton organization|small GTPase mediated signal transduction|actin cytoskeleton organization|positive regulation of Rac protein signal transduction|T cell proliferation|T cell activation|positive regulation of GTPase activity|macropinocytosis|positive thymic T cell selection|negative thymic T cell selection|alpha-beta T cell activation|alpha-beta T cell proliferation|positive regulation of phagocytosis|,GTPase activator activity|Rac guanyl-nucleotide exchange factor activity|T cell receptor binding|,5,6,102000000,4.1%
Q9QZB7,0.648073376,0.019833333,5.357047245,0.159666667,0.291269678,1.146671457,0.019,-0.016,-0.183,0.336,-0.138,0.101,Q9QZB7,Actr10,Q9QZB7_Actr10,Q9QZB7,Actr10,1,4,3,3,Q9QZB7,MOUSE,46777.6,11.9,2183,2183.1,40.06,40.06,,417,Actin-related protein 10,cytoplasm|dynactin complex|,microtubule-based movement|,protein binding|,3,4,245000000,11.9%
P97863,0.35633016,-0.021166667,11.30326714,-0.201666667,0.074075277,-2.114627275,0.103,0.123,0.013,-0.111,-0.241,-0.014,P97863,Nfib,P97863_Nfib,P97863,Nfib,1,3,3,2,P97863|A2BG77|A2BG75|I7HIP8|P97863-2|A2BG76|P97863-3,MOUSE,63905,8.7,2184,2184.1,40.01,30.83,,570,Nuclear factor 1 B-type,nucleus|nucleoplasm|nucleolus|cerebellar mossy fiber|,negative regulation of transcription from RNA polymerase II promoter|chondrocyte differentiation|DNA replication|transcription from RNA polymerase II promoter|negative regulation of cell proliferation|glial cell differentiation|principal sensory nucleus of trigeminal nerve development|anterior commissure morphogenesis|lung development|forebrain development|hindbrain development|negative regulation of DNA binding|positive regulation of transcription from RNA polymerase II promoter|Clara cell differentiation|Type I pneumocyte differentiation|Type II pneumocyte differentiation|salivary gland cavitation|cell differentiation involved in salivary gland development|lung ciliated cell differentiation|commissural neuron axon guidance|negative regulation of mesenchymal cell proliferation involved in lung development|negative regulation of epithelial cell proliferation involved in lung morphogenesis|,RNA polymerase II core promoter proximal region sequence-specific DNA binding|sequence-specific DNA binding RNA polymerase II transcription factor activity|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|RNA polymerase II transcription corepressor activity|DNA binding|double-stranded DNA binding|,3,3,387000000,8.7%
P70255,0.987391128,-0.003833333,0.217793225,0.007666667,0.951087946,0.063702294,0.092,0.089,-0.204,0.139,-0.078,-0.061,P70255,Nfic,P70255_Nfic,P70255,Nfic,1,2,3,2,A0A1Y7VK55|P70255|P70255-2|P70255-3|P70255-4|P70255-5|P70255-6|P70255-7,MOUSE,49166.8,7.7,2184,2184.2,32.16,22.98,,439,Nuclear factor 1 C-type,nucleus|nucleoplasm|nucleolus|,negative regulation of transcription from RNA polymerase II promoter|DNA replication|transcription from RNA polymerase II promoter|odontogenesis of dentin-containing tooth|positive regulation of transcription from RNA polymerase II promoter|,RNA polymerase II core promoter proximal region sequence-specific DNA binding|sequence-specific DNA binding RNA polymerase II transcription factor activity|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|double-stranded DNA binding|sequence-specific DNA binding transcription factor activity|,2,2,19900000,5.2%
Q3U1V6,0.951421295,0.032833333,0.737144285,-0.033,0.843889477,-0.204790536,-0.051,-0.019,0.218,0.331,-0.073,-0.209,Q3U1V6,Uevld,Q3U1V6_Uevld,Q3U1V6,Uevld,1,5,3,3,Q3U1V6,MOUSE,52022.7,11.4,2185,2185.1,39.95,39.95,,471,Ubiquitin-conjugating enzyme E2 variant 3,extracellular exosome|,carbohydrate metabolic process|cellular protein modification process|protein transport|carboxylic acid metabolic process|oxidation-reduction process|,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor|",3,5,131000000,11.4%
Q08EB6,0.387241291,0.039833333,10.66371337,0.349,0.085827935,2.017062091,0.021,-0.024,-0.401,0.502,0.004,0.137,Q08EB6,Clasp2,Q08EB6_Clasp2,Q08EB6,Clasp2,1,4,4,4,Q08EB5|Q08EB6|Q8BRT1|E9Q8N5|F7DCH5,MOUSE,141791.4,4.5,2186,2186.1,39.91,39.91,,1287,CLIP-associating protein 2,Golgi apparatus|trans-Golgi network|microtubule|cytoplasmic microtubule|plasma membrane|cell cortex|membrane|cell leading edge|ruffle membrane|basal cortex|microtubule|cytoplasmic microtubule|focal adhesion|,"microtubule cytoskeleton organization|vesicle targeting|microtubule nucleation|negative regulation of microtubule depolymerization|Golgi organization|establishment or maintenance of cell polarity|regulation of gastrulation|positive regulation of epithelial cell migration|regulation of epithelial to mesenchymal transition|cell migration|microtubule organizing center organization|regulation of microtubule polymerization or depolymerization|regulation of microtubule-based process|microtubule anchoring|positive regulation of exocytosis|negative regulation of stress fiber assembly|negative regulation of focal adhesion assembly|establishment of protein localization to plasma membrane|positive regulation of extracellular matrix disassembly|negative regulation of wound healing, spreading of epidermal cells|positive regulation of basement membrane assembly involved in embryonic body morphogenesis|",dystroglycan binding|protein binding|microtubule binding|microtubule plus-end binding|,4,4,51200000,4.5%
P14234,0.204708202,5.78241E-19,15.77736322,-0.268666667,0.026440136,-2.834842004,0.15,0.028,0.225,-0.066,-0.218,-0.119,P14234,Fgr,P14234_Fgr,P14234,Fgr,1,11,4,4,P14234,MOUSE,59436.1,10.4,2187,2187.1,39.89,39.89,,517,Tyrosine-protein kinase Fgr,mitochondrial inner membrane|mitochondrial intermembrane space|cytosol|plasma membrane|extrinsic component of cytoplasmic side of plasma membrane|extracellular exosome|cytoskeleton|actin cytoskeleton|ruffle membrane|,transmembrane receptor protein tyrosine kinase signaling pathway|integrin-mediated signaling pathway|regulation of cell shape|positive regulation of phosphatidylinositol 3-kinase signaling|peptidyl-tyrosine phosphorylation|cell differentiation|positive regulation of cell migration|regulation of actin cytoskeleton organization|peptidyl-tyrosine autophosphorylation|regulation of cell proliferation|positive regulation of mast cell degranulation|positive regulation of phosphatidylinositol 3-kinase activity|innate immune response|regulation of innate immune response|regulation of protein kinase activity|protein autophosphorylation|positive regulation of cytokine secretion|regulation of phagocytosis|defense response to Gram-positive bacterium|cellular response to peptide hormone stimulus|,phosphotyrosine binding|protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|protein binding|ATP binding|protein kinase binding|immunoglobulin receptor binding|Fc-gamma receptor I complex binding|,4,11,3250000000,10.4%
Q8R4K2,0.73101227,-0.027,4.103486968,-0.179333333,0.388732904,-0.922338213,-0.094,0.014,0.268,0.033,-0.52,0.137,Q8R4K2,Irak4,Q8R4K2_Irak4,Q8R4K2,Irak4,1,4,4,4,Q8R4K2|Q3USX5,MOUSE,51441.4,12.2,2188,2188.1,39.87,39.87,,459,Interleukin-1 receptor-associated kinase 4,extracellular space|nucleus|cytoplasm|plasma membrane|,cytokine production|neutrophil mediated immunity|JNK cascade|cytokine-mediated signaling pathway|intracellular signal transduction|positive regulation of I-kappaB kinase/NF-kappaB signaling|innate immune response|positive regulation of smooth muscle cell proliferation|neutrophil migration|,magnesium ion binding|protein kinase activity|protein serine/threonine kinase activity|interleukin-1 receptor binding|protein binding|ATP binding|,4,4,78900000,12.2%
D3YUP5,0.821409751,0.008666667,2.757422426,0.096,0.529977897,0.662589303,-0.03,0.155,-0.243,0.276,-0.047,-0.059,D3YUP5,Exoc3l2,D3YUP5_Exoc3l2,D3YUP5,Exoc3l2,1,6,4,4,D3YUP5,MOUSE,87759.1,5.1,2189,2189.1,39.81,39.81,,789,Exocyst complex component 3-like 2,exocyst|,exocytosis|exocyst localization|,SNARE binding|,4,6,94100000,5.1%
Q8K2Q7,0.961523652,0.017,0.541831714,-0.016,0.882707524,-0.153271434,0.11,0.049,-0.084,0.121,0.032,-0.126,Q8K2Q7,Brox,Q8K2Q7_Brox,Q8K2Q7,Brox,1,4,3,3,Q8K2Q7|Q8K2Q7-2,MOUSE,46714.4,8.7,2190,2190.1,39.77,39.77,,411,BRO1 domain-containing protein BROX,membrane|extracellular exosome|,,,3,4,174000000,8.7%
Q91W39,0.354656702,0.015,11.38090274,-0.39,0.072762854,-2.131510588,-0.038,0.28,0.388,-0.055,-0.52,0.035,Q91W39,Ncoa5,Q91W39_Ncoa5,Q91W39,Ncoa5,1,5,4,4,Q91W39|B7ZC24|B7ZC23,MOUSE,65546.2,6.5,2191,2191.1,39.76,39.76,,579,Nuclear receptor coactivator 5,extracellular space|nucleus|nucleoplasm|actin cytoskeleton|,"transcription, DNA-templated|regulation of transcription, DNA-templated|glucose homeostasis|negative regulation of insulin receptor signaling pathway|",chromatin binding|poly(A) RNA binding|,4,5,39500000,6.5%
P40936,0.216645849,0.169333333,15.32952715,0.640666667,0.029312124,2.76972054,-0.282,-0.01,-0.161,-0.011,0.915,0.565,P40936,Inmt,P40936_Inmt,P40936,Inmt,1,12,4,4,P40936,MOUSE,30086.8,16.2,2192,2192.1,39.7,39.7,,264,Indolethylamine N-methyltransferase,cytosol|,amine metabolic process|response to toxic substance|methylation|,thioether S-methyltransferase activity|amine N-methyltransferase activity|,4,12,1830000000,16.2%
Q61136,0.961523652,-0.019,0.572471089,-0.016666667,0.876501959,-0.161455874,-0.162,0.062,0.068,0.039,-0.122,0.001,Q61136,Prpf4b,Q61136_Prpf4b,Q61136,Prpf4b,1,6,4,4,Q61136,MOUSE,117373,4.5,2193,2193.1,39.7,39.7,,1007,Serine/threonine-protein kinase PRP4 homolog,nucleoplasm|chromosome|catalytic step 2 spliceosome|,mRNA processing|protein phosphorylation|RNA splicing|,protein kinase activity|protein serine/threonine kinase activity|ATP binding|poly(A) RNA binding|,4,6,156000000,4.5%
Q64310,0.684134411,-0.034666667,4.791306488,-0.089333333,0.331794629,-1.046103942,0.033,0.028,-0.031,-0.007,-0.162,-0.069,Q64310,Surf4,Q64310_Surf4,Q64310,Surf4,1,9,3,3,Q64310|E0CXD9,MOUSE,30608.7,11.5,2194,2194.1,39.7,39.7,,269,Surfeit locus protein 4,Golgi membrane|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|integral component of membrane|endoplasmic reticulum-Golgi intermediate compartment membrane|,Golgi organization|positive regulation of organelle organization|,,3,9,12200000000,11.5%
Q9DD06,0.211523046,-0.063166667,15.52118554,0.359,0.028046679,2.801349756,-0.088,-0.156,-0.484,0.038,0.216,0.095,Q9DD06,Rarres2,Q9DD06_Rarres2,Q9DD06,Rarres2,1,6,3,1,Q9DD06,MOUSE,18748.6,25.9,2195,2195.1,39.61,17.53,,162,Retinoic acid receptor responder protein 2,extracellular region|extracellular matrix|extracellular exosome|,retinoid metabolic process|in utero embryonic development|positive regulation of protein phosphorylation|chemotaxis|inflammatory response|positive regulation of macrophage chemotaxis|positive regulation of fat cell differentiation|embryonic digestive tract development|brown fat cell differentiation|positive regulation of chemotaxis|regulation of lipid catabolic process|positive regulation of glucose import in response to insulin stimulus|,receptor binding|protein binding|,3,6,369000000,25.9%
A0A0N4SVV4,0.213924885,-0.005833333,15.43036135,0.373666667,0.028639397,2.786351036,-0.077,-0.093,-0.408,0.096,0.367,0.08,A0A0N4SVV4,Rarres2,A0A0N4SVV4_Rarres2,A0A0N4SVV4,Rarres2,1,4,3,2,A0A0N4SVV4,MOUSE,18876.7,26.3,2195,2195.2,38.92,30.3,,163,Retinoic acid receptor responder protein 2,,,,2,4,77100000,13.4%
P49586,0.252632646,-0.071166667,14.10545793,0.313,0.038855653,2.569473295,-0.424,-0.208,-0.051,0.119,-0.028,0.165,P49586,Pcyt1a,P49586_Pcyt1a,P49586,Pcyt1a,1,5,5,5,P49586|D3Z3T5,MOUSE,42065.5,17.9,2196,2196.1,39.59,39.59,,367,Choline-phosphate cytidylyltransferase A,endoplasmic reticulum membrane|cytosol|glycogen granule|,phosphatidylcholine biosynthetic process|CDP-choline pathway|,choline-phosphate cytidylyltransferase activity|protein binding|lipid binding|protein homodimerization activity|,5,5,119000000,17.9%
A2ALW5,0.8287181,-0.010666667,2.654942591,0.069333333,0.542632424,0.641409222,-0.06,0.031,-0.107,0.184,-0.129,0.017,A2ALW5,Dnajc25,A2ALW5_Dnajc25,A2ALW5,Dnajc25,1,6,3,3,A2ALW5|A2ALW5-2|F2Z3Z8|F2Z410|G3UZK1,MOUSE,42221.8,8.9,2197,2197.1,39.57,39.57,,357,DnaJ homolog subfamily C member 25,integral component of membrane|,,,3,6,1620000000,8.9%
Q3UU56,0.991556352,-0.015333333,0.158378729,-0.004666667,0.964188899,-0.046602959,0.005,0.02,-0.064,0.124,-0.152,-0.025,Q3UU56,NotFound,Q3UU56_NotFound,Q3UU56,Gm29609,1,6,4,4,Q3UU56|D3Z7I0|Q8BL74,MOUSE,101393.6,4.7,2198,2198.1,39.57,39.57,,907,Predicted gene 29609,,,,4,6,7530000000,4.7%
Q8BGB2,0.760472992,0.0295,3.691891654,0.102333333,0.427376693,0.845414382,-0.041,0.038,-0.062,0.315,-0.055,-0.018,Q8BGB2,Ttc7,Q8BGB2_Ttc7,Q8BGB2,Ttc7a,1,6,4,4,Q8BGB2|D3Z0R8|D6RG81,MOUSE,97010.5,5.4,2199,2199.1,39.56,39.56,,858,Tetratricopeptide repeat protein 7A,cell|,cellular iron ion homeostasis|hemopoiesis|,,4,6,237000000,5.4%
Q8R1S9,0.312476077,0.041333333,12.46094768,-0.292666667,0.056742077,-2.304237614,0.188,0.389,-0.014,-0.036,-0.053,-0.226,Q8R1S9,Slc38a4,Q8R1S9_Slc38a4,Q8R1S9,Slc38a4,1,8,3,3,Q8R1S9,MOUSE,60748,6.5,2200,2200.1,39.53,39.53,,547,Sodium-coupled neutral amino acid transporter 4,integral component of plasma membrane|,amino acid transmembrane transport|sodium ion transport|,amino acid transmembrane transporter activity|symporter activity|,3,8,7950000000,6.5%
O88531,0.000426749,-0.147333333,51.02099002,1.478666667,7.90498E-06,12.41130496,-0.744,-0.828,-1.088,0.638,0.66,0.478,O88531,Ppt1,O88531_Ppt1,O88531,Ppt1,1,4,3,3,O88531|B1B0P9|B1B0P8,MOUSE,35060.1,14.7,2201,2201.1,39.52,39.52,,306,Palmitoyl-protein thioesterase 1,extracellular region|extracellular space|nucleus|lysosome|Golgi apparatus|cytosol|synaptic vesicle|membrane|axon|dendrite|neuronal cell body|lysosomal lumen|membrane raft|extracellular exosome|,protein depalmitoylation|receptor-mediated endocytosis|pinocytosis|lysosome organization|lysosomal lumen acidification|neurotransmitter secretion|nervous system development|brain development|visual perception|grooming behavior|associative learning|adult locomotory behavior|protein transport|lipid catabolic process|negative regulation of cell growth|membrane raft organization|regulation of phospholipase A2 activity|negative regulation of apoptotic process|negative regulation of neuron apoptotic process|cellular protein catabolic process|cellular macromolecule catabolic process|positive regulation of receptor-mediated endocytosis|positive regulation of pinocytosis|cofactor transport|cofactor metabolic process|,palmitoyl-(protein) hydrolase activity|palmitoyl-CoA hydrolase activity|,3,4,512000000,14.7%
Q9DBZ5,0.817236408,0.054333333,2.845916935,-0.179333333,0.519288024,-0.680471426,-0.388,0.197,0.623,-0.19,-0.16,0.244,Q9DBZ5,Eif3k,Q9DBZ5_Eif3k,Q9DBZ5,Eif3k,1,7,3,3,Q9DBZ5|A0A140LJ59|Q3TY56|Q9DBZ5-2,MOUSE,25371.5,17.8,2202,2202.1,39.49,39.49,,218,Eukaryotic translation initiation factor 3 subunit K,nucleus|cytoplasm|eukaryotic translation initiation factor 3 complex|membrane|eukaryotic 43S preinitiation complex|eukaryotic 48S preinitiation complex|extracellular exosome|,formation of translation preinitiation complex|translational initiation|regulation of translational initiation|,RNA binding|ribosome binding|translation initiation factor activity|,3,7,358000000,17.8%
Q9JHH9,0.64176206,-0.015166667,5.532703276,-0.128333333,0.279723963,-1.176221969,0.069,0.168,-0.09,-0.015,-0.009,-0.214,Q9JHH9,Copz2,Q9JHH9_Copz2,Q9JHH9,Copz2,1,11,2,2,Q9JHH9,MOUSE,22990.8,14.1,2203,2203.1,39.45,39.45,,205,Coatomer subunit zeta-2,cytosol|COPI vesicle coat|COPI-coated vesicle|endoplasmic reticulum-Golgi intermediate compartment membrane|,protein transport|vesicle-mediated transport|,,2,11,1050000000,14.1%
Q8BJ05,0.841746758,-0.041666667,2.493281191,-0.147333333,0.563211976,-0.608390035,-0.316,-0.014,0.426,0.061,-0.52,0.113,Q8BJ05,Zc3h14,Q8BJ05_Zc3h14,Q8BJ05,Zc3h14,1,3,3,3,Q8BJ05|Q8BJ05-3|Q8BJ05-2,MOUSE,83377.6,5.7,2204,2204.1,39.44,39.44,,735,Zinc finger CCCH domain-containing protein 14,nucleus|nucleoplasm|nucleolus|cytoplasm|nuclear speck|,regulation of mRNA stability|negative regulation of mRNA polyadenylation|,poly(A) binding|poly(A) RNA binding|metal ion binding|,3,3,108000000,5.7%
Q9CR67,0.967029453,-0.005,0.440623255,-0.016,0.903519801,-0.125938447,0.084,0.158,-0.233,-0.014,-0.105,0.08,Q9CR67,Tmem33,Q9CR67_Tmem33,Q9CR67,Tmem33,1,6,4,4,Q9CR67|A0A0R4J1Z3|Q9CZM3,MOUSE,28373,13.3,2205,2205.1,39.31,39.31,,247,Transmembrane protein 33,nuclear pore|endoplasmic reticulum|melanosome|extracellular exosome|,cellular protein localization|nuclear pore complex assembly|endoplasmic reticulum tubular network organization|,protein binding|structural constituent of nuclear pore|,4,6,599000000,13.3%
Q8C6K9,0.961523652,-0.007,0.545568885,-0.026,0.881948268,-0.154330691,-0.256,0.086,0.188,0.251,-0.213,-0.098,Q8C6K9,Col6a6,Q8C6K9_Col6a6,Q8C6K9,Col6a6,1,5,5,4,E9Q6A6|Q8C6K9|Q8C6K9-2,MOUSE,248087,2.7,2206,2206.1,39.28,34.7,,2265,Collagen alpha-6(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|,cell adhesion|,,5,5,95800000,2.7%
A6H584,0.045982527,0.024166667,24.04923149,-0.371666667,0.003936197,-4.303369151,0.134,0.262,0.234,-0.16,-0.223,-0.102,A6H584,Col6a5,A6H584_Col6a5,A6H584,Col6a5,1,5,3,2,A0A140T8W1|A6H584|A0A140T8T7,MOUSE,291566.4,0.9,2206,2206.2,19.38,14.8,,2640,Collagen alpha-5(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|,cell adhesion|,,2,5,92400000,0.6%
Q8BGS2,0.372565587,0.066666667,10.98088547,-0.357333333,0.0797832,-2.067670268,-0.037,0.214,0.559,-0.313,-0.011,-0.012,Q8BGS2,Bola2,Q8BGS2_Bola2,Q8BGS2,Bola2,1,6,3,3,Q8BGS2|Q8BGS2-2,MOUSE,10328.5,41.8,2207,2207.1,39.09,39.09,,86,BolA-like protein 2,,,,3,6,808000000,41.8%
Q8K1N1,0.892575628,0.030333333,1.717209846,-0.08,0.673409154,-0.440776142,0.081,0.371,-0.241,0.208,-0.042,-0.195,Q8K1N1,Pnpla8,Q8K1N1_Pnpla8,Q8K1N1,Pnpla8,1,5,3,3,Q8K1N1|E9QAC9|E9PXB0,MOUSE,88121.4,5.5,2208,2208.1,39.02,39.02,,776,Calcium-independent phospholipase A2-gamma,Golgi membrane|intracellular|peroxisome|peroxisomal membrane|endoplasmic reticulum membrane|membrane|integral component of membrane|perinuclear region of cytoplasm|,prostaglandin biosynthetic process|fatty acid metabolic process|cell death|arachidonic acid metabolic process|phosphatidylcholine catabolic process|linoleic acid metabolic process|phosphatidylethanolamine catabolic process|arachidonic acid secretion|,lysophospholipase activity|calcium-independent phospholipase A2 activity|,3,5,207000000,5.5%
Q8C0L8,0.78242277,0.010333333,3.367759109,0.114,0.46049412,0.7834045,-0.007,-0.142,0.009,0.345,-0.181,0.038,Q8C0L8,Cog5,Q8C0L8_Cog5,Q8C0L8,Cog5,1,8,4,4,Q8C0L8,MOUSE,91960.4,5.4,2209,2209.1,39.02,39.02,,829,Conserved oligomeric Golgi complex subunit 5,Golgi membrane|nucleoplasm|Golgi apparatus|cytosol|membrane|Golgi transport complex|,intra-Golgi vesicle-mediated transport|protein transport|inter-Golgi cisterna vesicle-mediated transport|,,4,8,892000000,5.4%
Q9D0T1,0.604209631,0.009333333,6.291667405,-0.107333333,0.234873089,-1.305210237,0.018,0.139,0.032,-0.064,-0.03,-0.039,Q9D0T1,Snu13,Q9D0T1_Snu13,Q9D0T1,Snu13,1,12,4,4,Q9D0T1|E9PZS4,MOUSE,14401.5,37.5,2210,2210.1,39.01,39.01,,128,NHP2-like protein 1,spliceosomal complex|box C/D snoRNP complex|protein complex|,mRNA processing|RNA splicing|ribosome biogenesis|,U4 snRNA binding|U3 snoRNA binding|box C/D snoRNA binding|poly(A) RNA binding|,4,12,1850000000,37.5%
Q60841,0.003387105,-0.154833333,37.619158,0.785,0.000173015,7.496477291,-0.598,-0.578,-0.466,0.159,0.15,0.404,Q60841,Reln,Q60841_Reln,Q60841,Reln,1,6,5,5,Q60841|Q60841-2|Q60841-3,MOUSE,394505.8,2.1,2211,2211.1,38.99,38.99,,3461,Reelin,proteinaceous extracellular matrix|extracellular space|cytoplasm|dendrite|,"cell morphogenesis involved in differentiation|neuron migration|proteolysis|cell adhesion|axon guidance|central nervous system development|brain development|learning|long-term memory|associative learning|glial cell differentiation|regulation of gene expression|positive regulation of neuron projection development|positive regulation of phosphatidylinositol 3-kinase signaling|dendrite development|cell migration|peptidyl-tyrosine phosphorylation|spinal cord patterning|ventral spinal cord development|hippocampus development|cerebral cortex tangential migration|layer formation in cerebral cortex|cerebral cortex development|forebrain development|positive regulation of TOR signaling|positive regulation of CREB transcription factor activity|protein localization to synapse|reelin-mediated signaling pathway|positive regulation of protein kinase activity|response to pain|positive regulation of peptidyl-tyrosine phosphorylation|regulation of behavior|regulation of synaptic transmission|positive regulation of small GTPase mediated signal transduction|positive regulation of synaptic transmission, glutamatergic|long-term synaptic potentiation|positive regulation of dendritic spine morphogenesis|positive regulation of protein tyrosine kinase activity|positive regulation of synapse maturation|postsynaptic density assembly|N-methyl-D-aspartate receptor clustering|postsynaptic density protein 95 clustering|receptor localization to synapse|lateral motor column neuron migration|positive regulation of long-term synaptic potentiation|positive regulation of lateral motor column neuron migration|regulation of N-methyl-D-aspartate selective glutamate receptor activity|positive regulation of excitatory postsynaptic membrane potential|positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity|",protein binding|serine-type peptidase activity|metal ion binding|lipoprotein particle receptor binding|very-low-density lipoprotein particle receptor binding|,5,6,476000000,2.1%
Q05117,0.886698259,0.066166667,1.803586162,0.115,0.660148109,0.460137711,0.521,-0.109,-0.386,0.417,0.01,-0.056,Q05117,Acp5,Q05117_Acp5,Q05117,Acp5,1,6,3,3,Q05117,MOUSE,36977.6,12.2,2212,2212.1,38.95,38.95,,327,Tartrate-resistant acid phosphatase type 5,lysosome|extracellular exosome|,dephosphorylation|response to lipopolysaccharide|negative regulation of interleukin-1 beta production|negative regulation of interleukin-12 production|negative regulation of tumor necrosis factor production|negative regulation of superoxide anion generation|response to cytokine|negative regulation of nitric oxide biosynthetic process|bone resorption|negative regulation of inflammatory response|defense response to Gram-positive bacterium|bone morphogenesis|,acid phosphatase activity|ferrous iron binding|ferric iron binding|,3,6,3310000000,12.2%
Q3TPE9,0.802513605,0.0245,3.037579104,-0.081,0.496869215,-0.718524206,0.21,-0.046,0.031,0.094,0.02,-0.162,Q3TPE9,Ankmy2,Q3TPE9_Ankmy2,Q3TPE9,Ankmy2,1,4,3,3,Q3TPE9|Q3TPE9-2,MOUSE,49743.1,8.6,2213,2213.1,38.93,38.93,,440,Ankyrin repeat and MYND domain-containing protein 2,cilium|,,metal ion binding|,3,4,245000000,8.6%
Q9CQ65,0.50495704,-0.070666667,8.12731566,0.25,0.153910566,1.609894473,-0.042,-0.006,-0.539,0.005,0.052,0.106,Q9CQ65,Mtap,Q9CQ65_Mtap,Q9CQ65,Mtap,1,5,4,4,Q9CQ65,MOUSE,31631.9,22.9,2214,2214.1,38.88,38.88,,283,S-methyl-5'-thioadenosine phosphorylase,nucleus|cytoplasm|extracellular exosome|,purine ribonucleoside salvage|L-methionine biosynthetic process from methylthioadenosine|methylation|response to testosterone|purine-containing compound salvage|,phosphorylase activity|S-methyl-5-thioadenosine phosphorylase activity|,4,5,233000000,22.9%
Q9CZX0-2,0.639638704,0.072833333,5.555977702,0.175,0.278228894,1.18116654,-0.029,-0.036,0.021,0.427,-0.135,0.189,Q9CZX0,Elp3,Q9CZX0-2_Elp3,Q9CZX0-2,Elp3,1,5,3,3,Q9CZX0-2|A0A286YDB8|Q9CZX0,MOUSE,64835.5,6,2215,2215.1,38.87,38.87,,547,Isoform 2 of Elongator complex protein 3,histone acetyltransferase complex|nucleolus|cytoplasm|transcription elongation factor complex|Elongator holoenzyme complex|,neuron migration|tRNA wobble uridine modification|regulation of transcription from RNA polymerase II promoter|transcription elongation from RNA polymerase II promoter|central nervous system development|histone acetylation|positive regulation of cell migration|histone H3 acetylation|histone H4 acetylation|regulation of protein kinase activity|,histone acetyltransferase activity|phosphorylase kinase regulator activity|H3 histone acetyltransferase activity|H4 histone acetyltransferase activity|metal ion binding|iron-sulfur cluster binding|RNA polymerase II core binding|,3,5,185000000,6.0%
Q8VCG4,0.581377911,0.005833333,6.695991897,0.180333333,0.213993613,1.374550145,-0.261,-0.069,0.077,0.018,-0.019,0.289,Q8VCG4,C8g,Q8VCG4_C8g,Q8VCG4,C8g,1,5,4,4,Q8VCG4|Q9DAC2,MOUSE,22678.7,24.7,2216,2216.1,38.79,38.79,,202,Complement component C8 gamma chain,membrane attack complex|extracellular exosome|blood microparticle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",complement binding|retinol binding|protein complex binding|,4,5,311000000,24.7%
Q80VC9-10,0.815095629,-0.010833333,2.881747506,0.063,0.51502137,0.687232903,-0.089,-0.029,-0.009,0.118,-0.092,0.036,Q80VC9,Camsap3,Q80VC9-10_Camsap3,Q80VC9-10,Camsap3,1,7,4,4,Q80VC9-10|Q80VC9|Q80VC9-2|Q80VC9-13|Q80VC9-9|Q80VC9-14|Q80VC9-5|Q80VC9-11|Q80VC9-4|Q80VC9-12|Q80VC9-3|Q80VC9-17|Q80VC9-8|Q80VC9-16|Q80VC9-7|Q80VC9-15|Q80VC9-6,MOUSE,136070.6,4.5,2217,2217.1,38.75,38.75,,1252,Isoform 10 of Calmodulin-regulated spectrin-associated protein 3,cytoplasm|zonula adherens|microtubule minus-end|centrosome|microtubule minus-end|,microtubule cytoskeleton organization|negative regulation of phosphatase activity|regulation of organelle organization|microtubule anchoring|zonula adherens maintenance|regulation of microtubule cytoskeleton organization|epithelial cell-cell adhesion|,protein binding|microtubule minus-end binding|,4,7,2210000000,4.5%
Q9QYC0,0.996670041,0.017333333,0.038932663,0.001333333,0.991075485,0.011612752,-0.056,-0.071,0.177,-0.04,-0.076,0.17,Q9QYC0,Add1,Q9QYC0_Add1,Q9QYC0,Add1,1,4,4,4,Q9QYC0|F8WGR0|F8WHZ9|E9Q1K3|Q9QYC0-2,MOUSE,81044.5,6.6,2218,2218.1,38.61,38.61,,735,Alpha-adducin,nucleus|nucleoplasm|cytoplasm|cytoskeleton|plasma membrane|focal adhesion|F-actin capping protein complex|membrane|intermediate filament cytoskeleton|,cell morphogenesis|in utero embryonic development|cell volume homeostasis|hemoglobin metabolic process|erythrocyte differentiation|positive regulation of protein binding|multicellular organism growth|homeostasis of number of cells within a tissue|barbed-end actin filament capping|actin filament bundle assembly|,structural molecule activity|calmodulin binding|transcription factor binding|spectrin binding|protein homodimerization activity|poly(A) RNA binding|protein heterodimerization activity|actin filament binding|,4,4,512000000,6.6%
P02798,0.422097197,0.187833333,9.93929589,-1.483666667,0.101407578,-1.901389942,-0.125,0.287,2.627,-0.099,-1.579,0.016,P02798,Mt2,P02798_Mt2,P02798,Mt2,1,14,4,4,P02798,MOUSE,7256.2,65.5,2219,2219.1,38.54,38.54,,61,Metallothionein-2,nucleus|cytoplasm|perinuclear region of cytoplasm|,cellular zinc ion homeostasis|nitric oxide mediated signal transduction|detoxification of copper ion|cellular response to erythropoietin|negative regulation of growth|cellular response to cadmium ion|cellular response to zinc ion|,zinc ion binding|,4,14,521000000,65.5%
Q8R079,0.805699632,0.010333333,2.99681115,-0.073333333,0.50155537,-0.710242012,0.187,0.033,-0.079,0.058,-0.035,-0.102,Q8R079,Bfar,Q8R079_Bfar,Q8R079,Bfar,1,4,3,3,Q8R079|A0A0R4J040|D6RG73|Q8R079-2,MOUSE,53651.8,6.6,2220,2220.1,38.47,38.47,,450,Bifunctional apoptosis regulator,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,protein polyubiquitination|apoptotic process|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|negative regulation of apoptotic process|proteasome-mediated ubiquitin-dependent protein catabolic process|protein autoubiquitination|protein K63-linked ubiquitination|protein K48-linked ubiquitination|negative regulation of IRE1-mediated unfolded protein response|,"zinc ion binding|protein binding, bridging|ubiquitin protein ligase activity|caspase binding|",3,4,89800000,6.6%
P61967,0.751736923,0.012,3.810633159,-0.105333333,0.415849979,-0.867803892,-0.159,0.184,0.169,-0.064,-0.111,0.053,P61967,Ap1s1,P61967_Ap1s1,P61967,Ap1s1,1,7,3,3,P61967,MOUSE,18960.9,21.5,2221,2221.1,38.45,38.45,,158,AP-1 complex subunit sigma-1A,trans-Golgi network|coated pit|membrane|AP-1 adaptor complex|terminal bouton|extracellular exosome|,"intracellular protein transport|response to virus|vesicle-mediated transport|retrograde transport, endosome to Golgi|",protein binding|protein transporter activity|,3,7,2.99E+11,21.5%
O54916,0.112765272,-0.012666667,19.32614084,0.346,0.011678469,3.435740338,-0.29,-0.11,-0.157,0.107,0.083,0.291,O54916,Reps1,O54916_Reps1,O54916,Reps1,1,8,5,4,O54916|E9Q632|O54916-4|O54916-3|D3Z2E3|Q80XA6|O54916-2,MOUSE,86688.5,5.9,2222,2222.1,38.43,27.16,,795,RalBP1-associated Eps domain-containing protein 1,plasma membrane|coated pit|,receptor-mediated endocytosis|,calcium ion binding|protein binding|SH3 domain binding|,5,8,1270000000,5.9%
B9EI38,0.993378838,-0.020833333,0.117143669,0.005666667,0.973387205,0.034641102,0.047,0.142,-0.26,0.264,-0.134,-0.184,B9EI38,Reps2,B9EI38_Reps2,B9EI38,Reps2,1,2,3,2,B9EI38|A2AFI8,MOUSE,71181.6,7,2222,2222.2,21.51,10.24,,648,RalBP1-associated Eps domain-containing protein 2,,,calcium ion binding|,2,2,16700000,5.5%
I3ITR1,0.951421295,-0.0165,0.747340483,0.035666667,0.84191055,0.207429391,-0.068,0.317,-0.352,0.06,0.027,-0.083,I3ITR1,NotFound,I3ITR1_NotFound,I3ITR1,AK157302,1,4,3,3,I3ITR1|Q9D924|A0A286YCW6,MOUSE,14389.3,31,2223,2223.1,38.41,38.41,,129,MCG50313,mitochondrion|,iron-sulfur cluster assembly|,structural molecule activity|iron-sulfur cluster binding|,3,4,212000000,31.0%
P48725,0.4568845,-0.012,9.225934849,0.162,0.119510624,1.784130336,-0.006,-0.07,-0.203,0.026,0.116,0.065,P48725,Pcnt,P48725_Pcnt,P48725,Pcnt,1,6,4,4,F8VPV0|A0A1W2P737|P48725|P48725-3|P48725-2,MOUSE,332197.6,1.2,2224,2224.1,38.41,38.41,,2898,Pericentrin,pericentriolar material|centrosome|centriole|microtubule organizing center|microtubule|motile cilium|centriolar satellite|ciliary basal body|intercellular bridge|cis-Golgi network|,microtubule cytoskeleton organization|in utero embryonic development|neuron migration|spindle organization|cerebellar cortex morphogenesis|olfactory bulb development|limb morphogenesis|multicellular organism growth|cilium assembly|negative regulation of apoptotic process|brain morphogenesis|neural precursor cell proliferation|positive regulation of intracellular protein transport|,protein binding|calmodulin binding|,4,6,1260000000,1.2%
Q6QD59,0.550359036,0.021,7.281676694,-0.126,0.186996006,-1.469694916,0.163,0.031,0.058,-0.032,-0.099,0.005,Q6QD59,Bnip1,Q6QD59_Bnip1,Q6QD59,Bnip1,1,5,3,3,Q6QD59|B8JJI4,MOUSE,26346,14,2225,2225.1,38.39,38.39,,228,Vesicle transport protein SEC20,Golgi membrane|nuclear envelope|cytoplasm|mitochondrion|endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|SNARE complex|intracellular membrane-bounded organelle|,autophagy|apoptotic process|endoplasmic reticulum organization|protein transport|vesicle-mediated transport|endoplasmic reticulum membrane fusion|,SNAP receptor activity|,3,5,620000000,14.0%
Q8R2R1,0.822567717,-0.003,2.726563318,0.06,0.533757104,0.65591278,0.034,0.012,-0.145,0.092,0.002,-0.013,Q8R2R1,Pomt1,Q8R2R1_Pomt1,Q8R2R1,Pomt1,1,5,5,5,Q8R2R1,MOUSE,85803.2,9.6,2226,2226.1,38.32,38.32,,746,Protein O-mannosyl-transferase 1,acrosomal vesicle|endoplasmic reticulum membrane|integral component of membrane|sarcoplasmic reticulum|,extracellular matrix organization|protein O-linked mannosylation|,dolichyl-phosphate-mannose-protein mannosyltransferase activity|,5,5,1640000000,9.6%
Q9DCT5,0.032221992,-0.000833333,25.96505408,0.479,0.00253218,4.683913497,-0.381,-0.13,-0.21,0.331,0.213,0.172,Q9DCT5,Sdf2,Q9DCT5_Sdf2,Q9DCT5,Sdf2,1,7,3,3,A0A0R4IZW9|Q9DCT5,MOUSE,23386.8,25.1,2227,2227.1,38.22,38.22,,211,Stromal cell-derived factor 2,extracellular region|membrane|,,,3,7,1490000000,25.1%
Q32NY4,0.885307507,-0.014333333,1.833928956,-0.066,0.655551936,-0.466893039,-0.053,0.025,0.084,0.21,-0.304,-0.048,Q32NY4,Cnnm3,Q32NY4_Cnnm3,Q32NY4,Cnnm3,1,5,4,4,Q32NY4|Q32NY4-2,MOUSE,76905.4,7.8,2228,2228.1,38.15,38.15,,713,Metal transporter CNNM3,plasma membrane|membrane|integral component of membrane|,ion transport|,,4,5,27500000,7.8%
Q9R1P0,0.649269492,0.0175,5.331047815,0.093666667,0.29301862,1.141013809,-0.069,-0.016,-0.003,0.118,0.003,0.072,Q9R1P0,Psma4,Q9R1P0_Psma4,Q9R1P0,Psma4,1,5,3,3,Q9R1P0,MOUSE,29755.5,10.7,2229,2229.1,38.11,38.11,,261,Proteasome subunit alpha type-4,"proteasome complex|cytoplasmic mRNA processing body|nucleus|cytoplasm|cytosol|proteasome core complex|plasma membrane|proteasome core complex, alpha-subunit complex|intracellular membrane-bounded organelle|extracellular exosome|",proteasomal ubiquitin-independent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|,endopeptidase activity|threonine-type endopeptidase activity|,3,5,2260000000,10.7%
E9Q3G8,0.461918472,-0.068,9.093827942,0.282,0.123201843,1.765940241,-0.073,-0.003,-0.551,-0.014,0.057,0.176,E9Q3G8,Nup153,E9Q3G8_Nup153,E9Q3G8,Nup153,1,6,4,4,E9Q3G8,MOUSE,153431.5,4.5,2230,2230.1,38.1,38.1,,1462,Nucleoporin 153,nuclear pore|nuclear lamina|nucleolus|cytoplasm|nuclear membrane|nuclear periphery|nuclear inclusion body|nuclear pore nuclear basket|,nucleocytoplasmic transport|negative regulation of RNA export from nucleus|nuclear pore complex assembly|,nucleocytoplasmic transporter activity|zinc ion binding|Ran GTPase binding|structural constituent of nuclear pore|identical protein binding|protein anchor|,4,6,159000000,4.5%
F8WI30,0.826177557,0.041833333,2.675729408,0.120333333,0.540041406,0.645961543,-0.278,-0.104,0.327,0.344,0.035,-0.073,F8WI30,Snx7,F8WI30_Snx7,F8WI30,Snx7,1,5,3,3,F8WI30|Q9CY18,MOUSE,51220,8.5,2231,2231.1,38.08,38.08,,445,Sorting nexin-7,endosome|extrinsic component of membrane|,endocytosis|vesicle organization|,phosphatidylinositol binding|,3,5,408000000,8.5%
Q5SUF2-2,0.122124581,-0.046333333,18.79412799,0.288666667,0.013200403,3.343195549,-0.204,-0.235,-0.133,0.165,0.019,0.11,Q5SUF2,Luc7l3,Q5SUF2-2_Luc7l3,Q5SUF2-2,Luc7l3,1,6,3,3,Q5SUF2-2|Q5SUF2-3|Q5SUF2|F8WGA8,MOUSE,58891.1,8.7,2232,2232.1,38.08,38.08,,432,Isoform 2 of Luc7-like protein 3,nucleus|nucleoplasm|U1 snRNP|nuclear speck|,mRNA splice site selection|RNA splicing|,DNA binding|mRNA binding|poly(A) RNA binding|,3,6,138000000,8.7%
Q9D824,0.198650353,0.0085,15.97628279,0.295666667,0.025256416,2.868401295,-0.088,-0.055,-0.275,0.253,0.053,0.163,Q9D824,Fip1l1,Q9D824_Fip1l1,Q9D824,Fip1l1,1,4,4,4,Q9D824|Q9D824-2|Q9D824-3|Q9D824-4,MOUSE,65014.6,9.8,2233,2233.1,38.07,38.07,,581,Pre-mRNA 3'-end-processing factor FIP1,nucleus|mRNA cleavage and polyadenylation specificity factor complex|,mRNA polyadenylation|,protein binding|poly(A) RNA binding|,4,4,128000000,9.8%
Q7TSI3,0.55391814,0.012,7.191757881,0.126666667,0.190908037,1.454912347,-0.111,-0.041,-0.002,0.088,-0.006,0.144,Q7TSI3,Ppp6r1,Q7TSI3_Ppp6r1,Q7TSI3,Ppp6r1,1,6,3,3,Q7TSI3,MOUSE,95096.1,6.8,2234,2234.1,38.05,38.05,,856,Serine/threonine-protein phosphatase 6 regulatory subunit 1,cytoplasm|,regulation of phosphoprotein phosphatase activity|,protein phosphatase binding|,3,6,538000000,6.8%
Q8R4R6,0.862027405,0.002666667,2.200439274,-0.064,0.602498642,-0.546666208,0.155,0.056,-0.107,0.095,-0.194,0.011,Q8R4R6,Nup35,Q8R4R6_Nup35,Q8R4R6,Nup35,1,5,3,3,Q8R4R6,MOUSE,34842.1,13.5,2235,2235.1,38.02,38.02,,325,Nucleoporin NUP53,nuclear pore|nuclear membrane|,protein transport|mRNA transport|transmembrane transport|,,3,5,235000000,13.5%
Q09200,0.000366358,-0.0895,52.83626686,1.320333333,5.20443E-06,13.05652666,-0.83,-0.754,-0.665,0.644,0.428,0.64,Q09200,B4galnt1,Q09200_B4galnt1,Q09200,B4galnt1,1,5,4,4,Q09200|A0A1W2P6F0,MOUSE,59610.2,8.4,2236,2236.1,38,38,,533,"Beta-1,4 N-acetylgalactosaminyltransferase 1",plasma membrane|integral component of Golgi membrane|,ganglioside biosynthetic process|protein glycosylation|glycosphingolipid metabolic process|spermatogenesis|lipid storage|lipid glycosylation|,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity|,4,5,123000000,8.4%
Q61103,0.52769863,0.007833333,7.667466895,0.173,0.1711013,1.533904762,0.04,-0.091,-0.185,0.027,-0.008,0.264,Q61103,Dpf2,Q61103_Dpf2,Q61103,Dpf2,1,5,3,3,D3Z5N6|Q61103,MOUSE,45369.9,9.2,2237,2237.1,37.99,37.99,,391,Zinc finger protein ubi-d4,nuclear chromatin|nucleus|nucleoplasm|cytoplasm|centrosome|intracellular membrane-bounded organelle|BAF-type complex|,"transcription, DNA-templated|regulation of transcription, DNA-templated|apoptotic process|",RNA polymerase II core promoter proximal region sequence-specific DNA binding|zinc ion binding|,3,5,102000000,9.2%
Q64339,0.334955273,0.0375,11.81110985,-0.241666667,0.065900546,-2.196469588,0.118,0.02,0.337,-0.068,-0.162,-0.02,Q64339,Isg15,Q64339_Isg15,Q64339,Isg15,1,8,3,3,Q64339,MOUSE,18068.5,30.4,2238,2238.1,37.98,37.98,,161,Ubiquitin-like protein ISG15,extracellular region|cytoplasm|,modification-dependent protein catabolic process|negative regulation of protein ubiquitination|ISG15-protein conjugation|regulation of interferon-gamma production|response to type I interferon|defense response to bacterium|negative regulation of viral genome replication|positive regulation of erythrocyte differentiation|defense response to virus|,protein binding|protein tag|,3,8,1090000000,30.4%
Q9D1G2,0.238389384,-0.014,14.53543168,0.256,0.035193044,2.631991192,-0.061,-0.122,-0.243,0.079,0.038,0.225,Q9D1G2,Pmvk,Q9D1G2_Pmvk,Q9D1G2,Pmvk,1,5,4,4,Q9D1G2|D3YXP6|Q9D1G2-2|Q9D1G2-3,MOUSE,22200.7,18.2,2239,2239.1,37.97,37.97,,192,Phosphomevalonate kinase,peroxisome|cytosol|membrane|extracellular exosome|,"cholesterol biosynthetic process|sterol biosynthetic process|phosphorylation|isopentenyl diphosphate biosynthetic process, mevalonate pathway|response to cholesterol|",phosphomevalonate kinase activity|ATP binding|,4,5,377000000,18.2%
Q8BTV2,0.237545691,0.0235,14.55909361,0.257666667,0.035001821,2.635828315,-0.18,0.002,-0.138,0.085,0.107,0.265,Q8BTV2,Cpsf7,Q8BTV2_Cpsf7,Q8BTV2,Cpsf7,1,6,3,3,Q8BTV2|Q8BTV2-2,MOUSE,52181.2,6.7,2240,2240.1,37.96,37.96,,471,Cleavage and polyadenylation specificity factor subunit 7,nucleus|mRNA cleavage factor complex|membrane|,mRNA processing|protein tetramerization|,nucleotide binding|poly(A) RNA binding|,3,6,189000000,6.7%
Q7TQI7,0.70184245,-0.048333333,4.513698162,-0.110666667,0.353696029,-0.996701621,0.023,0.051,-0.053,0.095,-0.189,-0.217,Q7TQI7,Abtb2,Q7TQI7_Abtb2,Q7TQI7,Abtb2,1,4,4,4,Q7TQI7,MOUSE,114699.1,4.2,2241,2241.1,37.96,37.96,,1024,Ankyrin repeat and BTB/POZ domain-containing protein 2,nucleus|nucleoplasm|,cellular response to toxic substance|,protein heterodimerization activity|,4,4,133000000,4.2%
Q5SS80,0.929192436,-0.015166667,1.012361207,0.021666667,0.792070574,0.274369351,-0.017,-0.01,-0.051,0.02,-0.05,0.017,Q5SS80,Dhrs13,Q5SS80_Dhrs13,Q5SS80,Dhrs13,1,4,4,4,Q5SS80|B0QZT2|Q5SS80-2,MOUSE,41200.2,11.1,2242,2242.1,37.93,37.93,,376,Dehydrogenase/reductase SDR family member 13,extracellular region|membrane|,oxidation-reduction process|,oxidoreductase activity|,4,4,67100000,11.1%
Q91WS7,0.928824475,-0.017166667,1.025828984,0.038333333,0.789618112,0.277831103,-0.122,0.168,-0.155,0.202,-0.031,-0.165,Q91WS7,Depdc7,Q91WS7_Depdc7,Q91WS7,Depdc7,1,4,3,3,Q91WS7,MOUSE,58762.8,8.8,2243,2243.1,37.93,37.93,,511,DEP domain-containing protein 7,intracellular|,intracellular signal transduction|,,3,4,145000000,8.8%
Q8VHR5,0.797504707,-0.005,3.106561766,0.084,0.48903937,0.732235195,-0.046,0.07,-0.165,0.203,-0.095,0.003,Q8VHR5,Gatad2b,Q8VHR5_Gatad2b,Q8VHR5,Gatad2b,1,6,5,5,Q8VHR5|A1L3S7|Q8VHR5-2,MOUSE,65752.1,8.9,2244,2244.1,37.87,37.87,,594,Transcriptional repressor p66-beta,nuclear chromatin|nucleoplasm|nuclear speck|protein complex|,"transcription, DNA-templated|regulation of transcription, DNA-templated|ATP-dependent chromatin remodeling|",sequence-specific DNA binding transcription factor activity|protein binding|zinc ion binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|,5,6,692000000,8.9%
Q91W86,0.933608247,0.011,0.949213426,-0.024,0.803671666,-0.25865304,-0.013,-0.007,0.089,0.118,-0.052,-0.069,Q91W86,Vps11,Q91W86_Vps11,Q91W86,Vps11,1,6,5,5,Q91W86,MOUSE,109028.9,4.9,2245,2245.1,37.83,37.83,,941,Vacuolar protein sorting-associated protein 11 homolog,lysosome|lysosomal membrane|endosome|early endosome|late endosome|actin filament|endocytic vesicle|HOPS complex|late endosome membrane|lysosome|early endosome|late endosome|,intracellular protein transport|vesicle docking involved in exocytosis|endosome organization|lysosome organization|regulation of protein stability|endosomal vesicle fusion|regulation of SNARE complex assembly|toxin transport|regulation of organelle assembly|positive regulation of cellular protein catabolic process|positive regulation of protein targeting to mitochondrion|positive regulation of early endosome to late endosome transport|,"nucleotide binding|protein binding|zinc ion binding|protein domain specific binding|syntaxin binding|protein binding, bridging|",5,6,416000000,4.9%
P35576,0.147202005,0.077666667,17.71118241,-0.479333333,0.016938766,-3.1692231,0.119,0.595,0.238,-0.33,-0.027,-0.129,P35576,G6pc,P35576_G6pc,P35576,G6pc,1,10,3,3,P35576,MOUSE,40985.4,12.3,2246,2246.1,37.81,37.81,,357,Glucose-6-phosphatase,endoplasmic reticulum|membrane|integral component of membrane|integral component of endoplasmic reticulum membrane|,glycogen metabolic process|glycogen catabolic process|gluconeogenesis|triglyceride metabolic process|steroid metabolic process|regulation of gene expression|glucose-6-phosphate transport|response to food|multicellular organism growth|glucose homeostasis|cholesterol homeostasis|urate metabolic process|phosphorylated carbohydrate dephosphorylation|glucose 6-phosphate metabolic process|,"glucose-6-phosphatase activity|phosphotransferase activity, alcohol group as acceptor|phosphate ion binding|",3,10,3380000000,12.3%
Q5F2F2,0.911487485,0.012333333,1.416620263,-0.042,0.721668873,-0.371691462,-0.052,0.155,-0.003,0.108,0.047,-0.181,Q5F2F2,Abhd15,Q5F2F2_Abhd15,Q5F2F2,Abhd15,1,4,4,4,Q5F2F2,MOUSE,52063.7,14.5,2247,2247.1,37.61,37.61,,459,Protein ABHD15,extracellular region|membrane|,metabolic process|,hydrolase activity|,4,4,238000000,14.5%
Q9D1J1,0.226782822,-0.0065,14.93510407,-0.289666667,0.032098859,-2.698647476,0.031,0.124,0.26,-0.034,-0.281,-0.139,Q9D1J1,Necap2,Q9D1J1_Necap2,Q9D1J1,Necap2,1,5,4,4,Q9D1J1,MOUSE,28711.6,19.1,2248,2248.1,37.55,37.55,,266,Adaptin ear-binding coat-associated protein 2,intracellular|plasma membrane|clathrin vesicle coat|,endocytosis|protein transport|,,4,5,5080000000,19.1%
Q8CIF4,0.015110733,-0.126333333,29.9595334,0.879333333,0.001009361,5.580140244,-0.371,-0.408,-0.919,0.334,0.33,0.276,Q8CIF4,Btd,Q8CIF4_Btd,Q8CIF4,Btd,1,6,4,4,A0A0R4J131|Q8CIF4,MOUSE,58952,10.1,2249,2249.1,37.49,37.49,,520,Biotinidase,extracellular space|nucleolus|perikaryon|apical part of cell|extracellular exosome|,biotin metabolic process|,biotinidase activity|,4,6,2780000000,10.1%
P82198,0.661323193,-0.012333333,5.16467957,0.104666667,0.304461262,1.111989843,-0.141,0.039,-0.092,0.122,0.038,-0.04,P82198,Tgfbi,P82198_Tgfbi,P82198,Tgfbi,1,5,4,4,P82198|Q3UXJ2,MOUSE,75223.3,8.6,2250,2250.1,37.47,37.47,,683,Transforming growth factor-beta-induced protein ig-h3,proteinaceous extracellular matrix|basement membrane|extracellular space|trans-Golgi network|extracellular exosome|extracellular matrix|,angiogenesis|chondrocyte differentiation|cell adhesion|extracellular matrix organization|,collagen binding|cell adhesion molecule binding|extracellular matrix binding|,4,5,87600000,8.6%
Q99JX3,0.714371377,-0.093666667,4.307200485,0.21,0.370919744,0.959738859,-0.056,0.17,-0.71,0.034,0.003,-0.003,Q99JX3,Gorasp2,Q99JX3_Gorasp2,Q99JX3,Gorasp2,1,5,4,4,Q99JX3|A2ATI9|Q99JX3-2|A2ATI6|A2ATI8,MOUSE,47265.7,14.8,2251,2251.1,37.42,37.42,,451,Golgi reassembly-stacking protein 2,Golgi membrane|Golgi apparatus|,organelle organization|,,4,5,325000000,14.8%
P59016,0.967029453,0.006166667,0.444942291,-0.011,0.902621701,-0.127062237,0.017,-0.01,0.028,0.085,-0.093,0.01,P59016,Vps33b,P59016_Vps33b,P59016,Vps33b,1,6,4,4,P59016,MOUSE,71209.7,8.7,2252,2252.1,37.42,37.42,,617,Vacuolar protein sorting-associated protein 33B,cytoplasm|lysosome|lysosomal membrane|late endosome|platelet alpha granule|late endosome membrane|perinuclear region of cytoplasm|HOPS complex|,vesicle docking involved in exocytosis|protein transport|vesicle-mediated transport|melanosome localization|lysosome localization|membrane fusion|platelet alpha granule organization|,protein binding|,4,6,219000000,8.7%
A2AKG8,0.493441063,0.016333333,8.34401265,-0.196,0.146419438,-1.645032478,-0.042,0.123,0.262,-0.027,-0.238,0.02,A2AKG8,Focad,A2AKG8_Focad,A2AKG8,Focad,1,7,4,4,A2AKG8|E9PYJ6,MOUSE,201228.6,3,2253,2253.1,37.35,37.35,,1798,Focadhesin,focal adhesion|integral component of membrane|,,,4,7,3160000000,3.0%
Q91X43,0.919618833,-0.009833333,1.193024637,0.028333333,0.759796933,0.318514811,-0.086,0.05,-0.036,0.023,-0.079,0.069,Q91X43,Sh3d19,Q91X43_Sh3d19,Q91X43,Sh3d19,1,7,4,4,Q91X43|Q91X43-2,MOUSE,86531.3,4.9,2254,2254.1,37.31,37.31,,789,SH3 domain-containing protein 19,nucleoplasm|Golgi apparatus|plasma membrane|,cytoskeleton organization|regulation of cell morphogenesis|positive regulation of membrane protein ectodomain proteolysis|,protein binding|proline-rich region binding|,4,7,99500000,4.9%
Q61733,0.857830933,0.032833333,2.242650657,-0.151666667,0.596671005,-0.555724178,-0.547,0.523,0.35,-0.125,-0.082,0.078,Q61733,Mrps31,Q61733_Mrps31,Q61733,Mrps31,1,3,3,3,Q61733,MOUSE,44108.3,9.3,2255,2255.1,37.29,37.29,,384,"28S ribosomal protein S31, mitochondrial",nucleolus|mitochondrion|mitochondrial small ribosomal subunit|,,structural constituent of ribosome|protein domain specific binding|poly(A) RNA binding|,3,3,59400000,9.3%
P13516,0.623895097,-0.049833333,5.89231511,0.271666667,0.257494815,1.238933184,-0.662,-0.133,0.238,0.172,0.055,0.031,P13516,Scd1,P13516_Scd1,P13516,Scd1,1,6,4,4,P13516|Q99PL7|P13011,MOUSE,41330.9,8.7,2256,2256.1,37.28,37.28,,355,Acyl-CoA desaturase 1,endoplasmic reticulum|membrane|integral component of endoplasmic reticulum membrane|,fatty acid biosynthetic process|positive regulation of cholesterol esterification|cholesterol esterification|negative regulation of growth of symbiont in host|defense response to Gram-positive bacterium|white fat cell differentiation|brown fat cell differentiation|oxidation-reduction process|monounsaturated fatty acid biosynthetic process|,stearoyl-CoA 9-desaturase activity|palmitoyl-CoA 9-desaturase activity|,4,6,260000000,8.7%
P62889,0.708523608,-0.0035,4.403430775,0.156333333,0.362791349,0.977264195,-0.212,0.259,-0.292,0.045,0.186,-0.007,P62889,Rpl30,P62889_Rpl30,P62889,Rpl30,1,10,3,3,P62889,MOUSE,12955,31.3,2257,2257.1,37.28,37.28,,115,60S ribosomal protein L30,nucleus|cytoplasm|focal adhesion|membrane|cytosolic large ribosomal subunit|extracellular exosome|,translation|,structural constituent of ribosome|poly(A) RNA binding|,3,10,937000000,31.3%
P62320,0.919416995,-0.032,1.227907928,-0.051333333,0.753718556,-0.327062382,-0.34,0.117,0.204,-0.094,-0.126,0.047,P62320,Snrpd3,P62320_Snrpd3,P62320,Snrpd3,1,10,4,4,P62320|A0A1W2P7K5,MOUSE,14030.1,37.3,2258,2258.1,37.27,37.27,,126,Small nuclear ribonucleoprotein Sm D3,nucleus|nucleoplasm|U7 snRNP|U1 snRNP|U4 snRNP|U12-type spliceosomal complex|cytoplasm|cytosol|methylosome|pICln-Sm protein complex|SMN-Sm protein complex|extracellular exosome|catalytic step 2 spliceosome|,spliceosomal snRNP assembly|protein methylation|,enzyme binding|poly(A) RNA binding|histone pre-mRNA DCP binding|,4,10,4630000000,37.3%
Q5RL57,0.951421295,0.025833333,0.745708788,-0.025,0.842226925,-0.207007401,0.005,-0.003,0.113,0.22,-0.178,-0.002,Q5RL57,Akap8l,Q5RL57_Akap8l,Q5RL57,Akap8l,1,5,4,4,Q9R0L7|Q5RL57,MOUSE,71869.9,7.4,2259,2259.1,37.25,37.25,,641,A kinase (PRKA) anchor protein 8-like,nucleoplasm|cytoplasm|nuclear matrix|,phosphorylation|,DNA binding|kinase activity|poly(A) RNA binding|,4,5,384000000,7.4%
Q9Z1M4,0.927777432,-0.040666667,1.038809346,-0.027333333,0.787261594,-0.280906606,0.025,-0.113,0.007,0.017,-0.184,0.004,Q9Z1M4,Rps6kb2,Q9Z1M4_Rps6kb2,Q9Z1M4,Rps6kb2,1,9,4,4,Q9Z1M4|D3YWB8,MOUSE,53936.6,6.5,2260,2260.1,37.19,37.19,,485,Ribosomal protein S6 kinase beta-2,nucleus|cytoplasm|,protein phosphorylation|protein kinase B signaling|positive regulation of translational initiation|,protein kinase activity|ribosomal protein S6 kinase activity|ATP binding|peptide binding|,4,9,518000000,6.5%
Q922E6,0.638602797,-0.028666667,5.590642852,0.165333333,0.276016926,1.187151713,-0.033,0.062,-0.363,0.094,-0.096,0.164,Q922E6,Fastkd2,Q922E6_Fastkd2,Q922E6,Fastkd2,1,6,4,4,Q922E6,MOUSE,79973.8,7.1,2261,2261.1,37,37,,689,"FAST kinase domain-containing protein 2, mitochondrial",mitochondrion|,protein phosphorylation|cellular respiration|,protein kinase activity|poly(A) RNA binding|,4,6,63600000,7.1%
Q9CYV5,0.993396811,0.030666667,0.106250164,-0.004666667,0.975831838,-0.031457724,-0.231,0.175,0.155,-0.125,0.209,0.001,Q9CYV5,Tmem135,Q9CYV5_Tmem135,Q9CYV5,Tmem135,1,7,4,4,Q9CYV5|Q8C8G3,MOUSE,53161.5,8.9,2262,2262.1,37,37,,458,Transmembrane protein 135,peroxisome|integral component of membrane|,peroxisome organization|,,4,7,276000000,8.9%
Q8C561,0.881050168,0.004833333,1.918418362,0.053,0.642921817,0.485380603,-0.168,0.084,0.019,0.112,-0.102,0.084,Q8C561,Lmbrd2,Q8C561_Lmbrd2,Q8C561,Lmbrd2,1,6,4,4,Q8C561|Q8C561-2|Q8C561-3,MOUSE,81841.3,9,2263,2263.1,36.99,36.99,,694,LMBR1 domain-containing protein 2,membrane|integral component of membrane|,,,4,6,251000000,9.0%
Q3UHD6,0.408707826,0.067166667,10.1952943,-0.326333333,0.095602791,-1.942290851,-0.095,0.236,0.55,-0.04,-0.197,-0.051,Q3UHD6,Snx27,Q3UHD6_Snx27,Q3UHD6,Snx27,1,7,4,4,Q3UHD6|Q3UHD6-2|A0A0G2JF85|A0A0G2JG07,MOUSE,61615.3,7.9,2264,2264.1,36.98,36.98,,539,Sorting nexin-27,immunological synapse|nucleoplasm|cytoplasm|endosome|early endosome|cytosol|early endosome membrane|retromer complex|WASH complex|,"intracellular protein transport|signal transduction|endosome to lysosome transport|endosomal transport|response to drug|retrograde transport, endosome to plasma membrane|",protein binding|phosphatidylinositol-3-phosphate binding|,4,7,308000000,7.9%
Q9CYW4,0.964822261,-0.0095,0.480695754,0.019666667,0.895221337,0.136845586,0.042,0.216,-0.316,-0.026,0.011,0.016,Q9CYW4,Hdhd3,Q9CYW4_Hdhd3,Q9CYW4,Hdhd3,1,8,4,4,Q9CYW4,MOUSE,28254.7,13.1,2265,2265.1,36.96,36.96,,251,Haloacid dehalogenase-like hydrolase domain-containing protein 3,mitochondrion|,metabolic process|,hydrolase activity|,4,8,175000000,13.1%
Q6NZF1,0.64206681,-0.021333333,5.515256636,0.158,0.280849941,1.174126151,0.021,0.009,-0.331,0.18,-0.105,0.098,Q6NZF1,Zc3h11a,Q6NZF1_Zc3h11a,Q6NZF1,Zc3h11a,1,5,3,3,Q6NZF1,MOUSE,87346,5,2266,2266.1,36.88,36.88,,792,Zinc finger CCCH domain-containing protein 11A,intracellular|transcription export complex|,poly(A)+ mRNA export from nucleus|,poly(A) RNA binding|metal ion binding|,3,5,78200000,5.0%
Q64012,0.056743102,0.128166667,22.98215665,-0.590333333,0.005032506,-4.119744533,0.122,0.628,0.52,-0.213,-0.114,-0.174,Q64012,Raly,Q64012_Raly,Q64012,Raly,1,5,4,4,Q64012|Q64012-2,MOUSE,33358.5,15.7,2267,2267.1,36.82,36.82,,312,RNA-binding protein Raly,nucleus|catalytic step 2 spliceosome|,mRNA processing|RNA splicing|,nucleotide binding|poly(A) RNA binding|,4,5,279000000,15.7%
Q8BGA9,0.961523652,0.012666667,0.573517427,0.015333333,0.87629081,0.161727863,-0.034,0.048,0.001,-0.086,-0.002,0.149,Q8BGA9,Oxa1l,Q8BGA9_Oxa1l,Q8BGA9,Oxa1l,1,4,4,4,Q8BGA9,MOUSE,48732.2,8.3,2268,2268.1,36.8,36.8,,433,Mitochondrial inner membrane protein OXA1L,mitochondrion|mitochondrial inner membrane|mitochondrial membrane|integral component of mitochondrial membrane|protein complex|,aerobic respiration|negative regulation of ATPase activity|mitochondrial respiratory chain complex I assembly|mitochondrial proton-transporting ATP synthase complex assembly|protein insertion into membrane|protein tetramerization|negative regulation of oxidoreductase activity|mitochondrial respiratory chain complex I biogenesis|,protein homodimerization activity|mitochondrial ribosome binding|,4,4,890000000,8.3%
F8WH69,0.454052388,0.0125,9.303133178,-0.278333333,0.117405024,-1.799540889,0.136,-0.123,0.442,-0.064,-0.244,-0.072,F8WH69,Ncf1,F8WH69_Ncf1,F8WH69,Ncf1,1,4,4,4,F8WH69|Q09014|S4R293,MOUSE,46185.6,10.3,2269,2269.1,36.79,36.79,,404,Neutrophil cytosol factor 1,cytoplasm|cytosol|extrinsic component of membrane|NADPH oxidase complex|,response to yeast|leukocyte mediated cytotoxicity|respiratory burst involved in defense response|protein targeting to membrane|leukotriene metabolic process|NADP catabolic process|inflammatory response|cellular defense response|cell proliferation|response to bacterium|superoxide anion generation|defense response to bacterium|respiratory burst|negative regulation of smooth muscle contraction|hydrogen peroxide biosynthetic process|defense response to Gram-positive bacterium|defense response to fungus|oxidation-reduction process|neutrophil mediated killing of gram-positive bacterium|neutrophil mediated killing of fungus|,"protein binding|superoxide-generating NADPH oxidase activity|SH3 domain binding|phosphatidylinositol binding|phosphatidylinositol-3,4-bisphosphate binding|",4,4,153000000,10.3%
Q5SX79,0.450471993,-0.060333333,9.384137842,0.48,0.11523548,1.812531006,-0.086,-0.063,-0.752,0.614,-0.196,0.121,Q5SX79,Shroom1,Q5SX79_Shroom1,Q5SX79,Shroom1,1,3,3,3,Q5SX79|Q5SX79-2|D3Z3D5,MOUSE,90463.2,5.5,2270,2270.1,36.77,36.77,,823,Protein Shroom1,cytoplasm|microtubule|myosin II complex|,cell morphogenesis|actin filament bundle assembly|,actin filament binding|,3,3,71600000,5.5%
Q9DB26,0.977544159,-0.007833333,0.329420297,-0.007666667,0.926953546,-0.09518442,0,-0.053,0.041,-0.021,-0.039,0.025,Q9DB26,Phyhd1,Q9DB26_Phyhd1,Q9DB26,Phyhd1,1,6,3,3,Q9DB26|A2AQZ7|D6RI61|D6RIQ3|A0A0R4J137,MOUSE,32744.7,13,2271,2271.1,36.75,36.75,,291,Phytanoyl-CoA dioxygenase domain-containing protein 1,,oxidation-reduction process|,metal ion binding|dioxygenase activity|,3,6,412000000,13.0%
Q4KMM3,0.54259951,0.020333333,7.417894637,0.126,0.18122184,1.492037514,-0.1,-0.077,0.049,0.073,0.094,0.083,Q4KMM3,Oxr1,Q4KMM3_Oxr1,Q4KMM3,Oxr1,1,5,4,4,Q4KMM3|Q4KMM3-4|E9Q0A7|Q4KMM3-2|Q4KMM3-3,MOUSE,96366.5,7.1,2272,2272.1,36.64,36.64,,866,Oxidation resistance protein 1,nucleolus|mitochondrion|,adult walking behavior|negative regulation of neuron apoptotic process|oxidation-reduction process|cellular response to hydroperoxide|,oxidoreductase activity|,4,5,61700000,7.1%
P49182,0.27048669,-0.007666667,13.63033814,0.494,0.043347713,2.492465074,-0.297,0.022,-0.489,0.598,0.119,0.001,P49182,Serpind1,P49182_Serpind1,P49182,Serpind1,1,8,4,4,P49182,MOUSE,54781,9.8,2273,2273.1,36.59,36.59,,478,Heparin cofactor 2,extracellular space|extracellular exosome|,blood coagulation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|heparin binding|,4,8,640000000,9.8%
Q9QZ06,0.666695042,0.011333333,5.063004801,0.111333333,0.311673243,1.094161433,0.038,-0.132,-0.039,0.204,0.036,-0.039,Q9QZ06,Tollip,Q9QZ06_Tollip,Q9QZ06,Tollip,1,9,3,3,Q9QZ06|F7AT44|A9JEI5|Q8C5G6,MOUSE,30572.5,13.8,2274,2274.1,36.57,36.57,,274,Toll-interacting protein,nuclear body|perinuclear region of cytoplasm|extracellular exosome|,autophagy|inflammatory response|signal transduction|phosphorylation|epithelial cell differentiation|positive regulation of protein sumoylation|protein localization to endosome|innate immune response|,"interleukin-1, Type I receptor binding|protein binding|kinase binding|ubiquitin conjugating enzyme binding|ubiquitin protein ligase binding|SUMO binding|Toll-like receptor binding|",3,9,303000000,13.8%
Q63918,0.91325,-0.036,1.39734093,0.053333333,0.724879649,0.367265645,0.077,0.104,-0.369,0.026,0.042,-0.096,Q63918,Cavin2,Q63918_Cavin2,Q63918,Cavin2,1,6,3,3,Q63918,MOUSE,46820.1,6.9,2275,2275.1,36.56,36.56,,418,Caveolae-associated protein 2,cytoplasm|cytosol|caveola|membrane raft|,positive regulation of transcription from RNA polymerase II promoter|,phosphatidylserine binding|protein kinase C binding|,3,6,1120000000,6.9%
Q6W4W7,0.606444877,0.002833333,6.254425354,0.143,0.236895856,1.299286301,-0.029,-0.207,0.03,0.22,-0.02,0.023,Q6W4W7,Diaph2,Q6W4W7_Diaph2,Q6W4W7,Diaph2,1,4,4,4,E9Q4U7|Q6W4W7|O70566,MOUSE,126181.8,4,2276,2276.1,36.54,36.54,,1102,DIA3,nucleolus|mitochondrion|Golgi apparatus|,female gamete generation|actin filament polymerization|,actin binding|Rho GTPase binding|,4,4,675000000,4.0%
Q9CXE7,0.000372555,-0.190333333,52.10532741,1.856666667,6.15839E-06,12.90608863,-0.965,-1.007,-1.384,0.573,0.795,0.846,Q9CXE7,Tmed5,Q9CXE7_Tmed5,Q9CXE7,Tmed5,1,9,4,4,Q9CXE7|E9PXY3|E9Q2J2|Q8C5H9|Q3V440|D3Z615,MOUSE,26285.5,13.1,2277,2277.1,36.53,36.53,,229,Transmembrane emp24 domain-containing protein 5,endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|cis-Golgi network|integral component of membrane|endoplasmic reticulum-Golgi intermediate compartment membrane|endoplasmic reticulum exit site|,protein transport|Golgi ribbon formation|,,4,9,805000000,13.1%
Q91XC9,0.695646919,-0.060666667,4.611725235,0.139333333,0.345801981,1.01490462,0.052,-0.066,-0.377,0.088,-0.137,0.076,Q91XC9,Pex16,Q91XC9_Pex16,Q91XC9,Pex16,1,7,4,4,Q91XC9,MOUSE,38733.5,19.6,2278,2278.1,36.48,36.48,,336,Peroxisomal membrane protein PE6,peroxisome|peroxisomal membrane|integral component of peroxisomal membrane|endoplasmic reticulum|endoplasmic reticulum membrane|membrane|,protein targeting to peroxisome|peroxisome organization|peroxisome membrane biogenesis|protein import into peroxisome matrix|protein to membrane docking|ER-dependent peroxisome organization|protein import into peroxisome membrane|protein localization to endoplasmic reticulum|,protein C-terminus binding|,4,7,2300000000,19.6%
Q9CZJ2,0.358757229,-0.035,11.26026348,0.234666667,0.074812411,2.1097188,0.002,-0.131,-0.328,0.129,-0.002,0.12,Q9CZJ2,Hspa12b,Q9CZJ2_Hspa12b,Q9CZJ2,Hspa12b,1,5,4,4,Q9CZJ2|H7BX84,MOUSE,76859.7,8.9,2279,2279.1,36.46,36.46,,685,Heat shock 70 kDa protein 12B,,,ATP binding|,4,5,200000000,8.9%
P62309,0.90651412,-0.011166667,1.508653696,0.045,0.706536545,0.393112345,-0.174,0.158,-0.085,-0.007,-0.062,0.103,P62309,Snrpg,P62309_Snrpg,P62309,Snrpg,1,11,4,4,P62309,MOUSE,8553,36.8,2280,2280.1,36.43,36.43,,76,Small nuclear ribonucleoprotein G,U7 snRNP|U1 snRNP|U4 snRNP|U12-type spliceosomal complex|small nucleolar ribonucleoprotein complex|cytosol|methylosome|SMN-Sm protein complex|catalytic step 2 spliceosome|,spliceosomal snRNP assembly|,poly(A) RNA binding|,4,11,1070000000,36.8%
Q9D1E8,0.378011992,0.028,10.8781952,-0.221333333,0.081692179,-2.048094732,0.126,-0.018,0.308,-0.054,-0.143,-0.051,Q9D1E8,Agpat5,Q9D1E8_Agpat5,Q9D1E8,Agpat5,1,4,4,4,Q9D1E8|F8WGD9,MOUSE,42429.8,13.4,2281,2281.1,36.43,36.43,,365,1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon,nuclear envelope|mitochondrion|endoplasmic reticulum membrane|integral component of membrane|,hematopoietic progenitor cell differentiation|acylglycerol metabolic process|CDP-diacylglycerol biosynthetic process|,1-acylglycerol-3-phosphate O-acyltransferase activity|,4,4,32600000,13.4%
I7HJQ9,0.938054337,0.027666667,0.871983632,0.026666667,0.818091041,0.239270162,0.063,0.023,-0.043,0.212,-0.136,0.047,I7HJQ9,NotFound,I7HJQ9_NotFound,I7HJQ9,Mtmr1,1,6,4,4,I7HJQ9|Q9Z2C4,MOUSE,76281,6.1,2282,2282.1,36.41,36.41,,671,Myotubularin-related protein 1,cytoplasm|plasma membrane|,peptidyl-tyrosine dephosphorylation|phosphatidylinositol dephosphorylation|,"phosphatidylinositol-3-phosphatase activity|protein tyrosine phosphatase activity|phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity|",4,6,440000000,6.1%
Q9D8S9,0.796085917,0.013833333,3.195168063,-0.069,0.47916291,-0.749300631,-0.078,0.1,0.123,-0.015,-0.058,0.011,Q9D8S9,Bola1,Q9D8S9_Bola1,Q9D8S9,Bola1,1,4,3,3,Q9D8S9,MOUSE,14550.3,29.1,2283,2283.1,36.39,36.39,,137,BolA-like protein 1,extracellular region|mitochondrion|,,,3,4,222000000,29.1%
Q14B01,0.25066574,0.007166667,14.18721555,0.328333333,0.038131022,2.582761561,0.033,-0.267,-0.237,0.348,0.05,0.116,Q14B01,Rnf113a2,Q14B01_Rnf113a2,Q14B01,Rnf113a2,1,5,3,3,Q14B01|Q8R3P8,MOUSE,38857.4,13.3,2284,2284.1,36.37,36.37,,337,Ring finger protein 113A2,,,zinc ion binding|,3,5,74100000,13.3%
Q9EPU4,0.568945216,-0.037166667,6.984478357,0.149666667,0.200240612,1.420996453,0.013,-0.106,-0.243,0.146,-0.052,0.019,Q9EPU4,Cpsf1,Q9EPU4_Cpsf1,Q9EPU4,Cpsf1,1,4,4,4,Q9EPU4,MOUSE,162127.4,4.3,2285,2285.1,36.24,36.24,,1441,Cleavage and polyadenylation specificity factor subunit 1,mRNA cleavage and polyadenylation specificity factor complex|,mRNA polyadenylation|mRNA cleavage|,mRNA binding|mRNA 3'-UTR binding|,4,4,36900000,4.3%
Q80YD1,0.840881127,0.035,2.528829595,0.112666667,0.55862072,0.615759229,0.012,0.243,-0.319,0.369,-0.06,-0.035,Q80YD1,Supv3l1,Q80YD1_Supv3l1,Q80YD1,Supv3l1,1,7,3,3,Q80YD1,MOUSE,87973.3,5.3,2286,2286.1,36.17,36.17,,779,"ATP-dependent RNA helicase SUPV3L1, mitochondrial",nucleus|mitochondrion|mitochondrial matrix|mitochondrial nucleoid|mitochondrial degradosome|,mitochondrial mRNA catabolic process|positive regulation of mitochondrial RNA catabolic process|mitochondrial RNA 3'-end processing|DNA recombination|RNA catabolic process|positive regulation of cell growth|DNA duplex unwinding|mitochondrial ncRNA surveillance|mitochondrial mRNA surveillance|negative regulation of apoptotic process|mitochondrion morphogenesis|chromatin maintenance|mitochondrial RNA surveillance|,DNA binding|DNA helicase activity|double-stranded RNA binding|ATP-dependent RNA helicase activity|ATP binding|3'-5' RNA helicase activity|protein homodimerization activity|poly(A) RNA binding|,3,7,282000000,5.3%
Q3UDW8,0.025956197,-0.048666667,27.09439973,0.739333333,0.001952361,4.947326318,-0.629,-0.429,-0.197,0.193,0.232,0.538,Q3UDW8,Hgsnat,Q3UDW8_Hgsnat,Q3UDW8,Hgsnat,1,4,3,3,Q3UDW8|Q3UDW8-2,MOUSE,73358.7,4.2,2287,2287.1,36.14,36.14,,656,Heparan-alpha-glucosaminide N-acetyltransferase,lysosomal membrane|integral component of membrane|,lysosomal transport|metabolic process|protein oligomerization|,"heparan-alpha-glucosaminide N-acetyltransferase activity|transferase activity, transferring acyl groups|",3,4,125000000,4.2%
P70375,0.016202227,-0.009333333,29.5663483,0.583333333,0.001105007,5.460510926,-0.279,-0.236,-0.388,0.275,0.138,0.434,P70375,F7,P70375_F7,P70375,F7,1,6,3,3,P70375,MOUSE,51701.8,10,2288,2288.1,36.12,36.12,,446,Coagulation factor VII,extracellular region|extracellular space|vesicle|,positive regulation of leukocyte chemotaxis|proteolysis|blood coagulation|circadian rhythm|positive regulation of platelet-derived growth factor receptor signaling pathway|positive regulation of blood coagulation|organ regeneration|response to vitamin K|response to estrogen|positive regulation of positive chemotaxis|positive regulation of protein kinase B signaling|response to growth hormone|,glycoprotein binding|serine-type endopeptidase activity|receptor binding|calcium ion binding|,3,6,40100000,10.0%
E9QN31,0.620776556,0.0145,5.939331426,-0.099666667,0.254722235,-1.245598557,0.114,0.056,0.023,-0.033,-0.064,-0.009,E9QN31,Nop2,E9QN31_Nop2,E9QN31,Nop2,1,6,4,4,E9QN31|Q922K7,MOUSE,87304.7,4.1,2289,2289.1,36.11,36.11,,794,Probable 28S rRNA (cytosine-C(5))-methyltransferase,nucleolus|,rRNA processing|methylation|,S-adenosylmethionine-dependent methyltransferase activity|poly(A) RNA binding|,4,6,1270000000,4.1%
P83882,0.823537665,5.78241E-19,2.710980396,-0.056666667,0.535675718,-0.652744829,-0.053,0.1,0.038,-0.026,0.022,-0.081,P83882,Rpl36a,P83882_Rpl36a,P83882,Rpl36a,1,13,4,4,P83882,MOUSE,12725.9,29.2,2290,2290.1,35.96,35.96,,106,60S ribosomal protein L36a,ribosome|,translation|,structural constituent of ribosome|,4,13,11400000000,29.2%
Q8K363,0.822165111,-0.013166667,2.741858492,-0.066333333,0.531880601,-0.659021047,0.064,0.113,-0.117,-0.142,-0.007,0.01,Q8K363,Ddx18,Q8K363_Ddx18,Q8K363,Ddx18,1,4,4,4,Q8K363,MOUSE,74521.8,6.8,2291,2291.1,35.96,35.96,,660,ATP-dependent RNA helicase DD8,nucleolus|membrane|,RNA secondary structure unwinding|,ATP-dependent RNA helicase activity|ATP binding|poly(A) RNA binding|,4,4,322000000,6.8%
Q9Z2N8,0.940251496,-0.015833333,0.852531809,0.023,0.821763446,0.234286925,0.007,0.09,-0.179,0.009,-0.006,-0.016,Q9Z2N8,Actl6a,Q9Z2N8_Actl6a,Q9Z2N8,Actl6a,1,4,3,2,Q9Z2N8,MOUSE,47960.6,9.5,2292,2292.1,35.93,20.7,,429,Actin-like protein 6A,nuclear chromatin|nucleus|plasma membrane|SWI/SNF complex|Ino80 complex|NuA4 histone acetyltransferase complex|protein complex|npBAF complex|BAF-type complex|,"neural retina development|DNA repair|DNA recombination|chromatin remodeling|transcription, DNA-templated|regulation of transcription, DNA-templated|nervous system development|spinal cord development|regulation of growth|ATP-dependent chromatin remodeling|histone H4 acetylation|histone H2A acetylation|regulation of mitochondrion degradation|positive regulation of protein targeting to mitochondrion|",chromatin binding|protein binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|,3,4,130000000,9.5%
Q61153,0.457736715,-0.089666667,9.199242251,0.43,0.120247422,1.782869606,-0.026,-0.027,-0.861,0.316,-0.001,0.061,Q61153,Dio1,Q61153_Dio1,Q61153,Dio1,1,6,3,3,A0A0R4J110|Q61153|A0A0R4J1U2|D3YVM7|D6RCH6,MOUSE,29953.6,17.8,2293,2293.1,35.89,35.89,,257,Type I iodothyronine deiodinase,endoplasmic reticulum membrane|integral component of membrane|,hormone biosynthetic process|oxidation-reduction process|,thyroxine 5'-deiodinase activity|selenium binding|,3,6,544000000,17.8%
Q3UEI1,0.746661233,0.007333333,3.868795318,0.068,0.410317905,0.878033954,-0.009,-0.057,-0.014,0.027,0.048,0.049,Q3UEI1,Pde4c,Q3UEI1_Pde4c,Q3UEI1,Pde4c,1,6,3,3,Q3UEI1|A0A286YD02|Q3UEI1-2,MOUSE,76488.4,4.9,2294,2294.1,35.89,35.89,,686,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",extracellular space|primary cilium|,cAMP catabolic process|signal transduction|negative regulation of insulin secretion|,"3',5'-cyclic-AMP phosphodiesterase activity|drug binding|metal ion binding|",3,6,639000000,4.9%
Q9D8N2,0.059243867,-0.06,22.76745302,0.756,0.005287553,4.078831147,-0.213,-0.247,-0.854,0.29,0.439,0.225,Q9D8N2,Fam45a,Q9D8N2_Fam45a,Q9D8N2,Fam45a,1,4,4,4,Q9D8N2|Q3TH34,MOUSE,40762.5,17.9,2295,2295.1,35.87,35.87,,357,Protein FAM45A,,,,4,4,86800000,17.9%
Q62086,0.543949462,0.003166667,7.396168275,0.292333333,0.182130707,1.490481019,-0.001,0.049,-0.477,0.472,-0.025,0.001,Q62086,Pon2,Q62086_Pon2,Q62086,Pon2,1,3,2,2,Q62086,MOUSE,39787.8,6.4,2296,2296.1,35.85,35.85,,354,Serum paraoxonase/arylesterase 2,extracellular region|nucleus|mitochondrion|lysosome|plasma membrane|,response to oxidative stress|aromatic compound catabolic process|,arylesterase activity|identical protein binding|metal ion binding|,2,3,850000000,6.4%
Q8BHC7,0.630749009,-0.044833333,5.793563142,0.297666667,0.263416931,1.222041024,-0.002,0.144,-0.723,0.362,0.002,-0.052,Q8BHC7,Rhbdd1,Q8BHC7_Rhbdd1,Q8BHC7,Rhbdd1,1,3,3,3,Q8BHC7,MOUSE,36175,9.8,2297,2297.1,35.81,35.81,,315,Rhomboid-related protein 4,mitochondrion|endoplasmic reticulum|endoplasmic reticulum membrane|integral component of endoplasmic reticulum membrane|endoplasmic reticulum quality control compartment|,"apoptotic process|positive regulation of protein processing|membrane protein intracellular domain proteolysis|membrane protein proteolysis|cellular response to unfolded protein|cellular response to UV|ERAD pathway|negative regulation of apoptotic process|post-translational protein modification|positive regulation of protein catabolic process|spermatid differentiation|positive regulation of secretion|membrane protein proteolysis involved in retrograde protein transport, ER to cytosol|regulation of male germ cell proliferation|",endopeptidase activity|serine-type endopeptidase activity|protein binding|peptidase activity|,3,3,107000000,9.8%
P28230,0.221078542,-0.015833333,15.14422311,0.397,0.030589874,2.739215622,-0.064,-0.122,-0.457,0.061,0.103,0.384,P28230,Gjb1,P28230_Gjb1,P28230,Gjb1,1,11,3,3,P28230,MOUSE,32573.5,12.3,2298,2298.1,35.79,35.79,,283,Gap junction beta-1 protein,cytoplasm|endoplasmic reticulum|plasma membrane|gap junction|connexon complex|integral component of membrane|,cell communication|purine ribonucleotide transport|protein oligomerization|transmembrane transport|,gap junction channel activity|protein homodimerization activity|,3,11,4100000000,12.3%
Q61543,0.000883505,-0.064333333,45.33724852,1.303333333,2.92601E-05,10.09104827,-0.856,-0.679,-0.613,0.403,0.565,0.794,Q61543,Glg1,Q61543_Glg1,Q61543,Glg1,1,2,2,2,Q61543,MOUSE,137611.2,2.3,2299,2299.1,35.72,35.72,,1175,Golgi apparatus protein 1,Golgi membrane|proteinaceous extracellular matrix|Golgi apparatus|plasma membrane|membrane|integral component of membrane|extracellular exosome|,negative regulation of protein processing|negative regulation of transforming growth factor beta receptor signaling pathway|regulation of chondrocyte differentiation|bone morphogenesis|,,2,2,80900000,2.3%
Q8C767,0.668733411,-0.034333333,5.02288786,0.142,0.31456559,1.088119021,-0.096,0.002,-0.222,0.212,0.092,-0.194,Q8C767,Ppp1r3b,Q8C767_Ppp1r3b,Q8C767,Ppp1r3b,1,6,4,4,Q8C767,MOUSE,32831.6,18.6,2300,2300.1,35.72,35.72,,284,Protein phosphatase 1 regulatory subunit 3B,protein phosphatase type 1 complex|glycogen granule|intracellular membrane-bounded organelle|,glycogen metabolic process|regulation of glycogen biosynthetic process|regulation of glycogen catabolic process|dephosphorylation|regulation of catalytic activity|,phosphoprotein phosphatase activity|protein phosphatase regulator activity|enzyme binding|,4,6,59700000,18.6%
Q80W47,0.809729234,0.004166667,2.962296778,0.059,0.505557226,0.703331532,0.005,-0.074,-0.007,-0.003,-0.005,0.109,Q80W47,Wipi2,Q80W47_Wipi2,Q80W47,Wipi2,1,5,3,3,Q80W47|D3YWK1,MOUSE,49275,8,2301,2301.1,35.67,35.67,,445,WD repeat domain phosphoinositide-interacting protein 2,pre-autophagosomal structure|nucleoplasm|cytoplasm|autophagosome|cytosol|extrinsic component of membrane|pre-autophagosomal structure membrane|protein complex|,autophagosome assembly|mitochondrion degradation|protein lipidation|cellular response to nitrogen starvation|protein localization to pre-autophagosomal structure|nucleophagy|,"phosphatidylinositol-3-phosphate binding|phosphatidylinositol-3,5-bisphosphate binding|",3,5,506000000,8.0%
Q6PAJ1,0.883573216,0.019333333,1.897655521,-0.038666667,0.646002871,-0.480747092,0.093,-0.01,0.033,-0.025,0.004,0.021,Q6PAJ1,Bcr,Q6PAJ1_Bcr,Q6PAJ1,Bcr,1,8,4,4,Q6PAJ1|Q5SSL4-2|Q5SSL4|Q5SSL4-4|E9PUE7|Q5SSL4-3,MOUSE,144039.1,3.8,2302,2302.1,35.66,35.66,,1270,Breakpoint cluster region protein,cytosol|plasma membrane|postsynaptic density|membrane|cell junction|protein complex|postsynaptic membrane|extracellular exosome|,negative regulation of cellular extravasation|brain development|actin cytoskeleton organization|negative regulation of cell migration|response to lipopolysaccharide|regulation of Rho protein signal transduction|intracellular signal transduction|inner ear morphogenesis|regulation of vascular permeability|negative regulation of neutrophil degranulation|positive regulation of GTPase activity|protein autophosphorylation|platelet-derived growth factor receptor signaling pathway|negative regulation of inflammatory response|positive regulation of phagocytosis|neuromuscular process controlling balance|regulation of cell cycle|negative regulation of blood vessel remodeling|,protein serine/threonine kinase activity|Rho guanyl-nucleotide exchange factor activity|GTPase activator activity|protein binding|ATP binding|enzyme binding|,4,8,206000000,3.8%
Q8VBZ0,0.919416995,0.016,1.218919607,0.038,0.755280095,0.324872979,0.077,0.029,-0.115,0.227,-0.018,-0.104,Q8VBZ0,NotFound,Q8VBZ0_NotFound,Q8VBZ0,Dhrsx,1,5,3,3,Q8VBZ0,MOUSE,36070.7,10.7,2303,2303.1,35.66,35.66,,335,Dehydrogenase/reductase SDR family member on chromosome X homolog,,oxidation-reduction process|,oxidoreductase activity|,3,5,112000000,10.7%
G5E8L3,0.242448099,0.022,14.42102517,-0.252666667,0.036132456,-2.613452313,0.043,0.109,0.293,-0.07,-0.123,-0.12,G5E8L3,Nat8f4,G5E8L3_Nat8f4,G5E8L3,Nat8f4,1,19,4,4,G5E8L3|Q9JIY7|E0CYM0,MOUSE,25670.5,11.9,2304,2304.1,35.62,35.62,,226,"MCG128680, isoform CRA_a",,metabolic process|,N-acetyltransferase activity|,6,19,33600000000,11.9%
Q3UBG2,0.586429925,0.056,6.589134905,0.237333333,0.219324178,1.356691509,-0.089,0.044,-0.143,0.093,-0.115,0.546,Q3UBG2,Pid1,Q3UBG2_Pid1,Q3UBG2,Pid1,1,2,2,2,Q3UBG2|Q3UBG2-2,MOUSE,25126.3,16.5,2305,2305.1,35.59,35.59,,217,"PTB-containing, cubilin and LRP1-interacting protein",nucleoplasm|cytoplasm|,negative regulation of protein phosphorylation|positive regulation of gene expression|cellular response to leptin stimulus|positive regulation of transcription from RNA polymerase II promoter|negative regulation of glucose import|negative regulation of insulin receptor signaling pathway|regulation of mitochondrial membrane potential|positive regulation of fat cell proliferation|mitochondrion morphogenesis|cellular response to cytokine stimulus|cellular response to interleukin-6|cellular response to tumor necrosis factor|cellular response to fatty acid|negative regulation of establishment of protein localization to plasma membrane|negative regulation of mitochondrial DNA replication|regulation of G1/S transition of mitotic cell cycle|regulation of reactive oxygen species metabolic process|positive regulation of reactive oxygen species metabolic process|negative regulation of ATP biosynthetic process|positive regulation of ATP biosynthetic process|negative regulation of glucose import in response to insulin stimulus|,protein binding|,2,2,16200000,16.5%
B1AZI6,0.532773459,0.014,7.544967777,-0.406666667,0.175996172,-1.514903899,-0.326,0.5,0.478,-0.568,-0.016,0.016,B1AZI6,Thoc2,B1AZI6_Thoc2,B1AZI6,Thoc2,1,6,4,4,B1AZI6|E9Q5E2,MOUSE,184653,3.1,2306,2306.1,35.49,35.49,,1594,THO complex subunit 2,transcription export complex|THO complex|THO complex part of transcription export complex|nucleus|nucleoplasm|nuclear speck|,cell morphogenesis|blastocyst development|mRNA processing|mRNA export from nucleus|RNA splicing|regulation of gene expression|regulation of mRNA export from nucleus|poly(A)+ mRNA export from nucleus|stem cell division|viral mRNA export from host cell nucleus|,mRNA binding|protein binding|,4,6,115000000,3.1%
Q99LB2,0.703057696,-0.011166667,4.488367877,0.100333333,0.355764994,0.991813721,-0.012,-0.011,-0.161,0.016,0.17,-0.069,Q99LB2,Dhrs4,Q99LB2_Dhrs4,Q99LB2,Dhrs4,1,7,3,3,Q99LB2,MOUSE,30112.3,21.5,2307,2307.1,35.43,35.43,,279,Dehydrogenase/reductase SDR family member 4,nucleus|mitochondrion|peroxisome|peroxisomal membrane|nuclear membrane|intracellular membrane-bounded organelle|extracellular exosome|,alcohol metabolic process|steroid metabolic process|cellular ketone metabolic process|retinal metabolic process|protein tetramerization|oxidation-reduction process|,"3-keto sterol reductase activity|retinal dehydrogenase activity|carbonyl reductase (NADPH) activity|receptor binding|oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor|alcohol dehydrogenase [NAD(P)+] activity|",3,7,958000000,21.5%
Q9Z2B9,0.287502731,0.012833333,13.20032083,-0.328333333,0.047859474,-2.423054155,0.123,0.075,0.333,0.057,-0.362,-0.149,Q9Z2B9,Rps6ka4,Q9Z2B9_Rps6ka4,Q9Z2B9,Rps6ka4,1,6,5,5,Q9Z2B9,MOUSE,86220.9,7.5,2308,2308.1,35.42,35.42,,773,Ribosomal protein S6 kinase alpha-4,nucleus|nucleoplasm|cytoplasm|,"regulation of transcription, DNA-templated|protein phosphorylation|inflammatory response|positive regulation of histone phosphorylation|positive regulation of histone acetylation|intracellular signal transduction|histone H3-S10 phosphorylation|histone H3-S28 phosphorylation|positive regulation of transcription from RNA polymerase II promoter|interleukin-1-mediated signaling pathway|",magnesium ion binding|protein serine/threonine kinase activity|protein binding|ATP binding|histone kinase activity (H3-S10 specific)|mitogen-activated protein kinase p38 binding|,5,6,7660000000,7.5%
P83887,0.873222165,-0.001666667,2.057844696,-0.04,0.622609195,-0.515754905,0.03,0.006,0.019,-0.048,0.008,-0.025,P83887,Tubg1,P83887_Tubg1,P83887,Tubg1,1,10,4,4,P83887|Q8VCK3,MOUSE,51442.3,13.5,2309,2309.1,35.36,35.36,,451,Tubulin gamma-1 chain,pericentriolar material|condensed nuclear chromosome|spindle pole|gamma-tubulin complex|cytoplasm|centrosome|centriole|microtubule organizing center|polar microtubule|spindle microtubule|cytoplasmic microtubule|cilium|cell leading edge|nonmotile primary cilium|ciliary basal body|apical part of cell|recycling endosome|,meiotic spindle organization|microtubule nucleation|mitotic spindle organization|regulation of mitotic nuclear division|metabolic process|cytoplasmic microtubule organization|,GTPase activity|structural constituent of cytoskeleton|protein binding|GTP binding|,4,10,1290000000,13.5%
Q8K019,0.295178337,0.030666667,12.93724346,0.366,0.050848208,2.380708105,-0.156,-0.063,-0.238,-0.047,0.17,0.518,Q8K019,Bclaf1,Q8K019_Bclaf1,Q8K019,Bclaf1,1,5,4,4,Q8K019|Q8K019-2|F8WI22|A0A087WQA0|Q8K019-3,MOUSE,106114.4,4.1,2310,2310.1,35.31,35.31,,919,Bcl-2-associated transcription factor 1,nucleus|nucleoplasm|nucleolus|cytoplasm|,"transcription, DNA-templated|apoptotic process|positive regulation of apoptotic process|regulation of DNA-templated transcription in response to stress|negative regulation of transcription, DNA-templated|positive regulation of DNA-templated transcription, initiation|positive regulation of response to DNA damage stimulus|positive regulation of intrinsic apoptotic signaling pathway|",DNA binding|protein binding|poly(A) RNA binding|,4,5,90700000,4.1%
Q3UMC0,0.991556352,0.052666667,0.159249017,0.007333333,0.963995704,0.04687471,0.228,-0.067,-0.014,0.358,-0.104,-0.085,Q3UMC0,Spata5,Q3UMC0_Spata5,Q3UMC0,Spata5,1,6,4,4,Q3UMC0|A0A0A0MQ80|A0A0G2JFY0,MOUSE,97938.7,7.2,2311,2311.1,35.3,35.3,,893,Spermatogenesis-associated protein 5,cytoplasm|mitochondrion|,multicellular organismal development|spermatogenesis|cell differentiation|,ATP binding|,4,6,536000000,7.2%
Q61553,0.869880514,0.0415,2.104091736,-0.063,0.616014346,-0.526041866,-0.079,0.03,0.268,0.04,-0.108,0.098,Q61553,Fscn1,Q61553_Fscn1,Q61553,Fscn1,1,6,3,3,Q61553|A0A0G2JDU7,MOUSE,55248.7,7.3,2312,2312.1,35.23,35.23,,493,Fascin,stress fiber|cytoplasm|cytosol|actin cytoskeleton|cell junction|filopodium|myelin sheath|extracellular exosome|invadopodium|,cell migration|actin cytoskeleton organization|cell motility|actin filament bundle assembly|,"actin binding|protein binding|drug binding|protein binding, bridging|poly(A) RNA binding|actin filament binding|",3,6,434000000,7.3%
A0A0R4J066,0.722439826,0.039333333,4.201680614,-0.083333333,0.380042301,-0.939649693,0.181,0.083,-0.021,-0.007,0.003,-0.003,A0A0R4J066,Coq10b,A0A0R4J066_Coq10b,A0A0R4J066,Coq10b,1,5,4,3,A0A0R4J066|Q3THF9|G5E8J7|Q3THF9-2,MOUSE,28022.1,15.2,2313,2313.1,35.21,21.82,,242,"Coenzyme Q-binding protein COQ10 homolog B, mitochondrial",,,,4,5,311000000,15.2%
E9Q3H6,0.950317114,-0.022166667,0.764647345,0.023666667,0.838562169,0.211849924,0.009,0.111,-0.222,-0.009,0.055,-0.077,E9Q3H6,Coq10a,E9Q3H6_Coq10a,E9Q3H6,Coq10a,1,6,3,2,E9Q3H6|A0A1W2P7J1|A0A1W2P7G5,MOUSE,29440.5,11.1,2313,2313.2,34.13,20.74,,259,Coenzyme Q10A,,,,2,6,3500000000,7.3%
Q3UPH1,0.842315612,0.025,2.484009998,-0.065333333,0.564415589,-0.606187192,-0.129,0.161,0.141,-0.017,-0.056,0.05,Q3UPH1,Prrc1,Q3UPH1_Prrc1,Q3UPH1,Prrc1,1,12,2,2,Q3UPH1,MOUSE,46353.9,6.5,2314,2314.1,35.17,35.17,,443,Protein PRRC1,Golgi apparatus|,,,2,12,648000000,6.5%
Q5QGU6,0.622281343,-0.077666667,5.919603418,0.333333333,0.255881954,1.243591382,-0.152,0.267,-0.848,0.02,0.21,0.037,Q5QGU6,Rtp3,Q5QGU6_Rtp3,Q5QGU6,Rtp3,1,3,3,3,Q5QGU6,MOUSE,53702.6,9.4,2315,2315.1,35.15,35.15,,474,Receptor-transporting protein 3,integral component of membrane|,,,3,3,86600000,9.4%
Q9JJK2,0.733766663,-0.038166667,4.038623408,-0.092333333,0.394582354,-0.909622614,-0.069,0.031,0.062,-0.234,-0.041,0.022,Q9JJK2,Lancl2,Q9JJK2_Lancl2,Q9JJK2,Lancl2,1,6,4,4,Q9JJK2,MOUSE,51518,15.1,2316,2316.1,35.14,35.14,,450,LanC-like protein 2,nucleus|cytoplasm|cytosol|plasma membrane|cortical actin cytoskeleton|,"metabolic process|positive regulation of abscisic acid-activated signaling pathway|negative regulation of transcription, DNA-templated|",catalytic activity|phosphatidylinositol-5-phosphate binding|phosphatidylinositol-3-phosphate binding|phosphatidylinositol-4-phosphate binding|,4,6,328000000,15.1%
Q91XI1,0.893374005,-0.0005,1.707324492,-0.054333333,0.674943704,-0.438547672,-0.181,0.098,0.163,-0.084,-0.109,0.11,Q91XI1,Dus3l,Q91XI1_Dus3l,Q91XI1,Dus3l,1,3,2,2,A0A0R4IZY9|Q91XI1|Q91XI1-2,MOUSE,72446.5,6.4,2317,2317.1,35.06,35.06,,637,tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like,,tRNA dihydrouridine synthesis|oxidation-reduction process|,tRNA dihydrouridine synthase activity|poly(A) RNA binding|metal ion binding|flavin adenine dinucleotide binding|,2,3,252000000,6.4%
Q3TDD9,0.726796323,0.144833333,4.155779121,0.289,0.384080349,0.931978865,0.057,-0.219,0.163,0.068,-0.211,1.011,Q3TDD9,Ppp1r21,Q3TDD9_Ppp1r21,Q3TDD9,Ppp1r21,1,5,5,5,Q3TDD9|Q3TDD9-2,MOUSE,88849.5,6.2,2318,2318.1,35.06,35.06,,780,Protein phosphatase 1 regulatory subunit 21,membrane|,,phosphatase binding|,5,5,1490000000,6.2%
P62315,0.954887447,-0.034166667,0.665462731,0.029,0.857933699,0.186108398,-0.328,0.085,0.097,-0.162,-0.084,0.187,P62315,Snrpd1,P62315_Snrpd1,P62315,Snrpd1,1,7,2,2,P62315,MOUSE,13281.3,27.7,2319,2319.1,34.96,34.96,,119,Small nuclear ribonucleoprotein Sm D1,nucleus|U1 snRNP|U4 snRNP|U12-type spliceosomal complex|cytoplasm|cytosol|methylosome|pICln-Sm protein complex|SMN-Sm protein complex|catalytic step 2 spliceosome|,spliceosomal snRNP assembly|positive regulation of defense response to virus by host|activation of mitophagy in response to mitochondrial depolarization|,poly(A) RNA binding|,2,7,788000000,27.7%
G3X9M0,0.450561932,0.1455,9.371773954,-0.360333333,0.11556401,-1.810548769,-0.125,0.675,0.427,-0.01,-0.054,-0.04,G3X9M0,Dap3,G3X9M0_Dap3,G3X9M0,Dap3,1,4,3,3,G3X9M0|Q9ER88|A0A0R4J1B9|Q9ER88-2,MOUSE,45685.6,10.8,2320,2320.1,34.91,34.91,,396,"28S ribosomal protein S29, mitochondrial",nucleus|nucleoplasm|nucleolus|mitochondrion|mitochondrial matrix|mitochondrial ribosome|small ribosomal subunit|,apoptotic mitochondrial changes|,poly(A) RNA binding|,3,4,319000000,10.8%
O88697,0.195983236,0.001333333,16.07350556,-0.444666667,0.024697298,-2.892967475,0.081,0.03,0.56,-0.287,-0.198,-0.178,O88697,Stk16,O88697_Stk16,O88697,Stk16,1,3,2,2,O88697|Q05DP1,MOUSE,34780.3,8.5,2321,2321.1,34.9,34.9,,305,Serine/threonine-protein kinase 16,cytoplasm|Golgi-associated vesicle|membrane|perinuclear region of cytoplasm|,transcription from RNA polymerase II promoter|protein phosphorylation|peptidyl-tyrosine phosphorylation|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|cellular response to transforming growth factor beta stimulus|,RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|protein serine/threonine kinase activity|non-membrane spanning protein tyrosine kinase activity|ATP binding|,2,3,137000000,8.5%
Q8BTY8,0.698956516,-0.023166667,4.564579644,-0.090333333,0.349576344,-1.005543028,0.073,0.016,-0.023,0.015,-0.049,-0.171,Q8BTY8,Scfd2,Q8BTY8_Scfd2,Q8BTY8,Scfd2,1,4,4,4,Q8BTY8|Q8BTY8-2|Q8BTY8-3|Q8BTY8-4,MOUSE,75434,8.9,2322,2322.1,34.83,34.83,,684,Sec1 family domain-containing protein 2,cell|,vesicle docking involved in exocytosis|protein transport|,,4,4,52400000,8.9%
P46938,0.015548689,-0.039333333,29.77545468,0.507333333,0.001053063,5.49937426,-0.31,-0.324,-0.245,0.31,0.097,0.236,P46938,Yap1,P46938_Yap1,P46938,Yap1,1,4,3,3,P46938|P46938-2|G3UYV4|G3UY62|G3UYA6,MOUSE,52439.5,7.5,2323,2323.1,34.76,34.76,,488,Transcriptional coactivator YAP1,nucleus|nucleoplasm|transcription factor complex|cytoplasm|cytosol|membrane|cell junction|,"cell morphogenesis|vasculogenesis|embryonic heart tube morphogenesis|transcription, DNA-templated|cellular response to DNA damage stimulus|DNA damage induced protein phosphorylation|cell proliferation|positive regulation of cell proliferation|regulation of keratinocyte proliferation|keratinocyte differentiation|negative regulation of epithelial cell differentiation|notochord development|somatic stem cell maintenance|hippo signaling|regulation of cell proliferation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of organ growth|paraxial mesoderm development|lateral mesoderm development|regulation of neurogenesis|contact inhibition|bud elongation involved in lung branching|lung epithelial cell differentiation|regulation of canonical Wnt signaling pathway|cellular response to retinoic acid|cellular response to gamma radiation|regulation of stem cell proliferation|regulation of metanephric nephron tubule epithelial cell differentiation|positive regulation of canonical Wnt signaling pathway|positive regulation of stem cell maintenance|negative regulation of nucleic acid-templated transcription|negative regulation of stem cell differentiation|negative regulation of extrinsic apoptotic signaling pathway|",RNA polymerase II core promoter sequence-specific DNA binding|RNA polymerase II transcription factor binding transcription factor activity|chromatin binding|transcription coactivator activity|transcription corepressor activity|protein binding|protein C-terminus binding|transcription regulatory region DNA binding|proline-rich region binding|,3,4,46100000,7.5%
Q8C0M0-3,0.748326411,-0.000666667,3.849495342,0.073333333,0.412145408,0.874424201,-0.043,0.005,-0.074,0.113,-0.007,0.002,Q8C0M0,Wdr59,Q8C0M0-3_Wdr59,Q8C0M0-3,Wdr59,1,4,4,4,Q8C0M0-3|Q8C0M0|A0A1D5RLJ8|Q8C0M0-2,MOUSE,113723.2,4.4,2324,2324.1,34.74,34.74,,992,Isoform 3 of GATOR complex protein WDR59,GATOR2 complex|,positive regulation of TOR signaling|cellular response to amino acid starvation|,,4,4,2.22E+11,4.4%
Q9DBR0,0.962486803,0.021,0.51885665,0.016666667,0.887389601,0.147124386,0.008,-0.042,0.072,0.202,-0.155,0.041,Q9DBR0,Akap8,Q9DBR0_Akap8,Q9DBR0,Akap8,1,9,4,4,Q9DBR0,MOUSE,76863.1,8.8,2325,2325.1,34.59,34.59,,687,A-kinase anchor protein 8,nuclear chromatin|condensed chromosome|female pronucleus|nucleus|nucleoplasm|mitochondrion|Golgi apparatus|membrane|nuclear matrix|,mitotic chromosome condensation|,chromatin binding|double-stranded DNA binding|protein binding|zinc ion binding|protein kinase A regulatory subunit binding|poly(A) RNA binding|,4,9,166000000,8.8%
Q3TQB2-2,0.829138664,-0.040333333,2.65087803,-0.069333333,0.543140512,-0.64057795,0.088,0.077,-0.182,-0.002,-0.064,-0.159,Q3TQB2,Foxred1,Q3TQB2-2_Foxred1,Q3TQB2-2,Foxred1,1,5,3,3,Q3TQB2-2|Q3TQB2,MOUSE,55261.3,9.3,2326,2326.1,34.57,34.57,,487,Isoform 2 of FAD-dependent oxidoreductase domain-containing protein 1,mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex I|integral component of membrane|mitochondrial respiratory chain complex I|,mitochondrial respiratory chain complex I assembly|oxidation-reduction process|,oxidoreductase activity|,3,5,458000000,9.3%
P06728,0.000510252,-0.152,49.4640399,1.531333333,1.13135E-05,11.73154164,-0.998,-0.718,-1.037,0.582,0.471,0.788,P06728,Apoa4,P06728_Apoa4,P06728,Apoa4,1,9,4,4,P06728,MOUSE,45028.2,11.3,2327,2327.1,34.53,34.53,,395,Apolipoprotein A-IV,extracellular region|extracellular space|cytosol|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|cell surface|,innate immune response in mucosa|cholesterol biosynthetic process|lipid transport|response to lipid hydroperoxide|leukocyte cell-cell adhesion|cholesterol metabolic process|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|removal of superoxide radicals|triglyceride catabolic process|regulation of intestinal cholesterol absorption|neuron projection regeneration|regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|negative regulation of plasma lipoprotein particle oxidation|response to stilbenoid|lipoprotein metabolic process|cholesterol homeostasis|hydrogen peroxide catabolic process|reverse cholesterol transport|multicellular organismal lipid catabolic process|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|positive regulation of lipoprotein lipase activity|lipid homeostasis|protein-lipid complex assembly|triglyceride homeostasis|,copper ion binding|lipid binding|cholesterol binding|antioxidant activity|cholesterol transporter activity|phosphatidylcholine binding|protein homodimerization activity|phosphatidylcholine-sterol O-acyltransferase activator activity|,4,9,2620000000,11.3%
Q7TMQ7,0.87503645,0.016333333,2.029347613,-0.048,0.626708,-0.509571741,-0.067,0.023,0.165,0.015,-0.054,0.016,Q7TMQ7,Wdr91,Q7TMQ7_Wdr91,Q7TMQ7,Wdr91,1,4,3,3,Q7TMQ7|S4R1,MOUSE,84446.1,5.7,2329,2329.1,34.41,34.41,,748,WD repeat-containing protein 91,,,,3,4,619000000,5.7%
B1AR74,0.247096783,-0.004333333,14.30866603,0.247333333,0.03707946,2.595266992,-0.169,-0.125,-0.09,0.243,0,0.115,B1AR74,NotFound,B1AR74_NotFound,B1AR74,Bcas3,1,3,3,3,B1AR74|Q8CCN5|Q0VF62|Q8CCN5-2,MOUSE,104310.2,4.2,2330,2330.1,34.38,34.38,,943,Breast carcinoma-amplified sequence 3 homolog,nucleus|cytoplasm|transcriptionally active chromatin|cell periphery|,response to starvation|positive regulation of catalytic activity|positive regulation of transcription from RNA polymerase II promoter|cellular response to estrogen stimulus|,chromatin binding|transcription factor binding|acetyltransferase activator activity|histone acetyltransferase binding|nuclear hormone receptor binding|histone binding|beta-tubulin binding|,3,3,67800000,4.2%
Q8BIL5,0.646166675,0.034,5.458483223,0.124,0.284545471,1.163336223,-0.06,-0.034,0.01,0.274,-0.046,0.06,Q8BIL5,Hook1,Q8BIL5_Hook1,Q8BIL5,Hook1,1,7,3,3,Q8BIL5|Q8BIL5-2,MOUSE,85007.8,6.3,2331,2331.1,34.23,34.23,,728,Protein Hook homolog 1,microtubule|microtubule cytoskeleton|FHF complex|HOPS complex|,endosome organization|lysosome organization|multicellular organismal development|spermatid development|endosome to lysosome transport|protein transport|early endosome to late endosome transport|,actin binding|protein binding|microtubule binding|identical protein binding|,3,7,37100000,6.3%
P58059,0.609202553,-0.022833333,6.203060941,-0.280333333,0.23971428,-1.291743196,-0.228,0.428,0.152,-0.512,0.086,-0.063,P58059,Mrps21,P58059_Mrps21,P58059,Mrps21,1,3,2,2,P58059,MOUSE,10732.3,31,2332,2332.1,34.21,34.21,,87,"28S ribosomal protein S21, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial small ribosomal subunit|ribosomal subunit|,mitochondrial translation|,structural constituent of ribosome|poly(A) RNA binding|,2,3,56100000,31.0%
Q3TPX4,0.989515943,0.014833333,0.202134943,-0.007,0.954523238,-0.059217774,-0.003,-0.023,0.081,0.229,-0.146,-0.049,Q3TPX4,Exoc5,Q3TPX4_Exoc5,Q3TPX4,Exoc5,1,6,3,3,Q3TPX4|E9PZ92,MOUSE,82763.3,3.9,2333,2333.1,34.17,34.17,,708,Exocyst complex component 5,cytosol|,exocytosis|protein transport|vesicle docking|,Ral GTPase binding|protein N-terminus binding|,3,6,1560000000,3.9%
P70451,0.784945336,-0.004833333,3.347571145,0.059666667,0.462639687,0.778950912,-0.048,-0.035,-0.021,0.026,0.021,0.028,P70451,Fer,P70451_Fer,P70451,Fer,1,3,3,3,P70451|P70451-5|P70451-2|P70451-4|P70451-3,MOUSE,95261.7,5.7,2334,2334.1,34.16,34.16,,823,Tyrosine-protein kinase Fer,nucleus|cytoplasm|cell cortex|extrinsic component of cytoplasmic side of plasma membrane|nuclear chromatin|actin cytoskeleton|microtubule cytoskeleton|lamellipodium|cell junction|,microtubule cytoskeleton organization|mitotic cell cycle|regulation of protein phosphorylation|protein phosphorylation|chemotaxis|cell adhesion|signal transduction|cell proliferation|positive regulation of cell proliferation|regulation of lamellipodium assembly|regulation of fibroblast migration|peptidyl-tyrosine phosphorylation|cytokine-mediated signaling pathway|cell differentiation|positive regulation of cell migration|positive regulation of actin filament polymerization|actin cytoskeleton reorganization|response to lipopolysaccharide|cellular response to insulin stimulus|negative regulation of mast cell activation involved in immune response|substrate adhesion-dependent cell spreading|cellular response to reactive oxygen species|extracellular matrix-cell signaling|cellular response to macrophage colony-stimulating factor stimulus|response to platelet-derived growth factor|insulin receptor signaling pathway via phosphatidylinositol 3-kinase|peptidyl-tyrosine autophosphorylation|Fc-epsilon receptor signaling pathway|Kit signaling pathway|regulation of epidermal growth factor receptor signaling pathway|regulation of cell proliferation|tyrosine phosphorylation of Stat3 protein|regulation of mast cell degranulation|cell-cell adhesion mediated by cadherin|innate immune response|protein autophosphorylation|platelet-derived growth factor receptor signaling pathway|diapedesis|positive regulation of NF-kappaB transcription factor activity|interleukin-6-mediated signaling pathway|,actin binding|protein kinase activity|non-membrane spanning protein tyrosine kinase activity|receptor binding|epidermal growth factor receptor binding|protein binding|ATP binding|protein phosphatase 1 binding|lipid binding|Rab GTPase binding|protein kinase binding|gamma-catenin binding|cadherin binding|,3,3,226000000,5.7%
Q99MB2,0.695431326,-0.009333333,4.624020245,0.172,0.344824389,1.017114318,0.175,-0.033,-0.428,0.234,-0.036,0.032,Q99MB2,Mtfr1,Q99MB2_Mtfr1,Q99MB2,Mtfr1,1,3,2,2,Q99MB2,MOUSE,36189.7,6.7,2335,2335.1,34.12,34.12,,328,Mitochondrial fission regulator 1,cytoplasm|mitochondrion|plasma membrane|,mitochondrial fission|mitochondrion organization|aerobic respiration|,,2,3,63600000,6.7%
Q5KU39,0.422611235,-0.0105,9.92051467,-0.186333333,0.101847068,-1.894934195,0.089,0.029,0.13,0.033,-0.224,-0.12,Q5KU39,Vps41,Q5KU39_Vps41,Q5KU39,Vps41,1,4,4,4,Q5KU39,MOUSE,99798.4,5.7,2336,2336.1,34.1,34.1,,853,Vacuolar protein sorting-associated protein 41 homolog,lysosomal membrane|early endosome|late endosome|Golgi-associated vesicle|cytosol|microtubule cytoskeleton|membrane|HOPS complex|CORVET complex|,"protein targeting to vacuole|regulation of SNARE complex assembly|vacuole fusion, non-autophagic|Golgi vesicle transport|",protein binding|microtubule binding|zinc ion binding|GTPase binding|,4,4,94500000,5.7%
D3Z286,0.916006223,0.0095,1.291698565,-0.044333333,0.742728593,-0.342308714,-0.112,-0.051,0.258,0.05,-0.156,0.068,D3Z286,Tmppe,D3Z286_Tmppe,D3Z286,Tmppe,1,4,3,3,D3Z286,MOUSE,49685.9,10.2,2337,2337.1,33.96,33.96,,447,Transmembrane protein with metallophosphoesterase domain,,metabolic process|,hydrolase activity|,3,4,594000000,10.2%
A2RSY6,0.788762682,0.011833333,3.281240875,-0.063666667,0.469759869,-0.766086793,0.018,0.12,-0.007,0.007,-0.052,-0.015,A2RSY6,Trmt1l,A2RSY6_Trmt1l,A2RSY6,Trmt1l,1,6,4,4,A0A0R4J0U8|A2RSY6|A2RSY6-2|A2RSY6-3|A2RSY6-4,MOUSE,82057.9,9.7,2338,2338.1,33.9,33.9,,728,TRMT1-like protein,nucleus|mitochondrion|,adult locomotory behavior|adult behavior|tRNA N2-guanine methylation|,tRNA binding|poly(A) RNA binding|metal ion binding|tRNA (guanine-N2-)-methyltransferase activity|,4,6,82100000,9.7%
Q61292,0.918513912,0.019833333,1.266317027,0.068333333,0.747082042,0.336258638,0.04,0.361,-0.444,-0.019,-0.001,0.182,Q61292,Lamb2,Q61292_Lamb2,Q61292,Lamb2,1,5,4,4,Q61292,MOUSE,203707.4,2.2,2339,2339.1,33.84,33.84,,1799,Laminin subunit beta-2,extracellular region|basement membrane|basal lamina|laminin-3 complex|laminin complex|synapse|extracellular exosome|extracellular matrix|,cell morphogenesis involved in differentiation|cell adhesion|axon guidance|neuromuscular junction development|visual perception|astrocyte development|Schwann cell development|neuron projection development|axon extension involved in regeneration|synapse organization|retina development in camera-type eye|metanephric glomerular visceral epithelial cell development|metanephric glomerular basement membrane development|,integrin binding|,4,5,316000000,2.2%
Q3U9N4,0.370379022,-0.0015,11.02355849,0.415,0.079003103,2.074479342,-0.058,-0.541,-0.028,0.498,-0.093,0.213,Q3U9N4,Grn,Q3U9N4_Grn,Q3U9N4,Grn,1,4,4,4,Q3U9N4|P28798,MOUSE,70037.8,8.8,2340,2340.1,33.82,33.82,,602,Granulins,extracellular space|mitochondrion|cell surface|intracellular membrane-bounded organelle|extracellular exosome|,blastocyst hatching|embryo implantation|response to estradiol|chondrocyte proliferation|synaptic vesicle endocytosis|positive regulation of epithelial cell proliferation|male mating behavior|positive regulation of dendritic spine development|neural precursor cell proliferation|,poly(A) RNA binding|,4,4,63300000,8.8%
Q9ERL9,0.991556352,-0.050333333,0.174644514,0.01,0.960584442,0.051320193,0.098,0.245,-0.509,-0.039,-0.065,-0.032,Q9ERL9,Gucy1a1,Q9ERL9_Gucy1a1,Q9ERL9,Gucy1a3,1,2,2,2,Q9ERL9,MOUSE,78841.4,5.7,2341,2341.1,33.82,33.82,,691,Guanylate cyclase soluble subunit alpha-3,cytoplasm|protein complex|,cGMP biosynthetic process|nitric oxide mediated signal transduction|regulation of blood pressure|response to herbicide|response to organic cyclic compound|positive regulation of cGMP biosynthetic process|response to defense-related host nitric oxide production|relaxation of vascular smooth muscle|,guanylate cyclase activity|GTP binding|heme binding|protein heterodimerization activity|,2,2,306000000,5.7%
Q9CQX2,0.406418919,0.049333333,10.26387957,-0.201333333,0.094104858,-1.949882478,-0.004,0.281,0.173,0.004,-0.115,-0.043,Q9CQX2,Cyb5b,Q9CQX2_Cyb5b,Q9CQX2,Cyb5b,1,5,4,4,Q9CQX2,MOUSE,16374.8,27.3,2342,2342.1,33.81,33.81,,146,Cytochrome b5 type B,mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|membrane|integral component of membrane|,positive regulation of catalytic activity|oxidation-reduction process|,enzyme activator activity|heme binding|metal ion binding|,4,5,801000000,27.3%
P59326,0.101759135,0.074166667,19.97699753,-0.494333333,0.010053106,-3.564978301,0.041,0.518,0.405,-0.252,-0.148,-0.119,P59326,Ythdf1,P59326_Ythdf1,P59326,Ythdf1,1,5,3,2,A2AWN8|P59326|Q8BYK6-2,MOUSE,60991.6,4.2,2343,2343.1,33.8,19.14,,559,YTH domain-containing family protein 1,,positive regulation of translational initiation|,ribosome binding|poly(A) RNA binding|N6-methyladenosine-containing RNA binding|,3,5,164000000,4.2%
Q8BYK6-3,0.273334376,-0.021833333,13.53945755,0.560333333,0.044264366,2.477774219,0,-0.101,-0.805,0.409,0.056,0.31,Q8BYK6,Ythdf3,Q8BYK6-3_Ythdf3,Q8BYK6-3,Ythdf3,1,2,3,2,Q8BYK6-3|Q8BYK6,MOUSE,65563,6.3,2343,2343.2,27.51,12.85,,585,Isoform 3 of YTH domain-containing family protein 3,,,poly(A) RNA binding|N6-methyladenosine-containing RNA binding|,2,2,28400000,4.8%
Q5PRF0,0.995757571,0.004,0.058023444,-0.002666667,0.986728462,-0.017272188,-0.173,0.315,-0.126,-0.089,-0.057,0.154,Q5PRF0,Heatr5a,Q5PRF0_Heatr5a,Q5PRF0,Heatr5a,1,6,4,4,Q5PRF0|Q5PRF0-2,MOUSE,223312.5,2.5,2344,2344.1,33.79,33.79,,2038,HEAT repeat-containing protein 5A,,,,4,6,388000000,2.5%
Q6GQT1,0.251008093,0.211666667,14.16529198,1.119333333,0.038323997,2.579197158,-0.13,-0.254,-0.66,1.817,0.15,0.347,Q6GQT1,A2m,Q6GQT1_A2m,Q6GQT1,A2m,1,5,5,5,Q6GQT1,MOUSE,165776,2.7,2345,2345.1,33.74,33.74,,1474,Alpha-2-macroglobulin-P,extracellular exosome|blood microparticle|,"negative regulation of complement activation, lectin pathway|female pregnancy|negative regulation of endopeptidase activity|stem cell differentiation|",protease binding|serine-type endopeptidase inhibitor activity|receptor binding|protein binding|growth factor binding|enzyme binding|interleukin-8 binding|interleukin-1 binding|peptidase inhibitor activity|tumor necrosis factor binding|calcium-dependent protein binding|,5,5,3720000000,2.7%
O09131,0.785249508,0.0725,3.340709572,0.174333333,0.463371206,0.778167078,-0.086,0.285,-0.243,-0.018,0.6,-0.103,O09131,Gsto1,O09131_Gsto1,O09131,Gsto1,1,6,3,3,O09131,MOUSE,27725.3,12.9,2346,2346.1,33.7,33.7,,240,Glutathione S-transferase omega-1,basement membrane|cytoplasm|cytosol|axon|nuclear membrane|myelin sheath|cell body|extracellular exosome|,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum|L-ascorbic acid metabolic process|L-ascorbic acid biosynthetic process|xenobiotic catabolic process|oxidation-reduction process|negative regulation of ryanodine-sensitive calcium-release channel activity|positive regulation of ryanodine-sensitive calcium-release channel activity|cellular response to arsenic-containing substance|,glutathione transferase activity|oxidoreductase activity|glutathione dehydrogenase (ascorbate) activity|methylarsonate reductase activity|,3,6,305000000,12.9%
P01887,0.002528295,-0.0695,39.15991998,1.037,0.000121341,8.014285051,-0.722,-0.698,-0.344,0.479,0.338,0.53,P01887,B2m,P01887_B2m,P01887,B2m,1,7,4,4,P01887,MOUSE,13892.8,22.6,2347,2347.1,33.68,33.68,,119,Beta-2-microglobulin,extracellular space|cytoplasm|Golgi apparatus|plasma membrane|focal adhesion|external side of plasma membrane|membrane|phagocytic vesicle membrane|MHC class I protein complex|extracellular exosome|,"positive regulation of T cell mediated cytotoxicity|response to molecule of bacterial origin|antigen processing and presentation of peptide antigen via MHC class I|antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent|cellular defense response|T cell differentiation in thymus|protein refolding|response to drug|response to cadmium ion|iron ion homeostasis|negative regulation of receptor binding|",glycoprotein binding|protein binding|identical protein binding|,4,7,6160000000,22.6%
E9PUQ7,0.294965152,-0.025666667,12.95819199,-0.273333333,0.050603529,-2.382119275,0.103,0.061,0.169,0.027,-0.341,-0.173,E9PUQ7,Trmt2a,E9PUQ7_Trmt2a,E9PUQ7,Trmt2a,1,8,4,4,E9PUQ7|Q3UYU2|Q8BNV1,MOUSE,68717.3,7.9,2348,2348.1,33.65,33.65,,613,tRNA (uracil-5-)-methyltransferase homolog A,,RNA methylation|RNA processing|,nucleotide binding|RNA methyltransferase activity|poly(A) RNA binding|,4,8,856000000,7.9%
Q8BPG6,0.01131451,-0.040333333,31.55757388,0.936666667,0.000698623,5.956109268,-0.763,-0.306,-0.457,0.646,0.252,0.386,Q8BPG6,Sumf2,Q8BPG6_Sumf2,Q8BPG6,Sumf2,1,3,2,2,Q8BPG6|A0A0J9YUF6,MOUSE,34907.7,10.7,2349,2349.1,33.63,33.63,,308,Sulfatase-modifying factor 2,endoplasmic reticulum|endoplasmic reticulum lumen|,,protein binding|protein homodimerization activity|metal ion binding|,2,3,60600000,10.7%
Q60714,0.904214516,-0.056833333,1.555341849,-0.049666667,0.698981715,-0.403946759,0.106,-0.034,-0.168,0.044,-0.271,-0.018,Q60714,Slc27a1,Q60714_Slc27a1,Q60714,Slc27a1,1,3,3,3,Q60714,MOUSE,72244.7,6.9,2350,2350.1,33.62,33.62,,646,Long-chain fatty acid transport protein 1,mitochondrial inner membrane|endoplasmic reticulum|plasma membrane|caveola|membrane|integral component of membrane|cytoplasmic vesicle|,medium-chain fatty acid transport|long-chain fatty acid metabolic process|phosphatidylethanolamine biosynthetic process|phosphatidic acid biosynthetic process|phosphatidylglycerol biosynthetic process|phosphatidylcholine biosynthetic process|phosphatidylserine biosynthetic process|phosphatidylinositol biosynthetic process|response to cold|fatty acid transport|long-chain fatty acid transport|positive regulation of heat generation|cardiolipin biosynthetic process|response to insulin|adiponectin-activated signaling pathway|negative regulation of phospholipid biosynthetic process|positive regulation of protein serine/threonine kinase activity|,nucleotide binding|long-chain fatty acid-CoA ligase activity|fatty acid transporter activity|very long-chain fatty acid-CoA ligase activity|protein homodimerization activity|,3,3,114000000,6.9%
Q9DBU3,0.344160393,0.005333333,11.57722437,0.168,0.069546866,2.158148972,-0.067,-0.083,-0.086,0.126,0.064,0.078,Q9DBU3,Riok3,Q9DBU3_Riok3,Q9DBU3,Riok3,1,3,3,3,Q9DBU3,MOUSE,59159.9,10.2,2351,2351.1,33.62,33.62,,519,Serine/threonine-protein kinase RIO3,,protein phosphorylation|,protein serine/threonine kinase activity|ATP binding|,3,3,23800000,10.2%
J3QNK8,0.672056103,-0.003666667,4.979755618,-0.109333333,0.317705284,-1.079499931,-0.013,0.193,-0.027,-0.053,-0.145,0.023,J3QNK8,NotFound,J3QNK8_NotFound,J3QNK8,Abi1,1,6,3,3,J3QNK8|Q8CBW3|B7ZCU0|Q8CBW3-3|Q8CBW3-4|B7ZCU3|B7ZCU4|Q8CBW3-2|B7ZCU5|B7ZCU2|Q8CBW3-5,MOUSE,52458.7,9.7,2352,2352.1,33.6,33.6,,481,Abl interactor 1,intracellular|lamellipodium|filopodium|SCAR complex|cell leading edge|extracellular exosome|,somitogenesis|cellular process|peptidyl-tyrosine phosphorylation|megakaryocyte development|positive regulation of protein tyrosine kinase activity|lamellipodium morphogenesis|,protein binding|protein tyrosine kinase activator activity|protein complex binding|,3,6,544000000,9.7%
Q6P9R4,0.121985139,-0.008833333,18.83440577,-0.395666667,0.013078545,-3.360714628,0.026,0.381,0.16,-0.163,-0.311,-0.146,Q6P9R4,Arhgef18,Q6P9R4_Arhgef18,Q6P9R4,Arhgef18,1,5,3,3,Q6P9R4|Q6P9R4-2|Q6P9R4-3,MOUSE,114961.5,6.2,2353,2353.1,33.59,33.59,,1021,Rho guanine nucleotide exchange factor 18,cytoplasm|apical part of cell|extracellular exosome|,small GTPase mediated signal transduction|regulation of cell shape|actin cytoskeleton organization|regulation of Rho protein signal transduction|positive regulation of GTPase activity|,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|,3,5,123000000,6.2%
A2ALK8,0.422611235,0.056166667,9.918816199,-0.208333333,0.101886907,-1.895452566,0.031,0.112,0.338,-0.032,-0.133,0.021,A2ALK8,Ptpn3,A2ALK8_Ptpn3,A2ALK8,Ptpn3,1,7,5,5,A2ALK8,MOUSE,105092.3,5.5,2354,2354.1,33.57,33.57,,913,Tyrosine-protein phosphatase non-receptor type 3,cytoplasm|cytoskeleton|cytoplasmic side of plasma membrane|,protein dephosphorylation|peptidyl-tyrosine dephosphorylation|negative regulation of mitotic cell cycle|negative regulation of membrane protein ectodomain proteolysis|liver regeneration|regulation of membrane depolarization during action potential|regulation of sodium ion transmembrane transporter activity|,phosphotyrosine binding|protein tyrosine phosphatase activity|cytoskeletal protein binding|sodium channel regulator activity|ATPase binding|,5,7,229000000,5.5%
Q8BZJ7,0.275720668,-0.043666667,13.49334454,-0.252666667,0.044736865,-2.463945665,0.118,0.081,0.049,-0.02,-0.319,-0.171,Q8BZJ7,Dcun1d2,Q8BZJ7_Dcun1d2,Q8BZJ7,Dcun1d2,1,4,3,2,Q8BZJ7|Q8BZJ7-2|A0A0N4SW97|G5E8Q6|Q8BZJ7-4|G5E8Q5|A0A0N4SW71,MOUSE,30352.9,12.3,2355,2355.1,33.56,29.18,,259,DCN1-like protein 2,,,,3,4,157000000,12.3%
Q8K183,0.456186328,-0.0225,9.237238763,0.177666667,0.119199964,1.785959179,-0.041,-0.069,-0.224,-0.053,0.12,0.132,Q8K183,Pdxk,Q8K183_Pdxk,Q8K183,Pdxk,1,5,4,4,Q8K183,MOUSE,35299.9,14.7,2356,2356.1,33.55,33.55,,312,Pyridoxal kinase,nucleus|nucleoplasm|cytoplasm|cytosol|extracellular exosome|,cell proliferation|pyridoxal 5'-phosphate salvage|phosphorylation|pyridoxal phosphate biosynthetic process|,magnesium ion binding|ATP binding|zinc ion binding|pyridoxal kinase activity|pyridoxal phosphate binding|potassium ion binding|sodium ion binding|lithium ion binding|protein homodimerization activity|,4,5,277000000,14.7%
A2AWT7,0.31921846,0.125333333,12.27526365,-0.496,0.059220713,-2.274484666,0.28,0.038,0.802,0.148,-0.274,-0.242,A2AWT7,Ubtf,A2AWT7_Ubtf,A2AWT7,Ubtf,1,3,6,3,A2AWT7|P25976|A2AWT5|P25976-2|A2AWT6,MOUSE,88785.3,3.4,2357,2357.1,33.54,20.94,,752,Nucleolar transcription factor 1,nucleolus|,chromatin silencing at rDNA|transcription elongation from RNA polymerase I promoter|,chromatin binding|protein binding|poly(A) RNA binding|,3,3,186000000,3.0%
Q62392,0.927777432,-0.018,1.04149704,0.041333333,0.786774537,0.281701139,-0.145,-0.119,0.148,0.137,-0.261,0.132,Q62392,Phlda1,Q62392_Phlda1,Q62392,Phlda1,1,5,2,2,Q62392,MOUSE,46038.5,5.9,2358,2358.1,33.41,33.41,,405,Pleckstrin homology-like domain family A member 1,nucleoplasm|nucleolus|plasma membrane|cytoplasmic vesicle membrane|,apoptotic process|forebrain neuron differentiation|positive regulation of apoptotic process|FasL biosynthetic process|,protein binding|,2,5,277000000,5.9%
P22366,0.88044681,-0.022833333,1.945279458,-0.051,0.638957621,-0.491259017,0.04,-0.056,0.024,0.12,-0.101,-0.164,P22366,Myd88,P22366_Myd88,P22366,Myd88,1,6,3,3,P22366|P22366-2,MOUSE,34265.9,13.1,2359,2359.1,33.39,33.39,,296,Myeloid differentiation primary response protein MyD88,cytoplasm|cytosol|plasma membrane|postsynaptic density|protein complex|,response to molecule of fungal origin|MyD88-dependent toll-like receptor signaling pathway|inflammatory response|immune response|cell surface receptor signaling pathway|transmembrane receptor protein serine/threonine kinase signaling pathway|JNK cascade|Toll signaling pathway|response to virus|immunoglobulin mediated immune response|cytokine-mediated signaling pathway|lipopolysaccharide-mediated signaling pathway|response to peptidoglycan|response to lipopolysaccharide|positive regulation of interleukin-17 production|positive regulation of interleukin-23 production|positive regulation of interleukin-6 production|positive regulation of tumor necrosis factor production|regulation of cell proliferation|positive regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of growth of symbiont in host|positive regulation of chemokine biosynthetic process|innate immune response|type I interferon biosynthetic process|positive regulation of JNK cascade|positive regulation of smooth muscle cell proliferation|positive regulation of lymphocyte proliferation|regulation of inflammatory response|defense response to Gram-positive bacterium|positive regulation of NF-kappaB transcription factor activity|response to interleukin-1|3'-UTR-mediated mRNA stabilization|establishment of endothelial intestinal barrier|,Toll binding|interleukin-1 receptor binding|protein binding|identical protein binding|TIR domain binding|,3,6,653000000,13.1%
Q71KU9,0.915900752,0.007833333,1.294566333,0.056333333,0.742238311,0.342990953,-0.096,-0.177,0.212,-0.017,-0.185,0.31,Q71KU9,Fgl1,Q71KU9_Fgl1,Q71KU9,Fgl1,1,5,4,4,Q71KU9|A0A0R4J0E1|Q3SZZ7,MOUSE,36724.1,17.1,2360,2360.1,33.38,33.38,,314,Fibrinogen-like protein 1,extracellular exosome|,cholesterol metabolic process|regulation of glucose metabolic process|response to stilbenoid|adipose tissue development|,,4,5,63700000,17.1%
Q56A08,0.580760484,-0.02,6.739121403,-0.110666667,0.211878973,-1.380050376,0.078,0.01,0.018,-0.049,-0.055,-0.122,Q56A08,Gpkow,Q56A08_Gpkow,Q56A08,Gpkow,1,6,4,4,Q56A08,MOUSE,54116,7.7,2361,2361.1,33.33,33.33,,488,G-patch domain and KOW motifs-containing protein,nucleoplasm|,,nucleic acid binding|,4,6,282000000,7.7%
Q91W36,0.88044681,-0.017,1.949440301,0.052,0.638345748,0.492172526,0.096,-0.034,-0.191,0.089,-0.068,0.006,Q91W36,Usp3,Q91W36_Usp3,Q91W36,Usp3,1,5,4,4,Q91W36|E9Q8W9|G3UZF0,MOUSE,60464.5,8.4,2362,2362.1,33.32,33.32,,520,Ubiquitin carboxyl-terminal hydrolase 3,nuclear chromatin|nucleus|,"mitotic cell cycle|DNA repair|regulation of transcription, DNA-templated|histone deubiquitination|regulation of protein stability|proteasome-mediated ubiquitin-dependent protein catabolic process|regulation of proteasomal protein catabolic process|",cysteine-type endopeptidase activity|ubiquitin-specific protease activity|zinc ion binding|histone binding|,4,5,4200000000,8.4%
P70280,0.51414471,-0.098833333,7.93984378,0.309,0.160699906,1.579409615,-0.114,0.046,-0.692,0.168,-0.038,0.037,P70280,Vamp7,P70280_Vamp7,P70280,Vamp7,1,3,3,3,P70280,MOUSE,25309,22.2,2363,2363.1,33.18,33.18,,220,Vesicle-associated membrane protein 7,cytoplasm|lysosomal membrane|endoplasmic reticulum membrane|Golgi apparatus|trans-Golgi network|plasma membrane|cell surface|membrane|integral component of membrane|lamellipodium|cell junction|transport vesicle|secretory granule|transport vesicle membrane|secretory granule membrane|phagocytic vesicle membrane|platelet alpha granule|pseudopodium|SNARE complex|late endosome membrane|azurophil granule membrane|neuron projection|intracellular membrane-bounded organelle|apical part of cell|synapse|phagocytic vesicle|perinuclear region of cytoplasm|extracellular exosome|,"exocytosis|ER to Golgi vesicle-mediated transport|vesicle fusion|phagocytosis, engulfment|endosome to lysosome transport|vesicle-mediated transport|calcium ion-dependent exocytosis|triglyceride transport|SNARE complex assembly|Golgi to plasma membrane protein transport|eosinophil degranulation|neutrophil degranulation|natural killer cell degranulation|vesicle transport along microtubule|vesicle fusion with Golgi apparatus|positive regulation of dendrite morphogenesis|regulation of protein targeting to vacuolar membrane|positive regulation of histamine secretion by mast cell|",SNARE binding|SNAP receptor activity|protein binding|syntaxin binding|,3,3,57400000,22.2%
Q62264,0.306010717,-0.141,12.61258507,0.652666667,0.054795071,2.328558323,-0.176,-0.087,-1.139,0.31,0.221,0.025,Q62264,Thrsp,Q62264_Thrsp,Q62264,Thrsp,1,4,3,3,Q62264,MOUSE,17264.2,21.3,2364,2364.1,33.13,33.13,,150,Thyroid hormone-inducible hepatic protein,nucleoplasm|cytosol|,"transcription, DNA-templated|regulation of transcription, DNA-templated|lipid metabolic process|regulation of triglyceride biosynthetic process|regulation of lipid biosynthetic process|",protein binding|protein homodimerization activity|,3,4,155000000,21.3%
Q9CQZ0,0.737344112,0.1175,3.979137519,-0.264333333,0.400024184,-0.899297284,-0.219,0.014,0.954,-0.147,0.01,0.093,Q9CQZ0,Ormdl2,Q9CQZ0_Ormdl2,Q9CQZ0,Ormdl2,1,11,3,3,Q9CQZ0|Q921I0,MOUSE,17389.2,18.9,2365,2365.1,33.12,33.12,,153,ORM1-like protein 2,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,ceramide metabolic process|negative regulation of sphingolipid biosynthetic process|,,3,11,5790000000,18.9%
Q6PEB4,0.75846242,-0.033333333,3.734653752,-0.084,0.423189248,-0.852859516,-0.081,-0.011,0.118,0.027,-0.089,-0.164,Q6PEB4,Osgepl1,Q6PEB4_Osgepl1,Q6PEB4,Osgepl1,1,2,2,2,Q6PEB4|Q6PEB4-2,MOUSE,45611.5,6,2365,2365.2,21.71,21.71,,414,"Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial",EKC/KEOPS complex|mitochondrion|,proteolysis|tRNA processing|,"metalloendopeptidase activity|transferase activity, transferring acyl groups|metal ion binding|",2,2,54000000,6.0%
Q61070,0.750398776,-0.0605,3.830303781,0.174333333,0.413970717,0.871496931,0.157,-0.087,-0.513,0.252,0.045,-0.217,Q61070,Ei24,Q61070_Ei24,Q61070,Ei24,1,10,2,2,A0A0R4J250|Q61070,MOUSE,39217.2,6.4,2366,2366.1,33.05,33.05,,340,Etoposide-induced protein 2.4,cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|Golgi apparatus|membrane|integral component of membrane|nuclear membrane|,autophagy|intrinsic apoptotic signaling pathway in response to DNA damage|negative regulation of cell growth|response to drug|neuromuscular process controlling balance|cellular response to UV-C|positive regulation of intrinsic apoptotic signaling pathway|,,2,10,6310000000,6.4%
A2APV2-3,0.977234082,-0.009666667,0.336721393,0.010666667,0.925396517,0.09723052,-0.126,0.049,0.032,0.088,-0.175,0.074,A2APV2,Fmnl2,A2APV2-3_Fmnl2,A2APV2-3,Fmnl2,1,4,4,4,A2APV2-3|A2APV2|F8VPR2|E9PXE6|A2APV2-2|A0A1W2P6X3|Q9JL26|Q6ZPF4|D3Z7A7|Q6ZPF4-2,MOUSE,124377.3,3.8,2367,2367.1,33.05,33.05,,1086,Isoform 3 of Formin-like protein 2,cytoplasm|,cytoskeleton organization|regulation of cell morphogenesis|cortical actin cytoskeleton organization|,actin binding|Rho GTPase binding|,4,4,63600000,3.8%
P12787,0.322547458,0.1025,12.18445736,0.428333333,0.06047199,2.259944849,-0.081,-0.161,-0.093,0.753,0.171,0.026,P12787,Cox5a,P12787_Cox5a,P12787,Cox5a,1,4,3,3,P12787,MOUSE,16329.4,26.7,2368,2368.1,33.05,33.05,,146,"Cytochrome c oxidase subunit 5A, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex IV|myelin sheath|extracellular exosome|,"mitochondrial electron transport, cytochrome c to oxygen|hydrogen ion transmembrane transport|",cytochrome-c oxidase activity|metal ion binding|,3,4,142000000,26.7%
P45376,0.964822261,-0.027166667,0.479969431,-0.023,0.895371068,-0.136648625,-0.019,-0.326,0.298,0.022,0.041,-0.179,P45376,Akr1b3,P45376_Akr1b3,P45376,Akr1b1,1,5,4,4,P45376|D3YVJ7,MOUSE,36073.9,13.6,2369,2369.1,33.05,33.05,,316,Aldose reductase,extracellular space|nucleoplasm|cytoplasm|cytosol|cell projection cytoplasm|paranodal junction|mast cell granule|Schmidt-Lanterman incisure|perinuclear region of cytoplasm|extracellular exosome|Schwann cell microvillus|,tissue homeostasis|monosaccharide metabolic process|sorbitol biosynthetic process|response to water deprivation|naphthalene metabolic process|stress-activated protein kinase signaling cascade|norepinephrine metabolic process|daunorubicin metabolic process|doxorubicin metabolic process|positive regulation of JAK-STAT cascade|positive regulation of smooth muscle cell proliferation|oxidation-reduction process|maternal process involved in female pregnancy|cellular response to hydrogen peroxide|inner medullary collecting duct development|response to thyroid hormone|cellular response to methylglyoxal|cellular response to peptide|,alditol:NADP+ 1-oxidoreductase activity|glyceraldehyde oxidoreductase activity|,4,5,243000000,13.6%
Q3TBW2,0.821409751,-0.051166667,2.750695534,0.115,0.530799429,0.661224522,-0.018,0.174,-0.482,0.102,-0.008,-0.075,Q3TBW2,Mrpl10,Q3TBW2_Mrpl10,Q3TBW2,Mrpl10,1,5,3,3,Q3TBW2|A2A715,MOUSE,29623.3,19.8,2370,2370.1,32.99,32.99,,262,"39S ribosomal protein L10, mitochondrial",nucleoplasm|mitochondrion|mitochondrial large ribosomal subunit|ribonucleoprotein complex|,translation|,structural constituent of ribosome|poly(A) RNA binding|,3,5,1190000000,19.8%
P10852-2,0.336787221,0.0265,11.72590617,-0.275666667,0.067206207,-2.186610704,-0.053,0.223,0.323,0.018,-0.177,-0.175,P10852,Slc3a2,P10852-2_Slc3a2,P10852-2,Slc3a2,1,3,3,3,P10852-2|P10852|A0A0U1RPK4,MOUSE,62352.7,8.1,2371,2371.1,32.92,32.92,,526,Isoform 2 of 4F2 cell-surface antigen heavy chain,nucleus|nucleoplasm|cytoplasm|plasma membrane|cell surface|membrane|integral component of membrane|apical plasma membrane|melanosome|extracellular exosome|,carbohydrate metabolic process|tryptophan transport|response to exogenous dsRNA|leucine import|,double-stranded RNA binding|catalytic activity|protein binding|neutral amino acid transmembrane transporter activity|cation binding|poly(A) RNA binding|,3,3,157000000,8.1%
P05201,0.817376822,0.087833333,2.84053548,0.201,0.519931886,0.679387771,-0.282,0.133,0.111,-0.15,0.873,-0.158,P05201,Got1,P05201_Got1,P05201,Got1,1,3,3,3,P05201,MOUSE,46532,7.5,2372,2372.1,32.79,32.79,,413,"Aspartate aminotransferase, cytoplasmic",nucleus|cytoplasm|lysosome|cytosol|axon terminus|extracellular exosome|,2-oxoglutarate metabolic process|oxaloacetate metabolic process|glycerol biosynthetic process|aspartate metabolic process|aspartate biosynthetic process|aspartate catabolic process|glutamate metabolic process|Notch signaling pathway|glutamate catabolic process to aspartate|glutamate catabolic process to 2-oxoglutarate|cellular response to insulin stimulus|response to glucocorticoid|fatty acid homeostasis|,L-aspartate:2-oxoglutarate aminotransferase activity|phosphatidylserine decarboxylase activity|pyridoxal phosphate binding|carboxylic acid binding|L-cysteine:2-oxoglutarate aminotransferase activity|L-phenylalanine:2-oxoglutarate aminotransferase activity|,3,3,67600000,7.5%
O88843,0.805121368,-0.0585,3.015621957,0.086333333,0.499387657,0.714402,-0.053,0.074,-0.326,0,0.023,-0.069,O88843,Cradd,O88843_Cradd,O88843,Cradd,1,3,3,3,O88843,MOUSE,22712.6,19,2373,2373.1,32.78,32.78,,199,Death domain-containing protein CRADD,nucleus|cytoplasm|,"activation of cysteine-type endopeptidase activity involved in apoptotic process|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|cellular response to mechanical stimulus|positive regulation of apoptotic signaling pathway|","protease binding|protein binding, bridging|death domain binding|",3,3,303000000,19.0%
P28661,0.692956416,0.026333333,4.670157031,0.116,0.341180575,1.024945921,-0.123,0.095,-0.067,-0.027,0.026,0.254,P28661,Sept4,P28661_Sept4,P28661,Sept4,1,3,2,2,P28661|P28661-2|P28661-3|P28661-4|P28661-5|P28661-6,MOUSE,55391.4,6.9,2374,2374.1,32.78,32.78,,478,Septin-4,mitochondrion|cytoskeleton|motile cilium|sperm flagellum|cell projection|myelin sheath|sperm annulus|,cell cycle|spermatid development|brain development|sperm mitochondrion organization|positive regulation of protein ubiquitination|positive regulation of apoptotic process|sperm capacitation|cell division|positive regulation of intrinsic apoptotic signaling pathway|,GTP binding|,2,3,43600000,6.9%
Q7TN98,0.71078078,-0.009333333,4.372987087,0.089333333,0.365343421,0.970911026,0.038,-0.183,-0.017,0.038,0.036,0.032,Q7TN98,Cpeb4,Q7TN98_Cpeb4,Q7TN98,Cpeb4,1,4,3,3,Q7TN98|Q7TN98-2|Q5SU48|Q7TN98-3|Q7TN98-5|Q7TN98-4|E9Q969|E9Q5X2|Q7TN99|A0A0R4J102|Q7TN99-2|D3Z5R9|Q7TN99-3|D3Z1R6|Q7TN99-4|Q812E0|Q7TN99-6|Q7TN99-5,MOUSE,80748.1,6,2375,2375.1,32.74,32.74,,729,Cytoplasmic polyadenylation element-binding protein 4,nucleus|cytoplasm|endoplasmic reticulum|postsynaptic density|dendrite|synapse|,response to ischemia|ionotropic glutamate receptor signaling pathway|cellular response to decreased oxygen levels|cellular response to glucose starvation|negative regulation of neuron apoptotic process|cellular response to amino acid stimulus|,nucleotide binding|RNA binding|poly(A) RNA binding|,3,4,48800000,6.0%
P19783,0.165274182,0.161333333,17.08298355,0.731333333,0.019574994,3.062382904,-0.14,-0.132,-0.341,1.05,0.454,0.077,P19783,Cox4i1,P19783_Cox4i1,P19783,Cox4i1,1,6,3,3,P19783,MOUSE,19587.2,16.5,2376,2376.1,32.67,32.67,,169,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",nucleus|mitochondrion|mitochondrial inner membrane|membrane|mitochondrial membrane|extracellular exosome|,response to nutrient|hydrogen ion transmembrane transport|,cytochrome-c oxidase activity|,3,6,723000000,16.5%
Q8K245,0.962544846,0.0145,0.517272903,0.018333333,0.887713265,0.146729955,0.015,-0.08,0.081,0.13,-0.214,0.155,Q8K245,Uvrag,Q8K245_Uvrag,Q8K245,Uvrag,1,6,5,5,Q8K245|A0A140LI21,MOUSE,78436.4,6.8,2377,2377.1,32.64,32.64,,698,UV radiation resistance associated protein,"lytic vacuole|chromosome, centromeric region|lysosome|endosome|early endosome|late endosome|endoplasmic reticulum|centrosome|midbody|protein complex|phagocytic vesicle|DNA-dependent protein kinase complex|","DNA repair|retrograde vesicle-mediated transport, Golgi to ER|autophagy|spindle organization|chromosome segregation|positive regulation of autophagy|regulation of cytokinesis|receptor catabolic process|SNARE complex assembly|viral entry into host cell|centrosome organization|maintenance of Golgi location|regulation of vesicle-mediated transport|regulation of protein serine/threonine kinase activity|double-strand break repair via classical nonhomologous end joining|",SNARE binding|protein binding|SH3 domain binding|,5,6,472000000,6.8%
P23950,0.472136605,0.008,8.769866517,-0.275333333,0.132743526,-1.713815745,-0.018,0.03,0.425,-0.132,-0.33,0.073,P23950,Zfp36l1,P23950_Zfp36l1,P23950,Zfp36l1,1,4,3,3,P23950,MOUSE,36840.4,10,2378,2378.1,32.63,32.63,,338,mRNA decay activator protein ZFP36L1,nucleus|cytoplasm|cytosol|,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|vasculogenesis|proepicardium development|mRNA catabolic process|regulation of translation|apoptotic process|heart development|cell proliferation|neural tube development|T cell differentiation in thymus|multicellular organism growth|regulation of mRNA stability|embryonic organ development|chorio-allantoic fusion|spongiotrophoblast layer development|",DNA binding|mRNA binding|AU-rich element binding|poly(A) RNA binding|metal ion binding|,3,4,32100000,10.0%
Q8BH55,0.464854041,-0.006833333,8.995220855,-0.285666667,0.126031154,-1.75009078,0.3,0.3,-0.192,0.018,-0.188,-0.279,Q8BH55,Thnsl1,Q8BH55_Thnsl1,Q8BH55,Thnsl1,1,4,3,3,Q8BH55|A2AUG7,MOUSE,84068.7,6.8,2379,2379.1,32.61,32.61,,747,Threonine synthase-like 1,nucleus|nucleoplasm|cytoplasm|mitochondrion|,threonine biosynthetic process|,threonine synthase activity|pyridoxal phosphate binding|,3,4,314000000,6.8%
A2AKQ0,0.951421295,-0.043833333,0.736901127,-0.049666667,0.843936727,-0.204727549,0.436,0.069,-0.562,-0.094,0.036,-0.148,A2AKQ0,Slc35d1,A2AKQ0_Slc35d1,A2AKQ0,Slc35d1,1,6,2,2,A2AKQ0|A2AKQ0-2,MOUSE,39499.6,9.2,2380,2380.1,32.59,32.59,,355,UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter,endoplasmic reticulum|integral component of membrane|,pyrimidine nucleotide-sugar transport|chondroitin sulfate biosynthetic process|embryonic skeletal system development|pyrimidine nucleotide-sugar transmembrane transport|anion transmembrane transport|,pyrimidine nucleotide-sugar transmembrane transporter activity|antiporter activity|,2,6,140000000,9.2%
P97370,0.857830933,-0.008333333,2.240106133,0.054,0.597020696,0.554866552,-0.131,0.047,-0.022,0.052,-0.095,0.099,P97370,Atp1b3,P97370_Atp1b3,P97370,Atp1b3,1,6,2,2,P97370,MOUSE,32117.4,7.5,2381,2381.1,32.51,32.51,,278,Sodium/potassium-transporting ATPase subunit beta-3,cytoplasm|plasma membrane|sodium:potassium-exchanging ATPase complex|caveola|melanosome|extracellular exosome|,cellular sodium ion homeostasis|potassium ion import|cellular potassium ion homeostasis|positive regulation of ATPase activity|sodium ion export from cell|protein stabilization|protein localization to plasma membrane|membrane repolarization|positive regulation of potassium ion transmembrane transporter activity|positive regulation of sodium ion export from cell|positive regulation of potassium ion import|,ATPase activator activity|sodium:potassium-exchanging ATPase activity|protein binding|ATPase binding|sodium:potassium-exchanging ATPase activity|,2,6,673000000,7.5%
Q3UHJ0,0.991556352,-0.029666667,0.165117535,0.005333333,0.962693959,0.04855489,-0.18,0.03,0.053,0.023,-0.166,0.062,Q3UHJ0,Aak1,Q3UHJ0_Aak1,Q3UHJ0,Aak1,1,3,3,3,Q3UHJ0|Q3UHJ0-2,MOUSE,104086.1,5.2,2382,2382.1,32.46,32.46,,959,AP2-associated protein kinase 1,coated pit|extrinsic component of plasma membrane|clathrin-coated vesicle|cell leading edge|terminal bouton|,protein phosphorylation|endocytosis|regulation of protein localization|positive regulation of Notch signaling pathway|protein autophosphorylation|protein stabilization|regulation of clathrin-mediated endocytosis|,protein serine/threonine kinase activity|Notch binding|ATP binding|AP-2 adaptor complex binding|,3,3,13000000,5.2%
Q8R3L2,0.951421295,0.054833333,0.738050092,-0.035666667,0.843713486,-0.20502515,-0.053,0.442,-0.171,0.051,-0.096,0.156,Q8R3L2,Tcf25,Q8R3L2_Tcf25,Q8R3L2,Tcf25,1,3,3,3,Q8R3L2|A0A1D5RM90|Q8R3L2-5|Q8R3L2-2|Q8R3L2-3|Q8R3L2-4,MOUSE,77311,7.2,2383,2383.1,32.37,32.37,,676,Transcription factor 25,nucleus|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|",DNA binding|sequence-specific DNA binding transcription factor activity|,3,3,485000000,7.2%
Q8VDP6,0.202323482,0.035666667,15.86804689,-0.282666667,0.025893771,-2.849844543,0.088,0.328,0.115,-0.081,-0.167,-0.069,Q8VDP6,Cdipt,Q8VDP6_Cdipt,Q8VDP6,Cdipt,1,5,3,3,Q8VDP6|A0A0U1RP13|A0A0U1RQ57|A0A0U1RPV3|A0A0U1RNI6,MOUSE,23940.8,13.1,2384,2384.1,32.36,32.36,,213,CDP-diacylglycerol--inositol 3-phosphatidyltransferase,Golgi membrane|endoplasmic reticulum membrane|Golgi apparatus|plasma membrane|membrane|integral component of membrane|,phosphatidylinositol biosynthetic process|CDP-diacylglycerol metabolic process|,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity|diacylglycerol binding|manganese ion binding|carbohydrate binding|alcohol binding|,3,5,555000000,13.1%
Q8C4X2,0.73832786,0.007166667,3.966612131,-0.140333333,0.40117955,-0.896967197,-0.033,0.2,0.065,-0.094,-0.328,0.233,Q8C4X2,Csnk1g3,Q8C4X2_Csnk1g3,Q8C4X2,Csnk1g3,1,3,3,3,Q8C4X2|A0A0U1RP94|Q8BTH8|Q99K78|Q6P2B2|A0A0U1RPM8|A0A0U1RNW0|Q8BVP5|A0A0U1RPD7|A0A140LHR2|A0A140LIJ6,MOUSE,49393.6,7.7,2385,2385.1,32.33,32.33,,424,Casein kinase I isoform gamma-3,cytoplasm|,endocytosis|regulation of cell shape|Wnt signaling pathway|peptidyl-serine phosphorylation|,protein serine/threonine kinase activity|ATP binding|,3,3,27100000,7.7%
D6RFQ2,0.514657719,-0.011166667,7.918250996,-0.201,0.161500883,-1.575892942,0.191,0.146,-0.069,-0.288,0.075,-0.122,D6RFQ2,NotFound,D6RFQ2_NotFound,D6RFQ2,Gm42957,1,4,3,3,D6RFQ2|Q9Z210|E9PXK7,MOUSE,40427.4,9,2386,2386.1,32.27,32.27,,366,Predicted gene 42957,peroxisome|peroxisomal membrane|integral component of peroxisomal membrane|membrane|protein complex|extracellular exosome|,peroxisome organization|cell adhesion|integrin-mediated signaling pathway|peroxisome fission|regulation of peroxisome size|protein homooligomerization|,protein homodimerization activity|,3,4,1130000000,9.0%
Q99MU3,0.906976301,-0.032333333,1.500188941,-0.04,0.707914986,-0.391033064,0.025,-0.132,0.07,0.013,-0.179,0.009,Q99MU3,Adar,Q99MU3_Adar,Q99MU3,Adar,1,4,4,4,Q99MU3|Q99MU3-2|Q99MU3-5|Q99MU3-4|Q99MU3-3,MOUSE,131757.1,3.7,2387,2387.1,32.24,32.24,,1178,Double-stranded RNA-specific adenosine deaminase,nucleus|nucleoplasm|nucleolus|cytoplasm|membrane|supraspliceosomal complex|,"osteoblast differentiation|in utero embryonic development|hematopoietic progenitor cell differentiation|somatic diversification of immune receptors via somatic mutation|transcription, DNA-templated|regulation of transcription, DNA-templated|adenosine to inosine editing|mRNA processing|protein import into nucleus|protein export from nucleus|response to virus|base conversion or substitution editing|erythrocyte differentiation|pre-miRNA processing|production of miRNAs involved in gene silencing by miRNA|miRNA loading onto RISC involved in gene silencing by miRNA|response to interferon-alpha|negative regulation of apoptotic process|negative regulation of protein kinase activity by regulation of protein phosphorylation|positive regulation of viral genome replication|negative regulation of viral genome replication|innate immune response|defense response to virus|definitive hemopoiesis|negative regulation of type I interferon-mediated signaling pathway|hematopoietic stem cell homeostasis|negative regulation of RNA interference|",left-handed Z-DNA binding|double-stranded RNA adenosine deaminase activity|protein binding|poly(A) RNA binding|metal ion binding|,4,4,1970000000,3.7%
P54276,0.394954305,0.026,10.51636454,0.273333333,0.088789896,1.993547896,-0.353,-0.042,0.063,0.296,0.027,0.165,P54276,Msh6,P54276_Msh6,P54276,Msh6,1,4,4,4,P54276,MOUSE,152907,4.7,2388,2388.1,32.2,32.2,,1358,DNA mismatch repair protein Msh6,nuclear chromosome|nuclear chromatin|nucleoplasm|cytoplasm|Golgi apparatus|plasma membrane|MutSalpha complex|intracellular membrane-bounded organelle|,meiotic mismatch repair|DNA repair|mismatch repair|reciprocal meiotic recombination|determination of adult lifespan|intrinsic apoptotic signaling pathway in response to DNA damage|response to UV|somatic hypermutation of immunoglobulin genes|somatic recombination of immunoglobulin gene segments|maintenance of DNA repeat elements|isotype switching|negative regulation of DNA recombination|positive regulation of helicase activity|intrinsic apoptotic signaling pathway|,four-way junction DNA binding|DNA binding|chromatin binding|damaged DNA binding|DNA-dependent ATPase activity|mismatched DNA binding|guanine/thymine mispair binding|single base insertion or deletion binding|methylated histone binding|magnesium ion binding|four-way junction DNA binding|double-stranded DNA binding|ATP binding|ATPase activity|mismatched DNA binding|guanine/thymine mispair binding|single guanine insertion binding|single thymine insertion binding|oxidized purine DNA binding|MutLalpha complex binding|ADP binding|,4,4,5510000000,4.7%
Q80X41,0.414373879,0.0275,10.10144166,-0.236333333,0.097691288,-1.927300072,0.14,0.006,0.291,-0.272,-0.035,0.035,Q80X41,Vrk1,Q80X41_Vrk1,Q80X41,Vrk1,1,3,3,3,Q80X41|Q80X41-3|Q80X41-5|A0A1Y7VMH3|Q80X41-2,MOUSE,50310.4,12.5,2389,2389.1,32.2,32.2,,440,Serine/threonine-protein kinase VRK1,nucleus|nucleoplasm|nucleolus|cytoplasm|Golgi stack|spindle|,protein phosphorylation|endocytosis|mitotic nuclear division|regulation of cell shape|Wnt signaling pathway|peptidyl-serine phosphorylation|histone H3-S10 phosphorylation|protein autophosphorylation|cell division|histone H3-T3 phosphorylation|Golgi disassembly|,protein serine/threonine kinase activity|ATP binding|protein kinase binding|nucleosomal histone binding|histone kinase activity (H3-S10 specific)|histone kinase activity (H3-T3 specific)|,3,3,40700000,12.5%
Q3TC72,0.514657719,-0.017666667,7.90304475,0.186666667,0.162067348,1.573273265,-0.298,-0.095,0.06,0.056,-0.009,0.18,Q3TC72,Fahd2a,Q3TC72_Fahd2a,Q3TC72,Fahd2,1,3,3,3,Q3TC72|A0A0R4J094,MOUSE,35089.1,13,2390,2390.1,32.12,32.12,,313,Fumarylacetoacetate hydrolase domain-containing protein 2A,mitochondrion|,metabolic process|,hydrolase activity|metal ion binding|,3,3,1170000000,13.0%
Q99NF7,0.332192581,-0.009,11.85911202,0.394,0.065176164,2.207900127,-0.149,0.082,-0.551,0.006,0.232,0.326,Q99NF7,Ppm1b,Q99NF7_Ppm1b,Q99NF7,Ppm1b,1,5,3,3,Q99NF7|P36993-5|P36993-3|P36993-2|P36993-4|P36993|P49443|Q9EQE2,MOUSE,52737.7,5.6,2391,2391.1,32.09,32.09,,477,Ppm1b protein,,protein dephosphorylation|negative regulation of interferon-beta production|peptidyl-threonine dephosphorylation|negative regulation of NF-kappaB import into nucleus|negative regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of defense response to virus|,magnesium ion binding|protein serine/threonine phosphatase activity|manganese ion binding|,3,5,6320000000,5.6%
Q8R0J2,0.983717661,-0.012,0.251729108,0.008,0.943685081,0.073337894,-0.026,0.153,-0.175,-0.074,0.008,0.042,Q8R0J2,Mpdu1,Q8R0J2_Mpdu1,Q8R0J2,Mpdu1,1,4,3,3,Q8R0J2|E9PVP3|Q9R0Q9,MOUSE,26723.3,11.7,2392,2392.1,32.08,32.08,,247,Mannose-P-dolichol utilization defect 1,mitochondrion|endoplasmic reticulum|membrane|extracellular exosome|,dolichol-linked oligosaccharide biosynthetic process|oligosaccharide biosynthetic process|,,3,4,792000000,11.7%
Q9WTX5,0.993721001,0.013666667,0.102352122,0.002666667,0.976708096,0.030303669,-0.056,0.026,0.067,-0.024,0.102,-0.033,Q9WTX5,Skp1a,Q9WTX5_Skp1a,Q9WTX5,Skp1,1,5,3,3,Q9WTX5,MOUSE,18842.9,19.6,2393,2393.1,32.06,32.06,,163,S-phase kinase-associated protein 1,centrosome|cytosol|SCF ubiquitin ligase complex|Cul7-RING ubiquitin ligase complex|extracellular exosome|PcG protein complex|,ubiquitin-dependent protein catabolic process|protein ubiquitination|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|histone H2A monoubiquitination|,ubiquitin-protein transferase activity|protein binding|ubiquitin-protein transferase activity|,3,5,2.53E+11,19.6%
Q3TIX9,0.51414471,0.104166667,7.926772773,-0.407666667,0.161184295,-1.577280966,-0.125,0.224,0.825,-0.295,-0.211,0.207,Q3TIX9,Usp39,Q3TIX9_Usp39,Q3TIX9,Usp39,1,3,3,3,Q3TIX9,MOUSE,65544.5,5.8,2394,2394.1,32.05,32.05,,564,U4/U6.U5 tri-snRNP-associated protein 2,spliceosomal complex|,mRNA processing|ubiquitin-dependent protein catabolic process|cell cycle|RNA splicing|cell division|,zinc ion binding|ubiquitinyl hydrolase activity|,3,3,34700000,5.8%
Q99J27,0.708523608,-0.017333333,4.399607239,-0.157333333,0.363110892,-0.976569535,-0.172,0.023,0.333,0.036,-0.312,-0.012,Q99J27,Slc33a1,Q99J27_Slc33a1,Q99J27,Slc33a1,1,7,4,4,Q99J27,MOUSE,61587.7,10.1,2395,2395.1,32.01,32.01,,550,Acetyl-coenzyme A transporter 1,endoplasmic reticulum membrane|membrane|integral component of membrane|,acetyl-CoA transport|proton transport|BMP signaling pathway|SMAD protein signal transduction|,acetyl-CoA transporter activity|solute:proton symporter activity|,4,7,846000000,10.1%
P59913,0.997013938,0.009833333,0.034983531,0.001,0.991977101,0.010436485,-0.113,0.123,0.018,0.072,-0.023,-0.018,P59913,Pcmtd1,P59913_Pcmtd1,P59913,Pcmtd1,1,6,3,3,P59913,MOUSE,40977.8,14,2396,2396.1,31.99,31.99,,357,Protein-L-isoaspartate O-methyltransferase domain-containing protein 1,cytoplasm|,protein methylation|,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity|,3,6,424000000,14.0%
Q922Z0,0.971528421,0.023833333,0.407628232,-0.015666667,0.91041033,-0.116894954,0.053,-0.019,0.061,0.296,-0.124,-0.124,Q922Z0,Ddo,Q922Z0_Ddo,Q922Z0,Ddo,1,5,4,4,Q922Z0,MOUSE,38059.1,14.3,2397,2397.1,31.98,31.98,,341,D-aspartate oxidase,peroxisome|,aspartate metabolic process|aspartate catabolic process|insemination|grooming behavior|D-amino acid catabolic process|hormone metabolic process|oxidation-reduction process|,receptor binding|D-aspartate oxidase activity|cofactor binding|FAD binding|,4,5,582000000,14.3%
Q9D2N9,0.956491812,-0.021833333,0.627076425,0.016333333,0.865550392,0.175929472,-0.065,0.078,-0.103,-0.082,-0.017,0.058,Q9D2N9,Vps33a,Q9D2N9_Vps33a,Q9D2N9,Vps33a,1,6,3,3,Q9D2N9,MOUSE,67952.9,4.6,2398,2398.1,31.98,31.98,,598,Vacuolar protein sorting-associated protein 33A,lysosomal membrane|early endosome|late endosome|late endosome membrane|perinuclear region of cytoplasm|HOPS complex|,vesicle docking involved in exocytosis|protein transport|vesicle-mediated transport|platelet formation|melanosome localization|lysosome localization|pigmentation|regulation of developmental pigmentation|,,3,6,338000000,4.6%
Q8R0F3,0.000987574,-0.217,44.6382444,1.846666667,3.43697E-05,9.834621986,-1.033,-0.869,-1.519,0.603,0.914,0.602,Q8R0F3,Sumf1,Q8R0F3_Sumf1,Q8R0F3,Sumf1,1,8,4,4,Q8R0F3|E9Q265|E9Q0Z7,MOUSE,41286.3,15.3,2399,2399.1,31.96,31.96,,372,Sulfatase-modifying factor 1,endoplasmic reticulum|endoplasmic reticulum lumen|,oxidation-reduction process|,protein binding|oxidoreductase activity|protein homodimerization activity|metal ion binding|,4,8,1050000000,15.3%
A2AR02,0.52944394,-0.04,7.637410896,0.135333333,0.17228954,1.527919768,-0.07,-0.046,-0.207,0.083,0.017,-0.017,A2AR02,Ppig,A2AR02_Ppig,A2AR02,Ppig,1,5,4,4,A2AR02,MOUSE,88836.5,6.6,2400,2400.1,31.93,31.93,,752,Peptidyl-prolyl cis-trans isomerase G,nucleoplasm|cytoplasm|nuclear matrix|nuclear speck|,protein peptidyl-prolyl isomerization|protein folding|,peptidyl-prolyl cis-trans isomerase activity|poly(A) RNA binding|,4,5,89900000,6.6%
Q8CGA0,0.581377911,0.015333333,6.708106324,-0.142,0.21339752,-1.375051163,-0.06,0.109,0.21,-0.142,-0.023,-0.002,Q8CGA0,Ppm1f,Q8CGA0_Ppm1f,Q8CGA0,Ppm1f,1,4,3,3,Q8CGA0,MOUSE,49952.4,8.6,2401,2401.1,31.92,31.92,,452,Protein phosphatase 1F,cytosol|protein complex|perinuclear region of cytoplasm|,"negative regulation of protein kinase activity|positive regulation of gene expression|positive regulation of epithelial cell migration|positive regulation of cell-substrate adhesion|histone dephosphorylation|negative regulation of peptidyl-serine phosphorylation|cellular response to drug|peptidyl-threonine dephosphorylation|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|negative regulation of protein kinase activity by regulation of protein phosphorylation|negative regulation of transcription, DNA-templated|positive regulation of growth|positive regulation of chemotaxis|positive regulation of stress fiber assembly|positive regulation of focal adhesion assembly|intrinsic apoptotic signaling pathway|",protein serine/threonine phosphatase activity|phosphatase activity|calmodulin-dependent protein phosphatase activity|metal ion binding|,3,4,146000000,8.6%
P62305,0.773512169,-0.000833333,3.541292266,-0.099666667,0.442456697,-0.816771068,-0.164,0.207,0.104,-0.036,-0.151,0.035,P62305,Snrpe,P62305_Snrpe,P62305,Snrpe,1,5,3,3,P62305|E9Q4F4|E9Q0W8,MOUSE,10860.5,29.3,2402,2402.1,31.86,31.86,,92,Small nuclear ribonucleoprotein E,nucleus|U5 snRNP|U7 snRNP|U1 snRNP|U2 snRNP|U4 snRNP|U12-type spliceosomal complex|cytosol|methylosome|pICln-Sm protein complex|SMN-Sm protein complex|U4/U6 x U5 tri-snRNP complex|extracellular exosome|precatalytic spliceosome|catalytic step 2 spliceosome|,spliceosomal snRNP assembly|hair cycle|,RNA binding|,3,5,1790000000,29.3%
E9Q5P0,0.584741827,0.046166667,6.627441212,0.219,0.217398167,1.363099069,-0.034,0.082,-0.238,0.468,-0.018,0.017,E9Q5P0,Hpn,E9Q5P0_Hpn,E9Q5P0,Hpn,1,7,3,3,E9Q5P0|O35453|O35453-2|G3UWE8|A0A0U1RNM3,MOUSE,48900.6,7.4,2403,2403.1,31.8,31.8,,445,Serine protease hepsin,endoplasmic reticulum membrane|plasma membrane|integral component of plasma membrane|cell surface|integral component of membrane|extracellular exosome|nuclear membrane|,proteolysis|sensory perception of sound|regulation of cell shape|negative regulation of alkaline phosphatase activity|negative regulation of epithelial to mesenchymal transition|positive regulation of plasminogen activation|positive regulation of cell growth|basement membrane disassembly|cholesterol homeostasis|negative regulation of apoptotic process|positive regulation by host of viral transcription|negative regulation of epithelial cell proliferation|positive regulation of hepatocyte proliferation|,serine-type endopeptidase activity|peptidase activity|serine-type peptidase activity|serine-type exopeptidase activity|,3,7,828000000,7.4%
Q9EPL8,0.773708352,-0.004333333,3.487393091,0.164,0.447982131,0.806449929,0.097,0.053,-0.409,0.438,-0.072,-0.133,Q9EPL8,Ipo7,Q9EPL8_Ipo7,Q9EPL8,Ipo7,1,5,4,4,Q9EPL8,MOUSE,120796.6,5.1,2404,2404.1,31.8,31.8,,1038,Importin-7,nucleoplasm|cytoplasm|membrane|,protein import into nucleus|innate immune response|,protein binding|Ran GTPase binding|histone binding|,4,5,649000000,5.1%
Q9Z127,0.979995204,0.009833333,0.30565479,0.013666667,0.932039935,0.088574367,-0.12,0.238,-0.109,0.102,-0.233,0.181,Q9Z127,Slc7a5,Q9Z127_Slc7a5,Q9Z127,Slc7a5,1,3,2,2,Q9Z127,MOUSE,56555.9,5.8,2405,2405.1,31.78,31.78,,512,Large neutral amino acids transporter small subunit 1,nucleus|nucleolus|cytoplasm|cytosol|plasma membrane|integral component of plasma membrane|membrane|apical plasma membrane|intracellular membrane-bounded organelle|extracellular exosome|,amino acid transmembrane transport|nervous system development|L-amino acid transport|leucine transport|phenylalanine transport|tryptophan transport|cell differentiation|cation transmembrane transport|L-alpha-amino acid transmembrane transport|,L-amino acid transmembrane transporter activity|L-leucine transmembrane transporter activity|L-phenylalanine transmembrane transporter activity|L-tryptophan transmembrane transporter activity|antiporter activity|,2,3,84700000,5.8%
G5E897,0.257079817,0.012833333,13.96307778,0.297,0.040150617,2.54502122,-0.06,-0.029,-0.318,0.213,0.026,0.245,G5E897,Kdelc2,G5E897_Kdelc2,G5E897,Kdelc2,1,4,3,3,G5E897,MOUSE,58084.4,6.5,2406,2406.1,31.77,31.77,,503,"KDEL (Lys-Asp-Glu-Leu) containing 2, isoform CRA_b",,,,3,4,134000000,6.5%
P62869,0.550913932,-0.083333333,7.250976302,0.347333333,0.188322569,1.466583174,-0.05,0.084,-0.805,0.234,-0.051,0.088,P62869,Elob,P62869_Elob,P62869,Elob,1,5,4,4,P62869,MOUSE,13226.7,44,2407,2407.1,31.69,31.69,,118,Elongin-B,VCB complex|Cul2-RING ubiquitin ligase complex|Cul5-RING ubiquitin ligase complex|extracellular exosome|elongin complex|,"regulation of transcription, DNA-templated|transcription elongation from RNA polymerase II promoter|protein ubiquitination|",protein binding|ubiquitin protein ligase binding|,4,5,561000000,44.0%
P36552,0.993120455,0.012,0.139840811,0.004,0.968313349,0.041231733,-0.051,-0.065,0.146,0.029,0.069,-0.056,P36552,Cpox,P36552_Cpox,P36552,Cpox,1,4,2,2,P36552,MOUSE,50284.2,5.8,2408,2408.1,31.56,31.56,,443,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial intermembrane space|membrane|,protoporphyrinogen IX biosynthetic process|heme biosynthetic process|potassium ion transport|sodium ion transport|response to iron ion|response to lead ion|response to insecticide|sodium ion transmembrane transport|response to arsenic-containing substance|response to methylmercury|oxidation-reduction process|,coproporphyrinogen oxidase activity|structural constituent of eye lens|sodium:potassium-exchanging ATPase activity|protein homodimerization activity|,2,4,126000000,5.8%
Q921H9,0.203116866,0.039833333,15.84153636,-0.264333333,0.026052318,-2.845411061,0.054,0.277,0.185,-0.057,-0.086,-0.134,Q921H9,Coa7,Q921H9_Coa7,Q921H9,Coa7,1,3,3,3,Q921H9,MOUSE,26358.2,16.4,2409,2409.1,31.56,31.56,,231,Cytochrome c oxidase assembly factor 7,mitochondrial intermembrane space|,,,3,3,85000000,16.4%
Q8BSK8,0.587827992,0.018166667,6.537201856,-0.173666667,0.221962606,-1.347994458,0.036,-0.057,0.336,-0.004,-0.194,-0.008,Q8BSK8,Rps6kb1,Q8BSK8_Rps6kb1,Q8BSK8,Rps6kb1,1,4,2,2,Q8BSK8|Q8BSK8-2,MOUSE,59486.9,4.9,2410,2410.1,31.56,31.56,,525,Ribosomal protein S6 kinase beta-1,nucleus|nucleoplasm|cytoplasm|mitochondrion|mitochondrial outer membrane|cell surface|cell junction|neuron projection|synapse|perinuclear region of cytoplasm|,G1/S transition of mitotic cell cycle|behavioral fear response|skeletal muscle contraction|protein phosphorylation|apoptotic process|germ cell development|aging|response to nutrient|long-term memory|response to heat|response to wounding|response to mechanical stimulus|response to toxic substance|response to glucose|skeletal muscle atrophy|response to electrical stimulus involved in regulation of muscle adaptation|positive regulation of smooth muscle cell migration|cell migration|TOR signaling|response to lipopolysaccharide|cellular response to insulin stimulus|response to testosterone|response to glucagon|response to tumor necrosis factor|response to drug|negative regulation of apoptotic process|response to leucine|protein kinase B signaling|response to ethanol|positive regulation of translation|positive regulation of mitotic cell cycle|positive regulation of translational initiation|regulation of glucose import|negative regulation of insulin receptor signaling pathway|positive regulation of skeletal muscle tissue growth|positive regulation of smooth muscle cell proliferation|response to glucocorticoid|cellular response to growth factor stimulus|cellular response to organic cyclic compound|negative regulation of extrinsic apoptotic signaling pathway|,protein kinase activity|ribosomal protein S6 kinase activity|protein serine/threonine/tyrosine kinase activity|protein binding|ATP binding|peptide binding|protein phosphatase 2A binding|,2,4,397000000,4.9%
P21278,0.480593503,0.0065,8.540111819,-0.157,0.139955129,-1.674134739,0.044,0.209,0.002,-0.132,-0.027,-0.057,P21278,Gna11,P21278_Gna11,P21278,Gna11,1,6,3,3,P21278|P30677|P21279,MOUSE,42308.7,12.2,2411,2411.1,31.44,31.44,,359,Guanine nucleotide-binding protein subunit alpha-11,lysosomal membrane|heterotrimeric G-protein complex|extracellular exosome|,skeletal system development|action potential|G-protein coupled receptor signaling pathway|adenylate cyclase-modulating G-protein coupled receptor signaling pathway|heart development|metabolic process|regulation of melanocyte differentiation|developmental pigmentation|phospholipase C-activating dopamine receptor signaling pathway|cellular response to pH|glutamate receptor signaling pathway|,GTPase activity|signal transducer activity|GTP binding|G-protein beta/gamma-subunit complex binding|type 2A serotonin receptor binding|metal ion binding|,3,6,380000000,12.2%
Q9D3B1,0.356166313,-0.055,11.34466922,0.348,0.07337246,2.125726402,-0.346,0.086,-0.427,0.134,-0.057,0.28,Q9D3B1,Hacd2,Q9D3B1_Hacd2,Q9D3B1,Hacd2,1,6,2,2,Q9D3B1,MOUSE,28458.9,7.8,2412,2412.1,31.42,31.42,,254,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,sphingolipid biosynthetic process|fatty acid elongation|very long-chain fatty acid biosynthetic process|,3-hydroxyacyl-CoA dehydratase activity|enzyme binding|,2,6,3370000000,7.8%
Q3UQ84,0.821409751,-0.023333333,2.749606706,0.059333333,0.530932523,0.660589615,0.009,0.002,-0.17,0.042,-0.008,-0.015,Q3UQ84,Tars2,Q3UQ84_Tars2,Q3UQ84,Tars2,1,4,3,3,Q3UQ84|Q922A3|E9Q7H6|Q3TP97,MOUSE,82725.7,3.7,2413,2413.1,31.37,31.37,,723,"Threonine--tRNA ligase, mitochondrial",mitochondrion|mitochondrial matrix|,threonyl-tRNA aminoacylation|,threonine-tRNA ligase activity|ATP binding|,3,4,169000000,3.7%
Q99P87,0.00177459,-0.06,41.38365042,1.282666667,7.27168E-05,8.714672995,-0.596,-0.517,-0.991,0.47,0.564,0.71,Q99P87,Retn,Q99P87_Retn,Q99P87,Retn,1,7,3,3,Q99P87,MOUSE,13119,28.9,2414,2414.1,31.36,31.36,,114,Resistin,extracellular region|extracellular space|extracellular exosome|,,hormone activity|,3,7,6510000000,28.9%
Q9CR89,0.751736923,-0.028333333,3.812803484,0.117333333,0.415642216,0.868211577,-0.013,0.113,-0.361,0.069,0.04,-0.018,Q9CR89,Ergic2,Q9CR89_Ergic2,Q9CR89,Ergic2,1,2,2,2,Q9CR89|Q9CR89-2,MOUSE,42766.2,8.4,2415,2415.1,31.32,31.32,,377,Endoplasmic reticulum-Golgi intermediate compartment protein 2,nucleus|nucleolus|cytoplasm|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|membrane|integral component of membrane|endoplasmic reticulum-Golgi intermediate compartment membrane|intracellular membrane-bounded organelle|,ER to Golgi vesicle-mediated transport|,,2,2,168000000,8.4%
P50543,0.956972055,0.0205,0.615970874,0.027,0.867766565,0.173072926,-0.106,-0.216,0.343,-0.034,0.103,0.033,P50543,S100a11,P50543_S100a11,P50543,S100a11,1,2,2,2,P50543,MOUSE,11253.7,27.5,2416,2416.1,31.3,31.3,,98,Protein S100-A11,ruffle|extracellular space|nucleoplasm|cytoplasm|extracellular exosome|,regulation of cell proliferation|spermatogenesis|,calcium ion binding|protein homodimerization activity|S100 protein binding|calcium-dependent protein binding|,2,2,73700000,27.5%
Q9DBE9,0.634404848,-0.015166667,5.715974697,-0.241,0.268165269,-1.208729721,-0.311,0.197,0.43,-0.024,-0.318,-0.065,Q9DBE9,Ftsj3,Q9DBE9_Ftsj3,Q9DBE9,Ftsj3,1,3,3,3,Q9DBE9,MOUSE,95930,4.5,2417,2417.1,31.24,31.24,,838,pre-rRNA processing protein FTSJ3,"nucleus|nucleolus|preribosome, small subunit precursor|",enzyme-directed rRNA 2'-O-methylation|,rRNA methyltransferase activity|poly(A) RNA binding|,3,3,99300000,4.5%
Q9JJ06,0.000366358,-0.077,52.82144244,1.057333333,5.22223E-06,13.04825766,-0.578,-0.606,-0.633,0.389,0.485,0.481,Q9JJ06,C1galt1,Q9JJ06_C1galt1,Q9JJ06,C1galt1,1,7,3,3,Q9JJ06,MOUSE,42759.8,11,2418,2418.1,31.21,31.21,,363,Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1,integral component of membrane|,"angiogenesis|kidney development|protein O-linked glycosylation|O-glycan processing, core 1|intestinal epithelial cell development|",galactosyltransferase activity|glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity|metal ion binding|,3,7,407000000,11.0%
O08705,0.657241764,-0.074666667,5.221014436,0.266666667,0.300537422,1.122931033,-0.017,0.148,-0.755,0.223,-0.015,-0.032,O08705,Slc10a1,O08705_Slc10a1,O08705,Slc10a1,1,19,2,2,O08705,MOUSE,39869,11,2419,2419.1,31.2,31.2,,362,Sodium/bile acid cotransporter,integral component of plasma membrane|membrane|basolateral plasma membrane|,sodium ion transport|bile acid and bile salt transport|transmembrane transport|,bile acid:sodium symporter activity|,2,19,38600000000,11.0%
Q91WM6,0.108483191,0.041,19.58646306,0.352,0.010999012,3.481324669,-0.154,-0.129,-0.122,0.353,0.06,0.238,Q91WM6,Eva1a,Q91WM6_Eva1a,Q91WM6,Eva1a,1,4,2,2,Q91WM6,MOUSE,18095.1,16,2420,2420.1,31.2,31.2,,156,Protein eva-1 homolog A,lysosomal membrane|endoplasmic reticulum membrane|plasma membrane|integral component of membrane|intracellular membrane-bounded organelle|,autophagy|apoptotic process|,,2,4,98600000,16.0%
O54946,0.956972055,0.007333333,0.61968602,-0.015333333,0.867024556,-0.173977914,0.039,0.034,-0.028,0.086,-0.096,0.009,O54946,Dnajb6,O54946_Dnajb6,O54946,Dnajb6,1,4,3,2,O54946|A0A0G2JER9|O54946-2|Q9QYI8|G3X8S5|A0A0G2JEI3,MOUSE,39863.6,8.7,2421,2421.1,31.14,12.92,,365,DnaJ homolog subfamily B member 6,nucleus|nucleoplasm|cytoplasm|cytosol|membrane|Z disc|perinuclear region of cytoplasm|,"protein folding|actin cytoskeleton organization|extracellular matrix organization|positive regulation of ATPase activity|protein localization to nucleus|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|intermediate filament organization|negative regulation of transcription, DNA-templated|chorio-allantoic fusion|syncytiotrophoblast cell differentiation involved in labyrinthine layer development|chorion development|chaperone-mediated protein folding|negative regulation of inclusion body assembly|",ATPase activator activity|DNA binding|protein binding|heat shock protein binding|protein binding involved in protein folding|unfolded protein binding|chaperone binding|,3,4,524000000,8.7%
Q8K4L0,0.995757571,-0.06,0.050271453,-0.002,0.988491308,-0.014977727,0.016,0.105,-0.298,0.076,-0.164,-0.095,Q8K4L0,Ddx54,Q8K4L0_Ddx54,Q8K4L0,Ddx54,1,3,3,3,Q8K4L0,MOUSE,98088.5,6,2422,2422.1,31.12,31.12,,874,ATP-dependent RNA helicase DDX54,nucleus|nucleolus|membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|RNA processing|RNA secondary structure unwinding|RNA metabolic process|negative regulation of nucleic acid-templated transcription|",transcription corepressor activity|ATP-dependent RNA helicase activity|receptor binding|ATP binding|estrogen receptor binding|poly(A) RNA binding|,3,3,88100000,6.0%
Q9DAM5,0.276153669,-0.050166667,13.47237011,-0.252333333,0.044953446,-2.460578601,0.021,0.062,0.145,-0.015,-0.263,-0.251,Q9DAM5,Slc25a19,Q9DAM5_Slc25a19,Q9DAM5,Slc25a19,1,3,3,3,Q9DAM5,MOUSE,36016.9,6.6,2423,2423.1,31.12,31.12,,318,Mitochondrial thiamine pyrophosphate carrier,nucleus|mitochondrion|mitochondrial inner membrane|integral component of membrane|,positive regulation of defense response to virus by host|transmembrane transport|,,3,3,2430000000,6.6%
G3UWD9,0.91325,0.004,1.369934562,-0.052666667,0.729468502,-0.360825367,0.021,0.143,-0.073,0.255,-0.25,-0.072,G3UWD9,Slc17a3,G3UWD9_Slc17a3,G3UWD9,Slc17a3,1,6,3,3,G3UWD9|Q5SZ93,MOUSE,55026.6,6.2,2424,2424.1,31.11,31.11,,498,"Solute carrier family 17 (Sodium phosphate), member 3, isoform CRA_c",cytoplasm|endoplasmic reticulum membrane|integral component of plasma membrane|apical plasma membrane|perinuclear region of cytoplasm|,drug transmembrane transport|organic anion transport|urate transport|drug transport|phosphate ion transmembrane transport|sodium ion transmembrane transport|sodium-dependent phosphate transport|urate metabolic process|toxin transport|organic acid transmembrane transport|regulation of anion transmembrane transport|,sodium:phosphate symporter activity|voltage-gated anion channel activity|organic anion transmembrane transporter activity|urate transmembrane transporter activity|drug transmembrane transporter activity|sodium-dependent phosphate transmembrane transporter activity|efflux transmembrane transporter activity|toxin transporter activity|,3,6,205000000,6.2%
P49722,0.584741827,-0.072833333,6.65249727,0.260333333,0.216147528,1.367286858,0.017,-0.012,-0.614,0.012,0.232,-0.072,P49722,Psma2,P49722_Psma2,P49722,Psma2,1,3,2,2,P49722,MOUSE,26040.2,14.9,2425,2425.1,31.08,31.08,,234,Proteasome subunit alpha type-2,"proteasome complex|cytoplasmic mRNA processing body|nucleus|cytoplasm|cytosol|proteasome core complex|proteasome core complex, alpha-subunit complex|extracellular exosome|",response to virus|proteasomal ubiquitin-independent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|,endopeptidase activity|threonine-type endopeptidase activity|,2,3,107000000,14.9%
Q6PEM6,0.227945036,0.008666667,14.87267901,0.349333333,0.032563577,2.694642999,-0.144,0.031,-0.385,0.301,0.156,0.093,Q6PEM6,Gramd3,Q6PEM6_Gramd3,Q6PEM6,Gramd2b,1,3,2,2,Q6PEM6|Q9D2W5,MOUSE,49670.9,9.6,2426,2426.1,31.07,31.07,,445,GRAM domain-containing protein 2B,cytoplasmic microtubule|,,,2,3,301000000,9.6%
Q8K4P0,0.841301073,-0.000666667,2.522993187,0.065333333,0.559371946,0.61425089,-0.055,0.128,-0.173,-0.003,0.11,-0.011,Q8K4P0,Wdr33,Q8K4P0_Wdr33,Q8K4P0,Wdr33,1,6,3,3,Q8K4P0|D3YX80,MOUSE,145721.1,2.1,2427,2427.1,31.02,31.02,,1330,pre-mRNA 3' end processing protein WDR33,collagen trimer|nucleus|nucleoplasm|nucleolus|mRNA cleavage and polyadenylation specificity factor complex|,mRNA polyadenylation|mRNA cleavage|,poly(A) RNA binding|,3,6,762000000,2.1%
Q8BZW8,0.926033297,-0.004,1.075023076,0.036666667,0.780724292,0.289951456,-0.007,0.069,-0.129,-0.208,0.188,0.063,Q8BZW8,Nhlrc2,Q8BZW8_Nhlrc2,Q8BZW8,Nhlrc2,1,6,3,3,Q8BZW8,MOUSE,79284.5,5.7,2428,2428.1,30.98,30.98,,725,NHL repeat-containing protein 2,,,,3,6,5420000000,5.7%
Q8BGQ1,0.473411328,0.018333333,8.70196112,0.214,0.134835388,1.702869421,-0.04,-0.108,-0.118,0.313,-0.116,0.179,Q8BGQ1,Vipas39,Q8BGQ1_Vipas39,Q8BGQ1,Vipas39,1,6,5,5,Q8BGQ1|Q8BGQ1-2,MOUSE,56909.2,9.1,2429,2429.1,30.84,30.84,,491,Spermatogenesis-defective protein 39 homolog,cytoplasm|early endosome|late endosome|cytoplasmic membrane-bounded vesicle|recycling endosome|HOPS complex|,"transcription, DNA-templated|regulation of transcription, DNA-templated|intracellular protein transport|spermatogenesis|endosome to lysosome transport|cell differentiation|",,5,6,145000000,9.1%
E9Q5K9,0.254403188,0.025333333,14.05674415,-0.297333333,0.039293941,-2.5598747,0.134,0.003,0.385,-0.144,-0.09,-0.136,E9Q5K9,Ythdc1,E9Q5K9_Ythdc1,E9Q5K9,Ythdc1,1,4,4,4,E9Q5K9|E9Q5K9-2|E9Q5K9-3|D6RG95,MOUSE,85933,4,2430,2430.1,30.79,30.79,,736,YTH domain-containing protein 1,nucleus|nuclear body|,mRNA splice site selection|,RNA binding|poly(A) RNA binding|N6-methyladenosine-containing RNA binding|,4,4,57700000,4.0%
O54865,0.880641665,-0.03,1.928909181,-0.044666667,0.64137065,-0.487625879,0.039,-0.068,0.006,-0.043,-0.156,0.042,O54865,Gucy1b1,O54865_Gucy1b1,O54865,Gucy1b3,1,3,3,3,O54865|Q80YP4,MOUSE,71395.1,5.9,2431,2431.1,30.79,30.79,,620,Guanylate cyclase soluble subunit beta-1,"cytoplasm|guanylate cyclase complex, soluble|intracellular membrane-bounded organelle|",cGMP biosynthetic process|nitric oxide mediated signal transduction|,guanylate cyclase activity|GTP binding|heme binding|metal ion binding|protein heterodimerization activity|Hsp90 protein binding|,3,3,42300000,5.9%
Q8C116,0.972962155,-0.037,0.389344249,-0.022666667,0.914251276,-0.111858712,0.212,0.162,-0.451,-0.166,0.18,-0.159,Q8C116,Fmo9,Q8C116_Fmo9,Q8C116,Fmo9,1,7,3,3,Q8C116|Q14DT3,MOUSE,61886.5,9,2432,2432.1,30.77,30.77,,539,Flavin-containing monooxygenase,endoplasmic reticulum membrane|,drug metabolic process|oxidation-reduction process|,"N,N-dimethylaniline monooxygenase activity|flavin adenine dinucleotide binding|NADP binding|",3,7,3460000000,9.0%
Q80ZM8,0.935853609,-0.019333333,0.913503476,0.030666667,0.810307115,0.249811526,-0.002,0.161,-0.263,0.017,-0.032,0.003,Q80ZM8,Crls1,Q80ZM8_Crls1,Q80ZM8,Crls1,1,11,2,2,Q80ZM8|E9PUW6|A0A0C3SFZ5,MOUSE,32900.9,13.2,2433,2433.1,30.77,30.77,,303,Cardiolipin synthase (CMP-forming),mitochondrion|mitochondrial inner membrane|integral component of membrane|,phospholipid biosynthetic process|,"phosphotransferase activity, for other substituted phosphate groups|",2,11,1490000000,13.2%
Q8C483,0.581377911,-0.040166667,6.710545137,0.166333333,0.213277719,1.376978674,-0.347,-0.047,0.024,-0.038,0.066,0.101,Q8C483,Sars,Q8C483_Sars,Q8C483,Sars,1,7,4,4,Q8C483|P26638,MOUSE,61679.4,10.8,2434,2434.1,30.76,30.76,,536,"Serine--tRNA ligase, cytoplasmic",cytoplasm|mitochondrion|extracellular exosome|,seryl-tRNA aminoacylation|,serine-tRNA ligase activity|ATP binding|,4,7,96600000,10.8%
O09159,0.013471457,-0.003,30.68292802,0.65,0.00085449,5.72795791,-0.443,-0.246,-0.295,0.335,0.158,0.473,O09159,Man2b1,O09159_Man2b1,O09159,Man2b1,1,3,3,3,O09159,MOUSE,115216.7,2.9,2435,2435.1,30.75,30.75,,1013,Lysosomal alpha-mannosidase,lysosome|extracellular exosome|,mannose metabolic process|cellular protein modification process|learning or memory|,alpha-mannosidase activity|mannose binding|zinc ion binding|,3,3,53600000,2.9%
Q8BWW9,0.80559115,0.116833333,3.011123934,0.149666667,0.499905145,0.713508608,-0.045,0.271,-0.1,0.249,-0.221,0.547,Q8BWW9,Pkn2,Q8BWW9_Pkn2,Q8BWW9,Pkn2,1,5,3,3,Q8BWW9|Q8BWW9-2|G3UZM9|G3UXH4|Q8BWW9-3,MOUSE,112460.8,3.1,2436,2436.1,30.72,30.72,,983,Serine/threonine-protein kinase N2,nucleus|nucleoplasm|cytoplasm|centrosome|plasma membrane|lamellipodium|cell junction|midbody|cleavage furrow|protein complex|apical junction complex|intermediate filament cytoskeleton|perinuclear region of cytoplasm|,"transcription, DNA-templated|regulation of transcription, DNA-templated|protein phosphorylation|apoptotic process|cell cycle|cell adhesion|signal transduction|epithelial cell migration|positive regulation of cytokinesis|apical junction assembly|positive regulation of viral genome replication|positive regulation of mitotic cell cycle|cell division|regulation of cell motility|",protein serine/threonine kinase activity|protein kinase C activity|protein binding|ATP binding|kinase activity|histone deacetylase binding|poly(A) RNA binding|RNA polymerase binding|,3,5,35300000000,3.1%
Q8VE95,0.713417662,0.033833333,4.320050698,-0.119666667,0.369823863,-0.96208426,0.039,0.33,-0.088,0.029,-0.04,-0.067,Q8VE95,C030006K11Rik,Q8VE95_C030006K11Rik,Q8VE95,,1,6,3,3,Q8VE95,MOUSE,24671.7,12.8,2437,2437.1,30.72,30.72,,218,UPF0598 protein C8orf82 homolog,,,,3,6,243000000,12.8%
B2RRE7,0.91325,-0.007833333,1.356511357,0.053,0.731726636,0.357662372,-0.295,0.099,0.093,-0.053,-0.106,0.215,B2RRE7,Otud4,B2RRE7_Otud4,B2RRE7,Otud4,1,3,3,3,B2RRE7|A0A0R4J260,MOUSE,123965.9,3.5,2438,2438.1,30.67,30.67,,1107,OTU domain-containing protein 4,,protein K48-linked deubiquitination|,ubiquitin-specific protease activity|poly(A) RNA binding|,3,3,35700000,3.5%
Q4KL35,0.91325,-0.0085,1.368296215,-0.029,0.729743741,-0.360262918,-0.038,0.034,0.022,-0.069,0.014,-0.014,Q4KL35,Magix,Q4KL35_Magix,Q4KL35,Magix,1,6,3,3,Q4KL35,MOUSE,34884.8,10.4,2439,2439.1,30.67,30.67,,324,PDZ domain-containing protein MAGIX,,,,3,6,397000000,10.4%
Q64505,0.64621906,-0.004666667,5.451871517,0.282666667,0.284978994,1.163146283,-0.083,0.262,-0.617,0.423,-0.091,0.078,Q64505,Cyp7a1,Q64505_Cyp7a1,Q64505,Cyp7a1,1,3,3,3,Q64505,MOUSE,57774.7,11.9,2440,2440.1,30.63,30.63,,503,Cholesterol 7-alpha-monooxygenase,endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,bile acid biosynthetic process|cholesterol catabolic process|cholesterol homeostasis|oxidation-reduction process|regulation of bile acid biosynthetic process|positive regulation of bile acid biosynthetic process|cellular response to glucose stimulus|cellular response to cholesterol|,iron ion binding|cholesterol 7-alpha-monooxygenase activity|heme binding|,3,3,93500000,11.9%
Q9D939,0.773512169,-0.062333333,3.517812095,0.145333333,0.444855322,0.812279474,-0.014,0.054,-0.445,0.187,0.106,-0.262,Q9D939,Sult1c2,Q9D939_Sult1c2,Q9D939,Sult1c2,1,4,2,2,Q9D939,MOUSE,35180.7,12.5,2442,2442.1,30.61,30.61,,296,Sulfotransferase 1C2,lysosome|extracellular exosome|,sulfation|,sulfotransferase activity|,2,4,1250000000,12.5%
Q9CR51,0.70831983,0.003666667,4.427097925,0.112666667,0.360819672,0.981284978,0.049,-0.051,-0.156,0.21,0.083,-0.113,Q9CR51,Atp6v1g1,Q9CR51_Atp6v1g1,Q9CR51,Atp6v1g1,1,3,2,2,Q9CR51,MOUSE,13838.3,22,2443,2443.1,30.58,30.58,,118,V-type proton ATPase subunit G 1,intracellular|lysosomal membrane|cytosol|plasma membrane|vacuolar proton-transporting V-type ATPase complex|extracellular exosome|synaptic vesicle|,hydrogen ion transmembrane transport|,"protein binding|hydrogen-exporting ATPase activity, phosphorylative mechanism|ATPase activity|ATPase binding|",2,3,778000000,22.0%
Q8BZA9,0.858120828,-0.0425,2.234065493,0.088333333,0.597851676,0.5538972,0.119,0.064,-0.443,0.05,-0.032,-0.013,Q8BZA9,Tigar,Q8BZA9_Tigar,Q8BZA9,Tigar,1,4,2,2,Q8BZA9,MOUSE,29589.4,15.2,2444,2444.1,30.45,30.45,,269,"Fructose-2,6-bisphosphatase TIGAR",intracellular|nucleus|cytoplasm|mitochondrion|mitochondrial outer membrane|cytosol|,"fructose 2,6-bisphosphate metabolic process|cellular response to DNA damage stimulus|response to xenobiotic stimulus|response to gamma radiation|positive regulation of cardiac muscle cell apoptotic process|dephosphorylation|fructose 1,6-bisphosphate metabolic process|negative regulation of kinase activity|negative regulation of programmed cell death|regulation of pentose-phosphate shunt|positive regulation of DNA repair|negative regulation of glycolytic process|intestinal epithelial cell development|cellular response to hypoxia|negative regulation of neuron death|negative regulation of macromitophagy|regulation of response to DNA damage checkpoint signaling|positive regulation of hexokinase activity|negative regulation of glucose catabolic process to lactate via pyruvate|negative regulation of reactive oxygen species metabolic process|","bisphosphoglycerate 2-phosphatase activity|fructose-2,6-bisphosphate 2-phosphatase activity|",2,4,115000000,15.2%
P51830,0.965288537,-0.047333333,0.471460047,-0.015333333,0.89712714,-0.134317116,0.079,-0.002,-0.196,0.026,-0.202,0.011,P51830,Adcy9,P51830_Adcy9,P51830,Adcy9,1,4,3,3,P51830|E9Q706,MOUSE,153176.6,2.4,2445,2445.1,30.4,30.4,,1353,Adenylate cyclase type 9,intracellular|plasma membrane|integral component of membrane|,cAMP biosynthetic process|activation of adenylate cyclase activity|intracellular signal transduction|,adenylate cyclase activity|ATP binding|metal ion binding|,3,4,142000000,2.4%
G3X9H7,0.045982527,-0.052166667,24.05369069,1.081666667,0.003932158,4.327141078,-0.449,-0.195,-1.135,0.251,0.553,0.662,G3X9H7,Mtss1,G3X9H7_Mtss1,G3X9H7,Mtss1,1,3,3,3,G3X9H7|Q8R1S4|Q8R1S4-2,MOUSE,83048.4,9.2,2446,2446.1,30.38,30.38,,759,"Metastasis suppressor 1, isoform CRA_e",cytoplasm|adherens junction|actin cytoskeleton|,in utero embryonic development|positive regulation of defense response to virus by host|plasma membrane organization|actin filament organization|magnesium ion homeostasis|actin filament polymerization|bone mineralization|positive regulation of actin filament bundle assembly|adherens junction maintenance|renal system development|,actin binding|actin monomer binding|receptor binding|identical protein binding|actin filament binding|,3,3,83900000,9.2%
Q01237,0.015548689,-0.06,29.76306668,1.04,0.001056072,5.535101975,-0.49,-0.46,-0.79,0.544,0.089,0.747,Q01237,Hmgcr,Q01237_Hmgcr,Q01237,Hmgcr,1,6,4,4,Q01237|F2Z470,MOUSE,98578.5,6,2447,2447.1,30.35,30.35,,887,3-hydroxy-3-methylglutaryl-coenzyme A reductase,intracellular|peroxisomal membrane|endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,cholesterol biosynthetic process|ubiquinone metabolic process|aging|response to nutrient|isoprenoid biosynthetic process|visual learning|negative regulation of striated muscle cell apoptotic process|positive regulation of cardiac muscle cell apoptotic process|coenzyme A metabolic process|positive regulation of stress-activated MAPK cascade|negative regulation of MAP kinase activity|myoblast differentiation|response to ethanol|negative regulation of vasodilation|positive regulation of skeletal muscle tissue development|positive regulation of smooth muscle cell proliferation|protein tetramerization|oxidation-reduction process|negative regulation of wound healing|negative regulation of insulin secretion involved in cellular response to glucose stimulus|positive regulation of ERK1 and ERK2 cascade|,hydroxymethylglutaryl-CoA reductase (NADPH) activity|hydroxymethylglutaryl-CoA reductase activity|protein homodimerization activity|coenzyme binding|protein phosphatase 2A binding|NADPH binding|,4,6,78000000,6.0%
Q99J23,0.873222165,-0.052833333,2.05254963,-0.063,0.623368764,-0.514890949,0.043,0.085,-0.192,0.018,-0.261,-0.01,Q99J23,Ghdc,Q99J23_Ghdc,Q99J23,Ghdc,1,4,2,2,Q99J23,MOUSE,59305.3,5.8,2448,2448.1,30.33,30.33,,532,GH3 domain-containing protein,nuclear envelope|endoplasmic reticulum|membrane|,,,2,4,144000000,5.8%
Q8VDC1,0.391635111,0.0045,10.5693131,0.241666667,0.087713954,2.001997979,-0.161,-0.255,0.067,0.089,0.019,0.268,Q8VDC1,Fyco1,Q8VDC1_Fyco1,Q8VDC1,Fyco1,1,6,4,4,Q8VDC1,MOUSE,164159.2,4.5,2449,2449.1,30.32,30.32,,1437,FYVE and coiled-coil domain-containing protein 1,lysosome|late endosome|autophagosome|membrane|integral component of membrane|cytoplasmic vesicle|,plus-end-directed vesicle transport along microtubule|,metal ion binding|,4,6,596000000,4.5%
E9QAQ5,0.374561053,0.034833333,10.93825309,-0.314333333,0.080570246,-2.060867818,-0.119,0.242,0.453,-0.146,-0.165,-0.056,E9QAQ5,Gsk3b,E9QAQ5_Gsk3b,E9QAQ5,Gsk3b,1,4,3,2,E9QAQ5|Q9WV60,MOUSE,48502.3,10.8,2450,2450.1,30.28,17.88,,433,Glycogen synthase kinase-3 beta,nucleus|nucleoplasm|cytoplasm|centrosome|cytosol|plasma membrane|growth cone|ribonucleoprotein complex|beta-catenin destruction complex|neuronal cell body|dendritic shaft|membrane-bounded organelle|cell body|neuronal postsynaptic density|,re-entry into mitotic cell cycle|epithelial to mesenchymal transition|positive regulation of cell-matrix adhesion|glycogen metabolic process|protein phosphorylation|protein export from nucleus|ER overload response|axonogenesis|myoblast fusion|cell proliferation|organ morphogenesis|negative regulation of cardiac muscle hypertrophy|positive regulation of peptidyl-threonine phosphorylation|regulation of neuron projection development|negative regulation of neuron projection development|negative regulation of neuron maturation|myotube differentiation|Wnt signaling pathway|cell migration|peptidyl-serine phosphorylation|hippocampus development|negative regulation of protein complex assembly|positive regulation of protein complex assembly|negative regulation of protein binding|positive regulation of protein binding|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|regulation of microtubule-based process|positive regulation of peptidyl-serine phosphorylation|protein localization to microtubule|intracellular signal transduction|negative regulation of apoptotic process|positive regulation of GTPase activity|fat cell differentiation|positive regulation of axon extension|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|positive regulation of protein export from nucleus|negative regulation of NFAT protein import into nucleus|canonical Wnt signaling pathway|superior temporal gyrus development|positive regulation of stem cell differentiation|,RNA polymerase II transcription factor binding|p53 binding|protein kinase activity|protein serine/threonine kinase activity|protein binding|ATP binding|beta-catenin binding|kinase activity|protein kinase binding|ubiquitin protein ligase binding|protein kinase A catalytic subunit binding|tau-protein kinase activity|NF-kappaB binding|,3,4,150000000,10.8%
Q5H8C4,0.708612439,-0.065333333,4.396685035,-0.115333333,0.363355298,-0.975903325,0.083,0.083,-0.189,0.014,-0.145,-0.238,Q5H8C4,Vps13a,Q5H8C4_Vps13a,Q5H8C4,Vps13a,1,4,4,4,Q5H8C4|Q5H8C4-2|A0A286YCT3,MOUSE,361162.8,2.1,2451,2451.1,30.25,30.25,,3166,Vacuolar protein sorting-associated protein 13A,extrinsic component of membrane|dense core granule|,protein targeting to vacuole|nervous system development|locomotory behavior|social behavior|protein retention in Golgi apparatus|,,4,4,113000000,2.1%
Q9JJL8,0.614913894,-0.004166667,6.074125903,-0.227666667,0.246937706,-1.269892659,-0.228,0.313,0.244,-0.352,-0.059,0.057,Q9JJL8,Sars2,Q9JJL8_Sars2,Q9JJL8,Sars2,1,3,3,3,Q9JJL8,MOUSE,58828.9,9,2452,2452.1,30.23,30.23,,518,"Serine--tRNA ligase, mitochondrial",cytoplasm|mitochondrion|mitochondrial matrix|,seryl-tRNA aminoacylation|selenocysteinyl-tRNA(Sec) biosynthetic process|,serine-tRNA ligase activity|ATP binding|poly(A) RNA binding|,3,3,36200000,9.0%
Q9CRT8,0.472136605,-0.0115,8.764472164,-0.179666667,0.132908508,-1.710612646,0.143,0.061,0.031,0.006,-0.036,-0.274,Q9CRT8,NotFound,Q9CRT8_NotFound,Q9CRT8,Xpot,1,4,2,2,A0A1W2P7Q6|Q9CRT8,MOUSE,110929.9,2.6,2453,2453.1,30.22,30.22,,963,Exportin-T,nucleoplasm|cytoplasm|nuclear pore|,tRNA export from nucleus|intracellular protein transport|,tRNA binding|Ran GTPase binding|,2,4,101000000,2.6%
Q8C166,0.470565279,0.017666667,8.844389989,0.149333333,0.130485124,1.723029497,-0.114,-0.031,-0.026,0.003,0.132,0.142,Q8C166,Cpne1,Q8C166_Cpne1,Q8C166,Cpne1,1,4,3,2,Q8C166|B7ZCP4|E9Q806|V9GWY2,MOUSE,59627.1,7,2454,2454.1,30.21,24.02,,536,Copine-1,nucleus|cytoplasm|cytosol|membrane|extracellular exosome|,proteolysis|negative regulation of gene expression|regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of DNA binding|positive regulation of neuron differentiation|positive regulation of protein kinase B signaling|cellular response to calcium ion|negative regulation of NIK/NF-kappaB signaling|positive regulation of tumor necrosis factor-mediated signaling pathway|neuron projection extension|,phosphatidylserine binding|endopeptidase activity|calcium ion binding|protein binding|protein homodimerization activity|NF-kappaB binding|,3,4,320000000,7.0%
Q8BT60,0.406418919,-0.070333333,10.27420859,0.596666667,0.09388131,1.954892478,-0.803,-0.577,0.274,0.089,-0.014,0.609,Q8BT60,Cpne3,Q8BT60_Cpne3,Q8BT60,Cpne3,1,4,3,2,Q8BT60,MOUSE,60325.6,5.2,2454,2454.2,23.62,17.43,,533,Copine-3,nucleus|cytoplasm|cytosol|plasma membrane|extracellular exosome|,protein phosphorylation|cellular response to calcium ion|,protein serine/threonine kinase activity|poly(A) RNA binding|,2,4,410000000,3.5%
E9QPX3,0.491484381,-0.029833333,8.378777306,0.358333333,0.14525205,1.650660449,-0.62,0.095,-0.102,0.395,-0.128,0.181,E9QPX3,Ndufs4,E9QPX3_Ndufs4,E9QPX3,Ndufs4,1,3,2,2,E9QPX3|Q9CXZ1,MOUSE,19859.4,10.8,2455,2455.1,30.21,30.21,,175,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial",mitochondrion|mitochondrial respiratory chain complex I|,regulation of protein phosphorylation|brain development|cAMP-mediated signaling|electron transport chain|mitochondrial respiratory chain complex I assembly|cellular respiration|positive regulation of fibroblast proliferation|response to cAMP|reactive oxygen species metabolic process|,NADH dehydrogenase (ubiquinone) activity|,2,3,923000000,10.8%
Q91VM9,0.634404848,0.032,5.740281343,0.109333333,0.266668591,1.211622919,0.012,-0.036,-0.044,-0.024,0.181,0.103,Q91VM9,Ppa2,Q91VM9_Ppa2,Q91VM9,Ppa2,1,5,3,3,Q91VM9|Q91VM9-2|D3Z636,MOUSE,38570.3,12.4,2456,2456.1,30.2,30.2,,330,"Inorganic pyrophosphatase 2, mitochondrial",mitochondrion|extracellular exosome|,dephosphorylation|,magnesium ion binding|inorganic diphosphatase activity|protein serine/threonine phosphatase activity|,3,5,648000000,12.4%
Q99PG2,0.656833435,-0.013,5.234478983,-0.122,0.299607101,-1.124446655,-0.032,0.144,0.032,-0.218,-0.082,0.078,Q99PG2,Ogfr,Q99PG2_Ogfr,Q99PG2,Ogfr,1,5,4,4,Q99PG2|Q99PG2-2,MOUSE,71248.6,6.7,2457,2457.1,30.18,30.18,,633,Opioid growth factor receptor,nucleus|cytoplasm|membrane|,regulation of growth|,receptor activity|,4,5,207000000,6.7%
Q9CSN1,0.933608247,0.025166667,0.960994404,-0.023,0.801494524,-0.261596806,-0.036,0.006,0.14,0.052,-0.005,-0.006,Q9CSN1,Snw1,Q9CSN1_Snw1,Q9CSN1,Snw1,1,5,4,4,Q9CSN1|A0A0B4J1E2,MOUSE,61531.4,7.8,2458,2458.1,30.17,30.17,,536,SNW domain-containing protein 1,nucleus|nucleoplasm|spliceosomal complex|nuclear matrix|catalytic step 2 spliceosome|positive transcription elongation factor complex b|SMAD3-SMAD4 protein complex|,"negative regulation of transcription from RNA polymerase II promoter|mRNA splicing, via spliceosome|transcription, DNA-templated|positive regulation of transforming growth factor beta receptor signaling pathway|skeletal muscle cell differentiation|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator|positive regulation by host of viral transcription|negative regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of mRNA splicing, via spliceosome|retinoic acid receptor signaling pathway|regulation of retinoic acid receptor signaling pathway|positive regulation of neurogenesis|positive regulation of histone H3-K4 methylation|regulation of vitamin D receptor signaling pathway|positive regulation of vitamin D receptor signaling pathway|cellular response to retinoic acid|",transcription coactivator activity|transcription corepressor activity|Notch binding|protein binding|nuclear hormone receptor binding|vitamin D receptor binding|retinoic acid receptor binding|poly(A) RNA binding|SMAD binding|,4,5,177000000,7.8%
Q3TZ02,0.328857596,0.016166667,12.01084667,0.199666667,0.062938347,2.227093925,-0.11,-0.067,-0.074,0.234,0.046,0.068,Q3TZ02,Cyth1,Q3TZ02_Cyth1,Q3TZ02,Cyth1,1,6,4,4,Q3TZ02|Q9Q1|Q9Q1-2|P63034|Q99KH2|P63034-2|O08967|P63034-3|A0A1B0GRX7|G5E8Q4,MOUSE,46904.5,12.2,2459,2459.1,30.17,30.17,,400,Cytohesin-1,plasma membrane|bicellular tight junction|trans-Golgi network|,regulation of cell adhesion|regulation of ARF protein signal transduction|positive regulation of GTPase activity|establishment of epithelial cell polarity|vesicle-mediated transport|,ARF guanyl-nucleotide exchange factor activity|protein binding|,4,6,98000000,12.2%
Q9R013,0.893904414,-0.001666667,1.702106421,0.056666667,0.67575514,0.437370292,-0.249,-0.053,0.212,0.067,-0.006,0.019,Q9R013,Ctsf,Q9R013_Ctsf,Q9R013,Ctsf,1,4,3,3,Q9R013,MOUSE,52287.6,11,2460,2460.1,30.15,30.15,,462,Cathepsin F,extracellular space|lysosome|extracellular exosome|extracellular vesicle|,proteolysis involved in cellular protein catabolic process|,cysteine-type endopeptidase activity|cysteine-type peptidase activity|,3,4,42200000,11.0%
Q9CWZ7,0.960902246,0.071166667,0.584575829,0.026333333,0.874062357,0.164744386,-0.066,-0.133,0.373,0.247,-0.052,0.058,Q9CWZ7,Napg,Q9CWZ7_Napg,Q9CWZ7,Napg,1,4,3,3,Q9CWZ7,MOUSE,35074,11.8,2461,2461.1,30.13,30.13,,312,Gamma-soluble NSF attachment protein,mitochondrion|lysosomal membrane|vacuolar membrane|SNARE complex|myelin sheath|extracellular exosome|,intracellular protein transport|vesicle-mediated transport|membrane fusion|,soluble NSF attachment protein activity|syntaxin binding|,3,4,60400000,11.8%
Q921M7,0.773512169,0.08,3.547111696,-0.156,0.441864214,-0.81788319,0.055,-0.058,0.477,0.311,-0.185,-0.12,Q921M7,Fam49b,Q921M7_Fam49b,Q921M7,Fam49b,1,3,3,3,Q921M7|Q8BHZ0,MOUSE,37060.6,12.6,2462,2462.1,30.07,30.07,,324,Protein FAM49B,cilium|extracellular exosome|,,protein binding|,3,3,110000000,12.6%
A8DIL0,0.473411328,-0.05,8.681739494,0.234,0.135464672,1.699608213,-0.045,0.002,-0.458,0.022,0.099,0.08,A8DIL0,Lgals8,A8DIL0_Lgals8,A8DIL0,Lgals8,1,3,3,3,A8DIL0|Q9JL15|Q8C6H0,MOUSE,37237.1,8.6,2463,2463.1,30.05,30.05,,325,Galectin,membrane|extracellular exosome|,plasma cell differentiation|T cell costimulation|,carbohydrate binding|,3,3,76700000,8.6%
Q9DB16,0.634404848,0.000166667,5.676131489,0.175,0.270636801,1.201880315,0.106,-0.021,-0.347,0.251,0.053,-0.041,Q9DB16,Cab39l,Q9DB16_Cab39l,Q9DB16,Cab39l,1,4,3,2,Q9DB16|Q9DB16-2,MOUSE,39333.1,8.9,2464,2464.1,30.03,21.93,,337,Calcium-binding protein 39-like,extracellular exosome|,,,3,4,94000000,8.9%
Q99MZ3,0.268140406,0.004166667,13.69440068,0.255666667,0.042712986,2.496251551,-0.12,0.003,-0.254,0.13,0.216,0.05,Q99MZ3,Mlxipl,Q99MZ3_Mlxipl,Q99MZ3,Mlxipl,1,7,4,4,Q99MZ3|Q99MZ3-2|Q99MZ3-3|Q99MZ3-4|Q99MZ3-5|A0A0J9YUT0,MOUSE,95500.9,6.7,2465,2465.1,29.98,29.98,,864,Carbohydrate-responsive element-binding protein,nucleus|nucleoplasm|transcription factor complex|cytoplasm|cytosol|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|positive regulation of cell proliferation|glucose mediated signaling pathway|negative regulation of peptidyl-serine phosphorylation|glucose homeostasis|positive regulation of fatty acid biosynthetic process|positive regulation of glycolytic process|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of lipid biosynthetic process|fatty acid homeostasis|negative regulation of cell cycle arrest|cellular response to carbohydrate stimulus|negative regulation of oxidative phosphorylation|regulation of energy homeostasis|",RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription|protein binding|transcription factor binding|carbohydrate response element binding|protein heterodimerization activity|DNA binding|,4,7,1150000000,6.7%
P70670,0.609221717,-0.0135,6.194624863,0.117666667,0.240180372,1.288855423,-0.157,-0.006,-0.054,-0.009,0.006,0.139,P70670,Naca,P70670_Naca,P70670,Naca,1,6,2,2,P70670|Q60817,MOUSE,221408.1,1.2,2466,2466.1,29.97,29.97,,2187,"Nascent polypeptide-associated complex subunit alpha, muscle-specific form",nucleus|cytoplasm|extracellular exosome|,"transcription, DNA-templated|regulation of transcription, DNA-templated|transport|myoblast migration|",DNA binding|transcription coactivator activity|TBP-class protein binding|,2,6,419000000,1.2%
Q99M51,0.904214516,0.009666667,1.559864318,-0.034666667,0.698254219,-0.404781043,-0.07,0.079,0.072,-0.022,-0.019,0.018,Q99M51,Nck1,Q99M51_Nck1,Q99M51,Nck1,1,5,4,4,Q99M51|Q8BH99|O55033,MOUSE,43118,11.1,2467,2467.1,29.94,29.94,,377,Cytoplasmic protein NCK1,protein phosphatase type 1 complex|nucleus|cytoplasm|endoplasmic reticulum|ribosome|plasma membrane|cell-cell junction|vesicle membrane|,"negative regulation of protein kinase activity|substrate-dependent cell migration, cell extension|actin filament organization|cell migration|lamellipodium assembly|positive regulation of actin filament polymerization|negative regulation of peptidyl-serine phosphorylation|positive regulation of translation in response to endoplasmic reticulum stress|positive regulation of T cell proliferation|T cell activation|positive regulation of transcription from RNA polymerase II promoter|response to other organism|negative regulation of cell death|peptidyl-serine dephosphorylation|positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|positive regulation of cap-dependent translational initiation|positive regulation of cap-independent translational initiation|negative regulation of PERK-mediated unfolded protein response|negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation|negative regulation of cyclin-dependent protein kinase activity|negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress|",protein kinase inhibitor activity|receptor binding|protein binding|protein domain specific binding|receptor tyrosine kinase binding|eukaryotic initiation factor eIF2 binding|,4,5,1100000000,11.1%
P50518,0.928824475,0.0095,1.027737958,0.024333333,0.789271106,0.278173265,-0.045,-0.038,0.075,-0.052,0.082,0.035,P50518,Atp6v1e1,P50518_Atp6v1e1,P50518,Atp6v1e1,1,3,2,2,P50518,MOUSE,26214,11.9,2468,2468.1,29.91,29.91,,226,V-type proton ATPase subunit E 1,"cytoplasm|mitochondrion|lysosomal membrane|endosome|cytosol|microvillus|apical plasma membrane|proton-transporting two-sector ATPase complex, catalytic domain|extracellular exosome|",metabolic process|ATP hydrolysis coupled proton transport|,"protein binding|hydrogen-exporting ATPase activity, phosphorylative mechanism|proton-transporting ATPase activity, rotational mechanism|ATPase binding|",2,3,177000000,11.9%
Q3UEB3-2,0.706444596,-0.003,4.448084397,0.240666667,0.359080284,0.985366746,-0.003,0.28,-0.647,0.352,-0.027,0.027,Q3UEB3,Puf60,Q3UEB3-2_Puf60,Q3UEB3-2,Puf60,1,5,3,3,Q3UEB3-2|Q3UEB3-3|Q3UEB3,MOUSE,58715,9.1,2469,2469.1,29.85,29.85,,564,Isoform 2 of Poly(U)-binding-splicing factor PUF60,nucleoplasm|mitochondrion|Golgi apparatus|ribonucleoprotein complex|cyclin-dependent protein kinase activating kinase holoenzyme complex|,"transcription, DNA-templated|regulation of transcription, DNA-templated|mRNA processing|apoptotic process|RNA splicing|",nucleotide binding|DNA binding|identical protein binding|poly(A) RNA binding|,3,5,21200000,9.1%
Q8R5L1,0.580760484,0.011166667,6.736508536,0.347,0.212006485,1.381309076,-0.389,-0.389,0.291,0.022,-0.067,0.599,Q8R5L1,C1qbp,Q8R5L1_C1qbp,Q8R5L1,C1qbp,1,4,2,2,Q8R5L1|O35658,MOUSE,31366.7,12.5,2470,2470.1,29.82,29.82,,279,"Complement component 1 Q subcomponent-binding protein, mitochondrial",extracellular space|nucleus|mitochondrion|mitochondrial matrix|cytosol|cell surface|membrane|,"negative regulation of transcription from RNA polymerase II promoter|phosphatidylinositol 3-kinase signaling|regulation of complement activation|negative regulation of interferon-gamma production|negative regulation of interleukin-12 production|negative regulation of MDA-5 signaling pathway|negative regulation of RIG-I signaling pathway|mature ribosome assembly|positive regulation of apoptotic process|positive regulation of cell adhesion|negative regulation of mRNA splicing, via spliceosome|negative regulation of defense response to virus|positive regulation of protein kinase B signaling|positive regulation of neutrophil chemotaxis|positive regulation of substrate adhesion-dependent cell spreading|positive regulation of trophoblast cell migration|positive regulation of dendritic cell chemotaxis|",complement component C1q binding|transcription corepressor activity|protein kinase C binding|hyaluronic acid binding|transcription factor binding|kininogen binding|adrenergic receptor binding|,2,4,334000000,12.5%
Q99LY9,0.952589741,0.048833333,0.708927074,0.038333333,0.849390291,0.197463816,-0.052,0.441,-0.3,0.215,0.008,-0.019,Q99LY9,Ndufs5,Q99LY9_Ndufs5,Q99LY9,Ndufs5,1,5,3,3,Q99LY9,MOUSE,12875.7,30.1,2471,2471.1,29.77,29.77,,106,NADH dehydrogenase [ubiquinone] iron-sulfur protein 5,mitochondrion|mitochondrial inner membrane|mitochondrial intermembrane space|respiratory chain|,mitochondrial respiratory chain complex I assembly|oxidation-reduction process|,,3,5,633000000,30.1%
O70494,0.556074497,0.028833333,7.153676853,0.263,0.192589371,1.450529081,-0.304,-0.041,0.037,0.512,-0.116,0.085,O70494,Sp3,O70494_Sp3,O70494,Sp3,1,2,2,2,O70494|O70494-2|O70494-3,MOUSE,82931,5.7,2472,2472.1,29.74,29.74,,783,Transcription factor Sp3,nucleus|nucleoplasm|cytoplasm|Golgi apparatus|plasma membrane|PML body|transcriptional repressor complex|,"negative regulation of transcription from RNA polymerase II promoter|ossification|in utero embryonic development|natural killer cell differentiation|trophectodermal cell differentiation|liver development|embryonic placenta development|transcription, DNA-templated|regulation of transcription, DNA-templated|B cell differentiation|T cell differentiation|erythrocyte differentiation|megakaryocyte differentiation|monocyte differentiation|lung development|granulocyte differentiation|enucleate erythrocyte differentiation|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|embryonic camera-type eye morphogenesis|embryonic skeletal system development|embryonic process involved in female pregnancy|definitive hemopoiesis|",RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II core promoter sequence-specific DNA binding|core promoter proximal region sequence-specific DNA binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription|DNA binding|chromatin binding|double-stranded DNA binding|sequence-specific DNA binding transcription factor activity|protein binding|metal ion binding|,2,2,21900000,5.7%
O35657,0.798009538,0.0235,3.092952468,0.069,0.490574255,0.729225121,0,-0.066,0.033,0.181,-0.046,0.039,O35657,Neu1,O35657_Neu1,O35657,Neu1,1,7,4,4,O35657,MOUSE,45046.9,8.8,2473,2473.1,29.7,29.7,,409,Sialidase-1,lysosome|lysosomal membrane|plasma membrane|cell surface|cytoplasmic membrane-bounded vesicle|cell junction|lysosomal lumen|intracellular membrane-bounded organelle|extracellular exosome|,oligosaccharide catabolic process|positive regulation of neuron projection development|lipid catabolic process|regulation of myoblast proliferation|,exo-alpha-sialidase activity|protein binding|exo-alpha-(2->3)-sialidase activity|exo-alpha-(2->6)-sialidase activity|exo-alpha-(2->8)-sialidase activity|,4,7,1110000000,8.8%
O55236,0.995757571,-0.002,0.053266197,-0.001333333,0.987809913,-0.01585775,0.042,-0.002,-0.044,0.05,0.019,-0.077,O55236,Rngtt,O55236_Rngtt,O55236,Rngtt,1,5,3,3,O55236|Q9DCC1,MOUSE,69538.6,6.3,2474,2474.1,29.56,29.56,,597,mRNA-capping enzyme,nucleus|,7-methylguanosine mRNA capping|RNA processing|peptidyl-tyrosine dephosphorylation|polynucleotide 5' dephosphorylation|,mRNA guanylyltransferase activity|polynucleotide 5'-phosphatase activity|protein tyrosine phosphatase activity|GTP binding|protein tyrosine/serine/threonine phosphatase activity|RNA guanylyltransferase activity|triphosphatase activity|,3,5,941000000,6.3%
Q8BXZ1,0.00097296,-0.312333333,44.77360791,2.234,3.3315E-05,9.883822033,-1.592,-1.795,-0.901,0.791,0.885,0.738,Q8BXZ1,Tmx3,Q8BXZ1_Tmx3,Q8BXZ1,Tmx3,1,11,3,3,Q8BXZ1,MOUSE,52189.4,7.2,2475,2475.1,29.56,29.56,,456,Protein disulfide-isomerase TMX3,endoplasmic reticulum membrane|cell surface|integral component of membrane|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|,protein disulfide isomerase activity|,3,11,16500000000,7.2%
Q9EQQ2,0.593471457,-0.009,6.436016159,0.133333333,0.227194798,1.329464326,-0.193,0.058,-0.092,-0.006,0.042,0.137,Q9EQQ2,Yipf5,Q9EQQ2_Yipf5,Q9EQQ2,Yipf5,1,4,2,2,Q9EQQ2,MOUSE,28329,8.1,2476,2476.1,29.56,29.56,,257,Protein YIPF5,endoplasmic reticulum membrane|integral component of membrane|ER to Golgi transport vesicle|Golgi cisterna membrane|nuclear outer membrane-endoplasmic reticulum membrane network|endoplasmic reticulum exit site|,protein transport|vesicle-mediated transport|regulation of ER to Golgi vesicle-mediated transport|,,2,4,705000000,8.1%
Q91V01,0.682212667,0.045833333,4.82872884,-0.181666667,0.328947898,-1.053716562,-0.119,0.072,0.457,0.161,-0.183,-0.113,Q91V01,Lpcat3,Q91V01_Lpcat3,Q91V01,Lpcat3,1,7,2,2,Q91V01|A0A0N4SUM3,MOUSE,56716.4,5.9,2477,2477.1,29.55,29.55,,487,Lysophospholipid acyltransferase 5,endoplasmic reticulum membrane|membrane|integral component of membrane|,phospholipid biosynthetic process|regulation of plasma lipoprotein particle levels|,1-acylglycerophosphocholine O-acyltransferase activity|,2,7,1280000000,5.9%
Q9WUL7,0.797504707,-0.060666667,3.131020512,0.136666667,0.486292922,0.737215809,0.074,0.087,-0.548,0.105,0.017,-0.099,Q9WUL7,Arl3,Q9WUL7_Arl3,Q9WUL7,Arl3,1,5,3,3,Q9WUL7,MOUSE,20657.3,23.6,2478,2478.1,29.54,29.54,,182,ADP-ribosylation factor-like protein 3,Golgi membrane|nucleus|Golgi apparatus|centrosome|spindle microtubule|cytoplasmic microtubule|midbody|photoreceptor connecting cilium|extracellular exosome|primary cilium|,cytokinesis|kidney development|post-Golgi vesicle-mediated transport|smoothened signaling pathway|small GTPase mediated signal transduction|protein transport|intraciliary transport|photoreceptor cell development|cilium morphogenesis|,GTPase activity|protein binding|GTP binding|microtubule binding|GDP binding|metal ion binding|,3,5,260000000,23.6%
Q8VE09,0.92551138,-0.056166667,1.093370275,0.065666667,0.777433002,0.294448968,0.241,0.083,-0.591,-0.074,0.148,-0.144,Q8VE09,Ttc39c,Q8VE09_Ttc39c,Q8VE09,Ttc39c,1,2,2,2,Q8VE09|G3X8|E9PV21,MOUSE,66413.8,7.2,2479,2479.1,29.51,29.51,,580,Tetratricopeptide repeat protein 39C,,,,2,2,520000000,7.2%
Q9ER41,0.797128744,-0.020333333,3.163869487,0.093333333,0.482628597,0.743673146,0.113,-0.006,-0.308,-0.012,0.006,0.085,Q9ER41,Tor1b,Q9ER41_Tor1b,Q9ER41,Tor1b,1,5,2,2,Q9ER41,MOUSE,38159.2,6.2,2480,2480.1,29.5,29.5,,336,Torsin-1B,nuclear envelope|cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|nuclear membrane|extracellular exosome|,endoplasmic reticulum organization|chaperone mediated protein folding requiring cofactor|protein homooligomerization|nuclear membrane organization|,protein binding|ATP binding|ATPase activity|,2,5,70500000,6.2%
O70572,0.318013011,-0.052333333,12.35789945,0.224,0.058104538,2.282387612,-0.177,-0.202,-0.114,0.177,-0.081,0.083,O70572,Smpd2,O70572_Smpd2,O70572,Smpd2,1,4,3,3,O70572,MOUSE,48435.6,8.3,2481,2481.1,29.48,29.48,,419,Sphingomyelin phosphodiesterase 2,intracellular|caveola|integral component of membrane|,response to mechanical stimulus|intracellular signal transduction|positive regulation of apoptotic process|ceramide biosynthetic process|,sphingomyelin phosphodiesterase activity|metal ion binding|,3,4,169000000,8.3%
Q8C0D4,0.663391411,0.0015,5.112479798,-0.123,0.308142797,-1.103334332,-0.02,0.006,0.203,-0.147,-0.129,0.096,Q8C0D4,Arhgap12,Q8C0D4_Arhgap12,Q8C0D4,Arhgap12,1,4,3,3,Q8C0D4|S4R248|S4R221|B2RUJ8|A0A0A0MQ95|S4R203,MOUSE,95750.1,4.2,2482,2482.1,29.48,29.48,,838,Rho GTPase-activating protein 12,,morphogenesis of an epithelial sheet|signal transduction|positive regulation of GTPase activity|,GTPase activator activity|,3,4,89000000,4.2%
Q64261,0.322381947,-0.008,12.19918358,-0.188,0.060267287,-2.257071058,0.133,0.047,0.078,-0.047,-0.167,-0.092,Q64261,Cdk6,Q64261_Cdk6,Q64261,Cdk6,1,9,2,2,Q64261,MOUSE,37255.9,6.1,2483,2483.1,29.42,29.42,,326,Cyclin-dependent kinase 6,cyclin-dependent protein kinase holoenzyme complex|ruffle|nucleus|nucleoplasm|cytoplasm|centrosome|,positive regulation of cell-matrix adhesion|hematopoietic progenitor cell differentiation|type B pancreatic cell development|protein phosphorylation|cell cycle|Notch signaling pathway|response to virus|regulation of gene expression|positive regulation of gene expression|hemopoiesis|T cell differentiation in thymus|gliogenesis|cell dedifferentiation|negative regulation of myeloid cell differentiation|regulation of erythrocyte differentiation|negative regulation of osteoblast differentiation|negative regulation of cell cycle|positive regulation of fibroblast proliferation|negative regulation of epithelial cell proliferation|cell division|hematopoietic stem cell differentiation|negative regulation of cellular senescence|,cyclin-dependent protein serine/threonine kinase activity|protein binding|ATP binding|kinase activity|cyclin binding|,2,9,2810000000,6.1%
Q91VN4,0.714714682,0.023666667,4.297075876,0.144666667,0.37178547,0.957889802,-0.137,-0.064,0.055,0.411,-0.03,-0.093,Q91VN4,Chchd6,Q91VN4_Chchd6,Q91VN4,Chchd6,1,2,2,2,Q91VN4|E9Q4M4,MOUSE,30193.7,10.6,2484,2484.1,29.38,29.38,,273,MICOS complex subunit Mic25,mitochondrion|mitochondrial inner membrane|,cellular response to DNA damage stimulus|cristae formation|,,2,2,126000000,10.6%
B2RRI2,0.64206681,0.016333333,5.498460612,0.143333333,0.28193821,1.171219174,-0.086,0.129,-0.209,0.219,-0.039,0.084,B2RRI2,Sbno1,B2RRI2_Sbno1,B2RRI2,Sbno1,1,4,4,4,B2RRI2|Q689Z5-2|Q689Z5|Q7TNB8|Q7TNB8-2|A0A1W2P6Y8|Q7TNB8-3,MOUSE,154604.6,4.5,2485,2485.1,29.3,29.3,,1391,Protein strawberry notch homolog 1,,"regulation of transcription, DNA-templated|",,4,4,219000000,4.5%
Q9QXN3,0.335940422,-0.014833333,11.77980899,-0.172333333,0.066377226,-2.190348465,0.088,0.039,0.087,-0.08,-0.085,-0.138,Q9QXN3,Trip4,Q9QXN3_Trip4,Q9QXN3,Trip4,1,4,3,3,Q9QXN3|Q9QXN3-2,MOUSE,67108.9,6.5,2486,2486.1,29.27,29.27,,581,Activating signal cointegrator 1,nucleus|nucleoplasm|cytoplasm|microtubule organizing center|cytosol|,"transcription, DNA-templated|intracellular estrogen receptor signaling pathway|positive regulation of transcription, DNA-templated|toxin transport|",protease binding|transcription coactivator activity|zinc ion binding|ligand-dependent nuclear receptor binding|estrogen receptor binding|histone acetyltransferase binding|ubiquitin-like protein ligase binding|,3,4,129000000,6.5%
Q4VC33-2,0.705390996,0.026166667,4.464277579,0.091,0.357743904,0.987454867,0.108,-0.054,-0.112,0.052,0.091,0.072,Q4VC33,Maea,Q4VC33-2_Maea,Q4VC33-2,Maea,1,4,4,4,Q4VC33-2|Q4VC33,MOUSE,51457.1,8,2487,2487.1,29.26,29.26,,396,Isoform 2 of Macrophage erythroblast attacher,nucleus|nucleoplasm|cytoplasm|spindle|actomyosin contractile ring|cytoskeleton|integral component of plasma membrane|actin cytoskeleton|nuclear matrix|,cytoskeleton organization|cell cycle|cell adhesion|negative regulation of myeloid cell apoptotic process|erythrocyte maturation|erythrocyte development|enucleate erythrocyte development|cell division|,actin binding|,4,4,22100000,8.0%
Q8R2R6,0.833338863,0.009833333,2.61100202,-0.067,0.548150479,-0.632388485,-0.1,0.138,0.092,0.018,-0.144,0.055,Q8R2R6,Mtg1,Q8R2R6_Mtg1,Q8R2R6,Mtg1,1,3,3,3,Q8R2R6,MOUSE,37191.9,11.6,2488,2488.1,29.22,29.22,,326,Mitochondrial ribosome-associated GTPase 1,mitochondrion|mitochondrial inner membrane|mitochondrial matrix|mitochondrial ribosome|,ribosome biogenesis|regulation of respiratory system process|regulation of mitochondrial translation|,GTPase activity|GTP binding|,3,3,61000000,11.6%
P62852,0.773701281,-0.020333333,3.489538455,0.074666667,0.447760887,0.806281636,-0.166,-0.068,0.061,-0.016,0.038,0.029,P62852,Rps25,P62852_Rps25,P62852,Rps25,1,6,2,2,P62852|A0A1L1SQA8,MOUSE,13798.9,15.2,2489,2489.1,29.21,29.21,,125,40S ribosomal protein S25,nucleus|nucleolus|cytoplasm|ribosome|small ribosomal subunit|cytosolic small ribosomal subunit|extracellular exosome|,,poly(A) RNA binding|,2,6,1110000000,15.2%
O09061,0.192839981,-0.0145,16.19235773,0.357666667,0.024030579,2.912777653,-0.319,-0.186,-0.075,0.053,0.369,0.071,O09061,Psmb1,O09061_Psmb1,O09061,Psmb1,1,4,3,3,O09061,MOUSE,26599.9,16.2,2490,2490.1,29.19,29.19,,240,Proteasome subunit beta type-1,proteasome complex|nucleus|cytoplasm|cytosol|proteasome core complex|extracellular exosome|,proteasomal ubiquitin-independent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|,endopeptidase activity|threonine-type endopeptidase activity|,3,4,5750000000,16.2%
Q6P5D3,0.886708184,0.003,1.796733242,-0.064666667,0.661190608,-0.458608741,-0.052,0.05,0.108,-0.116,-0.227,0.255,Q6P5D3,Dhx57,Q6P5D3_Dhx57,Q6P5D3,Dhx57,1,3,3,3,Q6P5D3|Q6P5D3-2|Q6P5D3-3|Q6P5D3-4|Q6P5D3-5,MOUSE,157585.3,2.5,2491,2491.1,29.19,29.19,,1388,Putative ATP-dependent RNA helicase DHX57,cytoplasm|mitochondrion|,RNA processing|,ATP-dependent RNA helicase activity|ATP binding|poly(A) RNA binding|metal ion binding|,3,3,33000000,2.5%
Q9QUH0,0.983457524,-0.059,0.262425246,-0.01,0.941363761,-0.076392942,0.063,0.086,-0.311,-0.046,0.009,-0.155,Q9QUH0,Glrx,Q9QUH0_Glrx,Q9QUH0,Glrx,1,5,3,3,Q9QUH0|A0A1Y7VM65,MOUSE,12156,25.2,2492,2492.1,29.16,29.16,,107,Glutaredoxin-1,nucleus|cytoplasm|mitochondrion|extracellular exosome|,cell redox homeostasis|positive regulation of membrane potential|oxidation-reduction process|positive regulation of sodium ion transmembrane transporter activity|,electron carrier activity|protein disulfide oxidoreductase activity|protein-disulfide reductase (glutathione) activity|protein N-terminus binding|,3,5,1210000000,25.2%
Q8BNU0,0.586429925,-0.048166667,6.587695491,0.243666667,0.219396882,1.356450613,0.084,-0.154,-0.44,0.352,0.004,-0.135,Q8BNU0,Armc6,Q8BNU0_Armc6,Q8BNU0,Armc6,1,2,2,2,Q8BNU0|Q8BNU0-2,MOUSE,51595.2,8.7,2493,2493.1,29.16,29.16,,468,Armadillo repeat-containing protein 6,,hematopoietic progenitor cell differentiation|,,2,2,119000000,8.7%
P70698,0.759504567,-0.002,3.719798859,0.092,0.42463923,0.850202949,0.012,-0.082,-0.074,0.102,-0.141,0.171,P70698,Ctps,P70698_Ctps,P70698,Ctps1,1,5,3,3,P70698,MOUSE,67365.9,4.7,2494,2494.1,29.13,29.13,,591,CTP synthase 1,membrane|,CTP biosynthetic process|glutamine metabolic process|T cell proliferation|B cell proliferation|'de novo' CTP biosynthetic process|,CTP synthase activity|ATP binding|,3,5,115000000,4.7%
Q8R0F8,0.475238737,0.0035,8.654530934,-0.213666667,0.136316023,-1.695219097,0.132,0.266,-0.067,0.067,-0.213,-0.164,Q8R0F8,Fahd1,Q8R0F8_Fahd1,Q8R0F8,Fahd1,1,4,3,3,Q8R0F8,MOUSE,25514.1,22.9,2495,2495.1,29.12,29.12,,227,"Acylpyruvase FAHD1, mitochondrial",nucleoplasm|cytoplasm|mitochondrion|mitochondrial inner membrane|cytosol|,metabolic process|,oxaloacetate decarboxylase activity|acetylpyruvate hydrolase activity|fumarylpyruvate hydrolase activity|metal ion binding|acylpyruvate hydrolase activity|,3,4,722000000,22.9%
Q9Z2X8,0.797128744,0.062666667,3.168513575,0.113333333,0.482112778,0.744584775,0.031,-0.016,0.003,0.454,-0.093,-0.003,Q9Z2X8,Keap1,Q9Z2X8_Keap1,Q9Z2X8,Keap1,1,3,3,3,Q9Z2X8|A0A1L1SS10,MOUSE,70978.1,5.2,2496,2496.1,28.89,28.89,,624,Kelch-like ECH-associated protein 1,nucleoplasm|cytoplasm|endoplasmic reticulum|microtubule organizing center|actin filament|cell-cell adherens junction|focal adhesion|midbody|Cul3-RING ubiquitin ligase complex|,"in utero embryonic development|selenium compound metabolic process|malate metabolic process|transcription, DNA-templated|regulation of transcription, DNA-templated|flavonoid metabolic process|response to metal ion|proteasomal ubiquitin-independent protein catabolic process|negative regulation of gene expression|protein ubiquitination|alkanesulfonate metabolic process|positive regulation of cellular protein metabolic process|response to immobilization stress|cytoplasmic sequestering of transcription factor|regulation of epidermal cell differentiation|protein oligomerization|cellular response to interleukin-4|cellular response to organic cyclic compound|response to thyroid hormone|",protein binding|transcription factor binding|,3,3,244000000,5.2%
Q91V04,0.775451947,0.041666667,3.45325067,0.198666667,0.451517859,0.799892416,-0.054,0.371,-0.49,0,-0.067,0.49,Q91V04,Tram1,Q91V04_Tram1,Q91V04,Tram1,1,8,2,2,Q91V04,MOUSE,43209.7,5.3,2497,2497.1,28.88,28.88,,374,Translocating chain-associated membrane protein 1,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,protein transport|,,2,8,1330000000,5.3%
P97376,0.733613685,-0.0285,4.042903507,-0.093,0.394193673,-0.910414522,-0.042,0.071,0.025,0.058,-0.223,-0.06,P97376,Frg1,P97376_Frg1,P97376,Frg1,1,3,2,2,P97376,MOUSE,29412,9.3,2498,2498.1,28.84,28.84,,258,Protein FRG1,nucleolus|Cajal body|Z disc|catalytic step 2 spliceosome|,rRNA processing|mRNA processing|muscle organ development|RNA splicing|,actin binding|poly(A) RNA binding|,2,3,368000000,9.3%
Q3UZ39,0.297132915,-0.053666667,12.81597518,0.348666667,0.052288054,2.361215541,-0.289,-0.405,0.01,0.027,0.002,0.333,Q3UZ39,Lrrfip1,Q3UZ39_Lrrfip1,Q3UZ39,Lrrfip1,1,4,3,3,Q3UZ39|Q3UZ39-3|A0A087WPK3|Q3UZ39-2|E9Q9T1|A0A1L1SSC0|A0A0G2JFV5|G5E8E1|A0A0G2JEP4|Q91WK0|E9QN52|A0A1L1SQW1|Q91WK0-2|A0A0R4J169|A0A1L1SVG1,MOUSE,79932.4,7.5,2499,2499.1,28.83,28.83,,729,Leucine-rich repeat flightless-interacting protein 1,nucleus|cytoplasm|plasma membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",DNA binding|protein binding|protein homodimerization activity|,3,4,256000000,7.5%
P30285,0.156441172,0.0175,17.35250737,-0.290333333,0.018397095,-3.097144165,0.161,0.054,0.273,-0.09,-0.189,-0.104,P30285,Cdk4,P30285_Cdk4,P30285,Cdk4,1,8,2,2,P30285|D3YWB0|D6RHS5,MOUSE,33978.5,6.6,2500,2500.1,28.8,28.8,,303,Cyclin-dependent kinase 4,cyclin-dependent protein kinase holoenzyme complex|chromatin|nucleus|nucleoplasm|transcription factor complex|nucleolus|cytosol|nuclear membrane|perinuclear region of cytoplasm|bicellular tight junction|,G1/S transition of mitotic cell cycle|lens development in camera-type eye|protein phosphorylation|signal transduction|circadian rhythm|positive regulation of cell proliferation|response to toxic substance|response to lead ion|regulation of gene expression|positive regulation of G2/M transition of mitotic cell cycle|organ regeneration|response to testosterone|regulation of cell proliferation|response to drug|positive regulation of apoptotic process|positive regulation of translation|positive regulation of cell size|positive regulation of fibroblast proliferation|cell division|regulation of cell cycle|response to hyperoxia|negative regulation of cell cycle arrest|,protein kinase activity|cyclin-dependent protein serine/threonine kinase activity|protein binding|ATP binding|kinase activity|cyclin binding|protein complex binding|,2,8,2810000000,6.6%
Q91ZE0,0.855039332,0.018333333,2.313732767,0.048,0.586984622,0.570461431,0.002,-0.002,-0.017,0.015,0.131,-0.019,Q91ZE0,Tmlhe,Q91ZE0_Tmlhe,Q91ZE0,Tmlhe,1,7,4,4,Q91ZE0,MOUSE,50236.3,8,2501,2501.1,28.78,28.78,,421,"Trimethyllysine dioxygenase, mitochondrial",mitochondrion|mitochondrial matrix|,carnitine biosynthetic process|negative regulation of oxidoreductase activity|oxidation-reduction process|,"iron ion binding|oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen|L-ascorbic acid binding|trimethyllysine dioxygenase activity|",4,7,125000000,8.0%
Q6NT99,0.797447147,0.01,3.152582244,-0.093333333,0.483884572,-0.741456145,0.036,0.19,-0.056,-0.037,0.15,-0.223,Q6NT99,Dusp23,Q6NT99_Dusp23,Q6NT99,Dusp23,1,3,3,3,Q6NT99,MOUSE,16865.1,21.3,2502,2502.1,28.76,28.76,,150,Dual specificity protein phosphatase 23,nucleus|cytosol|extracellular exosome|,peptidyl-tyrosine dephosphorylation|,protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity|,3,3,47200000,21.3%
Q9JHI7,0.331544957,0.0095,11.94316659,-0.261,0.063926855,-2.220367541,0.01,0.21,0.2,-0.274,-0.144,0.055,Q9JHI7,Exosc9,Q9JHI7_Exosc9,Q9JHI7,Exosc9,1,2,2,2,Q9JHI7,MOUSE,49563.5,5.7,2503,2503.1,28.76,28.76,,438,Exosome complex component RRP45,nuclear exosome (RNase complex)|exosome (RNase complex)|nuclear chromosome|nucleus|nucleoplasm|nucleolus|cytoplasm|intermediate filament cytoskeleton|extracellular exosome|,nuclear-transcribed mRNA catabolic process|rRNA processing|positive regulation of cell growth|exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay|nuclear mRNA surveillance|nuclear polyadenylation-dependent rRNA catabolic process|nucleic acid phosphodiester bond hydrolysis|,exonuclease activity|AU-rich element binding|poly(A) RNA binding|,2,2,126000000,5.7%
Q9CR16,0.321152189,0.0275,12.24246946,0.201666667,0.05966959,2.263964103,-0.076,-0.061,-0.083,0.017,0.218,0.15,Q9CR16,Ppid,Q9CR16_Ppid,Q9CR16,Ppid,1,5,3,3,Q9CR16,MOUSE,41141.2,7.8,2504,2504.1,28.72,28.72,,370,Peptidyl-prolyl cis-trans isomerase D,nucleus|nucleoplasm|nucleolus|cytoplasm|,negative regulation of transcription from RNA polymerase II promoter|protein peptidyl-prolyl isomerization|protein folding|protein complex assembly|apoptotic process|protein transport|lipid particle organization|regulation of apoptotic process|positive regulation of apoptotic process|positive regulation of viral genome replication|positive regulation of protein secretion|chaperone-mediated protein folding|cellular response to UV-A|,peptidyl-prolyl cis-trans isomerase activity|FK506 binding|transcription factor binding|estrogen receptor binding|Hsp70 protein binding|heat shock protein binding|peptide binding|Hsp90 protein binding|,3,5,497000000,7.8%
Q61526,0.52944394,0.003,7.631636212,0.142,0.17251878,1.526977688,-0.063,-0.04,-0.101,0.128,-0.058,0.152,Q61526,Erbb3,Q61526_Erbb3,Q61526,Erbb3,1,4,2,2,Q61526,MOUSE,150919.5,1.7,2505,2505.1,28.69,28.69,,1339,Receptor tyrosine-protein kinase erbB-3,extracellular space|intracellular|integral component of membrane|basolateral plasma membrane|apical plasma membrane|lateral plasma membrane|receptor complex|,endocardial cushion development|protein phosphorylation|negative regulation of cell adhesion|signal transduction|transmembrane receptor protein tyrosine kinase signaling pathway|peripheral nervous system development|negative regulation of signal transduction|Schwann cell differentiation|phosphatidylinositol 3-kinase signaling|cranial nerve development|regulation of cell proliferation|negative regulation of neuron apoptotic process|negative regulation of secretion|neuron apoptotic process|positive regulation of protein tyrosine kinase activity|positive regulation of calcineurin-NFAT signaling cascade|extrinsic apoptotic signaling pathway in absence of ligand|,protein binding|ATP binding|growth factor binding|protein tyrosine kinase activator activity|identical protein binding|protein heterodimerization activity|protein tyrosine kinase activity|,2,4,81900000,1.7%
Q3TJD7,0.744748173,0.094333333,3.894708159,0.195333333,0.40787697,0.883557428,-0.197,0.415,-0.228,0.524,0.019,0.033,Q3TJD7,Pdlim7,Q3TJD7_Pdlim7,Q3TJD7,Pdlim7,1,3,3,3,Q3TJD7,MOUSE,51202.1,7.8,2506,2506.1,28.69,28.69,,457,PDZ and LIM domain protein 7,stress fiber|ruffle|nucleus|cytoplasm|focal adhesion|actin cytoskeleton|,ossification|multicellular organismal development|actin cytoskeleton organization|cell differentiation|positive regulation of osteoblast differentiation|,protein binding|zinc ion binding|,3,3,536000000,7.8%
Q6P9N1-3,0.883328334,-0.017666667,1.903863688,-0.052666667,0.64508008,-0.482175865,0.089,0.107,-0.17,0.04,-0.049,-0.123,Q6P9N1,Fam126a,Q6P9N1-3_Fam126a,Q6P9N1-3,Fam126a,1,6,3,3,Q6P9N1-3|Q6P9N1|Q6P9N1-2|A0A0G2JH12,MOUSE,47367.4,11.1,2507,2507.1,28.67,28.67,,521,Isoform 3 of Hyccin,cytoplasm|plasma membrane|,,,3,6,234000000,11.1%
P35235,0.564845247,-0.012,7.052034977,0.168,0.197149873,1.433367355,-0.17,-0.219,0.101,0.141,-0.043,0.118,P35235,Ptpn11,P35235_Ptpn11,P35235,Ptpn11,1,4,3,3,P35235|P35235-2,MOUSE,69029.6,8,2508,2508.1,28.64,28.64,,597,Tyrosine-protein phosphatase non-receptor type 11,nucleus|cytoplasm|mitochondrion|cytosol|protein complex|,DNA damage checkpoint|activation of MAPK activity|lipid metabolic process|triglyceride metabolic process|epidermal growth factor receptor signaling pathway|integrin-mediated signaling pathway|axonogenesis|brain development|heart development|hormone-mediated signaling pathway|positive regulation of signal transduction|platelet formation|microvillus organization|abortive mitotic cell cycle|regulation of cell adhesion mediated by integrin|negative regulation of cell adhesion mediated by integrin|multicellular organism growth|organ growth|peptidyl-tyrosine dephosphorylation|megakaryocyte development|atrioventricular canal development|ERBB signaling pathway|regulation of multicellular organism growth|hormone metabolic process|glucose homeostasis|positive regulation of mitotic cell cycle|negative regulation of insulin secretion|regulation of protein export from nucleus|positive regulation of hormone secretion|negative regulation of hormone secretion|platelet-derived growth factor receptor signaling pathway|neurotrophin TRK receptor signaling pathway|ephrin receptor signaling pathway|multicellular organismal reproductive process|genitalia development|inner ear development|homeostasis of number of cells within a tissue|negative regulation of cortisol secretion|negative regulation of growth hormone secretion|face morphogenesis|intestinal epithelial cell migration|positive regulation of ERK1 and ERK2 cascade|positive regulation of glucose import in response to insulin stimulus|,phosphoprotein phosphatase activity|protein tyrosine phosphatase activity|non-membrane spanning protein tyrosine phosphatase activity|SH3/SH2 adaptor activity|insulin receptor binding|protein binding|protein domain specific binding|receptor tyrosine kinase binding|D1 dopamine receptor binding|phospholipase binding|insulin receptor substrate binding|peptide hormone receptor binding|,3,4,1310000000,8.0%
Q8R2T8,0.791332991,0.037833333,3.228398833,0.090333333,0.475510506,0.756311924,0.033,-0.05,-0.005,0.28,-0.123,0.092,Q8R2T8,Gtf3c5,Q8R2T8_Gtf3c5,Q8R2T8,Gtf3c5,1,8,4,4,Q8R2T8|Q8R2T8-2|H3BJX5,MOUSE,60957.1,7.8,2509,2509.1,28.62,28.62,,520,General transcription factor 3C polypeptide 5,transcription factor TFIIIC complex|,"transcription, DNA-templated|skeletal muscle cell differentiation|",DNA binding|,4,8,76800000,7.8%
A2ADA5,0.408707826,-0.003,10.2106703,-0.230666667,0.095264912,-1.944514793,0.232,0.208,-0.103,-0.035,-0.196,-0.124,A2ADA5,Pusl1,A2ADA5_Pusl1,A2ADA5,Pusl1,1,3,3,3,A2ADA5|A2ADA5-2|A2ADA5-3,MOUSE,32163.2,11.3,2510,2510.1,28.56,28.56,,291,tRNA pseudouridine synthase-like 1,intracellular membrane-bounded organelle|,pseudouridine synthesis|tRNA processing|,RNA binding|pseudouridine synthase activity|,3,3,360000000,11.3%
Q8CBA2,0.561710094,-0.080333333,7.092551159,0.225333333,0.195319176,1.440426822,0.02,-0.094,-0.505,0.047,0.154,-0.104,Q8CBA2,Slfn5,Q8CBA2_Slfn5,Q8CBA2,Slfn5,1,2,2,2,Q8CBA2,MOUSE,102300.8,3.6,2511,2511.1,28.54,28.54,,884,Schlafen family member 5,nucleus|,cell differentiation|,ATP binding|,2,2,42000000,3.6%
D3YUP0,0.995757571,0.039166667,0.050798074,0.002333333,0.988371451,0.015133725,-0.016,-0.141,0.271,0.285,-0.074,-0.09,D3YUP0,Vps8,D3YUP0_Vps8,D3YUP0,Vps8,1,2,2,2,D3YUP0|Q0P5W1|Q0P5W1-3|F8WI64|D3Z5P1|Q0P5W1-2,MOUSE,163496.3,1.5,2512,2512.1,28.5,28.5,,1429,Vacuolar protein sorting-associated protein 8 homolog,,,zinc ion binding|,2,2,115000000,1.5%
Q9CQR2,0.649578346,-0.036,5.32358407,0.099333333,0.293522632,1.139715853,-0.139,0.018,-0.136,0.041,-0.016,0.016,Q9CQR2,Rps21,Q9CQR2_Rps21,Q9CQR2,Rps21,1,5,2,2,Q9CQR2,MOUSE,9255.3,22.8,2513,2513.1,28.48,28.48,,83,40S ribosomal protein S21,cytoplasm|small ribosomal subunit|cytosolic small ribosomal subunit|,"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|translation|ribosomal small subunit biogenesis|",structural constituent of ribosome|ribosome binding|poly(A) RNA binding|protein N-terminus binding|,2,5,766000000,22.8%
O88532,0.084872091,-0.111166667,20.91572003,0.649,0.008098937,3.734305277,-0.368,-0.164,-0.775,0.385,0.179,0.076,O88532,Zfr,O88532_Zfr,O88532,Zfr,1,4,3,3,O88532,MOUSE,117997.8,4.4,2514,2514.1,28.47,28.47,,1074,Zinc finger RNA-binding protein,nucleoplasm|chromosome|cytoplasm|,multicellular organismal development|,DNA binding|zinc ion binding|poly(A) RNA binding|,3,4,47500000,4.4%
Q9DBB9,0.116705641,-0.107666667,19.14067005,0.442,0.012188015,3.416877219,-0.25,-0.183,-0.553,0.119,-0.015,0.236,Q9DBB9,Cpn2,Q9DBB9_Cpn2,Q9DBB9,Cpn2,1,3,3,3,Q9DBB9,MOUSE,61333.9,5.8,2515,2515.1,28.46,28.46,,547,Carboxypeptidase N subunit 2,extracellular exosome|blood microparticle|,,,3,3,44700000,5.8%
Q8C0E2,0.45181819,-0.042333333,9.344827754,0.292666667,0.116283267,1.806228049,-0.518,-0.006,-0.042,0.121,-0.046,0.237,Q8C0E2,Vps26b,Q8C0E2_Vps26b,Q8C0E2,Vps26b,1,4,2,2,Q8C0E2|Q8C0E2-2,MOUSE,39180.9,8.6,2516,2516.1,28.45,28.45,,336,Vacuolar protein sorting-associated protein 26B,early endosome|late endosome|retromer complex|intracellular membrane-bounded organelle|,"intracellular protein transport|retrograde transport, endosome to Golgi|",protein transporter activity|,2,4,1090000000,8.6%
Q8C547,0.953420192,-0.059833333,0.701371449,-0.020333333,0.850869302,-0.195421333,0.026,-0.016,-0.159,0.068,-0.177,-0.101,Q8C547,Heatr5b,Q8C547_Heatr5b,Q8C547,Heatr5b,1,6,3,3,Q8C547|Q8C547-2|Q8C547-3,MOUSE,226940,2.2,2517,2517.1,28.4,28.4,,2070,HEAT repeat-containing protein 5B,membrane|extracellular exosome|,,,3,6,123000000,2.2%
A2AKW0,0.841746758,-0.113333333,2.493555425,0.191333333,0.563176413,0.608446976,0.039,0.305,-0.971,0.081,-0.022,-0.112,A2AKW0,Slc25a51,A2AKW0_Slc25a51,A2AKW0,Slc25a51,1,4,2,2,A2AKW0|Q5HZI9,MOUSE,35717,8.8,2518,2518.1,28.36,28.36,,315,Solute carrier family 25 member 51,mitochondrion|integral component of membrane|,transport|,,2,4,1110000000,8.8%
Q8JZZ7-2,0.928824475,-0.029166667,1.026685065,0.045,0.789462478,0.278042794,-0.068,-0.126,0.039,0.285,-0.328,0.023,Q8JZZ7,NotFound,Q8JZZ7-2_NotFound,Q8JZZ7-2,Adgrl2,1,3,2,2,Q8JZZ7-2|A0A0G2JGM8|Q8JZZ7|A0A0G2JDK6|A0A0G2JFF5|A0A0G2JDF4|A0A0G2JG66|A0A0G2JDE3|A0A0G2JFV3|A0A0G2JH16|A0A0G2JEQ8,MOUSE,176033.4,3,2519,2519.1,28.33,28.33,,1487,Isoform 2 of Adhesion G protein-coupled receptor L2,integral component of membrane|,G-protein coupled receptor signaling pathway|positive regulation of synapse assembly|,G-protein coupled receptor activity|carbohydrate binding|,2,3,607000000,3.0%
Q61112,0.05611474,-0.071,23.04428312,0.492666667,0.004961028,4.131622405,-0.18,-0.245,-0.527,0.109,0.139,0.278,Q61112,Sdf4,Q61112_Sdf4,Q61112,Sdf4,1,2,2,2,Q61112|Q61112-2,MOUSE,42120.4,9.4,2520,2520.1,28.29,28.29,,361,45 kDa calcium-binding protein,late endosome|Golgi apparatus|Golgi lumen|membrane|extracellular exosome|,UV protection|cerebellum development|fat cell differentiation|response to ethanol|,calcium ion binding|,2,2,30900000,9.4%
O88829,0.365990558,0.059166667,11.14834781,0.419666667,0.076765347,2.09439247,-0.036,0.017,-0.433,0.515,-0.109,0.401,O88829,St3gal5,O88829_St3gal5,O88829,St3gal5,1,4,2,2,O88829|O88829-2|A0A0R4J1J3,MOUSE,47929.6,6.2,2521,2521.1,28.27,28.27,,414,"Lactosylceramide alpha-2,3-sialyltransferase",Golgi membrane|integral component of membrane|,protein glycosylation|sialylation|,"lactosylceramide alpha-2,3-sialyltransferase activity|",2,4,240000000,6.2%
Q8R1U1,0.846769943,0.0045,2.405717739,-0.077666667,0.574682836,-0.590133784,-0.085,-0.037,0.252,0.029,-0.212,0.08,Q8R1U1,Cog4,Q8R1U1_Cog4,Q8R1U1,Cog4,1,4,4,4,Q8R1U1|Q7TSQ9|G3UWY4|G3UZ15|G3UX78,MOUSE,89629,5.7,2522,2522.1,28.25,28.25,,785,Conserved oligomeric Golgi complex subunit 4,Golgi membrane|Golgi transport complex|,"retrograde vesicle-mediated transport, Golgi to ER|Golgi organization|protein transport|Golgi vesicle prefusion complex stabilization|",,4,4,483000000,5.7%
Q9D0R8,0.615860336,-0.041833333,6.041292452,0.191,0.248811675,1.264314719,0.051,-0.007,-0.456,0.006,0.156,-0.001,Q9D0R8,Lsm12,Q9D0R8_Lsm12,Q9D0R8,Lsm12,1,3,2,2,Q9D0R8|A0A0A0MQC9,MOUSE,21985.6,18.9,2523,2523.1,28.21,28.21,,195,Protein LSM12 homolog,,,,2,3,1500000000,18.9%
Q8N9S3,0.6812202,0.009166667,4.849530239,0.113,0.327376104,1.05665838,-0.057,0.056,-0.141,0.216,-0.048,0.029,Q8N9S3,Ahsa2,Q8N9S3_Ahsa2,Q8N9S3,Ahsa2,1,8,3,3,Q8N9S3|Q8N9S3-3|Q8N9S3-2,MOUSE,37989.8,8.4,2524,2524.1,28.17,28.17,,331,Activator of 90 kDa heat shock protein ATPase homolog 2,,response to stress|positive regulation of ATPase activity|,ATPase activator activity|chaperone binding|,3,8,7670000000,8.4%
A0A075B5V6,0.774891394,0.170333333,3.467169093,-0.387333333,0.450073135,-0.802567489,1.524,-0.514,0.082,-0.134,-0.112,0.176,A0A075B5V6,NotFound,A0A075B5V6_NotFound,A0A075B5V6,Ighv1-42,1,4,3,3,A0A075B5V6|P06330|A0A075B5V1|P01757|P01756|A0A075B5U6|A0A075B5V2|A0A075B5U7|A0A075B5V0|A0A075B5V7,MOUSE,10890,37.7,2525,2525.1,28.1,28.1,,98,Immunoglobulin heavy variable V1-42,,,,3,4,43100000,37.7%
Q9ESW8,0.92551138,-0.012166667,1.096147067,0.030333333,0.776936086,0.294998786,0.116,-0.012,-0.186,0.035,-0.023,-0.003,Q9ESW8,Pgpep1,Q9ESW8_Pgpep1,Q9ESW8,Pgpep1,1,4,2,2,Q9ESW8|A0A1B0GSY1,MOUSE,23447.3,14.8,2526,2526.1,28.07,28.07,,209,Pyroglutamyl-peptidase 1,cytosol|,proteolysis|,peptidase activity|cysteine-type peptidase activity|pyroglutamyl-peptidase activity|,2,4,738000000,14.8%
Q8R1T4,0.154702278,0.0515,17.43225783,-0.405666667,0.018062348,-3.121644091,0.033,0.405,0.325,-0.296,-0.116,-0.042,Q8R1T4,Slc35a3,Q8R1T4_Slc35a3,Q8R1T4,Slc35a3,1,10,2,2,Q8R1T4,MOUSE,36146.8,7,2527,2527.1,28.01,28.01,,326,UDP-N-acetylglucosamine transporter,Golgi membrane|integral component of membrane|,carbohydrate transport|UDP-N-acetylglucosamine transport|proton transport|nucleotide transmembrane transport|,nucleotide-sugar transmembrane transporter activity|sugar:proton symporter activity|,2,10,2630000000,7.0%
J3KMQ6,0.766683359,-0.045333333,3.620897191,0.104666667,0.43442047,0.831946745,-0.026,-0.069,-0.198,0.144,0.106,-0.229,J3KMQ6,NotFound,J3KMQ6_NotFound,J3KMQ6,5730455P16Rik,1,2,2,2,Q9CYI0|J3KMQ6,MOUSE,45037.1,11.4,2528,2528.1,27.97,27.97,,393,RIKEN cDNA 5730455P16 gene,,,,2,2,29200000,11.4%
Q921N6,0.77727097,-0.033833333,3.438068779,-0.077666667,0.453099019,-0.796404268,-0.021,0.048,-0.012,-0.017,-0.222,0.021,Q921N6,Ddx27,Q921N6_Ddx27,Q921N6,Ddx27,1,3,3,3,Q921N6|Q921N6-2,MOUSE,86336.6,5.1,2529,2529.1,27.95,27.95,,760,Probable ATP-dependent RNA helicase DDX27,nucleus|,RNA secondary structure unwinding|,ATP-dependent RNA helicase activity|ATP binding|poly(A) RNA binding|,3,3,32800000,5.1%
D3Z4E2,0.000365132,-0.508833333,53.1876638,2.769666667,4.79992E-06,13.41825397,-1.741,-1.589,-2.351,0.835,1.035,0.758,D3Z4E2,NotFound,D3Z4E2_NotFound,D3Z4E2,Nrn1,1,6,2,2,D3Z4E2|A0A286YD56|Q8CFV4,MOUSE,17406.3,17,2530,2530.1,27.94,27.94,,158,Neuritin,alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex|,axonogenesis|,,2,6,1260000000,17.0%
Q8K3K8,0.493441063,-0.009333333,8.341153763,0.168666667,0.146515855,1.642215708,-0.006,-0.151,-0.124,0.03,-0.03,0.225,Q8K3K8,Optn,Q8K3K8_Optn,Q8K3K8,Optn,1,3,3,3,Q8K3K8,MOUSE,67701.4,5.8,2531,2531.1,27.87,27.87,,584,Optineurin,nucleus|cytoplasm|autophagosome|Golgi apparatus|trans-Golgi network|cytoplasmic membrane-bounded vesicle|perinuclear region of cytoplasm|recycling endosome|,protein targeting to Golgi|negative regulation of receptor recycling|Golgi organization|positive regulation of cell proliferation|macroautophagy|cellular protein localization|wound healing|Golgi to plasma membrane protein transport|negative regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of neuron apoptotic process|cytokine secretion|defense response to Gram-negative bacterium|protein homooligomerization|Golgi ribbon formation|,TFIIIA-class transcription factor binding|protein binding|protein C-terminus binding|Rab GTPase binding|polyubiquitin binding|identical protein binding|K63-linked polyubiquitin binding|,3,3,5900000000,5.8%
Q8K0Q5,0.41100279,0.029166667,10.14299358,0.203666667,0.096761066,1.930850014,-0.185,-0.043,0.01,0.241,-0.01,0.162,Q8K0Q5,Arhgap18,Q8K0Q5_Arhgap18,Q8K0Q5,Arhgap18,1,3,3,3,Q8K0Q5,MOUSE,75157.1,5.8,2532,2532.1,27.86,27.86,,663,Rho GTPase-activating protein 18,,signal transduction|positive regulation of GTPase activity|,GTPase activator activity|,3,3,143000000,5.8%
Q9D2U5,0.926554478,-0.0345,1.062506012,-0.030333333,0.78297771,-0.28676267,-0.002,-0.086,0.03,0.093,-0.211,-0.031,Q9D2U5,Naa38,Q9D2U5_Naa38,Q9D2U5,Naa38,1,6,3,3,Q9D2U5|Q9D2U5-2,MOUSE,13715.2,30.4,2533,2533.1,27.79,27.79,,125,"N-alpha-acetyltransferase 38, NatC auxiliary subunit",nucleus|nucleoplasm|cytoplasm|NatC complex|polysome|,negative regulation of apoptotic process|,,3,6,433000000,30.4%
Q8JZY4,0.865173382,0.021666667,2.157316064,-0.048,0.608510944,-0.537192032,0.043,-0.056,0.15,-0.007,-0.014,0.014,Q8JZY4,1110008L16Rik,Q8JZY4_1110008L16Rik,Q8JZY4,Kiaa0391,1,8,2,2,Q8JZY4|V9GXP4|V9GXF2|V9GWT5,MOUSE,67654.1,7,2534,2534.1,27.77,27.77,,584,Mitochondrial ribonuclease P catalytic subunit,mitochondrion|mitochondrial nucleoid|,tRNA processing|,,2,8,242000000,7.0%
P99025,0.227563079,0.045333333,14.88969391,0.280666667,0.032436248,2.690721989,-0.018,-0.236,-0.031,0.164,0.297,0.096,P99025,Gchfr,P99025_Gchfr,P99025,Gchfr,1,6,2,2,P99025,MOUSE,9698.1,30.9,2535,2535.1,27.71,27.71,,84,GTP cyclohydrolase 1 feedback regulatory protein,nucleus|cytoplasm|cytosol|dendrite|nuclear membrane|melanosome|protein complex|,negative regulation of biosynthetic process|negative regulation of GTP cyclohydrolase I activity|protein heterooligomerization|,enzyme inhibitor activity|amino acid binding|GTP-dependent protein binding|GTP cyclohydrolase binding|,2,6,719000000,30.9%
P70245,0.247058045,-0.012166667,14.32289612,-0.273666667,0.036958164,-2.59865352,0.002,0.28,0.092,-0.17,-0.216,-0.061,P70245,Ebp,P70245_Ebp,P70245,Ebp,1,9,2,2,P70245,MOUSE,26442.6,10,2536,2536.1,27.68,27.68,,230,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,cholesterol biosynthetic process|sterol biosynthetic process|hemopoiesis|,C-8 sterol isomerase activity|cholestenol delta-isomerase activity|,2,9,53600000000,10.0%
Q9DBD5,0.87652273,0.079166667,1.986128533,0.109,0.632975859,0.500430196,-0.032,0.009,0.097,0.638,-0.228,-0.009,Q9DBD5,Pelp1,Q9DBD5_Pelp1,Q9DBD5,Pelp1,1,3,2,2,Q9DBD5|Q9D4T3,MOUSE,119378.9,2.3,2537,2537.1,27.67,27.67,,1123,"Proline-, glutamic acid- and leucine-rich protein 1",nucleus|nucleoplasm|nucleolus|cytoplasm|membrane|transcriptionally active chromatin|MLL1 complex|,"transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|cellular response to estrogen stimulus|",chromatin binding|transcription factor binding|poly(A) RNA binding|,2,3,148000000,2.3%
P61804,0.326803699,0.040666667,12.07521096,-0.262,0.062012452,-2.241467225,-0.024,0.298,0.241,-0.155,-0.14,0.024,P61804,Dad1,P61804_Dad1,P61804,Dad1,1,4,3,3,P61804,MOUSE,12667.6,28.3,2538,2538.1,27.66,27.66,,113,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1,oligosaccharyltransferase complex|membrane|integral component of membrane|extracellular exosome|,blastocyst development|protein glycosylation|apoptotic process|response to nutrient|response to drug|negative regulation of apoptotic process|,dolichyl-diphosphooligosaccharide-protein glycotransferase activity|oligosaccharyl transferase activity|,3,4,194000000,28.3%
O35604,0.73101227,-0.0695,4.100975891,0.165666667,0.388957734,0.921874553,-0.292,0.254,-0.419,-0.05,0.077,0.013,O35604,Npc1,O35604_Npc1,O35604,Npc1,1,5,3,3,O35604,MOUSE,145563.6,2.8,2539,2539.1,27.65,27.65,,1277,Niemann-Pick C1 protein,extracellular region|nuclear envelope|lysosome|lysosomal membrane|endosome|endoplasmic reticulum|Golgi apparatus|plasma membrane|integral component of plasma membrane|membrane|late endosome membrane|vesicle|membrane raft|perinuclear region of cytoplasm|extracellular exosome|,protein glycosylation|endocytosis|autophagy|lysosomal transport|signal transduction|adult walking behavior|cholesterol metabolic process|bile acid metabolic process|negative regulation of macroautophagy|cholesterol transport|membrane raft organization|cholesterol efflux|response to drug|cholesterol homeostasis|response to cadmium ion|viral entry into host cell|negative regulation of cell death|cellular response to steroid hormone stimulus|cellular response to low-density lipoprotein particle stimulus|establishment of protein localization to membrane|positive regulation of cholesterol homeostasis|,protein binding|hedgehog receptor activity|cholesterol binding|,3,5,500000000,2.8%
Q8BZ03,0.958288452,-0.034833333,0.608482156,0.024333333,0.869264181,0.171090545,0.141,-0.286,0.004,0.127,-0.185,-0.01,Q8BZ03,Prkd2,Q8BZ03_Prkd2,Q8BZ03,Prkd2,1,4,3,3,Q8BZ03,MOUSE,97852.5,5.7,2540,2540.1,27.63,27.63,,875,Serine/threonine-protein kinase D2,nucleus|nucleoplasm|cytoplasm|Golgi apparatus|plasma membrane|,angiogenesis|positive regulation of endothelial cell proliferation|protein phosphorylation|cell adhesion|cell death|positive regulation of endothelial cell migration|peptidyl-serine phosphorylation|positive regulation of vascular endothelial growth factor receptor signaling pathway|positive regulation of interleukin-2 production|positive regulation of interleukin-8 production|positive regulation of CREB transcription factor activity|positive regulation of peptidyl-serine phosphorylation|intracellular signal transduction|cellular response to vascular endothelial growth factor stimulus|positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway|positive regulation of blood vessel endothelial cell migration|positive regulation of fibroblast growth factor receptor signaling pathway|positive regulation of angiogenesis|positive regulation of cell adhesion|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|vascular endothelial growth factor receptor signaling pathway|T cell receptor signaling pathway|positive regulation of T cell receptor signaling pathway|positive regulation of sequence-specific DNA binding transcription factor activity|positive regulation of NF-kappaB transcription factor activity|positive regulation of ERK1 and ERK2 cascade|protein kinase D signaling|activation of mitophagy in response to mitochondrial depolarization|positive regulation of histone deacetylase activity|positive regulation of intracellular signal transduction|positive regulation of DNA biosynthetic process|positive regulation of endothelial cell chemotaxis|,protein kinase activity|protein serine/threonine kinase activity|protein kinase C activity|ATP binding|metal ion binding|,3,4,96500000,5.7%
Q3UJB0,0.703057696,0.010166667,4.48829129,0.171,0.355771267,0.99264665,-0.305,-0.187,0.266,-0.024,0.024,0.287,Q3UJB0,Sf3b2,Q3UJB0_Sf3b2,Q3UJB0,Sf3b2,1,4,4,4,Q3UJB0,MOUSE,98310.8,4.7,2541,2541.1,27.61,27.61,,878,"Splicing factor 3b, subunit 2",nucleoplasm|spliceosomal complex|U12-type spliceosomal complex|catalytic step 2 spliceosome|,,protein binding|poly(A) RNA binding|,4,4,4220000000,4.7%
Q9D1Q4,0.894042447,-0.013333333,1.691596483,0.058,0.67739245,0.434996644,-0.12,0.025,-0.032,0.177,-0.252,0.122,Q9D1Q4,Dpm3,Q9D1Q4_Dpm3,Q9D1Q4,Dpm3,1,5,2,2,Q9D1Q4,MOUSE,10309.8,23.9,2542,2542.1,27.57,27.57,,92,Dolichol-phosphate mannosyltransferase subunit 3,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of endoplasmic reticulum membrane|dolichol-phosphate-mannose synthase complex|,GPI anchor biosynthetic process|regulation of protein stability|protein O-linked mannosylation|,dolichyl-phosphate beta-D-mannosyltransferase activity|,2,5,1230000000,23.9%
Q8BTR5,0.953420192,-0.028833333,0.691223469,-0.022333333,0.852859818,-0.192824118,0.095,-0.006,-0.142,0.071,-0.217,0.026,Q8BTR5,Dusp28,Q8BTR5_Dusp28,Q8BTR5,Dusp28,1,3,3,3,Q8BTR5,MOUSE,17790.1,23.3,2543,2543.1,27.52,27.52,,163,Dual specificity phosphatase 28,intracellular|,protein dephosphorylation|JNK cascade|peptidyl-tyrosine dephosphorylation|,protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity|,3,3,82600000,23.3%
Q9EQ21,0.481746078,-0.0175,8.507133259,0.279666667,0.141021937,1.671419016,-0.302,-0.284,0.114,0.061,0.382,-0.076,Q9EQ21,Hamp,Q9EQ21_Hamp,Q9EQ21,Hamp,1,5,3,3,Q9EQ21|Q5M9M1|Q80T19,MOUSE,9865.4,42.1,2544,2544.1,27.48,27.48,,83,Hepcidin,extracellular region|extracellular space|nucleus|,negative regulation of transcription from RNA polymerase II promoter|myeloid cell homeostasis|cellular iron ion homeostasis|JAK-STAT cascade|cellular response to extracellular stimulus|membrane protein proteolysis|negative regulation of iron ion transmembrane transport|defense response to bacterium|positive regulation of macrophage activation|negative regulation of bone resorption|positive regulation of transcription from RNA polymerase II promoter|negative regulation of inflammatory response|defense response to fungus|iron ion homeostasis|cellular response to iron ion|positive regulation of cellular protein catabolic process|,hormone activity|copper ion binding|,3,5,410000000,42.1%
A0A0A0MQD7,0.842315612,0.023,2.481808608,0.052666667,0.564701757,0.605645592,-0.015,0.019,-0.014,0.153,-0.019,0.014,A0A0A0MQD7,Ralgapa2,A0A0A0MQD7_Ralgapa2,A0A0A0MQD7,Ralgapa2,1,3,3,3,A0A0A0MQD7|A3KGS3|A3KGS3-2,MOUSE,216399.8,1.3,2545,2545.1,27.47,27.47,,1910,Ral GTPase-activating protein subunit alpha-2,extracellular space|cytoplasm|plasma membrane|,Ral protein signal transduction|regulation of protein localization|regulation of small GTPase mediated signal transduction|regulation of exocyst localization|activation of GTPase activity|,GTPase activator activity|,3,3,282000000,1.3%
P97313,0.303511137,0.005,12.70300641,-0.214,0.053666016,-2.337393191,0.054,0.106,0.176,-0.155,-0.159,0.008,P97313,Prkdc,P97313_Prkdc,P97313,Prkdc,1,7,4,4,P97313|P97313-2,MOUSE,476768.4,0.7,2546,2546.1,27.47,27.47,,4128,DNA-dependent protein kinase catalytic subunit,nucleus|nucleoplasm|transcription factor complex|nucleolus|DNA-dependent protein kinase-DNA ligase 4 complex|membrane|nonhomologous end joining complex|,telomere maintenance|double-strand break repair via homologous recombination|somitogenesis|negative regulation of protein phosphorylation|B cell lineage commitment|pro-B cell differentiation|T cell lineage commitment|negative regulation of immunoglobulin production|positive regulation of immune system process|double-strand break repair|double-strand break repair via nonhomologous end joining|brain development|heart development|intrinsic apoptotic signaling pathway in response to DNA damage|response to ionizing radiation|response to gamma radiation|response to activity|peptidyl-serine phosphorylation|lymphocyte differentiation|protein destabilization|cellular response to insulin stimulus|T cell differentiation in thymus|V(D)J recombination|immunoglobulin V(D)J recombination|T cell receptor V(D)J recombination|ectopic germ cell programmed cell death|regulation of circadian rhythm|positive regulation of apoptotic process|negative regulation of apoptotic process|positive regulation of transcription from RNA polymerase II promoter|positive regulation of fibroblast proliferation|rhythmic process|spleen development|thymus development|positive regulation of developmental growth|signal transduction involved in mitotic G1 DNA damage checkpoint|negative regulation of cellular senescence|negative regulation of response to gamma radiation|,double-stranded DNA binding|protein kinase activity|protein serine/threonine kinase activity|DNA-dependent protein kinase activity|protein binding|ATP binding|transcription factor binding|enzyme binding|poly(A) RNA binding|,4,7,2260000000,0.7%
O70324,0.815095629,-0.000833333,2.876533463,-0.055,0.515640064,-0.686187166,0.031,0.031,0.018,0.023,-0.023,-0.085,O70324,Slc16a2,O70324_Slc16a2,O70324,Slc16a2,1,6,2,2,O70324,MOUSE,60708.7,5.3,2547,2547.1,27.45,27.45,,545,Monocarboxylate transporter 8,integral component of plasma membrane|integral component of membrane|,ion transmembrane transport|thyroid hormone transport|,symporter activity|thyroid hormone transmembrane transporter activity|,2,6,4930000000,5.3%
Q9D9K3,0.497394135,0.0295,8.224964011,0.179,0.150488599,1.623874438,-0.065,-0.133,0.018,0.078,-0.018,0.297,Q9D9K3,Aven,Q9D9K3_Aven,Q9D9K3,Aven,1,3,3,3,Q9D9K3|A2AGL5,MOUSE,37366,15.7,2548,2548.1,27.44,27.44,,342,Cell death regulator Aven,intracellular|endomembrane system|membrane|,apoptotic process|negative regulation of apoptotic process|,,3,3,63000000,15.7%
A0A0R4J1X4,0.762829105,0.011,3.67145681,0.112666667,0.429392366,0.841544226,-0.176,0.022,0.018,0.109,-0.169,0.262,A0A0R4J1X4,Als2cl,A0A0R4J1X4_Als2cl,A0A0R4J1X4,Als2cl,1,3,3,3,A0A0R4J1X4|Q60I26|Q60I26-2,MOUSE,109927.4,3.8,2549,2549.1,27.43,27.43,,952,ALS2 C-terminal-like protein,,,,3,3,27500000,3.8%
A2AQR0,0.891701906,0.043166667,1.731373537,-0.056333333,0.671216535,-0.443964513,0.039,0.279,-0.104,-0.04,0.151,-0.066,A2AQR0,NotFound,A2AQR0_NotFound,A2AQR0,Gpd2,1,3,3,3,A2AQR0|Q64521,MOUSE,83398.7,5.5,2550,2550.1,27.43,27.43,,745,Glycerol-3-phosphate dehydrogenase,mitochondrion|mitochondrial inner membrane|glycerol-3-phosphate dehydrogenase complex|,glycerol-3-phosphate metabolic process|gluconeogenesis|multicellular organism growth|camera-type eye development|oxidation-reduction process|,calcium ion binding|sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity|,3,3,8620000,5.5%
E9Q317,0.90651412,0.029666667,1.511071884,-0.041333333,0.706143249,-0.393576444,-0.115,0.1,0.166,-0.047,-0.01,0.084,E9Q317,Sap18,E9Q317_Sap18,E9Q317,Sap18,1,4,3,3,E9Q317|O55128|D3YY55|D3Z2N9|D3YY73,MOUSE,19643.2,26.1,2551,2551.1,27.37,27.37,,172,Histone deacetylase complex subunit SAP18,,,,3,4,1100000000,26.1%
Q9CRC0,0.663574238,0.008333333,5.101132625,-0.094,0.30894896,-1.100851352,0.106,0.087,-0.027,0.003,-0.03,-0.089,Q9CRC0,Vkorc1,Q9CRC0_Vkorc1,Q9CRC0,Vkorc1,1,13,2,2,Q9CRC0,MOUSE,18167.1,12.4,2552,2552.1,27.34,27.34,,161,Vitamin K epoxide reductase complex subunit 1,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,blood coagulation|drug metabolic process|peptidyl-glutamic acid carboxylation|vitamin K biosynthetic process|vitamin K metabolic process|positive regulation of coagulation|oxidation-reduction process|bone development|,vitamin-K-epoxide reductase (warfarin-sensitive) activity|quinone binding|,2,13,13400000000,12.4%
Q8VI63,0.510577517,0.0545,8.023614505,-0.163,0.157629882,-1.590732752,0.117,0.291,0,-0.01,0.007,-0.078,Q8VI63,Mob2,Q8VI63_Mob2,Q8VI63,Mob2,1,2,2,2,A0A1B0GR18|Q8VI63|Q8VI63-2,MOUSE,27193.3,11.4,2553,2553.1,27.34,27.34,,235,MOB kinase activator 2,nucleus|nucleolus|cytoplasm|neuron projection terminus|perinuclear region of cytoplasm|,positive regulation of protein phosphorylation|positive regulation of neuron projection development|actin cytoskeleton organization|,metal ion binding|,2,2,40500000,11.4%
A7TU71,0.689103135,-0.018,4.722342095,0.15,0.337105463,1.034738277,0.021,-0.126,-0.174,0.275,-0.225,0.121,A7TU71,Shroom2,A7TU71_Shroom2,A7TU71,Shroom2,1,4,2,2,A7TU71|A2ALU4,MOUSE,166630.3,2.4,2554,2554.1,27.34,27.34,,1487,Protein Shroom2,cytoplasm|cell-cell junction|cell cortex|neuronal cell body|apical junction complex|extracellular exosome|cortical actin cytoskeleton|filamentous actin|,negative regulation of actin filament depolymerization|establishment of melanosome localization|apical protein localization|cell-cell junction maintenance|,protein binding|protein domain specific binding|actin filament binding|,2,4,57200000,2.4%
A6H5Z3,0.909718781,0.033,1.467588774,0.057333333,0.71324892,0.383666991,-0.045,-0.029,0.087,0.348,-0.207,0.044,A6H5Z3,Exoc6b,A6H5Z3_Exoc6b,A6H5Z3,Exoc6b,1,5,3,3,A6H5Z3|A6H5Z3-2|E0CY34,MOUSE,94869.6,4.3,2555,2555.1,27.34,27.34,,810,Exocyst complex component 6B,exocyst|,vesicle docking involved in exocytosis|,,3,5,1740000000,4.3%
O88851,0.496866931,0.055,8.265118577,0.281333333,0.149103604,1.632251262,-0.314,0.109,-0.052,0.508,0.057,0.022,O88851,Rbbp9,O88851_Rbbp9,O88851,Rbbp9,1,4,3,3,O88851,MOUSE,21082.5,23.6,2556,2556.1,27.33,27.33,,186,Putative hydrolase RBBP9,nucleus|nucleoplasm|nucleolus|cytoplasm|extracellular exosome|,metabolic process|regulation of cell proliferation|,hydrolase activity|,3,4,200000000,23.6%
P25446,0.004478377,-0.034166667,36.24233396,0.643666667,0.000237556,7.10258964,-0.451,-0.354,-0.263,0.32,0.223,0.32,P25446,Fas,P25446_Fas,P25446,Fas,1,3,2,2,P25446,MOUSE,38805.5,8.8,2557,2557.1,27.31,27.31,,327,Tumor necrosis factor receptor superfamily member 6,extracellular region|nucleus|cytoplasm|plasma membrane|external side of plasma membrane|cell surface|integral component of membrane|death-inducing signaling complex|CD95 death-inducing signaling complex|membrane raft|extracellular exosome|,immunoglobulin production|renal system process|apoptotic process|activation-induced cell death of T cells|inflammatory cell apoptotic process|transformed cell apoptotic process|circadian rhythm|extrinsic apoptotic signaling pathway via death domain receptors|response to toxic substance|gene expression|B cell mediated immunity|positive regulation of protein homooligomerization|T cell homeostasis|positive regulation of apoptotic process|negative regulation of apoptotic process|negative thymic T cell selection|regulation of lymphocyte differentiation|regulation of myeloid cell differentiation|spleen development|negative regulation of B cell activation|protein homooligomerization|response to glucocorticoid|neuron apoptotic process|cellular response to mechanical stimulus|cellular response to lithium ion|cellular response to hyperoxia|positive regulation of release of cytochrome c from mitochondria|motor neuron apoptotic process|apoptotic signaling pathway|extrinsic apoptotic signaling pathway|extrinsic apoptotic signaling pathway in absence of ligand|hepatocyte apoptotic process|necroptotic signaling pathway|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand|,transmembrane signaling receptor activity|protein binding|kinase binding|identical protein binding|,2,3,35000000,8.8%
P62874,0.667069025,-0.008,5.044540729,-0.202666667,0.313001146,-1.091937623,-0.284,0.155,0.409,-0.271,-0.02,-0.037,P62874,Gnb1,P62874_Gnb1,P62874,Gnb1,1,4,2,2,P62874,MOUSE,38175.1,9.4,2558,2558.1,27.29,27.29,,340,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1,photoreceptor outer segment|photoreceptor inner segment|lysosomal membrane|cytosol|heterotrimeric G-protein complex|plasma membrane|dendrite|photoreceptor outer segment membrane|myelin sheath|cell body|extracellular exosome|extracellular vesicle|,"G-protein coupled receptor signaling pathway|phospholipase C-activating G-protein coupled receptor signaling pathway|positive regulation of cytosolic calcium ion concentration|phototransduction, visible light|metabolic process|cell proliferation|cardiac muscle cell apoptotic process|sensory perception of taste|retina development in camera-type eye|cellular response to hypoxia|",GTPase activity|signal transducer activity|spectrin binding|type 1 angiotensin receptor binding|protein complex binding|GTPase binding|,2,4,56100000,9.4%
A6H611,0.78138434,-0.034,3.379744421,0.077333333,0.459225037,0.785172253,0.03,-0.023,-0.225,0.047,-0.017,-0.016,A6H611,Mipep,A6H611_Mipep,A6H611,Mipep,1,4,2,2,A6H611|A0A286YDC5|A0A286YCX4,MOUSE,81820.6,2.8,2559,2559.1,27.24,27.24,,711,Mitochondrial intermediate peptidase,mitochondrion|mitochondrial matrix|,proteolysis|,metalloendopeptidase activity|metal ion binding|,2,4,57000000,2.8%
O89053,0.884566234,0.292,1.854008483,-0.253333333,0.652528,-0.471350501,-0.238,-0.243,1.737,0.118,-0.128,0.506,O89053,Coro1a,O89053_Coro1a,O89053,Coro1a,1,5,3,3,O89053|G3UYK8,MOUSE,51672.9,7.5,2560,2560.1,27.18,27.18,,461,Coronin-1A,immunological synapse|phagocytic cup|cytoplasm|early endosome|actin filament|plasma membrane|cell-cell junction|membrane|lamellipodium|axon|phagocytic vesicle membrane|cortical actin cytoskeleton|cell leading edge|protein complex|phagocytic vesicle|extracellular exosome|plasma membrane|actin cytoskeleton|cortical actin cytoskeleton|,phagolysosome assembly|calcium ion transport|phagocytosis|actin filament organization|regulation of actin polymerization or depolymerization|regulation of cell shape|cell migration|actin cytoskeleton organization|positive regulation of cell migration|leukocyte chemotaxis|regulation of actin filament polymerization|negative regulation of vesicle fusion|cell-substrate adhesion|uropod organization|regulation of actin cytoskeleton organization|response to cytokine|nerve growth factor signaling pathway|positive regulation of T cell proliferation|T cell homeostasis|natural killer cell degranulation|negative regulation of neuron apoptotic process|homeostasis of number of cells within a tissue|positive regulation of T cell activation|positive chemotaxis|negative regulation of actin nucleation|regulation of release of sequestered calcium ion into cytosol|early endosome to recycling endosome transport|cellular response to interleukin-4|,actin binding|actin monomer binding|protein binding|protein C-terminus binding|cytoskeletal protein binding|myosin heavy chain binding|identical protein binding|protein homodimerization activity|phosphatidylinositol 3-kinase binding|poly(A) RNA binding|actin filament binding|,3,5,293000000,7.5%
Q8BK08,0.416238741,-0.015333333,10.06130876,-0.247333333,0.098598231,-1.920888415,-0.063,0.237,0.151,-0.339,-0.042,-0.036,Q8BK08,Tmem11,Q8BK08_Tmem11,Q8BK08,Tmem11,1,6,2,2,Q8BK08|E9Q933,MOUSE,21767.6,8.9,2561,2561.1,27.14,27.14,,190,"Transmembrane protein 11, mitochondrial",mitochondrion|integral component of mitochondrial inner membrane|,mitochondrion organization|,,2,6,5270000000,8.9%
Q9CQJ6,0.695646919,0.078666667,4.607182207,-0.264666667,0.346163903,-1.0140878,-0.162,0.02,0.775,-0.341,0.059,0.121,Q9CQJ6,Denr,Q9CQJ6_Denr,Q9CQJ6,Denr,1,4,3,3,Q9CQJ6,MOUSE,22565.1,21.7,2562,2562.1,27.13,27.13,,198,Density-regulated protein,,formation of translation preinitiation complex|IRES-dependent translational initiation|ribosome disassembly|,translation initiation factor activity|,3,4,403000000,21.7%
Q5F2E7-2,0.615860336,-0.012333333,6.027840582,0.119333333,0.249583541,1.260634748,-0.062,-0.076,-0.078,-0.067,0.028,0.181,Q5F2E7,Nufip2,Q5F2E7-2_Nufip2,Q5F2E7-2,Nufip2,1,4,4,4,Q5F2E7-2|Q5F2E7,MOUSE,78054.4,6.7,2563,2563.1,27.1,27.1,,692,Isoform 2 of Nuclear fragile X mental retardation-interacting protein 2,nucleus|cytoplasm|membrane|polysomal ribosome|,,RNA binding|poly(A) RNA binding|,4,4,32400000,6.7%
Q64511,0.253738665,0.017,14.07856827,-0.406666667,0.039096976,-2.565105312,0.275,-0.042,0.428,0.041,-0.311,-0.289,Q64511,Top2b,Q64511_Top2b,Q64511,Top2b,1,5,2,2,Q64511|Q01320,MOUSE,182818.4,1.8,2564,2564.1,27.07,27.07,,1612,DNA topoisomerase 2-beta,nucleus|nucleoplasm|nucleolus|cytoplasm|cytosol|DNA topoisomerase complex (ATP-hydrolyzing)|chromosome|nucleoid|heterochromatin|,resolution of meiotic recombination intermediates|sister chromatid segregation|neuron migration|DNA topological change|DNA unwinding involved in DNA replication|axonogenesis|forebrain development|mitotic DNA integrity checkpoint|,"chromatin binding|DNA topoisomerase type II (ATP-hydrolyzing) activity|protein kinase C binding|protein binding|ATP binding|protein C-terminus binding|DNA binding, bending|enzyme binding|histone deacetylase binding|metal ion binding|protein heterodimerization activity|",3,5,64700000,1.8%
P30204,0.002995511,-0.115,38.29832303,1.736,0.000147968,7.755954243,-1.003,-1.21,-0.736,1.19,0.391,0.678,P30204,Msr1,P30204_Msr1,P30204,Msr1,1,2,2,2,P30204|P30204-2,MOUSE,50739.3,6.1,2565,2565.1,27.06,27.06,,458,Macrophage scavenger receptor types I and II,collagen trimer|cytosol|plasma membrane|integral component of membrane|cytoplasmic vesicle|low-density lipoprotein particle|,receptor-mediated endocytosis|positive regulation of macrophage derived foam cell differentiation|positive regulation of cholesterol storage|cholesterol transport|plasma lipoprotein particle clearance|lipoprotein transport|cellular response to organic cyclic compound|,scavenger receptor activity|low-density lipoprotein particle binding|,2,2,4540000,6.1%
Q8BKX6,0.972248418,-0.0775,0.398680537,0.028333333,0.912287966,0.114432584,0.148,0.261,-0.684,0.012,-0.174,-0.028,Q8BKX6,Smg1,Q8BKX6_Smg1,Q8BKX6,Smg1,1,7,4,4,Q8BKX6|Q8BKX6-3|Q8BKX6-2,MOUSE,413812.8,1.3,2566,2566.1,26.96,26.96,,3658,Serine/threonine-protein kinase SMG1,nucleus|cytoplasm|,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|double-strand break repair via homologous recombination|peptidyl-serine phosphorylation|protein autophosphorylation|phosphatidylinositol phosphorylation|",protein serine/threonine kinase activity|ATP binding|kinase activity|poly(A) RNA binding|metal ion binding|protein dimerization activity|,4,7,2260000000,1.3%
Q925B0,0.884566234,0.047333333,1.868752819,0.086,0.650316417,0.474617115,-0.128,0.111,0.03,-0.143,-0.074,0.488,Q925B0,Pawr,Q925B0_Pawr,Q925B0,Pawr,1,2,2,2,Q925B0|Q925B0-2,MOUSE,36079,8.7,2567,2567.1,26.96,26.96,,333,PRKC apoptosis WT1 regulator protein,nucleus|cytoplasm|actin filament|plasma membrane|actin cytoskeleton|axon|neuronal cell body|,"transcription, DNA-templated|regulation of transcription, DNA-templated|response to wounding|response to iron(II) ion|negative regulation of B cell proliferation|response to lipopolysaccharide|positive regulation of phosphoprotein phosphatase activity|interleukin-2 biosynthetic process|negative regulation of T cell proliferation|positive regulation of amyloid precursor protein biosynthetic process|positive regulation of apoptotic process|positive regulation of neuron apoptotic process|positive regulation of action potential|negative regulation of T cell receptor signaling pathway|detection of temperature stimulus involved in sensory perception of pain|detection of mechanical stimulus involved in sensory perception of pain|positive regulation of hindgut contraction|cellular response to vitamin E|cellular response to interleukin-1|cellular response to follicle-stimulating hormone stimulus|cellular response to estradiol stimulus|negative regulation of calcium ion import|apoptotic signaling pathway|activation of cysteine-type endopeptidase activity|regulation of neuronal action potential|positive regulation of relaxation of smooth muscle|positive regulation of leukocyte tethering or rolling|calcium ion import into cell|positive regulation of neutrophil extravasation|",protein kinase C binding|protein binding|protein phosphatase 1 binding|enzyme binding|leucine zipper domain binding|,2,2,21100000,8.7%
Q9CR26,0.951421295,-0.07,0.722994701,0.034666667,0.846643405,0.201120942,0.21,-0.023,-0.449,-0.029,0.019,-0.148,Q9CR26,Vta1,Q9CR26_Vta1,Q9CR26,Vta1,1,4,3,3,Q9CR26|F8WJC2,MOUSE,34197.8,13.5,2568,2568.1,26.95,26.95,,309,Vacuolar protein sorting-associated protein VTA1 homolog,cytoplasm|cytosol|endosome membrane|extracellular exosome|,protein transport|viral budding|multivesicular body sorting pathway|,protein binding|protein C-terminus binding|,3,4,541000000,13.5%
Q60676,0.99327985,0.03,0.125318419,0.003333333,0.971556716,0.037009014,0.081,0.015,-0.011,0.129,0.029,-0.063,Q60676,Ppp5c,Q60676_Ppp5c,Q60676,Ppp5c,1,4,3,3,Q60676,MOUSE,57503.2,7.8,2569,2569.1,26.95,26.95,,499,Serine/threonine-protein phosphatase 5,nucleoplasm|cytoplasm|cytosol|membrane|perikaryon|intracellular membrane-bounded organelle|cell periphery|proximal dendrite|,negative regulation of protein phosphorylation|signal transduction|response to lead ion|histone dephosphorylation|positive regulation of I-kappaB kinase/NF-kappaB signaling|response to morphine|protein heterooligomerization|cellular response to hydrogen peroxide|cellular response to cadmium ion|negative regulation of neuron death|positive regulation of glucocorticoid receptor signaling pathway|,G-protein alpha-subunit binding|RNA binding|phosphoprotein phosphatase activity|signal transducer activity|protein binding|microtubule binding|heat shock protein binding|identical protein binding|metal ion binding|,3,4,70900000,7.8%
Q5RIM6,0.929192436,0.017666667,1.008089447,-0.036,0.792850045,-0.27343826,0.017,0.279,-0.189,0.05,-0.052,0.001,Q5RIM6,Ncor1,Q5RIM6_Ncor1,Q5RIM6,Ncor1,1,5,5,5,Q5RIM6|Q60974|Q60974-2|E9Q2B2|E9Q9Y2,MOUSE,271809.4,3,2570,2570.1,26.94,26.94,,2454,"Nuclear receptor co-repressor 1, isoform CRA_a",nuclear chromatin|nucleus|transcription factor complex|cytoplasm|spindle microtubule|membrane|transcriptional repressor complex|histone deacetylase complex|Sin3 complex|,"negative regulation of transcription from RNA polymerase II promoter|regulation of thyroid hormone mediated signaling pathway|CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation|regulation of transcription from RNA polymerase II promoter|negative regulation of phosphatidylinositol 3-kinase signaling|thalamus development|positive regulation of histone deacetylation|circadian regulation of gene expression|regulation of multicellular organism growth|cholesterol homeostasis|negative regulation of transcription, DNA-templated|negative regulation of JNK cascade|spindle assembly|definitive erythrocyte differentiation|regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter|regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter|cellular response to Thyroglobulin triiodothyronine|",RNA polymerase II activating transcription factor binding|DNA binding|sequence-specific DNA binding transcription factor activity|transcription corepressor activity|protein binding|histone deacetylase regulator activity|nuclear hormone receptor binding|histone deacetylase binding|retinoic acid receptor binding|sequence-specific DNA binding|retinoid X receptor binding|thyroid hormone receptor binding|,5,5,798000000,3.0%
Q6KCD5,0.821409751,0.0015,2.768221914,0.092333333,0.528661652,0.664778715,0.099,0.065,-0.298,0.133,0.121,-0.111,Q6KCD5,Nipbl,Q6KCD5_Nipbl,Q6KCD5,Nipbl,1,4,4,4,Q6KCD5|Q6KCD5-2,MOUSE,317498.7,1.5,2571,2571.1,26.9,26.9,,2798,Nipped-B-like protein,chromatin|nucleus|SMC loading complex|extracellular exosome|,"negative regulation of transcription from RNA polymerase II promoter|heart morphogenesis|outflow tract morphogenesis|cellular response to DNA damage stimulus|mitotic sister chromatid cohesion|brain development|heart development|sensory perception of sound|stem cell maintenance|positive regulation of histone deacetylation|maintenance of mitotic sister chromatid cohesion|cellular protein localization|embryonic forelimb morphogenesis|forelimb morphogenesis|external genitalia morphogenesis|positive regulation of multicellular organism growth|ear morphogenesis|regulation of hair cycle|fat cell differentiation|positive regulation of ossification|negative regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|regulation of embryonic development|embryonic digestive tract morphogenesis|developmental growth|eye morphogenesis|regulation of developmental growth|embryonic cranial skeleton morphogenesis|embryonic viscerocranium morphogenesis|cognition|face morphogenesis|gall bladder development|uterus morphogenesis|cellular response to X-ray|",chromatin binding|protein C-terminus binding|mediator complex binding|histone deacetylase binding|protein N-terminus binding|chromo shadow domain binding|,4,4,779000000,1.5%
Q8VC42,0.524618164,0.079833333,7.731670124,-0.305666667,0.168590457,-1.545455833,-0.018,0.017,0.699,-0.105,-0.097,-0.017,Q8VC42,Rmc1,Q8VC42_Rmc1,Q8VC42,Mic1,1,5,3,3,Q8VC42,MOUSE,75662.8,6.2,2572,2572.1,26.87,26.87,,657,Uncharacterized protein C18orf8 homolog,lysosomal membrane|,,,3,5,88000000,6.2%
Q3UGR5,0.297132915,-0.022,12.82132511,0.239333333,0.052223682,2.356330101,-0.128,-0.03,-0.267,0.197,0.017,0.079,Q3UGR5,Hdhd2,Q3UGR5_Hdhd2,Q3UGR5,Hdhd2,1,4,2,2,Q3UGR5|Q3UGR5-2,MOUSE,28900.8,18.5,2573,2573.1,26.86,26.86,,259,Haloacid dehalogenase-like hydrolase domain-containing protein 2,extracellular exosome|,,enzyme binding|metal ion binding|,2,4,55700000,18.5%
Q3UR70,0.328373466,-0.025333333,12.02938853,-0.250666667,0.06267021,-2.232618497,-0.001,0.164,0.137,-0.02,-0.332,-0.1,Q3UR70,Tgfbrap1,Q3UR70_Tgfbrap1,Q3UR70,Tgfbrap1,1,4,3,3,Q3UR70,MOUSE,98442.5,3.9,2574,2574.1,26.86,26.86,,860,Transforming growth factor-beta receptor-associated protein 1,cytoplasm|membrane|,"regulation of transcription, DNA-templated|intracellular protein transport|signal transduction|vesicle-mediated transport|",transforming growth factor beta receptor binding|SMAD binding|,3,4,26400000,3.9%
P11862,0.962232805,0.014166667,0.522004652,-0.020333333,0.886746606,-0.148003734,0.018,0.114,-0.059,-0.019,0.255,-0.224,P11862,Gas2,P11862_Gas2,P11862,Gas2,1,2,2,2,P11862,MOUSE,35527.5,9.8,2575,2575.1,26.82,26.82,,314,Growth arrest-specific protein 2,cytoplasm|cytoskeleton|membrane|,apoptotic process|cell cycle arrest|regulation of cell shape|,,2,2,253000000,9.8%
Q3UTR7,0.255256702,-0.150666667,14.01328904,0.638666667,0.039689086,2.554506275,-0.383,-0.008,-1.019,0.006,0.279,0.221,Q3UTR7,Agt,Q3UTR7_Agt,Q3UTR7,Agt,1,2,2,2,Q3UTR7|P11859,MOUSE,52954.5,4.5,2576,2576.1,26.77,26.77,,482,Angiotensinogen,extracellular space|cytoplasm|extracellular exosome|blood microparticle|,"ovarian follicle rupture|blood vessel development|branching involved in ureteric bud morphogenesis|kidney development|regulation of systemic arterial blood pressure by circulatory renin-angiotensin|angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure|renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure|renin-angiotensin regulation of aldosterone production|regulation of renal output by angiotensin|regulation of heart rate|brain renin-angiotensin system|renal system process|angiotensin-mediated drinking behavior|positive regulation of extracellular matrix constituent secretion|cellular sodium ion homeostasis|cell-matrix adhesion|G-protein coupled receptor signaling pathway|activation of phospholipase C activity|activation of NF-kappaB-inducing kinase activity|female pregnancy|aging|excretion|establishment of blood-nerve barrier|regulation of blood pressure|negative regulation of cell proliferation|response to cold|response to salt stress|regulation of gene expression|positive regulation of activation of JAK2 kinase activity|positive regulation of endothelial cell migration|positive regulation of cardiac muscle hypertrophy|positive regulation of gene expression|positive regulation of cholesterol esterification|negative regulation of endopeptidase activity|regulation of norepinephrine secretion|positive regulation of phosphatidylinositol 3-kinase signaling|artery smooth muscle contraction|response to muscle activity involved in regulation of muscle adaptation|negative regulation of angiogenesis|extracellular matrix organization|negative regulation of cell growth|peristalsis|positive regulation of cellular protein metabolic process|positive regulation of superoxide anion generation|positive regulation of peptidyl-serine phosphorylation|negative regulation of tissue remodeling|catenin import into nucleus|positive regulation of renal sodium excretion|positive regulation of multicellular organism growth|vasodilation|hormone metabolic process|drinking behavior|regulation of apoptotic process|positive regulation of MAPK cascade|negative regulation of neuron apoptotic process|positive regulation of nitric oxide biosynthetic process|positive regulation of fatty acid biosynthetic process|positive regulation of epidermal growth factor receptor signaling pathway|positive regulation of transcription, DNA-templated|positive regulation of vasodilation|positive regulation of organ growth|astrocyte activation|fibroblast proliferation|positive regulation of fibroblast proliferation|regulation of long-term neuronal synaptic plasticity|smooth muscle cell proliferation|cytokine secretion|regulation of inflammatory response|positive regulation of peptidyl-tyrosine phosphorylation|smooth muscle cell differentiation|negative regulation of neurotrophin TRK receptor signaling pathway|stress-activated MAPK cascade|regulation of calcium ion transport|regulation of transmission of nerve impulse|cell growth involved in cardiac muscle cell development|positive regulation of protein tyrosine kinase activity|ERK1 and ERK2 cascade|uterine smooth muscle contraction|cellular response to mechanical stimulus|positive regulation of branching involved in ureteric bud morphogenesis|positive regulation of protein kinase C activity|regulation of extracellular matrix assembly|positive regulation of membrane hyperpolarization|positive regulation of gap junction assembly|regulation of cardiac conduction|positive regulation of extrinsic apoptotic signaling pathway|",serine-type endopeptidase inhibitor activity|hormone activity|sodium channel regulator activity|type 1 angiotensin receptor binding|type 2 angiotensin receptor binding|,2,2,122000000,4.5%
A2AQ25,0.737344112,-0.037333333,3.984609093,0.137333333,0.39952052,0.900314619,0.073,0.028,-0.419,-0.069,0.156,0.007,A2AQ25,Etl4,A2AQ25_Etl4,A2AQ25,Skt,1,4,4,4,E9QAU4|A2AQ25|A2AQ25-3|D3Z781|A2AQ25-4|A2AQ25-8|A2AQ25-7|Q8BHR1|A2AQ25-2|A2AQ25-5|A2AQ25-6|A2AQ25-9,MOUSE,214003,2.1,2577,2577.1,26.76,26.76,,1946,Sickle tail protein,cytoplasm|,embryonic skeletal system development|,,4,4,79600000,2.1%
Q91YT2-2,0.764663191,-0.019666667,3.641690397,0.076,0.432345517,0.835279944,0.016,-0.026,-0.163,0.046,0.059,-0.05,Q91YT2,Rnf185,Q91YT2-2_Rnf185,Q91YT2-2,Rnf185,1,6,4,4,Q91YT2-2|Q91YT2,MOUSE,25534.5,11.4,2578,2578.1,26.75,26.75,,192,Isoform 2 of E3 ubiquitin-protein ligase RNF185,mitochondrial outer membrane|endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,autophagy|ER-associated ubiquitin-dependent protein catabolic process|ERAD pathway|protein autoubiquitination|,zinc ion binding|ligase activity|ubiquitin-like protein conjugating enzyme binding|ubiquitin protein ligase activity|,4,6,1180000000,11.4%
Q6WVG3,0.469507952,0.100166667,8.907230529,-0.423666667,0.128610654,-1.735936201,0.166,-0.097,0.867,-0.013,-0.269,-0.053,Q6WVG3,Kctd12,Q6WVG3_Kctd12,Q6WVG3,Kctd12,1,6,3,3,Q6WVG3|A0A0R4J2B2,MOUSE,36176.6,11,2579,2579.1,26.74,26.74,,327,BTB/POZ domain-containing protein KCTD12,cell junction|presynaptic membrane|receptor complex|postsynaptic membrane|extracellular exosome|,regulation of G-protein coupled receptor protein signaling pathway|protein homooligomerization|,protein binding|poly(A) RNA binding|,3,6,288000000,11.0%
Q9D1F9,0.662925276,0.022666667,5.129339788,-0.136666667,0.306948857,-1.10685882,0.041,0.322,-0.09,-0.092,0.014,-0.059,Q9D1F9,Slc37a4,Q9D1F9_Slc37a4,Q9D1F9,Slc37a4,1,4,3,3,A0A1L1SUI3|Q9D1F9,MOUSE,46462.2,8.3,2580,2580.1,26.73,26.73,,429,"Solute carrier family 37 (Glucose-6-phosphate transporter), member 4",membrane|integral component of membrane|integral component of endoplasmic reticulum membrane|intracellular membrane-bounded organelle|,neutrophil homeostasis|cytokine production|positive regulation of defense response to virus by host|myeloid progenitor cell differentiation|glycogen metabolic process|lactate metabolic process|triglyceride metabolic process|anion transport|cellular calcium ion homeostasis|steroid metabolic process|response to glucose|glucose-6-phosphate transport|neutrophil chemotaxis|negative regulation of chemokine production|post-embryonic hemopoiesis|phosphate ion transmembrane transport|glucose homeostasis|cholesterol homeostasis|positive regulation of catalytic activity|respiratory burst|phosphate ion homeostasis|transmembrane transport|activation of mitophagy in response to mitochondrial depolarization|,glucose-6-phosphate transmembrane transporter activity|organophosphate:inorganic phosphate antiporter activity|,3,4,3300000000,8.3%
A0A023T778,0.741968945,0.0055,3.938522851,-0.094333333,0.403782707,-0.891149296,-0.117,0.155,0.12,0.007,-0.124,-0.008,A0A023T778,Magohb,A0A023T778_Magohb,A0A023T778,Magohb,1,2,2,2,A0A023T778|P61327|Q9CQL1|G3UZW7,MOUSE,17366.6,25,2581,2581.1,26.72,26.72,,148,Mago nashi protein,exon-exon junction complex|catalytic step 2 spliceosome|,RNA splicing|,poly(A) RNA binding|,2,2,395000000,25.0%
E9Q1Q9,0.247282424,0.01,14.27033809,0.433333333,0.037408147,2.596283386,-0.217,-0.088,-0.315,0.039,0.586,0.055,E9Q1Q9,Khk,E9Q1Q9_Khk,E9Q1Q9,Khk,1,6,4,4,E9Q1Q9|P97328|A0A0J9YU79,MOUSE,38294.7,9.6,2583,2583.1,26.65,26.65,,343,Ketohexokinase,nucleus|cytoplasm|extracellular exosome|,fructose metabolic process|carbohydrate phosphorylation|regulation of glycogen metabolic process|,ketohexokinase activity|fructokinase activity|,4,6,42700000,9.6%
Q9D3L3,0.2052132,0.020166667,15.72157577,0.233,0.026781964,2.8256615,-0.127,-0.098,-0.064,0.167,0.065,0.178,Q9D3L3,Snap23,Q9D3L3_Snap23,Q9D3L3,Snap23,1,6,4,4,Q9D3L3|O09044|E9Q8A1,MOUSE,24892.2,31.2,2584,2584.1,26.64,26.64,,221,Synaptosomal-associated protein,nucleoplasm|cytoplasm|plasma membrane|focal adhesion|SNARE complex|cytoplasmic vesicle|specific granule|azurophil granule|mast cell granule|extracellular exosome|,histamine secretion by mast cell|exocytosis|synaptic vesicle priming|synaptic vesicle fusion to presynaptic membrane|,SNAP receptor activity|protein binding|syntaxin binding|,4,6,833000000,31.2%
O88597,0.634404848,0.0635,5.685528648,0.217,0.270051837,1.203496625,-0.134,-0.04,0.039,0.577,-0.08,0.019,O88597,Becn1,O88597_Becn1,O88597,Becn1,1,3,3,3,O88597|E9PYD6,MOUSE,52101.5,8,2585,2585.1,26.61,26.61,,448,Beclin-1,"pre-autophagosomal structure|cytoplasm|endosome|autophagosome|endoplasmic reticulum|endoplasmic reticulum membrane|trans-Golgi network|cytoskeleton|endosome membrane|membrane|cytoplasmic membrane-bounded vesicle|extrinsic component of membrane|mitochondrial membrane|phosphatidylinositol 3-kinase complex, class III, type I|phosphatidylinositol 3-kinase complex, class III, type II|phosphatidylinositol 3-kinase complex, class III|protein complex|phagocytic vesicle|mitochondrion|",autophagosome assembly|cytokinesis|angiogenesis|autophagy|cellular response to nitrogen starvation|lysosome organization|mitotic metaphase plate congression|negative regulation of cell proliferation|positive regulation of autophagy|macroautophagy|positive regulation of macroautophagy|CVT pathway|regulation of cytokinesis|receptor catabolic process|cellular response to glucose starvation|negative regulation of apoptotic process|engulfment of apoptotic cell|nucleophagy|late endosome to vacuole transport|neuron development|beta-amyloid metabolic process|regulation of catalytic activity|defense response to virus|response to other organism|activation of mitophagy in response to mitochondrial depolarization|positive regulation of attachment of mitotic spindle microtubules to kinetochore|positive regulation of mitochondrion degradation|negative regulation of reactive oxygen species metabolic process|,protein binding|phosphatidylinositol 3-kinase binding|,3,3,238000000,8.0%
Q9QYB5,0.773512169,-0.0215,3.523878466,-0.097,0.444234367,-0.813440608,-0.051,0.101,0.031,0.006,-0.287,0.071,Q9QYB5,Add3,Q9QYB5_Add3,Q9QYB5,Add3,1,4,4,4,Q9QYB5|Q9QYB5-2,MOUSE,79118,5.8,2586,2586.1,26.6,26.6,,706,Gamma-adducin,condensed nuclear chromosome|nucleoplasm|cytoplasm|cytoskeleton|plasma membrane|brush border|cell-cell junction|cell cortex|membrane|neuronal postsynaptic density|,response to drug|,actin binding|protein kinase C binding|structural molecule activity|calmodulin binding|,4,4,874000000,5.8%
Q5SW15,0.875832617,-0.044333333,2.014679378,-0.11,0.628828276,-0.506658791,0.232,0.298,-0.498,-0.056,-0.216,-0.026,Q5SW15,NotFound,Q5SW15_NotFound,Q5SW15,Mettl16,1,3,3,3,Q5SW15|Q9CQG2|Q9CQG2-2,MOUSE,67661.5,7.5,2587,2587.1,26.58,26.58,,593,U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase,nucleus|,rRNA base methylation|,poly(A) RNA binding|23S rRNA (adenine(1618)-N(6))-methyltransferase activity|,3,3,60000000,7.5%
P49891,0.461918472,0.177833333,9.080750053,-0.561,0.1235734,-1.763838947,0.897,0.797,-0.319,-0.239,-0.099,0.03,P49891,NotFound,P49891_NotFound,P49891,Sult1e1,1,6,4,4,P49891|Q9D566,MOUSE,35874.8,18.9,2588,2588.1,26.57,26.57,,295,"Estrogen sulfotransferase, testis isoform",cytoplasm|,female pregnancy|estrogen metabolic process|positive regulation of fat cell differentiation|sulfation|,estrone sulfotransferase activity|steroid binding|flavonol 3-sulfotransferase activity|steroid sulfotransferase activity|,4,6,185000000,18.9%
Q8BGI5,0.837702479,-0.035166667,2.562229692,-0.115,0.554341038,-0.622661262,0.085,0.342,-0.36,-0.185,0.045,-0.138,Q8BGI5,Pex26,Q8BGI5_Pex26,Q8BGI5,Pex26,1,6,2,2,Q8BGI5|Q8BGI5-2,MOUSE,34301.1,5.9,2589,2589.1,26.57,26.57,,305,Peroxisome assembly protein 26,peroxisome|integral component of peroxisomal membrane|,protein import into peroxisome matrix|protein import into peroxisome membrane|,protein C-terminus binding|protein complex binding|ATPase binding|,2,6,4120000000,5.9%
Q9CPQ1,0.209394007,0.001333333,15.61534694,0.530666667,0.027445131,2.816919075,-0.399,-0.06,-0.333,0.655,0.024,0.121,Q9CPQ1,Cox6c,Q9CPQ1_Cox6c,Q9CPQ1,Cox6c,1,4,3,3,Q9CPQ1,MOUSE,8468.9,42.1,2590,2590.1,26.55,26.55,,76,Cytochrome c oxidase subunit 6C,mitochondrion|mitochondrial inner membrane|integral component of membrane|,hydrogen ion transmembrane transport|,cytochrome-c oxidase activity|,3,4,238000000,42.1%
P63280,0.826778144,0.0015,2.668845612,-0.086333333,0.540898079,-0.64455503,0.104,0.142,-0.112,-0.174,0.194,-0.145,P63280,Ube2i,P63280_Ube2i,P63280,Ube2i,1,7,2,2,P63280|Q8CFZ0,MOUSE,18234.7,14.5,2591,2591.1,26.53,26.53,,158,SUMO-conjugating enzyme UBC9,nucleus|nucleoplasm|cytoplasm|nuclear body|PML body|transferase complex|,"negative regulation of transcription from RNA polymerase II promoter|cellular protein modification process|chromosome segregation|mitotic nuclear division|multicellular organismal development|viral process|protein ubiquitination|protein sumoylation|positive regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of transcription, DNA-templated|cell division|positive regulation of SUMO transferase activity|",protein binding|ATP binding|transcription factor binding|ligase activity|SUMO transferase activity|enzyme binding|HLH domain binding|poly(A) RNA binding|SUMO conjugating enzyme activity|RING-like zinc finger domain binding|ubiquitin protein ligase binding|ubiquitin protein ligase activity|,2,7,1570000000,14.5%
Q8BIQ5,0.382438943,-0.044666667,10.79724206,0.444666667,0.083229214,2.03836838,-0.444,-0.516,0.159,0.031,0.018,0.484,Q8BIQ5,Cstf2,Q8BIQ5_Cstf2,Q8BIQ5,Cstf2,1,4,3,3,Q8BIQ5|Q8BIQ5-2|A2AEK1,MOUSE,61454.3,5.3,2592,2592.1,26.52,26.52,,580,Cleavage stimulation factor subunit 2,nucleoplasm|mRNA cleavage and polyadenylation specificity factor complex|cleavage body|,mRNA processing|,nucleotide binding|poly(A) RNA binding|,3,4,68600000,5.3%
Q93092,0.328224622,-0.018333333,12.03923329,0.301333333,0.062528307,2.236704732,-0.357,-0.125,-0.025,0.031,0.025,0.341,Q93092,Taldo1,Q93092_Taldo1,Q93092,Taldo1,1,3,3,3,A0A1B0GR11|Q93092,MOUSE,37557.4,9.1,2593,2593.1,26.51,26.51,,337,Transaldolase,nucleus|cytosol|extracellular exosome|,"carbohydrate metabolic process|fructose 6-phosphate metabolic process|pentose-phosphate shunt, non-oxidative branch|",sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity|monosaccharide binding|,3,3,7360000,9.1%
Q9CY28,0.133036535,-0.016833333,18.30149711,-0.265,0.014785986,-3.258407894,0.148,0.134,0.065,-0.111,-0.139,-0.198,Q9CY28,Gtpbp8,Q9CY28_Gtpbp8,Q9CY28,Gtpbp8,1,6,2,2,Q9CY28|Q9CY28-2,MOUSE,32099.8,8,2594,2594.1,26.49,26.49,,285,GTP-binding protein 8,mitochondrion|,barrier septum assembly|,GTP binding|metal ion binding|,2,6,396000000,8.0%
Q3ULW8,0.632582508,-0.0235,5.759570818,0.155666667,0.265486791,1.216213524,-0.135,-0.192,0.023,-0.156,0.245,0.074,Q3ULW8,Parp3,Q3ULW8_Parp3,Q3ULW8,Parp3,1,2,2,2,Q3ULW8|Q8CFB8,MOUSE,60575.5,6,2595,2595.1,26.47,26.47,,533,Poly [ADP-ribose] polymerase,site of double-strand break|,telomere maintenance|double-strand break repair|protein ADP-ribosylation|positive regulation of DNA ligation|regulation of mitotic spindle organization|protein localization to site of double-strand break|,NAD+ ADP-ribosyltransferase activity|,2,2,23000000,6.0%
Q3TLH4,0.318107191,0.0765,12.31016441,0.261666667,0.058746711,2.278323676,-0.176,-0.026,0.039,0.234,0.038,0.35,Q3TLH4,Prrc2c,Q3TLH4_Prrc2c,Q3TLH4,Prrc2c,1,6,4,4,Q3TLH4|A0A0A0MQ79|Q3TLH4-5|S4R2J9|S4R294,MOUSE,311514.2,1.3,2596,2596.1,26.46,26.46,,2846,Protein PRRC2C,membrane|,hematopoietic progenitor cell differentiation|,protein C-terminus binding|poly(A) RNA binding|,4,6,90000000,1.3%
Q9JJU8,0.908901084,-0.086166667,1.475393646,-0.089666667,0.711968264,-0.385479974,0.043,-0.178,0.011,-0.486,0.409,-0.316,Q9JJU8,Sh3bgrl,Q9JJU8_Sh3bgrl,Q9JJU8,Sh3bgrl,1,2,2,2,Q9JJU8,MOUSE,12925.1,24.5,2597,2597.1,26.45,26.45,,114,SH3 domain-binding glutamic acid-rich-like protein,extracellular space|extracellular exosome|,,SH3 domain binding|,2,2,18400000,24.5%
Q8CHT3,0.821409751,-0.057,2.747734936,-0.108666667,0.531161399,-0.660623615,0.121,0.236,-0.365,-0.183,-0.059,-0.092,Q8CHT3,Ints5,Q8CHT3_Ints5,Q8CHT3,Ints5,1,3,3,3,Q8CHT3,MOUSE,109657.9,3.5,2598,2598.1,26.3,26.3,,1018,Integrator complex subunit 5,nucleus|membrane|integral component of membrane|integrator complex|,snRNA processing|,,3,3,39900000,3.5%
P56391,0.273334376,0.039666667,13.54161558,0.661333333,0.044242376,2.478122926,-0.383,-0.467,-0.023,0.967,0.022,0.122,P56391,Cox6b1,P56391_Cox6b1,P56391,Cox6b1,1,3,2,2,P56391|A0A140LIU3,MOUSE,10299.5,33.7,2599,2599.1,26.27,26.27,,86,Cytochrome c oxidase subunit 6B1,mitochondrion|mitochondrial inner membrane|mitochondrial intermembrane space|,substantia nigra development|hydrogen ion transmembrane transport|,cytochrome-c oxidase activity|,2,3,29300000,33.7%
Q3TIR3,0.915689908,-0.0425,1.323368461,-0.055666667,0.737332121,-0.349828051,0.035,-0.036,-0.043,0.11,-0.427,0.106,Q3TIR3,Ric8a,Q3TIR3_Ric8a,Q3TIR3,Ric8a,1,3,2,2,Q3TIR3|A0A1B0GS30,MOUSE,60416.3,6.6,2600,2600.1,26.22,26.22,,530,Synembryn-A,cytoplasm|cytosol|plasma membrane|membrane|,in utero embryonic development|vasculature development|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway|gastrulation|regulation of G-protein coupled receptor protein signaling pathway|visual learning|response to light stimulus|cell migration involved in gastrulation|positive regulation of GTPase activity|cell-cell adhesion involved in gastrulation|basement membrane organization|,G-protein alpha-subunit binding|guanyl-nucleotide exchange factor activity|GTPase activator activity|protein binding|,2,3,683000000,6.6%
Q8BGC0,0.713841797,-0.024,4.315118824,0.096666667,0.370244075,0.960388722,-0.158,-0.151,0.092,-0.01,0.02,0.063,Q8BGC0,Htatsf1,Q8BGC0_Htatsf1,Q8BGC0,Htatsf1,1,4,3,3,Q8BGC0|Q8BGC0-2,MOUSE,86694.8,5.9,2601,2601.1,26.22,26.22,,757,HIV Tat-specific factor 1 homolog,nucleoplasm|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",nucleotide binding|poly(A) RNA binding|,3,4,443000000,5.9%
Q3UFS0,0.875832617,0.0145,2.01464007,-0.043666667,0.628833968,-0.506373143,-0.039,0.127,0.021,0.029,-0.03,-0.021,Q3UFS0,Zyg11b,Q3UFS0_Zyg11b,Q3UFS0,Zyg11b,1,3,3,3,Q3UFS0|Q3UFS0-3|Q3UFS0-2,MOUSE,85073.7,4.8,2602,2602.1,26.16,26.16,,744,Protein zyg-11 homolog B,Cul2-RING ubiquitin ligase complex|,protein ubiquitination|regulation of ubiquitin-protein transferase activity|,ubiquitin-protein transferase activity|,3,3,1130000000,4.8%
Q9CZD5,0.648863596,-0.065,5.33916872,-0.217333333,0.292471214,-1.143558524,-0.001,-0.02,0.152,0,-0.606,0.085,Q9CZD5,Mtif3,Q9CZD5_Mtif3,Q9CZD5,Mtif3,1,2,2,2,Q9CZD5,MOUSE,31909.9,14.4,2603,2603.1,26.14,26.14,,276,"Translation initiation factor IF-3, mitochondrial",mitochondrion|,ribosome disassembly|mitochondrial translational initiation|,"translation initiation factor activity|translation factor activity, RNA binding|ribosomal small subunit binding|",2,2,17800000,14.4%
Q61598,0.99327985,-0.019166667,0.126215223,-0.009666667,0.971356113,-0.037286276,-0.368,0.199,0.126,-0.416,0.48,-0.136,Q61598,Gdi2,Q61598_Gdi2,Q61598,Gdi2,1,4,2,2,Q61598|Q61598-2,MOUSE,51049.7,5.8,2604,2604.1,26.13,26.13,,445,Rab GDP dissociation inhibitor beta,Golgi apparatus|focal adhesion|membrane|vesicle|myelin sheath|extracellular exosome|,small GTPase mediated signal transduction|protein transport|vesicle-mediated transport|positive regulation of GTPase activity|,Rab GDP-dissociation inhibitor activity|GTPase activator activity|small GTPase binding|poly(A) RNA binding|,2,4,218000000,5.8%
Q03142,0.287502731,-0.007333333,13.20849976,-0.206,0.047769426,-2.418222709,0.162,0.047,0.078,-0.047,-0.167,-0.117,Q03142,Fgfr4,Q03142_Fgfr4,Q03142,Fgfr4,1,9,3,3,Q03142|A0A0R4IZY3|Q03142-2,MOUSE,89572.6,5.1,2605,2605.1,26.06,26.06,,799,Fibroblast growth factor receptor 4,nucleoplasm|cytoplasm|endosome|endoplasmic reticulum|Golgi apparatus|plasma membrane|integral component of plasma membrane|transport vesicle|cell-cell junction|,organ induction|positive regulation of cell proliferation|fibroblast growth factor receptor signaling pathway|positive regulation of gene expression|regulation of extracellular matrix disassembly|cell migration|peptidyl-tyrosine phosphorylation|regulation of lipid metabolic process|lung development|glucose homeostasis|positive regulation of proteolysis|protein autophosphorylation|positive regulation of metalloenzyme activity|phosphate ion homeostasis|alveolar secondary septum development|positive regulation of ERK1 and ERK2 cascade|regulation of bile acid biosynthetic process|regulation of cholesterol homeostasis|positive regulation of DNA biosynthetic process|,fibroblast growth factor-activated receptor activity|protein binding|ATP binding|heparin binding|fibroblast growth factor binding|,3,9,2800000000,5.1%
Q6PE54,0.552889506,-0.055333333,7.217510183,-0.263333333,0.189779362,-1.461065,0.321,0.247,-0.339,-0.153,-0.239,-0.169,Q6PE54,Dhx40,Q6PE54_Dhx40,Q6PE54,Dhx40,1,2,2,2,Q6PE54,MOUSE,89783.8,4.2,2606,2606.1,26.06,26.06,,779,Probable ATP-dependent RNA helicase DHX40,cytoplasm|,RNA processing|,ATP-dependent RNA helicase activity|ATP binding|poly(A) RNA binding|,2,2,50300000,4.2%
P47877,0.000578011,-0.076666667,48.26091847,1.411333333,1.49248E-05,11.22990133,-0.622,-0.82,-0.905,0.433,0.736,0.718,P47877,Igfbp2,P47877_Igfbp2,P47877,Igfbp2,1,4,3,3,P47877|D3YU40,MOUSE,33930.2,10.1,2607,2607.1,26.02,26.02,,305,Insulin-like growth factor-binding protein 2,extracellular region|extracellular space|apical plasma membrane|cytoplasmic vesicle|extracellular exosome|,regulation of cell growth|signal transduction|female pregnancy|aging|response to nutrient|response to mechanical stimulus|response to lithium ion|response to estradiol|response to retinoic acid|cellular response to hormone stimulus|positive regulation of activated T cell proliferation|response to drug|regulation of insulin-like growth factor receptor signaling pathway|response to glucocorticoid|,insulin-like growth factor binding|insulin-like growth factor I binding|insulin-like growth factor II binding|,3,4,1270000000,10.1%
Q9JK23,0.898097088,0.029666667,1.625072784,0.059333333,0.687848384,0.41990217,-0.139,-0.14,0.279,0.099,-0.066,0.145,Q9JK23,Psmg1,Q9JK23_Psmg1,Q9JK23,Psmg1,1,3,2,2,Q9JK23|D3Z795|D6RG59,MOUSE,33959.4,10,2608,2608.1,25.97,25.97,,289,Proteasome assembly chaperone 1,nucleus|cytoplasm|endoplasmic reticulum|,cerebellar granule cell precursor proliferation|proteasome assembly|proteasome core complex assembly|,proteasome binding|,2,3,160000000,10.0%
P53702,0.972962155,-0.002,0.389630974,-0.011333333,0.914190918,-0.111889248,0.007,0.143,-0.139,0.045,-0.051,-0.017,P53702,Hccs,P53702_Hccs,P53702,Hccs,1,3,2,2,P53702|G3UXK7,MOUSE,31319.4,11,2609,2609.1,25.97,25.97,,272,Cytochrome c-type heme lyase,mitochondrion|mitochondrial inner membrane|,metabolic process|,holocytochrome-c synthase activity|protein binding|metal ion binding|,2,3,274000000,11.0%
Q61166,0.926033297,0.0085,1.083702644,0.046333333,0.779165538,0.29208064,-0.283,0.036,0.203,-0.119,-0.029,0.243,Q61166,Mapre1,Q61166_Mapre1,Q61166,Mapre1,1,4,3,3,Q61166,MOUSE,30186.8,16.7,2610,2610.1,25.94,25.94,,268,Microtubule-associated protein RP/EB family member 1,cytoplasm|Golgi apparatus|centrosome|microtubule|microtubule cytoskeleton|cortical microtubule cytoskeleton|cell projection membrane|cell projection|spindle|cytoplasmic microtubule|microtubule plus-end|,mitotic nuclear division|negative regulation of microtubule polymerization|protein localization to microtubule|cell division|positive regulation of microtubule plus-end binding|,protein binding|poly(A) RNA binding|microtubule plus-end binding|,3,4,423000000,16.7%
Q8C341-2,0.017360166,-0.687833333,29.21326842,2.889,0.001198597,5.410395644,-1.731,-1.215,-3.451,0.629,0.756,0.885,Q8C341,Suco,Q8C341-2_Suco,Q8C341-2,Suco,1,2,2,2,Q8C341-2|Q8C341,MOUSE,140779.6,2.4,2611,2611.1,25.88,25.88,,1250,Isoform 2 of SUN domain-containing ossification factor,rough endoplasmic reticulum|membrane|integral component of membrane|rough endoplasmic reticulum membrane|,multicellular organismal development|positive regulation of collagen biosynthetic process|positive regulation of osteoblast differentiation|regulation of bone remodeling|,,2,2,27800000,2.4%
Q91W59,0.919416995,-0.007,1.254481945,0.032,0.749120713,0.333269606,-0.106,-0.088,0.125,-0.008,0,0.035,Q91W59,Rbms1,Q91W59_Rbms1,Q91W59,Rbms1,1,6,2,2,E9PZ21|Q91W59|Q91W59-3|Q91W59-2|Q8BWL5-5|Q8BWL5|Q8BWL5-2|Q8BWL5-3|Q8BWL5-6|Q8BWL5-4,MOUSE,44218.1,6.4,2612,2612.1,25.87,25.87,,403,"RNA-binding motif, single-stranded-interacting protein 1",nucleus|,DNA replication|,nucleotide binding|DNA binding|poly(A) RNA binding|,2,6,210000000,6.4%
Q9JMD0,0.797504707,0.019666667,3.131420523,-0.107333333,0.486248134,-0.737294539,-0.035,0.003,0.252,-0.003,-0.277,0.178,Q9JMD0,Zfp207,Q9JMD0_Zfp207,Q9JMD0,Znf207,1,3,2,2,Q9JMD0|Q9JMD0-2|Q9JMD0-3|Q9JMD0-4,MOUSE,53134.3,2.8,2613,2613.1,25.87,25.87,,495,BUB3-interacting and GLEBS motif-containing protein ZNF207,kinetochore|condensed chromosome kinetochore|nucleus|nucleolus|microtubule|,mitotic sister chromatid segregation|mitotic spindle assembly checkpoint|attachment of spindle microtubules to kinetochore|protein stabilization|cell division|regulation of chromosome segregation|,microtubule binding|heparin binding|poly(A) RNA binding|metal ion binding|,2,3,350000000,2.8%
P28867-2,0.634404848,0.057333333,5.681234881,-0.164,0.270318963,-1.202758164,0.105,-0.093,0.406,-0.053,0.001,-0.022,P28867,Prkcd,P28867-2_Prkcd,P28867-2,Prkcd,1,4,3,3,P28867-2|P28867|Q1MX42|Q1MX40|Q1MX43|Q1MX41,MOUSE,81662.1,3.7,2614,2614.1,25.85,25.85,,674,Isoform 2 of Protein kinase C delta type,nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|cytosol|plasma membrane|cell-cell junction|membrane|nuclear matrix|perinuclear region of cytoplasm|extracellular exosome|,protein phosphorylation|apoptotic process|cell cycle|immunoglobulin mediated immune response|peptidyl-threonine phosphorylation|peptidyl-tyrosine phosphorylation|termination of signal transduction|negative regulation of actin filament polymerization|interleukin-10 production|interleukin-12 production|positive regulation of superoxide anion generation|regulation of actin cytoskeleton organization|negative regulation of glial cell apoptotic process|positive regulation of protein dephosphorylation|intracellular signal transduction|B cell proliferation|neutrophil activation|defense response to bacterium|positive regulation of catalytic activity|negative regulation of MAP kinase activity|negative regulation of insulin receptor signaling pathway|negative regulation of peptidyl-tyrosine phosphorylation|negative regulation of filopodium assembly|negative regulation of platelet aggregation|cellular senescence|positive regulation of phospholipid scramblase activity|positive regulation of ceramide biosynthetic process|positive regulation of glucosylceramide catabolic process|positive regulation of sphingomyelin catabolic process|positive regulation of response to DNA damage stimulus|positive regulation of apoptotic signaling pathway|,protein serine/threonine kinase activity|protein kinase C activity|calcium-independent protein kinase C activity|non-membrane spanning protein tyrosine kinase activity|protein binding|ATP binding|enzyme activator activity|enzyme binding|insulin receptor substrate binding|metal ion binding|,3,4,64200000,3.7%
Q8CHS8,0.817688571,0.036,2.826914637,0.12,0.521565116,0.676642797,0.094,0.038,-0.204,0.465,-0.111,-0.066,Q8CHS8,Vps37a,Q8CHS8_Vps37a,Q8CHS8,Vps37a,1,4,2,2,Q8CHS8|Q8CHS8-3|Q8CHS8-2,MOUSE,44588.9,7,2615,2615.1,25.85,25.85,,397,Vacuolar protein sorting-associated protein 37A,ESCRT I complex|nucleoplasm|cytoplasm|centrosome|late endosome membrane|intracellular membrane-bounded organelle|,protein transport|ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway|,,2,4,116000000,7.0%
Q8BPM0,0.661008538,0.001166667,5.17560074,0.105,0.303696597,1.113901138,-0.014,-0.145,0.005,0.157,0.028,-0.024,Q8BPM0,Daam1,Q8BPM0_Daam1,Q8BPM0,Daam1,1,6,3,3,Q8BPM0|Q8BPM0-2|Q8BPM0-3,MOUSE,123938.6,2.6,2616,2616.1,25.83,25.83,,1077,Disheveled-associated activator of morphogenesis 1,stress fiber|cytoplasm|plasma membrane|membrane|,actin cytoskeleton organization|,actin binding|protein binding|Rho GTPase binding|identical protein binding|,3,6,898000000,2.6%
P63005,0.000108653,-0.304166667,63.7350006,2.021,4.23155E-07,19.21701256,-1.422,-1.177,-1.345,0.64,0.654,0.825,P63005,Pafah1b1,P63005_Pafah1b1,P63005,Pafah1b1,1,5,3,3,P63005|P63005-2,MOUSE,47239.7,8.5,2617,2617.1,25.81,25.81,,410,Platelet-activating factor acetylhydrolase IB subunit alpha,astral microtubule|kinetochore|nuclear envelope|cytoplasm|centrosome|cytosol|kinesin complex|microtubule associated complex|cell cortex|microtubule cytoskeleton|axon|growth cone|motile primary cilium|nuclear membrane|neuronal cell body|perinuclear region of cytoplasm|extracellular exosome|microtubule cytoskeleton|cell leading edge|,establishment of mitotic spindle orientation|microtubule cytoskeleton organization|ameboidal-type cell migration|acrosome assembly|neuron migration|positive regulation of cytokine-mediated signaling pathway|microtubule-based process|mitotic nuclear division|nuclear migration|synaptic transmission|neuroblast proliferation|learning or memory|retrograde axon cargo transport|adult locomotory behavior|protein secretion|negative regulation of neuron projection development|lipid catabolic process|cell migration|stem cell division|transmission of nerve impulse|corpus callosum morphogenesis|hippocampus development|layer formation in cerebral cortex|cerebral cortex neuron differentiation|cerebral cortex development|actin cytoskeleton organization|microtubule organizing center organization|osteoclast development|positive regulation of embryonic development|establishment of planar polarity of embryonic epithelium|regulation of GTPase activity|cortical microtubule organization|positive regulation of axon extension|positive regulation of mitotic cell cycle|negative regulation of JNK cascade|vesicle transport along microtubule|brain morphogenesis|neuromuscular process controlling balance|nuclear envelope disassembly|positive regulation of cellular component organization|establishment of centrosome localization|auditory receptor cell development|positive regulation of dendritic spine morphogenesis|regulation of microtubule cytoskeleton organization|cochlea development|microtubule cytoskeleton organization involved in establishment of planar polarity|,protein binding|microtubule binding|protein homodimerization activity|dynein binding|dynein intermediate chain binding|phosphoprotein binding|,3,5,4680000000,8.5%
Q3U3W5,0.676059904,-0.014,4.938628755,0.107333333,0.320728183,1.072237167,0.006,-0.055,-0.154,0.014,-0.066,0.171,Q3U3W5,Prmt9,Q3U3W5_Prmt9,Q3U3W5,Prmt9,1,2,2,2,Q3U3W5|F8WIU7,MOUSE,95473.7,2.9,2618,2618.1,25.81,25.81,,846,Protein arginine N-methyltransferase 9,,protein methylation|,methyltransferase activity|,2,2,15500000,2.9%
Q9WVS7,0.991656487,0.021166667,0.152994654,-0.005,0.965384973,-0.045052097,0.033,0.16,-0.122,0.148,-0.058,-0.034,Q9WVS7,Map2k5,Q9WVS7_Map2k5,Q9WVS7,Map2k5,1,3,3,3,Q9WVS7|Q9WVS7-2|Q9WVS7-3,MOUSE,50560.2,8,2619,2619.1,25.77,25.77,,448,Dual specificity mitogen-activated protein kinase kinase 5,nucleus|spindle|cytosol|,negative regulation of transcription from RNA polymerase II promoter|MAPK cascade|activation of MAPK activity|heart development|peptidyl-tyrosine phosphorylation|positive regulation of cell growth|negative regulation of NF-kappaB transcription factor activity|negative regulation of heterotypic cell-cell adhesion|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|negative regulation of interleukin-8 biosynthetic process|positive regulation of transcription from RNA polymerase II promoter|positive regulation of epithelial cell proliferation|negative regulation of response to cytokine stimulus|ERK5 cascade|cellular response to growth factor stimulus|negative regulation of cell migration involved in sprouting angiogenesis|negative regulation of chemokine (C-X-C motif) ligand 2 production|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand|,protein serine/threonine kinase activity|MAP kinase kinase activity|protein tyrosine kinase activity|protein binding|ATP binding|metal ion binding|,3,3,138000000,8.0%
O08915,0.949474693,0.015166667,0.769880475,0.017,0.837552333,0.21315043,0.025,0.021,-0.026,0.029,-0.022,0.064,O08915,Aip,O08915_Aip,O08915,Aip,1,3,2,2,O08915,MOUSE,38060.7,8.7,2620,2620.1,25.74,25.74,,330,AH receptor-interacting protein,nucleoplasm|cytoplasm|cytosol|membrane|aryl hydrocarbon receptor complex|plasma membrane|,protein targeting to mitochondrion|xenobiotic metabolic process|regulation of protein kinase A signaling|protein maturation by protein folding|negative regulation of cyclic-nucleotide phosphodiesterase activity|regulation of nucleic acid-templated transcription|,transcription cofactor activity|protein binding|aryl hydrocarbon receptor binding|GAF domain binding|unfolded protein binding|,2,3,71600000,8.7%
Q8BGQ4,0.942471768,-0.013333333,0.829754886,-0.025333333,0.826084572,-0.228524727,-0.055,-0.006,0.059,0.098,-0.221,0.045,Q8BGQ4,Pomt2,Q8BGQ4_Pomt2,Q8BGQ4,Pomt2,1,4,3,3,Q8BGQ4|Q8BGQ4-3|Q8BGQ4-2,MOUSE,92897.6,4.5,2621,2621.1,25.72,25.72,,820,Protein O-mannosyl-transferase 2,endoplasmic reticulum membrane|integral component of membrane|,protein O-linked mannosylation|,dolichyl-phosphate-mannose-protein mannosyltransferase activity|,3,4,85200000,4.5%
Q8R123-2,0.991706646,0.011833333,0.149779849,0.006333333,0.966099851,0.044133167,0.006,0.211,-0.191,-0.108,-0.072,0.225,Q8R123,Flad1,Q8R123-2_Flad1,Q8R123-2,Flad1,1,4,3,3,Q8R123-2|Q8R123,MOUSE,58185.3,9.4,2622,2622.1,25.72,25.72,,492,Isoform 2 of FAD synthase,cytoplasm|plasma membrane|,FAD biosynthetic process|,FMN adenylyltransferase activity|ATP binding|,3,4,163000000,9.4%
Q9CQA1,0.367306672,0.073333333,11.09992029,-0.330666667,0.077626136,-2.08666443,0.023,0.157,0.536,-0.251,-0.093,0.068,Q9CQA1,Trappc5,Q9CQA1_Trappc5,Q9CQA1,Trappc5,1,3,2,2,Q9CQA1,MOUSE,20908.8,9,2623,2623.1,25.72,25.72,,188,Trafficking protein particle complex subunit 5,endoplasmic reticulum|Golgi apparatus|TRAPP complex|,vesicle-mediated transport|,protein binding|,2,3,49900000,9.0%
Q9CZV8-3,0.731162978,-0.009,4.078825683,0.111333333,0.390946592,0.917781747,0.09,-0.044,-0.24,0.169,0.062,-0.091,Q9CZV8,Fbxl20,Q9CZV8-3_Fbxl20,Q9CZV8-3,Fbxl20,1,4,3,3,Q9CZV8-3|Q9CZV8|Q9CZV8-4,MOUSE,50373.3,7.5,2624,2624.1,25.68,25.68,,436,Isoform 3 of F-box/LRR-repeat protein 20,cytoplasm|,behavioral fear response|,protein binding|,3,4,3610000000,7.5%
Q8CFI2,0.895011612,0.031166667,1.658975137,0.043666667,0.682499734,0.42739179,-0.039,0.016,0.051,0.22,-0.017,-0.044,Q8CFI2,Cdc34,Q8CFI2_Cdc34,Q8CFI2,Cdc34,1,3,3,3,Q8CFI2|A0A1W2P7U1|A0A140T8I4|A0A087WP01,MOUSE,26792.3,11.9,2625,2625.1,25.67,25.67,,235,Ubiquitin-conjugating enzyme E2 R1,nucleoplasm|cytoplasm|,protein polyubiquitination|protein monoubiquitination|cell cycle|protein ubiquitination|proteasome-mediated ubiquitin-dependent protein catabolic process|negative regulation of cAMP-mediated signaling|protein K48-linked ubiquitination|,ubiquitin-protein transferase activity|ATP binding|ligase activity|ubiquitin protein ligase binding|ubiquitin protein ligase activity|ubiquitin conjugating enzyme activity|,3,3,162000000,11.9%
P59764,0.663391411,-0.016166667,5.114084496,0.143,0.308028961,1.104178412,-0.009,-0.263,0.009,0.188,-0.147,0.125,P59764,Dock4,P59764_Dock4,P59764,Dock4,1,3,3,3,P59764|A0A1Y7VLY2,MOUSE,228314.4,1.7,2626,2626.1,25.67,25.67,,1978,Dedicator of cytokinesis protein 4,cytosol|endomembrane system|membrane|stereocilium|stereocilium bundle|,small GTPase mediated signal transduction|positive regulation of GTPase activity|cell chemotaxis|,guanyl-nucleotide exchange factor activity|GTPase activator activity|SH3 domain binding|PDZ domain binding|receptor tyrosine kinase binding|Rac GTPase binding|,3,3,137000000,1.7%
Q9CPX8,0.522251937,0.113166667,7.783702078,-0.345666667,0.16658266,-1.553953065,0.418,0.636,-0.196,-0.047,0.11,-0.242,Q9CPX8,Uqcr11,Q9CPX8_Uqcr11,Q9CPX8,Uqcr11,1,5,2,2,Q9CPX8,MOUSE,6538.5,46.4,2627,2627.1,25.67,25.67,,56,Cytochrome b-c1 complex subunit 10,mitochondrion|mitochondrial inner membrane|integral component of membrane|respiratory chain|,oxidation-reduction process|hydrogen ion transmembrane transport|,ubiquinol-cytochrome-c reductase activity|electron carrier activity|,2,5,5230000000,46.4%
Q62193,0.788524745,-0.020833333,3.286646345,-0.089666667,0.469175543,-0.767565912,-0.026,0.117,-0.019,0.126,-0.234,-0.089,Q62193,NotFound,Q62193_NotFound,Q62193,Rpa2,1,2,2,2,Q62193|Q3TE40,MOUSE,29889.1,13.3,2628,2628.1,25.66,25.66,,270,Replication protein A 32 kDa subunit,"chromatin|nucleus|nucleoplasm|DNA replication factor A complex|PML body|chromosome, telomeric region|PML body|site of double-strand break|",telomere maintenance|double-strand break repair via homologous recombination|DNA replication|base-excision repair|nucleotide-excision repair|mismatch repair|regulation of double-strand break repair via homologous recombination|mitotic G1 DNA damage checkpoint|regulation of DNA damage checkpoint|,DNA binding|damaged DNA binding|single-stranded DNA binding|protein binding|enzyme binding|protein phosphatase binding|ubiquitin protein ligase binding|,2,2,107000000,13.3%
Q9D3N8,0.873472653,0.0045,2.041966745,-0.048333333,0.624889641,-0.512312113,0.054,0.094,-0.062,0.049,-0.127,0.019,Q9D3N8,Grtp1,Q9D3N8_Grtp1,Q9D3N8,Grtp1,1,2,2,2,Q9D3N8|Q9D3N8-2|Q9D3N8-4|Q9D3N8-3|A0A1B0GSU4|A0A1B0GSA2,MOUSE,41140.9,6.6,2629,2629.1,25.62,25.62,,359,Growth hormone-regulated TBC protein 1,,positive regulation of GTPase activity|,GTPase activator activity|,2,2,47500000,6.6%
Q9R0E2,0.663391411,0.0005,5.117574086,0.109,0.307781556,1.103743621,-0.197,0.064,-0.029,0.007,0.057,0.101,Q9R0E2,Plod1,Q9R0E2_Plod1,Q9R0E2,Plod1,1,3,3,3,Q9R0E2,MOUSE,84164,4.6,2630,2630.1,25.62,25.62,,728,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",rough endoplasmic reticulum membrane|extracellular exosome|,response to hypoxia|epidermis development|peptidyl-lysine hydroxylation|cellular response to hormone stimulus|oxidation-reduction process|,ferrous iron binding|procollagen-lysine 5-dioxygenase activity|L-ascorbic acid binding|peptide binding|,3,3,284000000,4.6%
Q9QZB9,0.81132483,0.0195,2.941214845,-0.067,0.508017316,-0.699128244,0.046,-0.068,0.181,0.027,-0.027,-0.042,Q9QZB9,Dctn5,Q9QZB9_Dctn5,Q9QZB9,Dctn5,1,3,2,2,Q9QZB9,MOUSE,20710.7,12,2631,2631.1,25.61,25.61,,182,Dynactin subunit 5,condensed chromosome kinetochore|cytoplasm|centrosome|,,,2,3,27500000,12.0%
Q9DB27,0.565040651,0.020333333,7.042180864,-0.146666667,0.197597713,-1.430272239,-0.009,0.219,0.071,-0.149,0.052,-0.062,Q9DB27,Mcts1,Q9DB27_Mcts1,Q9DB27,Mcts1,1,2,2,2,Q9DB27|Q9DB27-2|Q9CQ21,MOUSE,20783.1,20.9,2632,2632.1,25.58,25.58,,181,Malignant T-cell-amplified sequence 1,cytoplasm|plasma membrane|cytosolic small ribosomal subunit|,"formation of translation preinitiation complex|IRES-dependent translational initiation|transcription, DNA-templated|regulation of transcription, DNA-templated|cellular response to DNA damage stimulus|cell cycle|ribosome disassembly|regulation of growth|",translation initiation factor activity|,2,2,78500000,20.9%
Q14C51,0.797128744,0.007166667,3.161317165,-0.108333333,0.482912318,-0.743171992,-0.229,0.155,0.258,0.009,-0.169,0.019,Q14C51,Ptcd3,Q14C51_Ptcd3,Q14C51,Ptcd3,1,4,3,3,Q14C51|A0A0U1RQ61,MOUSE,78365.3,5.9,2633,2633.1,25.53,25.53,,685,"Pentatricopeptide repeat domain-containing protein 3, mitochondrial",mitochondrion|,regulation of translation|mitochondrial translation|,rRNA binding|ribosomal small subunit binding|poly(A) RNA binding|,3,4,74400000,5.9%
Q3U4I7,0.884484678,-0.028,1.879728472,0.101333333,0.648674988,0.477045234,0.108,0.084,-0.428,0.386,-0.229,-0.089,Q3U4I7,Pyroxd2,Q3U4I7_Pyroxd2,Q3U4I7,Pyroxd2,1,3,2,2,Q3U4I7,MOUSE,63509.5,6.8,2634,2634.1,25.5,25.5,,581,Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2,,oxidation-reduction process|,oxidoreductase activity|,2,3,418000000,6.8%
Q921L3,0.760357786,-0.087,3.697959904,-0.2,0.426779951,-0.846562672,-0.423,0.265,0.197,-0.561,0.005,-0.005,Q921L3,Tmco1,Q921L3_Tmco1,Q921L3,Tmco1,1,7,2,2,Q921L3,MOUSE,21402.8,11.7,2635,2635.1,25.46,25.46,,188,Calcium load-activated calcium channel,Golgi membrane|endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|,,,2,7,1920000000,11.7%
E9PZM4,0.622985437,-0.034166667,5.909078137,0.123666667,0.256502845,1.240458823,-0.011,-0.08,-0.197,-0.04,0.153,-0.03,E9PZM4,Chd2,E9PZM4_Chd2,E9PZM4,Chd2,1,4,4,4,E9PZM4|P40201,MOUSE,211769.7,2.1,2636,2636.1,25.45,25.45,,1827,Chromodomain-helicase-DNA-binding protein 2,nucleus|nucleoplasm|nucleolus|intracellular membrane-bounded organelle|extracellular exosome|,"transcription, DNA-templated|regulation of transcription, DNA-templated|cellular response to DNA damage stimulus|muscle organ development|chromatin modification|hematopoietic stem cell differentiation|",core promoter sequence-specific DNA binding|helicase activity|protein binding|ATP binding|histone binding|poly(A) RNA binding|,4,4,209000000,2.1%
P01837,0.883773419,-0.008,1.891673001,0.116,0.64689337,0.479684279,0.24,-0.432,-0.006,-0.308,0.005,0.453,P01837,NotFound,P01837_NotFound,P01837,,1,6,3,3,A0A075B5P2|P01837,MOUSE,11948.8,15,2637,2637.1,25.39,25.39,,106,Ig kappa chain C region,plasma membrane|,,antigen binding|,3,6,483000000,15.0%
Q6P8I6,0.550838715,0.034,7.26213786,-0.161333333,0.187839193,-1.466937739,-0.043,0.266,0.121,-0.13,-0.054,0.044,Q6P8I6,Cox11,Q6P8I6_Cox11,Q6P8I6,Cox11,1,5,3,3,Q6P8I6|Q5SRC5,MOUSE,31190.9,14.1,2638,2638.1,25.39,25.39,,275,"Cytochrome c oxidase assembly protein CO1, mitochondrial",mitochondrion|mitochondrial inner membrane|integral component of membrane|,negative regulation of glucokinase activity|,copper ion binding|protein binding|,3,5,617000000,14.1%
Q9CQJ4,0.629307568,0.061166667,5.823192802,-0.147666667,0.261625891,-1.227115176,0.339,0.12,-0.054,0.043,-0.089,0.008,Q9CQJ4,Rnf2,Q9CQJ4_Rnf2,Q9CQJ4,Rnf2,1,5,2,2,Q9CQJ4|A0A087WRE9,MOUSE,38079.1,6.2,2639,2639.1,25.36,25.36,,336,E3 ubiquitin-protein ligase RING2,ubiquitin ligase complex|euchromatin|heterochromatin|sex chromatin|nucleus|nucleoplasm|nuclear body|PcG protein complex|PRC1 complex|MLL1 complex|,"negative regulation of transcription from RNA polymerase II promoter|mitotic cell cycle|gastrulation with mouth forming second|transcription, DNA-templated|germ cell development|anterior/posterior axis specification|histone ubiquitination|histone H2A monoubiquitination|histone H2A-K119 monoubiquitination|negative regulation of sequence-specific DNA binding transcription factor activity|",chromatin binding|protein binding|zinc ion binding|ligase activity|ubiquitin protein ligase activity|RING-like zinc finger domain binding|ubiquitin-protein transferase activity|,2,5,5070000000,6.2%
O54825,0.963376742,0.046833333,0.500764616,-0.017,0.891094039,-0.1422772,0.004,-0.022,0.184,0.05,-0.14,0.205,O54825,Bysl,O54825_Bysl,O54825,Bysl,1,3,2,2,O54825,MOUSE,50067.9,6.1,2640,2640.1,25.36,25.36,,436,Bystin,nucleus|nucleolus|cytoplasm|cytoplasmic microtubule|membrane|cell projection|intracellular membrane-bounded organelle|apical part of cell|perinuclear region of cytoplasm|,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|in utero embryonic development|blastocyst formation|trophectodermal cell differentiation|cell adhesion|brain development|cell proliferation|neuron differentiation|cellular response to lipopolysaccharide|cellular response to interleukin-1|cellular response to growth factor stimulus|cellular response to organic cyclic compound|",poly(A) RNA binding|,2,3,165000000,6.1%
P03893,0.788130842,-0.084166667,3.291773002,0.369,0.468622029,0.768666085,-0.187,0.717,-1.336,0.3,0.165,-0.164,P03893,ND2,P03893_ND2,P03893,Mtnd2,1,4,2,2,P03893,MOUSE,38808.9,9.5,2641,2641.1,25.31,25.31,,345,NADH-ubiquinone oxidoreductase chain 2,mitochondrion|mitochondrial respiratory chain complex I|postsynaptic density|integral component of membrane|,"mitochondrial electron transport, NADH to ubiquinone|reactive oxygen species metabolic process|",NADH dehydrogenase (ubiquinone) activity|protein kinase binding|ionotropic glutamate receptor binding|,2,4,1790000000,9.5%
Q8VCL2,0.328857596,-0.061666667,12.0102357,0.303333333,0.062947202,2.232066067,-0.319,0.045,-0.366,0.173,0.135,-0.038,Q8VCL2,Sco2,Q8VCL2_Sco2,Q8VCL2,Sco2,1,6,3,3,Q8VCL2,MOUSE,29114.6,11.3,2642,2642.1,25.2,25.2,,255,"Protein SCO2 homolog, mitochondrial",nucleoplasm|mitochondrion|mitochondrial inner membrane|myofibril|,eye development|in utero embryonic development|muscle system process|copper ion transport|cellular copper ion homeostasis|respiratory chain complex IV assembly|response to activity|respiratory electron transport chain|copper ion homeostasis|,copper ion binding|,3,6,51900000,11.3%
Q80YR4,0.979995204,0.0645,0.305012613,0.011666667,0.932177763,0.088394192,0.007,-0.017,0.186,0.266,-0.158,0.103,Q80YR4,Zfp598,Q80YR4_Zfp598,Q80YR4,Znf598,1,2,2,2,Q80YR4|Q80YR4-3|Q80YR4-2,MOUSE,101187.1,4.4,2643,2643.1,25.17,25.17,,908,E3 ubiquitin-protein ligase ZNF598,,,zinc ion binding|poly(A) RNA binding|,2,2,6600000,4.4%
Q7TSC1,0.964822261,-0.0165,0.479343121,0.022333333,0.895500202,0.136478763,-0.141,0.087,-0.029,-0.003,-0.309,0.296,Q7TSC1,Prrc2a,Q7TSC1_Prrc2a,Q7TSC1,Prrc2a,1,3,3,3,Q7TSC1|G3UX48,MOUSE,229769,1.6,2644,2644.1,25.15,25.15,,2158,Protein PRRC2A,nucleus|cytoplasm|membrane|intracellular membrane-bounded organelle|extracellular exosome|,,poly(A) RNA binding|,3,3,222000000,1.6%
P63028,0.790512172,0.117666667,3.265483266,-0.197333333,0.471467405,-0.763548094,-0.097,-0.1,0.846,-0.067,0.078,0.046,P63028,Tpt1,P63028_Tpt1,P63028,Tpt1,1,2,2,2,P63028|D3YU75,MOUSE,19575.9,15.6,2645,2645.1,25.15,25.15,,172,Translationally-controlled tumor protein,extracellular space|nucleus|nucleoplasm|cytoplasm|multivesicular body|extracellular exosome|tubulin complex|,stem cell maintenance|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage|negative regulation of ectoderm development|,calcium ion binding|protein binding|transcription factor binding|poly(A) RNA binding|,2,2,220000000,15.6%
Q9QZQ8,0.881050168,-0.034666667,1.91886175,0.069333333,0.642856183,0.48567823,-0.355,0.073,0.074,0.02,-0.116,0.096,Q9QZQ8,H2afy,Q9QZQ8_H2afy,Q9QZQ8,H2afy,1,5,4,4,Q9QZQ8|Q9QZQ8-2|Q8CCK0,MOUSE,39905.6,14.7,2646,2646.1,25.15,25.15,,372,Core histone macro-H2A.1,nuclear chromosome|nucleosome|nuclear chromatin|condensed chromosome|Barr body|nucleus|nucleoplasm|pericentric heterochromatin|nucleolus|centrosome|extracellular exosome|ESC/E(Z) complex|,"negative regulation of transcription from RNA polymerase II promoter|nucleosome assembly|dosage compensation|chromatin modification|regulation of lipid metabolic process|negative regulation of histone phosphorylation|regulation of gene expression, epigenetic|positive regulation of keratinocyte differentiation|negative regulation of gene expression, epigenetic|positive regulation of gene expression, epigenetic|negative regulation of histone H3-K4 methylation|negative regulation of histone H3-K27 methylation|establishment of protein localization to chromatin|negative regulation of protein serine/threonine kinase activity|negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter|negative regulation of cell cycle G2/M phase transition|",rDNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II core promoter sequence-specific DNA binding|core promoter sequence-specific DNA binding|chromatin binding|double-stranded methylated DNA binding|protein kinase binding|protein serine/threonine kinase inhibitor activity|chromatin DNA binding|nucleosomal DNA binding|transcription regulatory region DNA binding|protein heterodimerization activity|,4,5,259000000,14.7%
Q80TY5,0.517357823,-0.015,7.849463588,0.2,0.164079242,1.564682147,-0.028,0.036,-0.353,0.173,0.099,-0.017,Q80TY5,Vps13b,Q80TY5_Vps13b,Q80TY5,Vps13b,1,4,3,3,Q80TY5,MOUSE,449255.6,0.9,2647,2647.1,25.14,25.14,,3993,Vacuolar protein sorting-associated protein 13B,,protein transport|,,3,4,283000000,0.9%
Q8C1Y8,0.382438943,0.038333333,10.79514704,-0.216,0.083269373,-2.034698103,0.119,0.063,0.257,-0.058,-0.207,0.056,Q8C1Y8,Ccz1,Q8C1Y8_Ccz1,Q8C1Y8,Ccz1,1,2,2,2,Q8C1Y8,MOUSE,55960.2,5.2,2648,2648.1,25.13,25.13,,480,Vacuolar fusion protein CCZ1 homolog,lysosomal membrane|membrane-bounded vesicle|intracellular membrane-bounded organelle|,vesicle-mediated transport|,,2,2,39500000,5.2%
Q9JKY0,0.095565296,-0.034833333,20.28690188,0.315,0.009360732,3.605045772,-0.171,-0.14,-0.266,0.124,0.191,0.053,Q9JKY0,Cnot9,Q9JKY0_Cnot9,Q9JKY0,Cnot9,1,2,2,2,Q9JKY0,MOUSE,33942.9,6,2649,2649.1,25.09,25.09,,299,CCR4-NOT transcription complex subunit 9,cytoplasmic mRNA processing body|nucleus|membrane|CCR4-NOT complex|,"transcription, DNA-templated|regulation of transcription, DNA-templated|regulation of translation|cytokine-mediated signaling pathway|gene silencing by RNA|negative regulation of intracellular estrogen receptor signaling pathway|positive regulation of ligand-dependent nuclear receptor transcription coactivator activity|",protein binding|protein domain specific binding|protein homodimerization activity|,2,2,206000000,6.0%
Q8BP92,0.002528295,0.006333333,39.22785038,1.138,0.000119458,8.034953597,-0.479,-0.429,-0.78,0.682,0.359,0.685,Q8BP92,Rcn2,Q8BP92_Rcn2,Q8BP92,Rcn2,1,3,3,3,Q8BP92,MOUSE,37270.1,13.4,2650,2650.1,25.06,25.06,,320,Reticulocalbin-2,nucleolus|endoplasmic reticulum|endoplasmic reticulum lumen|,,calcium ion binding|protein binding|,3,3,1080000000,13.4%
O88735-2,0.28467781,0.112,13.2808488,0.353333333,0.046980228,2.436033498,0,0,-0.194,-0.002,0.444,0.424,O88735,Map7,O88735-2_Map7,O88735-2,Map7,1,3,3,3,O88735-2|D3YWN7|O88735|E9QMU3|A0A1L1SVB6,MOUSE,83057.4,4.3,2651,2651.1,25.03,25.03,,730,Isoform 2 of Ensconsin,cytoplasm|microtubule|plasma membrane|microtubule cytoskeleton|basolateral plasma membrane|perinuclear region of cytoplasm|,cell morphogenesis|microtubule bundle formation|glycosphingolipid metabolic process|response to osmotic stress|nucleus organization|germ cell development|spermatogenesis|cell proliferation|fertilization|response to retinoic acid|Leydig cell differentiation|organ growth|homeostasis of number of cells|Sertoli cell development|protein localization to plasma membrane|,receptor binding|structural molecule activity|protein binding|,3,3,146000000,4.3%
K7N6K8,0.773512169,-0.0095,3.499224371,0.582333333,0.446763375,0.808718723,1.248,-0.473,-1.677,0.216,0.932,-0.303,K7N6K8,Sult2a7,K7N6K8_Sult2a7,K7N6K8,Sult2a7,1,7,3,3,A0A1B0GRF0|K7N6K8|A0A1B0GR21|A0A1B0GSJ3,MOUSE,34925.5,11.7,2652,2652.1,25,25,,298,Sulfotransferase,,metabolic process|,sulfotransferase activity|,3,7,24900000000,11.7%
Q9R020,0.223683903,-0.0615,15.04080544,0.311,0.031327047,2.719230364,-0.119,-0.096,-0.436,0.077,0.09,0.115,Q9R020,Zranb2,Q9R020_Zranb2,Q9R020,Zranb2,1,3,3,3,Q9R020|D3Z4U0|Q9R020-2|E9PUD0,MOUSE,37806.2,8.7,2653,2653.1,24.98,24.98,,330,Zinc finger Ran-binding domain-containing protein 2,nucleus|,mRNA processing|RNA splicing|,RNA binding|zinc ion binding|,3,3,86500000,8.7%
Q76LS9,0.407103215,-0.088,10.24605781,0.528666667,0.094491821,1.950397449,-0.613,-0.701,0.257,0.159,-0.051,0.421,Q76LS9,Mindy1,Q76LS9_Mindy1,Q76LS9,Mindy1,1,4,2,2,Q76LS9|Q76LS9-2|Q76LS9-3,MOUSE,51909.7,5.7,2654,2654.1,24.92,24.92,,468,Ubiquitin carboxyl-terminal hydrolase MINDY-1,nucleus|nucleoplasm|extracellular exosome|,,,2,4,476000000,5.7%
Q8BMD8,0.991462281,-0.090166667,0.187287597,-0.008333333,0.957792077,-0.054960009,-0.013,0.144,-0.389,0.024,-0.14,-0.167,Q8BMD8,Slc25a24,Q8BMD8_Slc25a24,Q8BMD8,Slc25a24,1,2,2,2,Q8BMD8,MOUSE,53129.2,6.1,2655,2655.1,24.92,24.92,,475,Calcium-binding mitochondrial carrier protein SCaMC-1,cytoplasm|mitochondrion|mitochondrial inner membrane|integral component of membrane|,mitochondrial transport|regulation of cell death|ATP transport|cellular response to oxidative stress|transmembrane transport|cellular response to calcium ion|,ATP transmembrane transporter activity|calcium ion binding|,2,2,331000000,6.1%
Q921J2,0.898097088,-0.0055,1.624889982,-0.034333333,0.687877338,-0.419645955,0.042,0.014,-0.021,0.044,-0.06,-0.052,Q921J2,Rheb,Q921J2_Rheb,Q921J2,Rheb,1,4,3,3,Q921J2,MOUSE,20508.1,18.4,2656,2656.1,24.92,24.92,,184,GTP-binding protein Rheb,Golgi membrane|spliceosomal complex|endoplasmic reticulum membrane|cytosol|extracellular exosome|,small GTPase mediated signal transduction|regulation of TOR signaling|positive regulation of TOR signaling|regulation of type B pancreatic cell development|,GTP binding|protein kinase binding|metal ion binding|,3,4,157000000,18.4%
Q3UZR5,0.295433851,-0.009833333,12.90652428,0.257666667,0.051209151,2.371272746,-0.241,-0.035,-0.14,0.279,0.023,0.055,Q3UZR5,Atp2c1,Q3UZR5_Atp2c1,Q3UZR5,Atp2c1,1,3,3,3,Q3UZR5|H3BIX7|Q80XR2|H3BL44|Q8BMS7,MOUSE,105385.8,4.7,2657,2657.1,24.9,24.9,,952,Calcium-transporting ATPase,Golgi membrane|Golgi apparatus|trans-Golgi network|membrane|integral component of membrane|,calcium ion transport|manganese ion transport|cellular calcium ion homeostasis|signal transduction|metabolic process|epidermis development|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|cellular manganese ion homeostasis|actin cytoskeleton reorganization|Golgi calcium ion homeostasis|Golgi calcium ion transport|positive regulation of I-kappaB kinase/NF-kappaB signaling|calcium ion transmembrane transport|manganese ion transmembrane transport|,signal transducer activity|calcium-transporting ATPase activity|calcium ion binding|ATP binding|manganese-transporting ATPase activity|manganese ion binding|,3,3,316000000,4.7%
Q8VDH1,0.961523652,0.102,0.573834682,0.034,0.876226799,0.161884159,0.089,0.165,0.001,0.599,-0.226,-0.016,Q8VDH1,Fbxo21,Q8VDH1_Fbxo21,Q8VDH1,Fbxo21,1,2,2,2,Q8VDH1|Q8VDH1-2,MOUSE,73027.2,5.4,2658,2658.1,24.87,24.87,,627,F-box only protein 21,,,DNA binding|,2,2,22400000,5.4%
Q91WG4,0.648073376,0.0525,5.347166051,0.161666667,0.291933138,1.144951252,-0.111,-0.006,0.032,0.427,-0.033,0.006,Q91WG4,Elp2,Q91WG4_Elp2,Q91WG4,Elp2,1,3,2,2,Q91WG4|Q91WG4-2,MOUSE,94574.7,3.4,2659,2659.1,24.87,24.87,,831,Elongator complex protein 2,histone acetyltransferase complex|proteasome complex|cytoplasm|transcription elongation factor complex|Elongator holoenzyme complex|,"regulation of transcription, DNA-templated|transcription elongation from RNA polymerase II promoter|positive regulation of endopeptidase activity|proteasome assembly|regulation of JAK-STAT cascade|",protein binding|protein kinase binding|endopeptidase activator activity|RNA polymerase II core binding|,2,3,554000000,3.4%
P57080,0.846769943,0.035166667,2.400511496,-0.059666667,0.575372168,-0.588700396,0.046,-0.063,0.212,0.054,-0.056,0.018,P57080,Usp25,P57080_Usp25,P57080,Usp25,1,3,3,3,P57080,MOUSE,122216.6,3,2660,2660.1,24.86,24.86,,1055,Ubiquitin carboxyl-terminal hydrolase 25,proteasome complex|nucleus|cytoplasm|,ubiquitin-dependent protein catabolic process|protein deubiquitination|proteasome-mediated ubiquitin-dependent protein catabolic process|regulation of proteasomal protein catabolic process|protein K63-linked deubiquitination|protein K48-linked deubiquitination|,cysteine-type endopeptidase activity|ubiquitin-specific protease activity|SUMO binding|,3,3,67500000,3.0%
Q69ZQ1,0.450092335,0.0145,9.404283564,0.247666667,0.114702172,1.815760511,-0.133,-0.333,0.138,0.075,0.099,0.241,Q69ZQ1,AI464131,Q69ZQ1_AI464131,Q69ZQ1,Myorg,1,3,3,3,Q69ZQ1,MOUSE,81759.4,3.4,2661,2661.1,24.85,24.85,,716,Myogenesis-regulating glycosidase,integral component of membrane|nuclear membrane|,carbohydrate metabolic process|positive regulation of insulin-like growth factor receptor signaling pathway|skeletal muscle fiber development|positive regulation of protein kinase B signaling|,"hydrolase activity, hydrolyzing O-glycosyl compounds|protein binding|",3,3,42900000,3.4%
Q9QXS6,0.025231806,0.057833333,27.24985855,0.563,0.00188371,4.965098559,-0.217,-0.344,-0.11,0.334,0.195,0.489,Q9QXS6,Dbn1,Q9QXS6_Dbn1,Q9QXS6,Dbn1,1,4,3,3,Q9QXS6|A0A0R4J1E3|Q9QXS6-3|Q9QXS6-2,MOUSE,78027.1,6,2662,2662.1,24.8,24.8,,706,Drebrin,plasma membrane|gap junction|cell cortex|actin cytoskeleton|membrane|cell-cell junction|,actin filament organization|cell communication by chemical coupling|cell communication by electrical coupling|maintenance of protein location in cell|generation of neurons|neural precursor cell proliferation|,actin binding|protein binding|profilin binding|,3,4,55200000,6.0%
Q8K274,0.843401516,-0.048,2.452335041,-0.082666667,0.568547162,-0.59987177,-0.084,0.028,0.036,-0.359,0.128,-0.037,Q8K274,Fn3krp,Q8K274_Fn3krp,Q8K274,Fn3krp,1,3,3,3,Q8K274,MOUSE,34695.9,11,2663,2663.1,24.78,24.78,,309,Ketosamine-3-kinase,,phosphorylation|,kinase activity|,3,3,36900000,11.0%
Q8R0J7,0.714714682,-0.010166667,4.288974951,0.111,0.372479611,0.956212491,-0.273,-0.017,0.093,0.02,0.006,0.11,Q8R0J7,Vps37b,Q8R0J7_Vps37b,Q8R0J7,Vps37b,1,2,2,2,Q8R0J7,MOUSE,31112.3,6.6,2665,2665.1,24.75,24.75,,285,Vacuolar protein sorting-associated protein 37B,ESCRT I complex|cytoplasm|endosome|plasma membrane|endosome membrane|midbody|late endosome membrane|extracellular exosome|,protein transport|positive regulation of viral release from host cell|positive regulation of viral budding via host ESCRT complex|,calcium-dependent protein binding|,2,2,12600000,6.6%
Q924T2,0.895444761,0.017166667,1.652612769,-0.055666667,0.683500321,-0.426165921,-0.023,0.249,-0.091,-0.179,0.022,0.125,Q924T2,Mrps2,Q924T2_Mrps2,Q924T2,Mrps2,1,4,2,2,Q924T2,MOUSE,32654.9,7.2,2666,2666.1,24.74,24.74,,291,"28S ribosomal protein S2, mitochondrial",mitochondrion|mitochondrial small ribosomal subunit|,positive regulation of defense response to virus by host|translation|mitochondrial translation|activation of mitophagy in response to mitochondrial depolarization|,structural constituent of ribosome|,2,4,43400000,7.2%
P10922,0.894455479,-0.006833333,1.667217362,-0.095,0.681205685,-0.429479088,-0.338,0.514,-0.054,-0.228,-0.028,0.093,P10922,H1f0,P10922_H1f0,P10922,H1f0,1,6,2,2,P10922,MOUSE,20860.5,10.8,2667,2667.1,24.7,24.7,,194,Histone H1.0,nucleosome|nuclear chromatin|nucleus|nucleoplasm|nuclear euchromatin|Golgi apparatus|actin cytoskeleton|nucleolus|,nucleosome assembly|,chromatin DNA binding|poly(A) RNA binding|,2,6,658000000,10.8%
P70297,0.983457524,-0.005833333,0.261784957,-0.011666667,0.941502558,-0.076211709,0.116,0.145,-0.261,0.204,-0.078,-0.161,P70297,Stam,P70297_Stam,P70297,Stam,1,3,3,3,P70297|Q3UGN9,MOUSE,60169.5,5.4,2668,2668.1,24.68,24.68,,548,Signal transducing adapter molecule 1,early endosome membrane|,intracellular protein transport|positive regulation of exosomal secretion|regulation of extracellular exosome assembly|,protein binding|,3,3,58000000,5.4%
Q99JR8,0.578909417,0.0525,6.77063221,-0.193666667,0.210347221,-1.386996341,-0.029,0.028,0.449,-0.04,-0.033,-0.06,Q99JR8,Smarcd2,Q99JR8_Smarcd2,Q99JR8,Smarcd2,1,3,3,3,Q99JR8|Q99JR8-2,MOUSE,59312.3,7.9,2669,2669.1,24.65,24.65,,531,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2,nuclear chromatin|nucleus|SWI/SNF complex|protein complex|BAF-type complex|,"nucleosome disassembly|chromatin remodeling|transcription, DNA-templated|regulation of transcription, DNA-templated|ATP-dependent chromatin remodeling|",RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|,3,3,1620000000,7.9%
Q9EQJ0,0.672056103,0.031,4.982860543,0.177333333,0.317478227,1.081050643,-0.245,0.141,-0.069,0.406,-0.103,0.056,Q9EQJ0,Tpcn1,Q9EQJ0_Tpcn1,Q9EQJ0,Tpcn1,1,6,2,2,Q9EQJ0,MOUSE,94950.8,3,2670,2670.1,24.65,24.65,,817,Two pore calcium channel protein 1,lysosomal membrane|plasma membrane|endosome membrane|integral component of membrane|,calcium ion transport|ion transmembrane transport|regulation of ion transmembrane transport|calcium ion transmembrane transport|membrane depolarization during action potential|,voltage-gated calcium channel activity|identical protein binding|NAADP-sensitive calcium-release channel activity|,2,6,111000000,3.0%
Q9D7N3,0.344160393,0.039166667,11.58533586,-0.317,0.069417092,-2.164154236,-0.084,0.441,0.236,-0.02,-0.195,-0.143,Q9D7N3,Mrps9,Q9D7N3_Mrps9,Q9D7N3,Mrps9,1,4,3,3,Q9D7N3,MOUSE,45270.9,9.7,2671,2671.1,24.64,24.64,,390,"28S ribosomal protein S9, mitochondrial",nucleolus|mitochondrion|ribosome|,translation|,structural constituent of ribosome|poly(A) RNA binding|,3,4,44100000,9.7%
Q9JJY4,0.785249508,-0.163666667,3.331192931,0.231333333,0.464387699,0.776322038,0.128,0.037,-1.003,-0.201,0.031,0.026,Q9JJY4,Ddx20,Q9JJY4_Ddx20,Q9JJY4,Ddx20,1,6,3,3,Q9JJY4|A0A0G2JE88,MOUSE,92621.5,4.9,2672,2672.1,24.63,24.63,,825,Probable ATP-dependent RNA helicase DDX20,nucleus|cytoplasm|cytosol|membrane|transcriptional repressor complex|SMN complex|SMN-Sm protein complex|RNA polymerase II transcription repressor complex|Gemini of coiled bodies|,negative regulation of transcription from RNA polymerase II promoter|spliceosomal snRNP assembly|RNA secondary structure unwinding|positive regulation of apoptotic process|oogenesis|regulation of steroid biosynthetic process|,"DNA binding|ATP-dependent RNA helicase activity|protein binding|ATP binding|protein domain specific binding|protein binding, bridging|histone deacetylase binding|repressing transcription factor binding|",3,6,32800000000,4.9%
A0A1D5RM83,0.308673665,0.048333333,12.56815386,0.256,0.055358538,2.317413396,-0.072,0.064,-0.231,0.162,0.284,0.083,A0A1D5RM83,Iqsec1,A0A1D5RM83_Iqsec1,A0A1D5RM83,Iqsec1,1,3,3,3,A0A1D5RM83|E9PUA3|Q8R0S2|Q8R0S2-2,MOUSE,118782.8,2.8,2673,2673.1,24.62,24.62,,1051,IQ motif and SEC7 domain-containing protein 1,,,,3,3,41200000,2.8%
Q62432,0.549818096,-0.021166667,7.30970306,0.159,0.185793148,1.474754845,-0.166,-0.021,-0.115,0.053,-0.093,0.215,Q62432,Smad2,Q62432_Smad2,Q62432,Smad2,1,6,2,2,Q62432|Q62432-2|E9Q3M0|Q8BUN5|Q9JIW5,MOUSE,53178,5.3,2674,2674.1,24.57,24.57,,467,Mothers against decapentaplegic homolog 2,nuclear chromatin|nucleus|transcription factor complex|cytoplasm|activin responsive factor complex|SMAD protein complex|SMAD2-SMAD3 protein complex|,"ureteric bud development|in utero embryonic development|endoderm formation|mesoderm formation|transcription from RNA polymerase II promoter|protein phosphorylation|transforming growth factor beta receptor signaling pathway|common-partner SMAD protein phosphorylation|SMAD protein complex assembly|zygotic specification of dorsal/ventral axis|gastrulation|pattern specification process|endoderm development|heart development|response to glucose|post-embryonic development|embryonic pattern specification|anterior/posterior pattern specification|positive regulation of gene expression|negative regulation of gene expression|positive regulation of epithelial to mesenchymal transition|regulation of transforming growth factor beta receptor signaling pathway|insulin secretion|lung development|positive regulation of BMP signaling pathway|pancreas development|activin receptor signaling pathway|organ growth|intracellular signal transduction|nodal signaling pathway|cell fate commitment|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|paraxial mesoderm morphogenesis|developmental growth|embryonic foregut morphogenesis|embryonic cranial skeleton morphogenesis|regulation of binding|palate development|pericardium development|SMAD protein signal transduction|response to cholesterol|positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry|","RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|chromatin binding|double-stranded DNA binding|sequence-specific DNA binding transcription factor activity|transforming growth factor beta receptor binding|protein binding|transcription factor binding|phosphatase binding|transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity|ubiquitin protein ligase binding|activating transcription factor binding|type I transforming growth factor beta receptor binding|protein homodimerization activity|SMAD binding|metal ion binding|protein heterodimerization activity|co-SMAD binding|I-SMAD binding|R-SMAD binding|DNA binding|sequence-specific DNA binding transcription factor activity|",2,6,249000000,5.3%
P34884,0.472645993,-0.0145,8.741268993,-0.158333333,0.133620503,-1.706477084,0.027,0.183,-0.016,-0.036,-0.1,-0.145,P34884,Mif,P34884_Mif,P34884,Mif,1,6,3,3,P34884,MOUSE,12675.2,32.1,2675,2675.1,24.46,24.46,,115,Macrophage migration inhibitory factor,extracellular region|extracellular space|nucleoplasm|cytoplasm|cell surface|vesicle|myelin sheath|extracellular exosome|,"prostaglandin biosynthetic process|positive regulation of protein phosphorylation|positive regulation of adaptive immune response|negative regulation of mature B cell apoptotic process|inflammatory response|cell surface receptor signaling pathway|cell aging|cell proliferation|negative regulation of gene expression|positive regulation of protein kinase A signaling|carboxylic acid metabolic process|DNA damage response, signal transduction by p53 class mediator|positive regulation of B cell proliferation|positive regulation of lipopolysaccharide-mediated signaling pathway|negative regulation of cellular protein metabolic process|negative regulation of myeloid cell apoptotic process|positive regulation of peptidyl-serine phosphorylation|regulation of cell proliferation|positive regulation of phosphorylation|negative regulation of apoptotic process|positive regulation of MAP kinase activity|negative regulation of DNA damage response, signal transduction by p53 class mediator|innate immune response|positive regulation of fibroblast proliferation|positive regulation of cytokine secretion|positive regulation of peptidyl-tyrosine phosphorylation|positive chemotaxis|positive regulation of prostaglandin secretion involved in immune response|positive regulation of myeloid leukocyte cytokine production involved in immune response|protein homotrimerization|positive regulation of ERK1 and ERK2 cascade|negative regulation of cell cycle arrest|positive regulation of arachidonic acid secretion|negative regulation of cell aging|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator|positive regulation of chemokine (C-X-C motif) ligand 2 production|",dopachrome isomerase activity|receptor binding|cytokine activity|cytokine receptor binding|chemoattractant activity|phenylpyruvate tautomerase activity|,3,6,17200000000,32.1%
P24788,0.104422423,0.036,19.84018795,-0.356666667,0.010374835,-3.525979546,0.057,0.348,0.238,-0.165,-0.143,-0.119,P24788,Cdk11b,P24788_Cdk11b,P24788,Cdk11b,1,4,4,4,P24788|A2A9P6|P24788-2,MOUSE,91683,4.3,2676,2676.1,24.43,24.43,,784,Cyclin-dependent kinase 11B,nucleus|nucleoplasm|cytoplasm|,blastocyst development|protein phosphorylation|cell cycle|regulation of mitotic nuclear division|regulation of mRNA processing|negative regulation of apoptotic signaling pathway|,protein serine/threonine kinase activity|cyclin-dependent protein serine/threonine kinase activity|ATP binding|,4,4,287000000,4.3%
Q9DAT5,0.744748173,-0.048166667,3.90258394,0.100333333,0.407137969,0.884690669,-0.006,0.024,-0.313,0.024,-0.024,0.006,Q9DAT5,Trmu,Q9DAT5_Trmu,Q9DAT5,Trmu,1,7,2,2,Q9DAT5,MOUSE,47809.7,4.7,2677,2677.1,24.43,24.43,,417,Mitochondrial tRNA-specific 2-thiouridylase 1,mitochondrion|,tRNA wobble position uridine thiolation|tRNA methylation|,tRNA binding|tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase activity|ATP binding|sulfurtransferase activity|,2,7,357000000,4.7%
Q3UI43,0.496866931,0.091333333,8.266564528,-0.294666667,0.14905397,-1.632485631,0.29,0.563,-0.137,0.023,-0.16,-0.031,Q3UI43,Babam1,Q3UI43_Babam1,Q3UI43,Babam1,1,6,2,2,Q3UI43,MOUSE,37306,5.4,2678,2678.1,24.42,24.42,,333,BRISC and BRCA1-A complex member 1,nucleus|nucleoplasm|cytoplasm|BRCA1-A complex|BRISC complex|,double-strand break repair|response to ionizing radiation|chromatin modification|G2 DNA damage checkpoint|positive regulation of DNA repair|protein K63-linked deubiquitination|,,2,6,617000000,5.4%
P09528,0.332103046,0.004166667,11.91332741,-0.285666667,0.064367592,-2.216567962,0.026,0.056,0.359,-0.219,0.025,-0.222,P09528,Fth1,P09528_Fth1,P09528,Fth1,1,3,2,2,P09528|O46414,MOUSE,21237.4,12,2679,2679.1,24.35,24.35,,182,Ferritin heavy chain,extracellular region|nucleus|mitochondrion|extracellular exosome|endocytic vesicle lumen|,iron ion transport|intracellular sequestering of iron ion|immune response|negative regulation of cell proliferation|negative regulation of fibroblast proliferation|oxidation-reduction process|negative regulation of necrotic cell death|,ferroxidase activity|ferric iron binding|,2,3,90300000,12.0%
Q6PGG6,0.524618164,-0.025333333,7.735295003,0.210666667,0.1684498,1.546048042,0.061,-0.086,-0.367,0.182,-0.064,0.122,Q6PGG6,Gnl3l,Q6PGG6_Gnl3l,Q6PGG6,Gnl3l,1,3,2,2,Q6PGG6,MOUSE,65992.5,6.5,2680,2680.1,24.35,24.35,,577,Guanine nucleotide-binding protein-like 3-like protein,nucleus|nucleoplasm|nucleolus|cytoplasm|mitochondrion|membrane|,ribosome biogenesis|,GTPase activity|GTP binding|poly(A) RNA binding|,2,3,8080000,6.5%
Q8K1X4,0.430679683,-0.014166667,9.724863371,-0.281,0.106540238,-1.867098307,-0.033,0.122,0.29,0.075,-0.405,-0.134,Q8K1X4,Nckap1l,Q8K1X4_Nckap1l,Q8K1X4,Nckap1l,1,3,2,2,Q8K1X4,MOUSE,130443.2,2,2681,2681.1,24.35,24.35,,1134,Nck-associated protein 1-like,cytosol|membrane|SCAR complex|extracellular exosome|,"B cell homeostasis|myeloid cell homeostasis|protein complex assembly|chemotaxis|maintenance of cell polarity|neutrophil chemotaxis|positive regulation of actin filament polymerization|cortical actin cytoskeleton organization|positive regulation of B cell proliferation|activation of protein kinase activity|negative regulation of interleukin-17 production|negative regulation of interleukin-6 production|positive regulation of cell adhesion mediated by integrin|negative regulation of myosin-light-chain-phosphatase activity|positive regulation of T cell proliferation|positive regulation of phosphorylation|response to drug|T cell homeostasis|negative regulation of apoptotic process|positive regulation of CD4-positive, alpha-beta T cell differentiation|positive regulation of CD8-positive, alpha-beta T cell differentiation|positive regulation of GTPase activity|positive regulation of B cell differentiation|positive regulation of gamma-delta T cell differentiation|positive regulation of lymphocyte differentiation|positive regulation of erythrocyte differentiation|positive regulation of protein kinase activity|erythrocyte development|B cell receptor signaling pathway|positive regulation of phagocytosis, engulfment|actin polymerization-dependent cell motility|positive regulation of neutrophil chemotaxis|",GTPase activator activity|protein kinase activator activity|protein complex binding|,2,3,928000000,2.0%
O35683,0.270713403,0.014166667,13.61910036,-0.264333333,0.043460024,-2.485318547,0.031,0.334,0.074,-0.088,-0.128,-0.138,O35683,Ndufa1,O35683_Ndufa1,O35683,Ndufa1,1,9,2,2,O35683,MOUSE,8195.4,22.8,2683,2683.1,24.3,24.3,,70,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1,mitochondrion|mitochondrial respiratory chain complex I|integral component of membrane|mitochondrial membrane|,oxidation-reduction process|,,2,9,2350000000,22.8%
B2KFW1,0.001558255,-0.014833333,42.22456589,1.477666667,5.99161E-05,8.992821347,-0.939,-0.616,-0.706,0.757,0.43,0.985,B2KFW1,Zscan20,B2KFW1_Zscan20,B2KFW1,Zscan20,1,7,4,4,B2KFW1|E9Q8Y3|E9PVW1|A0A1L1SU99,MOUSE,117658.8,5,2684,2684.1,24.29,24.29,,1030,Zinc finger and SCAN domain-containing protein 20,nucleoplasm|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",RNA polymerase II regulatory region sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity|metal ion binding|,4,7,4030000000,5.0%
Q8R5A6-2,0.593471457,-0.010166667,6.442853851,-0.112333333,0.226837376,-1.33059906,0.034,0.037,0.067,-0.026,-0.016,-0.157,Q8R5A6,Tbc1d22a,Q8R5A6-2_Tbc1d22a,Q8R5A6-2,Tbc1d22a,1,4,3,3,Q8R5A6-2|Q8R5A6,MOUSE,60393.3,8.2,2685,2685.1,24.26,24.26,,516,Isoform 2 of TBC1 domain family member 22A,,positive regulation of GTPase activity|,GTPase activator activity|protein homodimerization activity|,3,4,300000000,8.2%
Q9BCZ4,0.493441063,0.024833333,8.336690286,0.174333333,0.146666515,1.641814786,-0.109,0.055,-0.133,0.256,0.003,0.077,Q9BCZ4,Selenos,Q9BCZ4_Selenos,Q9BCZ4,Selenos,1,4,2,2,Q9BCZ4|A0A0U1RP62|A0A0U1RPI8,MOUSE,21609.3,14.2,2686,2686.1,24.23,24.23,,190,Selenoprotein S,endoplasmic reticulum|cytoplasmic microtubule|integral component of endoplasmic reticulum membrane|very-low-density lipoprotein particle|low-density lipoprotein particle|,"negative regulation of acute inflammatory response to antigenic stimulus|ER overload response|response to glucose|ER-associated ubiquitin-dependent protein catabolic process|endoplasmic reticulum unfolded protein response|retrograde protein transport, ER to cytosol|negative regulation of interleukin-6 production|negative regulation of tumor necrosis factor production|cellular response to oxidative stress|cell redox homeostasis|negative regulation of inflammatory response|negative regulation of nitric-oxide synthase biosynthetic process|response to redox state|cellular response to lipopolysaccharide|regulation of nitric oxide metabolic process|negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|negative regulation of macrophage apoptotic process|",protein binding|selenium binding|antioxidant activity|enzyme binding|ATPase binding|ubiquitin-specific protease binding|,2,4,66900000,14.2%
F2Z3U3,0.183375544,0.071333333,16.50984677,-0.298,0.02233651,-2.956118376,0.212,0.364,0.085,-0.044,-0.057,-0.132,F2Z3U3,Raph1,F2Z3U3_Raph1,F2Z3U3,Raph1,1,3,3,3,F2Z3U3|G5E867|F2Z4B7,MOUSE,137364.5,2.7,2687,2687.1,24.18,24.18,,1266,Ras association (RalGDS/AF-6) and pleckstrin homology domains 1,cell leading edge|,signal transduction|axon extension|,protein binding|,3,3,224000000,2.7%
Q68FM7,0.911411213,5.78241E-19,1.427546187,0.036666667,0.71985559,0.37415126,-0.018,0.091,-0.128,0.07,-0.078,0.063,Q68FM7,Arhgef11,Q68FM7_Arhgef11,Q68FM7,Arhgef11,1,4,3,3,Q68FM7,MOUSE,172769.9,1.7,2688,2688.1,24.17,24.17,,1552,Rho guanine nucleotide exchange factor (GEF) 11,cytoplasm|,"G-protein coupled receptor signaling pathway|Rho protein signal transduction|regulation of Rho protein signal transduction|termination of G-protein coupled receptor signaling pathway|positive regulation of GTPase activity|positive regulation of transcription, DNA-templated|",G-protein coupled receptor binding|Rho guanyl-nucleotide exchange factor activity|protein binding|,3,4,122000000,1.7%
Q99LT0,0.509001366,-0.017833333,8.040991823,0.210333333,0.157000421,1.595867695,0.019,-0.019,-0.369,-0.014,0.072,0.204,Q99LT0,Dpy30,Q99LT0_Dpy30,Q99LT0,Dpy30,1,3,2,2,Q99LT0,MOUSE,11212.5,31.3,2689,2689.1,24.1,24.1,,99,Protein dpy-30 homolog,nucleus|nucleoplasm|Golgi apparatus|trans-Golgi network|histone methyltransferase complex|Set1C/COMPASS complex|,"transcription, DNA-templated|regulation of transcription, DNA-templated|endosomal transport|histone H3-K4 methylation|",identical protein binding|protein homodimerization activity|,2,3,213000000,31.3%
Q61161,0.497302739,-0.003833333,8.250001856,-0.147,0.149623502,-1.627351573,0.146,-0.045,0.108,-0.033,-0.103,-0.096,Q61161,Map4k2,Q61161_Map4k2,Q61161,Map4k2,1,4,3,3,Q61161,MOUSE,92233.7,3.1,2690,2690.1,24.08,24.08,,821,Mitogen-activated protein kinase kinase kinase kinase 2,Golgi membrane|cytoplasm|basolateral plasma membrane|,MAPK cascade|activation of MAPKKK activity|protein phosphorylation|vesicle targeting|activation of JUN kinase activity|regulation of mitotic cell cycle|stress-activated protein kinase signaling cascade|activation of protein kinase activity|intracellular signal transduction|regulation of apoptotic process|innate immune response|positive regulation of JNK cascade|,protein serine/threonine kinase activity|ATP binding|MAP kinase kinase kinase kinase activity|mitogen-activated protein kinase kinase kinase binding|,3,4,84600000,3.1%
Q9CRG1,0.617494432,-0.056333333,5.992161602,0.194,0.251642412,1.255957448,-0.037,-0.44,0.017,0.173,-0.146,0.095,Q9CRG1,Tm7sf3,Q9CRG1_Tm7sf3,Q9CRG1,Tm7sf3,1,3,2,2,Q9CRG1|A0A0R4J0K4,MOUSE,63877.6,4.6,2691,2691.1,24.07,24.07,,565,Transmembrane 7 superfamily member 3,plasma membrane|integral component of membrane|extracellular exosome|,,,2,3,85200000,4.6%
A2AQE2,0.683562132,-0.052,4.807525493,0.266666667,0.330557831,1.049941516,0.036,0.133,-0.725,-0.079,0.389,-0.066,A2AQE2,Secisbp2l,A2AQE2_Secisbp2l,A2AQE2,Secisbp2l,1,3,3,3,A2AQE2|Q6A098,MOUSE,120716.7,3.1,2692,2692.1,24.04,24.04,,1089,SECIS binding protein 2-like,,,poly(A) RNA binding|,3,3,30400000,3.1%
E9Q9B7,0.303758531,0.103166667,12.6857026,0.415666667,0.053880267,2.340293467,-0.156,0.029,-0.187,0.58,-0.069,0.422,E9Q9B7,Kidins220,E9Q9B7_Kidins220,E9Q9B7,Kidins220,1,3,3,3,E9Q9B7|A0A1Y7VME9|A0A1Y7VMH7,MOUSE,200835.2,2.1,2693,2693.1,24.03,24.03,,1793,Kinase D-interacting substrate 220,nucleoplasm|membrane|,in utero embryonic development|nerve growth factor signaling pathway|regulation of protein kinase activity|dendrite morphogenesis|,protein kinase regulator activity|PDZ domain binding|,3,3,93600000,2.1%
Q9QYY8,0.904214516,-0.020333333,1.567879301,0.039333333,0.696966766,0.406619808,-0.046,0.089,-0.163,-0.041,0.044,-0.005,Q9QYY8,Spast,Q9QYY8_Spast,Q9QYY8,Spast,1,3,2,2,Q9QYY8|A0A286YE25|Q9QYY8-2,MOUSE,66797.4,4.3,2694,2694.1,24.03,24.03,,614,Spastin,nucleus|cytoplasm|centrosome|spindle|microtubule|microtubule cytoskeleton|integral component of membrane|midbody|cytoplasmic vesicle|perinuclear region of cytoplasm|extracellular exosome|endosome|endoplasmic reticulum|microtubule cytoskeleton|midbody|,microtubule bundle formation|ER to Golgi vesicle-mediated transport|axonogenesis|metabolic process|positive regulation of microtubule depolymerization|cytoplasmic microtubule organization|positive regulation of cytokinesis|cytokinetic process|protein hexamerization|microtubule severing|protein homooligomerization|,ATP binding|microtubule binding|microtubule-severing ATPase activity|alpha-tubulin binding|beta-tubulin binding|,2,3,32300000,4.3%
Q4VA93,0.52944394,-0.024166667,7.642263971,0.194333333,0.17209712,1.530837768,-0.331,-0.052,0.019,-0.018,0.013,0.224,Q4VA93,Prkca,Q4VA93_Prkca,Q4VA93,Prkca,1,4,3,3,Q4VA93|P20444|Q3TQ39,MOUSE,77963.7,5.5,2695,2695.1,24.03,24.03,,672,Protein kinase C,photoreceptor outer segment|nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|cytosol|plasma membrane|membrane|dendrite|neuronal cell body|apical part of cell|extracellular exosome|,inactivation of MAPK activity|negative regulation of protein phosphorylation|positive regulation of protein phosphorylation|positive regulation of endothelial cell proliferation|regulation of the force of heart contraction|chondrocyte differentiation|desmosome assembly|protein phosphorylation|negative regulation of protein kinase activity|cellular calcium ion homeostasis|regulation of muscle contraction|negative regulation of cell proliferation|positive regulation of endothelial cell migration|positive regulation of cell migration|neutrophil chemotaxis|positive regulation of lipopolysaccharide-mediated signaling pathway|negative regulation of glial cell apoptotic process|histone H3-T6 phosphorylation|peptidyl-serine autophosphorylation|positive regulation of blood vessel endothelial cell migration|positive regulation of angiogenesis|positive regulation of cell adhesion|positive regulation of mitotic cell cycle|negative regulation of glucose import|negative regulation of insulin receptor signaling pathway|positive regulation of inflammatory response|regulation of peptidyl-tyrosine phosphorylation|induction of positive chemotaxis|response to interleukin-1|cellular response to carbohydrate stimulus|regulation of platelet aggregation|intrinsic apoptotic signaling pathway|,protein kinase activity|protein serine/threonine kinase activity|protein kinase C activity|calcium-dependent protein kinase C activity|protein binding|ATP binding|zinc ion binding|enzyme binding|histone kinase activity (H3-T6 specific)|,3,4,51000000,5.5%
Q6PEE2-2,0.939288356,-0.087333333,0.86104758,0.050666667,0.820153688,0.236555733,0.188,0.088,-0.614,0.022,-0.049,-0.159,Q6PEE2,Ctif,Q6PEE2-2_Ctif,Q6PEE2-2,Ctif,1,3,3,3,Q6PEE2-2|E9Q1U6|Q6PEE2,MOUSE,71040.4,6.7,2696,2696.1,24.02,24.02,,600,Isoform 2 of CBP80/20-dependent translation initiation factor,cytoplasm|perinuclear region of cytoplasm|,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|regulation of translational initiation|",RNA binding|,3,3,147000000,6.7%
Q3UA37,0.299314168,-0.021166667,12.77037903,0.190333333,0.052839913,2.348150901,-0.057,-0.132,-0.16,0.041,0.099,0.082,Q3UA37,Qrich1,Q3UA37_Qrich1,Q3UA37,Qrich1,1,3,2,2,Q3UA37|G3X8R5|Q8BUN3|A0A0A6YXZ6,MOUSE,87010.7,3.9,2697,2697.1,24.01,24.01,,777,Glutamine-rich protein 1,nucleoplasm|,,,2,3,159000000,3.9%
P97314,0.714714682,-0.052833333,4.29725587,-0.186333333,0.371770061,-0.957922683,-0.14,0.075,0.186,0.033,-0.564,0.093,P97314,Csrp2,P97314_Csrp2,P97314,Csrp2,1,5,2,2,A0A1W2P845|P97314|A0A1W2P6I3|A0A1W2P780,MOUSE,21838.3,14.5,2698,2698.1,24.01,24.01,,193,Cysteine and glycine-rich protein 2,nucleus|focal adhesion|,multicellular organismal development|myoblast differentiation|,protein binding|zinc ion binding|,2,5,159000000,14.5%
Q8BYY4,0.6812202,0.017166667,4.854517874,-0.122333333,0.327000346,-1.058018614,-0.082,0.147,0.17,-0.157,-0.082,0.107,Q8BYY4,Ttc39b,Q8BYY4_Ttc39b,Q8BYY4,Ttc39b,1,5,3,3,Q8BYY4|Q8BYY4-2|Q8BYY4-3|E0CY48,MOUSE,71204.8,5.8,2699,2699.1,24.01,24.01,,617,Tetratricopeptide repeat protein 39B,,,,3,5,58200000,5.8%
Q8BH47,0.332192581,-0.006666667,11.86291027,-0.18,0.065119187,-2.203562121,0.124,0.042,0.084,-0.155,-0.07,-0.065,Q8BH47,Sec22a,Q8BH47_Sec22a,Q8BH47,Sec22a,1,3,2,2,Q8BH47,MOUSE,35651.7,6.8,2700,2700.1,23.99,23.99,,307,Vesicle-trafficking protein SEC22a,endoplasmic reticulum membrane|integral component of membrane|SNARE complex|,ER to Golgi vesicle-mediated transport|protein transport|vesicle fusion with Golgi apparatus|exocytosis|,SNARE binding|SNAP receptor activity|,2,3,204000000,6.8%
O35166,0.312476077,-0.0345,12.47585277,0.301666667,0.056547671,2.306627242,-0.437,-0.126,0.007,0.184,0.049,0.116,O35166,Gosr2,O35166_Gosr2,O35166,Gosr2,1,3,2,2,O35166|A2A9I0,MOUSE,24781.9,10.3,2701,2701.1,23.93,23.93,,212,Golgi SNAP receptor complex member 2,Golgi membrane|endoplasmic reticulum membrane|Golgi apparatus|ER to Golgi transport vesicle membrane|membrane|integral component of membrane|SNARE complex|late endosome membrane|,"protein targeting to vacuole|ER to Golgi vesicle-mediated transport|intra-Golgi vesicle-mediated transport|Golgi to vacuole transport|vesicle-mediated transport|retrograde transport, endosome to Golgi|vesicle fusion with Golgi apparatus|",SNARE binding|SNAP receptor activity|,2,3,36600000,10.3%
Q9EP53,0.483662608,-0.042,8.48157019,0.262,0.141854455,1.667287324,0.105,-0.219,-0.405,0.275,0.036,-0.044,Q9EP53,Tsc1,Q9EP53_Tsc1,Q9EP53,Tsc1,1,4,2,2,Q9EP53|Q9EP53-2|Q9EP53-3|Q9EP53-4,MOUSE,129770.4,3,2702,2702.1,23.92,23.92,,1161,Hamartin,cytoplasm|cytosol|plasma membrane|cell cortex|membrane|lamellipodium|growth cone|TSC1-TSC2 complex|intracellular membrane-bounded organelle|protein complex|actin filament|,kidney development|neural tube closure|regulation of cell-matrix adhesion|adaptive immune response|rRNA export from nucleus|regulation of translation|potassium ion transport|cell-matrix adhesion|nervous system development|negative regulation of cell proliferation|negative regulation of translation|hippocampus development|cerebral cortex development|cell projection organization|negative regulation of TOR signaling|response to insulin|regulation of actin cytoskeleton organization|myelination|regulation of GTPase activity|memory T cell differentiation|regulation of phosphoprotein phosphatase activity|negative regulation of cell size|regulation of protein kinase activity|glucose import|negative regulation of insulin receptor signaling pathway|synapse organization|protein stabilization|protein heterooligomerization|regulation of stress fiber assembly|regulation of cell cycle|positive regulation of focal adhesion assembly|cardiac muscle cell differentiation|activation of GTPase activity|,protein binding|GTPase regulator activity|GTPase activating protein binding|protein N-terminus binding|chaperone binding|,2,4,70000000,3.0%
Q6GV12,0.884484678,0.0325,1.87348404,-0.058333333,0.649608346,-0.475664162,0.268,0.008,-0.091,-0.039,0.127,-0.078,Q6GV12,Kdsr,Q6GV12_Kdsr,Q6GV12,Kdsr,1,6,2,2,Q6GV12,MOUSE,36354.6,8.1,2703,2703.1,23.9,23.9,,332,3-ketodihydrosphingosine reductase,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,3-keto-sphinganine metabolic process|sphingolipid biosynthetic process|oxidation-reduction process|,3-dehydrosphinganine reductase activity|,2,6,974000000,8.1%
Q99MK8,0.822662977,0.060666667,2.720428742,-0.118,0.534511589,-0.655074137,0.221,-0.284,0.422,-0.019,0.017,0.007,Q99MK8,Grk2,Q99MK8_Grk2,Q99MK8,Grk2,1,3,3,3,Q99MK8|Q7TS64|E9PW16|Q3UYH7|Q8BVT9|E9Q419,MOUSE,80436,4.7,2704,2704.1,23.87,23.87,,689,Beta-adrenergic receptor kinase 1,cytoplasm|plasma membrane|membrane|primary cilium|,regulation of the force of heart contraction|desensitization of G-protein coupled receptor protein signaling pathway|negative regulation of the force of heart contraction by chemical signal|protein phosphorylation|G-protein coupled receptor signaling pathway|tachykinin receptor signaling pathway|heart development|peptidyl-serine phosphorylation|peptidyl-threonine phosphorylation|viral genome replication|receptor internalization|termination of G-protein coupled receptor signaling pathway|negative regulation of striated muscle contraction|viral entry into host cell|cardiac muscle contraction|,protein kinase activity|protein serine/threonine kinase activity|G-protein coupled receptor kinase activity|protein binding|ATP binding|Edg-2 lysophosphatidic acid receptor binding|beta-adrenergic receptor kinase activity|,3,3,19300000,4.7%
E9QPU1,0.817642397,-0.061833333,2.830352853,0.116333333,0.521152367,0.677335986,-0.306,-0.124,0.07,0.118,-0.332,0.203,E9QPU1,Vwf,E9QPU1_Vwf,E9QPU1,Vwf,1,2,2,2,E9QPU1|Q8CIZ8,MOUSE,322558.9,1.1,2705,2705.1,23.8,23.8,,2813,von Willebrand factor,extracellular region|proteinaceous extracellular matrix|endoplasmic reticulum|external side of plasma membrane|extracellular matrix|Weibel-Palade body|extracellular exosome|,liver development|placenta development|cell adhesion|blood coagulation|hemostasis|platelet activation|cell-substrate adhesion|protein homooligomerization|platelet activation|,glycoprotein binding|protease binding|integrin binding|protein binding|collagen binding|immunoglobulin binding|identical protein binding|protein homodimerization activity|protein N-terminus binding|chaperone binding|,2,2,53300000,1.1%
Q80U93,0.636050842,0.012666667,5.636541903,-0.150666667,0.273115161,-1.19506507,-0.037,0.259,0.042,-0.252,0.022,0.042,Q80U93,Nup214,Q80U93_Nup214,Q80U93,Nup214,1,3,3,3,Q80U93,MOUSE,213944.8,1.8,2706,2706.1,23.8,23.8,,2085,Nuclear pore complex protein Nup214,nucleus|nuclear pore|focal adhesion|intracellular membrane-bounded organelle|,mRNA export from nucleus|protein import into nucleus|protein export from nucleus|regulation of cell cycle|,nucleocytoplasmic transporter activity|,3,3,79700000,1.8%
Q07968,0.000426749,-0.171166667,51.03895488,1.470333333,7.87235E-06,12.40642347,-0.833,-0.79,-1.096,0.526,0.47,0.696,Q07968,F13b,Q07968_F13b,Q07968,F13b,1,4,2,2,Q07968,MOUSE,78476.1,3.2,2707,2707.1,23.79,23.79,,669,Coagulation factor XIII B chain,extracellular region|,blood coagulation|,,2,4,128000000,3.2%
Q61830,0.000552294,-0.055833333,48.83706429,1.040333333,1.30705E-05,11.31541816,-0.568,-0.555,-0.605,0.586,0.441,0.366,Q61830,Mrc1,Q61830_Mrc1,Q61830,Mrc1,1,4,3,3,Q61830,MOUSE,167944.9,1.7,2708,2708.1,23.79,23.79,,1456,Macrophage mannose receptor 1,plasma membrane|cell surface|endosome membrane|integral component of membrane|,receptor-mediated endocytosis|signal transduction|cellular response to lipopolysaccharide|cellular response to interferon-gamma|cellular response to interleukin-4|,receptor activity|transmembrane signaling receptor activity|mannose binding|,3,4,127000000,1.7%
Q8C407-2,0.634404848,0.001666667,5.683533646,0.122,0.270175918,1.201903387,-0.18,0,0.002,0.17,0.063,-0.045,Q8C407,Yipf4,Q8C407-2_Yipf4,Q8C407-2,Yipf4,1,5,2,2,Q8C407-2|Q8C407,MOUSE,32953.2,10.7,2709,2709.1,23.79,23.79,,246,Isoform 2 of Protein YIPF4,endoplasmic reticulum|Golgi apparatus|plasma membrane|integral component of membrane|intracellular membrane-bounded organelle|,,,2,5,93600000,10.7%
Q9CZH3,0.850721826,0.016166667,2.364219735,0.084333333,0.580200403,0.581428781,0.047,-0.062,-0.063,0.16,-0.246,0.261,Q9CZH3,Psmg3,Q9CZH3_Psmg3,Q9CZH3,Psmg3,1,2,2,2,Q9CZH3|S4R185,MOUSE,13501.8,19.6,2710,2710.1,23.79,23.79,,122,Proteasome assembly chaperone 3,,,,2,2,38600000,19.6%
A2AKX3,0.797504707,-0.007333333,3.132755346,-0.132666667,0.486098706,-0.737557239,0.156,0.341,-0.32,-0.093,0.061,-0.189,A2AKX3,Setx,A2AKX3_Setx,A2AKX3,Setx,1,10,3,3,A2AKX3|A2AKX3-2|Q91ZU0,MOUSE,301805.8,0.7,2711,2711.1,23.78,23.78,,2646,Probable helicase senataxin,"nuclear chromosome|chromosome, telomeric region|nucleus|nucleoplasm|nucleolus|cytoplasm|axon|growth cone|","MAPK cascade|double-strand break repair|DNA recombination|termination of RNA polymerase II transcription|mRNA splice site selection|cellular response to DNA damage stimulus|spermatogenesis|circadian rhythm|fibroblast growth factor receptor signaling pathway|positive regulation of neuron projection development|positive regulation of RNA splicing|cellular response to oxidative stress|negative regulation of apoptotic process|protein kinase B signaling|cellular response to fibroblast growth factor stimulus|positive regulation of transcription from RNA polymerase II promoter|positive regulation of DNA-templated transcription, termination|cellular response to hydrogen peroxide|cellular response to retinoic acid|positive regulation of DNA-templated transcription, initiation|positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled|",transcription termination site sequence-specific DNA binding|helicase activity|protein binding|ATP binding|identical protein binding|,3,10,3870000000,0.7%
Q60973,0.919416995,-0.019333333,1.216329903,-0.038,0.755730604,-0.324250415,0.032,-0.092,0.059,-0.24,0.115,0.01,Q60973,Rbbp7,Q60973_Rbbp7,Q60973,Rbbp7,1,5,3,3,Q60973|A2AFJ1|A2AFI9|Q60972,MOUSE,48131.5,6.5,2712,2712.1,23.77,23.77,,425,Histone-binding protein RBBP7,nucleus|nucleoplasm|NuRD complex|ESC/E(Z) complex|,"negative regulation of transcription from RNA polymerase II promoter|chromatin silencing at rDNA|DNA replication|chromatin remodeling|transcription, DNA-templated|negative regulation of cell growth|negative regulation of transcription, DNA-templated|response to steroid hormone|cellular heat acclimation|",RNA binding|protein binding|,4,5,172000000,6.5%
Q8BPE4,0.99327985,0.042833333,0.132420981,-0.005,0.969969106,-0.039092803,0.02,0.247,-0.131,0.189,-0.035,-0.033,Q8BPE4,Tmem177,Q8BPE4_Tmem177,Q8BPE4,Tmem177,1,3,3,3,Q8BPE4,MOUSE,34237.9,9.3,2713,2713.1,23.75,23.75,,311,Transmembrane protein 177,integral component of membrane|,,,3,3,439000000,9.3%
E9QAQ7,0.919618833,0.015,1.166606653,0.048666667,0.764432838,0.312280984,0.225,0.095,-0.348,0.041,0.082,-0.005,E9QAQ7,Arid1a,E9QAQ7_Arid1a,E9QAQ7,Arid1a,1,4,4,4,E9QAQ7|A2BH40|A2BH40-2|A2BH40-4|A2BH40-3,MOUSE,243582.1,1.9,2714,2714.1,23.74,23.74,,2287,AT-rich interactive domain-containing protein 1A,nuclear chromatin|nucleoplasm|SWI/SNF complex|BAF-type complex|,"negative regulation of transcription from RNA polymerase II promoter|neural tube closure|cardiac chamber development|optic cup formation involved in camera-type eye development|chromatin organization|nucleosome disassembly|chromatin remodeling|maintenance of chromatin silencing|intracellular estrogen receptor signaling pathway|androgen receptor signaling pathway|forebrain development|glucocorticoid receptor signaling pathway|ATP-dependent chromatin remodeling|positive regulation of transcription, DNA-templated|cardiac muscle cell differentiation|placenta blood vessel development|toxin transport|",DNA binding|protein binding|ligand-dependent nuclear receptor binding|nucleosome binding|,4,4,2460000000,1.9%
Q99PM9,0.822662977,-0.043166667,2.723488548,0.123666667,0.534135133,0.655696634,0.116,0.072,-0.503,0.213,-0.102,-0.055,Q99PM9,Uck2,Q99PM9_Uck2,Q99PM9,Uck2,1,5,3,3,Q99PM9|A0A0A6YVQ3,MOUSE,29517.8,14.9,2715,2715.1,23.73,23.73,,261,Uridine-cytidine kinase 2,,CMP salvage|phosphorylation|UMP salvage|CTP salvage|,uridine kinase activity|protein binding|ATP binding|nucleoside kinase activity|,3,5,667000000,14.9%
Q9Z2E1,0.530524264,0.125,7.607861289,-0.378,0.173465803,-1.525206881,0.021,0.003,0.918,-0.003,-0.099,-0.09,Q9Z2E1,Mbd2,Q9Z2E1_Mbd2,Q9Z2E1,Mbd2,1,3,3,3,Q9Z2E1|Q9Z2E1-2,MOUSE,43842.3,9.4,2716,2716.1,23.73,23.73,,414,Methyl-CpG-binding domain protein 2,histone deacetylase complex|chromatin|nuclear chromatin|heterochromatin|nucleus|cytoplasm|protein complex|nucleolus|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|positive regulation of Wnt signaling pathway|regulation of cell proliferation|maternal behavior|ATP-dependent chromatin remodeling|cellular protein complex assembly|",DNA binding|chromatin binding|mRNA binding|protein binding|methyl-CpG binding|protein domain specific binding|siRNA binding|C2H2 zinc finger domain binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|,3,3,116000000,9.4%
E9Q912,0.843401516,0.013166667,2.457968963,0.081666667,0.567810087,0.601045759,-0.217,0.034,0.1,0.247,-0.128,0.043,E9Q912,Rap1gds1,E9Q912_Rap1gds1,E9Q912,Rap1gds1,1,5,3,3,E9Q912|Q3TU36|E9Q6Q4|A0A0G2JGC8|A0A0G2JF70,MOUSE,66817,4.6,2717,2717.1,23.7,23.7,,607,"RAP1, GTP-GDP dissociation stimulator 1",mitochondrion|endoplasmic reticulum|cytosol|extracellular exosome|,negative regulation of endoplasmic reticulum calcium ion concentration|positive regulation of mitochondrial calcium ion concentration|,,3,5,180000000,4.6%
Q6PAM1,0.260519648,0.026333333,13.88563531,0.436666667,0.040872996,2.533799862,-0.084,-0.311,-0.181,0.34,-0.118,0.512,Q6PAM1,Txlna,Q6PAM1_Txlna,Q6PAM1,Txlna,1,3,2,2,Q6PAM1|Q6PAM1-2,MOUSE,62824.1,7,2718,2718.1,23.67,23.67,,554,Alpha-taxilin,cytoplasm|membrane|,exocytosis|B cell activation|activation of mitophagy in response to mitochondrial depolarization|,syntaxin binding|,2,3,5750000,7.0%
Q3V2Q8,0.844723818,-0.064,2.429038722,0.142666667,0.571605143,0.595010712,0.057,0.243,-0.706,-0.062,0.064,0.02,Q3V2Q8,N4bp2l1,Q3V2Q8_N4bp2l1,Q3V2Q8,N4bp2l1,1,5,3,3,Q3V2Q8|Q3V2Q8-2|A0A0J9YV14|A0A0J9YTQ2|A0A0J9YVF4,MOUSE,28037.9,12.1,2719,2719.1,23.66,23.66,,238,NEDD4-binding protein 2-like 1,,,,3,5,78100000,12.1%
E9PUP1,0.934957223,-0.019666667,0.933521542,-0.035333333,0.806580737,-0.254841047,0.122,0.15,-0.278,0.075,-0.108,-0.079,E9PUP1,Syde2,E9PUP1_Syde2,E9PUP1,Syde2,1,6,4,2,E9PUP1|A0A0G2JEY9,MOUSE,146287.5,3.8,2720,2720.1,23.63,11.17,,1314,"Synapse defective 1, Rho GTPase, homolog 2 (C. elegans)",,signal transduction|,,4,6,3570000000,3.8%
E9QQ30,0.000883505,-0.103333333,45.36731461,1.224,2.90582E-05,10.10221025,-0.546,-0.689,-0.911,0.395,0.535,0.596,E9QQ30,Eif2ak3,E9QQ30_Eif2ak3,E9QQ30,Eif2ak3,1,3,3,3,E9QQ30|Q9Z2B5|A0A0R4J1Y1,MOUSE,125809.1,3,2721,2721.1,23.63,23.63,,1114,Eukaryotic translation initiation factor 2-alpha kinase 3,cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|membrane|,skeletal system development|ossification|angiogenesis|chondrocyte development|translation|protein phosphorylation|activation of cysteine-type endopeptidase activity involved in apoptotic process|ER overload response|endoplasmic reticulum organization|lactation|positive regulation of signal transduction|positive regulation of vascular endothelial growth factor production|positive regulation of gene expression|negative regulation of gene expression|regulation of translational initiation by eIF2 alpha phosphorylation|negative regulation of translation|regulation of fatty acid metabolic process|calcium-mediated signaling|bone mineralization|endoplasmic reticulum unfolded protein response|pancreas development|endocrine pancreas development|negative regulation of myelination|negative regulation of translation in response to stress|positive regulation of protein binding|SREBP signaling pathway|response to endoplasmic reticulum stress|cellular response to glucose starvation|negative regulation of apoptotic process|fat cell differentiation|positive regulation of transcription from RNA polymerase I promoter|protein autophosphorylation|insulin-like growth factor receptor signaling pathway|protein homooligomerization|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress|regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|,protein kinase activity|protein serine/threonine kinase activity|eukaryotic translation initiation factor 2alpha kinase activity|protein binding|ATP binding|enzyme binding|protein phosphatase binding|identical protein binding|Hsp90 protein binding|,3,3,155000000,3.0%
J3QJU5,0.857449938,-0.035166667,2.267636744,0.078333333,0.593248058,0.561032454,-0.152,0.086,-0.157,-0.249,0.163,0.098,J3QJU5,Llgl2,J3QJU5_Llgl2,J3QJU5,Llgl2,1,5,4,4,J3QJU5|Q3TJ91,MOUSE,118139.7,3.8,2722,2722.1,23.63,23.63,,1051,Lethal(2) giant larvae protein homolog 2,nucleoplasm|cytoplasm|intracellular membrane-bounded organelle|,regulation of establishment or maintenance of cell polarity|,PDZ domain binding|,4,5,533000000,3.8%
Q8BKF1,0.586429925,-0.011833333,6.591005563,-0.137,0.219229727,-1.355387424,0.076,-0.068,0.162,-0.025,-0.187,-0.029,Q8BKF1,Polrmt,Q8BKF1_Polrmt,Q8BKF1,Polrmt,1,4,4,4,Q8BKF1|E9PWD9|E0CY15,MOUSE,138014.6,3.1,2723,2723.1,23.62,23.62,,1207,"DNA-directed RNA polymerase, mitochondrial",mitochondrion|mitochondrial nucleoid|,transcription from mitochondrial promoter|,DNA binding|DNA-directed RNA polymerase activity|poly(A) RNA binding|,4,4,212000000,3.1%
Q8CI71,0.266256434,-0.012166667,13.76007317,-0.309,0.042071954,-2.513457855,0.144,0.026,0.257,0.022,-0.342,-0.18,Q8CI71,Vps50,Q8CI71_Vps50,Q8CI71,Vps50,1,4,3,3,Q8CI71|Q8CI71-3|Q8CI71-2,MOUSE,112027.9,2.8,2724,2724.1,23.58,23.58,,964,Syndetin,membrane|recycling endosome|extracellular exosome|EARP complex|,"protein transport|endocytic recycling|retrograde transport, endosome to Golgi|",,3,4,80900000,2.8%
Q68FH0,0.644449202,-0.131,5.472810736,0.147333333,0.283608293,1.166776332,-0.279,0.024,-0.359,0.007,-0.172,-0.007,Q68FH0,Pkp4,Q68FH0_Pkp4,Q68FH0,Pkp4,1,3,3,3,Q68FH0|A2AS45|Q68FH0-2|A2AS47,MOUSE,132347.3,4.2,2725,2725.1,23.57,23.57,,1190,Plakophilin-4,spindle pole|cytoplasm|cytoskeleton|plasma membrane|cell-cell junction|cytoplasmic side of plasma membrane|postsynaptic density|desmosome|midbody|perinuclear region of cytoplasm|spindle midzone|mitotic spindle|midbody|cell-cell contact zone|,cell-cell junction assembly|single organismal cell-cell adhesion|positive regulation of cytokinesis|positive regulation of GTPase activity|,,3,3,196000000,4.2%
Q8K301,0.838344776,-0.103666667,2.554811567,-0.250666667,0.55528871,-0.621130139,-0.158,0.473,-0.25,-1.137,0.308,0.142,Q8K301,Ddx52,Q8K301_Ddx52,Q8K301,Ddx52,1,3,2,2,Q8K301,MOUSE,67815.2,5.6,2726,2726.1,23.56,23.56,,598,Probable ATP-dependent RNA helicase DDX52,nucleus|nucleolus|membrane|,rRNA processing|RNA secondary structure unwinding|,ATP-dependent RNA helicase activity|ATP binding|poly(A) RNA binding|,2,3,356000000,5.6%
A0A0R4J078,0.550359036,-0.0565,7.276671015,0.225,0.187211662,1.470817395,-0.218,0.123,-0.412,-0.077,0.156,0.089,A0A0R4J078,Ubxn4,A0A0R4J078_Ubxn4,A0A0R4J078,Ubxn4,1,4,4,4,A0A0R4J078|Q8VCH8,MOUSE,56801.3,9.8,2727,2727.1,23.56,23.56,,506,"UBX domain containing 2, isoform CRA_a",,,,4,4,138000000,9.8%
Q8C9B9,0.972515437,-0.024666667,0.39393382,-0.018666667,0.913285617,-0.11312457,-0.086,-0.173,0.213,0.039,-0.319,0.178,Q8C9B9,Dido1,Q8C9B9_Dido1,Q8C9B9,Dido1,1,4,4,4,Q8C9B9,MOUSE,248769.1,2.2,2728,2728.1,23.52,23.52,,2256,Death-inducer obliterator 1,nucleus|nucleoplasm|cytoplasm|spindle|,"transcription, DNA-templated|apoptotic signaling pathway|",zinc ion binding|poly(A) RNA binding|,4,4,496000000,2.2%
E9QKQ5,0.651971232,0.025666667,5.291460329,-0.614666667,0.295701799,-1.135241128,-0.052,1.001,0.05,0.898,-1.086,-0.657,E9QKQ5,Lpin1,E9QKQ5_Lpin1,E9QKQ5,Lpin1,1,3,2,2,E9QKQ5|Q91ZP3|A0A1Y7VLN4|Q91ZP3-2,MOUSE,102895.6,3.6,2729,2729.1,23.47,23.47,,924,Phosphatidate phosphatase LPIN1,nucleus|transcription factor complex|,negative regulation of transcription from RNA polymerase II promoter|lipid metabolic process|fatty acid catabolic process|dephosphorylation|triglyceride biosynthetic process|positive regulation of histone deacetylation|ruffle organization|actin cytoskeleton reorganization|cellular response to insulin stimulus|regulation of fat cell differentiation|positive regulation of transcription from RNA polymerase II promoter|,RNA polymerase II transcription factor binding|protein binding|phosphatidate phosphatase activity|histone deacetylase binding|,2,3,69100000,3.6%
Q61753,0.472136605,0.316,8.771883406,-0.912,0.132681893,-1.71414075,-0.194,2.059,0.451,0.036,-0.314,-0.142,Q61753,Phgdh,Q61753_Phgdh,Q61753,Phgdh,1,3,3,3,Q61753,MOUSE,57383.3,6.7,2730,2730.1,23.46,23.46,,533,D-3-phosphoglycerate dehydrogenase,myelin sheath|extracellular exosome|,glutamine metabolic process|glycine metabolic process|L-serine metabolic process|L-serine biosynthetic process|threonine metabolic process|gamma-aminobutyric acid metabolic process|regulation of gene expression|taurine metabolic process|spinal cord development|glial cell development|neural tube development|neurogenesis|neuron projection development|oxidation-reduction process|G1 to G0 transition|,phosphoglycerate dehydrogenase activity|NAD binding|,3,3,43000000,6.7%
P18826,0.755660323,0.001,3.760858818,-0.082,0.420643438,-0.857790675,0.126,-0.003,0.003,-0.082,-0.119,0.081,P18826,Phka1,P18826_Phka1,P18826,Phka1,1,3,3,3,P18826|A2AI87|P18826-2|A2AI88|A2AI89|A2AI91,MOUSE,139963.3,2.1,2731,2731.1,23.43,23.43,,1241,"Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform",plasma membrane|phosphorylase kinase complex|,glycogen metabolic process|protein phosphorylation|,calmodulin binding|phosphorylase kinase activity|,3,3,31100000,2.1%
Q3URQ4,0.770893564,0.059333333,3.588360148,0.274,0.43768734,0.825753623,-0.034,-0.023,-0.176,0.872,-0.552,0.269,Q3URQ4,Fam8a1,Q3URQ4_Fam8a1,Q3URQ4,Fam8a1,1,3,2,2,Q3URQ4,MOUSE,42693.9,5.2,2732,2732.1,23.41,23.41,,399,"Family with sequence similarity 8, member A1",,,,2,3,82900000,5.2%
P61961,0.615860336,0.006666667,6.047918143,-0.127333333,0.248432372,-1.264049737,-0.011,0.233,-0.011,-0.07,-0.092,-0.009,P61961,Ufm1,P61961_Ufm1,P61961,Ufm1,1,11,2,2,P61961|D3YW97|H7BWZ1,MOUSE,9174.5,27,2733,2733.1,23.38,23.38,,85,Ubiquitin-fold modifier 1,nucleus|cytoplasm|extracellular exosome|,regulation of intracellular estrogen receptor signaling pathway|response to endoplasmic reticulum stress|protein ufmylation|protein K69-linked ufmylation|,,2,11,1970000000,27.0%
Q80Y,0.571733416,-0.067166667,6.943011506,0.275666667,0.202161685,1.415655718,-0.202,0.189,-0.602,0.028,0.137,0.047,Q80Y,NotFound,Q80Y_NotFound,Q80Y,Tnc,1,4,4,4,Q80Y|Q80Y-2|Q80Y-3|Q80Y-4|Q80Y-5,MOUSE,237451.3,2.2,2734,2734.1,23.38,23.38,,2110,Tenascin,extracellular region|basement membrane|interstitial matrix|extracellular space|focal adhesion|membrane|extracellular matrix|extracellular matrix|,osteoblast differentiation|cell adhesion|neuromuscular junction development|positive regulation of cell proliferation|positive regulation of gene expression|peripheral nervous system axon regeneration|mesenchymal-epithelial cell signaling involved in prostate gland development|prostate gland epithelium morphogenesis|,fibronectin binding|syndecan binding|,4,4,76000000,2.2%
Q9CQE3,0.615860336,0.033833333,6.040964459,-0.246333333,0.248830467,-1.264258969,-0.173,0.554,0.09,-0.25,0.063,-0.081,Q9CQE3,Mrps17,Q9CQE3_Mrps17,Q9CQE3,Mrps17,1,2,2,2,Q9CQE3,MOUSE,13495.7,15,2735,2735.1,23.34,23.34,,120,"28S ribosomal protein S17, mitochondrial",mitochondrion|mitochondrial small ribosomal subunit|,mitochondrial translation|,structural constituent of ribosome|rRNA binding|,2,2,13100000,15.0%
Q3V0A6,0.516682924,-0.033833333,7.858977717,0.456333333,0.163720186,1.566233456,-0.345,0.239,-0.68,-0.286,0.374,0.495,Q3V0A6,Gm5592,Q3V0A6_Gm5592,Q3V0A6,Gm5592,1,8,3,3,Q3V0A6|W4VSN8|E9PVP9|A0A0U1RPT6|B2RX47,MOUSE,94411.8,2.9,2736,2736.1,23.33,23.33,,857,Uncharacterized protein C2orf78 homolog,,,,3,8,78000000000,2.9%
Q8BGB5,0.140351716,-0.037,17.99819969,0.348,0.015855503,3.209343569,-0.093,-0.138,-0.402,0.162,0.086,0.163,Q8BGB5,Limd2,Q8BGB5_Limd2,Q8BGB5,Limd2,1,6,2,2,Q8BGB5,MOUSE,14636.3,17.9,2737,2737.1,23.29,23.29,,128,LIM domain-containing protein 2,,,zinc ion binding|,2,6,583000000,17.9%
Q8BXA5,0.561710094,0.124166667,7.08881909,-0.291,0.195487094,-1.439809595,0.023,0.058,0.728,0.127,-0.094,-0.097,Q8BXA5,Clptm1l,Q8BXA5_Clptm1l,Q8BXA5,Clptm1l,1,2,2,2,Q8BXA5,MOUSE,62524.5,5.3,2738,2738.1,23.28,23.28,,539,Cleft lip and palate transmembrane protein 1-like protein,membrane|integral component of membrane|,apoptotic process|,,2,2,315000000,5.3%
Q9D997,0.991556352,-0.025,0.176355076,0.005333333,0.96020617,0.051792688,-0.176,-0.029,0.122,0.007,-0.003,-0.071,Q9D997,Nagk,Q9D997_Nagk,Q9D997,Nagk,1,2,2,2,Q9D997|Q9QZ08|D3YXG2,MOUSE,39688.3,6.3,2739,2739.1,23.27,23.27,,361,N-acetyl-D-glucosamine kinase,extracellular exosome|,N-acetylglucosamine metabolic process|carbohydrate phosphorylation|,N-acylmannosamine kinase activity|N-acetylglucosamine kinase activity|,2,2,29400000,6.3%
P33587,0.204708202,0.042666667,15.79590825,0.445333333,0.026327473,2.846830998,-0.318,-0.225,0.003,-0.003,0.291,0.508,P33587,Proc,P33587_Proc,P33587,Proc,1,3,2,2,P33587,MOUSE,53186.4,5.8,2740,2740.1,23.24,23.24,,460,Vitamin K-dependent protein C,extracellular space|,proteolysis|blood coagulation|negative regulation of blood coagulation|negative regulation of apoptotic process|,calcium ion binding|peptidase activity|,2,3,51000000,5.8%
Q8BTX9,0.838867494,0.141666667,2.544035902,0.162,0.556668196,0.618904171,0.039,0.123,0.02,0.863,-0.063,-0.132,Q8BTX9,Hsdl1,Q8BTX9_Hsdl1,Q8BTX9,Hsdl1,1,2,2,2,Q8BTX9|A0A1D5RLG0,MOUSE,37266.2,10.6,2741,2741.1,23.23,23.23,,330,Inactive hydroxysteroid dehydrogenase-like protein 1,mitochondrion|,oxidation-reduction process|,oxidoreductase activity|,2,2,16400000,10.6%
Q80WT5,0.122124581,-0.052333333,18.78536309,0.354666667,0.013227071,3.344103094,-0.211,-0.093,-0.385,0.038,0.167,0.17,Q80WT5,Aftph,Q80WT5_Aftph,Q80WT5,Aftph,1,3,2,2,Q80WT5|Q80WT5-2|H3BJH7,MOUSE,102041.6,2.5,2742,2742.1,23.18,23.18,,931,Aftiphilin,nucleus|nucleoplasm|cytoplasm|Golgi apparatus|cytosol|AP-1 adaptor complex|intracellular membrane-bounded organelle|,protein transport|,clathrin binding|,2,3,53900000,2.5%
Q640L5,0.919618833,-0.035166667,1.167663586,0.069,0.764246822,0.312536941,-0.307,0.099,-0.001,0.312,-0.466,0.152,Q640L5,Ccdc18,Q640L5_Ccdc18,Q640L5,Ccdc18,1,5,4,4,Q640L5,MOUSE,170993.4,1.9,2743,2743.1,23.16,23.16,,1455,Coiled-coil domain-containing protein 18,,,,4,5,121000000,1.9%
A0A140LI67,0.983717661,-0.013,0.251818315,-0.014,0.943665697,-0.073387585,-0.191,-0.124,0.297,-0.351,0.136,0.155,A0A140LI67,NotFound,A0A140LI67_NotFound,A0A140LI67,Frmpd2,1,9,3,3,A0A140LI67,MOUSE,155130.6,2,2744,2744.1,23.09,23.09,,1392,FERM and PDZ domain-containing 2,,,,3,9,17100000000,2.0%
Q9CPY0,0.631701864,-0.0075,5.784089661,0.190333333,0.263992163,1.220417603,-0.27,-0.065,0.027,0.318,-0.199,0.144,Q9CPY0,Mrm2,Q9CPY0_Mrm2,Q9CPY0,Mrm2,1,2,2,2,Q9CPY0,MOUSE,27486.5,11.3,2745,2745.1,23.07,23.07,,246,"rRNA methyltransferase 2, mitochondrial",nucleolus|mitochondrion|,rRNA processing|rRNA methylation|,methyltransferase activity|,2,2,31100000,11.3%
Q2YDW2,0.994928853,0.024,0.070086568,-0.002666667,0.983991492,-0.020834749,0.168,-0.096,0.004,0.222,-0.15,-0.004,Q2YDW2,Msto1,Q2YDW2_Msto1,Q2YDW2,Msto1,1,3,3,3,Q2YDW2|E9PUB7|Q2YDW2-2,MOUSE,61856.9,6.4,2747,2747.1,23.01,23.01,,556,Protein misato homolog 1,cytoplasm|mitochondrial outer membrane|,mitochondrion organization|metabolic process|mitochondrion distribution|,GTPase activity|,3,3,55000000,6.4%
Q08943-2,0.23054984,-0.025333333,14.78087879,-0.313333333,0.033259225,-2.67810195,0.049,0.211,0.134,-0.002,-0.179,-0.365,Q08943,Ssrp1,Q08943-2_Ssrp1,Q08943-2,Ssrp1,1,3,3,3,Q08943-2|Q08943,MOUSE,81816,4.6,2748,2748.1,22.99,22.99,,708,Isoform 2 of FACT complex subunit SSRP1,nucleus|chromosome|nucleolus|cytoplasm|,"DNA replication|DNA repair|chromatin remodeling|transcription, DNA-templated|regulation of transcription, DNA-templated|",DNA binding|chromatin binding|poly(A) RNA binding|,3,3,139000000,4.6%
Q99KK1,0.90651412,-0.047666667,1.514497076,0.064666667,0.705586548,0.394535819,0.087,0.095,-0.422,0.112,-0.008,-0.15,Q99KK1,Reep3,Q99KK1_Reep3,Q99KK1,Reep3,1,4,3,3,A0A1W2P8A8|Q99KK1,MOUSE,29213.3,23.2,2749,2749.1,22.96,22.96,,254,Receptor expression-enhancing protein 3,endoplasmic reticulum membrane|microtubule|integral component of membrane|,nuclear envelope organization|mitotic nuclear division|mitotic nuclear envelope reassembly|cell division|,,3,4,333000000,23.2%
Q91VX9,0.661323193,0.004166667,5.162934871,-0.145666667,0.304583598,-1.112755637,0.002,0.003,0.226,0.099,-0.29,-0.015,Q91VX9,Tmem168,Q91VX9_Tmem168,Q91VX9,Tmem168,1,5,2,2,Q91VX9|A0A0N4SW50,MOUSE,80927.3,4.7,2750,2750.1,22.92,22.92,,697,Transmembrane protein 168,integral component of membrane|transport vesicle|,,,2,5,126000000,4.7%
Q564G0,0.597505754,0.031,6.390702824,-0.162666667,0.229577709,-1.323396088,0.072,0.314,-0.049,-0.034,0.052,-0.169,Q564G0,Guk1,Q564G0_Guk1,Q564G0,Guk1,1,6,2,2,Q564G0|E9Q7K1|Q64520,MOUSE,24146.2,10.5,2751,2751.1,22.9,22.9,,219,Guanylate kinase,cytosol|,purine nucleotide metabolic process|dGDP biosynthetic process|GDP-mannose metabolic process|glycoprotein transport|ATP metabolic process|GMP metabolic process|dGMP metabolic process|dATP metabolic process|GDP biosynthetic process|nucleotide phosphorylation|,guanylate kinase activity|,2,6,136000000,10.5%
E9PXD2,0.471962952,-0.155833333,8.792127555,0.507,0.132064851,1.717402572,0.116,-0.257,-1.087,0.154,0.22,-0.081,E9PXD2,Dlc1,E9PXD2_Dlc1,E9PXD2,Dlc1,1,9,3,3,E9PXD2|Q9R0Z9-2|A0A0R4J171|Q9R0Z9|E9QKB1,MOUSE,174663,3.5,2752,2752.1,22.83,22.83,,1543,Rho GTPase-activating protein 7,nucleus|cytoplasm|cytosol|caveola|focal adhesion|cortical actin cytoskeleton|ruffle membrane|,neural tube closure|heart morphogenesis|apoptotic process|activation of cysteine-type endopeptidase activity involved in apoptotic process|signal transduction|negative regulation of cell proliferation|regulation of cell shape|hindbrain morphogenesis|actin cytoskeleton organization|negative regulation of cell migration|forebrain development|regulation of actin cytoskeleton organization|negative regulation of Rho protein signal transduction|positive regulation of protein dephosphorylation|positive regulation of GTPase activity|focal adhesion assembly|negative regulation of stress fiber assembly|negative regulation of focal adhesion assembly|positive regulation of execution phase of apoptosis|,GTPase activator activity|lipid binding|SH2 domain binding|,3,9,30100000000,3.5%
O35955,0.908176819,0.079166667,1.480412064,0.137666667,0.711146036,0.386644728,-0.141,-0.628,0.8,0.429,-0.114,0.129,O35955,Psmb10,O35955_Psmb10,O35955,Psmb10,1,3,2,2,O35955,MOUSE,29348,8,2753,2753.1,22.83,22.83,,273,Proteasome subunit beta type-10,nucleus|cytoplasm|cytosol|proteasome core complex|spermatoproteasome complex|,cell morphogenesis|proteasomal ubiquitin-independent protein catabolic process|T cell proliferation|proteasome-mediated ubiquitin-dependent protein catabolic process|,endopeptidase activity|threonine-type endopeptidase activity|,2,3,213000000,8.0%
Q8K337-3,0.648073376,-0.072333333,5.354689772,0.22,0.29142783,1.146261107,-0.052,0.099,-0.594,0.188,0.031,-0.106,Q8K337,Inpp5b,Q8K337-3_Inpp5b,Q8K337-3,Inpp5b,1,3,3,1,Q8K337-3,MOUSE,85970.3,4.5,2754,2754.1,22.81,9.32,,993,"Isoform 3 of Type II inositol 1,4,5-trisphosphate 5-phosphatase",cytoplasm|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|cytosol|membrane|integral component of membrane|phagocytic vesicle membrane|early endosome membrane|,in utero embryonic development|signal transduction|spermatogenesis|sperm motility|phosphatidylinositol dephosphorylation|regulation of protein processing|,"phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity|inositol-polyphosphate 5-phosphatase activity|metal ion binding|inositol-1,4,5-trisphosphate 5-phosphatase activity|",3,3,124000000,4.5%
P70452,0.936982455,0.039,0.886714465,0.059333333,0.815320859,0.243055761,-0.416,-0.056,0.5,0.054,-0.157,0.309,P70452,Stx4a,P70452_Stx4a,P70452,Stx4,1,3,2,2,P70452|D6RJ29,MOUSE,34278.5,17.1,2755,2755.1,22.81,22.81,,298,Syntaxin-4,storage vacuole|extracellular space|intracellular|cytoplasm|endosome|trans-Golgi network|plasma membrane|synaptic vesicle|cell surface|endomembrane system|membrane|integral component of membrane|basolateral plasma membrane|lamellipodium|SNARE complex|myelin sheath adaxonal region|somatodendritic compartment|specific granule|dendritic spine|lateral loop|synapse|perinuclear region of cytoplasm|extracellular exosome|,intracellular protein transport|positive regulation of cell proliferation|synaptic vesicle exocytosis|regulation of exocytosis|positive regulation of cell migration|synaptic vesicle fusion to presynaptic membrane|response to hydroperoxide|SNARE complex assembly|positive regulation of insulin secretion involved in cellular response to glucose stimulus|positive regulation of catalytic activity|positive regulation of eosinophil degranulation|positive regulation of cell adhesion|vesicle docking|organelle fusion|positive regulation of chemotaxis|positive regulation of immunoglobulin secretion|long-term synaptic potentiation|positive regulation of establishment of protein localization to plasma membrane|regulation of extrinsic apoptotic signaling pathway via death domain receptors|positive regulation of protein localization to plasma membrane|positive regulation of protein localization to cell surface|,SNARE binding|SNAP receptor activity|protein binding|sphingomyelin phosphodiesterase activator activity|,2,3,1570000000,17.1%
Q9D4J7,0.470565279,-0.015,8.845802506,0.458666667,0.130442691,1.726047749,-0.017,0.009,-0.725,0.625,-0.14,0.158,Q9D4J7,Phf6,Q9D4J7_Phf6,Q9D4J7,Phf6,1,3,2,2,Q9D4J7|E9QAG2|Q9D4J7-2,MOUSE,42279.7,7.6,2757,2757.1,22.75,22.75,,364,PHD finger protein 6,condensed chromosome kinetochore|nucleus|nucleoplasm|nucleolus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",DNA binding|zinc ion binding|tubulin binding|enzyme binding|histone binding|histone deacetylase binding|ribonucleoprotein complex binding|poly(A) RNA binding|phosphoprotein binding|scaffold protein binding|,2,3,67900000,7.6%
Q6P4T0,0.06013765,0.0385,22.68878683,-0.381666667,0.005384202,-4.043916396,0.15,0.284,0.254,-0.04,-0.176,-0.241,Q6P4T0,Atg2a,Q6P4T0_Atg2a,Q6P4T0,Atg2a,1,4,4,4,Q6P4T0,MOUSE,213103.7,3.1,2758,2758.1,22.7,22.7,,1914,Autophagy-related protein 2 homolog A,pre-autophagosomal structure|lipid particle|extrinsic component of membrane|pre-autophagosomal structure membrane|,autophagosome assembly|mitochondrion degradation|cellular response to nitrogen starvation|nucleophagy|,,4,4,2900000000,3.1%
Q3U422,0.8541792,0.024166667,2.334355092,0.175666667,0.584203952,0.575142537,-0.666,0.096,0.379,-0.109,-0.103,0.548,Q3U422,Ndufv3,Q3U422_Ndufv3,Q3U422,Ndufv3,1,3,3,3,Q3U422,MOUSE,50554.6,5.9,2759,2759.1,22.69,22.69,,468,"NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial",nucleoplasm|mitochondrion|mitochondrial respiratory chain complex I|,,poly(A) RNA binding|,3,3,49200000,5.9%
Q9CQU8,0.88044681,0.020666667,1.937022377,0.056,0.640173603,0.489573785,0.11,0.095,-0.227,0.031,0.061,0.054,Q9CQU8,Immp1l,Q9CQU8_Immp1l,Q9CQU8,Immp1l,1,2,2,2,Q9CQU8,MOUSE,18729.9,15.6,2760,2760.1,22.67,22.67,,166,Mitochondrial inner membrane protease subunit 1,mitochondrion|mitochondrial inner membrane|,protein processing involved in protein targeting to mitochondrion|,serine-type peptidase activity|,2,2,45500000,15.6%
P42703-2,0.002001798,-0.3555,40.60063958,2.762333333,8.70835E-05,8.462356644,-2.119,-2.1,-0.991,0.907,0.815,1.355,P42703,Lifr,P42703-2_Lifr,P42703-2,Lifr,1,8,3,3,P42703-2|P42703,MOUSE,82255.7,4.7,2761,2761.1,22.6,22.6,,1092,Isoform 2 of Leukemia inhibitory factor receptor,plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,positive regulation of cell proliferation|negative regulation of muscle cell apoptotic process|response to organic cyclic compound|cytokine-mediated signaling pathway|organ regeneration|response to cytokine|oncostatin-M-mediated signaling pathway|neuron projection morphogenesis|leukemia inhibitory factor signaling pathway|ciliary neurotrophic factor-mediated signaling pathway|,leukemia inhibitory factor receptor activity|ciliary neurotrophic factor receptor binding|protein binding|growth factor binding|cytokine binding|protein heterodimerization activity|ciliary neurotrophic factor receptor activity|oncostatin-M receptor activity|,3,8,7040000000,4.7%
Q6P6M5-2,0.571046339,0.023,6.955215047,0.139333333,0.201594415,1.415899489,-0.081,0.043,-0.102,0.092,-0.022,0.208,Q6P6M5,Pex11g,Q6P6M5-2_Pex11g,Q6P6M5-2,Pex11g,1,7,3,3,Q6P6M5-2|Q6P6M5,MOUSE,20609.8,18.7,2762,2762.1,22.59,22.59,,241,Isoform 2 of Peroxisomal membrane protein 11C,peroxisome|integral component of peroxisomal membrane|intrinsic component of peroxisomal membrane|protein complex|,peroxisome fission|regulation of peroxisome size|,,3,7,501000000,18.7%
P28293,0.752869277,0.183333333,3.801033863,-0.416666667,0.416770157,-0.866000055,-0.309,0.242,1.242,0.721,-0.69,-0.106,P28293,Ctsg,P28293_Ctsg,P28293,Ctsg,1,2,2,2,P28293,MOUSE,29437.4,8,2763,2763.1,22.56,22.56,,261,Cathepsin G,extracellular space|nucleus|cytoplasm|intermediate filament|plasma membrane|secretory granule|intracellular membrane-bounded organelle|extracellular exosome|extracellular matrix|,protein phosphorylation|proteolysis|immune response|protein processing|response to lipopolysaccharide|negative regulation of growth of symbiont in host|positive regulation of immune response|defense response to Gram-positive bacterium|defense response to fungus|neutrophil mediated killing of gram-positive bacterium|,serine-type endopeptidase activity|heparin binding|peptidase activity|,2,2,30000000,8.0%
Q9CQV4,0.190028767,-0.054166667,16.31522361,0.469,0.023360258,2.9332937,-0.155,-0.089,-0.622,0.266,0.045,0.23,Q9CQV4,Retreg3,Q9CQV4_Retreg3,Q9CQV4,Retreg3,1,5,2,2,Q9CQV4|Q9CQV4-2,MOUSE,52036,4.5,2764,2764.1,22.54,22.54,,466,Reticulophagy regulator 3,integral component of membrane|,,,2,5,197000000,4.5%
Q8CB77,0.815606851,-0.037,2.86678926,0.086,0.516798297,0.684669891,-0.117,0.057,-0.18,0.126,-0.209,0.101,Q8CB77,Eloa,Q8CB77_Eloa,Q8CB77,Eloa,1,4,3,3,Q8CB77,MOUSE,87502.1,3.6,2765,2765.1,22.51,22.51,,773,Elongin-A,extracellular space|nucleus|cytoplasm|integral component of membrane|elongin complex|,regulation of transcription from RNA polymerase II promoter|transcription elongation from RNA polymerase II promoter|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|,DNA binding|ubiquitin-protein transferase activity|,3,4,62600000,3.6%
O35136,0.943283966,-0.114166667,0.816290327,-0.041,0.828649681,-0.22515624,0.035,0.059,-0.375,-0.01,0.058,-0.452,O35136,Ncam2,O35136_Ncam2,O35136,Ncam2,1,7,3,3,O35136|O35136-2,MOUSE,94000.9,3.1,2767,2767.1,22.46,22.46,,837,Neural cell adhesion molecule 2,plasma membrane|integral component of membrane|axon|anchored component of membrane|,cell adhesion|,,3,7,3090000000,3.1%
A0A1D5RLM8,0.823537665,0.0115,2.710189243,-0.052333333,0.535773311,-0.652583877,0.011,0.02,0.082,-0.043,-0.031,0.03,A0A1D5RLM8,NotFound,A0A1D5RLM8_NotFound,A0A1D5RLM8,Gm11639,1,7,3,3,A0A1D5RLM8|Q80X60,MOUSE,655392.6,0.4,2768,2768.1,22.45,22.45,,5808,Predicted gene 11639,,,,3,7,8470000000,0.4%
Q91VH2,0.834860518,-0.061333333,2.596794488,0.128666667,0.549946638,0.629782033,-0.28,-0.372,0.275,-0.269,0.167,0.111,Q91VH2,Snx9,Q91VH2_Snx9,Q91VH2,Snx9,1,3,2,2,Q91VH2,MOUSE,66943.9,4.3,2769,2769.1,22.45,22.45,,595,Sorting nexin-9,ruffle|cytoplasm|endosome|trans-Golgi network|plasma membrane|cytoplasmic membrane-bounded vesicle|extrinsic component of membrane|cytoplasmic vesicle membrane|extrinsic component of cytoplasmic side of plasma membrane|extracellular exosome|clathrin-coated vesicle|,mitotic cytokinesis|intracellular protein transport|endocytosis|receptor-mediated endocytosis|mitotic nuclear division|vesicle organization|endosomal transport|positive regulation of protein oligomerization|cleavage furrow formation|positive regulation of GTPase activity|positive regulation of protein kinase activity|positive regulation of membrane protein ectodomain proteolysis|lipid tube assembly|membrane tubulation|,protein binding|1-phosphatidylinositol binding|ubiquitin protein ligase binding|phosphatidylinositol binding|protein homodimerization activity|Arp2/3 complex binding|,2,3,69000000,4.3%
E9Q6E5,0.654964917,-0.036333333,5.255469346,0.147333333,0.29816253,1.128956185,-0.159,0.138,-0.309,-0.009,0.113,0.008,E9Q6E5,Srsf11,E9Q6E5_Srsf11,E9Q6E5,Srsf11,1,2,2,2,E9Q6E5|Q3UIX4,MOUSE,56811.1,4.8,2770,2770.1,22.36,22.36,,511,Serine/arginine-rich-splicing factor 11,nucleoplasm|,,nucleotide binding|poly(A) RNA binding|,2,2,403000000,4.8%
Q9D0K1,0.991124742,0.005666667,0.190165579,-0.008,0.957157578,-0.055787186,0.263,-0.014,-0.22,0.097,-0.136,0.044,Q9D0K1,Pex13,Q9D0K1_Pex13,Q9D0K1,Pex13,1,4,2,2,Q9D0K1|D6RH41,MOUSE,44666.3,6.4,2771,2771.1,22.3,22.3,,405,Peroxisomal membrane protein PE3,peroxisome|peroxisomal membrane|integral component of peroxisomal membrane|membrane|intracellular membrane-bounded organelle|,"fatty acid alpha-oxidation|neuron migration|suckling behavior|positive regulation of defense response to virus by host|locomotory behavior|protein import into peroxisome matrix, docking|cerebral cortex cell migration|microtubule-based peroxisome localization|activation of mitophagy in response to mitochondrial depolarization|",peroxisome targeting sequence binding|,2,4,83400000,6.4%
Q3UM18,0.626292064,0.021,5.860258879,-0.158,0.259402473,-1.233455796,-0.074,0.26,0.114,-0.213,-0.064,0.103,Q3UM18,Lsg1,Q3UM18_Lsg1,Q3UM18,Lsg1,1,2,2,2,Q3UM18|Q3UM18-2,MOUSE,73896.9,3.7,2772,2772.1,22.28,22.28,,644,Large subunit GTPase 1 homolog,nucleus|cytoplasm|endoplasmic reticulum|cytosol|Cajal body|membrane|,metabolic process|protein transport|ribosome biogenesis|nuclear export|,GTPase activity|GTP binding|,2,2,79300000,3.7%
Q60709,0.292164522,-0.0505,13.02999653,0.466333333,0.049773748,2.395628513,-0.049,-0.072,-0.73,0.07,0.214,0.264,Q60709,Aplp2,Q60709_Aplp2,Q60709,Aplp2,1,3,3,3,Q60709|Q06335|Q06335-2,MOUSE,86273.2,5.5,2773,2773.1,22.26,22.26,,751,Amyloid-like protein 2,nucleus|membrane|integral component of membrane|extracellular exosome|,suckling behavior|cellular copper ion homeostasis|regulation of epidermal growth factor-activated receptor activity|mating behavior|locomotory behavior|cholesterol metabolic process|negative regulation of endopeptidase activity|extracellular matrix organization|forebrain development|midbrain development|regulation of protein binding|neuromuscular process controlling balance|,serine-type endopeptidase inhibitor activity|protein binding|heparin binding|identical protein binding|transition metal ion binding|,3,3,28200000,5.5%
P62627,0.774891394,-0.042166667,3.461517012,-0.087666667,0.45065926,-0.801042408,0.05,-0.021,-0.024,0.02,-0.283,0.005,P62627,Dynlrb1,P62627_Dynlrb1,P62627,Dynlrb1,1,3,2,2,P62627|A2AVR9,MOUSE,10989.5,21.8,2774,2774.1,22.25,22.25,,96,Dynein light chain roadblock-type 1,cytoplasm|centrosome|cytoplasmic dynein complex|microtubule|membrane|,transport|visual behavior|metabolic process|,motor activity|protein binding|identical protein binding|,2,3,480000000,21.8%
Q9D0J4,0.919416995,0.006333333,1.217997544,-0.058,0.755440468,-0.324681463,0.014,0.089,0.003,0.39,-0.238,-0.22,Q9D0J4,Arl2,Q9D0J4_Arl2,Q9D0J4,Arl2,1,3,2,2,Q9D0J4,MOUSE,21034.7,23.9,2776,2776.1,22.23,22.23,,184,ADP-ribosylation factor-like protein 2,nucleus|cytoplasm|mitochondrial intermembrane space|centrosome|lateral plasma membrane|extracellular exosome|,cell cycle|small GTPase mediated signal transduction|metabolic process|positive regulation of cell-substrate adhesion|regulation of microtubule polymerization|positive regulation of microtubule polymerization|negative regulation of GTPase activity|centrosome organization|maintenance of protein location in nucleus|bicellular tight junction assembly|,GTPase activity|protein binding|GTP binding|GDP binding|,2,3,108000000,23.9%
Q62219-3,0.711236799,-0.011,4.362896125,0.11,0.366193295,0.969497533,-0.001,0.007,-0.204,0.157,-0.12,0.095,Q62219,Tgfb1i1,Q62219-3_Tgfb1i1,Q62219-3,Tgfb1i1,1,5,3,3,Q62219-3|Q62219|Q62219-2|E9Q1D5|Q62219-4|Q62219-5|Q62219-9|Q62219-10|Q62219-7,MOUSE,53641.4,7.8,2777,2777.1,22.23,22.23,,461,Isoform 3 of Transforming growth factor beta-1-induced transcript 1 protein,intracellular|cytoplasm|cytoskeleton|focal adhesion|nuclear matrix|extracellular matrix|,"response to heat|positive regulation of epithelial to mesenchymal transition|Wnt signaling pathway|morphogenesis of embryonic epithelium|positive regulation of transforming growth factor beta receptor signaling pathway|negative regulation of transforming growth factor beta receptor signaling pathway|ubiquitin-dependent SMAD protein catabolic process|epithelial cell differentiation|cell fate commitment|negative regulation of fat cell differentiation|positive regulation of transcription, DNA-templated|",transcription coactivator activity|protein binding|zinc ion binding|Roundabout binding|androgen receptor binding|I-SMAD binding|,3,5,103000000,7.8%
Q6ZWQ0,0.964822261,-0.071833333,0.48183365,-0.019,0.89498681,-0.137154102,0.029,0.071,-0.287,0.005,-0.276,0.027,Q6ZWQ0,Syne2,Q6ZWQ0_Syne2,Q6ZWQ0,Syne2,1,8,3,3,Q6ZWQ0|E9QP46,MOUSE,788473.2,0.4,2778,2778.1,22.21,22.21,,6874,Nesprin-2,nucleus|nuclear envelope|nuclear outer membrane|nucleoplasm|cytoplasm|mitochondrion|focal adhesion|integral component of membrane|aggresome|sarcoplasmic reticulum|Z disc|lamellipodium membrane|filopodium membrane|nuclear membrane|nuclear lumen|sarcoplasmic reticulum membrane|LINC complex|intermediate filament cytoskeleton|extracellular exosome|myofibril|Z disc|,nuclear envelope organization|nuclear migration|establishment or maintenance of cell polarity|fibroblast migration|positive regulation of cell migration|nuclear migration along microfilament|protein localization to nucleus|centrosome localization|cytoskeletal anchoring at nuclear membrane|,actin binding|actin filament binding|,3,8,4620000000,0.4%
E9PYG6,0.367306672,0.024166667,11.10175203,0.279666667,0.077593403,2.086956731,-0.079,-0.312,0.044,0.077,0.058,0.357,E9PYG6,Rasa1,E9PYG6_Rasa1,E9PYG6,Rasa1,1,2,2,2,E9PYG6,MOUSE,116396.8,2.7,2779,2779.1,22.15,22.15,,1038,RAS p21 protein activator 1,ruffle|cytoplasm|cytosol|plasma membrane|intrinsic component of the cytoplasmic side of the plasma membrane|,negative regulation of cell-matrix adhesion|negative regulation of cell adhesion|signal transduction|regulation of actin filament polymerization|positive regulation of GTPase activity|negative regulation of Ras protein signal transduction|blood vessel morphogenesis|,glycoprotein binding|GTPase activator activity|receptor binding|protein binding|GTPase binding|,2,2,19700000,2.7%
A0A0R4J0E4,0.47899797,0.067166667,8.584687653,0.338333333,0.138525981,1.683946492,-0.018,0.169,-0.457,0.539,0.082,0.088,A0A0R4J0E4,Ints7,A0A0R4J0E4_Ints7,A0A0R4J0E4,Ints7,1,4,2,2,A0A0R4J0E4|Q7TQK1,MOUSE,108129.2,3.9,2780,2780.1,22.14,22.14,,966,Integrator complex subunit 7,,,,2,4,185000000,3.9%
Q9DCZ4-3,0.57548373,0.072666667,6.862732672,0.460666667,0.205933373,1.402323143,0.141,-0.186,-0.428,1.048,0.028,-0.167,Q9DCZ4,Apoo,Q9DCZ4-3_Apoo,Q9DCZ4-3,Apoo,1,2,2,2,Q9DCZ4-3|Q9DCZ4|Q9DCZ4-2,MOUSE,24364.4,12.7,2781,2781.1,22.13,22.13,,198,Isoform 3 of MICOS complex subunit Mic26,Golgi membrane|extracellular region|endoplasmic reticulum membrane|integral component of mitochondrial inner membrane|MICOS complex|,cristae formation|,,2,2,1100000000,12.7%
P12246,0.88044681,-0.0405,1.949525146,0.132333333,0.638333277,0.492416446,-0.36,-0.322,0.362,0.291,-0.442,0.228,P12246,Apcs,P12246_Apcs,P12246,Apcs,1,6,2,2,P12246,MOUSE,26417.6,11.6,2782,2782.1,22.09,22.09,,224,Serum amyloid P-component,extracellular space|nucleus|protein complex|extracellular exosome|blood microparticle|extracellular matrix|,protein complex assembly|negative regulation by host of viral exo-alpha-sialidase activity|negative regulation by host of viral glycoprotein metabolic process|innate immune response|negative regulation of monocyte differentiation|negative regulation of viral entry into host cell|negative regulation of viral process|negative regulation of exo-alpha-sialidase activity|negative regulation of glycoprotein metabolic process|,complement component C1q binding|calcium ion binding|carbohydrate binding|virion binding|,2,6,431000000,11.6%
Q9CYG7-2,0.843083616,0.026333333,2.46326201,-0.128,0.56711848,-0.602148153,-0.069,-0.181,0.521,0.21,-0.249,-0.074,Q9CYG7,Tomm34,Q9CYG7-2_Tomm34,Q9CYG7-2,Tomm34,1,3,3,3,Q9CYG7-2|Q9CYG7,MOUSE,34678.8,13.2,2783,2783.1,22.07,22.07,,309,Isoform 2 of Mitochondrial import receptor subunit TOM34,nucleus|nucleoplasm|cytoplasm|mitochondrion|mitochondrial outer membrane|membrane|,protein targeting to mitochondrion|,protein binding|heat shock protein binding|,3,3,433000000,13.2%
Q99J10,0.530524264,0.054833333,7.604393466,-0.377,0.17360437,-1.524639095,-0.16,0.093,0.797,0.05,-0.288,-0.163,Q99J10,Ctu1,Q99J10_Ctu1,Q99J10,Ctu1,1,2,2,2,Q99J10,MOUSE,45134.7,7.3,2784,2784.1,21.95,21.95,,420,Cytoplasmic tRNA 2-thiolation protein 1,mitochondrion|cytosol|,tRNA wobble uridine modification|protein urmylation|tRNA thio-modification|,tRNA binding|nucleotidyltransferase activity|,2,2,59000000,7.3%
Q9D6J5,0.744748173,0.011666667,3.898208512,0.166666667,0.407548359,0.884211564,-0.472,0.243,0.014,0.183,0.145,-0.043,Q9D6J5,Ndufb8,Q9D6J5_Ndufb8,Q9D6J5,Ndufb8,1,4,3,3,Q9D6J5|Q3V406,MOUSE,21932.5,23.1,2785,2785.1,21.95,21.95,,186,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial respiratory chain complex I|endoplasmic reticulum|integral component of membrane|,"mitochondrial electron transport, NADH to ubiquinone|",NADH dehydrogenase (ubiquinone) activity|,3,4,1750000000,23.1%
Q8BU14,0.612170052,-0.006833333,6.141873026,0.120333333,0.243115527,1.279945168,-0.1,0.043,-0.144,0.018,0.003,0.139,Q8BU14,Sec62,Q8BU14_Sec62,Q8BU14,Sec62,1,3,3,3,Q8BU14,MOUSE,45922.1,7.2,2787,2787.1,21.91,21.91,,398,Translocation protein SEC62,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|aggresome|intermediate filament cytoskeleton|,posttranslational protein targeting to membrane|,protein transporter activity|,3,3,228000000,7.2%
Q8BK,0.909861937,0.100166667,1.462723539,-0.061,0.714048393,-0.382535923,-0.02,-0.02,0.432,0.005,-0.061,0.265,Q8BK,NotFound,Q8BK_NotFound,Q8BK,Baiap2,1,3,3,3,Q8BK|B1AZ46|Q8BK-2|Q8BK-3|Q8BK-4,MOUSE,59464,5.4,2788,2788.1,21.89,21.89,,535,Brain-specific angiogenesis inhibitor 1-associated protein 2,ruffle|nucleoplasm|cytoplasm|cytosol|plasma membrane|actin cytoskeleton|secretory granule|filopodium|neuron projection|neuronal cell body|dendritic spine|extracellular exosome|neuronal postsynaptic density|actin cytoskeleton|,plasma membrane organization|Rho protein signal transduction|insulin receptor signaling pathway|regulation of cell shape|response to bacterium|dendrite development|positive regulation of actin filament polymerization|regulation of actin cytoskeleton organization|regulation of synaptic plasticity|actin filament bundle assembly|actin crosslink formation|positive regulation of dendritic spine morphogenesis|positive regulation of actin cytoskeleton reorganization|,protein binding|cytoskeletal adaptor activity|PDZ domain binding|identical protein binding|proline-rich region binding|,3,3,417000000,5.4%
Q9Z0Y9,0.936982455,0.023833333,0.88302588,0.024333333,0.816013628,0.242013183,0.055,0.038,-0.058,0.19,-0.039,-0.043,Q9Z0Y9,Nr1h3,Q9Z0Y9_Nr1h3,Q9Z0Y9,Nr1h3,1,3,3,3,Q9Z0Y9|A2AGR4,MOUSE,51101.6,7.4,2789,2789.1,21.88,21.88,,445,Oxysterols receptor LXR-alpha,nuclear chromatin|nucleus|cytoplasm|receptor complex|RNA polymerase II transcription factor complex|,"negative regulation of transcription from RNA polymerase II promoter|regulation of transcription, DNA-templated|transcription from RNA polymerase II promoter|fatty acid biosynthetic process|insulin receptor signaling pathway|positive regulation of triglyceride biosynthetic process|positive regulation of receptor biosynthetic process|positive regulation of cholesterol efflux|negative regulation of cholesterol storage|intracellular receptor signaling pathway|positive regulation of cellular protein metabolic process|negative regulation of lipid transport|positive regulation of cholesterol transport|response to progesterone|positive regulation of toll-like receptor 4 signaling pathway|cholesterol homeostasis|negative regulation of macrophage activation|apoptotic cell clearance|steroid hormone mediated signaling pathway|cellular lipid metabolic process|positive regulation of fatty acid biosynthetic process|negative regulation of proteolysis|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|negative regulation of pinocytosis|negative regulation of inflammatory response|positive regulation of lipoprotein lipase activity|lipid homeostasis|sterol homeostasis|triglyceride homeostasis|cellular response to lipopolysaccharide|negative regulation of pancreatic juice secretion|negative regulation of secretion of lysosomal enzymes|regulation of cholesterol homeostasis|positive regulation of cholesterol homeostasis|",RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|DNA binding|sequence-specific DNA binding transcription factor activity|steroid hormone receptor activity|ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity|protein binding|zinc ion binding|sterol response element binding|transcription regulatory region DNA binding|retinoid X receptor binding|protein heterodimerization activity|ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity|transcription regulatory region DNA binding|,3,3,23900000,7.4%
Q6PFQ7,0.91325,0.018833333,1.376448362,-0.037666667,0.728375223,-0.362206913,0.202,-0.037,-0.052,-0.07,0.002,0.068,Q6PFQ7,Rasa4,Q6PFQ7_Rasa4,Q6PFQ7,Rasa4,1,9,3,3,Q6PFQ7|Q6PFQ7-2,MOUSE,91142.4,3.2,2790,2790.1,21.85,21.85,,802,Ras GTPase-activating protein 4,cytoplasm|cytosol|intrinsic component of the cytoplasmic side of the plasma membrane|plasma membrane|,negative regulation of GTPase activity|intracellular signal transduction|positive regulation of GTPase activity|negative regulation of Ras protein signal transduction|cellular response to calcium ion|,GTPase activator activity|metal ion binding|,3,9,1020000000,3.2%
P06683,0.009937266,0.072,32.20095172,0.822,0.000602428,6.112497903,-0.376,-0.356,-0.285,0.487,0.238,0.724,P06683,C9,P06683_C9,P06683,C9,1,3,2,2,A0A0R4J032|P06683,MOUSE,63256.4,4.5,2791,2791.1,21.84,21.84,,548,Complement component C9,membrane attack complex|cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",,2,3,259000000,4.5%
P56379,0.78602295,-0.027,3.320981407,-0.169333333,0.465480894,-0.774340882,0.243,0.257,-0.327,-0.345,0.244,-0.234,P56379,Atp5mpl,P56379_Atp5mpl,P56379,Mp68,1,8,2,2,P56379,MOUSE,6697.9,32.7,2792,2792.1,21.83,21.83,,58,6.8 kDa mitochondrial proteolipid,mitochondrion|mitochondrial proton-transporting ATP synthase complex|integral component of membrane|,,,2,8,9850000000,32.7%
Q80TP3,0.991556352,0.022666667,0.171701169,0.005333333,0.96123568,0.050452947,0.094,-0.028,-0.006,0.027,-0.126,0.175,Q80TP3,Ubr5,Q80TP3_Ubr5,Q80TP3,Ubr5,1,5,4,4,Q80TP3|E9Q2H1|Q64321,MOUSE,311541.6,1.3,2793,2793.1,21.81,21.81,,2792,E3 ubiquitin-protein ligase UBR5,nucleus|nucleoplasm|cytoplasm|membrane|,"protein polyubiquitination|DNA repair|cellular response to DNA damage stimulus|positive regulation of protein import into nucleus, translocation|positive regulation of catenin import into nucleus|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|progesterone receptor signaling pathway|positive regulation of canonical Wnt signaling pathway|negative regulation of histone H2A K63-linked ubiquitination|negative regulation of double-strand break repair|",RNA binding|ubiquitin-protein transferase activity|zinc ion binding|ligase activity|ubiquitin-ubiquitin ligase activity|ubiquitin binding|,4,5,252000000,1.3%
P97298,0.732367555,-0.087166667,4.061318601,0.186333333,0.392525739,0.914543221,0.027,0.094,-0.662,0.064,-0.026,-0.02,P97298,Serpinf1,P97298_Serpinf1,P97298,Serpinf1,1,7,2,2,P97298,MOUSE,46290.3,7.1,2794,2794.1,21.78,21.78,,417,Pigment epithelium-derived factor,extracellular region|basement membrane|extracellular space|melanosome|axon hillock|perinuclear region of cytoplasm|extracellular exosome|extracellular matrix|,kidney development|aging|short-term memory|response to acidic pH|negative regulation of endothelial cell migration|negative regulation of gene expression|negative regulation of endopeptidase activity|positive regulation of neuron projection development|negative regulation of angiogenesis|ovulation cycle|response to arsenic-containing substance|negative regulation of inflammatory response|positive regulation of neurogenesis|retina development in camera-type eye|negative regulation of epithelial cell proliferation involved in prostate gland development|cellular response to cobalt ion|cellular response to retinoic acid|cellular response to glucose stimulus|cellular response to dexamethasone stimulus|negative regulation of neuron death|,serine-type endopeptidase inhibitor activity|,2,7,177000000,7.1%
G3X8S1,0.933608247,-0.011333333,0.947767384,-0.040666667,0.803939304,-0.258410657,0.106,0.183,-0.262,-0.134,0.193,-0.154,G3X8S1,Dnajc19,G3X8S1_Dnajc19,G3X8S1,Dnajc19,1,3,3,3,G3X8S1|Q9CQV7-2|Q9CQV7-3|Q9CQV7|D3Z5K6,MOUSE,17424,26.1,2795,2795.1,21.73,21.73,,157,"DnaJ (Hsp40) homolog, subfamily C, member 19, isoform CRA_c",mitochondrial inner membrane|protein complex|,visual perception|genitalia development|,,3,3,408000000,26.1%
G3X9R9,0.304100014,0.011166667,12.66710124,-0.275666667,0.054111538,-2.336381572,0.065,0.027,0.355,-0.212,-0.029,-0.139,G3X9R9,Gpr182,G3X9R9_Gpr182,G3X9R9,Gpr182,1,2,2,2,G3X9R9,MOUSE,46182.3,5.7,2796,2796.1,21.72,21.72,,398,Adrenomedullin receptor,integral component of membrane|,response to hypoxia|G-protein coupled receptor signaling pathway|,adrenomedullin receptor activity|,2,2,733000000,5.7%
Q8BKE6,0.648073376,-0.030833333,5.352882275,-0.141666667,0.291549145,-1.145946463,0.171,-0.117,0.066,0.031,-0.282,-0.054,Q8BKE6,Cyp20a1,Q8BKE6_Cyp20a1,Q8BKE6,Cyp20a1,1,3,2,2,Q8BKE6,MOUSE,52490.6,4.7,2797,2797.1,21.68,21.68,,462,Cytochrome P450 20A1,membrane|integral component of membrane|,oxidation-reduction process|,"monooxygenase activity|iron ion binding|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen|heme binding|",2,3,207000000,4.7%
Q91WE6,0.73101227,0.056833333,4.112267936,-0.151,0.387947722,-0.923959064,-0.073,-0.03,0.5,-0.058,-0.033,0.035,Q91WE6,Cdkal1,Q91WE6_Cdkal1,Q91WE6,Cdkal1,1,2,2,2,Q91WE6|Q91WE6-2|Q91WE6-3|Q91WE6-4,MOUSE,65972.2,3.6,2798,2798.1,21.66,21.66,,578,Threonylcarbamoyladenosine tRNA methylthiotransferase,endoplasmic reticulum|endoplasmic reticulum membrane|rough endoplasmic reticulum|membrane|integral component of membrane|,tRNA methylthiolation|maintenance of translational fidelity|,"N6-threonylcarbomyladenosine methylthiotransferase activity|metal ion binding|4 iron, 4 sulfur cluster binding|",2,2,15700000,3.6%
P54818,0.000494278,-0.063,50.06586309,1.112,9.84949E-06,11.82575009,-0.557,-0.644,-0.656,0.584,0.525,0.37,P54818,Galc,P54818_Galc,P54818,Galc,1,2,2,2,P54818,MOUSE,77483.2,5.5,2799,2799.1,21.65,21.65,,684,Galactocerebrosidase,mitochondrion|lysosome|extracellular exosome|,carbohydrate metabolic process|galactosylceramide catabolic process|,galactosylceramidase activity|,2,2,92700000,5.5%
F8VQJ3,0.287502731,-0.124666667,13.20083395,0.478666667,0.047853819,2.423136832,-0.819,-0.074,-0.199,0.205,0.069,0.07,F8VQJ3,Lamc1,F8VQJ3_Lamc1,F8VQJ3,Lamc1,1,4,3,3,F8VQJ3|P02468,MOUSE,182889.8,1.6,2800,2800.1,21.63,21.63,,1607,Laminin subunit gamma-1,basement membrane|basal lamina|laminin-1 complex|extracellular matrix|laminin-10 complex|extracellular exosome|basement membrane|extracellular matrix|,protein complex assembly|cell adhesion|cell migration|extracellular matrix disassembly|neuron projection development|hemidesmosome assembly|substrate adhesion-dependent cell spreading|,extracellular matrix structural constituent|protein binding|glycosphingolipid binding|,3,4,81300000,1.6%
Q9D2V5,0.00858685,-0.0645,32.98476973,-0.561666667,0.000502948,-6.256938383,0.246,0.196,0.207,-0.407,-0.402,-0.227,Q9D2V5,Aar2,Q9D2V5_Aar2,Q9D2V5,Aar2,1,5,3,3,Q9D2V5,MOUSE,43806.6,9.1,2801,2801.1,21.63,21.63,,384,Protein AAR2 homolog,,,,3,5,1830000000,9.1%
P52633,0.915689908,0.020166667,1.323903278,-0.035666667,0.737241327,-0.349785586,0.11,0.121,-0.117,0.003,-0.068,0.072,P52633,Stat6,P52633_Stat6,P52633,Stat6,1,4,3,3,P52633|E9PWW5|Q8BLI0|B1ASU9|O55047|O55047-2|B7ZC85|O55047-3,MOUSE,94180.1,2.5,2802,2802.1,21.58,21.58,,837,Signal transducer and transcription activator 6,nuclear chromatin|nucleus|nucleoplasm|cytoplasm|,negative regulation of transcription from RNA polymerase II promoter|T-helper 1 cell lineage commitment|negative regulation of type 2 immune response|transcription from RNA polymerase II promoter|signal transduction|mammary gland epithelial cell proliferation|interleukin-4-mediated signaling pathway|regulation of cell proliferation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of isotype switching to IgE isotypes|mammary gland morphogenesis|,RNA polymerase II core promoter sequence-specific DNA binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription|DNA binding|signal transducer activity|protein phosphatase binding|identical protein binding|sequence-specific DNA binding|,3,4,189000000,2.5%
E9PYD1,0.474974327,-0.0275,8.661199447,0.198333333,0.136106873,1.695775041,-0.016,-0.071,-0.293,0.219,0.039,-0.043,E9PYD1,Fam98c,E9PYD1_Fam98c,E9PYD1,Fam98c,1,3,3,3,E9PYD1|D3Z100,MOUSE,37841.8,12.7,2803,2803.1,21.56,21.56,,344,"Family with sequence similarity 98, member C",tRNA-splicing ligase complex|,,poly(A) RNA binding|,3,3,26200000,12.7%
Q8BZX4-2,0.91325,-0.123666667,1.360705699,0.098,0.731020288,0.358651326,0.363,-0.087,-0.794,-0.023,-0.109,-0.092,Q8BZX4,Srek1,Q8BZX4-2_Srek1,Q8BZX4-2,Srek1,1,2,2,2,Q8BZX4-2|Q8BZX4|A0A1B0GSB4,MOUSE,69347.6,3.9,2804,2804.1,21.56,21.56,,494,Isoform 2 of Splicing regulatory glutamine/lysine-rich protein 1,nucleoplasm|spliceosomal complex|,mRNA processing|RNA splicing|,nucleotide binding|poly(A) RNA binding|,2,2,49000000,3.9%
Q64462,0.820260214,-0.023333333,2.787879494,-0.120666667,0.526274165,-0.668758809,-0.146,0.315,-0.058,0.061,-0.396,0.084,Q64462,Cyp4b1,Q64462_Cyp4b1,Q64462,Cyp4b1,1,4,3,3,Q64462,MOUSE,59412.7,9.1,2807,2807.1,21.52,21.52,,511,Cytochrome P450 4B1,endoplasmic reticulum membrane|,biphenyl metabolic process|fluorene metabolic process|exogenous drug catabolic process|oxidation-reduction process|,iron ion binding|drug binding|fluorene oxygenase activity|heme binding|aromatase activity|,3,4,517000000,9.1%
Q60631,0.390884549,0.047,10.59379063,0.258,0.087220975,2.00590417,-0.085,-0.147,-0.014,0.014,0.085,0.429,Q60631,Grb2,Q60631_Grb2,Q60631,Grb2,1,3,3,3,Q60631|B1AT92|Q60631-2,MOUSE,25352.1,13.3,2808,2808.1,21.49,21.49,,217,Growth factor receptor-bound protein 2,nucleus|nucleoplasm|nucleolus|cytoplasm|endosome|Golgi apparatus|cytosol|plasma membrane|cell-cell junction|COP9 signalosome|vesicle membrane|membrane|extracellular exosome|Grb2-EGFR complex|,Ras protein signal transduction|aging|insulin receptor signaling pathway|positive regulation of signal transduction|cell differentiation|positive regulation of actin filament polymerization|receptor internalization|signal transduction in response to DNA damage|regulation of MAPK cascade|anatomical structure formation involved in morphogenesis|protein heterooligomerization|branching involved in labyrinthine layer morphogenesis|cellular response to ionizing radiation|positive regulation of reactive oxygen species metabolic process|,phosphotyrosine binding|SH3/SH2 adaptor activity|epidermal growth factor receptor binding|neurotrophin TRKA receptor binding|protein binding|SH3 domain binding|protein kinase binding|protein phosphatase binding|protein domain specific binding|identical protein binding|insulin receptor substrate binding|poly(A) RNA binding|ephrin receptor binding|,3,3,82000000,13.3%
O09111,0.211826977,-0.089,15.49140944,0.356,0.028239634,2.796430507,-0.3,-0.034,-0.467,0.165,0.049,0.053,O09111,Ndufb11,O09111_Ndufb11,O09111,Ndufb11,1,5,2,2,O09111,MOUSE,17500.5,19.2,2809,2809.1,21.48,21.48,,151,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial",mitochondrion|mitochondrial respiratory chain complex I|integral component of membrane|,oxidation-reduction process|,,2,5,527000000,19.2%
Q6PJN8,0.884566234,-0.029166667,1.857623916,0.051666667,0.651985006,0.471959587,0.032,-0.217,0.02,-0.02,0.11,-0.1,Q6PJN8,Dalrd3,Q6PJN8_Dalrd3,Q6PJN8,Dalrd3,1,3,3,3,Q6PJN8|A0A0A6YW92,MOUSE,59587.8,7.6,2810,2810.1,21.46,21.46,,538,DALR anticodon-binding domain-containing protein 3,,arginyl-tRNA aminoacylation|,arginine-tRNA ligase activity|ATP binding|,3,3,1290000000,7.6%
Q9Z1K5,0.91325,0.007166667,1.377963687,-0.031666667,0.728121125,-0.362536509,0.001,0.013,0.055,0.086,-0.095,-0.017,Q9Z1K5,Arih1,Q9Z1K5_Arih1,Q9Z1K5,Arih1,1,3,3,3,Q9Z1K5|H9KV21|H7BWY7,MOUSE,65841.3,5.5,2813,2813.1,21.41,21.41,,555,E3 ubiquitin-protein ligase ARIH1,cytoplasm|,ubiquitin-dependent protein catabolic process|protein ubiquitination|,ubiquitin-protein transferase activity|zinc ion binding|ligase activity|ubiquitin protein ligase binding|,3,3,63000000,5.5%
Q9DB60,0.994928853,0.1295,0.082373458,-0.007,0.981211556,-0.024453548,-0.228,-0.028,0.655,-0.221,0.571,0.028,Q9DB60,Fam213b,Q9DB60_Fam213b,Q9DB60,Fam213b,1,3,2,2,Q9DB60,MOUSE,22069,8.9,2816,2816.1,21.32,21.32,,201,Prostamide/prostaglandin F synthase,cytoplasm|endoplasmic reticulum|cytosol|myelin sheath|extracellular exosome|cytoplasm|,prostaglandin biosynthetic process|oxidation-reduction process|,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor|prostaglandin-F synthase activity|",2,3,268000000,8.9%
Q9QZ25,0.020525288,-0.2325,28.26226788,1.424333333,0.001492015,5.199195414,-0.511,-0.714,-1.609,0.512,0.509,0.418,Q9QZ25,Vnn3,Q9QZ25_Vnn3,Q9QZ25,Vnn3,1,4,2,2,Q9QZ25,MOUSE,56931.6,5.4,2817,2817.1,21.31,21.31,,500,Vascular non-inflammatory molecule 3,extracellular space|plasma membrane|anchored component of membrane|,pantothenate metabolic process|,pantetheine hydrolase activity|,2,4,634000000,5.4%
E0CX20,0.977234082,0.0235,0.345974074,0.013,0.923427051,0.099840356,0.042,0.049,-0.04,0.288,-0.157,-0.041,E0CX20,Bud31,E0CX20_Bud31,E0CX20,Bud31,1,3,2,2,E0CX20|Q6PGH1,MOUSE,17570,14.5,2818,2818.1,21.3,21.3,,144,Protein BUD31 homolog,spliceosomal complex|,"mRNA splicing, via spliceosome|",,2,3,225000000,14.5%
Q9WU40-2,0.138051528,-0.0245,18.10801708,0.297,0.015459601,3.22531365,-0.136,-0.127,-0.256,0.068,0.228,0.076,Q9WU40,Lemd3,Q9WU40-2_Lemd3,Q9WU40-2,Lemd3,1,4,2,2,Q9WU40-2|D3YU56|Q9WU40|E9QP59,MOUSE,103764.6,2.3,2819,2819.1,21.27,21.27,,921,Isoform 2 of Inner nuclear membrane protein Man1,nuclear envelope|nuclear inner membrane|integral component of nuclear inner membrane|integral component of membrane|,angiogenesis|blood vessel endothelial cell migration involved in intussusceptive angiogenesis|nucleus organization|negative regulation of transforming growth factor beta receptor signaling pathway|negative regulation of BMP signaling pathway|negative regulation of activin receptor signaling pathway|skeletal muscle cell differentiation|regulation of cell cycle|regulation of extracellular matrix organization|,nucleotide binding|DNA binding|,2,4,112000000,2.3%
Q9D404,0.615860336,-0.0305,6.040442425,-0.125666667,0.248860379,-1.262782165,-0.04,0.137,0,-0.083,-0.207,0.01,Q9D404,Oxsm,Q9D404_Oxsm,Q9D404,Oxsm,1,4,2,2,Q9D404,MOUSE,49254.3,8,2820,2820.1,21.24,21.24,,459,"3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial",cytoplasm|mitochondrion|,acyl-CoA metabolic process|short-chain fatty acid biosynthetic process|medium-chain fatty acid biosynthetic process|,3-oxoacyl-[acyl-carrier-protein] synthase activity|,2,4,66000000,8.0%
Q6PDH0-2,0.919416995,0.000833333,1.213716894,-0.047666667,0.756185439,-0.323652024,0.299,0.028,-0.253,-0.086,0.018,-0.001,Q6PDH0,Phldb1,Q6PDH0-2_Phldb1,Q6PDH0-2,Phldb1,1,4,3,3,Q6PDH0-2|D3Z0X5|D3Z4N0|Q6PDH0|E9PWB1,MOUSE,159661.4,2.8,2821,2821.1,21.22,21.22,,1371,Isoform 2 of Pleckstrin homology-like domain family B member 1,basal cortex|,regulation of gastrulation|regulation of epithelial to mesenchymal transition|regulation of microtubule cytoskeleton organization|positive regulation of basement membrane assembly involved in embryonic body morphogenesis|,,3,4,6500000000,2.8%
P41230,0.12250324,-0.058,18.74836522,0.465333333,0.013340235,3.348248208,-0.051,-0.319,-0.502,0.173,0.049,0.302,P41230,Kdm5c,P41230_Kdm5c,P41230,Kdm5c,1,4,4,4,P41230|P41230-2|P41230-3,MOUSE,177991.4,2.6,2822,2822.1,21.2,21.2,,1554,Lysine-specific demethylase 5C,nucleus|cytoplasm|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|histone H3-K4 demethylation|regulation of circadian rhythm|negative regulation of transcription, DNA-templated|rhythmic process|oxidation-reduction process|","RNA polymerase II transcription factor binding|DNA binding|zinc ion binding|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors|histone demethylase activity (H3-K4 specific)|identical protein binding|",4,4,679000000,2.6%
Q6NSR8,0.689434001,0.018333333,4.712899078,-0.102666667,0.337839241,-1.032133365,0.081,0.146,-0.018,0.065,-0.002,-0.162,Q6NSR8,Npepl1,Q6NSR8_Npepl1,Q6NSR8,Npepl1,1,2,2,2,Q6NSR8,MOUSE,56851.9,4.1,2823,2823.1,21.2,21.2,,524,Probable aminopeptidase NPEPL1,nucleus|cytoplasm|,proteolysis|,aminopeptidase activity|metalloexopeptidase activity|manganese ion binding|,2,2,64700000,4.1%
P70697,0.269744581,-0.005166667,13.64988238,-0.268333333,0.043153076,-2.490582196,0.096,-0.015,0.306,-0.12,-0.196,-0.102,P70697,Urod,P70697_Urod,P70697,Urod,1,7,3,3,P70697,MOUSE,40976.4,8.4,2825,2825.1,21.17,21.17,,367,Uroporphyrinogen decarboxylase,nucleoplasm|cytoplasm|cytosol|,liver development|protoporphyrinogen IX biosynthetic process|heme biosynthetic process|response to iron ion|response to amine|response to estradiol|heme metabolic process|response to ethanol|uroporphyrinogen III metabolic process|response to mercury ion|response to methylmercury|response to fungicide|cellular response to arsenic-containing substance|,uroporphyrinogen decarboxylase activity|ferrous iron binding|,3,7,195000000,8.4%
Q3UL36,0.773512169,0.001833333,3.532035416,0.100333333,0.443400786,0.815001143,-0.136,-0.12,0.111,0.166,-0.139,0.129,Q3UL36,Arglu1,Q3UL36_Arglu1,Q3UL36,Arglu1,1,3,3,3,Q3UL36|Q3UL36-2,MOUSE,32886.4,8.1,2826,2826.1,21.17,21.17,,271,Arginine and glutamate-rich protein 1,nucleoplasm|mitochondrion|,,,3,3,61800000,8.1%
Q8BR90,0.666695042,-0.0205,5.07190938,0.167,0.311034857,1.09675921,0.17,-0.13,-0.352,0.217,-0.03,0.002,Q8BR90,AW549877,Q8BR90_AW549877,Q8BR90,,1,2,2,2,Q8BR90|Q8BR90-2,MOUSE,34155.4,11.5,2827,2827.1,21.17,21.17,,294,UPF0600 protein C5orf51 homolog,,,,2,2,71000000,11.5%
A1L3P4,0.990223955,-0.0425,0.196502182,-0.019666667,0.955762049,-0.05760665,-0.64,-0.11,0.652,0.18,-0.465,0.128,A1L3P4,Slc9a6,A1L3P4_Slc9a6,A1L3P4,Slc9a6,1,2,2,2,A1L3P4|B0QZV3,MOUSE,78522,3.5,2829,2829.1,21.14,21.14,,702,Sodium/hydrogen exchanger,mitochondrion|endosome|early endosome|late endosome|endoplasmic reticulum membrane|plasma membrane|integral component of membrane|dendrite|cytoplasmic vesicle|early endosome membrane|intracellular membrane-bounded organelle|axon terminus|axonal spine|synapse|recycling endosome|recycling endosome membrane|,regulation of pH|proton transport|brain-derived neurotrophic factor receptor signaling pathway|sodium ion transmembrane transport|axon extension|neuron projection morphogenesis|synapse organization|regulation of neurotrophin TRK receptor signaling pathway|dendritic spine development|dendrite extension|hydrogen ion transmembrane transport|,sodium:proton antiporter activity|,2,2,23400000,3.5%
Q3UBZ5,0.89105666,-0.016666667,1.752366137,0.058666667,0.667979888,0.448680294,-0.101,-0.197,0.16,0.113,-0.159,0.084,Q3UBZ5,Mif4gd,Q3UBZ5_Mif4gd,Q3UBZ5,Mif4gd,1,4,2,2,Q3UBZ5|A2A9W3|Q3UBZ5-2,MOUSE,25892.2,13.5,2830,2830.1,21.14,21.14,,222,MIF4G domain-containing protein,nucleolus|cytoplasm|,regulation of translation|,RNA binding|protein C-terminus binding|,2,4,90500000,13.5%
Q8CBR6,0.233437388,-0.1175,14.70995706,0.445,0.033806818,2.66800375,-0.423,0,-0.597,0.242,0.073,0,Q8CBR6,Tsku,Q8CBR6_Tsku,Q8CBR6,Tsku,1,6,2,2,Q8CBR6,MOUSE,38760.8,6.4,2831,2831.1,21.13,21.13,,354,Tsukushin,extracellular space|,regulation of gene expression|corpus callosum morphogenesis|lateral ventricle development|anterior commissure morphogenesis|negative regulation of Wnt signaling pathway|camera-type eye development|ciliary body morphogenesis|,protein binding|,2,6,119000000,6.4%
Q91W92,0.888492316,0.005166667,1.779540947,0.060333333,0.663813232,0.454767567,-0.076,0.072,-0.071,0.127,-0.224,0.203,Q91W92,Cdc42ep1,Q91W92_Cdc42ep1,Q91W92,Cdc42ep1,1,3,3,3,Q91W92|A0A0R4J0S1,MOUSE,43152.3,12.2,2832,2832.1,21.12,21.12,,409,Cdc42 effector protein 1,cytoplasm|Golgi apparatus|cytoskeleton|plasma membrane|focal adhesion|actin cytoskeleton|,Rho protein signal transduction|regulation of cell shape|positive regulation of actin filament polymerization|positive regulation of pseudopodium assembly|positive regulation of GTPase activity|,GTPase activator activity|protein binding|GTP-Rho binding|,3,3,347000000,12.2%
Q9DBU0,0.945552639,0.005333333,0.801697164,-0.043333333,0.831438793,-0.221421307,-0.138,0.119,0.1,-0.373,-0.052,0.376,Q9DBU0,Tm9sf1,Q9DBU0_Tm9sf1,Q9DBU0,Tm9sf1,1,2,2,2,Q9DBU0|D3Z6X7|D6RGM8,MOUSE,69497,3.6,2833,2833.1,21.11,21.11,,606,Transmembrane 9 superfamily member 1,autophagosome membrane|lysosomal membrane|integral component of membrane|cytoplasmic vesicle|,autophagy|,,2,2,112000000,3.6%
Q8BGR2,0.993378838,-0.022333333,0.109296109,-0.005333333,0.975147674,-0.032348598,0.057,0.238,-0.354,0.109,-0.124,-0.06,Q8BGR2,Lrrc8d,Q8BGR2_Lrrc8d,Q8BGR2,Lrrc8d,1,3,2,2,Q8BGR2,MOUSE,99252.3,3.4,2834,2834.1,21.08,21.08,,859,Volume-regulated anion channel subunit LRRC8D,endoplasmic reticulum membrane|plasma membrane|membrane|integral component of membrane|,ion transport|,,2,3,168000000,3.4%
P10107,0.88044681,0.028,1.939538035,-0.084,0.639802889,-0.490224313,-0.204,0,0.414,-0.079,-0.104,0.141,P10107,Anxa1,P10107_Anxa1,P10107,Anxa1,1,5,3,3,P10107,MOUSE,39018.9,11.2,2838,2838.1,20.97,20.97,,346,Annexin A1,cornified envelope|extracellular space|nucleus|cytoplasm|endosome|cytosol|plasma membrane|focal adhesion|cilium|cell surface|basolateral plasma membrane|mitochondrial membrane|vesicle|sarcolemma|mast cell granule|protein complex|extracellular exosome|,DNA strand renaturation|neutrophil homeostasis|signal transduction|cell surface receptor signaling pathway|response to X-ray|myoblast migration involved in skeletal muscle regeneration|peptide cross-linking|insulin secretion|keratinocyte differentiation|prostate gland development|endocrine pancreas development|positive regulation of vesicle fusion|positive regulation of prostaglandin biosynthetic process|response to estradiol|DNA duplex unwinding|positive regulation of neutrophil apoptotic process|DNA rewinding|gliogenesis|regulation of cell proliferation|response to drug|response to peptide hormone|estrous cycle|alpha-beta T cell differentiation|arachidonic acid secretion|cellular response to hydrogen peroxide|hepatocyte differentiation|prolactin secretion|response to interleukin-1|cellular response to glucocorticoid stimulus|neutrophil clearance|positive regulation of G1/S transition of mitotic cell cycle|negative regulation of phospholipase A2 activity|negative regulation of interleukin-8 secretion|,"single-stranded DNA binding|single-stranded RNA binding|helicase activity|structural molecule activity|calcium ion binding|protein binding|calcium-dependent phospholipid binding|phospholipase A2 inhibitor activity|protein binding, bridging|double-stranded DNA-dependent ATPase activity|annealing helicase activity|protein homodimerization activity|calcium-dependent protein binding|",3,5,24700000,11.2%
Q9CQ75,0.578909417,-0.047,6.771194606,0.249333333,0.210319984,1.387090034,-0.521,-0.023,0.029,0.265,-0.132,0.1,Q9CQ75,Ndufa2,Q9CQ75_Ndufa2,Q9CQ75,Ndufa2,1,5,2,2,Q9CQ75,MOUSE,11029.6,24.2,2839,2839.1,20.97,20.97,,99,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2,mitochondrion|mitochondrial respiratory chain complex I|mitochondrial membrane|,oxidation-reduction process|,NADH dehydrogenase (ubiquinone) activity|,2,5,870000000,24.2%
P0DP28,0.651828926,-0.011666667,5.303171557,0.178666667,0.294905481,1.137284282,-0.218,-0.255,0.17,-0.132,0.107,0.258,P0DP28,Calm1,P0DP28_Calm1,P0DP28,Calm3,1,2,2,2,P0DP28|Q3UKW2|Q9D6P8,MOUSE,16837.3,20.1,2840,2840.1,20.92,20.92,,149,Calmodulin-3,,,,2,2,52900000,20.1%
P06745,0.110135295,0.183333333,19.47596439,0.871333333,0.011282454,3.475953047,-0.168,-0.085,-0.504,0.072,0.793,0.992,P06745,Gpi1,P06745_Gpi1,P06745,Gpi,1,3,2,2,P06745,MOUSE,62994,4.1,2841,2841.1,20.91,20.91,,558,Glucose-6-phosphate isomerase,extracellular space|nucleoplasm|cytoplasm|plasma membrane|membrane|myelin sheath|ciliary membrane|extracellular exosome|,angiogenesis|in utero embryonic development|mesoderm formation|gluconeogenesis|glycolytic process|erythrocyte homeostasis|glucose homeostasis|glycolytic process through glucose-6-phosphate|,glucose-6-phosphate isomerase activity|cytokine activity|protein binding|growth factor activity|,2,3,160000000,4.1%
Q5SV85,0.000844502,-0.077833333,45.60757402,0.889,2.74943E-05,10.06807276,-0.568,-0.42,-0.579,0.376,0.318,0.406,Q5SV85,Synrg,Q5SV85_Synrg,Q5SV85,Synrg,1,2,2,2,V9GX40|Q5SV85|V9GXD9|Q5SV85-2,MOUSE,140526.3,2.3,2842,2842.1,20.87,20.87,,1306,Synergin gamma,Golgi apparatus|cytosol|membrane|,endocytosis|protein transport|,,2,2,41900000,2.3%
Q9Z2U2,0.89105666,-0.113666667,1.753418076,0.135333333,0.66781811,0.448916295,0.257,0.119,-0.92,-0.136,0.051,-0.053,Q9Z2U2,Zfp292,Q9Z2U2_Zfp292,Q9Z2U2,Zfp292,1,9,3,3,Q9Z2U2|Q9Z2U2-2,MOUSE,305721.4,1,2844,2844.1,20.72,20.72,,2698,Zinc finger protein 292,nucleus|,transcription from RNA polymerase II promoter|positive regulation of transcription from RNA polymerase II promoter|,RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|DNA binding|metal ion binding|,3,9,16300000000,1.0%
Q80UG1,0.593471457,-0.070666667,6.448028978,0.256,0.226567234,1.333033185,-0.177,0.18,-0.599,0.108,0.006,0.058,Q80UG1,Fads6,Q80UG1_Fads6,Q80UG1,Fads6,1,5,2,2,Q80UG1,MOUSE,39286.4,5.5,2845,2845.1,20.71,20.71,,342,Fatty acid desaturase 6,integral component of membrane|,fatty acid biosynthetic process|oxidation-reduction process|,oxidoreductase activity|,2,5,857000000,5.5%
Q91VZ6,0.06896066,-0.034166667,22.026694,0.533,0.00627091,3.939253293,-0.559,-0.217,-0.126,0.116,0.277,0.304,Q91VZ6,Smap1,Q91VZ6_Smap1,Q91VZ6,Smap1,1,2,2,2,Q91VZ6|D3YVX4,MOUSE,48001.8,5.4,2846,2846.1,20.61,20.61,,440,Stromal membrane-associated protein 1,cytoplasm|plasma membrane|,positive regulation of GTPase activity|positive regulation of erythrocyte differentiation|regulation of clathrin-mediated endocytosis|actin cytoskeleton reorganization|,GTPase activator activity|clathrin binding|metal ion binding|,2,2,15900000,5.4%
Q9EPR2,4.99445E-05,-0.461666667,70.01115991,2.778666667,9.97434E-08,24.18867613,-1.936,-1.737,-1.88,0.756,1.08,0.947,Q9EPR2,Pla2g12a,Q9EPR2_Pla2g12a,Q9EPR2,Pla2g12a,1,4,2,2,Q9EPR2|Q9EPR2-2,MOUSE,22117.7,11.4,2847,2847.1,20.6,20.6,,192,Group XIIA secretory phospholipase A2,extracellular region|intracellular|endoplasmic reticulum|Golgi apparatus|,phospholipid metabolic process|lipid catabolic process|,phospholipase A2 activity|calcium ion binding|,2,4,196000000,11.4%
Q9EPQ7,0.578909417,-0.023333333,6.792098228,0.242,0.209310096,1.390571595,0.058,-0.5,0.009,-0.061,0.264,0.09,Q9EPQ7,Stard5,Q9EPQ7_Stard5,Q9EPQ7,Stard5,1,3,2,2,Q9EPQ7|D3YU00,MOUSE,24378.1,11.2,2848,2848.1,20.58,20.58,,213,StAR-related lipid transfer protein 5,,lipid transport|,cholesterol binding|bile acid binding|,2,3,53200000,11.2%
Q8BHE8,0.695646919,0.0035,4.609116484,-0.108333333,0.346009762,-1.013737386,0.011,0.19,-0.028,0.012,0.026,-0.19,Q8BHE8,Maip1,Q8BHE8_Maip1,Q8BHE8,Maip1,1,2,2,2,Q8BHE8,MOUSE,33269.6,8.5,2849,2849.1,20.58,20.58,,291,"m-AAA protease-interacting protein 1, mitochondrial",mitochondrion|,,,2,2,739000000,8.5%
O88487,0.956491812,-0.077166667,0.628111289,0.025666667,0.865344168,0.176281083,-0.067,0.064,-0.267,0.185,-0.238,-0.14,O88487,Dync1i2,O88487_Dync1i2,O88487,Dync1i2,1,3,2,2,A2BFF9|A2BFF5|Q3TPJ8|O88487|A2BFF8,MOUSE,68792.3,5,2850,2850.1,20.54,20.54,,612,Cytoplasmic dynein 1 intermediate chain 2,cytoplasmic dynein complex|microtubule|vesicle|,transport|microtubule-based movement|metabolic process|,motor activity|,2,3,68600000,5.0%
Q6ZQH8,0.919618833,0.014666667,1.172030534,0.03,0.763478737,0.313444796,-0.097,0.039,0.057,0.016,-0.061,0.134,Q6ZQH8,Nup188,Q6ZQH8_Nup188,Q6ZQH8,Nup188,1,3,3,3,Q6ZQH8,MOUSE,199088.5,2.2,2851,2851.1,20.5,20.5,,1759,Nucleoporin NUP188 homolog,nuclear pore|membrane|,protein transport|mRNA transport|,,3,3,33300000,2.2%
Q8VDM6,0.469507952,0.2935,8.911182449,0.838333333,0.128493676,1.736572171,-0.258,-0.103,-0.016,1.93,0.058,0.15,Q8VDM6,Hnrnpul1,Q8VDM6_Hnrnpul1,Q8VDM6,Hnrnpul1,1,4,3,3,Q8VDM6|Q8VDM6-2|Q8VDM6-3,MOUSE,96570.7,3.2,2852,2852.1,20.49,20.49,,859,Heterogeneous nuclear ribonucleoprotein U-like protein 1,nucleus|nucleoplasm|ribonucleoprotein complex|,"transcription, DNA-templated|regulation of transcription, DNA-templated|RNA processing|response to virus|",enzyme binding|poly(A) RNA binding|,3,4,1140000000,3.2%
A0A1D5RMH7,0.902449182,-0.014,1.591182693,-0.055333333,0.693236995,-0.412164939,0.106,0.164,-0.229,-0.175,0.077,-0.027,A0A1D5RMH7,Psd3,A0A1D5RMH7_Psd3,A0A1D5RMH7,Psd3,1,15,3,3,A0A1D5RMH7|Q2PFD7|Q2PFD7-2|F6Z9E6|Q2PFD7-5|Q2PFD7-4|A0A1D5RLM2|A0A1D5RLK2|Q2PFD7-3|Q8C0E9|E9PUC5,MOUSE,143165.6,3.4,2853,2853.1,20.47,20.47,,1289,PH and SEC7 domain-containing protein 3,,,,3,15,39200000000,3.4%
O35083,0.991556352,0.007333333,0.177324134,0.004,0.95999194,0.052069909,0.018,0.002,-0.004,-0.001,0.027,0.002,O35083,Agpat1,O35083_Agpat1,O35083,Agpat1,1,2,2,2,A0A0R4J263|O35083,MOUSE,32051.1,11.2,2855,2855.1,20.42,20.42,,285,1-acyl-sn-glycerol-3-phosphate acyltransferase alpha,endoplasmic reticulum membrane|membrane|integral component of membrane|,positive regulation of cytokine production|phosphatidic acid biosynthetic process|CDP-diacylglycerol biosynthetic process|,1-acylglycerol-3-phosphate O-acyltransferase activity|,2,2,16200000,11.2%
Q8BWR8,0.612906454,0.016833333,6.115220311,-0.124333333,0.244612118,-1.275437855,0.09,0.141,0.006,-0.047,-0.162,0.073,Q8BWR8,Rhpn2,Q8BWR8_Rhpn2,Q8BWR8,Rhpn2,1,2,2,2,Q8BWR8,MOUSE,77583.4,4.5,2856,2856.1,20.41,20.41,,686,Rhophilin-2,nucleoplasm|cytoplasm|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|,signal transduction|,,2,2,19600000,4.5%
Q9CQU3,0.919618833,-0.043333333,1.193191436,-0.059333333,0.759767752,-0.318707205,-0.129,0.182,-0.094,-0.462,0.155,0.088,Q9CQU3,Rer1,Q9CQU3_Rer1,Q9CQU3,Rer1,1,6,2,2,Q9CQU3,MOUSE,23101.7,9.1,2857,2857.1,20.4,20.4,,196,Protein RER1,endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|cell surface|integral component of Golgi membrane|,"retrograde vesicle-mediated transport, Golgi to ER|neuromuscular junction development|skeletal muscle acetylcholine-gated channel clustering|positive regulation of establishment of protein localization to plasma membrane|",acetylcholine receptor binding|,2,6,2650000000,9.1%
Q8CEI1,0.911411213,-0.047166667,1.421006553,-0.041666667,0.720940369,-0.372715157,0.032,-0.15,0.039,-0.178,-0.127,0.101,Q8CEI1,Bola3,Q8CEI1_Bola3,Q8CEI1,Bola3,1,2,2,2,E9PX89|Q8CEI1|E9Q705,MOUSE,12399.2,30,2858,2858.1,20.35,20.35,,110,BolA-like protein 3,extracellular region|,,,2,2,7120000,30.0%
Q3TYT1,0.866224515,0.006,2.148578196,0.045333333,0.609736482,0.53531785,-0.004,-0.05,0.004,0.021,-0.044,0.109,Q3TYT1,Coq7,Q3TYT1_Coq7,Q3TYT1,Coq7,1,4,2,2,Q3TYT1|A0A140LIF0|P97478,MOUSE,38193.2,4.1,2859,2859.1,20.32,20.32,,337,"5-demethoxyubiquinone hydroxylase, mitochondrial",nucleus|mitochondrion|mitochondrial inner membrane|,age-dependent response to oxidative stress|in utero embryonic development|neural tube formation|ubiquinone biosynthetic process|response to oxidative stress|determination of adult lifespan|neurogenesis|respiratory electron transport chain|cellular response to oxidative stress|mitochondrial ATP synthesis coupled electron transport|mitochondrion morphogenesis|ubiquinone biosynthetic process|,monooxygenase activity|metal ion binding|,2,4,398000000,4.1%
P70429,0.692956416,0.161,4.671599929,-0.491333333,0.34106724,-1.02565317,-0.017,-0.165,1.402,0.46,-0.731,0.017,P70429,Evl,P70429_Evl,P70429,Evl,1,3,3,3,P70429|F8WJB9|E9PVP4|P70429-2,MOUSE,44450.7,8.4,2860,2860.1,20.3,20.3,,414,Ena/VASP-like protein,cytoplasm|cytoskeleton|focal adhesion|membrane|lamellipodium|,axon guidance|actin polymerization or depolymerization|negative regulation of epithelial cell migration|actin filament-based movement|platelet activation|positive regulation of actin filament polymerization|actin nucleation|barbed-end actin filament capping|protein homotetramerization|positive regulation of stress fiber assembly|negative regulation of ruffle assembly|,actin binding|protein binding|profilin binding|SH3 domain binding|,3,3,38600000,8.4%
Q9D136,0.001998261,0.036833333,40.63642946,0.969,8.63688E-05,8.444367119,-0.411,-0.403,-0.529,0.315,0.627,0.622,Q9D136,Ogfod3,Q9D136_Ogfod3,Q9D136,Ogfod3,1,3,3,3,Q9D136,MOUSE,35669.5,14.9,2861,2861.1,20.25,20.25,,315,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3,membrane|integral component of membrane|extracellular exosome|,oxidation-reduction process|,"iron ion binding|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors|L-ascorbic acid binding|",3,3,991000000,14.9%
Q99LI9,0.680162369,0.0285,4.867153555,-0.129666667,0.32605033,-1.060548462,-0.034,0.055,0.259,-0.103,-0.144,0.138,Q99LI9,Clp1,Q99LI9_Clp1,Q99LI9,Clp1,1,5,3,3,Q99LI9,MOUSE,48193.2,3.7,2862,2862.1,20.2,20.2,,425,Polyribonucleotide 5'-hydroxyl-kinase Clp1,tRNA-intron endonuclease complex|nucleus|nucleoplasm|cytoplasm|mRNA cleavage factor complex|,"mRNA polyadenylation|mRNA cleavage|tRNA splicing, via endonucleolytic cleavage and ligation|phosphorylation|cerebellar cortex development|targeting of mRNA for destruction involved in RNA interference|siRNA loading onto RISC involved in RNA interference|",ATP binding|ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity|polynucleotide 5'-hydroxyl-kinase activity|polydeoxyribonucleotide kinase activity|ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity|,3,5,102000000,3.7%
Q3U6U5,0.473411328,-0.0495,8.702700768,-0.185666667,0.134812426,-1.700913927,0.093,-0.038,0.075,0.037,-0.194,-0.27,Q3U6U5,Gtpbp6,Q3U6U5_Gtpbp6,Q3U6U5,Gtpbp6,1,2,2,2,Q3U6U5|A0A0R4J0Z0,MOUSE,56816.4,5.6,2863,2863.1,20.19,20.19,,514,Putative GTP-binding protein 6,,,GTP binding|metal ion binding|,2,2,14100000,5.6%
P98078,0.788130842,0.047833333,3.296803293,-0.095,0.468079553,-0.769644254,-0.029,-0.02,0.335,0.019,-0.071,0.053,P98078,Dab2,P98078_Dab2,P98078,Dab2,1,3,2,2,P98078|A0A0R4J104|P98078-2|E9QL31|P98078-3|Q3TRE6|E9PX84|E0CXT5|Q9DCE6,MOUSE,82481.5,3.5,2864,2864.1,20.19,20.19,,766,Disabled homolog 2,nucleus|nucleolus|cytoplasm|plasma membrane|coated pit|focal adhesion|apical plasma membrane|clathrin coat of coated pit|clathrin-coated vesicle|clathrin-coated vesicle membrane|intracellular membrane-bounded organelle|extracellular exosome|transforming growth factor beta receptor homodimeric complex|,"cell morphogenesis involved in differentiation|in utero embryonic development|positive regulation of receptor recycling|positive regulation of protein phosphorylation|positive regulation of receptor internalization|receptor-mediated endocytosis|pinocytosis|apoptotic process|activation of JUN kinase activity|endoderm development|excretion|positive regulation of epithelial to mesenchymal transition|positive regulation of pathway-restricted SMAD protein phosphorylation|protein transport|Wnt signaling pathway|myeloid cell differentiation|positive regulation of cell migration|positive regulation of transforming growth factor beta receptor signaling pathway|negative regulation of protein binding|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of transcription elongation from RNA polymerase II promoter|leading edge cell differentiation|negative regulation of apoptotic process|positive regulation of cell adhesion|positive regulation of endocytosis|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|clathrin coat assembly|positive regulation of SMAD protein import into nucleus|negative regulation of androgen receptor signaling pathway|cellular response to transforming growth factor beta stimulus|negative regulation of canonical Wnt signaling pathway|positive regulation of substrate adhesion-dependent cell spreading|negative regulation of protein localization to plasma membrane|positive regulation of Wnt signaling pathway, planar cell polarity pathway|positive regulation of clathrin-mediated endocytosis|positive regulation of early endosome to late endosome transport|positive regulation of integrin-mediated signaling pathway|negative regulation of extrinsic apoptotic signaling pathway|","integrin binding|protein binding|phosphatidylinositol-4,5-bisphosphate binding|protein C-terminus binding|clathrin binding|phosphatidylinositol binding|AP-2 adaptor complex binding|clathrin adaptor activity|cargo receptor activity|SMAD binding|",2,3,359000000,3.5%
J3QNW4,0.965288537,0.038166667,0.468712193,-0.017,0.897694947,-0.133592492,-0.086,-0.065,0.291,0.018,-0.048,0.119,J3QNW4,NotFound,J3QNW4_NotFound,J3QNW4,Trappc13,1,4,3,3,J3QNW4|Q3TIR1-2|Q3TIR1|Q3TIR1-3,MOUSE,47332.7,7.6,2865,2865.1,20.18,20.18,,418,Trafficking protein particle complex subunit 13,,,,3,4,144000000,7.6%
F8VPX2,0.330366427,0.037166667,11.97763814,0.243,0.063421453,2.22298755,-0.16,-0.034,-0.059,0.299,-0.019,0.196,F8VPX2,Fbxw9,F8VPX2_Fbxw9,F8VPX2,Fbxw9,1,2,2,2,F8VPX2,MOUSE,51274.3,7.6,2866,2866.1,20.17,20.17,,458,F-box and WD-40 domain protein 9,,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|,,2,2,26300000,7.6%
Q91W18,0.051347202,0.051333333,23.49937342,0.640666667,0.00446748,4.219175212,-0.494,-0.267,-0.046,0.443,0.157,0.515,Q91W18,Tdrd3,Q91W18_Tdrd3,Q91W18,Tdrd3,1,2,2,2,Q91W18|Q91W18-3|Q91W18-2,MOUSE,82650.7,4.5,2867,2867.1,20.17,20.17,,743,Tudor domain-containing protein 3,nucleus|cytoplasm|exon-exon junction complex|,mRNA processing|chromatin modification|regulation of nucleic acid-templated transcription|,chromatin binding|transcription coactivator activity|methylated histone binding|poly(A) RNA binding|,2,2,22400000,4.5%
Q78HU3,0.914318415,0.006833333,1.335937292,-0.043,0.735201308,-0.352803225,0.032,0.226,-0.173,-0.094,-0.003,0.053,Q78HU3,Mvb12a,Q78HU3_Mvb12a,Q78HU3,Mvb12a,1,5,2,2,Q78HU3,MOUSE,28989.8,11.4,2868,2868.1,20.15,20.15,,271,Multivesicular body subunit 12A,ESCRT I complex|nucleoplasm|cytoplasm|centrosome|cytosol|aggresome|late endosome membrane|vesicle|intracellular membrane-bounded organelle|extracellular exosome|,protein transport|virus maturation|regulation of epidermal growth factor receptor signaling pathway|positive regulation of viral process|regulation of viral budding via host ESCRT complex|,lipid binding|SH3 domain binding|ubiquitin binding|,2,5,1080000000,11.4%
Q8BGC3,0.121380249,0.012,18.89028588,0.294,0.012911343,3.359835595,-0.159,-0.041,-0.205,0.211,0.133,0.133,Q8BGC3,Slc16a12,Q8BGC3_Slc16a12,Q8BGC3,Slc16a12,1,2,2,2,Q8BGC3,MOUSE,54348.8,4.5,2869,2869.1,20.15,20.15,,486,Monocarboxylate transporter 12,integral component of plasma membrane|,plasma membrane lactate transport|creatine transmembrane transport|,creatine transmembrane transporter activity|lactate transmembrane transporter activity|symporter activity|,2,2,135000000,4.5%
P61290,0.935853609,-0.051166667,0.91523915,0.055,0.809983338,0.250248243,-0.053,0.33,-0.513,-0.2,-0.035,0.164,P61290,Psme3,P61290_Psme3,P61290,Psme3,1,2,2,2,P61290,MOUSE,29619.6,11,2870,2870.1,20.13,20.13,,254,Proteasome activator complex subunit 3,nucleus|nucleoplasm|cytoplasm|proteasome activator complex|membrane|,apoptotic process|cell cycle|positive regulation of endopeptidase activity|regulation of proteasomal protein catabolic process|negative regulation of extrinsic apoptotic signaling pathway|,p53 binding|identical protein binding|endopeptidase activator activity|MDM2/MDM4 family protein binding|,2,2,70600000,11.0%
Q9Z1Q2,0.16139334,0.085,17.20680924,-0.556666667,0.019024755,-3.083352653,0.301,0.074,0.715,-0.151,-0.377,-0.052,Q9Z1Q2,Abhd16a,Q9Z1Q2_Abhd16a,Q9Z1Q2,Abhd16a,1,7,3,3,Q9Z1Q2,MOUSE,63712.6,4.6,2871,2871.1,20.1,20.1,,558,Protein ABHD16A,integral component of membrane|,metabolic process|,hydrolase activity|,3,7,1640000000,4.6%
E9PWT1,0.257079817,0.0005,13.95892646,-0.419,0.040189014,-2.54568504,0.087,0.277,0.266,-0.546,0.057,-0.138,E9PWT1,NotFound,E9PWT1_NotFound,E9PWT1,Trrap,1,4,3,3,A0A1D5RLL4|E9PWT1|E9QLK7|E9PZA7|Q80YV3,MOUSE,441779.5,1.3,2872,2872.1,20.07,20.07,,3858,Transformation/transcription domain-associated protein,histone acetyltransferase complex|Swr1 complex|nucleus|nucleoplasm|transcription factor complex|Golgi apparatus|STAGA complex|transcription factor TFTC complex|NuA4 histone acetyltransferase complex|,"DNA repair|regulation of transcription, DNA-templated|mitotic cell cycle checkpoint|phosphorylation|histone deubiquitination|histone H4 acetylation|histone H2A acetylation|","transcription cofactor activity|transcription coactivator activity|kinase activity|phosphotransferase activity, alcohol group as acceptor|",3,4,3660000000,1.3%
Q19LI2,0.387241291,0.335166667,10.66936646,1.353,0.085716288,2.017964153,0.03,-0.665,-0.389,1.73,-0.649,1.954,Q19LI2,A1bg,Q19LI2_A1bg,Q19LI2,A1bg,1,3,2,2,Q19LI2,MOUSE,57237.7,3.3,2873,2873.1,20.05,20.05,,512,Alpha-1B-glycoprotein,extracellular region|extracellular space|extracellular exosome|blood microparticle|,,,2,3,190000000,3.3%
P81122,0.771800617,-0.028833333,3.566007776,-0.111,0.439945847,-0.821491346,0.178,0.093,-0.191,-0.038,-0.26,0.045,P81122,Irs2,P81122_Irs2,P81122,Irs2,1,2,2,2,P81122,MOUSE,137958.9,1.7,2874,2874.1,20.05,20.05,,1321,Insulin receptor substrate 2,cytosol|plasma membrane|,positive regulation of mesenchymal cell proliferation|negative regulation of B cell apoptotic process|brain development|cell proliferation|positive regulation of cell proliferation|insulin receptor signaling pathway|response to glucose|negative regulation of plasma membrane long-chain fatty acid transport|positive regulation of glucose metabolic process|regulation of lipid metabolic process|positive regulation of cell migration|mammary gland development|positive regulation of B cell proliferation|positive regulation of fatty acid beta-oxidation|positive regulation of insulin secretion|cellular response to insulin stimulus|negative regulation of kinase activity|positive regulation of glycogen biosynthetic process|positive regulation of glucose import|cellular response to glucose stimulus|,signal transducer activity|insulin receptor binding|protein binding|protein kinase binding|protein phosphatase binding|protein domain specific binding|phosphatidylinositol 3-kinase binding|14-3-3 protein binding|,2,2,38700000,1.7%
Q5NCJ1,0.753743834,0.000333333,3.791841587,-0.104,0.417653227,-0.864271697,0.018,0.081,0.058,0.036,-0.287,0.096,Q5NCJ1,Rapgef6,Q5NCJ1_Rapgef6,Q5NCJ1,Rapgef6,1,2,2,2,Q5NCJ1|B2RUJ6|Q5NCJ0|Q5NCJ5|Q5NCJ4,MOUSE,182005.5,1.4,2875,2875.1,20.03,20.03,,1609,Rap guanine nucleotide exchange factor (GEF) 6,cytosol|plasma membrane|apical plasma membrane|endocytic vesicle|,small GTPase mediated signal transduction|microvillus assembly|positive regulation of GTPase activity|protein localization to plasma membrane|,guanyl-nucleotide exchange factor activity|Ras GTPase binding|GTP-dependent protein binding|phosphatidic acid binding|,2,2,39200000,1.4%
Q3TX08,0.791332991,0.013833333,3.229901236,0.105666667,0.475346036,0.756605467,-0.105,0.115,-0.127,0.237,-0.188,0.151,Q3TX08,Trmt1,Q3TX08_Trmt1,Q3TX08,Trmt1,1,2,2,2,Q3TX08|A0A0R4IZW7|E9PWD4|H3BKS8,MOUSE,73660.7,4.8,2877,2877.1,19.99,19.99,,663,tRNA (guanine(26)-N(2))-dimethyltransferase,nucleus|mitochondrion|,tRNA N2-guanine methylation|,tRNA binding|tRNA (guanine-N2-)-methyltransferase activity|poly(A) RNA binding|metal ion binding|,2,2,645000000,4.8%
P98063,0.002528295,0.019333333,39.22171108,0.904,0.000119627,7.993448502,-0.431,-0.45,-0.417,0.537,0.261,0.616,P98063,Bmp1,P98063_Bmp1,P98063,Bmp1,1,2,2,2,P98063|G3X9F5|Q62381|Q9WVM6|E9Q5B9|Q62381-2,MOUSE,113889.4,2.6,2878,2878.1,19.96,19.96,,991,Bone morphogenetic protein 1,proteinaceous extracellular matrix|extracellular space|Golgi apparatus|membrane-bounded vesicle|,ossification|proteolysis|cell differentiation|cartilage development|positive regulation of cartilage development|,metalloendopeptidase activity|cytokine activity|calcium ion binding|protein binding|growth factor activity|peptidase activity|zinc ion binding|,2,2,24600000,2.6%
I7HPW8,0.001667629,-0.041833333,41.78062794,1.571666667,6.63647E-05,8.845041054,-0.939,-0.616,-0.928,0.757,0.43,1.045,I7HPW8,NotFound,I7HPW8_NotFound,I7HPW8,Myo15b,1,5,3,3,I7HPW8,MOUSE,335247.9,1.1,2879,2879.1,19.93,19.93,,3033,Myosin XVB,brush border|myosin complex|,metabolic process|,motor activity|ATP binding|,3,5,2310000000,1.1%
Q3TQN1,0.607857354,0.031833333,6.215760117,0.156333333,0.239014357,1.293890783,-0.009,-0.128,-0.002,0.204,-0.117,0.243,Q3TQN1,Tpst2,Q3TQN1_Tpst2,Q3TQN1,Tpst2,1,2,2,2,Q3TQN1|O88856,MOUSE,44156.7,4.3,2880,2880.1,19.93,19.93,,390,Protein-tyrosine sulfotransferase 2,endoplasmic reticulum|extracellular exosome|,peptidyl-tyrosine sulfation|fusion of sperm to egg plasma membrane|prevention of polyspermy|,protein-tyrosine sulfotransferase activity|,2,2,78600000,4.3%
Q3TGW2,0.055245391,-0.080666667,23.15365175,0.558666667,0.004837654,4.152575539,-0.163,-0.287,-0.63,0.241,0.138,0.217,Q3TGW2,Eepd1,Q3TGW2_Eepd1,Q3TGW2,Eepd1,1,2,2,2,Q3TGW2,MOUSE,63465.8,4.5,2881,2881.1,19.93,19.93,,569,Endonuclease/exonuclease/phosphatase family domain-containing protein 1,,DNA repair|,DNA binding|,2,2,98000000,4.5%
Q8R4U7,0.965288537,-0.064666667,0.471433949,0.02,0.897132531,0.134331992,-0.156,0.06,-0.128,0.044,-0.35,0.142,Q8R4U7,Luzp1,Q8R4U7_Luzp1,Q8R4U7,Luzp1,1,2,2,2,Q8R4U7,MOUSE,119879.4,2.5,2883,2883.1,19.9,19.9,,1068,Leucine zipper protein 1,nucleus|membrane|extracellular exosome|,ventricular septum development|neural fold bending|artery development|,,2,2,31700000,2.5%
Q91Y47,0.128295278,0.0465,18.48880037,0.865666667,0.014161849,3.303123247,-0.149,-0.098,-0.912,0.761,0.126,0.551,Q91Y47,F11,Q91Y47_F11,Q91Y47,F11,1,2,2,2,Q91Y47,MOUSE,71784.4,6.2,2884,2884.1,19.9,19.9,,624,Coagulation factor XI,extracellular space|extracellular exosome|,blood coagulation|regulation of blood coagulation|plasminogen activation|positive regulation of fibrinolysis|,serine-type endopeptidase activity|heparin binding|,2,2,90300000,6.2%
P97311,0.961523652,0.000166667,0.530367329,-0.051,0.885040749,-0.150252236,-0.015,-0.371,0.463,0.652,-0.52,-0.208,P97311,Mcm6,P97311_Mcm6,P97311,Mcm6,1,3,3,3,P97311|Q3ULG5,MOUSE,93778.3,2.6,2886,2886.1,19.89,19.89,,821,DNA replication licensing factor MCM6,nucleus|nucleoplasm|MCM complex|,DNA unwinding involved in DNA replication|DNA replication initiation|cell cycle|,single-stranded DNA binding|protein binding|ATP binding|identical protein binding|DNA helicase activity|ATP-dependent DNA helicase activity|,3,3,166000000,2.6%
Q91V09,0.798949474,-0.045833333,3.08059884,0.135666667,0.491971694,0.727272657,-0.001,0.194,-0.534,0.024,-0.027,0.069,Q91V09,Wdr13,Q91V09_Wdr13,Q91V09,Wdr13,1,2,2,2,Q91V09|S4R225,MOUSE,54290.7,4.1,2887,2887.1,19.89,19.89,,485,WD repeat-containing protein 13,nucleoplasm|cytoplasm|,,,2,2,33200000,4.1%
O70281,0.043399504,0.001166667,24.35764561,0.444333333,0.003666363,4.36354635,-0.198,-0.188,-0.277,0.379,0.193,0.098,O70281,Tpst1,O70281_Tpst1,O70281,Tpst1,1,2,2,2,O70281,MOUSE,42531,9.1,2888,2888.1,19.86,19.86,,370,Protein-tyrosine sulfotransferase 1,Golgi membrane|integral component of membrane|,peptidyl-tyrosine sulfation|,protein-tyrosine sulfotransferase activity|,2,2,150000000,9.1%
Q9CQW0,0.027446611,0.064666667,26.80357797,0.862,0.002087576,4.885841391,-0.536,-0.273,-0.29,0.127,0.63,0.73,Q9CQW0,Emc6,Q9CQW0_Emc6,Q9CQW0,Emc6,1,4,2,2,Q9CQW0,MOUSE,12074.1,20,2889,2889.1,19.81,19.81,,110,ER membrane protein complex subunit 6,integral component of membrane|integral component of endoplasmic reticulum membrane|ER membrane protein complex|integral component of omegasome membrane|,autophagosome assembly|,,2,4,2140000000,20.0%
B2RPV6,0.07838657,0.001833333,21.30135551,0.356333333,0.007410789,3.787596423,-0.133,-0.185,-0.211,0.303,0.071,0.166,B2RPV6,Mmrn1,B2RPV6_Mmrn1,B2RPV6,Mmrn1,1,2,2,2,B2RPV6|G3UVV6|A0A0N4SVL8,MOUSE,137358.3,2.1,2890,2890.1,19.79,19.79,,1210,Multimerin-1,extracellular region|,,,2,2,20800000,2.1%
A2A4J8,0.050597974,-0.033666667,23.57724219,0.402,0.004388093,4.212400518,-0.194,-0.289,-0.221,0.289,0.161,0.052,A2A4J8,Vps25,A2A4J8_Vps25,A2A4J8,Vps25,1,2,2,2,A2A4J8|Q9CQ80|A8XY17|A2A4K0|Q9CQ80-2|E9PXS9,MOUSE,21708.4,15.7,2891,2891.1,19.78,19.78,,184,Vacuolar protein-sorting-associated protein 25,ESCRT II complex|nucleus|nucleoplasm|nucleolus|cytoplasm|mitochondrion|cytosol|endosome membrane|extracellular exosome|,protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway|,structural molecule activity|protein homodimerization activity|protein N-terminus binding|,2,2,13100000,15.7%
P63166,0.891135171,0.051333333,1.749731127,0.039333333,0.668385296,0.447855105,0.006,0.108,-0.019,-0.01,0.107,0.116,P63166,Sumo1,P63166_Sumo1,P63166,Sumo1,1,2,2,2,P63166,MOUSE,11613.8,15.8,2892,2892.1,19.76,19.76,,101,Small ubiquitin-related modifier 1,heterochromatin|fibrillar center|XY body|nucleus|nucleolus|cytoplasm|plasma membrane|nuclear body|PML body|nuclear speck|dendrite|nuclear membrane|synapse|voltage-gated potassium channel complex|PML body|,"regulation of transcription, DNA-templated|protein sumoylation|PML body organization|positive regulation of protein complex assembly|regulation of protein stability|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|negative regulation of DNA binding|negative regulation of sequence-specific DNA binding transcription factor activity|negative regulation of action potential|negative regulation of transcription, DNA-templated|palate development|regulation of cardiac muscle cell contraction|protein localization to nuclear pore|positive regulation of calcium-transporting ATPase activity|negative regulation of delayed rectifier potassium channel activity|regulation of calcium ion transmembrane transport|",protein binding|transcription factor binding|potassium channel regulator activity|SUMO transferase activity|ubiquitin protein ligase binding|ion channel binding|poly(A) RNA binding|,2,2,54500000,15.8%
Q922Q4,0.121985139,0.144666667,18.83901644,-0.636666667,0.013064667,-3.364060352,0.044,0.682,0.663,-0.129,-0.323,-0.069,Q922Q4,Pycr2,Q922Q4_Pycr2,Q922Q4,Pycr2,1,3,2,2,Q922Q4|Q922W5,MOUSE,34000.8,11.8,2894,2894.1,19.73,19.73,,320,Pyrroline-5-carboxylate reductase 2,cytoplasm|,oxidation-reduction process|L-proline biosynthetic process|,pyrroline-5-carboxylate reductase activity|,2,3,2500000000,11.8%
Q63829,0.211052941,0.021,15.55326557,0.384666667,0.02784027,2.806651853,-0.157,-0.097,-0.26,0.488,0.114,0.038,Q63829,Commd3,Q63829_Commd3,Q63829,Commd3,1,2,2,2,Q63829,MOUSE,22321.8,10.2,2895,2895.1,19.72,19.72,,195,COMM domain-containing protein 3,nucleus|cytoplasm|,"transcription, DNA-templated|regulation of transcription, DNA-templated|sodium ion transport|",,2,2,113000000,10.2%
A6X919,0.649269492,0.018833333,5.332154863,-0.122333333,0.292943937,-1.14144979,-0.112,0.162,0.19,-0.046,-0.065,-0.016,A6X919,Dpy19l1,A6X919_Dpy19l1,A6X919,Dpy19l1,1,2,2,2,A6X919,MOUSE,85041.3,2.8,2896,2896.1,19.71,19.71,,746,Probable C-mannosyltransferase DPY19L1,nuclear inner membrane|membrane|integral component of membrane|,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan|,mannosyltransferase activity|,2,2,1300000000,2.8%
P62342,0.002528295,-0.219666667,39.16754116,1.529333333,0.000121128,8.016601659,-0.948,-0.669,-1.336,0.776,0.426,0.433,P62342,Selenot,P62342_Selenot,P62342,Selenot,1,3,2,2,P62342,MOUSE,22449.2,11.7,2897,2897.1,19.71,19.71,,195,Thioredoxin reductase-like selenoprotein T,endoplasmic reticulum|,response to glucose|pancreas development|insulin secretion involved in cellular response to glucose stimulus|glucose homeostasis|cell redox homeostasis|,selenium binding|,2,3,92900000,11.7%
J3QK52,0.73832786,-0.006833333,3.968776836,-0.160333333,0.400979635,-0.897370018,-0.073,-0.118,0.411,0.067,-0.326,-0.002,J3QK52,Noc2l,J3QK52_Noc2l,J3QK52,Noc2l,1,3,2,2,J3QK52|Q9WV70|Q8BHX6,MOUSE,86492.6,3.3,2898,2898.1,19.67,19.67,,750,Nucleolar complex protein 2 homolog,nucleus|nucleoplasm|nucleolus|,negative regulation of transcription from RNA polymerase II promoter|negative regulation of B cell apoptotic process|chromatin assembly|nucleolus to nucleoplasm transport|cellular response to UV|negative regulation of histone acetylation|negative regulation of intrinsic apoptotic signaling pathway|,p53 binding|chromatin binding|transcription corepressor activity|nucleosome binding|nucleosomal histone binding|histone binding|poly(A) RNA binding|repressing transcription factor binding|,2,3,677000000,3.3%
Q8BTZ7,0.436783765,0.0445,9.636557472,-0.170333333,0.108728714,-1.849679386,0.041,0.105,0.243,-0.026,-0.098,0.002,Q8BTZ7,Gmppb,Q8BTZ7_Gmppb,Q8BTZ7,Gmppb,1,2,2,2,Q8BTZ7,MOUSE,40429.3,8.3,2899,2899.1,19.66,19.66,,360,Mannose-1-phosphate guanyltransferase beta,cytoplasm|mitochondrion|extracellular exosome|,GDP-mannose biosynthetic process|,mannose-1-phosphate guanylyltransferase activity|GTP binding|,2,2,46400000,8.3%
Q9WUU9,0.994928853,-0.054,0.085170008,-0.004,0.980579928,-0.025275823,0.156,0.087,-0.399,0.006,-0.048,-0.126,Q9WUU9,Mcm3ap,Q9WUU9_Mcm3ap,Q9WUU9,Mcm3ap,1,4,2,2,Q9WUU9,MOUSE,219583.6,1.2,2900,2900.1,19.64,19.64,,1971,Germinal-center associated nuclear protein,nucleus|nuclear pore|cytoplasm|cytosol|nuclear membrane|,immune system process|protein transport|mRNA transport|,,2,4,31800000,1.2%
F8VQ28,0.821409751,0.059166667,2.767720207,0.141,0.528722728,0.664677047,-0.262,-0.184,0.412,-0.084,0.079,0.394,F8VQ28,Pxn,F8VQ28_Pxn,F8VQ28,Pxn,1,3,2,2,F8VQ28|Q8VI36|Q8VI36-2|A0A0J9YV30|A0A1D5RMM8,MOUSE,65931.5,5.4,2901,2901.1,19.63,19.63,,591,Paxillin,stress fiber|nucleoplasm|cytoplasm|plasma membrane|focal adhesion|lamellipodium|cell leading edge|,activation of MAPK activity|cytoskeleton organization|transforming growth factor beta receptor signaling pathway|integrin-mediated signaling pathway|regulation of cell shape|peptidyl-tyrosine phosphorylation|lamellipodium assembly|substrate adhesion-dependent cell spreading|cellular response to reactive oxygen species|positive regulation of protein kinase activity|focal adhesion assembly|branching morphogenesis of an epithelial tube|growth hormone receptor signaling pathway|,integrin binding|protein binding|beta-catenin binding|zinc ion binding|vinculin binding|protein kinase binding|receptor signaling complex scaffold activity|BH4 domain binding|,2,3,53300000,5.4%
P58466,0.734072404,-0.056166667,4.027756957,0.141,0.395570872,0.908325757,-0.166,0.172,-0.386,-0.11,0.101,0.052,P58466,Ctdsp1,P58466_Ctdsp1,P58466,Ctdsp1,1,2,2,2,P58466|P58465|G3UXN0,MOUSE,29608.1,9.9,2903,2903.1,19.6,19.6,,261,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,nucleus|extracellular exosome|,negative regulation of protein phosphorylation|regulation of transcription from RNA polymerase II promoter|protein dephosphorylation|negative regulation of neuron differentiation|negative regulation of neurogenesis|negative regulation of G1/S transition of mitotic cell cycle|,protein binding|CTD phosphatase activity|metal ion binding|,2,2,229000000,9.9%
Q9CY46,0.857449938,-0.013,2.256620958,-0.078666667,0.594754729,-0.55869379,0.088,-0.193,0.184,-0.033,-0.239,0.115,Q9CY46,Lsm4,Q9CY46_Lsm4,Q9CY46,Lsm4,1,2,2,2,Q9CY46|Q9QXA5|A0A1B0GRR9|A0A1B0GQZ9,MOUSE,15375.4,15.9,2906,2906.1,19.57,19.57,,138,"LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae), isoform CRA_b",nucleoplasm|spliceosomal complex|cytoplasm|,positive regulation of defense response to virus by host|RNA processing|activation of mitophagy in response to mitochondrial depolarization|,poly(A) RNA binding|,2,2,104000000,15.9%
P60605,0.32502652,0.066,12.1188196,-0.321333333,0.061392885,-2.249438967,0.005,0.229,0.446,0.08,-0.145,-0.219,P60605,Ube2g2,P60605_Ube2g2,P60605,Ube2g2,1,3,2,2,P60605,MOUSE,18737.2,23.6,2908,2908.1,19.53,19.53,,165,Ubiquitin-conjugating enzyme E2 G2,cytoplasm|endoplasmic reticulum|cytosol|,"protein polyubiquitination|protein N-linked glycosylation via asparagine|ER-associated ubiquitin-dependent protein catabolic process|cellular protein catabolic process|protein K48-linked ubiquitination|negative regulation of retrograde protein transport, ER to cytosol|",ubiquitin-protein transferase activity|protein binding|ATP binding|ligase activity|ubiquitin protein ligase binding|identical protein binding|ubiquitin protein ligase activity|ubiquitin conjugating enzyme activity|,2,3,2080000000,23.6%
Q3V3R4,0.00858685,-0.153,32.97835668,1.192666667,0.000503691,6.305483249,-0.585,-0.48,-1.183,0.36,0.472,0.498,Q3V3R4,Itga1,Q3V3R4_Itga1,Q3V3R4,Itga1,1,3,3,3,Q3V3R4,MOUSE,132233.8,2.2,2909,2909.1,19.5,19.5,,1179,Integrin alpha-1,acrosomal vesicle|plasma membrane|focal adhesion|external side of plasma membrane|cell surface|membrane|integrin alpha1-beta1 complex|neuron projection|perikaryon|membrane raft|basal part of cell|extracellular exosome|,activation of MAPK activity|cell adhesion|cell-matrix adhesion|integrin-mediated signaling pathway|negative regulation of cell proliferation|neutrophil chemotaxis|positive regulation of phosphoprotein phosphatase activity|negative regulation of epidermal growth factor receptor signaling pathway|vasodilation|positive regulation of neuron apoptotic process|cellular extravasation|neuron projection morphogenesis|,receptor binding|protein binding|protein phosphatase binding|metal ion binding|collagen binding involved in cell-matrix adhesion|,3,3,27300000,2.2%
E9PYT0,0.919618833,0.0235,1.198391673,-0.031666667,0.758858552,-0.31980958,-0.05,0.014,0.154,0.117,-0.058,-0.036,E9PYT0,Arhgap5,E9PYT0_Arhgap5,E9PYT0,Arhgap5,1,4,2,2,E9PYT0|P97393,MOUSE,173952.2,1.3,2910,2910.1,19.47,19.47,,1503,Rho GTPase-activating protein 5,intracellular|,positive regulation of mesenchymal cell proliferation|small GTPase mediated signal transduction|regulation of cell size|positive regulation of cell migration|,GTP binding|SH2 domain binding|,2,4,104000000,1.3%
Q8BVZ1,0.454052388,0.067333333,9.282506177,-0.538,0.117963971,-1.796231907,0.694,0.688,-0.373,-0.374,0.016,-0.247,Q8BVZ1,Plin5,Q8BVZ1_Plin5,Q8BVZ1,Plin5,1,4,3,3,Q8BVZ1|Q8BVZ1-2,MOUSE,51100.9,8.4,2911,2911.1,19.45,19.45,,463,Perilipin-5,cytoplasm|mitochondrion|lipid particle|cytosol|lipid particle|,lipid metabolic process|positive regulation of triglyceride biosynthetic process|positive regulation of lipid storage|positive regulation of sequestering of triglyceride|negative regulation of triglyceride catabolic process|lipid storage|negative regulation of fatty acid beta-oxidation|positive regulation of fatty acid beta-oxidation|lipid particle organization|negative regulation of peroxisome proliferator activated receptor signaling pathway|negative regulation of lipid catabolic process|mitochondrion localization|negative regulation of lipase activity|positive regulation of lipase activity|negative regulation of reactive oxygen species metabolic process|,protein binding|lipase binding|identical protein binding|,3,4,2110000000,8.4%
Q8VD31,0.000365132,-0.083166667,53.1761364,1.379,4.81267E-06,13.24337079,-0.754,-0.705,-0.859,0.539,0.765,0.515,Q8VD31,Tapbpl,Q8VD31_Tapbpl,Q8VD31,Tapbpl,1,2,2,2,Q8VD31,MOUSE,49188.1,3.7,2912,2912.1,19.41,19.41,,451,Tapasin-related protein,Golgi membrane|endoplasmic reticulum membrane|plasma membrane|integral component of membrane|,immune system process|negative regulation of antigen processing and presentation of peptide antigen via MHC class I|,protein complex binding|,2,2,213000000,3.7%
Q60809,0.399466839,0.037166667,10.43856298,0.271666667,0.090394853,1.98113033,-0.228,-0.223,0.155,0.312,0.057,0.15,Q60809,Cnot7,Q60809_Cnot7,Q60809,Cnot7,1,2,2,2,Q60809|Q3TLK9,MOUSE,33059.8,8,2913,2913.1,19.37,19.37,,285,CCR4-NOT transcription complex subunit 7,cytoplasmic mRNA processing body|nucleus|cytoplasm|membrane|CCR4-NOT complex|,"nuclear-transcribed mRNA poly(A) tail shortening|deadenylation-dependent decapping of nuclear-transcribed mRNA|transcription, DNA-templated|regulation of translation|positive regulation of cell proliferation|negative regulation of cell proliferation|negative regulation of gene expression|gene silencing by RNA|cytoplasmic mRNA processing body assembly|exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay|positive regulation of transcription from RNA polymerase II promoter|positive regulation of nuclear-transcribed mRNA poly(A) tail shortening|positive regulation of mRNA catabolic process|RNA phosphodiester bond hydrolysis, exonucleolytic|positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|",3'-5'-exoribonuclease activity|RNA binding|exoribonuclease activity|poly(A)-specific ribonuclease activity|protein binding|metal ion binding|,2,2,51000000,8.0%
Q8CF93-2,0.844723818,-0.312833333,2.430364827,0.329666667,0.571430632,0.595287707,0.261,0.128,-1.822,-0.532,0.198,-0.11,Q8CF93,Galnt13,Q8CF93-2_Galnt13,Q8CF93-2,Galnt13,1,8,3,3,Q8CF93-2|Q8CF93,MOUSE,68878.7,4,2914,2914.1,19.34,19.34,,556,Isoform 2 of Polypeptide N-acetylgalactosaminyltransferase 13,Golgi membrane|integral component of membrane|,protein O-linked glycosylation|,polypeptide N-acetylgalactosaminyltransferase activity|carbohydrate binding|metal ion binding|,3,8,7030000000,4.0%
Q8BWZ3,0.788130842,0.021833333,3.290865425,-0.111,0.46871997,-0.768489564,0.086,0.345,-0.199,-0.026,-0.005,-0.07,Q8BWZ3,Naa25,Q8BWZ3_Naa25,Q8BWZ3,Naa25,1,3,3,3,Q8BWZ3|Q8BWZ3-2,MOUSE,112732.6,3.7,2915,2915.1,19.32,19.32,,972,"N-alpha-acetyltransferase 25, NatB auxiliary subunit",nucleoplasm|cytoplasm|Golgi apparatus|,,,3,3,369000000,3.7%
Q9CPW4,0.92551138,-0.021333333,1.094646477,0.051333333,0.777204582,0.294761352,-0.248,-0.145,0.252,-0.26,0.142,0.131,Q9CPW4,Arpc5,Q9CPW4_Arpc5,Q9CPW4,Arpc5,1,2,2,2,Q9CPW4,MOUSE,16345.1,13.9,2916,2916.1,19.32,19.32,,151,Actin-related protein 2/3 complex subunit 5,cytoplasm|Arp2/3 protein complex|focal adhesion|lamellipodium|extracellular exosome|,cell migration|Arp2/3 complex-mediated actin nucleation|,structural constituent of cytoskeleton|actin filament binding|,2,2,117000000,13.9%
O89051,0.634404848,0.017166667,5.706518069,-0.126333333,0.268749827,-1.206026387,0.11,0.19,-0.059,0.039,-0.154,-0.023,O89051,Itm2b,O89051_Itm2b,O89051,Itm2b,1,3,2,2,O89051,MOUSE,30772.9,6.7,2917,2917.1,19.3,19.3,,266,Integral membrane protein 2B,extracellular space|Golgi apparatus|plasma membrane|endosome membrane|membrane|Golgi-associated vesicle membrane|integral component of organelle membrane|intracellular membrane-bounded organelle|extracellular exosome|,negative regulation of amyloid precursor protein biosynthetic process|,beta-amyloid binding|ATP binding|,2,3,136000000,6.7%
Q8R5L3,0.893904414,-0.060833333,1.701271492,0.044333333,0.675885066,0.436957136,-0.097,-0.151,-0.001,0.048,0.023,-0.187,Q8R5L3,Vps39,Q8R5L3_Vps39,Q8R5L3,Vps39,1,4,2,2,Q8R5L3|Q8R5L3-2,MOUSE,102832,3,2918,2918.1,19.25,19.25,,886,Vam6/Vps39-like protein,lysosomal membrane|HOPS complex|late endosome membrane|,intracellular protein transport|vesicle-mediated transport|,protein binding|,2,4,16900000,3.0%
Q3V1N5,0.117146007,-0.035166667,19.09057066,0.275666667,0.012329428,3.394591611,-0.107,-0.223,-0.189,0.111,0.114,0.083,Q3V1N5,Heca,Q3V1N5_Heca,Q3V1N5,Heca,1,2,2,2,Q3V1N5,MOUSE,60599.3,4,2919,2919.1,19.24,19.24,,544,"Hdc homolog, cell cycle regulator",membrane|,,,2,2,344000000,4.0%
D3YY67,0.289366522,-0.034333333,13.13908277,-0.715333333,0.0485391,-2.413189463,0.806,0.3,-0.136,-0.882,-0.073,-0.221,D3YY67,Repin1,D3YY67_Repin1,D3YY67,Repin1,1,2,2,2,D3YY67|A0A0R3P9D3|Q5U4E2,MOUSE,70058.6,4.1,2920,2920.1,19.22,19.22,,601,Replication initiator 1,nucleus|nucleoplasm|lipid particle|cytosol|cytosolic ribosome|nuclear membrane|,regulation of fatty acid transport|regulation of glucose import in response to insulin stimulus|,poly(A) RNA binding|metal ion binding|,2,2,45200000,4.1%
E9PYH6,0.622281343,-0.071,5.919548238,0.19,0.255885205,1.243581966,-0.025,0.024,-0.497,-0.054,0.052,0.074,E9PYH6,Setd1a,E9PYH6_Setd1a,E9PYH6,Setd1a,1,3,2,2,E9PYH6,MOUSE,186854.9,1.2,2922,2922.1,19.2,19.2,,1716,SET domain-containing 1A,nucleus|nucleoplasm|nuclear euchromatin|histone methyltransferase complex|Set1C/COMPASS complex|,stem cell maintenance|chromatin-mediated maintenance of transcription|histone H3-K4 methylation|positive regulation of neural precursor cell proliferation|positive regulation of stem cell proliferation|,nucleotide binding|nucleic acid binding|histone methyltransferase activity (H3-K4 specific)|euchromatin binding|histone methyltransferase activity (H3-K4 specific)|,2,3,1000000000,1.2%
Q9QXM1,0.833338863,-0.005166667,2.617368073,0.085,0.547347568,0.634009973,-0.193,-0.007,0.057,0.193,-0.201,0.12,Q9QXM1,Jmy,Q9QXM1_Jmy,Q9QXM1,Jmy,1,2,2,2,Q9QXM1|A0A0R4J0V4|Q9QXM1-3|Q9QXM1-2|A0A1Y7VLC3,MOUSE,111325.7,1.4,2923,2923.1,19.18,19.18,,983,Junction-mediating and -regulatory protein,nucleus|nucleoplasm|cytoplasm|cytoskeleton|plasma membrane|cell junction|cell leading edge|,DNA repair|regulation of transcription from RNA polymerase II promoter|cell cycle arrest|Arp2/3 complex-mediated actin nucleation|positive regulation of apoptotic process|regulation of DNA-templated transcription in response to stress|positive regulation of sequence-specific DNA binding transcription factor activity|'de novo' actin filament nucleation|actin polymerization-dependent cell motility|intrinsic apoptotic signaling pathway by p53 class mediator|,transcription coactivator activity|actin binding|protein binding|,2,2,27600000,1.4%
Q8CJ19,0.756005718,-0.132333333,3.755302312,0.344,0.421181967,0.857391682,0.005,0.367,-1.285,0.004,0.183,-0.068,Q8CJ19,Mical3,Q8CJ19_Mical3,Q8CJ19,Mical3,1,5,3,3,Q8CJ19|Q8CJ19-3|Q8CJ19-2|A0A0N4SVV2,MOUSE,224915.1,1,2925,2925.1,19.14,19.14,,1993,[F-actin]-monooxygenase MICAL3,nucleus|nucleoplasm|cytoplasm|cytoskeleton|plasma membrane|,exocytosis|cytoskeleton organization|actin filament depolymerization|oxidation-reduction process|,"actin binding|zinc ion binding|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen|Rab GTPase binding|FAD binding|",3,5,2210000000,1.0%
Q9D787,0.620776556,-0.048666667,5.942169937,0.191333333,0.254555806,1.247440456,-0.263,0.193,-0.363,0.057,0.021,0.063,Q9D787,Ppil2,Q9D787_Ppil2,Q9D787,Ppil2,1,5,3,3,Q9D787|D3YZQ4,MOUSE,59577,7.8,2926,2926.1,19.12,19.12,,521,Peptidyl-prolyl cis-trans isomerase-like 2,nucleus|nucleoplasm|cytoplasm|plasma membrane|,protein polyubiquitination|protein peptidyl-prolyl isomerization|protein folding|protein localization to plasma membrane|,peptidyl-prolyl cis-trans isomerase activity|ubiquitin-protein transferase activity|ligase activity|ubiquitin-ubiquitin ligase activity|ubiquitin protein ligase activity|,3,5,187000000,7.8%
Q6ZPR6,0.609221717,0.009166667,6.188517566,0.156333333,0.240518365,1.289282748,-0.129,0.137,-0.215,0.204,0.055,0.003,Q6ZPR6,Ibtk,Q6ZPR6_Ibtk,Q6ZPR6,Ibtk,1,3,3,3,Q6ZPR6|Q6ZPR6-2|A0A087WNN3,MOUSE,151677.1,2.2,2927,2927.1,19.1,19.1,,1352,Inhibitor of Bruton tyrosine kinase,nucleoplasm|cytoplasm|membrane|,negative regulation of protein phosphorylation|release of sequestered calcium ion into cytosol|negative regulation of protein tyrosine kinase activity|,protein kinase binding|protein tyrosine kinase inhibitor activity|,3,3,64000000,2.2%
P61963,0.900174519,0.004833333,1.606905968,-0.035,0.690731725,-0.415546821,0.062,-0.032,0.037,-0.023,-0.07,0.055,P61963,Dcaf7,P61963_Dcaf7,P61963,Dcaf7,1,2,2,2,P61963,MOUSE,39553.1,5.5,2928,2928.1,19.08,19.08,,342,DDB1- and CUL4-associated factor 7,nucleoplasm|cytoplasm|nuclear matrix|protein complex|Cul4-RING E3 ubiquitin ligase complex|,multicellular organismal development|protein ubiquitination|,,2,2,75100000,5.5%
Q8C129,0.450672886,-0.034,9.360589188,-0.352666667,0.115862016,-1.808755432,0.299,0.351,-0.223,-0.026,-0.118,-0.487,Q8C129,Lnpep,Q8C129_Lnpep,Q8C129,Lnpep,1,4,2,2,Q8C129|Q9QYM8,MOUSE,117872.3,1.2,2929,2929.1,19.08,19.08,,1025,Leucyl-cystinyl aminopeptidase,intracellular|lysosomal membrane|plasma membrane|endomembrane system|membrane|integral component of membrane|cytoplasmic vesicle membrane|perinuclear region of cytoplasm|,proteolysis|protein catabolic process|SMAD protein signal transduction|,aminopeptidase activity|protein binding|metallopeptidase activity|zinc ion binding|,2,4,6360000000,1.2%
K3W4P2,0.419379228,0.069166667,9.977510353,0.255666667,0.100519186,1.907497827,0.042,0.003,-0.221,0.4,-0.003,0.194,K3W4P2,Ints1,K3W4P2_Ints1,K3W4P2,Ints1,1,2,2,2,A0A0G2JH17|K3W4P2|Q6P4S8,MOUSE,249819.2,1.6,2930,2930.1,19.06,19.06,,2220,Integrator complex subunit 1,nucleus|membrane|integrator complex|,blastocyst growth|inner cell mass cell proliferation|snRNA processing|U2 snRNA 3'-end processing|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|,,2,2,29900000,1.6%
P61514,0.611607456,0.0855,6.159383542,-0.249,0.242137272,-1.284350668,-0.195,0.512,0.313,-0.052,0.126,-0.191,P61514,Rpl37a,P61514_Rpl37a,P61514,Rpl37a,1,3,2,2,P61514,MOUSE,10503.3,28.2,2931,2931.1,18.97,18.97,,92,60S ribosomal protein L37a,nucleus|focal adhesion|cytosolic large ribosomal subunit|extracellular exosome|,translation|,structural constituent of ribosome|poly(A) RNA binding|metal ion binding|,2,3,538000000,28.2%
Q80W93,0.443938694,0.094666667,9.520406539,-0.470666667,0.11167587,-1.834367679,-0.043,0.143,0.89,-0.393,-0.097,0.068,Q80W93,Hydin,Q80W93_Hydin,Q80W93,Hydin,1,7,3,3,Q80W93|Q80W93-2,MOUSE,587046.8,0.5,2932,2932.1,18.93,18.93,,5154,Hydrocephalus-inducing protein,axonemal central pair projection|,epithelial cell development|cilium movement|multicellular organismal development|ventricular system development|axoneme assembly|trachea development|,,3,7,5520000000,0.5%
Q80WW9,0.915900752,0.014666667,1.299041657,-0.048666667,0.741473842,-0.34405509,-0.237,0.063,0.291,-0.014,-0.035,0.02,Q80WW9,Ddrgk1,Q80WW9_Ddrgk1,Q80WW9,Ddrgk1,1,2,2,2,Q80WW9,MOUSE,35976.6,10.1,2933,2933.1,18.93,18.93,,315,DDRGK domain-containing protein 1,endoplasmic reticulum|endoplasmic reticulum membrane|,regulation of intracellular estrogen receptor signaling pathway|response to endoplasmic reticulum stress|positive regulation of NF-kappaB transcription factor activity|positive regulation of proteasomal protein catabolic process|positive regulation of I-kappaB phosphorylation|protein K69-linked ufmylation|,ubiquitin-like protein ligase binding|,2,2,16800000,10.1%
Q8VIK2,0.856747233,0.014166667,2.281352885,-0.096333333,0.591377384,-0.563940828,0.247,0.268,-0.328,-0.086,-0.003,-0.013,Q8VIK2,Mpv17l2,Q8VIK2_Mpv17l2,Q8VIK2,Mpv17l2,1,2,2,2,Q8VIK2,MOUSE,22799.1,13.5,2934,2934.1,18.93,18.93,,200,Mpv17-like protein 2,mitochondrion|mitochondrial inner membrane|mitochondrial large ribosomal subunit|integral component of membrane|,mitochondrial ribosome assembly|positive regulation of mitochondrial translation|,,2,2,25400000,13.5%
D3YUV9,0.993378838,-0.017333333,0.110276512,0.005333333,0.974927563,0.032635218,0.072,0.233,-0.365,0.013,0.06,-0.117,D3YUV9,Eif4e2,D3YUV9_Eif4e2,D3YUV9,Eif4e2,1,2,2,2,D3YUV9|Q8BMB3|Q0P688|D3Z729|G3X9H1|Q3UUT0|D3Z730,MOUSE,29676.9,8.1,2935,2935.1,18.92,18.92,,259,Eukaryotic translation initiation factor 4E type 2,cytoplasm|mRNA cap binding complex|,in utero embryonic development|translational initiation|negative regulation of translation|,translation initiation factor activity|ubiquitin protein ligase binding|poly(A) RNA binding|,2,2,33500000,8.1%
P53808,0.624979742,0.048333333,5.874523985,0.203333333,0.258551821,1.235893957,0.083,0.171,-0.414,0.059,0.18,0.211,P53808,NotFound,P53808_NotFound,P53808,Pctp,1,2,2,2,P53808|Q5SV41,MOUSE,25070.1,12.1,2936,2936.1,18.91,18.91,,214,Phosphatidylcholine transfer protein,cytoplasm|,cholesterol metabolic process|phospholipid transport|,phosphatidylcholine transporter activity|phosphatidylcholine binding|,2,2,39200000000,12.1%
Q3UHX2,0.797504707,0.018,3.101266873,-0.126666667,0.489635968,-0.731353034,-0.155,0.251,0.148,-0.053,-0.317,0.234,Q3UHX2,Pdap1,Q3UHX2_Pdap1,Q3UHX2,Pdap1,1,2,2,2,Q3UHX2,MOUSE,20604.5,13.2,2937,2937.1,18.91,18.91,,181,28 kDa heat- and acid-stable phosphoprotein,extracellular space|,platelet-derived growth factor receptor signaling pathway|,poly(A) RNA binding|platelet-derived growth factor binding|,2,2,133000000,13.2%
Q7TSI1,0.597715057,0.016,6.383618323,0.216666667,0.229952517,1.322204061,0.027,0.03,-0.334,0.115,0.376,-0.118,Q7TSI1,Plekhm1,Q7TSI1_Plekhm1,Q7TSI1,Plekhm1,1,3,3,3,Q7TSI1,MOUSE,120643.4,2.6,2938,2938.1,18.83,18.83,,1074,Pleckstrin homology domain-containing family M member 1,lysosomal membrane|endosome membrane|,autophagy|protein transport|intracellular signal transduction|,metal ion binding|,3,3,44000000,2.6%
Q9WVA2,0.034336129,-0.022333333,25.61219631,0.510666667,0.002746505,4.619863762,-0.337,-0.196,-0.3,0.377,0.055,0.267,Q9WVA2,Timm8a1,Q9WVA2_Timm8a1,Q9WVA2,Timm8a1,1,2,2,2,Q9WVA2,MOUSE,11270.5,22.6,2939,2939.1,18.83,18.83,,97,Mitochondrial import inner membrane translocase subunit Tim8 A,mitochondrial inner membrane|,protein transport|,metal ion binding|,2,2,74600000,22.6%
Q6A0D4,0.979750503,-0.0085,0.313983294,0.012333333,0.930254267,0.090908975,-0.126,-0.089,0.171,0.093,-0.223,0.123,Q6A0D4,Rftn1,Q6A0D4_Rftn1,Q6A0D4,Rftn1,1,2,2,2,Q6A0D4,MOUSE,61992.4,4.8,2941,2941.1,18.74,18.74,,554,Raftlin,cytoplasm|endosome|plasma membrane|protein complex|membrane raft|extracellular exosome|,membrane raft assembly|T cell antigen processing and presentation|protein transport into membrane raft|interleukin-17 production|dsRNA transport|toll-like receptor 3 signaling pathway|growth|response to exogenous dsRNA|T cell receptor signaling pathway|B cell receptor signaling pathway|protein localization to membrane raft|,double-stranded RNA binding|,2,2,40400000,4.8%
Q99MJ9,0.717934984,0.041666667,4.248781933,0.116,0.37594283,0.949056068,-0.166,0.07,0.047,0.165,-0.093,0.227,Q99MJ9,Ddx50,Q99MJ9_Ddx50,Q99MJ9,Ddx50,1,5,3,3,Q99MJ9,MOUSE,82744.6,5.8,2943,2943.1,18.72,18.72,,734,ATP-dependent RNA helicase DDX50,nucleolus|plasma membrane|membrane|,RNA secondary structure unwinding|,ATP-dependent RNA helicase activity|ATP binding|poly(A) RNA binding|,3,5,239000000,5.8%
Q9D7A8,0.600763538,-0.0735,6.335527448,0.238333333,0.232513008,1.314106154,-0.129,0.132,-0.581,0.002,0.01,0.125,Q9D7A8,Armc1,Q9D7A8_Armc1,Q9D7A8,Armc1,1,6,2,2,Q9D7A8,MOUSE,31474.2,10.9,2944,2944.1,18.69,18.69,,282,Armadillo repeat-containing protein 1,mitochondrion|,metal ion transport|,metal ion binding|,2,6,337000000,10.9%
A2A8R7,0.094490768,-0.0035,20.34847198,0.589,0.009228961,3.631581137,-0.079,-0.348,-0.467,0.579,0.126,0.168,A2A8R7,Tut4,A2A8R7_Tut4,A2A8R7,Zcchc11,1,2,2,2,A2A8R7|B2R4,MOUSE,187918.5,1.9,2945,2945.1,18.68,18.68,,1648,Terminal uridylyltransferase 4,extracellular space|nucleus|nucleolus|cytoplasm|extracellular exosome|,cytokine production|miRNA catabolic process|stem cell maintenance|pre-miRNA processing|RNA 3'-end processing|regulation of lipopolysaccharide-mediated signaling pathway|negative regulation of NF-kappaB transcription factor activity|,protein binding|zinc ion binding|poly(A) RNA binding|RNA uridylyltransferase activity|,2,2,39600000,1.9%
Q8BG09,0.424073513,0.0455,9.893715226,-0.433,0.102477489,-1.89410348,-0.044,0.101,0.729,-0.428,-0.155,0.07,Q8BG09,Tmem184b,Q8BG09_Tmem184b,Q8BG09,Tmem184b,1,4,2,2,Q8BG09,MOUSE,46272.5,3.9,2947,2947.1,18.66,18.66,,407,Transmembrane protein 184B,integral component of membrane|,,,2,4,147000000,3.9%
E9Q309,0.003655388,0.076333333,37.17240594,1.532666667,0.000191761,7.428762886,-0.687,-0.633,-0.75,0.438,1.283,0.807,E9Q309,Cep350,E9Q309_Cep350,E9Q309,Cep350,1,5,3,3,E9Q309|Q8VI16,MOUSE,348504.1,0.6,2948,2948.1,18.64,18.64,,3095,Centrosome-associated protein 350,nucleoplasm|cytoplasm|centrosome|membrane|,microtubule anchoring|,microtubule binding|,3,5,663000000,0.6%
Q9JI60,0.885307507,-0.0455,1.825601764,0.081,0.656810102,0.465041474,0.2,0.005,-0.463,0.038,0.042,-0.095,Q9JI60,Lrat,Q9JI60_Lrat,Q9JI60,Lrat,1,2,2,2,Q9JI60,MOUSE,26105,17.7,2949,2949.1,18.61,18.61,,231,Lecithin retinol acyltransferase,multivesicular body|endoplasmic reticulum membrane|rough endoplasmic reticulum|integral component of membrane|perinuclear region of cytoplasm|,"1,2-diacyl-sn-glycero-3-phosphocholine metabolic process|vitamin A metabolic process|visual perception|positive regulation of lipid transport|retinol metabolic process|retinoic acid metabolic process|response to stimulus|",retinoic acid binding|O-acyltransferase activity|retinol binding|phosphatidylcholine-retinol O-acyltransferase activity|,2,2,16800000,17.7%
Q99PL6,0.963376742,-0.007833333,0.497581769,-0.014333333,0.891747341,-0.141355274,0.083,0.041,-0.126,-0.108,-0.029,0.092,Q99PL6,Ubxn6,Q99PL6_Ubxn6,Q99PL6,Ubxn6,1,5,2,2,Q99PL6|Q99PL6-2,MOUSE,50023,6.1,2950,2950.1,18.6,18.6,,442,UBX domain-containing protein 6,nucleus|nucleolus|cytoplasm|microtubule organizing center|extracellular exosome|,,,2,5,34900000,6.1%
Q9Z321,0.888022593,-0.080833333,1.785101707,0.086333333,0.662963822,0.456010816,-0.335,-0.299,0.262,-0.231,-0.038,0.156,Q9Z321,Top3b,Q9Z321_Top3b,Q9Z321,Top3b,1,2,2,2,Q9Z321,MOUSE,98830.2,4,2951,2951.1,18.55,18.55,,862,DNA topoisomerase 3-beta-1,condensed chromosome|nucleus|nucleoplasm|,DNA topological change|chromosome segregation|,DNA binding|DNA topoisomerase type I activity|poly(A) RNA binding|,2,2,16800000,4.0%
Q8R3I3,0.472645993,0.001833333,8.733886756,-0.217666667,0.133847827,-1.708016772,0.185,-0.091,0.238,0.06,-0.182,-0.199,Q8R3I3,Cog6,Q8R3I3_Cog6,Q8R3I3,Cog6,1,2,2,2,Q8R3I3|A0A0R4J0L5|Q8BRB0,MOUSE,73494.9,3.3,2952,2952.1,18.53,18.53,,657,Conserved oligomeric Golgi complex subunit 6,Golgi membrane|Golgi transport complex|,intra-Golgi vesicle-mediated transport|protein transport|glycosylation|,,2,2,54500000,3.3%
Q8VDM1,0.90651412,0.000666667,1.519693073,0.043333333,0.704742873,0.395583443,0.001,0.078,-0.142,0.102,-0.135,0.1,Q8VDM1,Zgpat,Q8VDM1_Zgpat,Q8VDM1,Zgpat,1,4,2,2,Q8VDM1,MOUSE,56923.3,3.5,2953,2953.1,18.53,18.53,,511,Zinc finger CCCH-type with G patch domain-containing protein,nucleus|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|negative regulation of epidermal growth factor-activated receptor activity|negative regulation of transcription, DNA-templated|",RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription|sequence-specific DNA binding transcription factor activity|sequence-specific DNA binding|metal ion binding|,2,4,231000000,3.5%
Q7TMV3,0.862027405,-0.034333333,2.199210219,0.05,0.602669174,0.546154499,-0.006,-0.182,0.01,0.019,0.006,-0.053,Q7TMV3,Fastkd5,Q7TMV3_Fastkd5,Q7TMV3,Fastkd5,1,3,3,3,A0A0R4J291|Q7TMV3,MOUSE,87397.4,3.1,2955,2955.1,18.51,18.51,,762,"FAST kinase domain-containing protein 5, mitochondrial",mitochondrion|,protein phosphorylation|cellular respiration|,protein kinase activity|poly(A) RNA binding|,3,3,61400000,3.1%
E9Q2E4,0.515087795,0.114,7.883961722,-0.678,0.162781043,-1.570306071,-0.197,0.097,1.459,-0.171,-0.59,0.086,E9Q2E4,Hectd4,E9Q2E4_Hectd4,E9Q2E4,Hectd4,1,7,4,4,E9Q2E4,MOUSE,490395.8,0.8,2956,2956.1,18.51,18.51,,4418,HECT domain E3 ubiquitin protein ligase 4,cytoplasm|,protein ubiquitination involved in ubiquitin-dependent protein catabolic process|,ubiquitin-protein transferase activity|ligase activity|,4,7,2350000000,0.8%
B2RR83,0.745264968,-0.032666667,3.882846728,-0.109333333,0.408992484,-0.881339772,-0.074,0.009,0.131,-0.029,-0.303,0.07,B2RR83,Ythdc2,B2RR83_Ythdc2,B2RR83,Ythdc2,1,3,3,3,B2RR83,MOUSE,162458.5,2.9,2957,2957.1,18.5,18.5,,1445,Probable ATP-dependent RNA helicase YTHDC2,cytoplasm|endoplasmic reticulum|endoplasmic reticulum|,RNA processing|response to tumor necrosis factor|positive regulation by host of viral genome replication|response to interleukin-1|,ATP-dependent RNA helicase activity|ATP binding|RNA-dependent ATPase activity|poly(A) RNA binding|RNA polymerase binding|,3,3,66200000,2.9%
Q9ERV1,0.009138075,-0.009166667,32.6258151,0.641666667,0.000546284,6.175922668,-0.352,-0.166,-0.472,0.275,0.316,0.344,Q9ERV1,Mkrn2,Q9ERV1_Mkrn2,Q9ERV1,Mkrn2,1,2,2,2,Q9ERV1,MOUSE,47965.3,4.8,2958,2958.1,18.5,18.5,,416,Probable E3 ubiquitin-protein ligase makorin-2,intracellular|,protein ubiquitination|,zinc ion binding|ligase activity|poly(A) RNA binding|,2,2,41400000,4.8%
Q7TNV0,0.961523652,0.007,0.529820068,-0.014666667,0.885152282,-0.150038901,-0.021,-0.065,0.129,-0.016,-0.083,0.098,Q7TNV0,Dek,Q7TNV0_Dek,Q7TNV0,Dek,1,2,2,2,Q7TNV0,MOUSE,43386,5.2,2959,2959.1,18.46,18.46,,380,Protein DEK,nucleus|contractile fiber|,chromatin modification|regulation of double-strand break repair|regulation of double-strand break repair via nonhomologous end joining|,DNA binding|histone binding|poly(A) RNA binding|,2,2,33300000,5.2%
G5E8V9,0.002692004,0.026333333,38.81190814,1.007333333,0.000131465,7.90909365,-0.282,-0.615,-0.535,0.389,0.517,0.684,G5E8V9,Arfip1,G5E8V9_Arfip1,G5E8V9,Arfip1,1,3,2,2,G5E8V9|E9Q3G5|A2RSX9|E9QAY5,MOUSE,41631.4,4.2,2960,2960.1,18.44,18.44,,373,ADP-ribosylation factor-interacting protein 1,trans-Golgi network membrane|,regulation of protein secretion|,protein domain specific binding|phosphatidylinositol-4-phosphate binding|,2,3,3540000000,4.2%
Q8BUY5,0.951421295,0.008666667,0.722467126,0.021333333,0.846746261,0.200910414,-0.058,0.184,-0.132,0.021,0.01,0.027,Q8BUY5,Timmdc1,Q8BUY5_Timmdc1,Q8BUY5,Timmdc1,1,6,2,2,Q8BUY5,MOUSE,31847.5,8.4,2961,2961.1,18.43,18.43,,285,"Complex I assembly factor TIMMDC1, mitochondrial",nucleoplasm|mitochondrion|integral component of membrane|mitochondrial membrane|,,,2,6,775000000,8.4%
Q8BHL5-3,0.977234082,-0.060166667,0.339719895,0.012333333,0.924757816,0.098098753,0,0.039,-0.238,0.112,-0.054,-0.22,Q8BHL5,Elmo2,Q8BHL5-3_Elmo2,Q8BHL5-3,Elmo2,1,2,2,2,Q8BHL5-3|Q8BHL5|Q8BHL5-2,MOUSE,92162,2.1,2962,2962.1,18.42,18.42,,732,Isoform 3 of Engulfment and cell motility protein 2,cytoplasm|cytosol|membrane|,phagocytosis|apoptotic process|cytoskeleton organization|cell chemotaxis|cell-cell adhesion|,SH3 domain binding|receptor tyrosine kinase binding|,2,2,180000000,2.1%
O35350,0.530524264,0.041,7.611703571,0.213333333,0.173312403,1.525835938,-0.081,0.071,-0.187,0.03,0.003,0.41,O35350,Capn1,O35350_Capn1,O35350,Capn1,1,4,4,4,O35350,MOUSE,82789.5,4.4,2963,2963.1,18.39,18.39,,713,Calpain-1 catalytic subunit,cytoplasm|mitochondrion|lysosome|cytosol|plasma membrane|focal adhesion|membrane|extracellular exosome|,proteolysis|protein autoprocessing|receptor catabolic process|mammary gland involution|,calcium-dependent cysteine-type endopeptidase activity|calcium ion binding|protein binding|cytoskeletal protein binding|,4,4,37600000,4.4%
Q60692,0.447813439,-0.0795,9.446207207,0.222333333,0.113600248,1.822479801,-0.107,-0.095,-0.37,0.059,0.162,-0.126,Q60692,Psmb6,Q60692_Psmb6,Q60692,Psmb6,1,4,3,3,Q60692,MOUSE,25606.5,12.1,2964,2964.1,18.38,18.38,,238,Proteasome subunit beta type-6,proteasome complex|nucleus|nucleoplasm|cytoplasm|Golgi apparatus|cytosol|proteasome core complex|extracellular exosome|,proteasomal ubiquitin-independent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|,endopeptidase activity|threonine-type endopeptidase activity|,3,4,50500000,12.1%
Q80UW5,0.211523046,0.0215,15.51596989,0.401666667,0.028080382,2.800487947,-0.05,-0.115,-0.373,0.354,-0.021,0.334,Q80UW5,Cdc42bpg,Q80UW5_Cdc42bpg,Q80UW5,Cdc42bpg,1,3,3,3,Q80UW5,MOUSE,173684.2,1.9,2966,2966.1,18.35,18.35,,1551,Serine/threonine-protein kinase MRCK gamma,cytoplasm|cell leading edge|,protein phosphorylation|actin cytoskeleton reorganization|intracellular signal transduction|,magnesium ion binding|protein serine/threonine kinase activity|ATP binding|,3,3,52400000,1.9%
F8VQ05,0.919618833,-0.000166667,1.191053257,-0.054333333,0.760141904,-0.318191259,-0.225,-0.06,0.366,-0.005,-0.19,0.113,F8VQ05,Fryl,F8VQ05_Fryl,F8VQ05,Fryl,1,3,2,2,F8VQ05,MOUSE,340950.9,0.8,2967,2967.1,18.33,18.33,,3007,FRY-like transcription coactivator,cell cortex|site of polarized growth|,cell morphogenesis|neuron projection development|actin filament reorganization|,,2,3,24800000,0.8%
E9PUJ6,0.929192436,0.040666667,1.012608079,0.034,0.792025551,0.274558338,-0.186,0.046,0.211,0.146,-0.032,0.059,E9PUJ6,Mycbp2,E9PUJ6_Mycbp2,E9PUJ6,Mycbp2,1,2,2,2,E9PUJ6|Q7TPH6|Q7TPH6-2,MOUSE,529004.7,0.5,2968,2968.1,18.32,18.32,,4746,E3 ubiquitin-protein ligase MYCBP2,microtubule cytoskeleton|membrane|axon|,motor neuron axon guidance|protein ubiquitination|branchiomotor neuron axon guidance|central nervous system projection neuron axonogenesis|regulation of protein localization|negative regulation of protein catabolic process|cell morphogenesis involved in neuron differentiation|regulation of cytoskeleton organization|,ubiquitin-protein transferase activity|protein binding|zinc ion binding|protein homodimerization activity|,2,2,44600000,0.5%
Q9DAA6,0.468018408,0.025833333,8.956775304,-0.284333333,0.127151787,-1.743907613,-0.075,0.109,0.47,-0.202,-0.219,0.072,Q9DAA6,Exosc1,Q9DAA6_Exosc1,Q9DAA6,Exosc1,1,3,2,2,Q9DAA6|Q9DAA6-2,MOUSE,21765.6,13.8,2971,2971.1,18.3,18.3,,195,Exosome complex component CSL4,nuclear exosome (RNase complex)|exosome (RNase complex)|nucleus|nucleoplasm|nucleolus|cytoplasm|,rRNA processing|RNA processing|,RNA binding|protein binding|,2,3,18800000,13.8%
Q9Z1E4,0.661825967,0.065,5.156988665,-0.274666667,0.305000909,-1.111712516,-0.036,0.645,-0.002,0.248,-0.008,-0.457,Q9Z1E4,Gys1,Q9Z1E4_Gys1,Q9Z1E4,Gys1,1,4,2,2,Q9Z1E4|A0A1B0GT92,MOUSE,84723.9,1.8,2972,2972.1,18.29,18.29,,738,"Glycogen [starch] synthase, muscle",cytoplasm|membrane|inclusion body|,glycogen biosynthetic process|heart development|,"glycogen (starch) synthase activity|protein binding|glucose binding|protein kinase binding|glycogen synthase activity, transferring glucose-1-phosphate|",2,4,141000000,1.8%
P21803,0.184900222,0.002333333,16.46389133,-0.250666667,0.022574122,-2.948405865,0.189,0.047,0.147,-0.085,-0.167,-0.117,P21803,Fgfr2,P21803_Fgfr2,P21803,Fgfr2,1,8,2,2,P21803|P21803-2,MOUSE,93066.3,3.5,2973,2973.1,18.28,18.28,,821,Fibroblast growth factor receptor 2,extracellular region|nucleus|nucleoplasm|cytoplasm|Golgi apparatus|integral component of plasma membrane|cell cortex|cell surface|cytoplasmic membrane-bounded vesicle|intracellular membrane-bounded organelle|excitatory synapse|extracellular matrix|,negative regulation of transcription from RNA polymerase II promoter|angiogenesis|ureteric bud development|in utero embryonic development|positive regulation of mesenchymal cell proliferation|outflow tract septum morphogenesis|membranous septum morphogenesis|apoptotic process|cell-cell signaling|axonogenesis|neuromuscular junction development|positive regulation of cell proliferation|negative regulation of cell proliferation|fibroblast growth factor receptor signaling pathway|regulation of smoothened signaling pathway|post-embryonic development|embryonic pattern specification|organ morphogenesis|regulation of cell fate commitment|positive regulation of phospholipase activity|morphogenesis of embryonic epithelium|peptidyl-tyrosine phosphorylation|orbitofrontal cortex development|ventricular zone neuroblast division|pyramidal neuron development|gland morphogenesis|positive regulation of Wnt signaling pathway|bone mineralization|lung development|epithelial cell differentiation|midbrain development|otic vesicle formation|hair follicle morphogenesis|lacrimal gland development|multicellular organism growth|organ growth|fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow|fibroblast growth factor receptor signaling pathway involved in hemopoiesis|fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow|fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development|regulation of multicellular organism growth|regulation of fibroblast growth factor receptor signaling pathway|regulation of cell proliferation|inner ear morphogenesis|odontogenesis|positive regulation of MAPK cascade|cell fate commitment|positive regulation of cell cycle|negative regulation of mitotic nuclear division|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|lung alveolus development|synaptic vesicle transport|embryonic digestive tract morphogenesis|embryonic organ morphogenesis|digestive tract development|embryonic organ development|reproductive structure development|embryonic cranial skeleton morphogenesis|epidermis morphogenesis|branching morphogenesis of a nerve|mesenchymal cell differentiation|epithelial cell proliferation|regulation of epithelial cell proliferation|positive regulation of epithelial cell proliferation|regulation of smooth muscle cell differentiation|positive regulation of cell division|ventricular cardiac muscle tissue morphogenesis|positive regulation of cardiac muscle cell proliferation|limb bud formation|bone development|bone morphogenesis|coronal suture morphogenesis|epithelial tube branching involved in lung morphogenesis|branching involved in prostate gland morphogenesis|branching involved in salivary gland morphogenesis|bud elongation involved in lung branching|lung lobe morphogenesis|lung-associated mesenchyme development|positive regulation of epithelial cell proliferation involved in lung morphogenesis|prostate gland morphogenesis|prostate epithelial cord elongation|prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis|squamous basal epithelial stem cell differentiation involved in prostate gland acinus development|fibroblast growth factor receptor signaling pathway involved in mammary gland specification|lateral sprouting from an epithelium|mammary gland bud formation|epithelial cell proliferation involved in salivary gland morphogenesis|branch elongation involved in salivary gland morphogenesis|branching involved in labyrinthine layer morphogenesis|regulation of branching involved in prostate gland morphogenesis|regulation of morphogenesis of a branching structure|mesenchymal cell differentiation involved in lung development|mesenchymal cell proliferation involved in lung development|vasculogenesis involved in coronary vascular morphogenesis|endodermal digestive tract morphogenesis|lens fiber cell development|regulation of ERK1 and ERK2 cascade|positive regulation of ERK1 and ERK2 cascade|positive regulation of canonical Wnt signaling pathway|,fibroblast growth factor-activated receptor activity|protein binding|ATP binding|heparin binding|fibroblast growth factor binding|protein homodimerization activity|,2,8,6710000000,3.5%
Q8K561,0.905685074,-0.038333333,1.534500906,-0.118666667,0.702344053,-0.399150943,-0.191,-0.183,0.437,-0.704,0.136,0.275,Q8K561,Otoa,Q8K561_Otoa,Q8K561,Otoa,1,9,3,3,Q8K561,MOUSE,127625.8,4.5,2974,2974.1,18.27,18.27,,1137,Otoancorin,proteinaceous extracellular matrix|apical plasma membrane|anchored component of membrane|,cell-matrix adhesion|sensory perception of sound|transmission of nerve impulse|,,3,9,17100000000,4.5%
Q04690,0.983717661,0.002833333,0.250462532,0.009666667,0.943960337,0.073002965,-0.017,0.224,-0.213,-0.074,0.124,-0.027,Q04690,Nf1,Q04690_Nf1,Q04690,Nf1,1,8,2,2,Q04690|Q04690-2|Q04690-3|Q04690-4,MOUSE,323298.3,0.5,2975,2975.1,18.27,18.27,,2841,Neurofibromin,nucleolus|cytoplasm|membrane|axon|dendrite|intrinsic component of the cytoplasmic side of the plasma membrane|,"MAPK cascade|osteoblast differentiation|metanephros development|response to hypoxia|liver development|negative regulation of endothelial cell proliferation|positive regulation of endothelial cell proliferation|regulation of cell-matrix adhesion|negative regulation of cell-matrix adhesion|negative regulation of protein kinase activity|cell communication|Ras protein signal transduction|negative regulation of neuroblast proliferation|brain development|peripheral nervous system development|heart development|skeletal muscle tissue development|negative regulation of cell proliferation|visual learning|extrinsic apoptotic signaling pathway via death domain receptors|regulation of gene expression|Schwann cell development|phosphatidylinositol 3-kinase signaling|negative regulation of angiogenesis|spinal cord development|amygdala development|forebrain astrocyte development|neural tube development|cerebral cortex development|myelination in peripheral nervous system|actin cytoskeleton organization|extracellular matrix organization|collagen fibril organization|adrenal gland development|negative regulation of cell migration|regulation of synaptic transmission, GABAergic|cellular response to heat|negative regulation of Rac protein signal transduction|wound healing|regulation of cell proliferation|negative regulation of transcription factor import into nucleus|positive regulation of apoptotic process|regulation of GTPase activity|negative regulation of MAP kinase activity|regulation of MAPK cascade|negative regulation of MAPK cascade|pigmentation|positive regulation of neuron apoptotic process|regulation of blood vessel endothelial cell migration|positive regulation of GTPase activity|regulation of bone resorption|negative regulation of osteoclast differentiation|regulation of glial cell differentiation|positive regulation of adenylate cyclase activity|regulation of angiogenesis|negative regulation of Ras protein signal transduction|negative regulation of neurotransmitter secretion|negative regulation of fibroblast proliferation|regulation of long-term neuronal synaptic plasticity|sympathetic nervous system development|camera-type eye morphogenesis|negative regulation of astrocyte differentiation|negative regulation of oligodendrocyte differentiation|smooth muscle tissue development|artery morphogenesis|forebrain morphogenesis|cognition|gamma-aminobutyric acid secretion, neurotransmission|glutamate secretion, neurotransmission|observational learning|regulation of long-term synaptic potentiation|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand|",GTPase activator activity|protein binding|microtubule binding|phosphatidylethanolamine binding|phosphatidylcholine binding|,2,8,3840000000,0.5%
Q61263,0.876336175,0.108666667,1.993809782,0.123333333,0.631857321,0.502107821,-0.141,-0.187,0.469,0.592,-0.101,0.02,Q61263,Soat1,Q61263_Soat1,Q61263,Soat1,1,2,2,2,Q61263,MOUSE,64368.3,3.7,2977,2977.1,18.24,18.24,,540,Sterol O-acyltransferase 1,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,cholesterol metabolic process|macrophage derived foam cell differentiation|cholesterol storage|cholesterol efflux|very-low-density lipoprotein particle assembly|cholesterol esterification|cholesterol homeostasis|positive regulation of amyloid precursor protein biosynthetic process|,fatty-acyl-CoA binding|sterol O-acyltransferase activity|cholesterol binding|cholesterol O-acyltransferase activity|,2,2,112000000,3.7%
O35130,0.297132915,-0.093,12.82138811,0.429333333,0.052222925,2.362085263,-0.185,-0.092,-0.646,-0.129,0.268,0.226,O35130,Emg1,O35130_Emg1,O35130,Emg1,1,2,2,2,O35130,MOUSE,27259.1,6.1,2979,2979.1,18.22,18.22,,244,Ribosomal RNA small subunit methyltransferase NEP1,nucleolus|small-subunit processome|,blastocyst development|nucleologenesis|rRNA methylation|rRNA base methylation|,rRNA binding|poly(A) RNA binding|rRNA (pseudouridine) methyltransferase activity|,2,2,4770000000,6.1%
Q8BGV8,0.578909417,0.0035,6.781405608,0.269666667,0.209826067,1.388790926,0.013,0.036,-0.443,0.474,-0.065,0.006,Q8BGV8,Mief1,Q8BGV8_Mief1,Q8BGV8,Mief1,1,2,2,2,Q8BGV8,MOUSE,51639.6,4.1,2980,2980.1,18.2,18.2,,463,Mitochondrial dynamics protein MID51,mitochondrion|mitochondrial outer membrane|integral component of membrane|,mitochondrial fission|positive regulation of mitochondrial fission|positive regulation of protein targeting to membrane|,GDP binding|identical protein binding|ADP binding|,2,2,36700000,4.1%
Q8BPU7,0.195452263,-0.035333333,16.09497105,0.360666667,0.02457553,2.896542757,-0.039,-0.201,-0.407,0.22,0.006,0.209,Q8BPU7,Elmo1,Q8BPU7_Elmo1,Q8BPU7,Elmo1,1,4,2,2,Q8BPU7|Q8BPU7-3,MOUSE,84675.8,3.1,2981,2981.1,18.19,18.19,,727,Engulfment and cell motility protein 1,cytoplasm|plasma membrane|membrane|guanyl-nucleotide exchange factor complex|,"phagocytosis|phagocytosis, engulfment|apoptotic process|movement of cell or subcellular component|cell migration|Rac protein signal transduction|actin filament-based process|actin cytoskeleton organization|",protein binding|SH3 domain binding|,2,4,19200000,3.1%
A0A087WR24,0.234019027,-0.0695,14.68234893,0.313,0.034022413,2.662004067,-0.198,-0.048,-0.432,0.046,0.069,0.146,A0A087WR24,Edem3,A0A087WR24_Edem3,A0A087WR24,Edem3,1,3,3,3,A0A087WR24|Q2HXL6|A0A087WQK5|B7ZNP0,MOUSE,106696.6,3.5,2984,2984.1,18.12,18.12,,947,"alpha-1,2-Mannosidase",endoplasmic reticulum lumen|membrane|,N-glycan processing|glycoprotein catabolic process|ER-associated ubiquitin-dependent protein catabolic process|endoplasmic reticulum unfolded protein response|proteasome-mediated ubiquitin-dependent protein catabolic process|glycoprotein ERAD pathway|,"glycoprotein endo-alpha-1,2-mannosidase activity|mannosyl-oligosaccharide 1,2-alpha-mannosidase activity|calcium ion binding|",3,3,64200000,3.5%
E9Q1W3,0.683824379,-0.075666667,4.80307336,0.216666667,0.330896874,1.049148393,0.028,0.095,-0.675,0.052,-0.01,0.056,E9Q1W3,Neb,E9Q1W3_Neb,E9Q1W3,Neb,1,4,4,4,E9Q1W3|A2AQA9|A2AQB2,MOUSE,831956.2,1,2985,2985.1,18.12,18.12,,7152,Nebulin,striated muscle thin filament|Z disc|protein complex|contractile fiber|extracellular exosome|,regulation of actin filament length|sarcomere organization|,actin binding|protein binding|,4,4,306000000,1.0%
O89112,0.910011409,0.008,1.458650582,0.065333333,0.714718365,0.381588492,-0.059,0.075,-0.09,0.344,-0.312,0.09,O89112,Lancl1,O89112_Lancl1,O89112,Lancl1,1,4,2,2,O89112,MOUSE,46082,4.7,2987,2987.1,18.11,18.11,,399,LanC-like protein 1,nucleus|cytoplasm|extracellular exosome|integral component of plasma membrane|,metabolic process|G-protein coupled receptor signaling pathway|,catalytic activity|zinc ion binding|SH3 domain binding|glutathione binding|low-density lipoprotein particle receptor binding|,2,4,406000000,4.7%
Q8C9J3,0.117728711,0.047166667,19.05745589,-0.364333333,0.012423799,-3.39172594,0.103,0.188,0.397,-0.053,-0.148,-0.204,Q8C9J3,Spef2,Q8C9J3_Spef2,Q8C9J3,Spef2,1,4,3,3,A0A140LIV1|Q8C9J3|E0CYG3|Q8C9J3-2|E0CY95|Q8C9J3-3,MOUSE,199597.4,1.5,2988,2988.1,18.1,18.1,,1734,Sperm flagellar protein 2,manchette|cytoplasm|Golgi apparatus|sperm midpiece|,immune system development|spermatogenesis|fertilization|multicellular organismal aging|axoneme assembly|embryonic neurocranium morphogenesis|skeletal system morphogenesis|brain morphogenesis|cilium morphogenesis|respiratory system development|,protein binding|,3,4,824000000,1.5%
Q8C6G8,0.855039332,-0.066833333,2.316440189,0.085,0.586618805,0.57136284,-0.037,0.104,-0.395,0.048,0.046,-0.167,Q8C6G8,Wdr26,Q8C6G8_Wdr26,Q8C6G8,Wdr26,1,3,2,2,Q8C6G8|E0CYH4,MOUSE,71512.1,4.8,2992,2992.1,17.99,17.99,,641,WD repeat-containing protein 26,nucleoplasm|cytoplasm|,,,2,3,159000000,4.8%
Q61151,0.469507952,0.028833333,8.916428254,-0.186333333,0.128338564,-1.735192521,0.254,-0.007,0.119,0.03,-0.041,-0.182,Q61151,Ppp2r5e,Q61151_Ppp2r5e,Q61151,Ppp2r5e,1,4,2,2,Q61151|Q3UZJ4|A0A1W2P7D8,MOUSE,55111.8,6.6,2993,2993.1,17.98,17.98,,467,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform,protein phosphatase type 2A complex|cytoplasm|,signal transduction|regulation of protein phosphatase type 2A activity|,protein phosphatase type 2A regulator activity|,2,4,127000000,6.6%
Q80TR8-2,0.834860518,0.062833333,2.597897528,0.079,0.549806978,0.630008909,-0.009,0.141,-0.062,0.041,-0.056,0.322,Q80TR8,Dcaf1,Q80TR8-2_Dcaf1,Q80TR8-2,Dcaf1,1,8,3,3,Q80TR8-2|Q80TR8|Q80TR8-4,MOUSE,171471.7,2,2994,2994.1,17.97,17.97,,1506,Isoform 2 of DDB1- and CUL4-associated factor 1,nucleus|nucleolus|cytoplasm|COP9 signalosome|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|viral process|protein ubiquitination|B cell differentiation|V(D)J recombination|cell competition in a multicellular organism|histone H2A-T120 phosphorylation|",ATP binding|histone kinase activity (H2A-T120 specific)|,3,8,5810000000,2.0%
Q9D0I4,0.692956416,-0.0235,4.661096522,0.130333333,0.341893109,1.023769859,0.072,-0.008,-0.33,0.136,0.003,-0.014,Q9D0I4,Stx17,Q9D0I4_Stx17,Q9D0I4,Stx17,1,4,2,2,Q9D0I4|Q9D614,MOUSE,33391.8,7.6,2995,2995.1,17.97,17.97,,301,Syntaxin-17,autophagosome membrane|mitochondrion|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|cytosol|endomembrane system|ER to Golgi transport vesicle membrane|integral component of membrane|ER to Golgi transport vesicle|smooth endoplasmic reticulum membrane|SNARE complex|endoplasmic reticulum-Golgi intermediate compartment membrane|ER-mitochondrion membrane contact site|,autophagosome fusion|intracellular protein transport|ER to Golgi vesicle-mediated transport|vesicle fusion|Golgi organization|protein localization to pre-autophagosomal structure|vesicle docking|endoplasmic reticulum-Golgi intermediate compartment organization|,SNARE binding|SNAP receptor activity|protein kinase binding|protein phosphatase binding|,2,4,197000000,7.6%
P00493,0.291555338,0.022166667,13.06057886,-0.537,0.049424481,-2.400550267,-0.019,0.105,0.786,-0.335,-0.364,-0.04,P00493,Hprt,P00493_Hprt,P00493,Hprt1,1,2,2,2,P00493,MOUSE,24798.1,18.8,2997,2997.1,17.94,17.94,,218,Hypoxanthine-guanine phosphoribosyltransferase,cytoplasm|cytosol|extracellular exosome|,response to amphetamine|purine nucleotide biosynthetic process|purine ribonucleoside salvage|adenine salvage|guanine salvage|grooming behavior|locomotory behavior|cytolysis|striatum development|cerebral cortex neuron differentiation|central nervous system neuron development|GMP salvage|IMP salvage|dopamine metabolic process|hypoxanthine salvage|positive regulation of dopamine metabolic process|GMP catabolic process|IMP metabolic process|adenine metabolic process|hypoxanthine metabolic process|lymphocyte proliferation|dendrite morphogenesis|protein homotetramerization|grooming behavior|,nucleotide binding|magnesium ion binding|hypoxanthine phosphoribosyltransferase activity|identical protein binding|protein homodimerization activity|guanine phosphoribosyltransferase activity|,2,2,147000000,18.8%
P43406,0.000407054,-0.075,51.42823749,1.163333333,7.19741E-06,12.41624287,-0.74,-0.625,-0.605,0.396,0.544,0.58,P43406,Itgav,P43406_Itgav,P43406,Itgav,1,3,3,3,P43406|A2AKI5,MOUSE,116441.9,3.4,2998,2998.1,17.92,17.92,,1044,Integrin alpha-V,intracellular|plasma membrane|focal adhesion|integrin complex|external side of plasma membrane|cell surface|membrane|lamellipodium membrane|filopodium membrane|microvillus membrane|ruffle membrane|integrin alphav-beta3 complex|integrin alphav-beta5 complex|integrin alphav-beta8 complex|alphav-beta3 integrin-IGF-1-IGF1R complex|extracellular exosome|,angiogenesis|blood vessel development|inflammatory response|cell adhesion|cell-matrix adhesion|integrin-mediated signaling pathway|positive regulation of cell proliferation|fertilization|negative regulation of macrophage derived foam cell differentiation|negative regulation of lipid storage|cell growth|cell migration|positive regulation of cell migration|cell-substrate adhesion|negative regulation of lipid transport|detection of molecule of bacterial origin|positive regulation of osteoblast proliferation|heterotypic cell-cell adhesion|substrate adhesion-dependent cell spreading|gonad morphogenesis|endodermal cell differentiation|apolipoprotein A-I-mediated signaling pathway|T cell activation|apoptotic cell clearance|endothelial cell migration|regulation of bone resorption|negative regulation of low-density lipoprotein particle receptor biosynthetic process|positive regulation of cell adhesion|viral entry into host cell|focal adhesion assembly|negative regulation of lipoprotein metabolic process|regulation of phagocytosis|negative chemotaxis|release of sequestered calcium ion into cytosol|trophoblast giant cell differentiation|ERK1 and ERK2 cascade|calcium ion transmembrane transport|response to nitric oxide|extrinsic apoptotic signaling pathway in absence of ligand|regulation of apoptotic cell clearance|negative regulation of entry of bacterium into host cell|negative regulation of extrinsic apoptotic signaling pathway|,fibronectin binding|protease binding|voltage-gated calcium channel activity|metal ion binding|protein heterodimerization activity|transforming growth factor beta binding|extracellular matrix binding|extracellular matrix protein binding|opsonin binding|protein kinase C binding|insulin-like growth factor I binding|,3,3,26800000,3.4%
H7BWY6,0.461918472,-0.0675,9.092029073,0.256333333,0.123252885,1.765651221,-0.112,-0.142,-0.333,0.164,-0.223,0.241,H7BWY6,Rbp4,H7BWY6_Rbp4,H7BWY6,Rbp4,1,2,2,2,H7BWY6|Q00724,MOUSE,28746.7,11.4,2999,2999.1,17.92,17.92,,245,Retinol-binding protein 4,extracellular space|protein complex|extracellular exosome|,maintenance of gastrointestinal epithelium|positive regulation of insulin secretion|response to retinoic acid|retinol transport|retinol metabolic process|glucose homeostasis|response to ethanol|,retinol binding|retinol transporter activity|protein heterodimerization activity|,2,2,22300000,11.4%
P62876,0.960763421,0.051333333,0.587962323,0.028,0.873381056,0.165645018,0.017,0.097,-0.002,-0.074,-0.175,0.445,P62876,Polr2l,P62876_Polr2l,P62876,Polr2l,1,3,2,2,P62876,MOUSE,7873.2,23.8,3001,3001.1,17.88,17.88,,67,"DNA-directed RNA polymerases I, II, and III subunit RPABC5","nucleus|DNA-directed RNA polymerase II, core complex|DNA-directed RNA polymerase III complex|DNA-directed RNA polymerase I complex|",transcription from RNA polymerase I promoter|transcription from RNA polymerase II promoter|transcription from RNA polymerase III promoter|,DNA binding|zinc ion binding|RNA polymerase I activity|RNA polymerase II activity|RNA polymerase III activity|,2,3,54100000,23.8%
Q62087,0.057736734,-0.159,22.89304346,0.772666667,0.005136835,4.102737914,-0.218,-0.494,-0.924,0.376,0.086,0.22,Q62087,Pon3,Q62087_Pon3,Q62087,Pon3,1,3,2,2,Q62087,MOUSE,39578.7,7,3002,3002.1,17.88,17.88,,354,Serum paraoxonase/lactonase 3,extracellular space|intracellular membrane-bounded organelle|extracellular exosome|,phenylacetate catabolic process|dephosphorylation|aromatic compound catabolic process|negative regulation of superoxide anion generation|coumarin catabolic process|carboxylic acid catabolic process|,"aryldialkylphosphatase activity|arylesterase activity|3,4-dihydrocoumarin hydrolase activity|protein homodimerization activity|metal ion binding|dihydrocoumarin hydrolase activity|",2,3,70300000,7.0%
Q8BFQ4,0.698956516,0.009,4.564660595,0.099333333,0.349569828,1.005563875,-0.054,-0.16,0.092,0.003,0.049,0.124,Q8BFQ4,Wdr82,Q8BFQ4_Wdr82,Q8BFQ4,Wdr82,1,2,2,2,Q8BFQ4,MOUSE,35477.8,7,3003,3003.1,17.85,17.85,,313,WD repeat-containing protein 82,chromatin|nucleus|histone methyltransferase complex|Set1C/COMPASS complex|PTW/PP1 phosphatase complex|,histone H3-K4 methylation|,chromatin binding|histone methyltransferase activity (H3-K4 specific)|,2,2,118000000,7.0%
P04919,0.430679683,0.051333333,9.747056266,0.267333333,0.105997195,1.870648934,0.07,-0.1,-0.217,0.267,-0.073,0.361,P04919,Slc4a1,P04919_Slc4a1,P04919,Slc4a1,1,5,2,2,P04919|P04919-2,MOUSE,103475.9,2,3004,3004.1,17.83,17.83,,929,Band 3 anion transport protein,integral component of plasma membrane|membrane|basolateral plasma membrane|Z disc|cortical cytoskeleton|extracellular exosome|blood microparticle|,anion transport|chloride transport|bicarbonate transport|regulation of intracellular pH|anion transmembrane transport|chloride transmembrane transport|,actin binding|inorganic anion exchanger activity|protein binding|protein C-terminus binding|bicarbonate transmembrane transporter activity|chloride transmembrane transporter activity|anion:anion antiporter activity|ankyrin binding|protein homodimerization activity|,2,5,938000000,2.0%
Q8K3Z9,0.737323958,-0.028166667,3.990504468,0.087666667,0.398978555,0.900700897,-0.051,0.02,-0.185,0.078,-0.083,0.052,Q8K3Z9,Pom121,Q8K3Z9_Pom121,Q8K3Z9,Pom121,1,3,2,2,Q8K3Z9,MOUSE,121476.1,1.8,3005,3005.1,17.83,17.83,,1200,Nuclear envelope pore membrane protein POM 121,nuclear pore|endoplasmic reticulum membrane|nuclear membrane|,protein transport|mRNA transport|,,2,3,63300000,1.8%
D3YXG0,0.472645993,0.1885,8.734332033,-1.611,0.133834104,-1.708088552,0.017,-0.075,3.04,0.071,-1.905,-0.017,D3YXG0,Hmcn1,D3YXG0_Hmcn1,D3YXG0,Hmcn1,1,5,3,3,D3YXG0|D3YXG0-2,MOUSE,621820.2,0.5,3006,3006.1,17.81,17.81,,5634,Hemicentin-1,extracellular region|basement membrane|cell cortex|cell junction|extracellular exosome|,,calcium ion binding|,3,5,1740000000,0.5%
F6RWQ6,0.747435413,0.000166667,3.862077155,-0.096333333,0.410953122,-0.876935634,0.147,0.129,-0.131,0.016,-0.144,-0.016,F6RWQ6,NotFound,F6RWQ6_NotFound,F6RWQ6,Ankfn1,1,3,2,2,F6RWQ6|F6X7B3,MOUSE,88325.1,6.1,3008,3008.1,17.72,17.72,,763,Ankyrin-repeat and fibronectin type III domain-containing 1,,,,2,3,544000000,6.1%
O88737,0.954161889,-0.035666667,0.679756059,0.023333333,0.855114743,0.189852078,-0.129,-0.037,0.024,0.108,-0.256,0.076,O88737,Bsn,O88737_Bsn,O88737,Bsn,1,7,3,3,O88737|O88737-2,MOUSE,420832.3,0.9,3009,3009.1,17.72,17.72,,3942,Protein bassoon,trans-Golgi network|cytoskeleton|cell surface|postsynaptic density|extrinsic component of membrane|cell junction|axon|dendrite|neuronal cell body|neuron projection terminus|synapse|presynaptic active zone|excitatory synapse|neuronal postsynaptic density|integral component of membrane|,synapse assembly|,protein binding|metal ion binding|,3,7,8100000000,0.9%
G5E8F8,0.000440715,-0.2205,50.76821485,1.247,8.37874E-06,12.13681604,-0.884,-0.687,-0.961,0.455,0.335,0.419,G5E8F8,Itgb5,G5E8F8_Itgb5,G5E8F8,Itgb5,1,2,2,2,G5E8F8|O70309-2|Q6PE70|O70309,MOUSE,93484.2,3.3,3010,3010.1,17.69,17.69,,816,Integrin beta,focal adhesion|cell surface|cell leading edge|integrin alphav-beta5 complex|receptor complex|extracellular exosome|,cell-matrix adhesion|transforming growth factor beta receptor signaling pathway|integrin-mediated signaling pathway|endodermal cell differentiation|stress fiber assembly|epithelial cell-cell adhesion|,receptor activity|integrin binding|,2,2,19900000,3.3%
Q3UHF7,0.87311559,0.024,2.067451307,0.092,0.621233503,0.51812112,-0.014,0.189,-0.241,-0.047,-0.139,0.396,Q3UHF7,Hivep2,Q3UHF7_Hivep2,Q3UHF7,Hivep2,1,6,3,3,Q3UHF7|Q8VDR7,MOUSE,268753.9,1.1,3012,3012.1,17.64,17.64,,2430,Transcription factor HIVEP2,nucleoplasm|transcription factor complex|,"transcription, DNA-templated|regulation of transcription, DNA-templated|signal transduction|",DNA binding|sequence-specific DNA binding transcription factor activity|metal ion binding|,3,6,2140000000,1.1%
B2RY04,0.737344112,-0.042666667,3.983746617,-0.088,0.39959987,-0.899446636,0.024,-0.046,0.026,0.055,-0.203,-0.112,B2RY04,Dock5,B2RY04_Dock5,B2RY04,Dock5,1,4,3,3,B2RY04,MOUSE,215452.4,1.8,3013,3013.1,17.59,17.59,,1868,Dedicator of cytokinesis protein 5,cytoplasm|,small GTPase mediated signal transduction|positive regulation of GTPase activity|,guanyl-nucleotide exchange factor activity|,3,4,174000000,1.8%
A0A087WQ44,0.003655388,-0.159166667,37.17040771,1.423666667,0.000191849,7.428192394,-0.592,-0.74,-1.281,0.448,0.486,0.724,A0A087WQ44,Srcap,A0A087WQ44_Srcap,A0A087WQ44,Srcap,1,9,3,3,A0A087WQ44|A0A087WNL7|A0A087WNX7|A0A087WP63,MOUSE,351143.1,0.7,3014,3014.1,17.58,17.58,,3271,Snf2-related CREBBP activator protein,nucleus|nucleoplasm|Golgi apparatus|protein complex|perinuclear region of cytoplasm|,,DNA binding|ATP binding|,3,9,5980000000,0.7%
P11928,0.147261443,-0.0105,17.68829555,-0.325,0.017028267,-3.154862099,0.11,0.125,0.221,-0.15,-0.326,-0.043,P11928,Oas1a,P11928_Oas1a,P11928,Oas1a,1,2,2,2,Q8K469|P11928|Q05BJ7,MOUSE,42884.2,10,3016,3016.1,17.5,17.5,,367,2'-5'-oligoadenylate synthase 1A,nucleus|mitochondrion|endoplasmic reticulum|,purine nucleotide biosynthetic process|response to virus|innate immune response|defense response to virus|,2'-5'-oligoadenylate synthetase activity|double-stranded RNA binding|protein binding|ATP binding|metal ion binding|,2,2,47400000,10.0%
P35991,0.629307568,0.081,5.818693157,-0.353333333,0.261897097,-1.226344924,0.009,-0.109,0.873,0.162,-0.44,-0.009,P35991,Btk,P35991_Btk,P35991,Btk,1,3,2,2,P35991|A2BDW0,MOUSE,77120.7,2.5,3017,3017.1,17.49,17.49,,659,Tyrosine-protein kinase BTK,nucleus|cytoplasm|cytosol|plasma membrane|extrinsic component of cytoplasmic side of plasma membrane|cytoplasmic vesicle|intracellular membrane-bounded organelle|membrane raft|,"negative regulation of cytokine production|adaptive immune response|transcription, DNA-templated|regulation of transcription, DNA-templated|protein phosphorylation|apoptotic process|transmembrane receptor protein tyrosine kinase signaling pathway|I-kappaB kinase/NF-kappaB signaling|peptidyl-tyrosine phosphorylation|cell differentiation|peptidyl-tyrosine autophosphorylation|regulation of cell proliferation|innate immune response|cell maturation|B cell receptor signaling pathway|T cell receptor signaling pathway|","protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|protein binding|ATP binding|phosphatidylinositol-3,4,5-trisphosphate binding|identical protein binding|metal ion binding|receptor binding|",2,3,2370000000,2.5%
Q61851-2,0.233336184,0.01,14.72026502,-0.224,0.033726673,-2.661991156,0.199,0.054,0.113,-0.066,-0.121,-0.119,Q61851,NotFound,Q61851-2_NotFound,Q61851-2,Fgfr3,1,8,2,2,Q61851-2|E9QNJ9|F6TK14|Q61851|Q7TSI8|Q61563,MOUSE,89271,2.6,3018,3018.1,17.48,17.48,,801,Isoform 2 of Fibroblast growth factor receptor 3,lysosome|endoplasmic reticulum|Golgi apparatus|plasma membrane|integral component of plasma membrane|cytoplasmic side of plasma membrane|transport vesicle|perinuclear region of cytoplasm|,negative regulation of transcription from RNA polymerase II promoter|MAPK cascade|positive regulation of endothelial cell proliferation|morphogenesis of an epithelium|lens morphogenesis in camera-type eye|positive regulation of cell proliferation|negative regulation of cell proliferation|fibroblast growth factor receptor signaling pathway|positive regulation of phospholipase activity|oligodendrocyte development|peptidyl-tyrosine phosphorylation|substantia nigra development|central nervous system myelination|cell differentiation|bone mineralization|forebrain development|positive regulation of protein ubiquitination|somatic stem cell maintenance|post-anal tail morphogenesis|positive regulation of tyrosine phosphorylation of Stat1 protein|positive regulation of tyrosine phosphorylation of Stat3 protein|positive regulation of MAPK cascade|positive regulation of neuron apoptotic process|positive regulation of phosphatidylinositol 3-kinase activity|positive regulation of cell differentiation|negative regulation of mitotic nuclear division|negative regulation of smoothened signaling pathway|protein autophosphorylation|digestive tract morphogenesis|negative regulation of developmental growth|response to axon injury|negative regulation of astrocyte differentiation|inner ear development|negative regulation of epithelial cell proliferation|positive regulation of peptidyl-tyrosine phosphorylation|cartilage development|inner ear receptor cell differentiation|bone morphogenesis|axonogenesis involved in innervation|alveolar secondary septum development|lens fiber cell development|positive regulation of ERK1 and ERK2 cascade|bone maturation|epithelial cell fate commitment|positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway|cochlea development|positive regulation of canonical Wnt signaling pathway|fibroblast growth factor receptor apoptotic signaling pathway|,protein tyrosine kinase activity|fibroblast growth factor-activated receptor activity|protein binding|ATP binding|fibroblast growth factor binding|,2,8,2830000000,2.6%
Q3UDM0,0.817484327,0.0285,2.833105301,-0.113,0.520822179,-0.677890772,0.05,0.392,-0.187,0.093,0.029,-0.206,Q3UDM0,NotFound,Q3UDM0_NotFound,Q3UDM0,Mob1b,1,2,2,2,Q3UDM0|Q8BPB0|Q921Y0|Q921Y0-2,MOUSE,25837.2,11.3,3019,3019.1,17.46,17.46,,221,MOB kinase activator 1B,nucleus|cytoplasm|extracellular exosome|,hippo signaling|positive regulation of phosphorylation|protein autophosphorylation|,kinase activator activity|kinase binding|,2,2,50100000,11.3%
E9PZ36,0.676986185,0.0635,4.915541734,0.192333333,0.322437709,1.069135131,-0.124,0.332,-0.306,-0.02,0.252,0.247,E9PZ36,Pkhd1,E9PZ36_Pkhd1,E9PZ36,Pkhd1,1,4,2,2,E9PZ36,MOUSE,450351.1,0.4,3020,3020.1,17.45,17.45,,4059,Polycystic kidney and hepatic disease 1,cytoplasm|centrosome|apical plasma membrane|ciliary basal body|perinuclear region of cytoplasm|extracellular exosome|primary cilium|mitotic spindle|,kidney development|cellular calcium ion homeostasis|positive regulation of cell proliferation|regulation of centrosome duplication|regulation of TOR signaling|negative regulation of NF-kappaB transcription factor activity|cilium assembly|negative regulation of apoptotic process|negative regulation of protein kinase B signaling|regulation of ERK1 and ERK2 cascade|,protein binding|,2,4,670000000,0.4%
Q4U2R1,0.580377314,0.054833333,6.748307019,-0.199,0.211431309,-1.383276019,-0.073,0.225,0.311,-0.192,-0.103,0.161,Q4U2R1,Herc2,Q4U2R1_Herc2,Q4U2R1,Herc2,1,3,2,2,Q4U2R1|Q4U2R1-2,MOUSE,534293.3,0.3,3021,3021.1,17.44,17.44,,4836,E3 ubiquitin-protein ligase HERC2,nucleus|cytoplasm|mitochondrial inner membrane|centriole|membrane|,DNA repair|cellular response to DNA damage stimulus|spermatogenesis|protein ubiquitination|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|,ubiquitin-protein transferase activity|zinc ion binding|ligase activity|ubiquitin protein ligase binding|SUMO binding|,2,3,77200000,0.3%
Q6A0A2,0.956068722,0.015333333,0.649569947,-0.020666667,0.861079015,-0.181897215,0.219,0.004,-0.146,0.053,-0.004,-0.034,Q6A0A2,Larp4b,Q6A0A2_Larp4b,Q6A0A2,Larp4b,1,3,3,3,Q6A0A2|Q6A0A2-3|Q6A0A2-2,MOUSE,82082.3,2.9,3022,3022.1,17.43,17.43,,741,La-related protein 4B,nucleolus|cytoplasm|cytosol|cytoplasmic stress granule|membrane|polysomal ribosome|,positive regulation of translation|,poly(A) RNA binding|,3,3,56100000,2.9%
P98192,0.443938694,0.019333333,9.519963199,-0.148666667,0.111687271,-1.831085755,0.082,0.088,0.111,0.005,-0.055,-0.115,P98192,Gnpat,P98192_Gnpat,P98192,Gnpat,1,2,2,2,P98192,MOUSE,77552.9,5.4,3023,3023.1,17.41,17.41,,678,Dihydroxyacetone phosphate acyltransferase,mitochondrion|peroxisome|peroxisomal membrane|peroxisomal matrix|membrane|,glycerophospholipid metabolic process|synapse assembly|response to nutrient|ether lipid biosynthetic process|cerebellum morphogenesis|paranodal junction assembly|response to drug|myelination|response to starvation|membrane organization|response to fatty acid|,catalytic activity|receptor binding|protein binding|glycerone-phosphate O-acyltransferase activity|palmitoyl-CoA hydrolase activity|,2,2,29100000,5.4%
E9PVA6,0.81687669,-0.019166667,2.851652914,0.055666667,0.518602622,0.681190877,-0.096,-0.071,0.026,0.021,0.003,0.002,E9PVA6,Git2,E9PVA6_Git2,E9PVA6,Git2,1,3,2,2,E9PVA6|Q9JLQ2|D3Z1I2|J3QK07|Q80XR8|F7BIK4,MOUSE,85197.7,3.5,3024,3024.1,17.38,17.38,,759,ARF GTPase-activating protein GIT2,nucleoplasm|focal adhesion|,positive regulation of GTPase activity|behavioral response to pain|,GTPase activator activity|protein complex binding|metal ion binding|,2,3,360000000,3.5%
L7N1Y0,0.108483191,0.045833333,19.57744801,-0.666333333,0.011021868,-3.493911748,0.1,0.235,0.802,-0.361,-0.154,-0.347,L7N1Y0,Dnah7b,L7N1Y0_Dnah7b,L7N1Y0,Dnah7b,1,5,3,3,L7N1Y0|A0A087WR13|E9Q0T8,MOUSE,470219.4,0.5,3025,3025.1,17.37,17.37,,4068,"Dynein, axonemal, heavy chain 7B",inner dynein arm|,cilium movement|metabolic process|,microtubule motor activity|calcium ion binding|ATP binding|ATPase activity|,3,5,264000000,0.5%
Q9JLZ3,0.565788093,-0.002833333,7.032955651,-0.133666667,0.198017893,-1.42873594,-0.007,0.083,0.116,0.001,-0.022,-0.188,Q9JLZ3,Auh,Q9JLZ3_Auh,Q9JLZ3,Auh,1,3,2,2,Q9JLZ3|A0A0R4J023,MOUSE,33679.7,5.4,3026,3026.1,17.36,17.36,,314,"Methylglutaconyl-CoA hydratase, mitochondrial",mitochondrion|,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|leucine catabolic process|",RNA binding|mRNA 3'-UTR binding|enoyl-CoA hydratase activity|methylglutaconyl-CoA hydratase activity|,2,3,158000000,5.4%
Q9ERI6,0.909861937,-0.0235,1.461851072,-0.040333333,0.714191855,-0.382171216,-0.06,0.058,-0.008,-0.219,0.032,0.056,Q9ERI6,Rdh14,Q9ERI6_Rdh14,Q9ERI6,Rdh14,1,5,2,2,Q9ERI6,MOUSE,36764.6,6.2,3027,3027.1,17.36,17.36,,334,Retinol dehydrogenase 14,nucleus|mitochondrion|lysosomal membrane|endoplasmic reticulum|membrane|,osteoblast differentiation|retinol metabolic process|oxidation-reduction process|,alcohol dehydrogenase (NADP+) activity|,2,5,607000000,6.2%
E9PUU8,0.456186328,0.022166667,9.238910881,0.279666667,0.119154078,1.789236715,-0.244,0.075,-0.184,-0.097,0.174,0.409,E9PUU8,NotFound,E9PUU8_NotFound,E9PUU8,Pkhd1l1,1,7,3,3,E9PUU8|Q80ZA4|F8WH29|Q80ZA4-2,MOUSE,469488.1,1.4,3029,3029.1,17.3,17.3,,4249,Fibrocystin-L,cilium|,,protein binding|,3,7,2340000000,1.4%
E9QAF0,0.648073376,0.247333333,5.370065277,-0.536666667,0.290397901,-1.14893675,-0.189,0.099,1.637,-0.106,-0.271,0.314,E9QAF0,Spata31,E9QAF0_Spata31,E9QAF0,Spata31,1,3,3,3,E9QAF0,MOUSE,116801.9,3.6,3030,3030.1,17.28,17.28,,1014,Spermatogenesis-associated protein 31,integral component of membrane|acrosomal lumen|,spermatogenesis|cell differentiation|,actin binding|,3,3,17400000000,3.6%
P47941,0.639352439,-0.003666667,5.573840378,0.183333333,0.27708688,1.184251586,-0.269,0.051,-0.068,-0.191,0.15,0.305,P47941,Crkl,P47941_Crkl,P47941,Crkl,1,2,2,2,P47941,MOUSE,33943.5,10.2,3031,3031.1,17.27,17.27,,303,Crk-like protein,cytoplasm|extracellular exosome|,blood vessel development|pattern specification process|heart development|positive regulation of cell proliferation|organ morphogenesis|anterior/posterior pattern specification|thymus development|parathyroid gland development|,protein binding|poly(A) RNA binding|,2,2,81600000,10.2%
E9QAE4,0.316321776,-0.001666667,12.39442035,-0.259333333,0.057617972,-2.290906631,0.202,0.212,-0.03,-0.258,-0.134,-0.002,E9QAE4,Nsd1,E9QAE4_Nsd1,E9QAE4,Nsd1,1,18,3,3,E9QAE4|O88491|A0A286YE36|A0A0G2JE|Q7TPW1|A0A0G2JGI1|Q3UHP6|P59672-2|P59672|F8WHT3|A0A0G2JFD8|A2A3V1|Q7TPM1|Q7TPM1-2|A0A140LJB0|Q3U319|A0A0KG60|Q8R4U1|Q9ES52|Q9ES52-2|Q9ES52-3|Q9ES52-4|Q9ES52-5|Q9ES52-6|A6H690|Q7TN16|A0A140LIX9|A6H690-2|E9Q546|Q62504|A2ADB0|Q62504-2|A2ADB1|Q62504-3|Q80WC3|B2RT41|F8VQD1|E9Q4Y5|Q0P5|D3Z1N4|Q8BSQ9|Q69ZK0|E9Q7L2|Q8BSQ9-2|E9Q7L3|D3Z1W6|O88379|G3UWZ0|I7HPV9|H3BJQ9|P53564|H3BK24|P53564-3|H3BLS0|E9QKE9|P53564-2|K3W4S4|Q9ESN9-6|J3QNR6|Q9ESN9|Q9ESN9-4|Q9ESN9-5|Q9ESN9-3|E9Q6E0|Q9ESN9-2|P53564-4|E9Q6B6|A3KGF7|F8WIG5|Q9Z207|E9PYI3|P52785|Q69ZS0|G5E8Y2|Q69ZB0|E9QNC6|Q69ZB0-2|Q69ZS0-3|A0A0R4IZZ6|E9PUQ5|B9EI20|Q69ZB0-3|Q69ZS0-2|Q921M4|Q3UMR0-2|Q6ZQ03|Q921M4-2|Q8BTF7|Q91W97|A0A0U1RPJ4|Q8R554|Q9WU62|Q9WU62-2|D6RI94|D6RIL0|A4Q9F1|A4Q9E8|Q64691|Q0P5-2|Q3UYV9|Q6PFD6|A2AVV6|A2AVV7|Q9CSP9|A2AG50|A2AVV5|Q64691-2|A2AJQ3|A4Q9E8-2|Q0VGP9|Q8BM65-4|Q9CSP9-4|Q80YS6|G3X8V5|Q8K2Y0|A2AJQ3-2|Q8BM65-5|A0A0R4J1X0|Q8CGU1|Q9JLB2|Q8BYR1|A0A0N4SV92|Q8BYR1-2|E9Q7U2|Q8BSN3-3|A0A0R4J1K3|Q8BSN3|G3X951|Q5SQ20|Q6ZQ03-3|Q9EQ61|Q6ZQ03-2|Q80VP2|P27790|Q3TTL3|Q9D439|A0A0R4J147|Q5HZI1-4|Q9WVK8|Q60779|A0A1D5RM05|Q9JI44|Q91WM3|Q9D439-2|Q810K9|A0A0R4J0N9|Q5HZI1-2|P53564-5|O89109|D3Z0R2|Q3U5D0|Q5HZI1-3|Q3U4G3|Q8R3H7|Q8CC21|Q99J77|P03958|Q8CC21-2|A0A140LHS7|P28235|Q8CF90|A0A0R4J0X9|Q8VEW2|Q7TRX4|A0A140LHT7|Q7TR79|P05627|Q8CHR9|Q7TRW1|Q8BYK4|J3QPZ5|Q60892|A0A140LI22|A3KPP7|P15066|A0A0R4J1M3|D6RI72|A0A1W2P6P0|Q8K2X7|G3X9B4|Q9CZJ1|Q9CPW7|H3BKG4|Q9CY16|Q8R4U1-2|Q9CQA8|A0A1W2P8A7|Q9DCC8|P61219|A0A0A6YY82|Q32M00|A0A0R4J0D8|Q9D0Y8|D3Z200|Q9D0Y8-2|D3YYQ8|F7ABZ6|Q80T14|A6PW47|Q99K74|Q99K74-2|P10754|P10754-2|Q9QYS1|Q7TRX8|F7C7C4,MOUSE,301665,0.6,3032,3032.1,17.25,17.25,,2691,Histone-lysine N-methyltransferase,nucleolus|,"histone lysine methylation|positive regulation of transcription, DNA-templated|",transcription cofactor activity|zinc ion binding|histone-lysine N-methyltransferase activity|androgen receptor binding|,11,18,3580000000,0.6%
P49710,0.83266067,0.066166667,2.624201994,0.154333333,0.546486956,0.635412652,-0.231,-0.135,0.333,0.175,-0.288,0.543,P49710,Hcls1,P49710_Hcls1,P49710,Hcls1,1,2,2,2,P49710|E9Q4E5,MOUSE,54296.3,4.5,3034,3034.1,17.23,17.23,,486,Hematopoietic lineage cell-specific protein,nucleus|transcription factor complex|cytoplasm|mitochondrion|,negative regulation of transcription from RNA polymerase II promoter|positive regulation of cell proliferation|response to hormone|positive regulation of phosphatidylinositol 3-kinase signaling|actin filament polymerization|erythrocyte differentiation|regulation of actin filament polymerization|positive regulation of granulocyte differentiation|positive regulation of peptidyl-serine phosphorylation|positive regulation of tyrosine phosphorylation of STAT protein|positive regulation of transcription factor import into nucleus|positive regulation of macrophage differentiation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of protein kinase B signaling|cellular response to cytokine stimulus|negative regulation of leukocyte apoptotic process|,RNA polymerase II transcription factor binding|actin binding|protein binding|SH3 domain binding|protein kinase binding|protein complex binding|,2,2,10600000,4.5%
E9Q4F8,0.636050842,-0.020833333,5.632644725,0.647666667,0.273360354,1.194393667,0.338,-0.087,-1.285,1.242,0.082,-0.415,E9Q4F8,NotFound,E9Q4F8_NotFound,E9Q4F8,Ankrd11,1,5,3,3,E9Q4F8|E9Q4F7,MOUSE,300682.4,1.5,3036,3036.1,17.23,17.23,,2664,Ankyrin repeat domain-containing protein 11,nucleus|nucleoplasm|cytoplasm|plasma membrane|,in utero embryonic development|tissue homeostasis|multicellular organism growth|odontogenesis of dentin-containing tooth|skeletal system morphogenesis|head morphogenesis|face morphogenesis|bone development|,,3,5,1610000000,1.5%
Q6P549,0.919618833,-0.014,1.194211289,0.042,0.759589357,0.318953241,-0.109,-0.16,0.164,0.197,-0.073,-0.103,Q6P549,Inppl1,Q6P549_Inppl1,Q6P549,Inppl1,1,3,2,2,Q6P549,MOUSE,139769.5,1.7,3039,3039.1,17.18,17.18,,1257,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",cytoplasm|Golgi apparatus|cytosol|cytoskeleton|plasma membrane|lamellipodium|filopodium|,endochondral ossification|immune system process|glucose metabolic process|phosphatidylinositol biosynthetic process|endocytosis|actin filament organization|cell adhesion|negative regulation of cell proliferation|post-embryonic development|negative regulation of gene expression|response to insulin|cellular lipid metabolic process|phosphatidylinositol dephosphorylation|ruffle assembly|,actin binding|protein binding|hydrolase activity|SH3 domain binding|SH2 domain binding|,2,3,37400000,1.7%
Q62415,0.951421295,0.020333333,0.730756682,-0.038666667,0.845131583,-0.203135049,-0.172,-0.113,0.404,-0.259,0.113,0.149,Q62415,Ppp1r13b,Q62415_Ppp1r13b,Q62415,Ppp1r13b,1,6,2,2,Q62415,MOUSE,119738.4,1.8,3040,3040.1,17.15,17.15,,1087,Apoptosis-stimulating of p53 protein 1,nucleus|nucleoplasm|cytoplasm|plasma membrane|,negative regulation of cell cycle|intrinsic apoptotic signaling pathway by p53 class mediator|,transcription factor binding|,2,6,1450000000,1.8%
Q8CGC4,0.597505754,-0.012666667,6.395951886,-0.249333333,0.2293004,-1.324279137,0.139,0.317,-0.12,-0.473,0.152,-0.091,Q8CGC4,Lsm14b,Q8CGC4_Lsm14b,Q8CGC4,Lsm14b,1,5,2,2,Q8CGC4,MOUSE,42423.3,5.7,3041,3041.1,17.14,17.14,,385,Protein LSM14 homolog B,ribonucleoprotein complex|,regulation of translation|multicellular organismal development|,poly(A) RNA binding|,2,5,8210000000,5.7%
Q91Z49,0.911411213,-0.043833333,1.433352382,0.043,0.718893839,0.375623438,-0.097,-0.118,0.019,0.073,-0.226,0.086,Q91Z49,Fyttd1,Q91Z49_Fyttd1,Q91Z49,Fyttd1,1,5,2,2,Q91Z49|Q91Z49-3|Q91Z49-2|D3Z591,MOUSE,35943.9,6.9,3042,3042.1,17.14,17.14,,317,UAP56-interacting factor,nucleoplasm|nuclear speck|,mRNA export from nucleus|,mRNA binding|poly(A) RNA binding|,2,5,313000000,6.9%
Z4YLD0,0.512197848,-0.021,7.998268909,0.198,0.158552505,1.588919154,-0.03,0.005,-0.335,0.172,0.115,-0.053,Z4YLD0,NotFound,Z4YLD0_NotFound,Z4YLD0,C330007P06Rik,1,2,2,2,Q8VDP2-2|Z4YLD0|Q8VDP2,MOUSE,26461,11.4,3043,3043.1,17.12,17.12,,227,RIKEN cDNA C330007P06 gene,,,,2,2,834000000,11.4%
Q9D710,0.797128744,-0.037,3.164373642,0.112666667,0.482572574,0.743772126,-0.28,-0.135,0.135,-0.21,0.175,0.093,Q9D710,Tmx2,Q9D710_Tmx2,Q9D710,Tmx2,1,2,2,2,Q9D710|D3Z2J6,MOUSE,34341.4,7.4,3045,3045.1,17.07,17.07,,295,Thioredoxin-related transmembrane protein 2,cell|integral component of membrane|,cell redox homeostasis|,,2,2,56700000,7.4%
Q6A065,0.123749097,-0.012333333,18.68209177,-0.700666667,0.013545368,-3.336705563,0.05,0.551,0.413,-0.24,-0.759,-0.089,Q6A065,Cep170,Q6A065_Cep170,Q6A065,Cep170,1,4,3,3,Q6A065|H7BX26|Q6A065-3,MOUSE,175617.3,1.7,3046,3046.1,17.04,17.04,,1588,Centrosomal protein of 170 kDa,cytoplasm|centrosome|centriole|spindle|microtubule|nuclear membrane|,,,3,4,6580000000,1.7%
Q9CQF6,0.522251937,-0.025833333,7.770816972,-0.235,0.167077629,-1.551849503,-0.045,0.324,-0.004,-0.075,0.025,-0.38,Q9CQF6,Aasdhppt,Q9CQF6_Aasdhppt,Q9CQF6,Aasdhppt,1,3,2,2,Q9CQF6|Q9CQF6-2,MOUSE,36048.8,9.3,3047,3047.1,17.04,17.04,,309,L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase,cytoplasm|extracellular exosome|,metabolic process|,magnesium ion binding|holo-[acyl-carrier-protein] synthase activity|,2,3,20800000,9.3%
G3X9K7,0.64621906,-0.010333333,5.453827027,-0.128,0.284850704,-1.162585642,-0.021,0.167,0.015,-0.015,0.034,-0.242,G3X9K7,Apol10b,G3X9K7_Apol10b,G3X9K7,Apol10b,1,5,2,2,G3X9K7,MOUSE,37163.9,6.8,3048,3048.1,17.03,17.03,,334,Apolipoprotein L 10B,extracellular region|,lipid transport|lipoprotein metabolic process|,lipid binding|,2,5,4680000000,6.8%
Q80YQ8,0.450588065,0.019833333,9.366150437,0.243666667,0.115713747,1.809647126,-0.02,-0.025,-0.261,0.38,0.025,0.02,Q80YQ8,Rmnd5a,Q80YQ8_Rmnd5a,Q80YQ8,Rmnd5a,1,3,2,2,Q80YQ8,MOUSE,44847.6,5.6,3049,3049.1,17.03,17.03,,391,Protein RMD5 homolog A,,,,2,3,39500000,5.6%
Q8K2F8,0.758441855,-0.0075,3.736956633,-0.141666667,0.422964908,-0.853931409,0.082,0.285,-0.177,-0.328,0.135,-0.042,Q8K2F8,Lsm14a,Q8K2F8_Lsm14a,Q8K2F8,Lsm14a,1,6,2,2,Q8K2F8,MOUSE,50773.3,3,3050,3050.1,17.03,17.03,,462,Protein LSM14 homolog A,cytoplasmic mRNA processing body|cytoplasm|cytoplasmic stress granule|intracellular membrane-bounded organelle|,regulation of translation|multicellular organismal development|cytoplasmic mRNA processing body assembly|RIG-I signaling pathway|defense response to virus|positive regulation of type I interferon-mediated signaling pathway|,double-stranded DNA binding|double-stranded RNA binding|single-stranded RNA binding|poly(A) RNA binding|,2,6,8640000000,3.0%
Q283N4,0.204708202,0.007333333,15.77592575,0.370666667,0.026448888,2.843516969,-0.185,-0.102,-0.247,0.196,-0.034,0.416,Q283N4,Urad,Q283N4_Urad,Q283N4,Urad,1,2,2,2,Q283N4,MOUSE,20187.5,16.8,3053,3053.1,16.96,16.96,,178,2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase,peroxisome|,purine nucleobase metabolic process|allantoin biosynthetic process|urate catabolic process|,carboxy-lyase activity|,2,2,67000000,16.8%
A2AS37,0.003636524,-0.0045,37.23957585,1.215,0.000188818,7.447960502,-0.643,-0.408,-0.785,0.668,0.317,0.824,A2AS37,AI182371,A2AS37_AI182371,A2AS37,AI182371,1,2,2,2,A2AS37,MOUSE,40887.3,5.8,3055,3055.1,16.93,16.93,,356,Expressed sequence AI182371,extracellular region|,inflammatory response|complement activation|negative regulation of endopeptidase activity|,endopeptidase inhibitor activity|,2,2,17700000,5.8%
Q8K1R3,0.855538379,-0.019333333,2.302330148,0.084666667,0.588527804,0.568381226,0.176,0.005,-0.366,0.007,-0.038,0.1,Q8K1R3,Pnpt1,Q8K1R3_Pnpt1,Q8K1R3,Pnpt1,1,4,3,3,Q8K1R3|Q8K1R3-2,MOUSE,86594,4.3,3056,3056.1,16.91,16.91,,783,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",cytoplasm|mitochondrion|mitochondrial intermembrane space|membrane|mitochondrial degradosome|,"mitochondrial RNA catabolic process|mitochondrial mRNA catabolic process|positive regulation of mitochondrial RNA catabolic process|mitochondrial RNA 5'-end processing|mitochondrial RNA 3'-end processing|RNA catabolic process|mRNA catabolic process|cellular response to oxidative stress|cellular response to interferon-beta|RNA import into mitochondrion|rRNA import into mitochondrion|regulation of cellular respiration|RNA polyadenylation|negative regulation of growth|protein homooligomerization|positive regulation of mRNA catabolic process|protein homotrimerization|mitochondrion morphogenesis|nuclear polyadenylation-dependent mRNA catabolic process|mitotic cell cycle arrest|RNA phosphodiester bond hydrolysis, exonucleolytic|mitochondrial mRNA polyadenylation|positive regulation of miRNA catabolic process|regulation of cellular senescence|",3'-5'-exoribonuclease activity|polyribonucleotide nucleotidyltransferase activity|poly(U) RNA binding|poly(G) binding|miRNA binding|poly(A) RNA binding|,3,4,503000000,4.3%
Q9D1A2,0.639352439,-0.005166667,5.565851826,0.113,0.277597031,1.181656966,-0.178,-0.022,0.015,-0.028,0.053,0.129,Q9D1A2,Cndp2,Q9D1A2_Cndp2,Q9D1A2,Cndp2,1,2,2,2,Q9D1A2,MOUSE,53222.8,4.4,3057,3057.1,16.91,16.91,,475,Cytosolic non-specific dipeptidase,cytosol|extracellular exosome|,proteolysis|,carboxypeptidase activity|peptidase activity|metallopeptidase activity|dipeptidase activity|tripeptidase activity|metal ion binding|,2,2,183000000,4.4%
Q9D554,0.469507952,-0.0165,8.919856808,0.225666667,0.128237286,1.737968026,-0.256,-0.206,0.074,0.258,-0.048,0.079,Q9D554,Sf3a3,Q9D554_Sf3a3,Q9D554,Sf3a3,1,3,2,2,Q9D554,MOUSE,59183.1,6.3,3058,3058.1,16.9,16.9,,501,Splicing factor 3A subunit 3,nucleoplasm|spliceosomal complex|catalytic step 2 spliceosome|,"mRNA splicing, via spliceosome|mRNA processing|",RNA binding|zinc ion binding|poly(A) RNA binding|,2,3,132000000,6.3%
Q68ED3,0.765908264,0.009166667,3.63029165,-0.071666667,0.433481767,-0.83311763,-0.019,0.025,0.129,0.019,-0.026,-0.073,Q68ED3,Tent4b,Q68ED3_Tent4b,Q68ED3,Papd5,1,4,2,2,E9QJT6|Q68ED3|F8WI26,MOUSE,70102.3,3.7,3059,3059.1,16.89,16.89,,633,Non-canonical poly(A) RNA polymerase PAPD5,nucleolus|cytoplasm|,rRNA processing|mRNA processing|mitotic nuclear division|cell division|histone mRNA catabolic process|DNA biosynthetic process|,DNA binding|DNA-directed DNA polymerase activity|polynucleotide adenylyltransferase activity|poly(A) RNA binding|metal ion binding|,2,4,443000000,3.7%
Q99PT9,0.911411213,0.113833333,1.428666073,0.189666667,0.719669989,0.374598108,-0.531,-0.593,1.181,0.407,-0.339,0.558,Q99PT9,Kif19a,Q99PT9_Kif19a,Q99PT9,Kif19,1,3,3,3,Q99PT9,MOUSE,112127.5,2.4,3060,3060.1,16.89,16.89,,997,Kinesin-like protein KIF19,kinesin complex|microtubule|cilium|axoneme|,microtubule-based movement|metabolic process|axonemal microtubule depolymerization|plus-end specific microtubule depolymerization|,"ATP binding|microtubule binding|ATP-dependent microtubule motor activity, plus-end-directed|",3,3,420000000,2.4%
Q68FF6,0.676913023,-0.0385,4.918571046,0.083,0.322212879,1.068683202,-0.051,-0.083,-0.106,0.021,-0.01,-0.002,Q68FF6,Git1,Q68FF6_Git1,Q68FF6,Git1,1,4,2,2,Q68FF6|Q5F258,MOUSE,86097.3,2.9,3061,3061.1,16.85,16.85,,770,ARF GTPase-activating protein GIT1,cytoplasm|cytosol|focal adhesion|membrane|aggresome|,immunological synapse formation|regulation of cytokinesis|positive regulation of GTPase activity|ephrin receptor signaling pathway|dendritic spine development|,GTPase activator activity|protein binding|protein complex binding|metal ion binding|,2,4,374000000,2.9%
Q9CY57,0.791316333,-0.1165,3.243580824,0.225,0.473851127,0.759276717,0.046,0.223,-0.956,-0.048,0.061,-0.025,Q9CY57,Chtop,Q9CY57_Chtop,Q9CY57,Chtop,1,9,3,3,Q9CY57|Q9CY57-2|E9PW20|Q9CY57-3|Q9CY57-4|Q9CY57-5,MOUSE,26584.4,12.4,3062,3062.1,16.84,16.84,,249,Chromatin target of PRMT1 protein,transcription export complex|nucleolus|nuclear speck|,"transcription, DNA-templated|regulation of transcription, DNA-templated|mRNA export from nucleus|positive regulation of ATPase activity|positive regulation of helicase activity|",protein binding|poly(A) RNA binding|,3,9,32100000000,12.4%
H7BX49,0.961523652,0.001,0.566348386,-0.012666667,0.877738527,-0.159816532,0.028,-0.003,-0.003,0.045,-0.038,-0.023,H7BX49,Wdr90,H7BX49_Wdr90,H7BX49,Wdr90,1,10,2,2,H7BX49|Q6ZPG2,MOUSE,208275.8,1.6,3063,3063.1,16.83,16.83,,1892,WD repeat-containing protein 90,,,,2,10,68300000000,1.6%
O88668,0.089151776,-0.0975,20.65127379,0.405,0.008607413,3.673918046,-0.308,-0.159,-0.433,-0.019,0.205,0.129,O88668,Creg1,O88668_Creg1,O88668,Creg1,1,2,2,2,O88668|K4DI63,MOUSE,24565.5,8.1,3064,3064.1,16.81,16.81,,220,Protein CREG1,transcription factor complex|extracellular exosome|,"regulation of transcription, DNA-templated|regulation of growth|oxidation-reduction process|",transcription factor binding|FMN binding|oxidoreductase activity|,2,2,5390000,8.1%
Q80U40,0.369410714,-0.0545,11.05784539,-0.352333333,0.078381841,-2.079950428,0.41,0.127,-0.172,-0.036,-0.358,-0.298,Q80U40,Rimbp2,Q80U40_Rimbp2,Q80U40,Rimbp2,1,3,3,3,D3YXR8|Q80U40|A0A0G2JFB0|Q80U40-2,MOUSE,119081.8,3.2,3065,3065.1,16.77,16.77,,1072,RIMS-binding protein 2,plasma membrane|cell junction|synapse|,negative regulation of phosphatase activity|,,3,3,542000000,3.2%
Q8BWS5,0.114388745,-0.049166667,19.25230803,0.703666667,0.011878708,3.43650318,-0.195,-0.178,-0.83,0.536,0.158,0.214,Q8BWS5,Gprin3,Q8BWS5_Gprin3,Q8BWS5,Gprin3,1,3,2,2,Q8BWS5,MOUSE,81396,3.8,3066,3066.1,16.72,16.72,,763,G protein-regulated inducer of neurite outgrowth 3,,,,2,3,11700000,3.8%
E9Q4S3,0.168003025,-0.0045,16.9810979,-0.261,0.020039654,-3.034724221,0.219,0.07,0.089,-0.145,-0.095,-0.165,E9Q4S3,Nin,E9Q4S3_Nin,E9Q4S3,Nin,1,3,3,3,E9Q4S3|Q61043|Q61043-2|A0A1Y7VNC5,MOUSE,245939.1,1.1,3067,3067.1,16.7,16.7,,2113,Ninein,spindle pole|nucleolus|centrosome|centriole|,microtubule anchoring at centrosome|centrosome-templated microtubule nucleation|,calcium ion binding|protein binding|kinase binding|,3,3,989000000,1.1%
Q8VCT3,0.91325,0.042333333,1.377920793,-0.05,0.728128316,-0.362704507,0.002,0.143,0.057,-0.199,-0.035,0.286,Q8VCT3,Rnpep,Q8VCT3_Rnpep,Q8VCT3,Rnpep,1,3,2,2,Q8VCT3|E9PYF1,MOUSE,73099.6,4.7,3070,3070.1,16.69,16.69,,650,Aminopeptidase B,extracellular region|extracellular space|plasma membrane|extracellular exosome|,proteolysis|leukotriene biosynthetic process|,aminopeptidase activity|metallopeptidase activity|zinc ion binding|,2,3,68500000,4.7%
Q3UNA4,0.70184245,0.021833333,4.523323481,-0.149,0.352912996,-0.998977604,0.41,-0.048,-0.073,0.025,-0.032,-0.151,Q3UNA4,Nxt2,Q3UNA4_Nxt2,Q3UNA4,Nxt2,1,6,2,2,Q3UNA4|Q3UNA4-2|Q9QZV9,MOUSE,16484.4,10.5,3072,3072.1,16.68,16.68,,142,NTF2-related export protein 2,nucleus|cytoplasm|,protein transport|mRNA transport|,protein binding|,2,6,87000000,10.5%
O35459,0.612622361,0.001833333,6.128710044,0.162333333,0.243853501,1.279153338,-0.129,-0.207,0.098,0.039,-0.053,0.263,O35459,Ech1,O35459_Ech1,O35459,Ech1,1,2,2,2,O35459,MOUSE,36460.2,7.6,3073,3073.1,16.67,16.67,,327,"Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial",mitochondrion|peroxisome|membrane|extracellular exosome|,fatty acid beta-oxidation|,receptor binding|isomerase activity|,2,2,54600000,7.6%
A2ARZ3,0.000169989,-0.547666667,59.0826812,3.199333333,1.23518E-06,16.56174113,-1.794,-2.334,-2.314,0.775,1.265,1.116,A2ARZ3,NotFound,A2ARZ3_NotFound,A2ARZ3,Fsip2,1,8,2,2,A2ARZ3,MOUSE,790434.4,0.3,3074,3074.1,16.63,16.63,,6995,Fibrous sheath-interacting protein 2,mitochondrion|motile cilium|,,protein binding|,2,8,15900000000,0.3%
A3KMP2,0.796085917,0.03,3.19230227,0.083333333,0.479479201,0.7489598,0.019,0.04,-0.094,-0.02,0.264,-0.029,A3KMP2,Ttc38,A3KMP2_Ttc38,A3KMP2,Ttc38,1,3,2,2,A3KMP2|A3KMP2-2,MOUSE,52736.4,4.7,3077,3077.1,16.59,16.59,,465,Tetratricopeptide repeat protein 38,extracellular exosome|,,,2,3,28800000,4.7%
Q9D3E6,0.750389972,-0.000666667,3.833873172,-0.108,0.413630622,-0.872166583,0.07,-0.008,0.098,0.177,-0.237,-0.104,Q9D3E6,Stag1,Q9D3E6_Stag1,Q9D3E6,Stag1,1,2,2,2,Q9D3E6|F8WHU7|D6REF2|D6RHQ7,MOUSE,145407.7,1.2,3078,3078.1,16.58,16.58,,1258,Cohesin subunit SA-1,chromatin|nucleus|nucleoplasm|,transcription from RNA polymerase II promoter|chromosome segregation|mitotic nuclear division|positive regulation of transcription from RNA polymerase II promoter|cell division|,RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|chromatin binding|,2,2,131000000,1.2%
Q8JZV7,0.974796508,0.134333333,0.369505163,-0.022666667,0.918437238,-0.10637379,-0.149,-0.066,0.652,0.144,0.061,0.164,Q8JZV7,Amdhd2,Q8JZV7_Amdhd2,Q8JZV7,Amdhd2,1,2,2,2,Q8JZV7,MOUSE,43956.3,8.3,3080,3080.1,16.56,16.56,,409,N-acetylglucosamine-6-phosphate deacetylase,nucleus|,carbohydrate metabolic process|N-acetylglucosamine metabolic process|N-acetylneuraminate catabolic process|,N-acetylglucosamine-6-phosphate deacetylase activity|metal ion binding|,2,2,11400000,8.3%
P29452,0.677287369,0.074,4.908494674,-0.25,0.322961336,-1.067885753,0.099,-0.19,0.688,0.17,-0.244,-0.079,P29452,Casp1,P29452_Casp1,P29452,Casp1,1,2,2,2,P29452,MOUSE,46267.2,4.2,3081,3081.1,16.55,16.55,,402,Caspase-1,extracellular region|cytoplasm|mitochondrion|cytosol|IPAF inflammasome complex|NLRP1 inflammasome complex|NLRP3 inflammasome complex|AIM2 inflammasome complex|,response to hypoxia|proteolysis|apoptotic process|response to bacterium|regulation of autophagy|protein processing|response to lipopolysaccharide|interleukin-1 beta production|response to ATP|regulation of apoptotic process|positive regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of cytokine secretion|positive regulation of interleukin-1 alpha secretion|positive regulation of interleukin-1 beta secretion|regulation of inflammatory response|mitochondrial depolarization|membrane hyperpolarization|pyroptosis|cellular response to mechanical stimulus|cellular response to organic substance|programmed necrotic cell death|toxin transport|execution phase of apoptosis|,endopeptidase activity|protein binding|peptidase activity|cysteine-type endopeptidase activity involved in execution phase of apoptosis|,2,2,78400000,4.2%
Q8K203,0.000498463,-0.181333333,49.68943924,-1.441333333,1.07413E-05,-11.82777695,0.509,0.486,0.623,-1.128,-0.829,-0.749,Q8K203,Neil3,Q8K203_Neil3,Q8K203,Neil3,1,8,2,2,Q8K203|Q8K203-2,MOUSE,69183.9,5.4,3082,3082.1,16.52,16.52,,606,Endonuclease 8-like 3,nucleus|,base-excision repair|nucleotide-excision repair|,bubble DNA binding|damaged DNA binding|double-stranded DNA binding|single-stranded DNA binding|DNA-(apurinic or apyrimidinic site) lyase activity|zinc ion binding|DNA N-glycosylase activity|,2,8,1860000000,5.4%
A0A1L1SSA4,0.265145441,0.097,13.79368798,-0.458,0.04174757,-2.518901311,0.237,0.032,0.709,-0.017,-0.117,-0.262,A0A1L1SSA4,Cep164,A0A1L1SSA4_Cep164,A0A1L1SSA4,Cep164,1,5,3,3,A0A1L1SSA4|Q5DU05|Q5DU05-3|D3YVU3|Q5DU05-2,MOUSE,226797.3,1.3,3083,3083.1,16.51,16.51,,2034,Centrosomal protein of 164 kDa,,,,3,5,178000000,1.3%
Q8BH44,0.933608247,-0.012166667,0.961852313,-0.030333333,0.801336212,-0.261897404,-0.097,-0.091,0.197,-0.142,0.037,0.023,Q8BH44,Coro2b,Q8BH44_Coro2b,Q8BH44,Coro2b,1,2,2,2,Q8BH44,MOUSE,55505.9,5,3084,3084.1,16.5,16.5,,480,Coronin-2B,cytoplasm|actin cytoskeleton|membrane|,actin cytoskeleton organization|,actin filament binding|,2,2,40500000,5.0%
D3YTR0,0.015548689,-0.092,29.8101787,-1.291333333,0.001044677,-5.545878972,0.347,0.974,0.34,-1.083,-0.428,-0.702,D3YTR0,NotFound,D3YTR0_NotFound,D3YTR0,Apc2,1,6,2,2,D3YTR0|Q9Z1K7|G5E832,MOUSE,248334.3,0.6,3085,3085.1,16.49,16.49,,2303,Adenomatous polyposis coli protein 2,cytoplasm|Golgi apparatus|actin filament|microtubule cytoskeleton|catenin complex|lamellipodium membrane|perinuclear region of cytoplasm|cytoplasmic microtubule|,Wnt signaling pathway|negative regulation of catenin import into nucleus|negative regulation of canonical Wnt signaling pathway|,beta-catenin binding|microtubule binding|,2,6,6560000000,0.6%
B2RQG2,0.813380394,-0.1425,2.899190504,0.226333333,0.512956987,0.691173135,0.335,-0.068,-1.034,-0.053,0.075,-0.11,B2RQG2,Phf3,B2RQG2_Phf3,B2RQG2,Phf3,1,5,3,3,B2RQG2,MOUSE,227364.1,1.8,3087,3087.1,16.47,16.47,,2025,PHD finger protein 3,nucleus|,"transcription, DNA-templated|",zinc ion binding|,3,5,776000000,1.8%
Q8K1C9,0.836873322,-0.099333333,2.576578096,0.163333333,0.552512605,0.625619901,0.121,0.033,-0.697,0.265,0.061,-0.379,Q8K1C9,Lrrc41,Q8K1C9_Lrrc41,Q8K1C9,Lrrc41,1,3,3,3,Q8K1C9,MOUSE,89319.7,5,3090,3090.1,16.46,16.46,,807,Leucine-rich repeat-containing protein 41,nucleus|cytoplasm|membrane|,protein ubiquitination|,protein binding|protein homodimerization activity|,3,3,28000000,5.0%
Q68FE6,0.811929773,0.003333333,2.914680819,0.058666667,0.511130643,0.693827728,-0.005,0.007,-0.08,0.109,-0.012,0.001,Q68FE6,Ripor1,Q68FE6_Ripor1,Q68FE6,Ripor1,1,8,2,2,Q68FE6,MOUSE,133604.9,2,3091,3091.1,16.43,16.43,,1223,Rho family-interacting cell polarization regulator 1,cytoplasm|extracellular exosome|,,,2,8,35800000000,2.0%
P09925,0.506587963,-0.0015,8.08540794,0.179666667,0.155402931,1.601910517,-0.012,-0.046,-0.216,0.253,-0.035,0.047,P09925,Surf1,P09925_Surf1,P09925,Surf1,1,2,2,2,P09925,MOUSE,35140.1,7.5,3094,3094.1,16.32,16.32,,306,Surfeit locus protein 1,mitochondrion|mitochondrial inner membrane|integral component of membrane|,oxidative phosphorylation|ATP biosynthetic process|hydrogen ion transmembrane transport|,cytochrome-c oxidase activity|,2,2,15000000,7.5%
P46414,0.111560109,-0.048166667,19.38459073,0.426333333,0.011522346,3.45981473,-0.328,-0.358,-0.098,0.179,-0.005,0.321,P46414,Cdkn1b,P46414_Cdkn1b,P46414,Cdkn1b,1,3,2,2,P46414,MOUSE,22421.3,14.2,3095,3095.1,16.31,16.31,,197,Cyclin-dependent kinase inhibitor 1B,nucleus|cytoplasm|endosome|cytosol|Cul4A-RING E3 ubiquitin ligase complex|,"G1/S transition of mitotic cell cycle|response to hypoxia|potassium ion transport|activation of cysteine-type endopeptidase activity involved in apoptotic process|cell cycle arrest|Notch signaling pathway|sensory perception of sound|positive regulation of cell proliferation|negative regulation of cell proliferation|response to glucose|positive regulation of cell death|negative regulation of cell growth|positive regulation of microtubule polymerization|response to estradiol|negative regulation of kinase activity|negative regulation of phosphorylation|response to drug|negative regulation of apoptotic process|response to amino acid|response to peptide hormone|positive regulation of protein catabolic process|negative regulation of cyclin-dependent protein serine/threonine kinase activity|negative regulation of transcription, DNA-templated|negative regulation of mitotic cell cycle|response to cadmium ion|autophagic cell death|inner ear development|negative regulation of epithelial cell proliferation|negative regulation of cellular component movement|negative regulation of epithelial cell proliferation involved in prostate gland development|cellular response to antibiotic|cellular response to lithium ion|cellular response to organic cyclic compound|mitotic cell cycle arrest|",cyclin-dependent protein serine/threonine kinase inhibitor activity|protein binding|protein phosphatase binding|Hsp70 protein binding|protein complex binding|chaperone binding|cysteine-type endopeptidase activator activity involved in apoptotic process|,2,3,103000000,14.2%
Q8CGS6,0.790620052,0.0215,3.261659839,-0.076333333,0.471882657,-0.762281161,0.131,0.152,-0.104,-0.027,-0.04,0.017,Q8CGS6,Polq,Q8CGS6_Polq,Q8CGS6,Polq,1,5,3,3,Q8CGS6|Q8CGS6-2,MOUSE,283732.8,2.1,3097,3097.1,16.27,16.27,,2544,DNA polymerase theta,nucleus|chromosome|,DNA-dependent DNA replication|DNA repair|base-excision repair|double-strand break repair|cellular response to DNA damage stimulus|somatic hypermutation of immunoglobulin genes|protein homooligomerization|DNA biosynthetic process|double-strand break repair via alternative nonhomologous end joining|negative regulation of double-strand break repair via homologous recombination|,DNA binding|chromatin binding|DNA-directed DNA polymerase activity|ATP binding|single-stranded DNA-dependent ATPase activity|5'-deoxyribose-5-phosphate lyase activity|,3,5,5120000000,2.1%
Q8BJT9,0.029510731,-0.076,26.37791062,0.402666667,0.002302549,4.768137984,-0.25,-0.279,-0.303,0.18,0.038,0.158,Q8BJT9,Edem2,Q8BJT9_Edem2,Q8BJT9,Edem2,1,2,2,2,Q8BJT9,MOUSE,65122.1,5.1,3099,3099.1,16.22,16.22,,577,"alpha-1,2-Mannosidase",endoplasmic reticulum|membrane|,"N-glycan processing|ER-associated ubiquitin-dependent protein catabolic process|endoplasmic reticulum unfolded protein response|glycoprotein ERAD pathway|positive regulation of retrograde protein transport, ER to cytosol|","glycoprotein binding|mannosyl-oligosaccharide 1,2-alpha-mannosidase activity|calcium ion binding|",2,2,41400000,5.1%
Q3TIU4,0.894042447,0.108333333,1.682854397,-0.055333333,0.678757373,-0.433019975,-0.062,0.1,0.37,0.12,0.123,-0.001,Q3TIU4,Pde12,Q3TIU4_Pde12,Q3TIU4,Pde12,1,2,2,2,Q3TIU4,MOUSE,68482.3,3.9,3101,3101.1,16.2,16.2,,608,"2',5'-phosphodiesterase 12",mitochondrion|mitochondrial matrix|,"mRNA processing|RNA phosphodiester bond hydrolysis, exonucleolytic|",poly(A)-specific ribonuclease activity|metal ion binding|,2,2,146000000,3.9%
E9Q3P4,0.634404848,-0.0815,5.708324857,0.172333333,0.268638043,1.207415378,-0.014,-0.022,-0.467,0.065,-0.078,0.027,E9Q3P4,Cenpf,E9Q3P4_Cenpf,E9Q3P4,Cenpf,1,3,3,3,E9Q3P4,MOUSE,345546.7,1,3102,3102.1,16.17,16.17,,2997,Centromere protein F,"chromosome, centromeric region|spindle pole|condensed chromosome outer kinetochore|nucleus|nuclear envelope|nucleoplasm|cytoplasm|spindle|nuclear matrix|midbody|pronucleus|kinetochore|","mitotic cell cycle|chromosome segregation|regulation of G2/M transition of mitotic cell cycle|protein transport|regulation of striated muscle tissue development|negative regulation of transcription, DNA-templated|metaphase plate congression|",protein C-terminus binding|transcription factor binding|protein homodimerization activity|dynein binding|,3,3,657000000,1.0%
Q8K182,0.777827379,0.0745,3.42911588,0.507666667,0.454034038,0.795247709,-1.038,-0.798,1.298,-0.091,0.078,0.998,Q8K182,C8a,Q8K182_C8a,Q8K182,C8a,1,2,2,2,Q8K182|A2A997|A2A998,MOUSE,67733.7,4,3103,3103.1,16.12,16.12,,587,Complement component C8 alpha chain,membrane attack complex|extracellular exosome|blood microparticle|,"complement activation|complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",complement binding|protein complex binding|,2,2,10200000,4.0%
G3UVU2,0.695431326,0.014333333,4.625512498,0.124666667,0.344705926,1.017382422,-0.094,0.076,-0.126,-0.123,0.11,0.243,G3UVU2,Sf3a2,G3UVU2_Sf3a2,G3UVU2,Sf3a2,1,2,2,2,G3UVU2|Q62203|D3YW09,MOUSE,51392.1,3.7,3104,3104.1,16.1,16.1,,485,Splicing factor 3A subunit 2,nucleus|catalytic step 2 spliceosome|,"RNA splicing, via transesterification reactions|mRNA splicing, via spliceosome|",protein binding|zinc ion binding|poly(A) RNA binding|,2,2,47400000,3.7%
P20060,0.002220995,-0.0445,39.95753272,0.796333333,0.000100983,8.175440106,-0.391,-0.377,-0.56,0.395,0.415,0.251,P20060,Hexb,P20060_Hexb,P20060,Hexb,1,2,2,2,P20060,MOUSE,61513.9,5.4,3109,3109.1,16.01,16.01,,536,Beta-hexosaminidase subunit beta,acrosomal vesicle|lysosome|membrane|extracellular exosome|,skeletal system development|glycosphingolipid metabolic process|ganglioside catabolic process|cellular calcium ion homeostasis|lysosome organization|single fertilization|penetration of zona pellucida|sensory perception of sound|locomotory behavior|male courtship behavior|regulation of cell shape|phospholipid biosynthetic process|oligosaccharide catabolic process|lipid storage|sexual reproduction|glycosaminoglycan metabolic process|regulation of cellular metabolic process|myelination|astrocyte cell migration|cellular protein metabolic process|positive regulation of transcription from RNA polymerase II promoter|oogenesis|neuromuscular process controlling balance|neuromuscular process|,beta-N-acetylhexosaminidase activity|protein homodimerization activity|protein heterodimerization activity|,2,2,9450000,5.4%
O08692,0.454052388,0.150333333,9.295959668,-1.066666667,0.11759911,-1.798390171,0.209,-0.114,1.956,-0.023,-1.18,0.054,O08692,Ngp,O08692_Ngp,O08692,Ngp,1,3,3,3,O08692,MOUSE,19673.7,13.1,3111,3111.1,16.01,16.01,,167,Neutrophilic granule protein,extracellular space|cytoplasmic vesicle|,defense response|negative regulation of endopeptidase activity|negative regulation of angiogenesis|negative regulation of lymphangiogenesis|,cysteine-type endopeptidase inhibitor activity|,3,3,16300000,13.1%
Q8CI78,0.634404848,0.022333333,5.676057411,-0.176666667,0.270641417,-1.201867572,0.056,0.38,-0.104,-0.076,-0.195,0.073,Q8CI78,Rmnd1,Q8CI78_Rmnd1,Q8CI78,Rmnd1,1,3,2,2,Q8CI78,MOUSE,52298.4,3.5,3112,3112.1,16.01,16.01,,450,Required for meiotic nuclear division protein 1 homolog,mitochondrion|,translation|,,2,3,12500000,3.5%
Q3UMY5,0.070780923,-0.016666667,21.85991372,0.526666667,0.006516413,3.908157313,-0.394,-0.364,-0.082,0.442,0.09,0.208,Q3UMY5,Eml4,Q3UMY5_Eml4,Q3UMY5,Eml4,1,3,2,2,Q3UMY5|F8WJ93|Q3UMY5-3|Q3UMY5-2|A0A0R4J1G7|Q3UMY5-4|A0A0R4J0H0,MOUSE,111108.9,3.4,3114,3114.1,16,16,,988,Echinoderm microtubule-associated protein-like 4,cytoplasm|microtubule|membrane|microtubule cytoskeleton|mitotic spindle|,negative regulation of microtubule depolymerization|,,2,3,87700000,3.4%
E9QM38,0.043922217,-0.155666667,24.27688936,0.964666667,0.003735176,4.371034566,-1.121,-0.338,-0.455,0.532,0.282,0.166,E9QM38,Slc12a2,E9QM38_Slc12a2,E9QM38,Slc12a2,1,5,2,2,E9QM38|P55012,MOUSE,131407.2,3.2,3116,3116.1,15.93,15.93,,1206,Solute carrier family 12 member 2,integral component of membrane|basolateral plasma membrane|apical plasma membrane|extracellular exosome|extracellular vesicle|,ammonium transport|transepithelial chloride transport|multicellular organism growth|detection of mechanical stimulus involved in sensory perception of sound|branching involved in mammary gland duct morphogenesis|mammary duct terminal end bud growth|transepithelial ammonium transport|ammonium transmembrane transport|chloride transmembrane transport|,protein binding|ammonium transmembrane transporter activity|cation:chloride symporter activity|,2,5,74400000,3.2%
P07309,0.00450441,0.010166667,36.17144588,0.867666667,0.000241466,7.147387576,-0.462,-0.272,-0.537,0.618,0.299,0.415,P07309,Ttr,P07309_Ttr,P07309,Ttr,1,3,2,2,P07309,MOUSE,15889.7,10.8,3117,3117.1,15.92,15.92,,147,Transthyretin,extracellular space|protein complex|extracellular exosome|,retinol metabolic process|thyroid hormone transport|,hormone activity|protein binding|identical protein binding|protein heterodimerization activity|thyroid hormone binding|,2,3,77300000,10.8%
Q9DBZ1,0.032337696,-0.115666667,25.93400425,0.877333333,0.002550349,4.70482414,-0.865,-0.645,-0.153,0.308,0.225,0.436,Q9DBZ1,Ikbip,Q9DBZ1_Ikbip,Q9DBZ1,Ikbip,1,2,2,2,Q9DBZ1|E9QMH7|Q9DBZ1-2,MOUSE,42588.3,6.7,3118,3118.1,15.91,15.91,,373,Inhibitor of nuclear factor kappa-B kinase-interacting protein,endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,,,2,2,1130000000,6.7%
Q8BPB5,0.042395617,0.007333333,24.54672849,0.716,0.003510162,4.424429125,-0.219,-0.33,-0.503,0.192,0.21,0.694,Q8BPB5,Efemp1,Q8BPB5_Efemp1,Q8BPB5,Efemp1,1,2,2,2,Q8BPB5,MOUSE,57234.1,4,3120,3120.1,15.89,15.89,,493,EGF-containing fibulin-like extracellular matrix protein 1,proteinaceous extracellular matrix|extracellular space|extracellular exosome|extracellular matrix|,"regulation of transcription, DNA-templated|epidermal growth factor receptor signaling pathway|peptidyl-tyrosine phosphorylation|negative regulation of chondrocyte differentiation|",epidermal growth factor-activated receptor activity|epidermal growth factor receptor binding|calcium ion binding|growth factor activity|,2,2,392000000,4.0%
Q80UN9,0.755660323,0.009166667,3.761204255,0.134333333,0.420609981,0.85850403,0.059,-0.215,-0.018,-0.18,0.359,0.05,Q80UN9,Trit1,Q80UN9_Trit1,Q80UN9,Trit1,1,5,2,2,Q80UN9|Q80UN9-2,MOUSE,52778.2,3.6,3121,3121.1,15.86,15.86,,467,tRNA dimethylallyltransferase,nucleus|mitochondrion|,tRNA modification|,ATP binding|metal ion binding|tRNA dimethylallyltransferase activity|,2,5,283000000,3.6%
Q6PB75,0.919618833,-0.115,1.184563421,0.091333333,0.761278663,0.316624283,0.151,0.129,-0.762,-0.421,0.25,-0.037,Q6PB75,Tent4a,Q6PB75_Tent4a,Q6PB75,Papd7,1,4,2,2,A0A0G2JDV2|Q6PB75,MOUSE,60368.2,3.1,3123,3123.1,15.84,15.84,,542,Non-canonical poly(A) RNA polymerase PAPD7,nucleus|nucleoplasm|cytoplasm|,mitotic nuclear division|response to drug|cell division|DNA biosynthetic process|,DNA binding|DNA-directed DNA polymerase activity|polynucleotide adenylyltransferase activity|metal ion binding|,2,4,4130000000,3.1%
Q8VDD8,0.213924885,-0.026,15.43342759,0.326,0.028619184,2.785207276,-0.027,-0.184,-0.356,0.244,0.021,0.146,Q8VDD8,Washc1,Q8VDD8_Washc1,Q8VDD8,Washc1,1,4,2,2,Q8VDD8,MOUSE,51771.8,7.7,3125,3125.1,15.75,15.75,,475,WASH complex subunit 1,early endosome|autophagosome|centrosome|centriole|cytoplasmic vesicle|early endosome membrane|recycling endosome|recycling endosome membrane|WASH complex|invadopodium|exocyst|BLOC-1 complex|,"oocyte maturation|dendritic cell antigen processing and presentation|exocytosis|negative regulation of autophagy|endosomal transport|extracellular matrix disassembly|positive regulation of cell migration|positive regulation of pseudopodium assembly|regulation of protein ubiquitination|Arp2/3 complex-mediated actin nucleation|protein localization to cell surface|polar body extrusion after meiotic divisions|T cell proliferation|retrograde transport, endosome to Golgi|negative regulation of phosphatidylinositol 3-kinase activity|regulation of immune response|spindle assembly involved in meiosis|retrograde transport, endosome to plasma membrane|",actin binding|ubiquitin protein ligase binding|alpha-tubulin binding|gamma-tubulin binding|,2,4,31000000,7.7%
P27005,0.472136605,0.429,8.774792636,-1.333333333,0.132593043,-1.714609538,0.164,0.077,3.046,0.002,-0.633,-0.082,P27005,S100a8,P27005_S100a8,P27005,S100a8,1,5,2,2,P27005,MOUSE,10351.5,13.4,3126,3126.1,15.74,15.74,,89,Protein S100-A8,extracellular space|nucleus|cytoplasm|cytoskeleton|plasma membrane|extracellular exosome|,leukocyte migration involved in inflammatory response|acute inflammatory response|chronic inflammatory response|positive regulation of peptide secretion|autophagy|activation of cysteine-type endopeptidase activity involved in apoptotic process|response to zinc ion|peptidyl-cysteine S-nitrosylation|neutrophil chemotaxis|response to lipopolysaccharide|wound healing|innate immune response|response to ethanol|positive regulation of inflammatory response|neutrophil aggregation|positive regulation of intrinsic apoptotic signaling pathway|,calcium ion binding|microtubule binding|zinc ion binding|antioxidant activity|Toll-like receptor 4 binding|arachidonic acid binding|RAGE receptor binding|,2,5,815000000,13.4%
Q9D3U0,0.923890139,-0.088,1.130005813,0.076,0.770902437,0.303393099,-0.586,0.117,0.091,-0.098,-0.376,0.324,Q9D3U0,Pus10,Q9D3U0_Pus10,Q9D3U0,Pus10,1,3,3,3,Q9D3U0,MOUSE,60451.1,4.7,3130,3130.1,15.71,15.71,,527,Putative tRNA pseudouridine synthase Pus10,,tRNA processing|,RNA binding|pseudouridine synthase activity|,3,3,58500000,4.7%
Q9Z0H3,0.481746078,0.018,8.514181994,-0.168666667,0.140793239,-1.669978847,0.122,0.209,-0.024,-0.156,-0.067,0.024,Q9Z0H3,Smarcb1,Q9Z0H3_Smarcb1,Q9Z0H3,Smarcb1,1,3,3,3,Q9Z0H3|Q9Z0H3-2,MOUSE,44425.7,10.9,3131,3131.1,15.69,15.69,,385,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1,nuclear chromatin|XY body|nucleus|nucleoplasm|nucleolus|SWI/SNF complex|protein complex|npBAF complex|nBAF complex|BAF-type complex|,"blastocyst development|blastocyst hatching|DNA repair|nucleosome disassembly|chromatin remodeling|transcription, DNA-templated|regulation of transcription from RNA polymerase II promoter|nervous system development|negative regulation of cell proliferation|cell differentiation|single stranded viral RNA replication via double stranded DNA intermediate|ATP-dependent chromatin remodeling|positive regulation by host of viral transcription|mitotic cell cycle phase transition|positive regulation of transcription from RNA polymerase II promoter|positive regulation of sequence-specific DNA binding transcription factor activity|",p53 binding|transcription coactivator activity|protein binding|Tat protein binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|,3,3,1500000000,10.9%
Q3TMW1,0.840515128,-0.092666667,2.532555478,0.183333333,0.558141676,0.616530213,-0.17,0.183,-0.566,-0.6,0.266,0.331,Q3TMW1,Ccdc102a,Q3TMW1_Ccdc102a,Q3TMW1,Ccdc102a,1,3,2,2,Q3TMW1,MOUSE,62908.2,3,3132,3132.1,15.67,15.67,,549,Coiled-coil domain-containing protein 102A,,,,2,3,1780000000,3.0%
Q8BZN6-3,0.636050842,0.024833333,5.642404634,0.151666667,0.27274672,1.196074923,0.029,-0.097,-0.085,0.348,-0.049,0.003,Q8BZN6,Dock10,Q8BZN6-3_Dock10,Q8BZN6-3,Dock10,1,2,2,2,Q8BZN6-3|Q8BZN6-2|E9QM99|Q8BZN6-4|A0A087WQ86|A0A087WRP5|Q8BZN6,MOUSE,260015.6,1.3,3134,3134.1,15.63,15.63,,2150,Isoform 3 of Dedicator of cytokinesis protein 10,intracellular|membrane|extracellular exosome|,small GTPase mediated signal transduction|regulation of cell migration|positive regulation of GTPase activity|,Rho guanyl-nucleotide exchange factor activity|Rho GTPase binding|,2,2,13000000,1.3%
Q9JMK2,0.335858884,0.067666667,11.78703657,-0.313333333,0.066266853,-2.196379552,0.069,0.512,0.092,-0.19,-0.091,0.014,Q9JMK2,Csnk1e,Q9JMK2_Csnk1e,Q9JMK2,Csnk1e,1,2,2,2,Q9JMK2|Q9DC28|Q9DC28-2|Q3TYE1,MOUSE,47606.5,4.3,3135,3135.1,15.63,15.63,,416,Casein kinase I isoform epsilon,nucleus|nucleoplasm|cytoplasm|cytosol|ribonucleoprotein complex|,protein phosphorylation|endocytosis|circadian rhythm|regulation of cell shape|Wnt signaling pathway|peptidyl-serine phosphorylation|negative regulation of Wnt signaling pathway|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|circadian regulation of gene expression|cellular protein localization|regulation of circadian rhythm|positive regulation of canonical Wnt signaling pathway|,protein kinase activity|protein serine/threonine kinase activity|protein binding|ATP binding|poly(A) RNA binding|,2,2,15100000,4.3%
E9PVD3,0.123305336,0.101,18.7088435,-0.468666667,0.013462188,-3.341363076,0.124,0.345,0.537,-0.305,-0.114,0.019,E9PVD3,Dchs1,E9PVD3_Dchs1,E9PVD3,Dchs1,1,4,3,3,E9PVD3,MOUSE,347118.8,1.7,3136,3136.1,15.62,15.62,,3291,Protocadherin-16,intracellular|plasma membrane|integral component of membrane|apical part of cell|,branching involved in ureteric bud morphogenesis|establishment of planar polarity|kidney development|heart morphogenesis|homophilic cell adhesion via plasma membrane adhesion molecules|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|neural tube development|neurogenesis|hippo signaling|post-anal tail morphogenesis|ossification involved in bone maturation|digestive tract development|cochlea development|,calcium ion binding|,3,4,823000000,1.7%
Q78J03,0.235250036,0.031166667,14.63448401,0.273666667,0.034399458,2.648793266,-0.13,-0.064,-0.123,0.341,0.106,0.057,Q78J03,Msrb2,Q78J03_Msrb2,Q78J03,Msrb2,1,2,2,2,Q78J03,MOUSE,19670.1,20.5,3137,3137.1,15.62,15.62,,175,"Methionine-R-sulfoxide reductase B2, mitochondrial",mitochondrion|,response to oxidative stress|actin filament polymerization|protein repair|oxidation-reduction process|,actin binding|zinc ion binding|peptide-methionine (R)-S-oxide reductase activity|,2,2,396000000,20.5%
F8WI88,0.961523652,0.045166667,0.532111293,-0.033,0.884685422,-0.150720705,-0.218,0.077,0.326,-0.081,-0.272,0.439,F8WI88,NotFound,F8WI88_NotFound,F8WI88,Pcnp,1,3,2,2,F8WI88|Q6P8I4|D3YWA4,MOUSE,20279,11.1,3138,3138.1,15.61,15.61,,189,PEST proteolytic signal-containing nuclear protein,nucleus|nucleoplasm|,protein ubiquitination|proteasome-mediated ubiquitin-dependent protein catabolic process|,,2,3,83900000,11.1%
O88572,0.469507952,-0.087,8.92661398,0.406666667,0.128037918,1.739055295,-0.067,0.04,-0.844,0.066,0.233,0.05,O88572,Lrp6,O88572_Lrp6,O88572,Lrp6,1,2,2,2,A0A0R4J0A9|O88572,MOUSE,183275.6,2,3141,3141.1,15.58,15.58,,1613,Low-density lipoprotein receptor-related protein 6,early endosome|endoplasmic reticulum|plasma membrane|caveola|cell surface|membrane|integral component of membrane|cytoplasmic vesicle|neuronal cell body|receptor complex|synapse|early endosome|Golgi apparatus|caveola|,"gastrulation with mouth forming second|somitogenesis|neural tube closure|negative regulation of protein phosphorylation|heart looping|positive regulation of mesenchymal cell proliferation|pericardium morphogenesis|axis elongation|negative regulation of protein kinase activity|synaptic transmission|embryonic pattern specification|dorsal/ventral axis specification|anterior/posterior pattern specification|neural crest formation|neural crest cell differentiation|Wnt signaling pathway|cerebellum morphogenesis|thalamus development|cerebral cortex cell migration|forebrain radial glial cell differentiation|forebrain generation of neurons|Wnt signaling pathway involved in forebrain neuroblast division|neural tube development|formation of radial glial scaffolds|cerebral cortex development|negative regulation of Wnt signaling pathway|embryonic limb morphogenesis|forebrain development|midbrain development|midbrain-hindbrain boundary development|negative regulation of smooth muscle cell apoptotic process|limb morphogenesis|embryonic forelimb morphogenesis|embryonic hindlimb morphogenesis|external genitalia morphogenesis|post-anal tail morphogenesis|cell migration involved in gastrulation|regulation of cell proliferation|odontogenesis of dentin-containing tooth|embryonic digit morphogenesis|positive regulation of apoptotic process|Wnt signaling pathway involved in dorsal/ventral axis specification|negative regulation of fat cell differentiation|positive regulation of ossification|positive regulation of bone resorption|positive regulation of cell cycle|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|bone remodeling|embryonic camera-type eye morphogenesis|generation of neurons|skeletal system morphogenesis|negative regulation of epithelial cell proliferation|positive regulation of sequence-specific DNA binding transcription factor activity|response to folic acid|palate development|convergent extension|retina morphogenesis in camera-type eye|embryonic retina morphogenesis in camera-type eye|canonical Wnt signaling pathway|regulation of cell development|face morphogenesis|branching involved in mammary gland duct morphogenesis|trachea cartilage morphogenesis|mammary placode formation|mammary gland duct morphogenesis|canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development|canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation|cellular response to cholesterol|dopaminergic neuron differentiation|negative regulation of protein serine/threonine kinase activity|primitive streak formation|receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport|Wnt signaling pathway involved in somitogenesis|axis elongation involved in somitogenesis|positive regulation of canonical Wnt signaling pathway|toxin transport|negative regulation of non-canonical Wnt signaling pathway|positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification|negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis|negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis|negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis|negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis|negative regulation of planar cell polarity pathway involved in pericardium morphogenesis|negative regulation of planar cell polarity pathway involved in neural tube closure|",low-density lipoprotein receptor activity|receptor binding|frizzled binding|protein binding|Wnt-protein binding|kinase inhibitor activity|toxin transporter activity|identical protein binding|protein homodimerization activity|Wnt-activated receptor activity|coreceptor activity involved in Wnt signaling pathway|,2,2,20500000,2.0%
P48437,0.906976301,0.009,1.500878538,-0.092,0.707802588,-0.391387107,0.433,0.238,-0.506,-0.025,-0.028,-0.058,P48437,Prox1,P48437_Prox1,P48437,Prox1,1,2,2,2,P48437,MOUSE,83752.3,3.1,3142,3142.1,15.56,15.56,,737,Prospero homeobox protein 1,nucleus|cytoplasm|,"negative regulation of transcription from RNA polymerase II promoter|cell fate determination|kidney development|positive regulation of endothelial cell proliferation|lymph vessel development|lymphangiogenesis|lens morphogenesis in camera-type eye|hepatocyte cell migration|transcription, DNA-templated|circadian rhythm|positive regulation of cell proliferation|negative regulation of cell proliferation|regulation of gene expression|positive regulation of endothelial cell migration|dentate gyrus development|cerebellar granule cell differentiation|skeletal muscle thin filament assembly|lung development|response to nutrient levels|regulation of circadian rhythm|negative regulation of sequence-specific DNA binding transcription factor activity|negative regulation of viral genome replication|endothelial cell differentiation|positive regulation of cyclin-dependent protein serine/threonine kinase activity|positive regulation of cell cycle|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|optic placode formation involved in camera-type eye formation|inner ear development|venous blood vessel morphogenesis|ventricular cardiac myofibril assembly|atrial cardiac muscle tissue morphogenesis|ventricular cardiac muscle tissue morphogenesis|embryonic retina morphogenesis in camera-type eye|endocardium formation|positive regulation of sarcomere organization|ventricular septum morphogenesis|aorta smooth muscle tissue morphogenesis|positive regulation of heart growth|lymphatic endothelial cell differentiation|regulation of transcription involved in lymphatic endothelial cell fate commitment|branching involved in pancreas morphogenesis|lens fiber cell morphogenesis|hepatocyte differentiation|negative regulation of bile acid biosynthetic process|hepatocyte proliferation|acinar cell differentiation|neuronal stem cell maintenance|positive regulation of cell cycle checkpoint|positive regulation of neural precursor cell proliferation|positive regulation of forebrain neuron differentiation|",sequence-specific DNA binding RNA polymerase II transcription factor activity|core promoter sequence-specific DNA binding|DNA binding|sequence-specific DNA binding transcription factor activity|RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity|transcription corepressor activity|protein binding|ligand-dependent nuclear receptor binding|sequence-specific DNA binding|transcription regulatory region DNA binding|DBD domain binding|LBD domain binding|,2,2,88000000,3.1%
Q8BVL3,0.668311846,-0.0525,5.033407221,-0.145,0.31380458,-1.089974608,0.007,0.013,0.04,0.065,-0.399,-0.041,Q8BVL3,Snx17,Q8BVL3_Snx17,Q8BVL3,Snx17,1,3,2,2,Q8BVL3,MOUSE,53081.4,6.1,3147,3147.1,15.51,15.51,,470,Sorting nexin-17,cytoplasm|endosome|early endosome|Golgi apparatus|cytosol|endosome membrane|cytoplasmic membrane-bounded vesicle|cytoplasmic vesicle membrane|intracellular membrane-bounded organelle|protein complex|,receptor-mediated endocytosis|signal transduction|protein transport|,protein C-terminus binding|phosphatidylinositol binding|low-density lipoprotein particle receptor binding|,2,3,200000000,6.1%
P23591,0.977234082,-0.013666667,0.339101336,-0.010666667,0.924889537,-0.097893688,-0.199,0.05,0.124,0.026,-0.026,-0.057,P23591,Tsta3,P23591_Tsta3,P23591,Tsta3,1,3,2,2,P23591,MOUSE,36105.2,6.5,3148,3148.1,15.5,15.5,,321,GDP-L-fucose synthase,extracellular exosome|,GDP-mannose metabolic process|cytolysis|'de novo' GDP-L-fucose biosynthetic process|oxidation-reduction process|,isomerase activity|GDP-L-fucose synthase activity|coenzyme binding|,2,3,42900000,6.5%
Q9DBL0,0.52769863,-0.012,7.667253673,0.266666667,0.171109701,1.534925872,0.036,-0.023,-0.449,0.381,-0.037,0.02,Q9DBL0,Adra1b,Q9DBL0_Adra1b,Q9DBL0,Adra1b,1,3,2,2,Q9DBL0|P97717,MOUSE,57409.4,5,3149,3149.1,15.49,15.49,,515,"Adrenergic receptor, alpha 1b",nucleus|cytosol|integral component of plasma membrane|integral component of membrane|nuclear membrane|,blood vessel remodeling|response to amphetamine|vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure|norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure|positive regulation of heart rate by epinephrine-norepinephrine|positive regulation of the force of heart contraction by epinephrine-norepinephrine|phospholipase C-activating G-protein coupled receptor signaling pathway|positive regulation of cytosolic calcium ion concentration|cell-cell signaling|adult heart development|locomotory behavior|visual learning|cell growth|negative regulation of Rho protein signal transduction|organ growth|glucose homeostasis|response to morphine|positive regulation of MAPK cascade|negative regulation of glycogen catabolic process|positive regulation of glycogen catabolic process|positive regulation of vasoconstriction|positive regulation of smooth muscle contraction|behavioral response to cocaine|regulation of cardiac muscle contraction|adenylate cyclase-activating adrenergic receptor signaling pathway|,alpha1-adrenergic receptor activity|protein heterodimerization activity|,2,3,152000000,5.0%
P06797,0.003124398,-0.0965,38.09076221,0.813666667,0.000155211,7.634640181,-0.686,-0.363,-0.461,0.329,0.312,0.29,P06797,Ctsl,P06797_Ctsl,P06797,Ctsl,1,2,2,2,P06797,MOUSE,38117.2,8.9,3150,3150.1,15.45,15.45,,334,Cathepsin L1,extracellular space|nucleus|nucleolus|cytoplasm|lysosome|vacuole|microvillus|external side of plasma membrane|cytoplasmic vesicle|neuron projection|perikaryon|extracellular exosome|secretory granule|apical part of cell|,proteolysis|cell communication|spermatogenesis|male gonad development|cellular response to starvation|response to glucose|multicellular organismal aging|negative regulation of keratinocyte proliferation|response to organic cyclic compound|protein processing|protein autoprocessing|nerve development|hair follicle morphogenesis|response to gonadotropin|decidualization|autophagic cell death|response to glucocorticoid|proteolysis involved in cellular protein catabolic process|Sertoli cell differentiation|regulation of actin cytoskeleton reorganization|epithelial tube branching involved in lung morphogenesis|,aminopeptidase activity|cysteine-type endopeptidase activity|protein binding|cysteine-type carboxypeptidase activity|kininogen binding|protein complex binding|peptide binding|histone binding|,2,2,17100000,8.9%
Q62245,0.822248694,0.033333333,2.735768257,0.101333333,0.532626996,0.65819321,-0.174,0.08,0.042,0.315,-0.206,0.143,Q62245,Sos1,Q62245_Sos1,Q62245,Sos1,1,3,2,2,Q62245,MOUSE,151850.4,2.1,3151,3151.1,15.42,15.42,,1319,Son of sevenless homolog 1,cytosol|plasma membrane|postsynaptic density|neuronal cell body|,B cell homeostasis|lymphocyte homeostasis|small GTPase mediated signal transduction|Ras protein signal transduction|regulation of T cell differentiation in thymus|regulation of Rho protein signal transduction|regulation of T cell proliferation|positive regulation of GTPase activity|positive regulation of epidermal growth factor receptor signaling pathway|neurotrophin TRK receptor signaling pathway|positive regulation of small GTPase mediated signal transduction|regulation of pro-B cell differentiation|,DNA binding|Ras guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|protein binding|SH3 domain binding|protein heterodimerization activity|,2,3,28700000,2.1%
Q64337-2,0.322381947,0.044166667,12.19319274,0.501666667,0.06035048,2.261343267,-0.485,-0.27,0.135,0.31,-0.054,0.629,Q64337,Sqstm1,Q64337-2_Sqstm1,Q64337-2,Sqstm1,1,2,2,2,Q64337-2|Q64337|D3YZJ1,MOUSE,44933.3,7.6,3154,3154.1,15.35,15.35,,442,Isoform 2 of Sequestosome-1,pre-autophagosomal structure|cytoplasmic mRNA processing body|cytoplasm|lysosome|late endosome|autophagosome|endoplasmic reticulum|inclusion body|aggresome|PML body|cytoplasmic vesicle|extracellular exosome|,positive regulation of protein phosphorylation|immune system process|ubiquitin-dependent protein catabolic process|autophagy|apoptotic process|macroautophagy|positive regulation of macroautophagy|cell differentiation|regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of growth of symbiont in host|protein heterooligomerization|activation of mitophagy in response to mitochondrial depolarization|regulation of nucleic acid-templated transcription|,transcription cofactor activity|protein kinase C binding|protein binding|zinc ion binding|protein kinase binding|SH2 domain binding|identical protein binding|protein homodimerization activity|ubiquitin binding|K63-linked polyubiquitin binding|,2,2,27600000,7.6%
Q05860,0.61379227,0.003833333,6.102844184,-0.137666667,0.245310186,-1.273676164,0.131,-0.005,0.092,0.002,0.047,-0.244,Q05860,Fmn1,Q05860_Fmn1,Q05860,Fmn1,1,5,2,2,Q05860|Q05860-2|Q05860-3|E9Q7P6|Q05860-4|Q05860-5|Q05860-6,MOUSE,164889.9,1,3156,3156.1,15.34,15.34,,1466,Formin-1,nucleus|cytoplasm|actin filament|plasma membrane|adherens junction|microtubule cytoskeleton|,kidney development|gene expression|positive regulation of actin filament polymerization|forelimb morphogenesis|hindlimb morphogenesis|actin nucleation|skeletal system morphogenesis|dendrite morphogenesis|positive regulation of actin nucleation|positive regulation of focal adhesion assembly|limb development|ureteric bud invasion|,actin binding|protein binding|microtubule binding|SH3 domain binding|,2,5,853000000,1.0%
Q59J78,0.87652273,0.032166667,1.986928581,-0.057,0.632859264,-0.500488629,-0.01,-0.008,0.2,0.171,-0.061,-0.099,Q59J78,Ndufaf2,Q59J78_Ndufaf2,Q59J78,Ndufaf2,1,2,2,2,Q59J78,MOUSE,19627.5,19,3157,3157.1,15.34,15.34,,168,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2,mitochondrion|,respiratory electron transport chain|cellular respiration|negative regulation of insulin secretion involved in cellular response to glucose stimulus|reactive oxygen species metabolic process|,NADH dehydrogenase (ubiquinone) activity|,2,2,4390000000,19.0%
Q8K389,0.007959674,0.025333333,33.34950192,1.056,0.000462434,6.399208296,-0.613,-0.45,-0.445,0.291,0.47,0.899,Q8K389,Cdk5rap2,Q8K389_Cdk5rap2,Q8K389,Cdk5rap2,1,3,2,2,Q8K389,MOUSE,207196.3,1.5,3158,3158.1,15.33,15.33,,1822,CDK5 regulatory subunit-associated protein 2,pericentriolar material|spindle pole|cytoplasm|Golgi apparatus|centrosome|microtubule|cell junction|perinuclear region of cytoplasm|extracellular exosome|,"establishment of mitotic spindle orientation|microtubule cytoskeleton organization|microtubule bundle formation|chromosome segregation|brain development|neurogenesis|negative regulation of neuron differentiation|positive regulation of transcription, DNA-templated|negative regulation of centriole replication|centrosome organization|regulation of spindle checkpoint|",protein binding|calmodulin binding|microtubule binding|tubulin binding|protein kinase binding|transcription regulatory region DNA binding|,2,3,2050000000,1.5%
P01793,0.322381947,-0.227,12.1985498,3.228666667,0.060276083,2.262200891,-0.489,-0.402,-4.633,3.763,0.132,0.267,P01793,NotFound,P01793_NotFound,P01793,,1,9,3,3,P01793|A0A075B5S2|P01791|P01792|P01794|P01788|P01787|P01790|P01789|P01786,MOUSE,13922.3,27.6,3160,3160.1,15.27,15.27,,123,Ig heavy chain V region HPCG13,,,antigen binding|,4,9,1460000000,27.6%
Q4VAC9,0.399466839,0.071666667,10.42169952,-0.86,0.090746534,-1.978438615,-0.243,0.465,1.283,-1.016,-0.075,0.016,Q4VAC9,Plekhg3,Q4VAC9_Plekhg3,Q4VAC9,Plekhg3,1,3,3,3,Q4VAC9|Q4VAC9-2|Q4VAC9-5,MOUSE,149372.2,3.8,3163,3163.1,15.22,15.22,,1341,Pleckstrin homology domain-containing family G member 3,,regulation of Rho protein signal transduction|positive regulation of GTPase activity|,Rho guanyl-nucleotide exchange factor activity|,3,3,1120000000,3.8%
A2CG49-7,0.695431326,-0.024833333,4.622149024,0.220333333,0.344972994,1.016778102,-0.153,0.271,-0.523,0.114,0.286,-0.144,A2CG49,Kalrn,A2CG49-7_Kalrn,A2CG49-7,Kalrn,1,4,2,2,A2CG49-7|A2CG49|A2CG49-2|A0A0A0MQF1|A2CG49-8|A2CG49-9,MOUSE,342016.8,0.6,3165,3165.1,15.2,15.2,,2964,Isoform 7 of Kalirin,cytoplasm|cytoskeleton|extracellular exosome|,protein phosphorylation|regulation of Rho protein signal transduction|positive regulation of GTPase activity|,protein serine/threonine kinase activity|guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|ATP binding|metal ion binding|,2,4,1400000000,0.6%
Q811W2,0.351201759,-0.064333333,11.4472473,0.426,0.071659747,2.142102701,-0.215,0.051,-0.668,0.322,0.177,-0.053,Q811W2,Cyp26b1,Q811W2_Cyp26b1,Q811W2,Cyp26b1,1,3,2,2,Q811W2,MOUSE,57773.7,6.4,3166,3166.1,15.2,15.2,,512,Cytochrome P450 26B1,cytoplasm|endoplasmic reticulum membrane|,cell fate determination|establishment of T cell polarity|inflammatory response|male meiosis|spermatogenesis|proximal/distal pattern formation|positive regulation of gene expression|embryonic limb morphogenesis|retinoic acid catabolic process|retinoic acid metabolic process|tongue morphogenesis|regulation of T cell differentiation|retinoic acid receptor signaling pathway|regulation of retinoic acid receptor signaling pathway|negative regulation of retinoic acid receptor signaling pathway|oxidation-reduction process|bone morphogenesis|establishment of skin barrier|cornification|cellular response to retinoic acid|positive regulation of tongue muscle cell differentiation|,retinoic acid binding|iron ion binding|retinoic acid 4-hydroxylase activity|heme binding|,2,3,8710000000,6.4%
Q8QZZ7,0.505436633,0.031166667,8.107226086,-0.221,0.154624174,-1.606631653,-0.017,0.394,0.048,-0.221,0.032,-0.049,Q8QZZ7,Tprkb,Q8QZZ7_Tprkb,Q8QZZ7,Tprkb,1,3,2,2,Q8QZZ7,MOUSE,19669.5,10.2,3168,3168.1,15.19,15.19,,175,EKC/KEOPS complex subunit Tprkb,nucleus|cytoplasm|cytosol|,tRNA processing|,protein kinase binding|,2,3,67100000,10.2%
Q69ZT1,0.382438943,-0.045833333,10.78832694,0.393666667,0.083400241,2.036945894,-0.131,0.028,-0.625,-0.055,0.158,0.35,Q69ZT1,Fan1,Q69ZT1_Fan1,Q69ZT1,Fan1,1,5,2,2,Q69ZT1|Q69ZT1-2|Q69ZT1-3|Q69ZT1-4,MOUSE,114520.1,3.8,3169,3169.1,15.18,15.18,,1020,Fanconi-associated nuclease 1,nucleus|nucleoplasm|cytoplasm|intercellular bridge|,"double-strand break repair via homologous recombination|DNA catabolic process, endonucleolytic|DNA repair|nucleotide-excision repair|nucleotide-excision repair, DNA incision|interstrand cross-link repair|",phosphodiesterase I activity|5'-3' exonuclease activity|5'-flap endonuclease activity|ubiquitin binding|metal ion binding|flap-structured DNA binding|,2,5,55000000,3.8%
Q8R1,0.844381503,-0.045,2.441620304,0.097333333,0.56995159,0.597637334,0.001,0.165,-0.447,0.01,0.054,-0.053,Q8R1,NotFound,Q8R1_NotFound,Q8R1,Acsl6,1,6,2,2,Q8R1|Q91WC3-2|Q5ICG5|Q91WC3|Q5F2C5,MOUSE,81821,2.4,3170,3170.1,15.15,15.15,,722,Acyl-CoA synthetase long-chain family member 6,mitochondrion|membrane|,long-chain fatty acid metabolic process|neuroblast proliferation|,long-chain fatty acid-CoA ligase activity|protein binding|enzyme binding|protein homodimerization activity|,2,6,1920000000,2.4%
Q58A65,0.780743075,-0.007666667,3.387460011,-0.086666667,0.458409911,-0.78678735,-0.061,0.202,-0.034,0.033,-0.167,-0.019,Q58A65,Spag9,Q58A65_Spag9,Q58A65,Spag9,1,6,3,3,Q58A65|Q58A65-2|Q58A65-5|Q58A65-4|F8WH31|E9PUD1|Q58A65-3|A0A0R4J196|Q58A65-6,MOUSE,147072.6,1.5,3178,3178.1,15.07,15.07,,1321,C-Jun-amino-terminal kinase-interacting protein 4,cytoplasm|cytosol|perinuclear region of cytoplasm|extracellular exosome|,"activation of MAPK activity|activation of JUN kinase activity|vesicle-mediated transport|positive regulation of cell migration|retrograde transport, endosome to Golgi|positive regulation of MAPK cascade|positive regulation of neuron differentiation|striated muscle cell differentiation|protein homooligomerization|negative regulation of protein homodimerization activity|",MAP-kinase scaffold activity|protein binding|JUN kinase binding|kinesin binding|receptor signaling complex scaffold activity|mitogen-activated protein kinase p38 binding|,3,6,1130000000,1.5%
O08599-2,0.007392984,-0.241333333,33.79800024,1.563333333,0.000417061,6.513870342,-0.986,-0.625,-1.458,0.21,0.74,0.671,O08599,Stxbp1,O08599-2_Stxbp1,O08599-2,Stxbp1,1,2,2,2,O08599-2|O08599,MOUSE,69134.1,4.1,3181,3181.1,15.06,15.06,,594,Isoform 2 of Syntaxin-binding protein 1,nucleoplasm|cytoplasm|mitochondrion|cytosol|plasma membrane|platelet alpha granule|terminal bouton|myelin sheath|protein complex|extracellular exosome|,"platelet degranulation|exocytosis|vesicle docking involved in exocytosis|neurotransmitter secretion|neuromuscular synaptic transmission|axon target recognition|regulation of synaptic vesicle priming|protein transport|synaptic vesicle maturation|synaptic vesicle fusion to presynaptic membrane|negative regulation of synaptic transmission, GABAergic|negative regulation of neuron apoptotic process|positive regulation of calcium ion-dependent exocytosis|protein stabilization|long term synaptic depression|platelet aggregation|protein localization to plasma membrane|",protein binding|syntaxin-1 binding|protein kinase binding|protein domain specific binding|syntaxin binding|identical protein binding|poly(A) RNA binding|protein N-terminus binding|,2,2,625000000,4.1%
Q6PAL7,0.626515059,-0.030666667,5.855038128,0.138,0.259714494,1.231895436,-0.134,-0.168,0.003,0.142,-0.146,0.119,Q6PAL7,Ahdc1,Q6PAL7_Ahdc1,Q6PAL7,Ahdc1,1,2,2,2,Q6PAL7,MOUSE,169732.3,1.7,3182,3182.1,15.06,15.06,,1594,AT-hook DNA-binding motif-containing protein 1,,,DNA binding|,2,2,298000000,1.7%
Q9JIK9,0.722439826,-0.04,4.200128707,-0.216,0.380178129,-0.940133229,-0.332,0.397,0.139,-0.484,0.131,-0.091,Q9JIK9,Mrps34,Q9JIK9_Mrps34,Q9JIK9,Mrps34,1,3,2,2,Q9JIK9,MOUSE,25883.3,8.2,3183,3183.1,15.05,15.05,,218,"28S ribosomal protein S34, mitochondrial",mitochondrion|ribosome|,,,2,3,71300000,8.2%
Q52KF3-3,0.007959674,0.025333333,33.34950192,1.056,0.000462434,6.399208296,-0.613,-0.45,-0.445,0.291,0.47,0.899,Q52KF3,NotFound,Q52KF3-3_NotFound,Q52KF3-3,Spire1,1,3,2,2,Q52KF3-3|D3YTL8,MOUSE,76065.6,5,3184,3184.1,15.03,15.03,,598,Isoform 3 of Protein spire homolog 1,Golgi apparatus|cytosol|cytoskeleton|plasma membrane|cell cortex|cytoplasmic vesicle membrane|perinuclear region of cytoplasm|cleavage furrow|,protein transport|vesicle-mediated transport|actin cytoskeleton organization|cleavage furrow formation|polar body extrusion after meiotic divisions|actin nucleation|intracellular transport|Golgi vesicle transport|establishment of meiotic spindle localization|formin-nucleated actin cable assembly|,actin binding|,2,3,946000000,5.0%
Q64282,0.82082884,0.089666667,2.782011817,-0.135333333,0.526985685,-0.667571467,-0.048,-0.092,0.612,0.171,-0.111,0.006,Q64282,Ifit1,Q64282_Ifit1,Q64282,Ifit1,1,3,3,3,Q64282,MOUSE,54364.1,6.2,3185,3185.1,15.02,15.02,,463,Interferon-induced protein with tetratricopeptide repeats 1,cytoplasm|,response to virus|cellular response to interferon-alpha|cellular response to interferon-beta|innate immune response|defense response to virus|,RNA binding|protein binding|,3,3,104000000,6.2%
Q62240,0.151705713,-0.022666667,17.52765791,0.648,0.017669905,3.137891644,-0.019,-0.206,-0.815,0.405,0.205,0.294,Q62240,Kdm5d,Q62240_Kdm5d,Q62240,Kdm5d,1,6,3,3,Q62240|Q62240-2|Q62240-4|Q62240-3|Q8BQM3,MOUSE,179924.3,2.5,3186,3186.1,15.01,15.01,,1548,Lysine-specific demethylase 5D,nucleus|,histone H3-K4 demethylation|oxidation-reduction process|,"DNA binding|zinc ion binding|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors|histone demethylase activity (H3-K4 specific)|",3,6,895000000,2.5%
Q61464,0.416525979,-0.054166667,10.04290318,0.273666667,0.099016981,1.917947636,-0.004,-0.072,-0.497,0.083,0.047,0.118,Q61464,Zfp638,Q61464_Zfp638,Q61464,Znf638,1,2,2,2,E9QML5|Q61464|A0A0N4SV80|Q61464-4|E9QKZ7|Q61464-2|Q61464-5|A0A0N4SVI8|Q61464-7|A0A0N4SV38,MOUSE,219328,1.2,3189,3189.1,14.99,14.99,,1960,Zinc finger protein 638,nucleoplasm|nuclear speck|intracellular membrane-bounded organelle|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",nucleotide binding|DNA binding|zinc ion binding|poly(A) RNA binding|,2,2,82500000,1.2%
Q80XE1-1,0.91325,0.174,1.358795038,0.233333333,0.731341968,0.358200894,1.459,-0.123,-1.164,0,0.956,-0.084,Q80XE1,Ric8b,Q80XE1-1_Ric8b,Q80XE1-1,Ric8b,1,4,2,2,Q80XE1-1|Q80XE1,MOUSE,64149.5,5.1,3190,3190.1,14.98,14.98,,520,Isoform 1 of Synembryn-B,cytoplasm|centrosome|cytosol|plasma membrane|cell cortex|,G-protein coupled receptor signaling pathway|regulation of G-protein coupled receptor protein signaling pathway|positive regulation of GTPase activity|,G-protein alpha-subunit binding|guanyl-nucleotide exchange factor activity|GTPase activator activity|,2,4,1110000000,5.1%
Q9Z1M8,0.492209087,-0.067833333,8.364137358,0.217666667,0.145742517,1.648290719,-0.196,-0.216,-0.118,0.141,-0.228,0.21,Q9Z1M8,Ik,Q9Z1M8_Ik,Q9Z1M8,Ik,1,2,2,2,Q9Z1M8,MOUSE,65729.2,3.5,3191,3191.1,14.95,14.95,,557,Protein Red,nucleoplasm|nucleolus|,,identical protein binding|,2,2,20200000,3.5%
E9PW34,0.88044681,-0.083,1.953429218,0.124,0.637759708,0.493272718,0.101,0.192,-0.728,-0.059,0.163,-0.167,E9PW34,NotFound,E9PW34_NotFound,E9PW34,Ryr3,1,4,3,3,E9PW34|A0A140LJK7|A2AGL3|A0A140LJF7|A2AGL3-2,MOUSE,560547.5,0.8,3193,3193.1,14.91,14.91,,4888,Ryanodine receptor 3,cytosol|integral component of membrane|junctional membrane complex|sarcoplasmic reticulum membrane|perinuclear region of cytoplasm|,calcium ion transport|cellular calcium ion homeostasis|striated muscle contraction|negative regulation of cytosolic calcium ion concentration|calcium ion transmembrane transport|,ryanodine-sensitive calcium-release channel activity|calcium ion binding|calcium-release channel activity|calcium-induced calcium release activity|,3,4,1820000000,0.8%
Q99P72,0.561710094,-0.004166667,7.08958715,0.251666667,0.195452525,1.439936624,-0.418,0.255,-0.227,0.109,0.181,0.075,Q99P72,Rtn4,Q99P72_Rtn4,Q99P72,Rtn4,1,2,2,2,Q99P72|Q8BHF5|Q8BH78,MOUSE,127124.6,1.6,3194,3194.1,14.91,14.91,,1162,Reticulon-4,intracellular|nuclear envelope|endoplasmic reticulum|endomembrane system|integral component of endoplasmic reticulum membrane|cell projection|extracellular exosome|neuronal postsynaptic density|,nervous system development|axonogenesis|axonal fasciculation|cerebral cortex radial glia guided migration|negative regulation of cell growth|regulation of cell migration|negative regulation of axon extension|regulation of nervous system development|cardiac epithelial to mesenchymal transition|endoplasmic reticulum tubular network organization|regulation of branching morphogenesis of a nerve|,protein binding|poly(A) RNA binding|,2,2,176000000,1.6%
F8VQ87,0.891135171,-0.023,1.747554688,0.066666667,0.668720337,0.447600482,-0.143,0.262,-0.288,0.031,-0.011,0.011,F8VQ87,Xrn1,F8VQ87_Xrn1,F8VQ87,Xrn1,1,3,3,3,F8VQ87|P97789|A0A087WQN7|P97789-2|P97789-3|A0A087WNV6,MOUSE,196409,2.4,3195,3195.1,14.87,14.87,,1723,5'-3' exoribonuclease 1,cytoplasmic mRNA processing body|nucleus|cytoplasm|Golgi apparatus|plasma membrane|membrane|intermediate filament cytoskeleton|,nuclear-transcribed mRNA catabolic process|rRNA catabolic process|nuclear mRNA surveillance|histone mRNA catabolic process|nucleic acid phosphodiester bond hydrolysis|,5'-3' exonuclease activity|poly(A) RNA binding|,3,3,748000000,2.4%
A4Q9F6,0.632582508,0.114,5.757670499,-0.359333333,0.265602984,-1.215887543,-0.043,-0.082,1.006,-0.178,-0.131,0.112,A4Q9F6,Ttll13,A4Q9F6_Ttll13,A4Q9F6,Ttll13,1,3,3,3,A4Q9F6,MOUSE,94717,3.4,3196,3196.1,14.87,14.87,,804,Tubulin polyglutamylase TTLL13,,cellular protein modification process|,ligase activity|,3,3,140000000,3.4%
Q62447,0.662092914,-0.041333333,5.150216959,0.291333333,0.30547685,1.11052427,-0.111,-0.75,0.3,-0.025,0.025,0.313,Q62447,Ccnc,Q62447_Ccnc,Q62447,Ccnc,1,3,2,2,Q62447|Q8CAS3|Q3UXL9,MOUSE,33639.5,12.3,3198,3198.1,14.82,14.82,,283,Cyclin-C,ubiquitin ligase complex|nucleoplasm|mediator complex|,"regulation of cyclin-dependent protein serine/threonine kinase activity|transcription, DNA-templated|regulation of transcription, DNA-templated|protein ubiquitination|negative regulation of triglyceride metabolic process|",protein kinase binding|ubiquitin protein ligase activity|,2,3,94900000,12.3%
Q9D975,0.615860336,-0.123166667,6.063896195,0.286333333,0.247520048,1.268155381,-0.013,0.022,-0.808,0.071,0.043,-0.054,Q9D975,Srxn1,Q9D975_Srxn1,Q9D975,Srxn1,1,2,2,2,A2AQU8|Q9D975,MOUSE,14263,24.2,3199,3199.1,14.77,14.77,,136,Sulfiredoxin-1,cytosol|,response to oxidative stress|oxidation-reduction process|,"ATP binding|oxidoreductase activity, acting on a sulfur group of donors|sulfiredoxin activity|",2,2,345000000,24.2%
Q3U0P5,0.604209631,-0.012833333,6.284356491,0.181,0.235268807,1.305477565,-0.098,0.128,-0.34,0.176,0.099,-0.042,Q3U0P5,Entpd6,Q3U0P5_Entpd6,Q3U0P5,Entpd6,1,2,2,2,Q3U0P5,MOUSE,50140.7,6.1,3202,3202.1,14.72,14.72,,455,Ectonucleoside triphosphate diphosphohydrolase 6,extracellular space|Golgi apparatus|plasma membrane|cell surface|extracellular exosome|,metabolic process|response to magnesium ion|response to calcium ion|,"guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity|nucleoside-diphosphatase activity|nucleoside-triphosphatase activity|",2,2,65600000,6.1%
Q8R2V3,0.105765833,0.153666667,19.76020429,-0.386666667,0.010567678,-3.515172704,0.471,0.162,0.408,-0.069,0.04,-0.09,Q8R2V3,Zfp445,Q8R2V3_Zfp445,Q8R2V3,Znf445,1,4,2,2,Q8R2V3|A2AQW0,MOUSE,117111.4,1.4,3203,3203.1,14.65,14.65,,986,Zinc finger protein 445,nucleus|extracellular exosome|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",DNA binding|sequence-specific DNA binding transcription factor activity|metal ion binding|,2,4,2180000000,1.4%
Q3ZAQ4,0.406839224,0.0355,10.25412958,0.343666667,0.094316362,1.951686358,-0.294,-0.025,-0.09,0.54,-0.11,0.192,Q3ZAQ4,Atg9a,Q3ZAQ4_Atg9a,Q3ZAQ4,Atg9a,1,2,2,2,Q3ZAQ4,MOUSE,95393.3,3.2,3204,3204.1,14.64,14.64,,839,Autophagy-related protein 9,pre-autophagosomal structure|cytoplasm|endosome|late endosome|autophagosome|trans-Golgi network|membrane|recycling endosome|autophagosome membrane|,autophagosome assembly|mitochondrion degradation|autophagy|negative regulation of interferon-beta production|protein localization to Golgi apparatus|protein localization to pre-autophagosomal structure|piecemeal microautophagy of nucleus|late nucleophagy|innate immune response|,,2,2,41300000,3.2%
Q9CQV1,0.818402394,-0.1795,2.8186753,0.223,0.522555556,0.674980832,0.179,0.024,-1.076,0.011,0.094,-0.309,Q9CQV1,Pam16,Q9CQV1_Pam16,Q9CQV1,Pam16,1,2,2,2,Q9CQV1|A0A1L1SQA2,MOUSE,13784.4,21.6,3206,3206.1,14.63,14.63,,125,Mitochondrial import inner membrane translocase subunit TIM16,mitochondrial inner membrane presequence translocase complex|,ossification|protein import into mitochondrial matrix|,,2,2,107000000,21.6%
Q64345,0.648073376,0.056,5.347464284,0.17,0.291913091,1.14500318,0.049,-0.006,-0.13,-0.007,-0.022,0.452,Q64345,Ifit3,Q64345_Ifit3,Q64345,Ifit3,1,3,2,2,Q64345|E9PV48,MOUSE,47963.7,3.7,3209,3209.1,14.58,14.58,,403,Interferon-induced protein with tetratricopeptide repeats 3,cytoplasm|mitochondrion|,negative regulation of cell proliferation|response to virus|cellular response to interferon-alpha|cellular response to interferon-beta|response to stilbenoid|negative regulation of apoptotic process|innate immune response|defense response to virus|,protein binding|identical protein binding|,2,3,80100000,3.7%
Q8BKT2,0.942504874,0.011666667,0.826740573,-0.022666667,0.826658133,-0.227722421,-0.019,0.044,0.044,-0.046,-0.109,0.156,Q8BKT2,Hes7,Q8BKT2_Hes7,Q8BKT2,Hes7,1,3,2,2,Q8BKT2,MOUSE,25060.3,7.1,3211,3211.1,14.57,14.57,,225,Transcription factor HES-7,nucleus|,"negative regulation of transcription from RNA polymerase II promoter|skeletal system development|somitogenesis|transcription, DNA-templated|Notch signaling pathway|regulation of somitogenesis|post-anal tail morphogenesis|negative regulation of transcription, DNA-templated|rhythmic process|",DNA binding|transcription factor binding|protein dimerization activity|,2,3,94000000,7.1%
D3Z534,0.93595046,0.061,0.906953165,-0.04,0.811530195,-0.248162302,-0.1,-0.002,0.345,0.241,0.067,-0.185,D3Z534,NotFound,D3Z534_NotFound,D3Z534,Kalrn,1,2,2,2,D3Z534|A2CG49-4|D3Z532|D3Z535,MOUSE,76699.4,5.3,3212,3212.1,14.56,14.56,,674,Kalirin,extracellular exosome|,regulation of Rho protein signal transduction|positive regulation of GTPase activity|,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|,2,2,13100000,5.3%
P67871,0.387241291,-0.096,10.68410376,0.297333333,0.085425912,2.020315759,-0.126,-0.045,-0.563,0.021,0.095,0.042,P67871,Csnk2b,P67871_Csnk2b,P67871,Csnk2b,1,2,2,2,P67871|G3UXG7|G3UZX4,MOUSE,25284.3,9.3,3213,3213.1,14.56,14.56,,215,Casein kinase II subunit beta,nucleus|cytoplasm|protein kinase CK2 complex|extracellular exosome|plasma membrane|PcG protein complex|,positive regulation of pathway-restricted SMAD protein phosphorylation|Wnt signaling pathway|positive regulation of activin receptor signaling pathway|adiponectin-activated signaling pathway|negative regulation of blood vessel endothelial cell migration|regulation of protein kinase activity|endothelial tube morphogenesis|,chromatin binding|receptor binding|protein binding|transcription factor binding|protein kinase regulator activity|protein domain specific binding|identical protein binding|metal ion binding|,2,2,56300000,9.3%
Q9D1R1,0.857830933,0.044,2.247672186,-0.086,0.595981503,-0.556792063,0.031,0.404,-0.174,0.075,-0.041,-0.031,Q9D1R1,Tmem126b,Q9D1R1_Tmem126b,Q9D1R1,Tmem126b,1,3,2,2,Q9D1R1,MOUSE,25671.6,7.8,3214,3214.1,14.55,14.55,,230,"Complex I assembly factor TMEM126B, mitochondrial",integral component of membrane|mitochondrial membrane|,,,2,3,146000000,7.8%
B1AQZ2,0.440022872,0.036,9.579757166,-0.165333333,0.11016009,-1.840622965,0.103,0.093,0.16,0.049,-0.15,-0.039,B1AQZ2,Kif3a,B1AQZ2_Kif3a,B1AQZ2,Kif3a,1,2,2,2,B1AQZ2|P28741|Q3UI47|Q3TET1,MOUSE,83031.5,3.3,3216,3216.1,14.49,14.49,,725,Kinesin-like protein,centrosome|cilium|microtubule cytoskeleton|kinesin II complex|motile primary cilium|neuron projection|extracellular exosome|spindle microtubule|intraciliary transport particle|,in utero embryonic development|kidney development|heart looping|microtubule-based movement|smoothened signaling pathway|determination of left/right symmetry|heart development|metabolic process|epidermis development|anterior/posterior pattern specification|dorsal/ventral pattern formation|dentate gyrus development|dorsal/ventral neural tube patterning|neural tube development|nonmotile primary cilium assembly|epidermal stem cell homeostasis|cilium assembly|positive regulation of epithelial cell proliferation|inner ear receptor stereocilium organization|cilium morphogenesis|neural precursor cell proliferation|motile primary cilium assembly|,microtubule motor activity|protein binding|ATP binding|microtubule binding|ATPase activity|spectrin binding|,2,2,263000000,3.3%
P98064-2,0.012481381,-0.056666667,31.07248316,0.871333333,0.000781181,5.840133543,-0.379,-0.6,-0.498,0.393,0.108,0.636,P98064,Masp1,P98064-2_Masp1,P98064-2,Masp1,1,3,2,2,P98064-2|P98064,MOUSE,83984.9,4.3,3217,3217.1,14.47,14.47,,704,Isoform 2 of Mannan-binding lectin serine protease 1,extracellular space|,"complement activation, lectin pathway|proteolysis|",serine-type endopeptidase activity|calcium ion binding|protein homodimerization activity|calcium-dependent protein binding|,2,3,74700000,4.3%
Q9WV54,0.000552294,-0.229166667,48.58875234,1.701666667,1.38396E-05,11.36460829,-0.825,-1.341,-1.074,0.767,0.528,0.57,Q9WV54,Asah1,Q9WV54_Asah1,Q9WV54,Asah1,1,2,2,2,Q9WV54,MOUSE,45068.1,5,3219,3219.1,14.45,14.45,,394,Acid ceramidase,lysosome|extracellular exosome|,lipid metabolic process|,ceramidase activity|,2,2,13400000,5.0%
Q91XE9,0.956491812,-0.029333333,0.628563567,-0.026,0.865254055,-0.176400467,0.067,0.211,-0.327,-0.079,0.005,-0.053,Q91XE9,Creb3l3,Q91XE9_Creb3l3,Q91XE9,Creb3l3,1,2,2,2,Q91XE9,MOUSE,52600.6,6.2,3221,3221.1,14.42,14.42,,479,Cyclic AMP-responsive element-binding protein 3-like protein 3,nucleus|endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|,transcription from RNA polymerase II promoter|endoplasmic reticulum unfolded protein response|positive regulation of transcription from RNA polymerase II promoter|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress|,transcription regulatory region sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription|cAMP response element binding|protein homodimerization activity|protein heterodimerization activity|,2,2,18200000,6.2%
O70310,0.873222165,0.005166667,2.055592176,0.049666667,0.622932203,0.51526685,-0.11,-0.006,0.057,0,-0.053,0.143,O70310,Nmt1,O70310_Nmt1,O70310,Nmt1,1,2,2,2,O70310,MOUSE,57229.7,5,3224,3224.1,14.38,14.38,,496,Glycylpeptide N-tetradecanoyltransferase 1,cytoplasm|cytosol|plasma membrane|actin cytoskeleton|extrinsic component of membrane|cell junction|,in utero embryonic development|N-terminal protein myristoylation|N-terminal peptidyl-glycine N-myristoylation|,glycylpeptide N-tetradecanoyltransferase activity|,2,2,165000000,5.0%
Q8BJM7,0.915900752,-0.017833333,1.297283421,0.061,0.741774087,0.343637097,0.144,0.148,-0.437,-0.003,0.141,-0.1,Q8BJM7,Tyw1,Q8BJM7_Tyw1,Q8BJM7,Tyw1,1,2,2,2,Q8BJM7|A0A0R4J0L2|Q8BJM7-3,MOUSE,82909.9,6.2,3227,3227.1,14.34,14.34,,721,S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase,nucleoplasm|cytoplasm|,tRNA processing|oxidation-reduction process|,"iron ion binding|FMN binding|oxidoreductase activity|lyase activity|4 iron, 4 sulfur cluster binding|",2,2,105000000,6.2%
Q62018,0.048008954,0.116833333,23.83355203,-0.687,0.004136612,-4.284087367,0.637,0.324,0.42,0.062,-0.476,-0.266,Q62018,Ctr9,Q62018_Ctr9,Q62018,Ctr9,1,2,2,2,Q62018|Q62018-3|Q62018-2,MOUSE,134261.4,1.2,3230,3230.1,14.3,14.3,,1173,RNA polymerase-associated protein CTR9 homolog,nucleus|Cdc73/Paf1 complex|nuclear speck|transcriptionally active chromatin|,"negative regulation of transcription from RNA polymerase II promoter|endodermal cell fate commitment|inner cell mass cell differentiation|trophectodermal cell differentiation|blastocyst growth|transcription, DNA-templated|JAK-STAT cascade|histone monoubiquitination|Wnt signaling pathway|stem cell maintenance|positive regulation of transcription elongation from RNA polymerase II promoter|histone H2B ubiquitination|negative regulation of myeloid cell differentiation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of histone H3-K4 methylation|interleukin-6-mediated signaling pathway|cellular response to lipopolysaccharide|histone H3-K4 trimethylation|negative regulation of mRNA polyadenylation|regulation of genetic imprinting|positive regulation of histone H3-K79 methylation|positive regulation of histone H2B ubiquitination|",RNA polymerase II core binding|protein binding|SH2 domain binding|,2,2,75200000,1.2%
A0A0G2JG52,0.211723396,-0.121166667,15.50268629,0.609,0.028166402,2.7982933,-0.169,-0.159,-0.949,0.211,0.196,0.143,A0A0G2JG52,Crybg1,A0A0G2JG52_Crybg1,A0A0G2JG52,Crybg1,1,6,2,2,A0A0G2JG52|E9PVP1,MOUSE,225498,0.7,3231,3231.1,14.29,14.29,,2065,Crystallin beta-gamma domain-containing 1,,,,2,6,2420000000,0.7%
Q6L8S8,0.506587963,0.096166667,8.088132342,-0.667666667,0.155305475,-1.60352971,0.367,1.308,-0.385,-0.428,0.15,-0.435,Q6L8S8,B4galnt3,Q6L8S8_B4galnt3,Q6L8S8,B4galnt3,1,3,2,2,Q6L8S8|A0A1D5RMF7,MOUSE,113963.8,1.2,3232,3232.1,14.26,14.26,,986,"Beta-1,4-N-acetylgalactosaminyltransferase 3",integral component of membrane|Golgi cisterna membrane|,metabolic process|,acetylgalactosaminyltransferase activity|N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity|,2,3,448000000,1.2%
Q63739,0.221282636,0.002,15.12263288,-0.385333333,0.030742325,-2.735666144,0.12,0.049,0.415,0.016,-0.313,-0.275,Q63739,Ptp4a1,Q63739_Ptp4a1,Q63739,Ptp4a1,1,2,2,2,Q63739,MOUSE,20157.1,10.9,3236,3236.1,14.25,14.25,,173,Protein tyrosine phosphatase type IVA 1,nucleus|cytoplasm|endosome|early endosome|endoplasmic reticulum|spindle|plasma membrane|cytoplasmic side of plasma membrane|extracellular exosome|,cell cycle|multicellular organismal development|positive regulation of cell migration|peptidyl-tyrosine dephosphorylation|,prenylated protein tyrosine phosphatase activity|,2,2,284000000,10.9%
Q8BN21,0.430366134,0.140666667,9.794390617,-0.487333333,0.10484819,-1.878220645,-0.055,0.232,0.976,0.047,-0.254,-0.102,Q8BN21,Vrk2,Q8BN21_Vrk2,Q8BN21,Vrk2,1,3,2,2,Q8BN21|Q8BN21-2,MOUSE,58517.1,5.7,3237,3237.1,14.21,14.21,,503,Serine/threonine-protein kinase VRK2,nucleus|cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|mitochondrial membrane|protein complex|,protein phosphorylation|endocytosis|regulation of cell shape|Wnt signaling pathway|peptidyl-serine phosphorylation|cellular response to oxidative stress|regulation of MAPK cascade|protein autophosphorylation|regulation of interleukin-1-mediated signaling pathway|,protein serine/threonine kinase activity|ATP binding|protein kinase binding|protein domain specific binding|,2,3,36600000,5.7%
Q3TVI4,0.471687594,-0.047666667,8.820877143,-0.211333333,0.13119349,-1.7220337,0.24,0.087,-0.153,-0.18,-0.221,-0.059,Q3TVI4,Hexim2,Q3TVI4_Hexim2,Q3TVI4,Hexim2,1,2,2,2,Q3TVI4,MOUSE,35738.3,8.3,3240,3240.1,14.11,14.11,,313,Protein HEXIM2,nucleoplasm|cytoplasm|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|negative regulation of cyclin-dependent protein serine/threonine kinase activity|negative regulation of transcription, DNA-templated|",cyclin-dependent protein serine/threonine kinase inhibitor activity|snRNA binding|,2,2,593000000,8.3%
Q7SIG6,0.074838761,-0.079833333,21.55245,0.533666667,0.006994473,3.8511402,-0.305,-0.423,-0.312,0.146,-0.04,0.455,Q7SIG6,Asap2,Q7SIG6_Asap2,Q7SIG6,Asap2,1,2,2,2,E9PX52|Q7SIG6|D3YX85|Q7SIG6-2,MOUSE,108058.1,2.2,3244,3244.1,14.09,14.09,,958,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2",plasma membrane|Golgi cisterna membrane|,positive regulation of GTPase activity|,GTPase activator activity|metal ion binding|,2,2,1420000000,2.2%
H9KV04,0.108925331,-0.008,19.5478031,0.430666667,0.01109736,3.488661937,-0.429,-0.164,-0.077,0.073,0.266,0.283,H9KV04,NotFound,H9KV04_NotFound,H9KV04,Mcmbp,1,3,2,2,H9KV04|Q8R3C0,MOUSE,75430.1,2.8,3251,3251.1,14,14,,660,Mini-chromosome maintenance complex-binding protein,nucleus|nucleoplasm|cytoplasm|plasma membrane|MCM complex|,DNA-dependent DNA replication|sister chromatid cohesion|,chromatin binding|,2,3,60000000,2.8%
Q3TWI9,0.468155412,-0.088166667,8.951019966,0.321666667,0.127320403,1.742981804,-0.016,-0.058,-0.673,0.113,0.117,-0.012,Q3TWI9,Tmem63b,Q3TWI9_Tmem63b,Q3TWI9,Tmem63b,1,3,2,2,Q3TWI9,MOUSE,96370.8,2.1,3255,3255.1,13.92,13.92,,832,CSC1-like protein 2,integral component of membrane|,ion transport|,,2,3,221000000,2.1%
F8VQ79,0.143726505,-0.049,17.82555649,-0.314666667,0.016498496,-3.177284361,0.233,0.066,0.026,-0.289,-0.112,-0.218,F8VQ79,Myo3b,F8VQ79_Myo3b,F8VQ79,Myo3b,1,2,2,2,F8VQ79|Q1EG27|Q1EG27-2,MOUSE,152808,1.3,3256,3256.1,13.91,13.91,,1333,Myosin-IIIb,photoreceptor outer segment|photoreceptor inner segment|myosin complex|stereocilium bundle tip|filopodium tip|,peptidyl-serine phosphorylation|peptidyl-threonine phosphorylation|protein autophosphorylation|positive regulation of filopodium assembly|,microfilament motor activity|protein serine/threonine kinase activity|protein binding|ATP binding|,2,2,10300000000,1.3%
Q99PE8,0.915850537,0.010166667,1.313846642,0.043666667,0.73895048,0.347570735,-0.133,0.237,-0.139,0.031,-0.027,0.092,Q99PE8,Abcg5,Q99PE8_Abcg5,Q99PE8,Abcg5,1,2,2,2,Q99PE8|E9QA91,MOUSE,74155.9,3.2,3257,3257.1,13.9,13.9,,652,ATP-binding cassette sub-family G member 5,membrane|apical plasma membrane|ATP-binding cassette (ABC) transporter complex|receptor complex|apical part of cell|,response to nutrient|excretion|metabolic process|response to ionizing radiation|negative regulation of intestinal phytosterol absorption|intestinal cholesterol absorption|cholesterol efflux|response to drug|cholesterol homeostasis|negative regulation of intestinal cholesterol absorption|,protein heterodimerization activity|ATP binding|ATPase activity|cholesterol transporter activity|,2,2,7320000,3.2%
Q9DCX8,0.578909417,-0.009,6.788051608,0.150666667,0.209505216,1.388582401,0.038,-0.021,-0.27,0.05,0.129,0.02,Q9DCX8,Iyd,Q9DCX8_Iyd,Q9DCX8,Iyd,1,4,2,2,Q9DCX8,MOUSE,32984.6,7.3,3258,3258.1,13.89,13.89,,285,Iodotyrosine deiodinase 1,integral component of membrane|,oxidation-reduction process|,iodide peroxidase activity|,2,4,111000000,7.3%
E9PY03,0.773512169,0.029,3.534638304,0.231333333,0.443135119,0.81549893,0.135,-0.246,-0.149,-0.48,0.655,0.259,E9PY03,Tstd1,E9PY03_Tstd1,E9PY03,Tstd1,1,2,2,2,E9PY03,MOUSE,14442.3,21.8,3259,3259.1,13.88,13.88,,133,Thiosulfate sulfurtransferase (rhodanese)-like domain-containing 1,cytoplasm|mitochondrion|,,,2,2,1010000000,21.8%
A0A0A0MQF2,0.891135171,-0.029333333,1.745484514,-0.08,0.669039176,-0.447135694,0.318,0.065,-0.351,-0.197,0.059,-0.07,A0A0A0MQF2,Ano1,A0A0A0MQF2_Ano1,A0A0A0MQF2,Ano1,1,2,2,2,A0A0A0MQF2|G8JL82|Q8BHY3|Q8BHY3-2,MOUSE,117767,3,3263,3263.1,13.81,13.81,,1017,Anoctamin,plasma membrane|external side of plasma membrane|integral component of membrane|apical plasma membrane|extracellular exosome|,cation transport|chloride transport|iodide transport|positive regulation of insulin secretion involved in cellular response to glucose stimulus|regulation of membrane potential|cation transmembrane transport|chloride transmembrane transport|,calcium activated cation channel activity|intracellular calcium activated chloride channel activity|chloride channel activity|iodide transmembrane transporter activity|protein homodimerization activity|protein heterodimerization activity|,2,2,1220000000,3.0%
A2AJI0,0.634404848,0.0225,5.710324488,-0.193666667,0.268514381,-1.207758974,-0.072,0.018,0.412,-0.136,-0.217,0.13,A2AJI0,Map7d1,A2AJI0_Map7d1,A2AJI0,Map7d1,1,3,3,3,A2AJI0|A8Y5P4|A2AJI0-2|A2AJI1,MOUSE,93616.3,3.9,3264,3264.1,13.8,13.8,,846,MAP7 domain-containing protein 1,cytoplasm|spindle|microtubule cytoskeleton|,microtubule cytoskeleton organization|,structural molecule activity|,3,3,165000000,3.9%
Q6PIP5,0.364704918,-0.005666667,11.17135375,0.244,0.076359772,2.097213464,0.004,-0.053,-0.334,0.188,0.034,0.127,Q6PIP5,Nudcd1,Q6PIP5_Nudcd1,Q6PIP5,Nudcd1,1,2,2,2,Q6PIP5,MOUSE,67502.5,2.5,3266,3266.1,13.79,13.79,,582,NudC domain-containing protein 1,nucleus|nucleoplasm|cytoplasm|,,,2,2,51300000,2.5%
P49138,0.895444761,-0.009833333,1.650484807,-0.065666667,0.683835306,-0.425682684,0.059,0.23,-0.22,-0.264,0.031,0.105,P49138,Mapkapk2,P49138_Mapkapk2,P49138,Mapkapk2,1,3,2,2,P49138,MOUSE,44448.5,5.9,3267,3267.1,13.78,13.78,,386,MAP kinase-activated protein kinase 2,nucleus|nucleoplasm|cytoplasm|centrosome|extracellular exosome|,toll-like receptor signaling pathway|protein phosphorylation|inflammatory response|cellular response to DNA damage stimulus|peptidyl-serine phosphorylation|G2 DNA damage checkpoint|response to lipopolysaccharide|regulation of interleukin-6 production|regulation of tumor necrosis factor production|response to cytokine|cellular response to vascular endothelial growth factor stimulus|p38MAPK cascade|positive regulation of tumor necrosis factor biosynthetic process|macropinocytosis|protein autophosphorylation|vascular endothelial growth factor receptor signaling pathway|mRNA stabilization|inner ear development|3'-UTR-mediated mRNA stabilization|,protein serine/threonine kinase activity|calmodulin-dependent protein kinase activity|signal transducer activity|protein binding|calmodulin binding|ATP binding|calcium-dependent protein serine/threonine kinase activity|mitogen-activated protein kinase binding|,2,3,55900000,5.9%
E9Q4X2,0.001667629,-0.101333333,41.72186933,1.09,6.72687E-05,8.825639349,-0.508,-0.549,-0.882,0.437,0.375,0.519,E9Q4X2,Uggt2,E9Q4X2_Uggt2,E9Q4X2,Uggt2,1,3,2,2,E9Q4X2,MOUSE,173504.7,2.2,3269,3269.1,13.76,13.76,,1504,UDP-glucose glycoprotein glucosyltransferase 2,,protein glycosylation|UDP-glucosylation|,UDP-glucose:glycoprotein glucosyltransferase activity|,2,3,1140000000,2.2%
Q99NF8,0.297132915,0.166166667,12.8446896,-0.577666667,0.05194348,-2.365829594,0.25,0.079,1.036,-0.041,-0.209,-0.118,Q99NF8,Ranbp17,Q99NF8_Ranbp17,Q99NF8,Ranbp17,1,2,2,2,Q99NF8|M0QWL9|Q5SSA5,MOUSE,125592.2,1.6,3271,3271.1,13.74,13.74,,1088,Ran-binding protein 17,nuclear pore|cytoplasm|,intracellular protein transport|nucleocytoplasmic transport|mRNA transport|,Ran GTPase binding|,2,2,510000000,1.6%
Q9QZL0,0.956068722,0.0925,0.650499877,-0.073,0.860894657,-0.182179346,-0.204,-0.43,1.021,0.379,-0.39,0.179,Q9QZL0,Ripk3,Q9QZL0_Ripk3,Q9QZL0,Ripk3,1,3,2,2,Q9QZL0|E9PZP3,MOUSE,53835,6.5,3276,3276.1,13.7,13.7,,486,Receptor-interacting serine/threonine-protein kinase 3,intracellular|mitochondrion|cytosol|plasma membrane|ripoptosome|,"regulation of T cell mediated cytotoxicity|regulation of adaptive immune response|I-kappaB kinase/NF-kappaB signaling|positive regulation of phosphatase activity|viral process|activation of protein kinase activity|regulation of interferon-gamma production|T cell differentiation in thymus|NIK/NF-kappaB signaling|T cell homeostasis|regulation of activated T cell proliferation|protein autophosphorylation|lymph node development|spleen development|thymus development|positive regulation of NF-kappaB transcription factor activity|protein homooligomerization|protein heterooligomerization|positive regulation of ligase activity|positive regulation of oxidoreductase activity|positive regulation of necroptotic process|regulation of activation-induced cell death of T cells|necroptotic process|positive regulation of protein deacetylation|amyloid fibril formation|regulation of reactive oxygen species metabolic process|positive regulation of reactive oxygen species metabolic process|regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation|positive regulation of intrinsic apoptotic signaling pathway|",protein kinase activity|protein serine/threonine kinase activity|NF-kappaB-inducing kinase activity|protein binding|ATP binding|protein complex binding|identical protein binding|,2,3,47900000,6.5%
G5E8R8,0.473411328,0.015333333,8.682544651,-0.188,0.13543956,-1.697813204,0.091,0.15,0.087,-0.204,0.123,-0.155,G5E8R8,Ubxn7,G5E8R8_Ubxn7,G5E8R8,Ubxn7,1,2,2,2,G5E8R8|Q6P5G6,MOUSE,55210.6,4.9,3278,3278.1,13.68,13.68,,489,UBX domain-containing protein 7,nucleoplasm|VCP-NPL4-UFD1 AAA ATPase complex|,,transcription factor binding|ubiquitin protein ligase binding|ubiquitin binding|,2,2,105000000,4.9%
P84309-2,0.999384236,0.020833333,0.005113538,-0.000333333,0.998823257,-0.00153138,0.468,0.003,-0.408,-0.003,0.152,-0.087,P84309,Adcy5,P84309-2_Adcy5,P84309-2,Adcy5,1,3,2,2,P84309-2|P84309|F8VQ52|Q01341,MOUSE,150434.8,1.7,3279,3279.1,13.66,13.66,,1262,Isoform 2 of Adenylate cyclase type 5,intracellular|plasma membrane|membrane|integral component of membrane|primary cilium|,adenosine receptor signaling pathway|cAMP biosynthetic process|adenylate cyclase-activating G-protein coupled receptor signaling pathway|adenylate cyclase-activating dopamine receptor signaling pathway|adenylate cyclase-inhibiting dopamine receptor signaling pathway|locomotory behavior|intracellular signal transduction|neuromuscular process controlling balance|,adenylate cyclase activity|protein binding|ATP binding|adenylate cyclase binding|metal ion binding|protein heterodimerization activity|,2,3,97100000,1.7%
P49025-5,0.60945322,0.696666667,6.179644536,-1.458666667,0.241010268,-1.28778109,-0.111,0.111,4.278,-0.057,-0.498,0.457,P49025,Cit,P49025-5_Cit,P49025-5,Cit,1,5,2,2,P49025-5|D3YU89|P49025|E9QL53|D3Z1U0|F6SBR5|P49025-4|P49025-3,MOUSE,240895.9,0.7,3282,3282.1,13.63,13.63,,2055,Isoform 5 of Citron Rho-interacting kinase,ruffle|cytoplasm|vacuole|cytosol|actin cytoskeleton|membrane|,mitotic sister chromatid segregation|cytokinesis|protein phosphorylation|mitotic nuclear division|metaphase/anaphase transition of mitotic cell cycle|spermatogenesis|dendrite development|positive regulation of cytokinesis|intracellular signal transduction|negative regulation of neuron differentiation|generation of neurons|negative regulation of dendrite morphogenesis|,protein serine/threonine kinase activity|protein binding|ATP binding|SH3 domain binding|PDZ domain binding|metal ion binding|scaffold protein binding|,2,5,4930000000,0.7%
Q9CRA8,0.846769943,-0.027666667,2.409666821,-0.058,0.574160509,-0.590615301,-0.004,0.027,-0.019,0.015,-0.214,0.029,Q9CRA8,Exosc5,Q9CRA8_Exosc5,Q9CRA8,Exosc5,1,2,2,2,Q9CRA8|A0A0U1RPC2,MOUSE,25707,9.7,3285,3285.1,13.61,13.61,,235,Exosome complex component RRP46,nuclear exosome (RNase complex)|cytoplasmic exosome (RNase complex)|exosome (RNase complex)|nucleus|nucleolus|transcriptionally active chromatin|,"RNA catabolic process|rRNA catabolic process|rRNA 3'-end processing|nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'|U4 snRNA 3'-end processing|exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay|DNA deamination|defense response to virus|nuclear mRNA surveillance|polyadenylation-dependent snoRNA 3'-end processing|",RNA binding|,2,2,295000000,9.7%
Q99LH2,0.915850537,-0.0295,1.308949224,0.047666667,0.739784244,0.346408568,-0.227,0.039,0.028,0.213,-0.199,-0.031,Q99LH2,Ptdss1,Q99LH2_Ptdss1,Q99LH2,Ptdss1,1,8,2,2,Q99LH2|A0A286YDD2|A0A286YDW7,MOUSE,56344.4,5,3286,3286.1,13.6,13.6,,473,Phosphatidylserine synthase 1,endoplasmic reticulum membrane|membrane|integral component of membrane|,phosphatidylserine biosynthetic process|,transferase activity|,2,8,1500000000,5.0%
Q80U49,0.961523652,-0.011,0.541344707,0.018666667,0.882806515,0.153198518,0.099,0.09,-0.25,0.062,-0.085,0.018,Q80U49,Cep170b,Q80U49_Cep170b,Q80U49,Cep170b,1,2,2,2,Q80U49|B9EIX2,MOUSE,171274.2,1.5,3287,3287.1,13.6,13.6,,1574,Centrosomal protein of 170 kDa protein B,cytoplasm|microtubule|,,,2,2,19300000,1.5%
P97785,0.821409751,0.051166667,2.749082026,0.086333333,0.53099667,0.660897051,-0.129,0.107,0.046,0.327,0.004,-0.048,P97785,Gfra1,P97785_Gfra1,P97785,Gfra1,1,2,2,2,P97785|P97785-2|D6RDD4,MOUSE,53519.9,7.6,3288,3288.1,13.57,13.57,,468,GDNF family receptor alpha-1,plasma membrane|extrinsic component of membrane|anchored component of membrane|extracellular exosome|,transmembrane receptor protein tyrosine kinase signaling pathway|nervous system development|anatomical structure morphogenesis|,receptor activity|,2,2,8630000,7.6%
O89019-4,0.863857851,-0.024333333,2.170879734,0.058,0.606613438,0.540163461,-0.093,0.08,-0.147,-0.107,0.133,-0.012,O89019,NotFound,O89019-4_NotFound,O89019-4,Invs,1,2,2,2,O89019-4|H7BX37|Q5FWI2|S4R2B7,MOUSE,112192.7,2.2,3289,3289.1,13.57,13.57,,1062,Isoform 4 of Inversin,nucleus|spindle|microtubule|membrane|perinuclear region of cytoplasm|ciliary inversin compartment|ciliary base|,kidney development|post-embryonic development|Wnt signaling pathway|pancreas development|organ development|embryonic heart tube left/right pattern formation|negative regulation of canonical Wnt signaling pathway|,protein binding|calmodulin binding|,2,2,60600000,2.2%
Q80YP6,0.399799018,-0.138166667,10.40953245,0.601,0.091001124,1.976496478,0.065,-0.234,-1.147,0.325,0.191,-0.029,Q80YP6,Zik1,Q80YP6_Zik1,Q80YP6,Zik1,1,7,2,2,Q80YP6,MOUSE,54324,5.6,3290,3290.1,13.56,13.56,,463,Zinc finger protein interacting with ribonucleoprotein K,nucleoplasm|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",RNA polymerase II regulatory region sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity|metal ion binding|,2,7,14700000000,5.6%
O89016,0.607189465,0.0335,6.233281896,0.173666667,0.238051987,1.296852621,0.219,-0.143,-0.236,0.173,0.121,0.067,O89016,Abcd4,O89016_Abcd4,O89016,Abcd4,1,2,2,2,O89016|A0A1Y7VMF7|A0A1Y7VM74,MOUSE,69095.4,2.9,3292,3292.1,13.54,13.54,,606,ATP-binding cassette sub-family D member 4,endoplasmic reticulum membrane|integral component of membrane|peroxisome|,cobalamin metabolic process|transmembrane transport|,"ATP binding|ATPase activity, coupled to transmembrane movement of substances|",2,2,3570000,2.9%
Q8K284,0.472645993,-0.109,8.748617567,0.481333333,0.133394598,1.71039124,0.036,-0.088,-0.997,0.375,0.057,-0.037,Q8K284,Gtf3c1,Q8K284_Gtf3c1,Q8K284,Gtf3c1,1,3,3,3,Q8K284|A0A0U1RPD8|Q8K284-2|A0A0U1RP70,MOUSE,240096.6,2,3294,3294.1,13.53,13.53,,2101,General transcription factor 3C polypeptide 1,transcription factor TFIIIC complex|nucleus|nucleolus|membrane|ribonucleoprotein complex|,"transcription, DNA-templated|",DNA binding|,3,3,74700000,2.0%
Q9D868,0.241932648,0.033666667,14.43882662,0.33,0.035984655,2.623729209,-0.309,-0.047,-0.038,0.037,0.362,0.197,Q9D868,Ppih,Q9D868_Ppih,Q9D868,Ppih,1,3,2,2,Q9D868|Q9D868-2,MOUSE,20748.6,7.9,3296,3296.1,13.51,13.51,,188,Peptidyl-prolyl cis-trans isomerase H,spliceosomal complex|cytoplasm|nuclear speck|U4/U6 x U5 tri-snRNP complex|U4/U6 snRNP|,protein peptidyl-prolyl isomerization|mRNA processing|protein folding|RNA splicing|positive regulation of viral genome replication|,peptidyl-prolyl cis-trans isomerase activity|ribonucleoprotein complex binding|,2,3,422000000,7.9%
Q9CR95,0.273334376,-0.011333333,13.54242501,-0.292666667,0.044234131,-2.477191963,-0.045,0.211,0.239,-0.093,-0.075,-0.305,Q9CR95,Necap1,Q9CR95_Necap1,Q9CR95,Necap1,1,2,2,2,Q9CR95,MOUSE,29695.7,7.2,3300,3300.1,13.5,13.5,,275,Adaptin ear-binding coat-associated protein 1,plasma membrane|coated pit|clathrin vesicle coat|,endocytosis|protein transport|,protein binding|,2,2,5000000000,7.2%
Q8C052,0.22436839,0.036166667,15.01016424,-0.306333333,0.031548853,-2.71323006,0.205,0.024,0.339,-0.068,-0.231,-0.052,Q8C052,Map1s,Q8C052_Map1s,Q8C052,Map1s,1,3,3,3,Q8C052|A0A1D5RLY6,MOUSE,103964.2,2.8,3306,3306.1,13.4,13.4,,973,Microtubule-associated protein 1S,nucleus|nucleolus|cytoplasm|spindle|cytosol|microtubule|microtubule cytoskeleton|cell junction|dendrite|cell projection|neuronal cell body|synapse|perinuclear region of cytoplasm|,microtubule cytoskeleton organization|microtubule bundle formation|apoptotic process|nervous system development|brain development|regulation of chromatin disassembly|neuron projection morphogenesis|,DNA binding|microtubule binding|tubulin binding|identical protein binding|beta-tubulin binding|actin filament binding|,3,3,43100000000,2.8%
Q8BZ36,0.793095879,-0.062,3.216706627,-0.093333333,0.476792414,-0.754026369,0.087,0.111,-0.244,-0.013,-0.119,-0.194,Q8BZ36,Rint1,Q8BZ36_Rint1,Q8BZ36,Rint1,1,2,2,2,Q8BZ36|Q8BZ36-2,MOUSE,90948,3.2,3310,3310.1,13.33,13.33,,792,RAD50-interacting protein 1,endoplasmic reticulum|endoplasmic reticulum membrane|Dsl1p complex|,cell cycle|protein transport|Golgi vesicle transport|regulation of ER to Golgi vesicle-mediated transport|regulation of signal transduction involved in mitotic G2 DNA damage checkpoint|,,2,2,215000000,3.2%
P59997,0.352041358,-0.055833333,11.42494607,0.347666667,0.07202867,2.138542073,0.04,-0.199,-0.53,0.226,0.174,-0.046,P59997,Kdm2a,P59997_Kdm2a,P59997,Kdm2a,1,3,2,2,P59997|F6YRW4,MOUSE,135073.6,3.4,3311,3311.1,13.32,13.32,,1161,Lysine-specific demethylase 2A,nuclear chromatin|nucleus|nucleoplasm|nucleolus|,"double-strand break repair via nonhomologous end joining|transcription, DNA-templated|regulation of transcription, DNA-templated|oxidation-reduction process|histone H3-K36 demethylation|",zinc ion binding|unmethylated CpG binding|histone demethylase activity (H3-K36 specific)|,2,3,43000000,3.4%
Q8C0V0,0.552648107,0.0665,7.226514717,0.353,0.189386286,1.462550113,0.175,-0.305,-0.2,0.463,-0.268,0.534,Q8C0V0,Tlk1,Q8C0V0_Tlk1,Q8C0V0,Tlk1,1,4,2,2,Q8C0V0,MOUSE,87192.5,3.3,3314,3314.1,13.3,13.3,,766,Serine/threonine-protein kinase tousled-like 1,nucleus|,regulation of chromatin assembly or disassembly|protein phosphorylation|intracellular protein transport|cellular response to DNA damage stimulus|cell cycle|chromatin modification|intracellular signal transduction|,protein serine/threonine kinase activity|ATP binding|,2,4,3270000000,3.3%
Q9CQE1,0.911411213,0.184833333,1.439663188,-0.169666667,0.717849961,-0.37716509,-0.04,-0.383,1.232,-0.161,-0.218,0.679,Q9CQE1,Nipsnap3b,Q9CQE1_Nipsnap3b,Q9CQE1,Nipsnap3b,1,4,2,2,Q9CQE1|B1AWZ5|B1AWZ3|G3X8S9,MOUSE,28421.8,5.6,3316,3316.1,13.28,13.28,,247,Protein NipSnap homolog 3B,nucleus|mitochondrion|cytosol|,,,2,4,41700000,5.6%
Q9R0X5-5,0.228798704,0.082,14.83092302,0.447333333,0.032878175,2.687802162,-0.306,-0.058,-0.061,0.173,0.097,0.647,Q9R0X5,Rpgr,Q9R0X5-5_Rpgr,Q9R0X5-5,Rpgr,1,3,2,2,Q9R0X5-5|A0A067XG46|Q9R0X5|Q8CDM3|A2ADP2|Q9R0X5-2|Q3UWJ5|A2ADP5|Q9R0X5-3|Q9R0X5-4,MOUSE,147110.7,2.2,3317,3317.1,13.27,13.27,,1001,Isoform 5 of X-linked retinitis pigmentosa GTPase regulator,photoreceptor outer segment|cytoplasm|Golgi apparatus|centrosome|cilium|photoreceptor connecting cilium|ciliary basal body|sperm flagellum|,visual perception|intraciliary transport|cilium assembly|eye photoreceptor cell development|positive regulation of GTPase activity|retina morphogenesis in camera-type eye|cellular response to light stimulus|,guanyl-nucleotide exchange factor activity|protein binding|poly(A) RNA binding|,2,3,173000000,2.2%
Q8CE50,0.963376742,0.029833333,0.502040251,0.019,0.89083234,0.142621762,-0.073,0.112,0.022,-0.16,-0.007,0.285,Q8CE50,Snx30,Q8CE50_Snx30,Q8CE50,Snx30,1,3,2,2,Q8CE50,MOUSE,49861.7,4.5,3319,3319.1,13.27,13.27,,437,Sorting nexin-30,endosome|extrinsic component of membrane|,endocytosis|protein transport|vesicle organization|,phosphatidylinositol binding|,2,3,242000000,4.5%
P70677,0.365990558,0.029,11.13897732,0.254,0.076931158,2.092897101,0.106,-0.315,-0.085,0.162,0.138,0.168,P70677,Casp3,P70677_Casp3,P70677,Casp3,1,2,2,2,P70677|A0A1B0GR,MOUSE,31930.6,6.1,3321,3321.1,13.22,13.22,,277,Caspase-3,nucleus|cytoplasm|cytosol|death-inducing signaling complex|membrane raft|,response to hypoxia|B cell homeostasis|proteolysis|apoptotic process|cellular response to DNA damage stimulus|heart development|sensory perception of sound|learning or memory|response to UV|response to wounding|response to glucose|response to X-ray|protein processing|hippocampus development|neuron differentiation|keratinocyte differentiation|erythrocyte differentiation|negative regulation of B cell proliferation|response to cobalt ion|response to estradiol|response to lipopolysaccharide|glial cell apoptotic process|response to nicotine|wound healing|response to drug|response to hydrogen peroxide|T cell homeostasis|negative regulation of apoptotic process|positive regulation of catalytic activity|response to amino acid|positive regulation of neuron apoptotic process|cell fate commitment|negative regulation of cyclin-dependent protein serine/threonine kinase activity|negative regulation of cell cycle|negative regulation of activated T cell proliferation|response to antibiotic|neurotrophin TRK receptor signaling pathway|response to glucocorticoid|neuron apoptotic process|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress|cellular response to organic substance|cellular response to organic cyclic compound|execution phase of apoptosis|,protease binding|aspartic-type endopeptidase activity|cysteine-type endopeptidase activity|serine-type endopeptidase activity|cyclin-dependent protein serine/threonine kinase inhibitor activity|death receptor binding|protein binding|peptidase activity|cysteine-type peptidase activity|phospholipase A2 activator activity|protein complex binding|cysteine-type endopeptidase activity involved in apoptotic process|cysteine-type endopeptidase activity involved in execution phase of apoptosis|,2,2,41300000,6.1%
Q6ZQ93,0.886698259,-0.060166667,1.804286881,0.087666667,0.660041605,0.460293982,0.085,0.098,-0.495,0.189,-0.192,-0.046,Q6ZQ93,Usp34,Q6ZQ93_Usp34,Q6ZQ93,Usp34,1,2,2,2,Q6ZQ93|Q6ZQ93-2|Q6ZQ93-3|Q6ZQ93-4,MOUSE,413969.6,0.5,3322,3322.1,13.22,13.22,,3582,Ubiquitin carboxyl-terminal hydrolase 34,nucleus|cytoplasm|,Wnt signaling pathway|protein deubiquitination|proteasome-mediated ubiquitin-dependent protein catabolic process|regulation of proteasomal protein catabolic process|protein K48-linked deubiquitination|positive regulation of canonical Wnt signaling pathway|,cysteine-type endopeptidase activity|ubiquitin-specific protease activity|,2,2,476000000,0.5%
Q8K4Z5,0.461918472,0.056833333,9.07750588,0.245,0.123665743,1.763317653,-0.132,-0.042,-0.023,-0.004,0.074,0.468,Q8K4Z5,Sf3a1,Q8K4Z5_Sf3a1,Q8K4Z5,Sf3a1,1,3,2,2,Q8K4Z5,MOUSE,88600.3,2.4,3324,3324.1,13.19,13.19,,791,Splicing factor 3A subunit 1,nucleoplasm|spliceosomal complex|U2-type spliceosomal complex|U2 snRNP|U2-type prespliceosome|catalytic step 2 spliceosome|,"mRNA 3'-splice site recognition|mRNA splicing, via spliceosome|mRNA processing|",RNA binding|poly(A) RNA binding|,2,3,22900000,2.4%
Q9CQ33-2,0.998121345,-0.097833333,0.019150558,-0.001,0.995600129,-0.005725902,0.1,0.06,-0.452,0.041,-0.285,-0.051,Q9CQ33,Lztr1,Q9CQ33-2_Lztr1,Q9CQ33-2,Lztr1,1,2,2,2,Q9CQ33-2|E9PUQ1|Q9CQ33,MOUSE,99111.7,4.8,3327,3327.1,13.17,13.17,,837,Isoform 2 of Leucine-zipper-like transcriptional regulator 1,,,,2,2,69500000,4.8%
Q1ERP8,0.47899797,-0.008833333,8.589371287,0.667666667,0.138376669,1.684702695,-0.66,-0.789,0.421,0.087,-0.073,0.961,Q1ERP8,Cd300lg,Q1ERP8_Cd300lg,Q1ERP8,Cd300lg,1,8,2,2,Q1ERP8|Q1ERP8-3|Q1ERP8-2|Q1ERP8-5,MOUSE,37212,6.6,3328,3328.1,13.17,13.17,,331,CMRF35-like molecule 9,integral component of membrane|basolateral plasma membrane|apical plasma membrane|multivesicular body membrane|extracellular exosome|,immune system process|immunoglobulin transcytosis in epithelial cells|,IgM binding|,2,8,1060000000,6.6%
P54728,0.856747233,0.009,2.277391574,0.228666667,0.59191704,0.563101277,-0.448,-0.697,0.829,0.011,-0.153,0.512,P54728,Rad23b,P54728_Rad23b,P54728,Rad23b,1,2,2,2,P54728,MOUSE,43568.9,4,3333,3333.1,13.15,13.15,,416,UV excision repair protein RAD23 homolog B,proteasome complex|nucleoplasm|cytoplasm|XPC complex|,"nucleotide-excision repair, DNA damage recognition|nucleotide-excision repair|cellular response to DNA damage stimulus|spermatogenesis|regulation of proteasomal ubiquitin-dependent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|",damaged DNA binding|protein binding|polyubiquitin binding|,2,2,169000000,4.0%
Q8C050,0.87311559,-0.032833333,2.070633483,0.090333333,0.620778478,0.518810243,0.023,0.2,-0.457,-0.079,0.074,0.042,Q8C050,Rps6ka5,Q8C050_Rps6ka5,Q8C050,Rps6ka5,1,2,2,2,Q8C050|Q8C050-2,MOUSE,97209.3,4.5,3335,3335.1,13.13,13.13,,863,Ribosomal protein S6 kinase alpha-5,nucleus|nucleoplasm|cytoplasm|,"regulation of transcription, DNA-templated|protein phosphorylation|inflammatory response|histone phosphorylation|positive regulation of histone phosphorylation|positive regulation of histone acetylation|intracellular signal transduction|histone H3-S10 phosphorylation|histone H3-S28 phosphorylation|histone H2A-S1 phosphorylation|negative regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of NF-kappaB transcription factor activity|interleukin-1-mediated signaling pathway|",magnesium ion binding|protein kinase activity|protein serine/threonine kinase activity|protein binding|ATP binding|histone kinase activity (H3-S10 specific)|,2,2,253000000,4.5%
Q9D706,0.755660323,0.024833333,3.759475348,0.099,0.420777458,0.857987786,-0.061,-0.002,-0.011,0.282,-0.095,0.036,Q9D706,Rpap3,Q9D706_Rpap3,Q9D706,Rpap3,1,2,2,2,Q9D706,MOUSE,74322.4,4.8,3336,3336.1,13.11,13.11,,660,RNA polymerase II-associated protein 3,,,,2,2,3910000,4.8%
D3Z656,0.919257874,-0.051166667,1.259804659,0.098333333,0.748203153,0.334702871,0.476,-0.015,-0.762,-0.097,0.114,-0.023,D3Z656,Synj1,D3Z656_Synj1,D3Z656,Synj1,1,4,2,2,D3Z656|Q8CHC4|E9Q7S0,MOUSE,177812.9,1.1,3339,3339.1,13.07,13.07,,1607,Synaptojanin-1,membrane coat|clathrin coat|neuron projection|,neurotransmitter transport|brain development|learning|positive regulation of gliogenesis|synaptic vesicle priming|synaptic vesicle uncoating|response to retinoic acid|response to cytokine|phosphatidylinositol metabolic process|inositol phosphate dephosphorylation|phosphatidylinositol dephosphorylation|phosphatidylinositol-mediated signaling|positive regulation of receptor-mediated endocytosis|synaptic vesicle endocytosis|synaptic vesicle transport|positive regulation of synaptic vesicle recycling|,"nucleotide binding|nucleic acid binding|phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity|protein binding|protein C-terminus binding|SH3 domain binding|protein complex binding|phosphatidylinositol phosphate 5-phosphatase activity|",2,4,778000000,1.1%
Q80TM9,0.993378838,-0.0075,0.108491312,-0.003666667,0.975328396,-0.032108112,-0.054,0.103,-0.066,0.075,-0.2,0.097,Q80TM9,Nisch,Q80TM9_Nisch,Q80TM9,Nisch,1,2,2,2,Q80TM9|Q80TM9-3|Q80TM9-2|Q80TM9-6,MOUSE,176606.3,2.1,3340,3340.1,13.07,13.07,,1593,Nischarin,early endosome|cytosol|plasma membrane|recycling endosome|,"glucose metabolic process|apoptotic process|G-protein coupled receptor signaling pathway|regulation of blood pressure|Rac protein signal transduction|actin cytoskeleton organization|negative regulation of cell migration|regulation of synaptic transmission, GABAergic|norepinephrine secretion|",integrin binding|phosphatidylinositol binding|identical protein binding|,2,2,448000000,2.1%
Q9EQY0,0.195217182,-0.057833333,16.11962925,0.450333333,0.024436392,2.900651206,-0.058,-0.18,-0.611,0.252,0.163,0.087,Q9EQY0,Ern1,Q9EQY0_Ern1,Q9EQY0,Ern1,1,2,2,2,Q9EQY0,MOUSE,110924.2,3,3341,3341.1,13.02,13.02,,977,Serine/threonine-protein kinase/endoribonuclease IRE1,nuclear inner membrane|cytoplasm|mitochondrion|endoplasmic reticulum|endoplasmic reticulum membrane|integral component of endoplasmic reticulum membrane|AIP1-IRE1 complex|IRE1-TRAF2-ASK1 complex|IRE1-RACK1-PP2A complex|,"endothelial cell proliferation|transcription, DNA-templated|regulation of transcription, DNA-templated|mRNA cleavage|protein phosphorylation|activation of signaling protein activity involved in unfolded protein response|cell cycle arrest|activation of JUN kinase activity|endoplasmic reticulum unfolded protein response|UFP-specific transcription factor mRNA processing involved in endoplasmic reticulum unfolded protein response|positive regulation of RNA splicing|response to endoplasmic reticulum stress|cellular response to vascular endothelial growth factor stimulus|peptidyl-serine autophosphorylation|IRE1-mediated unfolded protein response|protein autophosphorylation|mRNA splicing, via endonucleolytic cleavage and ligation|HAC1-type intron splice site recognition and cleavage|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress|cellular response to glucose stimulus|RNA phosphodiester bond hydrolysis, endonucleolytic|positive regulation of endoplasmic reticulum unfolded protein response|insulin metabolic process|peptidyl-serine trans-autophosphorylation|",magnesium ion binding|endonuclease activity|endoribonuclease activity|protein serine/threonine kinase activity|protein binding|ATP binding|enzyme binding|Hsp70 protein binding|identical protein binding|protein homodimerization activity|ADP binding|Hsp90 protein binding|,2,2,54300000,3.0%
A2AJT5,0.956068722,-0.014666667,0.653546466,0.028666667,0.860290948,0.182980175,0.139,0.117,-0.343,-0.051,0.157,-0.107,A2AJT5,Pnisr,A2AJT5_Pnisr,A2AJT5,Pnisr,1,2,2,2,A2AJT5|A2AJT4,MOUSE,93307.9,1.5,3342,3342.1,12.99,12.99,,814,Arginine/serine-rich protein PNISR,nucleus|nucleoplasm|cytoplasm|,,poly(A) RNA binding|,2,2,27100000,1.5%
E9Q9F1,0.122124581,-0.039666667,18.7730177,-0.402666667,0.013264724,-3.352545583,0.019,0.103,0.363,-0.324,-0.276,-0.123,E9Q9F1,Kcnq5,E9Q9F1_Kcnq5,E9Q9F1,Kcnq5,1,4,3,3,E9Q9F1|Q9JK45|G3UYG5|G3UYP4,MOUSE,105647.8,3.1,3344,3344.1,12.99,12.99,,952,Potassium voltage-gated channel subfamily KQT member 5,voltage-gated potassium channel complex|integral component of membrane|,potassium ion transport|potassium ion transmembrane transport|,voltage-gated potassium channel activity|delayed rectifier potassium channel activity|,3,4,1130000000,3.1%
Q8BGZ4,0.857449938,0.127833333,2.255907438,0.160333333,0.594852452,0.558542221,0.081,-0.039,0.101,0.903,-0.027,-0.252,Q8BGZ4,Cdc23,Q8BGZ4_Cdc23,Q8BGZ4,Cdc23,1,3,2,2,A0A0R4J1W7|Q8BGZ4|G3X8W7|Q8BGZ4-2,MOUSE,69359,3.1,3345,3345.1,12.98,12.98,,597,Cell division cycle protein 23 homolog,intracellular|anaphase-promoting complex|,mitotic nuclear division|mitotic metaphase plate congression|regulation of mitotic metaphase/anaphase transition|cell division|protein K11-linked ubiquitination|,,2,3,41000000,3.1%
Q3UFT3,0.606444877,0.081833333,6.253852554,-0.303666667,0.236927103,-1.300327908,-0.078,0.07,0.709,0.212,-0.299,-0.123,Q3UFT3,Garem1,Q3UFT3_Garem1,Q3UFT3,Garem1,1,2,2,2,Q3UFT3|Q3UFT3-2,MOUSE,98731.9,2.9,3348,3348.1,12.95,12.95,,876,GRB2-associated and regulator of MAPK protein,,epidermal growth factor receptor signaling pathway|positive regulation of cell proliferation|positive regulation of cell division|positive regulation of ERK1 and ERK2 cascade|cellular response to epidermal growth factor stimulus|,proline-rich region binding|,2,2,10800000,2.9%
E9QKI4,0.582708025,-0.080333333,6.671089339,0.232,0.215224182,1.370392566,0.112,-0.355,-0.346,0.236,0.047,-0.176,E9QKI4,Akt1s1,E9QKI4_Akt1s1,E9QKI4,Akt1s1,1,2,2,2,E9QKI4|E9QKI5|Q9D1F4,MOUSE,35866.3,9.4,3350,3350.1,12.94,12.94,,328,Proline-rich AKT1 substrate 1,cytoplasm|TORC1 complex|,negative regulation of protein kinase activity|Notch signaling pathway|negative regulation of TOR signaling|negative regulation of cell size|neurotrophin TRK receptor signaling pathway|,,2,2,14900000,9.4%
Q8BGR5,0.471902671,-0.108333333,8.811314206,1.374,0.13148269,1.7204934,0.305,-0.309,-2.382,1.811,0.091,-0.166,Q8BGR5,Fam53b,Q8BGR5_Fam53b,Q8BGR5,Fam53b,1,7,2,2,Q8BGR5|Q8BGR5-2,MOUSE,47250.6,3.5,3351,3351.1,12.92,12.92,,422,Protein FAM53B,,,,2,7,384000000,3.5%
Q9QZZ4,0.884566234,-0.086666667,1.844832337,0.168666667,0.653908174,0.469314753,0.274,0.162,-0.949,-0.392,0.397,-0.012,Q9QZZ4,Myo15,Q9QZZ4_Myo15,Q9QZZ4,Myo15a,1,2,2,2,Q9QZZ4|Q9QZZ4-2|Q9QZZ4-3|F6VXK7,MOUSE,398296,0.8,3353,3353.1,12.91,12.91,,3511,Unconventional myosin-XV,cytoplasm|myosin complex|stereocilium|stereocilium bundle|extracellular exosome|,sensory perception of sound|locomotory behavior|metabolic process|inner ear morphogenesis|,motor activity|actin binding|protein binding|ATP binding|,2,2,1320000000,0.8%
G3X9N1,0.473411328,0.114,8.695081713,-0.354,0.135049142,-1.701760034,-0.011,0.1,0.784,-0.056,-0.035,-0.098,G3X9N1,Arhgap24,G3X9N1_Arhgap24,G3X9N1,Arhgap24,1,4,2,2,G3X9N1|Q8C4V1|D3Z5T4|Q8C4V1-2|Q8C4V1-3,MOUSE,84740.1,4.8,3357,3357.1,12.86,12.86,,747,"Rho GTPase activating protein 24, isoform CRA_b",focal adhesion|,"signal transduction|negative regulation of Rac protein signal transduction|wound healing, spreading of epidermal cells|activation of GTPase activity|negative regulation of ruffle assembly|",GTPase activator activity|,2,4,160000000,4.8%
Q03145,0.259933795,-0.1025,13.90318877,0.410333333,0.040708127,2.536645618,-0.092,-0.173,-0.658,0.11,0.187,0.011,Q03145,Epha2,Q03145_Epha2,Q03145,Epha2,1,2,2,1,Q03145|G1K381|Q62413|P54763-2|P54763-4|Q8CBF3|Q03137|P54763|P54754|Q8C8K1|P54761|Q8CBF3-2|Q03137-2|E9PWK7|E9PUK8,MOUSE,110333.7,3.3,3358,3358.1,12.83,6.03,,977,Ephrin type-A receptor 2,intracellular|plasma membrane|integral component of plasma membrane|focal adhesion|cell surface|leading edge membrane|lamellipodium membrane|ruffle membrane|,skeletal system development|angiogenesis|blood vessel development|vasculogenesis|osteoblast differentiation|cell adhesion|intrinsic apoptotic signaling pathway in response to DNA damage|regulation of lamellipodium assembly|notochord formation|cell migration|peptidyl-tyrosine phosphorylation|neural tube development|neuron differentiation|keratinocyte differentiation|osteoclast differentiation|mammary gland epithelial cell proliferation|regulation of cell adhesion mediated by integrin|post-anal tail morphogenesis|protein kinase B signaling|regulation of blood vessel endothelial cell migration|regulation of angiogenesis|bone remodeling|ephrin receptor signaling pathway|axial mesoderm formation|notochord morphogenesis|negative regulation of protein kinase B signaling|notochord cell development|cell chemotaxis|branching involved in mammary gland duct morphogenesis|lens fiber cell morphogenesis|regulation of ERK1 and ERK2 cascade|response to growth factor|positive regulation of establishment of protein localization to plasma membrane|activation of GTPase activity|,transmembrane receptor protein tyrosine kinase activity|ephrin receptor activity|protein binding|ATP binding|,2,2,183000000,3.3%
G3X987,0.666695042,-0.128333333,5.062136001,0.287333333,0.311735599,1.095038056,0.007,0.079,-0.902,0.133,0.02,-0.107,G3X987,Gimap9,G3X987_Gimap9,G3X987,Gimap9,1,2,2,2,G3X987,MOUSE,33696.9,12,3359,3359.1,12.82,12.82,,291,"GTPase, IMAP family member 9",,,GTP binding|,2,2,69400000,12.0%
E9PXF8,0.929192436,0.042666667,1.009537341,0.040666667,0.792585761,0.273797248,0.101,0.037,-0.071,0.132,-0.236,0.293,E9PXF8,Sbf2,E9PXF8_Sbf2,E9PXF8,Sbf2,1,2,2,2,E9PXF8|E9Q305|E9Q0D4,MOUSE,212451.4,1.1,3361,3361.1,12.81,12.81,,1872,SET-binding factor 2,vacuolar membrane|membrane|,positive regulation of GTPase activity|protein tetramerization|,Rab guanyl-nucleotide exchange factor activity|phosphatase regulator activity|phosphatase binding|phosphatidylinositol binding|protein homodimerization activity|,2,2,7040000000,1.1%
Q60674,0.013165443,-0.0425,30.8019784,0.784333333,0.000831385,5.776169872,-0.187,-0.676,-0.441,0.299,0.412,0.338,Q60674,Nr1d2,Q60674_Nr1d2,Q60674,Nr1d2,1,2,2,2,Q60674|Q3UV55,MOUSE,65384.8,2.9,3362,3362.1,12.79,12.79,,576,Nuclear receptor subfamily 1 group D member 2,nucleus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|regulation of lipid metabolic process|intracellular receptor signaling pathway|regulation of circadian rhythm|steroid hormone mediated signaling pathway|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|rhythmic process|regulation of inflammatory response|lipid homeostasis|regulation of energy homeostasis|regulation of skeletal muscle cell differentiation|",core promoter sequence-specific DNA binding|DNA binding|sequence-specific DNA binding transcription factor activity|steroid hormone receptor activity|thyroid hormone receptor activity|protein binding|zinc ion binding|,2,2,3770000000,2.9%
Q8BP71,0.461918472,0.004333333,9.093953743,-0.223333333,0.123198275,-1.765960454,0.023,0.3,0.025,-0.19,-0.209,0.077,Q8BP71,Rbfox2,Q8BP71_Rbfox2,Q8BP71,Rbfox2,1,3,2,2,Q8BP71|Q8BP71-5|Q8BP71-2|Q9JJ43-3|Q9JJ43|Q9JJ43-6|Q9JJ43-4|Q8BIF2|Q8BP71-3|Q9JJ43-2|Q9JJ43-5|Q8BP71-8|Q8BP71-7|Q8BIF2-2|Q8BP71-6|Q8BIF2-5|Q8BIF2-4,MOUSE,47329.4,3.7,3363,3363.1,12.78,12.78,,449,RNA binding protein fox-1 homolog 2,nucleus|nucleoplasm|cytoplasm|,"regulation of alternative mRNA splicing, via spliceosome|mRNA processing|RNA splicing|regulation of definitive erythrocyte differentiation|radial glia guided migration of Purkinje cell|intracellular estrogen receptor signaling pathway|negative regulation of transcription, DNA-templated|dendrite morphogenesis|neuromuscular process controlling balance|",nucleotide binding|transcription corepressor activity|RNA binding|mRNA binding|protein binding|transcription factor binding|poly(A) RNA binding|,2,3,20700000,3.7%
G5E8Q0,0.400494909,-0.048833333,10.37178187,-0.238333333,0.091795589,-1.97047035,0.068,0.068,0.075,0.074,-0.273,-0.305,G5E8Q0,Lyst,G5E8Q0_Lyst,G5E8Q0,Lyst,1,2,2,2,G5E8Q0|P97412,MOUSE,430850.7,0.6,3366,3366.1,12.73,12.73,,3787,"Lysosomal trafficking regulator, isoform CRA_a",cytosol|endomembrane system|microtubule cytoskeleton|extrinsic component of membrane|,neutrophil mediated immunity|T cell mediated immunity|phospholipid metabolic process|microtubule-based process|lysosome organization|blood coagulation|endosomal transport|leukocyte chemotaxis|melanosome organization|endosome to lysosome transport via multivesicular body sorting pathway|positive regulation of natural killer cell activation|secretion of lysosomal enzymes|mast cell secretory granule organization|natural killer cell mediated cytotoxicity|response to drug|defense response to bacterium|defense response to protozoan|pigmentation|pigment granule organization|defense response to virus|phospholipid homeostasis|,phospholipid binding|,2,2,271000000,0.6%
Q8VHH5,0.268140406,0.015166667,13.68585342,0.323666667,0.042797131,2.501445071,0.006,-0.063,-0.383,0.095,0.137,0.299,Q8VHH5,NotFound,Q8VHH5_NotFound,Q8VHH5,Agap3,1,2,2,2,Q8VHH5|F8VQE9|A0A0G2JDW1|A0A1D5RMG4|Q8VHH5-2,MOUSE,98933.3,2.5,3369,3369.1,12.7,12.7,,910,"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3",nucleus|cytoplasm|membrane|PML body|cell periphery|,"protein import into nucleus, translocation|small GTPase mediated signal transduction|PML body organization|cellular response to reactive oxygen species|cellular response to UV|proteasome-mediated ubiquitin-dependent protein catabolic process|positive regulation of GTPase activity|",GTPase activity|GTPase activator activity|GTP binding|polyubiquitin binding|metal ion binding|,2,2,171000000,2.5%
Q9WTR0,0.724858913,0.023666667,4.178667511,-0.105333333,0.382061476,-0.935813735,0.054,-0.09,0.265,-0.003,-0.087,0.003,Q9WTR0,Mmp16,Q9WTR0_Mmp16,Q9WTR0,Mmp16,1,3,2,2,Q9WTR0|V9GXD8,MOUSE,70026.6,2.1,3370,3370.1,12.7,12.7,,607,Matrix metalloproteinase-16,plasma membrane|integral component of membrane|extracellular matrix|,ossification|endochondral ossification|proteolysis|collagen catabolic process|chondrocyte proliferation|embryonic cranial skeleton morphogenesis|bone development|craniofacial suture morphogenesis|,metalloendopeptidase activity|calcium ion binding|zinc ion binding|,2,3,172000000,2.1%
E9Q6D8,0.419251875,0.006833333,9.999218832,0.392333333,0.100017989,1.910967133,-0.485,0.098,-0.181,0.232,-0.12,0.497,E9Q6D8,NotFound,E9Q6D8_NotFound,E9Q6D8,C6,1,2,2,2,E9Q6D8|Q91X70,MOUSE,108049.4,3,3372,3372.1,12.69,12.69,,931,Complement component 6,membrane attack complex|extracellular exosome|,in utero embryonic development|immune response|,,2,2,5910000,3.0%
Q9WU56-3,0.994928853,0.0075,0.089032927,0.003,0.979708119,0.026405527,-0.06,-0.019,0.097,0.174,-0.166,0.019,Q9WU56,Pus1,Q9WU56-3_Pus1,Q9WU56-3,Pus1,1,3,2,2,Q9WU56-3|Q9WU56-2|Q9WU56-4|H7BX59|Q9WU56,MOUSE,46693.3,6.8,3373,3373.1,12.69,12.69,,423,Isoform 3 of tRNA pseudouridine synthase A,nucleus|transcription factor complex|nucleolus|mitochondrion|nuclear chromatin|,tRNA pseudouridine synthesis|positive regulation of transcription from RNA polymerase II promoter|,protein binding|pseudouridine synthase activity|ligand-dependent nuclear receptor transcription coactivator activity|poly(A) RNA binding|,2,3,728000000,6.8%
G3UW,0.332192581,0.1205,11.8752545,-0.753,0.064934358,-2.210480765,0.095,0.113,1.283,0.006,-0.568,-0.206,G3UW,NotFound,G3UW_NotFound,G3UW,Rfc1,1,2,2,2,G3UW|Q5U4B1|P35601|G3X8Z6|P35601-2|A0A0N5E9G7,MOUSE,128488.6,2.3,3374,3374.1,12.68,12.68,,1145,Replication factor C subunit 1,nucleus|nucleoplasm|DNA replication factor C complex|Golgi apparatus|cell junction|extracellular exosome|,DNA replication|DNA repair|,DNA binding|DNA clamp loader activity|ATP binding|,2,2,41500000,2.3%
Q8BKT7,0.292164522,0.066166667,13.03563418,-0.281666667,0.049709178,-2.395375083,0.314,0.295,0.012,-0.012,-0.013,-0.199,Q8BKT7,Thoc5,Q8BKT7_Thoc5,Q8BKT7,Thoc5,1,3,2,2,A0A0R4J0J6|Q8BKT7|Q5SVF9,MOUSE,79426.3,2.4,3375,3375.1,12.68,12.68,,683,THO complex subunit 5 homolog,transcription export complex|THO complex|THO complex part of transcription export complex|nucleus|nucleoplasm|cytoplasm|nuclear speck|,"cell morphogenesis|blastocyst development|mRNA processing|mRNA export from nucleus|RNA splicing|regulation of gene expression|regulation of mRNA export from nucleus|stem cell division|monocyte differentiation|positive regulation of DNA-templated transcription, elongation|negative regulation of macrophage differentiation|viral mRNA export from host cell nucleus|primitive hemopoiesis|negative regulation of DNA damage checkpoint|regulation of stem cell division|",mRNA binding|protein binding|,2,3,22000000,2.4%
P24527,0.247122038,-0.069666667,14.28122069,0.28,0.037314526,2.592514812,-0.293,-0.187,-0.149,-0.106,0.137,0.18,P24527,Lta4h,P24527_Lta4h,P24527,Lta4h,1,3,2,2,P24527,MOUSE,69677.2,5.7,3381,3381.1,12.63,12.63,,611,Leukotriene A-4 hydrolase,nucleoplasm|cytoplasm|extracellular exosome|,proteolysis|response to zinc ion|leukotriene biosynthetic process|peptide catabolic process|response to peptide hormone|Type I pneumocyte differentiation|,aminopeptidase activity|epoxide hydrolase activity|leukotriene-A4 hydrolase activity|protein binding|metallopeptidase activity|zinc ion binding|poly(A) RNA binding|,2,3,3600000000,5.7%
Q99N42,0.472782242,-0.037666667,8.720532811,0.164,0.134260024,1.703146446,-0.02,-0.101,-0.238,-0.034,0.06,0.107,Q99N42,Tymp,Q99N42_Tymp,Q99N42,Tymp,1,3,2,2,Q99N42,MOUSE,49791.5,6.7,3382,3382.1,12.61,12.61,,471,Thymidine phosphorylase,,pyrimidine nucleobase metabolic process|pyrimidine nucleoside metabolic process|chemotaxis|organ morphogenesis|,"phosphorylase activity|thymidine phosphorylase activity|pyrimidine-nucleoside phosphorylase activity|transferase activity, transferring pentosyl groups|",2,3,74900000,6.7%
Q8C2E4,0.400494909,-0.0835,10.36465518,0.370333333,0.091946347,1.969332667,-0.076,-0.027,-0.703,0.136,0.149,0.02,Q8C2E4,Ptcd1,Q8C2E4_Ptcd1,Q8C2E4,Ptcd1,1,2,2,2,Q8C2E4,MOUSE,78334.7,3.7,3387,3387.1,12.57,12.57,,695,"Pentatricopeptide repeat-containing protein 1, mitochondrial",mitochondrial matrix|,tRNA 3'-end processing|,,2,2,30000000,3.7%
Q8VCC6,0.488591195,0.150833333,8.416808871,0.649,0.143985617,1.656814515,-0.015,-0.048,-0.458,1.419,-0.064,0.071,Q8VCC6,Ccm2l,Q8VCC6_Ccm2l,Q8VCC6,Ccm2l,1,2,2,2,Q8VCC6,MOUSE,52971.8,3.9,3388,3388.1,12.57,12.57,,481,Cerebral cavernous malformations 2 protein-like,,cardiac atrium morphogenesis|ventricular trabecula myocardium morphogenesis|negative regulation of protein binding|negative regulation of homotypic cell-cell adhesion|wound healing|cardiac muscle tissue growth|positive regulation of fibroblast growth factor production|,protein binding|,2,2,569000000,3.9%
E9Q3S4,0.948383862,0,0.781787276,-0.020666667,0.835259209,-0.21621313,-0.042,0.107,-0.034,-0.04,0.099,-0.09,E9Q3S4,Map3k19,E9Q3S4_Map3k19,E9Q3S4,Map3k19,1,4,2,2,A0A140LHL6|E9Q3S4,MOUSE,148006.9,1.3,3397,3397.1,12.51,12.51,,1311,Mitogen-activated protein kinase kinase kinase 19,cytoplasm|,activation of MAPKK activity|regulation of mitotic cell cycle|activation of protein kinase activity|regulation of apoptotic process|stress-activated MAPK cascade|,MAP kinase kinase kinase activity|ATP binding|,2,4,3920000000,1.3%
Q8CJ40,0.962232805,0.064333333,0.521325147,0.034666667,0.886885359,0.147820881,-0.082,-0.349,0.572,0.245,0.008,-0.008,Q8CJ40,Crocc,Q8CJ40_Crocc,Q8CJ40,Crocc,1,3,2,2,Q8CJ40|Q8CJ40-3|Q8CJ40-2,MOUSE,227511.1,1.3,3399,3399.1,12.5,12.5,,2009,Rootletin,photoreceptor inner segment|cytoplasm|centrosome|centriole|plasma membrane|actin cytoskeleton|ciliary rootlet|extracellular exosome|,cell cycle|protein localization|centriole-centriole cohesion|epithelial structure maintenance|cell projection organization|ciliary basal body organization|protein localization to organelle|photoreceptor cell maintenance|centrosome organization|establishment of organelle localization|,actin binding|structural molecule activity|protein binding|kinesin binding|,2,3,3600000000,1.3%
Q8BFR2,0.578909417,0.261833333,6.771632571,0.789666667,0.210298775,1.387162997,0.07,-0.075,-0.394,2.082,-0.036,-0.076,Q8BFR2,Fstl5,Q8BFR2_Fstl5,Q8BFR2,Fstl5,1,6,2,2,Q8BFR2,MOUSE,97126.3,2.4,3405,3405.1,12.47,12.47,,847,Follistatin-related protein 5,extracellular region|,,,2,6,2450000000,2.4%
Q9D8M4,0.318107191,-0.076833333,12.33154715,-0.410333333,0.058458179,-2.283500084,0.067,0.344,-0.026,-0.43,0.072,-0.488,Q9D8M4,Rpl7l1,Q9D8M4_Rpl7l1,Q9D8M4,Rpl7l1,1,3,2,2,Q9D8M4,MOUSE,28657.3,8.1,3406,3406.1,12.45,12.45,,246,60S ribosomal protein L7-like 1,nucleolus|ribosome|,blastocyst formation|,poly(A) RNA binding|,2,3,145000000,8.1%
B2KF50,0.586445778,-0.068166667,6.551886899,0.155666667,0.221213339,1.349981004,-0.05,-0.185,-0.203,0.022,-0.171,0.178,B2KF50,Uhrf1bp1,B2KF50_Uhrf1bp1,B2KF50,Uhrf1bp1,1,2,2,2,B2KF50,MOUSE,158264.5,1.5,3408,3408.1,12.43,12.43,,1429,UHRF1 (ICBP90)-binding protein 1,,,identical protein binding|histone deacetylase binding|,2,2,12300000,1.5%
E9QMN5,0.904214516,0.021166667,1.554078064,0.053,0.699185147,0.403656302,-0.068,0.034,0.018,0.092,-0.204,0.255,E9QMN5,Gatad2a,E9QMN5_Gatad2a,E9QMN5,Gatad2a,1,2,2,2,E9QMN5|Q8CHY6|A0A1I7Q4G8,MOUSE,67803.3,3.6,3409,3409.1,12.42,12.42,,630,Transcriptional repressor p66 alpha,nucleus|nucleoplasm|NuRD complex|,"blood vessel development|in utero embryonic development|neural fold formation|embryonic body morphogenesis|programmed cell death|anterior neuropore closure|negative regulation of transcription, DNA-templated|","protein binding, bridging|",2,2,268000000,3.6%
E9QAE1,0.915850537,-0.113833333,1.312769815,-0.123666667,0.739133725,-0.347315268,0.367,0.352,-0.875,0.019,-0.019,-0.527,E9QAE1,Nckap5,E9QAE1_Nckap5,E9QAE1,Nckap5,1,4,2,2,E9QAE1|Q6NZK2|Q29SA9,MOUSE,211127.9,2.3,3410,3410.1,12.42,12.42,,1909,NCK-associated protein 5,,,,2,4,1750000000,2.3%
Q05CL8,0.480593503,0.344333333,8.538884537,-1.47,0.139994685,-1.676549186,-0.24,0.232,3.246,-0.277,-0.897,0.002,Q05CL8,Larp7,Q05CL8_Larp7,Q05CL8,Larp7,1,3,2,2,Q05CL8|A2AMD0|Q05CL8-2,MOUSE,65257.5,2.4,3412,3412.1,12.4,12.4,,570,La-related protein 7,nucleus|nucleoplasm|cytoplasm|Golgi apparatus|ribonucleoprotein complex|,negative regulation of transcription from RNA polymerase II promoter|RNA processing|negative regulation of chromatin binding|germ cell proliferation|positive regulation of G1/S transition of mitotic cell cycle|,nucleotide binding|poly(A) RNA binding|,2,3,1510000000,2.4%
B2RUP2,0.289081769,-0.081666667,13.16278152,0.357333333,0.048274952,2.417006478,-0.035,-0.176,-0.57,0.114,0.143,0.034,B2RUP2,Unc13d,B2RUP2_Unc13d,B2RUP2,Unc13d,1,3,2,2,B2RUP2|B2RUP2-2|A0A0R4J257,MOUSE,124372,1.7,3413,3413.1,12.38,12.38,,1085,Protein unc-13 homolog D,lysosome|late endosome|membrane|Weibel-Palade body|recycling endosome|exocytic vesicle|,granuloma formation|germinal center formation|phagocytosis|regulation of mast cell degranulation|natural killer cell degranulation|positive regulation of exocytosis|defense response to virus|positive regulation of substrate adhesion-dependent cell spreading|positive regulation of regulated secretory pathway|,protein binding|Rab GTPase binding|,2,3,1360000000,1.7%
Q70KF4,0.436783765,0.250666667,9.631363687,1.52,0.108858822,1.852134909,-0.027,-0.01,-1.491,2.868,0.154,0.01,Q70KF4,NotFound,Q70KF4_NotFound,Q70KF4,Cmya5,1,3,2,2,Q70KF4|E9QLJ0|Q5SXY1|A0A0J9YTU3|Q5SXY1-3|A0A0J9YUR2|Q5SXY1-2|A0A0J9YUF8|A0A0J9YV86,MOUSE,414573.2,0.3,3414,3414.1,12.38,12.38,,3739,Cardiomyopathy-associated protein 5,M band|costamere|perinuclear region of cytoplasm|,regulation of skeletal muscle adaptation|negative regulation of protein phosphatase type 2B activity|negative regulation of calcineurin-NFAT signaling cascade|,protein binding|identical protein binding|,2,3,1320000000,0.3%
Q80YR7,0.600763538,0.034833333,6.331121489,-0.133,0.232749015,-1.311857178,0.013,0.08,0.211,-0.158,0.047,0.016,Q80YR7,Clspn,Q80YR7_Clspn,Q80YR7,Clspn,1,4,2,2,Q80YR7|Q8K394|Q3URV1|Q923P0|F6UFI2|Q923P0-2|Q3URV1-2|Q149L0,MOUSE,147454.4,0.9,3415,3415.1,12.38,12.38,,1315,Claspin,nucleus|chromosome|,DNA replication checkpoint|DNA damage checkpoint|DNA repair|peptidyl-serine phosphorylation|G2 DNA damage checkpoint|activation of protein kinase activity|mitotic DNA replication checkpoint|,DNA secondary structure binding|anaphase-promoting complex binding|,4,4,718000000,0.9%
A0A087WNW2,0.020231179,-0.102166667,28.35861496,-0.665666667,0.00145928,-5.220337979,0.211,0.317,0.164,-0.497,-0.612,-0.196,A0A087WNW2,Nfasc,A0A087WNW2_Nfasc,A0A087WNW2,Nfasc,1,2,2,2,A0A087WNW2,MOUSE,102020.6,2.1,3418,3418.1,12.35,12.35,,899,Neurofascin,plasma membrane|focal adhesion|axon|paranodal junction|paranode region of axon|extracellular exosome|,protein localization to paranode region of axon|axon guidance|peripheral nervous system development|transmission of nerve impulse|paranodal junction assembly|heterotypic cell-cell adhesion|clustering of voltage-gated sodium channels|synapse organization|protein localization to juxtaparanode region of axon|,protein binding involved in heterotypic cell-cell adhesion|,2,2,23900000,2.1%
Q9JM96,0.014689129,-0.132333333,30.11907771,0.568666667,0.000972954,5.577489319,-0.253,-0.458,-0.539,0.169,0.175,0.112,Q9JM96,Cdc42ep4,Q9JM96_Cdc42ep4,Q9JM96,Cdc42ep4,1,2,2,2,Q9JM96,MOUSE,37925.5,8.8,3421,3421.1,12.33,12.33,,349,Cdc42 effector protein 4,cytoplasm|cytoskeleton|plasma membrane|endomembrane system|actin cytoskeleton|microtubule cytoskeleton|,Rho protein signal transduction|regulation of cell shape|positive regulation of actin filament polymerization|positive regulation of pseudopodium assembly|positive regulation of GTPase activity|,GTPase activator activity|protein binding|GTP-Rho binding|poly(A) RNA binding|,2,2,3990000,8.8%
Q91XL9,0.013719524,-0.113333333,30.4898878,1.124666667,0.000893329,5.702993413,-0.454,-0.465,-1.108,0.276,0.58,0.491,Q91XL9,Osbpl1a,Q91XL9_Osbpl1a,Q91XL9,Osbpl1a,1,2,2,2,Q91XL9|Q3V156|Q91XL9-2|Q91XL9-3|Q8K2D2,MOUSE,109276.6,3.3,3427,3427.1,12.29,12.29,,950,Oxysterol-binding protein-related protein 1,nucleus|nucleoplasm|cytoplasm|late endosome|extracellular exosome|,lipid transport|,protein binding|cholesterol binding|,2,2,30700000,3.3%
E9QLJ3,0.866627606,-0.020666667,2.137908144,-0.189333333,0.611236367,-0.533325166,0.559,0.378,-0.715,0.286,-0.353,-0.279,E9QLJ3,Med13l,E9QLJ3_Med13l,E9QLJ3,Med13l,1,3,2,1,A0A0J9YUA8|E9QLJ3|Q6JPI3,MOUSE,244748.6,0.6,3429,3429.1,12.27,5.44,,2207,Mediator of RNA polymerase II transcription subunit 13,mediator complex|,regulation of transcription from RNA polymerase II promoter|transcription from RNA polymerase II promoter|,RNA polymerase II transcription cofactor activity|,2,3,52300000,0.6%
P70289,0.57548373,-0.196833333,6.880567565,0.374333333,0.205089414,1.40528727,-0.131,-0.029,-0.992,0.232,-0.117,-0.144,P70289,NotFound,P70289_NotFound,P70289,Ptprv,1,2,2,2,P70289,MOUSE,188617.9,2.8,3435,3435.1,12.21,12.21,,1705,Receptor-type tyrosine-protein phosphatase V,intracellular|integral component of membrane|,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|negative regulation of cell proliferation|protein carboxylation|pancreas development|mitotic G1 DNA damage checkpoint|cellular response to insulin stimulus|peptidyl-tyrosine dephosphorylation|glucose homeostasis|cellular lipid catabolic process|type B pancreatic cell proliferation|negative regulation of insulin secretion|",protein tyrosine phosphatase activity|,2,2,117000000,2.8%
P19973,0.926554478,-0.023166667,1.053695527,0.120333333,0.784567741,0.284707841,-0.518,-0.637,0.905,0.103,-0.341,0.349,P19973,Lsp1,P19973_Lsp1,P19973,Lsp1,1,2,2,2,P19973|P19973-2|A2A6J7|A2A6J4|A0A1B0GRF5,MOUSE,36827.3,8.1,3436,3436.1,12.2,12.2,,330,Lymphocyte-specific protein 1,plasma membrane|membrane|extracellular exosome|,apoptotic process|chemotaxis|defense response|cytoskeleton organization|signal transduction|,actin binding|signal transducer activity|,2,2,8170000,8.1%
Q6PHN1,0.226782822,-0.069666667,14.92487236,1.703333333,0.032174571,2.703198655,-0.455,0.01,-2.319,1.133,0.031,1.182,Q6PHN1,Ccdc57,Q6PHN1_Ccdc57,Q6PHN1,Ccdc57,1,2,2,2,Q6PHN1,MOUSE,116762.4,2.7,3441,3441.1,12.15,12.15,,1016,Coiled-coil domain-containing protein 57,,,,2,2,790000000,2.7%
Q8VHE6,0.216645849,-0.076333333,15.31220088,-0.647333333,0.029429299,-2.76686516,0.095,0.373,0.274,-0.185,-0.942,-0.073,Q8VHE6,Dnah5,Q8VHE6_Dnah5,Q8VHE6,Dnah5,1,7,2,2,Q8VHE6,MOUSE,531485.4,0.4,3444,3444.1,12.13,12.13,,4621,"Dynein heavy chain 5, axonemal",axonemal dynein complex|microtubule|axoneme|outer dynein arm|,cilium movement|determination of left/right symmetry|metabolic process|lateral ventricle development|sperm motility|outer dynein arm assembly|cilium assembly|left/right axis specification|,microtubule motor activity|ATP binding|ATPase activity|,2,7,5830000000,0.4%
Q8CI61,0.190066441,-0.0275,16.30445859,0.424333333,0.023418234,2.931494651,-0.079,-0.42,-0.22,-0.031,0.186,0.399,Q8CI61,Bag4,Q8CI61_Bag4,Q8CI61,Bag4,1,3,2,2,Q8CI61,MOUSE,49322,6.1,3446,3446.1,12.11,12.11,,457,BAG family molecular chaperone regulator 4,nucleus|cytosol|plasma membrane|,"apoptotic process|positive regulation of fibroblast migration|positive regulation of actin filament polymerization|positive regulation of peptidyl-serine phosphorylation|regulation of apoptotic process|positive regulation of cell adhesion|positive regulation of stress fiber assembly|positive regulation of protein kinase B signaling|cellular response to tumor necrosis factor|cellular response to epidermal growth factor stimulus|protein localization to plasma membrane|ruffle assembly|negative regulation of protein targeting to mitochondrion|negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity|",protein binding|ubiquitin protein ligase binding|poly(A) RNA binding|chaperone binding|,2,3,26100000,6.1%
A8C756,0.783637817,-0.033333333,3.358949523,-0.113333333,0.461429172,-0.781699861,0.074,-0.064,0.06,0.189,-0.338,-0.121,A8C756,Thada,A8C756_Thada,A8C756,Thada,1,4,2,2,A8C756|A8C756-2|A8C756-3,MOUSE,220594.2,2.8,3451,3451.1,12.08,12.08,,1938,Thyroid adenoma-associated protein homolog,,,,2,4,405000000,2.8%
Q5SUE3,0.639352439,0.3885,5.579851646,-0.945,0.276703617,-1.18528934,-0.108,-0.092,2.783,0.426,-0.741,0.063,Q5SUE3,Ccdc92b,Q5SUE3_Ccdc92b,Q5SUE3,Ccdc92b,1,3,2,2,Q5SUE3|Q3UVD5|Q9CXR4,MOUSE,33595.1,2.3,3454,3454.1,12.03,12.03,,299,Coiled-coil domain-containing 92B,,,,2,3,93500000,2.3%
Q8VD04,0.399466839,-0.072833333,10.42557166,0.310333333,0.090665661,1.979056686,-0.054,-0.058,-0.572,0.044,0.04,0.163,Q8VD04,Gripap1,Q8VD04_Gripap1,Q8VD04,Gripap1,1,2,2,2,A2AEW8|Q8VD04|A2AEW9|A0A140LJ06,MOUSE,92998.7,3.2,3456,3456.1,11.99,11.99,,806,GRIP1-associated protein 1,early endosome|blood microparticle|,,protein binding|,2,2,4770000,3.2%
Q9ER72,0.954161889,-0.0775,0.677084969,0.043666667,0.855640835,0.189153178,0.186,0.176,-0.66,-0.075,-0.037,-0.055,Q9ER72,Cars,Q9ER72_Cars,Q9ER72,Cars,1,2,2,2,Q9ER72|Q9ER72-2,MOUSE,95485.7,3.9,3461,3461.1,11.93,11.93,,831,"Cysteine--tRNA ligase, cytoplasmic",cytoplasm|cytosol|,cysteinyl-tRNA aminoacylation|,tRNA binding|cysteine-tRNA ligase activity|ATP binding|protein homodimerization activity|metal ion binding|,2,2,1940000000,3.9%
Q07797,0.000890083,-0.094333333,45.23204289,0.912,2.99775E-05,9.931353064,-0.458,-0.66,-0.533,0.36,0.311,0.414,Q07797,Lgals3bp,Q07797_Lgals3bp,Q07797,Lgals3bp,1,2,2,2,Q07797,MOUSE,65402.8,3.4,3462,3462.1,11.92,11.92,,577,Galectin-3-binding protein,proteinaceous extracellular matrix|extracellular space|membrane|extracellular exosome|blood microparticle|extracellular matrix|,receptor-mediated endocytosis|cell adhesion|,scavenger receptor activity|protein binding|,2,2,72200000,3.4%
Q61093,0.594107584,0.2015,6.428180748,-0.505666667,0.227605066,-1.329698206,-0.056,0.014,1.405,-0.148,-0.062,0.056,Q61093,Cybb,Q61093_Cybb,Q61093,Cybb,1,2,2,2,Q61093,MOUSE,66216.2,3.6,3463,3463.1,11.9,11.9,,570,Cytochrome b-245 heavy chain,cytoplasm|mitochondrion|plasma membrane|integral component of plasma membrane|NADPH oxidase complex|,superoxide metabolic process|ion transport|inflammatory response|regulation of ion transmembrane transport|superoxide anion generation|innate immune response|respiratory burst|hydrogen peroxide biosynthetic process|oxidation-reduction process|,voltage-gated ion channel activity|protein binding|superoxide-generating NADPH oxidase activity|heme binding|metal ion binding|protein heterodimerization activity|flavin adenine dinucleotide binding|electron carrier activity|superoxide-generating NADPH oxidase activity|,2,2,394000000,3.6%
Q7TMM8,0.885307507,-0.020166667,1.826164568,-0.073666667,0.656724991,-0.46516667,0.154,0.072,-0.176,0.213,-0.083,-0.301,Q7TMM8,Parp16,Q7TMM8_Parp16,Q7TMM8,Parp16,1,2,2,2,Q7TMM8,MOUSE,37105.8,7.4,3466,3466.1,11.86,11.86,,322,Mono [ADP-ribose] polymerase PARP16,nuclear envelope|endoplasmic reticulum|endoplasmic reticulum membrane|membrane|integral component of membrane|endoplasmic reticulum tubular network|,protein ADP-ribosylation|activation of signaling protein activity involved in unfolded protein response|endoplasmic reticulum unfolded protein response|negative regulation of cell death|protein auto-ADP-ribosylation|positive regulation of protein serine/threonine kinase activity|,NAD+ ADP-ribosyltransferase activity|kinase binding|protein serine/threonine kinase activator activity|,2,2,237000000,7.4%
P70194,0.295178337,-0.0515,12.9356297,0.711666667,0.050867106,2.380448601,-0.433,-0.886,0.097,0.728,-0.104,0.289,P70194,Clec4f,P70194_Clec4f,P70194,Clec4f,1,3,2,2,P70194|A0A0R4IZZ5,MOUSE,61667,4.5,3471,3471.1,11.81,11.81,,548,C-type lectin domain family 4 member F,plasma membrane|integral component of membrane|,endocytosis|NK T cell activation|,galactose binding|glycolipid binding|,2,3,108000000,4.5%
A0A140LI28,0.89105666,0.072333333,1.754121278,0.065333333,0.667709987,0.44907404,0.114,0.193,-0.188,-0.114,0.23,0.199,A0A140LI28,NotFound,A0A140LI28_NotFound,A0A140LI28,Fam81b,1,2,2,2,A0A140LI28,MOUSE,49980.2,3.7,3473,3473.1,11.79,11.79,,432,"Family with sequence similarity 81, member B",,,,2,2,2260000000,3.7%
Q5SS00,0.92551138,-0.0335,1.093273425,-0.042333333,0.777450339,-0.294425259,0.115,0.124,-0.276,-0.126,0.116,-0.154,Q5SS00,Zdbf2,Q5SS00_Zdbf2,Q5SS00,Zdbf2,1,6,2,2,Q5SS00,MOUSE,278250.1,1.2,3476,3476.1,11.76,11.76,,2493,DBF4-type zinc finger-containing protein 2 homolog,,,,2,6,6360000000,1.2%
P52734,0.234223037,-0.0345,14.66182871,-0.259,0.034183547,-2.652499824,0.068,0.175,0.042,-0.296,-0.074,-0.122,P52734,Fgd1,P52734_Fgd1,P52734,Fgd1,1,2,2,2,P52734|A2ALP5,MOUSE,107618.1,3.4,3482,3482.1,11.67,11.67,,960,"FYVE, RhoGEF and PH domain-containing protein 1",ruffle|cytoplasm|Golgi apparatus|cytoskeleton|lamellipodium|,cytoskeleton organization|regulation of cell shape|actin cytoskeleton organization|regulation of Rho protein signal transduction|regulation of GTPase activity|positive regulation of GTPase activity|filopodium assembly|,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|protein binding|small GTPase binding|metal ion binding|,2,2,212000000,3.4%
H3BJZ7,0.88044681,-0.155833333,1.951878867,0.148333333,0.637987417,0.492932727,0.17,0.099,-0.959,0.041,-0.043,-0.243,H3BJZ7,Unc13a,H3BJZ7_Unc13a,H3BJZ7,Unc13a,1,2,2,2,H3BJZ7|Q4KUS2,MOUSE,197878,1.7,3483,3483.1,11.67,11.67,,1731,Protein unc-13 homolog A,intracellular|axon|neuromuscular junction|synapse|,"positive regulation of neurotransmitter secretion|neuromuscular junction development|synaptic vesicle docking|synaptic vesicle maturation|synaptic transmission, glutamatergic|intracellular signal transduction|regulation of short-term neuronal synaptic plasticity|beta-amyloid metabolic process|innervation|positive regulation of dendrite extension|",protein binding|diacylglycerol binding|metal ion binding|,2,2,2090000000,1.7%
Q9JLC3,0.639352439,-0.010666667,5.568359186,-0.311333333,0.277436809,-1.183305146,-0.296,0.121,0.61,-0.532,-0.08,0.113,Q9JLC3,Msrb1,Q9JLC3_Msrb1,Q9JLC3,Msrb1,1,2,2,2,Q9JLC3,MOUSE,13116.7,9.4,3485,3485.1,11.65,11.65,,116,Methionine-R-sulfoxide reductase B1,nucleus|cytoplasm|actin cytoskeleton|,response to oxidative stress|actin filament polymerization|protein repair|innate immune response|oxidation-reduction process|,actin binding|zinc ion binding|peptide-methionine (R)-S-oxide reductase activity|methionine-R-sulfoxide reductase activity|,2,2,113000000,9.4%
Q91WR3-3,0.013624043,-0.153666667,30.60976526,0.865333333,0.000869007,5.731023192,-0.487,-0.363,-0.909,0.238,0.26,0.339,Q91WR3,Ascc2,Q91WR3-3_Ascc2,Q91WR3-3,Ascc2,1,2,2,2,Q91WR3-3|Q91WR3|Q91WR3-2,MOUSE,88681.3,5,3486,3486.1,11.64,11.64,,749,Isoform 3 of Activating signal cointegrator 1 complex subunit 2,,"transcription, DNA-templated|regulation of transcription, DNA-templated|",,2,2,523000000,5.0%
O70451,0.811763387,-0.021333333,2.922667203,-0.186,0.510191572,-0.695874406,0.076,0.401,-0.262,-0.498,0.403,-0.248,O70451,Slc16a7,O70451_Slc16a7,O70451,Slc16a7,1,2,2,2,O70451,MOUSE,53230.3,4.7,3489,3489.1,11.62,11.62,,484,Monocarboxylate transporter 2,cytoplasm|integral component of plasma membrane|,lactate transmembrane transport|plasma membrane lactate transport|pyruvate transmembrane transport|,lactate transmembrane transporter activity|symporter activity|pyruvate transmembrane transporter activity|,2,2,13600000,4.7%
E9PZQ0,0.858120828,0.101333333,2.233740523,-0.142666667,0.597896413,-0.553828014,-0.186,-0.05,0.754,-0.028,-0.142,0.26,E9PZQ0,Ryr1,E9PZQ0_Ryr1,E9PZQ0,Ryr1,1,2,2,2,A0A1L1SQG7|E9PZQ0|K3W4M2,MOUSE,570734.5,0.8,3494,3494.1,11.59,11.59,,5035,Ryanodine receptor 1,cytoplasm|smooth endoplasmic reticulum|plasma membrane|cell cortex|membrane|integral component of membrane|sarcoplasmic reticulum|junctional membrane complex|T-tubule|I band|sarcoplasmic reticulum membrane|protein complex|extracellular exosome|,response to hypoxia|outflow tract morphogenesis|calcium ion transport|muscle contraction|regulation of muscle contraction|release of sequestered calcium ion into cytosol by sarcoplasmic reticulum|skin development|ossification involved in bone maturation|skeletal muscle fiber development|release of sequestered calcium ion into cytosol|calcium ion transmembrane transport|cellular response to caffeine|,protease binding|ryanodine-sensitive calcium-release channel activity|voltage-gated calcium channel activity|calcium channel activity|protein binding|calmodulin binding|enzyme binding|,2,2,46700000,0.8%
Q9JJ61,0.416525979,-0.0905,10.04308989,-0.235,0.099012725,-1.917977468,-0.003,0.015,0.069,-0.374,-0.28,0.03,Q9JJ61,Galnt16,Q9JJ61_Galnt16,Q9JJ61,Galnt16,1,2,2,2,Q9JJ61,MOUSE,63615.5,5.5,3500,3500.1,11.53,11.53,,558,Polypeptide N-acetylgalactosaminyltransferase 16,Golgi membrane|integral component of membrane|extracellular exosome|,protein glycosylation|,polypeptide N-acetylgalactosaminyltransferase activity|carbohydrate binding|metal ion binding|,2,2,2410000000,5.5%
A2APT9,0.414743654,0.011833333,10.08723981,0.325666667,0.09801127,1.925031275,-0.35,-0.147,0.044,0.181,-0.102,0.445,A2APT9,Klhdc7a,A2APT9_Klhdc7a,A2APT9,Klhdc7a,1,2,2,2,A2APT9,MOUSE,84958.2,2.9,3503,3503.1,11.51,11.51,,773,Kelch domain-containing protein 7A,integral component of membrane|,,,2,2,125000000,2.9%
Q45VK7-2,0.372579595,-0.146333333,10.97503398,0.464,0.079890769,2.066736593,-0.07,-0.18,-0.885,0.085,0.248,-0.076,Q45VK7,Dync2h1,Q45VK7-2_Dync2h1,Q45VK7-2,Dync2h1,1,3,2,2,Q45VK7-2|Q45VK7,MOUSE,496551.4,0.5,3505,3505.1,11.5,11.5,,4306,Isoform 2 of Cytoplasmic dynein 2 heavy chain 1,Golgi apparatus|cytoplasmic dynein complex|microtubule|plasma membrane|axoneme|motile primary cilium|apical part of cell|extracellular exosome|,Golgi organization|determination of left/right symmetry|asymmetric protein localization|dorsal/ventral pattern formation|protein processing|spinal cord motor neuron differentiation|neuron differentiation|embryonic limb morphogenesis|forebrain development|intraciliary retrograde transport|cilium assembly|positive regulation of smoothened signaling pathway|cilium morphogenesis|,microtubule motor activity|ATP binding|ATPase activity|,2,3,871000000,0.5%
Q6RT24,0.923983669,0.004833333,1.128105631,-0.034333333,0.771239806,-0.302859678,0,0.197,-0.131,-0.082,0.089,-0.044,Q6RT24,Cenpe,Q6RT24_Cenpe,Q6RT24,Cenpe,1,2,2,2,Q6RT24|E9QKK1,MOUSE,288003.4,1,3508,3508.1,11.49,11.49,,2474,Centromere-associated protein E,"chromosome, centromeric region|kinetochore|condensed nuclear chromosome kinetochore|condensed chromosome, centromeric region|condensed chromosome outer kinetochore|nucleus|chromosome|cytoplasm|kinesin complex|microtubule|microtubule cytoskeleton|membrane|midbody|mitotic spindle midzone|",mitotic cell cycle|microtubule-based movement|chromosome segregation|mitotic metaphase plate congression|regulation of mitotic nuclear division|mitotic spindle assembly checkpoint|multicellular organismal development|metabolic process|attachment of spindle microtubules to kinetochore|regulation of mitotic metaphase/anaphase transition|establishment of protein localization|positive regulation of mitotic metaphase/anaphase transition|positive regulation of protein kinase activity|regulation of developmental process|cell division|attachment of mitotic spindle microtubules to kinetochore|positive regulation of chromosome segregation|positive regulation of attachment of spindle microtubules to kinetochore|,microtubule motor activity|ATP binding|microtubule binding|ATPase activity|protein kinase binding|kinetochore binding|,2,2,6860000000,1.0%
Q3U2A8,0.873023806,0.047333333,2.078433633,-0.066,0.619664529,-0.520498441,0.017,0.302,-0.078,0.139,-0.073,-0.023,Q3U2A8,Vars2,Q3U2A8_Vars2,Q3U2A8,Vars2,1,2,2,2,Q3U2A8,MOUSE,119714,2.3,3510,3510.1,11.47,11.47,,1060,"Valine--tRNA ligase, mitochondrial",mitochondrion|cytosol|,valyl-tRNA aminoacylation|regulation of translational fidelity|,aminoacyl-tRNA editing activity|valine-tRNA ligase activity|ATP binding|,2,2,80500000,2.3%
Q8BTQ0,0.454052388,-0.024333333,9.272168726,0.283333333,0.118245093,1.794573388,0.011,-0.023,-0.486,0.057,0.272,0.023,Q8BTQ0,Pcgf3,Q8BTQ0_Pcgf3,Q8BTQ0,PcgF3,1,4,2,2,Q8BTQ0|Q8BTQ0-2,MOUSE,28730.6,5.3,3513,3513.1,11.44,11.44,,241,Polycomb group RING finger protein 3,nucleus|nucleoplasm|PcG protein complex|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",zinc ion binding|,2,4,117000000,5.3%
Q8BH69,0.648073376,-0.041166667,5.347882573,-0.120333333,0.291884977,-1.144109676,0.005,-0.005,0.057,0.082,-0.193,-0.193,Q8BH69,Sephs1,Q8BH69_Sephs1,Q8BH69,Sephs1,1,3,2,2,Q8BH69,MOUSE,43419.3,8.9,3514,3514.1,11.4,11.4,,392,"Selenide, water dikinase 1",cytoplasm|plasma membrane|nuclear membrane|,phosphorylation|,"selenide, water dikinase activity|ATP binding|identical protein binding|protein homodimerization activity|protein heterodimerization activity|",2,3,485000000,8.9%
E9Q2C0,0.997585215,-0.022666667,0.027961232,-0.001333333,0.99358237,-0.008351832,0.157,0.134,-0.357,-0.056,0.107,-0.121,E9Q2C0,Cfap46,E9Q2C0_Cfap46,E9Q2C0,Cfap46,1,2,2,2,E9Q2C0|G3UVW5,MOUSE,305544.7,1.2,3515,3515.1,11.39,11.39,,2641,Cilia and flagella-associated protein 46,,,,2,2,773000000,1.2%
Q99LI7,0.247546341,-0.033833333,14.25765551,0.291666667,0.037517548,2.590662631,-0.09,-0.09,-0.359,0.107,0.216,0.013,Q99LI7,Cstf3,Q99LI7_Cstf3,Q99LI7,Cstf3,1,2,2,2,Q99LI7,MOUSE,83331.4,4,3516,3516.1,11.39,11.39,,717,Cleavage stimulation factor subunit 3,nucleus|nucleoplasm|,mRNA cleavage|mRNA processing|RNA 3'-end processing|,mRNA binding|poly(A) RNA binding|,2,2,38200000,4.0%
Q8BZ05,0.092143087,-0.186166667,20.48276965,1.025666667,0.008947939,3.655788512,-0.298,-0.428,-1.371,0.259,0.487,0.234,Q8BZ05,NotFound,Q8BZ05_NotFound,Q8BZ05,Arap2,1,2,2,2,Q8BZ05|E9QP44,MOUSE,195620.1,1.8,3521,3521.1,11.33,11.33,,1703,"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2",cytoplasm|,signal transduction|positive regulation of GTPase activity|,"GTPase activator activity|phosphatidylinositol-3,4,5-trisphosphate binding|metal ion binding|",2,2,291000000,1.8%
Q0VBD2,0.137118141,-0.045833333,18.14837834,-0.992333333,0.015316593,-3.24427218,0.052,0.472,0.827,-0.459,-1.113,-0.054,Q0VBD2,Mcm10,Q0VBD2_Mcm10,Q0VBD2,Mcm10,1,5,2,2,Q0VBD2,MOUSE,99545.3,3.1,3522,3522.1,11.32,11.32,,885,Protein MCM10 homolog,nucleus|nucleolus|cytoplasm|replication fork protection complex|,DNA replication initiation|cell proliferation|,DNA replication origin binding|double-stranded DNA binding|single-stranded DNA binding|identical protein binding|metal ion binding|,2,5,2050000000,3.1%
Q99JH8,0.530752353,0.038666667,7.579962823,-0.333333333,0.17458371,-1.52063808,-0.235,0.216,0.635,-0.282,-0.106,0.004,Q99JH8,Kdelr1,Q99JH8_Kdelr1,Q99JH8,Kdelr1,1,3,2,2,Q99JH8|Q9CQM2|A0A1B0GQW0|Q8R1L4|A0A1B0GT97,MOUSE,24787.8,6.6,3523,3523.1,11.32,11.32,,212,ER lumen protein-retaining receptor 1,endoplasmic reticulum|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|cis-Golgi network|integral component of membrane|COPI-coated vesicle membrane|endoplasmic reticulum-Golgi intermediate compartment membrane|,protein retention in ER lumen|protein transport|vesicle-mediated transport|,ER retention sequence binding|,2,3,209000000,6.6%
J3KMG9,0.786555092,-0.033166667,3.311871785,0.149,0.466458296,0.772572285,0.004,0.211,-0.538,-0.035,0.032,0.127,J3KMG9,NotFound,J3KMG9_NotFound,J3KMG9,Taf1a,1,2,2,2,J3KMG9|P97357,MOUSE,53209.1,7.5,3526,3526.1,11.3,11.3,,453,TATA box-binding protein-associated factor RNA polymerase I subunit A,RNA polymerase I transcription factor complex|nucleus|nucleoplasm|microtubule cytoskeleton|intracellular membrane-bounded organelle|,transcription from RNA polymerase I promoter|,protein binding|,2,2,16500000,7.5%
Q0ZLH2,0.091860884,-0.095333333,20.50866106,-1.104666667,0.008894753,-3.660463449,0.198,0.555,0.618,-0.23,-1.348,-0.365,Q0ZLH2,Pjvk,Q0ZLH2_Pjvk,Q0ZLH2,Pjvk,1,3,2,2,Q0ZLH2,MOUSE,40427.9,5.6,3529,3529.1,11.25,11.25,,352,Pejvakin,neuronal cell body|,sensory perception of sound|,,2,3,428000000,5.6%
Q91WC0,0.408707826,-0.198333333,10.19120882,0.620666667,0.095692768,1.941638378,-0.141,-0.082,-1.303,0.108,0.183,0.045,Q91WC0,Setd3,Q91WC0_Setd3,Q91WC0,Setd3,1,2,2,2,Q91WC0|F2Z420|D6RCY6,MOUSE,67574.4,7.4,3530,3530.1,11.24,11.24,,594,Histone-lysine N-methyltransferase setd3,nuclear chromatin|,"transcription, DNA-templated|histone H3-K36 methylation|peptidyl-lysine trimethylation|peptidyl-lysine monomethylation|peptidyl-lysine dimethylation|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of muscle cell differentiation|histone H3-K4 methylation|",RNA polymerase II activating transcription factor binding|transcription coactivator activity|histone methyltransferase activity (H3-K4 specific)|histone methyltransferase activity (H3-K36 specific)|,2,2,722000000,7.4%
F8VQH0,0.892090805,-0.079,1.723683714,0.103333333,0.672406075,0.442234133,0.054,0.21,-0.656,-0.134,0.171,-0.119,F8VQH0,Abl2,F8VQH0_Abl2,F8VQH0,Abl2,1,2,2,2,F8VQH0|Q4JIM5|B2RQ57,MOUSE,129185.2,3,3532,3532.1,11.22,11.22,,1182,Tyrosine-protein kinase,phagocytic cup|cytosol|actin cytoskeleton|cytoplasmic membrane-bounded vesicle|lamellipodium|extrinsic component of cytoplasmic side of plasma membrane|dendritic spine|,"phagocytosis|substrate-dependent cell migration, cell extension|actin filament organization|epidermal growth factor receptor signaling pathway|positive regulation of cytosolic calcium ion concentration|learning|visual learning|positive regulation of phospholipase C activity|positive regulation of neuron projection development|neuron remodeling|cell migration|peptidyl-tyrosine phosphorylation|cerebellum morphogenesis|negative regulation of cell-cell adhesion|positive regulation of protein binding|cellular protein localization|negative regulation of Rho protein signal transduction|exploration behavior|peptidyl-tyrosine autophosphorylation|regulation of cell proliferation|positive regulation of I-kappaB kinase/NF-kappaB signaling|innate immune response|alpha-beta T cell differentiation|platelet-derived growth factor receptor signaling pathway|dendrite morphogenesis|neuromuscular process controlling balance|actin filament bundle assembly|positive regulation of oxidoreductase activity|Bergmann glial cell differentiation|positive regulation of ERK1 and ERK2 cascade|cellular response to retinoic acid|dendritic spine maintenance|positive regulation of interleukin-2 secretion|positive regulation of interferon-gamma secretion|regulation of extracellular matrix organization|positive regulation of Wnt signaling pathway, planar cell polarity pathway|negative regulation of endothelial cell apoptotic process|",magnesium ion binding|protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|receptor binding|protein binding|ATP binding|manganese ion binding|,2,2,2760000000,3.0%
F7AFE4,0.024805415,-0.026333333,27.35665398,-1.295333333,0.001837954,-5.003187649,0.516,1.034,0.314,-1.145,-0.445,-0.432,F7AFE4,NotFound,F7AFE4_NotFound,F7AFE4,Zfp433,1,4,2,1,A0A1W2P6H7|A0A0J9YUD4|F7AFE4|Q3TPQ7|A2BG91|A2AU83|D3Z5L4|A2AE19|Q6NZI9|A2AE18|Q6P560|A0A0U1RQ46|A2ARW8|L7N208|A2ARX0|A0A1B0GT13|A2ARL5|A0A1B0GRI2|A2BFG5|A2ART0|Q9JIC0|A0A1B0GRI9|L7N248|A2ARR7|A2AR|A2AW67|F6ZS36|A2ART4|A0A087WRL6|F7CEW8|A2BE23|Q6PEE4|Q99LG7|F6R9A8|A2ANU6|K7N769|P08043|F8VPV1|A0A087WRH0|J3QK55|L7N1Z0|A0A087WRJ1|Q7TPX5|J3QPX0|Q4KL68|A2BFU4|Q3UT17|A2ARW1|G3UY53|A2ARV7|A2AHM2|E9QA51|A2ARW5|F7AIG4|O88245,MOUSE,72150.3,3.5,3533,3533.1,11.22,7.09,,599,Zinc finger protein 433,intracellular|,"regulation of transcription, DNA-templated|",nucleic acid binding|sequence-specific DNA binding transcription factor activity|metal ion binding|,2,4,29000000,3.5%
Q99J83,0.857449938,0.036666667,2.2553784,0.074666667,0.594924919,0.558429833,-0.096,-0.112,0.206,-0.086,0.059,0.249,Q99J83,Atg5,Q99J83_Atg5,Q99J83,Atg5,1,2,2,2,Q99J83,MOUSE,32629.8,6.9,3534,3534.1,11.19,11.19,,275,Autophagy protein 5,cytoplasm|autophagosome|cytosol|axoneme|membrane|pre-autophagosomal structure membrane|Atg12-Atg5-Atg16 complex|ER-mitochondrion membrane contact site|,autophagosome assembly|mitochondrion degradation|blood vessel remodeling|regulation of cytokine secretion involved in immune response|C-terminal protein lipidation|autophagy|apoptotic process|cellular response to nitrogen starvation|response to fungus|negative regulation of protein ubiquitination|negative stranded viral RNA replication|vasodilation|response to drug|negative regulation of apoptotic process|post-translational protein modification|nucleophagy|innate immune response|otolith development|regulation of release of sequestered calcium ion into cytosol|ventricular cardiac muscle cell development|heart contraction|positive regulation of mucus secretion|regulation of cilium assembly|positive regulation of mitochondrion degradation|regulation of reactive oxygen species metabolic process|negative regulation of reactive oxygen species metabolic process|negative regulation of histone H4-K16 acetylation|,protein binding|Atg8 ligase activity|,2,2,88400000,6.9%
Q8BUM9-2,0.917674517,-0.016166667,1.279951575,0.033666667,0.744740278,0.339348264,-0.021,0.052,-0.13,-0.107,0.11,-0.001,Q8BUM9,Usp43,Q8BUM9-2_Usp43,Q8BUM9-2,Usp43,1,2,2,2,Q8BUM9-2|Q8BUM9|A6PWR8,MOUSE,125611.6,1.4,3535,3535.1,11.19,11.19,,1132,Isoform 2 of Ubiquitin carboxyl-terminal hydrolase 43,,protein deubiquitination|proteasome-mediated ubiquitin-dependent protein catabolic process|regulation of proteasomal protein catabolic process|,cysteine-type endopeptidase activity|ubiquitin-specific protease activity|,2,2,53500000,1.4%
Q03172,0.457736715,-0.023,9.203512826,-0.263333333,0.120129237,-1.783555157,0.224,-0.05,0.152,-0.363,0.114,-0.215,Q03172,NotFound,Q03172_NotFound,Q03172,Hivep1,1,2,2,2,Q03172|F8VPM9,MOUSE,291248.2,1.1,3537,3537.1,11.18,11.18,,2688,Zinc finger protein 40,nucleus|nucleoplasm|mitochondrion|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|negative regulation of transcription, DNA-templated|",nucleic acid binding|DNA binding|protein binding|metal ion binding|HMG box domain binding|,2,2,822000000,1.1%
P97868,0.128295278,0.080833333,18.48108927,-0.343,0.014187016,-3.291101552,0.09,0.346,0.321,-0.129,-0.006,-0.137,P97868,Rbbp6,P97868_Rbbp6,P97868,Rbbp6,1,3,2,2,P97868|P97868-2,MOUSE,200610.8,1.4,3539,3539.1,11.17,11.17,,1790,E3 ubiquitin-protein ligase RBBP6,nucleoplasm|chromosome|nucleolus|cytoplasm|microtubule organizing center|,in utero embryonic development|multicellular organism growth|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|embryonic organ development|somite development|,ubiquitin-protein transferase activity|zinc ion binding|ligase activity|poly(A) RNA binding|,2,3,108000000,1.4%
Q0VG85-6,0.34703809,0.046166667,11.52177514,-0.265666667,0.070440509,-2.154003196,0.34,0.239,-0.042,-0.006,-0.182,-0.072,Q0VG85,Ccdc162,Q0VG85-6_Ccdc162,Q0VG85-6,Ccdc162p,1,4,2,2,Q0VG85-6,MOUSE,251486.3,1.7,3541,3541.1,11.14,11.14,,912,Isoform 4 of Coiled-coil domain-containing protein 162,,,,2,4,715000000,1.7%
Q6VVW5,0.951510623,-0.042333333,0.720690026,-0.038666667,0.847092814,-0.200522403,0.189,0.209,-0.467,-0.091,0.04,-0.134,Q6VVW5,Npr2,Q6VVW5_Npr2,Q6VVW5,Npr2,1,2,2,2,Q6VVW5|Q6VVW5-2,MOUSE,117913.8,1.8,3542,3542.1,11.14,11.14,,1047,Atrial natriuretic peptide receptor 2,intracellular|plasma membrane|integral component of membrane|,ossification|cGMP biosynthetic process|protein phosphorylation|receptor guanylyl cyclase signaling pathway|intracellular signal transduction|single organism reproductive process|negative regulation of meiotic cell cycle|bone development|cellular response to granulocyte macrophage colony-stimulating factor stimulus|negative regulation of oocyte maturation|,guanylate cyclase activity|protein kinase activity|ATP binding|GTP binding|natriuretic peptide receptor activity|peptide hormone binding|hormone binding|identical protein binding|,2,2,362000000,1.8%
Q8R3G1,0.386623778,0.041666667,10.70690997,-0.262666667,0.084978489,-2.023954861,-0.063,0.186,0.396,-0.035,-0.105,-0.129,Q8R3G1,Ppp1r8,Q8R3G1_Ppp1r8,Q8R3G1,Ppp1r8,1,2,2,2,Q8R3G1|A2ADR8,MOUSE,38698.3,10.8,3543,3543.1,11.12,11.12,,351,Nuclear inhibitor of protein phosphatase 1,nucleoplasm|spliceosomal complex|nuclear speck|,"transcription, DNA-templated|regulation of transcription, DNA-templated|mRNA processing|multicellular organismal development|cell proliferation|RNA splicing|negative regulation of catalytic activity|regulation of catalytic activity|",DNA binding|RNA binding|protein phosphatase inhibitor activity|protein phosphatase type 1 regulator activity|,2,2,34800000,10.8%
Q9JM62,0.459110142,-0.036666667,9.172333435,0.201333333,0.120994786,1.777073077,-0.267,-0.216,0.071,0.029,0.115,0.048,Q9JM62,Reep6,Q9JM62_Reep6,Q9JM62,Reep6,1,3,2,2,Q9JM62|Q9JM62-2|D3Z6V2,MOUSE,22374.6,11.4,3546,3546.1,11.11,11.11,,201,Receptor expression-enhancing protein 6,nucleus|endoplasmic reticulum membrane|integral component of membrane|rod spherule|apical part of cell|plasma membrane|,regulation of intracellular transport|,protein binding|,2,3,349000000,11.4%
Q8VCZ3,0.32502652,0.032333333,12.12360987,-0.254,0.061325206,-2.247654467,0.143,0.032,0.303,-0.208,-0.12,0.044,Q8VCZ3,Thap7,Q8VCZ3_Thap7,Q8VCZ3,Thap7,1,2,2,2,Q8VCZ3,MOUSE,35220.3,5.5,3550,3550.1,11.1,11.1,,309,THAP domain-containing protein 7,chromosome|nuclear speck|,"transcription, DNA-templated|negative regulation of transcription, DNA-templated|",DNA binding|metal ion binding|protein N-terminus binding|C2H2 zinc finger domain binding|,2,2,2290000000,5.5%
Q80TJ1-2,0.907855509,0.031,1.483505749,-0.094666667,0.710639634,-0.387362383,0.01,0.616,-0.391,-0.107,0.099,-0.041,Q80TJ1,Cadps,Q80TJ1-2_Cadps,Q80TJ1-2,Cadps,1,3,2,2,Q80TJ1-2|J3QJW3|K4DI76|Q80TJ1|Q80TJ1-4|A0A286YDH6,MOUSE,155142.6,2.1,3555,3555.1,11.08,11.08,,1355,Isoform 2 of Calcium-dependent secretion activator 1,cell junction|cytoplasmic vesicle membrane|cytoplasmic vesicle|synapse|,protein transport|vesicle organization|synaptic vesicle priming|catecholamine secretion|,protein binding|lipid binding|protein kinase binding|metal ion binding|,2,3,921000000,2.1%
Q8BKI2,0.387241291,0.023333333,10.67636987,0.417333333,0.085578173,2.019081679,-0.099,-0.228,-0.229,0.54,0.405,-0.249,Q8BKI2,Tnrc6b,Q8BKI2_Tnrc6b,Q8BKI2,Tnrc6b,1,2,2,2,Q8BKI2|Q8BKI2-2,MOUSE,192758.2,1.9,3558,3558.1,11.08,11.08,,1810,Trinucleotide repeat-containing gene 6B protein,cytoplasmic mRNA processing body|,"regulation of translation|gene silencing by RNA|positive regulation of nuclear-transcribed mRNA poly(A) tail shortening|positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|",nucleotide binding|poly(A) RNA binding|,2,2,414000000,1.9%
O55095,0.919416995,-0.034333333,1.255035595,0.064,0.74902522,0.33356267,-0.077,-0.199,0.077,-0.391,0.044,0.34,O55095,NotFound,O55095_NotFound,O55095,Flt1,1,3,2,2,O55095,MOUSE,78547.5,2.7,3560,3560.1,11.07,11.07,,688,SFlt-1,integral component of plasma membrane|focal adhesion|receptor complex|,angiogenesis|patterning of blood vessels|response to hypoxia|sprouting angiogenesis|monocyte chemotaxis|positive regulation of phospholipase C activity|positive regulation of phosphatidylinositol 3-kinase signaling|cell migration|peptidyl-tyrosine phosphorylation|positive regulation of cell migration|positive regulation of vascular endothelial growth factor receptor signaling pathway|cellular response to vascular endothelial growth factor stimulus|vascular endothelial growth factor receptor-1 signaling pathway|vascular endothelial growth factor signaling pathway|positive regulation of MAP kinase activity|positive regulation of MAPK cascade|positive regulation of phosphatidylinositol 3-kinase activity|positive regulation of angiogenesis|protein autophosphorylation|vascular endothelial growth factor receptor signaling pathway|positive regulation of hematopoietic progenitor cell differentiation|,vascular endothelial growth factor-activated receptor activity|ATP binding|growth factor binding|VEGF-A-activated receptor activity|VEGF-B-activated receptor activity|placental growth factor-activated receptor activity|identical protein binding|,2,3,249000000,2.7%
E9QPR5,0.000890083,-0.153833333,45.26774865,1.329,2.97321E-05,10.06528868,-0.649,-0.844,-0.962,0.691,0.327,0.514,E9QPR5,Ppp4r1,E9QPR5_Ppp4r1,E9QPR5,Ppp4r1,1,2,2,2,E9QPR5|Q8K2V1|E9PX53|Q8K2V1-2|E0CXK8,MOUSE,107977.8,2.7,3562,3562.1,11.06,11.06,,951,Serine/threonine-protein phosphatase 4 regulatory subunit 1,protein phosphatase 4 complex|,signal transduction|regulation of catalytic activity|,protein phosphatase type 4 regulator activity|,2,2,473000000,2.7%
D3Z6F0,0.570662736,0.209,6.964466687,-0.642,0.201165421,-1.419214814,0.035,-0.08,1.635,0.042,-0.414,0.036,D3Z6F0,Ifit1bl1,D3Z6F0_Ifit1bl1,D3Z6F0,Ifit1bl1,1,2,2,2,D3Z6F0|E9PXF7|Q3U687,MOUSE,55193.6,3.8,3566,3566.1,11.01,11.01,,470,Interferon-induced protein with tetratricpeptide repeats 1B-like 1,cytoplasm|host cell|,,RNA binding|,2,2,120000000,3.8%
D3YZ21,0.235913282,0.027,14.61392927,-0.474,0.034562653,-2.652307027,0.303,0.473,0.016,-0.089,-0.527,-0.014,D3YZ21,D430041D05Rik,D3YZ21_D430041D05Rik,D3YZ21,D430041D05Rik,1,4,2,2,D3YZ21,MOUSE,153776.1,0.9,3570,3570.1,10.98,10.98,,1414,RIKEN cDNA D430041D05 gene,,activation of mitophagy in response to mitochondrial depolarization|,,2,4,20900000000,0.9%
Q8VCX5-2,0.496176429,0.009,8.284224886,-0.159333333,0.14844908,-1.632879588,0.109,0.175,-0.018,-0.1,-0.147,0.035,Q8VCX5,Micu1,Q8VCX5-2_Micu1,Q8VCX5-2,Micu1,1,2,2,2,Q8VCX5-2|Q8VCX5-3|Q8VCX5,MOUSE,55515.3,8.4,3575,3575.1,10.92,10.92,,477,"Isoform 2 of Calcium uptake protein 1, mitochondrial",mitochondrion|mitochondrial inner membrane|mitochondrial intermembrane space|integral component of mitochondrial membrane|calcium channel complex|uniplex complex|,mitochondrial calcium ion transport|calcium ion transmembrane import into mitochondrion|protein homooligomerization|mitochondrial calcium ion homeostasis|positive regulation of mitochondrial calcium ion concentration|calcium ion import|,calcium ion binding|protein binding|identical protein binding|protein heterodimerization activity|,2,2,270000000,8.4%
Q9WTK2,0.744748173,-0.017833333,3.897914858,-0.110333333,0.407575917,-0.884156692,0.13,0.051,-0.069,0.121,-0.067,-0.273,Q9WTK2,Cdyl,Q9WTK2_Cdyl,Q9WTK2,Cdyl,1,3,2,2,Q9WTK2|Q9WTK2-2,MOUSE,65837.5,3.8,3578,3578.1,10.9,10.9,,593,Chromodomain Y-like protein,nucleus|nucleoplasm|,"transcription, DNA-templated|regulation of transcription, DNA-templated|histone acetylation|negative regulation of nucleic acid-templated transcription|",transcription corepressor activity|histone acetyltransferase activity|methylated histone binding|methylated histone binding|,2,3,166000000,3.8%
Q8CHI8,0.926033297,-0.080666667,1.082028366,0.076666667,0.779465977,0.291670137,0.141,0.247,-0.745,0.11,-0.14,-0.097,Q8CHI8,Ep400,Q8CHI8_Ep400,Q8CHI8,Ep400,1,2,2,2,Q8CHI8|Q8CHI8-4|Q8CHI8-2|Q8CHI8-3|Q8CHI8-5,MOUSE,338599.9,0.9,3580,3580.1,10.87,10.87,,3072,E1A-binding protein p400,Swr1 complex|nuclear speck|NuA4 histone acetyltransferase complex|,histone H4 acetylation|histone H2A acetylation|,DNA binding|helicase activity|protein binding|ATP binding|,2,2,957000000,0.9%
Q9WV76,0.873144039,-0.1185,2.061965209,-0.137666667,0.622018754,-0.516932518,-0.569,0.202,0.218,0.152,-0.544,-0.17,Q9WV76,Ap4b1,Q9WV76_Ap4b1,Q9WV76,Ap4b1,1,2,2,2,Q9WV76|B0V3P4|B0V3P3|A0A0G2JFY6,MOUSE,84172.7,2.4,3582,3582.1,10.86,10.86,,738,AP-4 complex subunit beta-1,trans-Golgi network|coated pit|clathrin adaptor complex|,intracellular protein transport|vesicle-mediated transport|,protein transporter activity|,2,2,3840000,2.4%
Q9CW79,0.204708202,0.036,15.76370055,-0.439333333,0.026523446,-2.84148992,0.03,0.268,0.469,-0.115,-0.414,-0.022,Q9CW79,Golga1,Q9CW79_Golga1,Q9CW79,Golga1,1,2,2,2,Q9CW79|Q9CW79-2,MOUSE,87792.6,2.1,3583,3583.1,10.86,10.86,,758,Golgin subfamily A member 1,Golgi apparatus|trans-Golgi network|Golgi cisterna membrane|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|,protein targeting to Golgi|,protein binding|,2,2,74500000,2.1%
Q6WKZ8-2,0.884484678,0.064666667,1.877914823,-0.043333333,0.648945937,-0.476389791,0.127,0.012,0.12,0.145,0.01,-0.026,Q6WKZ8,Ubr2,Q6WKZ8-2_Ubr2,Q6WKZ8-2,Ubr2,1,2,2,2,Q6WKZ8-2|Q6WKZ8|Q6WKZ8-3,MOUSE,202618.2,1,3589,3589.1,10.8,10.8,,1755,Isoform 2 of E3 ubiquitin-protein ligase UBR2,ubiquitin ligase complex|nucleoplasm|cytoplasm|plasma membrane|chromatin|,chromatin silencing|ubiquitin-dependent protein catabolic process|male meiosis I|spermatogenesis|negative regulation of TOR signaling|histone H2A ubiquitination|cellular response to leucine|ubiquitin-dependent protein catabolic process via the N-end rule pathway|,protein binding|zinc ion binding|ligase activity|ubiquitin protein ligase activity|leucine binding|,2,2,41200000,1.0%
Q8R322,0.447659397,-0.004166667,9.456615799,1.316333333,0.113328312,1.824147751,-0.103,0.142,-2.026,1.845,-0.23,0.347,Q8R322,Gle1,Q8R322_Gle1,Q8R322,Gle1,1,2,2,2,Q8R322,MOUSE,80029.4,3.5,3591,3591.1,10.78,10.78,,699,Nucleoporin GLE1,extracellular space|nuclear pore|cytoplasm|plasma membrane|membrane|,protein transport|poly(A)+ mRNA export from nucleus|,identical protein binding|,2,2,264000000,3.5%
Q6PFX7,0.663391411,-0.0655,5.118555259,-0.223,0.307712029,-1.104964116,-0.3,0.023,0.415,-0.367,-0.218,0.054,Q6PFX7,Nyap1,Q6PFX7_Nyap1,Q6PFX7,Nyap1,1,2,2,2,Q6PFX7|Q6PFX7-2|Q6PFX7-3,MOUSE,88693.9,2.2,3594,3594.1,10.73,10.73,,833,Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 1,intracellular|,phosphatidylinositol 3-kinase signaling|neuron projection morphogenesis|,protein binding|,2,2,217000000,2.2%
Q9D8S3,0.857830933,-0.037333333,2.242763203,0.061333333,0.596655543,0.555513623,-0.225,-0.008,0.029,0.008,-0.128,0.1,Q9D8S3,Arfgap3,Q9D8S3_Arfgap3,Q9D8S3,Arfgap3,1,2,2,2,A0A0R4J0T8|Q9D8S3,MOUSE,57911.2,4.3,3598,3598.1,10.66,10.66,,523,ADP-ribosylation factor GTPase-activating protein 3,Golgi membrane|cytoplasm|Golgi apparatus|cytosol|membrane|,protein secretion|vesicle-mediated transport|positive regulation of GTPase activity|,GTPase activator activity|metal ion binding|,2,2,2190000000,4.3%
H9H9S8,0.917704244,0.096166667,1.274815788,0.095666667,0.745621498,0.338286822,-0.339,-0.141,0.625,0.129,-0.179,0.482,H9H9S8,NotFound,H9H9S8_NotFound,H9H9S8,Bdnf,1,3,2,2,H9H9S8|A2AII2|P21237,MOUSE,33244.5,13.8,3603,3603.1,10.61,10.61,,289,Brain-derived neurotrophic factor,cytoplasmic membrane-bounded vesicle|,"ureteric bud development|behavioral fear response|transmembrane receptor protein tyrosine kinase signaling pathway|gamma-aminobutyric acid signaling pathway|cell-cell signaling|negative regulation of neuroblast proliferation|axon guidance|axon target recognition|learning or memory|feeding behavior|neuron recognition|glutamate secretion|dendrite development|regulation of metabolic process|nerve development|negative regulation of synaptic transmission, GABAergic|positive regulation of peptidyl-serine phosphorylation|mechanoreceptor differentiation|response to drug|fear response|negative regulation of apoptotic process|regulation of neuron apoptotic process|negative regulation of neuron apoptotic process|positive regulation of neuron differentiation|regulation of retinal cell programmed cell death|regulation of synaptic plasticity|axon extension|neuron projection morphogenesis|inner ear development|positive regulation of sequence-specific DNA binding transcription factor activity|positive regulation of synapse assembly|regulation of inhibitory postsynaptic membrane potential|negative regulation of cell death|taste bud development|dendrite extension|positive regulation of glucocorticoid receptor signaling pathway|",neurotrophin TRKB receptor binding|protein binding|growth factor activity|,2,3,257000000,13.8%
Q9D1R2,0.66870111,0.059166667,5.025689671,0.215,0.314362716,1.088613335,0.073,-0.05,-0.168,0.582,0.105,-0.187,Q9D1R2,Kti12,Q9D1R2_Kti12,Q9D1R2,Kti12,1,2,2,2,Q9D1R2,MOUSE,38729.2,8.8,3605,3605.1,10.61,10.61,,351,Protein KTI12 homolog,,,ATP binding|,2,2,6970000,8.8%
Q8BTF8,0.91325,0.245833333,1.382721525,-0.131666667,0.727323881,-0.363833139,-0.16,0.425,0.67,0.926,-0.343,-0.043,Q8BTF8,Ralyl,Q8BTF8_Ralyl,Q8BTF8,Ralyl,1,2,2,2,Q8BTF8|Q8BTF8-2|A0A0A6YXQ8|E9Q5X7|F8WIA1|D3Z2Z1|Q922J3|Q922J3-2,MOUSE,32565.1,4.7,3606,3606.1,10.6,10.6,,293,RNA-binding Raly-like protein,,,nucleotide binding|identical protein binding|poly(A) RNA binding|,2,2,157000000,4.7%
E0CZ42,0.99327985,-0.090833333,0.134450643,0.006333333,0.9695159,0.039683119,0.04,0.075,-0.397,-0.041,-0.276,0.054,E0CZ42,NotFound,E0CZ42_NotFound,E0CZ42,Fer1l6,1,3,2,2,E0CZ42,MOUSE,210968.2,2.1,3608,3608.1,10.59,10.59,,1862,Fer-1-like 6 (C. elegans),integral component of membrane|,,,2,3,3290000000,2.1%
P59511,0.764377317,-0.2,3.648800552,0.276666667,0.431638272,0.837247395,0.024,0.105,-1.144,0.027,0.033,-0.245,P59511,Adamts20,P59511_Adamts20,P59511,Adamts20,1,3,2,2,P59511,MOUSE,219538.5,1.3,3609,3609.1,10.59,10.59,,1906,A disintegrin and metalloproteinase with thrombospondin motifs 20,proteinaceous extracellular matrix|extracellular space|,proteolysis|positive regulation of signal transduction|extracellular matrix organization|negative regulation of apoptotic process|positive regulation of melanocyte differentiation|regulation of developmental pigmentation|,endopeptidase activity|metalloendopeptidase activity|zinc ion binding|,2,3,110000000,1.3%
Q9CRA4,0.279272295,-0.0445,13.39375122,0.221666667,0.045774634,2.447917526,-0.124,-0.106,-0.236,0.157,-0.007,0.049,Q9CRA4,Msmo1,Q9CRA4_Msmo1,Q9CRA4,Msmo1,1,2,2,2,Q9CRA4,MOUSE,35056.9,6.4,3610,3610.1,10.59,10.59,,293,Methylsterol monooxygenase 1,endoplasmic reticulum membrane|integral component of membrane|,fatty acid biosynthetic process|sterol biosynthetic process|oxidation-reduction process|,C-4 methylsterol oxidase activity|iron ion binding|,2,2,566000000,6.4%